FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Hayden, RS
   Quinn, KP
   Alonzo, CA
   Georgakoudi, I
   Kaplan, DL
AF Hayden, Rebecca S.
   Quinn, Kyle P.
   Alonzo, Carlo A.
   Georgakoudi, Irene
   Kaplan, David L.
TI Quantitative characterization of mineralized silk film remodeling during
   long-term osteoblast-osteoclast co-culture
SO BIOMATERIALS
LA English
DT Article
DE Bone tissue engineering; Bone remodeling; Scanning electron microscopy;
   Confocal microscopy; Surface topography; Silk
ID MESENCHYMAL STEM-CELLS; OPTICAL CHARACTERIZATION; SURFACE-ROUGHNESS;
   BREAST-CANCER; IN-VIVO; BONE; MICROSCOPY; FEATURES; DIFFERENTIATION;
   BIOMATERIALS
AB The goal of this study was to explore quantitative assessments of mineralized silk protein biomaterial films by co-cultures of human mesenchymal stem cell-derived osteoblasts and human acute monocytic leukemia cell line-derived osteoclasts during long-term culture (8-32 weeks). The remodeled films were quantitatively assessed using three different techniques during this extended cultivation to provide more comprehensive insight into the impact of co-cultures On surface remodeling. Scanning electron microscopy (SEM) with three dimensional surface reconstructions was used to quantitatively determine various surface morphological features and measures of roughness indicative of remodeling by the cells. Additionally, reconstructed surfaces were converted to depth images for Fourier analysis to quantify the potential fractal organization of biomineralization. The long-term remodeled films were also imaged using confocal reflectance microscopy and micro-computed tomography (micro-CT) to further quantify morphological changes. Films remodeled in co-culture demonstrated increased roughness parameters, fractal organization, and volume compared to films remodeled by osteoblasts alone. The combination of these techniques to quantify remodeling of mineralized protein films shows promise for quantifying processes related to mineralized surfaces. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Hayden, Rebecca S.; Quinn, Kyle P.; Alonzo, Carlo A.; Georgakoudi, Irene; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Quinn, Kyle/0000-0002-6876-3608
FU NIH [P41 EB002520]; NIAMS/NIH [F32AR061933]; NIH/NIBIB [R01E13007542];
   National Science Foundation [ECS-0335765]
FX This work has been funded by NIH grant number P41 EB002520 for the
   Tissue Engineering Resource Center. Additional funding support was
   provided by grant number F32AR061933 from NIAMS/NIH and NIH/NIBIB
   R01E13007542. This work was performed in part at the Center for
   Nanoscale Systems (CNS), a member of the National Nanotechnology
   Infrastructure Network (NNIN), which is supported by the National
   Science Foundation under NSF award no. ECS-0335765. CNS is a Harvard
   University affiliate. Funding sources had no role in study design, in
   the collection, analysis and interpretation of data, in the writing of
   the report, or in the decision to submit the paper for publication.
CR Altman Greg, 2002, FASEB Journal, V16, P270
   Bellas E, 2013, TISSUE ENG PART C-ME, V19, P745, DOI [10.1089/ten.tec.2012.0620, 10.1089/ten.TEC.2012.0620]
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Brightman AO, 2000, BIOPOLYMERS, V54, P222
   Cao X, 2011, NAT MED, V17, P1344, DOI 10.1038/nm.2499
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Cuijpers VMJI, 2011, TISSUE ENG PART C-ME, V17, P663, DOI 10.1089/ten.tec.2010.0455
   Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482
   Dougherty G, 2001, MED ENG PHYS, V23, P369, DOI 10.1016/S1350-4533(01)00057-1
   Dunn AK, 1996, APPL OPTICS, V35, P3441, DOI 10.1364/AO.35.003441
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Goldstein RH, 2010, CANCER RES, V70, P10044, DOI 10.1158/0008-5472.CAN-10-1254
   Gupta S, 2008, BIOMATERIALS, V29, P2359, DOI 10.1016/j.biomaterials.2008.01.034
   Gupta S, 2009, APPL OPTICS, V48, pD45, DOI 10.1364/AO.48.000D45
   Hayden RS, 2014, ADV FUNCT MATER, V24, P472, DOI 10.1002/adfm.201302210
   Hayden RS, 2014, ACTA BIOMATER, V10, P486, DOI 10.1016/j.actbio.2013.09.028
   Heinemann C, 2011, EUR CELLS MATER, V21, P80, DOI 10.22203/eCM.v021a07
   Heinemann S, 2013, ACTA BIOMATER, V9, P4878, DOI 10.1016/j.actbio.2012.10.010
   Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Jakob F, 1997, J STEROID BIOCHEM, V61, P167
   Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005
   Kim J, 2009, ARCH PHARM RES, V32, P117, DOI 10.1007/s12272-009-1125-1
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Levitt JM, 2007, OPT LETT, V32, P3305, DOI 10.1364/OL.32.003305
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115
   Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11
   Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483
   Nehal KS, 2008, SEMIN CUTAN MED SURG, V27, P37, DOI 10.1016/j.sder.2008.01.006
   Quinn KP, 2012, BIOMATERIALS, V33, P5341, DOI 10.1016/j.biomaterials.2012.04.024
   RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215
   Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509
   Sengupta S, 2010, BIOMACROMOLECULES, V11, P3592, DOI 10.1021/bm101054q
   Sims NA, 2012, CURR OSTEOPOROS REP, V10, P109, DOI 10.1007/s11914-012-0096-1
   Stary V, 2014, J BIOMED MATER RES A, V102, P1868, DOI 10.1002/jbm.a.34833
   Sun L, 2011, BIOMATERIALS, V32, P5581, DOI 10.1016/j.biomaterials.2011.04.028
   White WM, 1999, LARYNGOSCOPE, V109, P1709, DOI 10.1097/00005537-199910000-00029
   Xylas J, 2012, OPT EXPRESS, V20, P23442, DOI 10.1364/OE.20.023442
NR 44
TC 9
Z9 9
U1 5
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2014
VL 35
IS 12
BP 3794
EP 3802
DI 10.1016/j.biomaterials.2014.01.034
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC3OS
UT WOS:000332431700009
PM 24484674
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Cairo, F
   Nieri, M
   Pagliaro, U
AF Cairo, Francesco
   Nieri, Michele
   Pagliaro, Umberto
TI Efficacy of periodontal plastic surgery procedures in the treatment of
   localized facial gingival recessions. A systematic review
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE connective tissue graft; coronally advanced flap; gingival recession;
   periodontal plastic surgery; root coverage; systematic review
ID CONNECTIVE-TISSUE GRAFT; CORONALLY ADVANCED FLAP; ACELLULAR DERMAL
   MATRIX; ROOT-COVERAGE PROCEDURES; XENOGENEIC COLLAGEN MATRIX; RANDOMIZED
   CLINICAL-TRIAL; MILLER CLASS-I; POSITIONED FLAP; BIOABSORBABLE MEMBRANE;
   FOLLOW-UP
AB BackgroundThe aim of this Systematic Review (SR) was to assess the clinical efficacy of periodontal plastic surgery procedures in the treatment of localized gingival recessions (Rec) with or without inter-dental clinical attachment loss (iCAL).
   Material and MethodsElectronic and hand searches were performed to identify randomized clinical trials (RCTs) on treatment of single gingival recessions with at least 6months of follow-up. Primary outcome variable was complete root coverage (CRC). Secondary outcome variables were recession reduction (RecRed) and keratinized tissue (KT) gain. To evaluate treatment effect, Odds Ratios were combined for dichotomous data and mean differences in continuous data using a random-effect model.
   ResultsFifty-one RCTs (53 articles) with a total of 1574 treated patients (1744 recessions) were included in this SR. Finally, 30 groups of comparisons were identified and a total of 80 meta-analyses were performed. Coronally Advanced Flap (CAF) was associated with higher probability of CRC and higher amount of RecRed than Semilunar Coronal Positioned Flap (SCPF). The combination CAF plus Connective Tissue Graft (CAF+CTG) or CAF plus Enamel Matrix Derivative (CAF+EMD) was more effective than CAF alone in terms of CRC and RecRed. The combination CAF plus Collagen Matrix (CAF+CM) achieved higher RecRed than CAF alone. In addition, CAF+CTG achieved CRC more frequently than CAF+EMD, SCPF, Free Gingival Graft (FGG) and Laterally Positioned Flap (LPS). CAF+CTG was also associated with higher RecRed than Barrier Membranes (CAF+GTR), CAF+EMD and CAF+CM. GTR was not able to improve the clinical efficacy of CAF. Studies adding Acellular Dermal Matrix (ADM) under CAF showed a large heterogeneity and not significant benefits compared with CAF alone. Multiple combinations, using more than a single graft/biomaterial under the flap, usually provide similar or less benefits than simpler, control procedures in term of root coverage outcomes.
   ConclusionsCAF procedures alone or with CTG, EMD are supported by large evidence in modern periodontal plastic surgery. CAF+CTG achieved the best clinical outcomes in single gingival recessions with or without iCAL.
C1 [Cairo, Francesco; Nieri, Michele] Univ Florence, Tuscan Sch Dent Med, Dept Periodontol & Implant Dent, Florence, Italy.
   [Cairo, Francesco; Nieri, Michele] Univ Siena, Tuscan Sch Dent Med, Dept Periodontol & Implant Dent, I-53100 Siena, Italy.
RP Cairo, F (reprint author), Via Fra Giovanni Angelico 51, I-50121 Florence, Italy.
EM cairofrancesco@virgilio.it
CR Abolfazli N, 2009, MED ORAL PATOL ORAL, V14, pE304
   Aichelmann-Reidy ME, 2001, J PERIODONTOL, V72, P998, DOI 10.1902/jop.2001.72.8.998
   Al-Hamdan K, 2003, J PERIODONTOL, V74, P1520, DOI 10.1902/jop.2003.74.10.1520
   Alkan EA, 2011, J PERIODONTAL RES, V46, P637, DOI 10.1111/j.1600-0765.2011.01381.x
   ALLEN EP, 1989, J PERIODONTOL, V60, P316, DOI 10.1902/jop.1989.60.6.316
   Alves LB, 2012, J CLIN PERIODONTOL, V39, P393, DOI 10.1111/j.1600-051X.2012.01851.x
   Amarante ES, 2000, J PERIODONTOL, V71, P989, DOI 10.1902/jop.2000.71.6.989
   [Anonymous], 2007, J EVID-BASED DENT PR, V7, P45
   Barros R. R. M., 2013, EUROPEAN J IN PRESS
   Bittencourt S, 2009, J PERIODONTOL, V80, P1076, DOI 10.1902/jop.2009.080498
   Borghetti A, 1999, J PERIODONTOL, V70, P123, DOI 10.1902/jop.1999.70.2.123
   Buti J, 2013, J CLIN PERIODONTOL, V40, P372, DOI 10.1111/jcpe.12028
   CAFFESSE RG, 1978, J PERIODONTOL, V49, P357, DOI 10.1902/jop.1978.49.7.357
   CAFFESSE RG, 1980, J PERIODONTOL, V51, P167, DOI 10.1902/jop.1980.51.3.167
   Cairo F, 2008, J CLIN PERIODONTOL, V35, P136, DOI 10.1111/j.1600-051X.2008.01267.x
   Cairo F, 2012, J CLIN PERIODONTOL, V39, P760, DOI 10.1111/j.1600-051X.2012.01903.x
   Cairo F, 2011, J CLIN PERIODONTOL, V38, P661, DOI 10.1111/j.1600-051X.2011.01732.x
   Cairo F, 2010, J PERIODONTOL, V81, P1752, DOI 10.1902/jop.2010.100278
   Cairo F, 2009, J PERIODONTOL, V80, P705, DOI 10.1902/jop.2009.080565
   Castellanos A, 2006, J PERIODONTOL, V77, P7, DOI 10.1902/jop.2006.77.1.7
   Chambrone L, 2008, J DENT, V36, P659, DOI 10.1016/j.jdent.2008.05.007
   Chambrone L, 2012, J PERIODONTOL, V83, P477, DOI 10.1902/jop.2011.110382
   Chambrone L, 2010, J PERIODONTOL, V81, P452, DOI 10.1902/jop.2010.090540
   Chambrone L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007161.pub2
   Chambrone L, 2009, J AM DENT ASSOC, V140, P294, DOI 10.14219/jada.archive.2009.0158
   Cheng YF, 2007, J PERIODONTAL RES, V42, P474, DOI 10.1111/j.1600-0765.2007.00971.x
   Clauser C, 2003, J PERIODONTOL, V74, P741, DOI 10.1902/jop.2003.74.5.741
   Cortellini P, 2009, J CLIN PERIODONTOL, V36, P68, DOI 10.1111/j.1600-051X.2008.01346.x
   Cortes AD, 2004, J PERIODONTOL, V75, P1137
   da Silva RC, 2004, J PERIODONTOL, V75, P413, DOI 10.1902/jop.2004.75.3.413
   Cortes AD, 2006, J CLIN PERIODONTOL, V33, P683, DOI 10.1111/j.1600-051X.2006.00969.x
   Del Pizzo M, 2005, J CLIN PERIODONTOL, V32, P1181, DOI 10.1111/j.1600-051X.2005.00831.x
   Dodge JR, 2000, INT J PERIODONT REST, V20, P399
   Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140
   Espinel M C, 1981, Int J Periodontics Restorative Dent, V1, P30
   FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q
   Fu Jia-Hui, 2012, J Evid Based Dent Pract, V12, P129, DOI 10.1016/S1532-3382(12)70025-8
   Gapski R, 2005, J PERIODONTOL, V76, P1814, DOI 10.1902/jop.2005.76.11.1814
   Guiha R, 2001, J PERIODONTOL, V72, P470, DOI 10.1902/jop.2001.72.4.470
   GUINARD EA, 1978, J PERIODONTOL, V49, P457, DOI 10.1902/jop.1978.49.9.457
   Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Haghighati F, 2009, INT J PERIODONT REST, V29, P179
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184
   Huang LH, 2005, J PERIODONTOL, V76, P1768, DOI 10.1902/jop.2005.76.10.1768
   Hwang D, 2006, J PERIODONTOL, V77, P1625, DOI 10.1902/jop.2006.060107
   JAHNKE PV, 1993, J PERIODONTOL, V64, P315, DOI 10.1902/jop.1993.64.4.315
   Jankovic S., 2012, INT J PERIODONT REST, V32, P41
   Jankovic Sasha, 2010, Eur J Esthet Dent, V5, P260
   Jepsen K, 1998, J PERIODONTOL, V69, P383, DOI 10.1902/jop.1998.69.3.383
   Jepsen K, 2013, J CLIN PERIODONTOL, V40, P82, DOI 10.1111/jcpe.12019
   Jhaveri HM, 2010, J PERIODONTOL, V81, P616, DOI 10.1902/jop.2009.090530
   Joly JC, 2007, J PERIODONTOL, V78, P1017, DOI 10.1902/jop.2007.060428
   Kerner S, 2009, J CLIN PERIODONTOL, V36, P80, DOI 10.1111/j.1600-051X.2008.01348.x
   Kimble KM, 2004, J PERIODONTOL, V75, P210, DOI 10.1902/jop.2004.75.2.210
   Ko H. Y., 2010, J EXPT CLIN MED, V2, P63
   Leknes KN, 2005, J CLIN PERIODONTOL, V32, P518, DOI 10.1111/j.1600-051X.2005.00706.x
   Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI 10.7326/0003-4819-151-4-200908180-00136
   Lins LHS, 2003, J PERIODONTOL, V74, P168, DOI 10.1902/jop.2003.74.2.168
   Mahajan A, 2007, J PERIODONTOL, V78, P2348, DOI 10.1902/jop.2007.070074
   McGuire MK, 2012, J PERIODONTOL, V83, P1353, DOI 10.1902/jop.2012.110373
   McGuire MK, 2010, J PERIODONTOL, V81, P1108, DOI 10.1902/jop.2010.090698
   McGuire MK, 2009, J PERIODONTOL, V80, P550, DOI 10.1902/jop.2009.080502
   McGuire MK, 2003, J PERIODONTOL, V74, P1110, DOI 10.1902/jop.2003.74.8.1110
   Miller P D Jr, 1985, Int J Periodontics Restorative Dent, V5, P8
   Miller P D Jr, 1993, Pract Periodontics Aesthet Dent, V5, P15
   Modica F, 2000, J PERIODONTOL, V71, P1693, DOI 10.1902/jop.2000.71.11.1693
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   MORMANN W, 1977, J PERIODONTOL, V48, P681
   Moslemi N, 2011, J CLIN PERIODONTOL, V38, P1122, DOI 10.1111/j.1600-051X.2011.01789.x
   Nazareth CA, 2011, J PERIODONTOL, V82, P700, DOI 10.1902/jop.2010.100434
   Nieri M, 2013, J CLIN PERIODONTOL, V40, P707, DOI 10.1111/jcpe.12114
   Oates Thomas W, 2003, Ann Periodontol, V8, P303, DOI 10.1902/annals.2003.8.1.303
   Pagliaro U, 2003, J PERIODONTOL, V74, P709, DOI 10.1902/jop.2003.74.5.709
   Paolantonio M, 1997, J CLIN PERIODONTOL, V24, P51, DOI 10.1111/j.1600-051X.1997.tb01184.x
   Paolantonio M, 2002, J PERIODONTOL, V73, P1299, DOI 10.1902/jop.2002.73.11.1299
   Paolantonio M, 2002, J PERIODONTOL, V73, P53, DOI 10.1902/jop.2002.73.1.53
   Pilloni A, 2006, J PERIODONTOL, V77, P2031, DOI 10.1902/jop.2006.050390
   Prato GP, 2011, J CLIN PERIODONTOL, V38, P715, DOI 10.1111/j.1600-051X.2011.01744.x
   Rasperini G, 2011, INT J PERIODONT REST, V31, P133
   Ricci G, 1996, INT J PERIODONT REST, V16, P539
   Roccuzzo M, 2002, J CLIN PERIODONTOL, V29, P178, DOI 10.1034/j.1600-051X.29.s3.11.x
   Romagna-Genon C, 2001, J PERIODONTOL, V72, P1258, DOI 10.1902/jop.2000.72.9.1258
   Roman A, 2013, J PERIODONTAL RES, V48, P563, DOI 10.1111/jre.12039
   Santana RB, 2010, J PERIODONTOL, V81, P485, DOI 10.1902/jop.2010.090237
   Santana RB, 2010, J CLIN PERIODONTOL, V37, P651, DOI 10.1111/j.1600-051X.2010.01582.x
   Spahr A, 2005, J PERIODONTOL, V76, P1871, DOI 10.1902/jop.2005.76.11.1871
   Tal H, 2002, J PERIODONTOL, V73, P1405, DOI 10.1902/jop.2002.73.12.1405
   Tatakis DN, 2000, J PERIODONTOL, V71, P299, DOI 10.1902/jop.2000.71.2.299
   Trabulsi M, 2004, J PERIODONTOL, V75, P1446, DOI 10.1902/jop.2004.75.11.1446
   Trombelli L, 1998, J PERIODONTOL, V69, P1271, DOI 10.1902/jop.1998.69.11.1271
   Wang HL, 2001, J PERIODONTOL, V72, P1301, DOI 10.1902/jop.2001.72.10.1301
   WENNSTROM JL, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P193
   Wilson TG, 2005, J PERIODONTOL, V76, P881, DOI 10.1902/jop.2005.76.6.881
   Woodyard JG, 2004, J PERIODONTOL, V75, P44, DOI 10.1902/jop.2004.75.1.44
   Zucchelli G, 1998, J PERIODONTOL, V69, P138, DOI 10.1902/jop.1998.69.2.138
   Zucchelli G, 2012, J CLIN PERIODONTOL, V39, P1082, DOI 10.1111/jcpe.12002
   1996, ANN PERIODONTOL, V1, P702
NR 97
TC 74
Z9 81
U1 3
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
EI 1600-051X
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD APR
PY 2014
VL 41
SU 15
SI SI
BP S44
EP S62
DI 10.1111/jcpe.12182
PG 19
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AD0WX
UT WOS:000332956100005
PM 24641000
OA Bronze
DA 2018-10-20
ER

PT J
AU Carreira, AC
   Lojudice, FH
   Halcsik, E
   Navarro, RD
   Sogayar, MC
   Granjeiro, JM
AF Carreira, A. C.
   Lojudice, F. H.
   Halcsik, E.
   Navarro, R. D.
   Sogayar, M. C.
   Granjeiro, J. M.
TI Bone Morphogenetic Proteins Facts, Challenges, and Future Perspectives
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Review
DE biomaterial(s); bioengineering; bone remodeling/regeneration; systematic
   reviews and evidence-based medicine; regenerative medicine; growth
   factor(s)
ID GROWTH-FACTOR; DENTAL IMPLANT; PERIODONTAL REGENERATION; SEGMENTAL
   DEFECTS; LUMBAR SPINE; TGF-BETA; BMP; REPAIR; DELIVERY; CELLS
AB Bone morphogenetic proteins (BMPs) are members of the TGF-beta superfamily, acting as potent regulators during embryogenesis and bone and cartilage formation and repair. Cell and molecular biology approaches have unveiled the great complexity of BMP action, later confirmed by transgenic animal studies. Genetic engineering allows for the production of large amounts of BMPs for clinical use, but they have systematically been associated with a delivery system, such as type I collagen and calcium phosphate ceramics, to ensure controlled release and to maximize their biological activity at the surgical site, avoiding systemic diffusion. Clinical orthopedic studies have shown the benefits of FDA-approved recombinant human BMPs (rhBMPs) 2 and 7, but side effects, such as swelling, seroma, and increased cancer risk, have been reported, probably due to high BMP dosage. Several studies have supported the use of BMPs in periodontal regeneration, sinus lift bone-grafting, and non-unions in oral surgery. However, the clinical use of BMPs is growing mainly in off-label applications, with robust evidence to ascertain rhBMPs' safety and efficacy through well-designed, randomized, and double-blind clinical trials. Here we review and discuss the critical data on BMP structure, mechanisms of action, and possible clinical applications.
C1 [Carreira, A. C.; Lojudice, F. H.; Halcsik, E.; Sogayar, M. C.] Univ Sao Paulo, Dept Biochem, Inst Chem, Sao Paulo, Brazil.
   [Carreira, A. C.; Lojudice, F. H.; Halcsik, E.; Sogayar, M. C.] Univ Sao Paulo, Cell & Mol Therapy Ctr NUCEL NETCEM, Sch Med, Sao Paulo, Brazil.
   [Navarro, R. D.] St Francis Hosp, Oral & Maxillofacial Surg Div, Cambe, PR, Brazil.
   [Navarro, R. D.] Univ Estadual Maringa, Post Grad Program, Dept Dent, Area Oral & Maxillofacial Surg, Maringa, Parana, Brazil.
   [Granjeiro, J. M.] Natl Inst Metrol Qual & Technol, Bioengn Div, BR-25250020 Caxias, RJ, Brazil.
   [Granjeiro, J. M.] Univ Fed Fluminense, Dept Dent Mat, Sch Dent, Niteroi, RJ, Brazil.
RP Granjeiro, JM (reprint author), Natl Inst Metrol Qual & Technol, Bioengn Div, BR-25250020 Caxias, RJ, Brazil.
EM jmgranjeiro@inmetro.gov.br
RI Carreira, Ana Claudia/B-7655-2012
OI Granjeiro, Jose/0000-0002-8027-8293
FU Brazilian Development Bank (BNDES); National Council for Scientific and
   Technological Development (CNPq); Coordination for the Improvement of
   Higher Education Personnel (CAPES); Sao Paulo Research Foundation
   (FAPESP); Rio de Janeiro State Foundation Support Research (FAPERJ);
   Research and Projects Financier (FINEP); Ministry of Science, Technology
   and Innovation (MCTI); Ministry of Health of Brazil/Department of
   Science and Technology (MS-DECIT)
FX The authors acknowledge financial support from the Brazilian Development
   Bank (BNDES), National Council for Scientific and Technological
   Development (CNPq), Coordination for the Improvement of Higher Education
   Personnel (CAPES), Sao Paulo Research Foundation (FAPESP), Rio de
   Janeiro State Foundation Support Research (FAPERJ), Research and
   Projects Financier (FINEP), Ministry of Science, Technology and
   Innovation (MCTI) and Ministry of Health of Brazil/Department of Science
   and Technology (MS-DECIT). The authors declare no potential conflicts of
   interest with respect to the authorship and/or publication of this
   article.
CR Alt V, 2009, INJURY, V40, P1269, DOI 10.1016/j.injury.2009.02.007
   Ben-David D, 2013, BIOMATERIALS, V34, P2902, DOI 10.1016/j.biomaterials.2013.01.035
   BOWERS G, 1991, J PERIODONTOL, V62, P690, DOI 10.1902/jop.1991.62.11.690
   Bustos-Valenzuela JC, 2010, MOL BIOTECHNOL, V46, P118, DOI 10.1007/s12033-010-9287-0
   Bustos-Valenzuela Juan C, 2011, BMC Res Notes, V4, P370, DOI 10.1186/1756-0500-4-370
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Cestari TM, 2009, CLIN ORAL IMPLAN RES, V20, P340, DOI 10.1111/j.1600-0501.2008.01659.x
   Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929
   Chrastil J, 2013, SPINE, V38, pE1020, DOI 10.1097/BRS.0b013e3182982f8e
   Colin C, 2008, MOL BIOTECHNOL, V39, P89, DOI 10.1007/s12033-008-9052-9
   Degat MC, 2005, PATHOL BIOL, V53, P131, DOI 10.1016/j.patbio.2004.03.004
   Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002
   Devine John G, 2012, Evid Based Spine Care J, V3, P35, DOI 10.1055/s-0031-1298616
   Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x
   Dunn CA, 2005, MOL THER, V11, P294, DOI 10.1016/j.ymthe.2004.10.005
   Garrison KR, 2010, COCHRANE DATABASE SY, V6
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193
   Giannobile WV, 1998, J PERIODONTOL, V69, P129, DOI 10.1902/jop.1998.69.2.129
   Giannoudis PV, 2009, CLIN ORTHOP RELAT R, V467, P3239, DOI 10.1007/s11999-009-0846-2
   Giannoudis PV, 2005, INJURY, V36, P47, DOI 10.1016/j.injury.2005.07.035
   Granjeiro JM, 2005, BRAZ J MED BIOL RES, V38, P1463, DOI 10.1590/S0100-879X2005001000003
   Granjeiro JM, 2010, ODONTOLOGIA CLASSE M, P109
   Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878
   Hagi TT, 2010, BONE, V46, P1322, DOI 10.1016/j.bone.2010.02.010
   Halcsik E, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-47
   Hong P, 2013, J PLAST RECONSTR AES, V66, P883, DOI 10.1016/j.bjps.2013.03.030
   Hussein KA, 2013, J ORAL MAXIL SURG, V71, P1107, DOI 10.1016/j.joms.2012.12.018
   Ishibashi O, 2010, J CELL PHYSIOL, V222, P465, DOI 10.1002/jcp.21968
   Javier AL, 2012, PLOS ONE, V7
   JOHNSON EE, 1992, CLIN ORTHOP RELAT R, V277, P229
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Lan J, 2006, J PERIODONTOL, V77, P357, DOI 10.1902/jop.2006.050016
   Leknes KN, 2008, CLIN ORAL IMPLAN RES, V19, P1027, DOI 10.1111/j.1600-0501.2008.01567.x
   Li JY, 2011, DEVELOPMENT, V138, P1977, DOI 10.1242/dev.061341
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z
   Lomelino Rde O, 2011, J MATER SCI-MATER M, V23, P781
   Lu H, 2008, BIOMATERIALS, V33, P6140
   Luo T, 2012, CLIN ORAL IMPLAN RES, V23, P467, DOI 10.1111/j.1600-0501.2011.02164.x
   Mitri F, 2012, ARTIF ORGANS, V36, P535, DOI 10.1111/j.1525-1594.2011.01409.x
   Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043
   Neovius E, 2013, J PLAST RECONSTR AES, V66, P37, DOI 10.1016/j.bjps.2012.08.015
   Oh SH, 2011, BIOMATERIALS, V32, P8254, DOI 10.1016/j.biomaterials.2011.07.027
   Onichtchouk D, 1999, NATURE, V401, P480
   Papakostidis C, 2008, SPINE, V33, pE680, DOI 10.1097/BRS.0b013e3181844eca
   Polimeni G, 2008, CLIN IMPLANT DENT R, V10, P99, DOI 10.1111/j.1708-8208.2007.00067.x
   Ritting AW, 2012, J HAND SURG-AM, V37A, P316, DOI 10.1016/j.jhsa.2011.10.007
   Ronga M, 2013, INJURY, V44, pS34, DOI 10.1016/S0020-1383(13)70008-1
   Rotenberg SA, 2011, J PERIODONTOL, V82, P1212, DOI 10.1902/jop.2011.100626
   Rutherford R B, 1992, Int J Oral Maxillofac Implants, V7, P297
   Saito A, 2009, J PERIODONTOL, V80, P961, DOI 10.1902/jop.2009.080568
   Salgado P. C., 2011, J BIOMATER NANOBIOTE, V2, P318, DOI 10.4236/jbnb.2011.23039
   Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006
   Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131
   Simion M, 2008, INT J PERIODONT REST, V28, P239
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Walsh G, 2010, DRUG DISCOV TODAY, V15, P773, DOI 10.1016/j.drudis.2010.06.009
   Wei SJ, 2012, ORTHOPEDICS, V35, pE847, DOI 10.3928/01477447-20120525-23
   Wilkinson L, 2003, J BIOL CHEM, V278, P34181, DOI 10.1074/jbc.M301247200
   Williams BJ, 2011, SPINE, V36, P1685, DOI 10.1097/BRS.0b013e318216d825
   WINN SR, 1999, CLIN ORTHOP S, V367, P95
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yang X, 2012, J BIOMED MA IN PRESS
   Zambuzzi Willian F., 2012, Braz. Dent. J., V23, P315, DOI 10.1590/S0103-64402012000400002
NR 66
TC 128
Z9 139
U1 11
U2 101
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD APR
PY 2014
VL 93
IS 4
BP 335
EP 345
DI 10.1177/0022034513518561
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AC8ZM
UT WOS:000332823600002
PM 24389809
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Wiltschka, O
   Bocking, D
   Miller, L
   Brenner, RE
   Sahlgren, C
   Linden, M
AF Wiltschka, Oliver
   Boecking, Dominique
   Miller, Larissa
   Brenner, Rolf E.
   Sahlgren, Cecilia
   Linden, Mika
TI Preparation, characterization, and preliminary biocompatibility
   evaluation of particulate spin-coated mesoporous silica films
SO MICROPOROUS AND MESOPOROUS MATERIALS
LA English
DT Article
DE Mesoporous silica nanoparticles; Films; Cell substrate; Drug release;
   Stem cells
ID ANODIC POROUS ALUMINA; THIN-FILMS; SUBSTRATE STIFFNESS; DRUG-DELIVERY;
   MIDDLE-EAR; NANOPARTICLES; MORPHOLOGY; FABRICATION; PARTICLES; SURFACES
AB Porous, biocompatible supports are interesting substrates for biological applications, as they allow for release of actives with spatial control. Here we report on the synthesis and characterization of spin-coated thin films made of mesoporous silica nanoparticles of different size and shape on microscopy slides. By controlling processing parameters like spinning-speed and particle concentration, homogeneous films can be prepared with controlled thicknesses ranging from bilayers to several multilayers. Different particle diameters and shapes can be used, thus providing further parameters for film thickness and morphology control. The use of particles in the preparation of the spin-coated films has several advantages. Relatively homogeneous thick films can be prepared in one step with thicknesses exceeding those using molecular precursor solutions. Furthermore, as the morphological properties of the surface are known to influence cell attachment, proliferation, and also differentiation of stem cells, the possibility to influence the morphology of the films is highly attractive from a biomaterial perspective. Preliminary in vitro cell studies indicate that the particles can be endocytosed by cells cultivated on these films, and that model drugs can be released inside the cells showing the potential of these films for local drug delivery applications. The results are important for further optimization of novel scaffolds exhibiting spatial, and temporal control of the delivery of active cues in, for example, tissue engineering applications. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wiltschka, Oliver; Boecking, Dominique; Miller, Larissa; Linden, Mika] Univ Ulm, Inst Inorgan Chem 2, D-89081 Ulm, Germany.
   [Sahlgren, Cecilia] Tech Univ Eindhoven, NL-5600 MB Eindhoven, Netherlands.
   [Brenner, Rolf E.] Univ Ulm, Dept Orthopaed, Div Biochem Joint & Connect Tissue Dis, D-89081 Ulm, Germany.
RP Linden, M (reprint author), Univ Ulm, Inst Inorgan Chem 2, Albert Einstein Allee 11, D-89081 Ulm, Germany.
EM mlinden@uni-ulm.de
OI , cecilia/0000-0001-6365-6275
CR Asoh H, 2001, J ELECTROCHEM SOC, V148, pB152, DOI 10.1149/1.1355686
   Boarino L, 2011, PHYS STATUS SOLIDI A, V208, P1403, DOI 10.1002/pssa.201000316
   Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.3.CO;2-I
   Chattopadhyay S, 2004, J APPL PHYS, V96, P6888, DOI 10.1063/1.1806992
   Chattopadhyay S, 2002, J APPL PHYS, V91, P6134, DOI 10.1063/1.1465123
   Crepaldi EL, 2003, J AM CHEM SOC, V125, P9770, DOI 10.1021/ja030070g
   Ehlert N, 2013, CHEM SOC REV, V42, P3847, DOI 10.1039/c3cs35359a
   Ehlert N, 2011, J MATER CHEM, V21, P752, DOI 10.1039/c0jm01487g
   Graf C, 2003, LANGMUIR, V19, P6693, DOI 10.1021/la0347859
   Hu Y, 2012, ACTA BIOMATER, V8, P439, DOI 10.1016/j.actbio.2011.10.021
   Huh S, 2003, CHEM COMMUN, P2364, DOI 10.1039/b306255d
   Jiang P, 1999, CHEM MATER, V11, P2132, DOI 10.1021/cm990080+
   Juillerat F, 2006, LANGMUIR, V22, P2249, DOI 10.1021/la052304a
   Kobler J, 2008, ACS NANO, V2, P2324, DOI 10.1021/nn800505g
   Lebold T, 2009, NANO LETT, V9, P2877, DOI 10.1021/nl9011112
   Lee JE, 2011, ACCOUNTS CHEM RES, V44, P893, DOI 10.1021/ar2000259
   Lensing R, 2013, ACTA BIOMATER, V9, P4815, DOI 10.1016/j.actbio.2012.08.016
   Lian HY, 2011, J PHYS CHEM C, V115, P6581, DOI 10.1021/jp110852p
   Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002
   Lipski AM, 2007, ADV MATER, V19, P553, DOI 10.1002/adma.200502617
   Mamaeva V, 2013, ADV DRUG DELIVER REV, V65, P689, DOI 10.1016/j.addr.2012.07.018
   Masuda H, 1997, J ELECTROCHEM SOC, V144, pL127, DOI 10.1149/1.1837634
   Masuda H, 1996, JPN J APPL PHYS 2, V35, pL126, DOI 10.1143/JJAP.35.L126
   MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466
   Masuda H., 1998, JPN J APPL PHYS, V37, pL1340, DOI DOI 10.1143/JJAP.37.L1340
   Mortera R, 2010, ADV ENG MATER, V12, pB256, DOI 10.1002/adem.200980075
   Peng XL, 2012, J BIOMECH, V45, P116, DOI 10.1016/j.jbiomech.2011.09.013
   Prosser JH, 2012, NANO LETT, V12, P5287, DOI 10.1021/nl302555k
   REHG TJ, 1992, AICHE J, V38, P489, DOI 10.1002/aic.690380403
   Rosenholm JM, 2012, NANOMEDICINE-UK, V7, P111, DOI [10.2217/NNM.11.166, 10.2217/nnm.11.166]
   Rosenholm JM, 2010, NANOSCALE, V2, P1870, DOI 10.1039/c0nr00156b
   Rosenholm JM, 2009, ACS NANO, V3, P197, DOI 10.1021/nn800781r
   Rossi L, 2011, SOFT MATTER, V7, P4139, DOI 10.1039/c0sm01246g
   Simovic S, 2011, CURR DRUG DISCOV TEC, V8, P250, DOI DOI 10.2174/157016311796799026
   Tate MP, 2010, LANGMUIR, V26, P4357, DOI 10.1021/la903443p
   Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109
   Vivero-Escoto JL, 2010, SMALL, V6, P1952, DOI 10.1002/smll.200901789
   Yang H., 2012, J COLLOID INTERF SCI, V352, P558
NR 38
TC 5
Z9 5
U1 0
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1387-1811
EI 1873-3093
J9 MICROPOR MESOPOR MAT
JI Microporous Mesoporous Mat.
PD APR
PY 2014
VL 188
BP 203
EP 209
DI 10.1016/j.micromeso.2014.01.006
PG 7
WC Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AC8WT
UT WOS:000332816500023
DA 2018-10-20
ER

PT J
AU Kajbafzadeh, AM
   Sabetkish, S
   Heidari, R
   Ebadi, M
AF Kajbafzadeh, Abdol-Mohammad
   Sabetkish, Shabnam
   Heidari, Reza
   Ebadi, Maryam
TI Tissue-engineered cholecyst-derived extracellular matrix: a biomaterial
   for in vivo autologous bladder muscular wall regeneration
SO PEDIATRIC SURGERY INTERNATIONAL
LA English
DT Article
DE Gallbladder; Bladder; Augmentation; Scaffold; Transplantation
ID SMALL-INTESTINAL SUBMUCOSA; AUGMENTATION; CELLS; AUTOAUGMENTATION;
   CYSTOPLASTY; REPLACEMENT; CANCERS; RABBIT; MODEL; GRAFT
AB To compare the biocompatibility and histological aspects of cholecyst-derived extra cellular matrix (CDECM) graft, either alone or with application of autologous detrusor muscles small fragments (ADMSF) on rabbit bladder mucosa for bladder augmentation.
   The gallbladders were acellularized and evaluated for preserved acellular matrix scaffold and biophysical properties. Thirty rabbits were divided into five groups. Rabbits in the control group underwent partial detrusorectomy followed by perivesical fat coverage. Groups I and II underwent the same procedure and bladder mucosa was covered either by acellular rabbit gallbladder (ARG) (group I) or acellular sheep gallbladder (ASG) (group II). Groups III and IV underwent detrusorectomy and the bladder mucosal was seeded by ADMSF and covered by ARG (group III), or ASG (group IV). Biopsies were taken at 4, 12, and 24 weeks postoperatively.
   Higher expression of CD34 endothelial progenitor cells, CD31 microvessels, alpha-smooth muscle actin, S100, and cytokeratin with more organized muscular wall generation was demonstrated in groups III and IV. Expression of IHC markers was higher in groups III and IV compared with groups I and II in all the time points.
   The current study confirmed that autologous fragment-seeded CDECM can be considered as a reliable natural collagen scaffold for bladder augmentation.
C1 [Kajbafzadeh, Abdol-Mohammad; Sabetkish, Shabnam; Heidari, Reza; Ebadi, Maryam] Univ Tehran Med Sci, Childrens Hosp Med Ctr, Sect Tissue Engn & Stem Cells Therapy, Pediat Urol Res Ctr, Tehran 1419433151, Iran.
RP Kajbafzadeh, AM (reprint author), Univ Tehran Med Sci, Childrens Hosp Med Ctr, Sect Tissue Engn & Stem Cells Therapy, Pediat Urol Res Ctr, 62 Dr Qaribs St,Keshavarz Blvd, Tehran 1419433151, Iran.
EM kajbafzd@sina.tums.ac.ir
CR Domingos ALA, 2012, INT BRAZ J UROL, V38, P536, DOI 10.1590/S1677-55382012000400014
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Ayyildiz A, 2008, ANZ J SURG, V78, P82, DOI 10.1111/j.1445-2197.2007.04361.x
   Brody S, 2007, BIOMATERIALS, V28, P1461, DOI 10.1016/j.biomaterials.2006.11.030
   Burugapalli K, 2007, BIOMACROMOLECULES, V8, P3439, DOI 10.1021/bm700560k
   Coburn JC, 2007, J BIOMED MATER RES A, V81A, P250, DOI 10.1002/jbm.a.30943
   Drewa T, 2006, TRANSPLANT P, V38, P133, DOI 10.1016/j.transproceed.2005.11.086
   FISHMAN IJ, 1987, J UROLOGY, V138, P1291, DOI 10.1016/S0022-5347(17)43586-5
   Greenwell TJ, 2001, BJU INT, V88, P511, DOI 10.1046/j.1464-4096.2001.001206
   Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035
   Jayo MJ, 2008, J UROLOGY, V180, P392, DOI 10.1016/j.juro.2008.02.039
   Kaefer M, 1998, J UROLOGY, V160, P2187, DOI 10.1016/S0022-5347(01)62290-0
   Kajbafzadeh A. M., 2012, TISSUE ENG PART A, V18, P882
   Kajbafzadeh AM, 2007, J SURG RES, V139, P189, DOI 10.1016/j.jss.2006.11.003
   Kajbafzadeh AM, 2011, J PEDIATR UROL, V7, P317, DOI 10.1016/j.jpurol.2011.02.014
   Kajbafzadeh AM, 2010, J UROLOGY, V183, P1168, DOI [10.1076/j.juro.2009.11.052, 10.1016/j.juro.2009.11.052]
   KAMBIC H, 1992, J UROLOGY, V148, P539, DOI 10.1016/S0022-5347(17)36649-1
   Lai JY, 2005, J PEDIATR SURG, V40, P1869, DOI 10.1016/j.jpedsurg.2005.08.028
   Miyata H, 2000, CLIN CANCER RES, V6, P4859
   Pandit A, 2009, GOOGLE PATENTS
   Perovic SV, 2002, J UROLOGY, V168, P1877, DOI 10.1097/01.ju.0000030041.09225.41
   Pope JC, 1997, J UROLOGY, V158, P1105, DOI 10.1016/S0022-5347(01)64398-2
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   Stein R, 2012, J PEDIATR UROL, V8, P145, DOI 10.1016/j.jpurol.2011.03.015
   Wongsetthachai P, 2011, RES VET SCI, V90, P156, DOI 10.1016/j.rvsc.2010.05.015
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028
NR 27
TC 12
Z9 14
U1 1
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0179-0358
EI 1437-9813
J9 PEDIATR SURG INT
JI Pediatr. Surg. Int.
PD APR
PY 2014
VL 30
IS 4
BP 371
EP 380
DI 10.1007/s00383-014-3474-1
PG 10
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA AD2GJ
UT WOS:000333052000002
PM 24468716
DA 2018-10-20
ER

PT J
AU Barua, S
   Dutta, N
   Karmakar, S
   Chattopadhyay, P
   Aidew, L
   Buragohain, AK
   Karak, N
AF Barua, Shaswat
   Dutta, Nipu
   Karmakar, Sanjeev
   Chattopadhyay, Pronobesh
   Aidew, Lipika
   Buragohain, Alak K.
   Karak, Niranjan
TI Biocompatible high performance hyperbranched epoxy/clay nanocomposite as
   an implantable material
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE hyperbranched epoxy; clay; nanocomposite; antibacterial; biomaterial
ID TISSUE ENGINEERING APPLICATIONS; SEALERS IN-VITRO; FABRICATION;
   SCAFFOLDS; TOXICITY; CLAY
AB Polymeric biomaterials are in extensive use in the domain of tissue engineering and regenerative medicine. High performance hyperbranched epoxy is projected here as a potential biomaterial for tissue regeneration. Thermosetting hyperbranched epoxy nanocomposites were prepared with Homalomena aromatica rhizome oil-modified bentonite as well as organically modified montmorillonite clay. Fourier transformed infrared spectroscopy, x-ray diffraction and scanning and transmission electron microscopic techniques confirmed the strong interfacial interaction of clay layers with the epoxy matrix. The poly(amido amine)-cured thermosetting nanocomposites exhibited high mechanical properties like impact resistance (>100 cm), scratch hardness (>10 kg), tensile strength (48-58 MPa) and elongation at break (11.9-16.6%). Cytocompatibility of the thermosets was found to be excellent as evident by MTT and red blood cell hemolytic assays. The nanocomposites exhibited antimicrobial activity against Staphylococcus aureus (ATCC 11632), Escherichia coli (ATCC 10536), Mycobacterium smegmatis (ATCC14468) and Candida albicans (ATCC 10231) strains. In vivo biocompatibility of the best performing nanocomposite was ascertained by histopathological study of the brain, heart, liver and skin after subcutaneous implantation in Wistar rats. The material supported the proliferation of dermatocytes without induction of any sign of toxicity to the above organs. The adherence and proliferation of cells endorse the nanocomposite as a non-toxic biomaterial for tissue regeneration.
C1 [Barua, Shaswat; Dutta, Nipu; Karak, Niranjan] Tezpur Univ, Dept Chem Sci, Adv Polymer & Nanomat Lab, Tezpur 784028, Assam, India.
   [Karmakar, Sanjeev; Chattopadhyay, Pronobesh] Def Res Lab, Tezpur, Assam, India.
   [Aidew, Lipika; Buragohain, Alak K.] Tezpur Univ, Dept Mol Biol Biotechnol, Tezpur 784028, Assam, India.
RP Barua, S (reprint author), Tezpur Univ, Dept Chem Sci, Adv Polymer & Nanomat Lab, Tezpur 784028, Assam, India.
EM karakniranjan@yahoo.com
RI Barua, Shaswat/A-5032-2013; Karak, Niranjan/A-1030-2014
OI Barua, Shaswat/0000-0003-0050-3698; Karak, Niranjan/0000-0002-3402-9536
FU NRB [DNRD/05/4003/NRB/251]; SAP (UGC), India [F.3-30/2009(SAP-II)]; FIST
   program (DST), India [SR/FST/CSI-203/209/1]
FX The authors express their gratitude to NRB for financial assistance
   through grant no. DNRD/05/4003/NRB/251, dated 29.02.12., SAP (UGC),
   India, through grant no. F.3-30/2009(SAP-II) and FIST program-2009
   (DST), India, through grant no. SR/FST/CSI-203/209/1, dated 06.05.2010.
   SAIF, NEHU, Shillong is acknowledged for the TEM imaging.
CR Akcya G, 1999, TURK J CHEM, V23, P105
   Banerjee S, 2013, INT J TOXICOL, V32, P308, DOI 10.1177/1091581813489996
   Barua S, 2013, RSC ADV, V3, P1
   Barua S, 2013, ADV SCI ENG MED, V5, P201
   Barua S, 2013, CHEM ENG SCI, V95, P138, DOI 10.1016/j.ces.2013.03.026
   Barua S, 2013, COLLOID SURFACE B, V105, P37, DOI 10.1016/j.colsurfb.2012.12.015
   Borgaonkar P, 2007, MACROMOL BIOSCI, V7, P201, DOI 10.1002/mabi.200600212
   Dabritz F, 2012, J POLYM SCI POL CHEM, V50, P1979, DOI 10.1002/pola.25972
   Das B., 2012, MACROMOL BIOSCI, V13, P126
   Das B, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035003
   Das G, 2009, POLYM DEGRAD STABIL, V94, P1948, DOI 10.1016/j.polymdegradstab.2009.07.028
   De B, 2013, J MATER CHEM A, V1, P348, DOI 10.1039/c2ta00011c
   Deka H, 2009, POLYM ADVAN TECHNOL, V22, P973
   Garcia-Lopez D, 2003, EUR POLYM J, V39, P945, DOI 10.1016/S0014-3057(02)00333-6
   Hosseini MS, 2011, WORLD ACAD SCI ENG T, V60, P1159
   Huang TH, 2002, BIOMATERIALS, V23, P77, DOI 10.1016/S0142-9612(01)00081-3
   Katti KS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034122
   Kiliaris P, 2013, PROG POLYM SCI, V35, P902
   Li C, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025005
   Lodiene G, 2008, INT ENDOD J, V41, P72, DOI 10.1111/j.1365-2591.2007.01321.x
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Murata H, 2004, SURF SCI, V570, P111, DOI 10.1016/j.susc.2004.06.185
   Newton SM, 2002, J ETHNOPHARMACOL, V79, P57, DOI 10.1016/S0378-8741(01)00350-6
   Oh SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014101
   Phua SL, 2012, ACS APPL MATER INTER, V4, P4571, DOI 10.1021/am300947b
   Pramanik S, 2013, RSC ADV, V3, P4574, DOI 10.1039/c3ra22557g
   Sakai R, 2013, MACROMOL MATER ENG, V298, P45, DOI 10.1002/mame.201100436
   Schiraldi C, 2004, BIOMATERIALS, V25, P3645, DOI 10.1016/j.biomaterials.2003.10.059
   Shukla A, 2003, J MACROMOL SCI PURE, VA40, P61, DOI 10.1081/MA-120016674
   Singh G, 2000, FLAVOUR FRAG J, V15, P278, DOI 10.1002/1099-1026(200007/08)15:4<278::AID-FFJ913>3.0.CO;2-L
   Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101
   Wen LEI, 2010, SOYBEAN SCI, V1, P1
NR 32
TC 13
Z9 13
U1 0
U2 44
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2014
VL 9
IS 2
AR 025006
DI 10.1088/1748-6041/9/2/025006
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB9DU
UT WOS:000332090900006
PM 24495981
DA 2018-10-20
ER

PT J
AU Hogerheyde, TA
   Suzuki, S
   Stephenson, SA
   Richardson, NA
   Chirila, TV
   Harkin, DG
   Bray, LJ
AF Hogerheyde, Thomas A.
   Suzuki, Shuko
   Stephenson, Sally A.
   Richardson, Neil A.
   Chirila, Traian V.
   Harkin, Damien G.
   Bray, Laura J.
TI Assessment of freestanding membranes prepared from Antheraea pernyi silk
   fibroin as a potential vehicle for corneal epithelial cell
   transplantation
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE corneal epithelium; corneal transplantation; silk fibroin; Bombyx mori;
   Antheraea pernyi
ID FIBROBLAST CELLS; PROTEIN FIBROIN; IN-VITRO; FILM; ATTACHMENT; GROWTH;
   BIOMATERIALS; MULBERRY; GENE; FIBRONECTIN
AB Freestanding membranes created from Bombyx mori silk fibroin (BMSF) offer a potential vehicle for corneal cell transplantation since they are transparent and support the growth of human corneal epithelial (HCE) cells. Fibroin derived from the wild silkworm Antheraea pernyi (APSF) might provide a superior material by virtue of containing putative cell-attachment sites that are absent from BMSF. Thus we have investigated the feasibility of producing transparent, freestanding membranes from APSF and have analysed the behaviour of HCE cells on this material. No significant differences in cell numbers or phenotype were observed in short term HCE cell cultures established on either fibroin. Production of transparent freestanding APSF membranes, however, proved to be problematic as cast solutions of APSF were more prone to becoming opaque, displayed significantly lower permeability and were more brittle than BMSF-membranes. Cultures of HCE cells established on either membrane developed a normal stratified morphology with cytokeratin pair 3/12 being immuno-localized to the superficial layers. We conclude that while it is feasible to produce transparent freestanding membranes from APSF, the technical difficulties associated with this biomaterial, along with an absence of enhanced cell growth, currently favour the continued development of BMSF as a preferred vehicle for corneal cell transplantation. Nevertheless, it remains possible that refinement of techniques for processing APSF might yet lead to improvements in the handling properties and performance of this material.
C1 [Hogerheyde, Thomas A.; Stephenson, Sally A.; Richardson, Neil A.; Harkin, Damien G.; Bray, Laura J.] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Brisbane, Qld 4001, Australia.
   [Hogerheyde, Thomas A.; Stephenson, Sally A.; Richardson, Neil A.; Harkin, Damien G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.
   [Hogerheyde, Thomas A.; Suzuki, Shuko; Richardson, Neil A.; Chirila, Traian V.; Harkin, Damien G.; Bray, Laura J.] Queensland Eye Inst, South Brisbane, Qld 4101, Australia.
   [Chirila, Traian V.] Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia.
   [Chirila, Traian V.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia.
   [Chirila, Traian V.] Univ Queensland, Fac Hlth Sci, Herston, Qld 4006, Australia.
   [Chirila, Traian V.] Univ Western Australia, Fac Sci, Crawley, WA 6009, Australia.
   [Bray, Laura J.] Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Saxony, Germany.
RP Hogerheyde, TA (reprint author), Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Brisbane, Qld 4001, Australia.
EM thomas.hogerheyde@qut.edu.au
RI Umlauf, Ursula/D-3356-2014
OI Harkin, Damien/0000-0002-7358-7987; Bray, Laura/0000-0002-1174-0018;
   Stephenson, Sally-Anne/0000-0003-3227-2476
FU National Health & Medical Research Council (NHampMRC), Australia; School
   of Biomedical Sciences at the Queensland University of Technology (QUT;
   Brisbane, Australia); Prevent Blindness Foundation, Queensland,
   Australia; Australia Awards
FX This work was supported in part by a grant from the National Health &
   Medical Research Council (NHampMRC), Australia (awarded to DGH and TVC)
   with supplementary funding from the School of Biomedical Sciences at the
   Queensland University of Technology (QUT; Brisbane, Australia), the
   Prevent Blindness Foundation, Queensland, Australia (supported through
   Viertel's Vision Program), and the Australia Awards (awarded to LJB). We
   are grateful to the Australian Red Cross (Brisbane, Australia) for
   irradiating our feeder cells, and to the staff from the Queensland Eye
   Bank (Brisbane, Australia) and Queensland Eye Hospital (Brisbane,
   Australia) for facilitating our access to donor human tissue. Ethical
   approval was obtained from the QUT Human Research Ethics Committee
   (approval number: 0800000807).
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Benson-Martin J, 2006, EUR J OBSTET GYN R B, V128, P103, DOI 10.1016/j.ejogrb.2005.12.011
   Bray LJ, 2013, J FUNCT BIOMATER, V4, P74, DOI 10.3390/jfb4020074
   Bray LJ, 2012, BIOMATERIALS, V33, P3529, DOI 10.1016/j.biomaterials.2012.01.045
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI 10.1089/tea.2007.0224
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   George KA, 2013, MAT SCI ENG C-MATER, V33, P668, DOI 10.1016/j.msec.2012.10.016
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Harkin D G, 2012, CLIN EXPT OPHTHALMOL, V41, P272
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Higa K, 2011, J BIOMAT SCI-POLYM E, V22, P2261, DOI 10.1163/092050610X538218
   Lawrence BD, 2012, ACTA BIOMATER, V8, P3732, DOI 10.1016/j.actbio.2012.06.009
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Leal-Egana A, 2012, J MATER CHEM, V22, P14330, DOI 10.1039/c2jm31174g
   Luan XY, 2006, BIOMED MATER, V1, P181, DOI 10.1088/1748-6041/1/4/001
   Luan XY, 2009, CELL BIOL INT, V33, P1127, DOI 10.1016/j.cellbi.2009.07.005
   Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Sezutsu H, 2000, J MOL EVOL, V51, P329, DOI 10.1007/s002390010095
   Shadforth AMA, 2012, BIOMATERIALS, V33, P4110, DOI 10.1016/j.biomaterials.2012.02.040
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Yukuhiro K, 1997, INSECT MOL BIOL, V6, P89, DOI 10.1046/j.1365-2583.1997.00161.x
NR 35
TC 9
Z9 9
U1 0
U2 21
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2014
VL 9
IS 2
AR 025016
DI 10.1088/1748-6041/9/2/025016
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB9DU
UT WOS:000332090900016
PM 24565906
DA 2018-10-20
ER

PT J
AU Kim, BS
   Kang, HJ
   Yang, SS
   Lee, J
AF Kim, Beom-Su
   Kang, Hyo Jin
   Yang, Sun-Sik
   Lee, Jun
TI Comparison of in vitro and in vivo bioactivity: cuttlefish-bone-derived
   hydroxyapatite and synthetic hydroxyapatite granules as a bone graft
   substitute
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE cuttlefish bone; bone graft substitute; hydroxyapatite; hydrothermal
   reaction
ID MESENCHYMAL STEM-CELLS; POROUS HYDROXYAPATITE; OSTEOBLASTIC CELLS;
   SURFACE-ROUGHNESS; SEPIA-OFFICINALIS; SCAFFOLDS; CEMENT;
   OSTEOCONDUCTION; DIFFERENTIATION; EXPRESSION
AB Bone reconstruction in clinical settings often requires bone substitutes. Hydroxyapatite (HAp) is a widely used bone substitute due to its osteoconductive properties and bone bonding ability. The aim of this study was to evaluate HAp granules derived from cuttlefish bone (CB-HAp) as a substitute biomaterial for bone grafts. In this study, HAp granules were prepared from raw CB by using a hydrothermal reaction. The formation of HAp from CB was confirmed by scanning electron microscopy and x-ray diffraction analysis. The bioactivity of the CB-HAp granules was evaluated both in vitro and in vivo. Our results show that CB-HAp is non-toxic and that CB-HAp granules supported improved cell adhesion, proliferation and differentiation compared to stoichiometric synthetic HAp granules. Furthermore, in vivo bone defect healing experiments show that the formation of bone with CB-HAp is higher than that with pure HAp. These results show that CB-HAp granules have excellent potential for use as a bone graft material.
C1 [Kim, Beom-Su; Yang, Sun-Sik; Lee, Jun] Wonkwang Univ, Wonkwang Bone Regenerat Res Inst, Iksan 570749, South Korea.
   [Kim, Beom-Su; Kang, Hyo Jin] Bonecell Biotech Inc, Taejon 302830, South Korea.
RP Kim, BS (reprint author), Wonkwang Univ, Wonkwang Bone Regenerat Res Inst, Iksan 570749, South Korea.
EM omslee@wku.ac.kr
FU Fishery Commercialization Technology Development Program of the Ministry
   for Food, Agriculture, Forestry, and Fisheries of the Republic of Korea
   [112092-03-2-CG000]
FX This research was supported by the Fishery Commercialization Technology
   Development Program of the Ministry for Food, Agriculture, Forestry, and
   Fisheries of the Republic of Korea (112092-03-2-CG000).
CR ACKLEY MA, 1980, BIOMATERIALS, V1, P217, DOI 10.1016/0142-9612(80)90021-6
   BIRCHALL JD, 1983, J MATER SCI, V18, P2081, DOI 10.1007/BF00555001
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Tran CT, 2011, CELL TISSUE BANK, V12, P247, DOI 10.1007/s10561-010-9208-2
   DEBRUIJN JD, 1995, J BIOMED MATER RES, V29, P89, DOI 10.1002/jbm.820290113
   Garcia-Enriquez S, 2010, J BIOMAT SCI-POLYM E, V21, P113, DOI 10.1163/156856209X410265
   GERSTENFELD LC, 1987, DEV BIOL, V122, P49, DOI 10.1016/0012-1606(87)90331-9
   Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   HEISE U, 1990, INT ORTHOP, V14, P329
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   Ivankovic H, 2010, J MATER SCI-MATER M, V21, P2711, DOI 10.1007/s10856-010-4115-4
   Ivankovic H, 2009, J MATER SCI-MATER M, V20, P1039, DOI 10.1007/s10856-008-3674-0
   Jun IK, 2007, J MATER SCI-MATER M, V18, P1071, DOI 10.1007/s10856-007-0137-y
   Kim BS, 2012, J BIOMED MATER RES A, V100A, P1673, DOI 10.1002/jbm.a.34113
   Li Z, 1999, BONE, V25, P661, DOI 10.1016/S8756-3282(99)00227-6
   Liu H, 2006, J BIOMED MATER RES A, V78A, P798, DOI 10.1002/jbm.a.30734
   Manoli F, 2000, J CRYST GROWTH, V217, P422, DOI 10.1016/S0022-0248(00)00515-7
   Miramand P, 2006, SCI TOTAL ENVIRON, V361, P132, DOI 10.1016/j.scitotenv.2005.10.018
   Mourino V, 2012, J R SOC INTERFACE, V9, P401, DOI 10.1098/rsif.2011.0611
   Park JW, 2008, J BIOMED MATER RES A, V87A, P203, DOI 10.1002/jbm.a.31768
   Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P1278, DOI 10.1111/j.1600-0501.2010.01944.x
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Rocha JHG, 2006, J BIOMED MATER RES A, V77A, P160, DOI 10.1002/jbm.a.30566
   Shirakata Y, 2002, J PERIODONTOL, V73, P1043, DOI 10.1902/jop.2002.73.9.1043
   Stanic V, 2002, BIOMATERIALS, V23, P3833, DOI 10.1016/S0142-9612(02)00119-9
   Weissenbock M, 2006, CELLS TISSUES ORGANS, V182, P79, DOI 10.1159/000093062
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 32
TC 11
Z9 11
U1 0
U2 28
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2014
VL 9
IS 2
AR 025004
DI 10.1088/1748-6041/9/2/025004
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB9DU
UT WOS:000332090900004
PM 24487123
DA 2018-10-20
ER

PT J
AU Cao, YJ
   Zhu, D
   Ngai, T
   Qin, L
   Wu, C
   Shen, J
AF Cao, Yu-jie
   Zhu, Dan
   Ngai, To
   Qin, Ling
   Wu, Chi
   Shen, Jian
TI Dielectric investigations on how Mg salt is dispersed in and released
   from polylactic acid
SO CHINESE JOURNAL OF POLYMER SCIENCE
LA English
DT Article
DE Dielectric spectroscopy; Inorganic-polymer composite; Orthopaedic
   biomaterials; Biodegradation; Bioactivity
ID PHASE-SEPARATION; COMPOSITES; CONDUCTION; SCAFFOLDS; METAL; FILMS; IONS
AB Composite biomaterials made of biodegradable polylactic acid (PLA) and bioactive magnesium (Mg) salt are developed for orthopaedic implants or metal implant coatings. The releasing of Mg salt into the biological environment benefits the bone growth, while with the releasing of Mg salt and degradation of PLA there forms a porous scaffold for tissue engineering. The size and morphology of the salt and voids are adjustable with such preparation conditions as salt content, pH of casting solution, and the solidification rate, so that we can control the salt releasing and degradation rate of PLA. Dielectric spectroscopy is used to investigate the dispersive structures of Mg salt and voids in the polymer matrix and to monitor the in situ releasing of Mg salts in the simulated body fluid (SBF). The current study provides us with an orthopedic biomaterial with controllable multi-phase structures, and a tool to investigate the in vivo behaviors of biomaterials.
C1 [Cao, Yu-jie; Zhu, Dan; Shen, Jian] Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210046, Jiangsu, Peoples R China.
   [Ngai, To; Wu, Chi] Chinese Univ Hong Kong, Dept Chem, Shatin, Hong Kong, Peoples R China.
   [Qin, Ling] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Musculoskeletal Res Lab, Shatin, Hong Kong, Peoples R China.
RP Zhu, D (reprint author), Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210046, Jiangsu, Peoples R China.
EM zhudan@njnu.edu.cn
RI Ngai, To/G-1391-2010; Qin, Ling/J-9047-2018
OI Qin, Ling/0000-0001-6173-6167
FU National Natural Scientific Foundation of China [50773077, 20934005,
   51273091]; Hong Kong Special Administration Region Earmarked Projects
   [CUHK4042/09P, 2160396]
FX This work was financially supported by the National Natural Scientific
   Foundation of China (Nos. 50773077, 20934005 and 51273091) and the Hong
   Kong Special Administration Region Earmarked Projects (CUHK4042/09P,
   2160396).
CR Achour ME, 2008, J APPL PHYS, V103, DOI 10.1063/1.2912985
   Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557
   Brosseau C, 2006, J PHYS D APPL PHYS, V39, P1277, DOI 10.1088/0022-3727/39/7/S02
   Chen Y, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025005
   DYRE JC, 1988, J APPL PHYS, V64, P2456, DOI 10.1063/1.341681
   Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018
   Haas CK, 1997, PHYS REV E, V55, P3191, DOI 10.1103/PhysRevE.55.3191
   Hanai T., 1999, HETEROGENEOUS STRUCT, P61
   Jancar J, 2010, POLYMER, V51, P3321, DOI 10.1016/j.polymer.2010.04.074
   JONSCHER AK, 1977, NATURE, V267, P673, DOI 10.1038/267673a0
   Kremer F., 2002, DIELECTRIC NEWSL APR, V4
   Lasprilla AJR, 2012, BIOTECHNOL ADV, V30, P321, DOI 10.1016/j.biotechadv.2011.06.019
   Lu HB, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336494
   McMaster L.P., 1975, COPOLYMERS POLYBLEND, V142, P43
   Mourino V, 2012, J R SOC INTERFACE, V9, P401, DOI 10.1098/rsif.2011.0611
   NAMIKAWA H, 1975, J NON-CRYST SOLIDS, V18, P173, DOI 10.1016/0022-3093(75)90019-8
   Niki Y, 2003, BIOMATERIALS, V24, P1447, DOI 10.1016/S0142-9612(02)00531-8
   Popielarz R, 2001, MACROMOLECULES, V34, P5910, DOI 10.1021/ma001576b
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Steeman P.A.M., 2003, BROADBAND DIELECTRIC, P495
   TANAKA H, 1994, PHYS REV LETT, V72, P1702, DOI 10.1103/PhysRevLett.72.1702
   Tanaka T, 2004, J MEMBRANE SCI, V238, P65, DOI 10.1016/j.memsci.2004.03.020
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Wang GC, 2010, MATERIALS, V3, P3994, DOI 10.3390/ma3073994
   Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707
   Williams G., 1998, NOVOCONTROL APPL NOT, V3, P1
   Wubbenhorst M., 2000, DIELECTRIC NEWSL NOV, P1
   Zhou H, 2012, ACTA BIOMATER, V8, P1999, DOI 10.1016/j.actbio.2012.01.031
   Zhu D, 2007, J POLYM SCI POL PHYS, V45, P1037, DOI 10.1002/polb.21115
   Zhu D, 2012, J PHYS CHEM A, V116, P2024, DOI 10.1021/jp212446n
NR 30
TC 0
Z9 0
U1 0
U2 33
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7679
EI 1439-6203
J9 CHINESE J POLYM SCI
JI Chin. J. Polym. Sci.
PD APR
PY 2014
VL 32
IS 4
BP 497
EP 508
DI 10.1007/s10118-014-1421-1
PG 12
WC Polymer Science
SC Polymer Science
GA AC4HG
UT WOS:000332481200013
DA 2018-10-20
ER

PT J
AU Prabhakaran, MP
   Mobarakeh, LG
   Kai, D
   Karbalaie, K
   Nasr-Esfahani, MH
   Ramakrishna, S
AF Prabhakaran, Molamma P.
   Mobarakeh, Laleh Ghasemi
   Kai, Dan
   Karbalaie, Khadijeh
   Nasr-Esfahani, Mohammad Hossein
   Ramakrishna, Seeram
TI Differentiation of embryonic stem cells to cardiomyocytes on electrospun
   nanofibrous substrates
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE embryoid bodies; cardiac regeneration; electrospinning; embryonic stem
   cells; collagen
ID EXTRACELLULAR-MATRIX; FIBRIN SCAFFOLDS; CULTURE; GROWTH; THERAPY; REPAIR
AB The potential of pluripotent embryonic stem cells (ESCs) isolated from the inner mass of blastocysts are investigated for its ability to differentiate on biocompatible electrospun nanofibers, for regeneration of the myocardially infracted heart. Nanostructured poly(d,l-lactide-co-glycolide)/collagen (PLGA/Col) scaffolds with fiber diameters in the range of 300 +/- 65 nm, was fabricated by electrospinning to mimic the extracellular matrix of the native tissue. During the culture of embryoid bodies outgrowth on the scaffolds, and further differentiation of ESCs to cardiomyocytes, the PLGA/Col nanofibers was found better than that of the electrospun PLGA nanofibers, where a better interaction and growth of ESC differentiated cardiomyocytes was observed on the composite scaffolds. The phenotypical characteristics of ESC-derived cardiomyocytes and molecular protein expression were carried out by scanning electron microscopy and immunocytochemistry, respectively. Our studies highlight the significance of a suitable material, its architecture, and cell-biomaterial interactions that is essential at a nanoscale level signifying the application of a bioengineered cardiac graft for stem cell differentiation and transplantation, which could be an intriguing strategy for cardiac regeneration. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 447-454, 2014.
C1 [Prabhakaran, Molamma P.; Kai, Dan; Ramakrishna, Seeram] Fac Engn, Ctr Nanofibers & Nanotechnol, Nanosci & Nanotechnol Initiat, Singapore 117576, Singapore.
   [Mobarakeh, Laleh Ghasemi] Isfahan Univ Technol, Dept Text Engn, Esfahan 8415683111, Iran.
   [Karbalaie, Khadijeh; Nasr-Esfahani, Mohammad Hossein] ACECR, Royan Inst Biotechnol, Dept Cellular Biotechnol, Cell Sci Res Ctr, Tehran, Iran.
RP Prabhakaran, MP (reprint author), Fac Engn, Ctr Nanofibers & Nanotechnol, Nanosci & Nanotechnol Initiat, E305-14, Singapore 117576, Singapore.
EM nnimpp@nus.edu.sg; mh_nasr@med.mui.ac.ir
FU NRF-Technion [R-398-001-065-592]; Nanoscience and Nanotechnology
   Initiative, Faculty of Engineering, National University of Singapore,
   Singapore, Singapore
FX Contract grant sponsor: NRF-Technion; contract grant number:
   R-398-001-065-592; Contract grant sponsor: Nanoscience and
   Nanotechnology Initiative, Faculty of Engineering, National University
   of Singapore, Singapore, Singapore.
CR ALI SAM, 1993, J BIOMED MATER RES, V27, P1409, DOI 10.1002/jbm.820271108
   Atkins BZ, 1999, J SURG RES, V85, P234, DOI 10.1006/jsre.1999.5681
   Baharvand H, 2005, J MOL CELL CARDIOL, V38, P495, DOI 10.1016/j.yjmcc.2004.12.011
   Baharvand H, 2004, IN VITRO CELL DEV-AN, V40, P76
   Balasubramanian P, 2013, ADV POLYM SCI, V251, P173, DOI 10.1007/12_2012_176
   Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Czyz J, 2001, DIFFERENTIATION, V68, P67
   Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009
   Dan K, 2010, NANO BIOMED, V2, P1
   Dimarakis I, 2006, J CARDIOTHORAC RENAL, V1, P115
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dorfman J, 1998, J THORAC CARDIOV SUR, V116, P744, DOI 10.1016/S0022-5223(98)00451-6
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fine GC, 2008, PANMINERVA MED, V50, P129
   Kadivar M, 2006, BIOCHEM BIOPH RES CO, V340, P639, DOI 10.1016/j.bbrc.2005.12.047
   Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801
   Kim S, 2007, STEM CELLS, V25, P2601, DOI 10.1634/stemcells.2006-0814
   Kwon K, 2005, BIOMACROMOLECULES, V6, P2096
   Leor J, 2000, CIRCULATION, V102, P56
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Meng ZX, 2010, MAT SCI ENG C-MATER, V30, P1204, DOI 10.1016/j.msec.2010.06.018
   Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa
   O'Connor KC, 2003, BIOTECHNOL LETT, V25, P1967, DOI 10.1023/B:BILE.0000004386.08923.ab
   O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100
   Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057
   Prabhakaran MP, 2008, NANOTECHNOLOGY, V8
   Sheridan SD, 2008, METHOD CELL BIOL, V86, P29, DOI 10.1016/S0091-679X(08)00003-4
   Smith LA, 2010, BIOMATERIALS, V31, P5526, DOI 10.1016/j.biomaterials.2010.03.065
   Stojkovic M, 2004, REPRODUCTION, V128, P259, DOI 10.1530/rep.1.00243
   Vacanti JP, 1999, LANCET S1, V354, pSi32
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
   Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Yoon BS, 2006, DIFFERENTIATION, V74, P149, DOI 10.1111/j.1432-0436.2006.00063.x
NR 37
TC 14
Z9 15
U1 0
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2014
VL 102
IS 3
BP 447
EP 454
DI 10.1002/jbm.b.33022
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC2CV
UT WOS:000332306100005
PM 24039141
DA 2018-10-20
ER

PT J
AU Bajpai, I
   Balani, K
   Basu, B
AF Bajpai, Indu
   Balani, Kantesh
   Basu, Bikramjit
TI Synergistic effect of static magnetic field and HA-Fe3O4 magnetic
   composites on viability of S. aureus and E. coli bacteria
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE static magnetic field; magnetic biocomposites; bactericidal effect
ID IRON-OXIDE NANOPARTICLES; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS;
   HYDROXYAPATITE; BIOCOMPOSITES; CELLS
AB In addressing the issue of prosthetic infection, this work demonstrated the synergistic effect of the application of static magnetic field (SMF) and ferrimagnetic substrate properties on the bactericidal property in vitro. This aspect was studied using hydroxyapatite (HA)-xFe(3)O(4) (x=10, 20, and 40 wt.%) substrates, which have different saturation magnetization properties. During bacteria culture experiments, 100 mT SMF was applied to growth medium (with HA-xFe(3)O(4) substrate) in vitro for 30, 120, and 240 min. A combination of MTT assay, membrane rupture assays, live/dead assay, and fluorescence microscopic analysis showed that the bactericidal effect of SMF increases with the exposure duration as well as increasing Fe3O4 content in biomaterial substrates. Importantly, the synergistic bactericidal effect was found to be independent of bacterial cell type, as similar qualitative trend is measured with both gram negative Escherichia coli (E. coli) and gram positive Staphylococcus aureus (S. aureus) strains. The reduction in E. coli viability was 83% higher on HA-40 Wt % Fe3O4 composite after 4 h exposure to SMF as compared to nonexposed control. Interestingly, any statistically significant difference in ROS was not observed in bacterial growth medium after magnetic field exposure, indicating the absence of ROS enhancement due to magnetic field. Overall, this study illustrates significant role being played by magnetic substrate compositions towards bactericidal property than by magnetic field exposure alone. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 524-532, 2014.
C1 [Bajpai, Indu; Balani, Kantesh] Indian Inst Technol, Dept Mat Sci & Engn, Lab Biomat, Kanpur 208016, Uttar Pradesh, India.
   [Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Bangalore 560012, Karnataka, India.
RP Basu, B (reprint author), Indian Inst Sci, Mat Res Ctr, Bangalore 560012, Karnataka, India.
EM bikram@mrc.iisc.ernet.in
OI Balani, Kantesh/0000-0003-0619-9164
FU Department of Biotechnology; Department of Science and Technology,
   Government of India
FX Contract grant sponsor: Department of Biotechnology and Department of
   Science and Technology, Government of India
CR Afzal MAF, 2013, J BIOMATER APPL, V27, P967, DOI 10.1177/0885328211431856
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Arcos D, 2002, BIOMATERIALS, V23, P2151, DOI 10.1016/S0142-9612(01)00346-5
   Bajpai I, 2013, J AM CERAM SOC, V96, P2100, DOI 10.1111/jace.12386
   Bajpai I, 2012, J BIOMED MATER RES B, V100B, P1206, DOI 10.1002/jbm.b.32685
   Binhi VN, 2001, BIOELECTROMAGNETICS, V22, P79, DOI 10.1002/1521-186X(200102)22:2<79::AID-BEM1009>3.0.CO;2-7
   El-Housseiny GS, 2010, J AM SCI, V6, P260
   Feng QL, 1998, THIN SOLID FILMS, V335, P214, DOI 10.1016/S0040-6090(98)00956-0
   Fojt L, 2004, BIOELECTROCHEMISTRY, V63, P337, DOI 10.1016/j.bioelechem.2003.11.010
   Fojt L, 2009, MICRON, V40, P918, DOI 10.1016/j.micron.2009.06.009
   Ji WJ, 2009, MICRON, V40, P894, DOI 10.1016/j.micron.2009.05.010
   Kim J, 2008, ANTIMICROB AGENTS CH, V52, P1146
   Kohno, 2000, Pathophysiology, V7, P143, DOI 10.1016/S0928-4680(00)00042-0
   Lui H, 2004, INT J FOOD MICROBIOL, V95, P147
   Maharramov AM, 2011, DIG J NANOMATER BIOS, V6, P419
   Nakahara T, 2002, RADIOLOGY, V224, P817, DOI 10.1148/radiol.2243011300
   Nath S, 2010, J MATER SCI-MATER M, V21, P1273, DOI 10.1007/s10856-009-3939-2
   Saha N, 2010, J BIOMED MATER RES B, V95B, P430, DOI 10.1002/jbm.b.31734
   She ZC, 2009, INFRARED PHYS TECHN, V52, P138, DOI 10.1016/j.infrared.2009.06.002
   Singh B, 2011, MAT SCI ENG C-MATER, V31, P1320, DOI 10.1016/j.msec.2011.04.015
   Strasak L, 2002, BIOELECTROCHEMISTRY, V55, P161, DOI 10.1016/S1567-5394(01)00152-9
   Tagai H, 1980, PREPARATION SYNTHETI
   Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518
   Tran N, 2010, INT J NANOMED, V5, P277
NR 24
TC 12
Z9 13
U1 1
U2 50
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2014
VL 102
IS 3
BP 524
EP 532
DI 10.1002/jbm.b.33031
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC2CV
UT WOS:000332306100013
PM 24142888
DA 2018-10-20
ER

PT J
AU Barros, JAG
   Filippin-Monteiro, FB
   de Oliveira, EM
   Campa, A
   Catalani, LH
   Pitombo, RDM
   Polakiewicz, B
AF Galvao Barros, Janaina Aline
   Filippin-Monteiro, Fabiola Branco
   de Oliveira, Edson Mendes
   Campa, Ana
   Catalani, Luiz Henrique
   Moraes Pitombo, Ronaldo de Nogueira
   Polakiewicz, Bronislaw
TI Cytotoxicity of PVPAC-treated bovine pericardium: A potential
   replacement for glutaraldehyde in biological heart valves
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cytotoxicity; glutaraldehyde; poly (vinylpyrrolidone-co-acrolein);
   lyophilized bioprothesis; bovine pericardium; bioprosthesis
ID IN-VITRO; CALCIFICATION; TISSUE; SCAFFOLDS; ENDOTHELIALIZATION;
   DETOXIFICATION; FIBROBLASTS; MATRIX
AB Acellular biological tissues, including bovine pericardium (BP), have been proposed as biomaterial for tissue engineering. BP is usually modified chemically to improve mechanical and biological properties using glutaraldehyde, the standard reagent for preservation of fresh bioprosthetic materials. Glutaraldehyde-fixed BP (Glut-BP), the most widely used material in heart valve manufacture, has been associated with calcification in vivo. In an attempt to reduce this issue and maintain its biocompatibility, this study assesses the physical properties and cytotoxicity of lyophilized BP treated with poly (vinylpyrrolidone-co-acrolein) (PVPAC-BP), a novel copolymer, as a substitute for glutaraldehyde. For that, PVPAC-BP surface ultrastructure, elastic function, water uptake and tissue calcification were evaluated. For the analysis of biocompatibility, fibroblasts (3T3-L1) and endothelial cells (HUVEC) were cultured on PVPAC-BP, Untreated-BP and Glut-BP. Nitric oxide (NO) release assay, fluorescence and SEM images of endothelial cells adhered on scaffolds were also performed. As results, the data show some advantages of PVPAC-BP over the Glut-BP. The PVPAC-BP maintains partially the original ultrastructure and elastic properties, improves scaffold hydration, and presents less calcium phosphate deposits. The cells demonstrated strong attachment, high proliferation rate, and formation of a monolayer on PVPAC-BP. Attached cells were also able to release NO de-monstrating regular metabolism. In conclusion, PVPAC may be considered as a promising alternative to BP treatment improving the efficiency of cell attachment and proliferation and also avoid immunogenicity. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 574-582, 2014.
C1 [Galvao Barros, Janaina Aline; Filippin-Monteiro, Fabiola Branco; de Oliveira, Edson Mendes; Campa, Ana; Moraes Pitombo, Ronaldo de Nogueira; Polakiewicz, Bronislaw] Univ Sao Paulo, Fac Pharmaceut Sci, Sao Paulo, Brazil.
   [Galvao Barros, Janaina Aline; Catalani, Luiz Henrique] Univ Sao Paulo, Inst Chem, Sao Paulo, Brazil.
RP Filippin-Monteiro, FB (reprint author), Univ Sao Paulo, Fac Pharmaceut Sci, 580 BL17, Sao Paulo, Brazil.
EM filippinmonteiro@gmail.com
RI Institute of Chemistry - USP, Dept. of Chemistry/B-8988-2012; Catalani,
   Luiz/E-2841-2010; Campa, Ana/D-4669-2012; Filippin Monteiro,
   Fabiola/D-6509-2018; de Oliveira, Edson/C-9885-2014
OI Catalani, Luiz/0000-0003-3689-1792; Campa, Ana/0000-0002-6183-3378;
   Filippin Monteiro, Fabiola/0000-0003-4313-1783; de Oliveira,
   Edson/0000-0002-7330-7826; Filippin-Monteiro, Fabiola
   Branco/0000-0002-0826-2692
FU FAPESP; CAPES
FX Contract grant sponsors: FAPESP; CAPES
CR Abolhoda A, 1996, ANN THORAC SURG, V62, P169, DOI 10.1016/0003-4975(96)00277-9
   Aravind S, 1998, J BIOMATER APPL, V13, P158
   Barros JAG, 2011, MAT SCI APPL, V2, P12
   BEAUCHAMP RO, 1992, CRIT REV TOXICOL, V22, P143, DOI 10.3109/10408449209145322
   Borgognoni CF, 2010, J APPL BIOMATER BIOM, V8, P186, DOI 10.5301/JABB.2010.6104
   Burrows MC, 2012, MACROMOL BIOSCI, V12, P1660, DOI 10.1002/mabi.201200154
   Chen YM, 2011, CHINESE J POLYM SCI, V29, P23, DOI 10.1007/s10118-010-1021-7
   Ginty PJ, 2008, EUR J PHARM BIOPHARM, V68, P82, DOI 10.1016/j.ejpb.2007.05.023
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   Grases F, 2008, CARDIOVASC PATHOL, V17, P139, DOI 10.1016/j.carpath.2007.08.005
   Guldner NW, 2009, CIRCULATION, V119, P1653, DOI 10.1161/CIRCULATIONAHA.108.823948
   Hafeez Y M, 2004, Med J Malaysia, V59 Suppl B, P117
   Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Kim BW, 2007, SURGERY, V141, P832, DOI 10.1016/j.surg.2007.01.034
   Kim HJ, 2007, BIOMED MATER, V2, pS111, DOI 10.1088/1748-6041/2/3/S05
   Kim KM, 1999, AM J PATHOL, V154, P843, DOI 10.1016/S0002-9440(10)65331-X
   Lee C, 2011, EUR J CARDIO-THORAC, V39, P381, DOI 10.1016/j.ejcts.2010.07.015
   Lee WK, 2000, BIOMATERIALS, V21, P2323, DOI 10.1016/S0142-9612(00)00159-9
   Leirner AA, 2001, ARTIF ORGANS, V25, P907, DOI 10.1046/j.1525-1594.2001.06905.x
   Lichtenberg A, 2006, J HEART VALVE DIS, V15, P287
   Maizato MJS, 2011, ARTIF ORGANS, V35, P490, DOI 10.1111/j.1525-1594.2011.01261.x
   Maizato MJS, 2003, ARTIF ORGANS, V27, P692, DOI 10.1046/j.1525-1594.2003.07275.x
   Mavrilas D, 2004, J MATER SCI-MATER M, V15, P699, DOI 10.1023/B:JMSM.0000030212.55320.c2
   do Amaral JJM, 2010, REV BRAS CIR CARDIOV, V25, P543, DOI 10.1590/S0102-76382010000400019
   Nogueira GM, 2010, MAT SCI ENG C-MATER, V30, P575, DOI 10.1016/j.msec.2010.02.011
   Oswal D, 2007, J HEART VALVE DIS, V16, P165
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Quesada A, 2002, EUR J ENDOCRINOL, V147, P117, DOI 10.1530/eje.0.1470117
   Quintero LJ, 1998, J HEART VALVE DIS, V7, P262
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Rodriguez KJ, 2009, J BIOMED MATER RES A, V90A, P1043, DOI 10.1002/jbm.a.32187
   Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015
   Shen M, 2001, ANN THORAC SURG, V71, pS408, DOI 10.1016/S0003-4975(01)02506-1
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   Stacchino C, 1998, J HEART VALVE DIS, V7, P190
   Sun M, 2009, J MATER SCI-MATER M, V20, P1743, DOI 10.1007/s10856-009-3739-8
   Sung H W, 1993, ASAIO J, V39, pM532
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20
   Vasudev SC, 1997, ARTIF ORGANS, V21, P1007
   Vasudev SC, 1999, J MATER SCI-MATER M, V10, P121, DOI 10.1023/A:1008925204988
   Wang J, 2010, ACTA BIOMATER, V6, P3004, DOI 10.1016/j.actbio.2010.01.045
   Wong ML, 2011, BIOMATERIALS, V32, P8129, DOI 10.1016/j.biomaterials.2011.07.030
   Yang CY, 2010, EUR CELLS MATER, V20, P415
NR 45
TC 4
Z9 7
U1 3
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2014
VL 102
IS 3
BP 574
EP 582
DI 10.1002/jbm.b.33036
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC2CV
UT WOS:000332306100018
PM 24123957
DA 2018-10-20
ER

PT J
AU Uhm, SH
   Song, DH
   Kwon, JS
   Lee, SB
   Han, JG
   Kim, KN
AF Uhm, Soo-Hyuk
   Song, Doo-Hoon
   Kwon, Jae-Sung
   Lee, Sang-Bae
   Han, Jeon-Geon
   Kim, Kyoung-Nam
TI Tailoring of antibacterial Ag nanostructures on TiO2 nanotube layers by
   magnetron sputtering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE magnetron sputtering; titanium dioxide; nanotube; antibacterial activity
ID PLASMA ELECTROLYTIC OXIDATION; NANOCOMPOSITE THIN-FILMS; TITANIUM-OXIDE
   NANOTUBES; SILVER NANOPARTICLES; SURFACE-ROUGHNESS; MULTICOLOR
   PHOTOCHROMISM; PHOTOELECTROCHEMICAL PROPERTIES; MC3T3-E1 PREOSTEOBLAST;
   MAGNESIUM ALLOYS; GENE-EXPRESSION
AB To reduce the incidence of postsurgical bacterial infection that may cause implantation failure at the implant-bone interface, surface treatment of titanium implants with antibiotic materials such as silver (Ag) has been proposed. The purpose of this work was to create TiO2 nanotubes using plasma electrolytic oxidation (PEO), followed by formation of an antibacterial Ag nanostructure coating on the TiO2 nanotube layer using a magnetron sputtering system. PEO was performed on commercially pure Ti sheets. The Ag nanostructure was added onto the resulting TiO2 nanotube using magnetron sputtering at varying deposition rates. Field emission scanning electron microscopy and transmission electron microscopy were used to characterize the surface, and Ag content on the TiO2 nanotube layer was analyzed by X-ray diffraction and X-ray photoelectron spectroscopy. Scanning probe microscopy for surface roughness and contact angle measurement were used to indirectly confirm enhanced TiO2 nanotube hydrophilicity. Antibacterial activity of Ag ions in solution was determined by inductively coupled plasma mass spectrometry and antibacterial testing against Staphylococcus aureus (S. aureus). In vitro, TiO2 nanotubes coated with sputtered Ag resulted in significantly reduced S. aureus. Cell viability assays showed no toxicity for the lowest sputtering time group in the osteoblastic cell line MC3T3-E1. These results suggest that a multinanostructured layer with a biocompatible TiO2 nanotube and antimicrobial Ag coating is a promising biomaterial that can be tailored with magnetron sputtering for optimal performance. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 592-603, 2014.
C1 [Uhm, Soo-Hyuk; Song, Doo-Hoon; Kwon, Jae-Sung; Lee, Sang-Bae; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, Seoul 120752, South Korea.
   [Uhm, Soo-Hyuk; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Brain Korea PLUS Project 21, Seoul 120752, South Korea.
   [Han, Jeon-Geon] Sungkyunkwan Univ, Ctr Adv Plasma Surface Technol, NU SKKU Joint Inst Plasma Nano Mat, Suwon 440746, South Korea.
RP Kim, KN (reprint author), Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, 50 Yonsei Ro, Seoul 120752, South Korea.
EM kimkn@yuhs.ac
RI Kwon, Jae-Sung/M-5430-2018
OI Kwon, Jae-Sung/0000-0001-9803-7730
FU National Research Foundation of Korea (NRF) grant; Korea government
   (MSIP) [NRF-2010-0027963]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (NRF-2010-0027963).
CR Akhavan O, 2010, SURF COAT TECH, V204, P3676, DOI 10.1016/j.surfcoat.2010.04.048
   Akhavan O, 2009, CURR APPL PHYS, V9, P1381, DOI 10.1016/j.cap.2009.03.003
   Alarcon EI, 2012, BIOMATERIALS, V33, P4947, DOI 10.1016/j.biomaterials.2012.03.033
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   [Anonymous], 2009, 109935 ISO
   Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463
   Blawert C, 2006, ADV ENG MATER, V8, P511, DOI 10.1002/adem.200500257
   Brammer KS, 2011, ACTA BIOMATER, V7, P2697, DOI 10.1016/j.actbio.2011.02.039
   Brammer KS, 2011, ACTA BIOMATER, V7, P683, DOI 10.1016/j.actbio.2010.09.022
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Chang WT, 2013, J MATER CHEM A, V1, P1987, DOI 10.1039/c2ta00806h
   Chang WY, 2011, MICROPOR MESOPOR MAT, V145, P87, DOI 10.1016/j.micromeso.2011.04.035
   Chen M, 2003, J BIOMAT SCI-POLYM E, V14, P917, DOI 10.1163/156856203322381410
   Chen XY, 2013, SURF COAT TECH, V216, P158, DOI 10.1016/j.surfcoat.2012.11.049
   Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021
   Dale GR, 2009, J NANOSCI NANOTECHNO, V9, P4215, DOI 10.1166/jnn.2009.M35
   Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088
   Engelsman AF, 2009, ACTA BIOMATER, V5, P1905, DOI 10.1016/j.actbio.2009.01.041
   Ercan B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295102
   Ercan B, 2011, ACTA BIOMATER, V7, P3003, DOI 10.1016/j.actbio.2011.04.002
   Fang D, 2011, APPL SURF SCI, V257, P6451, DOI 10.1016/j.apsusc.2011.02.037
   Geesey GG, 2001, CURR OPIN MICROBIOL, V4, P296, DOI 10.1016/S1369-5274(00)00206-X
   Geoprincy G, 2011, DIG J NANOMATER BIOS, V6, P1557
   Goldschmidt H, 1995, ZBL BAKT-INT J MED M, V283, P215
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Han Y, 2002, SURF COAT TECH, V154, P314, DOI 10.1016/S0257-8972(02)00036-1
   He J, 2008, J MATER SCI-MATER M, V19, P3465, DOI 10.1007/s10856-008-3505-3
   Holthaus MG, 2013, J BIOMATER APPL, V27, P791, DOI 10.1177/0885328211426354
   Hwang ET, 2008, SMALL, V4, P746, DOI 10.1002/smll.200700954
   Ilie I, 2012, INT J NANOMED, V7, P3011, DOI 10.2147/IJN.S29975
   ISO, 2002, 1099312 ISO
   Jager M, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/69036
   Kawahara K, 2005, PHYS CHEM CHEM PHYS, V7, P3851, DOI 10.1039/b511489f
   Kheybari S, 2010, DARU, V18, P168
   Kim DY, 2009, ACTA BIOMATER, V5, P2196, DOI 10.1016/j.actbio.2009.02.021
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Kim KJ, 2008, J MICROBIOL BIOTECHN, V18, P1482
   Kumar A, 2008, NAT MATER, V7, P236, DOI 10.1038/nmat2099
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Le Guehennec L, 2008, ACTA BIOMATER, V4, P535, DOI 10.1016/j.actbio.2007.12.002
   Lee JS, 2013, ADV MATER, V25, P1173, DOI 10.1002/adma.201203370
   Lejeune P, 2003, TRENDS MICROBIOL, V11, P179, DOI 10.1016/S0966-842X(03)00047-7
   Li FY, 1998, CHEM MATER, V10, P2470, DOI 10.1021/cm980163a
   Li Y, 2008, BIOMATERIALS, V29, P2025, DOI 10.1016/j.biomaterials.2008.01.009
   Liang YQ, 2011, J CATAL, V278, P276, DOI 10.1016/j.jcat.2010.12.011
   Liao HB, 1997, APPL PHYS LETT, V70, P1, DOI 10.1063/1.119291
   LIEDBERG H, 1990, BRIT J UROL, V65, P379, DOI 10.1111/j.1464-410X.1990.tb14760.x
   Liu XY, 2008, BIOMED PHARMACOTHER, V62, P526, DOI 10.1016/j.biopha.2008.07.051
   Macak JM, 2008, J ELECTROANAL CHEM, V621, P254, DOI 10.1016/j.jelechem.2008.01.005
   Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Naoi K, 2005, CHEM COMMUN, P1288, DOI 10.1039/b416139d
   Naoi K, 2004, J AM CHEM SOC, V126, P3664, DOI 10.1021/ja039474z
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Ohko Y, 2003, NAT MATER, V2, P29, DOI 10.1038/nmat796
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   PETROV I, 1994, J VAC SCI TECHNOL A, V12, P2846, DOI 10.1116/1.578955
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Premchand YD, 2006, ELECTROCHEM COMMUN, V8, P1840, DOI 10.1016/j.elecom.2006.08.028
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Raffi M, 2008, J MATER SCI TECHNOL, V24, P192
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Raja KS, 2005, ELECTROCHIM ACTA, V51, P154, DOI 10.1016/j.electacta.2005.04.011
   Regiel A, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/1/015101
   ROSSNAGEL SM, 1993, APPL PHYS LETT, V63, P3285, DOI 10.1063/1.110176
   Sambhy V, 2005, ABSTR PAP AM CHEM S, V230, pU4334
   Sambhy V, 2006, J AM CHEM SOC, V128, P9798, DOI 10.1021/ja061442z
   Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509
   Smetana AB, 2008, LANGMUIR, V24, P7457, DOI 10.1021/la800091y
   Song DH, 2012, MATER RES BULL, V47, P2994, DOI 10.1016/j.materresbull.2012.04.085
   Song DH, 2011, THIN SOLID FILMS, V519, P7079, DOI 10.1016/j.tsf.2011.01.385
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song YY, 2012, MICROCHIM ACTA, V177, P129, DOI 10.1007/s00604-012-0769-6
   Toledo-Antonio JA, 2009, LANGMUIR, V25, P10195, DOI 10.1021/la9009702
   Traversa E, 2000, J SOL-GEL SCI TECHN, V19, P733, DOI 10.1023/A:1008787412057
   Traversa E, 2001, J SOL-GEL SCI TECHN, V22, P115, DOI 10.1023/A:1011276622863
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   Vandrovcova M, 2011, PHYSIOL RES, V60, P403
   Vasilev K, 2010, BIOMATERIALS, V31, P532, DOI 10.1016/j.biomaterials.2009.09.074
   Wang N, 2011, BIOMATERIALS, V32, P6900, DOI 10.1016/j.biomaterials.2011.06.023
   Wu CT, 2009, J R SOC INTERFACE, V6, P159, DOI 10.1098/rsif.2008.0274
   Xiao XF, 2008, J ALLOY COMPD, V466, P356, DOI 10.1016/j.jallcom.2007.11.032
   Xiong YQ, 2000, THIN SOLID FILMS, V375, P300, DOI 10.1016/S0040-6090(00)01253-0
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   Yerokhin AL, 2000, SURF COAT TECH, V130, P195, DOI 10.1016/S0257-8972(00)00719-2
   Yin LY, 2011, ENVIRON SCI TECHNOL, V45, P2360, DOI 10.1021/es103995x
   Yu JG, 2010, APPL CATAL B-ENVIRON, V94, P295, DOI 10.1016/j.apcatb.2009.12.003
   Yu WQ, 2010, ORAL DIS, V16, P624, DOI 10.1111/j.1601-0825.2009.01643.x
   Yu WQ, 2010, J BIOMED MATER RES A, V94A, P1012, DOI 10.1002/jbm.a.32687
   Zhao JL, 2007, J ALLOY COMPD, V434, P792, DOI 10.1016/j.jallcom.2006.08.317
   Zhao LZ, 2012, BIOMATERIALS, V33, P2629, DOI 10.1016/j.biomaterials.2011.12.024
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhao LZ, 2011, J BIOMED MATER RES A, V96A, P100, DOI 10.1002/jbm.a.32918
   Zhou Y, 2009, ADV MATER, V21, P1742, DOI 10.1002/adma.200803072
   Zuo J, 2007, MATER LETT, V61, P2632, DOI 10.1016/j.matlet.2006.10.010
NR 102
TC 22
Z9 23
U1 6
U2 151
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2014
VL 102
IS 3
BP 592
EP 603
DI 10.1002/jbm.b.33038
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC2CV
UT WOS:000332306100020
PM 24123999
DA 2018-10-20
ER

PT J
AU Kilic, B
   Omay, D
AF Kilic, Bayram
   Omay, Didem
TI In-situ deposition of zinc oxide nanowires onto UV-cured chitin
   derivatives and their antibacterial properties
SO MATERIALS SCIENCE IN SEMICONDUCTOR PROCESSING
LA English
DT Article
DE Chitin; ZnO; Nanowire; Characterization; Antibacterial
ID SENSITIZED SOLAR-CELLS; ZNO-NANOPARTICLES; PERFORMANCE; FILMS; DEVICES
AB ZnO nanowires were synthesized on UV-cured chitin film by using a hydrothermal method. Structural and optical characterization showed that one dimensional nanowires can be produced on the UV-cured chitin film. The morphological analysis indicated that nanowires structures can be obtained at about 30 nm radius and 10 mu m length. Surface morphology of the ZnO coated UV-cured chitin film was also investigated and a three-dimensional surface profile and high surface roughness were obtained. X-ray diffraction analysis of the film showed large and pure crystals of ZnO nanowires with wurtzite structure and UV-visible absorbance spectrum indicated that ZnO nanowires have 3.39 eV band-gap energy and nanostructures have very good transparency of about 80% in blue region. Also ZnO coated film was tested for its biocidal action against Gram positive Staphylococcus aureus using an agar plate method. This newly developed nano-biomaterial exhibited a strong antibacterial effect. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Kilic, Bayram] Yalova Univ, Fac Engn, Dept Energy Syst Engn, TR-77000 Yalova, Turkey.
   [Omay, Didem] Yalova Univ, Fac Engn, Dept Chem & Proc Engn, TR-77000 Yalova, Turkey.
RP Kilic, B (reprint author), Yalova Univ, Fac Engn, Dept Energy Syst Engn, TR-77000 Yalova, Turkey.
EM bayram.kilic@yalova.edu.tr
CR Abramov OV, 2009, SURF COAT TECH, V204, P718, DOI 10.1016/j.surfcoat.2009.09.030
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Baxter JB, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1861510
   Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h
   Chen DH, 2009, ADV MATER, V21, P2206, DOI 10.1002/adma.200802603
   Darder M, 2007, ADV MATER, V19, P1309, DOI 10.1002/adma.200602328
   Franklin NM, 2007, ENVIRON SCI TECHNOL, V41, P8484, DOI 10.1021/es071445r
   Fu L, 2005, ADV MATER, V17, P217, DOI 10.1002/adma.200400833
   Gao Y, 2008, TEXT RES J, V78, P60, DOI 10.1177/0040517507082332
   Gouveia I.C., 2010, INT J BIOTECHNOL, V150, P349
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Khor E, 2011, MATERIALS, V4, P1728, DOI 10.3390/ma4101728
   Kilic B, 2013, J NANOSCI NANOTECHNO, V13, P333, DOI 10.1166/jnn.2013.6921
   Lao CS, 2007, NANO LETT, V7, P1323, DOI 10.1021/nl070359m
   Liu Y, 2012, CARBOHYD POLYM, V89, P111, DOI 10.1016/j.carbpol.2012.02.058
   Makhluf S, 2005, ADV FUNCT MATER, V15, P1708, DOI 10.1002/adfm.200500029
   Reddy K.M., 2007, APPL PHYS LETT, V90
   Soga T, 2006, NANOSTRUCTURED MATERIALS FOR SOLAR ENERGY CONVERSION, P1
   Sun HK, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/39/395602
   Talebian N, 2013, J PHOTOCH PHOTOBIO B, V120, P66, DOI 10.1016/j.jphotobiol.2013.01.004
   Talebian N, 2011, APPL SURF SCI, V258, P547, DOI 10.1016/j.apsusc.2011.08.070
   Tankhiwale R, 2012, COLLOID SURFACE B, V90, P16, DOI 10.1016/j.colsurfb.2011.09.031
   Tominaga K, 2004, VACUUM, V74, P683, DOI 10.1016/j.vacuum.2004.01.042
   Tuzemen S, 2006, J APPL PHYS, V100, DOI 10.1063/1.2386926
   Wang H., 2005, J AM CHEM SOC, V127, P812
   Wu JJ, 2002, J PHYS CHEM B, V106, P9546, DOI 10.1021/jp025969j
   Yamamoto O, 2001, INT J INORG MATER, V3, P643, DOI 10.1016/S1466-6049(01)00197-0
   Zhang LL, 2010, J NANOPART RES, V12, P1625, DOI 10.1007/s11051-009-9711-1
NR 28
TC 3
Z9 3
U1 2
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-8001
EI 1873-4081
J9 MAT SCI SEMICON PROC
JI Mater. Sci. Semicond. Process
PD APR
PY 2014
VL 20
BP 35
EP 40
DI 10.1016/j.mssp.2013.12.012
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA AC3TW
UT WOS:000332445100007
DA 2018-10-20
ER

PT J
AU de Queiroz, JDF
   Leal, AMD
   Terada, M
   Agnez-Lima, LF
   Costa, I
   Pinto, NCD
   de Medeiros, SRB
AF Freires de Queiroz, Jana Dara
   de Sousa Leal, Angelica Maria
   Terada, Maysa
   Agnez-Lima, Lucymara Fassarela
   Costa, Isolda
   de Souza Pinto, Nadja Cristhina
   Batistuzzo de Medeiros, Silvia Regina
TI Surface modification by argon plasma treatment improves antioxidant
   defense ability of CHO-k1 cells on titanium surfaces
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE Biomaterial; Titanium; Plasma treatment; Oxidative stress
ID IN-VITRO EVALUATION; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; DENTAL
   IMPLANTS; BIOCOMPATIBILITY; ENZYMES; DIOXIDE; DAMAGE; ALLOY;
   OSSEOINTEGRATION
AB Titanium is one of the most used materials in implants and changes in its surface can modify the cellular functional response to better implant fixation. An argon plasma treatment generates a surface with improved mechanical proprieties without modifying its chemical composition. Oxidative stress induced by biomaterials is considered one of the major causes of implant failure and studies in this field are fundamental to evaluate the biocompatibility of a new material. Therefore, in this work, induction of oxidative stress by titanium surfaces subjected to plasma treatment (PITS) was evaluated. The viability of CHO-kl cells was higher on PITS discs. Cells grown on titanium surfaces are subjected to intracellular oxidative stress. Titanium discs subjected to the plasma treatment induced less oxidative stress than the untreated ones, which resulted in improved cellular survival. These were associated with improved cellular antioxidant response in Plasma Treated Titanium Surface (PITS). Furthermore, a decrease in protein and DNA oxidative damage was observed on cells grown on the roughed surface when compared to the smooth one. In conclusion, our data suggest that the treatment of titanium with argon plasma may improve its biocompatible, thus improving its performance as implants or as a scaffold in tissue engineering. (C) 2014 Published by Elsevier Ltd.
C1 [Freires de Queiroz, Jana Dara; de Sousa Leal, Angelica Maria; Agnez-Lima, Lucymara Fassarela; Batistuzzo de Medeiros, Silvia Regina] Univ Fed Rio Grande do Norte, CB, Dept Biol Celular & Genet, Natal, RN, Brazil.
   [Terada, Maysa; Costa, Isolda] IPEN CNEN SP, Inst Pesquisas Energet & Nucl, Sao Paulo, Brazil.
   [de Souza Pinto, Nadja Cristhina] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.
RP de Medeiros, SRB (reprint author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Biol Celular & Genet, BR-59072970 Natal, RN, Brazil.
EM sbatistu@cb.ufrn.br
RI Terada, Maysa/D-3277-2012; Souza-Pinto, Nadja/C-3462-2013; Agnez-Lima,
   Lucymara/F-9655-2012; Batistuzzo de Medeiros, Silvia/H-2117-2015
OI Terada, Maysa/0000-0002-2011-5759; Souza-Pinto,
   Nadja/0000-0003-4206-964X; Agnez-Lima, Lucymara/0000-0003-0642-3162;
   Batistuzzo de Medeiros, Silvia/0000-0003-2431-0479
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Brazil
FX Special thanks to Dr. Clodomiro Alves Junior (Department of Material
   Science - UFRN) for providing both titanium surfaces used in this study.
   We thank Deborah Alfonso Cornelio, Susana Moreira and members of my
   laboratory for rich discussions and critically reading this manuscript.
   We also thank Daniel Chaves for preparation of models presented here.
   The research was supported by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil.
CR Aikawa M, 2002, CIRCULATION, V106, P1390, DOI 10.1161/01.CIR.0000028465.52694.9B
   Alves C, 2005, SURF COAT TECH, V194, P196, DOI 10.1016/j.surfcoat.2004.10.009
   Barrilet S., 2010, TOXICOL LETT, V198, P324
   Binyamin Gary, 2006, Semin Pediatr Surg, V15, P276, DOI 10.1053/j.sempedsurg.2006.07.007
   Chiesa R, 2007, ORAL SURG ORAL MED O, V103, P745, DOI 10.1016/j.tripleo.2006.09.025
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9902
   Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2
   Freyre-Fonseca V, 2011, TOXICOL LETT, V202, P111, DOI 10.1016/j.toxlet.2011.01.025
   Fujii J, 2003, ASIAN J ANDROL, V5, P231
   Ge Y, 2011, PROTEOMICS, V11, P2406, DOI 10.1002/pmic.201000741
   Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007
   GUTTERIDGE JMC, 1985, FEBS LETT, V185, P19, DOI 10.1016/0014-5793(85)80732-8
   Husain K, 2003, MOL CELL BIOCHEM, V247, P37, DOI 10.1023/A:1024112532382
   Jiang J, 2008, BIOMATERIALS, V29, P544, DOI 10.1016/j.biomaterials.2007.10.013
   Jiang J, 2009, BIOMATERIALS, V30, P2661, DOI 10.1016/j.biomaterials.2009.01.044
   Jo J.-H., 2011, J BIOMATER APPL, V27, P469
   Kalbacova M, 2007, BIOMATERIALS, V28, P3263, DOI 10.1016/j.biomaterials.2007.02.026
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lefaix H, 2008, J MATER SCI-MATER M, V19, P1861, DOI 10.1007/s10856-007-3248-6
   Lino-dos-Santos-Franco A, 2011, TOXICOL LETT, V207, P278, DOI 10.1016/j.toxlet.2011.09.026
   Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1
   Tavares JCM, 2009, TOXICOLOGY, V262, P138, DOI 10.1016/j.tox.2009.05.020
   Meilhac O, 2000, J LIPID RES, V41, P1205
   Nygren H, 2001, COLLOID SURFACE B, V22, P87, DOI 10.1016/S0927-7765(00)00216-2
   Ozmen I, 2006, CELL BIOCHEM FUNCT, V24, P275, DOI 10.1027/cbf.1225
   Parrish AR, 1999, TOXICOL SCI, V51, P80, DOI 10.1093/toxsci/51.1.80
   Pereira VG, 2008, CLIN CHIM ACTA, V387, P75, DOI 10.1016/j.cca.2007.09.008
   Rahman Q, 1997, BIOCHEM BIOPH RES CO, V240, P669, DOI 10.1006/bbrc.1997.7373
   Ratner B D, 2001, J Dent Educ, V65, P1340
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Sa JC, 2009, SURF COAT TECH, V203, P1765, DOI 10.1016/j.surfcoat.2008.12.017
   SCHAPIRA RM, 1995, AM J RESP CELL MOL, V12, P220, DOI 10.1165/ajrcmb.12.2.7865220
   Serrano MC, 2005, BIOMATERIALS, V26, P5827, DOI 10.1016/j.biomaterials.2005.02.039
   Shukla RK, 2011, TOXICOL IN VITRO, V25, P231, DOI 10.1016/j.tiv.2010.11.008
   Simon Ziv, 2002, J Can Dent Assoc, V68, P286
   Tsaryk R, 2007, BIOMATERIALS, V28, P806, DOI 10.1016/j.biomaterials.2006.09.033
   Velasco-Ortega E, 2010, MUTAT RES-GEN TOX EN, V702, P17, DOI 10.1016/j.mrgentox.2010.06.013
   Wang RR, 1998, J PROSTHET DENT, V80, P495, DOI 10.1016/S0022-3913(98)70018-6
   Xin XZ, 2012, MATER LETT, V88, P101, DOI 10.1016/j.matlet.2012.08.032
   Yang JH, 2013, GENE, V518, P388, DOI 10.1016/j.gene.2012.12.101
NR 41
TC 2
Z9 2
U1 0
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD APR
PY 2014
VL 28
IS 3
BP 381
EP 387
DI 10.1016/j.tiv.2013.11.012
PG 7
WC Toxicology
SC Toxicology
GA AB8PZ
UT WOS:000332053800006
PM 24296152
OA Bronze
DA 2018-10-20
ER

PT J
AU Idrus, RBH
   Rameli, MAB
   Cheong, LK
   Xian, LJ
   Hui, CK
   Latiff, MB
   Bin Saim, A
AF Idrus, Ruszymah Bt Hj
   Rameli, Mohd Adha Bin P.
   Cheong, Low Kiat
   Xian, Law Jia
   Hui, Chua Kien
   Latiff, Mazlyzam Bin Abdul
   Bin Saim, Aminuddin
TI Allogeneic bilayered tissue-engineered skin promotes full-thickness
   wound healing in ovine model
SO BIOMEDICAL RESEARCH-INDIA
LA English
DT Article
DE Bilayered tissue-engineered skin; allogeneic; keratinocytes;
   fibroblasts; animal model
AB Skin injuries can be treated via grafting. However, since both autologous and allogeneic skin grafts have their own limitations, skin tissue engineering was developed as an alternative approach to promote healing. Autologous tissue-engineered skin requires a few weeks for cell culture and cannot be used for acute treatment. In this study, healing potential of allogeneic bilayered tissue-engineered skin (BTES) was evaluated in sheep. Isolated allogeneic skin cells from the sheep were cultured using a combined medium of DKSFM:F12:DMEM in the ratio 2: 1: 1 supplemented with 5% FBS. Differential trypsinization was later carried out to separate the fibroblasts and keratinocytes. The allogeneic BTES was fabricated using allogeneic fibrin as biomaterial by polymerizing the fibrin-keratinocyte layer with calcium chloride followed by fibrin-fibroblast layer. Half of the wounds were isolated with PVC rings to prevent cell migration. The wounds were treated with allogeneic BTES and silk, as control. Wounds were observed at days 7, 14 and 21 to determine the rate of re-epithelialization. After 3 weeks, the sheep were euthanized. Histological evaluation with H & E, elastin van Gieson and Masson's trichrome staining showed that allogeneic BTES treated wound healed faster compared to the control group. In conclusion, allogeneic BTES has the potential to be developed as off the shelf product for rapid treatment of full thickness wound.
C1 [Idrus, Ruszymah Bt Hj; Rameli, Mohd Adha Bin P.; Xian, Law Jia; Bin Saim, Aminuddin] Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia.
   [Idrus, Ruszymah Bt Hj; Xian, Law Jia; Hui, Chua Kien] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur 50300, Malaysia.
   [Cheong, Low Kiat] Univ Kebangsaan Malaysia, Fac Med, Lab Anim Resource Unit, Kuala Lumpur 50300, Malaysia.
   [Latiff, Mazlyzam Bin Abdul] Univ Kebangsaan Malaysia, Fac Hlth Sci, Sch Diagnost, Kuala Lumpur 50300, Malaysia.
   [Latiff, Mazlyzam Bin Abdul] Univ Kebangsaan Malaysia, Fac Hlth Sci, Sch Appl Hlth Sci, Kuala Lumpur 50300, Malaysia.
   [Bin Saim, Aminuddin] Ampang Puteri Specialist Hosp, Ear Nose & Throat Consultant Clin, Ampang, Selangor, Malaysia.
RP Idrus, RBH (reprint author), Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia.
RI Law, Jia Xian/M-9728-2017
OI Law, Jia Xian/0000-0001-9045-5145
FU  [06-02-02-0003-BTK/ER/022];  [UKM-AP-2011-26]
FX This work was financially supported by the research grant
   06-02-02-0003-BTK/ER/022 and UKM-AP-2011-26.
CR Benichou G, 2011, IMMUNOTHERAPY-UK, V3, P757, DOI [10.2217/IMT.11.2, 10.2217/imt.11.2]
   Bottcher-Haberzeth S, 2010, BURNS, V36, P450, DOI 10.1016/j.burns.2009.08.016
   Centanni JM, 2011, ANN SURG, V253, P672, DOI 10.1097/SLA.0b013e318210f3bd
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Ehrenreich M, 2006, TISSUE ENG, V12, P2407, DOI 10.1089/ten.2006.12.2407
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   Greaves NS, 2013, WOUND REPAIR REGEN
   Guerret S, 2003, WOUND REPAIR REGEN, V11, P35, DOI 10.1046/j.1524-475X.2003.11107.x
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Mazlyzam AL, 2007, BURNS, V33, P355, DOI 10.1016/j.burns.2006.08.022
   Mazlyzam A L, 2008, Med J Malaysia, V63 Suppl A, P32
   Phillips T, 2002, ARCH DERMATOL, V138, P1079, DOI 10.1001/archderm.138.8.1079
   Praveen G, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/9/095102
   Ramos-e-Silva M, 2012, CLIN DERMATOL, V30, P274, DOI 10.1016/j.clindermatol.2011.08.024
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Schurr MJ, 2012, ADV WOUND CARE, V1, P95, DOI 10.1089/wound.2011.0343
   Seet WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040978
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   THIVOLET J, 1986, ARCH DERMATOL RES, V278, P252, DOI 10.1007/BF00412936
   Wohlrab Johannes, 2007, J Dtsch Dermatol Ges, V5, P37, DOI 10.1111/j.1610-0387.2007.06073.x
   Zheng Yi-xiong, 2006, J Zhejiang Univ Sci B, V7, P817, DOI 10.1631/jzus.2006.B0817
NR 22
TC 1
Z9 1
U1 0
U2 1
PU SCIENTIFIC PUBLISHERS INDIA
PI ALIGARH
PA 87-GREATER AZAD ENCLAVE, P O QUARSI, ALIGARH, 00000, INDIA
SN 0970-938X
EI 0976-1683
J9 BIOMED RES-INDIA
JI Biomed. Res.-India
PD APR-JUN
PY 2014
VL 25
IS 2
BP 192
EP 198
PG 7
WC Engineering, Biomedical; Medicine, Research & Experimental
SC Engineering; Research & Experimental Medicine
GA V42ZN
UT WOS:000209651800001
DA 2018-10-20
ER

PT J
AU Ganguly, P
   Birch, M
AF Ganguly, Payal
   Birch, Mark
TI MAINTAINING THE STEMNESS OF MESENCHYMAL STEM CELLS IN BIOMATERIAL
   SCAFFOLDS
SO RHEUMATOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the British-Society-for-Rheumatology and
   British-Health-Professionals-in-Rheumatology
CY APR 29-MAY 01, 2014
CL Liverpool, ENGLAND
SP British Soc Rheumatol, British Hlth Profess Rheumatol
C1 [Ganguly, Payal; Birch, Mark] Newcastle Univ, Musculoskeletal Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1462-0324
EI 1462-0332
J9 RHEUMATOLOGY
JI RHEUMATOLOGY
PD APR
PY 2014
VL 53
SU 1
MA 197
BP 133
EP 133
PG 1
WC Rheumatology
SC Rheumatology
GA CV8EM
UT WOS:000364513000371
DA 2018-10-20
ER

PT J
AU Maggini, L
   Ahrens-Jensen, J
   Lo Re, G
   Raquez, JM
   Dubois, P
   Bonifazi, D
AF Maggini, Laura
   Ahrens-Jensen, Jennifer
   Lo Re, Giada
   Raquez, Jean-Marie
   Dubois, Philippe
   Bonifazi, Davide
TI Phenanthroline-functionalized MWCNTs as versatile platform for
   lanthanides complexation
SO CARBON
LA English
DT Article
ID WALLED CARBON NANOTUBES; EU-III COMPLEX; BIOCOMPATIBILITY EVALUATION;
   BIOMEDICAL APPLICATIONS; HYBRID MATERIALS; CANCER-CELLS; NANOCOMPOSITES;
   INTEGRATION; DESTRUCTION; STABILITY
AB A multiwalled carbon nanotube (MWCNT) scaffold was covalently functionalized with phenanthroline moieties capable to chelate tris Eu(III) complexes, such as Eu(III) tris(2-theonyl)-trifluoroacetonate ([EuL3]), yielding a brightly luminescent hybrid (MWCNTs-Phene center dot[EuL3]). The material was thoroughly characterized by means of TGA, XPS, TEM and steady-state UV-Vis absorption and emission investigations. These studies demonstrated both the integrity of the luminescent Eu(III)-based complex in the hybrid, as well. as its high loading. The versatility of the coordinating properties of phenanthroline allowed the anchoring of other lanthanides like Gd(III), producing functional hybrids with potential applicability as magnetic resonance agents. Finally, the developed hybrid revealed to be highly dispersible in biodegradable polymer matrices such as Poly(L-lactide) (PLLA), making it a promising luminophore for applications in biomaterial science. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Maggini, Laura; Ahrens-Jensen, Jennifer; Bonifazi, Davide] Univ Namur UNamur, Namur Res Coll NARC, B-5000 Namur, Belgium.
   [Maggini, Laura; Ahrens-Jensen, Jennifer; Bonifazi, Davide] Univ Namur UNamur, Dept Chem, B-5000 Namur, Belgium.
   [Lo Re, Giada; Raquez, Jean-Marie; Dubois, Philippe] Univ Mons, Serv Mat Polymeres & Composites, CIRMAP, B-7000 Mons, Belgium.
   [Bonifazi, Davide] Univ Trieste, INSTM UdR Trieste, Dept Chem & Pharmaceut Sci, I-34127 Trieste, Italy.
RP Bonifazi, D (reprint author), Univ Namur UNamur, Namur Res Coll NARC, Rue Bruxelles 61, B-5000 Namur, Belgium.
EM davide.bonifazi@unamur.be
RI Bonifazi, Davide/B-2718-2016; Lo Re, Giada/G-8086-2018
OI Bonifazi, Davide/0000-0001-5717-0121; Lo Re, Giada/0000-0001-8840-1172;
   Maggini, Laura/0000-0001-9434-9470; Dubois, Philippe/0000-0003-1534-1564
FU EU through the ERC Starting [GA-310651]; FRS-FNRS (FRFC) [2.4.550.09];
   "TINTIN" ARC project [09/14-023]; MIUR through the FIRB "Futuro in
   Ricerca" [RBFR10DAK6]; Science Policy Office of the Belgian Federal
   Government [PAI-6/27]
FX D.B. gratefully acknowledges the EU through the ERC Starting Grant
   "COLORLANDS" project and the FP7-NMP-2012-SMALL-6 "SACS" network
   (contract no GA-310651), the FRS-FNRS (FRFC contracts no 2.4.550.09),
   the "TINTIN" ARC project (09/14-023), the MIUR through the FIRB "Futuro
   in Ricerca" ("SUPRACARBON", contract no RBFR10DAK6). The Namur - Mons
   collaboration has been supported by the Science Policy Office of the
   Belgian Federal Government (project PAI-6/27). JMR is a Research
   Associate by the FRS-FNRS.
CR Accorsi G, 2007, ADV FUNCT MATER, V17, P2975, DOI 10.1002/adfm.200600696
   Accorsi G, 2009, CHEM SOC REV, V38, P1690, DOI 10.1039/b806408n
   Armentano I, 2011, J BIOMAT SCI-POLYM E, V22, P541, DOI 10.1163/092050610X487873
   Avouris P, 2007, NAT NANOTECHNOL, V2, P605, DOI 10.1038/nnano.2007.300
   Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727
   Bahr JL, 2001, CHEM MATER, V13, P3823, DOI 10.1021/cm0109903
   Bazin H., 2002, REV MOL BIOTECHNOL, V82, P233
   Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k
   Binnemans K, 2004, J MATER CHEM, V14, P191, DOI 10.1039/b311128h
   Bunzli JCG, 2010, CHEM REV, V110, P2729, DOI 10.1021/cr900362e
   Bunzli JCG, 2006, ACCOUNTS CHEM RES, V39, P53, DOI 10.1021/ar0400894
   Burlaka A., 2010, Experimental Oncology, V32, P48
   Cheng HM, 2001, CARBON, V39, P1447, DOI 10.1016/S0008-6223(00)00306-7
   Connally RE, 2008, ANN NY ACAD SCI, V1130, P106, DOI 10.1196/annals.1430.032
   Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640
   Divya V, 2013, DALTON T, V42, P12317, DOI 10.1039/c3dt51117k
   Divya V, 2013, J MATER CHEM C, V1, P160, DOI 10.1039/c2tc00186a
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.3.CO;2-5
   Gannon CJ, 2007, CANCER-AM CANCER SOC, V110, P2654, DOI 10.1002/cncr.23155
   GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5
   Hovinen J, 2009, BIOCONJUGATE CHEM, V20, P404, DOI 10.1021/bc800370s
   Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Kauffman DR, 2009, NAT CHEM, V1, P500, DOI [10.1038/NCHEM.323, 10.1038/nchem.323]
   Kong LB, 2009, MAT SCI ENG C-BIO S, V29, P85, DOI 10.1016/j.msec.2008.05.012
   Kostarelos K, 2009, NAT NANOTECHNOL, V4, P627, DOI 10.1038/nnano.2009.241
   Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209
   Li HR, 2002, MICROPOR MESOPOR MAT, V55, P103, DOI 10.1016/S1387-1811(02)00410-9
   Li QP, 2012, J COLLOID INTERF SCI, V380, P67, DOI 10.1016/j.jcis.2012.04.038
   Liu ZA, 2011, J MATER CHEM, V21, P586, DOI 10.1039/c0jm02020f
   Maggini L, 2011, CHEM COMMUN, V47, P1626, DOI 10.1039/c0cc02874f
   Maggini L, 2014, NANOSCALE, V6, P2887, DOI 10.1039/c3nr05876j
   Maggini L, 2013, ADV MATER, V25, P2462, DOI 10.1002/adma.201204698
   Maggini L, 2013, CHEMSUSCHEM, V6, P367, DOI 10.1002/cssc.201200413
   Maggini L, 2012, CHEM-EUR J, V18, P5889, DOI 10.1002/chem.201200237
   Maggini L, 2011, CHEMSUSCHEM, V4, P1464, DOI 10.1002/cssc.201100163
   Maggini L, 2011, CHEM-EUR J, V17, P8533, DOI 10.1002/chem.201101216
   Marega R, 2014, NEW J CHEM, V38, P22, DOI 10.1039/c3nj01008b
   Marega R, 2013, ADV FUNCT MATER, V23, P3173, DOI 10.1002/adfm.201202898
   Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988
   Mirochnik AG, 2000, POLYM SCI SER B+, V42, P271
   Mohanraj J, 2013, J PHYS CHEM LETT, V4, P767, DOI 10.1021/jz302137d
   Moon SI, 2005, MACROMOL SYMP, V224, P287, DOI 10.1002/masy.200550625
   O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631
   Ortiz-Acevedo A, 2005, J AM CHEM SOC, V127, P9512, DOI 10.1021/ja050507f
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b
   Raffa V, 2008, CARBON, V46, P1600, DOI 10.1016/j.carbon.2008.06.053
   Rao CNR, 2001, CHEMPHYSCHEM, V2, P78, DOI 10.1002/1439-7641(20010216)2:2<78::AID-CPHC78>3.0.CO;2-7
   Reddy MLP, 2013, DALTON T, V42, P15249, DOI 10.1039/c3dt52238e
   Reetz MT, 2008, CHEMBIOCHEM, V9, P552, DOI 10.1002/cbic.200700413
   SCAFF WL, 1969, J BACTERIOL, V98, P246
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Sitharaman B, 2011, CHEM COMMUN, V47, P1607, DOI 10.1039/c0cc03014g
   SOINI E, 1979, CLIN CHEM, V25, P353
   Sun S, 2006, BIOELECTROCHEMISTRY, V69, P133, DOI 10.1016/j.bioelechem.2005.11.007
   Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o
   Ventura DN, 2010, CARBON, V48, P987, DOI 10.1016/j.carbon.2009.11.016
   Wang SJ, 2013, J MATER SCI, V48, P805, DOI 10.1007/s10853-012-6799-y
   Wu HX, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/34/345701
   Xin X, 2012, CARBON, V50, P436, DOI 10.1016/j.carbon.2011.08.059
   Yan B, 2012, RSC ADV, V2, P9304, DOI 10.1039/c2ra20976d
   Zhang DH, 2006, J PHYS CHEM B, V110, P12910, DOI 10.1021/jp061628k
   Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j
   Zhao C, 2010, CHEM MATER, V22, P5718, DOI 10.1021/cm101767c
NR 65
TC 1
Z9 1
U1 3
U2 67
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0008-6223
EI 1873-3891
J9 CARBON
JI Carbon
PD APR
PY 2014
VL 70
BP 22
EP 29
DI 10.1016/j.carbon.2013.12.040
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA AB5TJ
UT WOS:000331851300002
DA 2018-10-20
ER

PT J
AU Iqbal, N
   Kadir, MRA
   Mahmood, NH
   Salim, N
   Froemming, GRA
   Balaji, HR
   Kamarul, T
AF Iqbal, Nida
   Kadir, Mohammed Rafiq Abdul
   Mahmood, Nasrul Humaimi
   Salim, Norita
   Froemming, Gabriele R. A.
   Balaji, H. R.
   Kamarul, Tunku
TI Characterization, antibacterial and in vitro compatibility of
   zinc-silver doped hydroxyapatite nanoparticles prepared through
   microwave synthesis
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Biomaterial; Bioactivity; Orthopedics; Antibacterial agent; Microwave
   synthesis
ID SUBSTITUTED HYDROXYAPATITE; TEMPERATURE; NANOPOWDERS; BIOACTIVITY;
   INFECTIONS; SURFACE; ZN
AB We investigated the possibility of enhancing hydroxyapatite (HA) bioactivity by co-substituting it with zinc and silver. Zn-Ag-HA nanoparticles were synthesized by using the microwave-assisted wet precipitation process, and their phase purity, elemental composition, morphology, and particle size were analyzed by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), and energy dispersive X-ray spectroscopy (EDX). FTIR, XRD, and EDX results showed the characteristic peaks of the Zn-Ag-HA structure, while SEM results demonstrated that the nanoparticles were of spherical shape with a particle size of 70-102 nm. Antibacterial tests of the nanoparticles revealed their antibacterial activity against Staphylococcus aureus and Escherichia colt. By using simulated body fluid (SBF), an apatite layer formation was observed at 28 days. In vitro cell adhesion assay confirmed the cell attachment of normal human osteoblast (NHOst) cells to the disc surface. MTT [(3(4, 5-dimethylthiazol-2-y1)-2, 5 diphenyhetrazolium bromide] assay indicated that the cells were viable, and the cells proliferated faster on the disks than on the control surface due to the presence of metal ions. In conclusion, the novel Zn-Ag-HA nanoparticles were found to be compatible with in vitro experiments and having potential antibacterial properties. Therefore these nanoparticles could be a promising candidate for future biomedical applications. (C) 2013 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Iqbal, Nida; Kadir, Mohammed Rafiq Abdul; Mahmood, Nasrul Humaimi] Univ Teknol Malaysia, UTM Skudai, Fac Biosci & Med Engn, Medial Implant Technol Grp MEDITEG, Johor Baharu 81310, Kagawa, Malaysia.
   [Salim, Norita; Froemming, Gabriele R. A.] UiTM Campus Sungai Buloh, Fac Med, IMMB, Selangor, Malaysia.
   [Balaji, H. R.; Kamarul, Tunku] Univ Malaya, Fac Med, Dept Orthopaed Surg, Tissue Engn Grp,NOCERAL, Kuala Lumpur 50603, Malaysia.
RP Kadir, MRA (reprint author), Univ Teknol Malaysia, UTM Skudai, Fac Biosci & Med Engn, Medial Implant Technol Grp MEDITEG, Johor Baharu 81310, Kagawa, Malaysia.
EM nidalchann6@gmail.com; rafiq@biomedical.utm.my; hbr_bala@yahoo.com
RI balaji raghavendran, hanumantha rao/B-8507-2012; Froemming,
   Gabriele/C-3274-2013; Mahmood, Nasrul Humaimi/G-7755-2016; Tunku Zainol
   Abidin, Tunku Kamarul Zaman/B-9633-2011; iqbal, nida/F-8852-2014
OI Froemming, Gabriele/0000-0002-5931-1968; Mahmood, Nasrul
   Humaimi/0000-0002-0004-7613; Tunku Zainol Abidin, Tunku Kamarul
   Zaman/0000-0002-6028-1313; iqbal, nida/0000-0002-8502-4954
FU UTM [45027]; Ministry of Higher Education (MOHE); RMC; University of
   Malaya HIR-MOHE
FX The authors would like to thank Nik Ahmad Nazim Nik Malek (Faculty of
   Biosciences and Medical Engineering, Universiti Teknologi Malaysia (UTM)
   for his support in antibacterial testing. The authors would like to
   acknowledge the Institute of Medical Molecular Biotechnology (IMMB),
   Faculty of Medicine UiTM Campus Sungai Buloh Selangor, Malaysia for
   providing cell culture facilities. The authors would like to acknowledge
   the financial support provided by UTM research Grant science funding
   (Vote: 45027), Ministry of Higher Education (MOHE) and RMC. More than
   one of the authors of this paper was supported under University of
   Malaya HIR-MOHE research grant.
CR Ann LC, 2013, APPL SURF SCI, V265, P137, DOI 10.1016/j.apsusc.2012.10.152
   Bir F, 2012, APPL SURF SCI, V258, P7021, DOI 10.1016/j.apsusc.2012.03.158
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Carsenti-Dellamonica H, 2008, ANTIBIOTIQUES, V10, P3, DOI 10.1016/j.antib.2007.12.006
   Chen X, 2012, MATER LETT, V89, P233, DOI 10.1016/j.matlet.2012.08.115
   Chung RJ, 2005, J SOL-GEL SCI TECHN, V33, P229, DOI 10.1007/s10971-005-5618-1
   Cremet L, 2012, J INFECTION, V64, P169, DOI 10.1016/j.jinf.2011.11.010
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Iqbal N, 2013, MATER RES BULL, V48, P3172, DOI 10.1016/j.materresbull.2013.04.068
   Iqbal N, 2012, MATER LETT, V89, P118, DOI 10.1016/j.matlet.2012.08.057
   Jansen WTM, 2006, DRUG RESIST UPDATE, V9, P123, DOI 10.1016/j.drup.2006.06.002
   Jenny F., 2011, DRUG RESIST UPDATE, V14, P125, DOI DOI 10.1016/J.DRUP.2011.02.001
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kumar GS, 2012, MATER CHEM PHYS, V134, P1127, DOI 10.1016/j.matchemphys.2012.04.005
   Miao SD, 2005, SURF COAT TECH, V198, P223, DOI 10.1016/j.surfcoat.2004.10.026
   Niranjan R, 2013, INT J BIOL MACROMOL, V54, P24, DOI 10.1016/j.ijbiomac.2012.11.026
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   Rameshbabu N, 2006, B MATER SCI, V29, P611, DOI 10.1007/s12034-006-0012-3
   Ravi N.D., 2009, J AM CERAM SOC, V95, P2700
   Saidin S, 2013, MAT SCI ENG C-MATER, V33, P4715, DOI 10.1016/j.msec.2013.07.026
   Samani S, 2013, J BIOMED MATER RES A, V101, P222, DOI 10.1002/jbm.a.34322
   Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002
   Stanic V, 2010, APPL SURF SCI, V256, P6083, DOI 10.1016/j.apsusc.2010.03.124
   Thian ES, 2013, J MATER SCI-MATER M, V24, P437, DOI 10.1007/s10856-012-4817-x
   Tin O.M., 2007, ARCH OROFACIAL SCI, V2, P41
   Zou ZY, 2012, ULTRASON SONOCHEM, V19, P1174, DOI 10.1016/j.ultsonch.2012.04.002
   Zreiqat H, 2010, BIOMATERIALS, V31, P3175, DOI 10.1016/j.biomaterials.2010.01.024
NR 28
TC 32
Z9 32
U1 2
U2 64
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD APR
PY 2014
VL 40
IS 3
BP 4507
EP 4513
DI 10.1016/j.ceramint.2013.08.125
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA AA3TV
UT WOS:000331017500089
DA 2018-10-20
ER

PT J
AU Fan, M
   Liao, JF
   Guo, G
   Ding, QX
   Yang, Y
   Luo, F
   Qian, ZY
AF Fan, Min
   Liao, JinFeng
   Guo, Gang
   Ding, QiuXia
   Yang, Yi
   Luo, Feng
   Qian, ZhiYong
TI Dexamethasone-Loaded Poly(D, L-lactic acid) Microspheres/Poly(ethylene
   glycol)-Poly(epsilon-caprolactone)-Poly(ethylene glycol) Micelles
   Composite for Skin Augmentation
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Microsphere; Dexamethasone; Micelles; Soft-Tissue Augmentation
ID IN-VITRO; TISSUE-RESPONSE; DRUG CARRIER; DELIVERY; MICROSPHERES; PLA;
   BIOCOMPATIBILITY; RESTORATION; NANOFIBERS; COPOLYMERS
AB Soft tissue augmentation using various injectable fillers has gained popularity as more patients seek esthetic improvement through minimally invasive procedures requiring little or no recovery time. The currently available injectable skin fillers can be divided into three categories. With careful assessment, stimulatory fillers are the most ideal fillers. In this study, dexamethasone-loaded poly(D, L-lactic acid) (PLA) microspheres of approximately 90 mu m suspended in poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) (PEG-PCL-PEG, PECE) micelles were prepared as stimulatory filler for skin augmentation. The biodegradable PECE copolymer can form nano-sized micelles in water, which instantly turns into a non-flowing gel at body temperature due to micellar aggregation. The PECE micelles (making up 90% of composite) served as vehicle for subcutaneous injection were metabolized within 44 days. At the same time, the dexamethasone-loaded PLA microspheres (10% of composite) merely served as stimulus for connective tissue formation. Dexamethasone-loaded PLA microspheres/PECE micelles composite presented great hemocompatibility in vitro. It was demonstrated in the in vivo study that the composite was biodegradable, biocompatible, nontoxic and nonmigratory. Histopathological studies indicated that the composite could stimulate collagen regeneration. Furthermore, granuloma, the main complication of the stimulatory fillers, did not appear when the composite was injected into the back of SD rats, because of the dexamethasone controlled release from the composite. All results suggested that dexamethasone-loaded PLA microspheres/PECE micelles composite may be an efficient and promising biomaterial for skin augmentation.
C1 [Fan, Min; Liao, JinFeng; Guo, Gang; Ding, QiuXia; Yang, Yi; Luo, Feng; Qian, ZhiYong] Sichuan Univ, West China Hosp, West China Med Sch, State Key Lab Biotherapy & Canc Ctr, Chengdu 610041, Peoples R China.
RP Qian, ZY (reprint author), Sichuan Univ, West China Hosp, West China Med Sch, State Key Lab Biotherapy & Canc Ctr, Chengdu 610041, Peoples R China.
EM anderson-qian@163.com
FU National Natural Science Foundation [NSFC31271021, NSFC31222023];
   National Science and Technology Major Project [2011ZX09102-001-10];
   Sichuan University [2011SCU04B18]; Chinese Key Basic Research 973
   Program [2010CB529906]
FX This work was financially supported by National Natural Science
   Foundation (NSFC31271021 and NSFC31222023), National Science and
   Technology Major Project (2011ZX09102-001-10), Distinguished young
   scholars of Sichuan University (2011SCU04B18), and Chinese Key Basic
   Research 973 Program (2010CB529906). We would like to show great thanks
   to Wang Hui (Analytical and Testing Center, Sichuan University) for her
   great help in SEM analysis.
CR Alijotas-Reig J, 2013, SEMIN ARTHRITIS RHEU, V43, P241, DOI 10.1016/j.semarthrit.2013.02.001
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Arras M, 1998, NAT BIOTECHNOL, V16, P159, DOI 10.1038/nbt0298-159
   Buyuktimkin B, 2012, MOL PHARMACEUT, V9, P979, DOI 10.1021/mp200614q
   Cao J, 2013, J BIOMED NANOTECHNOL, V9, P1847, DOI 10.1166/jbn.2013.1686
   Chen Y, 2013, J NANOSCI NANOTECHNO, V13, P2136, DOI 10.1166/jnn.2013.6903
   Deng Y, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-190
   Deng Y, 2013, NEUROCHEM RES, V38, P504, DOI 10.1007/s11064-012-0942-7
   Dijkhuizen-Radersma RV, 2002, BIOMATERIALS, V23, P4719
   DINARVAND R, 2003, AAPS PHARMSCITECH, V4
   Fan M, 2013, J BIOMATER APPL, V28, P288, DOI 10.1177/0885328212446097
   Fu SZ, 2009, J PHYS CHEM B, V113, P16518, DOI 10.1021/jp907974d
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Gong CY, 2013, J BIOMED NANOTECHNOL, V9, P1984, DOI 10.1166/jbn.2013.1754
   Gong CY, 2011, J NANOPART RES, V13, P721, DOI 10.1007/s11051-010-0071-7
   Gong CY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/21/215103
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   Guo G, 2011, J NANOSCI NANOTECHNO, V11, P4923, DOI 10.1166/jnn.2011.4119
   Hamilton TK, 2007, DERMATOL THER, V20, pS5, DOI 10.1111/j.1529-8019.2007.00100.x
   Ji XY, 2013, J BIOMED NANOTECHNOL, V9, P1672, DOI 10.1166/jbn.2013.1665
   Ji XY, 2013, J BIOMED NANOTECHNOL, V9, P417, DOI 10.1166/jbn.2013.1556
   Jin L, 2012, J BIOMED NANOTECHNOL, V8, P779, DOI 10.1166/jbn.2012.1443
   Kim TH, 2013, J NANOSCI NANOTECHNO, V13, P7325, DOI 10.1166/jnn.2013.8084
   Ladewig K, 2012, J BIOMATER TISS ENG, V2, P1, DOI 10.1166/jbt.2012.1028
   Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700
   Lee J, 2013, J NANOSCI NANOTECHNO, V13, P6983, DOI 10.1166/jnn.2013.7747
   Lee JB, 2013, J BIOMED NANOTECHNOL, V9, P424, DOI 10.1166/jbn.2013.1514
   Lemperle G, 2006, PLAST RECONSTR SURG, V118, p92S, DOI 10.1097/01.prs.0000234672.69287.77
   Li JM, 2012, J BIOMED NANOTECHNOL, V8, P809, DOI 10.1166/jbn.2012.1433
   Luo JC, 2011, BIOMATERIALS, V32, P706, DOI 10.1016/j.biomaterials.2010.09.017
   Nicolau PJ, 2007, PLAST RECONSTR SURG, V119, P2271, DOI 10.1097/01.prs.0000260710.30934.a1
   Park TG, 2006, INT J PHARM, V326, P169, DOI 10.1016/j.ijpharm.2006.06.041
   Peach MS, 2012, J BIOMED NANOTECHNOL, V8, P107, DOI 10.1166/jbn.2012.1368
   Ran Y, 2013, J NANOSCI NANOTECHNO, V13, P3004, DOI 10.1166/jnn.2013.7336
   Rudolph CM, 1999, AM J SURG PATHOL, V23, P113, DOI 10.1097/00000478-199901000-00013
   Schierle CF, 2011, AESTHET SURG J, V31, P95, DOI 10.1177/1090820X10391213
   Shalumon KT, 2012, J BIOMED NANOTECHNOL, V8, P405, DOI 10.1166/jbn.2012.1395
   Swaminathan S, 2013, J BIOMED NANOTECHNOL, V9, P998, DOI 10.1166/jbn.2013.1594
   The American Society for Aesthetic Plastic Surgery, 2011, 15 ANN COSM SURG NAT
   Valantin MA, 2003, AIDS, V17, P2471, DOI 10.1097/00002030-200311210-00009
   Victor S. P., 2013, J NANOPHARM DRUG DEL, V1, P193
   Xue BX, 2012, J BIOMED NANOTECHNOL, V8, P80, DOI 10.1166/jbn.2012.1358
   Yang C, 2013, J NANOSCI NANOTECHNO, V13, P6553, DOI 10.1166/jnn.2013.7520
   Yang WJ, 2009, J BIOMED NANOTECHNOL, V5, P591, DOI 10.1166/jbn.2009.1067
   Zhang LM, 2012, POLYM CHEM-UK, V3, P1958, DOI 10.1039/c2py20201h
NR 45
TC 9
Z9 9
U1 3
U2 66
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD APR
PY 2014
VL 10
IS 4
BP 592
EP 602
DI 10.1166/jbn.2014.1832
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 259AL
UT WOS:000327499700005
PM 24734511
DA 2018-10-20
ER

PT J
AU Rothamel, D
   Benner, M
   Fienitz, T
   Happe, A
   Kreppel, M
   Nickenig, HJ
   Zoller, JE
AF Rothamel, Daniel
   Benner, Marcel
   Fienitz, Tim
   Happe, Arndt
   Kreppel, Matthias
   Nickenig, Hans-Joachim
   Zoeler, Joachim E.
TI Biodegradation pattern and tissue integration of native and cross-linked
   porcine collagen soft tissue augmentation matrices - an experimental
   study in the rat
SO HEAD & FACE MEDICINE
LA English
DT Article
DE Collagen; Soft tissue augmentation; Bone regeneration; Biodegradation;
   Cross-linking; Native type I and III collagen
ID GUIDED BONE REGENERATION; MEMBRANES; DEFECTS; FIBROBLASTS; DEVICES;
   SITES
AB Introduction: Within the last decades, collagen types I and III have been established as a sufficient biomaterial for GBR and GTR procedures. They might also be an adequate matrix for soft tissue augmentations. However, collagen materials differ significantly regarding resorption time, biodegradation pattern and the invasion of inflammatory cells. The aim of the present study was to compare the biodegradation and tissue integration of native, differently processed and cross-linked collagen scaffolds in rats.
   Methods: Four experimental porcine collagen matrices of 1.0 mm thickness, developed for soft tissue augmentation procedures, were tested. Based on the same native dermal Type I and III collagen, native (ND, Mucoderm (R) prototype), specifically defatted (DD), ethylene dioxide cross-linked (ECL) and dehydrothermally cross-linked (DCL) dermis collagen (AAP/Botiss Biomaterials, Berlin, Germany) were evaluated. Two specimens of 1 x 1 cm were fixed around a non-absorbable spacer using non-absorbable sutures. After rehydration, specimens (N = 8) were randomly allocated in unconnected subcutaneous pouches on the back of 40 Wistar rats. Rats were divided into five groups (1, 2, 4, 8 and 12 weeks), including eight animals each. After each period, eight rats were sacrificed and explanted specimens were prepared for histological analysis. The following parameters were evaluated: membrane thickness as a sign of biodegradation and volume stability, cell ingrowth, vascularization, tissue integration and foreign body reaction.
   Results: Biodegradation pattern of the non cross-linked collagen scaffolds differed only slightly in terms of presence of inflammatory cells and cell invasion into the matrix. In terms of biodegradation, ECL displayed a considerable slower resorption than ND, DCL and DD. Chemical cross-linking using ethylene dioxide showed a significant higher invasion of inflammatory cells.
   Conclusion: Within the limits of the present study it was concluded that the processing techniques influenced the collagen properties in a different intensity. Dehydrothermal cross-linking and special defatting did not notably change the biodegradation pattern, whereas cross-linking using ethylene dioxide led to significant higher volume stability of the matrix. However, ECL showed an increased inflammatory response and compromised tissue integration. Therefore, ethylene dioxide seems to be not suitable for stabilization of collagen matrices for soft tissue augmentation procedures.
C1 [Rothamel, Daniel; Benner, Marcel; Fienitz, Tim; Happe, Arndt; Kreppel, Matthias; Nickenig, Hans-Joachim; Zoeler, Joachim E.] Univ Cologne, Dept Oral & Maxillofacial Plast Surg, D-50937 Cologne, Germany.
RP Rothamel, D (reprint author), Univ Cologne, Dept Oral & Maxillofacial Plast Surg, Kerpener Str 62, D-50937 Cologne, Germany.
EM daniel.rothamel@uk-koeln.de
CR Annen BM, 2011, EUR J ORAL IMPLANTOL, V4, P87
   Becker J, 2009, CLIN ORAL IMPLAN RES, V20, P742, DOI 10.1111/j.1600-0501.2008.01689.x
   Caffesse RG, 2002, AM J DENT, V15, P339
   Cranin A Norman, 2002, J Oral Implantol, V28, P230, DOI 10.1563/1548-1336(2002)028<0230:ISTMOS>2.3.CO;2
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Edel A, 1974, J Clin Periodontol, V1, P185, DOI 10.1111/j.1600-051X.1974.tb01257.x
   Gholami Gholam Ali, 2013, Dent Res J (Isfahan), V10, P506
   GOTTLOW J, 1986, J CLIN PERIODONTOL, V13, P604, DOI 10.1111/j.1600-051X.1986.tb00854.x
   Hammerle CHF, 1998, PERIODONTOL 2000, V17, P151, DOI 10.1111/j.1600-0757.1998.tb00132.x
   Hammerle CHF, 2001, CLIN ORAL IMPLAN RES, V12, P9, DOI 10.1034/j.1600-0501.2001.012001009.x
   HARDWICK R, 1995, J PERIODONTOL, V66, P495, DOI 10.1902/jop.1995.66.6.495
   HURLEY LA, 1959, J BONE JOINT SURG AM, V41, P1243, DOI 10.2106/00004623-195941070-00007
   Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667
   Karring T, 1993, Periodontol 2000, V1, P26, DOI 10.1111/j.1600-0757.1993.tb00204.x
   Kassab MM, 2010, CLIN COSMET INVESTIG, V2, P101, DOI 10.2147/CCIDEN.S13478
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Klinge B, 2009, CLIN ORAL IMPLAN RES, V20, P166, DOI 10.1111/j.1600-0501.2009.01774.x
   Locci P, 1997, J PERIODONTOL, V68, P857, DOI 10.1902/jop.1997.68.9.857
   Mahn DH, 2010, DENT TODAY, V96, P98
   Moses O, 2008, J PERIODONTOL, V79, P905, DOI [10.1902/jop.2008.070361, 10.1902/jop.2008.070361 ]
   Owens K W, 2001, Implant Dent, V10, P49
   Park Jun-Beom, 2006, Implant Dent, V15, P275, DOI 10.1097/01.id.0000227078.70869.20
   Paul B F, 1992, Int J Periodontics Restorative Dent, V12, P123
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   Rothamel D, 2005, CLIN ORAL IMPLAN RES, V16, P369, DOI 10.1111/j.1600-0501.2005.01108.x
   Rothamel D, 2006, ORAL MAXILLOFAC SURG, V10, P148, DOI 10.1007/s10006-006-0681-5
   Rothamel D, 2012, INT J ORAL MAX IMPL, V27, P146
   Sanz M, 2009, J CLIN PERIODONTOL, V36, P868, DOI 10.1111/j.1600-051X.2009.01460.x
   Schlegel AK, 1997, BIOMATERIALS, V18, P535, DOI 10.1016/S0142-9612(96)00175-5
   Schwarz F, 2008, CLIN ORAL IMPLAN RES, V19, P402, DOI 10.1111/j.1600-0501.2007.01486.x
   Sela MN, 2003, CLIN ORAL IMPLAN RES, V14, P263, DOI 10.1034/j.1600-0501.2003.140302.x
   Shanmugam M, 2012, J Indian Soc Periodontol, V16, P218, DOI 10.4103/0972-124X.99265
   Sionkowska A, 2013, INT J BIOL MACROMOL, V52, P250, DOI 10.1016/j.ijbiomac.2012.10.002
   Studer SP, 1997, J PERIODONTOL, V68, P145, DOI 10.1902/jop.1997.68.2.145
   SULLIVAN HC, 1969, DENT CLIN N AM, V13, P133
   Tatakis DN, 1999, PERIODONTOL 2000, V19, P59, DOI 10.1111/j.1600-0757.1999.tb00147.x
   Thoma DS, 2009, CLIN ORAL IMPLAN RES, V20, P146, DOI 10.1111/j.1600-0501.2009.01784.x
   Wessel JR, 2008, J PERIODONTOL, V79, P425, DOI [10.1902/jop.2008.070325, 10.1902/jop.2008.070325 ]
   YAFFE A, 1984, J PERIODONTOL, V55, P623, DOI 10.1902/jop.1984.55.11.623
NR 39
TC 19
Z9 20
U1 0
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1746-160X
J9 HEAD FACE MED
JI Head Face Med.
PD MAR 27
PY 2014
VL 10
AR 10
DI 10.1186/1746-160X-10-10
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AF7II
UT WOS:000334887700001
PM 24670219
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bendali, A
   Agnes, C
   Meffert, S
   Forster, V
   Bongrain, A
   Arnault, JC
   Sahel, JA
   Offenhausser, A
   Bergonzo, P
   Picaud, S
AF Bendali, Amel
   Agnes, Charles
   Meffert, Simone
   Forster, Valerie
   Bongrain, Alexandre
   Arnault, Jean-Charles
   Sahel, Jose-Alain
   Offenhaeusser, Andreas
   Bergonzo, Philippe
   Picaud, Serge
TI Distinctive Glial and Neuronal Interfacing on Nanocrystalline Diamond
SO PLOS ONE
LA English
DT Article
ID RETINAL GANGLION-CELLS; FILMS; PROSTHESIS; ELECTRODES; LAMININ;
   ADSORPTION; STABILITY; SURFACES; SPECTRA; CULTURE
AB Direct electrode/neuron interfacing is a key challenge to achieve high resolution of neuronal stimulation required for visual prostheses. Neuronal interfacing on biomaterials commonly requires the presence of glial cells and/or protein coating. Nanocrystalline diamond is a highly mechanically stable biomaterial with a remarkably large potential window for the electrical stimulation of tissues. Using adult retinal cell cultures from rats, we found that glial cells and retinal neurons grew equally well on glass and nanocrystalline diamond. The use of a protein coating increased cell survival, particularly for glial cells. However, bipolar neurons appeared to grow even in direct contact with bare diamond. We investigated whether the presence of glial cells contributed to this direct neuron/diamond interface, by using purified adult retinal ganglion cells to seed diamond and glass surfaces with and without protein coatings. Surprisingly, these fully differentiated spiking neurons survived better on nanocrystalline diamond without any protein coating. This greater survival was indicated by larger cell numbers and the presence of longer neurites. When a protein pattern was drawn on diamond, neurons did not grow preferentially on the coated area, by contrast to their behavior on a patterned glass. This study highlights the interesting biocompatibility properties of nanocrystalline diamond, allowing direct neuronal interfacing, whereas a protein coating was required for glial cell growth.
C1 [Bendali, Amel; Forster, Valerie; Sahel, Jose-Alain; Picaud, Serge] INSERM, U968, Inst Vis, Paris, France.
   [Bendali, Amel; Forster, Valerie; Sahel, Jose-Alain; Picaud, Serge] Sorbonne Univ, Univ Paris 06, UMR S968, Inst Vis, Paris, France.
   [Bendali, Amel; Forster, Valerie; Sahel, Jose-Alain; Picaud, Serge] CNRS, UMR7210, Inst Vis, Paris, France.
   [Agnes, Charles; Bongrain, Alexandre; Arnault, Jean-Charles; Bergonzo, Philippe] CEA LIST, Diamond Sensors Lab, Gif Sur Yvette, France.
   [Meffert, Simone; Offenhaeusser, Andreas] Forschungszentrum Julich, Inst Bio & Nanosyst Bioelect IBN2, D-52425 Julich, Germany.
   [Sahel, Jose-Alain] Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France.
   [Sahel, Jose-Alain; Picaud, Serge] Fdn Ophtalmol Adolphe de Rothschild, Paris, France.
   [Sahel, Jose-Alain] UCL, Inst Ophthalmol, London, England.
   [Sahel, Jose-Alain] French Acad Sci, Paris, France.
RP Picaud, S (reprint author), INSERM, U968, Inst Vis, Paris, France.
EM serge.picaud@inserm.fr
RI Picaud, Serge/H-4012-2014; Bergonzo, Philippe/A-6567-2015; Sahel,
   Jose-Alain/F-3172-2017; Offenhausser, Andreas/E-7990-2012
OI Picaud, Serge/0000-0002-0548-5145; Bergonzo,
   Philippe/0000-0002-0647-9134; Sahel, Jose-Alain/0000-0002-4831-1153;
   Offenhausser, Andreas/0000-0001-6143-2702
FU INSERM; UPMC (Paris VI); Fondation Ophtalmologique A. de Rothschild
   (Paris); Agence Nationale pour la Recherche (MEDINAS project)
   [ANR-07-TECSAN-014]; Fondation Fighting Blindness; Fondation pour la
   Recherche Medicale; sixth European framework (DREAMS)
   [FP6-NMP-2006-676033345]; sixth European framework (NEUROCARE)
   [FP7-NMP-280433]; IMPLANTS project from ITMO-TecSan; Federation des
   Aveugles de France; IRRP; city of Paris; Regional Council of
   Ile-de-France
FX This work was supported by INSERM, UPMC (Paris VI), the Fondation
   Ophtalmologique A. de Rothschild (Paris), Agence Nationale pour la
   Recherche (MEDINAS project, ANR-07-TECSAN-014), Fondation Fighting
   Blindness, Fondation pour la Recherche Medicale, the sixth European
   framework (DREAMS, project FP6-NMP-2006-676033345; NEUROCARE, project
   FP7-NMP-280433), IMPLANTS project from ITMO-TecSan, Federation des
   Aveugles de France, IRRP, the city of Paris, the Regional Council of
   Ile-de-France. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Ariano P, 2009, BIOSENS BIOELECTRON, V24, P2046, DOI 10.1016/j.bios.2008.10.017
   Aumailley M, 2013, CELL ADHES MIGR, V7, P48, DOI 10.4161/cam.22826
   BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4
   Bates CA, 1997, DEV BIOL, V181, P91, DOI 10.1006/dbio.1996.8438
   Beamson G., 1992, HIGH RESOLUTION XPS
   Butterwick A, 2009, EXP EYE RES, V88, P22, DOI 10.1016/j.exer.2008.09.018
   Chang JC, 2001, BIOSENS BIOELECTRON, V16, P527, DOI 10.1016/S0956-5663(01)00166-X
   Chang WC, 2008, LANGMUIR, V24, P13048, DOI 10.1021/la8021479
   Chen YC, 2010, BIOMATERIALS, V31, P5575, DOI 10.1016/j.biomaterials.2010.03.061
   Chen YC, 2009, BIOMATERIALS, V30, P3428, DOI 10.1016/j.biomaterials.2009.03.058
   Djilas M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046020
   Dobelle WH, 2000, ASAIO J, V46, P3, DOI 10.1097/00002480-200001000-00002
   Fuchs C, 2005, INVEST OPHTH VIS SCI, V46, P2983, DOI 10.1167/iov.04-1177
   Gao WL, 2010, APPL SURF SCI, V257, P538, DOI 10.1016/j.apsusc.2010.07.029
   Ghodbane S, 2010, DIAM RELAT MATER, V19, P630, DOI 10.1016/j.diamond.2010.01.014
   GI RS, 1995, JPN J APPL PHYS 1, V34, P5550, DOI 10.1143/JJAP.34.5550
   Granger MC, 2000, ANAL CHEM, V72, P3793, DOI 10.1021/ac0000675
   Graupner R, 1998, PHYS REV B, V57, P12397, DOI 10.1103/PhysRevB.57.12397
   Gupta S, 2008, J APPL PHYS, V104, DOI 10.1063/1.2990058
   Hadjinicolaou AE, 2012, BIOMATERIALS, V33, P5812, DOI 10.1016/j.biomaterials.2012.04.063
   Humayun MS, 2012, OPHTHALMOLOGY, V119, P779, DOI 10.1016/j.ophtha.2011.09.028
   Kiran R, 2012, SENSORS-BASEL, V12, P7669, DOI 10.3390/s120607669
   Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004
   Lions M, 2009, PHYS STATUS SOLIDI-R, V3, P205, DOI 10.1002/pssr.200903128
   Liu BF, 2006, COLLOID SURFACE B, V53, P175, DOI 10.1016/j.colsurfb.2006.08.018
   Maynard EM, 2000, J NEUROSCI METH, V97, P93, DOI 10.1016/S0165-0270(00)00159-X
   Mehes E, 2005, GLIA, V49, P492, DOI 10.1002/glia.20135
   Romano C, 2007, PROG RETIN EYE RES, V26, P379, DOI 10.1016/j.preteyeres.2007.03.001
   Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4
   Ruiz-Taylor LA, 2001, LANGMUIR, V17, P7313, DOI 10.1021/la010620t
   Snidero E, 2003, J APPL PHYS, V93, P2700, DOI 10.1063/1.1539922
   Specht CG, 2004, BIOMATERIALS, V25, P4073, DOI 10.1016/j.biomaterials.2003.11.006
   Thalhammer A, 2010, BIOMATERIALS, V31, P2097, DOI 10.1016/j.biomaterials.2009.11.109
   Vanhove E, 2007, PHYS STATUS SOLIDI A, V204, P2931, DOI 10.1002/pssa.200776340
   Vanhove E, 2009, PHYS STATUS SOLIDI A, V206, P2063, DOI 10.1002/pssa.200982235
   Wei M, 2009, CHEM COMMUN, P3624, DOI 10.1039/b903284c
   Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747
NR 37
TC 19
Z9 19
U1 0
U2 38
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 24
PY 2014
VL 9
IS 3
AR e92562
DI 10.1371/journal.pone.0092562
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD7QO
UT WOS:000333459900075
PM 24664111
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chang, HH
   Wang, YL
   Chiang, YC
   Chen, YL
   Chuang, YH
   Tsai, SJ
   Heish, KH
   Lin, FH
   Lin, CP
AF Chang, Hao-Hueng
   Wang, Yin-Lin
   Chiang, Yu-Chih
   Chen, Yen-Liang
   Chuang, Yu-Horng
   Tsai, Shang-Jye
   Heish, Kuo-Huang
   Lin, Feng-Huei
   Lin, Chun-Pin
TI A Novel Chitosan-gamma PGA Polyelectrolyte Complex Hydrogel Promotes
   Early New Bone Formation in the Alveolar Socket Following Tooth
   Extraction
SO PLOS ONE
LA English
DT Article
ID RIDGE PRESERVATION; FORMATION ADJACENT; IMPLANTS; TISSUE; SCAFFOLD; DOG;
   RECONSTRUCTION; REGENERATION; BIOCHEMISTRY; BIOMATERIAL
AB A novel chitosan-gamma PGA polyelectrolyte complex hydrogel (C-PGA) has been developed and proven to be an effective dressing for wound healing. The purpose of this study was to evaluate if C-PGA could promote new bone formation in the alveolar socket following tooth extraction. An animal model was proposed using radiography and histomorphology simultaneously to analyze the symmetrical sections of Wistar rats. The upper incisors of Wistar rats were extracted and the extraction sockets were randomly treated with gelatin sponge, neat chitosan, C-PGA, or received no treatment. The extraction sockets of selected rats from each group were evaluated at 1, 2, 4, or 6 wk post-extraction. The results of radiography and histopathology indicated that the extraction sockets treated with C-PGA exhibited lamellar bone formation (6.5%) as early as 2 wk after the extraction was performed. Moreover, the degree of new bone formation was significantly higher (P < 0.05) in the extraction sockets treated with C-PGA at 6 wk post-extraction than that in the other study groups. In this study, we demonstrated that the proposed animal model involving symmetrical sections and simultaneous radiography and histomorphology evaluation is feasible. We also conclude that the novel C-PGA has great potential for new bone formation in the alveolar socket following tooth extraction.
C1 [Chang, Hao-Hueng; Wang, Yin-Lin; Chiang, Yu-Chih; Chen, Yen-Liang; Chuang, Yu-Horng; Tsai, Shang-Jye; Lin, Chun-Pin] Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan.
   [Chang, Hao-Hueng; Wang, Yin-Lin; Chiang, Yu-Chih; Chen, Yen-Liang; Lin, Chun-Pin] Natl Taiwan Univ, Dept Dent, Taipei 10764, Taiwan.
   [Tsai, Shang-Jye] Cardinal Tien Hosp, Dept Dent, Yonghe Branch, New Taipei, Taiwan.
   [Heish, Kuo-Huang] Natl Taiwan Univ, Dept Chem Engn, Taipei 10764, Taiwan.
   [Lin, Feng-Huei] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.
RP Lin, CP (reprint author), Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan.
EM pinlin@ntu.edu.tw
OI CHIANG, YU-CHIH/0000-0001-8110-3033; Lin, Chun-Pin/0000-0002-3498-1113;
   WANG, YIN-LIN/0000-0001-6790-1311
FU National Science Council, Taiwan [98-2314-B-002-070-MY2]
FX The authors also declare this study was supported in part by a grant
   from the National Science Council, Taiwan (98-2314-B-002-070-MY2) and no
   additional or current funding sources for this study. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript. No additional external funding
   received for this study.
CR Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Arruda T, 2012, J BIOMED MATER RES A, V101, P1971
   Badawy Mohamed E. I., 2011, International Journal of Carbohydrate Chemistry, DOI 10.1155/2011/460381
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Boyan BD, 2006, J PERIODONTOL, V77, P1555, DOI 10.1902/jop.2006.060019
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P423, DOI 10.1163/156856203766652048
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P1401, DOI 10.1163/156856203322599734
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Ezoddini-Ardakani Fatemeh, 2012, Dent Res J (Isfahan), V9, P694
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Hsieh CY, 2006, DENT MATER, V22, P622, DOI 10.1016/j.dental.2005.05.012
   Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012
   Khanna R, 2011, ACTA BIOMATER, V7, P1173, DOI 10.1016/j.actbio.2010.10.028
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9
   Liu HH, 2013, BIOMATERIALS, V34, P4404, DOI 10.1016/j.biomaterials.2013.02.048
   Miranda SCCC, 2011, ARCH ORAL BIOL, V56, P1, DOI 10.1016/j.archoralbio.2010.08.018
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Muzzarelli RAA, 1999, EXS, V87, P235
   Muzzarelli RAA, 1999, EXS, V87, P293
   Muzzarelli RAA, 1999, EXS, V87, P251
   Oka S, 2013, TISSUE ENG PT A, V19, P1233, DOI [10.1089/ten.tea.2012.0325, 10.1089/ten.TEA.2012.0325]
   Roriz VM, 2010, CLIN ORAL IMPLAN RES, V21, P148, DOI 10.1111/j.1600-0501.2009.01812.x
   Santos FA, 2010, CLIN IMPLANT DENT R, V12, P18, DOI 10.1111/j.1708-8208.2008.00126.x
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   Shokrgozar Mohammad Ali, 2012, Iranian Biomedical Journal, V16, P68, DOI 10.6091/ibj.1053.2012
   Tsao CT, 2011, CARBOHYD POLYM, V84, P812, DOI 10.1016/j.carbpol.2010.04.034
   Tsao CT, 2011, CARBOHYD RES, V346, P94, DOI 10.1016/j.carres.2010.10.010
   Tsao CT, 2010, CARBOHYD RES, V345, P1774, DOI 10.1016/j.carres.2010.06.002
   TSUCHIDA E, 1994, J MACROMOL SCI PURE, VA31, P1
   Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x
NR 33
TC 9
Z9 9
U1 1
U2 35
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 21
PY 2014
VL 9
IS 3
AR e92362
DI 10.1371/journal.pone.0092362
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD6GL
UT WOS:000333355300075
PM 24658174
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Pilloni, A
   Pompa, G
   Saccucci, M
   Di Carlo, G
   Rimondini, L
   Brama, M
   Zeza, B
   Wannenes, F
   Migliaccio, S
AF Pilloni, Andrea
   Pompa, Giorgio
   Saccucci, Matteo
   Di Carlo, Gabriele
   Rimondini, Lia
   Brama, Marina
   Zeza, Blerina
   Wannenes, Francesca
   Migliaccio, Silvia
TI Analysis of human alveolar osteoblast behavior on a nano-hydroxyapatite
   substrate: an in vitro study
SO BMC ORAL HEALTH
LA English
DT Article
DE Nanohydroxyapatite; Human osteoblasts; Alveolar bone regeneration
ID NANOPHASE CERAMICS; DIFFERENTIATION; RESPONSES; NANOHYDROXYAPATITE;
   PROLIFERATION; OSTEOGENESIS; ROUGHNESS; ADHESION; DEFECTS; CELLS
AB Background: Nano-hydroxyapatite (nHA) is a potential ideal biomaterial for bone regeneration. However, studies have yet to characterize the behavior of human osteoblasts derived from alveolar bone on nHA. Thus, the aim of the present study was to evaluate the influence of nHA on the adhesion, proliferation and differentiation of these alveolar bone-derived cells.
   Methods: Primary human alveolar osteoblasts were collected from the alveolar ridge of a male periodontal patient during osseous resective surgery and grown on culture plates coated with either polylysine or polylysine with nano-hydroxyapatite (POL/nHA) composite. The cells were grown and observed for 14 days, and then assessed for potential modifications to osteoblasts homeostasis as evaluated by quantitative reverse transcriptase-polymerase chain reaction (real time RT-PCR), scanning electron microscopy and atomic force microscopy.
   Results: Real time PCR revealed a significant increase in the expression of the selected markers of osteoblast differentiation (bone morphogenetic protein (BMP)-2,-5,-7, ALP, COLL-1A2, OC, ON) in cells grown on the POL/nHA substrate. In addition, as compared with the POL surface, cells grown on the POL/nHA substrate demonstrated better osteoconductive properties, as demonstrated by the increase in adhesion and spreading, likely as a result of the increased surface roughness of the composite.
   Conclusions: The increased expression of BMPs and osteoinductive biomarkers suggest that nano-hydroxyapatite may stimulate the proliferation and differentiation of local alveolar osteoblasts and thus encourage bone regeneration at sites of alveolar bone regeneration.
C1 [Pilloni, Andrea; Zeza, Blerina] Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Periodont Unit, Rome, Italy.
   [Pompa, Giorgio] Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Prosthodont Unit, Rome, Italy.
   [Saccucci, Matteo; Di Carlo, Gabriele] Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Pediat Dent Unit, Rome, Italy.
   [Rimondini, Lia] Univ Oriental Piedmont Amedeo Avogadro, Dept Hlth Sci, Lab Biomed & Dent Mat, Novara, Italy.
   [Brama, Marina; Wannenes, Francesca; Migliaccio, Silvia] Sapienza Univ Rome, Dept Expt Med, Med Phatophysiol Endocrinol & Nutr Unit, Rome, Italy.
RP Saccucci, M (reprint author), Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Pediat Dent Unit, Rome, Italy.
EM matteo.saccucci@uniroma1.it
OI Di Carlo, Gabriele/0000-0002-8039-7022; Migliaccio,
   Silvia/0000-0002-4563-6630
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Bouyer E, 2000, J MATER SCI-MATER M, V11, P523, DOI 10.1023/A:1008918110156
   Boyan BD, 2003, EUR CELL MAT
   Carnevale G, 2000, PERIODONTOL 2000, V22, P59, DOI 10.1034/j.1600-0757.2000.2220106.x
   Fragale A, 1999, AM J PATHOL, V154, P1465, DOI 10.1016/S0002-9440(10)65401-6
   Giannobilie WV, CLIN PERIODONTOLOGY
   Heinz B, 2010, CLIN ORAL INVEST, V14, P525, DOI 10.1007/s00784-009-0325-x
   Hi W, 2005, J PERIODONTOL, V76, P1601
   Karring TH, 2008, CLIN PERIODONTOLOGY, P548
   Kasaj A, 2008, J PERIODONTOL, V79, P394, DOI [10.1902/jop.2008.070378, 10.1902/jop.2008.070378 ]
   Kasaj Adrian, 2008, J Oral Sci, V50, P279, DOI 10.2334/josnusd.50.279
   KENNEY EB, 1985, J PERIODONTOL, V56, P82, DOI 10.1902/jop.1985.56.2.82
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Klein MO, 2013, CLIN IMPLANT DENT R, V15, P166, DOI 10.1111/j.1708-8208.2011.00339.x
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Liu XC, 2012, INT J NANOMED, V7, P1239, DOI 10.2147/IJN.S28098
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lock J, 2011, INT J NANOMED, V6, P2769, DOI 10.2147/IJN.S24493
   Murugan R, 2004, BIOMATERIALS
   Ngiam M, 2011, ANN ACAD MED SINGAP, V40, P213
   Ochsenbein C, 1958, J PERIODONTOL, V29, P15
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Reynolds Mark A, 2010, Dent Clin North Am, V54, P55, DOI 10.1016/j.cden.2009.09.003
   Sculean A, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2008.01263.x
   Taranta A, 2002, BONE, V30, P368, DOI 10.1016/S8756-3282(01)00685-8
   The American Academy of Periodontology, 2001, GLOSS PER TERMS
   Thian ES, 2008, J BIOMED MATER RES A, V85A, P188, DOI 10.1002/jbm.a.31564
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wei G, 2004, BIOMATERIALS
   Yamashita D, 2009, DENT MATER J, V28, P461, DOI 10.4012/dmj.28.461
   Zhang L, 2005, J MATER SCI-MATER M, V16, P213, DOI 10.1007/s10856-005-6682-3
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zhou Z, 2009, J BIOMED MAT S3, V4, P3500
NR 35
TC 14
Z9 14
U1 0
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6831
J9 BMC ORAL HEALTH
JI BMC Oral Health
PD MAR 20
PY 2014
VL 14
AR 22
DI 10.1186/1472-6831-14-22
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AG1NG
UT WOS:000335181600002
PM 24650194
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Tang, J
   Liu, H
   Gao, C
   Mu, LX
   Yang, SL
   Rong, MQ
   Zhang, ZY
   Liu, J
   Ding, Q
   Lai, R
AF Tang, Jing
   Liu, Han
   Gao, Chen
   Mu, Lixian
   Yang, Shilong
   Rong, Mingqiang
   Zhang, Zhiye
   Liu, Jie
   Ding, Qiang
   Lai, Ren
TI A Small Peptide with Potential Ability to Promote Wound Healing
SO PLOS ONE
LA English
DT Article
ID GROWTH-FACTOR-BETA; TISSUE-REPAIR; SKIN; MYOFIBROBLASTS; MIGRATION;
   CYTOKINES; SMAD2; CELLS; MICE
AB Wound-healing represents a major health burden, such as diabetes-induced skin ulcers and burning. Many works are being tried to find ideal clinical wound-healing biomaterials. Especially, small molecules with low cost and function to promote production of endogenous wound healing agents (i.e. transforming growth factor beta, TGF-beta) are excellent candidates. In this study, a small peptide (tiger17, c[WCKPKPKPRCH-NH2]) containing only 11 amino acid residues was designed and proved to be a potent wound healer. It showed strong wound healing-promoting activity in a murine model of full thickness dermal wound. Tiger17 exerted significant effects on three stages of wound healing progresses including (1) the induction of macrophages recruitment to wound site at inflammatory reaction stage; (2) the promotion of the migration and proliferation both keratinocytes and fibroblasts, leading to reepithelialization and granulation tissue formation; and (3) tissue remodeling phase, by promoting the release of transforming TGF-beta 1 and interleukin 6 (IL-6) in murine macrophages and activating mitogen-activated protein kinases (MAPK) signaling pathways. Considering its easy production, store and transfer and function to promote production of endogenous wound healing agents (TGF-beta), tiger17 might be an exciting biomaterial or template for the development of novel wound-healing agents.
C1 [Tang, Jing; Liu, Han; Mu, Lixian; Yang, Shilong; Rong, Mingqiang; Zhang, Zhiye; Liu, Jie; Lai, Ren] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.
   [Tang, Jing; Liu, Han; Mu, Lixian; Yang, Shilong; Rong, Mingqiang; Zhang, Zhiye; Liu, Jie; Lai, Ren] Kunming Inst Zool, Kunming, Yunnan, Peoples R China.
   [Ding, Qiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.
   [Gao, Chen] Jiangsu Anim Husb & Vet Coll, Coll Vet Med, Taizhou, Jiangsu, Peoples R China.
   [Tang, Jing; Liu, Han; Mu, Lixian; Yang, Shilong; Zhang, Zhiye; Liu, Jie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China.
RP Ding, Q (reprint author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.
EM dqnj2000@aliyun.com; rlai@mail.kiz.ac.cn
FU Ministry of Science and Technology [2010CB529800, 2013CB911300];
   National Natural Science Foundation [30830021, 31070701, 31000960,
   31025025, U1132601, 31200590]; Yunnan Province [2011CI139, 2012BC009]
FX This work was supported by Ministry of Science and Technology
   (2010CB529800, 2013CB911300), National Natural Science Foundation
   (30830021, 31025025, 31070701, 31000960, 31025025, U1132601, 31200590),
   and Yunnan Province (2011CI139, 2012BC009). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Badid C, 2000, HISTOL HISTOPATHOL, V15, P269, DOI 10.14670/HH-15.269
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Block ER, 2010, MOL BIOL CELL, V21, P2172, DOI 10.1091/mbc.E09-12-1026
   Breitkreutz D, 2009, HISTOCHEM CELL BIOL, V132, P1, DOI 10.1007/s00418-009-0586-0
   Brem H, 2000, ARCH SURG-CHICAGO, V135, P627, DOI 10.1001/archsurg.135.6.627
   Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236
   DARBY I, 1990, LAB INVEST, V63, P21
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006
   Gabbiani G, 1972, PATHOL BIOL PA S DEC, P6
   Geoffrey CG, 2008, NATURE, V453, P314
   Haroon ZA, 2000, ANN SURG, V231, P137, DOI 10.1097/00000658-200001000-00020
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hosokawa R, 2005, J INVEST DERMATOL, V125, P1302, DOI 10.1111/j.0022-202X.2005.23963.x
   Katherine MM, 1998, J IMMUNOL, V160, P1001
   KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X
   Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943
   Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004
   Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   Luckett-Chastain LR, 2009, BRIT J DERMATOL, V161, P237, DOI 10.1111/j.1365-2133.2009.09215.x
   Mahdavian DB, 2011, IMMUNOBIOLOGY, V216, P753, DOI DOI 10.1016/J.IMBIO.2011.01.001
   Malinda KM, 1997, FASEB J, V11, P474
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Mathieu P, 2010, INT J CLIN EXP PATHO, V3, P643
   Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248
   Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353
   Nathan BM, 2007, CLIN DERMATOL, V25, P19
   Nwomeh BC, 1998, CLIN PLAST SURG, V25, P341
   Plikus MV, 2012, SEMIN CELL DEV BIOL, V23, P946, DOI 10.1016/j.semcdb.2012.10.001
   RAJA SK, 2007, FRONT BIOSCI, V12, P2849, DOI DOI 10.2741/2277
   Ryoichi M, 2008, J EXP MED, V205, P43
   Song YZ, 2009, PEPTIDES, V30, P1228, DOI 10.1016/j.peptides.2009.03.020
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Tredget EB, 2005, WOUND REPAIR REGEN, V13, P61, DOI 10.1111/j.1067-1927.2005.130108.x
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   WOODLEY DT, 1993, DERMATOL CLIN, V11, P641, DOI 10.1016/S0733-8635(18)30217-1
   Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327
   Zhang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072923
NR 39
TC 25
Z9 26
U1 1
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2014
VL 9
IS 3
AR e92082
DI 10.1371/journal.pone.0092082
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD6ER
UT WOS:000333348500081
PM 24647450
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Belitsky, JM
   Lye, DS
   Gittleman, HR
   Gorlin, TA
   Gorham, AN
   Moore, CA
   Chaves, MB
   Ellowitz, MZ
AF Belitsky, Jason M.
   Lye, Diane S.
   Gittleman, Haley R.
   Gorlin, Thomas A.
   Gorham, Arthur N.
   Moore, Christine A.
   Chaves, Matthew B.
   Ellowitz, Micah Z.
TI Colorimetric metal ion binding of catechol-based coatings inspired by
   melanin and molecular imprinting
SO SUPRAMOLECULAR CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 8th International Symposium of Macrocyclic and Supramolecular Chemistry
   (ISMSC)
CY JUL 07-11, 2013
CL Arlington, VA
DE catechol; melanin; molecular imprinting; colorimetric; metal ions
ID ATOMIC-ABSORPTION-SPECTROMETRY; BISMUTH VANADATE PIGMENTS; GOLD
   NANOPARTICLES; LEAD IONS; MULTIFUNCTIONAL COATINGS; OXIDATIVE
   POLYMERIZATION; SYNTHETIC MELANINS; AQUEOUS-MEDIA; MERCURY IONS;
   HEAVY-METALS
AB Catechol-containing biomolecules and related synthetic materials are of interest for a broad range of applications. Our group has been interested in the potential of eumelanin, a catechol-containing biomaterial and the black-to-brown pigment in humans, and synthetic eumelanin analogues for water purification applications. In an attempt to apply the strategy of molecular imprinting towards lead-binding synthetic eumelanin coatings, we developed a PbO2-mediated synthesis that was subsequently tested with a number of catechols in addition to the eumelanin and polydopamine monomers l-dopa and dopamine. Although this strategy did not provide significant improvements in affinity or selectivity, we found that the PbO2-mediated oxidative polymerisation of 1,2-dihydroxybenzene generates a coating that darkens visibly upon binding Pb2+ and other metal ions. Oxidative polymerisation of catechol with sodium periodate also yields a coating with this colorimetric response. Of eight metal ions tested, the coatings are most responsive to Pb2+ and Cu2+, as analysed by quantitative colorimetry. With further optimisation, these coatings could prove useful for the colorimetric sensing of metal ions.
C1 [Belitsky, Jason M.; Lye, Diane S.; Gittleman, Haley R.; Gorlin, Thomas A.; Gorham, Arthur N.; Moore, Christine A.; Chaves, Matthew B.; Ellowitz, Micah Z.] Oberlin Coll, Dept Chem & Biochem, Oberlin, OH 44074 USA.
RP Belitsky, JM (reprint author), Oberlin Coll, Dept Chem & Biochem, Oberlin, OH 44074 USA.
EM jason.belitsky@oberlin.edu
OI Lye, Diane/0000-0002-0684-0663
FU Society Petroleum Research Fund; Research Corporation; Oberlin College
FX Acknowledgement is made to the Donors of the American Chemical Society
   Petroleum Research Fund for partial support of this research. We thank
   Research Corporation (Cottrell College Science Award) and Oberlin
   College for additional support. We thank Dr Anna Mapp and members of the
   Mapp lab at the University of Michigan, where a portion of this work was
   performed, and acknowledge the Oberlin-Kalamazoo-University of Michigan
   collaborative programme for partial support of this work. We thank Chris
   Boyd and Christa Wagner (Oberlin College) for preliminary experiments,
   and Lauren Choban, Jessica Hubert, Ryan Hunter, Edmund Korley and Sophie
   Lewandowski (Oberlin College) for ongoing experiments related to those
   reported here.
CR Alexander C, 2006, J MOL RECOGNIT, V19, P106, DOI 10.1002/jmr.760
   Ambrico M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729754
   Arzillo M, 2012, BIOMACROMOLECULES, V13, P2379, DOI 10.1021/bm3006159
   Basu A., 2008, MOL RECOGNITION POLY, P309
   Belitsky JM, 2012, BIOORG MED CHEM LETT, V22, P5503, DOI 10.1016/j.bmcl.2012.07.027
   Belitsky JM, 2010, BIOORG MED CHEM LETT, V20, P4475, DOI 10.1016/j.bmcl.2010.06.039
   Beqa L, 2011, ACS APPL MATER INTER, V3, P668, DOI 10.1021/am101118h
   Bererok A., 2010, CHEM PHYS LETT, V497, P115
   Bernard J, 2008, REACT FUNCT POLYM, V68, P1362, DOI 10.1016/j.reactfunctpolym.2008.06.014
   Bernard J, 2012, REACT FUNCT POLYM, V72, P98, DOI 10.1016/j.reactfunctpolym.2011.11.001
   Bernsmann F, 2009, J PHYS CHEM C, V113, P8234, DOI 10.1021/jp901188h
   Blosi M, 2012, DYES PIGMENTS, V94, P355, DOI 10.1016/j.dyepig.2012.01.006
   Borghetti P, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4719211
   Borghetti P, 2010, LANGMUIR, V26, P19007, DOI 10.1021/la102973u
   Bridelli MG, 2008, ADSORPTION, V14, P101, DOI 10.1007/s10450-007-9059-8
   Brooksby PA, 2008, LANGMUIR, V24, P9074, DOI 10.1021/la8007816
   Brubaker CE, 2011, BIOMACROMOLECULES, V12, P4326, DOI 10.1021/bm201261d
   Chai F, 2010, ACS APPL MATER INTER, V2, P1466, DOI 10.1021/am100107k
   Chen AH, 2009, J HAZARD MATER, V163, P1068, DOI 10.1016/j.jhazmat.2008.07.073
   Chen SG, 2009, BIOINORG CHEM APPL, DOI 10.1155/2009/901563
   Chien SWC, 2007, J AGR FOOD CHEM, V55, P4820, DOI 10.1021/jf070021d
   Christl I, 2005, ENVIRON SCI TECHNOL, V39, P5319, DOI 10.1021/es050018f
   Clancy CMR, 2001, BIOCHEMISTRY-US, V40, P13353, DOI 10.1021/bi010786t
   Colarieti ML, 2006, J HAZARD MATER, V134, P161, DOI 10.1016/j.jhazmat.2005.10.054
   Costa TG, 2012, BIOINORG CHEM APPL, DOI 10.1155/2012/712840
   Cui A, 2002, BIOMACROMOLECULES, V3, P1353, DOI 10.1021/bm025615y
   Czechowski F, 2004, SPECTROCHIM ACTA A, V60, P1387, DOI 10.1016/j.saa.2003.10.037
   d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786
   Dalavi DS, 2012, J SOLID STATE ELECTR, V16, P253, DOI 10.1007/s10008-011-1314-y
   Della Vecchia NF, 2013, ADV FUNCT MATER, V23, P1331, DOI 10.1002/adfm.201202127
   Dreyer DR, 2012, LANGMUIR, V28, P6428, DOI 10.1021/la204831b
   Fisher OZ, 2012, ADV MATER, V24, P3032, DOI 10.1002/adma.201104437
   FRONCISZ W, 1980, ARCH BIOCHEM BIOPHYS, V202, P289, DOI 10.1016/0003-9861(80)90430-0
   Fujita M, 2006, DENT MATER J, V25, P352, DOI 10.4012/dmj.25.352
   Gallas JM, 1999, BIOPHYS J, V77, P1135, DOI 10.1016/S0006-3495(99)76964-X
   Gardette M, 2011, INVEST NEW DRUG, V29, P1253, DOI 10.1007/s10637-010-9471-x
   Ghosh A, 1998, J PULP PAP SCI, V24, P26
   Goa H., 2013, ACS APPL MATER INTER, V5, P425
   Orive AG, 2009, J PHYS CHEM C, V113, P17097, DOI 10.1021/jp905560d
   Gray KM, 2011, SOFT MATTER, V7, P9601, DOI 10.1039/c1sm05293d
   Guney O, 2010, J APPL POLYM SCI, V117, P2373, DOI 10.1002/app.32077
   Gurnani V, 2003, TALANTA, V61, P889, DOI 10.1016/S0039-9140(03)00373-4
   HANNINEN KI, 1987, SCI TOTAL ENVIRON, V62, P201, DOI 10.1016/0048-9697(87)90502-X
   Hansen DE, 2007, BIOMATERIALS, V28, P4178, DOI 10.1016/j.biomaterials.2007.06.017
   Holten-Andersen N, 2011, P NATL ACAD SCI USA, V108, P2651, DOI 10.1073/pnas.1015862108
   Hong L, 2007, J PHYS CHEM B, V111, P7938, DOI 10.1021/jp071439h
   Hong S, 2012, ADV FUNCT MATER, V22, P4711, DOI 10.1002/adfm.201201156
   Hong W, 2011, J MATER CHEM, V21, P17193, DOI 10.1039/c1jm12785c
   Howell RC, 2008, NUCL MED BIOL, V35, P353, DOI 10.1016/j.nucmedbio.2007.12.006
   Huang KW, 2010, BIOSENS BIOELECTRON, V25, P984, DOI 10.1016/j.bios.2009.09.006
   Huijser A, 2011, PHYS CHEM CHEM PHYS, V13, P9119, DOI 10.1039/c1cp20131j
   Hung YL, 2010, TALANTA, V82, P516, DOI 10.1016/j.talanta.2010.05.004
   Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x
   Jia XP, 2013, ANALYST, V138, P651, DOI 10.1039/c2an36313e
   Ju KY, 2011, BIOMACROMOLECULES, V12, P625, DOI 10.1021/bm101281b
   Kaur N, 2011, TETRAHEDRON, V67, P9233, DOI 10.1016/j.tet.2011.09.003
   Kim E, 2013, ACS CHEM BIOL, V8, P716, DOI 10.1021/cb300605s
   Kim HN, 2012, CHEM SOC REV, V41, P3210, DOI 10.1039/c1cs15245a
   Kulcar R, 2010, DYES PIGMENTS, V86, P271, DOI 10.1016/j.dyepig.2010.01.014
   LARSON RA, 1980, LIMNOL OCEANOGR, V25, P505, DOI 10.4319/lo.1980.25.3.0505
   Latt KK, 2011, ANAL CHIM ACTA, V689, P103, DOI 10.1016/j.aca.2011.01.032
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee M, 2012, CHEMPLUSCHEM, V77, P987, DOI 10.1002/cplu.201200209
   Lee YF, 2011, ACS APPL MATER INTER, V3, P2747, DOI 10.1021/am200535s
   Liu TG, 2012, J HAZARD MATER, V201, P155, DOI 10.1016/j.jhazmat.2011.11.060
   Liu Y, 2005, PIGM CELL RES, V18, P42, DOI 10.1111/j.1600-0749.2004.00197.x
   Lodeiro C, 2010, CHEM SOC REV, V39, P2948, DOI 10.1039/b819787n
   Pinheiro SCL, 2012, ANAL BIOANAL CHEM, V402, P3253, DOI 10.1007/s00216-011-5620-0
   Manceau A, 1996, ENVIRON SCI TECHNOL, V30, P1540, DOI 10.1021/es9505154
   Marszall MP, 2011, J CHROMATOGR A, V1218, P229, DOI 10.1016/j.chroma.2010.11.015
   Mayes AG, 2005, ADV DRUG DELIVER REV, V57, P1742, DOI 10.1016/j.addr.2005.07.011
   MCBRIDE MB, 1990, J INORG BIOCHEM, V39, P247, DOI 10.1016/0162-0134(90)84008-D
   MCBRIDE MB, 1988, SOIL SCI SOC AM J, V52, P985, DOI 10.2136/sssaj1988.03615995005200040016x
   Meng S, 2008, BIOPHYS J, V94, P2095, DOI 10.1529/biophysj.107.121087
   Mizuguchi H, 2004, ANAL CHIM ACTA, V527, P131, DOI 10.1016/j.aca.2004.09.080
   Muk NS, 2011, ANAL CHIM ACTA, V703, P226, DOI 10.1016/j.aca.2011.07.032
   Nematollahzadeh A, 2013, J COLLOID INTERF SCI, V404, P117, DOI 10.1016/j.jcis.2013.04.004
   Oladoja NA, 2011, DESALINATION, V271, P34, DOI 10.1016/j.desal.2010.12.008
   Orsetti S, 2006, CHEMOSPHERE, V65, P2313, DOI 10.1016/j.chemosphere.2006.05.009
   Oshita K, 2008, ANAL SCI, V24, P665, DOI 10.2116/analsci.24.665
   PALUMBO A, 1988, BIOCHIM BIOPHYS ACTA, V964, P193, DOI 10.1016/0304-4165(88)90166-3
   PALUMBO A, 1991, BIOCHIM BIOPHYS ACTA, V1115, P1, DOI 10.1016/0304-4165(91)90003-Y
   Pandey SS, 2004, J SCI IND RES INDIA, V63, P682
   Parajuli D, 2005, REACT FUNCT POLYM, V62, P129, DOI 10.1016/j.reactfunctpolym.2004.11.003
   Prabhakaran D, 2007, ANAL CHIM ACTA, V601, P108, DOI 10.1016/j.aca.2007.08.032
   Rao MA, 2007, SOIL BIOL BIOCHEM, V39, P493, DOI 10.1016/j.soilbio.2006.08.020
   Rao TP, 2006, ANAL CHIM ACTA, V578, P105, DOI 10.1016/j.aca.2006.06.065
   Russo F, 2005, APPL MICROBIOL BIOT, V68, P131, DOI 10.1007/s00253-005-1890-9
   Schweitzer AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007229
   Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343
   Shanmuganathan K, 2011, MACROMOLECULES, V44, P9499, DOI 10.1021/ma202170n
   Shaw BA, 2011, J SERB CHEM SOC, V76, P903, DOI 10.2298/JSC100601081S
   Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y
   Smejkalova D, 2007, BIOMACROMOLECULES, V8, P737, DOI 10.1021/bm060598o
   Sono K, 2012, BIOINORG CHEM APPL, DOI 10.1155/2012/361803
   Stark KB, 2005, J PHYS CHEM B, V109, P1970, DOI 10.1021/jp046710z
   Szpoganicz B, 2002, J INORG BIOCHEM, V89, P45, DOI 10.1016/S0162-0134(01)00406-8
   Takahashi Y, 2006, ANGEW CHEM INT EDIT, V45, P913, DOI 10.1002/anie.200503015
   Tarley CRT, 2012, REACT FUNCT POLYM, V72, P83, DOI 10.1016/j.reactfunctpolym.2011.10.008
   Tewari PK, 2002, TALANTA, V56, P735, DOI 10.1016/S0039-9140(01)00606-3
   Tucks A, 2005, J SOLID STATE CHEM, V178, P1145, DOI 10.1016/j.jssc.2004.11.025
   Tucks A, 2007, DYES PIGMENTS, V72, P163, DOI 10.1016/j.dyepig.2005.08.027
   Veleshko IE, 2012, FIBRE CHEM+, V44, P83, DOI 10.1007/s10692-012-9404-x
   Venkatesh G, 2004, MICROCHIM ACTA, V144, P233, DOI 10.1007/s00604-003-0132-z
   Wang XJ, 2008, J APPL POLYM SCI, V109, P64, DOI 10.1002/app.26805
   Wang ZH, 2012, APPL SURF SCI, V258, P2017, DOI 10.1016/j.apsusc.2011.05.005
   Watt AAR, 2009, SOFT MATTER, V5, P3754, DOI 10.1039/b902507c
   Wei Q, 2010, POLYM CHEM-UK, V1, P1430, DOI 10.1039/c0py00215a
   Wilke P, 2012, ACS MACRO LETT, V1, P871, DOI 10.1021/mz300258m
   Wu X, 2008, MOL RECOGNITION POLY, P395, DOI DOI 10.1002/9780470384053.CH15
   Wu YS, 2013, ACS APPL MATER INTER, V5, P1503, DOI 10.1021/am3030454
   Ye SQ, 2012, ANALYST, V137, P3365, DOI 10.1039/c2an35311c
   Yoon BH, 1999, J PULP PAP SCI, V25, P289
   Yoosaf K, 2007, J PHYS CHEM C, V111, P12839, DOI 10.1021/jp073923q
   Yu XH, 2011, ADV MATER RES-SWITZ, V156-157, P1378, DOI 10.4028/www.scientific.net/AMR.156-157.1378
   Zecca L, 2008, P NATL ACAD SCI USA, V105, P17567, DOI 10.1073/pnas.0808768105
   Zhai YH, 2008, REACT FUNCT POLYM, V68, P284, DOI 10.1016/j.reactfunctpolym.2007.08.013
   Zhai YH, 2007, ANAL CHIM ACTA, V593, P123, DOI 10.1016/j.aca.2007.04.040
   Zhang JF, 2011, CHEM SOC REV, V40, P3416, DOI 10.1039/c1cs15028f
   Zhang M, 2012, ANALYST, V137, P601, DOI 10.1039/c1an15909g
   Zhang XJ, 2012, NEW J CHEM, V36, P1621, DOI 10.1039/c2nj40242d
   Zhou QG, 2005, J ALLOY COMPD, V391, P141, DOI 10.1016/j.jallcom.2004.07.076
   Zhu DR, 2012, BIOSENS BIOELECTRON, V31, P505, DOI 10.1016/j.bios.2011.11.026
NR 124
TC 3
Z9 3
U1 4
U2 69
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1061-0278
EI 1029-0478
J9 SUPRAMOL CHEM
JI Supramol. Chem.
PD MAR 18
PY 2014
VL 26
IS 3-4
SI SI
BP 233
EP 244
DI 10.1080/10610278.2013.852672
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA AE6CR
UT WOS:000334076800014
DA 2018-10-20
ER

PT J
AU Hobbenaghi, R
   Mahboob, P
   Saifzadeh, S
   Javanbakht, J
   Manesh, JYY
   Mortezaee, R
   Touni, SR
   Hosseini, E
   Aghajanshakeri, S
   Moloudizargari, M
   Javaherypour, S
AF Hobbenaghi, Rahim
   Mahboob, Pariya
   Saifzadeh, Siamak
   Javanbakht, Javad
   Manesh, Javad Yaghoobi Yeganeh
   Mortezaee, Rasool
   Touni, Seyed Rashid
   Hosseini, Ehsan
   Aghajanshakeri, Shahin
   Moloudizargari, Milad
   Javaherypour, Soheil
TI RETRACTED: Histopathological features of bone regeneration in a canine
   segmental ulnar defect model(Retracted article. See vol. 11, 2016)
SO DIAGNOSTIC PATHOLOGY
LA English
DT Article; Retracted Publication
DE Bone defect; Bone regeneration; Vascular bone grafting; Histopathology;
   Dog
ID GRAFT SUBSTITUTE; DISTRACTION OSTEOGENESIS; MORPHOGENETIC PROTEIN-2;
   TUMOR-DIAGNOSIS; GROWTH-FACTOR; REPAIR; MODEL; HYDROXYAPATITE;
   RECONSTRUCTION; ANGIOGENESIS
AB Background: Today, finding an ideal biomaterial to treat the large bone defects, delayed unions and non-unions remains a challenge for orthopaedic surgeions and researchers. Several studies have been carried out on the subject of bone regeneration, each having its own advantages. The present study has been designed in vivo to evaluate the effects of cellular auto-transplantation of tail vertebrae on healing of experimental critical bone defect in a dog model.
   Methods: Six indigenous breeds of dog with 32 +/- 3.6 kg average weight from both sexes (5 males and 1 female) received bilateral critical-sized ulnar segmental defects. After determining the health condition, divided to 2 groups: The Group I were kept as control I (n = 1) while in Group II (experimental group; n = 5) bioactive bone implants were inserted. The defects were implanted with either autogeneic coccygeal bone grafts in dogs with 3-4 cm diaphyseal defects in the ulna. Defects were stabilized with internal plate fixation, and the control defects were not stabilized. Animals were euthanized at 16 weeks and analyzed by histopathology.
   Results: Histological evaluation of this new bone at sixteen weeks postoperatively revealed primarily lamellar bone, with the formation of new cortices and normal-appearing marrow elements. And also reformation cortical compartment and reconstitution of marrow space were observed at the graft-host interface together with graft resorption and necrosis responses. Finally, our data were consistent with the osteoconducting function of the tail autograft.
   Conclusions: Our results suggested that the tail vertebrae autograft seemed to be a new source of autogenous cortical bone in order to supporting segmental long bone defects in dogs. Furthermore, cellular autotransplantation was found to be a successful replacement for the tail vertebrae allograft bone at 3-4 cm segmental defects in the canine mid-ulna. Clinical application using graft expanders or bone autotransplantation should be used carefully and requires further investigation.
C1 [Hobbenaghi, Rahim] Urmia Univ, Fac Vet Med, Dept Pathol, Orumiyeh, Iran.
   [Mahboob, Pariya] Univ Tehran, Fac Vet Med, Tehran, Iran.
   [Saifzadeh, Siamak] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
   [Javanbakht, Javad] Univ Tehran, Fac Vet Med, Dept Pathobiol, Tehran, Iran.
   [Manesh, Javad Yaghoobi Yeganeh] Shahrekord Univ, Fac Vet Med, Gradute Islamic Azad Univ Shahrekord, Shahrekord, Iran.
   [Mortezaee, Rasool] Ferdowsi Univ Mashhad, Fac Vet Med, Ferdowsi Univ Mashhad, Mashahd, Iran.
   [Touni, Seyed Rashid] Urmia Univ, Fac Vet Med, Orumiyeh, Iran.
   [Hosseini, Ehsan] Ilam Univ, Fac Vet Med, Ilam, Iran.
   [Aghajanshakeri, Shahin; Moloudizargari, Milad; Javaherypour, Soheil] Urmia Univ, Fac Vet Med, Orumiyeh, Iran.
RP Javanbakht, J (reprint author), Univ Tehran, Fac Vet Med, Dept Pathobiol, Tehran, Iran.
EM javadpatho@gmail.com
RI Saifzadeh, Siamak/J-1240-2012
OI Saifzadeh, Siamak/0000-0002-0295-7477
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   Barati F, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-120
   BLACK L, 1967, VET REC, V80, P198, DOI 10.1136/vr.80.5.198
   Bojrab JM, 1993, DISEASEMECHANISM SMA, V663-667, P1009
   Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917
   Brighton CT, 1997, J ORTHOP TRAUMA, V11, P244, DOI 10.1097/00005131-199705000-00002
   Choupina M, 2004, BRIT J PLAST SURG, V57, P465, DOI 10.1016/j.bjps.2003.12.007
   DELLOYE C, 1992, CLIN ORTHOP RELAT R, P273
   Fossum TW, 2002, TXB SMALL ANIMAL SUR, P381
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   Gil-Albarova J, 2004, BIOMATERIALS, V25, P4639, DOI 10.1016/j.biomaterials.2003.12.009
   Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010
   Gogolewski S, 2000, BIOMATERIALS, V21, P2513, DOI 10.1016/S0142-9612(00)00119-8
   GONG JK, 1964, ANAT REC, V149, P319, DOI 10.1002/ar.1091490302
   GRUNDEL RE, 1991, CLIN ORTHOP RELAT R, P244
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1
   HOLMES RE, 1986, J BONE JOINT SURG AM, V68A, P904, DOI 10.2106/00004623-198668060-00013
   Itoh T, 1998, J VET MED SCI, V60, P451, DOI 10.1292/jvms.60.451
   Jazrawi LM, 1998, J ORTHOP TRAUMA, V12, P111, DOI 10.1097/00005131-199802000-00008
   Kato T, 1998, J ORTHOP RES, V16, P654, DOI 10.1002/jor.1100160605
   Khaki F, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-98
   Kroese-Deutman HC, 2008, INT J ORAL MAX SURG, V37, P542, DOI 10.1016/j.ijom.2008.01.009
   Li G, 1999, J ORTHOP RES, V17, P362, DOI 10.1002/jor.1100170310
   Macedo Nelson Luiz de, 2004, J. Appl. Oral Sci., V12, P137, DOI 10.1590/S1678-77572004000200011
   Mackenzie DJ, 2001, PLAST RECONSTR SURG, V107, P989, DOI 10.1097/00006534-200104010-00013
   Matsuzaki H, 2007, CALCIFIED TISSUE INT, V80, P391, DOI 10.1007/s00223-007-9031-3
   Murakami N, 2002, J BIOMED MATER RES, V62, P169, DOI 10.1002/jbm.10236
   Ongpipattanakul B, 1997, J BIOMED MATER RES, V36, P295, DOI 10.1002/(SICI)1097-4636(19970905)36:3<295::AID-JBM4>3.0.CO;2-9
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Petcu EB, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-78
   Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050
   Salkeld SL, 2001, J BONE JOINT SURG AM, V83A, P803, DOI 10.2106/00004623-200106000-00001
   Sheller MR, 2004, J ORTHOPAED RES, V22, P1094, DOI 10.1016/j.orthres.2004.03.009
   SHUKLA BP, 1989, THESIS INDIAN VET RE
   Singh S, 2000, INDIAN J ANIM SCI, V70, P276
   Slatter DH, 2002, TXB SMALL ANIMAL SUR, P1785
   Tavasoly A, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-86
   Tseng SS, 2008, J BONE JOINT SURG AM, V90A, P92, DOI 10.2106/JBJS.G.01192
   Vogelin E, 2005, J BONE JOINT SURG AM, V87A, P1323, DOI 10.2106/JBJS.C.00913
NR 40
TC 5
Z9 5
U1 2
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1746-1596
J9 DIAGN PATHOL
JI Diagn. Pathol.
PD MAR 17
PY 2014
VL 9
AR 59
DI 10.1186/1746-1596-9-59
PG 7
WC Pathology
SC Pathology
GA AF3KY
UT WOS:000334612400001
PM 24636669
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Preslar, AT
   Parigi, G
   McClendon, MT
   Sefick, SS
   Moyer, TJ
   Haney, C
   Waters, EA
   MacRenaris, KW
   Luchinat, C
   Stupp, SI
   Meade, TJ
AF Preslar, Adam T.
   Parigi, Giacomo
   McClendon, Mark T.
   Sefick, Samantha S.
   Moyer, Tyson J.
   Haney, Chad
   Waters, Emily A.
   MacRenaris, Keith W.
   Luchinat, Claudio
   Stupp, Samuel I.
   Meade, Thomas J.
TI Self-assembling peptide nanofibers modulate water exchange and report
   biomaterial localization in vivo
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 247th National Spring Meeting of the American-Chemical-Society (ACS)
CY MAR 16-20, 2014
CL Dallas, TX
SP Amer Chem Soc
C1 [Preslar, Adam T.; Sefick, Samantha S.; Stupp, Samuel I.; Meade, Thomas J.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
   [Moyer, Tyson J.; Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
   [Stupp, Samuel I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA.
   [McClendon, Mark T.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Haney, Chad; Waters, Emily A.; MacRenaris, Keith W.; Meade, Thomas J.] Northwestern Univ, Ctr Adv Mol Imaging, Evanston, IL 60208 USA.
   [Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA.
   [Parigi, Giacomo; Luchinat, Claudio] Univ Florence, Dept Chem, I-50019 Florence, Italy.
   [Parigi, Giacomo; Luchinat, Claudio] Univ Florence, Magnet Resonance Ctr CERM, I-50019 Florence, Italy.
   [Meade, Thomas J.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.
   [Meade, Thomas J.] Northwestern Univ, Dept Radiol, Evanston, IL 60208 USA.
   [Meade, Thomas J.] Northwestern Univ, Evanston, IL 60208 USA.
EM adampreslar@gmail.com
RI Waters, Emily/B-1023-2009; Stupp, Samuel/B-6737-2009
OI Waters, Emily/0000-0003-3479-6054; 
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 16
PY 2014
VL 247
MA 570-INOR
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA AZ8HZ
UT WOS:000348457601650
DA 2018-10-20
ER

PT J
AU Dhanalakshmi, CP
   Vijayalakshmi, L
   Narayanan, V
AF Dhanalakshmi, C. P.
   Vijayalakshmi, L.
   Narayanan, V.
TI Electrochemical Studies of Hydroxyapatitie-Poly Ethylene Glycol
   Nanocomposite
SO SYNTHESIS AND REACTIVITY IN INORGANIC METAL-ORGANIC AND NANO-METAL
   CHEMISTRY
LA English
DT Article
DE 4-nitrophenol; 2-nitrophenol hydroxyapatite; electrochemistry oxidation;
   nanocrystalline; nanocomposite; poly ethylene glycol
ID CARBON-PASTE ELECTRODE; VOLTAMMETRIC DETERMINATION; NITROPHENOL ISOMERS;
   4-NITROPHENOL; PHENOL; SENSOR; FILM
AB Hydroxyapatite(HAp)-poly ethylene glycol (PEG) nanocomposites of varying composition for biomaterial applications have been synthesized. The HAp/PEG nanocomposite materials were characterized by XRD, FTIR, FESEM, and HRTEM. Hydroxyapatite (HAp) nanorod embedded composite was prepared using PEG as a matrix with different weight percentages (wt%). The results indicated that the size and crystallinity of HAp nanoparticles decreases with increase in PEG concentration in the composite. HRTEM confirms the presence of HAp nano rod crystals in PEG matrix. Cyclic voltammograms (CVs) were recorded to evaluate the electrocatalytic behaviors of the modified electrode towards the oxidation of 4-NP in the potential range of 0 to +1.0V. A glassy carbon electrode was modified with HAp-PEG nanocomposite and characterized in terms of electrochemical oxidation of 4-nitrophenol (4-NP) and 2-nitrophenol (2-NP) via cyclic voltammetry. The catalytic reaction facilitates electron transfer between 4-NP and the modified electrode, as a result the electrochemical oxidation of 4-NP becomes easier. The reason for this is that the HAp-PEG 40 can act as a promoter to increase the rate of electron transfer, lower the overpotential of 4-NP and 2-NP at the bare electrode, and the anodic peak shifts less positive potential. Thus, it is clear that HAp-PEG 40 modified GCE can be successfully used for the determination of organic pollutant.
C1 [Dhanalakshmi, C. P.; Narayanan, V.] Univ Madras, Dept Inorgan Chem, Madras 600025, Tamil Nadu, India.
   [Dhanalakshmi, C. P.] Dhanalakshmi Coll Engn, Madras, Tamil Nadu, India.
   [Vijayalakshmi, L.] Annai Veilankannis Coll Women, Madras, Tamil Nadu, India.
RP Narayanan, V (reprint author), Univ Madras, Dept Inorgan Chem, Sch Chem Sci, Guindy Maraimalai Campus, Madras 600025, Tamil Nadu, India.
EM vnnara@yahoo.co.in
CR Choudhury A, 2009, POLYMER, V50, P201, DOI 10.1016/j.polymer.2008.10.044
   Cordero-Rando MD, 1999, MIKROCHIM ACTA, V132, P7
   Dhanalakshmi C. P., 2012, INT J NANOMATER SCI, V1, P81
   El Mhammedi MA, 2009, J HAZARD MATER, V163, P323, DOI 10.1016/j.jhazmat.2008.06.126
   El Mhanunedi MA, 2007, ELECTROANAL, V19, P1727, DOI 10.1002/elan.200703927
   El Mohammedi M. A., 2009, J HAZARD MATER, V161, P55
   Fischer J, 2007, INT J ELECTROCHEM SC, V2, P226
   Galeano-Diaz T, 2000, J AGR FOOD CHEM, V48, P4508, DOI 10.1021/jf000118z
   Guo XF, 2004, TALANTA, V64, P135, DOI 10.1016/j.talanta.2004.01.020
   Hu SS, 2001, TALANTA, V54, P115, DOI 10.1016/S0039-9140(00)00658-5
   Huang WS, 2003, ANAL BIOANAL CHEM, V375, P703, DOI 10.1007/s00216-002-1745-5
   Kafi AKM, 2009, TALANTA, V79, P97, DOI 10.1016/j.talanta.2009.03.015
   Killoy WJ, 1998, INT DENT J, V48, P305, DOI 10.1111/j.1875-595X.1998.tb00721.x
   Li JD, 2009, J MATER SCI-MATER M, V20, P1031, DOI 10.1007/s10856-008-3664-2
   Lin KL, 2009, J HAZARD MATER, V161, P231, DOI 10.1016/j.jhazmat.2008.03.076
   Liu ZN, 2009, ELECTROCHEM COMMUN, V11, P1365, DOI 10.1016/j.elecom.2009.05.004
   Niaz A., 2009, ELECTROANAL, V21, P178
   Niazi A, 2007, J HAZARD MATER, V146, P421, DOI 10.1016/j.jhazmat.2007.03.063
   Nistor C, 2001, ANAL CHIM ACTA, V426, P185, DOI 10.1016/S0003-2670(00)00825-4
   Raynaud S, 2002, BIOMATERIALS, V23, P1073, DOI 10.1016/S0142-9612(01)00219-8
   Thompson MJ, 1996, J CHROMATOGR B, V677, P117, DOI 10.1016/0378-4347(95)00368-1
   Wang B, 2009, BIOSENS BIOELECTRON, V24, P1141, DOI 10.1016/j.bios.2008.06.053
   Yang CH, 2004, MICROCHIM ACTA, V148, P87, DOI 10.1007/s00604-004-0240-4
   Yang X, 2001, MIKROCHIM ACTA, V136, P73, DOI 10.1007/s006040170070
   Yin HS, 2010, MICROCHIM ACTA, V169, P87, DOI 10.1007/s00604-010-0309-1
NR 25
TC 2
Z9 2
U1 1
U2 63
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1553-3174
EI 1553-3182
J9 SYNTH REACT INORG M
JI Synth. React. Inorg. Met.-Org. Nano-Metal Chem.
PD MAR 16
PY 2014
VL 44
IS 3
BP 329
EP 335
DI 10.1080/15533174.2013.770762
PG 7
WC Chemistry, Inorganic & Nuclear; Nanoscience & Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA 247KO
UT WOS:000326616500003
DA 2018-10-20
ER

PT J
AU Konig, K
   Uchugonova, A
   Breunig, HG
AF Koenig, Karsten
   Uchugonova, Aisada
   Breunig, Hans Georg
TI High-resolution multiphoton cryomicroscopy
SO METHODS
LA English
DT Article
DE Cryopreservation; Multiphoton imaging; Cryomicroscope; Freezing;
   Biobank; Two-photon; FLIM
ID CRYOGENIC LIGHT-MICROSCOPY; CRYOELECTRON MICROSCOPY; FLUORESCENCE
   MICROSCOPY; HUMAN SPERM; CELLS; CRYOPRESERVATION; ICE; TEMPERATURE;
   MATRIX; LASERS
AB An ultracompact high-resolution multiphoton cryomicroscope with a femtosecond near infrared fiber laser has been utilized to study the cellular autofluorescence during freezing and thawing of cells. Cooling resulted in an increase of the intracellular fluorescence intensity followed by morphological modifications at temperatures below -10 degrees C, depending on the application of the cryoprotectant DMSO and the cooling rate.
   Furthermore, fluorescence lifetime imaging revealed an increase of the mean lifetime with a decrease in temperature. Non-destructive, label-free optical biopsies of biomaterial in ice can be obtained with sub-20 mW mean powers. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Koenig, Karsten; Breunig, Hans Georg] JenLab GmbH, D-07745 Jena, Germany.
   [Koenig, Karsten; Uchugonova, Aisada; Breunig, Hans Georg] Univ Saarland, Dept Biophoton & Laser Technol, D-66123 Saarbrucken, Germany.
RP Konig, K (reprint author), JenLab GmbH, Schillerstr 1, D-07745 Jena, Germany.
EM koenig@jenlab.de
CR ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0
   Amorim CA, 2009, HUM REPROD, V24, P92, DOI 10.1093/humrep/den343
   An J, 2007, OPT LETT, V32, P2010, DOI 10.1364/OL.32.002010
   Breunig HG, 2013, PROC SPIE, V8588, DOI 10.1117/12.2001994
   Breunig HG, 2012, PROC SPIE, V8225, DOI 10.1117/12.908348
   Breunig H.G., 2012, J BIOPHOTONICS, DOI [10.1002/jbio.201200093, DOI 10.1002/JBI0.201200093]
   BROMWICH P, 1978, BRIT J OBSTET GYNAEC, V85, P641, DOI 10.1111/j.1471-0528.1978.tb14940.x
   Brown CTA, 2008, J BIOPHOTONICS, V1, P183, DOI 10.1002/jbio.200810011
   Bugiel I., 1989, LASER LIFE SCI, V3, P1
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Devireddy RV, 2000, HUM REPROD, V15, P1125, DOI 10.1093/humrep/15.5.1125
   Doerr Daniel, 2009, Biotechnology Journal, V4, P1215, DOI 10.1002/biot.200800212
   GALLY JA, 1962, BIOCHIM BIOPHYS ACTA, V60, P499, DOI 10.1016/0006-3002(62)90869-7
   Haga SB, 2008, ADV GENET, V60, P505, DOI 10.1016/S0065-2660(07)00418-X
   Harris L.W., 1977, CRYOBIOLOGY, P141
   Hashem Y, 2013, NATURE, V494, P385, DOI 10.1038/nature11872
   ISHIGURO H, 1994, CRYOBIOLOGY, V31, P483, DOI 10.1006/cryo.1994.1059
   Konig K, 2008, J BIOPHOTONICS, V1, P13, DOI 10.1002/jbio.200710022
   Konig K, 1996, J MICROSC-OXFORD, V183, P197
   Konig K., 1994, J FLUORESC, V4, P17
   Konig K., 2012, INTRAVITAL, V1, P11, DOI DOI 10.4161/INTV.21938
   Le Gros MA, 2009, J MICROSC-OXFORD, V235, P1, DOI 10.1111/j.1365-2818.2009.03184.x
   LOVELOCK JE, 1959, NATURE, V183, P1394, DOI 10.1038/1831394a0
   MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939
   Mazur P., 1984, CRYOBIOLOGY, V0363, P6143
   Morris GJ, 2006, HUM REPROD, V21, P2075, DOI 10.1093/humrep/del116
   Muller-Thurgau H, 1880, LANDW JB, V9, P133
   NAG KK, 1973, NATURE, V245, P270, DOI 10.1038/245270a0
   Pegg D.E., 2009, PRINCIPLES CRYOPRESE
   PISTON DW, 1992, P SOC PHOTO-OPT INS, V1640, P379, DOI 10.1117/12.58230
   POLGE C, 1949, NATURE, V164, P666, DOI 10.1038/164666a0
   QUISTORFF B, 1985, ANAL BIOCHEM, V148, P389, DOI 10.1016/0003-2697(85)90244-1
   Richardson D.J., 2010, J OPT SOC AM B, V27, P30
   Ryan J., 2004, LIFE SCI, P17
   Schenke-Layland K, 2006, ANN THORAC SURG, V81, P918, DOI 10.1016/j.athoracsur.2005.09.016
   Schwartz CL, 2007, J MICROSC-OXFORD, V227, P98, DOI 10.1111/j.1365-2818.2007.01794.x
   Smith D, 1998, WORLD J MICROB BIOT, V14, P49
   Spindler R., 2008, CRYOBIOLOGY, V57, P337
   Stark M, 2007, PROC SPIE, V6628, DOI 10.1117/12.728317
   Tathagata A., 2010, J BIOTECHNOL, V4, P26
   THORPE PE, 1976, CRYOBIOLOGY, V13, P126, DOI 10.1016/0011-2240(76)90123-1
   Warren SG, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009744
   Wise FW, 2008, LASER PHOTONICS REV, V2, P58, DOI 10.1002/lpor.200710041
   ZEILMAKER GH, 1984, FERTIL STERIL, V42, P293
NR 44
TC 6
Z9 6
U1 1
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD MAR 15
PY 2014
VL 66
IS 2
BP 230
EP 236
DI 10.1016/j.ymeth.2013.07.006
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AE1ZM
UT WOS:000333773100013
PM 23867337
DA 2018-10-20
ER

PT J
AU Czaja, W
   Kyryliouk, D
   DePaula, CA
   Buechter, DD
AF Czaja, Wojciech
   Kyryliouk, Dmytro
   DePaula, C. Alex
   Buechter, Douglas D.
TI Oxidation of gamma- Irradiated Microbial Cellulose Results in
   Bioresorbable, Highly Conformable Biomaterial
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID BACTERIAL CELLULOSE; REGENERATED CELLULOSE; MECHANICAL-PROPERTIES;
   BIODEGRADATION; RADIATION; SCAFFOLD
C1 [Czaja, Wojciech; Kyryliouk, Dmytro; DePaula, C. Alex; Buechter, Douglas D.] DePuy Synthes Biomat, W Chester, PA 19380 USA.
RP Czaja, W (reprint author), DePuy Synthes Biomat, 1230 Wilson Dr, W Chester, PA 19380 USA.
EM czaja.wojciech@synthes.com
CR Alvarez OM, 2004, WOUNDS, V16, P224
   [Anonymous], BACT END TEST
   [Anonymous], 2007, 10993 ISO 6
   Bodin A, 2007, J TISSUE ENG REGEN M, V1, P406, DOI 10.1002/term.51
   Calvini P, 2006, VIB SPECTROSC, V40, P177, DOI 10.1016/j.vibspec.2005.08.004
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   DEVI KS, 1986, BIOMATERIALS, V7, P193
   DIMITRIJEVICH SD, 1990, CARBOHYD RES, V195, P247
   DIMITRIJEVICH SD, 1990, CARBOHYD RES, V198, P331
   Driscoll M, 2009, RADIAT PHYS CHEM, V78, P539, DOI 10.1016/j.radphyschem.2009.03.080
   Ershov B. G, 1998, RUSS CHEM REV, V67, P315
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Hu Y, 2011, ACTA BIOMATER, V7, P2835, DOI 10.1016/j.actbio.2011.03.028
   Kim UJ, 2004, CARBOHYD POLYM, V56, P7, DOI 10.1016/j.carbpol.2003.10.013
   Kim UJ, 2000, BIOMACROMOLECULES, V1, P488, DOI 10.1021/bm0000337
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kovalev GV, 2003, HIGH ENERG CHEM+, V37, P209, DOI 10.1023/A:1024790415083
   Laurence S, 2005, J BIOMED MATER RES A, V73A, P422, DOI 10.1002/jbm.a.30280
   Li J, 2009, MAT SCI ENG C-BIO S, V29, P1635, DOI 10.1016/j.msec.2009.01.006
   Losquadro WD, 2009, ARCH FACIAL PLAST S, V11, P104, DOI 10.1001/archfacial.2008.512
   MARES T, 1969, J POLYM SCI POL LETT, V7, P419, DOI 10.1002/pol.1969.110070603
   Mester L., 1955, ACS, V77, P5452
   Nevell TP, 1963, METHODS CARBOHYDRATE, V3, P164
   NISHI Y, 1990, J MATER SCI, V25, P2997, DOI 10.1007/BF00584917
   OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579
   PIERCE AM, 1984, J ORAL PATHOL MED, V13, P661, DOI 10.1111/j.1600-0714.1984.tb01468.x
   POMMERENING K, 1992, CARBOHYD RES, V233, P219, DOI 10.1016/S0008-6215(00)90933-9
   RoyChowdhury P, 2006, J BIOMED MATER RES A, V76A, P300, DOI 10.1002/jbm.a.30503
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6
   SINGH M, 1982, BIOMATERIALS, V3, P16, DOI 10.1016/0142-9612(82)90055-2
   Stilwell R. L., 1997, HDB BIODEGRADABLE PO, P291
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Vicini S, 2004, THERMOCHIM ACTA, V418, P123, DOI 10.1016/j.tca.2003.11.049
   Yadav V, 2010, APPL ENVIRON MICROB, V76, P6257, DOI 10.1128/AEM.00698-10
   Yamada Y, 2012, J GEN APPL MICROBIOL, V58, P397, DOI 10.2323/jgam.58.397
NR 37
TC 9
Z9 9
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 15
PY 2014
VL 131
IS 6
AR 39995
DI 10.1002/app.39995
PG 12
WC Polymer Science
SC Polymer Science
GA AA3PM
UT WOS:000331004800066
DA 2018-10-20
ER

PT J
AU Cakic, SM
   Ristic, IS
   Krakovsky, I
   Stojiljkovic, DT
   Belsky, P
   Kollova, L
AF Cakic, Suzana M.
   Ristic, Ivan S.
   Krakovsky, Ivan
   Stojiljkovic, Dragan T.
   Belsky, Petr
   Kollova, Lucie
TI Crystallization and thermal properties in waterborne polyurethane
   elastomers: Influence of mixed soft segment block
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Elastomers; Chemical synthesis; X-ray scattering; Crystal structure
ID MASS-TRANSFER PROPERTIES; MOLECULAR-WEIGHT; STRUCTURAL-CHARACTERIZATION;
   MELTING TEMPERATURE; CHEMICAL-STRUCTURE; DEGRADATION; DISPERSIONS;
   POLYCARBONATE; GLYCOL); MORPHOLOGY
AB A series of nontoxic biodegradable waterborne polyurethane (WBPUs) elastomers were synthesized by two-step polymerization, using isophorone diisocyanate (IPDI), 1,4-butandiol (BDO) and L-lysine as a chain extender and a range of soft segments with various macrodiols composition. The soft segment was formed by replacing polycaprolactone diol (PCL) as a polyester type polyol with hydrophilic polyether type polyol. Hydrophilic poly(ethylene glycol) (PEG) or poly(propylene glycol) (PPG) different block lengths were used to this purpose.
   Fourier-transformed infrared spectroscopy (FTIR) was used for evaluation of degree of phase separation. The effect of the soft segment composition on the thermal properties of polyurethane elastomeric films was investigated by means of thermogravimetry analysis (TGA) and differential scanning calorimetry (DSC). The thermal stability of materials is influenced by composition of soft segments and it was explained by the effect of oxygen content of polyether polyols, the length polyether block and interaction between the soft and hard segment. The wide-angle X-ray scattering (WAXS) is used to investigate the degree of crystallinity of PCL in soft segment of WBPUs. It was found that the polyether polyol length in the soft segment had a significant influence on degree of microphase separation in the soft and hard segment and crystallization behaviour of the materials. The restriction of the crystallization of the PCL soft segment depends on the hard segment content and length of the polyether polyol.
   The results show that the properties of polyurethanes prepared are directly related to the soft segment composition and can be varied easily for a different set of properties that are significant for biomaterial application. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Cakic, Suzana M.; Stojiljkovic, Dragan T.] Univ Nis, Fac Technol, Leskovac 16000, Serbia.
   [Ristic, Ivan S.] Univ Novi Sad, Fac Technol, Novi Sad 21000, Serbia.
   [Krakovsky, Ivan] Charles Univ Prague, Fac Math & Phys, Dept Macromol Phys, CR-18000 Prague 2, Czech Republic.
   [Belsky, Petr; Kollova, Lucie] Univ W Bohemia, New Technol Res Ctr, Plzen 30614, Czech Republic.
RP Cakic, SM (reprint author), Univ Nis, Fac Technol, Bulevar Oslobodjenja 124, Leskovac 16000, Serbia.
EM suzana_cakic@yahoo.com
RI Ristic, Ivan/B-4774-2010; Belsky, Petr/E-7710-2016
OI Ristic, Ivan/0000-0003-4124-4901; Ristic, Ivan/0000-0002-4470-4929
FU Ministry of Education, Science and Technological Development of the
   Republic of Serbia [III 45022, TR 33034]
FX The project was financed by the Ministry of Education, Science and
   Technological Development of the Republic of Serbia (Projects No. III
   45022 and TR 33034).
CR Ayres E, 2007, EUR POLYM J, V43, P3510, DOI 10.1016/j.eurpolymj.2007.05.014
   Bogdanov B, 1999, POLYMER, V40, P3171, DOI 10.1016/S0032-3861(98)00552-7
   Cakic SM, 2013, MATER CHEM PHYS, V138, P277, DOI 10.1016/j.matchemphys.2012.11.057
   Cakic SM, 2013, INT J ADHES ADHES, V41, P132, DOI 10.1016/j.ijadhadh.2012.11.001
   Cakic SM, 2009, POLYM DEGRAD STABIL, V94, P2015, DOI 10.1016/j.polymdegradstab.2009.07.015
   Cakie S. M., 2012, THERMAL ANAL POLYURE, P79
   Chattopadhyay DK, 2009, PROG POLYM SCI, V34, P1068, DOI 10.1016/j.progpolymsci.2009.06.002
   Cometa S, 2010, POLYM DEGRAD STABIL, V95, P2013, DOI 10.1016/j.polymdegradstab.2010.07.007
   Coutinho FMB, 2000, POLYM DEGRAD STABIL, V70, P49, DOI 10.1016/S0141-3910(00)00087-2
   Eceiza A, 2008, POLYM ENG SCI, V48, P297, DOI 10.1002/pen.20905
   Garcia-Pacios V, 2011, INT J ADHES ADHES, V31, P787, DOI 10.1016/j.ijadhadh.2011.05.010
   Jiang X, 2007, EUR POLYM J, V43, P1838, DOI 10.1016/j.eurpolymj.2007.02.029
   Leonardi D, 2007, AAPS PHARMSCITECH, V8, P221
   Lin MC, 2012, MACROMOLECULES, V45, P5114, DOI 10.1021/ma300711k
   Lu MG, 2002, J APPL POLYM SCI, V85, P2552, DOI 10.1002/app.10882
   May-Hernandez L, 2011, J APPL POLYM SCI, V119, P2093, DOI 10.1002/app.32929
   Mondal S, 2006, J MEMBRANE SCI, V276, P16, DOI 10.1016/j.memsci.2005.09.029
   Mondal S, 2006, POLYM INT, V55, P1013, DOI 10.1002/pi.2026
   Mondal S, 2012, POLYM DEGRAD STABIL, V97, P1553, DOI 10.1016/j.polymdegradstab.2012.04.008
   O'Sickey MJ, 2002, J APPL POLYM SCI, V84, P229, DOI 10.1002/app.10168
   Perez-Liminana MA, 2005, INT J ADHES ADHES, V25, P507, DOI 10.1016/j.ijadhadh.2005.02.002
   PETROVIC ZS, 1994, J APPL POLYM SCI, V51, P1087, DOI 10.1002/app.1994.070510615
   Pielichowski K, 1996, THERMOCHIM ACTA, V284, P419, DOI 10.1016/0040-6031(95)02342-9
   Princi E, 2009, MACROMOL CHEM PHYSIC, V210, P879, DOI 10.1002/macp.200900013
   Rafaja D., 2000, MATER STRUCT, V7, P43
   Saralegi A, 2013, POLYM INT, V62, P106, DOI 10.1002/pi.4330
   Waghmare A, 2008, AAPS PHARMSCITECH, V9, P536, DOI 10.1208/s12249-008-9077-1
   Wang TL, 1997, POLYM DEGRAD STABIL, V55, P95, DOI 10.1016/S0141-3910(96)00130-9
   Wen TC, 1999, POLYMER, V40, P3979, DOI 10.1016/S0032-3861(98)00625-9
   Yu LQ, 2011, J COLLOID INTERF SCI, V358, P376, DOI 10.1016/j.jcis.2011.03.007
NR 30
TC 18
Z9 19
U1 13
U2 181
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD MAR 14
PY 2014
VL 144
IS 1-2
BP 31
EP 40
DI 10.1016/j.matchemphys.2013.12.008
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA AB3GD
UT WOS:000331678400005
DA 2018-10-20
ER

PT J
AU de la Puente, P
   Ludena, D
AF de la Puente, Pilar
   Ludena, Dolores
TI Cell culture in autologous fibrin scaffolds for applications in tissue
   engineering
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Review
DE Autologous; Fibrin scaffolds; Tissue engineering; Fibrinogen; Cell
   culture
ID MESENCHYMAL STEM-CELLS; HUMAN DERMAL FIBROBLASTS; IN-VITRO; OSTEOGENIC
   DIFFERENTIATION; THROMBIN CONCENTRATION; VASCULAR CONSTRUCTS;
   CALCIUM-CHLORIDE; COLLAGEN; GEL; GLUE
AB In tissue engineering techniques, three-dimensional scaffolds are needed to adjust and guide cell growth and to allow tissue regeneration. The scaffold must be biocompatible, biodegradable and must benefit the interactions between cells and biomaterial. Some natural biomaterials such as fibrin provide a structure similar to the native extracellular matrix containing the cells. Fibrin was first used as a sealant based on pools of commercial fibrinogen. However, the high risk of viral transmission of these pools led to the development of techniques of viral inactivation and elimination and the use of autologous fibrins. In recent decades, fibrin has been used as a release system and three-dimensional scaffold for cell culture. Fibrin scaffolds have been widely used for the culture of different types of cells, and have found several applications in tissue engineering. The structure and development of scaffolds is a key point for cell culture because scaffolds of autologous fibrin offer an important alternative due to their low fibrinogen concentrations, which are more suitable for cell growth.
   With this review our aim is to follow methods of development analyze the commercial and autologous fibrins available and assess the possible applications of cell culture in tissue engineering in these three-dimensional structures. (C) 2013 Elsevier Inc. All rights reserved.
C1 [de la Puente, Pilar] Washington Univ, St Louis Sch Med, Dept Radiat Oncol, Div Canc Biol, St Louis, MO 63108 USA.
   [Ludena, Dolores] Univ Hosp Salamanca, Pathol Serv, Salamanca, Spain.
RP de la Puente, P (reprint author), Washington Univ, St Louis Sch Med, Dept Radiat Oncol, Div Canc Biol, 4511 Forest Pk Ave,Room 3103, St Louis, MO 63108 USA.
EM ppuente@radonc.wustl.edu
FU Diputacion Provincial of Leon; Tissue Bank San Francisco Clinic
   Foundation of Leon; University of Leon from the Manuel Elkin Patarroyo
   Foundation
FX This research was supported by the Diputacion Provincial of Leon, the
   Tissue Bank San Francisco Clinic Foundation of Leon and the University
   of Leon thanks to a fellowship grant from the Manuel Elkin Patarroyo
   Foundation.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Ahmed TAE, 2007, TISSUE ENG, V13, P1469, DOI 10.1089/ten.2006.0354
   Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647
   Alston SM, 2007, TRANSL RES, V149, P187, DOI 10.1016/j.trsl.2006.08.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Barsotti MC, 2011, CELL PROLIFERAT, V44, P33, DOI 10.1111/j.1365-2184.2010.00715.x
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bergel S, 1909, DEUT MED WOCHENSCHR, V35, P663, DOI 10.1055/s-0029-1201395
   Birla RK, 2005, TISSUE ENG, V11, P803, DOI 10.1089/ten.2005.11.803
   Borges J, 2003, TISSUE ENG, V9, P1263, DOI 10.1089/10763270360728170
   Bosnakovski D, 2004, EXP HEMATOL, V32, P502, DOI 10.1016/j.exphem.2004.02.009
   Briganti E, 2010, J CONTROL RELEASE, V142, P14, DOI 10.1016/j.jconrel.2009.09.029
   Carriel V, 2012, CELLS TISSUES ORGANS, V196, P1, DOI 10.1159/000330682
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Cho SW, 2005, BIOMATERIALS, V26, P3577, DOI 10.1016/j.biomaterials.2004.09.013
   Cholewinski E, 2009, TISSUE ENG PT A, V15, P3645, DOI [10.1089/ten.tea.2009.0235, 10.1089/ten.TEA.2009.0235]
   Clark RAF, 2003, J INVEST DERMATOL, V121, pXXI, DOI 10.1046/j.1523-1747.2003.12575.x
   Cornelissen CG, 2012, ANN BIOMED ENG, V40, P679, DOI 10.1007/s10439-011-0437-8
   Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392
   Cronkite EP, 1944, J AMER MED ASSOC, V124, P976, DOI 10.1001/jama.1944.02850140022006
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   de la Puente P, 2013, EXP CELL RES, V319, P144, DOI 10.1016/j.yexcr.2012.10.009
   de la Puente P, 2011, J BIOMED MATER RES A, V99A, P648, DOI 10.1002/jbm.a.33231
   Demol J, 2011, EUR CELLS MATER, V21, P272, DOI 10.22203/eCM.v021a21
   Dodd RY, 2000, ANN MED, V32, P469, DOI 10.3109/07853890009002022
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Gailit J, 1997, EXP CELL RES, V232, P118, DOI 10.1006/excr.1997.3512
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   GIBBLE JW, 1990, TRANSFUSION, V30, P741, DOI 10.1046/j.1537-2995.1990.30891020337.x
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hale BW, 2012, AM J VET RES, V73, P313, DOI 10.2460/ajvr.73.2.313
   Han B, 2002, CORNEA, V21, P505, DOI 10.1097/01.ICO.0000016343.19018.1D
   Hankemeier S, 2007, ARCH ORTHOP TRAUM SU, V127, P815, DOI 10.1007/s00402-007-0366-z
   Henschen A., BLOOD COAGULATION, P171
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004
   Jackson MR, 1996, BLOOD COAGUL FIBRIN, V7, P737, DOI 10.1097/00001721-199611000-00001
   Jackson MR, 2001, AM J SURG, V182, p1S, DOI 10.1016/S0002-9610(01)00770-X
   Jeon O, 2005, J CONTROL RELEASE, V105, P249, DOI 10.1016/j.jconrel.2005.03.023
   Joch C, 2003, CARDIOVASC SURG, V11, P23, DOI 10.1016/S0967-2109(03)00068-1
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Kim DY, 2010, LARYNGOSCOPE, V120, P30, DOI 10.1002/lary.20652
   Kjaergard HK, 2000, THROMB RES, V98, P221, DOI 10.1016/S0049-3848(99)00234-0
   Klin B, 2007, J LAPAROENDOSC ADV S, V17, P342, DOI 10.1089/lap.2006.0165
   Lauricella AM, 2007, ACTA BIOQUIM CLIN L, V41, P7
   Le Guehennec L, 2007, J MATER SCI-MATER M, V18, P1489, DOI 10.1007/s10856-006-0086-x
   Lesman A, 2011, BIOMATERIALS, V32, P7856, DOI 10.1016/j.biomaterials.2011.07.003
   Li B, 2013, J BIOMED MATER RES A, V101, P3097, DOI 10.1002/jbm.a.34618
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Liu J, 2013, ACTA BIOMATER, V9, P4688, DOI 10.1016/j.actbio.2012.08.009
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Macedo A, 2004, J THORAC CARDIOV SUR, V127, P1593, DOI 10.1016/j.jtcvs.2004.01.039
   Makogonenko E, 2002, BIOCHEMISTRY-US, V41, P7907, DOI 10.1021/bi025770x
   Mandal BB, 2009, BIOMATERIALS, V30, P5019, DOI 10.1016/j.biomaterials.2009.05.064
   McGill Victoria, 1997, Journal of Burn Care and Rehabilitation, V18, P429, DOI 10.1097/00004630-199709000-00011
   Mosesson M W, 1999, Blood Coagul Fibrinolysis, V10 Suppl 1, pS45
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Ng KW, 2004, BIOMATERIALS, V25, P2807, DOI 10.1016/j.biomaterials.2003.09.058
   Page RL, 2011, TISSUE ENG PT A, V17, P2629, DOI [10.1089/ten.tea.2011.0024, 10.1089/ten.TEA.2011.0024]
   Paxton JZ, 2012, TISSUE ENG PT A, V18, P1596, DOI [10.1089/ten.tea.2011.0535, 10.1089/ten.TEA.2011.0535]
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P189
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Reiss RF, 1996, TRANSFUS MED REV, V10, P85, DOI 10.1016/S0887-7963(96)80085-X
   Rentsch C, 2010, J BIOMED MATER RES A, V92A, P185, DOI 10.1002/jbm.a.32314
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Sahni A, 2000, BLOOD, V96, P3772
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   SHIBA Y, 1989, CELL STRUCT FUNCT, V14, P473
   Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206
   Siedentop KH, 2001, AM J OTOLARYNG, V22, P230, DOI 10.1053/ajot.2001.24817
   Sierra DH, 2002, J BIOMED MATER RES, V59, P1
   SILVER FH, 1995, BIOMATERIALS, V16, P891, DOI 10.1016/0142-9612(95)93113-R
   Sung HJ, 2005, TISSUE ENG, V11, P267, DOI 10.1089/ten.2005.11.267
   Tabele C, 2012, J PHARM PHARM SCI, V15, P124, DOI 10.18433/J39K5H
   TREDWELL SJ, 1990, SPINE, V15, P913, DOI 10.1097/00007632-199009000-00014
   Vavken P, 2011, KNEE, V18, P42, DOI 10.1016/j.knee.2009.12.008
   Walles T, 2004, J THORAC CARDIOV SUR, V128, P900, DOI 10.1016/j.jtcvs.2004.07.036
   Wang MC, 1995, MAT SCI ENG C-BIOMIM, V3, P131, DOI 10.1016/0928-4931(95)00116-6
   Weber M., 2013, TISSUE ENG PART C-ME, DOI DOI 10.1089/TENSEC.2013.0258
   Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x
   Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang Y. I., 2007, Current Applied Physics, V7, pe103, DOI 10.1016/j.cap.2006.11.026
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
   Zhang Yun-song, 2008, Zhonghua Yi Xue Za Zhi, V88, P2705
   Zhao HG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015001
   Zhou HZ, 2011, BIOMATERIALS, V32, P7503, DOI 10.1016/j.biomaterials.2011.06.045
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zurita M, 2011, TRAUMA-SPAIN, V22, P38
NR 99
TC 37
Z9 37
U1 0
U2 44
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD MAR 10
PY 2014
VL 322
IS 1
BP 1
EP 11
DI 10.1016/j.yexcr.2013.12.017
PG 11
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA AB8QU
UT WOS:000332055900001
PM 24378385
DA 2018-10-20
ER

PT J
AU Bini, D
   Russo, L
   Battocchio, C
   Natalello, A
   Polzonetti, G
   Doglia, SM
   Nicotra, F
   Cipolla, L
AF Bini, Davide
   Russo, Laura
   Battocchio, Chiara
   Natalello, Antonin
   Polzonetti, Giovanni
   Doglia, Silvia Maria
   Nicotra, Francesco
   Cipolla, Laura
TI Dendron Synthesis and Carbohydrate Immobilization on a Biomaterial
   Surface by a Double-Click Reaction
SO ORGANIC LETTERS
LA English
DT Article
ID BIOLOGICAL-SIGNIFICANCE; CHEMICAL GLYCOBIOLOGY; MULTIVALENT LIGANDS; I
   COLLAGEN; GLYCOSYLATION; BINDING; TOOLS; NANOPARTICLES; GLYCOSCIENCE;
   STABILITY
AB The synthesis of new dendrons and their immobilization on collagen patches via thiol-ene photoclick reaction, followed by chemoselective alkoxyamino-carbonyl conjugation to carbohydrates is presented. XPS, FTIR, and ELLA assays confirmed the effectiveness of the collagen multivalent neoglycosylation.
C1 [Bini, Davide; Russo, Laura; Natalello, Antonin; Doglia, Silvia Maria; Nicotra, Francesco; Cipolla, Laura] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy.
   [Battocchio, Chiara; Polzonetti, Giovanni] Univ Roma Tre, INSTM, Dept Sci, CNISM, I-00146 Rome, Italy.
   [Battocchio, Chiara; Polzonetti, Giovanni] Univ Roma Tre, CISDiC, I-00146 Rome, Italy.
RP Cipolla, L (reprint author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.
EM laura.cipolla@unimib.it
RI Natalello, Antonino/B-9659-2012; battocchio, chiara/M-4686-2015; Russo,
   Laura/I-3237-2014
OI Natalello, Antonino/0000-0002-1489-272X; Russo,
   Laura/0000-0002-5914-766X
FU Cariplo Fundation [2010-0378]; PRIN [2010L9SH3K]
FX This research was financially supported by the Cariplo Fundation under
   Grant No. 2010-0378 and PRIN 2010L9SH3K.
CR Ambrosi M, 2005, ORG BIOMOL CHEM, V3, P1593, DOI 10.1039/b414350g
   Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241
   [Anonymous], N1ST XRAY PHOTOELECT
   Ashton PR, 1996, CHEM-EUR J, V2, P1115, DOI 10.1002/chem.19960020913
   Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012
   Baldini L, 2007, CHEM SOC REV, V36, P254, DOI 10.1039/b603082n
   Barnard A, 2012, ANGEW CHEM INT EDIT, V51, P6572, DOI 10.1002/anie.201200076
   Battocchio C, 2010, MATER SCI ENG B-ADV, V169, P36, DOI 10.1016/j.mseb.2009.12.051
   Beamson G., 1992, HIGH RESOLUTION XPS
   Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820
   Bishop JR, 2007, GLYCOBIOLOGY, V17, p23R, DOI 10.1093/glycob/cwm005
   Chawla K, 2012, BIOMATERIALS, V33, P6052, DOI 10.1016/j.biomaterials.2012.04.058
   Cipolla L, 2012, SPR CARB CH, V38, P416, DOI 10.1039/9781849734769-00416
   De la Fuente JM, 2006, BBA-GEN SUBJECTS, V1760, P636, DOI 10.1016/j.bbagen.2005.12.001
   Deng C, 2010, ACTA BIOMATER, V6, P187, DOI 10.1016/j.actbio.2009.07.027
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Guilbert M, 2013, BBA-GEN SUBJECTS, V1830, P3525, DOI 10.1016/j.bbagen.2013.01.016
   Hakomori S, 2001, ADV EXP MED BIOL, V491, P369
   Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008
   Imberty A, 2008, CHEM-EUR J, V14, P7490, DOI 10.1002/chem.200800700
   Irure A, 2013, BIOMATER SCI-UK, V1, P658, DOI 10.1039/c3bm60032g
   Iucci G, 2007, MAT SCI ENG C-BIO S, V27, P1201, DOI 10.1016/j.msec.2006.09.038
   Johnson JL, 2013, TRENDS IMMUNOL, V34, P290, DOI 10.1016/j.it.2013.01.006
   Jurgensen HJ, 2011, J BIOL CHEM, V286, P32736, DOI 10.1074/jbc.M111.266692
   Kalia J, 2008, ANGEW CHEM INT EDIT, V47, P7523, DOI 10.1002/anie.200802651
   Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794
   Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349
   Koepsel JT, 2012, CHEMBIOCHEM, V13, P1717, DOI 10.1002/cbic.201200226
   Ledin PA, 2011, CHEM-EUR J, V17, P839, DOI 10.1002/chem.201002052
   Lim Y, 2007, ORG BIOMOL CHEM, V5, P401, DOI 10.1039/b615744k
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Masand SN, 2012, BIOMATERIALS, V33, P790, DOI 10.1016/j.biomaterials.2011.10.013
   MILLER EJ, 1976, MOL CELL BIOCHEM, V13, P165, DOI 10.1007/BF01731779
   Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383
   Natalello A, 2005, BIOCHEM J, V385, P511, DOI 10.1042/BJ20041296
   Neel E. A. A., 2013, ADV DRUG DELIV REV, V65, P429
   Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019
   Paez JI, 2012, POLYMERS-BASEL, V4, P355, DOI 10.3390/polym4010355
   Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785
   Pieters RJ, 2007, MED RES REV, V27, P796, DOI 10.1002/med.20089
   Pieters RJ, 2009, ORG BIOMOL CHEM, V7, P2013, DOI 10.1039/b901828j
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Roglin L, 2011, ANGEW CHEM INT EDIT, V50, P102, DOI 10.1002/anie.201003968
   Santoyo-Gonzalez F, 2009, CHEM SOC REV, V38, P3449, DOI 10.1039/b909363j
   Sapsford KE, 2013, CHEM REV, V113, P1904, DOI 10.1021/cr300143v
   Seeberger PH, 2009, NAT CHEM BIOL, V5, P368, DOI 10.1038/nchembio0609-368
   Service RF, 2012, SCIENCE, V338, P321, DOI 10.1126/science.338.6105.321
   Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122
   Slaney AM, 2011, ACS APPL MATER INTER, V3, P1601, DOI 10.1021/am200158y
   Sricholpech M, 2012, J BIOL CHEM, V287, P22998, DOI 10.1074/jbc.M112.343954
   Stallforth P, 2009, J MED CHEM, V52, P5561, DOI 10.1021/jm900819p
   Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530
   Taga Y, 2013, J PROTEOME RES, V12, P2225, DOI 10.1021/pr400079d
   Taraballi F, 2013, J COLLOID INTERF SCI, V394, P590, DOI 10.1016/j.jcis.2012.11.041
   Taylor ME, 2009, GLYCOBIOLOGY, V19, P1155, DOI 10.1093/glycob/cwp076
   van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203
   Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499
NR 57
TC 15
Z9 15
U1 4
U2 45
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1523-7060
EI 1523-7052
J9 ORG LETT
JI Org. Lett.
PD MAR 7
PY 2014
VL 16
IS 5
BP 1298
EP 1301
DI 10.1021/ol403476z
PG 4
WC Chemistry, Organic
SC Chemistry
GA AC8AW
UT WOS:000332756400007
PM 24552198
DA 2018-10-20
ER

PT J
AU Li, X
   Fan, DD
   Zhu, CH
   Ma, XX
AF Li, Xian
   Fan, Daidi
   Zhu, Chenhui
   Ma, Xiaoxuan
TI Effects of self-assembled fibers on the synthesis, characteristics and
   biomedical applications of CCAG hydrogels
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID HYALURONIC-ACID; CHITOSAN HYDROGEL; GROWTH; FILMS; HYDROXYAPATITE;
   SCAFFOLDS
AB CS-HLC-HA-beta-GP (chitosan human-like collagen hyaluronic acid-beta-sodium glycerophosphate) hydrogels were prepared based on the self-assembly of CS-HLC-HA (CCA) fibers. The effects of the fibers on the synthesis, characteristics and biomedical applications of CS-HLC-HA-beta-GP (CCAG) hydrogels were studied for various HA contents. The synthesis mechanism of the novel CCAG hydrogel was explored using Fourier transform infrared spectroscopy (FT-IR) and X-ray photoelectron spectroscopy (XPS). The hydrogels were characterized by a swelling test, gelling time and enzymatic treatments. The results indicated that a new amide bond (-CONH) and -NRH2+ were formed. The gelling time and swelling behaviors were dependent on the intertwining, overlap and adsorption of the polymer chains at various temperatures and pH. Furthermore, biomedical applications were evaluated by transmission electron microscopy (TEM), immunohistochemical analysis and haematoxylin and eosin (H&E) staining. The effect of the fibers on the histocompatibility of the hydrogels revealed that the fibers inside the hydrogel pores reduced the quantity of macrophages, decreased the degree of inflammation, and improved the anti-degradation of the modified hydrogels. This type of new hydrogel emerges as an interesting injectable filling biomaterial for tissue engineering.
C1 [Li, Xian; Fan, Daidi; Zhu, Chenhui; Ma, Xiaoxuan] NW Univ Xian, Shaanxi Key Lab Degradable Biomed Mat, Dept Chem Engn, Xian 710069, Shaanxi, Peoples R China.
RP Fan, DD (reprint author), NW Univ Xian, Shaanxi Key Lab Degradable Biomed Mat, Dept Chem Engn, Taibai North Rd 229, Xian 710069, Shaanxi, Peoples R China.
EM fandaidi@nwu.edu.cn
RI Fan, daidi/J-1128-2017
FU National Natural Science Foundation of China [21276210, 21106112,
   21206135, 31000019, 21106111]; NWU Graduate Innovation and Creativity
   Funds [YZZ12037]; Shaanxi Key Subject Program, China
FX This study was financially supported by the National Natural Science
   Foundation of China (21276210, 21106112, 21206135, 31000019 and
   21106111), the NWU Graduate Innovation and Creativity Funds (YZZ12037)
   and the Shaanxi Key Subject Program, China.
CR BAKER JP, 1994, MACROMOLECULES, V27, P1446, DOI 10.1021/ma00084a026
   Casettari L, 2012, BIOMATERIALS, V33, P7565, DOI 10.1016/j.biomaterials.2012.06.104
   Chung HJ, 2005, CURR APPL PHYS, V5, P485, DOI 10.1016/j.cap.2005.01.015
   Costa RR, 2011, SMALL, V7, P2640, DOI 10.1002/smll.201100875
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   Degano IR, 2009, BIOMATERIALS, V30, P1156, DOI 10.1016/j.biomaterials.2008.11.021
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Feng Q, 2005, COLLOID SURFACE A, V257-58, P85, DOI 10.1016/j.colsurfa.2004.10.099
   Ganji F, 2007, J SOL-GEL SCI TECHN, V42, P47, DOI 10.1007/s10971-006-9007-1
   Guo TY, 2005, BIOMATERIALS, V26, P5737, DOI 10.1016/j.biomaterials.2005.02.017
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   Ito T, 2007, BIOMATERIALS, V28, P1778, DOI 10.1016/j.biomaterials.2006.12.012
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063
   Li X, 2014, SOFT MATER, V12, P1, DOI 10.1080/1539445X.2011.584269
   Li X, 2012, SOFT MATTER, V8, P3781, DOI 10.1039/c2sm06994f
   Li Y. S., 2009, CHIN J COLLOID POLYM, V27, P9
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   Oswaldo A., 2011, BIOMATERIALS, V32, P7389
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   SANTOS PM, 1991, OTOLARYNG HEAD NECK, V105, P12, DOI 10.1177/019459989110500103
   Seda Y., 2011, BIOMATERIALS, V32, P5590
   Soest JJG, 1996, POLYMER, V37, P3543
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Tjong SC, 1998, POLYM ENG SCI, V38, P392, DOI 10.1002/pen.10200
   Wang Y, 2006, MAT SCI ENG C-BIO S, V26, P635, DOI 10.1016/j.msec.2005.07.019
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
   Wu H. G., 2008, CHIN J BIOMED ENG, V27, P580
   Yang PF, 2007, BIOCHEM ENG J, V33, P284, DOI 10.1016/j.bej.2006.11.010
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
   Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043
   Zhai Y, 2006, J CRYST GROWTH, V291, P202, DOI 10.1016/j.jcrysgro.2006.03.006
   Zhai Y, 2005, CURR APPL PHYS, V5, P429, DOI 10.1016/j.cap.2005.01.004
   Zhu CH, 2009, J BIOMED MATER RES A, V89A, P829, DOI 10.1002/jbm.a.32256
NR 39
TC 9
Z9 9
U1 3
U2 51
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD MAR 7
PY 2014
VL 2
IS 9
BP 1234
EP 1249
DI 10.1039/c3tb21628d
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA AB6UD
UT WOS:000331924100014
DA 2018-10-20
ER

PT J
AU Jing, Y
   Kunze, A
   Svedhem, S
AF Jing, Yujia
   Kunze, Angelika
   Svedhem, Sofia
TI Phase Transition-Controlled Flip-Flop in Asymmetric Lipid Membranes
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID SUPPORTED PHOSPHOLIPID-BILAYERS; PHOSPHATIDYL SERINE; TITANIUM-DIOXIDE;
   SPECTROSCOPY; KINETICS; ADSORPTION; MOVEMENT; SURFACE; LAYERS; CELLS
AB Lipid membrane asymmetry is of fundamental importance for biological systems and also provides an attractive means for molecular control over biomaterial surface properties (including drug carriers). In particular, temperature-dependent changes of surface properties can be achieved by taking advantage of distinct phase transitions in lipid membrane coatings where lipids exchange (flip-flop) between leaflets. In this study, temperature is used to control flip-flop of lipids in asymmetric lipid membranes on planar solid supports, where the two leaflets of the lipid membrane are in different phase states. More specifically, the lower leaflet is prepared from a supported lipid membrane composed of a high T-m lipid mixture of phosphocholine (PC), phosphatidylserine (PS), and a bioactive lipid on TiO2, followed by selective removal of the top leaflet by detergent. Next, at a lower temperature, where the remaining leaflet is in the gel state, a top leaflet of a different lipid composition and in the fluid phase is formed. Phase transition-induced changes in membrane surface properties following upon temperature-activation of the prepared asymmetric membrane are demonstrated by the detection of biotinylated lipids, which were initially located (thus "hidden") in the lower-gel phase leaflet, at the surface of the top leaflet. These processes were monitored in real-time by the quartz crystal microbalance with dissipation (QCM-D) and the dual polarization interferometry (DPI) techniques, allowing modeling of the mass and the anisotropic property of the lipid structures in different phase states.
C1 [Jing, Yujia; Kunze, Angelika; Svedhem, Sofia] Chalmers, Dept Appl Phys, SE-41296 Gothenburg, Sweden.
RP Svedhem, S (reprint author), Chalmers, Dept Appl Phys, SE-41296 Gothenburg, Sweden.
EM sofia.svedhem@chalmers.se
FU Swedish Research Council Formas (Nanosphere); Swedish Research Council
   (VR) through the Linneaus program SUPRA; Chinese Scholarship Council
   (CSC)
FX We gratefully acknowledge financial support for this project from the
   Swedish Research Council Formas (Nanosphere), the Swedish Research
   Council (VR) through the Linneaus program SUPRA, and the Chinese
   Scholarship Council (CSC). We would also like to thank Dr. Marcus Swann
   (Biolin Scientific/Farfield group, London, U.K.) for the insightful
   discussions about the DPI data analysis and interpretation, and Gabriel
   Ohlsson, Mokhtar Mapar, and Henrik Frederiksen for their help with the
   modification of the sensors.
CR Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200
   DEFEIJTER JA, 1978, J COLLOID INTERF SCI, V64, P258, DOI 10.1016/0021-9797(78)90361-2
   Edvardsson M., 2008, ANAL CHEM, V81, P349
   Frost R, 2012, NANO LETT, V12, P3356, DOI 10.1021/nl203107k
   Gerelli Y, 2013, LANGMUIR, V29, P12762, DOI 10.1021/la402708u
   Horvath R, 2003, BIOSENS BIOELECTRON, V18, P415, DOI 10.1016/S0956-5663(02)00154-9
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   Kleinfeld AM, 1997, BIOCHEMISTRY-US, V36, P14146, DOI 10.1021/bi971440e
   Kunze A, 2009, J AM CHEM SOC, V131, P2450, DOI 10.1021/ja809608n
   Lin WC, 2006, BIOPHYS J, V90, P228, DOI 10.1529/biophysj.105.067066
   Liu J, 2004, J AM CHEM SOC, V126, P8376, DOI 10.1021/ja048245p
   Mashaghi A, 2008, ANAL CHEM, V80, P3666, DOI 10.1021/ac800027s
   Ohlsson G, 2011, SOFT MATTER, V7, P10749, DOI 10.1039/c1sm05923h
   PACE RJ, 1982, J CHEM PHYS, V76, P4241, DOI 10.1063/1.443501
   Richter R. P., 2006, LANGMUIR, V22, P3497
   Richter RP, 2005, BIOPHYS J, V89, P3372, DOI 10.1529/biophysj.105.064337
   Rossetti FF, 2006, LANGMUIR, V22, P3467, DOI 10.1021/la053000r
   Rossetti FF, 2005, LANGMUIR, V21, P6443, DOI 10.1021/la0509100
   ROTHMAN JE, 1977, SCIENCE, V195, P743, DOI 10.1126/science.402030
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Sharom FJ, 2011, IUBMB LIFE, V63, P736, DOI 10.1002/iub.515
   Sinn CG, 2006, COLLOID SURFACE A, V282, P410, DOI 10.1016/j.colsurfa.2005.10.014
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Voros J, 2004, BIOPHYS J, V87, P553, DOI 10.1529/biophysj.103.030072
   Wacklin HP, 2011, LANGMUIR, V27, P7698, DOI 10.1021/la200683e
   Williamson P, 2002, BBA-MOL CELL BIOL L, V1585, P53, DOI 10.1016/S1388-1981(02)00324-4
   ZWAAL RFA, 1989, MOL CELL BIOCHEM, V91, P23, DOI 10.1007/BF00228075
NR 29
TC 9
Z9 9
U1 3
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD MAR 6
PY 2014
VL 118
IS 9
BP 2389
EP 2395
DI 10.1021/jp406502b
PG 7
WC Chemistry, Physical
SC Chemistry
GA AC8AU
UT WOS:000332756200010
PM 24364807
DA 2018-10-20
ER

PT J
AU Correia, SI
   Pereira, H
   Silva-Correia, J
   Van Dijk, CN
   Espregueira-Mendes, J
   Oliveira, JM
   Reis, RL
AF Correia, S. I.
   Pereira, H.
   Silva-Correia, J.
   Van Dijk, C. N.
   Espregueira-Mendes, J.
   Oliveira, J. M.
   Reis, R. L.
TI Current concepts: tissue engineering and regenerative medicine
   applications in the ankle joint
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Review
DE ankle; biomaterials; osteochondral lesions; regenerative medicine;
   scaffold; tissue engineering
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; MESENCHYMAL STEM-CELLS;
   PLATELET-RICH PLASMA; MARROW STROMAL CELLS; ECTOPIC BONE-FORMATION;
   CARBOXYMETHYLCHITOSAN/POLY(AMIDOAMINE) DENDRIMER NANOPARTICLES;
   INTERVERTEBRAL DISC REGENERATION; HUMAN ARTICULAR CHONDROCYTES;
   OSTEOCHONDRAL TALAR LESIONS; CALCIUM-PHOSPHATE CERAMICS
AB Tissue engineering and regenerative medicine (TERM) has caused a revolution in present and future trends of medicine and surgery. In different tissues, advanced TERM approaches bring new therapeutic possibilities in general population as well as in young patients and high-level athletes, improving restoration of biological functions and rehabilitation. The mainstream components required to obtain a functional regeneration of tissues may include biodegradable scaffolds, drugs or growth factors and different cell types (either autologous or heterologous) that can be cultured in bioreactor systems (in vitro) prior to implantation into the patient. Particularly in the ankle, which is subject to many different injuries (e. g. acute, chronic, traumatic and degenerative), there is still no definitive and feasible answer to 'conventional' methods. This review aims to provide current concepts of TERM applications to ankle injuries under preclinical and/or clinical research applied to skin, tendon, bone and cartilage problems. A particular attention has been given to biomaterial design and scaffold processing with potential use in osteochondral ankle lesions.
C1 [Correia, S. I.; Pereira, H.; Silva-Correia, J.; Espregueira-Mendes, J.; Oliveira, J. M.; Reis, R. L.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Group Biomat Biodegradables & Biomimet 3B, P-4806909 Taipas, Guimaraes, Portugal.
   [Correia, S. I.; Pereira, H.; Silva-Correia, J.; Espregueira-Mendes, J.; Oliveira, J. M.; Reis, R. L.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Pereira, H.; Van Dijk, C. N.; Espregueira-Mendes, J.] Univ Minho, Saude Atlantica Sports Ctr FC Porto Stadium, Oporto, Portugal.
   [Pereira, H.; Van Dijk, C. N.; Espregueira-Mendes, J.] Univ Porto, Res Ctr, P-4100 Oporto, Portugal.
   [Pereira, H.] Ctr Hosp Povoa Varzim, Dept Orthoped, Vila Do Conde, Portugal.
   [Van Dijk, C. N.] Amsterdam Med Ctr, Dept Orthoped, Amsterdam, Netherlands.
RP Oliveira, JM (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Group Biomat Biodegradables & Biomimet 3B, AvePark, P-4806909 Taipas, Guimaraes, Portugal.
EM miguel.oliveira@dep.uminho.pt
RI Espregueira-Mendes, Joao/N-4752-2015; Reis, Rui L./A-8938-2008;
   Silva-Correia, Joana/D-4980-2012; Oliveira, Joaquim Miguel/H-8636-2012;
   Group, 3Bs/E-4374-2012
OI Espregueira-Mendes, Joao/0000-0001-7429-4900; Reis, Rui
   L./0000-0002-4295-6129; Silva-Correia, Joana/0000-0003-1312-3109;
   Oliveira, Joaquim Miguel/0000-0001-7052-8837; Group,
   3Bs/0000-0002-5195-3456
FU Portuguese Foundation for Science and Technology (FCT)
   [PTDC/CTM-BPC/115977/2009]
FX The authors acknowledge the Portuguese Foundation for Science and
   Technology (FCT) through the POCTI and FEDER programmes, including
   Project OsteoCart (grant no. PTDC/CTM-BPC/115977/2009) for providing
   funds.
CR Abarrategi A, 2010, J BIOMED MATER RES A, V95A, P1132, DOI 10.1002/jbm.a.32912
   Abukawa H, 2004, J ORAL MAXIL SURG, V62, P601, DOI 10.1016/j.joms.2003.11.010
   Agung M, 2004, ARTHROSCOPY, V20, P1075, DOI 10.1016/j.arthro.2004.04.039
   Agung M, 2006, KNEE SURG SPORT TR A, V14, P1307, DOI 10.1007/s00167-006-0124-8
   Anderson DD, 2010, J BONE JOINT SURG AM, V92A, P1490, DOI 10.2106/JBJS.I.00431
   Arnoczky SP, 2011, OPER TECHN SPORT MED, V19, P142, DOI 10.1053/j.otsm.2010.12.001
   Atesok K, 2012, KNEE SURG SPORT TR A, V20, P1366, DOI 10.1007/s00167-012-1940-7
   Augst A, 2008, J R SOC INTERFACE, V5, P929, DOI 10.1098/rsif.2007.1302
   Aurich M, 2011, AM J SPORT MED, V39, P311, DOI 10.1177/0363546510381575
   Badylak SF, 2010, P NATL ACAD SCI USA, V107, P3285, DOI 10.1073/pnas.1000256107
   Balash P, 2010, CARTILAGE, V1, P270, DOI 10.1177/1947603510367913
   Bandyopadhyay A, 2013, BIOCHEM PHARMACOL, V85, P857, DOI 10.1016/j.bcp.2013.01.004
   BATTAGLIA M, 2011, EUR J RADIOL, V80, P132, DOI DOI 10.1016/J.EJRAD.2010.08.008
   Becher C, 2008, KNEE SURG SPORT TR A, V16, P56, DOI 10.1007/s00167-007-0416-7
   Bernstein A, 2013, ACTA BIOMATER, V9, P7490, DOI 10.1016/j.actbio.2013.03.021
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63
   Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn025
   Bitton R, 2009, AM J MANAG CARE, V15, P230
   Brigido Stephen A, 2006, Int Wound J, V3, P181, DOI 10.1111/j.1742-481X.2006.00209.x
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58, DOI 10.2106/00004623-200300002-00008
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2010, AM J SPORT MED, V38, P1259, DOI 10.1177/0363546509346395
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Candrian C, 2010, OSTEOARTHR CARTILAGE, V18, P1067, DOI 10.1016/j.joca.2010.04.010
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   Centeno CJ, 2010, CURR STEM CELL RES T, V5, P81, DOI 10.2174/157488810790442796
   Chang J, 2012, J HAND SURG-AM, V37A, P552, DOI 10.1016/j.jhsa.2011.12.028
   Che JH, 2010, KNEE SURG SPORT TR A, V18, P496, DOI 10.1007/s00167-009-0962-2
   Chen HM, 2011, AM J SPORT MED, V39, P1731, DOI 10.1177/0363546511403282
   CHEN K, J TISSUE ENG REGEN M, DOI DOI 10.1002/TERM.1708
   Chen YT, 2011, TISSUE ENG PART C-ME, V17, P1211, DOI 10.1089/ten.tec.2011.0092
   Chou LB, 2007, FOOT ANKLE INT, V28, P199, DOI 10.3113/FAI.2007.0199
   Christensen BB, 2012, KNEE SURG SPORT TR A, V20, P1192, DOI 10.1007/s00167-011-1692-9
   Chung R, 2011, STEM CELLS INT, V2011, DOI DOI 10.4061/2011/570125
   CLAR C, 2005, HEALTH TECHNOL ASSES, V9, P1
   Cohen S, 2010, TISSUE ENG PT A, V16, P3119, DOI [10.1089/ten.tea.2009.0716, 10.1089/ten.TEA.2009.0716]
   Custers RJH, 2009, J BONE JOINT SURG AM, V91A, P900, DOI 10.2106/JBJS.H.00668
   de Jonge S, 2011, AM J SPORT MED, V39, P1623, DOI 10.1177/0363546511404877
   de Mos M, 2008, AM J SPORT MED, V36, P1171, DOI 10.1177/0363546508314430
   De Napoli IE, 2011, J MEMBRANE SCI, V379, P341, DOI 10.1016/j.memsci.2011.06.001
   DeCarbo William T, 2009, Foot Ankle Spec, V2, P299, DOI 10.1177/1938640009354041
   DeChellis DM, 2011, TECH REG ANESTH PAIN, V15, P74, DOI DOI 10.1053/J.TRAP.2011.05.002
   Deplaine H, 2013, J BIOMED MATER RES B, V101B, P173, DOI 10.1002/jbm.b.32831
   Dhollander AAM, 2011, KNEE SURG SPORT TR A, V19, P536, DOI 10.1007/s00167-010-1337-4
   Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477
   Doral MN, 2012, KNEE SURG SPORT TR A, V20, P1398, DOI 10.1007/s00167-011-1856-7
   Duan PG, 2014, J BIOMED MATER RES A, V102, P180, DOI 10.1002/jbm.a.34683
   Ducheyne P, 2012, NAT MATER, V11, P652, DOI 10.1038/nmat3392
   Ebinesan AD, 2008, DISABIL REHABIL, V30, P1721, DOI 10.1080/09638280701786815
   El-Amin SF, 2010, FOOT ANKLE CLIN, V15, P543, DOI 10.1016/j.fcl.2010.08.001
   ENEA D, 2012, KNEE SURG SPORT TR A, V11, P1783, DOI DOI 10.1007/S00167-012-2102-7
   Engebretsen L, 2010, BRIT J SPORT MED, V44, P1072, DOI 10.1136/bjsm.2010.079822
   Espregueira-Mendes J, 2012, KNEE SURG SPORT TR A, V20, P1136, DOI 10.1007/s00167-012-1910-0
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   Florczyk SJ, 2013, J BIOMED MATER RES A, V101, P2974, DOI 10.1002/jbm.a.34593
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Getgood AMJ, 2012, KNEE, V19, P422, DOI 10.1016/j.knee.2011.03.011
   Giannini S, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.E.00516
   Giannini S, 2008, AM J SPORT MED, V36, P873, DOI 10.1177/0363546507312644
   Giannini S, 2010, INJURY, V41, P1196, DOI 10.1016/j.injury.2010.09.028
   Giannini S, 2009, CLIN ORTHOP RELAT R, V467, P3307, DOI 10.1007/s11999-009-0885-8
   Giza E, 2010, FOOT ANKLE INT, V31, P747, DOI 10.3113/FAI.2010.0747
   Gobbi A, 2006, ARTHROSCOPY, V22, P1085, DOI 10.1016/j.arthro.2006.05.016
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Gotterbarm T, 2006, BIOMATERIALS, V27, P3387, DOI 10.1016/j.biomaterials.2006.01.041
   Gurkan UA, 2012, ADV HEALTHC MATER, V1, P149, DOI 10.1002/adhm.201200011
   Hangody L, 2010, AM J SPORT MED, V38, P1125, DOI 10.1177/0363546509360405
   Harris JD, 2010, J BONE JOINT SURG AM, V92A, P2220, DOI 10.2106/JBJS.J.00049
   Heijink A, 2012, KNEE SURG SPORT TR A, V20, P423, DOI 10.1007/s00167-011-1818-0
   Hogan MV, 2011, J AM ACAD ORTHOP SUR, V19, P134, DOI 10.5435/00124635-201103000-00002
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Huang X, 2007, BIOMATERIALS, V28, P3091, DOI 10.1016/j.biomaterials.2007.03.017
   Hui JH, 2013, CLIN ORTHOP RELAT R, V471, P1174, DOI 10.1007/s11999-012-2487-0
   Jeong CG, 2012, J BIOMED MATER RES A, V100A, P2088, DOI 10.1002/jbm.a.33249
   Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442
   Johnson B, 2013, FOOT ANKLE CLIN, V18, P135, DOI 10.1016/j.fcl.2012.12.008
   Kanitkar Medha, 2011, Open Orthop J, V5 Suppl 2, P271, DOI 10.2174/1874325001105010271
   Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002
   Khaled E G, 2011, Open Orthop J, V5 Suppl 2, P289, DOI 10.2174/1874325001105010289
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Kleinschmidt K, 2013, BIOMATERIALS, V34, P5926, DOI 10.1016/j.biomaterials.2013.04.029
   Koestler W, 2008, COMPUT AIDED SURG, V13, P207, DOI 10.1080/10929080802210814
   Kokemueller H, 2010, INT J ORAL MAX SURG, V39, P379, DOI 10.1016/j.ijom.2010.01.010
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kon E, 2014, KNEE SURG SPORT TR A, V22, P1452, DOI 10.1007/s00167-013-2467-2
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2011, AM J SPORT MED, V39, P1668, DOI 10.1177/0363546511404675
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, AM J SPORT MED, V37, p156S, DOI 10.1177/0363546509351649
   Kreuz PC, 2011, AM J SPORT MED, V39, P1697, DOI 10.1177/0363546511403279
   Kryger GS, 2007, J HAND SURG-AM, V32A, P597, DOI 10.1016/j.jhsa.2007.02.018
   Kubota K, 2002, BONE, V31, P465, DOI 10.1016/S8756-3282(02)00852-9
   Kurtz CA, 1999, AM J SPORT MED, V27, P363, DOI 10.1177/03635465990270031701
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017531
   Lim CT, 2013, TISSUE ENG PT A, V19, P1852, DOI [10.1089/ten.tea.2012.0621, 10.1089/ten.TEA.2012.0621]
   Lloyd J, 2006, FOOT ANKLE INT, V27, P793, DOI 10.1177/107110070602701006
   Loken S, 2008, KNEE SURG SPORT TR A, V16, P896, DOI 10.1007/s00167-008-0566-2
   Longo UG, 2009, BRIT J SPORT MED, V43, P603, DOI 10.1136/bjsm.2007.039016
   Longo UG, 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/517165
   Longo UG, 2011, BRIT MED BULL, V98, P31, DOI 10.1093/bmb/ldq030
   Longo UG, 2008, DISABIL REHABIL, V30, P1602, DOI 10.1080/09638280701786120
   Lopez-Vidriero E, 2010, ARTHROSCOPY, V26, P269, DOI 10.1016/j.arthro.2009.11.015
   Luyten FP, 2012, BONE, V51, P289, DOI 10.1016/j.bone.2011.10.007
   Maffulli Nicola, 2007, Foot Ankle Clin, V12, P583, DOI 10.1016/j.fcl.2007.07.007
   Mankani MH, 2006, AM J PATHOL, V168, P542, DOI 10.2353/ajpath.2006.050407
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Martel-Pelletier J, 2012, BONE, V51, P297, DOI 10.1016/j.bone.2011.10.008
   Mayr HO, 2013, ACTA BIOMATER, V9, P4845, DOI 10.1016/j.actbio.2012.07.040
   Miljkovic ND, 2009, KNEE SURG SPORT TR A, V17, P1326, DOI 10.1007/s00167-009-0881-2
   Moshiri A, 2013, J AM COLL SURGEONS, V217, P421, DOI 10.1016/j.jamcollsurg.2013.03.025
   Muramatsu K, 2003, ACTA ORTHOP SCAND, V74, P95, DOI 10.1080/00016470310013734
   Nagata M, 2012, BONE, V50, P1123, DOI 10.1016/j.bone.2012.02.631
   Nagura I, 2007, J BONE JOINT SURG BR, V89B, P258, DOI 10.1302/0301-620X.89B2.17754
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Nordsletten L, 2006, CURR MED RES OPIN, V22, pS13, DOI 10.1185/030079906X80585
   O'Loughlin PF, 2010, AM J SPORT MED, V38, P392, DOI 10.1177/0363546509336336
   Ohgushi H, 2005, BIOMATERIALS, V26, P4654, DOI 10.1016/j.biomaterials.2004.11.055
   Oliveira JM, 2010, BONE, V46, P1424, DOI 10.1016/j.bone.2010.02.007
   Oliveira JT, 2010, J BIOMED MATER RES A, V93A, P852, DOI 10.1002/jbm.a.32574
   Oliveira JT, 2009, J TISSUE ENG REGEN M, V3, P493, DOI 10.1002/term.184
   Oliveira JT, 2010, TISSUE ENG PT A, V16, P343, DOI [10.1089/ten.tea.2009.0117, 10.1089/ten.TEA.2009.0117]
   Oliveira JT, 2010, J ORTHOP RES, V28, P1193, DOI 10.1002/jor.21114
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Oliveira JM, 2011, NANOMED-NANOTECHNOL, V7, P914, DOI 10.1016/j.nano.2011.03.002
   Oliveira JM, 2009, BIOMATERIALS, V30, P804, DOI 10.1016/j.biomaterials.2008.10.024
   Omae H, 2009, J ORTHOP RES, V27, P937, DOI 10.1002/jor.20823
   Orth P, 2011, KNEE SURG SPORT TR A, V19, P2119, DOI 10.1007/s00167-011-1448-6
   Paxton JZ, 2009, TISSUE ENG PT A, V15, P1201, DOI 10.1089/ten.tea.2008.0105
   Pereira DR, 2011, TISSUE ENG PART C-ME, V17, P961, DOI [10.1089/ten.tec.2011.0115, 10.1089/ten.TEC.2011.0115]
   Qi YY, 2014, KNEE SURG SPORT TR A, V22, P1424, DOI 10.1007/s00167-012-2256-3
   Qi YY, 2012, MOL BIOL REP, V39, P5683, DOI 10.1007/s11033-011-1376-z
   Qiu YS, 2003, OSTEOARTHR CARTILAGE, V11, P810, DOI 10.1016/S1063-4584(03)00164-X
   RADIN EL, 1984, SEMIN ARTHRITIS RHEU, V13, P293, DOI 10.1016/0049-0172(84)90031-3
   Ramanujam Crystal L, 2010, Clin Podiatr Med Surg, V27, P327, DOI 10.1016/j.cpm.2009.12.004
   Reddy S, 2007, AM J SPORT MED, V35, P80, DOI 10.1177/0363546506290986
   Reverchon Ernesto, 2012, Muscles Ligaments Tendons J, V2, P181
   Reyes R, 2014, J TISSUE ENG REGEN M, V8, P521, DOI 10.1002/term.1549
   Reyes R, 2014, J BIOMED MATER RES A, V102, P1110, DOI 10.1002/jbma.34769
   Rodrigues MT, 2012, ACTA BIOMATER, V8, P2795, DOI 10.1016/j.actbio.2012.04.013
   Rush Shannon M, 2010, Foot Ankle Spec, V3, P140, DOI 10.1177/1938640010369638
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Savva N, 2007, FOOT ANKLE INT, V28, P669, DOI 10.3113/FAI.2007.0669
   Schachter AK, 2005, J AM ACAD ORTHOP SUR, V13, P152, DOI 10.5435/00124635-200505000-00002
   Schlichting K, 2008, AM J SPORT MED, V36, P2379, DOI 10.1177/0363546508322899
   SCHLIEPHAKE H, 2013, CLIN IMPLANT DENT R, DOI DOI 10.1111/CID.12114
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   Scholz B, 2010, EUR CELLS MATER, V20, P24
   Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850
   Shearer C, 2002, FOOT ANKLE INT, V23, P651, DOI 10.1177/107110070202300712
   Sheth U, 2012, J BONE JOINT SURG AM, V94A, P298, DOI 10.2106/JBJS.K.00154
   Silva-Correia J, 2012, TISSUE ENG PT A, V18, P1203, DOI [10.1089/ten.tea.2011.0632, 10.1089/ten.TEA.2011.0632]
   SILVACORREIA J, 2011, J TISSUE ENG REGEN M, V5, P97, DOI DOI 10.1002/TERM.363
   SILVACORREIA J, 2011, Patent No. 2011119059
   Smith L, 2012, CONNECT TISSUE RES, V53, P95, DOI 10.3109/03008207.2011.650804
   Soomekh DJ, 2011, CLIN PODIATR MED SUR, V28, P155, DOI 10.1016/j.cpm.2010.09.001
   Sotoudeh A, 2013, ACTA CIR BRAS, V28, P340, DOI 10.1590/S0102-86502013000500004
   Spadaccio C, 2009, ANN BIOMED ENG, V37, P1376, DOI 10.1007/s10439-009-9704-3
   Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VALDERRABANO V, 2009, AM J SPORT MED, V37, P105, DOI DOI 10.1177/0363546509351481
   van Bergen CJA, 2011, KNEE SURG SPORT TR A, V19, P999, DOI 10.1007/s00167-011-1465-5
   van Dijk CN, 2011, KNEE SURG SPORT TR A, V19, P835, DOI 10.1007/s00167-010-1374-z
   van Dijk CN, 2008, J AM ACAD ORTHOP SUR, V16, P635
   van Dijk CN, 2010, KNEE SURG SPORT TR A, V18, P570, DOI 10.1007/s00167-010-1064-x
   van Sterkenburg MN, 2011, KNEE SURG SPORT TR A, V19, P513, DOI 10.1007/s00167-011-1415-2
   Vasiliadis HS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003323.pub3
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Wang CC, 2011, BIOMATERIALS, V32, P7118, DOI 10.1016/j.biomaterials.2011.06.018
   Wang H, 2013, ACTA BIOMATER, V9, P8413, DOI 10.1016/j.actbio.2013.05.026
   Weil Lowell Jr, 2011, Foot Ankle Spec, V4, P249, DOI 10.1177/1938640011415373
   Willers C, 2005, TISSUE ENG, V11, P1065, DOI 10.1089/ten.2005.11.1065
   Winters Christopher L, 2008, Adv Skin Wound Care, V21, P375, DOI 10.1097/01.ASW.0000323532.98003.26
   Yamada N, 2008, J ARTIF ORGANS, V11, P100, DOI 10.1007/s10047-008-0406-7
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yin Z, 2010, EXPERT OPIN BIOL TH, V10, P689, DOI 10.1517/14712591003769824
   Zengerink M, 2012, KNEE SURG SPORT TR A, V20, P1420, DOI 10.1007/s00167-012-2063-x
   Zengerink M, 2010, KNEE SURG SPORT TR A, V18, P238, DOI 10.1007/s00167-009-0942-6
   Zhang XZ, 2012, J SHOULDER ELB SURG, V21, P266, DOI 10.1016/j.jse.2011.11.016
   Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246
NR 183
TC 26
Z9 27
U1 2
U2 62
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD MAR 6
PY 2014
VL 11
IS 92
AR 20130784
DI 10.1098/rsif.2013.0784
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC2ZL
UT WOS:000332384700001
PM 24352667
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Ashokkumar, S
   Ravi, S
   Kathiravan, V
   Velmurugan, S
AF Ashokkumar, S.
   Ravi, S.
   Kathiravan, V.
   Velmurugan, S.
TI Synthesis, characterization and catalytic activity of silver
   nanoparticles using Tribulus terrestris leaf extract
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE Silver nanoparticles; Tribulus terrestris; Catalytic activity; Methylene
   blue
ID METAL NANOPARTICLES; MICROORGANISMS
AB Biomediated silver nanoparticles were synthesized with the aid of an eco-friendly biomaterial, namely, aqueous Tribulus terrestris extract. Silver nanoparticles were synthesized using a rapid, single step, and completely green biosynthetic method employing aqueous T. terrestris leaf extracts as both the reducing and capping agent. Silver ions were rapidly reduced by aqueous T. terrestris leaf extracts, leading to the formation of highly crystalline silver nanoparticles. An attempt has been made and formation of the silver nanoparticles was verified by surface plasmon spectra using an UV-vis (Ultra violet), spectrophotometer. Morphology and crystalline structure of the prepared silver nanoparticles were characterized by TEM (Transmission Electron Microscope) and XRD (X-ray Diffraction), techniques, respectively. FT-IR (Fourier Transform Infrared), analysis suggests that the obtained silver nanoparticles might be stabilized through the interactions of carboxylic groups, carbonyl groups and the flavonoids present in the T. terrestris extract. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Ashokkumar, S.; Kathiravan, V.] Annamalai Univ, Dept Phys, Annamalainagar 608002, Tamil Nadu, India.
   [Ravi, S.; Velmurugan, S.] Annamalai Univ, Dept Engg Phys, Annamalainagar 608002, Tamil Nadu, India.
RP Ravi, S (reprint author), Annamalai Univ, Dept Engg Phys, Annamalainagar 608002, Tamil Nadu, India.
EM ambedraviphy@gmail.com
CR Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Krumov N, 2009, CHEM ENG TECHNOL, V32, P1026, DOI 10.1002/ceat.200900046
   Li HM, 2009, FOOD CHEM, V114, P547, DOI 10.1016/j.foodchem.2008.09.085
   Mandal D, 2006, APPL MICROBIOL BIOT, V69, P485, DOI 10.1007/s00253-005-0179-3
   Narayanan KB, 2010, ADV COLLOID INTERFAC, V156, P1, DOI 10.1016/j.cis.2010.02.001
   Park Hae-Jun, 2006, The Plant Pathology Journal, V22, P295
   Subash B, 2013, MATER RES BULL, V48, P63, DOI 10.1016/j.materresbull.2012.10.010
   Subash B, 2012, CATAL SCI TECHNOL, V2, P2319, DOI 10.1039/c2cy20254a
NR 9
TC 47
Z9 49
U1 2
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD MAR 5
PY 2014
VL 121
BP 88
EP 93
DI 10.1016/j.saa.2013.10.073
PG 6
WC Spectroscopy
SC Spectroscopy
GA AA8JF
UT WOS:000331341100012
PM 24231743
DA 2018-10-20
ER

PT J
AU Sterling, JA
   Guelcher, SA
AF Sterling, Julie A.
   Guelcher, Scott A.
TI Biomaterial Scaffolds for Treating Osteoporotic Bone
SO CURRENT OSTEOPOROSIS REPORTS
LA English
DT Article
DE Scaffold; Bone graft; Osteoporosis; Fracture; Cancer-induced bone
   disease
ID PLATELET-RICH PLASMA; MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2;
   DISTAL RADIUS; MANDIBULAR RECONSTRUCTION; FLAP RECONSTRUCTION;
   CALCIUM-PHOSPHATE; CANCER-PATIENTS; GENE-THERAPY; ORAL-CANCER
AB Healing fractures resulting from osteoporosis or cancer remains a significant clinical challenge. In these populations, healing is often impaired not only due to age and disease, but also by other therapeutic interventions such as radiation, steroids, and chemotherapy. Despite substantial improvements in the treatment of osteoporosis over the last few decades, osteoporotic fractures are still a major clinical challenge in the elderly population due to impaired healing. Similar fractures with impaired healing are also prevalent in cancer patients, especially those with tumor growing in bone. Treatment options for cancer patients are further complicated by the fact that bone anabolic therapies are contraindicated in patients with tumors. Therefore, many patients undergo surgery to repair the fracture, and bone grafts are often used to stabilize orthopedic implants and provide a scaffold for ingrowth of new bone. Both synthetic and naturally occurring biomaterials have been investigated as bone grafts for repair of osteoporotic fractures, including calcium phosphate bone cements, resorbable polymers, and allograft or autograft bone. In order to re-establish normal bone repair, bone grafts have been augmented with anabolic agents, such as mesenchymal stem cells or recombinant human bone morphogenetic protein-2. These developing approaches to bone grafting are anticipated to improve the clinical management of osteoporotic and cancer-induced fractures.
C1 [Sterling, Julie A.] Tennessee Valley Healthcare Syst VISN 9, Dept Vet Affairs, Nashville, TN USA.
   [Sterling, Julie A.] Vanderbilt Univ, Dept Med Clin Pharmacol, Nashville, TN 37235 USA.
   [Sterling, Julie A.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA.
   [Sterling, Julie A.; Guelcher, Scott A.] Vanderbilt Univ, Ctr Bone Biol, Nashville, TN 37235 USA.
   [Guelcher, Scott A.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA.
RP Guelcher, SA (reprint author), Vanderbilt Univ, Dept Chem & Biomol Engn, 2400 Highland Ave,107 Olin Hall, Nashville, TN 37235 USA.
EM julie.sterling@vanderbilt.edu; scott.guelcher@vanderbilt.edu
FU VA; NIH/NCI; NIH/NIAMS
FX JA Sterling has received research support from the VA and NIH/NCI. SA
   Guelcher has had a consultancy with Medtronic and received research
   support from NIH/NCI and NIH/NIAMS.
CR Aboulafia AJ, 2007, SEMIN ONCOL, V34, P206, DOI 10.1053/seminoncol.2007.03.002
   Alam DS, 2009, OTOLARYNG HEAD NECK, V141, P196, DOI 10.1016/j.otohns.2009.03.013
   Albanese A, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-23
   Anne-Gaelle B, 2011, ORAL ONCOL, V47, P1099, DOI 10.1016/j.oraloncology.2011.07.016
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   BARRIOS C, 1993, J ORTHOP TRAUMA, V7, P438, DOI 10.1097/00005131-199310000-00006
   Benisch P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045142
   Biau DJ, 2009, J BONE JOINT SURG AM, V91A, P142, DOI 10.2106/JBJS.G.01061
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Bohner M, 2010, EUR CELLS MATER, V20, P1
   Brown KV, 2011, TISSUE ENG PT A, V17, P1735, DOI 10.1089/ten.tea.2010.0446
   Cameron K, 2013, J BIOMED MATER RES A, V101, P13, DOI 10.1002/jbm.a.34261
   Cheng N, 2013, J MATER SCI-MATER M, V24, P1963, DOI 10.1007/s10856-013-4945-y
   Cleary J, 2013, BREAST, V22, P616, DOI 10.1016/j.breast.2013.07.052
   Coleman RE, 2012, CURR OPIN SUPPORT PA, V6, P322, DOI 10.1097/SPC.0b013e32835689cd
   Coleman RE, 2010, CANCER TREAT REV, V36, P615, DOI 10.1016/j.ctrv.2010.04.003
   Cornell Charles N, 2003, J Am Acad Orthop Surg, V11, P109
   Cornell CN, 2003, CLIN GERIATR MED, V19, P433, DOI 10.1016/S0749-0690(02)00076-9
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Edwards Claire M, 2008, Int J Med Sci, V5, P263
   Egermann M, 2005, OSTEOPOROSIS INT, V16, pS120, DOI 10.1007/s00198-004-1817-9
   Gadre PK, 2011, J CRANIOFAC SURG, V22, P1727, DOI 10.1097/SCS.0b013e31822e633b
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Goodman SB, 1998, CLIN ORTHOP RELAT R, P42
   Guerra MFM, 2003, J ORAL MAXIL SURG, V61, P1289, DOI 10.1016/S0278-2391(03)00730-4
   Hadji P, 2012, CANCER TREAT REV, V38, P798, DOI 10.1016/j.ctrv.2012.02.008
   Hadji P, 2013, INT J CLIN PHARM TH, V51, P868, DOI 10.5414/CP201931
   Hayden RE, 2012, CURR OPIN OTOLARYNGO, V20, P231, DOI 10.1097/MOO.0b013e328355d0f3
   Jacobson AS, 2013, INT J ORAL MAX SURG, V42, P1121, DOI 10.1016/j.ijom.2013.03.022
   Jupiter JB, 1997, J ORTHOP TRAUMA, V11, P110, DOI 10.1097/00005131-199702000-00008
   Kalavrezos ND, 1996, INT J ORAL MAX SURG, V25, P439, DOI 10.1016/S0901-5027(96)80079-8
   Kaner T, 2012, ORTHOP REV, V4, P46, DOI 10.4081/or.2012.e10
   Kim WY, 2001, INT ORTHOP, V25, P360, DOI 10.1007/s002640100287
   Kleeff J, 1999, GASTROENTEROLOGY, V116, P1202, DOI 10.1016/S0016-5085(99)70024-7
   Kokorina NA, 2012, LARYNGOSCOPE, V122, P95, DOI 10.1002/lary.22345
   Kokorina NA, 2011, LARYNGOSCOPE, V121, P1876, DOI 10.1002/lary.21914
   Ladd A L, 1999, J Am Acad Orthop Surg, V7, P279
   Laitinen M, 1997, INT ORTHOP, V21, P188, DOI 10.1007/s002640050148
   Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006
   Legname M, 2011, ORTHOP TRAUMATOL-SUR, V97, P762, DOI 10.1016/j.otsr.2011.06.010
   Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9
   Lill CA, 2003, J ORTHOPAED RES, V21, P836, DOI 10.1016/S0736-0266(02)00266-8
   Liu HY, 2011, BIOMATERIALS, V32, P6773, DOI 10.1016/j.biomaterials.2011.05.080
   Liu YH, 2013, BIOMATERIALS, V34, P9998, DOI 10.1016/j.biomaterials.2013.09.040
   Matsuo A, 2011, J CRANIO MAXILL SURG, V39, P628, DOI 10.1016/j.jcms.2011.01.003
   Moroni A, 2009, J ORTHOP TRAUMA, V23, P422, DOI 10.1097/BOT.0b013e3181771426
   Namdari S, 2012, J SHOULDER ELB SURG, V21, P1787, DOI 10.1016/j.jse.2012.04.003
   Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2
   Phillips Frank M, 2006, Spine J, V6, P500, DOI 10.1016/j.spinee.2006.01.014
   Ramachandra ML, 2013, PRIMER METABOLIC BON, P527
   Rao LP, 2012, SURG ONCOL, V21, P109, DOI 10.1016/j.suronc.2011.06.003
   Reid IR., 2013, PRIMER METABOLIC BON, P357
   Rey-Rico A, 2011, EUR CELLS MATER, V21, P317, DOI 10.22203/eCM.v021a24
   Riedel B, 2012, ORTHOPEDICS, V35, pE259, DOI 10.3928/01477447-20120123-20
   Robinson CM, 2003, J BONE JOINT SURG AM, V85A, P1647, DOI 10.2106/00004623-200309000-00001
   Rodriguez JP, 2000, J CELL BIOCHEM, V79, P557, DOI 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H
   Rodriguez JP, 1999, J CELL BIOCHEM, V75, P414, DOI 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.3.CO;2-3
   Simman R, 2008, ANN PLAS SURG, V61, P337, DOI 10.1097/SAP.0b013e318157a185
   Simon EN, 2012, INT J ORAL MAXILLOF, V42, P106
   Smolka K, 2008, ORAL ONCOL, V44, P571, DOI 10.1016/j.oraloncology.2007.07.005
   Tang YC, 2008, CELL BIOL INT, V32, P1150, DOI 10.1016/j.cellbi.2008.06.005
   Tei K, 2004, J ORAL MAXIL SURG, V62, P834, DOI 10.1016/j.joms.2003.09.014
   Tidermark J, 2003, J ORTHOP TRAUMA, V17, P193, DOI 10.1097/00005131-200303000-00007
   Urken ML, 1998, ARCH OTOLARYNGOL, V124, P46, DOI 10.1001/archotol.124.1.46
   Utzschneider S, 2011, INT ORTHOP, V35, P731, DOI 10.1007/s00264-010-1074-9
   Vidyadhara S, 2009, INT ORTHOP, V33, P1009, DOI 10.1007/s00264-008-0596-x
   Wegener B, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-232
   YOSHIKAWA H, 1994, CANCER, V73, P85, DOI 10.1002/1097-0142(19940101)73:1<85::AID-CNCR2820730116>3.0.CO;2-8
   Yu ZR, 2012, INT ORTHOP, V36, P2163, DOI 10.1007/s00264-012-1543-4
   Yue B, 2005, CALCIFIED TISSUE INT, V77, P395, DOI 10.1007/s00223-005-0180-y
   Zhang YF, 2012, BIOMATERIALS, V33, P6698, DOI 10.1016/j.biomaterials.2012.06.021
   Zimmermann R, 2003, ARCH ORTHOP TRAUM SU, V123, P22, DOI 10.1007/s00402-002-0458-8
NR 72
TC 21
Z9 21
U1 3
U2 36
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1544-2241
J9 CURR OSTEOPOROS REP
JI Curr. Osteoporos. Rep.
PD MAR
PY 2014
VL 12
IS 1
BP 48
EP 54
DI 10.1007/s11914-014-0187-2
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AY0IZ
UT WOS:000347281700007
PM 24458428
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Coad, BR
   Kidd, SE
   Ellis, DH
   Griesser, HJ
AF Coad, Bryan R.
   Kidd, Sarah E.
   Ellis, David H.
   Griesser, Hans J.
TI Biomaterials surfaces capable of resisting fungal attachment and biofilm
   formation
SO BIOTECHNOLOGY ADVANCES
LA English
DT Review
DE Review; Antifungal; Surface; Biomaterials; Immobilization; Mycology;
   Yeast; Mold; Fungus; Antimicrobial
ID QUATERNARY AMMONIUM-SALTS; AMPHOTERICIN-B; ANTIMICROBIAL ACTIVITY;
   ANTIBACTERIAL SURFACES; CANDIDA-ALBICANS; POLYMERIC MATERIALS; CATIONIC
   SURFACES; PEPTIDES; COATINGS; CELLS
AB Microbial attachment onto biomedical devices and implants leads to biofilm formation and infection; such biofilms can be bacterial, fungal, or mixed. In the past 15 years, there has been an increasing research effort into antimicrobial surfaces but the great majority of these publications present research on bacteria, with some reports also testing resistance to fungi. Very few studies have focused exclusively on antifungal surfaces. However, with increasing recognition of the importance of fungal infections to human health, particularly related to infections at biomaterials, it would seem that the interest in antifungal surfaces is disproportionately low. In studies of both bacteria and fungi, fungi tend to be the minor focus with hypothesized antibacterial mechanisms of action often generalized to also explain the antifungal effect. Yet bacteria and fungi represent two Distinct biological Domains and possess substantially different cellular physiology and structure. Thus it is questionable whether these generalizations are valid. Here we review the scientific literature focusing on surface coatings prepared with antifungal agents covalently attached to the biomaterial surface. We present a critical analysis of generalizations and their evidence. This review should be of interest to researchers of "antimicrobial" surfaces by addressing specific issues that are key to designing and understanding antifungal biomaterials surfaces and their putative mechanisms of action. (C) 2013 Elsevier Inc All rights reserved.
C1 [Coad, Bryan R.] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
   [Kidd, Sarah E.] Womens & Childrens Hosp, SA Pathol, Natl Mycol Reference Ctr, Adelaide, SA 5006, Australia.
   [Kidd, Sarah E.; Ellis, David H.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.
   [Griesser, Hans J.] Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
RP Coad, BR (reprint author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
EM bryan.coad@unisa.edu.au
RI Coad, Bryan/B-4505-2009; Griesser, Hans/E-5628-2011
OI Coad, Bryan/0000-0003-3297-3977; Griesser, Hans/0000-0003-1072-7863;
   Kidd, Sarah/0000-0002-5957-4178
CR Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Barratt G, 2007, INT J NANOMED, V2, P301
   BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511
   BEGGS WH, 1994, ANTIMICROB AGENTS CH, V38, P363, DOI 10.1128/AAC.38.2.363
   Benincasa M, 2011, ACS NANO, V5, P199, DOI 10.1021/nn1023522
   BRAJTBURG J, 1990, ANTIMICROB AGENTS CH, V34, P183, DOI 10.1128/AAC.34.2.183
   BRAJTBURG J, 1985, ANTIMICROB AGENTS CH, V27, P172, DOI 10.1128/AAC.27.2.172
   Carlson RP, 2008, J BIOMAT SCI-POLYM E, V19, P1035, DOI 10.1163/156856208784909372
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Cuellar-Cruz M, 2012, EUR J CLIN MICROBIOL, V31, P2513, DOI 10.1007/s10096-012-1634-6
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]
   De Prijck K, 2010, MYCOPATHOLOGIA, V170, P213, DOI 10.1007/s11046-010-9316-3
   De Prijck K, 2010, BIOFOULING, V26, P269, DOI 10.1080/08927010903501908
   Dupres V, 2010, ACS NANO, V4, P5498, DOI 10.1021/nn101598v
   ENDO Y, 1987, APPL ENVIRON MICROB, V53, P2050
   Ferreira L, 2009, J MATER CHEM, V19, P7796, DOI 10.1039/b905668h
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Green JBD, 2011, BIOINTERPHASES, V6, pMR13, DOI 10.1116/1.3645195
   Green JBD, 2011, BIOTECHNOL BIOENG, V108, P231, DOI 10.1002/bit.22929
   Hartsel S, 1996, TRENDS PHARMACOL SCI, V17, P445, DOI 10.1016/S0165-6147(96)01012-7
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Ignatova M, 2010, MACROMOL BIOSCI, V10, P944, DOI 10.1002/mabi.200900433
   ISQUITH AJ, 1972, APPL MICROBIOL, V24, P859
   Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103
   Karlsson AJ, 2010, BIOMACROMOLECULES, V11, P2321, DOI 10.1021/bm100424s
   Klibanov AM, 2007, J MATER CHEM, V17, P2479, DOI 10.1039/b702079a
   Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1111/j.1574-6976.2002.tb00613.x
   Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628
   Kugel A, 2011, PROG ORG COAT, V72, P222, DOI 10.1016/j.porgcoat.2011.07.004
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0
   Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]
   Lin J, 2003, BIOTECHNOL BIOENG, V83, P168, DOI 10.1002/bit.10651
   Lin J, 2003, BIOTECHNOL LETT, V25, P1661, DOI 10.1023/A:1025613814588
   Lipke PN, 1998, J BACTERIOL, V180, P3735
   Marriott D, 2006, INT J INFECT DIS, V10, pS77, DOI 10.1016/S1201-9712(06)80135-9
   Martinez LR, 2010, J INFECT DIS, V201, P1436, DOI 10.1086/651558
   McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147
   Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   MURRAY PR, 1988, J CLIN MICROBIOL, V26, P1884
   NAKAGAWA Y, 1984, APPL ENVIRON MICROB, V47, P513
   Nakagawa Y, 1979, J ANTIBACT ANTIFUNG, V7, P551
   Nikawa H, 2005, DENT MATER J, V24, P570, DOI 10.4012/dmj.24.570
   Onaizi SA, 2011, BIOTECHNOL ADV, V29, P67, DOI 10.1016/j.biotechadv.2010.08.012
   Oosterhof JJH, 2006, APPL ENVIRON MICROB, V72, P3673, DOI 10.1128/AEM.72.5.3673-3677.2006
   Paulo CSO, 2010, BIOMACROMOLECULES, V11, P2810, DOI 10.1021/bm100893r
   PITTMAN CU, 1981, J APPL POLYM SCI, V26, P2403, DOI 10.1002/app.1981.070260726
   Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x
   Ravikumar T, 2006, BIOMACROMOLECULES, V7, P2762, DOI 10.1021/bm060476w
   Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7
   Sedlak M, 2009, MINI-REV MED CHEM, V9, P1306, DOI 10.2174/138955709789878178
   Sheng CQ, 2011, CURR MED CHEM, V18, P733, DOI 10.2174/092986711794480113
   Smits GJ, 1999, CURR OPIN MICROBIOL, V2, P348
   Smits GJ, 2001, MICROBIOL-SGM, V147, P781, DOI 10.1099/00221287-147-4-781
   Theis T, 2004, CELL MOL LIFE SCI, V61, P437, DOI 10.1007/s00018-003-3231-4
   Tiller JC, 2011, ADV POLYM SCI, V240, P193, DOI 10.1007/12_2010_101
   Vasilev K, 2011, PLASMA PROCESS POLYM, V8, P1010, DOI 10.1002/ppap.201100097
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x
   Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946
   Wu W, 2005, ANGEW CHEM INT EDIT, V44, P6358, DOI 10.1002/anie.200501613
   Ye SJ, 2010, LANGMUIR, V26, P16455, DOI 10.1021/la1001539
   Zumbuehl A, 2007, P NATL ACAD SCI USA, V104, P12994, DOI 10.1073/pnas.0705250104
   Zumbuehl A, 2007, ORG BIOMOL CHEM, V5, P1339, DOI 10.1039/b701953j
NR 65
TC 31
Z9 32
U1 5
U2 74
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-9750
EI 1873-1899
J9 BIOTECHNOL ADV
JI Biotechnol. Adv.
PD MAR-APR
PY 2014
VL 32
IS 2
BP 296
EP 307
DI 10.1016/j.biotechadv.2013.10.015
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AR5RE
UT WOS:000343640400006
PM 24211473
DA 2018-10-20
ER

PT J
AU Ahmad, R
   Mondal, PK
AF Ahmad, Rais
   Mondal, Pijush Kanti
TI BIOREMEDIATION CONTAINING WASTEWATER BY OF P-NITROPHENOL AEROBIC
   GRANULES
SO ENVIRONMENTAL ENGINEERING AND MANAGEMENT JOURNAL
LA English
DT Article
DE aerobic granules; biodegradation; kinetics; p-nitrophenol; SBR
ID SEQUENCING BATCH REACTOR; 4-NITROPHENOL BIODEGRADATION; SLUDGE
AB Aerobic granulation is a novel biotechnique for the treatment of coloured wastewater containing toxic xenobiotics in sequencing batch reactor (SBR). The aerobic granules were investigated as a potential biomaterial for biodegradation of p-nitrophenol. The removal efficiency of p-nitrophenol was 93 % after 65 days of operation at 8 hr hydraulic retention time (HRT). The aerobic granules were cultivated at a p-nitrophenol loading rate of 0.9 kg m(-3) day(-1), with sodium acetate as co-substrate to accelerate the growth of p-nitrophenol degrading biomass. SBR was inoculated with activated sludge that was initially conditioned as a batch culture for a period of 30 days by supplying p-nitrophenol. Optimal pH of 9 was maintained throughout the experimental setup. This study clearly demonstrates that aerobic granules are efficient to degrade up to 300 mgL(-1) of p-nitrophenol to tolerate the toxicity in high-strength wastewater.
C1 [Ahmad, Rais; Mondal, Pijush Kanti] Aligarh Muslim Univ, Fac Engn & Technol, Dept Appl Chem, Environm Res Lab, Aligarh 202002, Uttar Pradesh, India.
RP Ahmad, R (reprint author), Aligarh Muslim Univ, Fac Engn & Technol, Dept Appl Chem, Environm Res Lab, Aligarh 202002, Uttar Pradesh, India.
EM rais45@rediffmail.com
FU UGC (University Grants Commission)
FX The authors are thankful to the Aligarh Muslim University, Aligarh
   (India) for providing research facilities and also thankful to the UGC
   (University Grants Commission) for providing financial assistance to one
   of the author, Pijush Kanti Mondal.
CR Ahmad R, 2010, BIORESOURCE TECHNOL, V101, P3787, DOI 10.1016/j.biortech.2009.12.116
   APHA, 2002, STAND METH EX WAT WA
   *ATSDR, 1992, PUBL HLTH ASS GUID M
   Beun JJ, 1999, WATER RES, V33, P2283, DOI 10.1016/S0043-1354(98)00463-1
   de Kreuk MK, 2006, J ENVIRON ENG-ASCE, V132, P694, DOI 10.1061/(ASCE)0733-9372(2006)132:6(694)
   Gupta Vinod K, 2010, J Colloid Interface Sci, V342, P533, DOI 10.1016/j.jcis.2009.10.074
   IUPAC-NIST, 2006, SOL DAT IUPAC NIST V
   JAIN RK, 1994, APPL ENVIRON MICROB, V60, P3030
   Jiang HL, 2002, LETT APPL MICROBIOL, V35, P439, DOI 10.1046/j.1472-765X.2002.01217.x
   Liu Y, 2004, BIOTECHNOL ADV, V22, P533, DOI 10.1016/j.biotechadv.2004.05.001
   Liu YQ, 2006, APPL MICROBIOL BIOT, V71, P761, DOI 10.1007/s00253-005-0209-1
   Mondal PK, 2010, BIODEGRADATION, V21, P1041, DOI 10.1007/s10532-010-9364-x
   Moy BYP, 2002, LETT APPL MICROBIOL, V34, P407, DOI 10.1046/j.1472-765X.2002.01108.x
   Rogers K. R., 1993, EPA600A93074
   SPAIN JC, 1991, APPL ENVIRON MICROB, V57, P812
   Tomei MC, 2004, WATER RES, V38, P375, DOI 10.1016/j.watres.2003.09.023
   Tomei MC, 2003, WATER RES, V37, P3803, DOI 10.1016/S0043-1354(03)00297-5
NR 17
TC 0
Z9 0
U1 1
U2 6
PU GH ASACHI TECHNICAL UNIV IASI
PI IASI
PA 71 MANGERON BLVD, IASI, 700050, ROMANIA
SN 1582-9596
EI 1843-3707
J9 ENVIRON ENG MANAG J
JI Environ. Eng. Manag. J.
PD MAR
PY 2014
VL 13
IS 3
BP 493
EP 498
DI 10.30638/eemj.2014.052
PG 6
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA AN3JD
UT WOS:000340482600001
OA Bronze
DA 2018-10-20
ER

PT J
AU Strang, AC
   Knetsch, MLW
   Idu, MM
   Bisoendial, RJ
   Kramer, G
   Speijer, D
   Koole, LH
   Stroes, ESG
   Rotmans, JI
AF Strang, Aart C.
   Knetsch, Menno L. W.
   Idu, Mirza M.
   Bisoendial, Radjesh J.
   Kramer, Gertjan
   Speijer, Dave
   Koole, Leo. H.
   Stroes, Erik S. G.
   Rotmans, Joris. I.
TI Superior in vivo compatibility of hydrophilic polymer coated prosthetic
   vascular grafts
SO JOURNAL OF VASCULAR ACCESS
LA English
DT Article
DE Endothelialization; Graft; Hydrophilic; Thrombosis; Vascular graft
ID HIGH-DENSITY-LIPOPROTEIN; INFLAMMATORY RESPONSES; THROMBUS FORMATION;
   ENDOTHELIAL-CELLS; BIOMATERIAL SURFACES; SAPHENOUS-VEIN;
   POLYTETRAFLUOROETHYLENE; PROTEIN; BYPASS; ADHESION
AB Purpose: Protein adsorption, cell adhesion and graft patency was compared in hydrophilic versus hydrophobic polymer-coated prosthetic vascular grafts. We hypothesize that in vivo compatibility of hydrophilic polymer-coated prosthetic vascular grafts is superior to in vivo compatibility of hydrophobic grafts.
   Methods: A pairwise side-to-side common carotid artery interposition graft was placed eight female landrace goats ( mean weight 55 kg). Protein adsorption was assessed using Western Blot in two hydrophilic and two hydrophobic grafts harvested after three days. Graft patency was monitored for 28 days in six goats with continuous wave Doppler ultrasonography. Adherence of endothelial cells, leukocytes and platelets was determined with ELISA and compared between the two graft types after 28 days.
   Results: After three days, more ApoA-I, albumin and VEGF and less fibrin adsorbed to hydrophilic grafts. After 28 days, compared to hydrophobic grafts, higher numbers of endothelial cells were present on hydrophilic grafts (P=0.016), and less thrombocytes and leukocytes (P=0.012 and 0.024, respectively). Two out of eight hydrophobic grafts lost patency, while none of the hydrophilic grafts failed (P=0.157).
   Conclusions: Hydrophilic polymer-coated vascular grafts have superior in vivo compatibility when compared to hydrophobic grafts as characterized by reduced platelet and leukocyte adherence as well as higher endothelialization.
C1 [Strang, Aart C.; Bisoendial, Radjesh J.; Stroes, Erik S. G.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands.
   Maastricht Univ, Maastricht, Netherlands.
   [Idu, Mirza M.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Surg, NL-1105 AZ Amsterdam, Netherlands.
   [Kramer, Gertjan; Speijer, Dave] Univ Amsterdam, Acad Med Ctr, Dept Biochem, NL-1105 AZ Amsterdam, Netherlands.
   [Rotmans, Joris. I.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.
RP Strang, AC (reprint author), Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
EM a.c.strang@amc.uva.nl
OI Speijer, Dave/0000-0002-2340-2753; Kramer, Gertjan/0000-0002-8541-0337
FU Dutch Heart Association [2008B070]
FX This work was supported by a grant from the Dutch Heart Association
   (2008B070).
CR Aldenhoff YBJ, 2004, BIOMATERIALS, V25, P3125, DOI 10.1016/j.biomaterials.2003.10.012
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   Assmann G, 2003, ANNU REV MED, V54, P321, DOI 10.1146/annurev.med.54.101601.152409
   Awan Z, 2008, CAN J CARDIOL, V24, p27C, DOI 10.1016/S0828-282X(08)71035-3
   Braet F, 1997, J MICROSC-OXFORD, V186, P84, DOI 10.1046/j.1365-2818.1997.1940755.x
   Cines DB, 1998, BLOOD, V91, P3527
   Crombez M, 2005, BIOMATERIALS, V26, P7402, DOI 10.1016/j.biomaterials.2005.05.051
   Griffin JH, 1999, J CLIN INVEST, V103, P219, DOI 10.1172/JCI5006
   Johnson WC, 2000, J VASC SURG, V32, P268, DOI 10.1067/mva.2000.106944
   Kapadia MR, 2008, CIRCULATION, V117, P1873, DOI 10.1161/CIRCULATIONAHA.107.714170
   Kaul S, 2003, CIRCULATION, V107, P2551, DOI 10.1161/01.CIR.0000074042.19447.B1
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Klinkert P, 2003, J VASC SURG, V37, P149, DOI 10.1067/mva.2002.86
   Knetsch MLW, 2010, J BIOMED MATER RES A, V93A, P77, DOI 10.1002/jbm.a.32538
   Knetsch MLW, 2006, BIOMATERIALS, V27, P2813, DOI 10.1016/j.biomaterials.2005.12.025
   Knetsch MLW, 2004, J BIOMED MATER RES A, V71A, P615, DOI 10.1002/jbm.a.30195
   Kreienberg PB, 2002, J VASC SURG, V35, P299, DOI 10.1067/mva.2002.121208
   Lee T, 2011, NEPHROL DIAL TRANSPL, V26, P2264, DOI 10.1093/ndt/gfq733
   Li DY, 1999, ARTERIOSCL THROM VAS, V19, P378, DOI 10.1161/01.ATV.19.2.378
   Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101
   Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93
   Murphy MO, 2006, J ENDOVASC THER, V13, P389, DOI 10.1583/06-1846.1
   Roll Stephanie, 2008, BMC Surg, V8, P22, DOI 10.1186/1471-2482-8-22
   Sayers RD, 1998, BRIT J SURG, V85, P934
   Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b
   Shin YM, 2012, BIOMACROMOLECULES, V13, P2020, DOI 10.1021/bm300194b
   Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053
   Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   Tang LP, 1999, BIOMATERIALS, V20, P1365, DOI 10.1016/S0142-9612(99)00034-4
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Van Leuven SI, 2009, J THROMB HAEMOST, V7, P347, DOI 10.1111/j.1538-7836.2008.03175.x
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   von Eckardstein A, 2009, CURR OPIN LIPIDOL, V20, P197, DOI 10.1097/MOL.0b013e32832afd63
   Wang SH, 2010, CLIN EXP IMMUNOL, V160, P137, DOI 10.1111/j.1365-2249.2009.04068.x
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yevzlin AS, 2006, SEMIN DIALYSIS, V19, P535, DOI 10.1111/j.1525-139X.2006.00218.x
   Zhang Q, 2009, INT J CARDIOL, V133, P286, DOI 10.1016/j.ijcard.2008.11.034
NR 41
TC 1
Z9 1
U1 2
U2 13
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1129-7298
EI 1724-6032
J9 J VASC ACCESS
JI J. Vasc. Access
PD MAR-APR
PY 2014
VL 15
IS 2
BP 95
EP 101
DI 10.5301/jva.5000166
PG 7
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA AM6TD
UT WOS:000339997000005
PM 24170585
DA 2018-10-20
ER

PT J
AU Lu, HX
   Yang, ZQ
   Jiao, Q
   Wang, YY
   Wang, L
   Yang, PB
   Chen, XL
   Zhang, PB
   Wang, P
   Chen, MX
   Lu, XY
   Liu, Y
AF Lu, Hai-xia
   Yang, Zhi-qian
   Jiao, Qian
   Wang, Yuan-yuan
   Wang, Li
   Yang, Peng-bo
   Chen, Xin-lin
   Zhang, Peng-bo
   Wang, Peng
   Chen, Ming-xia
   Lu, Xiao-yun
   Liu, Yong
TI Low concentration of serum helps to maintain the characteristics of
   NSCs/NPCs on alkali-treated PHBHHx film in vitro
SO NEUROLOGICAL RESEARCH
LA English
DT Article
DE Multiple differentiation; NSCs/NPCs; PHBHHx; Self-renewal; Serum
ID NEURAL STEM-CELLS; PERIPHERAL-NERVE REGENERATION; NEURONAL
   DIFFERENTIATION; THERAPY; BRAIN; POLYHYDROXYALKANOATES; TRANSPLANTATION;
   BIOMATERIALS; ENGRAFTMENT; CONDUITS
AB Objective: Efforts have been made by tissue engineers to create a permissive environment for neural regeneration, and to enhance the efficiency of neural stem cell (NSC) transplantation. However, to acquire sufficient number of seed cells on the material appears to be the main obstacle to constructing functional transplantable NSC-biomaterial complexes. A culture system has been optimized in the current study to maintain the specific characteristics of NSCs/neural progenitor cells (NPCs) on the material and achieve sustaining increased multipotent seed cells.
   Methods: The PHBHHx film was selected as biomaterial and the surface was firstly modified with NaOH treatment. The NSCs/NPCs isolated from the cerebral cortex of rat embryos were cultured on the treated PHBHHx films in growth medium containing 1%, 5%, and 10% fetal bovine serum (FBS). Then the attachment, survival, proliferation, and differentiation of NSCs/NPCs were assessed.
   Results: NaOH treatment significantly increased the hydrophilicity of PHBHHx and enhanced NSCs/NPCs attachment. On the treated PHBHHx film, NSCs/NPCs survived well and actively proliferated in the medium containing 1% FBS. After 7-14 days in culture, approximately two-thirds of cells remained as nestin and Sox2 positive NSCs/NPCs. However, in the medium containing 5% and 10% FBS, NSCs/NPCs proliferation was reduced and differentiation, particularly glial differentiation was significantly promoted.
   Conclusion: Growth medium containing low concentration of FBS is favorable for maintaining the characteristics, in terms of self-renewal and multiple differentiation, of NSCs/NPCs on NaOH-treated PHBHHx films. This could be a useful method to construct functional transplantable NSCs/NPCs-biomaterial complex.
C1 [Lu, Hai-xia; Yang, Zhi-qian; Jiao, Qian; Wang, Yuan-yuan; Wang, Li; Yang, Peng-bo; Chen, Xin-lin; Liu, Yong] Xi An Jiao Tong Univ, Coll Med, Inst Neurobiol, Xian 710061, Peoples R China.
   [Yang, Zhi-qian; Lu, Xiao-yun] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710061, Shaanxi, Peoples R China.
   [Wang, Li; Zhang, Peng-bo] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Obstet & Gynecol, Xian 710061, Peoples R China.
   [Wang, Li; Zhang, Peng-bo] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Anesthesiol, Xian 710061, Peoples R China.
   [Wang, Peng; Chen, Ming-xia] Xi An Jiao Tong Univ, Coll Med, Ctr Electron Microscopy, Xian 710061, Shaanxi, Peoples R China.
RP Liu, Y (reprint author), Xi An Jiao Tong Univ, Coll Med, Inst Neurobiol, Xian 710061, Peoples R China.
EM luxy05@mail.xjtu.edu.cn; liuy5599@mail.xjtu.edu.cn
FU National Natural Science Foundation of China [31070943, 31271151,
   81070998, 81172170]; Doctoral Fund of Ministry of Education of China
   [200806981053]; Fundamental Research Funds for the Central Universities
FX The authors would like to thank Prof. GQ Chen from School of Life
   Science, Tsinghua University for the kindly donation of PHBHHx material.
   This work was supported by grants from the National Natural Science
   Foundation of China (31070943, 31271151, 81070998, and 81172170), the
   Doctoral Fund of Ministry of Education of China (200806981053), and the
   Fundamental Research Funds for the Central Universities.
CR Bartlett PF, 1998, IMMUNOL CELL BIOL, V76, P414, DOI 10.1046/j.1440-1711.1998.00762.x
   Bian YZ, 2009, BIOMATERIALS, V30, P217, DOI 10.1016/j.biomaterials.2008.09.036
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Choi SS, 2010, GENES GENOM, V32, P225, DOI 10.1007/s13258-010-1001-x
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Faux CH, 2001, J NEUROSCI, V21, P5587
   GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879
   Gstraunthaler G, 2003, ALTEX-ALTERN TIEREXP, V20, P275
   Hadlock T, 1999, LARYNGOSCOPE, V109, P1412, DOI 10.1097/00005537-199909000-00010
   Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   Joannides AJ, 2008, J NEUROL SCI, V265, P84, DOI 10.1016/j.jns.2007.09.008
   Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006
   Kemp SWP, 2008, NEUROL RES, V30, P1030, DOI 10.1179/174313208X362505
   Lepore A C, 2006, Neuroscience, V142, P287, DOI 10.1016/j.neuroscience.2005.12.067
   Lepore AC, 2005, EXP NEUROL, V194, P230, DOI 10.1016/j.expneurol.2005.02.020
   Lepore AC, 2004, NEURON GLIA BIOL, V1, P113, DOI 10.1017/S1740925X04000213
   Lu HX, 2008, BRAIN RES BULL, V77, P158, DOI 10.1016/j.brainresbull.2008.02.037
   Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Okano H, 2007, J NEUROCHEM, V102, P1459, DOI 10.1111/j.1471-4159.2007.04674.x
   Park KI, 2006, EXP NEUROL, V199, P179, DOI 10.1016/j.expneurol.2006.03.016
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809
   Rothstein JD, 2004, NAT BIOTECHNOL, V22, P283, DOI 10.1038/nbt0304-283
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Temple S, 2001, NAT REV NEUROSCI, V2, P513, DOI 10.1038/35081577
   Wang TY, 2012, BIOMATERIALS, V33, P9188, DOI 10.1016/j.biomaterials.2012.09.013
   Wang Y, 2007, J NEUROIMMUNE PHARM, V2, P243, DOI 10.1007/s11481-007-9074-2
   Xu XY, 2010, BIOMATERIALS, V31, P3967, DOI 10.1016/j.biomaterials.2010.01.132
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   YASUDA T, 1994, LANGMUIR, V10, P2435, DOI 10.1021/la00019a068
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
NR 35
TC 2
Z9 5
U1 0
U2 10
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0161-6412
EI 1743-1328
J9 NEUROL RES
JI Neurol. Res.
PD MAR
PY 2014
VL 36
IS 3
BP 207
EP 214
DI 10.1179/1743132813Y.0000000281
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AI7VL
UT WOS:000337108800003
PM 24512014
DA 2018-10-20
ER

PT J
AU Dai, LH
   He, ZM
   Zhang, X
   Hu, XQ
   Yuan, L
   Qiang, M
   Zhu, JX
   Shao, ZX
   Zhou, CY
   Ao, YF
AF Dai, Linghui
   He, Zhenming
   Zhang, Xin
   Hu, Xiaoqing
   Yuan, Lan
   Qiang, Ming
   Zhu, Jingxian
   Shao, Zhenxing
   Zhou, Chunyan
   Ao, Yingfang
TI One-Step Repair for Cartilage Defects in a Rabbit Model A Technique
   Combining the Perforated Decalcified Cortical-Cancellous Bone Matrix
   Scaffold With Microfracture
SO AMERICAN JOURNAL OF SPORTS MEDICINE
LA English
DT Article
DE articular cartilage; cartilage repair; microfracture; decalcified
   cortical-cancellous bone matrix (DCCBM); medical applications
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; THICKNESS CHONDRAL DEFECTS;
   TERM-FOLLOW-UP; ARTICULAR-CARTILAGE; ELASTIC-MODULUS; OSTEOCHONDRAL
   REGENERATION; ABRASION ARTHROPLASTY; FUNCTIONAL-EVALUATION; KNEE;
   NANOINDENTATION
AB Background: Cartilage repair still presents a challenge to clinicians and researchers alike. A more effective, simpler procedure that can produce hyaline-like cartilage is needed for articular cartilage repair.
   Hypothesis: A technique combining microfracture with a biomaterial scaffold of perforated decalcified cortical-cancellous bone matrix (DCCBM; composed of cortical and cancellous parts) would create a 1-step procedure for hyaline-like cartilage repair.
   Study Design: Controlled laboratory study.
   Methods: For the in vitro portion of this study, mesenchymal stem cells (MSCs) were isolated from bone marrow aspirates of New Zealand White rabbits. Scanning electron microscopy (SEM), confocal microscopy, and 1,9-dimethylmethylene blue assay were used to assess the attachment, proliferation, and cartilage matrix production of MSCs grown on a DCCBM scaffold. For the in vivo experiment, full-thickness defects were produced in the articular cartilage of the trochlear groove of 45 New Zealand White rabbits, and the rabbits were then assigned to 1 of 3 treatment groups: perforated DCCBM combined with microfracture (DCCBM+M group), perforated DCCBM alone (DCCBM group), and microfracture alone (M group). Five rabbits in each group were sacrificed at 6, 12, or 24 weeks after the operation, and the repair tissues were analyzed by histological examination, assessment of matrix staining, SEM, and nanoindentation of biomechanical properties.
   Results: The DCCBM+M group showed hyaline-like articular cartilage repair, and the repair tissues appeared to have better matrix staining and revealed biomechanical properties close to those of the normal cartilage. Compared with the DCCBM+M group, there was unsatisfactory repair tissues with less matrix staining in the DCCBM group and no matrix staining in the M group, as well as poor integration with normal cartilage and poor biomechanical properties.
   Conclusion: The DCCBM scaffold is suitable for MSC growth and hyaline-like cartilage repair induction when combined with microfracture.
   Clinical Relevance: Microfracture combined with a DCCBM scaffold is a promising method that can be performed and adopted into clinical treatment for articular cartilage injuries.
C1 [Dai, Linghui; He, Zhenming; Zhang, Xin; Hu, Xiaoqing; Yuan, Lan; Qiang, Ming; Zhu, Jingxian; Shao, Zhenxing; Zhou, Chunyan; Ao, Yingfang] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100191, Peoples R China.
RP Ao, YF (reprint author), Peking Univ, Hosp 3, Inst Sports Med, 49 North Garden Rd, Beijing 100191, Peoples R China.
EM chunyanzhou@bjmu.edu.cn; Yingfang.ao@vip.sina.com
OI Shao, Zhenxing/0000-0001-5811-1254
FU National Natural Science Foundation of China (NFSC) [81101390,
   81071474]; Specialized Research Fund for the Doctoral Program of Higher
   Education [20110001130001, 20090001120117]; Leading Academic Discipline
   Project of Beijing Education Bureau; 111 Project of China [B07001]
FX One or more of the authors has declared the following potential conflict
   of interest or source of funding: This work was supported by National
   Natural Science Foundation of China (NFSC; grants 81101390 and
   81071474), Specialized Research Fund for the Doctoral Program of Higher
   Education (20110001130001 and 20090001120117), Leading Academic
   Discipline Project of Beijing Education Bureau, and the 111 Project of
   China (B07001).
CR Abedi G, 2010, J BIOMATER SCI POLYM
   Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950
   [Anonymous], 2011, PRESCRIRE INT, V20, P122
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   Bekkers JEJ, 2009, AM J SPORT MED, V37, p148S, DOI 10.1177/0363546509351143
   Beris AE, 2012, AM J SPORT MED, V40, P562, DOI 10.1177/0363546511428778
   Berninger MT, 2013, JOVE-J VIS EXP, DOI 10.3791/4423
   Bouard D, 2009, BRIT J PHARMACOL, V157, P153, DOI 10.1038/bjp.2008.349
   Bouwmeester PSJM, 2002, J ORTHOPAED RES, V20, P267, DOI 10.1016/S0736-0266(01)00099-7
   Buda R, 2010, J BONE JOINT SURG AM, V92A, P2, DOI 10.2106/JBJS.J.00813
   Chang NJ, 2012, BIOMATERIALS, V33, P3153, DOI 10.1016/j.biomaterials.2011.12.054
   Ebenstein DM, 2004, J MATER RES, V19, P273, DOI 10.1557/jmr.2004.0031
   Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9
   Franke O, 2007, ACTA BIOMATER, V3, P873, DOI 10.1016/j.actbio.2007.04.005
   Gelse K, 2008, ARTHRITIS RHEUM-US, V58, P475, DOI 10.1002/art.23124
   Giannini S, 2009, CLIN ORTHOP RELAT R, V467, P3307, DOI 10.1007/s11999-009-0885-8
   Hangody L, 2010, AM J SPORT MED, V38, P1125, DOI 10.1177/0363546509360405
   Johnson LL, 2001, CLIN ORTHOP RELAT R, pS306
   Kitamura N, 2011, AM J SPORT MED, V39, P1160, DOI 10.1177/0363546511399383
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003
   Li C, 2006, J BIOMED MATER RES A, V78A, P729, DOI 10.1002/jbm.a.30751
   Lotz M, 2001, CLIN ORTHOP RELAT R, pS108
   Matsunaga D, 2007, KNEE, V14, P465, DOI 10.1016/j.knee.2007.06.008
   Miller Bruce S, 2004, J Knee Surg, V17, P13
   Morille M, 2013, J CONTROL RELEASE, V170, P99, DOI 10.1016/j.jconrel.2013.04.017
   Moseley JB, 2010, AM J SPORT MED, V38, P238, DOI 10.1177/0363546509348000
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Park JS, 2008, TRANSPLANTATION, V85, P589, DOI 10.1097/TP.0b013e3181639b3a
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   PHARR GM, 1992, J MATER RES, V7, P613, DOI 10.1557/JMR.1992.0613
   Schindler OS, 2011, ACTA ORTHOP BELG, V77, P709
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Williams Riley J 3rd, 2007, Instr Course Lect, V56, P419
   Young LS, 2006, J PATHOL, V208, P299, DOI 10.1002/path.1896
   Zhang X, 2008, BIOMATERIALS, V29, P4616, DOI 10.1016/j.biomaterials.2008.07.051
NR 39
TC 25
Z9 26
U1 2
U2 23
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0363-5465
EI 1552-3365
J9 AM J SPORT MED
JI Am. J. Sports Med.
PD MAR
PY 2014
VL 42
IS 3
BP 583
EP 591
DI 10.1177/0363546513518415
PG 9
WC Orthopedics; Sport Sciences
SC Orthopedics; Sport Sciences
GA AH6EA
UT WOS:000336222300008
PM 24496505
DA 2018-10-20
ER

PT J
AU Mohite, BV
   Patil, SV
AF Mohite, Bhavna V.
   Patil, Satish V.
TI A novel biomaterial: bacterial cellulose and its new era applications
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Article
DE microbial cellulose; production; biopolymer; functional material;
   Acetobacter
ID ACETOBACTER-XYLINUM; MICROBIAL CELLULOSE; SKIN SUBSTITUTES;
   GLUCONACETOBACTER-HANSENII; MECHANICAL-PROPERTIES; SILVER NANOPARTICLES;
   DRUG-DELIVERY; CULTURE; NANOCOMPOSITES; MEMBRANES
AB Bacterial cellulose (BC) is a promising natural polymer that is produced by bacteria and that has unique and desirable structural, physical, and chemical properties. From the time when the remarkable properties of BC were found 15 years ago compared with plant cellulose, interest has grown in BC and it has become an article of trade in diverse applications. Following this trend, this paper reviews the progress of relevant studies, including general information about cellulose, production by microorganisms as well as BC cultivation, and its properties. The applications reviewed in the present article comprise biological and nonbiological fields. The latest use of BC in the biomedical, environmental, agricultural, electronic, food, and industrial fields is discussed with its applications in composite form. The present article attempts to amass the assorted uses of BC under one umbrella. Thus, recent advances in BC applications in different fields are thoroughly reviewed. This article concludes with the need for future research of BC to make it commercialized as vital biomaterial.
C1 [Mohite, Bhavna V.; Patil, Satish V.] North Maharashtra Univ, Sch Life Sci, Jalagoan 425001, MS, India.
RP Patil, SV (reprint author), North Maharashtra Univ, Sch Life Sci, POB 80, Jalagoan 425001, MS, India.
EM satish.patil7@gmail.com
OI Mohite, Bhavana/0000-0002-8821-8631
FU University Grants Commission, New Delhi
FX The research fellowship to Bhavna Mohite from the University Grants
   Commission, New Delhi, under the Research Fellowship in Sciences for the
   meritorious students scheme is gratefully acknowledged.
CR Abdelhak M., 2009, THESIS U MENTOURI CO
   Amano Y., 2005, BIOL MACROMOL, V5, P3
   Amin MCIM, 2012, SAINS MALAYS, V41, P561
   Amin MCIM, 2012, CARBOHYD POLYM, V88, P465, DOI 10.1016/j.carbpol.2011.12.022
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Basta AH, 2009, J APPL MICROBIOL, V107, P2098, DOI 10.1111/j.1365-2672.2009.04467.x
   Blaker JJ, 2010, COMPOS SCI TECHNOL, V70, P1879, DOI 10.1016/j.compscitech.2010.05.028
   Brown A. J., 1886, CHEM SOC, V49, P432
   Brown A. J., 1886, J CHEM SOC, V49, P172, DOI DOI 10.1039/CT8864900172
   Brown Jr R. M., 2006, Provisional Patent, Patent No. 2914BRO
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   BROWN RM, 1989, CELLULOSE STRUCTURAL, P145
   Budhiono A, 1999, CARBOHYD POLYM, V40, P137, DOI 10.1016/S0144-8617(99)00050-8
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Cai Z, 2010, CELLULOSE, V17, P83, DOI 10.1007/s10570-009-9362-5
   Chawla PR, 2009, FOOD TECHNOL BIOTECH, V47, P107
   Costa L. M. M., 2012, J BIOMATER NANOBIOTE, V3, P92, DOI [10.4236/jbnb.2012.31012, DOI 10.4236/JBNB.2012.31012]
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja W, 2007, CELLULOSE MOL STRUCT
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Dahman Y, 2009, J NANOSCI NANOTECHNO, V9, P5105, DOI 10.1166/jnn.2009.1466
   Demling RH, 1999, BURNS, V25, P256, DOI 10.1016/S0305-4179(98)00165-X
   Drogat N, 2011, J NANOPART RES, V13, P1557, DOI 10.1007/s11051-010-9995-1
   Evans BR, 2003, BIOSENS BIOELECTRON, V18, P917, DOI 10.1016/S0956-5663(02)00212-9
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Gabriels D., 1990, NATO ASI SER B-PHYS, P557
   Gallin WJ, 1998, BURNS, V24, P613, DOI 10.1016/S0305-4179(98)00089-8
   Gao CA, 2011, J POROUS MAT, V18, P139, DOI 10.1007/s10934-010-9364-6
   George J, 2005, INT J BIOL MACROMOL, V37, P189, DOI 10.1016/j.ijbiomac.2005.10.007
   George J, 2005, WORLD J MICROB BIOT, V21, P1323, DOI 10.1007/s11274-005-3574-0
   GEYER U, 1994, INT J BIOL MACROMOL, V16, P343, DOI 10.1016/0141-8130(94)90067-1
   GEYER U, 1994, ACTA BIOTECHNOL, V14, P261, DOI 10.1002/abio.370140308
   GROMETELHANAN Z, 1963, J BACTERIOL, V85, P284
   Hasan N, 2012, INT J ADV SCI ENG IN, V2, P1, DOI DOI 10.18517/IJASEIT.2.4.201
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Hu WL, 2009, MAT SCI ENG C-BIO S, V29, P1216, DOI 10.1016/j.msec.2008.09.017
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Isizawa S., 1976, ACTINOMYCETES BOUNDA, P43
   Jeon JH, 2010, SENSOR ACTUAT B-CHEM, V146, P307, DOI 10.1016/j.snb.2010.02.046
   Jiang GP, 2012, INT J HYDROGEN ENERG, V37, P9182, DOI 10.1016/j.ijhydene.2012.02.195
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   Jung JY, 2005, ENZYME MICROB TECH, V37, P347, DOI 10.1016/j.enzmictec.2005.02.019
   Jung R, 2009, J BIOMAT SCI-POLYM E, V20, P311, DOI 10.1163/156856209X412182
   Kawecki M., 2004, P INT REV C BIOT VIE, P14
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D., 2003, US Patent, Patent No. 0013163A1
   Km J. Y., 2007, APPL BIOCHEM BIOTECH, V137, P529
   KUDLICKA K, 1987, PROTOPLASMA, V136, P96, DOI 10.1007/BF01276358
   Kulkarni P.K., 2012, AM J DRUG DISCOV DEV, V2, P72
   Kurisaki H., 1991, US Patent, Patent No. 5024831
   LATARJET J, 1995, BURNS, V21, P221, DOI 10.1016/0305-4179(95)80015-G
   Legendre JY, 2009, US Patent, Patent No. [2009/0041815, 20090041815]
   lguchi M. S., 1988, U.S. Patent, Patent No. 4742164
   Liang HW, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.34
   Lopez-Delgado A, 1998, WATER RES, V32, P989, DOI 10.1016/S0043-1354(97)00304-7
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Min L. U., 2011, CHEM RES CHINESE U, V27, P1031
   Mormino R, 2003, APPL MICROBIOL BIOT, V62, P503, DOI 10.1007/s00253-003-1377-5
   Ng CC, 2004, WORLD J MICROB BIOT, V20, P875, DOI 10.1007/s11274-004-0873-9
   Nge TT, 2010, CELLULOSE, V17, P349, DOI 10.1007/s10570-009-9394-x
   Nguyen D. N., 2009, International Food Research Journal, V16, P59
   Nogi M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2191667
   Nogi M, 2008, ADV MATER, V20, P1849, DOI 10.1002/adma.200702559
   OSTER GA, 2003, Patent No. 6599518
   Ougiya H, 1997, BIOSCI BIOTECH BIOCH, V61, P1541, DOI 10.1271/bbb.61.1541
   Park JK, 2003, BIOTECHNOL LETT, V25, P2055, DOI 10.1023/B:BILE.0000007065.63682.18
   Patel UD, 2008, J COLLOID INTERF SCI, V319, P462, DOI 10.1016/j.jcis.2007.12.019
   Patil SV, 2011, APPL BIOCHEM BIOTECH, V163, P780, DOI 10.1007/s12010-010-9082-1
   Payen A., 1838, SEANCES ACAD SCI, V7, P1052
   Payen A., 1838, SEANCES ACAD SCI, V7, P1125
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Pirkkalainen K, 2008, EUR PHYS J D, V49, P333, DOI 10.1140/epjd/e2008-00180-5
   Pirkkalainen K, 2007, J APPL CRYSTALLOGR, V40, pS489, DOI 10.1107/S0021889806055804
   Pommet M, 2008, BIOMACROMOLECULES, V9, P1643, DOI 10.1021/bm800169g
   Prasanna M, 2004, BURNS, V30, P169, DOI 10.1016/j.burns.2003.09.028
   Qiu KY, 2012, J MATER SCI, V47, P6066, DOI 10.1007/s10853-012-6517-9
   QUINN KJ, 1985, BIOMATERIALS, V6, P369, DOI 10.1016/0142-9612(85)90095-X
   REED BE, 1994, J ENVIRON ENG-ASCE, V120, P416, DOI 10.1061/(ASCE)0733-9372(1994)120:2(416)
   Rezaee A., 2008, J BIOL SCI, V8, P209
   Rezaee A, 2008, ENVIRON ENG MANAG J, V7, P589, DOI 10.30638/eemj.2008.082
   Rezaee J. D., 2005, AM J ENV SCI, V1, P102
   Richmond PA, 1999, BIOSYNTHESIS BIODEGR, P5
   Roberts E. M., 1986, European Patent, Patent No. [0186495, 19860186495]
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Saibuatong OA, 2010, CARBOHYD POLYM, V79, P455, DOI 10.1016/j.carbpol.2009.08.039
   Schrecker ST, 2005, BIOTECHNOL LETT, V27, P1435, DOI 10.1007/s10529-005-1465-y
   Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6
   Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175
   Srivastava SK, 1997, J ENVIRON ENG-ASCE, V123, P461, DOI 10.1061/(ASCE)0733-9372(1997)123:5(461)
   Stephens RS, 1990, Production of cholesterol-absorbing bacterial cellulose for use as dietary fiber, Patent No. [4960763, US 4960763 A, CAN 114:60730]
   Sun DP, 2010, NANOSCALE, V2, P287, DOI 10.1039/b9nr00158a
   Sun DP, 2010, APPL SURF SCI, V256, P2241, DOI 10.1016/j.apsusc.2009.10.034
   Suwannapinunt N., 2007, SURANAREE J SCI TECH, V14, P357
   Teeri T., 1977, TRENDS BIOTECHNOL, V15, P160
   Thanaporn A., 2011, MED DEVICES, V4, P77
   Ton NMN, 2011, INT FOOD RES J, V18, P983
   Tournilhac F, 2003, US patent, Patent No. [US 6534071 B1, 6534071]
   Vandamme EJ, 1998, POLYM DEGRAD STABIL, V59, P93, DOI 10.1016/S0141-3910(97)00185-7
   Vashistha S., 2010, INT C ADV POL TECHN, P56
   Vyjayanthi JP, 2010, WATER ENVIRON RES, V82, P601, DOI 10.2175/106143009X12529484816114
   Wallace A., 1997, HDB SOIL CONDITIONER
   Wan YZ, 2009, COMPOS SCI TECHNOL, V69, P1212, DOI 10.1016/j.compscitech.2009.02.024
   Watanabe K, 1998, BIOSCI BIOTECH BIOCH, V62, P1290, DOI 10.1271/bbb.62.1290
   WATANABE K, 1993, CYTOTECHNOLOGY, V13, P107, DOI 10.1007/BF00749937
   Watanabe M., 1998, CELLULOSE, V5, P187
   Weimer PJ, 2000, J AGR FOOD CHEM, V48, P1727, DOI 10.1021/jf991372y
   Westland JA, 1994, U. S. Patent, Patent No. [US5350528 A, 5350528]
   WHITE AR, 1981, P NATL ACAD SCI-BIOL, V78, P1047, DOI 10.1073/pnas.78.2.1047
   Wu SC, 2008, J MOL CATAL B-ENZYM, V54, P103, DOI 10.1016/j.molcatb.2007.12.021
   YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032
   Yamanaka S., 1990, European Patent, Patent No. [0396344, 19900396344]
   Yang JZ, 2009, ELECTROCHIM ACTA, V54, P6300, DOI 10.1016/j.electacta.2009.05.073
   Yoon SH, 2006, BIOMACROMOLECULES, V7, P1280, DOI 10.1021/bm050597g
   Yoshinaga F, 1997, BIOSCI BIOTECH BIOCH, V61, P219, DOI 10.1271/bbb.61.219
   Yoshino T, 1996, J FERMENT BIOENG, V81, P32, DOI 10.1016/0922-338X(96)83116-3
   Yu XC, 1996, INT J BIOL MACROMOL, V19, P145, DOI 10.1016/0141-8130(96)01109-9
   ZAAR K, 1977, CYTOBIOLOGIE, V16, P1
   Zhu HX, 2011, BIOTECHNOL BIOTEC EQ, V25, P2233, DOI 10.5504/BBEQ.2011.0010
NR 122
TC 30
Z9 30
U1 7
U2 117
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
EI 1470-8744
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD MAR
PY 2014
VL 61
IS 2
BP 101
EP 110
DI 10.1002/bab.1148
PG 10
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA AF3KG
UT WOS:000334610400004
PM 24033726
DA 2018-10-20
ER

PT J
AU Mota, A
   Lotfi, AS
   Barzin, J
   Hatam, M
   Adibi, B
   Khalaj, Z
   Massumi, M
AF Mota, Ali
   Lotfi, Abbas Sahebghadam
   Barzin, Jalal
   Hatam, Mostafa
   Adibi, Behzad
   Khalaj, Zahra
   Massumi, Mohammad
TI Human Bone Marrow Mesenchymal Stem Cell Behaviors on PCL/Gelatin
   Nanofibrous Scaffolds Modified with A Collagen IV-Derived RGD-Containing
   Peptide
SO CELL JOURNAL
LA English
DT Article
DE Nanofibers; Polycaprolactone; RGD Peptide; Surface Modification;
   Mesenchymal Stem Cell
ID ELECTROSPUN POLYCAPROLACTONE; FIBROUS SCAFFOLDS; CROSS-LINKING; GELATIN;
   SURFACE; POLYMERS; FILMS; BIOCOMPATIBILITY; DIFFERENTIATION;
   PROLIFERATION
AB Objective: We introduce an RGD (Arg-Gly-Asp)-containing peptide of collagen IV origin that possesses potent cell adhesion and proliferation properties.
   Materials and Methods: In this experimental study, the peptide was immobilized on an electrospun nanofibrous polycaprolactone/gelatin (PCL/Gel) hybrid scaffold by a chemical bonding approach to improve cell adhesion properties of the scaffold. An iodine-modified phenylalanine was introduced in the peptide to track the immobilization process. Native and modified scaffolds were characterized with scanning electron microscopy (SEM) and fourier transform infrared spectroscopy (FTIR). We studied the osteogenic and adipogenic differentiation potential of human bone marrow-derived mesenchymal stem cells (hBMSCs). In addition, cell adhesion and proliferation behaviors of hBMSCs on native and peptide modified scaffolds were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and 4',6-diamidino-2-phenylindole (DAPI) staining, and the results compared with tissue culture plate, as the control.
   Results: FTIR results showed that the peptide successfully immobilized on the scaffold. MU assay and DAPI staining results indicated that peptide immobilization had a dramatic effect on cell adhesion and proliferation.
   Conclusion: This peptide modified nanofibrous scaffold can be a promising biomaterial for tissue engineering and regenerative medicine with the use of hBMSCs.
C1 [Mota, Ali; Lotfi, Abbas Sahebghadam; Adibi, Behzad] Tarbiat Modares Univ, Fac Med Sci, Dept Clin Biochem, Tehran, Iran.
   [Lotfi, Abbas Sahebghadam; Hatam, Mostafa; Khalaj, Zahra; Massumi, Mohammad] Natl Inst Genet Engn & Biotechnol, Tehran, Iran.
   [Barzin, Jalal] Iran Polymer & Petrochem Inst, Tehran, Iran.
RP Lotfi, AS (reprint author), Tarbiat Modares Univ, Fac Med Sci, Dept Clin Biochem, POB 14115-11l, Tehran, Iran.
EM Lotfi_ab@modares.ac.ir
FU Tarbiat Modares University
FX This study was financially supported by Tarbiat Modares University. The
   authors would like to thank Dr. Mozhgan Zandi and Mandi Saeed for
   technical support. The authors declare that there is no conflict of
   interest.
CR Andukuri A, 2011, ACTA BIOMATER, V7, P225, DOI 10.1016/j.actbio.2010.08.013
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Eslaminejad MB, 2011, YAKHTEH, V12, P469
   Gabriel M, 2006, J BIOMAT SCI-POLYM E, V17, P567, DOI 10.1163/156856206776986288
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Grover CN, 2012, J MECH BEHAV BIOMED, V10, P62, DOI 10.1016/j.jmbbm.2012.02.028
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hunt JA, 2008, NAT MATER, V7, P617, DOI 10.1038/nmat2242
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f
   Jahani H, 2012, CELL J, V14, P31
   Jo S, 2000, POLYMER, V41, P7595, DOI 10.1016/S0032-3861(00)00117-8
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Massumi M, 2012, TISSUE ENG PT A, V18, P609, DOI [10.1089/ten.tea.2011.0368, 10.1089/ten.TEA.2011.0368]
   McClure MJ, 2010, ACTA BIOMATER, V6, P2422, DOI 10.1016/j.actbio.2009.12.029
   Park KH, 2002, BIOTECHNOL LETT, V24, P1401, DOI 10.1023/A:1019890229822
   Pena J, 2006, POLYM DEGRAD STABIL, V91, P1424, DOI 10.1016/j.polymdegradstab.2005.10.016
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Seo HS, 2010, APPL SURF SCI, V257, P596, DOI 10.1016/j.apsusc.2010.07.040
   Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s
   Songchotikunpan P, 2008, INT J BIOL MACROMOL, V42, P247, DOI 10.1016/j.ijbiomac.2007.11.005
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tambralli A, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/025001
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   Tomihata K, 1996, Tissue Eng, V2, P307, DOI 10.1089/ten.1996.2.307
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   Wang SD, 2009, J APPL POLYM SCI, V113, P2675, DOI 10.1002/app.30346
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhang YZ, 2006, POLYMER, V47, P2911, DOI 10.1016/j.polymer.2006.02.046
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
NR 37
TC 11
Z9 11
U1 2
U2 17
PU ROYAN INST
PI TEHRAN
PA PO BOX 19395-4644, TEHRAN, 00000, IRAN
SN 2228-5806
EI 2228-5814
J9 CELL J
JI Cell J.
PD SPR
PY 2014
VL 16
IS 1
BP 1
EP 10
PG 10
WC Cell Biology
SC Cell Biology
GA AH8XF
UT WOS:000336420800001
PM 24511574
DA 2018-10-20
ER

PT J
AU Khayyatan, F
   Nemati, S
   Kiani, S
   Emami, SH
   Baharvand, H
AF Khayyatan, Fahimeh
   Nemati, Shiva
   Kiani, Sahar
   Emami, Shahriar Hojjati
   Baharvand, Hossein
TI Behaviour of Human Induced Pluripotent Stem Cell-Derived Neural
   Progenitors on Collagen Scaffolds Varied in Freezing Temperature and
   Laminin Concentration
SO CELL JOURNAL
LA English
DT Article
DE Collagen; Laminin; Neural Progenitors; Tissue Engineering
ID SPINAL-CORD; DIFFERENTIATION; REGENERATION; INTEGRINS; RECOVERY;
   ADHESION; PROMOTE; REPAIR
AB Objective: Biomaterial technology, when combined with emerging human induced pluripotent stem cell (hiPSC) technology, provides a promising strategy for patient-specific tissue engineering. In this study, we have evaluated the physical effects of collagen scaffolds fabricated at various freezing temperatures on the behavior of hiPSC-derived neural progenitors (hiPSC-NPs). In addition, the coating of scaffolds using different concentrations of laminin was examined on the cells.
   Materials and Methods: Initially, in this experimental study, the collagen scaffolds fabricated from different collagen concentrations and freezing temperatures were characterized by determining the pore size, porosity, swelling ratio, and mechanical properties. Effects of cross-linking on free amine groups, volume shrinkage and mass retention was also assessed. Then, hiPSC-NPs were seeded onto the most stable three-dimensional collagen scaffolds and we evaluated the effect of pore structure. Additionally, the different concentrations of laminin coating of the scaffolds on hiPSC-NPs behavior were assessed.
   Results: Scanning electron micrographs of the scaffolds showed a pore diameter in the range of 23-232 mu m for the scaffolds prepared with different fabrication parameters. Also porosity of all scaffolds was >98% with more than 94% swelling ratio. hiPSC-NPs Were subsequently seeded onto the scaffolds that were made by different freezing temperatures in order to assess for physical effects of the scaffolds. We observed similar proliferation, but more cell infiltration in scaffolds prepared at lower freezing temperatures. The laminin coating of the scaffolds improved NPs proliferation and infiltration in a dose-dependent manner. Immunofluorescence staining and scanning electron microscopy confirmed the compatibility of undifferentiated and differentiated hiPSC-NPs on these scaffolds.
   Conclusion: The results have suggested that the pore structure and laminin coating of collagen scaffolds significantly impact cell behavior. These biocompatible three-dimensional laminin-coated collagen scaffolds are good candidates for future hiPSC-NPs biomedical nerve tissue engineering applications.
C1 [Khayyatan, Fahimeh; Nemati, Shiva; Kiani, Sahar; Baharvand, Hossein] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, Tehran, Iran.
   [Khayyatan, Fahimeh; Emami, Shahriar Hojjati] Amirkabir Univ Technol, Dept Biomed Engn, Tehran, Iran.
   [Baharvand, Hossein] Univ Sci & Culture, ACECR, Dept Dev Biol, Tehran, Iran.
RP Baharvand, H (reprint author), ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, POB 16635-148, Tehran, Iran.
EM Baharvand@RoyanInstitute.org
FU Royan Institute
FX This study was funded by a grant provided by Royan Institute. The
   authors have no conflict of interest to declare.
CR Baharvand H, 2007, INT J DEV BIOL, V51, P371, DOI 10.1387/ijdb.072280hb
   Buttafoco L, 2006, J BIOMED MATER RES B, V77B, P357, DOI 10.1002/jbm.b.30444
   Cao JI, 2011, BIOMATERIALS, V32, P3939, DOI 10.1016/j.biomaterials.2011.02.020
   Cary LA, 1999, HISTOL HISTOPATHOL, V14, P1001, DOI 10.14670/HH-14.1001
   Chen DC, 2007, J BIOMED MATER RES A, V80A, P399, DOI 10.1002/jbm.a.30932
   Coutu DL, 2009, J CELL BIOCHEM, V108, P537, DOI 10.1002/jcb.22296
   Ding T, 2010, INJURY, V41, P522, DOI 10.1016/j.injury.2009.04.003
   Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778
   Habermehl J, 2005, MACROMOL BIOSCI, V5, P821, DOI 10.1002/mabi.200500102
   Hall PE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-71
   Hatami M, 2009, CYTOTHERAPY, V11, P618, DOI 10.1080/14653240903005802
   Hong S, 2008, J NEUROCHEM, V104, P316, DOI 10.1111/j.1471-4159.2007.04952.x
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jurga M, 2011, BIOMATERIALS, V32, P3423, DOI 10.1016/j.biomaterials.2011.01.049
   Kumada Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010305
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90
   Mollers S, 2009, TISSUE ENG PT A, V15, P461, DOI 10.1089/ten.tea.2007.0107
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Neal RA, 2009, TISSUE ENG PART C-ME, V15, P11, DOI 10.1089/ten.tec.2007.0366
   Nemati S, 2011, STEM CELLS DEV, V20, P503, DOI 10.1089/scd.2010.0143
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Ohan MP, 2002, J BIOMED MATER RES, V60, P384, DOI 10.1002/jbm.10111
   Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Tatard VM, 2005, CURR DRUG TARGETS, V6, P81, DOI 10.2174/1389450053344885
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Totonchi M, 2010, INT J DEV BIOL, V54, P877, DOI 10.1387/ijdb.092903mt
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
NR 29
TC 10
Z9 10
U1 0
U2 4
PU ROYAN INST
PI TEHRAN
PA PO BOX 19395-4644, TEHRAN, 00000, IRAN
SN 2228-5806
EI 2228-5814
J9 CELL J
JI Cell J.
PD SPR
PY 2014
VL 16
IS 1
BP 53
EP 62
PG 10
WC Cell Biology
SC Cell Biology
GA AH8XF
UT WOS:000336420800007
PM 24518975
DA 2018-10-20
ER

PT J
AU Huang, ZB
   Yin, GF
   Liao, XM
   Gu, JW
AF Huang, Zhong-Bing
   Yin, Guang-Fu
   Liao, Xiao-Ming
   Gu, Jian-Wen
TI Conducting polypyrrole in tissue engineering applications
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Review
DE conducting polypyrrole; doping; modification; tissue engineering
ID NEURITE OUTGROWTH; IN-VIVO; ELECTRICAL-STIMULATION; POLYMERIC MATERIALS;
   NERVE REGENERATION; METALLIC POLYMERS; GLUCOSE-OXIDASE; 4TH GENERATION;
   STEM-CELLS; COMPOSITE
AB Polypyrrole (PPy), the earliest prepared conducting polymer, has good biocompatibility, easy synthesis and flexibility in processing. Compared with metal and inorganic materials, doped PPy has better mechanical match with live tissue, resulting in its many applications in biomedical field. This mini-review presents some information on specific PPy properties for tissue engineering applications, including its synthesis, doping, bio-modification. Although some challenges and unanswered problems still remain, PPy as novel biomaterial has promoted the development tissue engineering for its clinical application in the future.
C1 [Huang, Zhong-Bing; Yin, Guang-Fu; Liao, Xiao-Ming] Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610064, Peoples R China.
   [Gu, Jian-Wen] PLA Gen Hosp Chengdu Mil Reg, Chengdu 610083, Peoples R China.
RP Yin, GF (reprint author), Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610064, Peoples R China.
EM nic0700@scu.edu.cn; 2914081083@qq.com
FU National Natural Science Foundation of China [51273122, 51173120,
   51372157]
FX This work was supported by the National Natural Science Foundation of
   China (Grant Nos. 51273122, 51173120 and 51372157).
CR Ahuja T, 2007, BIOMATERIALS, V28, P791, DOI 10.1016/j.biomaterials.2006.09.046
   Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141
   Ateh DD, 2006, TISSUE ENG, V12, P645, DOI 10.1089/ten.2006.12.645
   Broda CR, 2011, J BIOMED MATER RES A, V98A, P509, DOI 10.1002/jbm.a.33128
   Castano H, 2004, MACROMOL BIOSCI, V4, P785, DOI 10.1002/mabi.200300123
   Cen L, 2003, BIOSENS BIOELECTRON, V18, P363, DOI 10.1016/S0956-5663(02)00149-5
   Cen Lian, 2004, Biomacromolecules, V5, P2238, DOI 10.1021/bm040048v
   Chen SJ, 2000, J MATER SCI LETT, V19, P2157, DOI 10.1023/A:1026799415199
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   DIAZ AF, 1986, HDB CONDUCTING POLYM, V1, P81
   Forciniti L, 2014, ACTA BIOMAT IN PRESS, DOI [10.1016/j.actbio.2014.01.030, DOI 10.1016/J.ACTBI0.2014.01.030]
   Garner B, 1999, J MATER SCI-MATER M, V10, P19, DOI 10.1023/A:1008835925998
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   Gomez N, 2007, ADV FUNCT MATER, V17, P1645, DOI 10.1002/adfm.200600669
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Hardy JG, 2013, CURR OPIN BIOTECH, V24, P847, DOI 10.1016/j.copbio.2013.03.011
   Heeger AJ, 2001, ANGEW CHEM INT EDIT, V40, P2591, DOI 10.1002/1521-3773(20010716)40:14<2591::AID-ANIE2591>3.0.CO;2-0
   Heeger AJ, 2001, J PHYS CHEM B, V105, P8475, DOI 10.1021/jp011611w
   Hodgson AJ, 1996, PROC SPIE, V2716, P164, DOI 10.1117/12.232137
   Hu WW, 2014, MAT SCI ENG C-MATER, V37, P28, DOI 10.1016/j.msec.2013.12.019
   Kim SY, 2011, ACS APPL MATER INTER, V3, P16, DOI 10.1021/am1008369
   Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee JW, 2006, LANGMUIR, V22, P9816, DOI 10.1021/la062129d
   Li GN, 2008, TISSUE ENG PT B-REV, V14, P33, DOI 10.1089/teb.2007.0181
   Miodek A, 2014, BIOSENS BIOELECTRON, V56, P104, DOI 10.1016/j.bios.2013.12.051
   Moon JM, 2014, BIOSENS BIOELECTRON, V57, P157, DOI 10.1016/j.bios.2014.02.016
   Navale ST, 2014, MEASUREMENT, V50, P363, DOI 10.1016/j.measurement.2014.01.012
   Nickels JD, 2013, J BIOMED MATER RES A, V101, P1464, DOI 10.1002/jbm.a.34435
   Pyo M, 1996, CHEM MATER, V8, P128, DOI 10.1021/cm950299y
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Sajesh KM, 2013, INT J BIOL MACROMOL, V62, P465, DOI 10.1016/j.ijbiomac.2013.09.028
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Sangian D, 2014, SYNTHETIC MET, V189, P53, DOI 10.1016/j.synthmet.2013.12.021
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578
   Song HK, 2006, BIOMATERIALS, V27, P473, DOI 10.1016/j.biomaterials.2005.06.030
   Stauffer WR, 2006, BIOMATERIALS, V27, P2405, DOI 10.1016/j.biomaterials.2005.10.024
   Thomas CA, 2000, ADV MATER, V12, P222, DOI 10.1002/(SICI)1521-4095(200002)12:3<222::AID-ADMA222>3.0.CO;2-D
   TISCHLER AS, 1975, NATURE, V258, P341, DOI 10.1038/258341a0
   Tonazzini I, 2013, BIOMATERIALS, V34, P6027, DOI 10.1016/j.biomaterials.2013.04.039
   Tourillon G., 1986, HDB CONDUCTING POLYM, V1, P293
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   UMANA M, 1986, ANAL CHEM, V58, P2979, DOI 10.1021/ac00127a018
   Upadhyay J, 2014, SYNTHETIC MET, V189, P119, DOI 10.1016/j.synthmet.2014.01.004
   Vaitkuviene A, 2014, COLLOID SURFACE A, V442, P152, DOI 10.1016/j.colsurfa.2013.06.030
   Vaitkuviene A, 2013, J HAZARD MATER, V250, P167, DOI 10.1016/j.jhazmat.2013.01.038
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Wang ZX, 2003, J BIOMED MATER RES A, V66A, P738, DOI 10.1002/jbm.a.10037
   Wang ZX, 2004, J BIOMED MATER RES A, V70A, P28, DOI 10.1002/jbm.a.30047
   Weiland JD, 2000, IEEE T BIO-MED ENG, V47, P911, DOI 10.1109/10.846685
   WILLIAMS RL, 1994, J MATER SCI-MATER M, V5, P429, DOI 10.1007/BF00058978
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Xu HX, 2014, BIOMATERIALS, V35, P225, DOI 10.1016/j.biomaterials.2013.10.002
   ZELIKIN AN, 2002, ANGEW CHEM, V114, P149
   Zeng J. W., 2013, MAT SCI, V3, P125
   Zeng JW, 2013, COLLOID SURFACE B, V110, P450, DOI 10.1016/j.colsurfb.2013.05.012
NR 64
TC 24
Z9 24
U1 13
U2 121
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD MAR
PY 2014
VL 8
IS 1
BP 39
EP 45
DI 10.1007/s11706-014-0238-8
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA AH9BL
UT WOS:000336433900005
DA 2018-10-20
ER

PT J
AU Rajendran, K
   Walsh, MF
   de Ruiter, NJA
   Chernoglazov, AI
   Panta, RK
   Butler, APH
   Butler, PH
   Bell, ST
   Anderson, NG
   Woodfield, TBF
   Tredinnick, SJ
   Healy, JL
   Bateman, CJ
   Aamir, R
   Doesburg, RMN
   Renaud, PF
   Gieseg, SP
   Smithies, DJ
   Mohr, JL
   Mandalika, VBH
   Opie, AMT
   Cook, NJ
   Ronaldson, JP
   Nik, SJ
   Atharifard, A
   Clyne, M
   Bones, PJ
   Bartneck, C
   Grasset, R
   Schleich, N
   Billinghurst, M
AF Rajendran, K.
   Walsh, M. F.
   de Ruiter, N. J. A.
   Chernoglazov, A. I.
   Panta, R. K.
   Butler, A. P. H.
   Butler, P. H.
   Bell, S. T.
   Anderson, N. G.
   Woodfield, T. B. F.
   Tredinnick, S. J.
   Healy, J. L.
   Bateman, C. J.
   Aamir, R.
   Doesburg, R. M. N.
   Renaud, P. F.
   Gieseg, S. P.
   Smithies, D. J.
   Mohr, J. L.
   Mandalika, V. B. H.
   Opie, A. M. T.
   Cook, N. J.
   Ronaldson, J. P.
   Nik, S. J.
   Atharifard, A.
   Clyne, M.
   Bones, P. J.
   Bartneck, C.
   Grasset, R.
   Schleich, N.
   Billinghurst, M.
TI Reducing beam hardening effects and metal artefacts in spectral CT using
   Medipix3RX
SO JOURNAL OF INSTRUMENTATION
LA English
DT Article
DE Medical-image reconstruction methods and algorithms, computer-aided
   diagnosis; X-ray detectors; Computerized Tomography (CT) and Computed
   Radiography (CR)
ID COMPUTED-TOMOGRAPHY; REDUCTION; MODEL
AB This paper discusses methods for reducing beam hardening effects and metal artefacts using spectral x-ray information in biomaterial samples. A small-animal spectral scanner was operated in the 15 to 80 keV x-ray energy range for this study. We use the photon-processing features of a CdTe-Medipix3RX ASIC in charge summing mode to reduce beam hardening and associated artefacts. We present spectral data collected for metal alloy samples, its analysis using algebraic 3D reconstruction software and volume visualisation using a custom volume rendering software. The cupping effect and streak artefacts are quantified in the spectral datasets. The results show reduction in beam hardening effects and metal artefacts in the narrow high energy range acquired using the spectroscopic detector. A post-reconstruction comparison between CdTe-Medipix3RX and Si-Medipix3.1 is discussed. The raw data and processed data are made available (http://hdl.handle.net/10092/8851) for testing with other software routines.
C1 [Rajendran, K.; Walsh, M. F.; de Ruiter, N. J. A.; Panta, R. K.; Butler, A. P. H.; Anderson, N. G.; Woodfield, T. B. F.; Bateman, C. J.; Aamir, R.; Mohr, J. L.; Ronaldson, J. P.; Atharifard, A.] Univ Otago, Christchurch 8140, New Zealand.
   [Chernoglazov, A. I.; Butler, A. P. H.; Butler, P. H.; Woodfield, T. B. F.; Tredinnick, S. J.; Healy, J. L.; Doesburg, R. M. N.; Renaud, P. F.; Gieseg, S. P.; Mandalika, V. B. H.; Opie, A. M. T.; Nik, S. J.; Bones, P. J.; Bartneck, C.; Grasset, R.; Billinghurst, M.] Univ Canterbury, Christchurch 8140, New Zealand.
   [Butler, A. P. H.; Butler, P. H.; Doesburg, R. M. N.] CERN, European Org Nucl Res, CH-1211 Geneva, Switzerland.
   [Butler, A. P. H.; Butler, P. H.; Bell, S. T.; Smithies, D. J.] MARS Bioimaging Ltd, Christchurch, New Zealand.
   [Cook, N. J.] Canterbury Dist Hlth Board, Christchurch 8140, New Zealand.
   [Clyne, M.] ILR, Christchurch, New Zealand.
   [Schleich, N.] Univ Otago, Wellington 6021, New Zealand.
RP Rajendran, K (reprint author), Univ Otago, 2 Riccarton Ave, Christchurch 8140, New Zealand.
EM kishore.rajendran@canterbury.ac.nz
RI Bartneck, Christoph/B-5699-2008; Woodfield, Tim/A-2705-2009
OI Bartneck, Christoph/0000-0003-4566-4815; Woodfield,
   Tim/0000-0002-5428-7575; Mandalika, Veera Bhadra
   Harish/0000-0001-8027-6645; Anderson, Nigel/0000-0003-0518-5625;
   Rajendran, Kishore/0000-0002-8314-3642; Bateman,
   Christopher/0000-0002-7512-5583
FU Ministry of Business, Innovation and Employment (MBIE), New Zealand
   [UOCX0805]
FX This project was funded by Ministry of Business, Innovation and
   Employment (MBIE), New Zealand under contract number UOCX0805. The
   authors would like to thank all members of MARS-CT project, the Medipix2
   collaboration, and the Medipix3 collaboration. In particular we
   acknowledge the CERN based designers Michael Campbell, Lukas Tlustos,
   Xavier Llopart, Rafael Ballabriga and Winnie Wong, and the material
   scientists Alex Fauler, Simon Procz, Elias Hamann, Martin Pichotka, and
   Michael Fiederle from Freiburger Materialforschungszentrum (FMF) and
   X-ray Imaging Europe GmbH. We also thank Graeme Kershaw, University of
   Canterbury for preparing the hardware phantom, and Anton Angelo,
   University of Canterbury for co-ordinating access to the data
   repository.
CR Aamir R, 2011, J INSTRUM, V6, DOI 10.1088/1748-0221/6/01/C01059
   ANDERSEN AH, 1984, ULTRASONIC IMAGING, V6, P81, DOI 10.1016/0161-7346(84)90008-7
   Ballabriga R, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/02/C02016
   Bamberg F, 2011, EUR RADIOL, V21, P1424, DOI 10.1007/s00330-011-2062-1
   Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065
   Berger M, 2011, NIST XCOM PHOTON CRO
   Biemond JE, 2013, J MATER SCI-MATER M, V24, P745, DOI 10.1007/s10856-012-4836-7
   Chmeissani M., 2004, INSTR MEAS TECHN C 2, V1, P787
   Cho HM, 2013, PHYS MED BIOL, V58, P4865, DOI 10.1088/0031-9155/58/14/4865
   Cormode DP, 2010, RADIOLOGY, V256, P774, DOI 10.1148/radiol.10092473
   Feuerlein S, 2008, RADIOLOGY, V249, P1010, DOI 10.1148/radiol.2492080560
   Habibovic P., 2007, TISSUE ENG, V585, P327
   Kroes T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038586
   Meyer E, 2012, MED PHYS, V39, P1904, DOI 10.1118/1.3691902
   Meyer E, 2010, MED PHYS, V37, P5482, DOI 10.1118/1.3484090
   Nguyen TL, 2011, ADV ENG MATER, V13, P872, DOI 10.1002/adem.201100029
   Panta R.K., ENERGY RESOLVI UNPUB
   Procz S, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/01/C01025
   Ronaldson JP, 2012, MED PHYS, V39, P6847, DOI 10.1118/1.4760773
   Sijbers J, 2004, PHYS MED BIOL, V49, pN247, DOI 10.1088/0031-9155/49/14/N06
   Takahashi T, 2001, IEEE T NUCL SCI, V48, P950, DOI 10.1109/23.958705
   Tang N.D., 2012, IVCNZ 12, P216
   Van de Casteele E, 2004, J X-RAY SCI TECHNOL, V12, P43
   Van de Casteele E, 2002, PHYS MED BIOL, V47, P4181, DOI 10.1088/0031-9155/47/23/305
   Walsh MF, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/10/P10012
   Walsh MF, 2011, J INSTRUM, V6, DOI 10.1088/1748-0221/6/01/C01095
   Walsh M.F., 2013, THESIS U OTAGO
   Zainon R, 2012, EUR RADIOL, V22, P2581, DOI 10.1007/s00330-012-2538-7
   Zeller H, 2009, 2009 24TH INTERNATIONAL CONFERENCE IMAGE AND VISION COMPUTING NEW ZEALAND (IVCNZ 2009), P363, DOI 10.1109/IVCNZ.2009.5378381
NR 29
TC 11
Z9 11
U1 2
U2 21
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-0221
J9 J INSTRUM
JI J. Instrum.
PD MAR
PY 2014
VL 9
AR P03015
DI 10.1088/1748-0221/9/03/P03015
PG 13
WC Instruments & Instrumentation
SC Instruments & Instrumentation
GA AH4UE
UT WOS:000336123200075
OA Other Gold
DA 2018-10-20
ER

PT J
AU Li, YH
   Yang, C
   Zhao, HD
   Qu, SG
   Li, XQ
   Li, YY
AF Li, Yuhua
   Yang, Chao
   Zhao, Haidong
   Qu, Shengguan
   Li, Xiaoqiang
   Li, Yuanyuan
TI New Developments of Ti-Based Alloys for Biomedical Applications
SO MATERIALS
LA English
DT Review
DE beta-type Ti-based alloys; porous Ti-based alloys; microstructure;
   mechanical properties
ID SHAPE-MEMORY ALLOYS; TITANIUM DENTAL IMPLANTS; TOTAL HIP-ARTHROPLASTY;
   LOW YOUNGS MODULUS; POWDER-METALLURGY TECHNIQUE; HIGH-TEMPERATURE
   SYNTHESIS; POROUS TI-10MO ALLOY; ZR SYSTEM ALLOYS;
   MECHANICAL-PROPERTIES; BONE-TISSUE
AB Ti-based alloys are finding ever-increasing applications in biomaterials due to their excellent mechanical, physical and biological performance. Nowdays, low modulus beta-type Ti-based alloys are still being developed. Meanwhile, porous Ti-based alloys are being developed as an alternative orthopedic implant material, as they can provide good biological fixation through bone tissue ingrowth into the porous network. This paper focuses on recent developments of biomedical Ti-based alloys. It can be divided into four main sections. The first section focuses on the fundamental requirements titanium biomaterial should fulfill and its market and application prospects. This section is followed by discussing basic phases, alloying elements and mechanical properties of low modulus beta-type Ti-based alloys. Thermal treatment, grain size, texture and properties in Ti-based alloys and their limitations are dicussed in the third section. Finally, the fourth section reviews the influence of microstructural configurations on mechanical properties of porous Ti-based alloys and all known methods for fabricating porous Ti-based alloys. This section also reviews prospects and challenges of porous Ti-based alloys, emphasizing their current status, future opportunities and obstacles for expanded applications. Overall, efforts have been made to reveal the latest scenario of bulk and porous Ti-based materials for biomedical applications.
C1 [Li, Yuhua; Yang, Chao; Zhao, Haidong; Qu, Shengguan; Li, Xiaoqiang; Li, Yuanyuan] S China Univ Technol, Natl Engn Res Ctr Near Net Shape Forming Metall M, Guangzhou 510640, Guangdong, Peoples R China.
RP Yang, C (reprint author), S China Univ Technol, Natl Engn Res Ctr Near Net Shape Forming Metall M, Guangzhou 510640, Guangdong, Peoples R China.
EM liyuhuascut@126.com; cyang@scut.edu.cn; hdzhao@scut.edu.cn;
   qusg@scut.edu.cn; lixq@scut.edu.cn; mehjli@scut.edu.cn
RI Yang, Chao/H-1905-2015
FU Guangdong Natural Science Foundation [S2013010012147]; Science and
   Technology Innovation Project of Higher School of Guangdong Province
   [2012KJCX0010]; Fundamental Research Funds for the Central Universities
   [2013ZZ0008]; Program for New Century Excellent Talents in University
   [NCET-11-0163]; Excellent Young Talents of South China University of
   Technology
FX This work was supported by the Guangdong Natural Science Foundation (No.
   S2013010012147), the Science and Technology Innovation Project of Higher
   School of Guangdong Province (No. 2012KJCX0010), the Fundamental
   Research Funds for the Central Universities (No. 2013ZZ0008), the
   Program for New Century Excellent Talents in University (No.
   NCET-11-0163), and the Excellent Young Talents of South China University
   of Technology.
CR Abdel-Hady M, 2007, SCRIPTA MATER, V57, P1000, DOI 10.1016/j.scriptamat.2007.08.003
   Maya AEA, 2012, MAT SCI ENG C-MATER, V32, P321, DOI 10.1016/j.msec.2011.10.035
   Ahmed T., 1996, TITANIUM 95 SCI TECH, P1760
   Alves APR, 2004, MAT SCI ENG C-BIO S, V24, P693, DOI 10.1016/j.msec.2004.08.013
   Alves C, 2005, SURF COAT TECH, V194, P196, DOI 10.1016/j.surfcoat.2004.10.009
   Angelo P.C., 2009, POWDER METALLURGY SC, P41
   Arakawa Y, 2012, MATERIALS, V5, P1267, DOI 10.3390/ma5071267
   Arakawa Y, 2011, J JPN I MET, V75, P379, DOI 10.2320/jinstmet.75.379
   Ari-Gur P, 1998, MAT SCI ENG A-STRUCT, V257, P118, DOI 10.1016/S0921-5093(98)00829-6
   ARZT E, 1983, METALL TRANS A, V14, P211, DOI 10.1007/BF02651618
   ASAOKA K, 1985, J BIOMED MATER RES, V19, P699, DOI 10.1002/jbm.820190609
   Ashida S, 2012, MATER SCI FORUM, V706-709, P1943, DOI 10.4028/www.scientific.net/MSF.706-709.1943
   Asthana R, 2006, MATERIALS PROCESSING AND MANUFACTURING SCIENCE, pXVIII, DOI 10.1016/B978-075067716-5/50001-7
   Aydogmus T, 2012, J MECH BEHAV BIOMED, V15, P59, DOI 10.1016/j.jmbbm.2012.05.018
   Aydogmus T, 2009, J ALLOY COMPD, V478, P705, DOI 10.1016/j.jallcom.2008.11.141
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Bandyopadhyay A, 2010, ACTA BIOMATER, V6, P1640, DOI 10.1016/j.actbio.2009.11.011
   Banerjee R, 2003, ACTA MATER, V51, P3277, DOI 10.1016/S1359-6454(03)00158-7
   Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   Banhart J., 1999, P INT C METF
   Bannon BP, 1983, TITANIUM ALLOYS SURG, V796, P7
   Bansiddhi A, 2008, ACTA BIOMATER, V4, P1996, DOI 10.1016/j.actbio.2008.06.005
   Barrabes A, 2008, MAT SCI ENG C-BIO S, V28, P23, DOI 10.1016/j.msec.2007.02.001
   Bastawros AF, 2000, J MECH PHYS SOLIDS, V48, P301, DOI 10.1016/S0022-5096(99)00035-6
   Bertheville B, 2006, BIOMATERIALS, V27, P1246, DOI 10.1016/j.biomaterials.2005.09.014
   Biswas A, 2005, ACTA MATER, V53, P1415, DOI 10.1016/j.actamat.2004.11.036
   Black J., 1998, HDB BIOMATERIAL PROP, P16
   Bonisch M, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/5/055004
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   Boyer B., 2007, MAT PROPERTIES HDB T, P790
   Brailovski V, 2011, MAT SCI ENG C-MATER, V31, P643, DOI 10.1016/j.msec.2010.12.008
   Brailovski V., 2013, J ALLOY COMPD, V577, pS414
   Bram M, 2000, ADV ENG MATER, V2, P196, DOI 10.1002/(SICI)1527-2648(200004)2:4<196::AID-ADEM196>3.0.CO;2-K
   Branemark R, 2001, J REHABIL RES DEV, V38, P175
   Brizuela M, 2002, J MATER SCI-MATER M, V13, P1129, DOI 10.1023/A:1021129718737
   Burstein A.H., 1993, SURG KNEE, V7, P43
   BURSTEIN AH, 1976, J BONE JOINT SURG AM, V58, P82, DOI 10.2106/00004623-197658010-00015
   Cachinho SCP, 2007, POWDER TECHNOL, V178, P109, DOI 10.1016/j.powtec.2007.04.014
   Calin M, 2013, MAT SCI ENG C-MATER, V33, P875, DOI 10.1016/j.msec.2012.11.015
   CAMERON HU, 1978, INT J ARTIF ORGANS, V1, P104
   Capela MV, 2008, J ALLOY COMPD, V465, P479, DOI 10.1016/j.jallcom.2007.10.115
   Chen LJ, 2009, T NONFERR METAL SOC, V19, P1174, DOI 10.1016/S1003-6326(08)60424-0
   Chen YJ, 2009, MATER LETT, V63, P2659, DOI 10.1016/j.matlet.2009.09.029
   Chino Y, 2008, ACTA MATER, V56, P105, DOI 10.1016/j.actamat.2007.09.002
   Chu CL, 2004, MAT SCI ENG A-STRUCT, V366, P114, DOI 10.1016/j.msea.2003.08.118
   Chung CY, 2004, MATER LETT, V58, P1683, DOI 10.1016/j.matlet.2003.10.045
   Cleason T.A., 1999, U.S. Patent, Patent No. [5,871,595 A, 5871595A]
   Cochran G.V.B., 1982, PRIMER ORTHOPAEDIC B, P143
   Curodeau A, 2000, J BIOMED MATER RES, V53, P525, DOI 10.1002/1097-4636(200009)53:5<525::AID-JBM12>3.0.CO;2-1
   Ding M, 1997, J BONE JOINT SURG BR, V79B, P995, DOI 10.1302/0301-620X.79B6.7538
   Ducheyne P, 1974, Acta Orthop Belg, V40, P799
   Dunand DC, 2004, ADV ENG MATER, V6, P369, DOI 10.1002/adem.200405576
   Eosoly S, 2010, ACTA BIOMATER, V6, P2511, DOI 10.1016/j.actbio.2009.07.018
   Erk KA, 2008, ACTA MATER, V56, P5147, DOI 10.1016/j.actamat.2008.06.035
   Esen Z, 2007, SCRIPTA MATER, V56, P341, DOI 10.1016/j.scriptamat.2006.11.010
   Esen Z, 2011, MAT SCI ENG A-STRUCT, V528, P3200, DOI 10.1016/j.msea.2011.01.008
   EVANS FG, 1976, ANAT REC, V185, P1, DOI 10.1002/ar.1091850102
   Fang Z, 2005, COMPUT AIDED DESIGN, V37, P65, DOI 10.1016/j.cad.2004.04.002
   Ford CM, 1998, INT J MECH SCI, V40, P521, DOI 10.1016/S0020-7403(97)00064-7
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Gabriel SB, 2012, J ALLOY COMPD, V536, pS208, DOI 10.1016/j.jallcom.2011.11.035
   Gao ZF, 2012, MATER DESIGN, V42, P13, DOI 10.1016/j.matdes.2012.05.041
   Geetha M, 2004, J ALLOY COMPD, V384, P131, DOI 10.1016/j.jallcom.2004.04.113
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   Gepreel MAH, 2013, J MECH BEHAV BIOMED, V20, P407, DOI 10.1016/j.jmbbm.2012.11.014
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   Gilissen R, 2000, MATER DESIGN, V21, P251, DOI 10.1016/S0261-3069(99)00075-8
   Gross S, 2001, J BIOMECH, V34, P995, DOI 10.1016/S0021-9290(01)00072-0
   Guglielmotti MB, 1999, INT J ORAL MAX IMPL, V14, P565
   Guo S, 2013, PROG NAT SCI-MATER, V23, P174, DOI 10.1016/j.pnsc.2013.03.008
   HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Hanawa T, 2006, MATER SCI FORUM, V512, P243, DOI 10.4028/www.scientific.net/MSF.512.243
   Hao YL, 2003, METALL MATER TRANS A, V34A, P1007, DOI 10.1007/s11661-003-0230-x
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   HAYASHI K, 1991, J BIOMED MATER RES, V25, P515, DOI 10.1002/jbm.820250408
   He G, 2006, MAT SCI ENG C-BIO S, V26, P14, DOI 10.1016/j.msec.2005.03.007
   He G, 2012, J MECH BEHAV BIOMED, V5, P16, DOI 10.1016/j.jmbbm.2011.09.016
   HEAD WC, 1995, CLIN ORTHOP RELAT R, P85
   Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HIRSCHHORN JS, 1971, J BIOMED MATER RES S, V2, P49
   Ho WF, 2009, MAT SCI ENG C-BIO S, V29, P36, DOI 10.1016/j.msec.2008.05.004
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hollander DA, 2006, BIOMATERIALS, V27, P955, DOI 10.1016/j.biomaterials.2005.07.041
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   HOMSY CA, 1972, CLIN ORTHOP RELAT R, P220
   Hrabe N.W., 2010, THESIS U WASHINGTON
   Hsu HC, 2013, J ALLOY COMPD, V575, P326, DOI 10.1016/j.jallcom.2013.05.186
   Hsu HC, 2009, J ALLOY COMPD, V488, P279, DOI 10.1016/j.jallcom.2009.08.105
   HULTH A, 1989, CLIN ORTHOP RELAT R, P265
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Hutzschenreuter P., 1980, CURRENT CONCEPTS INT, P244
   Hynowska A, 2012, MAT SCI ENG C-MATER, V32, P2418, DOI 10.1016/j.msec.2012.07.016
   Ibrahim A, 2011, MATER DESIGN, V32, P146, DOI 10.1016/j.matdes.2010.06.019
   Ikeda M, 2012, MATER SCI FORUM, V706-709, P1893, DOI 10.4028/www.scientific.net/MSF.706-709.1893
   Ikeda M, 2009, MATER TRANS, V50, P2737, DOI 10.2320/matertrans.MA200902
   Imwinkelried T, 2007, J BIOMED MATER RES A, V81A, P964, DOI 10.1002/jbm.a.31118
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Jablokov V. R., 2005, J ASTM INT, V2, P1
   Jee CSY, 2000, METALL MATER TRANS B, V31, P1345, DOI 10.1007/s11663-000-0021-3
   Jha N, 2013, MATER DESIGN, V47, P810, DOI 10.1016/j.matdes.2013.01.005
   Jiang HC, 2006, ACTA METALL SIN, V42, P1153
   Josephajr G, 2006, U.S. Patent, Patent No. [2,006,002,810 A1, 2006002810A1]
   Jung HD, 2013, MAT SCI ENG C-MATER, V33, P59, DOI 10.1016/j.msec.2012.08.004
   Jung TK, 2013, MAT SCI ENG C-MATER, V33, P1629, DOI 10.1016/j.msec.2012.12.072
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   KARAGIANES M T, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P171
   Kato K, 2013, ACTA BIOMATER, V9, P5802, DOI 10.1016/j.actbio.2012.11.018
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Klawitter J J, 1974, Acta Orthop Belg, V40, P755
   Kohl M, 2008, POROUS METALS AND METALLIC FOAMS: METFOAM 2007, P295
   Kon M, 2004, J BIOMED MATER RES B, V68B, P88, DOI 10.1002/jbm.b.20004
   Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008
   KUHLMAN GW, 1991, MICROSTRUCTURE / PROPERTY RELATIONSHIPS IN TITANIUM ALUMINIDES AND ALLOYS, P465
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Kumar S, 2003, JOM-J MIN MET MAT S, V55, P43, DOI 10.1007/s11837-003-0175-y
   Kuroda D, 2005, MAT SCI ENG C-BIO S, V25, P312, DOI 10.1016/j.msec.2005.04.004
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Kusano Y, 2010, MATER SCI FORUM, V654-656, P2118, DOI 10.4028/www.scientific.net/MSF.654-656.2118
   Kutty MG, 2004, J MATER SCI-MATER M, V15, P145, DOI 10.1023/B:JMSM.0000011815.50383.bd
   Laheurte P, 2005, MAT SCI ENG A-STRUCT, V396, P223, DOI 10.1016/j.msea.2005.01.022
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   Laptev A, 2005, POWDER METALL, V48, P358, DOI 10.1179/174329005X73838
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   Lee DG, 2004, MAT SCI ENG A-STRUCT, V366, P25, DOI 10.1016/j.msea.2003.08.061
   Lee JH, 2010, MATER LETT, V64, P2526, DOI 10.1016/j.matlet.2010.08.038
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Li BQ, 2013, MATER DESIGN, V50, P613, DOI 10.1016/j.matdes.2013.02.082
   Li BQ, 2012, MAT SCI ENG A-STRUCT, V534, P43, DOI 10.1016/j.msea.2011.11.028
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   Li BY, 2000, INTERMETALLICS, V8, P881, DOI 10.1016/S0966-9795(00)00024-8
   Li BY, 1998, MAT SCI ENG A-STRUCT, V255, P70, DOI 10.1016/S0921-5093(98)00780-1
   Li CF, 2005, POWDER METALL, V48, P237, DOI 10.1179/174329005X64162
   Li DS, 2009, J ALLOY COMPD, V474, pL1, DOI 10.1016/j.jallcom.2008.06.043
   Li H, 2006, RARE METAL MAT ENG, V35, P154
   Li HL, 2004, MATER TRANS, V45, P1124, DOI 10.2320/matertrans.45.1124
   Li JC, 2011, ACTA MATER, V59, P146, DOI 10.1016/j.actamat.2010.09.019
   Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020
   Li JP, 2006, BIOMATERIALS, V27, P1223, DOI 10.1016/j.biomaterials.2005.08.033
   Li JP, 2005, J BIOMED MATER RES A, V73A, P223, DOI 10.1002/jbm.a.30278
   Li JP, 2003, KEY ENG MAT, V240-2, P547, DOI 10.4028/www.scientific.net/KEM.240-242.547
   Li JP, 2002, KEY ENG MAT, V218-2, P51, DOI 10.4028/www.scientific.net/KEM.218-220.51
   Li P, 2009, ACTA MATER, V57, P3539, DOI 10.1016/j.actamat.2009.04.008
   Li SJ, 2008, ACTA BIOMATER, V4, P305, DOI 10.1016/j.actbio.2007.09.009
   Li YY, 2013, MAT SCI ENG A-STRUCT, V560, P857, DOI 10.1016/j.msea.2012.09.047
   Li YH, 2001, J ALLOY COMPD, V325, P259, DOI 10.1016/S0925-8388(01)01382-2
   Li YH, 2009, J ALLOY COMPD, V485, P215, DOI 10.1016/j.jallcom.2009.06.003
   LIFLAND MI, 1994, CLIN MATER, V17, P203, DOI 10.1016/0267-6605(94)90037-X
   LINDAHL O, 1976, ACTA ORTHOP SCAND, V47, P11, DOI 10.3109/17453677608998966
   LINDAHL O, 1967, ACTA ORTHOP SCAND, V38, P141, DOI 10.3109/17453676708989628
   Liu P, 2009, MAT SCI ENG A-STRUCT, V509, P69, DOI 10.1016/j.msea.2009.01.014
   Liu WP, 2003, SCRIPTA MATER, V48, P1337, DOI 10.1016/S1359-6462(03)00020-4
   Liu X, 2011, ACTA BIOMATER, V7, P406, DOI 10.1016/j.actbio.2010.08.025
   Liu Y, 2006, MAT SCI ENG A-STRUCT, V418, P25, DOI [10.1016/j.msea.2005.10.057, 10.1016/j.msca.2005.10.057]
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Long M, 1999, ACTA MATER, V47, P661, DOI 10.1016/S1359-6454(98)00343-7
   Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021
   LUECK R A, 1969, Surgical Forum (Chicago), V20, P456
   Lutjering G, 1999, MAT SCI ENG A-STRUCT, V263, P117, DOI 10.1016/S0921-5093(98)01169-1
   Lutjering G., 2003, TITANIUM, P20
   Majumdar JD, 2005, APPL SURF SCI, V247, P320, DOI 10.1016/j.apsusc.2005.01.039
   Malinov S, 2001, METALL MATER TRANS A, V32, P879, DOI 10.1007/s11661-001-0345-x
   Mansourighasri A, 2012, J MATER PROCESS TECH, V212, P83, DOI 10.1016/j.jmatprotec.2011.08.008
   Manukyan K, 2010, CHEM ENG J, V162, P406, DOI 10.1016/j.cej.2010.05.042
   Markaki AE, 2001, ACTA MATER, V49, P1677, DOI 10.1016/S1359-6454(01)00072-6
   Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070
   Matsumoto H., 2006, P MAT PROC MED DEV C
   Mazumder J, 2005, PROC SPIE, V5706, P38, DOI 10.1117/12.601652
   Menini R, 2006, J ELECTROCHEM SOC, V153, pB13, DOI 10.1149/1.2128098
   Mitchell A, 1998, MAT SCI ENG A-STRUCT, V243, P257, DOI 10.1016/S0921-5093(97)00810-1
   Miyao R., 2000, J JAPAN SOC POWDER M, V47, P1239
   Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054
   MOYEN BJL, 1978, J BONE JOINT SURG AM, V60, P940, DOI 10.2106/00004623-197860070-00012
   Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219
   Munir ZA, 2006, J MATER SCI, V41, P763, DOI 10.1007/s10853-006-6555-2
   Murayama Y., 2009, B NIIGATA I TECH, V14, P1
   Nag S, 2005, MAT SCI ENG C-BIO S, V25, P357, DOI 10.1016/j.msec.2004.12.013
   Nakai M, 2011, MATER LETT, V65, P688, DOI 10.1016/j.matlet.2010.11.006
   Nakai M, 2010, J MECH BEHAV BIOMED, V3, P41, DOI 10.1016/j.jmbbm.2009.03.003
   Narayan R., 2012, ASM HDB, V23, P6
   Neirinck B, 2009, ADV ENG MATER, V11, P633, DOI 10.1002/adem.200900074
   Nicula R, 2007, BIOMOL ENG, V24, P564, DOI 10.1016/j.bioeng.2007.08.008
   Niinomi M, 2011, INT J BIOMATER, DOI 10.1155/2011/836587
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M., 2004, BIOMATERIALS ORTHOPE, P41
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Niinomi M, 2007, MATER SCI FORUM, V539-543, P193, DOI 10.4028/www.scientific.net/MSF.539-543.193
   Niinomi M, 2007, MAT SCI ENG C-BIO S, V27, P154, DOI 10.1016/j.msec.2006.04.008
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Niinomi M, 2010, EXPERT REV MED DEVIC, V7, P481, DOI [10.1586/erd.10.16, 10.1586/ERD.10.16]
   Niu WJ, 2010, COMP MATER SCI, V50, P172, DOI 10.1016/j.commatsci.2010.07.022
   Niu WJ, 2009, MAT SCI ENG A-STRUCT, V506, P148, DOI 10.1016/j.msea.2008.11.022
   Nomura N, 2005, MATER SCI FORUM, V475-479, P2313, DOI 10.4028/www.scientific.net/MSF.475-479.2313
   Nugroho AW, 2010, J MATER SCI-MATER M, V21, P3103, DOI 10.1007/s10856-010-4162-x
   Oghbaei M, 2010, J ALLOY COMPD, V494, P175, DOI 10.1016/j.jallcom.2010.01.068
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Oh IH, 2007, MATER SCI FORUM, V539-543, P635, DOI 10.4028/www.scientific.net/MSF.539-543.635
   Oliveira NTC, 2008, CORROS SCI, V50, P938, DOI 10.1016/j.corsci.2007.09.009
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Oliveira V., 1998, BRAZ J CHEM ENG, V17, P326
   OTANI T, 1992, ORTHOP CLIN N AM, V23, P335
   Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013
   OUCHI C, 1994, METALLURGY AND TECHNOLOGY OF PRACTICAL TITANIUM ALLOYS, P37
   Ozaki T., 2005, ADV MATER PROCESS, V163, P68
   Park J.B., 2000, BIOMEDICAL ENG HDB, V1, pIV1
   Park J.B., 2003, BIOMATERIALS PRINCIP, P1
   Patnaik P., 2003, HDB INORGANIC CHEM
   Perren M.S., 2001, TITANIUM MED, P772
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   PRAKASH O, 1995, MAT SCI ENG A-STRUCT, V199, P195, DOI 10.1016/0921-5093(94)09708-9
   Qazi J, 2003, TITANIUM 2003 SCI TE, V1, P651
   Qazi J.I., 2004, TITANIUM 2003 SCI TE, P1651
   Qazi JI, 2005, ADV ENG MATER, V7, P993, DOI 10.1002/adem.200500060
   Qazi JI, 2005, MAT SCI ENG C-BIO S, V25, P389, DOI 10.1016/j.msec.2005.01.022
   Qiu J, 1997, BIOMATERIALS, V18, P153, DOI 10.1016/S0142-9612(96)00097-X
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Raj RE, 2009, J ALLOY COMPD, V467, P550, DOI 10.1016/j.jallcom.2007.12.040
   Rak ZS, 2006, J MATER PROCESS TECH, V175, P358, DOI 10.1016/j.jmatprotec.2005.04.006
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   de Vasconcellos LMR, 2008, MATER RES-IBERO-AM J, V11, P275, DOI 10.1590/S1516-14392008000300008
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Roberts AP, 2000, J AM CERAM SOC, V83, P3041, DOI 10.1111/j.1151-2916.2000.tb01680.x
   Roberts AP, 2001, ACTA MATER, V49, P189, DOI 10.1016/S1359-6454(00)00314-1
   Roberts AP, 2002, J MECH PHYS SOLIDS, V50, P33, DOI 10.1016/S0022-5096(01)00056-4
   ROBERTSON DM, 1976, J BIOMED MATER RES, V10, P335, DOI 10.1002/jbm.820100304
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Ryan GE, 2008, BIOMATERIALS, V29, P3625, DOI 10.1016/j.biomaterials.2008.05.032
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Saha MC, 2005, MAT SCI ENG A-STRUCT, V406, P328, DOI 10.1016/j.msea.2005.07.006
   Saitou K, 2006, SCRIPTA MATER, V54, P875, DOI 10.1016/j.scriptamat.2005.11.006
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P363, DOI 10.1016/j.msec.2004.12.014
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P370, DOI 10.1016/j.msec.2005.04.003
   Sakaguchi N, 2004, MATER SCI FORUM, V449-4, P1269, DOI 10.4028/www.scientific.net/MSF.449-452.1269
   Sakaguchi N, 2003, J JPN I MET, V67, P681, DOI 10.2320/jinstmet1952.67.11_681
   Sakamoto Y, 2006, BIO-MED MATER ENG, V16, P83
   Salito A, 1998, SULZER TECH REV, V1, P34
   Sanchez-Herencia AJ, 2001, ACTA MATER, V49, P645, DOI 10.1016/S1359-6454(00)00347-5
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   SARMIENTO A, 1990, J BONE JOINT SURG BR, V72, P996
   SAUER BW, 1974, J BIOMED MATER RES, V8, P145, DOI 10.1002/jbm.820080315
   Savalani MM, 2012, RAPID PROTOTYPING J, V18, P16, DOI 10.1108/13552541211193467
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   SCHNEIDER E, 1989, CLIN ORTHOP RELAT R, P200
   Schneider J.A., 1996, CERAM T, V79, P143
   Schroers J, 2009, JOM-US, V61, P21, DOI 10.1007/s11837-009-0128-1
   Schwendner KI, 2001, SCRIPTA MATER, V45, P1123, DOI 10.1016/S1359-6462(01)01107-1
   SEMLITSCH M, 1980, MED BIOL ENG COMPUT, V18, P511, DOI 10.1007/BF02443329
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Shen H, 2008, MECH MATER, V40, P708, DOI 10.1016/j.mechmat.008.03.009
   Shishkovsky IV, 2010, INT J SELF-PROPAG HI, V19, P157, DOI 10.3103/S1061386210020123
   Simancik F., 2002, HDB CELLULAR METALS, P1
   Singh R, 2010, MATER TECHNOL, V25, P127, DOI 10.1179/175355510X12744412709403
   Soon YM, 2011, J EUR CERAM SOC, V31, P415, DOI 10.1016/j.jeurceramsoc.2010.09.019
   Spoerke ED, 2008, J BIOMED MATER RES A, V84A, P402, DOI 10.1002/jbm.a.31317
   Stephani G., 2009, J PHYS C SER, V165
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P29, DOI 10.1042/BA20030108
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   Tan QB, 2009, MAT SCI ENG A-STRUCT, V527, P38, DOI 10.1016/j.msea.2009.07.022
   Tane M, 2008, ACTA MATER, V56, P2856, DOI 10.1016/j.actamat.2008.02.017
   Tang CY, 2013, J ALLOY COMPD, V557, P67, DOI 10.1016/j.jallcom.2012.12.147
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   TAYLOR N, 1993, ACTA METALL MATER, V41, P955, DOI 10.1016/0956-7151(93)90030-V
   Temenoff J.S., 2008, BIOMATERIALS INTERSE, P235
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Thakur SK, 2007, MAT SCI ENG A-STRUCT, V452, P61, DOI 10.1016/j.msea.2006.10.156
   Torres Y, 2012, J MATER PROCESS TECH, V212, P1061, DOI 10.1016/j.jmatprotec.2011.12.015
   Torres Y, 2011, METALL MATER TRANS B, V42, P891, DOI 10.1007/s11663-011-9521-6
   Traini T, 2008, DENT MATER, V24, P1525, DOI 10.1016/j.dental.2008.03.029
   Tuncer N, 2011, MAT SCI ENG A-STRUCT, V530, P633, DOI 10.1016/j.msea.2011.10.036
   Upadhyaya A, 2007, SCRIPTA MATER, V56, P5, DOI 10.1016/j.scriptmat.2006.09.010
   Valiev R.Z., 2004, MED DEVICE MAT, P362
   Viceconti M, 2000, J BIOMECH, V33, P1611, DOI 10.1016/S0021-9290(00)00140-8
   Vinz H., 1975, MECH COMPOS MATER, V11, P568
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Wang L.Q., 2013, TITANIUM ALLOYS FORM, P110
   Wang Xi-han, 2010, Chinese Journal of Nonferrous Metals, V20, ps967
   Wang XJ, 2010, TISSUE ENG PT A, V16, P309, DOI [10.1089/ten.tea.2009.0074, 10.1089/ten.TEA.2009.0074]
   Wang XJ, 2009, ACTA BIOMATER, V5, P3616, DOI 10.1016/j.actbio.2009.06.002
   Watari F, 2004, COMPOS SCI TECHNOL, V64, P893, DOI 10.1016/j.compscitech.2003.09.005
   Watari F., 2002, J JPN SOC POWDER MET, V49, P1063
   WEBER JN, 1972, MATER RES BULL, V7, P1005, DOI 10.1016/0025-5408(72)90092-X
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Wegst UGK, 2010, PHILOS T R SOC A, V368, P2099, DOI 10.1098/rsta.2010.0014
   Wen CE, 2006, MAT SCI ENG C-BIO S, V26, P1439, DOI 10.1016/j.msec.2005.08.006
   Wen CE, 2002, J MATER RES, V17, P2633, DOI 10.1557/JMR.2002.0382
   Wen CE, 2004, MATER LETT, V58, P357, DOI 10.1016/S0167-577X(03)004500-7
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Whitcher FD, 1997, COMPUT STRUCT, V64, P1005, DOI 10.1016/S0045-7949(97)00014-X
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wilson CE, 2004, J BIOMED MATER RES A, V68A, P123, DOI 10.1002/jbm.a.20015
   Wise D.L., 2000, BIOMATERIALS ENG DEV, P205
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Wu X, 2003, J MATER PROCESS TECH, V135, P266, DOI 10.1016/S0924-0136(02)00906-8
   Xie FX, 2013, CORROS SCI, V67, P217, DOI 10.1016/j.corsci.2012.10.036
   Xie KY, 2013, MAT SCI ENG C-MATER, V33, P3530, DOI 10.1016/j.msec.2013.04.044
   Xu Q, 2012, KEY ENG MATER, V520, P330, DOI 10.4028/www.scientific.net/KEM.520.330
   Xue W, 2007, ACTA BIOMATER, V3, P1007, DOI 10.1016/j.actbio.2007.05.009
   Yamada Y, 2000, ADV ENG MATER, V2, P184, DOI 10.1002/(SICI)1527-2648(200004)2:4<184::AID-ADEM184>3.0.CO;2-W
   Yang D.H., 2011, BIOMED MATER, V6, Patent No. 045010:1-045010:8
   Yang DH, 2012, PROCEDIA ENGINEER, V36, P160, DOI 10.1016/j.proeng.2012.03.025
   Yang GJ, 2005, J ALLOY COMPD, V392, P291, DOI 10.1016/j.jallcom.2004.08.099
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yao C., 2004, P 106 ANN M AM CER S
   Yeh CL, 2004, J ALLOY COMPD, V376, P79, DOI 10.1016/j.jallcom.2003.12.016
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Yook SW, 2012, ACTA BIOMATER, V8, P2401, DOI 10.1016/j.actbio.2012.03.020
   Yook SW, 2009, MATER LETT, V63, P1502, DOI 10.1016/j.matlet.2009.03.056
   Yoon B.H., 2008, SCRIPTA MATER, V58, P37
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Yu ZT, 2006, MAT SCI ENG A-STRUCT, V438, P391, DOI 10.1016/j.msea.2005.12.079
   Yuan B, 2006, METALL MATER TRANS A, V37A, P755, DOI 10.1007/s11661-006-0047-5
   Yuan B, 2004, MAT SCI ENG A-STRUCT, V382, P181, DOI 10.1016/j.msea.2004.04.068
   Zadra M, 2008, POWDER METALL, V51, P59, DOI 10.1179/174329008X277000
   Zhang FM, 2010, ADV ENG MATER, V12, P863, DOI 10.1002/adem.201000106
   Zhang L, 2005, ALGORITHMICA, V43, P1, DOI 10.1007/s00453-005-1154-1
   Zhang LC, 2011, SCRIPTA MATER, V65, P21, DOI 10.1016/j.scriptamat.2011.03.024
   Zhang LC, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2766861
   Zhang X, 2001, Biomed Sci Instrum, V37, P463
   Zhang YP, 2007, J MATER PROCESS TECH, V192, P439, DOI 10.1016/j.jmatprotec.2007.04.069
   Zhao CL, 2011, J ALLOY COMPD, V509, P8235, DOI 10.1016/j.jallcom.2011.05.090
   Zhao J, 2008, MATER LETT, V62, P2921, DOI 10.1016/j.matlet.2008.01.075
   Zhao XL, 2011, MAT SCI ENG C-MATER, V31, P1436, DOI 10.1016/j.msec.2011.05.013
   Zhao XL, 2011, ACTA BIOMATER, V7, P3230, DOI 10.1016/j.actbio.2011.04.019
   Zhao XK, 2009, MATER LETT, V63, P2402, DOI 10.1016/j.matlet.2009.07.069
   Zhao YY, 2001, SCRIPTA MATER, V44, P105, DOI 10.1016/S1359-6462(00)00548-0
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhuravleva K, 2013, MAT SCI ENG C-MATER, V33, P2280, DOI 10.1016/j.msec.2013.01.049
   Zou CM, 2008, J MATER SCI-MATER M, V19, P401, DOI 10.1007/s10856-006-0103-0
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
   Zwicker U., 1980, TITANIUM 80 SCI TECH, V1, P505
NR 345
TC 169
Z9 172
U1 25
U2 239
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2014
VL 7
IS 3
BP 1709
EP 1800
DI 10.3390/ma7031709
PG 92
WC Materials Science, Multidisciplinary
SC Materials Science
GA AH4IB
UT WOS:000336089500015
PM 28788539
OA DOAJ Gold, Green Published
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Donato, TAG
   de Almeida, LH
   Arana-Chavez, VE
   Grandini, CR
AF Goto Donato, Tatiani Ayako
   de Almeida, Luciano Henrique
   Arana-Chavez, Victor Elias
   Grandini, Carlos Roberto
TI In Vitro Cytotoxicity of a Ti-35Nb-7Zr-5Ta Alloy Doped with Different
   Oxygen Contents
SO MATERIALS
LA English
DT Article
DE Ti-35Nb-7Zr-5Ta alloy; MC3T3-E1 cells; biocompatibility; cell culture
ID BETA-TITANIUM ALLOY; PHASE-TRANSFORMATIONS; MECHANICAL-PROPERTIES;
   CELL-CULTURES; MICROSTRUCTURE; BIOMATERIAL
AB Cp-Ti is the most common material used for dental implants, but its elastic modulus is around five times higher than that of bone. Recently, promising alloys that add Nb, Ta, Zr and Mo to Ti have been developed. The mechanical properties of these alloys are directly related to its microstructure and the presence of interstitial elements, such as oxygen, carbon, nitrogen and hydrogen. In this study, the in vitro cytotoxicity of Ti-35Nb-7Zr-5Ta (TNZT) alloys was analyzed in the as-received condition and after being doped with several small quantities of oxygen on a cultured osteogenic cell. The cell's morphology was also examined by scanning electron microscopy (SEM). The TNZT alloy presented no cytotoxic effects on osteoblastic cells in the studied conditions.
C1 [Goto Donato, Tatiani Ayako; de Almeida, Luciano Henrique; Grandini, Carlos Roberto] UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
   [Goto Donato, Tatiani Ayako; Arana-Chavez, Victor Elias] Univ Sao Paulo, Fac Odontol, Dept Biomat & Biol Oral, BR-05508900 Sao Paulo, Brazil.
RP Grandini, CR (reprint author), UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
EM tatianidonato@gmail.com; almeidalh@hotmail.com; vearana@usp.br;
   betog@fc.unesp.br
RI Grandini, Carlos Roberto/A-3790-2008
OI Grandini, Carlos Roberto/0000-0002-3336-309X
FU Brazilian agency, Coordenacao de Pessoal de Nivel Superior (Capes);
   Brazilian agency, Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) e Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP)
FX The authors would like to thank Rubens Caram for the facilities for the
   sample preparation, Elizabeth F. Martinez and Arnaldo R. Santos Jr. for
   their advice with the cell cultures and Fernanda Barrence for her
   technical assistance. This work was supported by the Brazilian agencies,
   Coordenacao de Pessoal de Nivel Superior (Capes), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) e Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP).
CR Almeida LH, 2009, MAT SCI ENG A-STRUCT, V521-22, P59, DOI 10.1016/j.msea.2008.09.123
   Ankem S, 1999, MAT SCI ENG A-STRUCT, V263, P127, DOI 10.1016/S0921-5093(98)01170-8
   Arisu HD, 2006, LASER MED SCI, V21, P175, DOI 10.1007/s10103-006-0398-6
   Azimzadeh S, 1998, METALL MATER TRANS A, V29, P2455, DOI 10.1007/s11661-998-0217-8
   Bellows CG, 1999, CALCIFIED TISSUE INT, V65, P59, DOI 10.1007/s002239900658
   BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311
   Besse M, 2011, ACTA MATER, V59, P5982, DOI 10.1016/j.actamat.2011.06.006
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Donato TAG, 2009, MAT SCI ENG C-BIO S, V29, P1365, DOI 10.1016/j.msec.2008.10.021
   Duan HP, 2012, INT J MIN MET MATER, V19, P1128, DOI 10.1007/s12613-012-0681-4
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Grandini C.R., 2002, REV BRAS APL VACUO, V21, P13
   He WJ, 2009, SCRIPTA MATER, V61, P16, DOI 10.1016/j.scriptamat.2009.02.030
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   ISO, 2009, BIOL EV MED DEV 5
   Li Y, 2010, J DENT RES, V89, P493, DOI 10.1177/0022034510363675
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nanci A, 1996, MICROSC RES TECHNIQ, V33, P214
   Niinomi M., 2011, INT J BIOMATER, V2011
   Niinomi M, 2008, MATER TRANS, V49, P2170, DOI 10.2320/matertrans.L-MRA2008828
   Pintao C.A.F., 2006, REV BRASILEIRA APLIC, V25, P189
   Qazi JI, 2005, MAT SCI ENG C-BIO S, V25, P389, DOI 10.1016/j.msec.2005.01.022
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Steinemann SG, 1998, PERIODONTOL 2000, V17, P7, DOI 10.1111/j.1600-0757.1998.tb00119.x
   Tane M, 2011, ACTA MATER, V59, P6975, DOI 10.1016/j.actamat.2011.07.050
   Trinkle DR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.025701
   Wang LQ, 2008, MAT SCI ENG A-STRUCT, V490, P421, DOI 10.1016/j.msea.2008.03.003
NR 27
TC 1
Z9 1
U1 3
U2 17
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2014
VL 7
IS 3
BP 2183
EP 2193
DI 10.3390/ma7032183
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA AH4IB
UT WOS:000336089500038
PM 28788562
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Rodrigues, SF
   Silva, ES
   Reis, GS
   de Sousa, RC
   Balancin, O
AF Rodrigues, Samuel Filgueiras
   Silva, Eden Santos
   Reis, Gedeon Silva
   de Sousa, Regina Celia
   Balancin, Oscar
TI Prediction of Hot Flow Plastic Curves of ISO 5832-9 Steel Used as
   Orthopedic Implants
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE flow stress curves; modeling of hot deformation; dynamic
   recristalization
ID DYNAMIC RECRYSTALLIZATION; HIGH-TEMPERATURES; INITIATION; WORKING;
   DEFORMATION; BIOMATERIAL
AB An austenitic stainless steel ISO 5832-9 used as a biomaterial was torsion-deformed over the temperature range of 1000-1200 degrees C and strain rates of 0.05, 0.1, 1.0 and 5.0 s(-1). The flow stress curves obtained showed two regions where firstly there is a rising on stress characterized as work hardening mechanism acting and secondly a decreasing in work-softening after a peak stress. The flow curves were modeled by adjusting the experimental data with Zener-Hollomom parameter to construct the constitutive equations that describe the plastic behavior in both regions. The first region was described until the peak stress, taking into consideration the competition between work hardening and recovery while the second one was described applying the softening time of 50% and the Avrami equation. In some hot deformation conditions the simulated curves showed good agreement with the experimental ones while in others conditions the simulated showed differences to experimental curves that was discussed and associated with other mechanisms that acted during hot deformation.
C1 [Rodrigues, Samuel Filgueiras; Reis, Gedeon Silva] Fed Inst Educ Sci & Technol Maranhao IFMA, Dept Mech & Mat, BR-65030005 Sao Luis, MA, Brazil.
   [Silva, Eden Santos] Fed Inst Educ Sci & Technol Maranhao IFMA, Dept Phys, BR-65030005 Sao Luis, MA, Brazil.
   [de Sousa, Regina Celia] Fed Univ Maranhao UFMA, Dept Phys, BR-65080805 Sao Luis, MA, Brazil.
   [Balancin, Oscar] Fed Univ Sao Carlos UFSCar, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
RP Rodrigues, SF (reprint author), Fed Inst Educ Sci & Technol Maranhao IFMA, Dept Mech & Mat, Av Getulio Vargas 4, BR-65030005 Sao Luis, MA, Brazil.
EM samuel.filgueiras@ifma.edu.br
RI Rodrigues, Samuel/I-2873-2017
OI Rodrigues, Samuel/0000-0003-0002-4566
FU Federal Institute of Education, Science and Technology of Maranhao
   (IFMA); CAPES
FX The financial support of the Federal Institute of Education, Science and
   Technology of Maranhao (IFMA) and CAPES is gratefully acknowledged.
CR Ahlblom B., 1982, INT MET REV, V27, P1
   Barbosa RANM, 1993, MATER SCI FORUM, V113-115, P461
   CAHN RW, 1965, PHYSICAL METALLURGY, P925
   ESTRIN Y, 1984, ACTA METALL MATER, V32, P57, DOI 10.1016/0001-6160(84)90202-5
   Fields D. S., 1957, P AM SOCIETY SOCIETY, V57, P1259
   Giordani EJ, 2006, SCRIPTA MATER, V55, P743, DOI 10.1016/j.scriptamat.2006.05.015
   Giordani EJ, 2004, INT J FATIGUE, V26, P1129, DOI 10.1016/j.ijfatigue.2004.03.002
   Jonas JJ, 1978, ADV DEFORMATION PROC, P215
   Jonas JJ, 2009, ACTA MATER, V57, P2748, DOI 10.1016/j.actamat.2009.02.033
   Jorge Junior Alberto Moreira, 2005, Mat. Res., V8, P309, DOI 10.1590/S1516-14392005000300015
   Kocks UF, 2003, PROG MATER SCI, V48, P171, DOI 10.1016/S0079-6425(02)00003-8
   LAASRAOUI A, 1991, METALL TRANS A, V22, P1545, DOI 10.1007/BF02667368
   McQueen HJ, 2004, MAT SCI ENG A-STRUCT, V387, P203, DOI 10.1016/j.msea.2004.01.064
   MCQUEEN HJ, 1995, J MATER PROCESS TECH, V53, P293, DOI 10.1016/0924-0136(95)01987-P
   McQueen HJ, 2002, MAT SCI ENG A-STRUCT, V322, P43, DOI 10.1016/S0921-5093(01)01117-0
   McQueen HJ, 1976, TREATISE MAT SCI TEC
   Poliak EI, 2003, ISIJ INT, V43, P684, DOI 10.2355/isijinternational.43.684
   Poliak EI, 1996, ACTA MATER, V44, P127, DOI 10.1016/1359-6454(95)00146-7
   Ponge D, 1998, ACTA MATER, V46, P69, DOI 10.1016/S1359-6454(97)00233-4
   RYAN ND, 1990, J MATER PROCESS TECH, V21, P177, DOI 10.1016/0924-0136(90)90005-F
   Sakai T, 1984, ACTA METALL, V32, P198
   SELLARS CM, 1966, MEM ETUD SCI REV MET, V63, P731
   Silva ES, 2012, MAT SCI ENG A-STRUCT, V543, P69, DOI 10.1016/j.msea.2012.02.048
   Sousa R.C., 2012, MAT SCI ENG A-STRUCT, V582, P96
   Stein G, 1995, INT J MATER PROD TEC, V10, P290
   UVIRA JL, 1968, T METALL SOC AIME, V242, P1619
NR 26
TC 6
Z9 6
U1 0
U2 7
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD MAR-APR
PY 2014
VL 17
IS 2
BP 436
EP 444
DI 10.1590/S1516-14392014005000001
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA AH6QO
UT WOS:000336255900023
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Li, CX
   Zhao, YH
   Peng, F
   Li, LL
   Gao, Y
   Wang, ZF
AF Li, Chunxia
   Zhao, Yuhang
   Peng, Fei
   Li, Lili
   Gao, Ya
   Wang, Zhoufeng
TI Biosynthesis Bacteria Cellulose by Strain of Bacteria Isolated from
   Native Corrupt Fruit
SO ASIAN JOURNAL OF CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 7th International Conference on Multi-Functional Materials and
   Applications (ICMMA)
CY NOV 22-24, 2013
CL Huainan, PEOPLES R CHINA
SP Anhui Univ Sci & Technol, Hanseo Univ, Anhui Jianzhu Univ, Hefei Univ, Anhui Univ, Suzhou Univ Sci Technol, Int Photoscience Soc
DE Bacterial cellulose; Isolate; Yield; Crystal structure
AB Bacterial cellulose (BC) is an interesting biomaterial for widespread applications. However, bacterial cellulose still expensive compared with other popular organic products and limit its widespread commercial applications. We had isolated a high bacterial cellulose producing strain from local corrupt fruit successfully. The yields of bacterial cellulose from three strains isolated-from native corrupt fruit were 3.5, 5.6 and 1.2 g/L, respectively. FT-IR and XRD results indicated the bacterial cellulose fabricated from local strain was typical cellulose I.
C1 [Li, Chunxia; Zhao, Yuhang; Peng, Fei; Li, Lili; Gao, Ya] Anhui Univ Sci & Technol, Coll Med, Huainan 232001, Peoples R China.
   [Wang, Zhoufeng] Anhui Univ Sci & Technol, Sch Mat Sci & Engn, Huainan 232001, Peoples R China.
RP Li, CX (reprint author), Anhui Univ Sci & Technol, Coll Med, Huainan 232001, Peoples R China.
EM springlw@sina.com; zfwang@aust.edu.cn
CR Bielecki S., 2005, BIOPOLYMERS
   Castro C, 2011, CARBOHYD POLYM, V84, P96, DOI 10.1016/j.carbpol.2010.10.072
   Kataoka Y, 1996, MACROMOLECULES, V29, P6356, DOI 10.1021/ma960206d
   NELSON M. L., 1964, J APPL POLYM SCI, V8, P1311, DOI DOI 10.1002/APP.1964.070080322
   Rani MU, 2011, J APPL POLYM SCI, V120, P2835, DOI 10.1002/app.33307
   Ruka DR, 2012, CARBOHYD POLYM, V89, P613, DOI 10.1016/j.carbpol.2012.03.059
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Wu JM, 2013, J BIOSCI BIOENG, V115, P284, DOI 10.1016/j.jbiosc.2012.09.014
   Yamamoto H, 1996, CELLULOSE, V3, P229, DOI 10.1007/BF02228804
   Yang Y, 2013, CARBOHYD POLYM, V92, P2012, DOI 10.1016/j.carbpol.2012.11.065
   Yoshino A, 2013, ACTA BIOMATER, V9, P6116, DOI 10.1016/j.actbio.2012.12.022
NR 11
TC 0
Z9 0
U1 1
U2 3
PU ASIAN JOURNAL OF CHEMISTRY
PI SAHIBABAD
PA 11/100 RAJENDRA NAGAR, SECTOR 3,, SAHIBABAD 201 005, GHAZIABAD, INDIA
SN 0970-7077
EI 0975-427X
J9 ASIAN J CHEM
JI Asian J. Chem.
PD MAR
PY 2014
VL 26
IS 6
BP 1738
EP 1740
PN B
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA AH2EN
UT WOS:000335934400051
DA 2018-10-20
ER

PT J
AU Kumar, V
   Gupta, PK
   Pawar, VK
   Verma, A
   Khatik, R
   Tripathi, P
   Shukla, P
   Yadav, B
   Parmar, J
   Dixit, R
   Mishra, PR
   Dwivedi, AK
AF Kumar, Vivek
   Gupta, Pramod K.
   Pawar, Vivek K.
   Verma, Ashwni
   Khatik, Renuka
   Tripathi, Priyanka
   Shukla, Prasant
   Yadav, Bholenath
   Parmar, Jeetesh
   Dixit, Rohit
   Mishra, P. R.
   Dwivedi, Anil Kumar
TI In-Vitro and In-Vivo Studies on Novel Chitosan-g-Pluronic F-127
   Copolymer Based Nanocarrier of Amphotericin B for Improved Antifungal
   Activity
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Nanomedicine; Toxicity; Fungizone; Mycosis; Micelles
ID THERMOSENSITIVE CHITOSAN; DRUG-DELIVERY; BLOCK-COPOLYMERS; GENE
   DELIVERY; MICELLES; RELEASE; BIOMATERIAL
AB The present communication is focusing on development of safe nanotemplates for sustained delivery of amphotericin B (AmB). We synthesized a block copolymer based on chitosan and Pluronic F-127 (PEO-b-PPO-b-PEO). Selection of Pluronic F-127 was based upon the criteria's that it has smaller size, higher aqueous solubility and stability whereas; chitosan is a non toxic, biodegradable polysaccharide. AmB loaded micelles were prepared by direct dissolution and pH dependent method. Various formulations were prepared using different drug polymer ratio to optimize the size, size distribution, zeta potential and drug loading efficiency. Optimized formulation was characterized for drug release pattern, haemolytic potential, in-vitro anti fungal activity and, in-vivo toxicity and compared with the marketed formulation (fungizone). The particle size and zeta potential of the micelles were found in the range between 90.2 +/- 10.21 to 148.7 +/- 21.03 and -16.3 +/- 4.24 to +31.1 +/- 6.10, respectively. The drug loading was found between 16.7 +/- 4.76% to 33.3 +/- 2.67% for all the developed formulations. Developed formulations showed negligible hemolytic toxicity with comparison to marketed formulation. In vitro antifungal studies demonstrated that micelles were more active than fungizone against C. albicans and A. fumigatus. Furthermore, AmB showed less nephrotoxicity when encapsulated in micelles in comparison to marketed formulation. These results together revealed that the developed formulation would be a safe and efficacious alternative to current marketed formulation to ameliorate the treatment of fungal infection.
C1 [Kumar, Vivek; Gupta, Pramod K.; Pawar, Vivek K.; Verma, Ashwni; Khatik, Renuka; Tripathi, Priyanka; Shukla, Prasant; Yadav, Bholenath; Parmar, Jeetesh; Dixit, Rohit; Mishra, P. R.; Dwivedi, Anil Kumar] CSIR Cent Drug Res Inst, Div Pharmaceut, Lucknow 226031, Uttar Pradesh, India.
RP Dwivedi, AK (reprint author), CSIR Cent Drug Res Inst, Div Pharmaceut, Lucknow 226031, Uttar Pradesh, India.
RI Shukla, Prashant/I-7886-2014
OI Shukla, Prashant/0000-0003-1286-4183
FU Council of Scientific and Industrial Research (CSIR), India
FX Author Dr. Anil Kumar Dwivedi is thankful to Indian Institute of
   Technology, Kanpur, India for providing scanning electron microscopy
   (SEM) facility. Vivek Kumar is thankful to Council of Scientific and
   Industrial Research (CSIR), India for providing senior research
   fellowships.
CR Adams ML, 2003, BIOMACROMOLECULES, V4, P750, DOI 10.1021/bm0257614
   Ali Y, 2006, ADV DRUG DELIVER REV, V58, P1258, DOI 10.1016/j.addr.2006.07.022
   Bae JW, 2006, MACROMOL RES, V14, P461, DOI 10.1007/BF03219111
   Cha J, 2006, MACROMOL RES, V14, P573, DOI 10.1007/BF03218726
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Eriksson U, 2001, BRIT MED J, V322, P579, DOI 10.1136/bmj.322.7286.579
   Espuelas MS, 2003, J ANTIMICROB CHEMOTH, V52, P419, DOI 10.1093/jac/dkg351
   Gaucher G, 2005, J CONTROL RELEASE, V109, P169, DOI 10.1016/j.jconrel.2005.09.034
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P223, DOI 10.1016/S0169-409X(02)00018-2
   Kim SY, 1998, J CONTROL RELEASE, V51, P13, DOI 10.1016/S0168-3659(97)00124-7
   Lee JW, 2004, J BIOMAT SCI-POLYM E, V15, P1065, DOI 10.1163/1568562041526496
   Liu SQ, 2005, BIOMATERIALS, V26, P5064, DOI 10.1016/j.biomaterials.2005.01.030
   Nishiyama N, 2006, PHARMACOL THERAPEUT, V112, P630, DOI 10.1016/j.pharmthera.2006.05.006
   Park KM, 2008, COLLOID SURFACE B, V63, P1, DOI 10.1016/j.colsurfb.2007.10.024
   Schroder CP, 1999, J ANTIMICROB CHEMOTH, V43, P741, DOI 10.1093/jac/43.5.741
NR 16
TC 8
Z9 8
U1 0
U2 18
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD MAR
PY 2014
VL 4
IS 3
BP 210
EP 216
DI 10.1166/jbt.2014.1160
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA AH4DB
UT WOS:000336075900007
DA 2018-10-20
ER

PT J
AU Millas, ALG
   McKean, R
   Stevens, R
   Yusuf, M
   Silveira, JVW
   Puzzi, MB
   Bittencourt, E
AF Millas, Ana Luiza G.
   McKean, Robert
   Stevens, Robert
   Yusuf, Mohammed
   Silveira, Joao V. W.
   Puzzi, Maria Beatriz
   Bittencourt, Edison
TI Fabrication of Electrospun Scaffolds Incorporating an Amazonian
   Therapeutic Oil from the Copaifera Species for Wound Care Application
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Tissue Engineering; Poly(lactic-co-glycolic acid); Skin Regeneration;
   Copaiba; Electrospinning; Fibroblasts
ID SKIN SUBSTITUTES; DUCKEI DWYER; DEGRADATION; TERPENOIDS; OLEORESINS;
   MEMBRANES; PROGRESS; RATS
AB Electrospinning provides an efficient and versatile method to produce novel biomaterials from a range of natural and synthetic polymers, which show excellent biocompatibility due to the very high surface area-to-volume ratio. In addition, the incorporation of bioactive compounds into biodegradable polymers, such as poly(lactic-co-glycolic acid) (PLGA) allows the fabrication of drug releasing bioactive scaffolds for potential use in novel wound care applications. Native to the tropical region of Latin America, Copaiba oil is extracted from material from the Copaifera species. The oil is a FDA approved compound known for its wound healing, anti-inflammatory, analgesics, antifungal and antimicrobial functions. In this study, microfiber non-woven scaffolds were fabricated via electrospinning solutions of PLGA containing copaiba oil. Tests of cell growth with lung fibroblasts reported a strong affinity of the fibroblasts and the biomaterial.
C1 [Millas, Ana Luiza G.; Silveira, Joao V. W.; Bittencourt, Edison] State Univ Campinas UNICAMP, Sch Chem Engn, Dept Mat & Bioproc Engn, BR-13083852 Sao Paulo, Brazil.
   [McKean, Robert] Rutherford Appleton Lab, Electrospinning Co, Harwell Oxford OX11 0QX, England.
   [Stevens, Robert] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG1 4BU, England.
   [Yusuf, Mohammed] UCL, London Ctr Nanotechnol, London OX11 0FA, England.
   [Puzzi, Maria Beatriz] State Univ Campinas UNICAMP, Sch Med Sci, Dept Clin Med, BR-13083852 Sao Paulo, Brazil.
RP Millas, ALG (reprint author), State Univ Campinas UNICAMP, Sch Chem Engn, Dept Mat & Bioproc Engn, BR-13083852 Sao Paulo, Brazil.
FU FAPESP
FX Sincere thanks to Professor Ian Robinson of the Research Complex at
   Harwell (RCaH), United Kingdom. Santander International Students Program
   from Brazil. FAPESP for financial support. And The Elecrospinning
   Company which provided all the infrastructure and materials for the
   scaffolds production.
CR ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   Barauna G, 2013, MATER RES-IBERO-AM J, V16, P221, DOI [10.1590/S1516-14392013000100028, 10.1590/S1516-14392012005000154]
   BASILE AC, 1988, J ETHNOPHARMACOL, V22, P101, DOI 10.1016/0378-8741(88)90235-8
   Berthiaume F, 2011, ANNU REV CHEM BIOMOL, V2, P403, DOI 10.1146/annurev-chembioeng-061010-114257
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   BRITO N.M.B., 1998, REV PARA MED, V12, P28
   Carvalho JCT, 2005, PHYTOTHER RES, V19, P946, DOI 10.1002/ptr.1762
   Cascon V, 2000, PHYTOCHEMISTRY, V55, P773, DOI 10.1016/S0031-9422(00)00284-3
   Chen DW, 2012, INT J PHARMACEUT, V430, P335, DOI 10.1016/j.ijpharm.2012.04.010
   Fernandes R. M., 1989, S BRAS CHIN QUIM FAR
   FERNANDES RM, 1992, REV BRASILEIRA FARMA, V73, P53
   Ji W., 2011, EXPERT REV SPRINGERL, P1261, DOI 10.1007.s11095-010-0320-6
   Khademhosseini A, 2009, SCI AM, V300, P64, DOI 10.1038/scientificamerican0509-64
   KOBAYASHI H, 1992, J BIOMED MATER RES, V26, P1463, DOI 10.1002/jbm.820261106
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Leandro LM, 2012, MOLECULES, V17, P3866, DOI 10.3390/molecules17043866
   MacNeil S., 2008, MAT TODAY, V11
   Masson-Meyers DS, 2013, INT J APPL MICROBIOL, V2, P9
   MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   Neto JN, 2011, ACTA CIR BRAS, V26, P20, DOI 10.1590/S0102-86502011000800005
   Oliveira DF, 2007, FITOTERAPIA, V78, P142, DOI 10.1016/j.fitote.2006.09.027
   Paiva LAF, 2002, PHYTOTHER RES, V16, P737, DOI [10.1002/ptr.1049, 10.1002/prt.1049]
   Pontiggia L, 2013, PEDIATR SURG INT, V29, P249, DOI 10.1007/s00383-013-3268-x
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Sander EA, 2004, J BIOMED MATER RES A, V70A, P506, DOI 10.1002/jbm.a.30109
   Tincusi BM, 2002, PLANTA MED, V68, P808, DOI 10.1055/s-2002-34399
   Vieira RC, 2008, PESQUISA VET BRASIL, V28, P358, DOI 10.1590/S0100-736X2008000800002
   Xinhua Z., 2003, BIOMACROMOLECULES, V4, P416
NR 29
TC 5
Z9 5
U1 2
U2 29
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD MAR
PY 2014
VL 4
IS 3
BP 217
EP 220
DI 10.1166/jbt.2014.1162
PG 4
WC Cell & Tissue Engineering
SC Cell Biology
GA AH4DB
UT WOS:000336075900008
DA 2018-10-20
ER

PT J
AU Abedi, G
   Jahanshahi, A
   Fathi, MH
   Haghdost, IS
   Veshkini, A
AF Abedi, Gholamreza
   Jahanshahi, Amirali
   Fathi, Mohamad Hosein
   Haghdost, Iraj Sohrabi
   Veshkini, Abas
TI STUDY OF NANO-HYDROXYAPATITE/ZIRCONIA STABILIZED WITH YTTRIA IN BONE
   HEALING: HISTOPATHOLOGICAL STUDY IN RABBIT MODEL
SO POLISH JOURNAL OF PATHOLOGY
LA English
DT Article
DE zirconia-stabilized yttria; bone healing; histological changes; rabbits
ID GRAFT SUBSTITUTES; ZIRCONIA; IMPLANT; BIOMATERIALS; OSTEOBLAST; CERAMICS
AB Acceleration of bone healing has always been a major challenge in orthopedic surgery, the aim of this study was an evaluation of the biological effects of zirconia-stabilized yttria on bone healing, using an in vivo model.
   Nano-hydroxyapatite powder with zirconia-stabilized yttria were inserted in rabbit tibia and then histologically analyzed and compared with non-treated controls so thirty six. New Zealand white male rabbits randomly divided into two groups of 18 rabbits each. A cortical hole of 4 mm diameter and 8 mm depth in each tibia was drilled. In group I, the defect was left empty, whereas in group II, the bone defect was packed with nano-hydroxyapatite/5% zirconia stabilized with yttria. Histological evaluations were performed at two, four and six weeks after the implantation.
   Microscopic changes on two groups along with the time course were scored and statistical analysis showed that the average scores in group II were significantly higher than the other groups (p < 0.05).
   Histological analysis was shown to be significantly improved by the nano-hydroxy-apatite/5% zirconia stabilized with yttria compared with the control group, suggesting that this biomaterial promote the healing of cortical bone, presumably by acting as an osteoconductive.
C1 [Abedi, Gholamreza; Jahanshahi, Amirali] Islamic Azad Univ, Fac Specialized Vet Sci, Dept Surg, Sci & Res Branch, Tehran 127365634, Iran.
   [Fathi, Mohamad Hosein] Isfahan Univ Technol, Dept Mat Engn, Esfahan, Iran.
   [Haghdost, Iraj Sohrabi] Islamic Azad Univ, Fac Specialized Vet Sci, Dept Pathol, Sci & Res Branch, Tehran 127365634, Iran.
   [Veshkini, Abas] Islamic Azad Univ, Fac Specialized Vet Sci, Dept Radiol, Sci & Res Branch, Tehran 127365634, Iran.
RP Jahanshahi, A (reprint author), Islamic Azad Univ, Fac Specialized Vet Sci, Dept Surg, Sci & Res Branch, Tehran 127365634, Iran.
EM Amirali.jahanshahi@gmail.com
FU Faculty of Specialized Veterinary Sciences, Islamic Azad University,
   Science and Research Branch, Tehran, Iran; Research Council
FX The authors wish to acknowledge the Faculty of Specialized Veterinary
   Sciences, Islamic Azad University, Science and Research Branch, Tehran,
   Iran, Research Council for approval and financial support of this
   research work.
CR Ahmad I, 1998, INT J PERIODONT REST, V18, P455
   Akagawa Y, 1998, J PROSTHET DENT, V80, P551, DOI 10.1016/S0022-3913(98)70031-9
   AKAGAWA Y, 1993, J PROSTHET DENT, V69, P599, DOI 10.1016/0022-3913(93)90289-Z
   An HS, 2012, DENT MATER, V28, P1221
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   BAUER TW, 2000, CLIN ORTHOP RELAT R, V371, P10, DOI DOI 10.1097/00003086-200002000-00003
   Bilkay U, 2004, J CRANIOFAC SURG, V15, P585, DOI 10.1097/00001665-200407000-00011
   BRUDER SP, 1999, CLIN ORTHOP S, V367, P68
   BUCHOLZ RW, 2002, CLIN ORTHOP FEBRUARY, V395, P44
   Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P1037
   Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   ICHIKAWA Y, 1992, J PROSTHET DENT, V68, P322, DOI 10.1016/0022-3913(92)90338-B
   Inui Atsuyuki, 2011, Sports Med Arthrosc Rehabil Ther Technol, V3, P29, DOI 10.1186/1758-2555-3-29
   Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y
   Kim BK, 2005, J PROSTHET DENT, V94, P357, DOI 10.1016/j.prosdent.2005.08.012
   Kohal RJ, 2013, DENT MATER, V29, P763, DOI 10.1016/j.dental.2013.04.003
   Kong DJ, 2012, T NONFERR METAL SOC, V22, P104, DOI 10.1016/S1003-6326(11)61147-3
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Kurtz LT, 1989, SPINE, V14, P1324
   Lappalainen R, 1998, CLIN ORTHOP RELAT R, P118
   Le Guehennec L, 2004, Eur Cell Mater, V8, P1
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Palissery V, 2004, J MATER SCI-MATER M, V15, P61, DOI 10.1023/B:JMSM.0000010098.65572.3b
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   REDDI AH, 1994, J CELL BIOCHEM, V56, P192, DOI 10.1002/jcb.240560213
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   Salehi S, 2010, CERAM INT, V36, P1659, DOI 10.1016/j.ceramint.2010.02.045
   Sammarco V James, 2002, Foot Ankle Clin, V7, P19, DOI 10.1016/S1083-7515(01)00003-1
   Sepulveda P, 2000, J AM CERAM SOC, V83, P3021, DOI 10.1111/j.1151-2916.2000.tb01677.x
   Stefanic M, 2013, J EUR CERAM SOC, V33, P3455, DOI 10.1016/j.jeurceramsoc.2013.05.015
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 36
TC 4
Z9 4
U1 0
U2 4
PU VESALIUS UNIV MEDICAL PUBL
PI CRACOW
PA WISLISKO 1, CRACOW, 00000, POLAND
SN 1233-9687
J9 POL J PATHOL
JI Pol. J. Pathol.
PD MAR
PY 2014
VL 65
IS 1
BP 40
EP 47
DI 10.5114/PJP.2014.42668
PG 8
WC Pathology
SC Pathology
GA AH4ON
UT WOS:000336108000006
PM 25119008
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Tuinstra, HM
   Margul, DJ
   Goodman, AG
   Boehler, RM
   Holland, SJ
   Zelivyanskaya, ML
   Cummings, BJ
   Anderson, AJ
   Shea, LD
AF Tuinstra, Hannah M.
   Margul, Daniel J.
   Goodman, Ashley G.
   Boehler, Ryan M.
   Holland, Samantha J.
   Zelivyanskaya, Marina L.
   Cummings, Brian J.
   Anderson, Aileen J.
   Shea, Lonnie D.
TI Long-Term Characterization of Axon Regeneration and Matrix Changes Using
   Multiple Channel Bridges for Spinal Cord Regeneration
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID NERVOUS-SYSTEM INJURY; ADULT-RAT; SCHWANN-CELLS; GUIDANCE SCAFFOLDS;
   CORTICOSPINAL TRACT; FUNCTIONAL RECOVERY; AGAROSE SCAFFOLDS; POLYMER
   SCAFFOLDS; CONTUSION INJURY; CNS INJURY
AB Spinal cord injury (SCI) results in loss of sensory and motor function below the level of injury and has limited available therapies. The host response to SCI is typified by limited endogenous repair, and biomaterial bridges offer the potential to alter the microenvironment to promote regeneration. Porous multiple channel bridges implanted into the injury provide stability to limit secondary damage and support cell infiltration that limits cavity formation. At the same time, the channels provide a path that physically directs axon growth across the injury. Using a rat spinal cord hemisection injury model, we investigated the dynamics of axon growth, myelination, and scar formation within and around the bridge in vivo for 6 months, at which time the bridge has fully degraded. Axons grew into and through the channels, and the density increased overtime, resulting in the greatest axon density at 6 months postimplantation, despite complete degradation of the bridge by that time point. Furthermore, the persistence of these axons contrasts with reports of axonal dieback in other models and is consistent with axon stability resulting from some degree of connectivity. Immunostaining of axons revealed both motor and sensory origins of the axons found in the channels of the bridge. Extensive myelination was observed throughout the bridge at 6 months, with centrally located and peripheral channels seemingly myelinated by oligodendrocytes and Schwann cells, respectively. Chondroitin sulfate proteoglycan deposition was restricted to the edges of the bridge, was greatest at 1 week, and significantly decreased by 6 weeks. The dynamics of collagen I and IV, laminin, and fibronectin deposition varied with time. These studies demonstrate that the bridge structure can support substantial long-term axon growth and myelination with limited scar formation.
C1 [Tuinstra, Hannah M.; Goodman, Ashley G.; Boehler, Ryan M.; Holland, Samantha J.; Zelivyanskaya, Marina L.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Margul, Daniel J.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Dept Phys Med & Rehabil, Irvine, CA USA.
   [Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA.
   [Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
   [Shea, Lonnie D.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA.
   [Shea, Lonnie D.] Northwestern Univ, Chem Life Proc Inst, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem Engn, 2145 Sheridan Rd Tech E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Cummings, Brian/C-9180-2012; Shea, Lonnie/B-7615-2009
OI Cummings, Brian/0000-0003-3628-5290; Margul, Daniel/0000-0002-0907-1839
FU NIH [RO1 EB005678, R21 EB006520, RO1 EB003806]
FX Financial support for this research was provided by the NIH (RO1
   EB005678, R21 EB006520, RO1 EB003806). The authors thank the Christopher
   and Dana Reeve Foundation SCI core at UC Irvine.
CR Asher RA, 2000, J NEUROSCI, V20, P2427
   Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002
   AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9
   Beattie M. S, 1992, J NEUROTRAUM, V9, P9
   BEATTIE MS, 1992, J NEUROTRAUM, V9, P157, DOI 10.1089/neu.1992.9.157
   Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695
   BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197
   BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cb.07.110191.001001
   BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7
   BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0
   Camand E, 2004, EUR J NEUROSCI, V20, P1161, DOI 10.1111/j.1460-9568.2004.03558.x
   Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]
   Chen BKK, 2011, BIOMATERIALS, V32, P8077, DOI 10.1016/j.biomaterials.2011.07.029
   Cheng H, 2007, BIOCHEM BIOPH RES CO, V357, P938, DOI 10.1016/j.bbrc.2007.04.049
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   Eyre JA, 2007, NEUROSCI BIOBEHAV R, V31, P1136, DOI 10.1016/j.neubiorev.2007.05.011
   Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Friedman JA, 2002, NEUROSURGERY, V51, P742, DOI 10.1097/00006123-200209000-00024
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   GLEDHILL RF, 1973, EXP NEUROL, V38, P472, DOI 10.1016/0014-4886(73)90169-6
   Hiruma H, 2000, BRAIN RES, V883, P184, DOI 10.1016/S0006-8993(00)02892-4
   Houweling DA, 1998, EXP NEUROL, V153, P49, DOI 10.1006/exnr.1998.6867
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Joosten EAJ, 2012, CELL TISSUE RES, V349, P375, DOI 10.1007/s00441-012-1352-5
   Keirstead HS, 1999, EXP NEUROL, V159, P225, DOI 10.1006/exnr.1999.7100
   Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033
   King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Krych AJ, 2009, ACTA BIOMATER, V5, P2551, DOI 10.1016/j.actbio.2009.03.021
   Lonjon N, 2010, J NEUROSURG-SPINE, V12, P106, DOI 10.3171/2009.7.SPINE0989
   Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168
   MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409
   Moon LDF, 2002, NEUROSCIENCE, V109, P101, DOI 10.1016/S0306-4522(01)00457-2
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Okada M, 2007, NEUROSCI RES, V58, P371, DOI 10.1016/j.neures.2007.04.009
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Phillips JB, 2004, BIOMATERIALS, V25, P2769, DOI 10.1016/j.biomaterias.2003.09.052
   RICHARDSON PM, 1982, BRAIN RES, V237, P147, DOI 10.1016/0006-8993(82)90563-7
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   Schwab ME, 1996, PHYSIOL REV, V76, P319
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0
   Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736
   Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   Tuszynski MH, 1998, CELL TRANSPLANT, V7, P187, DOI 10.1016/S0963-6897(97)00166-8
   Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687
   Wang MD, 2011, TISSUE ENG PART B-RE, V17, P177, DOI 10.1089/ten.teb.2010.0648
   Weidner N, 1999, J COMP NEUROL, V413, P495, DOI 10.1002/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z
   Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798
   Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473
   Yang Y, 2009, TISSUE ENG PT A, V15, P3283, DOI [10.1089/ten.tea.2009.0081, 10.1089/ten.TEA.2009.0081]
   Yao L, 2010, BIOMATERIALS, V31, P5789, DOI 10.1016/j.biomaterials.2010.03.081
   Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120
   Young W, 2002, PROG BRAIN RES, V137, P231
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002
   Zhang SX, 2011, BRAIN RES, V1399, P1, DOI 10.1016/j.brainres.2011.05.005
   Zhang SX, 2011, HISTOL HISTOPATHOL, V26, P45, DOI 10.14670/HH-26.45
   Zhang SX, 2005, HISTOL HISTOPATHOL, V20, P519, DOI 10.14670/HH-20.519
   Zhou LJ, 2003, J NEUROSCI, V23, P1424
NR 73
TC 7
Z9 10
U1 2
U2 24
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR 1
PY 2014
VL 20
IS 5-6
BP 1027
EP 1037
DI 10.1089/ten.tea.2013.0111
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AB8DZ
UT WOS:000332021600014
PM 24168314
OA Green Published
DA 2018-10-20
ER

PT J
AU Bourke, JL
   Coleman, HA
   Pham, V
   Forsythe, JS
   Parkington, HC
AF Bourke, Justin L.
   Coleman, Harold A.
   Vi Pham
   Forsythe, John S.
   Parkington, Helena C.
TI Neuronal Electrophysiological Function and Control of Neurite Outgrowth
   on Electrospun Polymer Nanofibers Are Cell Type Dependent
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ROOT GANGLION NEURONS; NEURAL STEM-CELLS; EMBRYONIC HIPPOCAMPAL-NEURONS;
   3-DIMENSIONAL COLLAGEN GELS; MICROPATTERNED SURFACES; SYNAPSE FORMATION;
   CONTACT GUIDANCE; CARBON NANOTUBES; CHANNEL DENSITY; CNS NEUROBLASTS
AB Modeling of cellular environments with nanofabricated biomaterial scaffolds has the potential to improve the growth and functional development of cultured cellular models, as well as assist in tissue engineering efforts. An understanding of how such substrates may alter cellular function is critical. Highly plastic central nervous system hippocampal cells and non-network forming peripheral nervous system dorsal root ganglion (DRG) cells from embryonic rats were cultured upon laminin-coated degradable polycaprolactone (PCL) and nondegradable polystyrene (PS) electrospun nanofibrous scaffolds with fiber diameters similar to those of neuronal processes. The two cell types displayed intrinsically different growth patterns on the nanofibrous scaffolds. Hippocampal neurites grew both parallel and perpendicular to the nanofibers, a property that would increase neurite-to-neurite contacts and maximize potential synapse development, essential for extensive network formation in a highly plastic cell type. In contrast, non-network-forming DRG neurons grew neurites exclusively along fibers, recapitulating the simple direct unbranching pathway between sensory ending and synapse in the spinal cord that occurs in vivo. In addition, the two primary neuronal types showed different functional capacities under patch clamp testing. The substrate composition did not alter the neuronal functional development, supporting electrospun PCL and PS as candidate materials for controlled cellular environments in culture and electrospun PCL for directed neurite outgrowth in tissue engineering applications.
C1 [Bourke, Justin L.; Coleman, Harold A.; Vi Pham; Parkington, Helena C.] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia.
   [Bourke, Justin L.; Forsythe, John S.] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
RP Bourke, JL (reprint author), Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia.
EM justin.bourke@monash.edu
RI bourke, justin/A-6900-2008
OI bourke, justin/0000-0003-2584-2127; Forsythe, John/0000-0003-2849-229X
FU National Health and Medical Research Council
FX We thank Monash Micro Imaging for provision of instrumentation and
   training in optical microscopy techniques, and the National Health and
   Medical Research Council for the Dora Lush Biomedical Postgraduate
   Scholarship to J.B.
CR Arhem P, 2006, BIOPHYS J, V90, P4392, DOI 10.1529/biophysj.105.077032
   Arhem P, 2007, BIOSYSTEMS, V89, P117, DOI 10.1016/j.biosystems.2006.03.015
   Bi GQ, 1998, J NEUROSCI, V18, P10464
   Bolgen N, 2005, J BIOMAT SCI-POLYM E, V16, P1537, DOI 10.1163/156856205774576655
   CAFFREY JM, 1992, BRAIN RES, V592, P283, DOI 10.1016/0006-8993(92)91687-A
   Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   Daud MFB, 2012, BIOMATERIALS, V33, P5901, DOI 10.1016/j.biomaterials.2012.05.008
   Edelman DB, 2005, EXP NEUROL, V192, P1, DOI 10.1016/j.expneurol.2004.10
   Eubanks JH, 1996, NEUROSCI LETT, V204, P5, DOI 10.1016/0304-3940(96)12337-5
   Fozdar DY, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035005
   Heller DA, 2005, BIOMATERIALS, V26, P883, DOI 10.1016/j.biomaterials.2004.03.029
   Ho C, 2011, MOL CELL NEUROSCI, V46, P159, DOI 10.1016/j.mcn.2010.08.017
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619
   Irons HR, 2008, J NEURAL ENG, V5, P333, DOI 10.1088/1741-2560/5/3/006
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   Larsson K, 2012, CELLS TISSUES ORGANS, V196, P82, DOI 10.1159/000330696
   Lee JY, 2010, J BIOMED MATER RES A, V92A, P1398, DOI 10.1002/jbm.a.32471
   Liu QY, 2000, DEV BRAIN RES, V120, P223, DOI 10.1016/S0165-3806(00)00014-6
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   Lutton C, 2008, NAT BIOTECHNOL, V26, P613, DOI 10.1038/nbt0608-613
   Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016
   Ma W, 1998, DEV BRAIN RES, V111, P231, DOI 10.1016/S0165-3806(98)00142-4
   Magnusson AK, 2008, J NEUROSCI RES, V86, P2363, DOI 10.1002/jnr.21688
   Martinez-Ramos C, 2008, TISSUE ENG PT A, V14, P1365, DOI 10.1089/ten.tea.2007.0295
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   NAGATA I, 1991, DEVELOPMENT, V112, P581
   NAGATA I, 1993, DEVELOPMENT, V117, P401
   Nisbet DR, 2008, J BIOMAT SCI-POLYM E, V19, P623, DOI 10.1163/156856208784089652
   O'Shaughnessy TJ, 2003, NEUROSCI LETT, V340, P169, DOI 10.1016/S0304-3940(03)00083-1
   Park KH, 2003, J BIOL CHEM, V278, P50212, DOI 10.1074/jbc.M310216200
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   SCROGGS RS, 1994, J NEUROPHYSIOL, V71, P271
   SCROGGS RS, 1992, J PHYSIOL-LONDON, V445, P639, DOI 10.1113/jphysiol.1992.sp018944
   Shahbazi E, 2011, TISSUE ENG PT A, V17, P3021, DOI [10.1089/ten.tea.2011.0121, 10.1089/ten.TEA.2011.0121]
   Shao HJ, 2010, BIOMATERIALS, V31, P4695, DOI 10.1016/j.biomaterials.2010.02.037
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tao HZW, 2000, J NEUROSCI, V20, P3233, DOI 10.1523/JNEUROSCI.20-09-03233.2000
   Thalhammer A, 2010, BIOMATERIALS, V31, P2097, DOI 10.1016/j.biomaterials.2009.11.109
   Villiere V, 1996, J NEUROPHYSIOL, V76, P1924
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387
   Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z
   Xu HF, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/28/285102
   Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048
   Xu T, 2009, BIOMATERIALS, V30, P4377, DOI 10.1016/j.biomaterials.2009.04.047
NR 48
TC 16
Z9 16
U1 1
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR 1
PY 2014
VL 20
IS 5-6
BP 1089
EP 1095
DI 10.1089/ten.tea.2013.0295
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AB8DZ
UT WOS:000332021600020
PM 24147808
OA Green Published
DA 2018-10-20
ER

PT J
AU Mericli, AF
   Gampper, TJ
AF Mericli, Alexander F.
   Gampper, Thomas J.
TI Treatment of Postsurgical Temporal Hollowing With High- Density Porous
   Polyethylene
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Temporal hollowing; Medpor; highly porous polyethylene
ID CRANIOFACIAL RECONSTRUCTION; BONE; IMPLANTS; SURGERY; BIOMATERIALS;
   CEMENT; CRANIOPLASTY; GRAFTS; FLAP; FACE
AB Temporal hollowing is most frequently an acquired defect and can be caused by a volumetric deficiency of bone, soft tissue, or both. Given high-density porous polyethylene's ease of use, customizability, long-term strength and resiliency, and successful application in other areas of the craniofacial skeleton, the authors have used it as the first-line material for reconstruction of temporal hollowing. Herein, we present 4 illustrative cases demonstrating this technique and further describe subtypes of the temporal defect with appropriate means of reconstruction. The cases were reviewed for comorbidities, intraoperative details, and the postoperative course. There were no complications, and all patients were pleased with their final result. High-density porous polyethylene is a safe, well-studied, and easily handled biomaterial that is useful for the treatment of temporal hollowing.
C1 [Mericli, Alexander F.; Gampper, Thomas J.] Univ Virginia Hlth Syst, Dept Plast Surg, Charlottesville, VA 22908 USA.
RP Gampper, TJ (reprint author), Univ Virginia Hlth Syst, Dept Plast Surg, POB 800376, Charlottesville, VA 22908 USA.
EM tjg6f@virginia.edu
CR Carboni A, 2002, Minerva Chir, V57, P283
   Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc
   CHAJCHIR A, 1989, PLAST RECONSTR SURG, V84, P921, DOI 10.1097/00006534-198912000-00009
   Cho YR, 2004, CLIN PLAST SURG, V31, P377, DOI 10.1016/j.cps.2004.03.001
   Coleman SR, 1997, CLIN PLAST SURG, V24, P347
   EDGERTON MT, 1985, ANN SURG, V202, P459, DOI 10.1097/00000658-198510000-00007
   Gosain AK, 1999, J CRANIOFAC SURG, V10, P404, DOI 10.1097/00001665-199909000-00006
   HOMSY C A, 1970, Journal of Biomedical Materials Research, V4, P341, DOI 10.1002/jbm.820040306
   Kim S, 2005, J CRANIOFAC SURG, V16, P651, DOI 10.1097/01.scs.0000168764.48486.a2
   Kim SG, 2001, INT J ORAL MAX SURG, V30, P438, DOI 10.1054/ijom.2001.0104
   Kumar AR, 2011, PLAST RECONSTR SURG, V127, P1279, DOI 10.1097/PRS.0b013e318205f47c
   Lacey M, 1994, J Craniofac Surg, V5, P223, DOI 10.1097/00001665-199409000-00005
   Lee DW, 2010, J CRANIOFAC SURG, V21, P1084, DOI 10.1097/SCS.0b013e3181e1b64b
   Lin AY, 2012, J CRANIOFAC SURG, V23, P67, DOI 10.1097/SCS.0b013e318240c876
   MANSON PN, 1986, PLAST RECONSTR SURG, V77, P888, DOI 10.1097/00006534-198606000-00003
   Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055
   Matic DB, 2008, PLAST RECONSTR SURG, V121, P379
   Menderes A, 2004, J CRANIOFAC SURG, V15, P719, DOI 10.1097/00001665-200409000-00004
   Pryor LS, 2009, CRANIOMAX TRAUM REC, V2, P151, DOI [10.1055/s-0029-1224777, 10.1055/s-0029-1224777.ISSN1943-3875]
   Rapidis AD, 2006, J ORAL MAXIL SURG, V64, P12, DOI 10.1016/j.joms.2005.09.007
   Romano J J, 1993, J Craniofac Surg, V4, P142, DOI 10.1097/00001665-199307000-00007
   SPECTOR M, 1975, J BIOMED MATER RES, V9, P537, DOI 10.1002/jbm.820090514
   Tanna N, 2011, PLAST RECONSTR SURG, V127, P802, DOI 10.1097/PRS.0b013e3181fed6e4
   VAANDRAGER JM, 1988, ANN PLAS SURG, V21, P583, DOI 10.1097/00000637-198812000-00016
   WOLFE SA, 1982, CLIN PLAST SURG, V9, P539
   Wong RK, 2011, J CRANIOFAC SURG, V22, P247, DOI 10.1097/SCS.0b013e3181f7b7db
   Xie Y, 2010, J PLAST RECONSTR AES, V63, P270, DOI 10.1016/j.bjps.2008.11.016
   Yaremchuk MJ, 2003, PLAST RECONSTR SURG, V111, P1818, DOI 10.1097/01.PRS.0000056866.80665.7A
NR 28
TC 3
Z9 3
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2014
VL 25
IS 2
BP 563
EP 567
DI 10.1097/SCS.0000000000000506
PG 5
WC Surgery
SC Surgery
GA AG4IB
UT WOS:000335381800108
PM 24514889
DA 2018-10-20
ER

PT J
AU Lopez, MA
   Bassi, MA
   Confalone, L
   Carinci, F
AF Lopez, Michele Antonio
   Bassi, Mirko Andreasi
   Confalone, Luca
   Carinci, Francesco
TI Maxillary Sinus Floor Elevation via Crestal Approach: The Evolution of
   the Hydraulic Pressure Technique
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Sinus floor elevation; bone graft; hydraulic detachment; hydraulic
   elevation
ID OSTEOTOME TECHNIQUE; MOLAR EXTRACTION; IMPLANTS; AUGMENTATION;
   PLACEMENT; MEMBRANE; SUCCESS; RATES; TIME
AB The current study describes an innovative protocol for the surgical maxillary sinus augmentation via a crestal approach that uses hydraulic pressure to lift the Schneiderian membrane and simultaneously fill the subantral space with a biomaterial for bone regeneration (nanocrystalline hydroxyapatite in aqueous solution). The technique in question combines the advantages of large amounts of grafted biomaterial with reduced trauma, high precision, and predictability.
C1 [Lopez, Michele Antonio; Bassi, Mirko Andreasi; Confalone, Luca; Carinci, Francesco] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept Morphol Surg & Expt Med, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
CR Aimetti M, 2001, INT J PERIODONT REST, V21, P581
   Andreasi Bassi M, 2010, J OSTEOL BIOMAT, V1, P93
   Buser D, 2000, CLIN ORAL IMPLAN RES, V11, P59, DOI 10.1034/j.1600-0501.2000.011S1059.x
   Cavicchia F, 2001, INT J PERIODONT REST, V21, P475
   Coatoam G W, 1997, J Oral Implantol, V23, P117
   Favero GA, 1994, G STOMATOL ORTOGNATO, V1, P57
   Fugazzotto P A, 2001, Implant Dent, V10, P259
   Fugazzotto PA, 1998, INT J ORAL MAX IMPL, V13, P52
   Fugazzotto PA, 2002, INT J ORAL MAX IMPL, V17, P113
   Fugazzotto PA, 2002, J PERIODONTOL, V73, P39, DOI 10.1902/jop.2002.73.1.39
   Fugazzotto PA, 1999, INT J ORAL MAX IMPL, V14, P536
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P595, DOI 10.1034/j.1600-0501.2002.130604.x
   Nkenke E, 2002, INT J ORAL MAX IMPL, V17, P557
   Ozyuvaci H, 2003, J PERIODONTOL, V74, P909, DOI 10.1902/jop.2003.74.6.909
   Reiser GM, 2001, INT J ORAL MAX IMPL, V16, P833
   Smiler DG, 1992, DENT CLIN N AM, V36, P151
   Sotirakis Emmanouil G, 2005, J Oral Implantol, V31, P197, DOI 10.1563/1548-1336(2005)31[197:EOTMSF]2.0.CO;2
   Summers R B, 1994, Compendium, V15, P702
   Summers R B, 1994, Compendium, V15, P154
   Summers R B, 1995, Compend Contin Educ Dent, V16, P1094
   Summers R. B., 1994, COMPENDIUM, V15, P162
   Summers RB, 1994, COMPENDIUM, V15, P158
   Summers RB., 1995, COMPEND CONTIN ED DE, V16, P1098
   Summers RB., 1995, COMPEND CONTIN ED DE, V16, P1099
   Summers RB, 1995, COMPEND CONTIN ED DE, V16, P1092
   Summers RB, 1994, COMPENDIUM, V15, P154
   Summers RB., 1995, COMPEND CONTIN ED DE, V16, P1094
   SUMMERS RB, 1994, COMPENDIUM, V15, P700
   SUMMERS RB, 1994, COMPENDIUM, V15, P702
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tatum H Jr, 1988, CDA J, V16, P71
   Tatum O H Jr, 1989, Fla Dent J, V60, P23
   Vercellotti T, 2001, INT J PERIODONT REST, V21, P561
   Winter AA, 2002, INT J ORAL MAX IMPL, V17, P687
NR 35
TC 10
Z9 10
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2014
VL 25
IS 2
BP E127
EP E132
DI 10.1097/SCS.0000000000000457
PG 6
WC Surgery
SC Surgery
GA AG4IB
UT WOS:000335381800014
PM 24448532
DA 2018-10-20
ER

PT J
AU Yang, JL
   Huang, YJ
   Gao, CM
   Liu, MZ
   Zhang, XJ
AF Yang, Jinlong
   Huang, Yinjuan
   Gao, Chunmei
   Liu, Mingzhu
   Zhang, Xinjie
TI Fabrication and evaluation of the novel reduction-sensitive starch
   nanoparticles for controlled drug release
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Starch nanoparticles; BAC; Reduction-sensitive; Drug release
ID LINKED HIGH AMYLOSE; IN-VITRO; 5-AMINOSALICYLIC ACID; DELIVERY
   PLATFORMS; DISULFIDE; POLYMERS; MICELLES; CHITOSAN; CARRIER; PH
AB A novel type of reduction-sensitive starch nanoparticles was prepared via the reversed-phase microemulsion method by using crosslinker, N,N-bisacryloylcystamine (BAC) with the disulfide linkages, which was specifically cleaved by dithiothreitol (DTT). Starch nanoparticles had a spherical morphology with a small size of 40 nm in the optimal condition. The influences of process parameters (starch amount, surfactant amount and oil/water (O/W) ratio) on the size of starch nanoparticles were studied by dynamic light scattering (DLS). BAC crosslinked starch nanoparticles were degraded into oligomers with the reducing agent of DTT due to the cleavage of the disulfide linkages. A model drug 5-aminosalicylic acid (5-ASA) could be loaded efficiently into starch nanoparticles and the in vitro drug release behaviors were also studied. The results suggested that the disulfide crosslinked starch nanoparticles exhibited an accelerated drug release behavior in the presence of DTT. In vitro methyl thiazolyl tetrazolium (MTT) assays indicated that BAC crosslinked starch nanoparticles had a good biocompatibility when cocultured with human HeLa cancer cells. Hence, with excellent biocompatibility and biodegradability, and rapid drug release in response to DTT, BAC crosslinked starch nanoparticles showed a great potential as a biomaterial carrier for the application of drug controlled release. In contrast to BAC crosslinked starch nanoparticles, N,N-methylenebisacrylamine (MBA) crosslinked starch nanoparticles were prepared as the control without the disulfide linkages. (C) 2013 Elsevier Ky. All rights reserved.
C1 [Liu, Mingzhu] Lanzhou Univ, Key Lab Nonferrous Met Chem & Resources Utilizat, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.
   Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China.
RP Liu, MZ (reprint author), Lanzhou Univ, Key Lab Nonferrous Met Chem & Resources Utilizat, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.
EM mzliu@lzu.edu.cn
FU National Natural Science Foundation of China [51273086]; Special
   Doctorial Program Fund from the Ministry of the Education of China
   [20090211110004]
FX The authors acknowledge gratefully the financial support of the National
   Natural Science Foundation of China (Grant No. 51273086) and the Special
   Doctorial Program Fund from the Ministry of the Education of China
   (Grant No. 20090211110004).
CR Antonietti M, 2002, PROG POLYM SCI, V27, P689, DOI 10.1016/S0079-6700(01)00051-X
   Assaad E, 2010, INT J PHARMACEUT, V394, P75, DOI 10.1016/j.ijpharm.2010.04.037
   Bajomo M, 2007, J PHYS CHEM B, V111, P8655, DOI 10.1021/jp070491a
   Chang D, 2012, CARBOHYD POLYM, V88, P663, DOI 10.1016/j.carbpol.2012.01.020
   Cury BSF, 2008, REACT FUNCT POLYM, V68, P1200, DOI 10.1016/j.reactfunctpolym.2008.04.003
   De Graaf RA, 2003, ADV POLYM TECH, V22, P56, DOI 10.1002/adv.10034
   Ding JX, 2011, POLYM CHEM-UK, V2, P2857, DOI 10.1039/c1py00360g
   Fan HL, 2010, POLYMER, V51, P5107, DOI 10.1016/j.polymer.2010.09.004
   Garcia-Gonzalez CA, 2012, CARBOHYD POLYM, V88, P1378, DOI 10.1016/j.carbpol.2012.02.023
   Han SC, 2009, J POLYM SCI POL CHEM, V47, P4074, DOI 10.1002/pola.23468
   Hirayama M, 2011, MOL PHARMACEUT, V8, P1083, DOI 10.1021/mp200088z
   Huang YJ, 2013, CARBOHYD POLYM, V96, P426, DOI 10.1016/j.carbpol.2013.04.013
   Huang YJ, 2012, EUR POLYM J, V48, P1734, DOI 10.1016/j.eurpolymj.2012.06.012
   Huttunen K.M., 2012, MOL PHARM, V10, P532
   Jain JP, 2010, BIOMACROMOLECULES, V11, P1027, DOI 10.1021/bm1000026
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Le Corre D, 2010, BIOMACROMOLECULES, V11, P1139, DOI 10.1021/bm901428y
   Lemieux M, 2009, INT J PHARMACEUT, V382, P172, DOI 10.1016/j.ijpharm.2009.08.030
   Li BZ, 2009, J FOOD ENG, V92, P250, DOI 10.1016/j.jfoodeng.2008.08.011
   Li YT, 2005, MACROMOLECULES, V38, P8155, DOI 10.1021/ma051121s
   Liang K, 2011, ADV MATER, V23, pH273, DOI 10.1002/adma.201101690
   Liu MQ, 2011, J CHROMATOGR A, V1218, P286, DOI 10.1016/j.chroma.2010.11.037
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Meng FH, 2009, BIOMATERIALS, V30, P2180, DOI 10.1016/j.biomaterials.2009.01.026
   Moad G, 2011, PROG POLYM SCI, V36, P218, DOI 10.1016/j.progpolymsci.2010.11.002
   Mura C, 2011, CARBOHYD POLYM, V85, P578, DOI 10.1016/j.carbpol.2011.03.017
   Na K, 2007, BIOCONJUGATE CHEM, V18, P1568, DOI 10.1021/bc070052e
   Oh JK, 2006, J AM CHEM SOC, V128, P5578, DOI 10.1021/ja060586a
   Onofre FO, 2010, INT J PHARMACEUT, V385, P104, DOI 10.1016/j.ijpharm.2009.10.038
   Pan YJ, 2013, POLYM CHEM-UK, V4, P3545, DOI 10.1039/c3py00249g
   Pan YJ, 2012, BIOMATERIALS, V33, P6570, DOI 10.1016/j.biomaterials.2012.05.062
   Shi AM, 2011, CARBOHYD POLYM, V83, P1604, DOI 10.1016/j.carbpol.2010.10.011
   Soares GA, 2013, CARBOHYD POLYM, V91, P135, DOI 10.1016/j.carbpol.2012.08.014
   Sun HL, 2009, BIOMATERIALS, V30, P6358, DOI 10.1016/j.biomaterials.2009.07.051
   Thiele C, 2011, POLYM CHEM-UK, V2, P209, DOI 10.1039/c0py00241k
   Thielemans W, 2006, LANGMUIR, V22, P4804, DOI 10.1021/la053394m
   Tian Z, 2008, POLYMER, V49, P446, DOI 10.1016/j.polymer.2007.11.048
   Tsarevsky NV, 2002, MACROMOLECULES, V35, P9009, DOI 10.1021/ma021061f
   Wang H, 2013, BIOMACROMOLECULES, V14, P3706, DOI 10.1021/bm401086d
   Wu Y, 2009, CARBOHYD POLYM, V76, P299, DOI 10.1016/j.carbpol.2008.10.031
   Wu YH, 2009, J MEMBRANE SCI, V344, P182, DOI 10.1016/j.memsci.2009.07.050
   Xu Y, 2010, CARBOHYD POLYM, V80, P1078, DOI 10.1016/j.carbpol.2010.01.027
   Yan LS, 2012, POLYM CHEM-UK, V3, P2403, DOI 10.1039/c2py20240a
   Yessine MA, 2006, EUR J PHARM BIOPHARM, V63, P1, DOI 10.1016/j.ejpb.2005.10.010
   YU H, 1994, MACROMOLECULES, V27, P4554, DOI 10.1021/ma00094a019
   Yu JH, 2011, SOFT MATTER, V7, P7386, DOI 10.1039/c1sm05426k
   Zhang AP, 2013, SOFT MATTER, V9, P2224, DOI 10.1039/c2sm27189c
   Zhang YR, 2009, CARBOHYD POLYM, V78, P157, DOI 10.1016/j.carbpol.2009.04.023
   Zhou HF, 2010, BIOMACROMOLECULES, V11, P3480, DOI 10.1021/bm100989x
NR 49
TC 23
Z9 24
U1 4
U2 59
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 1
PY 2014
VL 115
BP 368
EP 376
DI 10.1016/j.colsurfb.2013.12.007
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AG0JK
UT WOS:000335101600049
PM 24463097
DA 2018-10-20
ER

PT J
AU Mikhailova, I
   Sandomirsky, B
   Gorlenko, A
AF Mikhailova, Irina
   Sandomirsky, Boris
   Gorlenko, Anna
TI Effect of low temperatures and ionizing irradiation upon
   physical-mechanical properties and connective-tissue structures of
   porcine fibrous pericardium and aortic valve leaflets
SO PERIODICUM BIOLOGORUM
LA English
DT Article
DE fibrous pericardium; aortic valve leaflets; physical and mechanical
   properties; morphological structure; cell-free xenogeneic materials;
   freeze; ionizing irradiation; devitalization
ID GAMMA-IRRADIATION; VASCULAR GRAFTS; COLLAGEN; MATRIX; CRYOPRESERVATION;
   CROSSLINKING; BIOMATERIALS; REACTIVITY
AB Xenogeneic tissue devitalization is one of the creating methods of the tissue-replacing the biocompatible cell-free shells for the regenerative surgery. The work describes the possibility of applying the complex approach based on the continuous usage of cryo and radioactive (electron irradiation exposure) biological tissue damage effects. The pre-implant treatment provides sterilization and a possibility for the low temperature preservation of xenografts. After the transplantation such a cell-free xenoscaffold can be gradually replaced with the autogenic extracellular matrix from the recipient's cells and forms a stable long-term structure of the biological prosthesis.
   Fibrous pericardium (FP) and aortic valve leaflets (AVLs) were extracted from the mature pig. The prepared tissues were rinsed with the sterile normal saline solution and frozen down to the liquid-nitrogen temperature. After one time placing on water-bath (37 degrees C) they were exposed to electron irradiation within dosage range of 25-30 kGray and submerged into the liquid nitrogen vapors. After influence of low temperature and ionizing radiation, tissue morphological structure was assessed using the optical microscopy. Deformations, i.e. longitudinal and transverse monoaxial strength were performed to calculate the physical and mechanical properties of FP and AVLs.
   Such a devitalization method of the FP and AVLs causes significant destructive changes in cell elements, however the spatial arrangement and structural integrity of the connective tissue fiber are preserved. Joint impact of low temperatures and ionizing radiation gives the synergetic effect, increasing the strength and elastic tissue properties. Freezing down to -196 degrees C and electron irradiation initiate formation of the intra- and intermolecular transverse cross-linking due to the binding activity of fibrous proteins. It leads to a more dense arrangement of the collagen fiber, adds strength to the implant and provides the structural tissue stabilization. The authors believe that during the remodeling in the recipient organism, the biomaterial structure modified in such a manner can successfully prevent physiological tension.
C1 [Mikhailova, Irina; Sandomirsky, Boris; Gorlenko, Anna] Natl Acad Sci Ukraine, Inst Problems Cryobiol & Cryomed, Dept Expt Cryomed, UA-61015 Kharkov, Ukraine.
RP Gorlenko, A (reprint author), Dept Expt Cryomed, Klochkovskaya St 105a,23, UA-61145 Kharkov, Ukraine.
EM anna.gorlenko@gmail.com
OI Sandomirsky, Boris/0000-0002-2440-1971
CR BAILEY AJ, 1964, RADIAT RES, V22, P606, DOI 10.2307/3571543
   Borschel GH, 2005, TISSUE ENG, V11, P778, DOI 10.1089/ten.2005.11.778
   BYSOV D V, 2011, VESTNIK TRANSPLANTOL, V12, P81
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   CUI D., 2011, WOLKERS KL, V1, P56
   CUI X, 2002, CELL PRESERV TECHNOL, V1, P121
   GIBERT T, 2006, BIOMATERIALS, V27, P3675
   GRANT RA, 1970, J CELL SCI, V7, P387
   GRANT RA, 1973, J ANAT, V115, P29
   GRASSL E D, 2004, ASME HEAT TRANSFER D, V375, P699
   Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   GRODZINSKY A J, 1987, ADV MICROCIRCULAT, V13, P35
   GRODZINSKY AJ, 1983, CRIT REV BIOMED ENG, V9, P133
   HENNER WD, 1983, J BIOL CHEM, V258, P711
   IMPARATO FM, 1992, MODERN VASCULAR SURG, V5, P26
   ITKIN U, 1981, ACTUAL PROBLEMS CRYO, P606
   LUYET B, 1968, CRYOBIOLOGY, V4, P247
   Muratov R, 2010, INTERACT CARDIOV TH, V10, P408, DOI 10.1510/icvts.2009.216549
   Ota T, 2007, ANN THORAC SURG, V83, P1501, DOI 10.1016/j.athoracsur.2006.11.083
   Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77
   RAYMOND ZEEMAN, 1998, THESIS U TWENTE ENSC
   ROSS M H, 2011, WOLKERS KL, V6, P158
   Roy S., 2005, AM J PHYSIOL-HEART C, V289, P1567
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Seto A, 2009, CLIN ORTHOP RELAT R, V467, P2994, DOI 10.1007/s11999-009-0934-3
   SOLANESA N, 2004, TRANSPL P, V1, P3288
   SPIRIDONOV S V, 2013, NOVOSTI KHIRURGII, V21, P76
   Sung HW, 1999, J BIOMED MATER RES, V47, P116, DOI 10.1002/(SICI)1097-4636(199911)47:2<116::AID-JBM2>3.0.CO;2-J
   Thakrar RR, 2006, FASEB J, V20, P874, DOI 10.1096/fj.05-5304com
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Vasin SL, 1998, J BIOMED MATER RES, V39, P491, DOI 10.1002/(SICI)1097-4636(19980305)39:3<491::AID-JBM21>3.3.CO;2-Z
   Venkatasubramanian RT, 2006, ANN BIOMED ENG, V34, P823, DOI 10.1007/s10439-005-9044-x
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052
   YARMONENKO S P, 2004, RADIOBIOLOGIYA CHELO, P549
   Zhu CH, 2008, BIOMATERIALS, V29, P2628, DOI 10.1016/j.biomaterials.2008.03.005
NR 38
TC 1
Z9 1
U1 0
U2 4
PU PERIODICUM BIOLOGORUM
PI ZAGREB
PA HRVATSKO PRIRODOSLOVNO DRUSTVO ILICA 16/111, 41000 ZAGREB, CROATIA
SN 0031-5362
J9 PERIOD BIOL
JI Period. Biol.
PD MAR
PY 2014
VL 116
IS 1
BP 105
EP 114
PG 10
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA AG1VL
UT WOS:000335204200019
DA 2018-10-20
ER

PT J
AU Higuchi, A
   Lin, FL
   Cheng, YK
   Kao, TC
   Kumar, SS
   Ling, QD
   Hou, CH
   Chen, DC
   Hsu, ST
   Wu, GJ
AF Higuchi, Akon
   Lin, Feng-Ling
   Cheng, Yu-Kai
   Kao, Ta-Chun
   Kumar, S. Suresh
   Ling, Qing-Dong
   Hou, Chun-Han
   Chen, Da-Chung
   Hsu, Shih-Tien
   Wu, Gwo-Jang
TI Preparation of induced pluripotent stem cells on dishes grafted on
   oligopeptide under feeder-free conditions
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article
DE Induced pluripotent stem cell; Feeder-free culture; Adipose-derived stem
   cell; Vitronectin; Oligopeptide; Biomaterial
ID ADIPOSE-DERIVED CELLS; SYNTHETIC-POLYMER COATINGS; XENO-FREE CONDITIONS;
   TERM SELF-RENEWAL; DIFFERENTIATION ABILITY; EXTRACELLULAR MATRICES;
   MEMBRANE FILTRATION; HUMAN FIBROBLASTS; HUMAN BLASTOCYSTS;
   TEMPORAL-CHANGES
AB Human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) have potentially therapeutic applications in the treatment of many diseases, due to their unique ability to differentiate into any type of somatic cell. However, the clinical potential of hESCs and hiPSCs is restricted by the use of mouse embryonic fibroblasts (MEFs) as a feeder layer for these cells. We report that hiPSCs can be successfully generated without the use of a feeder layer of MEFs. We generated hiPSCs by transducing human adipose-derived stem cells (hADSCs) with a retrovirus containing pluripotency genes, and the hiPSCs were cultured on synthetic dishes grafted with an oligopeptide derived from vitronectin (VN-dish). On the fourth day after transduction, the hADSCs transduced with pluripotency genes were transferred to a MEF layer for culturing as a control condition or to VN-dishes for culture. The hiPSC colonies in the MEF-cultures were clearly observed at day 14 after transduction, whereas hiPSC colonies were detected on the VN-dishes after the cells were passaged. When 105 hADSCs were seeded on the dishes, the number of colonies generated on the MEFs was 120 28, while the number of colonies generated on VN-dishes was 25 +/- 8. Thus, the efficiency of hiPSC generation on the VN-dishes under feeder-free conditions was lower than hiPSCs cultured on MEFs. However, the hiPSC colonies from VN-dishes demonstrated alkaline phosphatase activity, and immunohistochemistry suggested that the hiPSCs generated on VN-dishes expressed the pluripotency protein, stage-specific embryonic antigen-4 (SSEA-4), under feeder-free conditions. (C) 2013 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Higuchi, Akon; Cheng, Yu-Kai; Kao, Ta-Chun; Kumar, S. Suresh] Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan 32001, Taiwan.
   [Higuchi, Akon] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo 1578535, Japan.
   [Higuchi, Akon; Ling, Qing-Dong] Cathay Gen Hosp, Cathay Med Res Inst, Taipei 10630, Taiwan.
   [Lin, Feng-Ling] Cathay Gen Hosp, Dept Dermatol, Sijhih Branch, Taipei 22174, Taiwan.
   [Kumar, S. Suresh] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Slangor, Malaysia.
   [Ling, Qing-Dong] Natl Cent Univ, Inst Syst Biol & Bioinformat, Taoyuan 32001, Taiwan.
   [Hou, Chun-Han] Natl Taiwan Univ, Sch Med, Dept Orthoped Surg, Taipei 10051, Taiwan.
   [Chen, Da-Chung] Taiwan Landseed Hosp, Dept Obster & Gynecol, Taoyuan 32405, Taiwan.
   [Hsu, Shih-Tien] Taiwan Landseed Hosp, Dept Community Med, Taoyuan 32405, Taiwan.
   [Wu, Gwo-Jang] Tri Serv Gen Hosp, Natl Def Med Ctr, Grad Inst Med Sci, Taipei 11490, Taiwan.
   [Wu, Gwo-Jang] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Obstet & Gynecol, Taipei 11490, Taiwan.
RP Higuchi, A (reprint author), Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan 32001, Taiwan.
EM higuchi@ncu.edu.tw
OI Higuchi, Akon/0000-0003-2970-8531; Kumar S, Suresh/0000-0002-0505-7554;
   Hou, Chun-han/0000-0002-3850-0997
CR Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Higuchi A, 2012, CHEM REV, V112, P4507, DOI 10.1021/cr3000169
   Higuchi A, 2011, CURR NANOSCI, V7, P893, DOI 10.2174/157341311798220592
   Higuchi A, 2011, CHEM REV, V111, P3021, DOI 10.1021/cr1003612
   Higuchi A, 2011, J MEMBRANE SCI, V366, P286, DOI 10.1016/j.memsci.2010.10.009
   Holden C, 2009, SCIENCE, V326, P358, DOI 10.1126/science.326_358
   Hongisto H, 2012, STEM CELL RES, V8, P97, DOI 10.1016/j.scr.2011.08.005
   Hoshiba T, 2010, ADV MATER, V22, P3042, DOI 10.1002/adma.201000038
   Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532
   Liu HY, 2012, BIOMATERIALS, V33, P6105, DOI 10.1016/j.biomaterials.2012.05.024
   Liu Y, 2011, BIOMATERIALS, V32, P8058, DOI 10.1016/j.biomaterials.2011.07.052
   Lu HE, 2011, EXP CELL RES, V317, P1895, DOI 10.1016/j.yexcr.2011.05.017
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235
   Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629
   Meng GL, 2012, STEM CELLS DEV, V21, P2036, DOI 10.1089/scd.2011.0489
   Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234
   Nandivada H, 2011, NAT PROTOC, V6, P1037, DOI 10.1038/nprot.2011.342
   Noguchi H, 2010, CURR DIABETES REV, V6, P184, DOI 10.2174/157339910791162934
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Park IS, 2009, BIOMATERIALS, V30, P6835, DOI 10.1016/j.biomaterials.2009.08.057
   Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399
   Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620
   Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248
   Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106
   Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tsai WB, 2013, J TAIWAN INST CHEM E, V44, P1, DOI 10.1016/j.jtice.2012.09.003
   Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084
   Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631
   Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974
   Wu CH, 2012, BIOMATERIALS, V33, P8228, DOI 10.1016/j.biomaterials.2012.08.027
   Yang YI, 2011, ACTA BIOMATER, V7, P4109, DOI 10.1016/j.actbio.2011.07.027
   Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482
   Zou CL, 2012, STEM CELLS DEV, V21, P2298, DOI 10.1089/scd.2011.0688
NR 36
TC 7
Z9 7
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
EI 1876-1089
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD MAR
PY 2014
VL 45
IS 2
BP 295
EP 301
DI 10.1016/j.jtice.2013.06.022
PG 7
WC Engineering, Chemical
SC Engineering
GA AE5GB
UT WOS:000334014700001
DA 2018-10-20
ER

PT J
AU Lee, SJ
   Yoo, JJ
   Atala, A
AF Lee, Sang Jin
   Yoo, James J.
   Atala, Anthony
TI Recent Applications of Polymeric Biomaterials and Stem Cells in Tissue
   Engineering and Regenerative Medicine
SO POLYMER-KOREA
LA English
DT Review
DE biomaterials; polymers; extracellular matrix; stem cells; tissue
   engineering; regenerative medicine
ID SKELETAL-MUSCLE TISSUE; NEUROMUSCULAR-JUNCTION FORMATION; IN-VITRO
   EVALUATION; COLLAGEN MATRIX; BLOOD-VESSELS; EXTRACELLULAR-MATRIX; BONE
   REGENERATION; AURICULAR RECONSTRUCTION; URETHRAL RECONSTRUCTION;
   SYNTHETIC BIOMATERIALS
AB Tissue engineering and regenerative medicine strategies could offer new hope for patients with serious tissue injuries or end-stage organ failure. Scientists are now applying the principles of cell transplantation, material science, and engineering to create biological substitutes that can restore and maintain normal function in diseased or injured tissues/organs. Specifically, creation of engineered tissue construct requires a polymeric biomaterial scaffold that serves as a cell carrier, which would provide structural support until native tissue forms in vivo. Even though the requirements for scaffolds may be different depending on the target applications, a general function of scaffolds that need to be fulfilled is biodegradability, biological and mechanical properties, and temporal structural integrity. The scaffold's internal architecture should also enhance the permeability of nutrients and neovascularization. In addition, the stem cell field is advancing, and new discoveries in tissue engineering and regenerative medicine will lead to new therapeutic strategies. Although use of stem cells is still in the research phase, some therapies arising from tissue engineering endeavors that make use of autologous adult cells have already entered the clinic. This review discusses these tissue engineering and regenerative medicine strategies for various tissues and organs.
C1 [Lee, Sang Jin; Yoo, James J.; Atala, Anthony] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Lee, SJ (reprint author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM sjlee@wakehealth.edu
RI Yoo, James/L-4850-2017
CR AEBISCHER P, 1987, LIFE SUPPORT SYST, V5, P159
   Amiel GE, 2000, WORLD J UROL, V18, P71, DOI 10.1007/s003450050013
   Amiel GE, 2006, TISSUE ENG, V12, P2355, DOI 10.1089/ten.2006.12.2355
   Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583
   Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2004, REJUV RES, V7, P15, DOI 10.1089/154916804323105053
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890
   Atala A, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.05.038
   Atala A, 2009, CURR OPIN BIOTECH, V20, P575, DOI 10.1016/j.copbio.2009.10.003
   Atala A, 2009, UROL CLIN N AM, V36, P199, DOI 10.1016/j.ucl.2009.02.009
   Auchincloss H, 2002, NAT BIOTECHNOL, V20, P665, DOI 10.1038/nbt0702-665
   Bach AD, 2004, J CELL MOL MED, V8, P413, DOI 10.1111/j.1582-4934.2004.tb00466.x
   Bach AD, 2003, CELL TISSUE RES, V314, P263, DOI 10.1007/s00441-003-0757-6
   Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337
   BAZEED MA, 1983, UROLOGY, V21, P53, DOI 10.1016/0090-4295(83)90123-1
   Beck DE, 2003, DIS COLON RECTUM, V46, P1310, DOI 10.1097/01.DCR.0000089117.62296.E4
   Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   Bian WN, 2012, FASEB J, V26, P955, DOI 10.1096/fj.11-187575
   BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2
   Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019
   Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940
   Bujan J, 2004, BIOTECHNOL APPL BIOC, V39, P17, DOI 10.1042/BA20030111
   Cao Baohong, 2005, Phys Med Rehabil Clin N Am, V16, P889, DOI 10.1016/j.pmr.2005.08.020
   Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc
   Cesar M, 2008, MUSCLE NERVE, V37, P219, DOI 10.1002/mus.20918
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Cheung C, 2011, J MOL CELL CARDIOL, V51, P651, DOI 10.1016/j.yjmcc.2011.07.014
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   CILENTO BG, 1994, J UROLOGY, V152, P665, DOI 10.1016/S0022-5347(17)32676-9
   Cossu G, 2005, SEMIN CELL DEV BIOL, V16, P623, DOI 10.1016/j.semcdb.2005.07.003
   Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004
   De Coppi P, 2005, TISSUE ENG, V11, P1034, DOI 10.1089/ten.2005.11.1034
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1097/01.ju.0000027662.69103.72
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   DeRosimo JF, 2000, CELL TRANSPLANT, V9, P369, DOI 10.1177/096368970000900308
   DEUEL TF, 1987, ANNU REV CELL BIOL, V3, P443, DOI 10.1146/annurev.cb.03.110187.002303
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   DiEdwardo CA, 1999, CLIN PLAST SURG, V26, P647
   Drilling S, 2009, J BIOMED MATER RES A, V88A, P923, DOI 10.1002/jbm.a.31926
   Eberli D, 2007, INT J IMPOT RES, V19, P602, DOI 10.1038/sj.ijir.3901587
   Eberli D., 2010, J MATER SCI-MATER M, V22, P741
   Edelman ER, 1999, CIRC RES, V85, P1115
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0
   Gong ZD, 2006, TRENDS CARDIOVAS MED, V16, P153, DOI 10.1016/j.tcm.2006.02.006
   Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hoffman AS, 2000, J BIOMED MATER RES, V52, P577, DOI 10.1002/1097-4636(20001215)52:4<577::AID-JBM1>3.3.CO;2-X
   Humes HD, 1999, NAT BIOTECHNOL, V17, P451, DOI 10.1038/8626
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776
   Joki T, 2001, NAT BIOTECHNOL, V19, P35
   Jones Peter Lloyd, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P137
   Joo S, 2012, ARCH PHARM RES, V35, P271, DOI 10.1007/s12272-012-0207-7
   Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043
   Ju YM, 2010, BIOMATERIALS, V31, P4313, DOI 10.1016/j.biomaterials.2010.02.002
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI200112131
   Kemper F, 2005, CURR MED RES OPIN, V21, P1261, DOI 10.1185/030079905X56501
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim BS, 2008, WORLD J UROL, V26, P307, DOI 10.1007/s00345-008-0300-1
   Kingham PJ, 2006, J ANAT, V209, P511, DOI 10.1111/j.1469-7580.2006.00623.x
   Ko IK, 2013, BIOMATERIALS, V34, P3246, DOI 10.1016/j.biomaterials.2013.01.029
   Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190
   Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lanza RP, 1996, NAT BIOTECHNOL, V14, P1107, DOI 10.1038/nbt0996-1107
   Lanza RP, 2002, NAT BIOTECHNOL, V20, P689, DOI 10.1038/nbt703
   Le Roux PJ, 2005, J UROLOGY, V173, P140, DOI 10.1097/01.ju.0000146554.79487.7f
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee SJ, 2008, REJUV RES, V11, P747, DOI 10.1089/rej.2008.0691
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Lee SJ, 2011, BIOMACROMOLECULES, V12, P306, DOI 10.1021/bm100856g
   Lee SJ, 2006, BIOMATERIALS, V27, P3466, DOI 10.1016/j.biomaterials.2006.01.059
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999
   Lie KH, 2012, PANCREAS, V41, P54, DOI 10.1097/MPA.0b013e31822362e4
   Liebert M, 1997, DIFFERENTIATION, V61, P177, DOI 10.1046/j.1432-0436.1997.6130177.x
   Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008
   Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902
   Luo XS, 2012, J CRANIOFAC SURG, V23, P654, DOI 10.1097/SCS.0b013e31824db808
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Moorefield EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026535
   Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512
   Murray MM, 2003, J ORTHOPAED RES, V21, P238, DOI 10.1016/S0736-0266(02)00142-0
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   OLSEN L, 1992, SCAND J UROL NEPHROL, V26, P323, DOI 10.3109/00365599209181220
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   Patino Maria G, 2002, J Oral Implantol, V28, P220, DOI 10.1563/1548-1336(2002)028<0220:CAAIMI>2.3.CO;2
   Payumo FC, 2002, CLIN ORTHOP RELAT R, pS228, DOI 10.1097/01.blo.0000031992.92980.6f
   Powell CA, 2002, AM J PHYSIOL-CELL PH, V283, pC1557, DOI 10.1152/ajpcell.00595.2001
   Puthenveettil JA, 1999, ADV EXP MED BIOL, V462, P83
   Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9
   Reid L, 1981, Ann N Y Acad Sci, V372, P354, DOI 10.1111/j.1749-6632.1981.tb15488.x
   Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134
   Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726
   Rodrigues MT, 2012, TISSUE ENG PT A, V18, P2518, DOI 10.1089/ten.tea.2011.0672
   Rodrigues MT, 2012, BIOMATERIALS, V33, P6069, DOI 10.1016/j.biomaterials.2012.05.016
   Rodrigues MT, 2012, ACTA BIOMATER, V8, P2795, DOI 10.1016/j.actbio.2012.04.013
   ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   Schuch G, 2002, BLOOD, V100, P4622, DOI 10.1182/blood.V100.13.4622
   Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Sevin K, 2000, BRIT J ORAL MAX SURG, V38, P44, DOI 10.1054/bjom.1998.0038
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Siegert R, 2009, FACIAL PLAST SURG, V25, P169, DOI 10.1055/s-0029-1239449
   Siegert R, 2009, FACIAL PLAST SURG, V25, P149, DOI 10.1055/s-0029-1239451
   Sievert KD, 2000, J UROLOGY, V163, P1958, DOI 10.1016/S0022-5347(05)67610-0
   Solomon LZ, 1998, J LAB CLIN MED, V132, P279, DOI 10.1016/S0022-2143(98)90040-3
   Spicer Andrew P, 2004, Birth Defects Res C Embryo Today, V72, P89, DOI 10.1002/bdrc.20006
   Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069
   Sterodimas A, 2009, J PLAST RECONSTR AES, V62, P447, DOI 10.1016/j.bjps.2008.11.046
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Sullivan DC, 2012, BIOMATERIALS, V33, P7756, DOI 10.1016/j.biomaterials.2012.07.023
   Suutarla S, 2009, FACIAL PLAST SURG, V25, P164, DOI 10.1055/s-0029-1239445
   Swain Timothy W 3rd, 2004, Vasc Endovascular Surg, V38, P75, DOI 10.1177/153857440403800110
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   TANZER R C, 1959, Plast Reconstr Surg Transplant Bull, V23, P1
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   Waddell David D, 2006, J Surg Orthop Adv, V15, P53
   Waddell David D, 2006, J Knee Surg, V19, P19
   WAKELAM MJO, 1985, BIOCHEM J, V228, P1
   Wernig A., 2000, J PHYSL, V522, P233
   Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944
   Wilkes GH, 2009, FACIAL PLAST SURG, V25, P158, DOI 10.1055/s-0029-1239452
   Williams JD, 1997, ARCH OTOLARYNGOL, V123, P578
   Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711
   Yamada A, 2007, BURNS, V33, P112, DOI 10.1016/j.burns.2006.04.011
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zaidi N, 2007, ANN NY ACAD SCI, V1117, P62, DOI 10.1196/annals.1402.074
   Zhang QG, 2010, ANN PLAS SURG, V64, P428, DOI 10.1097/SAP.0b013e3181b0bb7e
   Zhao WX, 2013, BIOMATERIALS, V34, P8235, DOI 10.1016/j.biomaterials.2013.07.057
   Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2
NR 165
TC 5
Z9 5
U1 4
U2 57
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 0379-153X
J9 POLYM-KOREA
JI Polym.-Korea
PD MAR
PY 2014
VL 38
IS 2
BP 113
EP 128
DI 10.7317/pk.2014.38.2.113
PG 16
WC Polymer Science
SC Polymer Science
GA AE5GE
UT WOS:000334015000001
OA Bronze
DA 2018-10-20
ER

PT J
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
TI Finite element simulation and experimental validation of residual
   stresses in high speed dry milling of biodegradable magnesium-calcium
   alloys
SO INTERNATIONAL JOURNAL OF MECHANICAL SCIENCES
LA English
DT Article
DE Residual stress; Magnesium; Biomaterial; Finite element simulation; High
   speed machining; Dry cutting
ID MACHINED LAYER; SURFACE; MODEL; TOOL; TEMPERATURE; GEOMETRY; STEEL
AB Magnesium-calcium (Mg-Ca) alloys have become attractive biodegradable orthopedic biomaterials recently. Residual stresses are proven to be very influential on the degradation rate of an Mg-Ca implant in the human body. Due to the time and cost reasons, development of finite element models to predict residual stress profiles in cutting of Mg-Ca implants is highly desirable. In this study, a finite element simulation model of orthogonal cutting without explicit chip formation has been developed by using the plowing depth approach in order to predict process-induced residual stresses in high speed dry cutting of Mg-Ca0.8 (wt%) alloy using diamond tools. Mechanical properties of Mg-Ca0.8 biomaterial at high strain rates and large strains were determined using the split-Hopkinson pressure bar test. The internal state variable (ISV) plasticity model has been implemented to model the dynamic material behavior under cutting regimes. The residual stress evolution and effects of plowing speed and plowing depth on residual stress profiles are studied. Residual stress measurements were also performed utilizing the X-ray diffraction technique for validation purposes. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
FU National Science Foundation [CMMI-1000706]
FX The authors would like to thank National Science Foundation for
   supporting this study under Grant No. CMMI-1000706.
CR Bach F. W., 2007, P 7 INT C MG ALL THE, P1076
   Bammann D. J., 1996, THEORETICAL APPL MEC, P359
   Bammann DJ, 1993, STRUCTURAL CRASHWORT, P1
   Brinksmeier E., 1982, ANN CIRP, V31, P491, DOI DOI 10.1016/S0007-8506(07)60172-3
   Caruso S, 2010, INT J MATER FORM, V3, P515, DOI 10.1007/s12289-010-0820-2
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Ee KC, 2005, INT J MECH SCI, V47, P1611, DOI [10.1016/j.ijmecsci.2005.06.001, 10.1016/j.ijmensci.2005.06.001]
   Fang FZ, 2007, J MATER PROCESS TECH, V184, P407, DOI 10.1016/j.jmatprotec.2006.12.007
   Grzesik W, 2003, INT J MACH TOOL MANU, V43, P1311, DOI 10.1016/S0890-6955(03)00160-3
   Guo YB, 2009, CIRP ANN-MANUF TECHN, V58, P81, DOI 10.1016/j.cirp.2009.03.110
   Guo YB, 2005, TRANS N AMER MANUFAC, V33, P469
   Jacobus K, 2001, J MANUF SCI E-T ASME, V123, P537, DOI 10.1115/1.1372197
   Jacobus K, 2000, J MANUF SCI E-T ASME, V122, P20, DOI 10.1115/1.538906
   Jawahir IS, 2011, CIRP ANN-MANUF TECHN, V60, P603, DOI 10.1016/j.cirp.2011.05.002
   Liu CR, 2000, INT J MECH SCI, V42, P1069, DOI 10.1016/S0020-7403(99)00042-9
   Ozel T, 2007, INT J ADV MANUF TECH, V35, P255, DOI 10.1007/s00170-006-0720-2
   Outeiro JC, 2008, CIRP ANN-MANUF TECHN, V57, P77, DOI 10.1016/j.cirp.2008.03.076
   Outeiro JC, 2006, INT J MACH TOOL MANU, V46, P1786, DOI 10.1016/j.ijmachtools.2005.11.013
   Palmer W. B., 1963, P 4 INT MACH TOOL DE, P61
   Salahshoor M, 2011, INT J MACH TOOL MANU, V51, P579, DOI 10.1016/j.ijmachtools.2011.04.004
   Sasahara H, 2004, INT J MACH TOOL MANU, V44, P815, DOI 10.1016/j.ijmachtools.2004.01.002
   Sasahara H, 1996, J MATER PROCESS TECH, V62, P448, DOI 10.1016/S0924-0136(96)02451-X
   Schulze V, 2010, CIRP ANN-MANUF TECHN, V59, P117, DOI 10.1016/j.cirp.2010.03.064
   Spear H. E., 1994, SYNTHETIC DIAMOND EM
   STRENKOWSKI JS, 1985, J ENG IND-T ASME, V107, P349, DOI 10.1115/1.3186008
   Ulutan D, 2011, INT J MACH TOOL MANU, V51, P250, DOI 10.1016/j.ijmachtools.2010.11.003
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   Zong WJ, 2007, INT J ADV MANUF TECH, V32, P666, DOI 10.1007/s00170-005-0388-z
NR 28
TC 10
Z9 10
U1 4
U2 34
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7403
EI 1879-2162
J9 INT J MECH SCI
JI Int. J. Mech. Sci.
PD MAR
PY 2014
VL 80
BP 153
EP 159
DI 10.1016/j.ijmecsci.2014.01.010
PG 7
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA AE3CI
UT WOS:000333854200014
DA 2018-10-20
ER

PT J
AU Guarnieri, R
   Serra, M
   Bava, L
   Grande, M
   Farronato, D
   Iorio-Siciliano, V
AF Guarnieri, Renzo
   Serra, Mario
   Bava, Luca
   Grande, Maurizio
   Farronato, Davide
   Iorio-Siciliano, Vincenzo
TI The Impact of a Laser-Microtextured Collar on Crestal Bone Level and
   Clinical Parameters Under Various Placement and Loading Protocols
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE delayed loading; delayed placement; immediate nonocclusal loading;
   immediate placement; laser microtexturing
ID SINGLE-TOOTH IMPLANTS; DEFINED BIOMATERIAL SURFACES; CONNECTIVE-TISSUE
   ATTACHMENT; FRESH EXTRACTION SITES; ETCHED SLA SURFACE; FOLLOW-UP
   REPORT; DENTAL IMPLANTS; TITANIUM IMPLANTS; HISTOLOGIC EVIDENCE;
   PERIIMPLANT MUCOSA
AB Purpose: Physical attachment of connective tissue fibers to a laser-microtextured (8- and 12-mu m grooves) surface on the collar of an implant has been demonstrated using human histology. Related clinical research has suggested that this microtextured surface may help to decrease initial bone loss after implant placement. The aim of this retrospective study was to compare crestal bone heights and clinical parameters between implants with laser-microtextured and machined collars placed and loaded with different protocols. Materials and Methods: This study evaluated 300 single implants in 300 patients (155 men, 145 women; mean age: 49.3 years; range: 45 to 75 years). One hundred sixty implants with laser-microtextured collars (L) and 140 with machined collars (M) were used. Implants were grouped into the treatment categories of immediate placement, delayed placement, immediate nonocclusal loading, and delayed loading. For all groups, crestal bone level, attachment level (CAL), Plaque Index, and bleeding on probing were recorded at baseline and 6, 12, and 24 months after loading with the definitive restoration. Results: Nine implants were lost (four L and five M). The type of implant and timing of placement and loading showed no significant influence on survival rates. A mean CAL loss of 1.12 mm was observed during the first 2 years in the M group, while the mean CAL loss observed in the L group was 0.55 mm. Radiographically, L group implants showed a mean crestal bone loss of 0.58 mm, compared to 1.09 mm for the M group. Conclusion: A laser-microtextured surface on the implant collar may mitigate the negative sequelae associated with peri-implant bone loss, regardless of the placement and loading protocols used.
C1 [Guarnieri, Renzo] SCS Sci Consulting Serv, I-00144 Rome, Italy.
   [Farronato, Davide] Insubria Univ, Dept Biomat Sci, Varese, Italy.
   [Iorio-Siciliano, Vincenzo] Univ Naples Federico II, Dept Periodontol, Naples, Italy.
RP Guarnieri, R (reprint author), SCS Sci Consulting Serv, Via Paolo Emilio 7-5, I-00144 Rome, Italy.
EM renzoguarnieri@gmail.com
OI Farronato, Davide/0000-0003-0328-470X
CR Abt Elliot, 2008, Evid Based Dent, V9, P51, DOI 10.1038/sj.ebd.6400584
   Alexander H, 2007, J BIOMED MATER RES B, V23, P200
   Andersen E, 2002, CLIN ORAL IMPLAN RES, V13, P281, DOI 10.1034/j.1600-0501.2002.130307.x
   Bader Jim, 2008, J Evid Based Dent Pract, V8, P232, DOI 10.1016/j.jebdp.2008.09.011
   BARZILAY I, 1991, International Journal of Oral and Maxillofacial Implants, V6, P277
   Berglundh T, 1996, J CLIN PERIODONTOL, V23, P971, DOI 10.1111/j.1600-051X.1996.tb00520.x
   Bornstein MM, 2003, INT J ORAL MAX IMPL, V18, P659
   Botos S, 2011, INT J ORAL MAX IMPL, V26, P492
   Branemark P I, 1999, Clin Implant Dent Relat Res, V1, P2, DOI 10.1111/j.1708-8208.1999.tb00086.x
   Calandriello Roberto, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P74, DOI 10.1111/j.1708-8208.2003.tb00018.x
   Chaushu G, 2001, INT J ORAL MAX IMPL, V16, P267
   Chen ST, 2004, INT J ORAL MAX IMPL, V19, P12
   Cochran DL, 2002, CLIN ORAL IMPLAN RES, V13, P144, DOI 10.1034/j.1600-0501.2002.130204.x
   Covani U, 2004, J PERIODONTOL, V75, P982, DOI 10.1902/jop.2004.75.7.982
   Degidi M, 2008, CLIN ORAL IMPLAN RES, V19, P276, DOI 10.1111/j.1600-0501.2007.01449.x
   Ellingsen JE, 1998, PERIODONTOL 2000, V17, P36, DOI 10.1111/j.1600-0757.1998.tb00121.x
   Ericsson I, 2000, CLIN ORAL IMPLAN RES, V11, P26, DOI 10.1034/j.1600-0501.2000.011001026.x
   Esposito M, 2007, INT J ORAL MAX IMPL, V22, P893
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Hamilton DW, 2007, BIOMATERIALS, V28, P2281, DOI 10.1016/j.biomaterials.2007.01.026
   Hermann F, 2007, IMPLANT DENT, V16, P165, DOI 10.1097/ID.0b013e318065aa81
   Hermann JS, 1997, J PERIODONTOL, V68, P1117, DOI 10.1902/jop.1997.68.11.1117
   Hermann JS, 2001, INT J ORAL MAX IMPL, V16, P475
   Hermann JS, 2000, CLIN ORAL IMPLAN RES, V11, P1, DOI 10.1034/j.1600-0501.2000.011001001.x
   Hui E, 2001, Clin Implant Dent Relat Res, V3, P79, DOI 10.1111/j.1708-8208.2001.tb00235.x
   Jung RE, 2008, CLIN ORAL IMPLAN RES, V19, P119, DOI 10.1111/j.1600-0501.2007.01453.x
   Lazzara R J, 1989, Int J Periodontics Restorative Dent, V9, P332
   Listgarten MA, 1991, CLIN ORAL IMPLAN RES, V2, P1, DOI 10.1034/j.1600-0501.1991.020101.x
   Lorenzoni M, 2003, CLIN ORAL IMPLAN RES, V14, P180, DOI 10.1034/j.1600-0501.2003.140207.x
   Luongo G, 2005, INT J ORAL MAX IMPL, V20, P84
   Maeda Y, 2007, CLIN ORAL IMPLAN RES, V18, P581, DOI 10.1111/j.1600-0501.2007.01398.x
   Malo P, 2000, Clin Implant Dent Relat Res, V2, P138, DOI 10.1111/j.1708-8208.2000.tb00004.x
   Malo Paulo, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P37, DOI 10.1111/j.1708-8208.2003.tb00014.x
   Nevins M, 2008, INT J PERIODONT REST, V28, P111
   Nevins M, 2010, INT J PERIODONT REST, V30, P245
   Nikellis I, 2004, INT J ORAL MAX IMPL, V19, P116
   PAREL S M, 1990, International Journal of Oral and Maxillofacial Implants, V5, P337
   Pecora GE, 2009, IMPLANT DENT, V18, P57, DOI 10.1097/ID.0b013e31818c5a6d
   Quinlan P, 2005, INT J ORAL MAX IMPL, V20, P360
   QUIRYNEN M, 1992, J PROSTHET DENT, V68, P655, DOI 10.1016/0022-3913(92)90383-L
   Quirynen M, 2007, INT J ORAL MAX IMPL, V22, P203
   Ricci J, 2000, BONE ENG, P282
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   RICHTER EJ, 1989, J PROSTHET DENT, V61, P602, DOI 10.1016/0022-3913(89)90285-0
   Rocci Antonio, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P29, DOI 10.1111/j.1708-8208.2003.tb00013.x
   Roccuzzo M, 2001, CLIN ORAL IMPLAN RES, V12, P572, DOI 10.1034/j.1600-0501.2001.120604.x
   Schropp L, 2008, J ORAL REHABIL, V35, P33, DOI 10.1111/j.1365-2842.2007.01827.x
   Schropp L, 2005, J CLIN PERIODONTOL, V32, P480, DOI 10.1111/j.1600-051X.2005.00699.x
   Schropp L, 2003, INT J ORAL MAX IMPL, V18, P189
   Schulte W, 1978, Dtsch Zahnarztl Z, V33, P319
   Schupbach P, 2008, J PROSTHET DENT, V99, P167
   Schupbach P, 2007, J PROSTHET DENT, V97, pS15, DOI 10.1016/S0022-3913(07)60004-3
   SchwartzArad D, 1997, J PERIODONTOL, V68, P915, DOI 10.1902/jop.1997.68.10.915
   Schwarz F, 2007, CLIN ORAL IMPLAN RES, V18, P481, DOI 10.1111/j.1600-0501.2007.01341.x
   Shapoff CA, 2010, INT J PERIODONT REST, V30, P129
   Shin SY, 2010, CLIN ORAL IMPLAN RES, V21, P804, DOI 10.1111/j.1600-0501.2010.01917.x
   Tarnow DP, 1997, INT J ORAL MAX IMPL, V12, P319
   van Steenberghe D, 1990, Int J Oral Maxillofac Implants, V5, P272
   Weber HP, 2009, INT J ORAL MAX IMPL, V24, P180
   Weiner S, 2008, IMPLANT DENT, V17, P217, DOI 10.1097/ID.0b013e3181779016
   Werbitt M J, 1992, Int J Periodontics Restorative Dent, V12, P206
   Zafiropoulos GGK, 2010, J PERIODONTOL, V81, P604, DOI 10.1902/jop.2009.090316
NR 62
TC 17
Z9 17
U1 1
U2 3
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 2014
VL 29
IS 2
BP 354
EP 363
DI 10.11607/jomi.3250
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AE0MM
UT WOS:000333660400009
PM 24683561
OA Bronze
DA 2018-10-20
ER

PT J
AU Pezzotti, G
   Yamamoto, K
AF Pezzotti, Giuseppe
   Yamamoto, Kengo
TI Artificial hip joints: The biomaterials challenge
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Biomaterial; Artificial hip joint; Wear
ID POLYETHYLENE ACETABULAR LINER; IMPROVED FRACTURE-TOUGHNESS; CROSS-LINKED
   POLYETHYLENE; OXIDIZED ZIRCONIUM KNEE; THERMAL RESIDUAL-STRESS; CERAMIC
   FEMORAL HEADS; SILICON-NITRIDE; MICROSTRUCTURAL DESIGN; RESURFACING
   ARTHROPLASTY; FATIGUE RESISTANCE
AB What is new and what comes next in artificial hip joints? These are the crucial questions we attempt to answer after accurately surveying the state of the art in the field of hip arthroplasty, especially related to non-metallic materials. Summarizing the present situation, one could safely state that the current generation of hard-on-soft and hard-on-hard hip bearings has become quite effective in exhibiting extremely low degrees of wear when compared to traditional implants made of cobalt-chromium alloys coupled with conventional polyethylene materials or to the primitive alumina materials used in the past. Moreover, at a stage of more than 10 years in the clinical follow-up of new generations of hard-on-hard bearings, and more than 10 years follow-up for highly cross-linked polyethylene materials, we should soon be expecting a new set of officially compiled statistics that show significant reductions in failures due to particle-mediated osteolysis as compared to past statistical compilations. However, further important issues (other than wear) remain unsolved, including structural reliability of advanced ceramic and polyethylene components. Severe challenges yet stand in optimizing the biomaterials choice for significantly extended lifetimes and reduced failure risks. Moreover, joint healing trends are expected to evolve more radically in the next few decades. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Pezzotti, Giuseppe] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068585, Japan.
   [Yamamoto, Kengo] Tokyo Med Univ, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1600023, Japan.
RP Pezzotti, G (reprint author), Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068585, Japan.
EM pezzotti@kit.ac.jp; kengo-y@tkg.att.ne.jp
CR Akiniwa Y, 2000, MATER SCI RES INT, V6, P281
   [Anonymous], 2011, 8 NAT JOINT REG ENGL
   [Anonymous], 2008, ANN REP
   ANTONOV PI, 1981, J CRYST GROWTH, V52, P404, DOI 10.1016/0022-0248(81)90226-8
   Australian Orthopaedic Association National Joint Replacement Registry, 2011, ANN REPORT
   Bal BS, 2008, J BIOMED MATER RES B, V87B, P447, DOI 10.1002/jbm.b.31123
   Becher PF, 1998, J AM CERAM SOC, V81, P2821
   BECHER PF, 1991, J AM CERAM SOC, V74, P255, DOI 10.1111/j.1151-2916.1991.tb06872.x
   Beltran JI, 2003, J EUR CERAM SOC, V23, P2737, DOI 10.1016/S0955-2219(03)00284-X
   Bizot P, 2001, CLIN ORTHOP RELAT R, P85
   Blumenfeld TJ, 2011, J ARTHROPLASTY, V26, P5
   BOUTIN P, 1988, J BIOMED MATER RES, V22, P1203, DOI 10.1002/jbm.820221210
   Bracco P, 2011, CLIN ORTHOP RELAT R, V469, P2286, DOI 10.1007/s11999-010-1717-6
   Campbell DG, 2010, CLIN ORTHOP RELAT R, V468, P2704, DOI 10.1007/s11999-010-1259-y
   Cappi B., 2009, J BIOMED MATER RES A, V93, P67
   Chen JJ, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/3/034001
   Cho HJ, 2004, MATER CHEM PHYS, V88, P9, DOI 10.1016/j.matchemphys.2003.10.021
   CHRISTEL PS, 1992, CLIN ORTHOP RELAT R, P10
   CLARKE DR, 1980, ACTA METALL MATER, V28, P913, DOI 10.1016/0001-6160(80)90107-8
   Clarke MT, 2003, J BONE JOINT SURG BR, V85B, P913, DOI 10.1302/0301-620X.85B6.14166
   D'Antonio JA, 2005, CLIN ORTHOP RELAT R, P143, DOI 10.1097/01.blo.0000194090.77500.b4
   Daniel J, 2007, J BONE JOINT SURG BR, V89B, P169, DOI 10.1302/0301-620X.8982.18519
   Davidson J. A., 1992, BIOCERAMICS, V5, P389
   DORLOT JM, 1992, CLIN ORTHOP RELAT R, P47
   Drory MD, 1996, P ROY SOC A-MATH PHY, V452, P2319, DOI 10.1098/rspa.1996.0124
   Duffy GP, 2009, J ARTHROPLASTY, V24, P15
   Dumbleton JH, 2006, CLIN ORTHOP RELAT R, P265, DOI 10.1097/01.blo.0000238856.61862.7d
   EVANS AG, 1978, ACTA METALL MATER, V26, P1845, DOI 10.1016/0001-6160(78)90097-4
   EVANS AG, 1983, OXID MET, V20, P193, DOI 10.1007/BF00656841
   EYERER P, 1984, J BIOMED MATER RES, V18, P1137, DOI 10.1002/jbm.820180915
   Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9
   Fett T, 2005, J EUR CERAM SOC, V25, P29, DOI 10.1016/j.jeurceramsoc.2004.03.005
   Fett T., 1987, INT J FRACTURE, V33, P47
   Fouad H, 2010, J APPL POLYM SCI, V118, P17, DOI 10.1002/app.32290
   Fu YQ, 1998, SURF COAT TECH, V106, P193, DOI 10.1016/S0257-8972(98)00528-3
   GATES RS, 1989, TRIBOL T, V32, P357, DOI 10.1080/10402008908981900
   GILBERT CJ, 1995, J AM CERAM SOC, V78, P2291, DOI 10.1111/j.1151-2916.1995.tb08660.x
   Glyn-Jones S., 2008, J BONE JOINT SURG BR, V9, P556
   GOODFELLOW JW, 1993, J BONE JOINT SURG AM, V75A, P1423, DOI 10.2106/00004623-199310000-00001
   Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562
   Granchi D, 2003, J BONE JOINT SURG BR, V85B, P758, DOI 10.1302/0301-620X.85B5.13729
   Grigoris P, 2006, P I MECH ENG H, V220, P95, DOI 10.1243/095441105X69042
   GRISS P, 1980, MECH PROPERTIES BIOM, P217
   Hannink RHJ, 2000, J AM CERAM SOC, V83, P461
   Hannouche D, 2003, CLIN ORTHOP RELAT R, P19, DOI 10.1097/01.blo.0000096806.78689.50
   Harlan NR, 2002, J AM CERAM SOC, V85, P2025, DOI 10.1111/j.1151-2916.2002.tb00399.x
   Hart AJ, 2009, J BONE JOINT SURG BR, V91B, P835, DOI 10.1302/0301-620X.91B6.21844
   HIRAO K, 1994, J AM CERAM SOC, V77, P1857, DOI 10.1111/j.1151-2916.1994.tb07062.x
   Hobbs LW, 2005, INT J APPL CERAM TEC, V2, P221, DOI 10.1111/j.1744-7402.2005.02025.x
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   HUTCHINSON JW, 1992, ADV APPL MECH, V29, P63
   Irwin G. R, 1957, J APPL MECH, V24, P361, DOI DOI 10.1111/J.1460-2695.2012.01707.X
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P1447, DOI 10.2106/00004623-199810000-00006
   JACOBS JJ, 1996, CLIN ORTHOP S, V329, pS256
   Jazrawi L M, 1998, J Am Acad Orthop Surg, V6, P198
   Kaul G, 2012, KNEE SURG SPORT TR A, V20, P2315, DOI 10.1007/s00167-011-1853-x
   Krell A, 1996, J EUR CERAM SOC, V16, P803, DOI 10.1016/0955-2219(96)00003-9
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Kurtz S, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P237, DOI 10.1016/B978-0-12-374721-1.00016-X
   LANCASTER JK, 1990, TRIBOL INT, V23, P371, DOI 10.1016/0301-679X(90)90053-R
   Laskin RS, 2003, CLIN ORTHOP RELAT R, P191, DOI 10.1097/01.blo.0000093003.04535.1f
   Lerf R, 2010, BIOMATERIALS, V31, P3643, DOI 10.1016/j.biomaterials.2010.01.076
   Li C.-W., 1989, CERAM ENG SCI P, V105, P632
   Mao WG, 2007, SURF COAT TECH, V201, P6217, DOI 10.1016/j.surfcoat.2006.11.025
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2889, DOI 10.1007/s10856-008-3437-y
   MCKELLOP H, 1978, J BIOMED MATER RES, V12, P895, DOI 10.1002/jbm.820120611
   Mishra A.K., 1993, MATER TECHNOL, V8, P16
   Mont MA, 2008, J BONE JOINT SURG AM, V90A, P3, DOI 10.2106/JBJS.H.00750
   Moon H, 2010, J AM CERAM SOC, V93, P1264, DOI 10.1111/j.1551-2916.2009.03580.x
   Moore KD, 2008, J BONE JOINT SURG AM, V90A, P2499, DOI 10.2106/JBJS.G.01304
   MORI T, 1973, ACTA METALL MATER, V21, P571, DOI 10.1016/0001-6160(73)90064-3
   Morscher E W, 2003, Scand J Surg, V92, P113
   National Joint Registry of England and Wales, 2010, NJR PROSTH US
   National Joint Registry of England and Wales (NJR), 2008, 4 NJR
   Ong KL, 2008, J BONE JOINT SURG AM, V90A, P81, DOI 10.2106/JBJS.H.00574
   Oral E, 2004, BIOMATERIALS, V25, P5515, DOI 10.1016/j.biomaterials.2003.12.048
   Oral E, 2011, INT ORTHOP, V35, P215, DOI 10.1007/s00264-010-1161-y
   Oral E, 2009, J BIOMED MATER RES B, V90B, P720, DOI 10.1002/jbm.b.31340
   ORTIZ M, 1993, J APPL MECH-T ASME, V60, P77, DOI 10.1115/1.2900782
   Parise M, 1998, TEXTURE MICROSTRUCT, V30, P247
   Patel AM, 1995, BIOCERAMICS, V8, P169
   Pezzotti G, 1999, PHYS REV B, V60, P4018, DOI 10.1103/PhysRevB.60.4018
   Pezzotti G, 2001, J AM CERAM SOC, V84, P1785
   Pezzotti G, 1999, J RAMAN SPECTROSC, V30, P867
   Pezzotti G., 2007, J BIOMEDICAL OPTICS, V12
   Pezzotti G, 2007, EXPERT REV MED DEVIC, V4, P165, DOI 10.1586/17434440.4.2.165
   Pezzotti G, 2011, J BIOMAT SCI-POLYM E, V22, P2165, DOI 10.1163/092050610X537129
   Pezzotti G, 2010, BIOMATERIALS, V31, P6901, DOI 10.1016/j.biomaterials.2010.05.035
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Ries MD, 2002, J BONE JOINT SURG AM, V84A, P129, DOI 10.2106/00004623-200200002-00018
   ROSE LRF, 1986, J AM CERAM SOC, V69, P203, DOI 10.1111/j.1151-2916.1986.tb07407.x
   RUHLE M, 1989, MAT SCI ENG A-STRUCT, V107, P187, DOI 10.1016/0921-5093(89)90387-0
   Savarino L, 2006, J BONE JOINT SURG BR, V88B, P472, DOI 10.1302/0301-620X.88B4.17333
   Savarino L, 2003, J BIOMED MATER RES A, V66A, P450, DOI 10.1002/jbm.a.10595
   Seidel J, 1997, J AM CERAM SOC, V80, P433
   Shimmin AJ, 2005, J BONE JOINT SURG BR, V87B, P463, DOI 10.1302/0301-620X.87B4
   STEINBRECH RW, 1992, J EUR CERAM SOC, V10, P131, DOI 10.1016/0955-2219(92)90026-A
   Sun EY, 1998, J AM CERAM SOC, V81, P2831
   Takahashi Y, 2011, J MECH BEHAV BIOMED, V4, P993, DOI 10.1016/j.jmbbm.2011.02.014
   Tateiwa Toshiyuki, 2008, Am J Orthop (Belle Mead NJ), V37, pE26
   TAYA M, 1990, J AM CERAM SOC, V73, P1382, DOI 10.1111/j.1151-2916.1990.tb05209.x
   Tomsia AP, 2011, INT J ORAL MAX IMPL, V26, P25
   Tower SS, 2007, J BONE JOINT SURG AM, V89A, P2212, DOI 10.2106/JBJS.F.00758
   Wang L, 2000, WEAR, V246, P159, DOI 10.1016/S0043-1648(00)00504-4
   Weisse B, 2010, P I MECH ENG H, V224, P1051, DOI 10.1243/09544119JEIM743
   WHITE SE, 1994, CLIN ORTHOP RELAT R, P176
   Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp
   Willmann G, 1998, MATERIALWISS WERKST, V29, P595, DOI 10.1002/mawe.19980291010
   Zhang W, 2010, J MATER SCI-MATER M, V21, P3049, DOI 10.1007/s10856-010-4144-z
NR 109
TC 32
Z9 34
U1 5
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAR
PY 2014
VL 31
BP 3
EP 20
DI 10.1016/j.jmbbm.2013.06.001
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE2BQ
UT WOS:000333778700002
PM 23867294
DA 2018-10-20
ER

PT J
AU Demnati, I
   Grossin, D
   Errassifi, F
   Combes, C
   Rey, C
   Le Bolay, N
AF Demnati, I.
   Grossin, D.
   Errassifi, F.
   Combes, C.
   Rey, C.
   Le Bolay, N.
TI Synthesis of fluor-hydroxyapatite powder for plasma sprayed biomedical
   coatings: Characterization and improvement of the powder properties
SO POWDER TECHNOLOGY
LA English
DT Article
DE Fluor-hydroxyapatite powder; Physical-chemical characterization;
   Physical properties; Biomaterial; Surface energy
ID ALKALINE-PHOSPHATASE ACTIVITY; SURFACE; MICROSTRUCTURE; PROLIFERATION;
   CELLS
AB Fluor-hydroxyapatite (FHA) powder was synthesized by double decomposition in a view to produce bioactive and thermally stable coatings by plasma spray process. This work aims at studying the influence of chemical composition, microstructure and surface energy on the flowability of the FHA particles which is known as a determinant property during plasma spraying for the quality of the product in terms of yield and homogeneity of composition. The as-synthesized FHA powder was sieved in order to obtain two ranges of particles size: 50-80 mu m and 80-100 mu m. The phase composition and structure and physical characteristics of FHA particles have been determined by complementary analytical techniques (X-ray diffraction, Fourier transform infrared spectroscopy, scanning electron spectroscopy and laser granulometry). Then, the FHA flowability was determined as recommended by the European Pharmacopeia.
   The results showed that the 80-100 mu m FHA powder has a longer flow time compared to a reference hydroxyapatite powder whereas the 50-80 mu m FHA particles did not flow. We propose a simple treatment of the FHA particles using ethanol as solvent which showed to significantly improve the flowability of FHA powders. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Demnati, I.; Grossin, D.; Errassifi, F.; Combes, C.; Rey, C.] Univ Toulouse, CIRIMAT Carnot Inst, CNRS INPT UPS, ENSIACET, Toulouse, France.
   [Le Bolay, N.] Univ Toulouse, LGC, CNRS INPT UPS, ENSIACET, Toulouse, France.
RP Demnati, I (reprint author), Univ Toulouse, CIRIMAT Carnot Inst, CNRS INPT UPS, ENSIACET, Toulouse, France.
EM imanedemnati@yahoo.fr
RI GROSSIN, David/C-3217-2009
OI GROSSIN, David/0000-0002-4320-2919
CR [Anonymous], 2008, 1377932008 ISO
   Azami Mahmoud, 2012, Key Engineering Materials, V493-494, P626, DOI 10.4028/www.scientific.net/KEM.493-494.626
   Cheang P, 1996, BIOMATERIALS, V17, P537, DOI 10.1016/0142-9612(96)82729-3
   CHRISTOFFERSEN MR, 1984, J CRYST GROWTH, V67, P107, DOI 10.1016/0022-0248(84)90138-6
   De Groot K., 1990, HDB BIOACTIVE CERAMI, P3
   Demnati I, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/054101
   DEMNATI I, 2011, SURF COAT TECH, V206, P2346
   Demnati I., 2011, THESIS I NATL POLYTE
   Dyshlovenko S, 2006, SURF COAT TECH, V200, P3845, DOI 10.1016/j.surfcoat.2004.11.037
   FARLEY JR, 1983, SCIENCE, V222, P330
   FOWKES FM, 1963, J PHYS CHEM-US, V67, P2538, DOI 10.1021/j100806a008
   Frances C, 2001, INT J MINER PROCESS, V61, P41, DOI 10.1016/S0301-7516(00)00025-9
   Freund F., 1977, DALTON T, P1136
   Gross KA, 1998, J BIOMED MATER RES, V39, P580, DOI 10.1002/(SICI)1097-4636(19980315)39:4<580::AID-JBM12>3.3.CO;2-Y
   Gross KA, 2002, J BIOMED MATER RES, V63, P106, DOI 10.1002/jbm.10090
   Gross KA, 2012, ACTA BIOMATER, V8, P1948, DOI 10.1016/j.actbio.2012.01.023
   Heimann RB, 2006, SURF COAT TECH, V201, P2012, DOI 10.1016/j.surfcoat.2006.04.052
   Jaworski R, 2010, J THERM SPRAY TECHN, V19, P240, DOI 10.1007/s11666-009-9425-z
   Kaelble D., 1970, DISPERSION POLAR SUR
   Kim HW, 2003, BIOMATERIALS, V24, P3277, DOI 10.1016/S0142-9612(03)00162-5
   Nakade O, 1999, ARCH ORAL BIOL, V44, P89, DOI 10.1016/S0003-9969(98)00099-5
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Penel G, 1997, J MATER SCI-MATER M, V8, P271, DOI 10.1023/A:1018504126866
   RANZ X, 1997, BIOCERAMICS, V10, P455
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Young E., 1969, 196984 US GEOL SURV, P84
   Young T, 1804, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
NR 27
TC 6
Z9 6
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0032-5910
EI 1873-328X
J9 POWDER TECHNOL
JI Powder Technol.
PD MAR
PY 2014
VL 255
SI SI
BP 23
EP 28
DI 10.1016/j.powtec.2013.10.022
PG 6
WC Engineering, Chemical
SC Engineering
GA AE2IH
UT WOS:000333796000005
DA 2018-10-20
ER

PT J
AU Wang, L
   Li, YK
   Xu, YQ
   Wang, CQ
AF Wang, Liang
   Li, Ya-Kun
   Xu, Youqian
   Wang, Cai-Qi
TI A facile construction method for pH and oxidation dual-responsive
   assembly based on ferrocene-modified chitooligosaccharide
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article
DE Biodegradable; Chitooligosaccharide; Oxidation-responsive;
   Self-assembly; "Snowflake-like"
ID AMPHIPHILIC GRAFT COPOLYMER; DIBLOCK COPOLYMERS; HYDROGEN-PEROXIDE;
   POLYMERIC MICELLES; BLOCK-COPOLYMER; CHITOSAN; DELIVERY; MICELLIZATION;
   NANOCARRIERS; MORPHOLOGIES
AB Here, we present a novel and facile method for constructing "snowflake-like" assemblies that respond to external stimuli, similar to snowflakes in nature, via the self-organization of ferrocene-modified chitooligosaccharide (FcCOS) in an acid aqueous solution. Interestingly, the snowflakes were sensitive to pH and redox stimuli. They not only formed irregular network-like aggregates when the pH was adjusted to 7.0, they also gradually transformed into loose snowflakes with holes after exposure to air for 5 d and totally collapsed after treatment with hydrogen peroxide. Due to their interesting responses to pH and oxidation, these assemblies are a very interesting and promising system for biomaterial applications. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Wang, Liang; Li, Ya-Kun; Xu, Youqian; Wang, Cai-Qi] Univ Chinese Acad Sci, Sch Chem & Chem Engn, Beijing 100049, Peoples R China.
RP Wang, CQ (reprint author), Univ Chinese Acad Sci, Sch Chem & Chem Engn, 19A Yuquan Rd, Beijing 100049, Peoples R China.
EM wang-caiqi@ucas.ac.cn
FU National Natural Science Foundation of China [20604033]; Foundation of
   Graduate University of Chinese Academy of Sciences
FX This research was financially supported by the National Natural Science
   Foundation of China (No. 20604033) and the Foundation of Graduate
   University of Chinese Academy of Sciences.
CR Bian J, 2013, REACT FUNCT POLYM, V73, P579, DOI 10.1016/j.reactfunctpolym.2012.12.010
   Braga D, 1998, CHEM REV, V98, P1375, DOI 10.1021/cr960091b
   Cao L, 2002, MACROMOLECULES, V35, P8258, DOI 10.1021/ma021068x
   Cao M.Y., 2011, J APPL POLYM SCI, V123, P3137
   Chang KLB, 2001, J AGR FOOD CHEM, V49, P4845, DOI 10.1021/jf001469g
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Eloi JC, 2011, J AM CHEM SOC, V133, P8903, DOI 10.1021/ja1105656
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Garcia A, 2007, MACROMOL BIOSCI, V7, P435, DOI 10.1002/mabi.200700032
   Gohy JF, 2004, CHEM-EUR J, V10, P4315, DOI 10.1002/chem.200400222
   He XH, 2011, REACT FUNCT POLYM, V71, P544, DOI 10.1016/j.reactfunctpolym.2011.02.001
   Holder SJ, 2011, POLYM CHEM-UK, V2, P1018, DOI 10.1039/c0py00379d
   Hu F.Q., 2012, GENE THER, V20, P606
   Janczewski D, 2012, J MATER CHEM, V22, P6429, DOI 10.1039/c2jm15755a
   Jia LJ, 2013, POLYM CHEM-UK, V4, P156, DOI 10.1039/c2py20781h
   Korchagina EV, 2012, LANGMUIR, V28, P7880, DOI 10.1021/la3013409
   Korchagina EV, 2010, BIOMACROMOLECULES, V11, P3457, DOI 10.1021/bm100990u
   Li QH, 2010, COLLOID SURFACE A, V355, P146, DOI 10.1016/j.colsurfa.2009.12.004
   Liu JY, 2010, J SURFACTANTS DETERG, V13, P83, DOI 10.1007/s11743-009-1132-8
   LUBACH J, 1973, RECL TRAV CHIM PAY B, V92, P586
   Meng FH, 2009, BIOMACROMOLECULES, V10, P197, DOI 10.1021/bm801127d
   Nie L, 2007, ANGEW CHEM INT EDIT, V46, P6321, DOI 10.1002/anie.200700209
   PAPANAGOPOULOS D, 1995, EUR POLYM J, V31, P977, DOI 10.1016/0014-3057(95)00058-5
   Park JH, 2010, ADV DRUG DELIVER REV, V62, P28, DOI 10.1016/j.addr.2009.10.003
   Philippova OE, 2001, BIOMACROMOLECULES, V2, P483, DOI 10.1021/bm005649a
   Raez J, 2002, LANGMUIR, V18, P7229, DOI 10.1021/la0200562
   Srinivas G, 2004, NAT MATER, V3, P638, DOI 10.1038/nmat1185
   Tonhauser C, 2012, MACROMOLECULES, V45, P3409, DOI 10.1021/ma3000048
   Torchilin V, 2009, EUR J PHARM BIOPHARM, V71, P431, DOI 10.1016/j.ejpb.2008.09.026
   Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382
   Wu G, 2012, CHEM-EUR J, V18, P12237, DOI 10.1002/chem.201103961
   Xiao ZP, 2010, J MATER CHEM, V20, P8375, DOI 10.1039/c0jm01453b
   Xu ZS, 1998, EUR POLYM J, V34, P1499
   Yang WW, 2007, MACROMOL RAPID COMM, V28, P265, DOI 10.1002/marc.200600654
   Ye YQ, 2008, INT J PHARMACEUT, V352, P294, DOI 10.1016/j.ijpharm.2007.10.035
   You J, 2007, BIOMACROMOLECULES, V8, P2450, DOI 10.1021/bm070365c
   Zhai SJ, 2012, J POLYM SCI POL CHEM, V50, P811, DOI 10.1002/pola.25836
   ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728
   Zhang WA, 2012, REACT FUNCT POLYM, V72, P580, DOI 10.1016/j.reactfunctpolym.2012.04.001
   Zhu LZ, 2010, SOFT MATTER, V6, P5541, DOI 10.1039/c0sm00246a
   Zotti G, 1998, LANGMUIR, V14, P1728, DOI 10.1021/la971092h
NR 41
TC 11
Z9 12
U1 6
U2 66
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
EI 1873-166X
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD MAR
PY 2014
VL 76
BP 1
EP 7
DI 10.1016/j.reactfunctpolym.2013.12.009
PG 7
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA AE3DJ
UT WOS:000333856900001
DA 2018-10-20
ER

PT J
AU Coriolano, MC
   de Melo, CML
   Silva, FD
   Schirato, GV
   Porto, CS
   dos Santos, PJP
   Correia, MTD
   Porto, ALF
   Carneiro-Leo, AMD
   Coelho, LCBB
AF Coriolano, Marilia Cavalcanti
   Lagos de Melo, Cristiane Moutinho
   Silva, Flavio de Oliveira
   Schirato, Giuliana Viegas
   Porto, Camila Souza
   Parreira dos Santos, Paulo Jorge
   dos Santos Correia, Maria Tereza
   Figueiredo Porto, Ana Lucia
   dos Anjos Carneiro-Leo, Ana Maria
   Breitenbach Barroso Coelho, Luana Cassandra
TI Parkia pendula Seed Lectin: Potential Use to Treat Cutaneous Wounds in
   Healthy and Immunocompromised Mice
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article
DE Parkia pendula; Lectin; Skin; Cutaneous wound; Immunocompromised mice
ID IN-VITRO; NEUTROPHIL MIGRATION; BINDING LECTIN; CELLS; CD18;
   MACROPHAGES; CYTOKINES; INJURY
AB Parkia pendula seed lectin was used to treat cutaneous wounds of normal and immunocompromised mice, inducing cicatrization. Methotrexate (0.8 mg/kg/week) was used as immunosuppressive drug. Wounds were produced in the dorsal region (1 cm(2)) of female albino Swiss mice (Mus musculus), health and immunocompromised. Wounds were daily topically treated with 100 mu L of the following solutions: (1) control (NaCl 0.15 M), (2) control Im (0.15 M NaCl), (3) P. pendula seed lectin (100 mu g/mL), and (4) P. pendula seed lectin Im (100 mu g/mL). Clinical evaluation was performed during 12 days. Biopsies for histopathology analysis and microbiological examinations were carried out in the second, seventh, and 12th days. The presence of edema and hyperemia was observed in all groups during inflammatory period. The first crust was detected from the second day, only in the groups treated with P. pendula seed lectin. Microbiological analysis of wounds from day 0 to day 2 did not show bacterium at P. pendula seed lectin group; however, Staphylococcus sp. was detected every day in the other groups. The lectin markedly induced a total wound closing at P. pendula seed lectin and P. pendula seed lectin Im groups on 11th day of evolution. The present study suggests that P. pendula seed lectin is a biomaterial potential to show pharmacological effect in the repair process of cutaneous wounds.
C1 [Coriolano, Marilia Cavalcanti; dos Santos Correia, Maria Tereza; Breitenbach Barroso Coelho, Luana Cassandra] Univ Fed Pernambuco, Dept Bioquim, Ctr Ciencias Biol, BR-50670420 Recife, PE, Brazil.
   [Lagos de Melo, Cristiane Moutinho; Schirato, Giuliana Viegas] Ctr Pesquisas Aggeu Magalhaes CPqAM FIOCRUZ, BR-50670420 Recife, PE, Brazil.
   [Parreira dos Santos, Paulo Jorge] Univ Fed Pernambuco, Dept Zool, Ctr Ciencias Biol, BR-50670420 Recife, PE, Brazil.
   [Silva, Flavio de Oliveira; Porto, Camila Souza; Figueiredo Porto, Ana Lucia] Univ Fed Pernambuco, LIKA, BR-50670420 Recife, PE, Brazil.
   [dos Anjos Carneiro-Leo, Ana Maria] Univ Fed Pernambuco, Dept Morfol & Fisiol Anim, BR-52171030 Recife, PE, Brazil.
RP Coelho, LCBB (reprint author), Univ Fed Pernambuco, Dept Bioquim, Ctr Ciencias Biol, BR-50670420 Recife, PE, Brazil.
EM lcbbcoelho@gmail.com
RI Carneiro-Leao, Ana Maria/P-9369-2016; porto, ana/R-4619-2018; Santos,
   Paulo/G-6511-2011
OI Carneiro-Leao, Ana Maria/0000-0002-8815-8624; porto,
   ana/0000-0001-5561-5158; Santos, Paulo/0000-0003-4826-362X; Moutinho,
   Cristiane/0000-0002-8831-0163
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
FX The authors express their gratitude to the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico for research grants and
   fellowships (MTSC and LCBBC).
CR Alencar NMN, 2003, INT J BIOCHEM CELL B, V35, P1674, DOI 10.1016/S1357-2725(03)00138-9
   Alencar VBM, 2005, INT J BIOCHEM CELL B, V37, P1805, DOI 10.1016/j.biocel.2005.02.027
   Assreuy AMS, 2003, BIOL REPROD, V68, P1836, DOI 10.1095/biolreprod.102.013425
   Beltrao EIC, 2003, EUR J HISTOCHEM, V47, P139
   CARTER G. R., 1988, FUNDAMENTOS BACTERIO
   Chahud F, 2009, INT J EXP PATHOL, V90, P166, DOI 10.1111/j.1365-2613.2008.00626.x
   Choi S., 2003, SEMIN INTEGR MED, V1, P53, DOI DOI 10.1016/S1543-1150(03)00005-X
   Ciesielski CJ, 1998, TRANSPL IMMUNOL, V6, P122, DOI 10.1016/S0966-3274(98)80027-0
   Coriolano M.C., 2010, 14 INT BIOT S EXH RI, P454
   DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x
   do Nascimento LG, 2011, MOLECULES, V16, P9298, DOI 10.3390/molecules16119298
   Favacho ARM, 2007, BIOLOGICALS, V35, P189, DOI 10.1016/j.biologicals.2006.09.005
   Figueiredo JG, 2009, TOXICON, V54, P736, DOI 10.1016/j.toxicon.2009.05.037
   Ganiko L, 2005, BBA-GEN SUBJECTS, V1721, P152, DOI 10.1016/j.bbagen.2004.10.012
   Gemeiner P, 2009, BIOTECHNOL ADV, V27, P1, DOI 10.1016/j.biotechadv.2008.07.003
   Gorudko IV, 2008, ARCH MED RES, V39, P674, DOI 10.1016/j.arcmed.2008.06.002
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hall L.W., 1991, PRINCIPLES SEDATION
   Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016
   Kesherwani V, 2007, CYTOKINE, V37, P62, DOI 10.1016/j.cyto.2007.02.018
   Koning B. A. E., 2006, INT IMMUNOL, V18, P941
   de Melo CML, 2011, INT J PHARMACEUT, V408, P113, DOI 10.1016/j.ijpharm.2011.02.011
   Lombardi FR, 1998, PROTEIN PEPTIDE LETT, V5, P117
   Lorenzi H., 1998, ARVORES BRASILEIRAS
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Moller-Kristensen M, 2007, J INVEST DERMATOL, V127, P1524, DOI 10.1038/sj.jid.5700748
   Estevao LRM, 2013, ACTA CIR BRAS, V28, P202, DOI 10.1590/S0102-86502013000300008
   Neto L. G. N., 2012, MARINE DRUGS, V10, P1936
   Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846
   Pereira D.S., 2012, J BIOMEDICINE BIOTEC
   Pereira-Da-Silva G, 2006, BBA-GEN SUBJECTS, V1760, P86, DOI 10.1016/j.bbagen.2005.09.011
   Pessoa WS, 2012, ACTA CIR BRAS, V27, P665
   Peters T, 2006, J INVEST DERM SYMP P, V11, P7, DOI 10.1038/sj.jidsymp.5650006
   Pilcher BK, 1999, ANN NY ACAD SCI, V878, P12, DOI 10.1111/j.1749-6632.1999.tb07671.x
   Prata MB, 1988, ACTA CIR BRAS, V3, P43
   Rahier JF, 2009, J CROHNS COLITIS, V3, P47, DOI 10.1016/j.crohns.2009.02.010
   Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427
   Sell AM, 2003, BRAZ ARCH BIOL TECHN, V46, P349, DOI 10.1590/S1516-89132003000300006
   Sindrilaru A, 2007, J INVEST DERMATOL, V127, P447, DOI 10.1038/sj.jid.5700563
   Singer AJ, 2002, WOUND REPAIR REGEN, V10, P372, DOI 10.1046/j.1524-475X.2002.10606.x
   Toegel S, 2007, J CONTROL RELEASE, V117, P121, DOI 10.1016/j.jconrel.2006.10.004
   Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786
NR 42
TC 5
Z9 5
U1 0
U2 10
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0273-2289
EI 1559-0291
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD MAR
PY 2014
VL 172
IS 5
BP 2682
EP 2693
DI 10.1007/s12010-013-0692-2
PG 12
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA AD4VJ
UT WOS:000333249100033
PM 24425299
DA 2018-10-20
ER

PT J
AU Dolci, LS
   Quiroga, SD
   Gherardi, M
   Laurita, R
   Liguori, A
   Sanibondi, P
   Fiorani, A
   Calza, L
   Colombo, V
   Focarete, ML
AF Dolci, Luisa Stella
   Quiroga, Santiago David
   Gherardi, Matteo
   Laurita, Romolo
   Liguori, Anna
   Sanibondi, Paolo
   Fiorani, Andrea
   Calza, Laura
   Colombo, Vittorio
   Focarete, Maria Letizia
TI Carboxyl Surface Functionalization of Poly( L-lactic acid) Electrospun
   Nanofibers through Atmospheric Non-Thermal Plasma Affects Fibroblast
   Morphology
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE atmospheric pressure non-thermal plasma; biocompatibility;
   electrospinning; fibroblast cells; scaffolds
ID TISSUE ENGINEERING APPLICATIONS; GRAFT-COPOLYMERIZATION; DISCHARGE
   PLASMA; GLOW-DISCHARGE; CELL-ADHESION; SCAFFOLDS; BIOMATERIALS;
   IMMOBILIZATION; COMPLEXITY; DEPOSITION
AB In this study, atmospheric pressure non-thermal plasma treatment of electrospun poly(L-lactic acid) scaffolds is used to improve scaffold hydrophilicity and to introduce carboxyl groups on scaffold surface. Thermo-mechanical properties, morphology, hydrophilicity, and water uptake of the plasma-treated scaffolds are studied. The amount of carboxyl functional groups on the scaffold surface is evaluated using fluorescein isothiocyanate conjugation and microdensitometry. The effect of plasma treatment on mouse embryonic fibroblast morphology is assessed through image analysis. Results show an enhancement of scaffold biocompatibility, demonstrating that atmospheric plasma technology is a flexible process that can be integrated in in-line procedures of biomaterial fabrication and functionalization.
C1 [Dolci, Luisa Stella; Quiroga, Santiago David; Calza, Laura; Focarete, Maria Letizia] Univ Bologna, Ctr Ind Res HST ICIR, I-40064 Bologna, Italy.
   [Calza, Laura] IRET Fdn, I-40064 Bologna, Italy.
   [Gherardi, Matteo; Laurita, Romolo; Liguori, Anna; Sanibondi, Paolo; Colombo, Vittorio] Univ Bologna, Dept Ind Engn DIN, I-40123 Bologna, Italy.
   [Colombo, Vittorio] Univ Bologna, Interdept Ctr Ind Res AMM ICIR, I-40123 Bologna, Italy.
   [Fiorani, Andrea; Focarete, Maria Letizia] Univ Bologna, Dept Chem G Ciamician, Natl Consortium Mat Sci & Technol INSTM, RU Bologna, I-40126 Bologna, Italy.
RP Colombo, V (reprint author), Univ Bologna, Interdept Ctr Ind Res AMM ICIR, Via Saragozza 8, I-40123 Bologna, Italy.
EM vittorio.colombo@unibo.it; marialetizia.focarete@unibo.it
RI Calza, Laura/G-1059-2014; Focarete, Maria Letizia/B-2369-2009; Laurita,
   Romolo/U-6968-2017
OI Focarete, Maria Letizia/0000-0002-0458-7836; Laurita,
   Romolo/0000-0003-1744-3329; Quiroga, Santiago David/0000-0002-8904-9809;
   Fiorani, Andrea/0000-0001-8413-6439; COLOMBO,
   VITTORIO/0000-0001-9145-198X
FU Regione Emilia Romagna grant (POR-FESR); Montecatone Rehabilitation
   Institute, Imola, Italy (LC); IRET Foundation; Ozzano dell'Emilia
   (Bologna), Italy; FP7 COST Action [MP1101]
FX This work has been supported by a Regione Emilia Romagna grant (POR-FESR
   2011-2013), by the Montecatone Rehabilitation Institute, Imola, Italy
   (LC), IRET Foundation, Ozzano dell'Emilia (Bologna), Italy, and by FP7
   COST Action MP1101 "BioPlasma".
CR Amornsudthiwat P, 2013, COLLOID SURFACE B, V111, P579, DOI 10.1016/j.colsurfb.2013.07.009
   Bruggeman P, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/053001
   Callebaut T, 2004, PLASMA SOURCES SCI T, V13, P245, DOI 10.1088/0963-0252/13/2/008
   Chan CM, 1996, SURF SCI REP, V24, P3
   Chen JP, 2011, ACTA BIOMATER, V7, P234, DOI 10.1016/j.actbio.2010.08.015
   Cheng Q, 2013, TISSUE ENG PT A, V19, P1188, DOI [10.1089/ten.tea.2011.0725, 10.1089/ten.TEA.2011.0725]
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Delaittre G, 2012, SOFT MATTER, V8, P7323, DOI 10.1039/c2sm07407a
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031
   Ehlbeck J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013002
   Fang Z, 2003, J PHYS D APPL PHYS, V36, P2980, DOI 10.1088/0022-3727/36/23/019
   Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Greig B., 2009, NAT REV MOL CELL BIO, V10, P21
   Gu MH, 2012, BIOMATERIALS, V33, P1261, DOI 10.1016/j.biomaterials.2011.11.001
   Gualandi C, 2012, EUR POLYM J, V48, P2008, DOI 10.1016/j.eurpolymj.2012.09.016
   Heo GY, 2012, CARBOHYD POLYM, V88, P562, DOI 10.1016/j.carbpol.2011.12.038
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Hogan B, 1994, MANIPULATING MOUSE E
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hyun-Uk L., 2011, POLYM DEGRAD STABIL, V96, P1204
   Kang YH, 2011, THIN SOLID FILMS, V519, P7090, DOI 10.1016/j.tsf.2011.04.056
   Langevin HM, 2005, AM J PHYSIOL-CELL PH, V288, pC747, DOI 10.1152/ajpcell.00420.2004
   Lee HU, 2008, APPL SURF SCI, V254, P5700, DOI 10.1016/j.apsusc.2008.03.049
   Lee HU, 2010, ACTA BIOMATER, V6, P519, DOI 10.1016/j.actbio.2009.07.011
   Lu T, 2012, INTERFACE FOCUS, V2, P325, DOI 10.1098/rsfs.2012.0003
   Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   Mukherjee S, 2011, J MATER SCI-MATER M, V22, P1689, DOI 10.1007/s10856-011-4351-2
   Park H, 2007, MACROMOL RES, V15, P238, DOI 10.1007/BF03218782
   Park H, 2010, COLLOID SURFACE B, V77, P90, DOI 10.1016/j.colsurfb.2010.01.011
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Polini A, 2010, SOFT MATTER, V6, P1668, DOI 10.1039/b921932c
   Sarra-Bournet C, 2006, J PHYS D APPL PHYS, V39, P3461, DOI 10.1088/0022-3727/39/16/S03
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Sun FQ, 2010, CHINESE J POLYM SCI, V28, P705, DOI 10.1007/s10118-010-9110-1
   Taraballi F, 2013, J COLLOID INTERF SCI, V394, P590, DOI 10.1016/j.jcis.2012.11.041
   Tsai PP, 2005, TEXT RES J, V75, P819, DOI 10.1177/0040517505057526
   Vasilets VN, 2006, HIGH ENERG CHEM+, V40, P79, DOI 10.1134/S0018143906020032
   Wang JK, 2008, J POLYM SCI POL PHYS, V46, P1594, DOI 10.1002/polb.21496
   Wang XL, 2007, J APPL POLYM SCI, V104, P3614, DOI 10.1002/app.26081
   Wyrwa R, 2011, ADV ENG MATER, V13, pB165, DOI 10.1002/adem.201080116
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zanden C, 2012, EUR POLYM J, V48, P472, DOI 10.1016/j.eurpolymj.2012.01.004
   Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 52
TC 18
Z9 18
U1 1
U2 50
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1612-8850
EI 1612-8869
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD MAR
PY 2014
VL 11
IS 3
BP 203
EP 213
DI 10.1002/ppap.201300104
PG 11
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA AD4BV
UT WOS:000333192000001
DA 2018-10-20
ER

PT J
AU Mangano, C
   Iaculli, F
   Piattelli, A
   Mangano, F
   Shibli, JA
   Perrotti, V
   Iezzi, G
AF Mangano, Carlo
   Iaculli, Flavia
   Piattelli, Adriano
   Mangano, Francesco
   Shibli, Jamil Awad
   Perrotti, Vittoria
   Iezzi, Giovanna
TI Clinical and Histologic Evaluation of Calcium Carbonate in Sinus
   Augmentation: A Case Series
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID GUIDED TISSUE REGENERATION; REPLACEMENT GRAFT MATERIAL; BONE-FORMATION;
   DEFECTS; BIOMATERIAL; IMPLANTS; LIFT
AB The aim of this case series was a clinical, histologic, and histomorphometric evaluation of calcium carbonate in sinus elevation procedures. Sinus augmentation was performed in the atrophic maxillae of 24 subjects using calcium carbonate. Six months after the regeneration procedures, 68 implants were placed and clinically followed for 1 to 5 years, depending on the placement timing. At the last implant placement procedure, 8 bone cores were harvested and processed for histology. After a 6-month healing period, sinuses grafted with calcium carbonate showed a mean vertical bone gain of 6.93 +/- 0.23 mm. The histomorphometric analysis revealed 15% +/- 3% residual grafted biomaterial, 28% +/- 2% newly formed bone, and 57% +/- 2% marrow spaces. The implant survival rate was 98.5%. It can be concluded that calcium carbonate was shown to be clinically suitable for sinus elevation procedures after 1 to 5 years of follow-up and histologically biocompatible and osteoconductive.
C1 [Mangano, Carlo; Mangano, Francesco] Univ Insubria Varese, Dept Surg & Morphol Sci, Varese, Italy.
   [Iaculli, Flavia; Piattelli, Adriano; Perrotti, Vittoria; Iezzi, Giovanna] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
   [Shibli, Jamil Awad] Univ Guarulhos, Dent Res Div, Sao Paulo, Brazil.
RP Iezzi, G (reprint author), Via Vestini 31, I-66100 Chieti, Italy.
EM gio.iezzi@unich.it
OI Mangano, Francesco/0000-0001-5488-4268
FU Ministry of Education, University and Research (MIUR), Rome, Italy; PRIN
   [20102011, 20102ZLNJ5]
FX This work was by supported by PRIN 20102011 (PRIN 20102ZLNJ5), financed
   by the Ministry of Education, University and Research (MIUR), Rome,
   Italy. The funders had no role in study design, data collection or
   analysis, decision to publish, or preparation of the manuscript. The
   authors reported no conflicts of interest related to this study.
CR Artese L, 2011, IMPLANT DENT, V20, P383, DOI 10.1097/ID.0b013e3182310b3d
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Guerra F, 2010, J BIOMED MAT RES B, V92, P409
   Hernandez-Alfaro F, 2008, CLIN ORAL IMPLAN RES, V19, P91, DOI 10.1111/j.1600-0501.2007.01372.x
   Koo KT, 2005, J CLIN PERIODONTOL, V32, P104, DOI 10.1111/j.1600-051X.2004.00632.x
   Kruyt MC, 2003, TISSUE ENG, V9, P327, DOI 10.1089/107632703764664792
   Leize EM, 1999, J MATER SCI-MATER M, V10, P47, DOI 10.1023/A:1008892027815
   Mangano C, 2009, CLIN IMPLANT DENT R, V11, P92
   Mangano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018721
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Polimeni G, 2004, J CLIN PERIODONTOL, V31, P725, DOI 10.1111/j.1600-051X.2004.00542.x
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Sandor GKB, 2003, DENT TRAUMATOL, V19, P221, DOI 10.1034/j.1600-9657.2003.00164.x
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Simon JL, 2003, J BIOMED MATER RES A, V66A, P275, DOI 10.1002/jbm.a.10569
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tschon M, 2009, J BIOMED MATER RES B, V88B, P349, DOI 10.1002/jbm.b.31062
   YUKNA RA, 1994, J PERIODONTOL, V65, P177, DOI 10.1902/jop.1994.65.2.177
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
NR 21
TC 5
Z9 5
U1 0
U2 4
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
EI 1945-3388
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD MAR-APR
PY 2014
VL 34
IS 2
BP E43
EP E49
DI 10.11607/prd.1832
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AC8ES
UT WOS:000332766900003
PM 24600666
OA Bronze
DA 2018-10-20
ER

PT J
AU Suganya, S
   Venugopal, J
   Mary, SA
   Ramakrishna, S
   Lakshmi, BS
   Dev, VRG
AF Suganya, S.
   Venugopal, J.
   Mary, S. Agnes
   Ramakrishna, S.
   Lakshmi, B. S.
   Dev, V. R. Giri
TI Aloe vera incorporated biomimetic nanofibrous scaffold: a regenerative
   approach for skin tissue engineering
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE Aloe vera; Polycaprolactone; Electrospinning; Nanomaterials; Tissue
   engineering
ID COMPOSITE NANOFIBERS; IN-VITRO; COLLAGEN; GEL; ANTIBACTERIAL;
   BARBADENSIS
AB Aloe vera (AV) is one of the medicinal herbs with a well-established spectrum of wound healing, antimicrobial and anti-inflammatory property. AV-mediated therapeutics present significant tissue regenerative activity by modulating the inflammatory and proliferative phases of wound healing. The purpose of the present work was to combine the biological properties of AV and the advantages of electrospun meshes to prepare a potent transdermal biomaterial. The polycaprolactone (PCL) containing 5 and 10 wt % of lyophilized powder of AV was studied for electrospinning into nanoscale fiber mats and compared with PCL/Collagen blend for dermal substitutes. SEM revealed the average diameters of PCL, PCL-AV 5 %, PCL-AV 10 % and PCL/Collagen nanofiber scaffolds in the range of 519 +/- 28, 264 +/- 46, 215 +/- 63 and 249 +/- 52 nm, respectively. PCL-AV 10 % nanofiber scaffolds showed finer fiber morphology with improved hydrophilic properties and higher tensile strength of 6.28 MPa with a Young's modulus of 16.11 MPa desirable for skin tissue engineering. The nanofibers were then used to investigate differences in biological responses in terms of proliferation and cell morphology of mice dermal fibroblasts. It was found that PCL-AV 10 % nanofibrous matrix favored cell proliferation compared to other scaffolds which almost increased linearly by (p <= 0.01) 17.79 % and (p <= 0.01) 21.28 % compared to PCL on sixth and ninth day. CMFDA dye expression, secretion of collagen and F-actin expression were significantly increased in PCL-AV 10 % scaffolds compared to other nanofibrous scaffolds. The obtained results proved that the PCL-AV 10 % nanofibrous scaffold is a potential biomaterial for skin tissue regeneration.
C1 [Suganya, S.; Mary, S. Agnes; Dev, V. R. Giri] Anna Univ, AC Tech, Dept Text Technol, Madras 600025, Tamil Nadu, India.
   [Suganya, S.; Lakshmi, B. S.] Anna Univ, Ctr Biotechnol, Madras 600025, Tamil Nadu, India.
   [Venugopal, J.; Ramakrishna, S.] Natl Univ Singapore, Fac Engn, Nanosci & Nanotechnol Initiat, Singapore 117548, Singapore.
RP Dev, VRG (reprint author), Anna Univ, AC Tech, Dept Text Technol, Madras 600025, Tamil Nadu, India.
EM vrgiridev@yahoo.com
OI Jayarama Reddy, Venugopal/0000-0001-5867-8007
FU Department of Textile Technology, Anna University, Chennai, India;
   NUSNNI, National University of Singapore, Singapore
FX This study was supported by the Department of Textile Technology, Anna
   University, Chennai, India and NUSNNI, National University of Singapore,
   Singapore.
CR Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen YW, 2008, BRAZ J CHEM ENG, V25, P321, DOI 10.1590/S0104-66322008000200011
   Chithra P, 1998, MOL CELL BIOCHEM, V181, P71, DOI 10.1023/A:1006813510959
   Choi SW, 2001, BRIT J DERMATOL, V145, P535, DOI 10.1046/j.1365-2133.2001.04410.x
   Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783
   Gaspar A, 2011, J Med Life, V4, P172
   He JX, 2013, IRAN POLYM J, V22, P537, DOI 10.1007/s13726-013-0153-3
   HEGGERS JP, 1993, PHYTOTHER RES, V7, pS48, DOI 10.1002/ptr.2650070715
   Hutter JA, 1996, J NAT PROD, V59, P541, DOI 10.1021/np9601519
   Kang MC, 2014, CARBOHYD POLYM, V99, P365, DOI 10.1016/j.carbpol.2013.07.091
   Krishnan P., 2006, CURR ANAESTH CRIT CA, V17, P21
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Liu WL, 2009, IRAN POLYM J, V18, P89
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Qian YF, 2010, IRAN POLYM J, V19, P123
   Qin JW, 2013, IRAN POLYM J, V22, P729, DOI 10.1007/s13726-013-0171-1
   Sahu P. K., 2013, Pharmacology and Pharmacy, V4, P599, DOI 10.4236/pp.2013.48086
   Song AR, 2012, ACTA BIOMATER, V8, P41, DOI 10.1016/j.actbio.2011.10.004
   Suganya S, 2014, J BIOMATER TISS ENG, V4, P9, DOI 10.1166/jbt.2014.1139
   Takzare N, 2009, TOXICOL MECH METHOD, V19, P73, DOI 10.1080/15376510802442444
   Tao H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000697
   Tian F, 2008, J BIOMED MATER RES A, V84A, P291, DOI 10.1002/jbm.a.31304
   Vazquez B, 1996, J ETHNOPHARMACOL, V55, P69, DOI 10.1016/S0378-8741(96)01476-6
   Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x
   Vujanovic S, 2013, BURNS, V39, P1031, DOI 10.1016/j.burns.2013.03.016
   Yannas IV, 2007, TISSUE ENG, V13, P1789, DOI 10.1089/ten.2006.0054
   Zargarian SS, 2010, IRAN POLYM J, V19, P457
   Zhang YQ, 2013, COLLOID SURFACE A, V423, P63, DOI 10.1016/j.colsurfa.2013.01.059
   Zheng L, 2013, IRAN POLYM J, V22, P833, DOI 10.1007/s13726-013-0182-y
NR 30
TC 27
Z9 27
U1 2
U2 62
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1026-1265
EI 1735-5265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD MAR
PY 2014
VL 23
IS 3
BP 237
EP 248
DI 10.1007/s13726-013-0219-2
PG 12
WC Polymer Science
SC Polymer Science
GA AD3GW
UT WOS:000333127300008
DA 2018-10-20
ER

PT J
AU Tan, Q
   Chen, B
   Yan, X
   Lin, Y
   Xiao, ZF
   Hou, XL
   Dai, JW
AF Tan, Qian
   Chen, Bing
   Yan, Xin
   Lin, Yue
   Xiao, Zhifeng
   Hou, Xianglin
   Dai, Jianwu
TI Promotion of diabetic wound healing by collagen scaffold with
   collagen-binding vascular endothelial growth factor in a diabetic rat
   model
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE VEGF; collagen scaffolds; healing; wounds
ID FOOT ULCERS; DELIVERY; CLOSURE
AB Aims: Studies show that VEGF can promote tissue regeneration in diabetic wounds. The aim of this study was to evaluate the effects of a new composite biomaterial, a collagen scaffold with CBD-VEGF, for wound healing in a diabetic rat model. Materials and methods: We produced a collagen scaffold loaded with CBD-VEGF, which allowed VEGF to bind to the collagen scaffold. The diabetic rat model was constructed by injecting streptozocin (STZ) peritoneally and removing a 2 x 2.5 cm thick slice of skin from the back of the animal. Animals were randomly divided into 4 groups: blank control (BC Group, n = 24), collagen scaffold loaded with PBS (PBS Group, n = 24), collagen scaffold loaded with NAT-VEGF (NAT-VEGF Group, n = 24), and collagen scaffold loaded with CBD-VEGF (CBD-VEGF Group, n = 24). Wounds of the BC Group were covered with gauze and those of the PBS, NAT-VEGF and CBD-VEGF Groups were grafted by corresponding collagen scaffolds, respectively. Healing rates were calculated and compared among groups. Wound tissue was evaluated by histologic analysis. Results: The CBD-VEGF group showed a higher wound healing rate, better vascularization and higher level of VEGF in the granulation tissue wound compared with NAT-VEGF and PBS groups. Conclusions: The collagen scaffold with CBD-VEGF promoted wound healing in a diabetic rat model, which could potentially provide better therapeutic options for the treatment of diabetic wounds. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Tan, Qian; Yan, Xin; Lin, Yue] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Burns & Plast Surg, Nanjing 210008, Jiangsu, Peoples R China.
   [Chen, Bing; Xiao, Zhifeng; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100190, Peoples R China.
   [Hou, Xianglin] Yantai Zhenghai Biotechnol Co Ltd, Yantai, Shangdong, Peoples R China.
RP Tan, Q (reprint author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Burns & Plast Surg, Nanjing 210008, Jiangsu, Peoples R China.
EM smmutan-qian@sina.com; jwdai@genetics.ac.cn
FU Key Talent Foundation of China, Jiangsu Province [RC2007009]; 333
   Project Talent Foundation of China, Jiangsu Province [NJGL2007116];
   Technology Foundation of China, Jiangsu Province, Nanjing [NJGL2006024];
   National Natural Science Foundation of China [30688002]; K.C. Wong
   Education Foundation
FX This work was supported by grounds from the Key Talent Foundation of
   China, Jiangsu Province (RC2007009); the 333 Project Talent Foundation
   of China, Jiangsu Province (NJGL2007116); the Technology Foundation of
   China, Jiangsu Province, Nanjing (NJGL2006024); the National Natural
   Science Foundation of China (30688002) and the K.C. Wong Education
   Foundation.
CR Chen L, 2010, J MATER SCI-MATER M, V21, P309, DOI 10.1007/s10856-009-3827-9
   Chen W, 2009, J UROLOGY, V183, P2432
   Galkowska H, 2006, WOUND REPAIR REGEN, V14, P558, DOI 10.1111/j.1743-6109.2006.00155.x
   Goodridge D, 2006, FOOT ANKLE INT, V27, P274, DOI 10.1177/107110070602700408
   Gwynne Babs, 2006, Br J Nurs, V15, pS4
   Hang LN, 2006, BIOMATERIALS, V27, P5708
   He JQ, 2002, J ORAL MAXILLOFAC SU, V60, P1449
   He QF, 2011, ACTA BIOMATER, V7, P1084, DOI 10.1016/j.actbio.2010.10.022
   Lee RJ, 2000, CIRCULATION, V102, P898
   Lobmann R, 2003, MED KLIN, V98, P292, DOI 10.1007/s00063-003-1260-2
   Losordo DW, 2002, CIRCULATION, V105, P2012, DOI 10.1161/01.CIR.0000015982.70785.B7
   [陆树良 Lu Shuliang], 2004, [中华创伤杂志, Chinese Journal of Traumatology], V20, P468
   Morykwas MJ, 1997, ANN PLAS SURG, V38, P553, DOI 10.1097/00000637-199706000-00001
   Onodera H, 2004, DIGEST SURG, V21, P146, DOI 10.1159/000078381
   Pradhan L, 2009, EXPERT REV MOL MED, V11, P2
   Rosengart TK, 1999, CIRCULATION, V100, P468, DOI 10.1161/01.CIR.100.5.468
   Shi CY, 2011, BIOMATERIALS, V32, P753, DOI 10.1016/j.biomaterials.2010.09.038
   Testori T, 2008, INT J PERIODONT REST, V28, P9
   Trousdale RK, 2009, J SURG RES, V151, P100, DOI 10.1016/j.jss.2008.01.023
   Wang Zheng, 2002, Zhonghua Yu Fang Yi Xue Za Zhi, V36, P505
   Yan X, 2010, DIABETES RES CLIN PR, V90, P66, DOI 10.1016/j.diabres.2010.07.001
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yang YF, 2009, TISSUE ENG PART A, V15, P11
   Zhang J, 2009, CIRCULATION, V119, P1776, DOI 10.1161/CIRCULATIONAHA.108.800565
NR 24
TC 22
Z9 24
U1 6
U2 29
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR
PY 2014
VL 8
IS 3
BP 195
EP 201
DI 10.1002/term.1513
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AD1DE
UT WOS:000332973200004
PM 22570298
DA 2018-10-20
ER

PT J
AU Zhou, GH
   Chen, CH
   Zhang, LY
   Guo, XF
   Wang, H
   Ji, XH
   He, ZK
AF Zhou, Guohua
   Chen, Chaohui
   Zhang, Liyun
   Guo, Xiaofeng
   Wang, Hong
   Ji, Xinghu
   He, Zhike
TI Robust Aqueous Quantum Dots Capped with Peptide Ligands as Biomaterials:
   Facile Preparation, Good Stability, and Multipurpose Application
SO PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION
LA English
DT Article
DE quantum dots; peptides; biomaterials; graphene; FRET
ID GOLD NANOPARTICLES; PARTICLE-SIZE; BIOLOGICAL APPLICATIONS; SURFACE
   MODIFICATION; CDSE NANOCRYSTALS; ENERGY-TRANSFER; CYTOTOXICITY;
   GRAPHENE; BINDING; CELLS
AB We have obtained robust peptide-capped quantum dots (QDs) using a facile approach. The pentapeptide Cys-Ala-Leu-Asn-Asn (CALNN) is involved as the capping ligand, forming a self-assembly monolayer on the surface of QDs, and solubilization of hydrophobic QDs in water is realized by simply mixing with the ligands in sodium hydroxide solution. All of the characterization results show that the prepared small-sized QDs have excellent stability in acidic and high salt solutions. Additionally, the protein-mimicking surface property of the peptide-capped QDs eliminates the nonspecific cellular interaction, which in combination with the low cytotoxicity promises an ideal biomaterial in the future. Further functionalization and achievement of fluorescence resonance energy transfer (FRET) to graphene also display great potential for analytical applications.
C1 [Zhou, Guohua; Chen, Chaohui; Zhang, Liyun; Guo, Xiaofeng; Wang, Hong; Ji, Xinghu; He, Zhike] Wuhan Univ, Coll Chem & Mol Sci, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China.
RP Zhou, GH (reprint author), Wuhan Univ, Coll Chem & Mol Sci, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China.
EM xhu@whu.edu.cn; zhkhe@whu.edu.cn
OI Zhou, Guohua/0000-0001-6252-959X
FU National Key Scientific Program-Nanoscience and Nanotechnology
   [2011CB933600]; National Science Foundation of China [21075093,
   21275109, 21205089]
FX This work was commercially supported by the National Key Scientific
   Program-Nanoscience and Nanotechnology (2011CB933600), and the National
   Science Foundation of China (21075093, 21275109 and 21205089).
CR Aldana J, 2005, J AM CHEM SOC, V127, P2496, DOI 10.1021/ja047000+
   Aldana J, 2001, J AM CHEM SOC, V123, P8844, DOI 10.1021/ja016424q
   Algar WR, 2007, CHEMPHYSCHEM, V8, P561, DOI 10.1002/cphc.200600686
   Bailey RE, 2003, J AM CHEM SOC, V125, P7100, DOI 10.1021/ja035000o
   Bentzen EL, 2005, BIOCONJUGATE CHEM, V16, P1488, DOI 10.1021/bc0502006
   Biju V, 2010, CHEM SOC REV, V39, P3031, DOI 10.1039/b926512k
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Carrillo-Carrion C, 2009, CHEM COMMUN, P5214, DOI 10.1039/b904381k
   Carrillo-Carrion C, 2009, ANAL CHEM, V81, P4730, DOI 10.1021/ac900034h
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Chang E, 2006, SMALL, V2, P1412, DOI 10.1002/smll.200600218
   Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI [10.1038/nbt1340, 10.1038/nbtl340]
   Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y
   Daou TJ, 2009, LANGMUIR, V25, P3040, DOI 10.1021/la8035083
   Delehanty JB, 2006, BIOCONJUGATE CHEM, V17, P920, DOI 10.1021/bc060044i
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Duchesne L, 2008, LANGMUIR, V24, P13572, DOI 10.1021/la802876u
   Esteve-Turrillas FA, 2013, BIOSENS BIOELECTRON, V41, P12, DOI 10.1016/j.bios.2012.09.025
   Gaal o., 1980, ELECTROPHORESIS SEPA, P15
   Gao JQ, 2008, ANAL CHEM, V80, P8822, DOI 10.1021/ac8015328
   Gao XH, 2002, J BIOMED OPT, V7, P532, DOI 10.1117/1.1506706
   Gerion D, 2001, J PHYS CHEM B, V105, P8861, DOI 10.1021/jp0105488
   Guzelian AA, 1996, APPL PHYS LETT, V69, P1432, DOI 10.1063/1.117605
   Hines MA, 2003, ADV MATER, V15, P1844, DOI 10.1002/adma.200305395
   Hines MA, 1998, J PHYS CHEM B, V102, P3655, DOI 10.1021/jp9810217
   Hines MA, 1996, J PHYS CHEM-US, V100, P468, DOI 10.1021/jp9530562
   Hoshino A, 2004, NANO LETT, V4, P2163, DOI 10.1021/nl048715d
   Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m
   Lee JS, 2012, ACS NANO, V6, P2978, DOI 10.1021/nn300684d
   LENTZ BR, 1994, CHEM PHYS LIPIDS, V73, P91, DOI 10.1016/0009-3084(94)90176-7
   Levy R, 2004, J AM CHEM SOC, V126, P10076, DOI 10.1021/ja0487269
   Levy R, 2006, CHEMBIOCHEM, V7, P1141, DOI 10.1002/cbic.200600129
   Liu JA, 2006, SMALL, V2, P999, DOI 10.1002/smll.200500421
   Liu M, 2010, CHEM COMMUN, V46, P7909, DOI 10.1039/c0cc02085k
   Liu XS, 2013, ADV HEALTHC MATER, V2, P352, DOI 10.1002/adhm.201200210
   Liu YS, 2007, J PHYS CHEM C, V111, P2872, DOI 10.1021/jp0654718
   Masilela N, 2012, J PHOTOCH PHOTOBIO A, V247, P82, DOI 10.1016/j.jphotochem.2012.07.016
   Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390
   Muro E, 2010, J AM CHEM SOC, V132, P4556, DOI 10.1021/ja1005493
   Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a
   Park J, 2011, ADV FUNCT MATER, V21, P1558, DOI 10.1002/adfm.201001924
   Pellegrino T, 2004, NANO LETT, V4, P703, DOI 10.1021/nl035172j
   Peng XG, 1997, J AM CHEM SOC, V119, P7019, DOI 10.1021/ja970754m
   Pinaud F, 2004, J AM CHEM SOC, V126, P6115, DOI 10.1021/ja031691c
   Prasuhn DE, 2010, SMALL, V6, P555, DOI 10.1002/smll.200901845
   Rosenthal SJ, 2011, CHEM BIOL, V18, P10, DOI 10.1016/j.chembiol.2010.11.013
   Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k
   Ryman-Rasmussen JP, 2007, NANO LETT, V7, P1344, DOI 10.1021/nl070375j
   Ryman-Rasmussen JP, 2007, J INVEST DERMATOL, V127, P143, DOI 10.1038/sj.jid.5700508
   Si Y, 2008, NANO LETT, V8, P1679, DOI 10.1021/nl080604h
   Sun LL, 2008, LANGMUIR, V24, P10293, DOI 10.1021/la8015063
   Uyeda HT, 2005, J AM CHEM SOC, V127, P3870, DOI 10.1021/ja044031w
   Wei YF, 2009, BIOCONJUGATE CHEM, V20, P1752, DOI 10.1021/bc8003777
   Yu DH, 2007, ENZYME MICROB TECH, V41, P127, DOI 10.1016/j.enzmictec.2006.12.012
   Yu GH, 2006, CHEM BIOL, V13, P723, DOI 10.1016/j.chembiol.2006.05.007
   Zhao D., 2008, J PHYS CHEM C, V113, P1293, DOI [10.1021/jp808465s, DOI 10.1021/JP808465S]
   Zhou GH, 2013, LANGMUIR, V29, P4697, DOI 10.1021/la400404g
   Zhou GH, 2012, ACS APPL MATER INTER, V4, P5010, DOI 10.1021/am301380q
   Zhou Y, 2009, CHEM MATER, V21, P2950, DOI 10.1021/cm9006603
   Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g
NR 61
TC 4
Z9 4
U1 2
U2 51
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0934-0866
EI 1521-4117
J9 PART PART SYST CHAR
JI Part. Part. Syst. Charact.
PD MAR
PY 2014
VL 31
IS 3
BP 382
EP 389
DI 10.1002/ppsc.201300250
PG 8
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AD0MK
UT WOS:000332928100009
DA 2018-10-20
ER

PT J
AU Veronesi, E
   Murgia, A
   Caselli, A
   Grisendi, G
   Piccinno, MS
   Rasini, V
   Giordano, R
   Montemurro, T
   Bourin, P
   Sensebe, L
   Rojewski, MT
   Schrezenmeier, H
   Layrolle, P
   Ginebra, MP
   Panaitescu, CB
   Gomez-Barrena, E
   Catani, F
   Paolucci, P
   Burns, JS
   Dominici, M
AF Veronesi, Elena
   Murgia, Alba
   Caselli, Anna
   Grisendi, Giulia
   Piccinno, Maria Serena
   Rasini, Valeria
   Giordano, Rosaria
   Montemurro, Tiziana
   Bourin, Philippe
   Sensebe, Luc
   Rojewski, Markus T.
   Schrezenmeier, Hubert
   Layrolle, Pierre
   Pau Ginebra, Maria
   Panaitescu, Carmen Bunu
   Gomez-Barrena, Enrique
   Catani, Fabio
   Paolucci, Paolo
   Burns, Jorge S.
   Dominici, Massimo
TI Transportation Conditions for Prompt Use of Ex Vivo Expanded and Freshly
   Harvested Clinical-Grade Bone Marrow Mesenchymal Stromal/Stem Cells for
   Bone Regeneration
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; TISSUE-ENGINEERED BONE; PLATELET-RICH
   PLASMA; HUMAN SERUM-ALBUMIN; STEM-CELLS; OSTEOCONDUCTIVE SCAFFOLDS;
   IN-VITRO; BIOMATERIALS; EXPANSION; REPAIR
AB Successful preliminary studies have encouraged a more translational phase for stem cell research. Nevertheless, advances in the culture of human bone marrow-derived mesenchymal stromal/stem cells (hBM-MSC) and osteoconductive qualities of combined biomaterials can be undermined if necessary cell transportation procedures prove unviable. We aimed at evaluating the effect of transportation conditions on cell function, including the ability to form bone in vivo, using procedures suited to clinical application. hBM-MSC expanded in current Good Manufacturing Practice (cGMP) facilities (cGMP-hBM-MSC) to numbers suitable for therapy were transported overnight within syringes and subsequently tested for viability. Scaled-down experiments mimicking shipment for 18h at 4 degrees C tested the influence of three different clinical-grade transportation buffers (0.9% saline alone or with 4% human serum albumin [HSA] from two independent sources) compared with cell maintenance medium. Cell viability after shipment was >80% in all cases, enabling evaluation of (1) adhesion to plastic flasks and hydroxyapatite tricalcium phosphate osteoconductive biomaterial (HA/-TCP 3D scaffold); (2) proliferation rate; (3) ex vivo osteogenic differentiation in contexts of 2D monolayers on plastic and 3D HA/-TCP scaffolds; and (4) in vivo ectopic bone formation after subcutaneous implantation of cells with HA/-TCP scaffold into NOD/SCID mice. Von Kossa staining was used to assess ex vivo osteogenic differentiation in 3D cultures, providing a quantifiable test of 3D biomineralization ex vivo as a rapid, cost-effective potency assay. Near-equivalent capacities for cell survival, proliferation, and osteogenic differentiation were found for all transportation buffers. Moreover, cGMP-hBM-MSC transported from a production facility under clinical-grade conditions of 4% HSA in 0.9% saline to a destination 18h away showed prompt adhesion to HA/-TCP 3D scaffold and subsequent in vivo bone formation. A successfully validated transportation protocol extends the applicability of fresh stem cells involving multicentric trials for regenerative medicine.
C1 [Veronesi, Elena; Murgia, Alba; Grisendi, Giulia; Piccinno, Maria Serena; Rasini, Valeria; Catani, Fabio; Paolucci, Paolo; Burns, Jorge S.; Dominici, Massimo] Univ Hosp Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Lab Cell Biol & Adv Canc Therapies, I-41124 Modena, Italy.
   [Caselli, Anna] Univ Bari A Moro, Dept Internal Med & Oncol, Bari, Italy.
   [Giordano, Rosaria; Montemurro, Tiziana] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Cell Factory, Milan, Italy.
   [Bourin, Philippe] EFS Pyrenees Mediterranee, Toulouse, France.
   [Sensebe, Luc] Univ Toulouse 3, EFS, INSERM, STROMALab UMR5273 U1031,CNRS, F-31062 Toulouse, France.
   [Rojewski, Markus T.; Schrezenmeier, Hubert] German Red Cross Blood Transfus Serv, Inst Clin Transfus Med & Immungenet Ulm, Ulm, Germany.
   [Rojewski, Markus T.; Schrezenmeier, Hubert] Univ Ulm, D-89069 Ulm, Germany.
   [Layrolle, Pierre] Univ Nantes, Fac Med, Lab Pathophysiol Bone Resorpt, INSERM U957, Nantes, France.
   [Pau Ginebra, Maria] Tech Univ Catalonia, Dept Mat Sci & Met Engn, Barcelona, Spain.
   [Panaitescu, Carmen Bunu] Victor Babes Univ Med & Pharm, Timisoara, Romania.
   [Gomez-Barrena, Enrique] Hosp La Paz IdiPaz, Serv Cirugia Ortoped & Traumatol, Madrid, Spain.
   [Gomez-Barrena, Enrique] Univ Autonoma Madrid, Madrid, Spain.
RP Dominici, M (reprint author), Univ Hosp Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Lab Cell Biol & Adv Canc Therapies, Via Pozzo 71, I-41124 Modena, Italy.
EM massimo.dominici@unimore.it
RI Caselli, Anna/B-9734-2015; Layrolle, Pierre/K-9257-2015; GOMEZ-BARRENA,
   ENRIQUE/A-2799-2008; Burns, Jorge S./J-3395-2012; Giordano,
   Rosaria/N-6565-2015; Catani, Fabio/B-3642-2017; Grisendi,
   Giulia/J-6360-2016; Ginebra, Maria-Pau/J-8149-2017
OI Caselli, Anna/0000-0002-8859-2738; Layrolle, Pierre/0000-0001-9800-5210;
   GOMEZ-BARRENA, ENRIQUE/0000-0003-1065-6137; Burns, Jorge
   S./0000-0002-8602-1536; Giordano, Rosaria/0000-0002-7263-0752; Catani,
   Fabio/0000-0002-1078-7666; Grisendi, Giulia/0000-0002-0120-6129;
   Ginebra, Maria-Pau/0000-0002-4700-5621; Dominici,
   Massimo/0000-0002-4007-1503; Rojewski, Markus/0000-0003-4265-0442;
   PAOLUCCI, PAOLO/0000-0002-0352-1456; Piccinno, Maria
   Serena/0000-0001-5387-3022; Bourin, Philippe/0000-0002-9652-4380
FU European Commission [241879]; REBORNE project; Italian Ministry of
   Health "Bando Cellule Staminali"; Regione Emilia Romagna; Associazione
   ASEOP
FX This work was supported in part by the European Commission Seventh
   Framework Program (FP7/2007-2013) (grant no. 241879), through the
   REBORNE project, the Italian Ministry of Health "Bando Cellule Staminali
   2008" (M. D., P. P.), Regione Emilia Romagna (P. P., M. D.), and the
   Associazione ASEOP (P. P.). The authors are thankful to Flavia Parise
   and Renata Battini for their constant support in preclinical
   investigation studies.
CR Abdallah Basem M., 2008, V455, P89, DOI 10.1007/978-1-59745-104-8_6
   Ahmadbeigi N, 2012, CYTOTHERAPY, V14, P917, DOI 10.3109/14653249.2012.689426
   Baltanas FC, 2009, NEUROSCI LETT, V450, P23, DOI 10.1016/j.neulet.2008.10.108
   Benoit DSW, 2007, J BIOMED MATER RES A, V81A, P259, DOI 10.1002/jbm.a.31292
   Bernardo ME, 2011, BEST PRACT RES CL HA, V24, P73, DOI 10.1016/j.beha.2010.11.002
   Bernhardt A, 2013, CLIN ORAL IMPLAN RES, V24, P441, DOI 10.1111/j.1600-0501.2011.02350.x
   Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Burns JS, 2010, TISSUE ENG PT A, V16, P2331, DOI [10.1089/ten.tea.2009.0735, 10.1089/ten.TEA.2009.0735]
   CALDWELL J, 1991, J CELL PHYSIOL, V147, P344, DOI 10.1002/jcp.1041470221
   Cho HS, 2011, KOREAN J LAB MED, V31, P212, DOI 10.3343/kjlm.2011.31.3.212
   Ciapetti G, 2012, CURR PHARM DESIGN, V18, P1796, DOI 10.2174/138161212799859648
   Cuomo AV, 2009, J BONE JOINT SURG AM, V91A, P1073, DOI 10.2106/JBJS.H.00303
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   Dennis JE, 1998, BIOMATERIALS, V19, P1323, DOI 10.1016/S0142-9612(97)00170-1
   Di GH, 2012, J CELL PHYSIOL, V227, P879, DOI 10.1002/jcp.23066
   Dingari NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032406
   Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459
   Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391
   Fekete N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043255
   Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420
   Francois M, 2012, CYTOTHERAPY, V14, P147, DOI 10.3109/14653249.2011.623691
   Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384
   Garcovich M, 2009, BLOOD TRANSFUS-ITALY, V7, P268, DOI 10.2450/2008.0080-08
   Geesink RGT, 2002, CLIN ORTHOP RELAT R, P53, DOI 10.1097/00003086-200202000-00007
   Griffon DJ, 2011, J TISSUE ENG REGEN M, V5, P169, DOI 10.1002/term.302
   Hunt CJ, 2011, TRANSFUS MED HEMOTH, V38, P107, DOI 10.1159/000326623
   Impens S, 2010, TISSUE ENG PART C-ME, V16, P1575, DOI 10.1089/ten.TEC.2010.0069
   Jansen J, 2009, CYTOTHERAPY, V11, P79, DOI 10.1080/14653240802666050
   Kuznetsov SA, 2013, J TISSUE ENG REGEN M, V7, P226, DOI 10.1002/term.515
   Lane TA, 2009, TRANSFUSION, V49, P1471, DOI 10.1111/j.1537-2995.2009.02138.x
   Liu GP, 2008, CRYOBIOLOGY, V56, P209, DOI 10.1016/j.cryobiol.2008.02.008
   Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404
   Mankani MH, 2008, TISSUE ENG PT A, V14, P1949, DOI 10.1089/ten.tea.2007.0348
   Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190
   Miao D, 2004, TISSUE ENG, V10, P807, DOI 10.1089/1076327041348473
   Muraki K, 2006, TISSUE ENG, V12, P1711, DOI 10.1089/ten.2006.12.1711
   Ng AMH, 2008, J BIOMED MATER RES A, V85A, P301, DOI 10.1002/jbm.a.31324
   Nikolaev NI, 2012, J R SOC INTERFACE, V9, P2503, DOI 10.1098/rsif.2012.0271
   Pamphilon DH, 2010, VOX SANG, V99, P168, DOI 10.1111/j.1423-0410.2010.01329.x
   PUCHTLER H, 1978, HISTOCHEMISTRY, V56, P177, DOI 10.1007/BF00495978
   PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110
   Quan RF, 2012, CHIN J TRAUMATOL, V15, P131, DOI 10.3760/cma.j.issn.1008-1275.2012.03.001
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Rasini V, 2013, CYTOTHERAPY, V15, P292, DOI 10.1016/j.jcyt.2012.11.009
   Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104
   ROSS DD, 1989, CANCER RES, V49, P3776
   Scaglione S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00274
   Schallmoser K, 2009, BIO-MED MATER ENG, V19, P271, DOI 10.3233/BME-2009-0591
   Schrezenmeier H, 2010, VOX SANG, V99, P1, DOI 10.1111/j.1423-0410.2009.01295.x
   Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197
   Tilley S, 2006, REGEN MED, V1, P685, DOI 10.2217/17460751.1.5.685
   Vogel JP, 2006, PLATELETS, V17, P462, DOI 10.1080/09537100600758867
   Weber Christian, 2007, Open Biomed Eng J, V1, P64, DOI 10.2174/1874120700701010064
   Weszl M, 2012, J ORTHOP RES, V30, P489, DOI 10.1002/jor.21527
   Wiedmann-Al-Ahmad M, 2002, BIOMATERIALS, V23, P3319, DOI 10.1016/S0142-9612(02)00019-4
   Xia WJ, 2011, CELL BIOL INT, V35, P639, DOI 10.1042/CBI20100361
   Xu C, 2009, COLLOID SURFACE B, V73, P360, DOI 10.1016/j.colsurfb.2009.06.001
   Yoshikawa T, 2005, TISSUE ENG, V11, P152, DOI 10.1089/ten.2005.11.152
   Zoellner H, 1996, J CELL SCI, V109, P2571
NR 60
TC 13
Z9 14
U1 0
U2 16
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD MAR 1
PY 2014
VL 20
IS 3
BP 239
EP 251
DI 10.1089/ten.tec.2013.0250
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AB8CV
UT WOS:000332018600007
PM 23845029
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Lupoi, JS
   Singh, S
   Simmons, BA
   Henry, RJ
AF Lupoi, Jason S.
   Singh, Seema
   Simmons, Blake A.
   Henry, Robert J.
TI Assessment of Lignocellulosic Biomass Using Analytical Spectroscopy: an
   Evolution to High-Throughput Techniques
SO BIOENERGY RESEARCH
LA English
DT Article
DE Biomass; Spectroscopy; Raman spectroscopy; Near-infrared spectroscopy;
   Fourier transform infrared spectroscopy; High-throughput; Chemometrics
ID FOURIER-TRANSFORM RAMAN; NEAR-INFRARED SPECTROSCOPY; EUCALYPTUS-GLOBULUS
   WOOD; IONIC LIQUID PRETREATMENT; PLANT-CELL-WALLS; LIGNIN MONOMER
   COMPOSITION; CELLULOSE-I CRYSTALLINITY; CORN STOVER COMPOSITION; CUPRIC
   OXIDE OXIDATION; PINUS-SYLVESTRIS WOOD
AB Lignocellulosic biomass has been proposed as an option for reducing global dependence on nonrenewable energy sources, such as oil. Selection and development of biomass feedstocks that efficiently yield the maximum fuel or biomaterial requires the availability of reliable methods for compositional and structural characterization of plant material. Many standard methods for biomass analysis are laborious and slow, and employ a variety of harsh reagents requiring some degree of remediation. The use of simpler and more rapid spectroscopic methods has proved invaluable in analyzing biomass. In the twenty-first century, researchers have employed techniques such as Raman, mid-infrared, and near-infrared spectroscopy for a wide range of applications in endeavors to further understand biofuel feedstocks. While many methods remain time consuming and expensive, a growing interest in high-throughput spectroscopic techniques has provided faster and larger scale feedstock screening for desirable traits. This review seeks to provide an overview of both high-throughput techniques and those requiring longer analysis times but still providing abundant qualitative and quantitative data. While applications of these instrumental methods have been researched for decades, more recent developments will be discussed here.
C1 [Lupoi, Jason S.; Simmons, Blake A.; Henry, Robert J.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia.
   [Lupoi, Jason S.; Singh, Seema; Simmons, Blake A.] Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Emeryville, CA 94608 USA.
   [Singh, Seema; Simmons, Blake A.] Sandia Natl Labs, Biol & Mat Sci Ctr, Livermore, CA 94551 USA.
RP Lupoi, JS (reprint author), Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, 5885 Hollis St, Emeryville, CA 94608 USA.
EM jslupoi@lbl.gov; seesing@sandia.gov; basimmons@lbl.gov;
   robert.henry@uq.edu.au
RI Henry, Robert/B-5824-2008
OI Henry, Robert/0000-0002-4060-0292; Simmons, Blake/0000-0002-1332-1810
FU Queensland Alliance for Agriculture and Food Innovation; Joint BioEnergy
   Institute; Office of Science, Office of Biological and Environmental
   Research, of the US Department of Energy [DE-AC02-05CH11231]
FX This review was supported as part of a collaboration between the
   Queensland Alliance for Agriculture and Food Innovation and the Joint
   BioEnergy Institute. The work conducted by the Joint BioEnergy Institute
   was supported by the Office of Science, Office of Biological and
   Environmental Research, of the US Department of Energy under contract
   no. DE-AC02-05CH11231.
CR Abdul Khalil HPS, 2009, IND CROP PROD, V31, P113, DOI [10.1016/j.jndcrop.2009.09.008, DOI 10.1016/J.INDCR0P.2009.09.008]
   Adapa P., 2011, J AGR SCI TECH, V1, P177
   Adler PR, 2009, ECOL APPL, V19, P2202, DOI 10.1890/07-2094.1
   Agarwal U. P., 2011, P 16 INT S WOOD FIB, P170
   Agarwal U. P., 2010, LIGNIN LIGNANS ADV C, P103
   Agarwal U.P., 2008, CHARACTERIZATION LIG, P17, DOI [DOI 10.1002/9781444305425.CH2, 10.1002/9781444305425.ch2]
   Agarwal U. P., 1999, ADV LIGNOCELLULOSICS, P201
   Agarwal UP, 2006, PLANTA, V224, P1141, DOI 10.1007/s00425-006-0295-z
   Agarwal UP, 2013, J AGR FOOD CHEM, V61, P103, DOI 10.1021/jf304465k
   Agarwal UP, 2012, APPL SPECTROSC, V66, P750, DOI 10.1366/11-06563
   Agarwal UP, 2011, J WOOD CHEM TECHNOL, V31, P324, DOI 10.1080/02773813.2011.562338
   Agarwal UP, 2010, CELLULOSE, V17, P721, DOI 10.1007/s10570-010-9420-z
   Agarwal UP, 2009, J RAMAN SPECTROSC, V40, P1527, DOI 10.1002/jrs.2294
   Agarwal UP, 2008, HOLZFORSCHUNG, V62, P667, DOI 10.1515/HF.2008.112
   Agarwal UP, 2005, APPL SPECTROSC, V59, P385, DOI 10.1366/0003702053585327
   Agarwal UP, 1997, APPL SPECTROSC, V51, P1648, DOI 10.1366/0003702971939316
   Agarwal UP, 2003, TAPPI J, V2, P22
   Agarwal UP, 1995, INT S WOOD PULP CHEM, V3, P67
   AGBLEVOR FA, 1994, J ANAL APPL PYROL, V30, P125, DOI 10.1016/0165-2370(94)00808-6
   Akerholm M, 2003, HOLZFORSCHUNG, V57, P459, DOI 10.1515/HF.2003.069
   Albinsson B, 1999, J MOL STRUCT, V508, P19, DOI 10.1016/S0022-2860(98)00913-2
   Allison GG, 2009, BIORESOURCE TECHNOL, V100, P6428, DOI 10.1016/j.biortech.2009.07.015
   Alves A, 2006, J ANAL APPL PYROL, V76, P209, DOI 10.1016/j.jaap.2005.11.004
   Alves A, 2011, J NEAR INFRARED SPEC, V19, P343, DOI 10.1255/jnirs.946
   Alves A, 2009, J ANAL APPL PYROL, V85, P30, DOI 10.1016/j.jaap.2008.09.006
   Alves AMM, 2012, J NEAR INFRARED SPEC, V20, P275, DOI 10.1255/jnirs.987
   Armenta S, 2010, CRIT REV FOOD SCI, V50, P567, DOI 10.1080/10408390802606790
   Atalla RH, 1999, SOLID STATE NUCL MAG, V15, P1, DOI 10.1016/S0926-2040(99)00042-9
   Backa S, 2001, HOLZFORSCHUNG, V55, P225, DOI 10.1515/HF.2001.037
   Bailleres H, 2002, ANN FOR SCI, V59, P479, DOI [10.1051/forest:2002032, 10.1051/forest:20032]
   Balakshin MY, 2003, J AGR FOOD CHEM, V51, P6116, DOI 10.1021/jf034372d
   Bardet M, 2009, PROG NUCL MAG RES SP, V55, P199, DOI 10.1016/j.pnmrs.2009.02.001
   Barsberg S, 2006, BIOPHYS J, V90, P2978, DOI 10.1529/biophysj.105.070391
   Barsberg S, 2005, MACROMOL BIOSCI, V5, P743, DOI 10.1002/mabi.200500042
   Bermello A, 2002, INT J POLYM MATER, V51, P557, DOI [DOI 10.1080/00914030209696301, 10.1080/00914030209696301]
   Biagini E, 2006, IND ENG CHEM RES, V45, P4486, DOI 10.1021/ie0514049
   Bjarnestad S, 2002, ANAL CHEM, V74, P5851, DOI 10.1021/ac025926z
   BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5
   Blanco M, 2002, TRAC-TREND ANAL CHEM, V21, P240, DOI 10.1016/S0165-9936(02)00404-1
   Blanco M, 2004, BIOTECHNOL BIOENG, V88, P536, DOI 10.1002/bit.20214
   BONDAR RJL, 1974, CLIN CHEM, V20, P586
   Browning BL, 1963, CHEM WOOD, P249
   Bunzel M, 2006, J AGR FOOD CHEM, V54, P8352, DOI 10.1021/jf061525z
   Burns DA, 2008, HDB NEAR INFRARED AN, V35, P479
   Cao Y, 2004, J MOL STRUCT, V693, P87, DOI 10.1016/j.molstruc.2004.02.017
   Capanema EA, 2004, J AGR FOOD CHEM, V52, P1850, DOI 10.1021/jf035282b
   Capanema EA, 2005, J AGR FOOD CHEM, V53, P9639, DOI 10.1021/jf0515330
   Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125
   Casas A, 2012, SEP PURIF TECHNOL, V97, P115, DOI 10.1016/j.seppur.2011.12.032
   Castellan A, 2007, HOLZFORSCHUNG, V61, P504, DOI 10.1515/HF.2007.090
   Cetinkol OP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052820
   Cetinkol OP, 2010, BIOFUELS-UK, V1, P33, DOI 10.4155/BFS.09.5
   Chen C.-L., 1992, METHODS LIGNIN CHEM, P409
   Chen C.L, 1992, METHODS LIGNIN CHEM, P301, DOI DOI 10.1007/978-3-642-74065-7_21
   Chen C.-L., 1992, METHODS LIGNIN CHEM, P446
   Chundawat SPS, 2008, BIOTECHNOL BIOENG, V99, P1281, DOI 10.1002/bit.21805
   Chundawat SPS, 2011, ENERG ENVIRON SCI, V4, P973, DOI 10.1039/c0ee00574f
   Coates J., 2000, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A5606
   Cozzani V, 1997, CAN J CHEM ENG, V75, P127, DOI 10.1002/cjce.5450750120
   Dao NQ, 2006, ENCY ANAL CHEM, P13024
   Decker SR, 2009, BIOENERG RES, V2, P179, DOI 10.1007/s12155-009-9051-0
   del Rio JC, 2007, J ANAL APPL PYROL, V79, P39, DOI 10.1016/j.jaap.2006.09.003
   del Rio JC, 2012, J AGR FOOD CHEM, V60, P5922, DOI 10.1021/jf301002n
   del Rio JC, 2012, J AGR FOOD CHEM, V60, P3619, DOI 10.1021/jf300099g
   DeMartini JD, 2011, BIOTECHNOL BIOENG, V108, P306, DOI 10.1002/bit.22937
   Dence CW, 1992, METHODS LIGNIN CHEM, P33
   DENCE CW, 1992, METHODS LIGNIN CHEM, P458
   DeThomas F. A., 2002, HDB VIBRATIONAL SPEC, V1, P383
   Djikanovic D, 2007, RUSS J PHYS CHEM A+, V81, P1425, DOI 10.1134/S0036024407090142
   Dolan JW, 2000, ENCY ANAL CHEM, P11342
   Dorsey JG, 2000, ENCY ANAL CHEM, P11334
   Downes GM, 2012, CAN J FOREST RES, V42, P1577, DOI [10.1139/X2012-083, 10.1139/x2012-083]
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   DUCKWORTH JH, 1998, APPL SPECTROSCOPY CO, P93, DOI DOI 10.1016/B978-012764070-9/50006-8
   Edwards HGM, 2006, ENCY ANAL CHEM, P13058
   Lopes FJF, 2011, J WOOD CHEM TECHNOL, V31, P309, DOI 10.1080/02773813.2010.550379
   FENGEL D, 1979, ADV CHEM SER, P145
   Foster CE, 2010, JOVE-J VIS EXP, V1837, DOI [10.3791/1837, DOI 10.3791/1837]
   Foster Cliff E, 2010, J Vis Exp, DOI 10.3791/1745
   Fox SC, 2010, BIORESOURCES, V5, P990
   Foyle T, 2007, BIORESOURCE TECHNOL, V98, P3026, DOI 10.1016/j.biortech.2006.10.013
   Freda C, 2012, APPL BIOCHEM BIOTECH, V167, P2283, DOI 10.1007/s12010-012-9756-y
   Fukushima RS, 2001, J AGR FOOD CHEM, V49, P3133, DOI 10.1021/jf010449r
   Gao XD, 2013, BIOTECHNOL BIOENG, V110, P754, DOI 10.1002/bit.24751
   Gierlinger N, 2006, PLANT PHYSIOL, V140, P1246, DOI 10.1104/pp.105.066993
   Godin B, 2011, TALANTA, V85, P2014, DOI 10.1016/j.talanta.2011.07.044
   Goldman D.S., 2000, ENCY ANAL CHEM APPL, V9, P8256
   Gollapalli LE, 2002, APPL BIOCHEM BIOTECH, V98, P23, DOI 10.1385/ABAB:98-100:1-9:23
   Guerra A, 2006, J AGR FOOD CHEM, V54, P9696, DOI 10.1021/jf062433c
   Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x
   Hallac BB, 2009, J AGR FOOD CHEM, V57, P1275, DOI 10.1021/jf8030277
   Halttunen M, 2001, HOLZFORSCHUNG, V55, P631, DOI 10.1515/HF.2001.103
   Hames BR, 2003, APPL BIOCHEM BIOTECH, V105, P5, DOI 10.1385/ABAB:105:1-3:5
   Harris DC, 2003, QUANTITATIVE CHEM AN, P578
   HARRIS PJ, 1984, CARBOHYD RES, V127, P59, DOI 10.1016/0008-6215(84)85106-X
   Hatfield R, 2005, CROP SCI, V45, P832, DOI 10.2135/cropsci2004.0238
   Hatfield RD, 1999, J AGR FOOD CHEM, V47, P628, DOI 10.1021/jf9808776
   Hedenstrom M, 2009, MOL PLANT, V2, P933, DOI 10.1093/mp/ssp047
   HEDGES JI, 1982, ANAL CHEM, V54, P174, DOI 10.1021/ac00239a007
   Hoareau W, 2004, POLYM DEGRAD STABIL, V86, P567, DOI 10.1016/j.polymdegradstab.2004.07.005
   Hori K, 2000, ACS SYM SER, V742, P172
   Hou S, 2011, J INTEGR PLANT BIOL, V53, P166, DOI 10.1111/j.1744-7909.2010.01003.x
   Houghton TP, 2009, APPL BIOCHEM BIOTECH, V153, P4, DOI 10.1007/s12010-008-8406-x
   Huang F, 2011, J AGR FOOD CHEM, V59, P12910, DOI 10.1021/jf202701b
   Huber R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-42
   International A, 2007, STAND TEST METH DET
   International A, 2007, STAND TEST METH AC I
   Irfan M, 2011, TURK J BIOCHEM, V36, P322
   Jaaskelainen AS, 2006, HOLZFORSCHUNG, V60, P231, DOI 10.1515/HF.2006.038
   Jaaskelainen AS, 2005, J WOOD CHEM TECHNOL, V25, P51, DOI 10.1081/WCT-200058239
   Jaaskelainen AS, 2003, WOOD SCI TECHNOL, V37, P91, DOI 10.1007/s00226-003-0163-y
   Jehlicka J, 2009, J RAMAN SPECTROSC, V40, P1645, DOI 10.1002/jrs.2313
   Jehlicka J, 2009, SPECTROCHIM ACTA A, V73, P410, DOI 10.1016/j.saa.2008.09.004
   Jimare BMT, 2008, APPL SPECTROSC REV, V43, P452, DOI [10.1080/05704920802031382, DOI 10.1080/05704920802031382]
   Jin SY, 2007, IND CROP PROD, V26, P207, DOI 10.1016/j.indcrop.2007.03.004
   Johnson D. B., 1961, TAPPI, V44, P793
   Jones PD, 2006, WOOD SCI TECHNOL, V40, P709, DOI 10.1007/s00226-006-0085-6
   Jones RW, 2002, ANAL CHEM, V74, P453, DOI 10.1021/ac0106445
   Kacurikova M, 1998, FOOD HYDROCOLLOIDS, V13, P35
   Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x
   Katahira R, 2013, J AGR FOOD CHEM, V61, P3286, DOI 10.1021/jf303727t
   Kataoka Y, 2001, J WOOD SCI, V47, P325, DOI 10.1007/BF00766722
   Kelley SS, 2004, BIOMASS BIOENERG, V27, P77, DOI 10.1016/j.biomboie.2003.11.005
   Kensy F, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-68
   Kensy F, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-31
   Kihara M, 2002, SPECTROCHIM ACTA A, V58, P2213, DOI 10.1016/S1386-1425(01)00693-X
   Kline LM, 2010, BIORESOURCES, V5, P1366
   Kuroda K, 2005, IND CROP PROD, V22, P223, DOI 10.1016/j.indcrop.2005.01.002
   Labbe N, 2008, BIORESOURCES, V3, P1329
   Lai Y.Z., 1992, METHODS LIGNIN CHEM, P423
   LAPIERRE C, 1985, J WOOD CHEM TECHNOL, V5, P277, DOI 10.1080/02773818508085193
   LAPIERRE C, 1983, HOLZFORSCHUNG, V37, P189, DOI 10.1515/hfsg.1983.37.4.189
   Lapierre C., 2010, LIGNIN LIGNANS ADV C, P11
   Larsen KL, 2010, J PHYS CHEM B, V114, P8009, DOI 10.1021/jp1028239
   Lavine BK, 2013, ANAL CHEM, V85, P705, DOI 10.1021/ac303193j
   Lavine BK, 2001, APPL SPECTROSC, V55, P960, DOI 10.1366/0003702011953108
   Lee SH, 2009, BIOTECHNOL BIOENG, V102, P1368, DOI 10.1002/bit.22179
   Lemus R, 2002, BIOMASS BIOENERG, V23, P433, DOI 10.1016/S0961-9534(02)00073-9
   Lewis IR, 2001, PRACT SPECTROSC SERI, V28, P919
   Li CL, 2013, BIOENERG RES, V6, P14, DOI 10.1007/s12155-012-9220-4
   Li CL, 2011, BIORESOURCE TECHNOL, V102, P6928, DOI 10.1016/j.biortech.2011.04.005
   Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066
   Li HJ, 2012, RSC ADV, V2, P4951, DOI 10.1039/c2ra20557b
   Liu L, 2010, CARBOHYD POLYM, V81, P820, DOI 10.1016/j.carbpol.2010.03.058
   Liu YD, 2006, J AGR FOOD CHEM, V54, P2810, DOI 10.1021/jf052889e
   Liukko S, 2007, HOLZFORSCHUNG, V61, P509, DOI 10.1515/HF.2007.107
   Lozovaya VV, 1999, PHYTOCHEMISTRY, V50, P395, DOI 10.1016/S0031-9422(98)00575-5
   Lu FC, 2003, PLANT J, V35, P535, DOI 10.1046/j.1365-313X.2003.01817.x
   Lu FC, 1997, J AGR FOOD CHEM, V45, P2590, DOI 10.1021/jf970258h
   Lu Y, 2012, BIORESOURCE TECHNOL, V116, P114, DOI 10.1016/j.biortech.2012.04.006
   Lupoi JS, 2012, APPL SPECTROSC, V66, P903, DOI 10.1366/12-06621
   Lygin AV, 2011, GCB BIOENERGY, V3, P333, DOI 10.1111/j.1757-1707.2011.01091.x
   Machado AEH, 2001, J PHOTOCH PHOTOBIO A, V138, P253, DOI 10.1016/S1010-6030(00)00413-5
   Mansfield SD, 2012, NAT PROTOC, V7, P1579, DOI 10.1038/nprot.2012.064
   Marita JM, 2003, J AGR FOOD CHEM, V51, P1313, DOI 10.1021/jf0260592
   Marita JM, 1999, P NATL ACAD SCI USA, V96, P12328, DOI 10.1073/pnas.96.22.12328
   Martin-Sampedro R, 2011, J AGR FOOD CHEM, V59, P8761, DOI 10.1021/jf201605f
   Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001
   Maunu SL, 2002, PROG NUCL MAG RES SP, V40, P151, DOI 10.1016/S0079-6565(01)00041-3
   McCann MC, 2007, PLANT PHYSIOL, V143, P1314, DOI 10.1104/pp.106.093054
   McCreery RL, 2000, RAMAN SPECTROSCOPY C, P448
   McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3
   Meder R, 1999, HOLZFORSCHUNG, V53, P261, DOI 10.1515/HF.1999.044
   Meier D., 1992, METHODS LIGNIN CHEM, P177
   Meyer MW, 2011, ANAL CHIM ACTA, V706, P164, DOI 10.1016/j.aca.2011.08.031
   Mononen K, 2005, HOLZFORSCHUNG, V59, P381, DOI 10.1515/HF.2005.063
   Morrison WH, 2003, J AGR FOOD CHEM, V51, P2565, DOI 10.1021/jf020885t
   National Academy of Sciences, 2009, LIQ TRANSP FUELS COA
   Nelson GH, 1957, TAPPI, V40, P846
   Newman RH, 2004, HOLZFORSCHUNG, V58, P91, DOI 10.1515/HF.2004.012
   Nkansah K, 2010, J RENEW SUSTAIN ENER, V2, DOI 10.1063/1.3404181
   Nkansah K, 2010, J RENEW SUSTAIN ENER, V2, DOI 10.1063/1.3290749
   Nousiainen J, 2004, ANIM FEED SCI TECH, V115, P295, DOI 10.1016/j.anifeedsci.2004.03.004
   Nousiainen J, 2003, ANIM FEED SCI TECH, V110, P61, DOI 10.1016/S0377-8401(03)00206-2
   Nuopponen M, 2004, SPECTROCHIM ACTA A, V60, P2963, DOI 10.1016/j.saa.2004.02.007
   Nuopponen M, 2004, SPECTROCHIM ACTA A, V60, P2953, DOI 10.1016/j.saa.2004.02.008
   Nuopponen M, 2004, J WOOD CHEM TECHNOL, V24, P13, DOI 10.1081/WCT-120035941
   Nuopponen MH, 2006, J APPL POLYM SCI, V102, P810, DOI 10.1002/app.24143
   OBST JR, 1986, J WOOD CHEM TECHNOL, V6, P311, DOI 10.1080/02773818608085230
   Ona T, 2003, J PULP PAP SCI, V29, P6
   Ona T, 1997, J WOOD CHEM TECHNOL, V17, P399, DOI 10.1080/02773819708003141
   Ona T, 1998, J WOOD CHEM TECHNOL, V18, P367, DOI 10.1080/02773819809349586
   Ona T, 1998, J WOOD CHEM TECHNOL, V18, P43, DOI 10.1080/02773819809350124
   Ona T, 1998, J WOOD CHEM TECHNOL, V18, P27, DOI 10.1080/02773819809350123
   Ona T, 2000, J PULP PAP SCI, V26, P43
   OWEN NL, 1989, APPL SPECTROSC, V43, P451, DOI 10.1366/0003702894202760
   Pandey KK, 2008, HOLZFORSCHUNG, V62, P183, DOI 10.1515/HF2008.046
   Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10
   PEPPER JM, 1959, CAN J CHEM, V37, P1241, DOI 10.1139/v59-183
   Perlack RD, 2005, DOEGO1020052135 ORNL
   Perlack RD, 2011, ORNLTM2011224
   Pinto PC, 2005, IND ENG CHEM RES, V44, P9777, DOI 10.1021/ie0580760o
   Pinto PC, 2005, J AGR FOOD CHEM, V53, P7856, DOI 10.1021/jf058081b
   Poke FS, 2004, J WOOD CHEM TECHNOL, V24, P55, DOI 10.1081/WCT-120035944
   Poke FS, 2006, J WOOD CHEM TECHNOL, V26, P187, DOI 10.1080/02773810600732708
   Pordesimo LO, 2005, BIOMASS BIOENERG, V28, P366, DOI 10.1016/j.biombioe.2004.09.003
   Proniewicz LM, 2002, J MOL STRUCT, V614, P345, DOI 10.1016/S0022-2860(02)00275-2
   Rabemanolontsoa H, 2011, BIOMASS BIOENERG, V35, P4630, DOI 10.1016/j.biombioe.2011.09.014
   Ralph J, 1998, P NATL ACAD SCI USA, V95, P12803, DOI 10.1073/pnas.95.22.12803
   Ralph J, 2010, LIGNIN LIGNANS ADV C, P137, DOI DOI 10.1201/EBK1574444865-C5
   Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9
   Rencoret J, 2008, HOLZFORSCHUNG, V62, P514, DOI 10.1515/HF.2008.096
   Rencoret J, 2013, J AGR FOOD CHEM, V61, P2434, DOI 10.1021/jf304686x
   Rencoret J, 2011, PLANT PHYSIOL, V155, P667, DOI 10.1104/pp.110.167254
   Robinson AR, 2009, PLANT J, V58, P706, DOI 10.1111/j.1365-313X.2009.03808.x
   Roder T, 2005, MACROMOL SYMP, V223, P57, DOI 10.1002/masy.200550504
   Rodrigues J, 2001, HOLZFORSCHUNG, V55, P265, DOI 10.1515/HF.2001.044
   Ruiz R., 1996, HPLC ANAL LIQUID FRA
   Rutkowski P, 2012, J ANAL APPL PYROL, V95, P38, DOI 10.1016/j.jaap.2012.01.003
   Saar BG, 2010, ANGEW CHEM INT EDIT, V49, P5476, DOI 10.1002/anie.201000900
   Saariaho AM, 2005, VIB SPECTROSC, V37, P111, DOI 10.1016/j.vibspec.2004.08.001
   Saariaho AM, 2004, HOLZFORSCHUNG, V58, P82, DOI 10.1515/HF.2004.011
   Saariaho AM, 2003, APPL SPECTROSC, V57, P58, DOI 10.1366/000370203321165214
   Samorski M, 2005, BIOTECHNOL BIOENG, V92, P61, DOI 10.1002/bit.20573
   Samuel R, 2010, APPL BIOCHEM BIOTECH, V162, P62, DOI 10.1007/s12010-009-8749-y
   Santos RB, 2012, J AGR FOOD CHEM, V60, P4923, DOI 10.1021/jf301276a
   SARKANEN KV, 1971, LIGNINS OCCURRENCE F, P43
   Sathitsuksanoh N, 2011, BIOTECHNOL BIOENG, V108, P521, DOI 10.1002/bit.22964
   Schenzel K, 2005, CELLULOSE, V12, P223, DOI 10.1007/s10570-004-3885-6
   Schenzel K, 2001, CELLULOSE, V8, P49, DOI 10.1023/A:1016616920539
   Schenzel K, 2009, CELLULOSE, V16, P407, DOI 10.1007/s10570-009-9286-0
   Schimleck LR, 2004, CAN J FOREST RES, V34, P2363, DOI [10.1139/x04-119, 10.1139/X04-119]
   Schmer MR, 2012, AGRON J, V104, P54, DOI 10.2134/agronj2011.0195
   Schmidt J, 2010, LIGNIN LIGNANS ADV C, p[49, 1]
   Schulz H, 2007, VIB SPECTROSC, V43, P13, DOI 10.1016/j.vibspec.2006.06.001
   Selig MJ, 2011, BIOTECHNOL LETT, V33, P961, DOI 10.1007/s10529-011-0526-7
   SENE CFB, 1994, PLANT PHYSIOL, V106, P1623, DOI 10.1104/pp.106.4.1623
   Serapiglia MJ, 2008, APPL BIOCHEM BIOTECH, V145, P3, DOI 10.1007/s12010-007-8061-7
   Shaver JM, 2001, PRACT SPECTROSC SERI, V28, P275
   Shepherd M, 2011, BIOFUELS-UK, V2, P639, DOI [10.4155/bfs.11.136, 10.4155/BFS.11.136]
   Shih CJ, 2011, BIORESOURCE TECHNOL, V102, P5169, DOI 10.1016/j.biortech.2011.01.043
   Shih CJ, 2009, ANAL CHIM ACTA, V653, P200, DOI 10.1016/j.aca.2009.09.012
   Simmons BA, 2011, PLANT BIOTECHNOLOGY, P495
   Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046
   Singh S, 2009, BIOTECHNOL BIOENG, V104, P68, DOI 10.1002/bit.22386
   Sivakesava S, 2001, J IND MICROBIOL BIOT, V26, P185, DOI 10.1038/sj.jim.7000124
   Skoog D.A, 1998, PRINCIPLES INSTRUMEN
   Sluiter JB, 2010, J AGR FOOD CHEM, V58, P9043, DOI 10.1021/jf1008023
   Smith E, 2005, MODERN RAMAN SPECTROSCOPY: A PRACTICAL APPROACH, P1
   Smith M.E., 2000, NUCL MAGN RESON, V29, P251, DOI [DOI 10.1039/9781847553850-00251, 10.1039/9781847553850-00251]
   Smith-Moritz AM, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-26
   Sonoda T, 2001, ANAL CHEM, V73, P5429, DOI 10.1021/ac010557c
   Stackpole DJ, 2011, G3-GENES GENOM GENET, V1, P151, DOI 10.1534/g3.111.000372
   Stark E. W., 2002, HDB VIBRATIONAL SPEC, V1, P393
   Sticklen M, 2006, CURR OPIN BIOTECH, V17, P315, DOI 10.1016/j.copbio.2006.05.003
   Studer MH, 2009, BIOTECHNOL BIOENG, V105, P231, DOI [10.1002/bit.22527, DOI 10.1002/BIT.22527]
   Sun L, 2010, BIOTECHNOL BIOENG, V108, P286, DOI [DOI 10.1002/BIT.22931, 10.1002/bit.22931]
   Sun L, 2013, RSC ADV, V3, P2017, DOI 10.1039/c2ra20706k
   Sun L, 2012, BIOTECHNOL BIOENG, V109, P647, DOI 10.1002/bit.24348
   Sun R, 1999, POLYM DEGRAD STABIL, V67, P101, DOI [10.1016/s0141-3910(99)00099-3, DOI 10.1016/S0141-3910]
   Sun RC, 2001, J AGR FOOD CHEM, V49, P5122, DOI 10.1021/jf010500r
   Sun XF, 2004, POLYM DEGRAD STABIL, V86, P245, DOI 10.1016/j.polymdegradstab.2004.05.003
   Sykes R, 2009, METHODS MOL BIOL, V581, P169, DOI 10.1007/978-1-60761-214-8_12
   Takayama M, 1997, SPECTROCHIM ACTA A, V53, P1621, DOI 10.1016/S1386-1425(97)00100-5
   Templeton DW, 2009, CELLULOSE, V16, P621, DOI 10.1007/s10570-009-9325-x
   Templeton David W, 1994, DETERMINATION ETHANO
   Terashima N, 2009, HOLZFORSCHUNG, V63, P379, DOI 10.1515/HF.2009.074
   Thygesen A, 2005, CELLULOSE, V12, P563, DOI 10.1007/s10570-005-9001-8
   Tsuchikawa S, 2007, APPL SPECTROSC REV, V42, P43, DOI 10.1080/05704920601036707
   TSUTSUMI Y, 1995, HOLZFORSCHUNG, V49, P423, DOI 10.1515/hfsg.1995.49.5.423
   Tucker MP, 2000, APPL BIOCHEM BIOTECH, V84-6, P39, DOI 10.1385/ABAB:84-86:1-9:39
   Tuskan G, 1999, APPL BIOCHEM BIOTECH, V77-9, P55, DOI 10.1385/ABAB:77:1-3:55
   UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6
   VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2
   Vester J, 2004, APPL SPECTROSC, V58, P404, DOI 10.1366/000370204773580239
   Vitek P, 2012, SPECTROCHIM ACTA A, V86, P320, DOI 10.1016/j.saa.2011.10.043
   White KE, 2011, GEODERMA, V167-68, P197, DOI 10.1016/j.geoderma.2011.08.009
   Wolfrum EJ, 2009, CELLULOSE, V16, P567, DOI 10.1007/s10570-009-9320-2
   Workman J, 2011, ANAL CHEM, V83, P4557, DOI 10.1021/ac200974w
   Workman JJ, 1996, APPL SPECTROSC REV, V31, P251, DOI 10.1080/05704929608000571
   Workman JJ, 2001, APPL SPECTROSC REV, V36, P139, DOI 10.1081/ASR-100106154
   Workman Jr J, 2008, HDB NEAR INFRARED AN, P123
   Yamada T, 2006, HOLZFORSCHUNG, V60, P24, DOI 10.1515/HF.2006.005
   Yan JH, 2010, BIOMASS BIOENERG, V34, P48, DOI 10.1016/j.biombioe.2009.09.010
   Ye XP, 2008, BIORESOURCE TECHNOL, V99, P7323, DOI 10.1016/j.biortech.2007.12.063
   Yeh TF, 2005, J AGR FOOD CHEM, V53, P3328, DOI 10.1021/jf0480647
   Yeh TF, 2004, J AGR FOOD CHEM, V52, P1435, DOI 10.1021/jf034874r
   Yelle DJ, 2013, BIOENERG RES, V6, P211, DOI 10.1007/s12155-012-9247-6
   Yoshida M, 2008, BIOSCI BIOTECH BIOCH, V72, P805, DOI 10.1271/bbb.70689
   Yuen SN, 2009, FOOD CHEM, V114, P1091, DOI 10.1016/j.foodchem.2008.10.053
   Zavrel M, 2009, BIORESOURCE TECHNOL, V100, P2580, DOI 10.1016/j.biortech.2008.11.052
   Zhang AP, 2009, PLANTA, V229, P1099, DOI 10.1007/s00425-009-0894-6
NR 282
TC 46
Z9 47
U1 1
U2 93
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1939-1234
EI 1939-1242
J9 BIOENERG RES
JI BioEnergy Res.
PD MAR
PY 2014
VL 7
IS 1
BP 1
EP 23
DI 10.1007/s12155-013-9352-1
PG 23
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA AC4IG
UT WOS:000332484000001
DA 2018-10-20
ER

PT J
AU Wu, HF
   Teng, P
   Cai, JF
AF Wu, Haifan
   Teng, Peng
   Cai, Jianfeng
TI Rapid Access to Multiple Classes of Peptidomimetics from Common
   gamma-AApeptide Building Blocks
SO EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
LA English
DT Article
DE Solid-phase synthesis; Acylation; Peptidomimetics; -AApeptides
ID SOLID-PHASE SYNTHESIS; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL AGENTS;
   PEPTIDE; OLIGOMERS; DESIGN; POTENT; FOLDAMERS; RNA; PNA
AB Herein we report a highly efficient new method for preparing -AApeptides capable of theoretically containing any functionality; the method uses a few common N-alloc -AApeptide building blocks. More importantly, using the same approach, new classes of peptidomimetics bearing novel backbone scaffolds can also be readily generated. Our results not only demonstrate the versatility of this new synthetic method, but also highlight the possibility that the resulting novel peptidomimetics may find discrete biomedical/biomaterial applications in the future.
C1 [Wu, Haifan; Teng, Peng; Cai, Jianfeng] Univ S Florida, Dept Chem, Tampa, FL 33620 USA.
RP Cai, JF (reprint author), Univ S Florida, Dept Chem, 4202 E Fowler Ave, Tampa, FL 33620 USA.
EM jianfengcai@usf.edu
RI Wu, Haifan/F-8818-2014; Wu, Haifan/O-1935-2013; Teng, Peng/K-1046-2015
OI Wu, Haifan/0000-0002-2050-9950; Wu, Haifan/0000-0002-2050-9950; Teng,
   Peng/0000-0002-7412-9646
FU Elsa U. Pardee Foundation (USF start-up fund); Florida Bankhead-Coley
   Cancer Research Program
FX This work was partially supported by the Elsa U. Pardee Foundation (USF
   start-up fund) and by the Florida Bankhead-Coley Cancer Research
   Program.
CR Aguilera J, 2013, EUR J ORG CHEM, P3494, DOI 10.1002/ejoc.201300066
   Bouillere F, 2011, AMINO ACIDS, V41, P687, DOI 10.1007/s00726-011-0893-3
   Cheng PN, 2012, J AM CHEM SOC, V134, P14179, DOI 10.1021/ja305416a
   CHO CY, 1993, SCIENCE, V261, P1303, DOI 10.1126/science.7689747
   Gellman S, 2009, BIOPOLYMERS, V92, P293
   GENNARI C, 1995, ANGEW CHEM INT EDIT, V34, P1763, DOI 10.1002/anie.199517631
   Gennari C, 1998, EUR J ORG CHEM, P2437
   Gennari C., 1995, ANGEW CHEM INT EDIT, V107, P1892
   Gomez-Martinez P, 1999, J CHEM SOC PERK T 1, P2871, DOI 10.1039/a906025a
   Goodman CM, 2007, NAT CHEM BIOL, V3, P252, DOI 10.1038/nchembio876
   Haase HS, 2012, J AM CHEM SOC, V134, P7652, DOI 10.1021/ja302469a
   Harker EA, 2009, BIOORGAN MED CHEM, V17, P2038, DOI 10.1016/j.bmc.2009.01.039
   Huang ML, 2012, CHEMMEDCHEM, V7, P114, DOI 10.1002/cmdc.201100358
   Kapoor R, 2011, ANTIMICROB AGENTS CH, V55, P3054, DOI 10.1128/AAC.01516-10
   Kim JM, 1996, TETRAHEDRON LETT, V37, P5305, DOI 10.1016/0040-4039(96)01100-8
   Liu YH, 2001, SYNLETT, P1626
   Mathieu L., 2013, ANGEW CHEM, V125, P6122
   Mathieu L, 2013, ANGEW CHEM INT EDIT, V52, P6006, DOI 10.1002/anie.201302106
   Niu YH, 2012, MACROMOLECULES, V45, P7350, DOI 10.1021/ma3015992
   Niu YH, 2012, MOL PHARMACEUT, V9, P1529, DOI 10.1021/mp300070w
   Niu YH, 2012, J MED CHEM, V55, P4003, DOI 10.1021/jm300274p
   Niu YH, 2011, CHEM COMMUN, V47, P12197, DOI 10.1039/c1cc14476f
   Niu YH, 2011, ORG BIOMOL CHEM, V9, P6604, DOI 10.1039/c1ob05738c
   Niu YH, 2011, NEW J CHEM, V35, P542, DOI 10.1039/c0nj00943a
   Rapireddy S, 2007, J AM CHEM SOC, V129, P15596, DOI 10.1021/ja074886j
   Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749
   Tamilarasu N, 2001, BIOORG MED CHEM LETT, V11, P505, DOI 10.1016/S0960-894X(00)00709-5
   Wu HF, 2012, CHEM SCI, V3, P2570, DOI 10.1039/c2sc20428b
   Wu HF, 2012, ORG LETT, V14, P3446, DOI 10.1021/ol301406a
   Wu YD, 2008, ACCOUNTS CHEM RES, V41, P1231, DOI 10.1021/ar800216e
   Yang YA, 2012, CHEM COMMUN, V48, P7850, DOI 10.1039/c2cc33620k
NR 31
TC 12
Z9 12
U1 1
U2 17
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1434-193X
EI 1099-0690
J9 EUR J ORG CHEM
JI Eur. J. Org. Chem.
PD MAR
PY 2014
VL 2014
IS 8
BP 1760
EP 1765
DI 10.1002/ejoc.201301841
PG 6
WC Chemistry, Organic
SC Chemistry
GA AC0CH
UT WOS:000332161900021
DA 2018-10-20
ER

PT J
AU Yoon, H
   Kim, EY
   Kim, H
   Park, CH
   Joo, CK
   Khang, G
AF Yoon, Hyeon
   Kim, Eun Young
   Kim, Hyeongseok
   Park, Chan Hum
   Joo, Choun-Ki
   Khang, Gilson
TI Fabrication of transparent silk fibroin film for the regeneration of
   corneal endothelial cells; preliminary study
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE Bombyx mori; silk fibroin; transparent film; cornea endothelial cell
ID STEM-CELLS; IN-VIVO; SERICIN; PROTEIN; BIOMATERIAL; SKIN; PROLIFERATION;
   STRATEGIES; SCAFFOLDS; APOPTOSIS
AB Dystrophies related to the corneal endothelium result in edema, loss of transparency, and finally, blindness. Currently, the only treatment of patients with these corneal endothelial dystrophies is transplantation. However, the limited availability of donor corneas is a main obstacle to transplanting healthy endothelia. In this study, we have chosen silk from the silkworm to make a substratum for corneal endothelial cells (CEnCs). This approach offers the possibility of overcoming the issue of limited supply of donor corneas. Two types of transparent silk films with different sericin contents have been prepared by boiling for 30 min and 1 h, respectively, as delivery vehicles for application on the corneal endothelium. The contents of sericin for high-sericin silk (HSS) and low-sericin silk (LSS) are 9.83% and 6.25%, respectively. Physical and chemical properties were analyzed by contact angle, transparency, tensile strength, FTIR, and DSC. Proliferation assay by MTT was conducted to confirm the viability of the CEnCs. These results demonstrate that the fabricated transparent silk films have sufficient physical and chemical properties as a possible carrier for CEnCs.
C1 [Yoon, Hyeon; Kim, Eun Young; Kim, Hyeongseok; Khang, Gilson] Chonbuk Natl Univ, Dept PolymerNano Sci & Technol, Dept BIN Fus Technol, Jeonju 561756, South Korea.
   [Yoon, Hyeon; Kim, Eun Young; Kim, Hyeongseok; Khang, Gilson] Chonbuk Natl Univ, Polymer BIN Res Ctr, Jeonju 561756, South Korea.
   [Park, Chan Hum] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Gangwon 200702, South Korea.
   [Joo, Choun-Ki] Catholic Univ Korea, Gangnam St Mary Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul 137701, South Korea.
RP Khang, G (reprint author), Chonbuk Natl Univ, Dept PolymerNano Sci & Technol, Dept BIN Fus Technol, Jeonju 561756, South Korea.
EM gskhang@jbnu.ac.kr
RI Khang, Gilson/B-2109-2013
OI Park, Chan Hum/0000-0002-9732-361X
FU Bio & Medical Technology Development Program of the National Research
   Foundation; Korean government [NRF-2012M3A9C6050204]; Bio-industry
   Technology Development Program, Ministry for Food, Agriculture, Forestry
   and Fisheries, Republic of Korea [112007-05-2-SB010]
FX This research was supported by the Bio & Medical Technology Development
   Program of the National Research Foundation funded by the Korean
   government (NRF-2012M3A9C6050204) and Bio-industry Technology
   Development Program (112007-05-2-SB010), Ministry for Food, Agriculture,
   Forestry and Fisheries, Republic of Korea.
CR Aldave A. J., 2013, CLIN GENET
   Aldave AJ, 2007, ARCH OPHTHALMOL-CHIC, V125, P177, DOI 10.1001/archopht.125.2.177
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Baba T, 1996, J DERMATOL SCI, V12, P18, DOI 10.1016/0923-1811(95)00452-1
   Chu C. C., 1981, ANN SURG, P365
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Joyce NC, 2012, MOL VIS, V18, P547
   Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014
   Kaewkorn W, 2012, BIOL RES, V45, P45, DOI 10.4067/S0716-97602012000100006
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   Khang G, 2000, POLYM-KOREA, V24, P869
   Kim TH, 2011, INT J TISSUE REGEN, V2, P1
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lee O. J., 2010, INT J TISSUE REGEN, V1, P68
   Li MZ, 2003, POLYM ADVAN TECHNOL, V14, P694, DOI 10.1002/pat.409
   Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876
   Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mimura T, 2012, J FUNCT BIOMATER, V3, P726, DOI 10.3390/jfb3040726
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nishida A, 2011, INT J PHARMACEUT, V414, P193, DOI 10.1016/j.ijpharm.2011.05.033
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Sabater AL, 2013, REGEN MED, V8, P183, DOI [10.2217/rme.13.11, 10.2217/RME.13.11]
   Sah M. K., 2010, International Journal of Environmental Science and Development, V1, P404
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Takeuchi A, 2005, J ROY SOC INTERFACE, V2, P373, DOI 10.1098/rsif.2005.0052
   Terada S, 2005, J BIOSCI BIOENG, V100, P667, DOI 10.1263/jbb.100.667
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang JH, 2006, BIOMATERIALS, V27, P3441, DOI 10.1016/j.biomaterials.2006.02.002
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Yamamoto M., 2013, INT J TISSUE REGEN, V4, P36
   Yang D. H., 2011, INT J TISSUE REGEN, V2, P119
   Zavala J, 2013, EYE, V27, P579, DOI 10.1038/eye.2013.15
   Zeng YJ, 2001, J BIOMECH, V34, P533, DOI 10.1016/S0021-9290(00)00219-0
   Zhaorigetu S, 2003, J PHOTOCH PHOTOBIO B, V71, P11, DOI 10.1016/S1011-1344(03)00092-7
NR 41
TC 8
Z9 9
U1 0
U2 33
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
EI 2092-7673
J9 MACROMOL RES
JI Macromol. Res.
PD MAR
PY 2014
VL 22
IS 3
BP 297
EP 303
DI 10.1007/s13233-014-2037-6
PG 7
WC Polymer Science
SC Polymer Science
GA AC4JO
UT WOS:000332487400010
DA 2018-10-20
ER

PT J
AU Mahadik, BP
   Wheeler, TD
   Skertich, LJ
   Kenis, PJA
   Harley, BAC
AF Mahadik, Bhushan P.
   Wheeler, Tobias D.
   Skertich, Luke J.
   Kenis, Paul J. A.
   Harley, Brendan A. C.
TI Microfluidic Generation of Gradient Hydrogels to Modulate Hematopoietic
   Stem Cell Culture Environment
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE collagen hydrogels; gradients; hematopoietic progenitor cells;
   microfluidics; stem cell niches
ID EXTRACELLULAR-MATRIX PROTEINS; BONE-MARROW; FLUORESCENCE RECOVERY;
   LIVING CELLS; IN-VITRO; DIFFERENTIATION; MIGRATION; CHEMOTAXIS;
   BEHAVIOR; NICHES
AB The bone marrow provides spatially and temporally variable signals that impact the behavior of hematopoietic stem cells (HSCs). While multiple biomolecular signals and bone marrow cell populations have been proposed as key regulators of HSC fate, new tools are required to probe their importance and mechanisms of action. Here, a novel method based on a microfluidic mixing platform to create small volume, 3D hydrogel constructs containing overlapping patterns of cell and matrix constituents inspired by the HSC niche is described. This approach is used to generate hydrogels containing opposing gradients of fluorescent microspheres, MC3T3-E1 osteoblasts, primary murine hematopoietic stem and progenitor cells (HSPCs), and combinations thereof in a manner independent of hydrogel density and cell/particle size. Three different analytical methods are described to characterize local properties of these hydrogels at multiple scales: 1) whole construct fluorescent analysis; 2) multi-photon imaging of individual cells within the construct; 3) retrieval of discrete sub-regions from the hydrogel post-culture. The approach reported here allows the creation of stable gradients of cell and material cues within a single, optically translucent 3D biomaterial to enable a range of investigations regarding how microenvironmental signals impact cell fate.
C1 [Mahadik, Bhushan P.; Wheeler, Tobias D.; Skertich, Luke J.; Kenis, Paul J. A.; Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Roger Adams Lab 110, Urbana, IL 61801 USA.
   [Kenis, Paul J. A.; Harley, Brendan A. C.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
RP Harley, BAC (reprint author), Univ Illinois, Dept Chem & Biomol Engn, Roger Adams Lab 110, 600 S Mathews St, Urbana, IL 61801 USA.
EM bharley@illinois.edu
RI Kenis, Paul/S-7229-2016
OI Kenis, Paul/0000-0001-7348-0381; Harley, Brendan/0000-0001-5458-154X;
   Mahadik, Bhushan/0000-0001-5989-9880
FU American Cancer Society, Illinois Division, Inc. [160673, 189782];
   National Science Foundation [1254738]; Department of Chemical &
   Biomolecular Engineering at the University of Illinois at
   Urbana-Champaign; Institute for Genomic Biology at the University of
   Illinois at Urbana-Champaign
FX The authors would like to acknowledge Barbara Pilas and Bernard Montez
   (Flow Cytometry Facility, UIUC) as well as Sunny Choi (ChBE, UIUC) for
   assistance with bone marrow cell isolation and flow cytometry, Dr.
   Mayandi Sivaguru (IGB, UIUC) for assistance with fluorescence imaging,
   Dr. Peter Yau and Dr. Brian Ismai (Protein Sciences Facility, UIUC) for
   assistant with fluorescence scanner analyses, and Dr. Amit Desai (ChBE,
   UIUC) regarding microfluidic mixer design. This work was partially
   supported by Grants #160673 and #189782 from the American Cancer
   Society, Illinois Division, Inc. This material is based upon work
   supported by the National Science Foundation under Grant No. 1254738.
   The authors are also grateful for additional funding provided by the
   Department of Chemical & Biomolecular Engineering and the Institute for
   Genomic Biology at the University of Illinois at Urbana-Champaign.
CR Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054
   Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200
   Beta C, 2008, LAB CHIP, V8, P1087, DOI 10.1039/b801331d
   Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001
   Caelen I, 2000, LANGMUIR, V16, P9125, DOI 10.1021/la000851k
   Campos DFD, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015003
   Catros S, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/025001
   Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674
   Du YN, 2010, BIOMATERIALS, V31, P2686, DOI 10.1016/j.biomaterials.2009.12.012
   Ehninger A, J EXP MED, V208, P421
   Fosser KA, 2003, ANAL CHEM, V75, P5775, DOI 10.1021/ac034634a
   Gruene M, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/015005
   Gunawan RC, 2006, LANGMUIR, V22, P4250, DOI 10.1021/la0531493
   Gunawan RC, 2005, LANGMUIR, V21, P3061, DOI 10.1021/la048303k
   Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   He JK, 2011, BIOTECHNOL BIOENG, V108, P175, DOI 10.1002/bit.22901
   Hong S, 2013, J BIOSCI BIOENG, V116, P224, DOI 10.1016/j.jbiosc.2013.02.011
   Hosokawa K, 2010, BLOOD, V116, P554, DOI 10.1182/blood-2009-05-224857
   Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h
   JAIN RK, 1990, MICROVASC RES, V39, P77, DOI 10.1016/0026-2862(90)90060-5
   Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001
   Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b
   Ker EDP, 2011, BIOMATERIALS, V32, P8097, DOI 10.1016/j.biomaterials.2011.07.025
   Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381
   Klein RM, 2009, CANCER RES, V69, P2224, DOI 10.1158/0008-5472.CAN-08-3201
   Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657
   Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005
   Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI [10.1039/c0lc00240b, 10.1039/c01c00240b]
   Le Y, 2007, IMMUNITY, V27, P811, DOI 10.1016/j.immuni.2007.09.011
   Lecault V, 2011, NAT METHODS, V8, P581, DOI [10.1038/NMETH.1614, 10.1038/nmeth.1614]
   Liao JH, 2011, J ORTHOP RES, V29, P1544, DOI 10.1002/jor.21436
   Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068
   Magnusson M, 2008, CELL STEM CELL, V2, P302, DOI 10.1016/j.stem.2008.03.017
   Mosadegh B, 2007, LANGMUIR, V23, P10910, DOI 10.1021/la7026835
   OKADA S, 1992, BLOOD, V80, P3044
   Park SY, 2013, J IMMUNOL, V190, P1094, DOI 10.4049/jimmunol.1202639
   Pedron S., 2013, J BIOMED MAT A UNPUB
   Phillippi JA, 2008, STEM CELLS, V26, P127, DOI 10.1634/stemcells.2007-0520
   Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615
   Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9
   Selimovic S, 2011, ANAL CHEM, V83, P2020, DOI 10.1021/ac2001737
   Shin Y, 2011, LAB CHIP, V11, P2175, DOI 10.1039/c1lc20039a
   Silvestre J, 2009, LANGMUIR, V25, P10092, DOI 10.1021/la901109e
   SOKAL RR, 1982, CC/AGR BIOL ENVIRON, P22
   Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012
   Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001
   Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765
   Stroock AD, 2004, PHILOS T ROY SOC A, V362, P971, DOI 10.1098/rsta.2003.1357
   Tasoglu S, 2013, TRENDS BIOTECHNOL, V31, P10, DOI 10.1016/j.tibtech.2012.10.005
   Toh C. R., 2009, LANGMUIR
   Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X
   Wheeler TD, 2010, LAB CHIP, V10, P3387, DOI [10.1039/c0lc00162g, 10.1039/c01c00162g]
   Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779
   Xu F, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3580752
   Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159
   Yang YL, 2009, BIOPHYS J, V96, P1566, DOI [10.1016/j.bpj.2008.10.063, 10.1016/j.bpj.20()8.10.063]
   Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568
   Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384
NR 64
TC 39
Z9 39
U1 0
U2 75
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAR
PY 2014
VL 3
IS 3
BP 449
EP 458
DI 10.1002/adhm.201300263
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA AC2MW
UT WOS:000332336400017
PM 23997020
DA 2018-10-20
ER

PT J
AU Nabzdyk, CS
   Chun, MC
   Oliver-Allen, HS
   Pathan, SG
   Phaneuf, MD
   You, JO
   Pradhan-Nabzdyk, LK
   LoGerfo, FW
AF Nabzdyk, Christoph S.
   Chun, Maggie C.
   Oliver-Allen, Hunter S.
   Pathan, Saif G.
   Phaneuf, Matthew D.
   You, Jin-Oh
   Pradhan-Nabzdyk, Leena K.
   LoGerfo, Frank W.
TI Gene silencing in human aortic smooth muscle cells induced by PEI-siRNA
   complexes released from dip-coated electrospun poly(ethylene
   terephthalate) grafts
SO BIOMATERIALS
LA English
DT Article
DE Polyester; Silencing RNA; Transfection reagents; Human aortic smooth
   muscle cells; Thrombospondin-2
ID RNA INTERFERENCE; SUTURE MATERIAL; VASCULAR CELLS; BYPASS GRAFTS;
   IN-VITRO; DACRON; MIGRATION; THROMBOSPONDIN-2; NANOPARTICLES;
   ANASTOMOSIS
AB An excessive tissue response to prosthetic arterial graft material leads to intimal hyperplasia (IH), the leading cause of late graft failure. Seroma and abnormal capsule formation may also occur after prosthetic material implantation. The matricellular protein Thrombospondin-2 (TSP-2) has shown to be upregulated in response to biomaterial implantation. This study evaluates the uptake and release of small interfering RNA (siRNA) from unmodified and surface functionalized electrospun PET graft materials. ePET graft materials were synthesized using electrospinning technology. Subsets of the ePET materials were then chemically modified to create surface functional groups. Unmodified and surface-modified ePET grafts were dip-coated in siRNAs alone or siRNAs complexed with transfection reagents polyethyleneimine (PEI) or Lipofectamine RNAiMax. Further, control and TSP-2 siRNA PEI complex treated ePET samples were placed onto a confluent layer of human aortic smooth muscle cells (AoSMCs).
   Complexation of all siRNAs with PEI led to a significant increase in adsorption to unmodified ePET. TSP-2 siRNA-PEI released from unmodified-ePET silenced TSP-2 in AoSMC. Regardless of the siRNA-PEI complex evaluated, AoSMC migrated into the ePET. siRNA PEI complexes delivered to AoSMC from dip-coated ePET can result in gene knockdown. This methodology for siRNA delivery may improve the tissue response to vascular and other prosthetics. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
C1 [Nabzdyk, Christoph S.; Chun, Maggie C.; Oliver-Allen, Hunter S.; Pradhan-Nabzdyk, Leena K.; LoGerfo, Frank W.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Vasc & Endovasc Surg, Sch Med, Boston, MA 02215 USA.
   [Nabzdyk, Christoph S.] Tufts Univ, Sch Med, Tufts Med Ctr, Dept Surg, Boston, MA 02111 USA.
   [Pathan, Saif G.; Phaneuf, Matthew D.] BioSurfaces Inc, Ashland, MA USA.
   [You, Jin-Oh] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [You, Jin-Oh] Chungbuk Natl Univ, Dept Chem Engn, Cheongju, South Korea.
RP Pradhan-Nabzdyk, LK (reprint author), 330 Brookline Ave,Dana 805, Boston, MA 02215 USA.
EM lpradhan@bidmc.harvard.edu; flogerfo@bidmc.harvard.edu
FU National Institutes of Health [NIH 5R01 HL021796, NIH 2R01 HL086741, T32
   HL007734]; William J. von Liebig Foundation
FX This work was supported, in part, by grants from the National Institutes
   of Health (NIH 5R01 HL021796, NIH 2R01 HL086741 and T32 HL007734) and
   the William J. von Liebig Foundation.
CR Abdollahi A, 2010, HERNIA, V14, P569, DOI 10.1007/s10029-010-0685-9
   Andersen ND, 2007, J AM COLL SURGEONS, V204, P399, DOI 10.1016/j.jamcollsurg.2006.12.029
   Andersen ND, 2010, J VASC SURG, V52, P1608, DOI 10.1016/j.jvs.2010.06.169
   Annis D, 1984, POLYURETHANES BIOMED
   Bouillot JL, 2012, J VISC SURG, V149, pE53, DOI 10.1016/j.jviscsurg.2012.07.007
   Coda A, 2003, Hernia, V7, P29
   Cordero JA, 1998, J VASC SURG, V28, P157, DOI 10.1016/S0741-5214(98)70211-3
   DETTINGER GB, 1957, SURGERY, V42, P325
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Goyal R, 2012, NANOMED-NANOTECHNOL, V8, P167, DOI 10.1016/j.nano.2011.06.001
   HAMDAN AD, 1995, J VASC SURG, V21, P228, DOI 10.1016/S0741-5214(95)70264-4
   HENSHAW R E, 1964, J Am Osteopath Assoc, V63, P734
   Hohman MM, 2001, PHYS FLUIDS, V13, P2201, DOI 10.1063/1.1383791
   Junaid Y, 2007, N ENGL SOC VASC SURG
   Kadakol AK, 2011, J VASC SURG, V54, P637, DOI 10.1016/j.jvs.2011.03.258
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kyriakides TR, 2009, J CELL COMMUN SIGNAL, V3, P215, DOI 10.1007/s12079-009-0077-z
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   LATIMER EO, 1961, SURG GYNECOL OBSTET, V112, P373
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Mehrabi M, 2010, WORLD J SURG, V34, P1696, DOI 10.1007/s00268-010-0426-3
   Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016
   Monahan TS, 2009, FASEB J, V23, P557, DOI 10.1096/fj.08-114173
   Nabzdyk CS, 2012, BIOCHEM BIOPH RES CO, V425, P261, DOI 10.1016/j.bbrc.2012.07.078
   Nabzdyk CS, 2011, AM J PHYSIOL-HEART C, V301, pH1841, DOI 10.1152/ajpheart.00089.2011
   NARAT J K, 1957, Surg Forum, V7, P176
   Nimesh S, 2012, CURR CLIN PHARMACOL, V7, P121, DOI 10.2174/157488412800228857
   Nimesh S, 2009, EUR J PHARM BIOPHARM, V73, P43, DOI 10.1016/j.ejpb.2009.04.001
   Nolte A, 2011, MOL MED, V17, P1213, DOI 10.2119/molmed.2011.00143
   PHANEUF MD, 1995, J APPL BIOMATER, V6, P289, DOI 10.1002/jab.770060410
   PHELAN JT, 1958, SURGERY, V43, P969
   Roll Stephanie, 2008, BMC Surg, V8, P22, DOI 10.1186/1471-2482-8-22
   Sarkar S, 2006, EUR J VASC ENDOVASC, V31, P627, DOI 10.1016/j.ejvs.2006.01.006
   SHUMACKER HB, 1961, ARCH SURG-CHICAGO, V83, P647
   Stein Andrew J, 2011, Tech Hand Up Extrem Surg, V15, P12, DOI 10.1097/BTH.0b013e3181e71728
   Wang J, 2011, J SURG RES, V169, pE85, DOI 10.1016/j.jss.2011.03.060
   Wang L, 2009, CIRC RES, V104, P688, DOI 10.1161/CIRCRESAHA.108.188425
   Wehbe MA, 2013, HAND CLIN, V29, P27, DOI 10.1016/j.hcl.2012.08.019
   Willis DJ, 2004, J SURG RES, V120, P27, DOI 10.1016/j.jss.2003.12.014
   Yoshida S, 2011, J AM COLL SURGEONS, V213, P668, DOI 10.1016/j.jamcollsurg.2011.07.006
   Zhong T, 2003, BIFUNCTIONAL SURFACE, P24
   Zintchenko A, 2008, BIOCONJUGATE CHEM, V19, P1448, DOI 10.1021/bc800065f
NR 42
TC 16
Z9 16
U1 3
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2014
VL 35
IS 9
BP 3071
EP 3079
DI 10.1016/j.biomaterials.2013.12.026
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC0MH
UT WOS:000332188900051
PM 24397987
OA Green Accepted, Other Gold
DA 2018-10-20
ER

PT J
AU Unger, RE
   Peters, K
   Sartoris, A
   Freese, C
   Kirkpatrick, CJ
AF Unger, Ronald E.
   Peters, Kirsten
   Sartoris, Anne
   Freese, Christian
   Kirkpatrick, C. James
TI Human endothelial cell-based assay for endotoxin as sensitive as the
   conventional Limulus Amebocyte Lysate assay
SO BIOMATERIALS
LA English
DT Article
DE Endotoxin; Lipopolysaccharide; Limulus amebocyte assay; Endothelial
ID NANOPARTICLE FORMULATIONS; GENE-REGULATION; HOST RESPONSE; IN-VITRO;
   CONTAMINATION; BIOMATERIALS; COCULTURES; REMOVAL; SEPSIS
AB Endotoxin, also known as lipopolysaccharide (LPS) produced by bacteria can be present in any liquid or on any biomaterial even if the material is sterile. Endotoxin in mammals can cause fever, inflammation, cell and tissue damage and irreversible septic shock and death. In the body, endothelial cells making up the blood vasculature and endothelial cells in vitro rapidly react to minute amounts of endotoxin resulting in a rapid induction of the cell adhesion molecule E-selectin. In this study we have used immunofluorescent staining to evaluate the expression of E-selectin on human microvascular endothelial cells from the skin (HDMEC) and human umbilical vein endothelial cells (HUVEC) exposed to various concentrations of LPS. In addition, the sensitivity of detection was compared with the most widely used assay for the presence of endotoxin, the Limulus Amebocyte Lysate assay (LAL). The detection of E-selectin on endothelial cells in the presence of LPS for 4 h was found to be at least as sensitive in detecting the same concentration using the LAL assay. A cell adhesion molecule-enzyme immunosorbent assay was also developed and used to quantify LPS using the endothelial cell model. A comparison of LAL and the immunofluorescent staining method was carried out with solutions, nanoparticles, biomaterial extracts and endothelial cells grown directly on biomaterials. Under all conditions, the endothelial/E-selectin model system was positive for the test samples that were positive by LAL. Thus, we propose the use of this highly sensitive, rapid, reproducible assay for the routine testing of endotoxin in all steps in the manufacturing process of materials destined for use in humans. This can give a rapid feedback and localization of bacterial contamination sources with the LAL being reserved for the testing of the final product. (C) 2014 The Authors. Published by Elsevier Ltd. All rights reserved.
C1 [Unger, Ronald E.; Sartoris, Anne; Freese, Christian; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, Mainz, Germany.
   [Peters, Kirsten] Univ Rostock, Biomed Res Ctr, Med Res Ctr, D-18055 Rostock, Germany.
RP Unger, RE (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, Mainz, Germany.
EM runger@uni-mainz.de
RI Peters, Kirsten/S-3484-2016; Freese, Christian/Q-5540-2016
OI Freese, Christian/0000-0001-8411-1573
FU European Commission, FP6 project 'NanoBioPharmaceutics'
   [NMP4-CT-2006-026723]
FX This work has been supported by the European Commission, FP6 project
   'NanoBioPharmaceutics' (NMP4-CT-2006-026723).
CR [Anonymous], 1987, GUID VAL LIM AM LYS, P1
   BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238
   BEVILACQUA MP, 1987, SEMIN THROMB HEMOST, V13, P425, DOI 10.1055/s-2007-1003519
   Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010
   Daly KA, 2012, TISSUE ENG PT A, V18, P1293, DOI [10.1089/ten.tea.2011.0597, 10.1089/ten.TEA.2011.0597]
   Dobrovolskaia MA, 2010, NANOMEDICINE-UK, V5, P555, DOI [10.2217/nnm.10.29, 10.2217/NNM.10.29]
   Fiske MJ, 2001, J CHROMATOGR B, V753, P269, DOI 10.1016/S0378-4347(00)00561-2
   GLAUSER MP, 1991, LANCET, V338, P732, DOI 10.1016/0140-6736(91)91452-Z
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150
   HURLEY JC, 1995, CLIN MICROBIOL REV, V8, P268
   International Standards Organization, 1996, 10993 INT STAND OR 2
   Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385
   Lieder R, 2013, TISSUE ENG PART B-RE, V19, P391, DOI [10.1089/ten.teb.2012.0636, 10.1089/ten.TEB.2012.0636]
   Lynn WA, 1998, J ANTIMICROB CHEMOTH, V41, P71, DOI 10.1093/jac/41.suppl_1.71
   Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388
   Maitz MF, 2009, J BIOMED MATER RES B, V90B, P18, DOI 10.1002/jbm.b.31247
   Neun BW, 2011, METHODS MOL BIOL, V697, P121, DOI 10.1007/978-1-60327-198-1_12
   Peters K, 2003, CARDIOVASC RES, V60, P49, DOI 10.1016/S0008-6363(03)00397-3
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Rietschel ET, 1996, CURR TOP MICROBIOL, V216, P39
   Smulders S, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-41
   Stoddard MB, 2010, CLIN VACCINE IMMUNOL, V17, P98, DOI 10.1128/CVI.00342-09
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   Unger RE, 2005, BIOMATERIALS, V26, P3461, DOI 10.1016/j.biomaterials.2004.09.047
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002
   Williams David, 2003, Med Device Technol, V14, P8
NR 32
TC 19
Z9 19
U1 0
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2014
VL 35
IS 10
BP 3180
EP 3187
DI 10.1016/j.biomaterials.2013.12.059
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC0MC
UT WOS:000332188400005
PM 24456607
OA Other Gold
DA 2018-10-20
ER

PT J
AU Vitton, V
   Soudan, D
   Siproudhis, L
   Abramowitz, L
   Bouvier, M
   Faucheron, JL
   Leroi, AM
   Meurette, G
   Pigot, F
   Damon, H
AF Vitton, V.
   Soudan, D.
   Siproudhis, L.
   Abramowitz, L.
   Bouvier, M.
   Faucheron, J. -L.
   Leroi, A. -M.
   Meurette, G.
   Pigot, F.
   Damon, H.
TI Treatments of faecal incontinence: recommendations from the French
   National Society of Coloproctology
SO COLORECTAL DISEASE
LA English
DT Review
DE Faecal incontinence; national recommendations; coloproctology
ID SACRAL NERVE-STIMULATION; RADIOFREQUENCY ENERGY DELIVERY; INJECTABLE
   SILICONE BIOMATERIAL; CONSERVATIVE BOWEL MANAGEMENT; RANDOMIZED
   CONTROLLED-TRIAL; EXTERNAL ANAL-SPHINCTER; PELVIC FLOOR EXERCISES;
   DOUBLE-BLIND CROSSOVER; TOPICAL PHENYLEPHRINE; TRANSANAL IRRIGATION
AB Faecal incontinence is common and significantly affects quality of life. Its treatment involves dietary manipulation, medical treatments, perineal rehabilitation or surgery. In this paper, the French National Society of Coloproctology offers recommendations based on the data in the current literature, including those on recently developed treatments. There is a lack of high quality data and most of the recommendations are therefore based either on grade of recommendation B or expert recommendation (Level 4). However, the literature supports the construction of an algorithm based on the available scientific evidence and expert recommendation which may be useful in clinical practice. The French National Society of Coloproctology proposes a decision-making algorithm that includes recent developments of treatment. The current recommendations support sacral nerve modulation as the key treatment for faecal incontinence. They do not support the use of sphincter substitutions except in certain circumstances. Transanal irrigation is a novel often successful treatment of faecal incontinence due to neurological disorders.
C1 [Vitton, V.; Bouvier, M.] Aix Marseille Univ, Hop Nord, AP HM, Serv Gastroenterol,CRN2M,UMR 7286, F-13915 Marseille 20, France.
   [Soudan, D.] Grp Hosp Paris St Joseph, Inst Proctol Leopold Bellan, Paris, France.
   [Siproudhis, L.] CHU Pontchaillou, Serv Gastroenterol, Rennes, France.
   [Siproudhis, L.] Univ Rennes 1, Rennes, France.
   [Abramowitz, L.] CHU Bichat Claude Bernard, AP HP, Serv Gastroenterol, Unite Proctol Medicochirurgicale, Paris, France.
   [Faucheron, J. -L.] Hop Albert Michallon, Unite Chirurg Colorectale, Serv Chirurg Digest & Urgence, Grenoble, France.
   [Leroi, A. -M.] Ctr Hosp Univ Rouen, INSERM, Serv Physiol Digest Urinaire Resp & Sport, U1073, Rouen, France.
   [Meurette, G.] CHU Nantes Hotel Dieu, Inst Malad Appareil Digestif, Clin Chirurg Digest & Endocrine, Nantes, France.
   [Pigot, F.] Hop Bagatelle, Talence, France.
   [Damon, H.] Hosp Civils Lyon, Hop Edouard Herriot, Serv Explorat Fonct Digest, Lyon, France.
RP Vitton, V (reprint author), Aix Marseille Univ, Hop Nord, AP HM, Serv Gastroenterol,CRN2M,UMR 7286, Chemin Bourrely, F-13915 Marseille 20, France.
EM vittonv@yahoo.com
RI Meurette, Guillaume/M-1419-2015
CR Badvie S, 2005, CLIN ONCOL-UK, V17, P122, DOI 10.1016/j.clon.2004.07.011
   Beddy P, 2004, J GASTROINTEST SURG, V8, P64, DOI 10.1016/j.gassur.2003.10.005
   Bliss DZ, 2011, NURS RES, V60, pS58, DOI 10.1097/NNR.0b013e3182186d8c
   Bliss DZ, 2001, NURS RES, V50, P203, DOI 10.1097/00006199-200107000-00004
   Bliss DZ, 2000, J WOUND OSTOMY CONT, V27, P3
   Boyle DJ, 2009, DIS COLON RECTUM, V52, P1234, DOI 10.1007/DCR.0b013e31819f7400
   Brouwer R, 2010, DIS COLON RECTUM, V53, P273, DOI 10.1007/DCR.0b013e3181ceeb22
   Carapeti EA, 2000, DIS COLON RECTUM, V43, P1059, DOI 10.1007/BF02236550
   Caremel R, 2012, UROLOGY, V79, P80, DOI 10.1016/j.urology.2011.06.013
   Chan MKY, 2008, DIS COLON RECTUM, V51, P1015, DOI 10.1007/s10350-008-9326-0
   Christensen P, 2009, SPINAL CORD, V47, P138, DOI 10.1038/sc.2008.98
   Christensen P, 2006, GASTROENTEROLOGY, V131, P738, DOI 10.1053/j.gastro.2006.06.004
   CHRISTIANSEN J, 1987, LANCET, V2, P244
   CHRISTIANSEN J, 1990, BRIT J SURG, V77, P1039, DOI 10.1002/bjs.1800770928
   Croswell E, 2010, J WOUND OSTOMY CONT, V37, P677, DOI 10.1097/WON.0b013e3181feb017
   Del Popolo G, 2008, SPINAL CORD, V46, P517, DOI 10.1038/sj.sc.3102167
   Donnelly V, 1997, BRIT J OBSTET GYNAEC, V104, P311, DOI 10.1111/j.1471-0528.1997.tb11459.x
   Dudding TC, 2008, COLORECTAL DIS, V10, P249, DOI 10.1111/j.1463-1318.2007.01319.x
   Efron JE, 2003, DIS COLON RECTUM, V46, P1606, DOI 10.1097/01.DCR.0000098927.47914.D0
   Felt-Bersma RJ, 2007, EUR J GASTROEN HEPAT, V19, P575, DOI 10.1097/MEG.0b013e32811ec010
   Fox M, 2005, DIGEST DIS SCI, V50, P1576, DOI 10.1007/s10620-005-2900-6
   Ganio E, 2001, DIS COLON RECTUM, V44, P1261, DOI 10.1007/BF02234782
   Garcia V, 2005, AM J OBSTET GYNECOL, V192, P1697, DOI 10.1016/j.ajog.2004.11.045
   Gourcerol G, 2011, COLORECTAL DIS, V13, pE203, DOI 10.1111/j.1463-1318.2011.02623.x
   Hansen JL, 2006, J WOUND OSTOMY CONT, V33, P52, DOI 10.1097/00152192-200601000-00007
   Heymen S, 2009, DIS COLON RECTUM, V52, P1730, DOI 10.1007/DCR.0b013e3181b55455
   Holzer B, 2007, BRIT J SURG, V94, P749, DOI 10.1002/bjs.5499
   Jarrett MED, 2005, BRIT J SURG, V92, P734, DOI 10.1002/bjs.4859
   Jarrett MED, 2008, DIS COLON RECTUM, V51, P531, DOI 10.1007/s10350-008-9199-2
   Kenefick NJ, 2002, BRIT J SURG, V89, P896, DOI 10.1046/j.1365-2168.2002.02119.x
   Kenefick NJ, 2002, GUT, V51, P881, DOI 10.1136/gut.51.6.881
   Kim DW, 2009, AM J SURG, V197, P14, DOI 10.1016/j.amjsurg.2007.11.023
   KUMAR D, 1995, BRIT J SURG, V82, P1645, DOI 10.1002/bjs.1800821219
   Lauti M, 2008, COLORECTAL DIS, V10, P553, DOI 10.1111/j.1463-1318.2007.01439.x
   Lehur P A, 1999, Int J Surg Investig, V1, P268
   Lehur PA, 2010, DIS COLON RECTUM, V53, P1604, DOI 10.1007/DCR.0b013e3181f5d5f7
   Leroi AM, 2005, ANN SURG, V242, P662, DOI 10.1097/01.sla.0000186281.09475.db
   Leroi AM, 2001, DIS COLON RECTUM, V44, P779, DOI 10.1007/BF02234695
   Maeda K, 2002, Tech Coloproctol, V6, P15, DOI 10.1007/s101510200002
   Maeda Y, 2010, COCHRANE DATABASE SY, V5
   Martinez-Puente Mdel C, 2003, INT J COLORECTAL DIS, V7, P7
   MATZEL KE, 1995, LANCET, V346, P1124, DOI 10.1016/S0140-6736(95)91799-3
   Melenhorst J, 2007, COLORECTAL DIS, V9, P725, DOI 10.1111/j.1463-1318.2007.01241.x
   Mentes B B, 2007, Tech Coloproctol, V11, P115, DOI 10.1007/s10151-007-0340-3
   Norton C, 2006, DIS COLON RECTUM, V49, P190, DOI 10.1007/s10350-005-0251-1
   Norton C, 2003, GASTROENTEROLOGY, V125, P1320, DOI 10.1053/S0016-5085(03)01368-4
   Norton C, 2001, ALIMENT PHARM THER, V15, P1147, DOI 10.1046/j.1365-2036.2001.01039.x
   Pager CK, 2002, DIS COLON RECTUM, V45, P997, DOI 10.1097/01.DCR.0000019495.92696.34
   PALMER KR, 1980, GASTROENTEROLOGY, V79, P1272
   Park JS, 2007, INT J COLORECTAL DIS, V22, P1319, DOI 10.1007/s00384-007-0335-6
   Queralto M, 2006, INT J COLORECTAL DIS, V21, P670, DOI 10.1007/s00384-005-0068-3
   Rasmussen OO, 1999, DIS COLON RECTUM, V42, P193, DOI 10.1007/BF02237126
   Ratto C, 2012, COLORECTAL DIS, V14, pE297, DOI 10.1111/j.1463-1318.2012.03003.x
   Remes-Troche JM, 2008, INT J COLORECTAL DIS, V23, P189, DOI 10.1007/s00384-007-0391-y
   Rosen HR, 2001, GASTROENTEROLOGY, V121, P536, DOI 10.1053/gast.2001.27120
   Santoro GA, 2000, DIS COLON RECTUM, V43, P1676, DOI 10.1007/BF02236848
   SHOJI Y, 1993, SURGERY, V113, P560
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Solomon MJ, 2003, DIS COLON RECTUM, V46, P703, DOI 10.1097/01.DCR.0000070034.58255.06
   Sun WM, 1997, SCAND J GASTROENTERO, V32, P34, DOI 10.3109/00365529709025060
   Takahashi T, 2002, DIS COLON RECTUM, V45, P915, DOI 10.1007/s10350-004-6328-4
   Takahashi-Monroy T, 2008, DIS COLON RECTUM, V51, P355, DOI 10.1007/s10350-007-9169-0
   Thornton M J, 2004, Colorectal Dis, V6, P470, DOI 10.1111/j.1463-1318.2004.00714.x
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2003, DIS COLON RECTUM, V46, P937, DOI 10.1097/01.DCR.0000074687.97942.92
   Veronique V, 2010, INT J COLORECTAL DIS, V25, P1017, DOI 10.1007/s00384-010-0962-1
   Vitton V, 2008, NEUROGASTROENT MOTIL, V20, P407, DOI 10.1111/j.1365-2982.2007.01022.x
   Vitton V, 2008, DIS COLON RECTUM, V51, P924, DOI 10.1007/s10350-008-9209-4
   Vitton V, 2009, INFLAMM BOWEL DIS, V15, P402, DOI 10.1002/ibd.20774
   Wexner SD, 2002, DIS COLON RECTUM, V45, P809, DOI 10.1097/01.DCR.0000017604.54619.64
   Wong MTC, 2011, DIS COLON RECTUM, V54, P773, DOI 10.1007/DCR.0b013e3182182689
   Young CJ, 1998, DIS COLON RECTUM, V41, P344, DOI 10.1007/BF02237489
NR 73
TC 9
Z9 8
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-8910
EI 1463-1318
J9 COLORECTAL DIS
JI Colorectal Dis.
PD MAR
PY 2014
VL 16
IS 3
BP 159
EP 166
DI 10.1111/codi.12410
PG 8
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA AA3VW
UT WOS:000331024300007
PM 24521273
DA 2018-10-20
ER

PT J
AU Saadaldin, SA
   Rizkalla, AS
AF Saadaldin, Selma A.
   Rizkalla, Amin S.
TI Synthesis and characterization of wollastonite glass-ceramics for dental
   implant applications
SO DENTAL MATERIALS
LA English
DT Article
DE Wollastonite; Cristobalite; Glass-ceramics; Chemical durability;
   Fracture toughness; Machinability; Brittleness index
ID MECHANICAL-PROPERTIES; FRACTURE-TOUGHNESS; ZIRCONIA; BIOMATERIAL;
   DEGRADATION
AB Objectives. To synthesize a glass-ceramic (GC) that is suitable for non-metallic one-piece dental implant application.
   Methods. Three glasses in a SiO2-Al2O3-CaO-CaF2-K2O-B2O3-P2O5-CeO2-Y2O3 system were produced by wet chemistry. Differential thermal analysis (DTA) was carried out to determine the glass crystallization kinetic parameters and the heating schedules that were used for sintering of GCs. Crystalline phases and crystal morphologies were studied by X-ray diffraction (XRD) and scanning electron microscopy (SEM), respectively. Mechanical properties of the GCs were determined by ultrasonic and indentation tests and its machinability were evaluated. Chemical durability was carried out according to ISO 6872, whereas testing chemical degradation in tris buffered solution was executed according to ISO 10993-14.
   Results. XRD of the GC specimens showed that wollastonite was the main crystalline with other secondary phases; GC2 had cristobalite as an additional phase. SEM of the GCs revealed dense acicular interlocking crystals. Young's modulus of elasticity (E), true hardness (H-o) and fracture toughness (K-IC) of the GCs were 89-100 GPa, 4.85-5.17 GPa and 4.62-5.58 MPa m(0.5), respectively. All GCs were demonstrated excellent machinability. The GCs exhibited various chemical durability and degradation rates. K-1C values of the GCs following chemical durability testing were not significantly different from those of the original materials (p > 0.05). GC2 exhibited significantly higher K-1C value compared with GC1 and GC3 (p < 0.05) and its chemical durability satisfied ISO 6872 specification for dental ceramics.
   Significance. Wollastonite-cristobalite GC can be considered as a promising material for one-piece dental implant applications due to its strength, machinability and chemical durability. (C) 2014 Published by Elsevier Ltd on behalf of Academy of Dental Materials. All rights reserved.
C1 [Saadaldin, Selma A.; Rizkalla, Amin S.] Univ Western Ontario, Schulich Sch Med & Dent, Med Biophys Dept, London, ON N6A 5C1, Canada.
   [Saadaldin, Selma A.; Rizkalla, Amin S.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.
   [Rizkalla, Amin S.] Univ Western Ontario, Fac Engn, London, ON N6A 5C1, Canada.
RP Rizkalla, AS (reprint author), Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.
EM arizkalla@eng.uwo.ca
RI Rizkalla, Amin/D-8845-2015
OI Rizkalla, Amin/0000-0003-0548-3817
FU Natural Sciences and Engineering Research Council of Canada
FX The authors acknowledge the funding from the Natural Sciences and
   Engineering Research Council of Canada. Also the authors would like to
   thank Tim Goldhawk from the Western Nanofabrication for assistance with
   SEM, and Dr. Peter Canham from the Medical Biophysics Department for his
   valuable and constructive comments on the manuscript.
CR Anusavice K J, 1992, Adv Dent Res, V6, P82
   Anusavice KJ, 1997, DENT MATER, V13, P13, DOI 10.1016/S0109-5641(97)80003-6
   AUGIS JA, 1978, J THERM ANAL, V13, P283, DOI 10.1007/BF01912301
   Boccaccini AR, 1997, J MATER PROCESS TECH, V65, P302, DOI 10.1016/S0924-0136(96)02275-3
   Cannillo V, 2009, J EUR CERAM SOC, V29, P1665, DOI 10.1016/j.jeurceramsoc.2008.09.022
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P4457, DOI 10.1016/j.actbio.2010.06.031
   Esquivel-Upshaw JF, 2013, J DENT RES, V92, P467, DOI 10.1177/0022034513484332
   EVANS AG, 1984, J AM CERAM SOC, V67, P255
   FULTZ B., 2008, TRANSMISSION ELECT M, P1
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Holand W, 2002, GLASS CERAMIC TECHNO
   International Standard, 2001, ISO 10993 14
   International standard, 2008, ISO STANDARD 6782
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   LANKFORD J, 1982, J MATER SCI LETT, V1, P493, DOI 10.1007/BF00721938
   Leyens C., 2003, TITANIUM AND TITANIU
   MORENA R, 1986, DENT MATER, V2, P58, DOI 10.1016/S0109-5641(86)80052-5
   Natali AN., 2003, DENTAL BIOMECHANICS
   O'Brien WJ., 2008, DENTAL MATERIALS AND
   Park JB, 2007, BIOMATERIALS AN INTR
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rizkalla AS, 1996, J BIOMED MATER RES, V32, P119, DOI 10.1002/(SICI)1097-4636(199609)32:1<119::AID-JBM14>3.0.CO;2-H
   Rizkalla AS, 2004, DENT MATER, V20, P207, DOI 10.1016/S0109-5641(03)00093-9
   Saadaldin SA, 2013, DENT MATER, V29, P645, DOI 10.1016/j.dental.2013.03.013
   San O, 2009, J EUR CERAM SOC, V29, P2945, DOI 10.1016/j.jeurceramsoc.2009.04.013
   Schreiber E, 1973, ELASTIC CONSTANTS AN
   Volpato C. A. M., 2011, ADV CERAMICS ELECT M, P397, DOI DOI 10.5772/21630
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
   Zhang FM, 2008, J MATER SCI-MATER M, V19, P167, DOI 10.1007/s10856-006-0056-3
   Zhu HL, 2010, MAT SCI ENG C-MATER, V30, P132, DOI 10.1016/j.msec.2009.09.009
NR 32
TC 19
Z9 21
U1 3
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD MAR
PY 2014
VL 30
IS 3
BP 364
EP 371
DI 10.1016/j.dental.2013.12.007
PG 8
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA AB3VQ
UT WOS:000331718700017
PM 24444788
DA 2018-10-20
ER

PT J
AU Skwarek, E
   Janusz, W
   Sternik, D
AF Skwarek, E.
   Janusz, W.
   Sternik, D.
TI Adsorption of citrate ions on hydroxyapatite synthetized by various
   methods
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
LA English
DT Article
DE Hydroxyapatite; Adsorption; Citric acid; Thermal analysis
ID SYNTHETIC HYDROXYAPATITE; THERMAL-STABILITY; AQUEOUS-SOLUTIONS;
   SURFACE-CHARGE; CITRIC-ACID; TEMPERATURE; MORPHOLOGY; PH
AB The specific adsorption of citric acid ions at hydroxyapatite interface was investigated by the means of radioisotope method (C-14) as a function of citric acid ions concentration, NaCl concentration and pH. Application of the hydroxyapatite has become wide in the biomaterial field as the Ca-10(OH)(2)(PO4)(6) possess biocompatibility with human hard tissue. Hydroxyapatite was synthesized using three different methods. The physical properties of the resulting powder were characterized by DTA/TG, XRD, AFM and SEM microscopy. Physicochemical qualities characterizing the electrical double layer of the hydroxyapatite/NaCl solution interface were determined. The zeta potential and the adsorption of citric acid molecule were studied as a function of pH. The point of zero charge and the isoelectric point of samples were determined. Electrical double layer parameters of hydroxyapatite/NaCl interface are influenced by a synthesis method. The points pH(pzc) and pH(IEP) for sample 1 are pHpzc 7.5 and pH(IEP) 3; for sample 2 pH(pzc) 7.05 and pH(IEP) 3, for smaple 3 pH(pzc) 6.7 and pH(IEP) 3. Temperature has weak influence both on pure substance and with citric acid adsorbed, as derivatographic analysis has shown, and characterization of hydroxyapatite structure may be carried out by this thermal analysis. Two phenomena are responsible for citric acid adsorption: phosphate group's replacement at hydroxyapatite surface by citric ions parallel to intraspherical complexes formation.
C1 [Skwarek, E.; Janusz, W.; Sternik, D.] Marie Curie Sklodowska Univ, Fac Chem, PL-20031 Lublin, Poland.
RP Skwarek, E (reprint author), Marie Curie Sklodowska Univ, Fac Chem, Maria Curie Sklodowska Sq 5, PL-20031 Lublin, Poland.
EM ewunias@hektor.umcs.lublin.pl
CR Bianco A, 2007, J THERM ANAL CALORIM, V88, P237, DOI 10.1007/s10973-006-8011-6
   Dean-Mo L, 1996, BIOMATERIALS, V17, P1955
   Filgueiras MRT, 2006, J CRYST GROWTH, V294, P60, DOI 10.1016/j.jcrysgro.2006.05.077
   Goodwin JW, 1981, SPECIAL PUBLICATION, V43
   Harding IS, 2005, BIOMATERIALS, V26, P6818, DOI 10.1016/j.biomaterials.2005.04.060
   Janusz W, 2008, POL J CHEM, V82, P57
   Jillavenkatesa A, 1998, J MATER SCI, V33, P4111, DOI 10.1023/A:1004436732282
   Krajewski A, 2005, J MOL STRUCT, V744, P221, DOI 10.1016/j.molstruc.2004.10.044
   Liu JB, 2003, CERAM INT, V29, P629, DOI 10.1016/S0272-8842(02)00210-9
   Lopez-Macipe A, 1998, J COLLOID INTERF SCI, V200, P114, DOI 10.1006/jcis.1997.5343
   Lyklema JH, 1995, FUNDAMENTALS INTERFA
   Misra DN, 1998, COLLOID SURFACE A, V141, P173, DOI 10.1016/S0927-7757(98)00332-X
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Predoana L, 2009, J THERM ANAL CALORIM, V98, P361, DOI 10.1007/s10973-009-0315-x
   Riman RE, 2002, SOLID STATE IONICS, V151, P393, DOI 10.1016/S0167-2738(02)00545-3
   Rosskopfova O, 2013, J RADIOANAL NUCL CH, V295, P459, DOI 10.1007/s10967-012-1799-6
   Rosskopfova O, 2012, J RADIOANAL NUCL CH, V293, P641, DOI 10.1007/s10967-012-1711-4
   Rosskopfova O., 2010, J RADIOANAL NUCL CHE, V287, P715
   Skartsila P, 2007, J COLLOID INTERF SCI, V308, P405
   Suzuki S, 1998, J MATER SCI LETT, V17, P381, DOI 10.1023/A:1006526915828
   Tonsuaadu K, 2012, J THERM ANAL CALORIM, V110, P647, DOI 10.1007/s10973-011-1877-y
   Vega ED, 2003, J COLLOID INTERF SCI, V268, P37, DOI 10.1016/j.jcis.2003.07.033
   Wiese GR, 1976, INT REV SCI PHYS CHE, V2
   Yin G, 2002, CHEM ENG J, V87, P181, DOI 10.1016/S1385-8947(01)00248-0
NR 24
TC 21
Z9 21
U1 1
U2 31
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0236-5731
EI 1588-2780
J9 J RADIOANAL NUCL CH
JI J. Radioanal. Nucl. Chem.
PD MAR
PY 2014
VL 299
IS 3
BP 2027
EP 2036
DI 10.1007/s10967-013-2825-z
PG 10
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA AB8IU
UT WOS:000332034400111
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Kim, YM
   Oh, SH
   Choi, JS
   Lee, S
   Ra, JC
   Lee, JH
   Lim, JY
AF Kim, Young-Mo
   Oh, Se H.
   Choi, Jeong-Seok
   Lee, Songyi
   Ra, Jeong C.
   Lee, Jin H.
   Lim, Jae-Yol
TI Adipose-Derived Stem Cell-Containing Hyaluronic Acid/Alginate Hydrogel
   Improves Vocal Fold Wound Healing
SO LARYNGOSCOPE
LA English
DT Article
DE Mesenchymal stem cells; vocal folds; regeneration; hydrogel; hyaluronic
   acid; alginate
ID STROMAL CELLS; GROWTH-FACTOR; TISSUE REGENERATION; STEM/STROMAL CELLS;
   DIFFERENTIATION; INJECTION; BIOMATERIALS; FIBROBLASTS; SCAFFOLDS; MODEL
AB Objectives/Hypothesis The purpose of this study was to investigate the regenerative efficacy of an injectable hyaluronic acid/mildly cross-linked alginate hydrogel (HA/ALG hydrogel) containing human adipose-derived mesenchymal stem cells (hAdMSCs) for vocal fold (VF) wound healing.
   Study DesignAnimal research.
   MethodsHA/ALG hydrogel containing hAdMSCs was injected into the VFs of rabbits immediately after direct injury. Endoscopic evaluations were performed at 1 and 3 months after injury, and functional evaluations of mucosal vibration and viscoelastic properties were carried out posteuthanization at 3 months after injury. Histopathologic and immunohistochemical evaluations of extracellular matrix (ECM) components and of hepatocyte growth factor (HGF) activity were conducted in injured VFs. The engraftment of implanted hAdMSCs was investigated by detecting fluorescent-labeled cells.
   ResultsThe administration of hAdMSCs and hAdMSCs in HA/ALG hydrogel produced better macroscopic morphologies than the injection of phosphate-buffered saline (PBS). Histologic evaluations revealed that treatment with hAdMSCs in HA/ALG produced more favorable ECM changes than hAdMSC. In particular, the treatment of hAdMSCs in HA/ALG hydrogel ameliorated excessive deposition of collagen type I and increased HGF activity in regenerating VFs. hAdMSCs in HA/ALG-treated VFs also exhibited functional improvements in viscoelastic properties. hAdMSCs in HA/ALG remained viable in recipient VFs at 1 month after transplantation, and some were observed to be fostered to differentiate into fibroblasts.
   ConclusionsThe findings of the present study suggest that HA/ALG hydrogel is a promising biomaterial for prolonging the retention time of stem cells in VFs and for promotion of VF wound healing.
C1 [Kim, Young-Mo; Choi, Jeong-Seok; Lee, Songyi; Lim, Jae-Yol] Inha Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Inchon 400711, South Korea.
   [Kim, Young-Mo; Choi, Jeong-Seok; Lee, Songyi; Lim, Jae-Yol] Inha Univ, Sch Med, Incheon & Translat Res Ctr, Inchon 400711, South Korea.
   [Oh, Se H.] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.
   [Oh, Se H.] Dankook Univ, WCU Res Ctr, Cheonan, South Korea.
   [Ra, Jeong C.] RNL Bio Co Ltd, Stem Cell Res Ctr, Seoul, South Korea.
   [Lee, Jin H.] Hannam Univ, Dept Adv Mat, Taejon, South Korea.
RP Lim, JY (reprint author), Inha Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 27 Inhang Ro, Inchon 400711, South Korea.
EM jylim@inha.ac.kr
FU Basic Science Research Program of the National Research Foundation
   (NRF); Korean Ministry of Education, Science, and Technology
   [NRF-2010-0004316]; Inha University
FX This research was supported by the Basic Science Research Program of the
   National Research Foundation (NRF) funded by the Korean Ministry of
   Education, Science, and Technology (NRF-2010-0004316) and by an Inha
   University Research Grant. The funders had no role in study design, data
   collection or analysis, decision to publish, or preparation of this
   manuscript.
CR Benninger MS, 1996, OTOLARYNG HEAD NECK, V115, P474, DOI 10.1016/S0194-5998(96)70087-6
   Bless DM, 2010, CURR OPIN OTOLARYNGO, V18, P481, DOI 10.1097/MOO.0b013e3283407d87
   Cedervall J, 2007, LARYNGOSCOPE, V117, P2075, DOI 10.1097/MLG.0b013e3181379c7c
   Chhetri DK, 2004, OTOLARYNG HEAD NECK, V131, P864, DOI 10.1016/j.otohns.2004.07.010
   Choi JS, 2012, OTOLARYNG HEAD NECK, V147, P515, DOI 10.1177/0194599812446913
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Hertegard S, 2006, LARYNGOSCOPE, V116, P1248, DOI 10.1097/01.mlg.0000224548.68499.35
   Hong SJ, 2011, ACTA OTO-LARYNGOL, V131, P1198, DOI 10.3109/00016489.2011.599816
   Jay SM, 2009, J CONTROL RELEASE, V134, P26, DOI 10.1016/j.jconrel.2008.10.019
   Johnson BQ, 2010, LARYNGOSCOPE, V120, P537, DOI 10.1002/lary.20782
   Kanemaru S, 2005, ANN OTO RHINOL LARYN, V114, P907, DOI 10.1177/000348940511401203
   Kanemaru SI, 2003, ANN OTO RHINOL LARYN, V112, P915, DOI 10.1177/000348940311201101
   Kim YM, 2013, ANN OTO RHINOL LARYN, V122, P121, DOI 10.1177/000348941312200208
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kumai Y, 2010, LARYNGOSCOPE, V120, P330, DOI 10.1002/lary.20753
   Kumai Y, 2009, LARYNGOSCOPE, V119, P799, DOI 10.1002/lary.20149
   Lee BJ, 2006, CELLS TISSUES ORGANS, V184, P198, DOI 10.1159/000099627
   Liang Q, 2012, LARYNGOSCOPE, V122, P1815, DOI 10.1002/lary.23330
   Lim JY, 2008, EUR ARCH OTO-RHINO-L, V265, P321, DOI 10.1007/s00405-007-0458-y
   LIM JY, 2013, PLOS ONE, V8
   Long JL, 2010, LARYNGOSCOPE, V120, P125, DOI 10.1002/lary.20719
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maytag AL, 2013, J VOICE, V27, P24, DOI 10.1016/j.jvoice.2012.08.004
   Na SY, 2012, J MATER SCI-MATER M, V23, P2303, DOI 10.1007/s10856-012-4689-0
   Oh SH, 2005, J BIOMED MATER RES A, V72A, P306, DOI 10.1002/jbm.a.30239
   Ohno S, 2012, LARYNGOSCOPE, V122, P2503, DOI 10.1002/lary.23543
   Ohno S, 2011, ANN OTO RHINOL LARYN, V120, P401, DOI 10.1177/000348941112000610
   Ohta M, 2004, J BIOMED MATER RES A, V71A, P661, DOI 10.1002/jbm.a.30194
   Park H, 2010, TISSUE ENG PT A, V16, P535, DOI [10.1089/ten.tea.2009.0029, 10.1089/ten.TEA.2009.0029]
   Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466
   Rowe SL, 2006, BIOMACROMOLECULES, V7, P2942, DOI 10.1021/bm0602233
   Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8
   Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q
   Silva CM, 2006, EUR J PHARM SCI, V29, P148, DOI 10.1016/j.ejps.2006.06.008
   Thibeault SL, 2009, TISSUE ENG PT A, V15, P1481, DOI 10.1089/ten.tea.2008.0299
   Tong ZX, 2011, TISSUE ENG PT A, V17, P2773, DOI [10.1089/ten.tea.2011.0219, 10.1089/ten.TEA.2011.0219]
   Vyas B, 2010, ANN OTO RHINOL LARYN, V119, P350, DOI 10.1177/000348941011900513
   Xu W, 2011, ANN OTO RHINOL LARYN, V120, P123, DOI 10.1177/000348941112000209
NR 38
TC 28
Z9 32
U1 3
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0023-852X
EI 1531-4995
J9 LARYNGOSCOPE
JI Laryngoscope
PD MAR
PY 2014
VL 124
IS 3
BP E64
EP E72
DI 10.1002/lary.24405
PG 9
WC Medicine, Research & Experimental; Otorhinolaryngology
SC Research & Experimental Medicine; Otorhinolaryngology
GA AA8VY
UT WOS:000331374300002
PM 24115025
DA 2018-10-20
ER

PT J
AU Francisco, AT
   Hwang, PY
   Jeong, CG
   Jing, LF
   Chen, J
   Setton, LA
AF Francisco, Aubrey T.
   Hwang, Priscilla Y.
   Jeong, Claire G.
   Jing, Liufang
   Chen, Jun
   Setton, Lori A.
TI Photocrosslinkable laminin-functionalized polyethylene glycol hydrogel
   for intervertebral disc regeneration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nucleus pulposus; Intervertebral disc; Polyethylene glycol;
   Photocrosslinking; Laminin
ID NUCLEUS PULPOSUS CELLS; PROTEIN GENE-EXPRESSION; MESENCHYMAL STEM-CELLS;
   EXTRACELLULAR-MATRIX; NOTOCHORDAL CELLS; PROTEOGLYCAN PRODUCTION; ANULUS
   FIBROSUS; IN-VITRO; DEGENERATION; DIFFERENTIATION
AB Intervertebral disc (IVD) disorders and age-related degeneration are believed to contribute to lower back pain. There is significant interest in cell-based strategies for regenerating the nucleus pulposus (NP) region of the disc; however, few scaffolds have been evaluated for their ability to promote or maintain an immature NP cell phenotype. Previous studies have shown that NP cell-laminin interactions promote cell adhesion and biosynthesis, which suggests a laminin-functionalized biomaterial may be useful for promoting or maintaining the NP cell phenotype. Here, a photocrosslinkable poly(ethylene glycol)-laminin 111 (PEG-LM111) hydrogel was developed. The mechanical properties of PEG-LM111 hydrogel could be tuned within the range of dynamic shear moduli values previously reported for human NP. When primary immature porcine NP cells were seeded onto PEG-LM111 hydrogels of varying stiffnesses, LM111-presenting hydrogels were found to promote cell clustering and increased levels of sGAG production as compared to stiffer LM111-presenting and PEG-only gels. When cells were encapsulated in 3-D gels, hydrogel formulation was found to influence NP cell metabolism and expression of proposed NP phenotypic markers, with higher expression of N-cadherin and cytokeratin 8 observed for cells cultured in softer (<1 kPa) PEG-LM111 hydrogels. Overall, these findings suggest that soft, LM111-functionalized hydrogels may promote or maintain the expression of specific markers characteristic of an immature NP cell phenotype. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Francisco, Aubrey T.; Hwang, Priscilla Y.; Jeong, Claire G.; Jing, Liufang; Setton, Lori A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.
   [Chen, Jun; Setton, Lori A.] Duke Univ, Med Ctr, Div Orthopaed Surg, Durham, NC 27710 USA.
RP Setton, LA (reprint author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.
EM lori.setton@duke.edu
FU NIH [R01AR047442, R01EB002263, R01AR057410, T32GM008555]
FX This work was completed with support from NIH Grants R01AR047442,
   R01EB002263, R01AR057410 and T32GM008555.
CR Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Anderson JM, 2011, ACTA BIOMATER, V7, P675, DOI 10.1016/j.actbio.2010.08.016
   Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884
   Bibby SRS, 2005, SPINE, V30, P487, DOI 10.1097/01.brs.0000154619.38122.47
   Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002
   Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108
   Boyd LM, 2004, SPINE, V29, P2217, DOI 10.1097/01.brs.0000142747.90488.1d
   Bridgen DT, 2013, J ORTHOP RES, V31, P1661, DOI 10.1002/jor.22395
   BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022
   Chen J, 2002, BIOCHEM BIOPH RES CO, V293, P932, DOI 10.1016/S0006-291X(02)00314-5
   Chen J, 2006, EUR SPINE J, V15, pS303, DOI 10.1007/s00586-006-0088-x
   Chen J, 2009, CONNECT TISSUE RES, V50, P294, DOI 10.3109/03008200802714925
   Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805
   Chou AI, 2009, OSTEOARTHR CARTILAGE, V17, P1377, DOI 10.1016/j.joca.2009.04.012
   Cloyd JM, 2007, EUR SPINE J, V16, P1892, DOI 10.1007/s00586-007-0443-6
   Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018
   Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033
   Ekblom P, 2003, MATRIX BIOL, V22, P35, DOI 10.1016/S0945-053X(03)00015-5
   Erwin WM, 2006, SPINE, V31, P1094, DOI 10.1097/01.brs.0000216593.97157.dd
   Estes BT, 2008, BIOTECHNOL BIOENG, V99, P986, DOI 10.1002/bit.21662
   Francisco AT, 2013, BIOMATERIALS, V34, P7381, DOI 10.1016/j.biomaterials.2013.06.038
   Gilchrist CL, 2011, EUR CELLS MATER, V21, P523, DOI 10.22203/eCM.v021a39
   Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343
   Gilchrist CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027170
   Gilson A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2931
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005
   GOTZ W, 1995, CELL TISSUE RES, V280, P455
   Gruber H E, 2000, BMC Musculoskelet Disord, V1, P1, DOI 10.1186/1471-2474-1-1
   Gruber Helen E, 2004, Spine J, V4, P44, DOI 10.1016/S1529-9430(03)00425-X
   Grunhagen T, 2006, J BONE JOINT SURG AM, V88A, P30, DOI 10.2106/JBJS.E.01290
   Hayes AJ, 1999, DEV DYNAM, V215, P179, DOI 10.1002/(SICI)1097-0177(199907)215:3<179::AID-AJA1>3.3.CO;2-H
   HOLM S, 1981, CONNECT TISSUE RES, V8, P101, DOI 10.3109/03008208109152130
   Hunter CJ, 2004, SPINE, V29, P1099, DOI 10.1097/00007632-200405150-00010
   Iatridis JC, 1996, SPINE, V21, P1174, DOI 10.1097/00007632-199605150-00009
   Iatridis JC, 1997, J BIOMECH, V30, P1005, DOI 10.1016/S0021-9290(97)00069-9
   Iatridis JC, 1997, J ORTHOP RES, V15, P318, DOI 10.1002/jor.1100150224
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   Korecki CL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt18
   Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y
   LYONS G, 1981, BIOCHIM BIOPHYS ACTA, V673, P443, DOI 10.1016/0304-4165(81)90476-1
   Marquardt L, 2011, J BIOMED MATER RES A, V98A, P1, DOI 10.1002/jbm.a.33044
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929
   Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27
   Mizuno H, 2004, SPINE, V29, P1297
   Moss IL, 2010, SPINE, V36, P1022
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   Nettles DL, 2009, TISSUE ENG PT A, V15, P2113, DOI 10.1089/ten.tea.2008.0448
   Nettles DL, 2004, J ANAT, V204, P515, DOI 10.1111/j.0021-8782.2004.00306.x
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608
   Peroglio M, 2013, SPINE J, V13, P1627, DOI 10.1016/j.spinee.2013.05.029
   Reza AT, 2010, ACTA BIOMATER, V6, P179, DOI 10.1016/j.actbio.2009.06.004
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   RUFAI A, 1995, ANAT EMBRYOL, V192, P53
   Sakai D, 2006, BIOMATERIALS, V27, P346, DOI 10.1016/j.biomaterials.205.06.040
   Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705
   Scott R, 2010, J BIOMED MATER RES A, V93A, P817, DOI 10.1002/jbm.a.32775
   Tang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052020
   TROUT JJ, 1982, TISSUE CELL, V14, P359, DOI 10.1016/0040-8166(82)90033-7
   Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629
   Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 68
TC 20
Z9 20
U1 3
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2014
VL 10
IS 3
BP 1102
EP 1111
DI 10.1016/j.actbio.2013.11.013
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3AO
UT WOS:000331663900005
PM 24287160
OA Green Published, Green Accepted
DA 2018-10-20
ER

PT J
AU Battiston, KG
   Ouyang, B
   Labow, RS
   Simmons, CA
   Santerre, JP
AF Battiston, K. G.
   Ouyang, B.
   Labow, R. S.
   Simmons, C. A.
   Santerre, J. P.
TI Monocyte/macrophage cytokine activity regulates vascular smooth muscle
   cell function within a degradable polyurethane scaffold
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Polyurethane; Monocyte; Co-culture; Smooth muscle cell; Cytokines
ID BIOMATERIAL SURFACE-CHEMISTRY; IN-VITRO; GROWTH-FACTORS; BLOOD-VESSELS;
   MACROPHAGE ACTIVATION; HUMAN ARTERIAL; UP-REGULATION; PROLIFERATION;
   DIFFERENTIATION; EXPRESSION
AB Tissue engineering strategies rely on the ability to promote cell proliferation and migration into porous biomaterial constructs, as well as to support specific phenotypic states of the cells in vitro. The present study investigated the use of released factors from monocytes and their derived macrophages (MDM) and the mechanism by which they regulate vascular smooth muscle cell (VSMC) response in a VSMC-monocyte co-culture system within a porous degradable polyurethane (D-PHI) scaffold. VSMCs cultured in monocyte/MDM-conditioned medium (MCM), generated from the culture of monocytes/MDM on D-PHI scaffolds for up to 28 days, similarly affected VSMC contractile marker expression, growth and three-dimensional migration when compared to direct VSMC-monocyte co-culture. Monocyte chemotactic protein-1 (MCP-1) and interleukin-6 (IL-6) were identified as two cytokines present in MCM, at concentrations that have previously been shown to influence VSMC phenotype. VSMCs cultured alone on D-PHI scaffolds and exposed to MCP-1 (5 ng ml(-1)) or IL-6 (1 ng ml(-1)) for 7 days experienced a suppression in contractile marker expression (with MCP-1 or IL-6) and increased growth (with MCP-1) compared to no cytokine medium supplementation. These effects were also observed in VSMC-monocyte co-culture on D-PHI. Neutralization of IL-6, but not MCP-1, was subsequently shown to decrease VSMC growth and enhance calponin expression for VSMC-monocyte co-cultures on D-PHI scaffolds for 7 days, implying that IL-6 mediates VSMC response in monocyte-VSMC co-cultures. This study highlights the use of monocytes and their derived macrophages in conjunction with immunomodulatory biomaterials, such as D-PHI, as agents for regulating VSMC response, and demonstrates the importance of monocyte/MDM-released factors, such as IL-6 in particular, in this process. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Battiston, K. G.; Ouyang, B.; Simmons, C. A.; Santerre, J. P.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Labow, R. S.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Labow, R. S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
   [Simmons, C. A.; Santerre, J. P.] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, 124 Edward St, Toronto, ON M5G 1G6, Canada.
EM paul.santerre@utoronto.ca
RI Simmons, Craig/A-5880-2008
OI Simmons, Craig/0000-0001-7729-1772
FU Natural Sciences and Engineering Research Council/Canadian Institutes of
   Health Research (NSERC/CIHR) [337246/83459]; CIHR [230762, STP-53877];
   NSERC; Ontario Graduate Scholarship (OGS)
FX This study was funded by an Natural Sciences and Engineering Research
   Council/Canadian Institutes of Health Research (NSERC/CIHR)
   collaborative grant #337246/83459 (J.P.S., R.S.L.) and CIHR operating
   grant #230762 (J.P.S., R.S.L., C.A.S.). B.O. was funded by an NSERC
   Undergraduate Student Research Award (USRA). K.G.B. was funded by a CIHR
   Strategic Training Fellowship (STP-53877) and by an Ontario Graduate
   Scholarship (OGS). Thanks to Feryal Sarraf for help with preparation of
   histology samples and staining and to Gurbaksh Basi for collection of
   the microarray data.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bajaj MS, 2007, J THROMB HAEMOST, V5, P1493, DOI 10.1111/j.1538-7836.2007.02604.x
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]
   BONIN PD, 1989, EXP CELL RES, V181, P475, DOI 10.1016/0014-4827(89)90104-3
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Boyle JJ, 2001, ARTERIOSCL THROM VAS, V21, P1402, DOI 10.1161/hq0901.094279
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Cai QK, 2004, AM J PHYSIOL-CELL PH, V287, pC707, DOI 10.1152/ajpcell.00170.2004
   Chan-Park MB, 2009, J BIOMED MATER RES A, V88A, P1104, DOI 10.1002/jbm.a.32318
   Daly KA, 2012, TISSUE ENG PT A, V18, P1293, DOI [10.1089/ten.tea.2011.0597, 10.1089/ten.TEA.2011.0597]
   Dinnes DLM, 2008, DIFFERENTIATION, V76, P232, DOI 10.1111/j.1432-0436.2007.00221.x
   Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357
   FRID MG, 1992, DEV BIOL, V153, P185, DOI 10.1016/0012-1606(92)90104-O
   Gong Z, 2009, TISSUE ENG PT A, V15, P319, DOI 10.1089/ten.tea.2008.0161
   Ikeda U, 1998, CARDIOVASC RES, V37, P820, DOI 10.1016/S0008-6363(97)00265-4
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852
   Kunigal S, 2003, BLOOD, V102, P4377, DOI 10.1182/blood-203-12-3872
   Laflamme K, 2006, TISSUE ENG, V12, P2275, DOI 10.1089/ten.2006.12.2275
   Li L, 2011, J CELL BIOCHEM, V112, P289, DOI 10.1002/jcb.22924
   Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397
   Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048
   McBane JE, 2011, BIOMATERIALS, V32, P3584, DOI 10.1016/j.biomaterials.2011.01.069
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Miano JM, 1996, J BIOL CHEM, V271, P7095, DOI 10.1074/jbc.271.12.7095
   Mirensky TL, 2010, J PEDIATR SURG, V45, P1299, DOI 10.1016/j.jpedsurg.2010.02.102
   Mosser DM, 2010, NAT REV IMMUNOL, V10, P460, DOI 10.1038/nri2788
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Nam MH, 2011, BBA-GEN SUBJECTS, V1810, P907, DOI 10.1016/j.bbagen.2011.06.005
   Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871
   Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005
   Postiglione L, 2005, J RHEUMATOL, V32, P656
   Proudfoot D, 1999, ATHEROSCLEROSIS, V145, P157, DOI 10.1016/S0021-9150(99)00028-3
   Ratajska A, 2001, HISTOCHEM CELL BIOL, V116, P79
   Risinger GM, 2010, AM J PHYSIOL-CELL PH, V298, pC191, DOI 10.1152/ajpcell.00417.2008
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Ross JJ, 2006, J CLIN INVEST, V116, P3139, DOI 10.1172/JCI28184
   Sandbo N, 2007, CARDIOVASC RES, V74, P262, DOI 10.1016/j.cardiores.2007.01.011
   Schatteman GC, 2010, AM J PATHOL, V177, P2002, DOI 10.2353/ajpath.2010.091232
   Schepers A, 2006, ARTERIOSCL THROM VAS, V26, P2063, DOI 10.1161/01.ATV.0000235694.69719.e2
   Sharifpoor S, 2010, ACTA BIOMATER, V6, P4218, DOI 10.1016/j.actbio.2010.06.018
   Sharifpoor S, 2009, BIOMACROMOLECULES, V10, P2729, DOI 10.1021/bm9004194
   Shinozaki M, 2009, ARCH DERMATOL RES, V301, P531, DOI 10.1007/s00403-009-0969-z
   Shireman PK, 2006, J SURG RES, V134, P145, DOI 10.1016/j.jss.2005.12.003
   Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356
   Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490
   Spinetti G, 2004, ARTERIOSCL THROM VAS, V24, P1397, DOI 10.1161/01.ATV.0000134529.65173.08
   Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031
   Sudhakaran PR, 2007, GLYCOCONJUGATE J, V24, P49, DOI 10.1007/s10719-006-9011-2
   Syedain ZH, 2011, J BIOMECH, V44, P848, DOI 10.1016/j.jbiomech.2010.12.007
   Syedain ZH, 2011, BIOMATERIALS, V32, P714, DOI 10.1016/j.biomaterials.2010.09.019
   Thomay AA, 2009, AM J PATHOL, V174, P2129, DOI 10.2353/ajpath.2009.080765
   Wakelin SJ, 2006, IMMUNOL LETT, V106, P1, DOI 10.1016/j.imlet.2006.04.007
   Wang C, 2010, BIOMATERIALS, V31, P621, DOI 10.1016/j.biomaterials.2009.09.086
   Wang ZB, 2003, J SURG RES, V111, P261, DOI 10.1016/S0022-4804(03)00087-8
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Yu HX, 2011, ARTERIOSCL THROM VAS, V31, P2402, DOI 10.1161/ATVBAHA.111.235622
   Zhu Y, 2000, J CARDIOVASC PHARM, V36, P152, DOI 10.1097/00005344-200008000-00003
NR 65
TC 12
Z9 12
U1 2
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2014
VL 10
IS 3
BP 1146
EP 1155
DI 10.1016/j.actbio.2013.12.022
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3AO
UT WOS:000331663900009
PM 24361424
DA 2018-10-20
ER

PT J
AU Jiang, B
   Akar, B
   Waller, TM
   Larson, JC
   Appel, AA
   Brey, EM
AF Jiang, B.
   Akar, B.
   Waller, T. M.
   Larson, J. C.
   Appel, A. A.
   Brey, E. M.
TI Design of a composite biomaterial system for tissue engineering
   applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Neovascularization; Tissue engineering; Fibroblast growth factor;
   Platelet-derived growth factor; Poly(lactic-co-glycolic acid)
ID POLY(ETHYLENE GLYCOL) HYDROGELS; FIBROBLAST-GROWTH-FACTOR; SEQUENTIAL
   DELIVERY; PDGF-BB; ANGIOGENESIS
AB Biomaterials that regulate vascularized tissue formation have the potential to contribute to new methods of tissue replacement and reconstruction. The goal of this study was to develop a porous, degradable tissue engineering scaffold that could deliver multiple growth factors and regulate vessel assembly within the porous structure of the material. Porous hydrogels of poly(ethylene glycol)-co-(L-lactic acid) (PEG-PLLA) were prepared via salt leaching. The degradation time of the hydrogels could be controlled between 1 and 7 weeks, based on hydrogel composition. Fibrin was incorporated into the interconnected pores of the hydrogels to promote neovascularization and as a reservoir for rapid (<5 days) growth factor delivery. Poly(lactic-co-glycolic acid) (PLGA) microspheres were incorporated into the degradable polymeric hydrogel scaffold to allow sustained (>30 days) growth factor delivery. Fibroblast growth factor-1 (FGF-1) and platelet-derived growth factor-BB (PDGF-BB) were delivered from the system owing to their roles in the promotion of angiogenesis and vascular stabilization, respectively. Hydrogels tested in vivo with a subcutaneous implantation model were selected based on the results from in vitro degradation and growth factor release kinetics. Dual growth factor delivery promoted significantly more tissue ingrowth in the scaffold compared with blank or single growth factor delivery. The sequential delivery of FGF-1 following PDGF-BB promoted more persistent and mature blood vessels. In conclusion, a biomaterials system was developed to provide structural support for tissue regeneration, as well as delivery of growth factors that stimulate neovascularization within the structure prior to complete degradation. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Jiang, B.; Akar, B.; Waller, T. M.; Larson, J. C.; Appel, A. A.; Brey, E. M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Jiang, B.; Akar, B.; Larson, J. C.; Appel, A. A.; Brey, E. M.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL USA.
RP Brey, EM (reprint author), 3255 South Dearborn St,WH 314, Chicago, IL 60616 USA.
EM brey@iit.edu
RI Jiang, Bin/Q-4150-2017
OI Jiang, Bin/0000-0003-2390-4312
FU Veterans Administration; National Science Foundation [IIS-1125412]
FX This work was supported by grants from the Veterans Administration and
   the National Science Foundation (IIS-1125412).
CR Au P, 2009, AM J PATHOL, V175, P294, DOI 10.2353/ajpath.2009.080887
   Buetow BS, 2001, AM J PATHOL, V159, P1869, DOI 10.1016/S0002-9440(10)63033-7
   Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848
   Chen F, 2007, ACTA PHARMACOL SIN, V28, P493, DOI 10.1111/j.1745-7254.2007.00527.x
   Cheng MH, 2009, PLAST RECONSTR SURG, V124, P787, DOI 10.1097/PRS.0b013e3181b17a91
   Chiu YC, 2010, TISSUE ENG PART C-ME, V16, P905, DOI [10.1089/ten.tec.2009.0646, 10.1089/ten.TEC.2009.0646]
   Chiu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060728
   Chiu YC, 2012, J FLUORESC, V22, P907, DOI 10.1007/s10895-011-1029-6
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Jiang B, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P477
   Jiang B, 2013, ACTA BIOMATER, V9, P4976, DOI 10.1016/j.actbio.2012.10.005
   Jiang B, 2013, TISSUE ENG PT A, V19, P224, DOI 10.1089/ten.tea.2012.0120
   Khanna O, 2010, J BIOMED MATER RES A, V95A, P632, DOI 10.1002/jbm.a.32883
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Tengood JE, 2011, TISSUE ENG PT A, V17, P1181, DOI [10.1089/ten.TEA.2010.0551, 10.1089/ten.tea.2010.0551]
   Tengood JE, 2010, BIOMATERIALS, V31, P7805, DOI 10.1016/j.biomaterials.2010.07.010
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
NR 20
TC 33
Z9 35
U1 1
U2 70
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2014
VL 10
IS 3
BP 1177
EP 1186
DI 10.1016/j.actbio.2013.11.029
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3AO
UT WOS:000331663900012
PM 24321351
DA 2018-10-20
ER

PT J
AU Freitas, SC
   Maia, S
   Figueiredo, AC
   Gomes, P
   Pereira, PJB
   Barbosa, MA
   Martins, MCL
AF Freitas, Sidonio C.
   Maia, Silvia
   Figueiredo, Ana C.
   Gomes, Paula
   Pereira, Pedro J. B.
   Barbosa, Mario A.
   Martins, M. Cristina L.
TI Selective albumin-binding surfaces modified with a thrombin-inhibiting
   peptide
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Blood compatibility; Clotting; Surface modification; Thrombin; Albumin
ID SELF-ASSEMBLED MONOLAYERS; PRO-ARG-CHLOROMETHYLKETONE; PROTEIN
   ADSORPTION; RECOMBINANT HIRUDIN; PLATELET-ADHESION; IN-VITRO; COVALENT
   IMMOBILIZATION; BLOOD COMPATIBILITY; ALPHA-THROMBIN; MODEL SYSTEM
AB Blood-contacting medical devices have been associated with severe clinical complications, such as thrombus formation, triggered by the activation of the coagulation cascade due to the adsorption of certain plasma proteins on the surface of biomaterials. Hence, the coating of such surfaces with antithrombotic agents has been used to increase biomaterial haemocompatibility. Biomaterial-induced clotting may also be decreased by albumin adsorption from blood plasma in a selective and reversible way, since this protein is not involved in the coagulation cascade. In this context, this paper reports that the immobilization of the thrombin inhibitor D-Phe-Pro-D-Arg-D-Thr-CONH2 (fPrt) onto nanostructured surfaces induces selective and reversible adsorption of albumin, delaying the clotting time when compared to peptide-free surfaces. fPrt, synthesized with two glycine residues attached to the N-terminus (GGfPrt), was covalently immobilized onto self-assembled monolayers (SAMs) having different ratios of carboxylate-hexa(ethylene glycol)- and tri(ethylene glycol)-terminated thiols (EG6-COOH/EG3) that were specifically designed to control GGfPrt orientation, exposure and density at the molecular level. In solution, GGfPrt was able to inactivate the enzymatic activity of thrombin and to delay plasma clotting time in a concentration-dependent way. After surface immobilization, and independently of its concentration, GGfPrt lost its selectivity to thrombin and its capacity to inhibit thrombin enzymatic activity against the chromogenic substrate n-p-tosyl-Gly-Pro-Arg-p-nitroanilide. Nevertheless, surfaces with low concentrations of GGfPrt could delay the capacity of adsorbed thrombin to cleave fibrinogen. In contrast, GGfPrt immobilized in high concentrations was found to induce the procoagulant activity of the adsorbed thrombin. However, all surfaces containing GGfPrt have a plasma clotting time similar to the negative control (empty polystyrene wells), showing resistance to coagulation, which is explained by its capacity to adsorb albumin in a selective and reversible way. This work opens new perspectives to the improvement of the haemocompatibility of blood-contacting medical devices. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Freitas, Sidonio C.; Barbosa, Mario A.; Martins, M. Cristina L.] Univ Porto, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Freitas, Sidonio C.] Univ Porto, Fac Engn, P-4200465 Oporto, Portugal.
   [Maia, Silvia; Gomes, Paula] Univ Porto, Fac Ciencias, CIQ UP Dept Quim & Bioquim, P-4169007 Oporto, Portugal.
   [Figueiredo, Ana C.; Pereira, Pedro J. B.] Univ Porto, IBMC, P-4150180 Oporto, Portugal.
   [Barbosa, Mario A.; Martins, M. Cristina L.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4050313 Oporto, Portugal.
RP Martins, MCL (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM cmartins@ineb.up.pt
RI Gomes, Paula/C-6698-2008; Freitas, Sidonio/C-8818-2014; Barbosa,
   Mario/F-5964-2011; Martins, M. Cristina/J-8284-2013; Pereira,
   Pedro/F-8972-2011
OI Gomes, Paula/0000-0002-6018-4724; Freitas, Sidonio/0000-0002-4900-6388;
   Barbosa, Mario/0000-0003-3568-7482; Martins, M.
   Cristina/0000-0002-6574-4794; Pereira, Pedro/0000-0003-0969-5438;
   Figueiredo, Ana/0000-0001-8386-8216; Maia, Silvia/0000-0002-1329-0946
FU FEDER funds through the Programa Operacional Factores de Competitividade
   (COMPETE); Portuguese funds through FCT (Fundacao para a Ciencia e a
   Tecnologia) [PTDC/BIA-PRO/70627/2006, PEst-C/SAU/LA0002/2011]; FCT
   [SFRH/BD/40537/2007]
FX This work was financed by FEDER funds through the Programa Operacional
   Factores de Competitividade (COMPETE) and by Portuguese funds through
   FCT (Fundacao para a Ciencia e a Tecnologia) in the framework of the
   projects PTDC/BIA-PRO/70627/2006 and PEst-C/SAU/LA0002/2011. The authors
   would like to thank to Doctor Carlos Sa and Liliana Alves (CEMUP) for
   assistance in the XPS investigation and IPS for donating the human
   plasma. Sidonio Freitas acknowledges FCT for PhD fellowship
   SFRH/BD/40537/2007.
CR Acharya G, 2007, J AM CHEM SOC, V129, P732, DOI 10.1021/ja0656649
   Alibeik S, 2011, ACTA BIOMATER, V7, P4177, DOI 10.1016/j.actbio.2011.07.022
   Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148
   [Anonymous], 1993, IOD 125 GUID RAD TEC
   [Anonymous], 2009, PROP THROMB
   Barrias CC, 2005, BIOMATERIALS, V26, P2695, DOI 10.1016/j.biomaterials.2004.07.033
   Berceli SA, 1998, J VASC SURG, V27, P1117, DOI 10.1016/S0741-5214(98)70014-X
   BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x
   Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027
   Briand E, 2006, COLLOID SURFACE B, V53, P215, DOI 10.1016/j.colsurfb.2006.09.010
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Chen H, 2009, J BIOMED MATER RES A, V90A, P940, DOI 10.1002/jbm.a.32152
   Clement CC, 2006, UNDERSTANDING BIOLOGY USING PEPTIDES, P553, DOI 10.1007/978-0-387-26575-9_239
   Clement CC, 2009, ADV EXP MED BIOL, V611, P579, DOI 10.1007/978-0-387-73657-0_255
   Clement CC, 2007, FASEB J, V21, pA1013
   Collins JM, 2007, ORG BIOMOL CHEM, V5, P1141, DOI 10.1039/b617084f
   Du YJ, 2000, COLLOID SURFACE B, V17, P59, DOI 10.1016/S0927-7765(99)00053-3
   FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x
   Figueiredo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034354
   Figueiredo AC, 2011, ACTA CRYSTALLOGR F, V67, P54, DOI 10.1107/S1744309110043472
   Freitas SC, 2012, ACTA BIOMATER, V8, P4101, DOI 10.1016/j.actbio.2012.07.020
   Freitas SC, 2010, BIOMATERIALS, V31, P3772, DOI 10.1016/j.biomaterials.2010.01.097
   Frey BL, 1996, ANAL CHEM, V68, P3187, DOI 10.1021/ac9605861
   Goncalves IC, 2005, BIOMATERIALS, V26, P3891, DOI 10.1016/j.biomaterials.2004.10.006
   Goncalves IC, 2011, J MATER SCI-MATER M, P1
   Goncalves IC, 2009, BIOMATERIALS, V30, P5541, DOI 10.1016/j.biomaterials.2009.06.025
   Goncalves IC, 2009, J BIOMED MATER RES A, V89A, P642, DOI 10.1002/jbm.a.32011
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y
   HORBETT TA, 1986, TECHNIQUES BIOCOMPAT, P183
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Lahiri J, 1999, LANGMUIR, V15, P7186, DOI 10.1021/la9815650
   Lahiri J, 1999, ANAL CHEM, V71, P777, DOI 10.1021/ac980959t
   Laux V, 2009, THROMB HAEMOSTASIS, V102, P892, DOI 10.1160/TH09-02-0134
   Lee CJ, 2011, BRIT J CLIN PHARMACO, V72, P581, DOI 10.1111/j.1365-2125.2011.03916.x
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   Li D, 2009, ACTA BIOMATER, V5, P1864, DOI 10.1016/j.actbio.2009.03.001
   LOTTENBERG R, 1981, METHOD ENZYMOL, V80, P341
   Maitz MF, 2010, J BIOMED MATER RES A, V94A, P905, DOI 10.1002/jbm.a.32780
   MARAGANORE JM, 1990, BIOCHEMISTRY-US, V29, P7095, DOI 10.1021/bi00482a021
   Martin MCL, 2003, J MATER SCI-MATER M, V14, P945, DOI 10.1023/A:1026394431100
   Martins MCL, 2009, J BIOMED MATER RES A, V88A, P162, DOI 10.1002/jbm.a.31849
   Martins MCL, 2003, BIOMATERIALS, V24, P2067, DOI 10.1016/S0142-9612(03)00002-4
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   Martins MCL, 2003, BIOMATERIALS, V24, P3697, DOI 10.1016/S0142-9612(03)00244-8
   Metallo SJ, 2003, J AM CHEM SOC, V125, P4534, DOI 10.1021/ja030045a
   Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Murugesan S, 2008, CURR TOP MED CHEM, V8, P80
   Phaneuf MD, 1997, BIOMATERIALS, V18, P755, DOI 10.1016/S0142-9612(96)00193-7
   Phaneuf MD, 1998, ARTIF ORGANS, V22, P657, DOI 10.1046/j.1525-1594.1998.05091.x
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Ranucci M, 2009, ANN THORAC SURG, V87, P1311, DOI 10.1016/j.athoracsur.2008.09.076
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Roeges N. P. G., 1994, GUIDE COMPLETE INTER
   SARKAR B, 1968, CAN J BIOCHEM CELL B, V46, P601, DOI 10.1139/o68-092
   Sask KN, 2010, ACTA BIOMATER, V6, P2911, DOI 10.1016/j.actbio.2010.02.043
   Schwienhorst A, 2006, CELL MOL LIFE SCI, V63, P2773, DOI 10.1007/s00018-006-6219-z
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   Subramanian A, 2006, BIOSENS BIOELECTRON, V21, P998, DOI 10.1016/j.bios.2005.03.007
   Sun XL, 2000, J BIOMED MATER RES, V49, P66, DOI 10.1002/(SICI)1097-4636(200001)49:1<66::AID-JBM9>3.3.CO;2-O
   Thakurta SG, 2011, J MATER SCI-MATER M, V22, P137, DOI 10.1007/s10856-010-4169-3
   Wagner P, 1996, BIOPHYS J, V70, P2052, DOI 10.1016/S0006-3495(96)79810-7
   Weisel JW, 1996, J BIOL CHEM, V271, P31485, DOI 10.1074/jbc.271.49.31485
   Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b
   Wyers MC, 1999, CARDIOVASC PATHOL, V8, P153, DOI 10.1016/S1054-8807(99)00005-8
   YU XJ, 1993, TEST PROCEDURES BLOO, P287
NR 71
TC 1
Z9 1
U1 6
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2014
VL 10
IS 3
BP 1227
EP 1237
DI 10.1016/j.actbio.2013.11.023
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3AO
UT WOS:000331663900017
PM 24316365
OA Green Published
DA 2018-10-20
ER

PT J
AU Yu, L
   Xu, W
   Shen, WJ
   Cao, LP
   Liu, Y
   Li, ZS
   Ding, JD
AF Yu, Lin
   Xu, Wei
   Shen, Wenjia
   Cao, Luping
   Liu, Yan
   Li, Zhaoshen
   Ding, Jiandong
TI Poly(lactic acid-co-glycolic acid)-poly(ethylene glycol)-poly(lactic
   acid-co-glycolic acid) thermogel as a novel submucosal cushion for
   endoscopic submucosal dissection
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Endoscopic submucosal dissection (ESD); Submucosal injection;
   Biodegradable thermogel; Perforation; Mucosal elevation
ID COPOLYMER AQUEOUS-SOLUTIONS; BIODEGRADABLE BLOCK-COPOLYMERS; EARLY
   GASTRIC-CANCER; HYALURONIC-ACID; TRIBLOCK COPOLYMER; FLUID CUSHION;
   IN-VIVO; BIOMEDICAL APPLICATIONS; INJECTABLE HYDROGEL;
   CONTROLLED-RELEASE
AB Endoscopic submucosal dissection (ESD) is a clinical therapy for early stage neoplastic lesions in the gastrointestinal tract. It is, however, faced with a crucial problem: the high occurrence of perforation. The formation of a submucosal fluid cushion (SFC) via a fluid injection is the best way to avoid perforation, and thus an appropriate biomaterial is vital for this minimally invasive endoscopic technique. In this study, we introduced an injectable thermogel as a novel submucosal injection substance in ESD. The hydrogel synthesized by us was composed of poly(lactic acid-co-glycolic acid)-poly(ethylene glycol)-poly(lactic acid-co-glycolic acid) (PLGA-PEG-PLGA) triblock copolymers. The polymer/water system was a low-viscosity fluid at room temperature and thus easily injected, and turned into a non-flowing gel at body temperature after injection. The submucosal injection of the thermogel to create SFCs was performed in both resected porcine stomachs and living minipigs. High mucosal elevation with a clear margin was maintained for a long duration. Accurate en bloc resection was achieved with the assistance of the thermogel. The mean procedure time was strikingly reduced. Meanwhile, no obvious bleeding, perforation and tissue damage were observed. The application of the thermogel not only facilitated the ESD procedure, but also increased the efficacy and safety of ESD. Therefore, the PLGA-PEG-PLGA thermogel provides an excellent submucosal injection system, and has great potential to improve the ESD technique significantly. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Yu, Lin; Shen, Wenjia; Cao, Luping; Ding, Jiandong] Fudan Univ, Dept Macromol Sci, Adv Mat Lab, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
   [Liu, Yan] 307 Hosp Chinese Peoples Liberat Army, Dept Gastroenterol, Beijing 100071, Peoples R China.
   [Xu, Wei; Liu, Yan; Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.
   [Ding, Jiandong] Fudan Univ, Sch Pharm, Key Lab Smart Drug Delivery, Minist Educ, Shanghai 201203, Peoples R China.
RP Liu, Y (reprint author), 307 Hosp Chinese Peoples Liberat Army, Dept Gastroenterol, Beijing 100071, Peoples R China.
EM 13044161270@163.com; jdding1@fudan.edu.cn
FU NSF of China [51273217, 81001074, 91127028, 21034002]; Chinese Ministry
   of Science and Technology (973 Program) [2011CB606203]; Science and
   Technology Developing Foundation of Shanghai [12JC1402600, 13XD1401000]
FX The group was supported by NSF of China (Grants No. 51273217, No.
   81001074, No. 91127028 and No. 21034002), Chinese Ministry of Science
   and Technology (973 Program No. 2011CB606203) and Science and Technology
   Developing Foundation of Shanghai (Grants No. 12JC1402600 and No.
   13XD1401000).
CR Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bae SJ, 2006, MACROMOLECULES, V39, P4873, DOI 10.1021/ma060153s
   Bearat HH, 2012, ACTA BIOMATER, V8, P3629, DOI 10.1016/j.actbio.2012.06.012
   Chang GT, 2011, J CONTROL RELEASE, V156, P21, DOI 10.1016/j.jconrel.2011.07.008
   Chang GT, 2009, POLYMER, V50, P6111, DOI 10.1016/j.polymer.2009.10.036
   Chen YC, 2013, ACTA BIOMATER, V9, P5181, DOI 10.1016/j.actbio.2012.09.039
   Cho KB, 2011, WORLD J GASTROENTERO, V17, P2611, DOI 10.3748/wjg.v17.i21.2611
   Huynh CT, 2011, MACROMOLECULES, V44, P6629, DOI 10.1021/ma201261m
   Huynh CT, 2011, SOFT MATTER, V7, P4974, DOI 10.1039/c1sm05080j
   Duvall A, 2007, GASTROENTEROLOGY, V132, pA417
   Epstein-Barash H, 2012, ACTA BIOMATER, V8, P1703, DOI 10.1016/j.actbio.2012.01.028
   Feitoza AB, 2003, GASTROINTEST ENDOSC, V57, P41, DOI 10.1067/mge.2003.25
   Fujishiro M, 2005, GASTROINTEST ENDOSC, V62, P933, DOI 10.1016/j.gie.2005.07.052
   Fujishiro M, 2007, DIGEST ENDOSC, V19, P26, DOI 10.1111/j.1443-1661.2007.00682.x
   Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3
   Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Kang EY, 2012, MACROMOLECULES, V45, P2007, DOI 10.1021/ma202809c
   Kang YM, 2011, BIOMATERIALS, V32, P4556, DOI 10.1016/j.biomaterials.2011.03.007
   Kang YM, 2010, BIOMATERIALS, V31, P2453, DOI 10.1016/j.biomaterials.2009.11.115
   Nguyen K, 2013, ACTA BIOMATER, V9, P4487, DOI 10.1016/j.actbio.2012.08.012
   Khashab MA, 2013, GASTROENTEROLOGY, V144, P505, DOI 10.1053/j.gastro.2013.01.005
   Kim JI, 2012, BIOMATERIALS, V33, P4836, DOI 10.1016/j.biomaterials.2012.03.048
   Kumano I, 2012, GASTROINTEST ENDOSC, V75, P841, DOI 10.1016/j.gie.2011.10.035
   Li K, 2013, BIOMATERIALS, V34, P2834, DOI 10.1016/j.biomaterials.2013.01.013
   Loh XJ, 2010, J CONTROL RELEASE, V143, P175, DOI 10.1016/j.jconrel.2009.12.030
   Matsui Y, 2004, GASTROINTEST ENDOSC, V60, P539, DOI 10.1016/S0016-5107(04)01890-5
   Moon HJ, 2012, CHEM SOC REV, V41, P4860, DOI 10.1039/c2cs35078e
   Nelson DM, 2012, J BIOMED MATER RES A, V100A, P776, DOI 10.1002/jbm.a.34015
   Oka S, 2006, GASTROINTEST ENDOSC, V64, P877, DOI 10.1016/j.gie.2006.03.932
   Peng Q, 2013, ACTA BIOMATER, V9, P5063, DOI 10.1016/j.actbio.2012.09.034
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Shim MS, 2002, J BIOMED MATER RES, V61, P188, DOI 10.1002/jbm.10164
   Vermonden T, 2012, CHEM REV, V112, P2853, DOI 10.1021/cr200157d
   Wang WW, 2012, ACTA BIOMATER, V8, P3963, DOI 10.1016/j.actbio.2012.07.021
   Yoshida N, 2011, J GASTROEN HEPATOL, V26, P286, DOI 10.1111/j.1440-1746.2010.06505.x
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Yu L, 2013, J PHARM SCI-US, V102, P4140, DOI 10.1002/jps.23735
   Yu L, 2013, BIOMATER SCI-UK, V1, P411, DOI 10.1039/c2bm00159d
   Yu L, 2011, BIOMACROMOLECULES, V12, P1290, DOI 10.1021/bm101572j
   Yu L, 2010, BIOMACROMOLECULES, V11, P2169, DOI 10.1021/bm100549q
   Yu L, 2009, BIOMACROMOLECULES, V10, P1547, DOI 10.1021/bm900145g
   Yun EJ, 2012, BIOMACROMOLECULES, V13, P1106, DOI 10.1021/bm2018596
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang H, 2010, J BIOMAT SCI-POLYM E, V21, P253, DOI 10.1163/156856209X415747
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
   Zhang Z, 2010, BIOMATERIALS, V31, P7873, DOI 10.1016/j.biomaterials.2010.07.014
NR 52
TC 32
Z9 33
U1 4
U2 119
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2014
VL 10
IS 3
BP 1251
EP 1258
DI 10.1016/j.actbio.2013.12.007
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3AO
UT WOS:000331663900019
PM 24345554
DA 2018-10-20
ER

PT J
AU Seras-Franzoso, J
   Peebo, K
   Garcia-Fruitos, E
   Vazquez, E
   Rinas, U
   Villaverde, A
AF Seras-Franzoso, Joaquin
   Peebo, Karl
   Garcia-Fruitos, Elena
   Vazquez, Esther
   Rinas, Ursula
   Villaverde, Antonio
TI Improving protein delivery of fibroblast growth factor-2 from bacterial
   inclusion bodies used as cell culture substrates
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Inclusion bodies; Protein release; Drug delivery; Nanomedicine; Surface
   functionalization
ID ESCHERICHIA-COLI; AMYLOID AGGREGATION; IN-VIVO; POLYPEPTIDES; RELEASE;
   FUSION; DRUGS; SIZE
AB Bacterial inclusion bodies (IBs) have recently been used to generate biocompatible cell culture interfaces, with diverse effects on cultured cells such as cell adhesion enhancement, stimulation of cell growth or induction of mesenchymal stem cell differentiation. Additionally, novel applications of IBs as sustained protein delivery systems with potential applications in regenerative medicine have been successfully explored. In this scenario, with IBs gaining significance in the biomedical field, the fine tuning of this functional biomaterial is crucial. In this work, the effect of temperature on fibroblast growth factor-2 (FGF-2) IB production and performance has been evaluated. FGF-2 was overexpressed in Escherichia coli at 25 and 37 degrees C, producing IBs with differences in size, particle structure and biological activity. Cell culture topographies made with FGF-2 IBs biofabricated at 25 degrees C showed higher levels of biological activity as well as a looser supramolecular structure, enabling a higher protein release from the particles. In addition, the controlled use of FGF-2 protein particles enabled the generation of functional topographies with multiple biological activities being effective on diverse cell types. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Seras-Franzoso, Joaquin; Garcia-Fruitos, Elena; Vazquez, Esther; Villaverde, Antonio] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.
   [Seras-Franzoso, Joaquin; Garcia-Fruitos, Elena; Vazquez, Esther; Villaverde, Antonio] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain.
   [Seras-Franzoso, Joaquin; Garcia-Fruitos, Elena; Vazquez, Esther; Villaverde, Antonio] CIBER BBN, Barcelona 08193, Spain.
   [Peebo, Karl] Competence Ctr Food & Fermentat Technol, EE-12618 Tallinn, Estonia.
   [Rinas, Ursula] Leibniz Univ Hannover, Inst Tech Chem Life Sci, D-30167 Hannover, Germany.
   [Rinas, Ursula] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany.
RP Seras-Franzoso, J (reprint author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.
EM Joaquin.Seras@uab.cat
OI Garcia-Fruitos, Elena/0000-0001-7498-4864; Villaverde,
   Antonio/0000-0002-2615-4521; Seras-Franzoso,
   Joaquin/0000-0002-7893-4773; Vazquez, Esther/0000-0003-1052-0424
FU CIBER de Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN, Spain);
   VI National RDi Plan; Iniciativa Ingenio; Consolider Program; CIBER
   Actions; Instituto de Salud Carlos III; MINECO [BFU2010-17450]; AGAUR
   [2009SGR-0108]; ICREA ACADEMIA award
FX We are indebted to MINECO (BFU2010-17450), AGAUR (2009SGR-0108) and
   CIBER de Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN, Spain)
   for funding our research on inclusion bodies. CIBER-BBN is an initiative
   funded by the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010,
   Consolider Program, CIBER Actions and financed by the Instituto de Salud
   Carlos III with assistance from the European Regional Development Fund.
   We also acknowledge technical assistance from the Servei de Cultius
   Cellulars, Produccio d'Anticossos i Citometria (SCAC) at the Universitat
   Autonoma de Barcelona (UAB). A.V. received an ICREA ACADEMIA award. We
   are also indebted to the Protein Production Platform (CIBER-BBN) for
   helpful technical assistance and for protein production and purification
   services
   (http://www.bbn.ciber-bbn.es/programas/plataformas/equipamiento).
CR Arese M, 1999, MOL BIOL CELL, V10, P1429, DOI 10.1091/mbc.10.5.1429
   Bhang SH, 2009, BIOMATERIALS, V30, P126, DOI 10.1016/j.biomaterials.2008.09.021
   Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26
   Carrio MM, 1999, BBA-PROTEIN STRUCT M, V1434, P170, DOI 10.1016/S0167-4838(99)00177-6
   Carrio MM, 1998, FEMS MICROBIOL LETT, V169, P9, DOI 10.1016/S0378-1097(98)00444-3
   Diez-Gil C, 2010, BIOMATERIALS, V31, P5805, DOI 10.1016/j.biomaterials.2010.04.008
   FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978
   FRIESEL RE, 1995, FASEB J, V9, P919
   Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27
   Garcia-Fruitos E, 2007, J MOL BIOL, V374, P195, DOI 10.1016/j.jmb.2007.09.004
   Garcia-Fruitos E, 2011, FEBS J, V278, P2419, DOI 10.1111/j.1742-4658.2011.08165.x
   Garcia-Fruitos E, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/20/205101
   Garcia-Fruitos E, 2009, ADV MATER, V21, P4249, DOI 10.1002/adma.200900283
   Gonzalez-Montalban N, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-26
   Hoffmann F, 2004, ENZYME MICROB TECH, V34, P235, DOI 10.1016/j.enzmictec.2003.10.011
   Huang ZL, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-25
   Jevsevar S, 2005, BIOTECHNOL PROGR, V21, P632, DOI 10.1021/bp[0497839
   Liovic M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-67
   MARSTON FAO, 1986, BIOCHEM J, V240, P1
   Nahalka J, 2008, J IND MICROBIOL BIOT, V35, P219, DOI 10.1007/s10295-007-0287-4
   Nahalka J, 2007, BIOTECHNOL BIOENG, V97, P454, DOI 10.1002/bit.21244
   Pandey N, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-43
   Peternel S, 2008, BIOTECHNOL APPL BIOC, V49, P239, DOI 10.1042/BA20070140
   Peternel S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-34
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Roessl U, 2010, BIOTECHNOL LETT, V32, P341, DOI 10.1007/s10529-009-0173-4
   Seras-Franzoso J, 2013, NANOMEDICINE LOND
   Seras-Franzoso J, 2013, NANOMEDICINE-UK, V8, P1587, DOI [10.2217/NNM.12.188, 10.2217/nnm.12.188]
   Seras-Franzoso J, 2012, NANOMEDICINE-UK, V7, P79, DOI [10.2217/nnm.11.83, 10.2217/NNM.11.83]
   Talafova K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-16
   TAYLOR G, 1986, BIO-TECHNOL, V4, P553, DOI 10.1038/nbt0686-553
   Vazquez E, 2012, ADV MATER, V24, P1742, DOI 10.1002/adma.201104330
   Villar-Pique A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-55
   Villaverde A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-76
   Visser R, 2009, BIOMATERIALS, V30, P2032, DOI 10.1016/j.biomaterials.2008.12.046
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
NR 36
TC 14
Z9 14
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2014
VL 10
IS 3
BP 1354
EP 1359
DI 10.1016/j.actbio.2013.12.021
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3AO
UT WOS:000331663900029
PM 24361427
DA 2018-10-20
ER

PT J
AU Koshy, ST
   Ferrante, TC
   Lewin, SA
   Mooney, DJ
AF Koshy, Sandeep T.
   Ferrante, Thomas C.
   Lewin, Sarah A.
   Mooney, David J.
TI Injectable, porous, and cell-responsive gelatin cryogels
SO BIOMATERIALS
LA English
DT Article
DE Injectable; Gelatin; Cryogel; Degradable; Matrix metalloproteinase
ID METHACRYLATE HYDROGELS; DELIVERY; CSF
AB The performance of biomaterials-based therapies can be hindered by complications associated with surgical implant, motivating the development of materials systems that allow minimally invasive introduction into the host. In this study, we created cell-adhesive and degradable gelatin scaffolds that could be injected through a conventional needle while maintaining a predefined geometry and architecture. These scaffolds supported attachment, proliferation, and survival of cells in vitro and could be degraded by recombinant matrix metalloproteinase-2 and -9. Prefabricated gelatin cryogels rapidly resumed their original shape when injected subcutaneously into mice and elicited only a minor host response following injection. Controlled release of granulocyte-macrophage colony-stimulating factor from gelatin cryogels resulted in complete infiltration of the scaffold by immune cells and promoted matrix metalloproteinase production leading to cell-mediated degradation of the cryogel matrix. These findings suggest that gelatin cryogels could serve as a cell-responsive platform for biomaterial-based therapy. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Koshy, Sandeep T.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Koshy, Sandeep T.; Ferrante, Thomas C.; Lewin, Sarah A.; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Koshy, Sandeep T.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
OI Koshy, Sandeep/0000-0003-2836-5813
FU NIH [R01 EB015498]; NSERC PGS-D; HHMI ISRF; National Science Foundation
   under NSF [ECS-0335765]
FX This work was supported by NIH Grant R01 EB015498 to DJM. SK was
   supported by a NSERC PGS-D and a HHMI ISRF. This work was performed in
   part at the Center for Nanoscale Systems (CNS) at Harvard University, a
   member of the National Nanotechnology Infrastructure Network (NNIN),
   which is supported by the National Science Foundation under NSF award
   no. ECS-0335765. The authors would like to thank Alexander Cheung, Dr.
   Manav Mehta, Rajiv Desai, Max Darnell, Anup Tuladhar, Dr. Cathal Kearney
   and Dr. Yevgeny Brudno for scientific discussions. We especially thank
   DE Roderick Bronson of the Harvard Rodent Histopathology Core for his
   pathological assessment of H&E sections, and Charles Sheahan of the
   Harvard Medical School East Quad NMR facility for assistance with NMR.
CR Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056
   Bae KH, 2013, J MATER CHEM B, V1, P5371, DOI 10.1039/c3tb20940g
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]
   Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662
   Dranoff G, 2002, IMMUNOL REV, V188, P147, DOI 10.1034/j.1600-065X.2002.18813.x
   Elisseeff J, 2004, EXPERT OPIN BIOL TH, V4, P1849, DOI 10.1517/14712598.4.12.1849
   Henderson TMA, 2013, J MATER CHEM B, V1, P2682, DOI 10.1039/c3tb20280a
   Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI [10.1089/ten.TEA.2010.0666, 10.1089/ten.tea.2010.0666]
   Kang HW, 1999, J BIOACT COMPAT POL, V14, P331, DOI 10.1177/088391159901400404
   Khajah M, 2011, J LEUKOCYTE BIOL, V89, P945, DOI 10.1189/jlb.0809546
   Kuwahara K, 2010, TISSUE ENG PART C-ME, V16, P609, DOI [10.1089/ten.tec.2009.0406, 10.1089/ten.TEC.2009.0406]
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lin RZ, 2013, BIOMATERIALS, V34, P6785, DOI 10.1016/j.biomaterials.2013.05.060
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Mollinedo F, 1997, BIOCHEM J, V327, P917, DOI 10.1042/bj3270917
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Qi H, 2010, ADV MATER, V22, P5276, DOI 10.1002/adma.201002873
   Ramon-Azcon J, 2012, LAB CHIP, V12, P2959, DOI 10.1039/c2lc40213k
   Sakai S, 2009, BIOMATERIALS, V30, P3371, DOI 10.1016/j.biomaterials.2009.03.030
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052
   TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2
   Toth Marta, 2012, Methods Mol Biol, V878, P121, DOI 10.1007/978-1-61779-854-2_8
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Von den Hoff JW, 2005, BIOTECHNIQUES, V38, P73
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zhang YH, 1998, J IMMUNOL, V161, P3071
NR 31
TC 92
Z9 96
U1 4
U2 104
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2014
VL 35
IS 8
BP 2477
EP 2487
DI 10.1016/j.biomaterials.2013.11.044
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3GL
UT WOS:000331679200010
PM 24345735
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Acasigua, GAX
   de Olyveira, GM
   Costa, LMM
   Braghirolli, DI
   Fossati, ACM
   Guastaldi, AC
   Pranke, P
   Daltro, GD
   Basmaji, P
AF Xavier Acasigua, Gerson Arisoly
   de Olyveira, Gabriel Molina
   Manzine Costa, Ligia Maria
   Braghirolli, Daikelly Iglesias
   Medeiros Fossati, Anna Christina
   Guastaldi, Antonio Carlos
   Pranke, Patricia
   Daltro, Gildasio de Cerqueira
   Basmaji, Pierre
TI Novel Chemically Modified Bacterial Cellulose Nanocomposite as Potential
   Biomaterial for Stem Cell Therapy Applications
SO CURRENT STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Bacterial cellulose; cell viability study; nanoskin (R); natural
   nanocomposites; regenerative medicine; stem cells
ID DECIDUOUS TEETH; IN-VITRO; REGENERATION; SCAFFOLDS; MATRIX; RESPONSES;
   PULP
AB Bacterial cellulose (BC) has become established as a remarkably versatile biomaterial and can be used in a wide variety of applied scientific applications, especially for medical devices. In this work, the bacterial cellulose fermentation process is modified by the addition of hyaluronic acid and gelatin (1% w/w) to the culture medium before the bacteria is inoculated. Hyaluronic acid and gelatin influence in bacterial cellulose was analyzed using Transmission Infrared Spectroscopy (FTIR) and Scanning Electron Microscopy (SEM). Adhesion and viability studies with human dental pulp stem cells using natural bacterial cellulose/hyaluronic acid as scaffolds for regenerative medicine are presented for the first time in this work. MTT viability assays show higher cell adhesion in bacterial cellulose/gelatin and bacterial cellulose/ hyaluronic acid scaffolds over time with differences due to fiber agglomeration in bacterial cellulose/gelatin. Confocal microscopy images showed that the cell were adhered and well distributed within the fibers in both types of scaffolds.
C1 [Xavier Acasigua, Gerson Arisoly; Medeiros Fossati, Anna Christina] Univ Fed Rio Grande do Sul, Postgrad Program Dent, BR-90610000 Porto Alegre, RS, Brazil.
   [de Olyveira, Gabriel Molina; Guastaldi, Antonio Carlos] UNESP, Dept Phys Chem, BR-14800900 Araraquara, SP, Brazil.
   [Manzine Costa, Ligia Maria] Univ Fed Abc, Dept Nanosci & Adv Mat, BR-09210170 Santo Andre, SP, Brazil.
   [Braghirolli, Daikelly Iglesias; Pranke, Patricia] Univ Fed Rio Grande do Sul, Fac Pharm, Hematol & Stem Cell Lab, BR-90610000 Porto Alegre, RS, Brazil.
   [Braghirolli, Daikelly Iglesias; Pranke, Patricia] Univ Fed Rio Grande do Sul, Postgrad Program Physiol, BR-90610000 Porto Alegre, RS, Brazil.
   [Pranke, Patricia] SCRI, BR-90610000 Porto Alegre, RS, Brazil.
   [Daltro, Gildasio de Cerqueira] Univ Fed Bahia, Coll Hosp Complex Prof Edgard Santos COM HUPES, BR-40110910 Salvador, BA, Brazil.
   [Basmaji, Pierre] Innovatecs Biotechnol Res & Dev, BR-13560042 Sao Carlos, SP, Brazil.
RP de Olyveira, GM (reprint author), UNESP, Dept Phys Chem, BR-14800900 Araraquara, SP, Brazil.
EM gmolyveira@yahoo.com.br
RI Manzine Costa, Ligia Maria/N-1780-2015; Guastaldi, Antonio/O-7379-2014
OI Manzine Costa, Ligia Maria/0000-0001-6483-7633; Guastaldi,
   Antonio/0000-0002-6433-3555
CR Andrews KD, 2007, BIOMATERIALS, V28, P1014, DOI 10.1016/j.biomaterials.2006.10.014
   Bae WJ, 2012, DENT MATER, V28, P1271, DOI 10.1016/j.dental.2012.09.011
   Barbara PF, 1996, J PHYS CHEM-US, V100, P13148, DOI 10.1021/jp9605663
   Bernardi L, 2011, J ENDODONT, V37, P973, DOI 10.1016/j.joen.2011.04.010
   Bunting KD, 2003, BIOL CELL, V95, P563, DOI 10.1016/j.biolcel.2003.10.001
   Cherian B. M., 2013, ADV NATURAL POLYM AD, V18, P337, DOI [10.1007/978-3-642-20940-6_10, DOI 10.1007/978-3-642-20940-6_10]
   Cherian BM, 2012, RSC GREEN CHEM SER, P255, DOI 10.1039/9781849735315-00255
   Costa L. M. M., 2011, J BIONANOSCIENCE, V5, P167
   Costa L. M. M., 2012, J BIOMATER NANOBIOTE, V3, P92, DOI [10.4236/jbnb.2012.31012, DOI 10.4236/JBNB.2012.31012]
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   DENLINGER JL, 1980, EXP EYE RES, V31, P81, DOI 10.1016/0014-4835(80)90092-5
   Dong SJ, 2002, ELECTROANAL, V14, P7, DOI 10.1002/1521-4109(200201)14:1<7::AID-ELAN7>3.0.CO;2-V
   Gilardi G, 2001, TRENDS BIOTECHNOL, V19, P468, DOI 10.1016/S0167-7799(01)01769-3
   Gois P. B. P., 2013, INT REV BIOPHYSICAL, V3, P48
   Han WQ, 2012, J APPL POLYM SCI, V128, P1332
   Hild N, 2012, BIOMED MATER, V7
   Hung HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065738
   Kacurakova M, 2002, CARBOHYD RES, V337, P1145, DOI 10.1016/S0008-6215(02)00102-7
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P698, DOI 10.1002/jbm.a.30848
   Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Leong Natalie L, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P2651
   Lock J, 2012, J MATER SCI-MATER M, V23, P2543, DOI 10.1007/s10856-012-4709-0
   Lu LX, 2013, ACS APPL MATER INTER, V5, P319, DOI 10.1021/am302146w
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P185, DOI 10.1166/jbt.2012.1044
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Nie L, 2013, MATER LETT, V92, P25, DOI 10.1016/j.matlet.2012.10.077
   Olyveira G. M., 2011, J NANOTECH ENG MED, V2, P34001
   Olyveira G. M., 2013, J BIOMATER TISS ENG, V2, P1
   Olyveira G. M., 2013, J BIOMEDICAL NANOTEC, V9, P1
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013
   Saad B., 2008, EVID-BASED COMPL ALT, V14
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   SIX N, 2004, ORAL BIOSCI MED, V1, P35
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   TOOLE BP, 1977, CLIN ORTHOP RELAT R, P258
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   Williams SJ, 2009, BIOPOLYMERS, V91, P676, DOI 10.1002/bip.21196
   Xavier L, 2013, J NANOSCI NANOTECHNO, V13, P4715, DOI 10.1166/jnn.2013.7191
   Zhbanko R. G., 1966, INFRARED SPECTRA CEL, P325
   Zhou CJ, 2013, ACS APPL MATER INTER, V5, P3847, DOI 10.1021/am4005072
   Zugenmaier P, 2001, PROG POLYM SCI, V26, P1341, DOI 10.1016/S0079-6700(01)00019-3
NR 45
TC 7
Z9 7
U1 0
U2 33
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1574-888X
EI 2212-3946
J9 CURR STEM CELL RES T
JI Curr. Stem Cell Res. Ther.
PD MAR
PY 2014
VL 9
IS 2
BP 117
EP 123
DI 10.2174/1574888X08666131124135654
PG 7
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA AB6IE
UT WOS:000331890000006
PM 24266631
DA 2018-10-20
ER

PT J
AU Ulmeanu, M
   Sima, LE
   Ursescu, D
   Enculescu, M
   Bazan, X
   Quintana, I
AF Ulmeanu, M.
   Sima, L. E.
   Ursescu, D.
   Enculescu, M.
   Bazan, X.
   Quintana, I.
TI Cell Adhesion Response on Femtosecond Laser Initiated Liquid Assisted
   Silicon Surface
SO CURRENT TOPICS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Femtosecond laser; liquid assisted; actin filaments organization
ID MESENCHYMAL STEM-CELLS; NITRIDE TIN FILMS; DIFFERENTIATION;
   NANOTOPOGRAPHY; COMMITMENT; CHEMISTRY; MATRIX
AB Silicon substrates were irradiated at normal incidence with a femtosecond Ti:sapphire laser (Quatronix, 90 fs pulse duration, 1 kHz repetition rate, M-2 similar to 1.2, maximum energy peak 350 mJ) operating at a wavelength of 400 nm and focused via a microscope objective (Newport; UV Objective Model, 37x 0.11 N.A.). The laser scanning was assisted by liquids precursors media such as methanol and 1,1,2-trichlorotrifluoroethane. By altering the processing parameters, such as incident laser energy, scanning speed, and different irradiation media, various surface structures were produced on areas with 1 mm 2 dimensions. We analyzed the dependence of the surface morphology on laser pulse energy, scanning speed and irradiation media. Well ordered areas are developed without imposing any boundary conditions for the capillary waves that coarsens the ripple pattern. To assess biomaterial-driven cell adhesion response we investigated actin filaments organization and cell morphological changes following growth onto processed silicon substrates. Our study of bone cell progenitor interaction with laser nanoprocessed silicon lines has shown that cells anchor mainly to contact points along the nanostructured surface. Consequently, actin filaments are stretched towards the 15 mu m wide parallel lines increasing lateral cell spreading and changing the bipolar shape of mesenchymal stem cells.
C1 [Ulmeanu, M.; Ursescu, D.] Natl Inst Laser Plasma & Radiat Phys, Laser Dept, Magurele 077125, Romania.
   [Sima, L. E.] Acad Romana, Inst Biochem, Dept Mol Cell Biol, Bucharest 060031, Romania.
   [Ursescu, D.] Natl Inst Phys & Nucl Engn, Magurele 077125, Romania.
   [Enculescu, M.] Natl Inst Mat Phys, Magurele 077125, Romania.
   [Bazan, X.; Quintana, I.] Fdn IK4 Tekniker, Ultraprecis Proc Unit, Polo Tecnol Eibar, Gipuzkoa, Spain.
RP Ulmeanu, M (reprint author), Natl Inst Laser Plasma & Radiat Phys, Laser Dept, Atomistilor 409,POB MG-36, Magurele 077125, Romania.
EM magda.ulmeanu@inflpr.ro
RI Enculescu, Monica/C-2091-2011; Ursescu, Daniel/F-2216-2010; Sima,
   Livia/C-2882-2011
OI Enculescu, Monica/0000-0002-4476-5545; Ursescu,
   Daniel/0000-0002-0612-670X; Sima, Livia/0000-0002-3404-4162
FU EUMI-NAFAB [1059]; European Social Fund POSDRU [POSDRU/89/1.5/S/60746]
FX M. U. acknowledges the financial support of the EUMI-NAFAB project no.
   1059. L.E.S. acknowledges the financial support from the European Social
   Fund POSDRU 2007-2013 through the contract POSDRU/89/1.5/S/60746.
CR Anselme K, 2011, INT MATER REV, V56, P243, DOI 10.1179/1743280411Y.0000000001
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Biggs MJP, 2008, J MICROSC-OXFORD, V231, P28, DOI 10.1111/j.1365-2818.2008.02013.x
   Bressan E, 2013, NANOMEDICINE-UK, V8, P469, DOI [10.2217/NNM.13.12, 10.2217/nnm.13.12]
   CLARK P, 1992, J CELL SCI, V103, P287
   Conway A., 2012, STEM CELL RES THER, V3, P1
   Cyster LA, 2003, J BIOMED MATER RES A, V67A, P138, DOI 10.1002/jbm.a.10087
   Cyster LA, 2004, BIOMATERIALS, V25, P97, DOI 10.1016/S0142-9612(03)00480-0
   Devi P., 2011, AIP ADVANCES, V1
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Matei A, 2011, APPL PHYS A-MATER, V104, P821, DOI 10.1007/s00339-011-6421-1
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McNamara LE, 2012, BIOMATERIALS, V33, P2835, DOI 10.1016/j.biomaterials.2011.11.047
   Menendez-Manjon A, 2011, J PHYS CHEM C, V115, P5108, DOI 10.1021/jp109370q
   Miura K., 2011, NANOWIRES FUNDAMENTA, P395
   Ranella A, 2010, ACTA BIOMATER, V6, P2711, DOI 10.1016/j.actbio.2010.01.016
   Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013
   Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015
   Sima LE, 2013, J TISSUE ENG REGEN M, V7, P129, DOI 10.1002/term.507
   Sima LE, 2010, J BIOMED MATER RES A, V95A, P1203, DOI 10.1002/jbm.a.32947
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Ulmeanu M, 2012, APPL SURF SCI, V258, P9314, DOI 10.1016/j.apsusc.2011.08.110
   Wang C., 2010, NANOTECHNOLOGY, V21
   Wanzenboeck H., 2006, PROCEEDINGS OF THE 6
   Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620
   Zervos H., 2006, EUSPEN HEADQUARTERS, P377
NR 28
TC 2
Z9 2
U1 1
U2 26
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1568-0266
EI 1873-4294
J9 CURR TOP MED CHEM
JI Curr. Top. Med. Chem.
PD MAR
PY 2014
VL 14
IS 5
BP 624
EP 629
DI 10.2174/1568026614666140118204946
PG 6
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AB7ZT
UT WOS:000332010600006
PM 24444164
DA 2018-10-20
ER

PT J
AU Ninan, N
   Thomas, S
   Grohens, Y
AF Ninan, Neethu
   Thomas, Sabu
   Grohens, Yves
TI Zeolites incorporated polymeric gel beads-Promising drug carriers
SO MATERIALS LETTERS
LA English
DT Article
DE Pectin; Zeolite; Copper; Bacteria; Gel bead; Biomaterial
ID IN-VITRO; SCAFFOLDS; DELIVERY; RELEASE
AB Novel hybrid gel beads comprising of pectin and copper exchanged zeolites were prepared using ionotropic gelation technique. The prepared beads were transparent and spherical. The egg-box model crosslinking of pectin was visualised on the surface of the bead. The embedded zeolites maintained their crystallinity inspite of their weak interactions with pectin. Their anti-bacterial properties were attributed due to the copper ions leached from the cavities of zeolites incorporated in polymer matrix. The obtained results proved their versatility as promising drug carriers. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Ninan, Neethu; Grohens, Yves] Univ Bretagne Sud, Lab Ingn Mat Bretagne, F-56321 Lorient, France.
   [Ninan, Neethu; Thomas, Sabu] Mahatma Gandhi Univ, Ctr Nanosci & Nanotechnol, Kottayam 686560, Kerala, India.
   [Ninan, Neethu; Thomas, Sabu] Mahatma Gandhi Univ, Sch Chem Sci, Kottayam 686560, Kerala, India.
RP Ninan, N (reprint author), Univ Bretagne Sud, LIMatB, Ctr Rech Christiaan Huygens, Rue St Maude,BP 92116,Bur 32 Bis, F-56321 Lorient, France.
EM neethuninan85@yahoo.co.in
RI Thomas, Prof. Sabu/G-7310-2016
OI Thomas, Prof. Sabu/0000-0003-4726-5746
FU Brittany region; European Union (FEDER); French Ministry for research
FX We are thankful to Brittany region, The European Union (FEDER) and the
   French Ministry for research for rendering financial support for
   conducting the studies.
CR Baran R, 2012, MICROPOR MESOPOR MAT, V163, P122, DOI 10.1016/j.micromeso.2012.06.055
   Chaves TF, 2012, MICROPOR MESOPOR MAT, V161, P67, DOI 10.1016/j.micromeso.2012.05.022
   Climent MJ, 2005, J CATAL, V233, P308, DOI 10.1016/j.jcat.2005.05.003
   Dyer A, 2000, J HELMINTHOL, V74, P137, DOI 10.1017/S0022149X00000184
   Fox S, 2010, ACTA BIOMATER, V6, P1515, DOI 10.1016/j.actbio.2009.10.038
   Ghaffari A, 2007, EUR J PHARM BIOPHARM, V67, P175, DOI 10.1016/j.ejpb.2007.01.013
   Kim YH, 2012, APPL SURF SCI, V258, P3823, DOI 10.1016/j.apsusc.2011.12.036
   Malekian R, 2011, APPL CLAY SCI, V51, P323, DOI 10.1016/j.clay.2010.12.020
   Ninan N, 2013, COLLOIDS SURF B
   Ninan N, 2013, ACS APPL MATER INTER, V5, P11194, DOI 10.1021/am403436y
   Ninan N, 2013, EUR POLYM J, V49, P2433, DOI 10.1016/j.eurpolymj.2013.02.014
   Ninan N, 2013, CARBOHYD POLYM, V98, P877, DOI 10.1016/j.carbpol.2013.06.067
   Ninan N, 2011, THER DELIV, V2, P711, DOI 10.4155/TDE.11.47
   Nguyen S, 2011, COLLOID SURFACE B, V88, P664, DOI 10.1016/j.colsurfb.2011.07.058
   Schurz F, 2009, APPL CATAL A-GEN, V355, P42, DOI 10.1016/j.apcata.2008.11.014
   Shams K, 2013, MICROPOR MESOPOR MAT, V180, P61, DOI 10.1016/j.micromeso.2013.06.019
   Tamura C, 2013, CARBOHYD POLYM, V93, P747, DOI 10.1016/j.carbpol.2012.12.046
   Vilaca N, 2013, COLLOID SURFACE B, V112, P237, DOI 10.1016/j.colsurfb.2013.07.042
   Wei XL, 2006, INT J PHARM, V318, P132, DOI 10.1016/j.ijpharm.2006.03.024
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Zhang YL, 2011, J BIOMAT SCI-POLYM E, V22, P809, DOI 10.1163/092050610X496242
NR 21
TC 7
Z9 7
U1 1
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD MAR 1
PY 2014
VL 118
BP 12
EP 16
DI 10.1016/j.matlet.2013.12.055
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AB3BP
UT WOS:000331666600004
DA 2018-10-20
ER

PT J
AU Kirubaharan, CJ
   Edayadulla, N
   Kumar, GG
   Nahm, KS
AF Kirubaharan, C. Joseph
   Edayadulla, N.
   Kumar, G. Gnana
   Nahm, Kee Suk
TI The Catalytic Activity of Bio-Mediated Palladium Nanoparticles on Imine
   Formation Reactions
SO SCIENCE OF ADVANCED MATERIALS
LA English
DT Article
DE Active Sites; Nanoparticles; Recyclability; Surface Area; Yield
ID DIRECT REDUCTIVE AMINATION; ASYMMETRIC ADDITION; AZADIRACHTA-INDICA;
   COUPLING REACTIONS; HYDROGEN-PEROXIDE; PD NANOPARTICLES; GREEN
   SYNTHESIS; AMINES; WATER; FABRICATION
AB Bio-mediated palladium nanoparticles were synthesized with the aid of an eco-friendly biomaterial Azadirachta indica extract. The influence of extract volume, temperature and pH on the formation of palladium nanoparticles were analyzed in detail. The morphological and structural properties of the prepared palladium nanoparticles were characterized by TEM and XRD techniques, respectively. Moreover, the bio-mediated palladium nanoparticles were employed as effective catalysts in the preparation of imine derivatives without any surface modification. The excellent yield and high purity of the imine derivatives and prompt recyclability behavior of the prepared green nanocatalysts make them a potential contender in the imine formation reactions.
C1 [Kirubaharan, C. Joseph; Kumar, G. Gnana] Madurai Kamaraj Univ, Dept Phys Chem, Madurai 625021, Tamil Nadu, India.
   [Edayadulla, N.] Mother Teresa Womens Univ, Dept Chem, Kodaikanal 624102, Tamil Nadu, India.
   [Nahm, Kee Suk] Chonbuk Natl Univ, Sch Chem Engn, Jeonju 561756, South Korea.
RP Kumar, GG (reprint author), Madurai Kamaraj Univ, Dept Phys Chem, Madurai 625021, Tamil Nadu, India.
EM kumarg2006@gmail.com; nahmks@jbnu.ac.kr
FU Department of Science and Technology-SERB, New Delhi
   [SR/FT/CS-113/2010(G)]; Human Resources Development Program of the Korea
   Institute of Energy Technology Evaluation and Planning (KETEP)
   [20114030200060]; Korea government Ministry of Trade, Industry and
   Energy; Chonbuk National University
FX This work was supported by Department of Science and Technology-SERB,
   New Delhi, Fast Track Project for Young Scientist Grant No.
   SR/FT/CS-113/2010(G). This work was supported by the Human Resources
   Development Program (No. 20114030200060) of the Korea Institute of
   Energy Technology Evaluation and Planning (KETEP) grant funded by the
   Korea government Ministry of Trade, Industry and Energy and was also
   supported by research grant of Chonbuk National University in 2011.
CR Arpad M, 2011, CHEM REV, V111, P2251, DOI 10.1021/cr100355b
   Balanta A, 2011, CHEM SOC REV, V40, P4973, DOI 10.1039/c1cs15195a
   Bandyopadhyay Debasish, 2011, Org Med Chem Lett, V1, P11, DOI 10.1186/2191-2858-1-11
   Bankar A, 2010, MATER LETT, V64, P1951, DOI 10.1016/j.matlet.2010.06.021
   Bhor MD, 2008, TETRAHEDRON LETT, V49, P965, DOI 10.1016/j.tetlet.2007.12.023
   Bode CA, 2006, TETRAHEDRON, V62, P11499, DOI 10.1016/j.tet.2006.07.071
   Bunzen H, 2013, MOLECULES, V18, P3745, DOI 10.3390/molecules18043745
   Chakraborti AK, 2004, TETRAHEDRON LETT, V45, P7641, DOI 10.1016/j.tetlet.2004.08.097
   Chen L, 2010, J AM CHEM SOC, V132, P9138, DOI 10.1021/ja1028556
   Dalpozzo R, 2010, CHEM REV, V110, P3501, DOI 10.1021/cr9003488
   Guerrero M, 2010, LANGMUIR, V26, P15532, DOI 10.1021/la1016802
   Hadjipavlou-litina DJ, 1996, DRUG DES DISCOV, V15, P199
   Hamza K, 2004, ORG LETT, V6, P925, DOI 10.1021/ol030140o
   KUZNETSOV VV, 1991, ZH ORG KHIM+, V27, P1579
   Largeron M, 2008, CHEM-EUR J, V14, P996, DOI 10.1002/chem.200700876
   Lenardao EJ, 2007, TETRAHEDRON LETT, V48, P7668, DOI 10.1016/j.tetlet.2007.08.094
   Li XH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01743
   Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P6893, DOI 10.1021/es300839e
   Lu ZL, 2002, CHEM REV, V102, P3543, DOI 10.1021/cr010358t
   Nand P, 2012, J PHARM NEGAT RESULT, V3, P29, DOI 10.4103/0976-9234.99650
   NISHINAGA A, 1988, J MOL CATAL, V48, P249, DOI 10.1016/0304-5102(88)85009-0
   Okitsu K, 2000, CHEM MATER, V12, P3006, DOI 10.1021/cm0001915
   Orito K, 1998, TETRAHEDRON, V54, P8403, DOI 10.1016/S0040-4020(98)00461-X
   Peng QL, 2011, CHEM COMMUN, V47, P6476, DOI 10.1039/c1cc11057h
   Perez-Lorenzo M, 2012, J PHYS CHEM LETT, V3, P167, DOI 10.1021/jz2013984
   Petla RK, 2012, J BIOMATER NANOBIOTE, V3, P14, DOI DOI 10.4236/JBNB.2012.31003
   Pritchard J, 2010, LANGMUIR, V26, P16568, DOI 10.1021/la101597q
   Reier T, 2012, ACS CATAL, V2, P1765, DOI 10.1021/cs3003098
   Roberta B., 2007, J NANOSCI NANOTECHNO, V7, P2696
   Robichaud A, 2006, TETRAHEDRON LETT, V47, P3633, DOI 10.1016/j.tetlet.2006.03.153
   ROSS IA, 2003, MED PLANTS WORLD CHE, V1
   Roucoux A, 2002, CHEM REV, V102, P3757, DOI 10.1021/cr010350j
   Saggiomo V, 2009, TETRAHEDRON LETT, V50, P4663, DOI 10.1016/j.tetlet.2009.05.117
   Sathishkumar M, 2009, J HAZARD MATER, V171, P400, DOI 10.1016/j.jhazmat.2009.06.014
   SCHELLENBERG KA, 1963, J ORG CHEM, V28, P3259, DOI 10.1021/jo01046a537
   SCHROEDER DR, 1987, J NAT PROD, V50, P241, DOI 10.1021/np50050a023
   Sheny DS, 2012, SPECTROCHIM ACTA A, V91, P35, DOI 10.1016/j.saa.2012.01.063
   Shukla VK, 2012, J HAZARD MATER, V213, P161, DOI 10.1016/j.jhazmat.2012.01.071
   Siddiqui BS, 2004, PHYTOCHEMISTRY, V65, P2363, DOI 10.1016/j.phytochem.2004.04.031
   SIDDIQUI S, 1986, PHYTOCHEMISTRY, V25, P2183, DOI 10.1016/0031-9422(86)80087-5
   Tsuge O, 1989, ADV HETEROCYCL CHEM, V45, P231
   Vicini P, 2003, BIOORGAN MED CHEM, V11, P4785, DOI 10.1016/S0968-0896(03)00493-0
   Wei CM, 2004, P NATL ACAD SCI USA, V101, P5749, DOI 10.1073/pnas.0307150101
   Yang X, 2010, J NANOPART RES, V12, P1589, DOI 10.1007/s11051-009-9675-1
   Zhong ZY, 2011, SCI ADV MATER, V3, P968, DOI 10.1166/sam.2011.1223
   Zhou XF, 2013, EUR POLYM J, V49, P1957, DOI 10.1016/j.eurpolymj.2013.04.006
   Zhou XF, 2012, J MATER CHEM, V22, P8862, DOI 10.1039/c2jm16411f
NR 47
TC 1
Z9 1
U1 0
U2 9
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1947-2935
EI 1947-2943
J9 SCI ADV MATER
JI Sci. Adv. Mater.
PD MAR
PY 2014
VL 6
IS 3
BP 483
EP 491
DI 10.1166/sam.2014.1741
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA AB8KG
UT WOS:000332038300009
DA 2018-10-20
ER

PT J
AU Wheeler, DL
   Lane, JM
   Seim, HB
   Puttlitz, CM
   Itescu, S
   Turner, AS
AF Wheeler, Donna L.
   Lane, Joseph M.
   Seim, Howard B., III
   Puttlitz, Christian M.
   Itescu, Silviu
   Turner, A. Simon
TI Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine
   fusion in sheep
SO SPINE JOURNAL
LA English
DT Article
DE Ovine posterolateral lumbar spine fusion; Mesenchymal stem cells; Bone
   graft substitute; Biomechanics; Histology; Computed tomography
ID STEM-CELLS; BONE-MARROW; GROWTH-FACTOR; CANINE MODEL; GRAFT; CERAMICS;
   EFFICACY
AB BACKGROUND CONTEXT: Osteoconductive porous ceramic bone graft materials supplemented with mesenchymal precursor cells (MPC) derived from autologous bone marrow aspirates have been shown to stimulate successful interbody and posterolateral spine fusion in preclinical models. Recent advances in immunomagnetic cell sorting have enabled purification and isolation of pluripotent stem cells from marrow aspirates and have expanded stem cell technology to allogeneic cell sources. Allogeneic MPC technology combined with appropriate synthetic biomaterial carriers could provide both the osteogenic and osteoconductive components needed for successful posterolateral spine fusion without the need for autologous bone harvest or expensive recombinant protein technology.
   PURPOSE: To determine the safety and efficacy of a hydroxyapatite: tricalcium phosphate graft material supplemented with allogeneic mesenchymal precursor cells in posterolateral lumbar spine fusion using an ovine model.
   STUDY DESIGN: Skeletally mature ewes underwent single-level instrumented posterolateral lumbar spine fusion using either autograft (AG), hydroxyapatite: tricalcium phosphate carrier (CP), or CP supplemented with allogeneic mesenchymal progenitor cells (MPCs). Three doses of MPCs were evaluated: 25 x 10(6) cells (low dose, LD), 75 x 10(6) cells (mid dose, MD), and 225 x 10(6) cell (high dose, HD). Animals survived for either 4 or 9 months.
   METHODS: Plain radiographs were acquired and scored for bridging bone at regular intervals during healing to monitor fusion development. Hematology, coagulation, and serum chemistry were monitored at regular intervals throughout the study to monitor animal health. After necropsy, computed tomography, high-resolution radiography, biomechanical testing, organ pathology, bone histopathology, and bone histomorphometry were conducted to monitor the safety and ascertain the efficacy of MPC treatment.
   RESULTS: MPC treatment in this spine fusion model resulted in no observed adverse systemic or local tissue responses. Radiographically, fusion scores for MPC-treated animals were uniformly higher compared with those treated with carrier alone (CP) after 3 months and continued the same trend throughout 9 month of healing. Quantitative computed tomography confirmed better connectivity of the fusion for MPC treatment groups compared with CP. Biomechanical analyses were not able to differentiate between treatment groups. Histomorphometry results confirmed radiographic and quantitative computed tomography results; cell-supplemented treatment groups and autograft had equivalent amounts of bone within the fusion mass and less bony fusion tissue was found within the fusion mass in specimens from the CP treatment group. No conclusive effects of cell dose of fusion efficacy were noted.
   CONCLUSIONS: Adult allogeneic mesenchymal precursor cells delivered via a hydroxyapatite:tricalcium phosphate carrier were both safe and efficacious in this ovine spine fusion model. Results from this preclinical study support that allogeneic mesenchymal precursor cells produced fusion efficacy similar to that achieved using iliac crest autograft, thereby providing a safe and viable option to achieve successful posterolateral spine fusion. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wheeler, Donna L.] BioSolut Consulting LLC, Santa Rosa, CA 95403 USA.
   [Lane, Joseph M.] Hosp Special Surg, Dept Orthopaed, New York, NY 10021 USA.
   [Seim, Howard B., III; Turner, A. Simon] Colorado State Univ, Coll Vet Med, Dept Clin Sci, Ft Collins, CO 80525 USA.
   [Puttlitz, Christian M.] Colorado State Univ, Coll Engn, Dept Mech Engn, Ft Collins, CO 80525 USA.
   [Itescu, Silviu] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA.
   [Itescu, Silviu] Mesoblast Ltd, New York, NY 10036 USA.
RP Wheeler, DL (reprint author), BioSolut Consulting LLC, 3416 Henderson Cir, Santa Rosa, CA 95403 USA.
EM donna.wheeler@biosoln.com
FU Colorado State University
FX DLW: Nothing to disclose. JML: Stock Ownership: CollPlant, Inc (20,000
   Shares.); Consulting: Amgen (B, Paid directly to institution/employer),
   BioMimetics (B, Paid directly to institution/employer), CollPlant (C,
   Paid directly to institution/employer), DFine (B, Paid directly to
   institution/employer), Graftys (B, Paid directly to
   institution/employer), Zimmer (C, Paid directly to
   institution/employer); Speaking and/orTeaching Arrangements: Eli Lilly
   (D), Novartis (B), Warner Chilcott (B); Trips/Travel: Zimmer (A, Paid
   directly to institution/employer); Scientific Advisory Board: Zimmer
   (A); Research Support - Staff and/or Materials: Cohn Foundation (F).
   HBS: Research Support (Investigator Salary, Staff/Materials): Colorado
   State University (B, Paid directly to institution/employer). CMP:
   Nothing to disclose. SI: Other: Mesoblast (CEO, > 5% stock ownership,
   Paid directly to institution/employer); Stock Ownership: Mesoblast (> 5%
   ownership); Board of Directors: Mesoblast (> 5% stock ownership). AST:
   Nothing to disclose.
CR Anderson James M., 1996, P165
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004
   Bozkus H, 2004, SPINE, V29, P635, DOI 10.1097/01.BRS.0000115126.13081.7D
   Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   Cinotti G, 2004, J BONE JOINT SURG BR, V86B, P135, DOI 10.1302/0301-620X.86B1.14308
   Cricchio Giovanni, 2003, Clin Implant Dent Relat Res, V5, P161, DOI 10.1111/j.1708-8208.2003.tb00198.x
   Cui QJ, 2001, SPINE, V26, P2305, DOI 10.1097/00007632-200111010-00003
   Delecrin J, 1997, SPINE, V22, P1683, DOI 10.1097/00007632-199708010-00001
   DELWICHE LD, 2003, LITTLE SAS BOOK
   Emery SE, 1996, SPINE, V21, P2713, DOI 10.1097/00007632-199612010-00003
   Goldschlager T, 2011, SPINE, V36, P615, DOI 10.1097/BRS.0b013e3181dfcec9
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369
   Gupta MC, 2007, SPINE, V32, P720, DOI 10.1097/01.brs.0000258863.40984.32
   Kai T, 2003, SPINE, V28, P1653, DOI 10.1097/00007632-200308010-00005
   Kanayama M, 1999, SPINE, V24, P1058, DOI 10.1097/00007632-199906010-00003
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P129, DOI 10.5435/00124635-200503000-00006
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   MARINI JA, 2005, ORTH RES SOC FEBR 20
   Martens Timothy P, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS18, DOI 10.1038/ncpcardio0404
   Minamide A, 2005, SPINE, V30, P1134, DOI 10.1097/01.brs.0000162394.75425.04
   Minamide A, 2007, SPINE, V32, P1067, DOI 10.1097/01.brs.0000261626.32999.8a
   Nakajima T, 2007, SPINE, V32, P2432, DOI 10.1097/BRS.0b013e3181573924
   O'Brien FJ, 2002, J BIOMECH, V35, P523, DOI 10.1016/S0021-9290(01)00200-7
   Orii Hisaya, 2005, Journal of Medical and Dental Sciences, V52, P51
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   SCHENK R, 1994, BONE FORMATION REPAI
   Seiler J G 3rd, 2000, J South Orthop Assoc, V9, P91
   Simmons P J, 1994, Prog Clin Biol Res, V389, P271
   Wheeler DL, 2007, SPINE J, V7, P308, DOI 10.1016/j.spinee.2006.01.005
   Wilke HJ, 1997, SPINE, V22, P2365, DOI 10.1097/00007632-199710150-00009
NR 32
TC 8
Z9 8
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1529-9430
EI 1878-1632
J9 SPINE J
JI Spine Journal
PD MAR
PY 2014
VL 14
IS 3
SI SI
BP 435
EP 444
DI 10.1016/j.spinee.2013.09.048
PG 10
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA AB3TY
UT WOS:000331714300008
PM 24438940
DA 2018-10-20
ER

PT J
AU Liang, HX
   Li, XD
   Shimer, AL
   Balian, G
   Shen, FH
AF Liang, Haixiang
   Li, Xudong
   Shimer, Adam L.
   Balian, Gary
   Shen, Francis H.
TI A novel strategy of spine defect repair with a degradable bioactive
   scaffold preloaded with adipose-derived stromal cells
SO SPINE JOURNAL
LA English
DT Article
DE Poly(lactide-co-glycolide) acid; Microspheres; Vertebral body; Bone
   defect; Growth and differentiation factor 5; Bone repair
ID STIMULATES OSTEOGENIC DIFFERENTIATION; FORMATION IN-VIVO; BONE REPAIR;
   PLASMA TREATMENT; TISSUE; VEGF; VITRO; POLY(LACTIDE-CO-GLYCOLIDE);
   TRANSPLANTATION; ANGIOGENESIS
AB BACKGROUND CONTEXT: Although the use of mesenchymal stem cells (MSC) with scaffolds for bone repair has been considered an effective method, the interactions between implanted materials and bone tissues have not been fully elucidated. At some specific sites, such as the vertebral body (VB) of the spine, the process of bone repair with implanted biomaterials is rarely reported. Recently, adipose tissue was found to be an alternative source of MSC besides bone marrow. However, the strategy of using adipose-derived stromal (ADS) cells with bioactive scaffold for the repair of spinal bone defects has seldom been studied.
   PURPOSE: To use a sintered poly(lactide-co-glycolide) acid (PLGA) microspheres scaffold seeded with induced rat ADS cells to repair a bone defect of the VB in a rat model.
   STUDY DESIGN: Basic science and laboratory study.
   METHODS: A sintered porous microspheres scaffold was manufactured by PLGA. ADS cells were isolated from Fischer 344 rats and then induced by osteogenic medium with growth and differentiation factor 5 (GDF5) in vitro. Before implantation, cells were cultured with inductive media for 2 weeks as a monolayer situation and 1 more week on a PLGA scaffold as a three-dimensional structure. These assembled bioactive scaffolds then were implanted in lumbar VB bone defects in Fischer 344 rats. The ex vivo differentiation of the cells was confirmed by von Kossa staining and real-time polymerase chain reaction. The performance of cells on the scaffold was detected by scanning electron microscopy and (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)2-(4-sulfophenyl)-2H-tetrazolium) assay. In vivo bone formation was quantitatively measured by computed tomography study. And the effect of tissue repair was also evaluated by histological studies.
   RESULTS: Proliferation and differentiation of cells were confirmed before in vivo implantation. Quantification of bone formation in vivo through serial three-dimensional computed tomography images revealed that the VB implanted with GDF5-induced cells demonstrated more bone formation than the control groups. Besides the bone formation period that occurred between 2 and 4 weeks in all groups, a second bone formation period was found to occur only in the groups that received cells with previous induction in vitro. This second period of significant bone formation happened simultaneously with collapsing of the scaffolds. It was then demonstrated histologically that vascularization early in the process and cooperation between host bone and implanted cells accompanied by collapse of the scaffold may be the factors that influence bone formation. This study not only provides a therapeutic strategy of using biomaterial for bone repair in the spine, but also may lead to a technological method for studying the relationship between implanted stem cells and host tissue.
   CONCLUSIONS: Adipose-derived stromal cells maintained in culture on a scaffold and treated with osteogenic induction with growth factor ex vivo could be used to enhance bone repair in vivo. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Liang, Haixiang; Li, Xudong; Shimer, Adam L.; Balian, Gary; Shen, Francis H.] Univ Virginia, Sch Med, Dept Orthopaed Surg, Orthopaed Res Labs, Charlottesville, VA 22908 USA.
   [Balian, Gary] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.
RP Shen, FH (reprint author), Univ Virginia Hlth Syst, Dept Orthopaed Surg, Box 800159, Charlottesville, VA 22908 USA.
EM fhs2g@virginia.edu
OI Liang, Haixiang/0000-0002-2276-1367
FU Orthopedic Trauma Association; Orthopedic Research and Education
   Foundation
FX Supported by a research grant from the Orthopedic Trauma Association and
   by a Faculty Research Grant and a Clinician Scientist Award (to F.H.S.)
   from the Orthopedic Research and Education Foundation.
CR Borden M, 2004, J BONE JOINT SURG BR, V86B, P1200, DOI 10.1302/0301-620X.86B8.14267
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   Borden M, 2002, BIOMATERIALS, V23, P551, DOI 10.1016/S0142-9612(01)00137-5
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Cui FA, 2010, GROWTH FACTORS, V28, P306, DOI 10.3109/08977194.2010.484423
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029
   Hattori H, 2004, CELLS TISSUES ORGANS, V178, P2, DOI 10.1159/000081088
   hen FH, 2006, SPINE J, V6, P615
   Khang G, 1997, BIO-MED MATER ENG, V7, P357
   Kim ES, 2010, J ADV PROSTHODONT, V2, P7, DOI [10.4047/jap.2010.2.7-13, 10.4047/jap.2010.2.1.7]
   Liang HX, 2010, BONE, V47, P197, DOI 10.1016/j.bone.2010.05.023
   Oshima Y, 2005, J HISTOCHEM CYTOCHEM, V53, P207, DOI 10.1369/jhc.4A6280.2005
   Scherberich A, 2010, J CELL PHYSIOL, V225, P348, DOI 10.1002/jcp.22313
   Sena K, 2007, CONNECT TISSUE RES, V48, P324, DOI 10.1080/03008200701692743
   Shoji T, 2010, LAB INVEST, V90, P637, DOI 10.1038/labinvest.2010.39
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Tan SH, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3466882
   Wang YJ, 2006, J BIOMED MATER RES A, V76A, P589, DOI 10.1002/jbm.a.30575
   Wang YQ, 2004, BIOMATERIALS, V25, P4777, DOI 10.1016/j.biomaterials.2003.11.051
   Wernike E, 2010, EUR CELLS MATER, V19, P30
   Zeng Q, 2007, BONE, V40, P374, DOI 10.1016/j.bone.2006.09.022
   Zeng Q, 2006, CONNECT TISSUE RES, V47, P264, DOI 10.1080/03008200600980769
   Zheng B, 2006, TISSUE ENG, V12, P1891, DOI 10.1089/ten.2006.12.1891
NR 24
TC 8
Z9 9
U1 0
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1529-9430
EI 1878-1632
J9 SPINE J
JI Spine Journal
PD MAR
PY 2014
VL 14
IS 3
SI SI
BP 445
EP 454
DI 10.1016/j.spinee.2013.09.045
PG 10
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA AB3TY
UT WOS:000331714300009
PM 24360747
DA 2018-10-20
ER

PT J
AU Ma, M
   Zhang, B
   Lu, WP
   Liu, JL
   Guo, YC
AF Ma, Ming
   Zhang, Bing
   Lu, Weipeng
   Liu, Junli
   Guo, Yanchuan
TI Preparation, thermal stability and biocompatibility studies of
   gelatin-induced hydroxyapatite co-substituted with essential
   physiological trace elements
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE Gelatin; Calcium phosphates; Co-substitution; Precipitation; In vitro
   biological tests; MC3T3-E1 cell lines
ID OSTEOCLAST DIFFERENTIATION; NANO-HYDROXYAPATITE; IN-VITRO; BONE;
   CALCIUM; MAGNESIUM; BIOMINERALIZATION; TEMPERATURE; CARBONATE; SODIUM
AB Gelatin-induced hydroxyapatite with combined substitution of essential physiological trace elements (G-FAP) was prepared by a precipitation method. Pure hydroxyapatite (HAP) and ion-substituted hydroxyapatite (FAP) were also prepared for comparison. The characteristics of the precipitated powders were determined using X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FT-IR), specific surface area measurement (SSA), X-ray fluorescence spectroscopy (XRF), and thermogravimetric (TG) analysis. The biocompatibility was also determined by an in vitro investigation with MC3T3-E1 cells. SEM and TEM results showed that the G-FAP powders were composed of dense aggregates of agglomerated whisker-like crystals of 200-300 nm in length and 10-20 nm in width. XRD and FT-IR analyses indicated the formation of pure apatite phase, and the substituted ions and gelatin did not change the diffraction pattern of the precipitated powders. The SSAs of the precipitated powder were 64.741, 72.492, and 107.745 m(2)/g, for HAP, FAP, and G-FAP, respectively. XRF analysis showed that Na+, Mg2+, and F- were substituted into the crystal lattice. TG results showed a reduced thermal stability of the precipitated G-FAP powders, with an advanced phase transformation beginning at 800 A degrees C and a serious phase transformation from hexagonal apatite phase to rhombohedral beta-TCP phase at 1,200 A degrees C in comparison with HAP and FAP. In vitro biological tests showed non-cytotoxic effects for all powders. However, G-FAP stimulated the proliferation of MC3T3-E1 cells earlier than HAP and FAP. The present G-FAP will therefore be a promising primary biomaterial for bone regeneration, tooth filling, or as a coating for metal artificial limbs.
C1 [Ma, Ming; Zhang, Bing; Lu, Weipeng; Guo, Yanchuan] Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Photochem Convers & Optoelect Mat, Beijing 100190, Peoples R China.
   [Liu, Junli] 306th Hosp Peoples Liberat Army, Beijing 100101, Peoples R China.
RP Guo, YC (reprint author), Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Photochem Convers & Optoelect Mat, Beijing 100190, Peoples R China.
EM yanchuanguo@mail.ipc.ac.cn
FU Programs of International Science and Technology Corporation, China
   [S2013ZR0442]; Beijing Municipal Science and Technology Project
   [Z131100005213007]
FX This work was supported by Programs of International Science and
   Technology Corporation, China (S2013ZR0442) and Beijing Municipal
   Science and Technology Project (Z131100005213007).
CR Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C
   Bianco A, 2010, CERAM INT, V36, P313, DOI 10.1016/j.ceramint.2009.09.007
   Bianco A, 2009, MATER RES BULL, V44, P345, DOI 10.1016/j.materresbull.2008.05.013
   Bigi A, 2007, INORG CHIM ACTA, V360, P1009, DOI 10.1016/j.ica.2006.07.074
   BLUMENTHAL NC, 1975, CALC TISS RES, V18, P81, DOI 10.1007/BF02546228
   Braye F, 1996, BIOMATERIALS, V17, P1345, DOI 10.1016/0142-9612(96)88682-0
   Cho JS, 2014, J BIOMED MATER RES A, V102, P455, DOI 10.1002/jbm.a.34722
   CONAWAY HH, 1971, ANAL BIOCHEM, V39, P218, DOI 10.1016/0003-2697(71)90479-9
   Deng Y, 2013, MATER LETT, V104, P8, DOI 10.1016/j.matlet.2013.03.145
   DEVINE A, 1995, AM J CLIN NUTR, V62, P740
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Dorozhkin Sergey V, 2011, Biomatter, V1, P121, DOI 10.4161/biom.18790
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Eiden-Assmann S, 2002, J INORG BIOCHEM, V91, P481, DOI 10.1016/S0162-0134(02)00481-6
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Ergun C, 2008, J EUR CERAM SOC, V28, P2137, DOI 10.1016/j.jeurceramsoc.2008.03.007
   Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   GLOWACKI J, 1991, J CELL BIOCHEM, V45, P292, DOI 10.1002/jcb.240450312
   GORSKI JP, 1992, CALCIFIED TISSUE INT, V50, P391, DOI 10.1007/BF00296767
   GRUBBS RD, 1987, MAGNESIUM, V6, P113
   Jenkins R, 2012, INTRO XRAY POWDER DI
   KANDORI K, 1992, COLLOID SURFACE, V68, P283, DOI 10.1016/0166-6622(92)80214-M
   Kannan S, 2006, CHEM MATER, V18, P2181, DOI 10.1021/cm052567q
   Kannan S, 2006, J INORG BIOCHEM, V100, P1692, DOI 10.1016/j.jinorgbio.2006.06.005
   Kannan S, 2006, CHEM MATER, V18, P198, DOI 10.1021/cm051966i
   Kleerekoper M, 1998, ENDOCRIN METAB CLIN, V27, P441, DOI 10.1016/S0889-8529(05)70015-3
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Kumar GS, 2012, MATER CHEM PHYS, V134, P1127, DOI 10.1016/j.matchemphys.2012.04.005
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Laurencin D, 2011, BIOMATERIALS, V32, P1826, DOI 10.1016/j.biomaterials.2010.11.017
   Lijuan X., 2013, MATER LETT, V106, P246
   LIU JK, 2005, EUR J INORG CHEM, V20, P4145
   Lu X, 2005, BIOMATERIALS, V26, P1097, DOI 10.1016/j.biomaterials.2004.05.034
   Marelli B, 2012, BIOMATERIALS, V33, P102, DOI 10.1016/j.biomaterials.2011.09.039
   Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3
   MORTIER A, 1989, THERMOCHIM ACTA, V143, P265, DOI 10.1016/0040-6031(89)85065-8
   Nakamura M, 2013, J BIOMED MATER RES A, V101, P3141, DOI 10.1002/jbm.a.34621
   Peng SF, 2001, MACROMOLECULES, V34, P6795, DOI 10.1021/ma010376c
   Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   Tucker KL, 1999, AM J CLIN NUTR, V69, P727
   Wang CY, 2004, BIOMATERIALS, V25, P2949, DOI 10.1016/j.biomaterials.2003.09.088
   Wang T, 2004, MATER LETT, V58, P3025, DOI 10.1016/j.matlet.2004.05.033
   Yuan H, 2005, CALCIUM PHOSPHATE BI
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
NR 46
TC 4
Z9 4
U1 3
U2 53
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
EI 1861-9541
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD MAR
PY 2014
VL 59
IS 7
BP 606
EP 615
DI 10.1007/s11434-013-0091-7
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AB1PC
UT WOS:000331563700003
DA 2018-10-20
ER

PT J
AU Gaume, B
   Denis, F
   Van Wormhoudt, A
   Huchette, S
   Jackson, DJ
   Avignon, S
   Auzoux-Bordenave, S
AF Gaume, B.
   Denis, F.
   Van Wormhoudt, A.
   Huchette, S.
   Jackson, D. J.
   Avignon, S.
   Auzoux-Bordenave, S.
TI Characterisation and expression of the biomineralising gene Lustrin A
   during shell formation of the European abalone Haliotis tuberculata
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
DE Biomineralisation; Haliotis tuberculata; Larval development; Lustrin A;
   Shell
ID CALCIUM-CARBONATE CRYSTALS; NACRE PROTEIN; IN-VITRO; DOMAINS; MANTLE;
   IDENTIFICATION; GASTROPODA; LAEVIGATA; ARAGONITE; SEQUENCE
AB The molluscan shell is a remarkable product of a highly coordinated biomineralisation process, and is composed of calcium carbonate most commonly in the form of calcite or aragonite. The exceptional mechanical properties of this biomaterial are imparted by the embedded organic matrix which is secreted by the underlying mantle tissue. While many shell-matrix proteins have already been identified within adult molluscan shell, their presence and role in the early developmental stages of larval shell formation are not well understood. In the European abalone Haliotis tuberculata, the shell first forms in the early trochophore larva and develops into a mineralised protoconch in the veliger. Following metamorphosis, the juvenile shell rapidly changes as it becomes flattened and develops a more complex crystallographic profile including an external granular layer and an internal nacreous layer. Amongst the matrix proteins involved in abalone shell formation, Lustrin A is thought to participate in the formation of the nacreous layer: Here we have identified a partial cDNA coding for the Lustrin A gene in H. tuberculata and have analysed its spatial and temporal expression during abalone development. RTPCR experiments indicate that Lustrin A is first expressed in juvenile (post-metamorphosis) stages, suggesting that Lustrin A is a component of the juvenile shell, but not of the larval shell. We also detect Lustrin A mRNAs in non-nacre forming cells at the distal-most edge of the juvenile mantle as well as in the nacre-forming region of the mantle. Lustrin A was also expressed in 7-day-old post-larvae, prior to the formation of nacre. These results suggest that Lustrin A plays multiple roles in the shell-forming process and further highlight the dynamic ontogenic nature of molluscan shell formation. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Gaume, B.; Denis, F.; Van Wormhoudt, A.; Avignon, S.; Auzoux-Bordenave, S.] UPMC, Museum Natl Hist Nat, UMR BOREA Biol Organismes & Ecosyst Aquat, Stn Biol Marine Concarneau,CNRS 7208,IRD 207, F-29900 Concarneau, France.
   [Denis, F.] Univ Maine, F-72085 Le Mans, France.
   [Huchette, S.] Ecloserie France Haliotis, F-29880 Kerazan, Plouguerneau, France.
   [Jackson, D. J.] Univ Gottingen, Courant Res Ctr Geobiol, D-37077 Gottingen, Germany.
   [Auzoux-Bordenave, S.] Univ Paris 06, F-75005 Paris, France.
RP Gaume, B (reprint author), Univ Antilles Guyane, DYNECAR EA 926, Lab Biol Marine, Campus Fouillole, F-97110 Pointe a Pitre, Guadeloupe, Guadeloupe.
EM beatrice-gaume@hotmail.fr; fdenis@mnhn.fr; avw@mnhn.fr;
   sylvain.huchette@wanadoo.fr; djackso@uni-goettingen.de; bordenav@mnhn.fr
RI Jackson, Daniel/J-5158-2012
OI Jackson, Daniel/0000-0001-9045-381X; HUCHETTE,
   Sylvain/0000-0002-9253-6907; AUZOUX-BORDENAVE,
   Stephanie/0000-0001-7429-1654
FU ATM program "Biomineralisation" of the MNHN; Ministere delegue a
   l'Enseignement Superieur et la Recherche (Paris, France); Deutsche
   Forschungsgemeinschaft (DFG) through the CRC for Geobiology; German
   Excellence Initiative; ATM program "Biomineralisation" of the MNHN;
   Ministere delegue a l'Enseignement Superieur et la Recherche (Paris,
   France); Deutsche Forschungsgemeinschaft (DFG) through the CRC for
   Geobiology; German Excellence Initiative
FX This work was financed in part by the ATM program "Biomineralisation" of
   the MNHN funded by the Ministere delegue a l'Enseignement Superieur et
   la Recherche (Paris, France). This work was supported by the Deutsche
   Forschungsgemeinschaft (DFG) funding to DJJ through the CRC for
   Geobiology and the German Excellence Initiative.
CR Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381
   ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110
   Amos FF, 2009, BIOCHEMISTRY-US, V48, P1332, DOI 10.1021/bi802148r
   Auzoux-Bordenave S, 2010, J STRUCT BIOL, V171, P277, DOI 10.1016/j.jsb.2010.05.012
   Bedouet L, 2012, MAR BIOTECHNOL, V14, P446, DOI 10.1007/s10126-011-9425-0
   Blank S, 2003, J MICROSC-OXFORD, V212, P280, DOI 10.1111/j.1365-2818.2003.01263.x
   de Vicose GC, 2007, J SHELLFISH RES, V26, P847, DOI 10.2983/0730-8000(2007)26[847:EALDOH]2.0.CO;2
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67
   Gaume B, 2011, MAR BIOL, V158, P341, DOI 10.1007/s00227-010-1562-x
   Giusti AF, 2000, EVOL DEV, V2, P294, DOI 10.1046/j.1525-142x.2000.00071.x
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Jackson DJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-160
   Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40
   Jardillier E, 2008, MAR BIOL, V154, P735, DOI 10.1007/s00227-008-0966-3
   Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613
   Le Roy N, 2012, J EXP ZOOL PART B, V318B, P353, DOI 10.1002/jez.b.22452
   Lowenstam H.A., 1989, ON BIOMINERALISATION
   Mann K, 2007, BIOPHYS J, V93, P1246, DOI 10.1529/biophysj.106.100636
   Mann S., 2001, BIOMINERALISATION PR
   Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54
   Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8
   McDougall C, 2011, CELLS TISSUES ORGANS, V194, P103, DOI 10.1159/000324213
   Michenfelder M, 2003, BIOPOLYMERS, V70, P522, DOI 10.1002/bip.10536
   Ranganathan S, 1999, J MOL GRAPH MODEL, V17, P106, DOI 10.1016/S1093-3263(99)00023-6
   Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Smith VJ, 2011, BIOCHEM SOC T, V39, P1403, DOI 10.1042/BST0391403
   Sud D, 2002, J SHELLFISH RES, V21, P201
   Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108
   Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001
   Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907
   Wustman BA, 2004, BIOPOLYMERS, V74, P363, DOI 10.1002/bip.20086
   Wustman BA, 2003, CONNECT TISSUE RES, V44, P10, DOI 10.1080/03008200390152016
   Zhang B, 2002, BIOPOLYMERS, V63, P358, DOI 10.1002/bip.10069
NR 35
TC 8
Z9 9
U1 1
U2 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1096-4959
EI 1879-1107
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol. B-Biochem. Mol. Biol.
PD MAR
PY 2014
VL 169
BP 1
EP 8
DI 10.1016/j.cbpb.2013.11.010
PG 8
WC Biochemistry & Molecular Biology; Zoology
SC Biochemistry & Molecular Biology; Zoology
GA AB0LZ
UT WOS:000331485100001
PM 24321821
DA 2018-10-20
ER

PT J
AU Costa-Pinto, AR
   Martins, AM
   Castelhano-Carlos, MJ
   Correlo, VM
   Sol, PC
   Longatto, A
   Battacharya, M
   Reis, RL
   Neves, NM
AF Costa-Pinto, Ana R.
   Martins, Ana M.
   Castelhano-Carlos, Magda J.
   Correlo, Vitor M.
   Sol, Paula C.
   Longatto-Filho, Adhemar
   Battacharya, Mrinal
   Reis, Rui L.
   Neves, Nuno M.
TI In vitro degradation and in vivo biocompatibility of
   chitosan-poly(butylene succinate) fiber mesh scaffolds
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE scaffold; biocompatibility; biodegradation; subcutaneous implantation;
   Tissue engineering; chitosan
ID TISSUE ENGINEERING APPLICATIONS; N-ACETYLATED CHITOSANS; OSTEOGENIC
   DIFFERENTIATION; POLY(BUTYLENE SUCCINATE); CHITIN; HYDROLYSIS;
   POLYESTERS; LYSOZYME; CELLS; BIODEGRADATION
AB In tissue engineering, the evaluation of the host response to the biomaterial implantation must be assessed to determine the extent of the inflammatory reaction. We studied the degradation of poly(butylene succinate) and chitosan in vitro using lipase and lysozyme enzymes, respectively. The subcutaneous implantation of the scaffolds was performed to assess tissue response. The type of inflammatory cells present in the surrounding tissue, as well as within the scaffold, was determined histologically and by immunohistochemistry. In the presence of lipase or lysozyme, the water uptake of the scaffolds increased. Based on the weight loss data and scanning electron microscopy analysis, the lysozyme combined with lipase had a notable effect on the in vitro degradation of the scaffolds. The in vivo implantation showed a normal inflammatory response, with presence of neutrophils, in a first stage, and macrophages, lymphocytes, and giant cells in a later stage. Vascularization in the surrounding tissue and within the implant increased with time. Moreover, the collagen deposition increased with time inside the implant. In vivo, the scaffolds maintained the structural integrity. The degradation in vitro was faster and greater compared to that observed in vivo within the same time periods.
C1 [Costa-Pinto, Ana R.; Martins, Ana M.; Correlo, Vitor M.; Sol, Paula C.; Reis, Rui L.; Neves, Nuno M.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Guimaraes, Portugal.
   [Costa-Pinto, Ana R.; Martins, Ana M.; Castelhano-Carlos, Magda J.; Correlo, Vitor M.; Sol, Paula C.; Longatto-Filho, Adhemar; Reis, Rui L.; Neves, Nuno M.] ICVS 3Bs, PT Govt Associate Lab, Braga, Portugal.
   [Castelhano-Carlos, Magda J.; Longatto-Filho, Adhemar] Life & Hlth Sci Res Inst ICVS, Braga, Portugal.
   [Battacharya, Mrinal] Univ Minnesota, Dept Biosyst Engn, St Paul, MN 55108 USA.
RP Neves, NM (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM nuno@dep.uminho.pt
RI Castelhano Carlos, Magda Joao/Q-9490-2017; Reis, Rui L./A-8938-2008;
   Neves, Nuno/B-4685-2008; Group, 3Bs/E-4374-2012; Correlo,
   Vitor/O-4227-2015; Longatto Filho, Adhemar/A-2889-2016
OI Castelhano Carlos, Magda Joao/0000-0002-5409-5987; Reis, Rui
   L./0000-0002-4295-6129; Neves, Nuno/0000-0003-3041-0687; Group,
   3Bs/0000-0002-5195-3456; Correlo, Vitor/0000-0002-5516-7583; Sol,
   Paula/0000-0003-0512-0928; longatto-filho, adhemar/0000-0002-5779-9752;
   Martins, Ana/0000-0001-5655-5564; Pinto, Ana Rita/0000-0002-4764-8539
FU Portuguese "Fundacao para a Ciencia e a Tecnologia" (FCT)
   [SFRH/24735/2005]; European Network of Excellence EXPERTISSUES
   [NMP3-CT-2004-500283]; FCT [PTDC/SAU-ENB/115179/2009]
FX Ana R Costa-Pinto was supported by the scholarship SFRH/24735/2005 from
   the Portuguese "Fundacao para a Ciencia e a Tecnologia" (FCT). This work
   was partially supported by the European Network of Excellence
   EXPERTISSUES (NMP3-CT-2004-500283) and FCT funded project Maxbone
   (PTDC/SAU-ENB/115179/2009).
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   [Anonymous], 1099361994 ISO
   Azevedo HS, 2005, BIODEGRADABLE SYSTEMS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE, P177
   Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   Balmayor ER, 2008, J MATER SCI-MATER M, V19, P1617, DOI 10.1007/s10856-008-3378-5
   Correlo VM, 2007, MACROMOL BIOSCI, V7, P354, DOI 10.1002/mabi.200600233
   Correlo VM, 2010, MACROMOL BIOSCI, V10, P1495, DOI 10.1002/mabi.201000011
   Costa-Pinto AR, 2009, BIOMACROMOLECULES, V10, P2067, DOI 10.1021/bm9000102
   Costa-Pinto AR, 2008, TISSUE ENG PT A, V14, P1049, DOI [10.1089/ten.tea.2007.0153, 10.1089/tea.2007.0153]
   Cui ZW, 2013, J BIOACT COMPAT POL, V28, P115, DOI 10.1177/0883911512472278
   Ferreira L, 2004, J BIOMED MATER RES A, V68A, P584, DOI 10.1002/jm.a.20102
   Gomes ME, 2008, J TISSUE ENG REGEN M, V2, P243, DOI 10.1002/term.89
   Grech JMR, 2008, J BIOACT COMPAT POL, V23, P367, DOI 10.1177/0883911508093389
   Griffiths Marie M., 1996, Methods (Orlando), V9, P295, DOI 10.1006/meth.1996.0034
   Hasham SN, 2006, CLIN CHIM ACTA, V372, P179, DOI 10.1016/j.cca.2006.04.020
   Hashitani T, 2002, FUJITSU SCI TECH J, V38, P112
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   Hirotsu T, 2000, J APPL POLYM SCI, V78, P1121, DOI 10.1002/1097-4628(20001031)78:5<1121::AID-APP210>3.3.CO;2-8
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Ishihara M, 2001, WOUND REPAIR REGEN, V9, P513, DOI 10.1046/j.1524-475x.2001.00513.x
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Kumar V, 2010, ROBBINS COTRAN PATHO, P43
   Li HY, 2005, MACROMOL BIOSCI, V5, P433, DOI 10.1002/mabi.200400183
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Malafaya BPP, 2005, J MATER SCI-MATER M, V16, P1077
   Malafaya PB, 2008, BIOMATERIALS, V29, P3914, DOI 10.1016/j.biomaterials.2008.06.023
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Marten E, 2003, POLYM DEGRAD STABIL, V80, P485, DOI 10.1016/S0141-3910(03)00032-6
   Martins AM, 2009, TISSUE ENG PT A, V15, P1953, DOI 10.1089/ten.tea.2008.0023
   Martins AM, 2008, ACTA BIOMATER, V4, P1637, DOI 10.1016/j.actbio.2008.06.004
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Nishikawa H, 2000, J ENDODONT, V26, P169, DOI 10.1097/00004770-200003000-00010
   Nishimura K, 1984, Vaccine, V2, P93, DOI 10.1016/S0264-410X(98)90039-1
   Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   SASHIWA H, 1990, INT J BIOL MACROMOL, V12, P295, DOI 10.1016/0141-8130(90)90016-4
   Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383, DOI 10.1080/02648725.1996.10647935
   Silva SS, 2013, J BIOACT COMPAT POL, V28, P385, DOI 10.1177/0883911513490361
   Silva SS, 2005, J MATER SCI-MATER M, V16, P575, DOI 10.1007/s10856-005-0534-z
   TOKIWA Y, 1977, NATURE, V270, P76, DOI 10.1038/270076a0
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Usami Y, 1998, J BIOMED MATER RES, V42, P517
   van Dijkhuizen-Radersma R, 2008, ACAD PR SER BIOM ENG, P193, DOI 10.1016/B978-0-12-370869-4.00007-0
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
NR 50
TC 31
Z9 31
U1 0
U2 46
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAR
PY 2014
VL 29
IS 2
BP 137
EP 151
DI 10.1177/0883911514521919
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA AB2JK
UT WOS:000331618800004
DA 2018-10-20
ER

PT J
AU Bojar, W
   Kucharska, M
   Ciach, T
   Koperski, L
   Jastrzebski, Z
   Szalwinski, M
AF Bojar, Witold
   Kucharska, Martyna
   Ciach, Tomasz
   Koperski, Lukasz
   Jastrzebski, Zenon
   Szalwinski, Michal
TI Bone regeneration potential of the new chitosan-based alloplastic
   biomaterial
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
ID BETA-TRICALCIUM PHOSPHATE
C1 [Bojar, Witold] Natl Med Inst, Med Devices Dept, PL-00725 Warsaw, Poland.
   [Kucharska, Martyna; Ciach, Tomasz] Warsaw Univ Technol, Fac Chem & Proc Engn, Biomed Engn Lab, PL-00661 Warsaw, Poland.
   [Koperski, Lukasz] Med Univ Warsaw, Dept Pathol, Warsaw, Poland.
   [Jastrzebski, Zenon] Natl Med Inst, Dept Pharmacol, PL-00725 Warsaw, Poland.
   [Szalwinski, Michal] Med Univ Warsaw, Dept Descript & Clin Anat, Warsaw, Poland.
RP Bojar, W (reprint author), Natl Med Inst, Med Devices Dept, Chelmska 30-34, PL-00725 Warsaw, Poland.
EM bojar@il.waw.pl
OI Ciach, Tomasz/0000-0002-8726-8944
FU Foundation of Polish Science in the framework of Innovative Economy
   Operational Programme
FX This work was financially supported by the Foundation of Polish Science
   in the framework of Innovative Economy Operational Programme.
CR Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P445, DOI 10.1111/j.1600-0501.2009.01876.x
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Bojar W, 2012, ACTA BIOENG BIOMECH, V14, P39
   Bojar W, 2009, ADV CLIN EXP MED, V18, P615
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   HOFMANN GO, 1995, ARCH ORTHOP TRAUM SU, V114, P159, DOI 10.1007/BF00443390
   Horovitz RA, 2009, TITANIUM, V1, P1
   Hsu SH, 2004, J POLYM RES, V11, P141, DOI 10.1023/B:JPOL.0000031080.70010.0b
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Lassus J, 1998, CLIN ORTHOP RELAT R, P7
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Marins Lucele Vieira, 2004, J. Appl. Oral Sci., V12, P62, DOI 10.1590/S1678-77572004000100012
   Mendonca T.A., 2008, BRAZ ORAL RES, V22, P5
   Shegarfi Hamid, 2009, J Orthop Surg (Hong Kong), V17, P206
   Wenz B, 2001, BIOMATERIALS, V22, P1599, DOI 10.1016/S0142-9612(00)00312-4
NR 17
TC 15
Z9 15
U1 0
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2014
VL 28
IS 7
BP 1060
EP 1068
DI 10.1177/0885328213493682
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA6JZ
UT WOS:000331205900010
PM 23796631
DA 2018-10-20
ER

PT J
AU Iqbal, NM
   Amirul, AA
AF Iqbal, Nurhezreen Md.
   Amirul, A. A.
TI Synthesis of P(3HB-co-4HB) copolymer with target-specific 4HB molar
   fractions using combinations of carbon substrates
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Cupriavidus sp; P(3HB-co-4HB); mixture design; copolymer; one-stage
   fermentation
ID COMAMONAS-ACIDOVORANS; CUPRIAVIDUS-NECATOR; RALSTONIA-EUTROPHA; PHA
   SYNTHASE; POLYHYDROXYALKANOATE COPOLYMERS; MICROBIAL SYNTHESIS;
   MOLECULAR-WEIGHT; IN-VITRO;
   POLY(3-HYDROXYBUTYRATE-CO-4-HYDROXYBUTYRATE); BIOSYNTHESIS
AB BACKGROUNDThe incorporation of 4HB units into P(3HB) improves the material application potential as the copolymer exhibits a wide range of physical properties ranging from crystalline plastic to elastic rubber depending on the copolymer composition. Thus, the prospects of synthesizing P(3HB-co-4HB) copolymer with various compositions of 4HB would increase its effectiveness as biomaterial.
   RESULTSThe residual cell dry weight (RCDW) and PHA concentration obtained under optimized conditions, namely C/N ratio 30, K2HPO4 6.1 g L-1, incubation period 66 h, temperature 32 degrees C and volume-to-flask ratio 47/250 mL increased from 2.9 g L-1 to 4.9 g L-1 and 4.2 g L-1 to 7.6 g L-1, respectively. P(3HB-co-4HB) with varied M-n between 26 kDa and 270 kDa were successfully synthesized using combinations of oleic acid, 1,6-hexanediol and/or 1,4-butanediol. The tensile strength and Young's modulus of the copolymers varied from 2 MPa to 24 MPa and 13 MPa to 192 MPa, respectively. T-m and T-g decreased with increasing 4HB molar fractions from 170 degrees C to 68 degrees C and 2.5 degrees C to -31 degrees C, respectively.
   CONCLUSIONOleic acid and (NH4)(2)SO4 was the best carbon and nitrogen source for PHA biosynthesis. P(3HB-co-4HB) copolymer with targeted 4HB molar fractions ranged from 0-65 mol% were synthesized using combinations of two or more carbon substrates by Cupriavidus sp. USMAA2-4 (DSM 19379) using mixture design. (c) 2013 Society of Chemical Industry
C1 [Iqbal, Nurhezreen Md.; Amirul, A. A.] Univ Sains Malaysia, Sch Biol Sci, Minden 11800, Penang, Malaysia.
   [Amirul, A. A.] MOSTI, Malaysian Inst Pharmaceut & Nutraceut, Putrajaya, Malaysia.
RP Amirul, AA (reprint author), Univ Sains Malaysia, Sch Biol Sci, Minden 11800, Penang, Malaysia.
EM amirul@usm.my
OI Abdullah, Amirul Al-Ashraf/0000-0002-5014-1472
FU Ministry of Science Technology and Innovations (MOSTI), Malaysia;
   Universiti Sains Malaysia [1001/PBIOLOGI/821109]; National Science
   Fellowship [MOSTI/BMI/TAJ/1-1/2 Jld 10(4)]
FX The authors acknowledge the research grants provided by the Ministry of
   Science Technology and Innovations (MOSTI), Malaysia, Universiti Sains
   Malaysia (1001/PBIOLOGI/821109) and National Science Fellowship
   [MOSTI/BMI/TAJ/1-1/2 Jld 10(4)].
CR Amirul AA, 2009, WORLD J MICROB BIOT, V25, P1199, DOI 10.1007/s11274-009-0002-x
   [Anonymous], 1995, ANN BOOK ASTM STAND, V08.01
   Bhubalan K, 2008, POLYM DEGRAD STABIL, V93, P17, DOI 10.1016/j.polymdegradstab.2007.11.004
   BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854
   Cavalheiro JMBT, 2012, BIORESOURCE TECHNOL, V111, P391, DOI 10.1016/j.biortech.2012.01.176
   Chanprateep S, 2010, POLYM DEGRAD STABIL, V95, P2003, DOI 10.1016/j.polymdegradstab.2010.07.014
   Chee JW, 2008, BIOCHEM ENG J, V38, P314, DOI 10.1016/j.bej.2007.07.018
   Chia KH, 2010, POLYM DEGRAD STABIL, V95, P2226, DOI 10.1016/j.polymdegradstab.2010.09.011
   DOI Y, 1990, MICROBIAL POLYESTER
   GERNGROSS TU, 1995, P NATL ACAD SCI USA, V92, P6279, DOI 10.1073/pnas.92.14.6279
   HIRAMITSU M, 1993, BIOTECHNOL LETT, V15, P461, DOI 10.1007/BF00129318
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Hsieh WC, 2009, J TAIWAN INST CHEM E, V40, P143, DOI 10.1016/j.jtice.2008.11.004
   HUISMAN GW, 1992, APPL MICROBIOL BIOT, V38, P1
   Imandi SB, 2008, BIORESOURCE TECHNOL, V99, P4445, DOI 10.1016/j.biortech.2007.08.071
   Iram SH, 2006, J BACTERIOL, V188, P599, DOI 10.1128/JB.188.2.599-608.2006
   Khanna S, 2005, PROCESS BIOCHEM, V40, P2173, DOI 10.1016/j.procbio.2004.08.011
   KUNZ DA, 1983, J BACTERIOL, V156, P567
   Lee WH, 2004, POLYM DEGRAD STABIL, V84, P129, DOI 10.1016/j.polymdegradstab.2003.10.003
   Lee WH, 2008, BIORESOURCE TECHNOL, V99, P6844, DOI 10.1016/j.biortech.2008.01.051
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lo KW, 2005, APPL BIOCHEM BIOTECH, V121, P575
   Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3
   Madden LA, 2000, POLYMER, V41, P3499, DOI 10.1016/S0032-3861(99)00611-4
   Marangoni C, 2000, BIOTECHNOL LETT, V22, P1635, DOI 10.1023/A:1005684525264
   Martinko J., 2005, BROCK BIOL MICROORGA
   Mitomo H, 2001, POLYMER, V42, P3455, DOI 10.1016/S0032-3861(00)00678-9
   Myers R. H., 2002, RESPONSE SURFACE MET
   Nomura CT, 2007, APPL MICROBIOL BIOT, V73, P969, DOI 10.1007/s00253-006-0566-4
   Park DH, 2011, NEW BIOTECHNOL, V28, P719, DOI 10.1016/j.nbt.2011.01.007
   Poetter Markus, 2006, V1, P109, DOI 10.1007/7171_005
   Rao U, 2010, BIOCHEM ENG J, V49, P13, DOI 10.1016/j.bej.2009.11.005
   Saito Y, 1996, POLYM INT, V39, P169
   SAITO Y, 1994, INT J BIOL MACROMOL, V16, P99, DOI 10.1016/0141-8130(94)90022-1
   Sim SJ, 1997, NAT BIOTECHNOL, V15, P63, DOI 10.1038/nbt0197-63
   Solaiman DKY, 2006, APPL MICROBIOL BIOT, V71, P783, DOI 10.1007/s00253-006-0451-1
   Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   TAIDI B, 1994, APPL MICROBIOL BIOT, V40, P786, DOI 10.1007/s002530050067
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Tsuge T, 2007, MACROMOL BIOSCI, V7, P846, DOI 10.1002/mabi.200700023
   Vigneswari S, 2012, J APPL POLYM SCI, V124, P2777, DOI 10.1002/app.35336
   Vigneswari S, 2009, J IND MICROBIOL BIOT, V36, P547, DOI 10.1007/s10295-009-0525-z
   Volova TG, 2011, APPL BIOCHEM MICRO+, V47, P494, DOI 10.1134/S0003683811050152
   Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429
   Ying TH, 2008, BIOMATERIALS, V29, P1307, DOI 10.1016/j.biomaterials.2007.11.031
   Yu J, 2001, J BIOTECHNOL, V86, P105, DOI 10.1016/S0168-1656(00)00405-3
   Zakaria MR, 2010, POLYM DEGRAD STABIL, V95, P1382, DOI 10.1016/j.polymdegradstab.2010.01.020
NR 48
TC 4
Z9 5
U1 2
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
EI 1097-4660
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD MAR
PY 2014
VL 89
IS 3
BP 407
EP 418
DI 10.1002/jctb.4133
PG 12
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA AA6PB
UT WOS:000331219200008
DA 2018-10-20
ER

PT J
AU Cai, XM
   Yuan, J
   Chen, SC
   Li, PF
   Li, L
   Shen, J
AF Cai, Xianmei
   Yuan, Jiang
   Chen, Shuangchun
   Li, Pengfei
   Li, Li
   Shen, Jian
TI Hemocompatibility improvement of poly(ethylene terephthalate) via
   self-polymerization of dopamine and covalent graft of zwitterions
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Zwitterions; Poly(dopamine); Hemocompatibility; Poly(ethylene
   terephthalate); Surface modification
ID QUINONE-RICH POLYDOPAMINE; PROTEIN ADSORPTION; BLOOD COMPATIBILITY;
   PLATELET-ADHESION; CELL-ADHESION; SURFACE; MEMBRANES; CHEMISTRY;
   FUNCTIONALIZATION; BIOMOLECULES
AB Poly (ethylene terephthalate) (PET) has been widely adopted as a scaffold biomaterial, but further hemocompatibility improvement is still needed for wide biomedical applications. Inspired by the composition of adhesive proteins in mussels, we propose to use self-polymerized dopamine to form a surface-adherent polydopamine layer onto PET sheet, followed by Michael addition with N,N-dimethylethylenediamine (DMDA) to build tertiary amine, and final zwitterions(sulfobetaine and carboxybetaine) construction through ring-opening reaction. Physicochemical properties of substrates were demonstrated by water contact angle measurement, attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR) and X-ray photoelectron spectroscopy (XPS). The hemocompatibility was evaluated by platelet adhesion, hemolytic, and protein adsorption. The results showed that the zwitterions immobilized PET endowed with improved resistance to nonspecific protein adsorption and platelet adhesion as well as nonhemolytic. The zwitterions with desirable hemocompatibility can be readily tailored to catheter for various biomedical applications. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Cai, Xianmei; Yuan, Jiang; Chen, Shuangchun; Li, Pengfei; Li, Li; Shen, Jian] Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210023, Jiangsu, Peoples R China.
RP Yuan, J (reprint author), Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210023, Jiangsu, Peoples R China.
EM bioalchem@yahoo.com; lili3@njnu.edu.cn
FU Nanjing Normal University [2011103XGQ0055]; Jiangsu Higher Education
   Institutions of China [11KJD430003, 10KJA430026]; National Natural
   Science Foundation [21274063]; Jiangsu Co-Innovation Center for
   Biomedical Functional Materials
FX This work was supported by the Nanjing Normal University
   (2011103XGQ0055), the Jiangsu Higher Education Institutions of China
   (11KJD430003, 10KJA430026, and PAPD), the National Natural Science
   Foundation (21274063), and the Jiangsu Co-Innovation Center for
   Biomedical Functional Materials.
CR Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434
   Chen C, 2008, J BIOMED MATER RES A, V87A, P290, DOI 10.1002/jbm.a.31719
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Dhahri M, 2011, J BIOMED MATER RES A, V98A, P114, DOI 10.1002/jbm.a.33077
   Greisler HP, 1996, BIOMATERIALS, V17, P329, DOI 10.1016/0142-9612(96)85571-2
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   Jiang JH, 2010, J MEMBRANE SCI, V364, P194, DOI 10.1016/j.memsci.2010.08.017
   Jiang JH, 2011, LANGMUIR, V27, P14180, DOI 10.1021/la202877k
   Keuren JFW, 2004, ARTERIOSCL THROM VAS, V24, P613, DOI 10.1161/01.ATV.0000116026.18945.66
   Kim HW, 2013, ACS APPL MATER INTER, V5, P233, DOI 10.1021/am302439g
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Kohri M, 2013, POLYM CHEM-UK, V4, P2696, DOI 10.1039/c3py00181d
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104
   Luo RF, 2013, COLLOID SURFACE B, V106, P66, DOI 10.1016/j.colsurfb.2013.01.033
   Luo RF, 2013, ACS APPL MATER INTER, V5, P1704, DOI 10.1021/am3027635
   Muthuvijayan V, 2009, ACTA BIOMATER, V5, P3382, DOI 10.1016/j.actbio.2009.05.020
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Sagert J, 2006, BIOLOGICAL ADHESIVES, P125, DOI 10.1007/978-3-540-31049-5_7
   Sun SD, 2003, J MEMBRANE SCI, V222, P3, DOI 10.1016/S0376-7388(03)00313-2
   Wu JJ, 2011, LANGMUIR, V27, P13684, DOI 10.1021/la2027237
   Xi ZY, 2009, J MEMBRANE SCI, V327, P244, DOI 10.1016/j.memsci.2008.11.037
   Xu LQ, 2010, MACROMOLECULES, V43, P8336, DOI 10.1021/ma101526k
   Xu Y, 2009, BIOMATERIALS, V30, P4930, DOI 10.1016/j.biomaterials.2009.06.005
   Yuan J, 2003, J BIOMAT SCI-POLYM E, V14, P1339, DOI 10.1163/156856203322599680
   Yuan J, 2003, COLLOID SURFACE B, V30, P147, DOI 10.1016/S0927-7765(03)00082-1
   Zhu BC, 2011, POLYMER, V52, P2141, DOI 10.1016/j.polymer.2011.03.027
NR 30
TC 19
Z9 19
U1 5
U2 119
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2014
VL 36
BP 42
EP 48
DI 10.1016/j.msec.2013.11.038
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA AB0VD
UT WOS:000331509300007
PM 24433885
DA 2018-10-20
ER

PT J
AU Hua, ZK
   Fan, YW
   Jin, ZM
AF Hua, Zikai
   Fan, Yongwei
   Jin, Zhongmin
TI A biotribo-acoustic testing method for ceramic orthopaedic biomaterials
SO TRIBOLOGY INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT 5th World Tribology Congress (WTC)
CY SEP 08-13, 2013
CL Torino, ITALY
DE Biotribology; Acoustic; Squeaking; Artificial joint
ID TOTAL HIP-ARTHROPLASTY; WEAR; SQUEAKING; BEARINGS; SIMULATOR; JOINTS;
   FRICTION
AB A new biotribo-acoustic testing system for orthopaedic biomaterials was developed and validated. Experiments on the biotribo-acoustic testing methodology, especially for ceramic-on-ceramic biomaterial wear couples, were carried out via this testing system. Deionized water and biomimetic synovial fluids (BSF) were chosen as two lubricants in the tests. The results showed that the coefficient of friction agreed well with the sound pressure and sound power. The correlation between the biotribological and acoustic data was established in vitro. The difference in wear mechanisms was distinguished. A potential solution can be provided to investigate the biotribological and acoustic properties of orthopaedic biomaterials in vitro. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Hua, Zikai; Fan, Yongwei] Shanghai Univ, Sch Mechatron Engn & Automat, Shanghai, Peoples R China.
   [Jin, Zhongmin] Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Peoples R China.
   [Jin, Zhongmin] Univ Leeds, Sch Mech Engn, Leeds LS2 9JT, W Yorkshire, England.
RP Hua, ZK (reprint author), Room 321,Mech Bldg,149,Yanchang Rd, Shanghai 200072, Peoples R China.
EM eddie_hua@shu.edu.cn
CR Brockett CL, 2013, J ARTHROPLASTY, V28, P90, DOI 10.1016/j.arth.2012.01.023
   Calonius O, 2003, J BIOMECH, V36, P1719, DOI 10.1016/S0021-9290(03)00166-0
   D'Antonio JA, 2005, CLIN ORTHOP RELAT R, P151, DOI 10.1097/01.blo.0000194084.67364.6c
   Fan N, 2012, TRIBOL INT, V48, P172, DOI 10.1016/j.triboint.2011.11.023
   Grimm G, TRIBOLOGY TOTAL HIP
   Hua ZK, 2007, TRIBOL LETT, V28, P51, DOI 10.1007/s11249-007-9247-4
   Hua ZK, 2010, SCI CHINA TECHNOL SC, V53, P2996, DOI 10.1007/s11431-010-4124-z
   Hua ZK, 2010, P STLE ASME INT JOIN
   Jin ZM, 2006, CURR ORTHOPAED, V20, P32, DOI 10.1016/j.cuor.2005.09.005
   Keurentjes JC, 2008, CLIN ORTHOP RELAT R, V466, P1438, DOI 10.1007/s11999-008-0177-8
   Korduba LA, 2011, WEAR, V271, P1220, DOI 10.1016/j.wear.2011.01.039
   Liu F, 2013, TRIBOL INT, V63, P105, DOI 10.1016/j.triboint.2012.05.029
   Lusty PJ, 2007, J BONE JOINT SURG AM, V89A, P2676, DOI 10.2106/JBJS.F01466
   Morlock M, 2001, J ARTHROPLASTY, V16, P1071, DOI 10.1054/arth.2001.27233
   Restrepo C, 2010, J BONE JOINT SURG AM, V92A, P550, DOI 10.2106/JBJS.H.01326
   Saikko V, 2005, P I MECH ENG H, V219, P309, DOI 10.1243/095441105X34301
   Saikko V, 2002, J AM CERAM SOC, V85, P2785
   Saikko V, 1998, J BIOMED MATER RES, V41, P58, DOI 10.1002/(SICI)1097-4636(199807)41:1<58::AID-JBM7>3.3.CO;2-U
   Saikko V, 1998, ACTA ORTHOP SCAND, V69, P443, DOI 10.3109/17453679808997776
   Saikko V., 2005, P IMECHE C, V224, P697
   Saikko V, 2009, J TRIBOL-T ASME, V131, DOI 10.1115/1.2991121
   Stewart TD, 2003, J ARTHROPLASTY, V18, P726, DOI 10.1054/S0883-5403(03)00204-3
   Walter WL, 2008, J BONE JOINT SURG AM, V90A, P102, DOI 10.2106/JBJS.H.00867
   Walter WL, 2010, J AM ACAD ORTHOP SUR, V18, P319, DOI 10.5435/00124635-201006000-00004
   Walter WL, 2004, J ARTHROPLASTY, V19, P402, DOI 10.1016/j.arth.2003.09.018
   Weiss C, 2012, J BIOMECH, V45, P297, DOI 10.1016/j.jbiomech.2011.10.025
   Zhang HY, 2013, J MECH BEHAV BIOMED, V20, P209, DOI 10.1016/j.jmbbm.2013.01.001
   Zhang HY, 2012, CLIN BIOMECH, V27, P666, DOI 10.1016/j.clinbiomech.2012.02.008
   Zhang HY, 2013, J TRIBOL-T ASME, V135, DOI 10.1115/1.4023802
   Zywiel MG, 2011, EXPERT REV MED DEVIC, V8, P187, DOI [10.1586/ERD.10.75, 10.1586/erd.10.75]
NR 30
TC 5
Z9 7
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-679X
EI 1879-2464
J9 TRIBOL INT
JI Tribol. Int.
PD MAR
PY 2014
VL 71
BP 1
EP 6
DI 10.1016/j.triboint.2013.10.015
PG 6
WC Engineering, Mechanical
SC Engineering
GA AA8MI
UT WOS:000331349200001
DA 2018-10-20
ER

PT J
AU Chen, N
   Hu, WW
   Feng, CP
   Zhang, ZY
AF Chen, Nan
   Hu, Weiwu
   Feng, Chuanping
   Zhang, Zhenya
TI Removal of phosphorus from water using scallop shell synthesized ceramic
   biomaterials
SO ENVIRONMENTAL EARTH SCIENCES
LA English
DT Article
DE Scallop shell; Phosphorus removal; Ceramic biomaterial; Isotherm
   modeling; Sorption
ID PHOSPHATE REMOVAL; WASTE-WATER; AQUEOUS-SOLUTIONS; FLY-ASH; ADSORPTIVE
   REMOVAL; COIR PITH; RED MUD; IONS; MECHANISM; EQUILIBRIUM
AB This study describes the development of scallop shell synthesized ceramic biomaterial for phosphorus removal from water. The synthesized biomaterial was characterized by scanning electron microscope, Brunauer-Emmett-Teller and X-ray diffractometer methods. The influences of contact time, initial phosphate concentration, initial solution pH, co-existing ions and temperature for phosphorus removal were investigated by batch experiments. The results indicated that the equilibrium data can be fitted by the Langmuir isotherm model at temperatures ranging from 15 to 55 A degrees C, with the maximum sorption capacity of 13.6 mg/g. Sorption kinetics followed a pseudo-second-order kinetic equation model. The sorption process was optimal at a wide range of solution pH (above 2.4), with a relatively high sorption capacity level. Phosphorus sorption was slightly impeded by the presence of F-, HCO3 (-) and NH4 (+) ions, and significantly inhibited by Cl-, SO4 (2-) and NO3 (-) ions. Sorption process appeared to be controlled by a chemical precipitation processes. The mechanism may be attributed to ion complexation during subsequent sorption of phosphorus on scallop shell synthesized ceramic biomaterial.
C1 [Chen, Nan; Hu, Weiwu; Feng, Chuanping] China Univ Geosci, Key Lab Groundwater Cycle & Environm Evolut, Minist Educ, Beijing 100083, Peoples R China.
   [Chen, Nan; Feng, Chuanping] China Univ Geosci, Sch Water Resources & Environm, Beijing 100083, Peoples R China.
   [Hu, Weiwu] China Univ Geosci, Journal Ctr, Beijing 100083, Peoples R China.
   [Zhang, Zhenya] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.
RP Chen, N (reprint author), China Univ Geosci, Sch Water Resources & Environm, Beijing 100083, Peoples R China.
EM cnjing2008@hotmail.com; fengchuanping@gmail.com
FU Fundamental Research Funds for the Central Universities [2652013025];
   National Natural Science Foundation [31140082]
FX The authors thank "the Fundamental Research Funds for the Central
   Universities" (No. 2652013025), and the "National Natural Science
   Foundation" (No. 31140082) for financial support of this work.
CR Akhurst DJ, 2006, ENVIRON CHEM, V3, P65, DOI 10.1071/EN05038
   Blaney LM, 2007, WATER RES, V41, P1603, DOI 10.1016/j.watres.2007.01.008
   Chen N, 2011, J HAZARD MATER, V186, P863, DOI 10.1016/j.jhazmat.2010.11.083
   Chen N, 2010, J COLLOID INTERF SCI, V348, P579, DOI 10.1016/j.jcis.2010.04.048
   Chubar NI, 2005, COLLOID SURFACE A, V255, P55, DOI 10.1016/j.colsurfa.2004.12.015
   de-Bashan LE, 2004, WATER RES, V38, P4222, DOI 10.1016/j.watres.2004.07.014
   Ennil-Kose T, 2011, CHEM ENG J, V178, P34
   Feng C, 2003, J HAZARD MATER, V103, P65, DOI 10.1016/S0304-3894(03)00222-X
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Fytianos K, 1998, ENVIRON POLLUT, V101, P123, DOI 10.1016/S0269-7491(98)00007-4
   Georgantas DA, 2007, J COLLOID INTERF SCI, V315, P70, DOI 10.1016/j.jcis.2007.06.058
   Guo HM, 2011, J HAZARD MATER, V186, P1847, DOI 10.1016/j.jhazmat.2010.12.078
   Haghseresht F, 2009, APPL CLAY SCI, V46, P369, DOI 10.1016/j.clay.2009.09.009
   Hanif A, 2009, ECOL ENG, V35, P1427, DOI 10.1016/j.ecoleng.2009.05.013
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Huang WW, 2008, J HAZARD MATER, V158, P35, DOI 10.1016/j.jhazmat.2008.01.061
   Huang X, 2009, J HAZARD MATER, V166, P1261, DOI 10.1016/j.jhazmat.2008.12.045
   Jeon DJ, 2009, BIORESOURCE TECHNOL, V100, P2646, DOI 10.1016/j.biortech.2008.11.035
   Karaca S, 2006, J HAZARD MATER, V128, P273, DOI 10.1016/j.jhazmat.2005.08.003
   Krishnan KA, 2008, J HAZARD MATER, V152, P527, DOI 10.1016/j.jhazmat.2007.07.015
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Leofanti G, 1998, CATAL TODAY, V41, P207, DOI 10.1016/S0920-5861(98)00050-9
   Li KQ, 2010, J HAZARD MATER, V178, P553, DOI 10.1016/j.jhazmat.2010.01.120
   Li YZ, 2006, J HAZARD MATER, V137, P374, DOI 10.1016/j.jhazmat.2006.02.011
   Liao XP, 2006, IND ENG CHEM RES, V45, P3896, DOI 10.1021/ie051076c
   Liu HL, 2008, J HAZARD MATER, V151, P616, DOI 10.1016/j.jhazmat.2007.06.033
   Liu RX, 2002, J COLLOID INTERF SCI, V248, P268, DOI 10.1006/jcis.2002.8260
   Lu SG, 2009, J HAZARD MATER, V161, P95, DOI 10.1016/j.jhazmat.2008.02.123
   Morse GK, 1998, SCI TOTAL ENVIRON, V212, P69, DOI 10.1016/S0048-9697(97)00332-X
   Mustafa S, 2008, CHEM ENG J, V141, P51, DOI 10.1016/j.cej.2007.10.020
   Namasivayam C, 2004, J COLLOID INTERF SCI, V280, P359, DOI 10.1016/j.jcis.2004.08.015
   National Environmental Protection Agency of China, 1996, GB89781996 NAT ENV P, V1, P1
   Nowack B, 2006, WATER RES, V40, P2201, DOI 10.1016/j.watres.2006.03.018
   Razmouski R, 2008, ECOL ENG, V34, P179, DOI 10.1016/j.ecoleng.2008.07.020
   Rodrigues LA, 2009, QUIM NOVA, V32, P1206, DOI 10.1590/S0100-40422009000500023
   Shin EW, 2004, ENVIRON SCI TECHNOL, V38, P912, DOI 10.1021/es.030488e
   [宋丹 Song Dan], 2013, [地学前缘, Earth Science Frontiers], V20, P118
   State Environmental Protection Administration, 2002, WAT WAST MON AN METH, V4, P46
   Swain SK, 2011, CHEM ENG J, V171, P1218, DOI 10.1016/j.cej.2011.05.030
   Tian SL, 2009, CHEM ENG J, V151, P141, DOI 10.1016/j.cej.2009.02.006
   Tsai WT, 2008, BIORESOURCE TECHNOL, V99, P1623, DOI 10.1016/j.biortech.2007.04.010
   [王浩然 Wang Haoran], 2013, [地学前缘, Earth Science Frontiers], V20, P147
   [王欣宝 Wang Xinbao], 2012, [地学前缘, Earth Science Frontiers], V19, P243
   Xiong JB, 2008, J HAZARD MATER, V152, P211, DOI 10.1016/j.jhazmat.2007.06.103
   Yildiz E, 2004, SEP PURIF TECHNOL, V35, P241, DOI 10.1016/S1383-5866(03)00145-X
   Zeng L, 2004, WATER RES, V38, P1318, DOI 10.1016/j.watres.2003.12.009
   Zhang JD, 2011, J HAZARD MATER, V186, P76, DOI 10.1016/j.jhazmat.2010.10.076
   Zhou JB, 2011, J HAZARD MATER, V192, P1114, DOI 10.1016/j.jhazmat.2011.06.013
NR 49
TC 4
Z9 5
U1 1
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1866-6280
EI 1866-6299
J9 ENVIRON EARTH SCI
JI Environ. Earth Sci.
PD MAR
PY 2014
VL 71
IS 5
BP 2133
EP 2142
DI 10.1007/s12665-013-2618-2
PG 10
WC Environmental Sciences; Geosciences, Multidisciplinary; Water Resources
SC Environmental Sciences & Ecology; Geology; Water Resources
GA AA3KX
UT WOS:000330992400012
DA 2018-10-20
ER

PT J
AU Cheng, CX
   Alt, V
   Pan, LY
   Thormann, U
   Schnettler, R
   Strauss, LG
   Schumacher, M
   Gelinsky, M
   Dimitrakopoulou-Strauss, A
AF Cheng, Caixia
   Alt, Volker
   Pan, Leyun
   Thormann, Ulrich
   Schnettler, Reinhard
   Strauss, Ludwig G.
   Schumacher, Matthias
   Gelinsky, Michael
   Dimitrakopoulou-Strauss, Antonia
TI Preliminary evaluation of different biomaterials for defect healing in
   an experimental osteoporotic rat model with dynamic PET-CT (dPET-CT)
   using F-18-Sodium Fluoride (NaF)
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE PET-CT; F-18-Sodium Fluoride (NaF); Bone defect; Osteoporosis;
   Biomaterials
ID POSITRON-EMISSION-TOMOGRAPHY; BONE-GRAFT SUBSTITUTES; OSTEOBLAST-LIKE
   CELLS; STRONTIUM RANELATE; CALCIUM-CARBONATE; CEMENT; F-18-FLUORIDE;
   HISTOMORPHOMETRY; RECONSTRUCTION; OSTEOCLAST
AB The aim of the current study was to measure and compare the effect of calcium phosphate cement (CPC) and CPC enriched with strontium (SrCPC) for the healing of osteoporotic bone defects in the rat femur using F-18-Sodium Fluoride dPET-CT. Methods: Osteoporosis was induced by ovariectomy and a calcium restricted diet. After three months, rats were operated to create a 4 mm defect in the distal metaphyseal femur with internal fixation. 7 Rats have been treated either with CPC (Group 2) or with SrCPC (Group 3) for bone replacement and defect healing. Furthermore, a control group of 7 rats without any biomaterial (Group 1) was used for reference. 18 weeks after osteoporosis induction and 6 weeks following femoral surgery, dPET-CT studies scan were performed with 18F-Sodium Fluoride. SUVs and a 2-tissue compartmental learning-machine model (K1-k4, VB, influx) were used for quantitative analysis. Results: VB, reflecting the fractional blood volume and k3, reflecting the formation of fluoroapatite were the most sensitive parameters for the characterisation of healing process and revealed the best differentiation for the control group and the CPC group (Group 2) as well as for the CPC with strontium carbonate group (Group 3) (p < 0.05). VB was decreased by the order of Group1, Group 2 and Group3, while k3 was increased by the same order. Therefore, the data direct to a decreased fractional blood volume and increased fixation of fluoride in rats with these biomaterials. Conclusion: We found PET scanning using F-18-Sodium Fluoride to be a sensitive and useful method for evaluation of bone healing after replacement with CPC or SrCPC. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Cheng, Caixia; Pan, Leyun; Strauss, Ludwig G.; Dimitrakopoulou-Strauss, Antonia] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, Heidelberg, Germany.
   [Alt, Volker; Thormann, Ulrich; Schnettler, Reinhard] Univ Hosp Giessen Marburg GmbH, Dept Trauma Surg, Giessen, Germany.
   [Schumacher, Matthias; Gelinsky, Michael] Tech Univ Dresden, Ctr Translat Bone Joint & Soft Tissue Res, Fac Med, D-01062 Dresden, Germany.
   [Schumacher, Matthias; Gelinsky, Michael] Univ Hosp Carl Gustav Carus, Dresden, Germany.
RP Cheng, CX (reprint author), German Canc Res Ctr, Clin Cooperat Unit Nucl Med, Heidelberg, Germany.
EM c.cheng@dkfz.de
RI Dimitrakopoulou-Strauss, Antonia/E-6314-2014; Schumacher,
   Matthias/I-1530-2013
OI Dimitrakopoulou-Strauss, Antonia/0000-0003-0338-9472; Schumacher,
   Matthias/0000-0001-7207-7355; Gelinsky, Michael/0000-0001-9075-5121
CR Agarwal R, 2009, J NEUROSURG-SPINE, V11, P729, DOI 10.3171/2009.6.SPINE08669
   Alt V, 2013, ACTA BIOMATER, V9, P7035, DOI 10.1016/j.actbio.2013.02.002
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Burger C, 1997, J NUCL MED, V38, P1818
   Capuccini C, 2009, J BIOMED MATER RES A, V89A, P594, DOI 10.1002/jbm.a.31975
   Cheng CX, 2013, MOL IMAGING BIOL, V15, P336, DOI 10.1007/s11307-012-0592-9
   Combes C, 2006, J BIOMED MATER RES A, V79A, P318, DOI 10.1002/jbm.a.30795
   Cook GJR, 2002, J BONE MINER RES, V17, P854, DOI 10.1359/jbmr.2002.17.5.854
   Currey J.D., 2002, BONES STRUCTURE MECH
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Dimitrakopoulou-Strauss A, 2001, J NUCL MED, V42, P248
   Dimitrakopoulou-Strauss A, 2003, WORLD J NUCL MED, V2, P306
   Gazdag A.R., 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Heiss C, 2012, MED SCI MONITOR, V18, pBR199, DOI 10.12659/MSM.882895
   Hsu WK, 2007, EUR J NUCL MED MOL I, V34, P1291, DOI 10.1007/s00259-006-0280-6
   Khairoun I, 1997, BIOMATERIALS, V18, P1535, DOI 10.1016/S0142-9612(97)80005-1
   Kokesch-Himmelreich J, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-17
   Koort JK, 2005, ANTIMICROB AGENTS CH, V49, P1502, DOI 10.1128/AAC.49.4.1502-1508.2005
   Li CH, 2010, J BONE MINER RES, V25, P968, DOI 10.1359/jbmr.091038
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   Marie PJ, 2006, BONE, V38, P10, DOI 10.1016/j.bone.2005.07.029
   MESSA C, 1993, J CLIN ENDOCR METAB, V77, P949, DOI 10.1210/jc.77.4.949
   Mikolajczyk K, 1998, MED INFORM, V23, P207, DOI 10.3109/14639239809001400
   NARITA N, 1990, CALCIFIED TISSUE INT, V46, P200, DOI 10.1007/BF02555045
   Nkenke E, 2009, CLIN ORAL IMPLAN RES, V20, P124, DOI 10.1111/j.1600-0501.2009.01776.x
   Peltola MJ, 2012, EUR ARCH OTO-RHINO-L, V269, P623, DOI 10.1007/s00405-011-1607-x
   Piert M, 2001, J NUCL MED, V42, P1091
   Schumacher M, 2013, ACTA BIOMATER, V9, P7536, DOI 10.1016/j.actbio.2013.03.014
   Schumacher M, 2013, ACTA BIOMATER, DOI [DOI 10.1016/J.ACTBI0.2013.07.027, 10.1016/j.actbio.2013.07.027]
   Sorensen J, 2003, ACTA ORTHOP SCAND, V74, P633, DOI 10.1080/00016470310018126
   STRAUSS LG, 1991, J NUCL MED, V32, P623
   Strauss LG, 2007, IEEE T MED IMAGING, V26, P804, DOI 10.1109/TMI.2007.892645
   Tadier S, 2012, J BIOMED MATER RES B, V100B, P378, DOI 10.1002/jbm.b.31959
   Tadier S, 2011, J BIOMED MATER RES B, V99B, P302, DOI 10.1002/jbm.b.31899
   Thormann U, 2013, BIOMATERIALS, V34, P8589, DOI 10.1016/j.biomaterials.2013.07.036
   Toegel S, 2006, EUR J NUCL MED MOL I, V33, P491, DOI 10.1007/s00259-005-0026-x
   Ullmark G, 2009, ACTA ORTHOP, V80, P179, DOI 10.3109/17453670902947416
NR 37
TC 7
Z9 7
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD MAR
PY 2014
VL 45
IS 3
BP 501
EP 505
DI 10.1016/j.injury.2013.11.023
PG 5
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA 302BH
UT WOS:000330575800007
PM 24332163
DA 2018-10-20
ER

PT J
AU Maerz, T
   Mu, R
   Baker, KC
AF Maerz, Tristan
   Mu, Richard
   Baker, Kevin C.
TI Cell and scaffold surface engineering to enhance cell migration and
   tissue regeneration
SO SURFACE INNOVATIONS
LA English
DT Review
DE biomaterial; bone; cell-surface interaction; drug delivery;
   regeneration; scaffold; soft tissue; tissue engineering
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTOR; IN-VIVO; INFARCTED MYOCARDIUM;
   PROGENITOR CELLS; PLASMA TREATMENT; BONE; TRACKING; NANOPARTICLES;
   AFFINITY
AB The principles of surface engineering can be applied to cells and biomaterial scaffolds in efforts to treat disease, disorder, infection and injury. Although the body's endogenous response to some injuries is limited, cell-based approaches exploiting native physiology, namely, through the use of gene therapy or cell surface receptors hold significant promise in treating injured or diseased tissues. Shifting binding affinities of native receptors, causing expression of non-native receptors, or binding synthetic receptors onto the surfaces of cells are the techniques that increase cellular targeting, migration and engraftment. Scaffold modification techniques that increase a scaffold's bioactivity by providing signaling factors to endogenous cells can be used to elicit a desired response from an otherwise inert polymer. This review summarizes the endogenous homing and targeting response of leukocytes and stem cells to provide context for subsequent sections outlining existing ways of surface-modifying cells and biomaterials.
C1 [Maerz, Tristan; Mu, Richard; Baker, Kevin C.] Beaumont Hlth Syst, Orthopaed Res Labs, Royal Oak, MI 48073 USA.
RP Baker, KC (reprint author), Beaumont Hlth Syst, Orthopaed Res Labs, Royal Oak, MI 48073 USA.
EM kevin.baker@beaumont.edu
CR Andreas K, 2012, BIOMATERIALS, V33, P4515, DOI 10.1016/j.biomaterials.2012.02.064
   Arabi A, 2014, SURF INNOV, V2, P47, DOI 10.1680/si.13.00018
   Balyasnikova IV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009750
   BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3
   Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674
   Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Cheng Q, 2013, TISSUE ENG PT A, V19, P1188, DOI [10.1089/ten.tea.2011.0725, 10.1089/ten.TEA.2011.0725]
   Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374
   Chim H, 2012, CELL TISSUE RES, V350, P89, DOI 10.1007/s00441-012-1449-x
   Chinitz N, 2012, NOVEL STRATEGY ENHAN
   Choi JS, 2008, BIOMATERIALS, V29, P587, DOI 10.1016/j.biomaterials.2007.10.012
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Chute JP, 2006, CURR OPIN HEMATOL, V13, P399, DOI 10.1097/01.moh.0000245698.62511.3d
   DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Dennis JE, 2004, J ORTHOPAED RES, V22, P735, DOI 10.1016/j.orthres.2003.12.002
   Fong ELS, 2011, BIOMATERIALS, V32, P395, DOI 10.1016/j.biomaterials.2010.08.101
   Gade TPF, 2005, CANCER RES, V65, P9080, DOI 10.1158/0008-5472.CAN-05-0436
   Goncalves RM, 2012, EUR CELLS MATER, V23, P249, DOI 10.22203/eCM.v023a19
   Guan M, 2012, NAT MED, V18, P456, DOI 10.1038/nm.2665
   Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742
   Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030
   Imai K, 1999, BLOOD, V93, P149
   Intranuovo F., 2008, BONE, V15, P16
   Ko IK, 2012, FASEB J, V26, P158, DOI 10.1096/fj.11-182998
   Komarova S, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-12
   Kumar S, 2007, FASEB J, V21, P3917, DOI 10.1096/fj.07-8275com
   Lee RJ, 2007, STEM CELLS, V25, P712, DOI 10.1634/stemcells.2005-0602
   Levesque SG, 2006, BIOMATERIALS, V27, P5277, DOI 10.1016/j.biomaterials.2006.06.004
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Mahmoudi M, 2011, CHEM REV, V111, P253, DOI 10.1021/cr1001832
   McEver R. P, 2010, ANNU REV CELL DEV BI, V2, P363
   Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988
   Netelenbos T, 2003, J LEUKOCYTE BIOL, V74, P1035, DOI 10.1189/jlb.1202593
   Pek YS, 2008, BIOMATERIALS, V29, P4300, DOI 10.1016/j.biomaterials.2008.07.030
   Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882
   Quesenberry PJ, 1998, P NATL ACAD SCI USA, V95, P15155, DOI 10.1073/pnas.95.26.15155
   Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782
   Rogers WJ, 2006, NAT CLIN PRACT CARD, V3, P554, DOI 10.1038/ncpcardio0659
   Sarkar D, 2010, BIOMATERIALS, V31, P5266, DOI 10.1016/j.biomaterials.2010.03.006
   Seo WS, 2006, NAT MATER, V5, P971, DOI 10.1038/nmat1775
   Shao ZX, 2012, BIOMATERIALS, V33, P3375, DOI 10.1016/j.biomaterials.2012.01.033
   Shen H, 2008, BIOMATERIALS, V29, P2388, DOI 10.1016/j.biomaterials.2008.02.008
   Shen H, 2007, BIOMATERIALS, V28, P4219, DOI 10.1016/j.biomaterials.2007.06.004
   Shen H, 2009, BIOMATERIALS, V30, P3150, DOI 10.1016/j.biomaterials.2009.02.004
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198
   Sun M, 2010, IN VIVO TRACKING MES
   Taylor A, 2012, CHEM SOC REV, V41, P2707, DOI 10.1039/c2cs35031a
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Willerth SM, 2008, COMBINING STEM CELLS
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yao W, 2013, STEM CELLS, V31, P2003, DOI 10.1002/stem.1461
   Yoon JJ, 2006, J BIOMED MATER RES A, V79A, P934, DOI 10.1002/jbm.a.30843
NR 55
TC 0
Z9 0
U1 1
U2 12
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2050-6252
EI 2050-6260
J9 SURF INNOV
JI Surf. Innov.
PD MAR
PY 2014
VL 2
IS 1
BP 17
EP 25
DI 10.1680/si.13.00023
PG 9
WC Chemistry, Physical; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA CZ3AG
UT WOS:000366975800003
DA 2018-10-20
ER

PT J
AU McKay, CA
   Gilbert, RJ
AF McKay, Christopher A.
   Gilbert, Ryan J.
TI Design of hydrogel biomaterial interfaces for the injured spinal cord
SO SURFACE INNOVATIONS
LA English
DT Review
DE adhesion; biomimetic; surface modifications
ID HYALURONIC-ACID HYDROGELS; CENTRAL-NERVOUS-SYSTEM; 3-DIMENSIONAL NEURITE
   EXTENSION; MYELIN-ASSOCIATED GLYCOPROTEIN; TENDON CHITOSAN TUBES;
   CROSS-LINKED HYDROGEL; REGENERATION IN-VIVO; 3D COLLAGEN GELS;
   CELL-MIGRATION; GLIAL SCAR
AB Following spinal cord injury, changes in glial cell behavior and the local extracellular environment combine to produce an inhibitory environment for neuronal regeneration. Hydrogel biomaterials are ideal for treating spinal cord injury as many are injectable and conform to irregular lesion geometries. Numerous studies present novel hydrogel systems modified to control the interface between hydrogels and the injury environment and to mitigate detrimental changes in cellular behavior and extracellular composition. The goal for any spinal cord injury treatment is to promote beneficial cellular behavior and reduce the growth inhibitory nature of the extracellular environment to promote regeneration. Hydrogel systems have been designed to target particular problems affecting regeneration following spinal cord injury: (a) promoting neuronal attachment and axonal growth, (b) promoting remyelination, (c) reducing astrocyte reactivity and glial scar formation, (d) limiting inflammatory response and (e) controlling the release of therapeutic drugs. This review presents a summary of hydrogel systems exhibiting surface characteristics designed to elicit a specific cellular or extracellular response relevant to promoting regeneration. The purpose of this review is to provide insight for researchers deciding what components and characteristics to incorporate into a hydrogel scaffold for the treatment of spinal cord injury.
C1 [McKay, Christopher A.; Gilbert, Ryan J.] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
RP Gilbert, RJ (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
EM gilber2@rpi.edu
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Akeson Wayne H, 2005, Spine J, V5, P180, DOI 10.1016/j.spinee.2004.06.019
   Ananthanarayanan B, 2010, BIOMATERIALS, V31, P8706, DOI 10.1016/j.biomaterials.2010.07.104
   [Anonymous], 2012, SPIN CORD INJ FACTS
   Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005
   Austin JW, 2012, BIOMATERIALS, V33, P4555, DOI 10.1016/j.biomaterials.2012.03.022
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Bandtlow CE, 2000, GLIA, V29, P175, DOI 10.1002/(SICI)1098-1136(20000115)29:2<175::AID-GLIA11>3.0.CO;2-F
   Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x
   Brodbelt AR, 2003, J CLIN NEUROSCI, V10, P401, DOI 10.1016/S0967-5868(02)00326-0
   Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109
   Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004
   Butterfield Karen Chao, 2011, Biomatter, V1, P174, DOI 10.4161/biom.18791
   Caicco MJ, 2013, J BIOMED MATER RES A, V101, P1472, DOI 10.1002/jbm.a.34454
   Cao WL, 2005, J BIOMATER APPL, V20, P157, DOI 10.1177/0885328205049897
   Cao Z, 2009, BIOMACROMOLECULES, V10, P2954, DOI 10.1021/bm900670n
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219
   Cheng S, 2008, MED ENG PHYS, V30, P1318, DOI 10.1016/j.medengphy.2008.06.003
   Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7
   Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018
   Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0
   Dhoot NO, 2004, J BIOMED MATER RES A, V71A, P191, DOI 10.1002/jbm.a.30103
   Dillon GP, 2000, J BIOMED MATER RES, V51, P510, DOI 10.1002/1097-4636(20000905)51:3<510::AID-JBM28>3.0.CO;2-G
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002
   ESTES JM, 1993, J PEDIATR SURG, V28, P1227, DOI 10.1016/S0022-3468(05)80303-3
   Farooque M, 1997, J NEUROTRAUM, V14, P469, DOI 10.1089/neu.1997.14.469
   Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Fukushima Kazuyuki, 2008, J Med Dent Sci, V55, P71
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867
   Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006
   GIOVANNI SD, 2009, EXPER OPIN THER TAR, V13, P1387, DOI DOI 10.1517/14728220903307517
   GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226
   GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hadlock T, 2006, EXPERT OPIN BIOL TH, V6, P1105, DOI 10.1517/14712598.6.11.1105
   HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8
   Hejcl A, 2009, J MATER SCI-MATER M, V20, P1571, DOI 10.1007/s10856-009-3714-4
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Hejcl A, 2013, STEM CELLS DEV, V22, P2794, DOI 10.1089/scd.2012.0616
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Horn EM, 2007, J NEUROSURG-SPINE, V6, P133, DOI 10.3171/spi.2007.6.2.133
   Hosseinkhani H, 2013, ACS CHEM NEUROSCI, V4, P1229, DOI 10.1021/cn400075h
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746
   Huber AB, 2000, BIOL CHEM, V381, P407, DOI 10.1515/BC.2000.053
   Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002
   Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337
   Jiang FX, 2008, ANN BIOMED ENG, V36, P1565, DOI 10.1007/s10439-008-9530-z
   Jiang FX, 2010, TISSUE ENG PT A, V16, P1873, DOI [10.1089/ten.tea.2009.0574, 10.1089/ten.TEA.2009.0574]
   Kang CE, 2013, CELLS TISSUES ORGANS, V197, P55, DOI 10.1159/000339589
   Kang CE, 2010, J CONTROL RELEASE, V144, P25, DOI 10.1016/j.jconrel.2010.01.029
   Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349
   Karumbaiah L, 2011, GLIA, V59, P981, DOI 10.1002/glia.21170
   Kato Tsuyoshi, 2005, Spine J, V5, P479, DOI 10.1016/j.spinee.2005.01.010
   Katz JS, 2009, WIRES NANOMED NANOBI, V1, P128, DOI 10.1002/wnan.010
   Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033
   Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375
   Klekamp J, 1997, J NEUROSURG, V86, P233, DOI 10.3171/jns.1997.86.2.0233
   Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852
   Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Lee JW, 2011, J CONTROL RELEASE, V152, pE219, DOI 10.1016/j.jconrel.2011.09.021
   Li QQ, 2010, J BIOMED MATER RES A, V94A, P688, DOI 10.1002/jbm.a.32707
   Li XW, 2013, FASEB J, V27, P1127, DOI 10.1096/fj.12-211151
   Lin PW, 2005, J BIOMED MATER RES B, V75B, P146, DOI 10.1002/jbm.b.30276
   Liu BF, 2006, COLLOID SURFACE B, V53, P175, DOI 10.1016/j.colsurfb.2006.08.018
   Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]
   Liverman C.T., 2005, SPINAL CORD INJURY P
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Man AJ, 2011, TISSUE ENG PT A, V17, P2931, DOI 10.1089/ten.tea.2011.0030
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Masand SN, 2012, BIOMATERIALS, V33, P8353, DOI 10.1016/j.biomaterials.2012.08.018
   MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081
   MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X
   McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001
   Mehrishi JN, 2002, ELECTROPHORESIS, V23, P1984, DOI 10.1002/1522-2683(200207)23:13<1984::AID-ELPS1984>3.0.CO;2-U
   Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032
   Mekhail M, 2012, PROG NEUROBIOL, V96, P322, DOI 10.1016/j.pneurobio.2012.01.008
   Meng XL, 2013, J BIOMED MATER RES A, V101, P1095, DOI 10.1002/jbm.a.34400
   MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nelson DM, 2012, J BIOMED MATER RES A, V100A, P776, DOI 10.1002/jbm.a.34015
   Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021
   Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575
   Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453
   Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116
   PITTMAN RN, 1989, DEV NEUROSCI-BASEL, V11, P41, DOI 10.1159/000111884
   Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407
   Previtera ML, 2010, J BIOSCI BIOENG, V110, P459, DOI 10.1016/j.jbiosc.2010.04.004
   Puckett WR, 1997, EXP NEUROL, V148, P424, DOI 10.1006/exnr.1997.6692
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Rasouli A, 2009, J ORTHOP RES, V27, P931, DOI 10.1002/jor.20793
   Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8
   Rhodes KE, 2003, NEUROSCIENCE, V120, P41, DOI 10.1016/S0306-4522(03)00285-9
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   Sayer Faisal T, 2006, Spine J, V6, P335, DOI 10.1016/j.spinee.2005.11.001
   Seeds NW, 1997, CELL TISSUE RES, V290, P367, DOI 10.1007/s004410050942
   Sehgal RR, 2013, NANOMEDICINE-UK, V8, P521, DOI 10.2217/nnm.13.40
   Shaw D, 2003, J CRANIOFAC SURG, V14, P308, DOI 10.1097/00001665-200305000-00008
   Shepard JA, 2012, BIOTECHNOL BIOENG, V109, P830, DOI 10.1002/bit.24355
   Shoichet MS, 2007, PROG BRAIN RES, V161, P385, DOI 10.1016/S0079-6123(06)61027-3
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+
   Stanwick JC, 2012, J CONTROL RELEASE, V160, P666, DOI 10.1016/j.jconrel.2012.03.024
   Stanwick JC, 2012, INT J PHARMACEUT, V426, P284, DOI 10.1016/j.ijpharm.2012.01.035
   STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215
   Sundararaghavan HG, 2011, J NEUROTRAUM, V28, P2377, DOI 10.1089/neu.2010.1606
   Sundararaghavan HG, 2009, BIOTECHNOL BIOENG, V102, P632, DOI 10.1002/bit.22074
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Sur S, 2012, BIOMATERIALS, V33, P545, DOI 10.1016/j.biomaterials.2011.09.093
   Suzuki M, 2003, J NEUROSCI RES, V72, P646, DOI 10.1002/jnr.10589
   Swindle-Reilly KE, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046007
   Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6
   Tator C H, 1996, J Spinal Cord Med, V19, P206
   Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007
   TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x
   Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373
   Todor D R, 2000, Neurosurg Focus, V8, pE11
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9
   Vulic K, 2012, J AM CHEM SOC, V134, P882, DOI 10.1021/ja210638x
   Wang F, 2010, ACTA BIOMATER, V6, P1978, DOI 10.1016/j.actbio.2009.12.011
   Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867
   Wang XH, 2013, J BIOMAT SCI-POLYM E, V24, P1185, DOI 10.1080/09205063.2012.745714
   Wang YF, 2009, J CONTROL RELEASE, V140, P218, DOI 10.1016/j.jconrel.2009.05.025
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607
   Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1
   Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002
   Zhang C, 2014, J BIOMED MATER RES A, V102, P170, DOI 10.1002/jbm.a.34687
   Zhang ZP, 2005, BIOMATERIALS, V26, P47, DOI 10.1016/j.biomaterials.2004.02.004
   Zuidema JM, 2011, ACTA BIOMATER, V7, P1634, DOI 10.1016/j.actbio.2010.11.039
   Zustiak S. P., 2013, BIOTECHNOL PROGR, DOI [10.1021/btpr.1761, DOI 10.1021/BTPR.1761]
NR 164
TC 2
Z9 2
U1 0
U2 18
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2050-6252
EI 2050-6260
J9 SURF INNOV
JI Surf. Innov.
PD MAR
PY 2014
VL 2
IS 1
BP 26
EP 46
DI 10.1680/si.13.00016
PG 21
WC Chemistry, Physical; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA CZ3AG
UT WOS:000366975800004
DA 2018-10-20
ER

PT J
AU Arabi, A
   Boggs, E
   Patel, MR
   Zwiesler-Vollick, J
   Maerz, T
   Baker, K
   Tuck, S
   Corey, J
   Li, YW
AF Arabi, Ahmad
   Boggs, Emily
   Patel, Manan R.
   Zwiesler-Vollick, Julie
   Maerz, Tristan
   Baker, Kevin
   Tuck, Samuel
   Corey, Joseph
   Li, Yawen
TI Surface modification of electrospun polycaprolactone fibers and effect
   on cell proliferation
SO SURFACE INNOVATIONS
LA English
DT Article
DE biocompatibility; hydrophilic; plasma processing; surface
   characterization; surface modification
ID EPIDERMAL-GROWTH-FACTOR; BIOMIMETIC MATERIALS; BINDING-SPECIFICITY;
   ADHESION; POLYMERS; RGD; BIOMATERIALS; OSTEOBLAST; CHEMISTRY; PEPTIDES
AB Surface modification is an essential tool in tissue engineering using synthetic biomaterial scaffolds. The authors report in this study a simple approach to modify the surface hydrophobicity, roughness and chemistry of electrospun polycaprolactone (PCL) fibers using a combination of oxygen plasma treatment, sodium hydroxide treatment and arginine-glycine-aspartic acid (RGD) immobilization. The modified surfaces were characterized using scanning electron microscopy, atomic force microscopy, water contact angle measurement and X-ray photoelectron spectroscopy (XPS). Plasma treatment decreased the water contact angle. Sodium hydroxide treatment further improved the hydrophilicity and increased the surface roughness. XPS analysis confirmed the presence of amide bonds on RGD-treated fibers. The enhancement of proliferation of ligament fibroblasts within 1 week of culturing on both the plasma- and sodium hydroxide-treated fibers was most likely due to improved wettability by the oxygen plasma treatment. The alignment and penetration of cells on PCL fibers suggested that these materials could be potential scaffold materials for the regeneration of fibrous tissues.
C1 [Arabi, Ahmad; Boggs, Emily; Patel, Manan R.; Li, Yawen] Lawrence Technol Univ, Biomed Engn Program, Southfield, MI 48075 USA.
   [Zwiesler-Vollick, Julie] Lawrence Technol Univ, Dept Nat Sci, Southfield, MI USA.
   [Maerz, Tristan; Baker, Kevin] Beaumont Hlth Syst, Orthopaed Res Labs, Royal Oak, MI USA.
   [Tuck, Samuel; Corey, Joseph] Univ Michigan, Dept Neurol, Ann Arbor, MI USA.
RP Li, YW (reprint author), Lawrence Technol Univ, Biomed Engn Program, Southfield, MI 48075 USA.
EM yli@ltu.edu
FU Lawrence Technological University (LTU) Faculty Research Seed Grant; NSF
   MRI program [1040607]
FX This study is supported by the Lawrence Technological University (LTU)
   Faculty Research Seed Grant. The authors thank Dr. Hsiao-Ping Moore for
   providing access to and supplies in the LTU Life Sciences Facilities,
   Dr. Pilar Herrera-Fierro and Dr. Haiping Sun at the University of
   Michigan for assistance with the AFM analysis, as well as Mr.
   Christopher Thrush at Wayne State University for assistance with the XPS
   measurement. The authors also acknowledge the usage of environmental
   scanning electron microscope at LTU funded by the NSF MRI program
   (1040607).
CR Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Causa F, 2010, LANGMUIR, V26, P9875, DOI 10.1021/la100207q
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   JANSEN RJJ, 1995, CARBON, V33, P1021, DOI 10.1016/0008-6223(95)00030-H
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim MS, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494017
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Landis WJ, 2006, J MATER CHEM, V16, P1495, DOI 10.1039/b505706j
   Luca A. C. D., 2013, J BIOMEDICAL MAT R A, V101, P491
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   MORRA M, 1990, J COLLOID INTERF SCI, V137, P11, DOI 10.1016/0021-9797(90)90038-P
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   Parrish B, 2005, J AM CHEM SOC, V127, P7404, DOI 10.1021/ja050310n
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   Sabbatini L., 1993, SURFACE CHARACTERIZA
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Tuck SJ, 2012, MAT SCI ENG C-MATER, V32, P1779, DOI 10.1016/j.msec.2012.04.060
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
NR 35
TC 4
Z9 4
U1 5
U2 18
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2050-6252
EI 2050-6260
J9 SURF INNOV
JI Surf. Innov.
PD MAR
PY 2014
VL 2
IS 1
BP 47
EP 59
DI 10.1680/si.13.00018
PG 13
WC Chemistry, Physical; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA CZ3AG
UT WOS:000366975800005
DA 2018-10-20
ER

PT J
AU Ljunggren, MK
   Elizondo, RA
   Edin, J
   Olsen, D
   Merrett, K
   Lee, CJ
   Salerud, G
   Polarek, J
   Fagerholm, P
   Griffith, M
AF Ljunggren, Monika Kozak
   Elizondo, Rodolfo A.
   Edin, Joel
   Olsen, David
   Merrett, Kimberley
   Lee, Chyan-Jang
   Salerud, Goran
   Polarek, James
   Fagerholm, Per
   Griffith, May
TI Effect of Surgical Technique on Corneal Implant Performance
SO TRANSLATIONAL VISION SCIENCE & TECHNOLOGY
LA English
DT Article
DE biosynthetic cornea; corneal regeneration; biomaterials; recombinant
   human collagen; corneal transplantation
AB Purpose: Our aim was to determine the effect of a surgical technique on biomaterial implant performance, specifically graft retention.
   Methods: Twelve mini pigs were implanted with cell-free, 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC)/N-hydroxysuccinimide (NHS) cross-linked recombinant human collagen type III (RHCIII) hydrogels as substitutes for donor corneal allografts using overlying sutures with or without human amniotic membrane (HAM) versus interrupted sutures with HAM. The effects of the retention method were compared as well as the effects of collagen concentration (13.7% to 15% RHCIII).
   Results: All implanted corneas showed initial haze that cleared with time, resulting in corneas with optical clarity matching those of untreated controls. Biochemical analysis showed that by 12 months post operation, the initial RHCIII implants had been completely remodeled, as type I collagen, was the major collagenous protein detected, whereas no RHCIII could be detected. Histological analysis showed all implanted corneas exhibited regeneration of epithelial and stromal layers as well as nerves, along with touch sensitivity and tear production. Most neovascularization was seen in corneas stabilized by interrupted sutures.
   Conclusions: This showed that the surgical technique used does have a significant effect on the overall performance of corneal implants, overlying sutures caused less vascularization than interrupted sutures.
   Translational Relevance: Understanding the significance of the suturing technique can aid the selection of the most appropriate procedure when implanting artificial corneal substitutes. The same degree of regeneration, despite a higher collagen content indicates that future material development can progress toward stronger, more resistant implants.
C1 [Ljunggren, Monika Kozak; Elizondo, Rodolfo A.; Edin, Joel; Merrett, Kimberley; Lee, Chyan-Jang; Salerud, Goran; Fagerholm, Per; Griffith, May] Linkoping Univ, Integrat Regenerat Med Ctr, S-58185 Linkoping, Sweden.
   [Ljunggren, Monika Kozak; Elizondo, Rodolfo A.; Edin, Joel; Merrett, Kimberley; Lee, Chyan-Jang; Fagerholm, Per; Griffith, May] Linkoping Univ, Dept Clin & Expt Med, S-58185 Linkoping, Sweden.
   [Olsen, David; Polarek, James] FibroGen Inc, San Francisco, CA USA.
   [Merrett, Kimberley; Lee, Chyan-Jang; Griffith, May] Ottawa Hosp, Res Inst, Vis Programme, Ottawa, ON, Canada.
   [Salerud, Goran] Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden.
RP Ljunggren, MK (reprint author), Linkoping Univ, Integrat Regenerat Med Ctr, S-58185 Linkoping, Sweden.
EM Monika.Kozak.Ljunggren@liu.se
RI Edin, Joel/H-3227-2017
OI Edin, Joel/0000-0001-8465-1764
CR Altmann S, 2010, INVEST OPHTH VIS SCI, V51, P4531, DOI 10.1167/iovs.09-5106
   Bonini S, 2003, EYE, V17, P989, DOI 10.1038/sj.eye.6700616
   CHU ML, 1988, J BIOL CHEM, V263, P18601
   CINTRON C, 1988, INVEST OPHTH VIS SCI, V29, P767
   CINTRON C, 1988, INVEST OPHTH VIS SCI, V29, P760
   Cruzat A, 2010, SEMIN OPHTHALMOL, V25, P171, DOI 10.3109/08820538.2010.518133
   DANA MR, 1995, CORNEA, V14, P604
   Deng C, 2010, ACTA BIOMATER, V6, P187, DOI 10.1016/j.actbio.2009.07.027
   DOANE KJ, 1992, EXP CELL RES, V202, P113, DOI 10.1016/0014-4827(92)90410-A
   Fagerholm P., 2010, TRANSL MED, V2, P46, DOI DOI 10.1126/SCITRANSLMED.3001022
   Griffith M, 2009, EYE, V23, P1985, DOI 10.1038/eye.2008.409
   JANDER R, 1983, EUR J BIOCHEM, V133, P39, DOI 10.1111/j.1432-1033.1983.tb07427.x
   KERN P, 1991, BIOCHEM J, V274, P615, DOI 10.1042/bj2740615
   LEE RE, 1984, EXP EYE RES, V39, P639, DOI 10.1016/0014-4835(84)90063-0
   Lee RMH, 2012, CLIN OPHTHALMOL, V6, P1335, DOI 10.2147/OPTH.S35460
   Liu YW, 2006, INVEST OPHTH VIS SCI, V47, P1869, DOI 10.1167/iovs.05-1339
   McLaughlin CR, 2008, CORNEA, V27, P580, DOI 10.1097/ICO.0b013e3181658408
   Merrett K, 2008, INVEST OPHTH VIS SCI, V49, P3887, DOI 10.1167/iovs.07-1348
   Priest D., 1998, IOVS, V39, pS352
   Richter A, 1997, GER J OPHTHALMOL, V5, P513
   Williams KA, 2006, TRANSPLANTATION, V81, P896, DOI 10.1097/01.tp.0000185197.37824.35
   Wilson SE, 2012, EXP EYE RES, V99, P78, DOI 10.1016/j.exer.2012.03.018
   You LT, 2000, INVEST OPHTH VIS SCI, V41, P692
   ZIMMERMANN DR, 1986, FEBS LETT, V197, P55, DOI 10.1016/0014-5793(86)80297-6
NR 24
TC 5
Z9 5
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 2164-2591
J9 TRANSL VIS SCI TECHN
JI Transl. Vis. Sci. Technol.
PD MAR
PY 2014
VL 3
IS 2
AR 6
DI 10.1167/tvst.3.2.6
PG 13
WC Ophthalmology
SC Ophthalmology
GA V45JS
UT WOS:000209813500006
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Yu, T
   Liu, X
   Ye, JD
   Zhang, M
AF Yu, Tao
   Liu, Xuan
   Ye, Jiandong
   Zhang, Ming
TI Investigation of mechanical behavior of CPC/bone specimens by finite
   element analysis
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Biomaterial; Bone repair; Finite element analysis
ID CALCIUM-PHOSPHATE CEMENT; VERTEBRAL TRABECULAR BONE; IN-VITRO; STRENGTH;
   REINFORCEMENT; SCAFFOLDS; MODELS; VERTEBROPLASTY; KYPHOPLASTY; HYDRATION
AB Calcium phosphate cement (CPC), as an important injectable biomaterial, is extensively used for bone repair in clinical application. If mechanical properties of CPC match well with that of bone tissue, it can create an appropriate mechanical environment for bone repair. In our study, the objective was to investigate the responses of bone tissue to CPC in different series of elastic modulus combinations. Finite element analysis (FEA) was applied to calculate the stress/strain on CPC-bone specimens and to further forecast the potential risky area. The predicted results indicated that CPC materials and bone tissue had different stress distribution patterns under the same loading condition. For CPC material, the Von Mises Stress peak occurred in the bone cement joint area; while for bone tissue, the risky area was located at the bridge area among trabecular bones. The porous and loose structure of cancellous bone induced a greater Von Mises Stress in bone tissue. Quantitative analysis indicated that stress/strain distribution was directly correlated with the elastic modulus of material. When Young's modulus of bone and CPC was 1 GPa and 6.10 GPa respectively, the optimal stress matching between bone and CPC was achieved. In sum, this work confirmed that FE modeling was the ideal method for predicting fracture behavior of bone CPC specimen both qualitatively and quantitatively. (c) 2013 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Yu, Tao; Liu, Xuan; Zhang, Ming] Hong Kong Polytech Univ, Interdisciplinary Div Biomed Engn, Kowloon, Hong Kong, Peoples R China.
   [Yu, Tao; Ye, Jiandong] S China Univ Technol, Minist Educ, Key Lab Specially Funct Mat, Guangzhou 510641, Guangdong, Peoples R China.
   [Yu, Tao; Ye, Jiandong] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
RP Ye, JD (reprint author), S China Univ Technol, Minist Educ, Key Lab Specially Funct Mat, Guangzhou 510641, Guangdong, Peoples R China.
EM jdye@scut.edu.cn; ming.zhang@polyu.edu
RI Zhang, Ming/F-8331-2011
OI Zhang, Ming/0000-0002-6027-4594
FU National Natural Science Foundation of China [51172074, 51302089];
   Natural Science Foundation of Guangdong Province of China [04205786];
   Hong Kong Scholars Program [XJ2011010]; China Postdoctoral Science
   Foundation [2012M511571]; China Postdoctoral Science Foundation (CPSF)
   [201104358]; Guangdong Natural Science Foundation [S2012040007845];
   Fundamental Research Funds for the Central Universities [2013770010]
FX This research was supported by National Natural Science Foundation of
   China, Grant number: 51172074; Natural Science Foundation of Guangdong
   Province of China, Grant number: 04205786; Hong Kong Scholars Program
   (XJ2011010); China Postdoctoral Science Foundation: 2012M511571; China
   Postdoctoral Science Foundation (CPSF): 201104358; Guangdong Natural
   Science Foundation: S2012040007845; Fundamental Research Funds for the
   Central Universities (2013770010); National Natural Science Foundation
   of China (51302089).
CR [Anonymous], 2011, ABAQUS ABAQUS US MAN
   Brown PW, 1999, CEMENT CONCRETE RES, V29, P1167, DOI 10.1016/S0008-8846(99)00051-4
   Brown PW, 1986, CEMENTS RES PROGR, P352
   Burguera EF, 2005, J BIOMED MATER RES A, V75A, P966, DOI 10.1002/jbm.a.30497
   Carrino JA, 2004, SEMIN ROENTGENOL, V39, P68, DOI 10.1053/j.ro.2003.10.012
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   Chow L. C., 1991, J CERAM SOC JPN, V99, P954
   COWIN SC, 1986, J BIOMECH ENG-T ASME, V108, P83, DOI 10.1115/1.3138584
   Dejaco A, 2012, J BIOMECH, V45, P1068, DOI 10.1016/j.jbiomech.2011.12.026
   Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   FERNANDEZ E, 1995, J MATER SCI LETT, V14, P4, DOI 10.1007/BF02565267
   Gong H, 2007, ANN BIOMED ENG, V35, P1622, DOI 10.1007/s10439-007-9332-8
   Gong H, 2009, ACTA MECH SINICA-PRC, V25, P121, DOI 10.1007/s10409-008-0198-2
   GOODSHIP AE, 2001, BONE MECH HDB, P261
   Hadjipavlou AG, 2005, J BONE JOINT SURG BR, V87B, P1595, DOI 10.1302/0301-620X.87B12.16074
   Han B, 2009, ACTA BIOMATER, V5, P3165, DOI 10.1016/j.actbio.2009.04.024
   ISHIKAWA K, 1995, J BIOMED MATER RES, V29, P1537, DOI 10.1002/jbm.820291210
   KEAVENY TM, 1994, J BIOMECH, V27, P1137, DOI 10.1016/0021-9290(94)90054-X
   Lacroix D, 2006, BIOMATERIALS, V27, P5326, DOI 10.1016/j.biomaterials.2006.06.009
   Liu CS, 2003, BIOMATERIALS, V24, P4103, DOI 10.1016/S0142-9612(03)00238-2
   Luczynski KW, 2012, CMES-COMP MODEL ENG, V87, P505
   Miranda P, 2008, ACTA BIOMATER, V4, P1715, DOI 10.1016/j.actbio.2008.05.020
   Morgan H., 2003, J MATER SCI-MATER M, V14, P647
   Pegoretti A, 2002, BIOMATERIALS, V23, P2667, DOI 10.1016/S0142-9612(01)00407-0
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Ratner BD, 2004, BIOMATERIALS SCI INT, P28
   Scheiner S, 2009, BIOMATERIALS, V30, P2411, DOI 10.1016/j.biomaterials.2008.12.048
   STONE JL, 1983, J BIOMECH, V16, P743, DOI 10.1016/0021-9290(83)90083-0
   Takahashi K, 2004, CERAM INT, V30, P199, DOI 10.1016/S0272-8842(03)00089-0
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Tozzi G, 2012, J BIOMECH, V45, P356, DOI 10.1016/j.jbiomech.2011.10.011
   Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5
   van der Meulen MCH, 2002, J BIOMECH, V35, P401, DOI 10.1016/S0021-9290(01)00184-1
   VANRIETBERGEN B, 1995, J BIOMECH, V28, P69
   VOSE G. P., 1959, HUMAN BIOL, V31, P261
   Wang XP, 2007, J AM CERAM SOC, V90, P962, DOI 10.1111/j.1551-2916.2006.01460.x
   Wolff J, 1892, GESETZ TRANSFORMATIO
   Xu HHK, 2000, J BIOMED MATER RES, V52, P107, DOI 10.1002/1097-4636(200010)52:1<107::AID-JBM13>3.0.CO;2-0
   Yamamoto H, 1998, BIOMATERIALS, V19, P1587, DOI 10.1016/S0142-9612(97)00121-X
   YOUSSEF JA, 2003, OPER TECH ORTHOP, V13, P222
   Yu T, 2009, ACTA BIOMATER, V5, P2717, DOI 10.1016/j.actbio.2009.03.015
   Yu T, 2009, J AM CERAM SOC, V92, P949, DOI 10.1111/j.1551-2916.2009.02975.x
   Zainali K, 2013, J BIOMED MATER RES A, V101, P195, DOI 10.1002/jbm.a.34307
   Zhang Y, 2005, J BIOMED MATER RES A, V75A, P832, DOI 10.1002/jbm.a.30461
NR 45
TC 2
Z9 3
U1 3
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAR
PY 2014
VL 40
IS 2
BP 2933
EP 2942
DI 10.1016/j.ceramint.2013.10.018
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA 292DJ
UT WOS:000329882100051
DA 2018-10-20
ER

PT J
AU Hunt, HK
   Armani, AM
AF Hunt, Heather K.
   Armani, Andrea M.
TI Bioconjugation Strategies for Label-Free Optical Microcavity Sensors
SO IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS
LA English
DT Article
DE Biophotonics; nanobiotechnology; biological techniques; optical
   resonators; biosensors
ID SELF-ASSEMBLED MONOLAYERS; FREQUENCY COMB GENERATION; SILICON-NITRIDE
   SURFACES; CLICK-CHEMISTRY; PROTEIN ADSORPTION; POLYMER BRUSHES;
   LIPID-BILAYERS; ALKYLSILANE MONOLAYERS; VESICLE ADSORPTION; RESIST
   ADSORPTION
AB Whispering gallery mode optical microcavities have significantly impacted the field of label-free optical biodetection. By combining the evanescent field generated by the microcavity with biomimetic surface chemistries, it is now possible to use the microcavities as not only biosensors, but as analytical tools to explore fundamental chemical and physical interactions of biomolecules and biomaterials. Here, we review the recent advancements of these applications from a surface chemistry perspective. For example, surface chemistries can be generated from a standard coating perspective, where active molecules, such as laser or fluorescent dyes can be embedded in a biomaterial matrix. Alternatively, direct and reverse grafting techniques can be used to tether biomolecules of interest to the surface to tune the surface properties (hydrophobicity/hydrophilicity, protein adsorption, cell adhesion, etc.). Finally, we discuss how to apply advancements in biomimetic chemistry from other sensor approaches to these devices to continue the development of new analytical tools. All of these developments rely on a firm understanding of how proper surface chemistries can be merged with whispering gallery mode optical microcavities to achieve not just a platform, but a precisely defined tool for a given application.
C1 [Hunt, Heather K.] Univ Missouri, Dept Bioengn, Columbia, MO 65211 USA.
   [Armani, Andrea M.] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA.
   [Armani, Andrea M.] Univ So Calif, Ming Hsieh Dept Elect Engn Electrophys, Los Angeles, CA 90089 USA.
RP Hunt, HK (reprint author), Univ Missouri, Dept Bioengn, Columbia, MO 65211 USA.
EM hunthk@missouri.edu; armani@usc.edu
RI Armani, Andrea/A-8132-2010
OI Armani, Andrea/0000-0001-9890-5104
FU National Institutes of Health through NIH Director's New Innovator Award
   [1DP2OD007391-01]
FX This work was supported by the National Institutes of Health through NIH
   Director's New Innovator Award Program (1DP2OD007391-01).
CR Almeida VR, 2004, NATURE, V431, P1081, DOI 10.1038/nature02921
   Arafat A, 2007, LANGMUIR, V23, P6233, DOI 10.1021/la7007045
   Arlett JL, 2011, NAT NANOTECHNOL, V6, P203, DOI 10.1038/nnano.2011.44
   Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Bhat RR, 2006, ADV POLYM SCI, V198, P51, DOI 10.1007/12_060
   Biggs BW, 2012, J COLLOID INTERF SCI, V369, P477, DOI 10.1016/j.jcis.2011.11.082
   Bocking T, 2006, LANGMUIR, V22, P3494, DOI 10.1021/la030331a
   Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741
   Byeon JY, 2010, LANGMUIR, V26, P15430, DOI 10.1021/la1021824
   Caballero D, 2012, ANAL CHIM ACTA, V720, P43, DOI 10.1016/j.aca.2012.01.031
   Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1
   Castellana ET, 2006, SURF SCI REP, V61, P429, DOI 10.1016/j.surfrep.2006.06.001
   Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chapman RG, 2000, LANGMUIR, V16, P6927, DOI 10.1021/la9915791
   Cheema MI, 2012, OPT EXPRESS, V20, P9090, DOI 10.1364/OE.20.009090
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Chen SF, 2009, BIOMATERIALS, V30, P5892, DOI 10.1016/j.biomaterials.2009.07.001
   Chistiakova MV, 2012, OPT LETT, V37, P4068, DOI 10.1364/OL.37.004068
   Ciampi S, 2007, LANGMUIR, V23, P9320, DOI 10.1021/la701035g
   Clare TL, 2005, LANGMUIR, V21, P6344, DOI 10.1021/la050362q
   Cloarec JP, 2002, BIOSENS BIOELECTRON, V17, P405, DOI 10.1016/S0956-5663(01)00282-2
   Daaboul GG, 2012, IEEE J SEL TOP QUANT, V18, P1422, DOI 10.1109/JSTQE.2011.2180516
   Del'Haye P, 2007, NATURE, V450, P1214, DOI 10.1038/nature06401
   Duckworth BP, 2006, BIOCONJUGATE CHEM, V17, P967, DOI 10.1021/bc060125e
   EDWARDS PR, 1995, ANAL BIOCHEM, V231, P210, DOI 10.1006/abio.1995.1522
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022
   Freeman LM, 2012, IEEE J SEL TOP QUANT, V18, P1160, DOI 10.1109/JSTQE.2011.2166059
   Freeman LM, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3576908
   Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777
   Gelbart WM, 1996, J PHYS CHEM-US, V100, P13169, DOI 10.1021/jp9606570
   Goetz R, 1999, PHYS REV LETT, V82, P221, DOI 10.1103/PhysRevLett.82.221
   Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900
   Gorodetsky ML, 1996, OPT LETT, V21, P453, DOI 10.1364/OL.21.000453
   Grossmann T, 2011, OPT EXPRESS, V19, P10009, DOI 10.1364/OE.19.010009
   GUESDON JL, 1979, J HISTOCHEM CYTOCHEM, V27, P1131, DOI 10.1177/27.8.90074
   Gupta A, 2004, APPL PHYS LETT, V84, P1976, DOI 10.1063/1.1667011
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Hanay MS, 2012, NAT NANOTECHNOL, V7, P602, DOI [10.1038/NNANO.2012.119, 10.1038/nnano.2012.119]
   Harms ZD, 2011, ANAL CHEM, V83, P9573, DOI 10.1021/ac202358t
   Hernandez K, 2011, ENZYME MICROB TECH, V48, P107, DOI 10.1016/j.enzmictec.2010.10.003
   Himo F, 2005, J AM CHEM SOC, V127, P210, DOI 10.1021/ja0471525
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a
   Huang E, 2000, LANGMUIR, V16, P3272, DOI 10.1021/la9910834
   Hunt HK, 2011, OPT LETT, V36, P1092, DOI 10.1364/OL.36.001092
   Hunt HK, 2010, SENSORS-BASEL, V10, P9317, DOI 10.3390/s101009317
   Hunt HK, 2010, NANOSCALE, V2, P1544, DOI 10.1039/c0nr00201a
   Ilic B, 2004, APPL PHYS LETT, V85, P2604, DOI 10.1063/1.1794378
   Iliuk AB, 2011, ANAL CHEM, V83, P4440, DOI 10.1021/ac201057w
   Iqbal SS, 2000, BIOSENS BIOELECTRON, V15, P549, DOI 10.1016/S0956-5663(00)00108-1
   Jiang XS, 2008, BIOSENS BIOELECTRON, V23, P1577, DOI 10.1016/j.bios.2008.01.035
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   Kozma P, 2011, SENSOR ACTUAT B-CHEM, V155, P446, DOI 10.1016/j.snb.2010.12.045
   LANG H, 1994, LANGMUIR, V10, P197, DOI 10.1021/la00013a029
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   Lee H, 2012, NAT PHOTONICS, V6, P369, DOI [10.1038/nphoton.2012.109, 10.1038/NPHOTON.2012.109]
   Liu RH, 2000, METHOD ENZYMOL, V318, P268
   Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178
   Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014
   Luchansky MS, 2012, ANAL CHEM, V84, P793, DOI 10.1021/ac2029024
   Manova RK, 2012, LANGMUIR, V28, P8651, DOI 10.1021/la300921e
   MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660
   Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2
   Narayan S, 2005, ANGEW CHEM INT EDIT, V44, P3275, DOI 10.1002/anie.200462883
   Nitkowski A, 2011, BIOMED OPT EXPRESS, V2, P271, DOI 10.1364/BOE.2.000271
   Okawachi Y, 2011, OPT LETT, V36, P3398, DOI 10.1364/OL.36.003398
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Parvole J, 2003, MACROMOL RAPID COMM, V24, P1074, DOI 10.1002/marc.200300035
   Patel N, 1997, LANGMUIR, V13, P6485, DOI 10.1021/la970933h
   PORSTMANN T, 1992, J IMMUNOL METHODS, V150, P5, DOI 10.1016/0022-1759(92)90061-W
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325
   Reimhult E, 2003, LANGMUIR, V19, P1681, DOI 10.1021/la0263920
   Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297
   Rye RR, 1997, LANGMUIR, V13, P2965, DOI 10.1021/la960919p
   Salafsky J, 1996, BIOCHEMISTRY-US, V35, P14773, DOI 10.1021/bi961432i
   Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   Shi C, 2012, OPT LETT, V37, P1643, DOI 10.1364/OL.37.001643
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Soteropulos CE, 2012, LANGMUIR, V28, P15743, DOI 10.1021/la302041d
   Soteropulos CE, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3634023
   Stevens MJ, 1999, LANGMUIR, V15, P2773, DOI 10.1021/la981064e
   Sullivan TP, 2003, EUR J ORG CHEM, P17
   Sun XL, 2006, BIOCONJUGATE CHEM, V17, P52, DOI 10.1021/bc0502311
   Therien-Aubin H, 2011, POLYMER, V52, P5419, DOI 10.1016/j.polymer.2011.09.017
   Vernooy DW, 1998, OPT LETT, V23, P247, DOI 10.1364/OL.23.000247
   Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221
   Walcarius A, 2003, CHEM MATER, V15, P2161, DOI 10.1021/cm021310e
   Washburn AL, 2010, ANAL CHEM, V82, P69, DOI 10.1021/ac902451b
   Wei MY, 2009, PROG CHEM, V21, P492
   Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198
   Wilson KA, 2012, BIOMATERIALS, V33, P225, DOI 10.1016/j.biomaterials.2011.09.036
   Wu HJ, 2012, NAT METHODS, V9, P1189, DOI [10.1038/nmeth.2211, 10.1038/NMETH.2211]
   Wu P, 2004, ANGEW CHEM INT EDIT, V43, P3928, DOI 10.1002/anie.200454078
   Wu T, 2003, MACROMOLECULES, V36, P2448, DOI 10.1021/ma0257189
   Xie P, 2012, NAT NANOTECHNOL, V7, P119, DOI [10.1038/NNANO.2011.217, 10.1038/nnano.2011.217]
   Zhang XM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3398008
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
   Zhao C, 2012, CHEM PAP, V66, P323, DOI 10.2478/s11696-012-0147-1
   Zinoviev KE, 2011, J LIGHTWAVE TECHNOL, V29, P1926, DOI 10.1109/JLT.2011.2150734
NR 106
TC 18
Z9 18
U1 2
U2 72
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1077-260X
EI 1558-4542
J9 IEEE J SEL TOP QUANT
JI IEEE J. Sel. Top. Quantum Electron.
PD MAR-APR
PY 2014
VL 20
IS 2
AR 6900213
DI 10.1109/JSTQE.2013.2272916
PG 13
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA 293TS
UT WOS:000329997200013
DA 2018-10-20
ER

PT J
AU Singh, AK
   Srivastava, GK
   Martin, L
   Alonso, M
   Pastor, JC
AF Singh, Amar K.
   Srivastava, Girish K.
   Martin, Laura
   Alonso, Matilde
   Carlos Pastor, J.
TI Bioactive substrates for human retinal pigment epithelial cell growth
   from elastin-like recombinamers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; elastin-like recombinamers; hRPE cells
ID HUMAN BRUCHS MEMBRANE; MACULAR DEGENERATION; RCS RATS; VISUAL FUNCTION;
   RODENT MODEL; RPE CELLS; TRANSPLANTATION; CULTURE; EXPRESSION; RESCUE
AB The aim of this study was to investigate the use of bioactive RGD-containing elastin-like recombinamers (ELR-RGDs) as a substrate that can maintain human retinal pigment epithelial cell (hRPE) phenotype and growth pattern. Results obtained are compared with previously published behavior of ARPE19 cells. The extension of these results to hRPE is required because ARPE19 cells cannot be used clinically to treat age-related macular degeneration. hRPE cells were isolated, cultured, seeded, and grown on surface of glass, treated polystyrene (TCP), and solvent-cast ELR-RGD and ELR-IK film with no specific sequence. Cells were analyzed to study cell adhesion, proliferation, morphology, and RPE65 protein expression by staining with diamidino-2-phenylindole, Rhodamine-Phalloidin, and anti-RPE65 antibody at 12, 24, 72, 120, 168, and 360 h. hRPE cells always grew better on ELR-RGD than on glass and ELR-IK but not on TCP. The kinetic hRPE growth curves confirmed that growth differences started to appear at 24 h for these surfaces in ascending order of cell growths, namely glass, ELR-IK, ELR-RGD, and TCP. There was a clear difference at 360 h. ELR-RGD maintained hRPE cells stable morphology and RPE65 protein expression. ELR-RGD seems to be a good substrate for growing hRPE cells with stable morphology and RPE65 protein expression. As such, this work confirms our hypothesis regarding ELR-RGD substrates viability, which can be used as a Bruch's membrane prosthesis for further studies in animals. However, these results must subsequently be extrapolated to use of hRPE cells in animals to evaluate them as a transplantation vehicle in human. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 639-646, 2014.
C1 [Singh, Amar K.; Srivastava, Girish K.; Carlos Pastor, J.] Univ Valladolid, IOBA Eye Inst, Valladolid, Spain.
   [Srivastava, Girish K.] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Valladolid, Spain.
   [Srivastava, Girish K.; Carlos Pastor, J.] Regenerat Med & Cell Therapy Networking Ctr Casti, Madrid, Spain.
   [Martin, Laura; Alonso, Matilde] Univ Valladolid, BIOFORGE Grp, Valladolid, Spain.
RP Srivastava, GK (reprint author), Univ Valladolid, IOBA Eye Inst, Valladolid, Spain.
EM girish@ioba.med.uva.es
RI ALONSO, MATILDE/G-6719-2017; SINGH, AMAR/H-6569-2016; Martin,
   Laura/J-9291-2017; Srivastava, Girish/L-7608-2014
OI ALONSO, MATILDE/0000-0002-6853-8427; SINGH, AMAR/0000-0002-1767-5907;
   Martin, Laura/0000-0002-6583-8731; Srivastava,
   Girish/0000-0002-9791-4057
CR Al-Hussaini H, 2008, MOL VIS, V14, P1784
   Alge CS, 2006, J PROTEOME RES, V5, P862, DOI 10.1021/pr050420t
   Bian QN, 2012, FREE RADICAL BIO MED, V53, P1298, DOI 10.1016/j.freeradbiomed.2012.06.024
   Burke JM, 1998, INVEST OPHTH VIS SCI, V39, P1478
   CAMPOCHIARO PA, 1986, INVEST OPHTH VIS SCI, V27, P1615
   Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782
   Curcio CA, 2010, J LIPID RES, V51, P451, DOI 10.1194/jlr.R002238
   Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020
   Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724
   Girman SV, 2003, VISION RES, V43, P1817, DOI 10.1016/S0042-6989(03)00276-1
   Green W R, 1999, Mol Vis, V5, P27
   Gullapalli VK, 2008, EXP EYE RES, V86, P189, DOI 10.1016/j.exer.2007.10.009
   Gupta SK, 1997, BIOCHEM CELL BIOL, V75, P119, DOI 10.1139/bcb-75-2-119
   Hornof M, 2005, EUR J PHARM BIOPHARM, V60, P207, DOI 10.1016/j.ejpb.2005.01.009
   Hynes SR, 2010, GRAEF ARCH CLIN EXP, V248, P763, DOI 10.1007/s00417-009-1263-7
   Ishida M, 1998, CURR EYE RES, V17, P392, DOI 10.1080/02713689808951220
   Kaur Gurvinder, 2012, Spermatogenesis, V2, P1
   Kearns V, 2012, J MATER SCI-MATER M, V23, P2013, DOI 10.1007/s10856-012-4675-6
   Kwan ASL, 1999, EXP NEUROL, V159, P21, DOI 10.1006/exnr.1999.7157
   Lu B, 2012, BIOMED MICRODEVICES, V14, P659, DOI 10.1007/s10544-012-9645-8
   Ma ZZ, 2009, INVEST OPHTH VIS SCI, V50, P2975, DOI 10.1167/iovs.08-2573
   MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161
   Martin L, 2009, BIOMACROMOLECULES, V10, P3015, DOI 10.1021/bm900560a
   Mazumder MAJ, 2012, J BIOMED MATER RES A, V100A, P1877, DOI 10.1002/jbm.a.34021
   Sagdullaev BT, 2003, INVEST OPHTH VIS SCI, V44, P1686, DOI 10.1167/iovs.02-0615
   Schwartz JR, 1998, BIOL REPROD, V59, P1187, DOI 10.1095/biolreprod59.5.1187
   Seiler MJ, 2008, EUR J NEUROSCI, V28, P208, DOI 10.1111/j.1460-9568.2008.06279.x
   Shadforth AMA, 2012, BIOMATERIALS, V33, P4110, DOI 10.1016/j.biomaterials.2012.02.040
   Sheridan C, 2007, EXPERT REV OPHTHALMO, V2, P1
   Srivastava GK, 2013, J IMMUNOL METHODS, V389, P61, DOI 10.1016/j.jim.2013.01.003
   Srivastava GK, 2011, EXP EYE RES, V93, P956, DOI 10.1016/j.exer.2011.07.002
   Srivastava GK, 2011, J BIOMED MATER RES A, V97A, P243, DOI 10.1002/jbm.a.33050
   Subrizi A, 2012, BIOMATERIALS, V33, P8047, DOI 10.1016/j.biomaterials.2012.07.033
   Sugino IK, 2011, INVEST OPHTH VIS SCI, V52, P4979, DOI 10.1167/iovs.10-5386
   Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8
   van Zeeburg EJT, 2012, AM J OPHTHALMOL, V153, P120, DOI 10.1016/j.ajo.2011.06.007
   Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P3201, DOI 10.1167/iovs.08-1831
   Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P416, DOI 10.1167/iovs.07-0992
   Zhang L, 2006, EXP EYE RES, V83, P1405, DOI 10.1016/j.exer.2006.07.020
NR 39
TC 7
Z9 7
U1 1
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2014
VL 102
IS 3
BP 639
EP 646
DI 10.1002/jbm.a.34726
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289JS
UT WOS:000329679100004
PM 23554132
DA 2018-10-20
ER

PT J
AU Shie, MY
   Chang, HC
   Ding, SJ
AF Shie, Ming-You
   Chang, Hsien-Chang
   Ding, Shinn-Jyh
TI Composition-dependent protein secretion and integrin level of
   osteoblastic cell on calcium silicate cements
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE calcium silicate; cell adhesion; protein secretion; protein adsorption;
   integrin
ID SI-SUBSTITUTED HYDROXYAPATITE; MESENCHYMAL STEM-CELLS; IN-VITRO;
   OSTEOGENIC DIFFERENTIATION; SIGNAL-TRANSDUCTION; BONE-GRAFTS;
   PROLIFERATION; SURFACE; ADHESION; FIBRONECTIN
AB The purpose of this study was to investigate the responses of the human osteosarcoma cell line MG63 to calcium silicate cements with different Si/Ca molar ratios and different surface roughness. In particular, the study evaluated integrin subunit levels, phosphor-focal adhesion kinase (pFAK) levels and protein production at the cell attachment stage. The results indicated that the surface roughness (variations within a factor of 10) of the cements did not play a prominent role in cell attachment and proliferation, but the effect of composition was highlighted. Increased pFAK and total integrin levels and promoted cell attachment and cell cycle progression were observed upon an increase in cement Si content. Cement with a higher Si content was beneficial for collagen Type I (COL I) adsorption, COL I secretion, and lib3 subintegrin expression, whereas cement with a higher Ca content increased fibronectin (FN) adsorption, FN secretion, and enhanced v1 subintegrin levels. These results establish composition-dependent differences in integrin binding as a mechanism regulating cellular responses to biomaterial surfaces. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 769-780, 2014.
C1 [Shie, Ming-You; Ding, Shinn-Jyh] Chung Shan Med Univ, Inst Oral Sci, Taichung 402, Taiwan.
   [Chang, Hsien-Chang] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.
   [Ding, Shinn-Jyh] Chung Shan Med Univ Hosp, Dept Dent, Taichung 402, Taiwan.
RP Chang, HC (reprint author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.
EM hcchang@mail.ncku.edu.tw; sjding@csmu.edu.tw
CR Andrade Ângela Leão, 2004, Mat. Res., V7, P631, DOI 10.1590/S1516-14392004000400018
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Au AY, 2010, J BIOMED MATER RES A, V94A, P380, DOI 10.1002/jbm.a.32668
   Blanc K. L., 2003, EXP HEMATOL, V31, P890
   Botelho CM, 2002, J MATER SCI-MATER M, V13, P1123, DOI 10.1023/A:1021177601899
   Bouafsoun A, 2007, MACROMOL BIOSCI, V7, P599, DOI 10.1002/mabi.200600263
   Chen CC, 2011, INT ENDOD J, V44, P836, DOI 10.1111/j.1365-2591.2011.01890.x
   Chen CC, 2009, J ENDODONT, V35, P1554, DOI 10.1016/j.joen.2009.08.006
   Chou L, 1999, BIOMATERIALS, V20, P977, DOI 10.1016/S0142-9612(98)00254-3
   Chow LC, 2000, J BIOMED MATER RES, V53, P511, DOI 10.1002/1097-4636(200009)53:5<511::AID-JBM10>3.3.CO;2-5
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   Davis D, 2010, J BONE JOINT SURG AM, V92A, P129, DOI 10.2106/JBJS.H.01561
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Ding SJ, 2010, TISSUE ENG PT A, V16, P2343, DOI [10.1089/ten.tea.2009.0749, 10.1089/ten.TEA.2009.0749]
   Ding SJ, 2011, ACS APPL MATER INTER, V3, P4142, DOI 10.1021/am201017v
   Ding SJ, 2011, J MATER CHEM, V21, P12793, DOI 10.1039/c1jm11171j
   Ding SJ, 2009, J MATER CHEM, V19, P1183, DOI 10.1039/b819033j
   Dulgar-Tulloch AJ, 2009, J BIOMED MATER RES A, V90A, P586, DOI 10.1002/jbm.a.32116
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Gough JE, 2004, J BIOMED MATER RES A, V68A, P640, DOI 10.1002/jbm.a.20075
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Jeon H, 2012, LANGMUIR, V28, P13423, DOI 10.1021/la302937k
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522
   Leroy C, 2000, EUR J CELL BIOL, V79, P936, DOI 10.1078/0171-9335-00119
   Lin KL, 2005, CERAM INT, V31, P323, DOI 10.1016/j.ceramint.2004.05.023
   Lu HH, 2000, J BIOMED MATER RES, V51, P80, DOI 10.1002/(SICI)1097-4636(200007)51:1<80::AID-JBM11>3.0.CO;2-6
   Martinez A, 2000, CHEM MATER, V12, P3080, DOI 10.1021/cm001107o
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Peng WW, 2011, J ENDODONT, V37, P1240, DOI 10.1016/j.joen.2011.05.035
   RAMP WK, 1994, BONE MINER, V24, P59, DOI 10.1016/S0169-6009(08)80131-6
   Rosa AL, 2003, DENT MATER, V19, P768, DOI 10.1016/S0109-5641(03)00024-1
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   Shie MY, 2012, INT ENDOD J, V45, P337, DOI 10.1111/j.1365-2591.2011.01981.x
   Shie MY, 2011, ACTA BIOMATER, V7, P2604, DOI 10.1016/j.actbio.2011.02.023
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Singh A, 2010, J MATER CHEM, V20, P8832, DOI 10.1039/c0jm01613f
   Slowing II, 2007, ADV FUNCT MATER, V17, P1225, DOI 10.1002/adfm.200601191
   Tian T, 2008, MAT SCI ENG C-BIO S, V28, P57, DOI 10.1016/j.msec.2007.10.049
   Toworfe GK, 2009, J TISSUE ENG REGEN M, V3, P26, DOI 10.1002/term.131
   Xia LG, 2011, EUR CELLS MATER, V22, P68, DOI 10.22203/eCM.v022a06
   Xu GL, 2003, POWDER TECHNOL, V134, P218, DOI 10.1016/S0032-5910(03)00172-4
   Xue WC, 2009, ACTA BIOMATER, V5, P1686, DOI 10.1016/j.actbio.2009.01.012
   Xynos ID, 2000, J BIOMED MATER RES, V155, P151
   Zhang NL, 2010, BIOMATERIALS, V31, P7653, DOI 10.1016/j.biomaterials.2010.06.043
NR 49
TC 24
Z9 24
U1 0
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2014
VL 102
IS 3
BP 769
EP 780
DI 10.1002/jbm.a.34737
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289JS
UT WOS:000329679100017
PM 23554363
DA 2018-10-20
ER

PT J
AU Okabe, M
   Kitagawa, K
   Yoshida, T
   Suzuki, T
   Waki, H
   Koike, C
   Furuichi, E
   Katou, K
   Nomura, Y
   Uji, Y
   Hayashi, A
   Saito, S
   Nikaido, T
AF Okabe, Motonori
   Kitagawa, Kiyotaka
   Yoshida, Toshiko
   Suzuki, Takuma
   Waki, Hiroki
   Koike, Chika
   Furuichi, Etsuko
   Katou, Kiyoshi
   Nomura, Yoshihiro
   Uji, Yoshinori
   Hayashi, Atsushi
   Saito, Shigeru
   Nikaido, Toshio
TI Hyperdry human amniotic membrane is useful material for tissue
   engineering: Physical, morphological properties, and safety as the new
   biological material
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hyperdry human amniotic membrane; biological material; freeze-dried
   human amniotic membrane; clinical use; recurrent pterygium
ID STEM-CELL DEFICIENCY; SURFACE RECONSTRUCTION; CLINICAL-APPLICATION;
   OCULAR SURFACE; FIBRIN GLUE; ORAL-MUCOSA; TRANSPLANTATION;
   VESTIBULOPLASTY; REGENERATION; PERFORATIONS
AB Human amniotic membrane (AM) has been used widely as graft biomaterial for a variety of clinical applications. But, there are some persistent problems related to the preparation, storage, and sterilization. To resolve these problems, we developed hyperdry AM (HD-AM) using far-infrared rays, depression of air, and microwaves and then sterilized by -ray irradiation. To elucidate the benefit of HD-AM as biological materials, compare with the physical and histological properties of HD-AM with a freeze-dried AM (FD-AM) as typical freeze-dried methods, evaluate the safety of HD-AM in vivo experiment used nude mice, and demonstrate the feasibility of HD-AM transplant in pterygium. The water permeability and the sieving coefficient of HD-AM were significantly lower than that of FD-AM. HD-AM has kept the morphological structure of epithelium and connective tissues. At 18 months after transplanted, single and multilayers of HD-AM in the intraperitoneal cavity was degraded without any infiltrated cells. For clinical treatment, recurrence of pterygium and regrowth of the subconjunctival fibrosis were not observed during the 6-month follow-up periods after the surgery. It was proposed that HD-AM was a safe and effective new biological material for clinical use including treatment for recurrent pterygium. (c) 2013 Wiley Periodicals, Inc.
C1 [Okabe, Motonori; Kitagawa, Kiyotaka; Yoshida, Toshiko; Koike, Chika; Furuichi, Etsuko; Nikaido, Toshio] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Regenerat Med, Toyama 930, Japan.
   [Suzuki, Takuma; Nomura, Yoshihiro] Tokyo Univ Agr & Technol, Fac Agr, Tokyo, Japan.
   [Waki, Hiroki; Katou, Kiyoshi] Takaoka City Hosp, Dept Obstet & Gynecol, Toyama, Japan.
   [Uji, Yoshinori] Toyama Univ Hosp, Clin Lab Ctr, Toyama, Japan.
   [Hayashi, Atsushi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Ophthalmol, Toyama 930, Japan.
   [Saito, Shigeru] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Obstet & Gynecol, Toyama 930, Japan.
RP Nikaido, T (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Regenerat Med, Toyama 930, Japan.
EM tnikaido@med.u-toyama.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [22590498, 25460647]
FX Contract grant sponsor: Grant-in-Aid for Scientific Research from the
   Ministry of Education, Culture, Sports, Science and Technology of Japan
   (to MO); contract grant number: 22590498 & 25460647
CR Arai N, 2012, J ORAL MAXIL SURG, V70, P2221, DOI 10.1016/j.joms.2011.09.033
   Barabino S, 2003, OPHTHALMOLOGY, V110, P474, DOI 10.1016/S0160-6420(02)01892-4
   BENNETT JP, 1980, LANCET, V1, P1153
   Bhatia M, 2007, WOUNDS, V19, P207
   BOURNE GL, 1966, P ROY SOC MED, V59, P1127
   COSLET JG, 1980, DENT CLIN N AM, V24, P651
   Espana EM, 2003, OPHTHALMOLOGY, V110, P481, DOI 10.1016/S0161-6420(02)01764-5
   Espana EM, 2003, J CATARACT REFR SURG, V29, P279, DOI 10.1016/S0886-3350(02)01525-0
   Filipas D, 2001, Curr Opin Urol, V11, P267, DOI 10.1097/00042307-200105000-00004
   Fujisato T, 1999, J BIOMAT SCI-POLYM E, V10, P1171, DOI 10.1163/156856299X00829
   Gomes JAP, 2003, OPHTHALMOLOGY, V110, P466, DOI 10.1016/S0161-6420(02)01888-2
   Graue-Hernandez EO, 2012, CASE REP OPHTHALMOL, V2012
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   He Qingyi, 2002, Chin J Traumatol, V5, P200
   Hick S, 2005, CORNEA, V24, P369, DOI 10.1097/01.ico.0000151547.08113.d1
   Kanazawa Y, 2012, ACTA OTO-LARYNGOL, V132, P1282, DOI 10.3109/00016489.2012.701329
   KIM JC, 1995, CORNEA, V14, P473
   Kinoshita S, 2004, ARTIF ORGANS, V28, P22, DOI 10.1111/j.1525-1594.2004.07319.x
   Kitagawa K, 2009, TOYAMA MED J, V20, P1
   Kitagawa K, 2011, JPN J OPHTHALMOL, V55, P16, DOI 10.1007/s10384-010-0903-0
   Kitagawa K, 2009, AM J OPHTHALMOL, V148, P383, DOI 10.1016/j.ajo.2009.03.030
   Kjaergaard N, 2001, EUR J OBSTET GYN R B, V94, P224, DOI 10.1016/S0301-2115(00)00345-6
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Lim LS, 2010, ARCH OPHTHALMOL-CHIC, V128, P1303, DOI 10.1001/archophthalmol.2010.222
   Mahdy RA, 2010, CUTAN OCUL TOXICOL, V29, P164, DOI 10.3109/15569521003775005
   Maral T, 1999, BURNS, V25, P625, DOI 10.1016/S0305-4179(99)00072-8
   Mligiliche N, 2002, J BIOMED MATER RES, V63, P591, DOI 10.1002/jbm.10349
   Nakamura T, 2006, ACTA OPHTHALMOL SCAN, V84, P401, DOI 10.1111/j.1600-0420.2006.00667.x
   NEI T, 1978, J MICROSC-OXFORD, V112, P197, DOI 10.1111/j.1365-2818.1978.tb01165.x
   Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P81, DOI 10.1007/s10561-006-9019-7
   Nikaido T, 2007, Japan patent, Patent No. [2007-54015, 200754015]
   Okabe M, 2003, APPL SURF SCI, V203, P714, DOI 10.1016/S0169-4332(02)00797-3
   Okabe M, 2013, CLIN OPHTHALMOL, V7, P649, DOI 10.2147/OPTH.S43106
   ROBSON MC, 1973, ANN SURG, V177, P144, DOI 10.1097/00000658-197302000-00003
   SACHS BP, 1979, BRIT J OBSTET GYNAEC, V86, P81, DOI 10.1111/j.1471-0528.1979.tb10572.x
   Samandari MH, 2004, ORAL SURG ORAL MED O, V97, P574, DOI 10.1016/j.tripleo.2003.10.031
   Sekeroglu Hande Taylan, 2011, International Ophthalmology, V31, P433, DOI 10.1007/s10792-011-9488-y
   Sezer B, 2004, QUINTESSENCE INT, V35, P234
   Shojaku H, 2011, LARYNGOSCOPE, V121, P1953, DOI 10.1002/lary.22082
   Szabo A, 2000, EUR SURG RES, V32, P125, DOI 10.1159/000008751
   Takaya K, 2003, APPL SURF SCI, V203, P684, DOI 10.1016/S0169-4332(02)00791-2
   Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CP0070034
   Tomita T, 2012, J NEUROL SURG PART B, V73, P302, DOI 10.1055/s-0032-1321506
   TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8
   Tseng SCG, 1997, AM J OPHTHALMOL, V124, P765, DOI 10.1016/S0002-9394(14)71693-9
   Tsubota K, 1996, AM J OPHTHALMOL, V122, P38, DOI 10.1016/S0002-9394(14)71962-2
   Tsuno H, 2012, ORAL SURG ORAL MED O, DOI 10.1016/j.oooo.2012.05.014
   UEDA M, 1984, J ORAL MAXIL SURG, V42, P213, DOI 10.1016/0278-2391(84)90452-X
   WAIKAKUL S, 1990, B HOSP JOINT DIS ORT, V50, P27
   Yagi S, 2001, Patent US, Patent No. [6,323,471 B1, 6323471]
NR 50
TC 6
Z9 8
U1 0
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2014
VL 102
IS 3
BP 862
EP 870
DI 10.1002/jbm.a.34753
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289JS
UT WOS:000329679100026
PM 23589398
DA 2018-10-20
ER

PT J
AU King, SN
   Hanson, SE
   Chen, X
   Kim, J
   Hematti, P
   Thibeault, SL
AF King, Suzanne N.
   Hanson, Summer E.
   Chen, Xia
   Kim, Jaehyup
   Hematti, Peiman
   Thibeault, Susan L.
TI In vitro characterization of macrophage interaction with mesenchymal
   stromal cell-hyaluronan hydrogel constructs
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE mesenchymal stromal/stem cells; immunomodulation; biomaterials; tissue
   engineering; hyaluronic acid
ID SYNTHETIC EXTRACELLULAR-MATRIX; VOCAL FOLD FIBROBLASTS; UMBILICAL-CORD
   BLOOD; STEM-CELLS; ADIPOSE-TISSUE; LAMINA PROPRIA; GROWTH-FACTORS;
   BONE-MARROW; IMMUNOPHENOTYPE; ACTIVATION
AB Macrophages play a critical role in mediating not only normal tissue healing, but also the host reaction against biomaterial scaffolds. There is increasing interest in regenerative medicine to combine mesenchymal stromal/stem cells (MSCs) with biomaterial scaffolds to modulate inflammatory response while restoring tissue architecture. The objective of the current study was to investigate the interaction between MSCs (derived from bone marrow, adipose or vocal fold tissue) encapsulated in hyaluronan-based hydrogel and differentiating macrophages as measured by extracellular matrix (ECM) gene expression and cytokine, chemokine, and growth factor concentrations. Gene expression was analyzed using real-time polymerase chain reaction from MSCs embedded in Carbylan-GSX after 7 days of coculture with or without CD14+ cells. Protein concentrations were measured using a Bio-plex assay from cell culture supernatants on days 3 and 7 for all conditions. Following 7 days, we identified upregulation of collagen-I, collagen-III, procollagen, and matrix metalloproteinase-9 genes compared to control conditions. We demonstrate increased concentrations of immunoregulatory cytokines [interleukin (IL)-1, tumor necrosis factor-, macrophage inflammatory protein-1, IFN-, IL-12, and IL-10] and remodeling growth factors (vascular endothelial growth factor, hepatocyte growth factor) in MSC-3D constructs cocultured with macrophages compared to control conditions, with some temporal variation. Our results indicate an alteration of expression of ECM proteins important to tissue regeneration and cytokines critical to the inflammatory cascade when 3D constructs were cultured with differentiating macrophages. (c) 2013 Wiley Periodicals, Inc.
C1 [King, Suzanne N.; Chen, Xia; Thibeault, Susan L.] Univ Wisconsin, Div Otolaryngol Head & Neck Surg, Madison, WI 53715 USA.
   [Hanson, Summer E.] Univ Wisconsin, Sch Med & Publ Hlth, Div Plast & Reconstruct Surg, Madison, WI USA.
   [Kim, Jaehyup; Hematti, Peiman] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA.
   [Hematti, Peiman; Thibeault, Susan L.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA.
RP Thibeault, SL (reprint author), Univ Wisconsin, Div Otolaryngol Head & Neck Surg, Madison, WI 53715 USA.
EM pxh@medicine.wisc.edu; thibeaul@surgery.wisc.edu
RI Kim, Jaehyup/N-5800-2015
OI Kim, Jaehyup/0000-0003-0373-5080
FU NIDCD - NIH [R01 DC4336, R01 DC4336S1, T32 DC009401]; NHLBI - NIH [K08
   HL081076]
FX Contract grant sponsor: NIDCD - NIH; contract grant numbers: R01 DC4336;
   R01 DC4336S1 (to SLT); T32 DC009401 (to SNK); Contract grant sponsor:
   NHLBI - NIH; contract grant number: K08 HL081076 (to PH)
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Cantu DA, 2012, STEM CELL TRANSL MED, V1, P740, DOI 10.5966/sctm.2012-0061
   Chen X, 2010, ACTA BIOMATER, V6, P2940, DOI 10.1016/j.actbio.2010.01.032
   Chen X, 2009, TISSUE ENG PART C-ME, V15, P201, DOI 10.1089/ten.tec.2008.0390
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Duflo S, 2006, TISSUE ENG, V12, P3201, DOI 10.1089/ten.2006.12.3201
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   Hanson SE, 2011, TISSUE ENG PT A, V17, P2463, DOI [10.1089/ten.tea.2010.0716, 10.1089/ten.TEA.2010.0716]
   Hanson SE, 2010, LARYNGOSCOPE, V120, P546, DOI 10.1002/lary.20797
   Hattori H, 2012, CELL TRANSPLANT
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Larson BJ, 2010, PLAST RECONSTR SURG, V126, P1172, DOI 10.1097/PRS.0b013e3181eae781
   Laurila JP, 2009, CYTOTHERAPY, V11, P726, DOI 10.3109/14653240903067299
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x
   Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014
   Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001
   Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272
   Thibeault SL, 2011, J VOICE, V25, P249, DOI 10.1016/j.jvoice.2009.10.003
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459
   Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003
NR 31
TC 15
Z9 15
U1 1
U2 47
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2014
VL 102
IS 3
BP 890
EP 902
DI 10.1002/jbm.a.34746
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289JS
UT WOS:000329679100029
PM 23564555
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kong, N
   Lin, KL
   Li, HY
   Chang, J
AF Kong, Ni
   Lin, Kaili
   Li, Haiyan
   Chang, Jiang
TI Synergy effects of copper and silicon ions on stimulation of
   vascularization by copper-doped calcium silicate
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; BIOLOGICAL-PROPERTIES;
   ANGIOGENESIS; CELLS; SCAFFOLDS; PROTEIN; OXYGEN; PROLIFERATION;
   CERULOPLASMIN
AB Copper (Cu) has been reported to be able to stimulate vascularization/angiogenesis, which is critical for regeneration of vascularized tissue in tissue engineering. Silicate bioceramics have also been reported to have stimulatory effects on vascularization due to the silicon (Si) ions released from silicate biomaterrals. Therefore, we hypothesize that a combination of Cu and Si ions may show synergy effects on vascularization. Therefore, a copper-doped calcium silicate bioceramic (Cu-CaSiO3, Cu-CS) was designed and synthesized with the purpose to enhance the stimulatory effects of copper salts or pure silicate bioceramics on vascularization by combining the effects of Cu and Si ions. The cytocompatibility of Cu-CS was firstly assessed by testing the influence of Cu-CS ion extracts on proliferation of human umbilical vein endothelial cells (HUVECs). Thereafter, vascularization of HUVECs on ECMatrix (TM) gel or co-cultured with human dermal fibroblasts (HDFs) in Cu-CS extracts was evaluated and expression of angiogenic growth factors was analyzed. Results revealed that, as compared to CS extracts and media containing soluble CuSO4, Cu-CS extracts possessed stronger stimulatory effects on upregulation of angiogenic growth factors, which finally resulted in better stimulatory effects on vascularization. During the vascularization process, paracrine effects dominated in the co-culture system. In addition, lower concentrations of Cu and Si ions released from Cu-CS than those released from pure CS or CuSO4 were enough to stimulate vascularization, which indicated that there were synergy effects between Cu and Si ions during stimulation of vascularization by Cu-CS. Taken together, the designed Cu-CS may be suitable as a new biomaterial for regenerating blood vessels in tissue engineering.
C1 [Kong, Ni; Li, Haiyan; Chang, Jiang] Shanghai Jiao Tong Univ, Med X Res Inst, Sch Biomed Engn, Shanghai 200030, Peoples R China.
   [Lin, Kaili; Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Li, HY (reprint author), Shanghai Jiao Tong Univ, Med X Res Inst, Sch Biomed Engn, 1954 HuaShan Rd, Shanghai 200030, Peoples R China.
EM haiyan.li@sjtu.edu.cn; jchang@mail.sic.ac.cn
FU National Natural Science Foundation of China [81190132, 31200714];
   Natural Science Foundation of Shanghai Municipality [12ZR1413900]; State
   Key Laboratory of High Performance Ceramics and Superfine Structure
   (Shanghai Institute of Ceramics, Chinese Academy of Science)
   [SKL201203SIC]; SMC-"Chenxing" Talent Program in Shanghai Jiaotong
   University
FX This work was supported by National Natural Science Foundation of China
   (Grant no.: 81190132 and 31200714), Natural Science Foundation of
   Shanghai Municipality (Grant no.: 12ZR1413900), the Opening Project of
   State Key Laboratory of High Performance Ceramics and Superfine
   Structure (Shanghai Institute of Ceramics, Chinese Academy of Science)
   (Grant no.: SKL201203SIC) and The 2012 SMC-"Chenxing" Talent Program in
   Shanghai Jiaotong University.
CR ALESSANDRI G, 1984, MICROCIRC ENDOTH LYM, V1, P329
   Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370
   Carmeliet P, 2004, J INTERN MED, V255, P538, DOI 10.1111/j.1365-2796.2003.01297.x
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   COCKERILL GW, 1995, INT REV CYTOL, V159, P113, DOI 10.1016/S0074-7696(08)62106-3
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Feng WK, 2009, MOL PHARMACOL, V75, P174, DOI 10.1124/mol.108.051516
   Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019
   Finney L, 2009, CLIN EXP PHARMACOL P, V36, P88, DOI 10.1111/j.1440-1681.2008.04969.x
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Guillotin B, 2008, BONE, V42, P1080, DOI 10.1016/j.bone.2008.01.025
   Haro L. A., 2012, BIOCELL, V36
   Hu GF, 1998, J CELL BIOCHEM, V69, P326, DOI 10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kanczler JA, 2008, BIOMATERIALS, V29, P1892, DOI [10.1016/j.biomaterials.2007.12.031, 10.1016/j.biomaterials.2007.12-031]
   Li H, 2013, ACTA BIOMATER, V9, P6981, DOI 10.1016/j.actbio.2013.02.014
   Li HY, 2013, ACTA BIOMATER, V9, P5379, DOI 10.1016/j.actbio.2012.10.019
   Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016767
   Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052
   Li S, 2012, EXP BIOL MED, V237, P77, DOI 10.1258/ebm.2011.011267
   Lin KL, 2013, BIOMATERIALS, V34, P10028, DOI 10.1016/j.biomaterials.2013.09.056
   Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038
   MARCUS Y, 1988, CHEM REV, V88, P1475, DOI 10.1021/cr00090a003
   Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980
   Maxwell P, 2004, CANCER BIOL THER, V3, P29, DOI 10.4161/cbt.3.1.547
   Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459
   MCAUSLAN BR, 1983, MICROVASC RES, V26, P323, DOI 10.1016/0026-2862(83)90080-8
   OSKARSSON A, 1981, ANN CLIN LAB SCI, V11, P165
   Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685
   RAJU KS, 1982, J NATL CANCER I, V69, P1183
   Ramaswamy Y, 2008, BIOMATERIALS, V29, P4392, DOI 10.1016/j.biomaterials.2008.08.006
   Rocha FG, 2008, BIOMATERIALS, V29, P2884, DOI 10.1016/j.biomaterials.2008.03.026
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551
   Sohier J, 2008, EXPERT OPIN DRUG DEL, V5, P543, DOI [10.1517/17425247.5.5.543 , 10.1517/17425240802088033]
   Sorrell JM, 2003, EXP DERMATOL, V12, P315, DOI 10.1034/j.1600-0625.2003.120312.x
   Tang XL, 2005, MATER LETT, V59, P3841, DOI 10.1016/j.matlet.2005.06.060
   Terman BI, 1996, CANCER METAST REV, V15, P159, DOI 10.1007/BF00437468
   Tsuchiya T, 1994, J Biomater Appl, V9, P138
   van Heerden D, 2004, AQUAT TOXICOL, V69, P271, DOI 10.1016/j.aquatox.2004.06.002
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200
   Zhang ML, 2012, J MATER CHEM, V22, P21686, DOI 10.1039/c2jm34395a
   Zhou Y, 2009, CARDIOVASC RES, V84, P54, DOI 10.1093/cvr/cvp178
NR 46
TC 42
Z9 42
U1 3
U2 75
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD FEB 28
PY 2014
VL 2
IS 8
BP 1100
EP 1110
DI 10.1039/c3tb21529f
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AB0RW
UT WOS:000331500800017
DA 2018-10-20
ER

PT J
AU Erakovic, S
   Jankovic, A
   Ristoscu, C
   Duta, L
   Serban, N
   Visan, A
   Mihailescu, IN
   Stan, GE
   Socol, M
   Iordache, O
   Dumitrescu, I
   Luculescu, CR
   Janackovic, D
   Miskovic-Stankovic, V
AF Erakovic, S.
   Jankovic, A.
   Ristoscu, C.
   Duta, L.
   Serban, N.
   Visan, A.
   Mihailescu, I. N.
   Stan, G. E.
   Socol, M.
   Iordache, O.
   Dumitrescu, I.
   Luculescu, C. R.
   Janackovic, Dj.
   Miskovic-Stankovic, V.
TI Antifungal activity of Ag:hydroxyapatite thin films synthesized by
   pulsed laser deposition on Ti and Ti modified by TiO2 nanotubes
   substrates
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Antifungal activity; Ag doped thin films; TiO2 nanotubes;
   Hydroxyapatite; Pulsed laser deposition
ID CALCIUM-PHOSPHATE COATINGS; SIMULATED BODY-FLUID; ANTIMICROBIAL
   ACTIVITY; IMPLANT APPLICATIONS; HYDROXYAPATITE; TITANIUM; SILVER;
   ANTIBACTERIAL; BONE; BIOACTIVITY
AB Hydroxyapatite (HA) is a widely used biomaterial for implant thin films, largely recognized for its excellent capability to chemically bond to hard tissue inducing the osteogenesis without immune response from human tissues. Nowadays, intense research efforts are focused on development of antimicrobial HA doped thin films. In particular, HA doped with Ag (Ag:HA) is expected to inhibit the attachment of microbes and contamination of metallic implant surface. We herewith report on nano-sized HA and Ag:HA thin films synthesized by pulsed laser deposition on pure Ti and Ti modified with 100 nm diameter TiO2 nanotubes (fabricated by anodization of Ti plates) substrates. The HA-based thin films were characterized by SEM, AFM, EDS, FUR, and XRD. The cytotoxic activity was tested with HEp2 cells against controls. The antifungal efficiency of the deposited layers was tested against the Candida albicans and Aspergillus niger strains. The Ti substrates modified with TiO2 nanotubes covered with Ag:HA thin films showed the highest antifungal activity. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Erakovic, S.; Jankovic, A.; Janackovic, Dj.; Miskovic-Stankovic, V.] Univ Belgrade, Fac Technol & Met, Belgrade 11000, Serbia.
   [Ristoscu, C.; Duta, L.; Serban, N.; Visan, A.; Mihailescu, I. N.; Luculescu, C. R.] Natl Inst Lasers Plasma & Radiat Phys, Magurele Ilfov 077125, Romania.
   [Stan, G. E.; Socol, M.] Natl Inst Mat Phys, Magurele Ilfov 077125, Romania.
   [Iordache, O.; Dumitrescu, I.] Natl Inst Text & Leather, Bucharest 030508, Romania.
RP Mihailescu, IN (reprint author), Natl Inst Lasers Plasma & Radiat Phys, 409 Atomistilor St, Magurele Ilfov 077125, Romania.
EM ion.mihailescu@inflpr.ro
RI Stan, George/B-5690-2011; MIHAILESCU (Serban), Natalia/C-5879-2011;
   Erakovic, Sanja/G-9199-2018; Visan, Anita Ioana/I-7288-2016; Luculescu,
   Catalin/A-7999-2010; Duta, Liviu Marian/G-3417-2011; Ristoscu,
   Carmen/B-8628-2011; Socol, Marcela/B-6045-2012
OI Stan, George/0000-0003-0289-8988; Erakovic, Sanja/0000-0003-1188-5177;
   Visan, Anita Ioana/0000-0003-0539-4160; Luculescu,
   Catalin/0000-0001-6852-401X; Duta, Liviu Marian/0000-0002-6408-6056;
   Ristoscu, Carmen/0000-0002-8433-9217; Miskovic-Stankovic,
   Vesna/0000-0001-6525-9820
FU Ministry of Education. Science and Technological Development, Republic
   of Serbia [III - 45019]; UEFISCDI [ID 304/2011, TE49/2011]
FX This research was financed by the Ministry of Education. Science and
   Technological Development, Republic of Serbia, under contract No. III -
   45019.; C.R., L.D., N.S., A.V. and I.N.M. acknowledge with thanks the
   financial support of UEFISCDI under the contract ID 304/2011.; G.E.S,
   gratefully acknowledges the support of UEFISCDI under contract
   TE49/2011.
CR Antonakos A, 2007, BIOMATERIALS, V28, P3043, DOI 10.1016/j.biomaterials.2007.02.028
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Ciobanu CS, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-324
   Djosic MS, 2012, COLLOID SURFACE A, V400, P36, DOI 10.1016/j.colsurfa.2012.02.040
   Erakovic S, 2013, J PHYS CHEM B, V117, P1633, DOI 10.1021/jp305252a
   Erakovic S, 2012, PROG ORG COAT, V75, P275, DOI 10.1016/j.porgcoat.2012.07.005
   Ewald A, 2011, ACTA BIOMATER, V7, P4064, DOI 10.1016/j.actbio.2011.06.049
   Fahim NF, 2009, ELECTROCHIM ACTA, V54, P3255, DOI 10.1016/j.electacta.2008.12.035
   Fielding GA, 2012, ACTA BIOMATER, V8, P3144, DOI 10.1016/j.actbio.2012.04.004
   Gajbhiye M, 2009, NANOMED-NANOTECHNOL, V5, P382, DOI 10.1016/j.nano.2009.06.005
   Hu MZ, 2009, J MATER SCI, V44, P2820, DOI 10.1007/s10853-009-3372-4
   Huang Y, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045003
   Jeyachandran YL, 2006, SURF COAT TECH, V201, P3462, DOI 10.1016/j.surfcoat.2006.07.236
   Kar A, 2006, SURF COAT TECH, V201, P3723, DOI 10.1016/j.surfcoat.2006.09.008
   Khandelwal H, 2013, APPL SURF SCI, V265, P30, DOI 10.1016/j.apsusc.2012.10.072
   Kotharu V, 2012, CERAM INT, V38, P731, DOI 10.1016/j.ceramint.2011.07.065
   Laurel VL, 1999, J CLIN MICROBIOL, V37, P1612
   Li J, 2012, J DENT, V40, P686, DOI 10.1016/j.jdent.2012.04.026
   Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   Mihailescu I. N., 1999, 4 INT COMM OPT ICO B, P201
   Mihailescu IN, 2002, P SOC PHOTO-OPT INS, V4762, P64, DOI 10.1117/12.478666
   Narayanan R, 2008, MAT SCI ENG C-BIO S, V28, P1265, DOI 10.1016/j.msec.2007.11.009
   Nelea V., 2007, PULSED LASER DEPOSIT, P421
   Okada S, 2010, ACTA BIOMATER, V6, P591, DOI 10.1016/j.actbio.2009.07.037
   Pasteris JD, 2004, BIOMATERIALS, V25, P229, DOI 10.1016/S0142-9612(03)00487-3
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Raimondo T, 2010, INT J NANOMED, V5, P647, DOI 10.2147/IJN.S13047
   Rautray TR, 2010, J BIOMED MATER RES B, V93B, P581, DOI 10.1002/jbm.b.31596
   Sadjadi MS, 2011, MATER CHEM PHYS, V130, P67, DOI 10.1016/j.matchemphys.2011.05.033
   Saravanan S, 2011, INT J BIOL MACROMOL, V49, P188, DOI 10.1016/j.ijbiomac.2011.04.010
   Sima LE, 2010, J BIOMED MATER RES A, V95A, P1203, DOI 10.1002/jbm.a.32947
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Smith GC, 2011, ACTA BIOMATER, V7, P3209, DOI 10.1016/j.actbio.2011.05.003
   Socol G, 2012, DIG J NANOMATER BIOS, V7, P563
   Socrates G., 2004, INFRARED RAMAN CHARA
   Spence G, 2008, J BONE JOINT SURG BR, V90B, P1635, DOI 10.1302/0301-620X.90B12.20931
   Stan GE, 2010, THIN SOLID FILMS, V518, P5955, DOI 10.1016/j.tsf.2010.05.104
   Stoica TF, 2008, THIN SOLID FILMS, V516, P8112, DOI 10.1016/j.tsf.2008.04.071
   Sygnatowicz M, 2009, MAT SCI ENG C-BIO S, V29, P1071, DOI 10.1016/j.msec.2008.08.036
   Torres N, 2010, ACTA BIOMATER, V6, P3242, DOI 10.1016/j.actbio.2010.02.032
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   Tuttle PV, 2006, INT J NANOMED, V1, P497, DOI 10.2147/nano.2006.1.4.497
   YOUNG RA, 1984, CALCIFIED TISSUE INT, V36, P60, DOI 10.1007/BF02405294
NR 45
TC 39
Z9 40
U1 2
U2 88
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD FEB 28
PY 2014
VL 293
BP 37
EP 45
DI 10.1016/j.apsusc.2013.12.029
PG 9
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 302BP
UT WOS:000330576600005
DA 2018-10-20
ER

PT J
AU Brunner, EW
   Jurewicz, I
   Heister, E
   Fahimi, A
   Bo, C
   Sear, RP
   Donovan, PJ
   Dalton, AB
AF Brunner, Eric W.
   Jurewicz, Izabela
   Heister, Elena
   Fahimi, Azin
   Bo, Chiara
   Sear, Richard P.
   Donovan, Peter J.
   Dalton, Alan B.
TI Growth and Proliferation of Human Embryonic Stem Cells on Fully
   Synthetic Scaffolds Based on Carbon Nanotubes
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE Tissue engineering; human embryonic stem cells; carbon nanotubes; stern
   cell substrates; pluripotency; biomaterial
ID CELLULAR BEHAVIOR; DIFFERENTIATION; COMPOSITE; MATRIX
AB Here we show an industrially scalable and inexpensive method of fabricating entirely synthetic, non-xenogeneic carbon nanotube-based scaffolds by vacuum filtration for the culture of human embryonic stem cells. We show that controlled exposure of carbon nanotubes to sonication and the amount of energy delivered to the dispersion directly impacts the surface properties, allowing for control over the nanotopography of the resulting carbon nanotube films, which in turn has demonstrable effects upon in vitro human embryonic stem cells cultures. By altering the nanotube processing conditions before film fabrication, it is possible to influence cell adherence, proliferation and colony morphology. Such a tunable surface with capabilities of influencing stem cell behaviors, combined with the ability to slow or speed population doubling times, will provide crucial solutions for achieving applications envisioned by stem cell biologists to assist future industrial and clinical implementation of human embryonic stem cells.
C1 [Brunner, Eric W.; Jurewicz, Izabela; Heister, Elena; Fahimi, Azin; Bo, Chiara; Sear, Richard P.; Dalton, Alan B.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England.
   [Brunner, Eric W.; Jurewicz, Izabela; Heister, Elena; Fahimi, Azin; Bo, Chiara; Sear, Richard P.; Dalton, Alan B.] Univ Surrey, Surrey Mat Inst, Guildford GU2 7XH, Surrey, England.
   [Brunner, Eric W.; Donovan, Peter J.] Univ Calif Irvine, Dept Biol Chem, Ctr Mol & Mitochondrial Med & Genet, Dept Dev & Cell Biol,Sue & Bill Gross Stem Cell R, Irvine, CA 92617 USA.
RP Dalton, AB (reprint author), Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England.
EM a.dalton@surrey.ac.uk
RI Dalton, Alan/A-1643-2018; Dalton, Alan/B-3739-2010
OI Dalton, Alan/0000-0001-8043-1377; Dalton, Alan/0000-0001-8043-1377
FU Human Frontier Science Program; Royal Society; Engineering and Physical
   Sciences Research Council; SETsquared; Beckman Coulter Inc.; Engineering
   and Physical Sciences Research Council [EP/G060878/1, EP/K031562/1]
FX The authors gratefully acknowledge financial support from Human Frontier
   Science Program, Royal Society, Engineering and Physical Sciences
   Research Council, SETsquared, and Beckman Coulter Inc.
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Abdullah CAC, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/20/205102
   Akasaka T, 2011, CARBON, V49, P2287, DOI 10.1016/j.carbon.2011.01.061
   Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]
   Chao TI, 2009, BIOCHEM BIOPH RES CO, V384, P426, DOI 10.1016/j.bbrc.2009.04.157
   Chen Chi-Shuo, 2012, Nanoscale Res Lett, V7, P126, DOI 10.1186/1556-276X-7-126
   Cheng Q, 2013, ANN BIOMED ENG, V41, P904, DOI 10.1007/s10439-012-0728-8
   Edwards SL, 2009, BIOMATERIALS, V30, P1725, DOI 10.1016/j.biomaterials.2008.12.031
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eroshenko N, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-7
   Han ZZ, 2009, J NANOSCI NANOTECHNO, V9, P1400, DOI 10.1166/jnn.2009.C165
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Liao HH, 2011, COLLOID SURFACE B, V84, P528, DOI 10.1016/j.colsurfb.2011.02.010
   Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929
   Moon SU, 2012, INT J NANOMED, V7, P2751, DOI 10.2147/IJN.S30273
   Mwenifumbo S, 2007, J MATER CHEM, V17, P1894, DOI 10.1039/b617708e
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Rainaldi G, 1998, J MATER SCI-MATER M, V9, P755, DOI 10.1023/A:1008915305681
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Sebaa M, 2013, MATER LETT, V92, P122, DOI 10.1016/j.matlet.2012.10.035
   Shi XF, 2005, NANOTECHNOLOGY, V16, pS531, DOI 10.1088/0927-4484/16/7/030
   Sridharan I, 2009, BIOCHEM BIOPH RES CO, V381, P508, DOI 10.1016/j.bbrc.2009.02.072
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Tay CY, 2010, CARBON, V48, P1095, DOI 10.1016/j.carbon.2009.11.031
   Thompson BC, 2009, CARBON, V47, P1282, DOI 10.1016/j.carbon.2009.01.013
   Tutak W, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/31/315102
   WADE LG, 1999, ORGANIC CHEM
   Zawadzak E, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015008
NR 30
TC 16
Z9 16
U1 1
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD FEB 26
PY 2014
VL 6
IS 4
BP 2598
EP 2603
DI 10.1021/am405097w
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AB9VU
UT WOS:000332144600053
PM 24456005
DA 2018-10-20
ER

PT J
AU Ruan, CS
   Hu, N
   Hu, Y
   Jiang, LX
   Cai, QQ
   Wang, HY
   Pan, HB
   Lu, WW
   Wang, YL
AF Ruan, Changshun
   Hu, Nan
   Hu, Yang
   Jiang, Lixin
   Cai, Qingqing
   Wang, Huaiyu
   Pan, Haobo
   Lu, William W.
   Wang, Yuanliang
TI Piperazine-based polyurethane-ureas with controllable degradation as
   potential bone scaffolds
SO POLYMER
LA English
DT Article
DE Piperazine-based polyurethane-urea; In vitro degradation; Controllable
   degradation
ID ORTHOPEDIC BIOMATERIALS; MECHANICAL-BEHAVIOR; REGENERATION; ACID);
   COMPOSITES; PRODUCTS; DESIGN; CYTOCOMPATIBILITY; COPOLYMERS; STRATEGIES
AB Piperazine-based polyurethane ureas (P-PUUs) with piperazine (PP) units as the functional ingredients have been designed to explore a novel polymeric biomaterial with the controllable degradation for bone repair in this study. P-PUUs were prepared upon the chain-growth polymerization of poly (D, L -lactic acid) diol (PDLLA diol), 1, 6-hexamethylene diisocyanate (HDI) where PP functioned as the chain extender. The investigation of in vitro degradation of P-PUUs was performed and the mechanical properties of P-PUUs during degradation were calculated. The results revealed that manipulating the ratio of PDLLA diol: HDI: PP could obtain the precise number of PP units (Num(pp)) in P-PUUs which may significantly impact the degradation stability and the degradation rate of P-PUUs. The negative linear correlation between the degradation rate and the Num(pp) of P-PUUs has been proved, suggesting the P-PUUs were endowed with controllable degradation. Such a linear correlation is expected to be applied to bone repair where the specific degradation rate of P-PUUs for the specific bone defect can be precisely predicted once the Num(pp) and the bone repairing period are known. Additionally, P-PUUs with higher Num(pp) exhibited remarkable mechanical properties during degradation which allowed polymers to provide more persistent mechanical support to bone repair. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Ruan, Changshun; Hu, Yang; Jiang, Lixin; Cai, Qingqing; Wang, Huaiyu; Pan, Haobo; Lu, William W.] Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Human Tissue & Organs Degenerat, Inst Biomed & Biotechnol, Shenzhen 518055, Peoples R China.
   [Ruan, Changshun; Hu, Yang; Jiang, Lixin; Cai, Qingqing; Wang, Huaiyu; Pan, Haobo; Lu, William W.] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab Marine Biomed Mat, Shenzhen 518055, Peoples R China.
   [Hu, Nan; Wang, Yuanliang] Chongqing Univ, Coll Bioengn, Chongqing 400030, Peoples R China.
   [Lu, William W.] Univ Hong Kong, Dept Orthoped & Traumatol, Hong Kong, Hong Kong, Peoples R China.
RP Pan, HB (reprint author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Human Tissue & Organs Degenerat, Inst Biomed & Biotechnol, Shenzhen 518055, Peoples R China.
EM hb.pan@siat.ac.cn; wyl@cqu.edu.cn
FU National Natural Science Foundation of China [31200723]; Development of
   Strategic Emerging Industries of Shenzhen Basic Research Project
   [JCYJ20120617122433296, JCYJ20120831180118537]; Shenzhen Peacock Program
   [110811003586331]
FX This work was supported by grant from the National Natural Science
   Foundation of China (31200723) and the Development of Strategic Emerging
   Industries of Shenzhen Basic Research Project (JCYJ20120617122433296,
   JCYJ20120831180118537) and the Shenzhen Peacock Program
   (110811003586331).
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   Cai Q, 2003, BIOMACROMOLECULES, V4, P828, DOI 10.1021/bm034051a
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Elliott S, 2002, J BIOMAT SCI-POLYM E, V13, P691, DOI 10.1163/156856202320269166
   FRIEDMAN RJ, 1993, J BONE JOINT SURG AM, V75A, P1086, DOI 10.2106/00004623-199307000-00017
   Gu XZ, 2012, POLYMER, V53, P5924, DOI 10.1016/j.polymer.2012.09.056
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Guo C, 2012, MATER LETT, V74, P197, DOI 10.1016/j.matlet.2012.01.085
   Hakkarainen M, 2007, J AM CHEM SOC, V129, P6308, DOI 10.1021/ja0702871
   He MY, 2013, POLYMER, V54, P4112, DOI 10.1016/j.polymer.2013.05.046
   Hoglund A, 2012, MACROMOL BIOSCI, V12, P260, DOI 10.1002/mabi.201100288
   Hojabri L, 2012, POLYMER, V53, P3762, DOI 10.1016/j.polymer.2012.06.011
   Hu ZG, 2009, POLYMER, V50, P4175, DOI 10.1016/j.polymer.2009.06.073
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   Knight PT, 2009, MACROMOLECULES, V42, P6596, DOI 10.1021/ma901237h
   Lei B, 2012, J BIOMED MATER RES B, V100B, P967, DOI 10.1002/jbm.b.32659
   Luo YF, 2008, EUR POLYM J, V44, P1390, DOI 10.1016/j.eurpolymj.2008.01.043
   Ma CF, 2013, J MATER CHEM B, V1, P3099, DOI 10.1039/c3tb20454e
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Niu XF, 2008, J BIOMED MATER RES A, V84A, P908, DOI 10.1002/jbm.a.31360
   Niu X, 2009, POLYM DEGRAD STABIL, V94, P176, DOI 10.1016/j.polymdegradstab.2008.11.008
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pilliar R, 2004, J BIOMED MATER RES, V13, P799
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Rizvi MS, 2012, ACTA BIOMATER, V8, P4111, DOI 10.1016/j.actbio.2012.07.025
   Ruan CS, 2012, POLYM INT, V61, P524, DOI 10.1002/pi.3197
   Shen YH, 2012, J MATER CHEM, V22, P8662, DOI 10.1039/c2jm16141a
   Shen YH, 2011, LANGMUIR, V27, P2701, DOI 10.1021/la104876w
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]
   Tsuji H, 2002, J APPL POLYM SCI, V86, P186, DOI 10.1002/app.10813
   Wang Ching-Sung, 2012, J BIOMED BIOTECHNOL, V2012, P1
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Wang Y., 2011, POLYM DEGRAD STABIL, V95, P1687
   Wang YL, 2010, POLYM DEGRAD STABIL, V95, P549, DOI 10.1016/j.polymdegradstab.2009.12.016
   Wei L, 2011, POLYMER, V52, P5139, DOI 10.1016/j.polymer.2011.09.006
   Wu CS, 2007, POLYMER, V48, P4449, DOI 10.1016/j.polymer.2007.06.004
   Xu SH, 2013, POLYMER, V54, P6589, DOI 10.1016/j.polymer.2013.10.011
NR 41
TC 18
Z9 18
U1 3
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD FEB 25
PY 2014
VL 55
IS 4
BP 1020
EP 1027
DI 10.1016/j.polymer.2014.01.011
PG 8
WC Polymer Science
SC Polymer Science
GA AB6UZ
UT WOS:000331926300006
DA 2018-10-20
ER

PT J
AU Izawa, H
   Nishino, S
   Maeda, H
   Morita, K
   Ifuku, S
   Morimoto, M
   Saimoto, H
   Kadokawa, J
AF Izawa, Hironori
   Nishino, Shoji
   Maeda, Hiroyuki
   Morita, Kohei
   Ifuku, Shinsuke
   Morimoto, Minoru
   Saimoto, Hiroyuki
   Kadokawa, Jun-ichi
TI Mineralization of hydroxyapatite upon a unique xanthan gum hydrogel by
   an alternate soaking process
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Xanthan gum; Hydroxyapatite; Alternate soaking process;
   Inorganic-organic composite hydrogel; Mineralization
ID EXTRACELLULAR POLYSACCHARIDE; BIOMIMETIC MINERALIZATION;
   XANTHOMONAS-CAMPESTRIS; BIOCOMPOSITES; CHEMISTRY; POLYMERS; DELIVERY
AB We previously reported a xanthan gum (Xan) hydrogel showing excellent mechanical properties. Mineralization of hydroxyapatite (Hap) upon the Xan hydrogel would provide a unique biomaterial applicable for bone tissue engineering. Here, we show the mineralization of Hap upon the Xan hydrogel by means of an alternate soaking process. Hap was gradually grown upon the Xan-matrix surface with increasing number of soaking cycles due to the ionic interactions between calcium cations and carboxyl groups. Interestingly, the mineralization induced a microstructure change in the gel-matrix from a layered structure to a porous structure. The mechanical properties of the resulting Hap-Xan composite hydrogels were further investigated by a tensile test, where the Hap-Xan composite hydrogel with an appropriate amount of Hap (Xan/Hap = 2.7) was capable of approximately 370% elongation. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Izawa, Hironori; Nishino, Shoji; Maeda, Hiroyuki; Morita, Kohei; Ifuku, Shinsuke; Morimoto, Minoru; Saimoto, Hiroyuki] Tottori Univ, Grad Sch Engn, Tottori 6808550, Japan.
   [Kadokawa, Jun-ichi] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan.
   [Kadokawa, Jun-ichi] Muroran Inst Technol, Res Ctr Environm Friendly Mat Engn, Muroran, Hokkaido 0508585, Japan.
RP Izawa, H (reprint author), Tottori Univ, Grad Sch Engn, Dept Sci & Biotechnol, 4-101 Koyama Minami, Tottori 6808550, Japan.
EM h-izawa@chem.tottori-u.ac.jp
RI Izawa, Hironori/M-7037-2014
OI Izawa, Hironori/0000-0002-8715-8462
FU Tottori Prefecture Environment and Academic Promotion Project
FX This work was in part supported by the Tottori Prefecture Environment
   and Academic Promotion Project.
CR Alistair M. S., 2006, FOOD POLYSACCHARIDES
   Arias JL, 2008, CHEM REV, V108, P4475, DOI 10.1021/cr078269p
   Brantley JN, 2013, POLYM CHEM-UK, V4, P3916, DOI 10.1039/c3py00001j
   Calvert P, 1996, CHEM MATER, V8, P1715, DOI 10.1021/cm960126o
   Camesano TA, 2001, BIOMACROMOLECULES, V2, P1184, DOI 10.1021/bm015555g
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Colfen H, 2007, TOP CURR CHEM, V271, P1, DOI 10.1007/128_056
   Du MC, 2011, J MATER CHEM, V21, P2228, DOI 10.1039/c0jm02869j
   Dujardin E, 2002, ADV MATER, V14, P775, DOI 10.1002/1521-4095(20020605)14:11<775::AID-ADMA775>3.0.CO;2-0
   Green DW, 2005, ADV FUNCT MATER, V15, P917, DOI 10.1002/adfm.200400322
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   Izawa H, 2010, J MATER CHEM, V20, P5235, DOI 10.1039/c0jm00595a
   Izawa H, 2009, J MATER CHEM, V19, P6969, DOI 10.1039/b916864h
   JANSSON PE, 1975, CARBOHYD RES, V45, P275, DOI 10.1016/S0008-6215(00)85885-1
   Kuo CK, 2008, J BIOMED MATER RES A, V84A, P899, DOI 10.1002/jbm.a.31375
   Mann S, 2000, ANGEW CHEM INT EDIT, V39, P3393
   MELTON LD, 1976, CARBOHYD RES, V46, P245, DOI 10.1016/S0008-6215(00)84296-2
   MILLANE RP, 1990, CARBOHYD POLYM, V12, P315, DOI 10.1016/0144-8617(90)90072-Z
   Moorhouse R., 1977, XANTHAN GUM MOL CONF
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Okada M., 2012, SCI TECHNOLOGY ADV M, V13
   Rosalam S, 2006, ENZYME MICROB TECH, V39, P197, DOI 10.1016/j.enzmictec.2005.10.019
   Shi J, 2012, INT J BIOL MACROMOL, V50, P747, DOI 10.1016/j.ijbiomac.2011.12.003
   Shi Y, 2009, CHEM COMMUN, P442, DOI 10.1039/b814095b
   Sun F, 2011, ACTA BIOMATER, V7, P3813, DOI 10.1016/j.actbio.2011.07.002
   TAGUCHI T, 1998, CHEM LETT, V8, P711
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Zhong C, 2012, J MATER CHEM, V22, P6080, DOI 10.1039/c2jm15610e
NR 28
TC 11
Z9 11
U1 1
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD FEB 15
PY 2014
VL 102
BP 846
EP 851
DI 10.1016/j.carbpol.2013.10.080
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA AB4SG
UT WOS:000331779600109
PM 24507355
DA 2018-10-20
ER

PT J
AU Cui, Y
   Xiao, ZF
   Chen, T
   Wei, JS
   Chen, L
   Liu, LJ
   Chen, B
   Wang, XJ
   Li, XR
   Dai, JW
AF Cui, Yi
   Xiao, Zhifeng
   Chen, Tong
   Wei, Jianshu
   Chen, Lei
   Liu, Lijun
   Chen, Bing
   Wang, Xiujie
   Li, Xiaoran
   Dai, Jianwu
TI The miR-7 Identified from Collagen Biomaterial-Based Three-Dimensional
   Cultured Cells Regulates Neural Stem Cell Differentiation
SO STEM CELLS AND DEVELOPMENT
LA English
DT Article
ID TISSUE; MICRORNAS; 3D; PROLIFERATION; CANCER; REGENERATION; MAINTENANCE;
   BIOGENESIS; PHENOTYPES; SCAFFOLDS
C1 [Cui, Yi; Wei, Jianshu; Chen, Lei; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100080, Peoples R China.
   [Cui, Yi] Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing, Peoples R China.
   [Xiao, Zhifeng; Chen, Bing; Dai, Jianwu] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Inst Combined Injury Burns & Combined Injury, Chongqing Engn Res Ctr Nanomed,Coll Prevent Med, Chongqing, Peoples R China.
   [Chen, Tong; Wei, Jianshu; Chen, Lei] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Chen, Tong; Wang, Xiujie] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100080, Peoples R China.
   [Liu, Lijun] Xinjiang Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Sch Stomatol, Urumqi, Xinjiang, Peoples R China.
   [Li, Xiaoran] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Div Nanobiomed, Suzhou, Peoples R China.
RP Dai, JW (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100080, Peoples R China.
EM jwdai@genetics.ac.cn
FU Ministry of Science and Technology of China [2011CB965001]; National
   Science Foundation of China [30930032]; Chinese Academy of Sciences
   [KSCX2-EW-Q-24]
FX This work was supported by grants from the Ministry of Science and
   Technology of China (2011CB965001), the National Science Foundation of
   China (30930032), and the Chinese Academy of Sciences (KSCX2-EW-Q-24).
CR Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Ayala P, 2010, TISSUE ENG PT A, V16, P2519, DOI [10.1089/ten.tea.2009.0815, 10.1089/ten.TEA.2009.0815]
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434
   Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056
   Choudhury NR, 2013, GENE DEV, V27, P24, DOI 10.1101/gad.199190.112
   Cui Y, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-116
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Han J, 2013, BIOMATERIALS, V34, P1921, DOI 10.1016/j.biomaterials.2012.11.063
   Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07
   Khoshnan A, 2012, PLOS ONE, V7
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Li CL, 2008, ONCOL REP, V20, P1465, DOI 10.3892/or_00000167
   Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040
   Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737
   Palm T, 2013, NUCLEIC ACIDS RES, V41, P3699, DOI 10.1093/nar/gkt070
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Qin S, 2011, P NATL ACAD SCI USA, V108, P21117, DOI 10.1073/pnas.1112351109
   Qutub AA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-13
   Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503
   Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13
   Thiel Gerald, 2013, Biochem J, V450, pe1, DOI 10.1042/BJ20130176
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200
NR 31
TC 21
Z9 21
U1 5
U2 23
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1547-3287
EI 1557-8534
J9 STEM CELLS DEV
JI Stem Cells Dev.
PD FEB 15
PY 2014
VL 23
IS 4
BP 393
EP 405
DI 10.1089/scd.2013.0342
PG 13
WC Cell & Tissue Engineering; Hematology; Medicine, Research &
   Experimental; Transplantation
SC Cell Biology; Hematology; Research & Experimental Medicine;
   Transplantation
GA AA8WD
UT WOS:000331374800007
PM 24200387
OA Green Published
DA 2018-10-20
ER

PT J
AU Senatov, FS
   Gorshenkov, MV
   Kaloshkin, SD
   Tcherdyntsev, VV
   Anisimova, NY
   Kopylov, AN
   Kiselevsky, MV
AF Senatov, F. S.
   Gorshenkov, M. V.
   Kaloshkin, S. D.
   Tcherdyntsev, V. V.
   Anisimova, N. Yu
   Kopylov, A. N.
   Kiselevsky, M. V.
TI Biocompatible polymer composites based on ultrahigh molecular weight
   polyethylene perspective for cartilage defects replacement
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE UHMWPE; Composite; Biomaterial; Wear; Mechanical activation
ID ARTICULAR-CARTILAGE; PROPERTY CHANGES; FRICTION; CRYSTALLIZATION;
   NANOCOMPOSITES; STRESS; BLENDS; WEAR
AB The purpose of this study was to evaluate mechanical properties, microstructure and biocompatibility of nano-compounds obtained by mechanical activation of UHMWPE powder and several types of particulate fillers in a planetary ball mill. The effect of particle shape and concentration of Al2O3 on properties of the composite was investigated. The effectiveness of reinforcing a polyethylene matrix by mechanoactivated alumina in the form of nanopowder or microspheres was shown. Reinforcing of the polymer by nanoparticles significantly improves wear-resistance. No signs of blood serum fibrin deposition on the surface of the samples were observed. Also no signs of pathological changes in physiology or anatomy were noticed on the animals with implanted samples. UHMWPE-based composites obtained by mechanical activation and hot pressing and filled with ceramic particles can be used as a biocompatible material for the replacement of cartilage. (C) 2012 Elsevier B. V. All rights reserved.
C1 [Senatov, F. S.; Gorshenkov, M. V.; Kaloshkin, S. D.; Tcherdyntsev, V. V.] Natl Univ Sci & Technol MISIS, Moscow, Russia.
   [Anisimova, N. Yu; Kopylov, A. N.; Kiselevsky, M. V.] RAMS, NN Blokhin Russian Canc Res Ctr, Moscow, Russia.
RP Gorshenkov, MV (reprint author), Natl Univ Sci & Technol MISIS, Moscow, Russia.
EM mvg@misis.ru
RI Kiselevskiy, Mikhail/D-8822-2017; Anisimova, Natalia/A-6640-2014
OI Kiselevskiy, Mikhail/0000-0002-0132-167X; Anisimova,
   Natalia/0000-0002-4370-6578; Senatov, Fedor/0000-0003-3907-5344;
   Gorshenkov, Mikhail/0000-0001-8780-7584
CR [Anonymous], 2008, HEMATOXYLIN EOSIN ST, DOI DOI 10.1101/PDB.PR0T4986
   Basalo IM, 2007, J BIOMECH, V40, P1847, DOI 10.1016/j.jbiomech.2006.07.007
   BASTIAANSEN CWM, 1990, POLYMER, V31, P1435, DOI 10.1016/0032-3861(90)90147-Q
   Bazhenov S.L., 1998, FILLERS THEIR EFFECT, P252
   Esterly DM, 2004, J POLYM SCI POL PHYS, V42, P91, DOI 10.1002/polb.10613
   Font J, 2001, MATER RES BULL, V36, P1665, DOI 10.1016/S0025-5408(01)00648-1
   Fu SY, 2008, COMPOS PART B-ENG, V39, P933, DOI 10.1016/j.compositesb.2008.01.002
   HAN KS, 1981, J MACROMOL SCI PHYS, VB19, P313, DOI 10.1080/00222348108015307
   Hassan Mahfuz, 2004, COMPOSITES, V35, P543
   Huang H, 2000, J APPL POLYM SCI, V78, P2016, DOI 10.1002/1097-4628(20001209)78:11<2016::AID-APP230>3.0.CO;2-6
   Huang H, 1999, J APPL POLYM SCI, V74, P1459, DOI 10.1002/(SICI)1097-4628(19991107)74:6<1459::AID-APP19>3.0.CO;2-D
   Katta J, 2009, OSTEOARTHR CARTILAGE, V17, P662, DOI 10.1016/j.joca.2008.10.008
   Mallikarjuna NN, 2004, J APPL POLYM SCI, V94, P2551, DOI 10.1002/app.21144
   McCann L, 2009, OSTEOARTHR CARTILAGE, V17, P995, DOI 10.1016/j.joca.2009.02.012
   Senatov F.S., 2012, RUSS METALL METALLY, V4, P344
   Stranz M, 2005, J METASTAB NANOCRYST, V24-25, P463, DOI 10.4028/www.scientific.net/JMNM.24-25.463
   Stranz M, 2007, J ALLOY COMPD, V434, P447, DOI 10.1016/j.jallcom.2006.08.097
   Wang GL, 2008, J POLYM SCI POL PHYS, V46, P807, DOI 10.1002/polb.21417
   Xiong DS, 2006, BIOMED MATER, V1, P175, DOI 10.1088/1748-6041/1/3/013
NR 19
TC 7
Z9 8
U1 0
U2 48
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD FEB 15
PY 2014
VL 586
SU 1
BP S544
EP S547
DI 10.1016/j.jallcom.2012.10.014
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 268RS
UT WOS:000328188800116
DA 2018-10-20
ER

PT J
AU Perumal, S
   Ramadass, SK
   Madhan, B
AF Perumal, Sathiamurthi
   Ramadass, Satiesh Kumar
   Madhan, Balaraman
TI Sol-gel processed mupirocin silica microspheres loaded collagen
   scaffold: A synergistic bio-composite for wound healing
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Mupirocin; Silica microspheres; Collagen; Burns; Foot ulcers
ID RESISTANT STAPHYLOCOCCUS-AUREUS; SILVER SULFADIAZINE; INFECTION;
   CHLORHEXIDINE; GENTAMICIN; DRESSINGS; DYNAMICS; DELIVERY; RELEASE;
   MATRIX
AB Development of a bio-composite using synergistic combination is a promising strategy to address various pathological manifestations of acute and chronic wounds. In the present work, we have combined three materials viz., mupirocin as an antimicrobial drug, sol-gel processed silica microsphere as drug carrier for sustained delivery of drug and collagen, an established wound healer as scaffold. The mupirocin-loaded silica microspheres (Mu-SM) and Mu-SM loaded collagen scaffold were characterized for surface morphology, entrapment efficiency and distribution homogeneity, in vitro drug release, water uptake capacity, cell proliferation and antibacterial activity. In vivo wound healing efficacy of the bio-composite was experimented using full thickness excision wound model in Wistar albino rats. The Mu-SM incorporated collagen scaffold showed good in vitro characteristics in terms of better water uptake, sustained drug availability and antimicrobial activity. The wound closure analysis revealed that the complete epithelialisation was observed at 14.2 +/- 0.44 days for Mu-SM loaded collagen, whereas this was 17.4 +/- 0.44 days and 20.6 +/- 0.54 days for collagen and control groups, respectively. Consequently, the synergistic strategy of combining mupirocin-loaded silica microspheres and collagen as a Mu-SM loaded collagen dressing material would be an ideal biomaterial for the treatment of surface wounds, burns and foot ulcers. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Perumal, Sathiamurthi; Ramadass, Satiesh Kumar; Madhan, Balaraman] CSIR, Cent Leather Res Inst, Madras 20, Tamil Nadu, India.
   [Perumal, Sathiamurthi] CSIR, Cent Leather Res Inst, Acad Sci & Innovat Res, Madras 20, Tamil Nadu, India.
RP Madhan, B (reprint author), CSIR, Cent Leather Res Inst, Madras 20, Tamil Nadu, India.
EM bmadhan76@yahoo.co.in
RI Madhan, Balaraman/B-3136-2009
OI Madhan, Balaraman/0000-0002-4198-8452
FU CSIR, India under the M2D XII plan Project [CSC 0134]
FX The authors are grateful to CSIR, India for providing financial
   assistance under the M2D XII plan Project (CSC 0134). Authors are
   thankful to Dr. Lawrence D'Cruze, Department of Pathology, Sri
   Ramachandra University for his assistance in histopathological
   interpretation and Mr V. Elango, Senior Technician for his assistance in
   animal experimental study.
CR Adhirajan N, 2009, EUR J PHARM SCI, V36, P235, DOI 10.1016/j.ejps.2008.09.010
   Baharestani MM, 2007, OSTOMY WOUND MANAG, V53, P34
   Chang JS, 2007, ENVIRON SCI TECHNOL, V41, P2064, DOI 10.1021/es062347t
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   CHVAPIL M, 1982, J BIOMED MATER RES, V16, P245, DOI 10.1002/jbm.820160306
   CLARKE AM, 1975, MED J AUSTRALIA, V1, P413
   Dai T, 2010, Recent Pat Antiinfect Drug Discov, V5, P124
   Friess W, 2002, PHARM DEV TECHNOL, V7, P235, DOI 10.1081/PDT-120003491
   Gorham S.D., 1991, BIOMATERIALS
   INMAN RJ, 1984, BURNS, V11, P35, DOI 10.1016/0305-4179(84)90159-1
   LINNEMANN CC, 1982, AM J EPIDEMIOL, V115, P941, DOI 10.1093/oxfordjournals.aje.a113381
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Muthukumar T, 2013, COLLOID SURFACE B, V102, P694, DOI 10.1016/j.colsurfb.2012.09.041
   Natarajan V, 2013, J BIOMED MATER RES B, V101B, P560, DOI 10.1002/jbm.b.32856
   Newton PM, 2004, INFLAMMATION, V28, P207, DOI 10.1023/B:IFLA.0000049045.41784.59
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Radin S, 2009, BIOMATERIALS, V30, P850, DOI 10.1016/j.biomaterials.2008.09.066
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   RODE H, 1989, ANTIMICROB AGENTS CH, V33, P1358, DOI 10.1128/AAC.33.8.1358
   Russell R.C.G., 2000, BAILYS LOVES SHORT P
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Schlapp M, 2003, J PHARM SCI-US, V92, P2145, DOI 10.1002/jps.10460
   Spann CT, 2004, DM-DIS MON, V50, P407, DOI 10.1016/j.disamonth.2004.05.011
   Sripriya R, 2007, J BIOMAT SCI-POLYM E, V18, P335, DOI 10.1163/156856207779996913
   Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6
   TANAKA S, 1988, J BIOL CHEM, V263, P17650
   Zahedi P, 2010, POLYM ADVAN TECHNOL, V21, P77, DOI 10.1002/pat.1625
NR 28
TC 21
Z9 23
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
EI 1879-0720
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD FEB 14
PY 2014
VL 52
BP 26
EP 33
DI 10.1016/j.ejps.2013.10.006
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AA3VF
UT WOS:000331022100004
PM 24514452
DA 2018-10-20
ER

PT J
AU Augustine, R
   Malik, HN
   Singhal, DK
   Mukherjee, A
   Malakar, D
   Kalarikkal, N
   Thomas, S
AF Augustine, Robin
   Malik, Hruda Nanda
   Singhal, Dinesh Kumar
   Mukherjee, Ayan
   Malakar, Dhruba
   Kalarikkal, Nandakumar
   Thomas, Sabu
TI Electrospun polycaprolactone/ZnO nanocomposite membranes as biomaterials
   with antibacterial and cell adhesion properties
SO JOURNAL OF POLYMER RESEARCH
LA English
DT Article
DE Polycaprolactone; ZnO nanoparticles; Scaffolds; Wound healing;
   Antimicrobial; Fibroblasts
ID ZINC-OXIDE; MECHANICAL-PROPERTIES; ZNO NANOPARTICLES; CERAMIC POWDERS;
   PARTICLE-SIZE; POLYMER-FILMS; SCAFFOLD; GROWTH; PHOSPHORYLATION;
   TEMPERATURE
AB In the present study we have investigated the effect of zinc oxide (ZnO) nanoparticles on the fiber diameter, fiber morphology, antibacterial activity, and enhanced cell proliferation of the electrospun polycaprolactone (PCL) non-woven membrane. The effect of the ZnO nanoparticle concentration on the fiber diameter and fiber morphology was investigated using a scanning electron microscope (SEM). Fourier transform infrared spectroscopy (FT-IR) analysis was carried out to determine the nature of the interaction between the PCL and the ZnO nanoparticles. We also investigated the mechanical stability and antibacterial activity of the fabricated material. Interestingly, the membranes with ZnO nanoparticles showed enhanced mechanical stability, antibacterial properties, fibroblast proliferation, and improved metabolic activity of the cells. Further, this is the first report regarding the ability of a biomaterial containing ZnO nanoparticles to enhance cell proliferation.
C1 [Augustine, Robin; Kalarikkal, Nandakumar; Thomas, Sabu] Mahatma Gandhi Univ, Int & Inter Univ Ctr Nanosci & Nanotechnol, Kottayam 686560, Kerala, India.
   [Kalarikkal, Nandakumar] Mahatma Gandhi Univ, Sch Pure & Appl Phys, Kottayam 686560, Kerala, India.
   [Thomas, Sabu] Mahatma Gandhi Univ, Sch Chem Sci, Kottayam 686560, Kerala, India.
   [Malik, Hruda Nanda; Singhal, Dinesh Kumar; Mukherjee, Ayan; Malakar, Dhruba] Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal 132001, India.
RP Kalarikkal, N (reprint author), Mahatma Gandhi Univ, Int & Inter Univ Ctr Nanosci & Nanotechnol, Kottayam 686560, Kerala, India.
EM nkkalarikkal@mgu.ac.in; sabupolymer@yahoo.com
RI Thomas, Prof. Sabu/G-7310-2016
OI Thomas, Prof. Sabu/0000-0003-4726-5746; KALARIKKAL,
   NANDAKUMAR/0000-0002-4595-6466; Augustine, Robin/0000-0001-9724-8392
FU Department of Science and Technology (DST), Government of India, New
   Delhi through the Nanomission program; Department of Science and
   Technology (DST), Government of India, New Delhi through the PURSE
   program; UGC SAP; DST-FIST
FX The authors acknowledge the Department of Science and Technology (DST),
   Government of India, New Delhi, for the financial support through the
   Nanomission and PURSE programs. Funding from UGC SAP and DST-FIST are
   also gratefully acknowledged.
CR Ashutosh K, 2011, FREE RADICAL BIO MED, V51, P1872
   Aslan S, 2010, NANOSCALE, V2, P1789, DOI 10.1039/c0nr00329h
   Barui AK, 2012, NANOSCALE, V4, P7861, DOI 10.1039/c2nr32369a
   BAUMGARTEN PK, 1971, J COLLOID INTERF SCI, V36, P71, DOI 10.1016/0021-9797(71)90241-4
   Branda o-Neto J, 1995, NUTR RES, V15, P335
   Bryan N, 2012, EUR CELLS MATER, V24, P249, DOI 10.22203/eCM.v024a18
   Cevat E, 2008, BIOMATERIALS, V29, P4065
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Dutta RK, 2012, COLLOID SURFACE B, V94, P143, DOI 10.1016/j.colsurfb.2012.01.046
   Elen K, 2012, POLYM ADVAN TECHNOL, V23, P1422, DOI 10.1002/pat.2062
   Fashandi H, 2012, POLYMER, V53, P5832, DOI 10.1016/j.polymer.2012.10.003
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Francois B, 1995, ADV MATER, V7, P1041, DOI 10.1002/adma.19950071217
   Fujiwara Y, 1997, RES COMMUN MOL PATH, V97, P95
   GAMOU S, 1995, FEBS LETT, V357, P161, DOI 10.1016/0014-5793(94)01335-X
   Goldkorn T, 1998, AM J RESP CELL MOL, V19, P786, DOI 10.1165/ajrcmb.19.5.3249
   Guo DD, 2013, TOXICOL IN VITRO, V27, P731, DOI 10.1016/j.tiv.2012.12.001
   Huo YA, 2009, EXP EYE RES, V89, P876, DOI 10.1016/j.exer.2009.07.012
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Lee KH, 2003, POLYMER, V44, P1287, DOI 10.1016/S0032-3861(02)00820-0
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li XH, 2010, FOOD SCI TECHNOL INT, V16, P225, DOI 10.1177/1082013209353986
   Li ZH, 2005, SOLID STATE IONICS, V176, P1903, DOI 10.1016/j.ssi.2005.05.006
   Lim CT, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857478
   Limaye AV, 1996, PHYS REV LETT, V76, P3762, DOI 10.1103/PhysRevLett.76.3762
   Luigi C, 2008, BIOMACROMOLECULES, V9, P1527
   Ma GP, 2009, POLYM ADVAN TECHNOL, V20, P147, DOI 10.1002/pat.1180
   MacArthur BD, 2005, NATURE, V433, P19, DOI 10.1038/433019a
   MACK CF, 1993, INT J RADIAT ONCOL, V27, P217, DOI 10.1016/0360-3016(93)90774-P
   Mariappan Premanathan, 2011, NANOTECHNOLOGY BIOL, V7, P184
   Mathieu HJ, 2001, SURF INTERFACE ANAL, V32, P3, DOI 10.1002/sia.995
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Moniruzzaman M, 2007, NANO LETT, V7, P1178, DOI 10.1021/nl062868e
   NEWELL KJ, 1994, MOL CARCINOGEN, V10, P199, DOI 10.1002/mc.2940100404
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Park MS, 2004, LANGMUIR, V20, P5347, DOI 10.1021/la035915g
   Patcharaporn W, 2006, MACROMOL BIOSCI, V6, P70
   Patricia BM, 2007, ADV DRUG DELIV REV, V59, P207
   Peng J, 2004, POLYMER, V45, P447, DOI 10.1016/j.polymer.2003.11.019
   Rajesh V, 2006, INT J NANOMED, V1, P15
   Reddy KM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742324
   Salgueiro MJ, 2002, NUTRITION, V18, P510, DOI 10.1016/S0899-9007(01)00812-7
   Sawai J, 1996, J CHEM ENG JPN, V29, P251, DOI 10.1252/jcej.29.251
   Sawai J, 1996, J CHEM ENG JPN, V29, P627, DOI 10.1252/jcej.29.627
   Seema A. S., 2008, POLYMER, V49, P5603
   Selahattin A, 1998, T J MED SCI, V28, P595
   Silke M., 2002, MACROMOLECULES, V35, P8456
   Sokolsky PM, 2007, ADV DRUG DELIV REV, V59, P187
   Srinivasarao M, 2001, SCIENCE, V292, P79, DOI 10.1126/science.1057887
   Stoimenov PK, 2002, LANGMUIR, V18, P6679, DOI 10.1021/la0202374
   Sudheesh Kumar PT, 2013, PHARM RES, P523
   Thandavamoorthy S, 2005, APPL POLY SCI, V96, P557
   Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005
   Toduka Y, 2012, ENVIRON SCI TECHNOL, V46, P7629, DOI 10.1021/es300433x
   Vlad S, 2011, DIG J NANOMATER BIOS, V6, P921
   Yamamoto O, 2001, INT J INORG MATER, V3, P643, DOI 10.1016/S1466-6049(01)00197-0
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 60
TC 61
Z9 62
U1 4
U2 69
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1022-9760
EI 1572-8935
J9 J POLYM RES
JI J. Polym. Res.
PD FEB 13
PY 2014
VL 21
IS 3
AR 347
DI 10.1007/s10965-013-0347-6
PG 17
WC Polymer Science
SC Polymer Science
GA AB3XM
UT WOS:000331723500001
DA 2018-10-20
ER

PT J
AU Carrasco-Sanchez, V
   Vergara-Jaque, A
   Zuniga, M
   Comer, J
   John, A
   Nachtigall, FM
   Valdes, O
   Duran-Lara, EF
   Sandoval, C
   Santos, LS
AF Carrasco-Sanchez, Veronica
   Vergara-Jaque, Ariela
   Zuniga, Matias
   Comer, Jeffrey
   John, Amalraj
   Nachtigall, Fabiane M.
   Valdes, Oscar
   Duran-Lara, Esteban F.
   Sandoval, Claudia
   Santos, Leonardo S.
TI In situ and in silico evaluation of amine- and folate-terminated
   dendrimers as nanocarriers of anesthetics
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE PAMAM dendrimers; Drug delivery; Molecular dynamics; MM-GBSA; MALDI-MS
ID MOLECULAR-DYNAMICS SIMULATION; DRUG-DELIVERY; POLYAMIDOAMINE DENDRIMERS;
   SOLUBILITY ENHANCERS; MAGNETIC-RESONANCE; CELLULAR-TRANSPORT;
   FORCE-FIELDS; ENCAPSULATION; MECHANICS; DIFFUSION
AB The search for new nano-systems for targeted biomedical applications and controlled drug release has attracted significant attention in polymer chemistry, pharmaceutics, and biomaterial science. Controlled drug delivery has many advantages over conventional drug administration, such as reduction of side effects, maintaining a stable plasma level concentration and improving the quality of life of patients. In this study, PAMAM G5 dendrimers and PAMAM G5-folic acid conjugates (PAMAM G5-FA) are synthesized and characterized by mass spectrometry (MALDI-MS). Controlled release studies at different pH values show that PAMAM G5-FA is a good candidate as a carrier for tramadol and morphine, while mathematical modeling is conducted, suggesting that the release process is governed by a diffusion mechanism. In addition, using molecular dynamics simulations, we investigate the structural and energetic properties that facilitate the encapsulation of tramadol and morphine by unmodified and functionalized PAMAM-G5 dendrimers at low, neutral and high pH. Our results correlate well with experimental data, confirming that tramadol and morphine may be encapsulated both by functionalized PAMAM dendrimers and unmodified PAMAM. Moreover, the simulations further reveal that hydrogen-bond and electrostatic interactions govern the affinity the dendrimers for both drugs. This information is envisioned to prove useful for the encapsulation of other drugs and for the design of novel functionalized dendrimers. (C) 2013 Elsevier Masson SAS. All rights reserved.
C1 [Carrasco-Sanchez, Veronica; Vergara-Jaque, Ariela; Zuniga, Matias; John, Amalraj; Nachtigall, Fabiane M.; Valdes, Oscar; Duran-Lara, Esteban F.; Santos, Leonardo S.] Univ Talca, Fraunhofer Chile Res Fdn, Nanobiotechnol Div,Ctr Syst Biotechnol, FCR CSB,Lab Asymmetr Synth,Chem Inst Nat Resource, Talca, Chile.
   [Comer, Jeffrey; Sandoval, Claudia] Univ Andres Bello, Ctr Bioinformat & Integrat Biol, Santiago, Chile.
RP Santos, LS (reprint author), Univ Talca, Fraunhofer Chile Res Fdn, Nanobiotechnol Div,Ctr Syst Biotechnol, FCR CSB,Lab Asymmetr Synth,Chem Inst Nat Resource, POB 747, Talca, Chile.
EM claudia.sandoval@unab.cl; lssantos@utalca.cl
RI Vergara-Jaque, Ariela/H-1275-2017; Santos, Leonardo/A-7953-2008;
   Amalraj, John/L-1564-2013; Valdes Lizama, Oscar/J-9243-2016; Duran-Lara,
   Esteban/G-9053-2017
OI Vergara-Jaque, Ariela/0000-0002-1236-013X; Santos,
   Leonardo/0000-0003-0908-0134; Amalraj, John/0000-0003-1872-5133; Valdes
   Lizama, Oscar/0000-0003-1477-2549; Duran-Lara,
   Esteban/0000-0002-8796-6830
FU CONICYT-Chile; CONICYT [21121007]; University of Talca for Doctoral
   Program in Sciences; Fondecyt postdoctoral grant [3120178]
FX We thank a partial contribution to the Programa Iniciativa Cientifica
   Milenio (ICM) del Ministerio de Economia, Fomento y Turismo, Fraunhofer
   Chile Research Foundation Innova-Chile Corfo (FCR-CSB 09CEII-6991), and
   Proyecto Anillo Cientifico ACT1107. A.V.J. thanks the Doctoral Program
   of Applied Sciences of Talca University, as well as CONICYT-Chile for a
   doctoral fellowship. V.C.S. is in debt to CONICYT for doctoral
   fellowship No. 21121007 and University of Talca for Doctoral Program in
   Sciences. E.D.L. thanks to Fondecyt postdoctoral grant N 3120178.
CR ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503
   Abderrezak A., 2012, PLOS ONE, V7, P33102
   Abroshan H, 2010, J PHYS ORG CHEM, V23, P866, DOI 10.1002/poc.1679
   Aranovich GL, 2009, PHYSICA A, V388, P3355, DOI 10.1016/j.physa.2009.05.012
   Beezer AE, 2003, TETRAHEDRON, V59, P3873, DOI 10.1016/S0040-4020(03)00437-X
   Chandrasekar D, 2007, BIOMATERIALS, V28, P504, DOI 10.1016/j.biomaterials.2006.07.046
   Cheng YY, 2008, FRONT BIOSCI-LANDMRK, V13, P1447, DOI 10.2741/2774
   Cheng YY, 2008, J PHYS CHEM B, V112, P8884, DOI 10.1021/jp801742t
   Cheng YY, 2008, J PHARM SCI-US, V97, P123, DOI 10.1002/jps.21079
   Cheng YY, 2005, EUR J MED CHEM, V40, P1390, DOI 10.1016/j.ejmech.2005.08.002
   Chotia C, 1975, J MOL BIOL, V105, P1
   D'Emanuele A, 2005, ADV DRUG DELIVER REV, V57, P2147, DOI 10.1016/j.addr.2005.09.012
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648
   Gillies ER, 2005, DRUG DISCOV TODAY, V10, P35, DOI 10.1016/S1359-6446(04)03276-3
   Grond S, 2004, CLIN PHARMACOKINET, V43, P879, DOI 10.2165/00003088-200443130-00004
   Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Khandare J, 2005, BIOCONJUGATE CHEM, V16, P330, DOI 10.1021/bc0498018
   Kobayashi H, 2003, MAGNET RESON MED, V50, P758, DOI 10.1002/mrm.10583
   Kojima C, 2010, EXPERT OPIN DRUG DEL, V7, P307, DOI 10.1517/17425240903530651
   Kolhe P, 2006, BIOMATERIALS, V27, P660, DOI 10.1016/j.biomaterials.2005.06.007
   Korsmeyer R.W., 1983, SWELLING CONTROLLED, P77
   Lee I, 2002, MACROMOLECULES, V35, P4510, DOI 10.1021/ma010354q
   Liu Y, 2009, J AM CHEM SOC, V131, P2798, DOI 10.1021/ja8100227
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   Maiti K. Prabal, 2005, MACROMOLECULES, V38, P979
   Milhem OM, 2000, INT J PHARM, V197, P239, DOI 10.1016/S0378-5173(99)00463-9
   Morales ME, 2011, MOL PHARMACEUT, V8, P629, DOI 10.1021/mp200019q
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Nakamura K, 2007, BIOL PHARM BULL, V30, P1456, DOI 10.1248/bpb.30.1456
   PEPPAS NA, 1989, INT J PHARM, V57, P169, DOI 10.1016/0378-5173(89)90306-2
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104
   Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018
   Svenson S, 2009, EUR J PHARM BIOPHARM, V71, P445, DOI 10.1016/j.ejpb.2008.09.023
   Sweetman S, 2007, MARTINDALE COMPLETE
   Talanov VS, 2006, NANO LETT, V6, P1459, DOI 10.1021/nl060765q
   Tanner DE, 2011, J CHEM THEORY COMPUT, V7, P3635, DOI 10.1021/ct200563j
   Tomalia DA, 2005, PROG POLYM SCI, V30, P294, DOI 10.1016/j.progpolymsci.2005.01.007
   TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137
   Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367
   Wang Y, 2011, BIOMATERIALS, V32, P3322, DOI 10.1016/j.biomaterials.2010.12.060
   Zhang YH, 2010, BIOCONJUGATE CHEM, V21, P489, DOI 10.1021/bc9003958
NR 47
TC 11
Z9 12
U1 1
U2 43
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD FEB 12
PY 2014
VL 73
BP 250
EP 257
DI 10.1016/j.ejmech.2013.11.040
PG 8
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AB6RF
UT WOS:000331916500026
PM 24412500
DA 2018-10-20
ER

PT J
AU Collart-Dutilleul, PY
   Secret, E
   Panayotov, I
   de Periere, DD
   Martin-Palma, RJ
   Torres-Costa, V
   Martin, M
   Gergey, C
   Durand, JO
   Cunin, F
   Cuisinier, FJ
AF Collart-Dutilleul, Pierre-Yves
   Secret, Emilie
   Panayotov, Ivan
   de Periere, Dominique Deville
   Martin-Palma, Raul J.
   Torres-Costa, Vicente
   Martin, Marta
   Gergey, Csilla
   Durand, Jean-Olivier
   Cunin, Frederique
   Cuisinier, Frederic J.
TI Adhesion and Proliferation of Human Mesenchymal Stem Cells from Dental
   Pulp on Porous Silicon Scaffolds
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE porous silicon; dental pulp stem cells; cell adhesion; surface
   functionalization; tissue engineering
ID IN-VITRO; GRADIENTS; DIFFERENTIATION; NANOPARTICLES; FABRICATION;
   TOPOGRAPHY; PEPTIDES; SURFACES; BEHAVIOR; NUCLEUS
AB In regenerative medicine, stem-cell-based therapy often requires a scaffold to deliver cells and/or growth factors to the injured site. Porous silicon (pSi) is a promising biomaterial for tissue engineering as it is both nontoxic and bioresorbable. Moreover, surface modification can offer control over the degradation rate of pSi and can also promote cell adhesion. Dental pulp stem cells (DPSC) are pluripotent mesenchymal stem cells found within the teeth and constitute a readily source of stem cells. Thus, coupling the good proliferation and differentiation capacities of DPSC with the textural and chemical properties of the pSi substrates provides an interesting approach for therapeutic use. In this study, the behavior of human DPSC is analyzed on pSi substrates presenting pores of various sizes, 10 +/- 2 nm, 36 +/- 4 nm, and 1.0 +/- 0.1 mu m, and undergoing different chemical treatments, thermal oxidation, silanization with aminopropyltriethoxysilane (APTES), and hydrosilylation with undecenoic acid or semicarbazide. DPSC adhesion and proliferation were followed for up to 72 h by fluorescence microscopy, scanning electron microscopy (SEM), enzymatic activity assay, and BrdU assay for mitotic activity. Porous silicon with 36 nm pore size was found to offer the best adhesion and the fastest growth rate for DPSC compared to pSi comporting smaller pore size (10 nm) or larger pore size (1 mu m), especially after silanization with APTES. Hydrosilylation with semicarbazide favored cell adhesion and proliferation, especially mitosis after cell adhesion, but such chemical modification has been found to led to a scaffold that is stable for only 24-48 h in culture medium. Thus, semicarbazide-treated pSi appeared to be an appropriate scaffold for stem cell adhesion and immediate in vivo transplantation, whereas APTES-treated pSi was found to be more suitable for long-term in vitro culture, for stem cell proliferation and differentiation:
C1 [Collart-Dutilleul, Pierre-Yves; Panayotov, Ivan; de Periere, Dominique Deville; Cuisinier, Frederic J.] Univ Montpellier I, BioNano Lab EA 4203, Montpellier, France.
   [Secret, Emilie; Durand, Jean-Olivier; Cunin, Frederique] Ecole Natl Super Chim Montpellier, Inst Charles Gerhardt Montpellier, UMR CNRS UM2 ENSCM UM1 5253, F-34296 Montpellier, France.
   [Martin-Palma, Raul J.; Torres-Costa, Vicente] Univ Autonoma Madrid, Dept Fis Aplicada, E-28049 Madrid, Spain.
   [Martin, Marta; Gergey, Csilla] Univ Montpellier 2, UMR Lab Charles Coulomb 5221, Montpellier, France.
   [Martin, Marta; Gergey, Csilla] CNRS, Lab Charles Coulomb UMR 5221, Montpellier, France.
RP Cuisinier, FJ (reprint author), Univ Montpellier I, BioNano Lab EA 4203, Montpellier, France.
EM frederic.cuisinier@univ-montp1.fr
RI Martin-Palma, Raul J/L-2720-2013; Torres-Costa, Vicente/L-2379-2013
OI Martin-Palma, Raul J/0000-0003-3434-8331; Torres-Costa,
   Vicente/0000-0001-5066-2799
CR Ainslie KM, 2008, ACS NANO, V2, P1076, DOI 10.1021/nn800071k
   Alvarez SD, 2009, BIOMATERIALS, V30, P26, DOI 10.1016/j.biomaterials.2008.09.005
   Bateman JE, 1997, CHEM COMMUN, P2275, DOI 10.1039/a707107h
   Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Cao D, 2011, COLLOID SURFACE B, V84, P26, DOI 10.1016/j.colsurfb.2010.12.005
   Cheng L, 2008, BRIT J OPHTHALMOL, V92, P705, DOI 10.1136/bjo.2007.133587
   Clements LR, 2012, LAB CHIP, V12, P1480, DOI 10.1039/c2lc20732j
   Coffinier Y, 2005, LANGMUIR, V21, P1489, DOI 10.1021/la047781s
   Coppe C, 2009, PEDIATR DENT, V31, P467
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916
   Gentile F, 2012, ACS APPL MATER INTER, V4, P2903, DOI 10.1021/am300519a
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Horner PJ, 2000, J NEUROSCI, V20, P2218
   Jarvis KL, 2011, J COLLOID INTERF SCI, V363, P327, DOI 10.1016/j.jcis.2011.07.063
   Kemoun P, 2007, CELL TISSUE RES, V329, P283, DOI 10.1007/s00441-007-0397-3
   Khung YL, 2008, EXP CELL RES, V314, P789, DOI 10.1016/j.yexcr.2007.10.015
   Krishna OD, 2011, BIOMATERIALS, V32, P6412, DOI 10.1016/j.biomaterials.2011.05.034
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Ma Teng, 2010, World J Stem Cells, V2, P13, DOI 10.4252/wjsc.v2.i2.13
   Marolt D, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt10
   Noval AM, 2013, ACTA BIOMATER, V9, P6169, DOI 10.1016/j.actbio.2012.12.008
   Noval AM, 2012, J BIOMED MATER RES A, V100A, P1615, DOI 10.1002/jbm.a.34108
   Naveas N., 2012, ADV MATER, V13
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Paski J, 2005, PHYS STATUS SOLIDI C, V2, P3379, DOI 10.1002/pssc.200461175
   Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095
   Sailor M. J., 2012, POROUS SILICON PRACT
   Santos H., 2014, POROUS SILICON BIOME, V68, P486
   Sapelkin AV, 2006, BIOMATERIALS, V27, P842, DOI 10.1016/j.biomaterials.2005.06.023
   Secret E, 2013, ADV HEALTHC MATER, V2, P718, DOI 10.1002/adhm.201200335
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469
   Torres-Costa V, 2012, INT J NANOMED, V7, P623, DOI 10.2147/IJN.S27745
   UEDA Y, 1994, NEUROSCI LETT, V165, P203, DOI 10.1016/0304-3940(94)90745-5
   Wang PY, 2012, ADV FUNCT MATER, V22, P3414, DOI 10.1002/adfm.201200447
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Werner S, 2009, BIOMATERIALS, V30, P2291, DOI 10.1016/j.biomaterials.2009.01.004
   Whitehead MA, 2008, TISSUE ENG PT A, V14, P195, DOI 10.1089/ten.a.2006.0370
   Zangooie S, 1997, J ELECTROCHEM SOC, V144, P4027, DOI 10.1149/1.1838130
NR 43
TC 23
Z9 25
U1 10
U2 52
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD FEB 12
PY 2014
VL 6
IS 3
BP 1719
EP 1728
DI 10.1021/am4046316
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AB0OY
UT WOS:000331493200052
PM 24428409
DA 2018-10-20
ER

PT J
AU Nazaruk, E
   Szlezak, M
   Gorecka, E
   Bilewicz, R
   Osornio, YM
   Uebelhart, P
   Landau, EM
AF Nazaruk, Ewa
   Szlezak, Monika
   Gorecka, Ewa
   Bilewicz, Renata
   Osornio, Yazmin M.
   Uebelhart, Peter
   Landau, Ehud M.
TI Design and Assembly of pH-Sensitive Lipidic Cubic Phase Matrices for
   Drug Release
SO LANGMUIR
LA English
DT Article
ID LIQUID-CRYSTALLINE PHASES; BUPIVACAINE-LOADED FORMULATIONS;
   X-RAY-DIFFRACTION; MEMBRANE-PROTEINS; MONOOLEIN/WATER SYSTEM; MESOPHASE
   STRUCTURE; ALPHA-CHYMOTRYPSIN; DELIVERY SYSTEMS; WATER CHANNELS; NETWORK
AB Bicontinuous lipidic cubic phases (LCPs) exhibit a combination of material properties that make them highly interesting for various biomaterial applications: they are nontoxic, biodegradable, optically transparent, thermodynamically stable in excess water, and can incorporate active molecules of virtually any polarity. Here we present a molecular system comprising host lipid, water, and designed lipidic additive, which form a structured, pH-sensitive lipidic matrix for hydrophilic as well as hydrophobic drug incorporation and release. The model drug doxorubicin (Dox) was loaded into the LCP. Tunable interactions with the lipidic matrix led to the observed pH-dependent drug release from the phase. The rate of Dox release from the cubic phase at pH 7.4 was low but increased significantly at more acidic pH. A small amount of a tailored diacidic lipid (lipid 1) added to the monoolein LCP modified the release rate of the drug. Phase identity and structural parameters of pure and doped mesophases were characterized by small-angle X-ray scattering (SAXS), and release profiles from the matrix were monitored electrochemically. Analysis of the release kinetics revealed that the total amount of drug released from the LCP matrix is linearly dependent on the square root of time, implying that the release mechanism proceeds according to the Higuchi model.
C1 [Nazaruk, Ewa; Szlezak, Monika; Gorecka, Ewa; Bilewicz, Renata] Univ Warsaw, Dept Chem, PL-02093 Warsaw, Poland.
   [Osornio, Yazmin M.; Uebelhart, Peter; Landau, Ehud M.] Univ Zurich, Dept Chem, CH-8057 Zurich, Switzerland.
RP Bilewicz, R (reprint author), Univ Warsaw, Dept Chem, Pasteura 1, PL-02093 Warsaw, Poland.
EM bilewicz@chem.uw.edu.pl; ehud.landau@chem.uzh.ch
RI Gorecka, Ewa/Q-6197-2018
OI Gorecka, Ewa/0000-0002-8076-5489
FU  [PSPB 079/2010]
FX This work was supported by grant PSPB 079/2010 to R.B. and E.M.L.
   through the Swiss Contribution to the enlarged European Union.
CR Addeo R, 2008, CANCER CHEMOTH PHARM, V62, P285, DOI 10.1007/s00280-007-0605-6
   Angelov B, 2003, J AM CHEM SOC, V125, P7188, DOI 10.1021/ja034578v
   Angelova A, 2003, LANGMUIR, V19, P6928, DOI 10.1021/la0345284
   Barauskas J, 2003, LANGMUIR, V19, P9562, DOI 10.1021/la0350812
   Boyd BJ, 2007, INT J PHARM, V340, P52, DOI 10.1016/j.ijpharm.2007.03.020
   Boyd BJ, 2003, INT J PHARMACEUT, V260, P239, DOI 10.1016/S0378-5173(03)00262-X
   Briggs J, 1996, J PHYS II, V6, P723, DOI 10.1051/jp2:1996208
   Caboi F, 1997, LANGMUIR, V13, P5476, DOI 10.1021/la9702188
   Chang CM, 1997, INT J PHARMACEUT, V147, P135, DOI 10.1016/S0378-5173(96)04805-3
   Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577
   Chiu ML, 2000, ACTA CRYSTALLOGR D, V56, P781, DOI 10.1107/S0907444900004716
   Conn CE, 2013, SOFT MATTER, V9, P3449, DOI 10.1039/c3sm27743g
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   Engstrom S, 1999, EUR J PHARM SCI, V8, P243, DOI 10.1016/S0928-0987(99)00012-3
   ENGSTROM S, 1990, ACS POLYM PREP, V31, P157
   Fong C, 2012, CHEM SOC REV, V41, P1297, DOI 10.1039/c1cs15148g
   Guo CY, 2010, DRUG DISCOV TODAY, V15, P1032, DOI 10.1016/j.drudis.2010.09.006
   Komisarski M, 2013, CHEM-EUR J, V19, P1262, DOI 10.1002/chem.201203372
   Komorsky-Lovric S, 2006, BIOELECTROCHEMISTRY, V69, P82, DOI 10.1016/j.bioelechem.2005.10.006
   Kraineva J, 2006, BBA-PROTEINS PROTEOM, V1764, P424, DOI 10.1016/j.bbapap.2005.11.004
   Kulkarni CV, 2010, SOFT MATTER, V6, P3191, DOI 10.1039/c0sm00068j
   Landau E. M., 2005, BICONTINUOUS STRUCTU, P422
   Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532
   LANDAU EM, 1993, J AM CHEM SOC, V115, P2102, DOI 10.1021/ja00059a002
   Lindell K, 1998, PROG COLL POL SCI S, V108, P111
   Lynch M. L., 2005, SURFACTANT SCI SERIE, V127
   Nazaruk E, 2008, J POWER SOURCES, V183, P533, DOI 10.1016/j.jpowsour.2008.05.061
   Nazaruk E, 2012, J COLLOID INTERF SCI, V385, P130, DOI 10.1016/j.jcis.2012.06.087
   Nazaruk E, 2009, ELECTROANAL, V21, P507, DOI 10.1002/elan.200804435
   Negrini R, 2012, LANGMUIR, V28, P16455, DOI 10.1021/la303833s
   Negrini R, 2011, LANGMUIR, V27, P5296, DOI 10.1021/la200591u
   Osornio YM, 2012, J ORG CHEM, V77, P10583, DOI 10.1021/jo301659c
   Peng XS, 2010, AAPS PHARMSCITECH, V11, P1405, DOI 10.1208/s12249-010-9481-1
   Phan S, 2011, INT J PHARMACEUT, V421, P176, DOI 10.1016/j.ijpharm.2011.09.022
   PORTMANN M, 1991, J PHYS CHEM-US, V95, P8437, DOI 10.1021/j100175a006
   Qiu H, 2000, BIOMATERIALS, V21, P223, DOI 10.1016/S0142-9612(99)00126-X
   Razumas V, 1996, J PHYS CHEM-US, V100, P11766, DOI 10.1021/jp952613h
   Rowinski P, 2003, CHEM PHYS LIPIDS, V124, P147, DOI 10.1016/S0009-3084(03)00051-3
   Shah JC, 2001, ADV DRUG DELIVER REV, V47, P229, DOI 10.1016/S0169-409X(01)00108-9
   TARDIEU A, 1970, BIOCHIM BIOPHYS ACTA, V219, P11, DOI 10.1016/0005-2736(70)90056-8
   Wyatt D., 1992, PHARM TECHNOL, V16, P116
   Yaghmur A, 2012, LANGMUIR, V28, P2881, DOI 10.1021/la203577v
   Yaghmur A, 2011, SOFT MATTER, V7, P8291, DOI 10.1039/c1sm05854a
   Zeng N, 2012, INT J NANOMED, V7, P3703, DOI 10.2147/IJN.S32599
NR 44
TC 42
Z9 42
U1 3
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 11
PY 2014
VL 30
IS 5
BP 1383
EP 1390
DI 10.1021/la403694e
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AA8KI
UT WOS:000331344000025
PM 24443890
DA 2018-10-20
ER

PT J
AU Cohen, B
   Shefy-Peleg, A
   Zilberman, M
AF Cohen, Benny
   Shefy-Peleg, Adaya
   Zilberman, Meital
TI Novel gelatin/alginate soft tissue adhesives loaded with drugs for pain
   management: structure and properties
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE gelatin; alginate; carbodiimide; bupivacaine; ibuprofen; adhesive;
   controlled drug delivery; bonding strength; cytotoxicity
ID POLY(L-GLUTAMIC ACID); BIOLOGICAL GLUE; SODIUM ALGINATE; GELATIN GELS;
   IN-VITRO; RELEASE; MATRIX; MICROSPHERES; BIOMATERIAL; BEHAVIOR
AB Interest in tissue adhesives as alternatives for conventional wound closing applications, such as sutures and staples, has increased in the last few decades due to numerous possible advantages, including less discomfort and lower cost. Novel tissue adhesives based on gelatin, with alginate as a polymeric additive and crosslinked by carbodiimide were developed and loaded with two types of drugs for pain relief, bupivacaine and ibuprofen, in order to improve the therapeutic effect. The release of the drugs from the adhesive matrix was found to be controlled mainly by the adhesive's characteristics, i.e. swelling and hydrophilic group concentration. The drug characteristics, i.e. hydrophilicity and electrical interactions between the drug and the polymeric components, were also found to have some effect. Incorporation of bupivacaine was found to improve the bonding strength of the adhesive due to its inert nature and the reinforcing effect of its fibrous crystals, whereas incorporation of ibuprofen was found to have an adverse effect on the bonding strength, probably due to its reaction with the other adhesive components which increased the crosslinking density. Overall, the novel drug-eluting gelatin-based bioadhesives investigated in this research, especially those loaded with bupivacaine, demonstrated a promising potential for use in wound closing applications.
C1 [Cohen, Benny; Shefy-Peleg, Adaya; Zilberman, Meital] Tel Aviv Univ, Dept Biomed Engn, Fac Engn, IL-69978 Tel Aviv, Israel.
RP Zilberman, M (reprint author), Tel Aviv Univ, Dept Biomed Engn, Fac Engn, IL-69978 Tel Aviv, Israel.
EM meitalz@post.tau.ac.il
FU Office of the Chief Scientist [OCS] in the Israel Ministry of Industry,
   Trade and Labor
FX The authors are grateful to the Office of the Chief Scientist [OCS] in
   the Israel Ministry of Industry, Trade and Labor for supporting this
   research and to Ms Ruth Gottlieb, the Department of Biomedical
   Engineering, Faculty of Engineering, Tel-Aviv University, Israel, for
   her help in the preparation of cell cultures.
CR Ashley Martin, 2005, Dent Update, V32, P169
   Babst C R, 1978, Anesth Prog, V25, P87
   Bae SK, 2002, J ADHES SCI TECHNOL, V16, P361, DOI 10.1163/156856102760067163
   Dawson CW, 2001, INFECTION, V13, P14
   DJABOUROV M, 1983, POLYMER, V24, P537, DOI 10.1016/0032-3861(83)90101-5
   Donkerwolcke M, 1998, BIOMATERIALS, V19, P1461, DOI 10.1016/S0142-9612(98)00059-3
   DRAGET KI, 2002, BIOPOLYMERS, V6, P215
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GROUSELLE M, 1990, BIOCHEM J, V271, P269, DOI 10.1042/bj2710269
   Heiss C, 2006, EUR J TRAUMA, V32, P141
   HODSDON AC, 1995, J CONTROL RELEASE, V33, P143, DOI 10.1016/0168-3659(94)00076-7
   Jia XQ, 2004, BIOMATERIALS, V25, P4797, DOI 10.1016/j.biomaterials.2003.12.012
   JONAS RA, 1988, J VASC SURG, V7, P414, DOI 10.1067/mva.1988.avs0070414
   Kuijpers AJ, 1999, MACROMOLECULES, V32, P3325, DOI 10.1021/ma981929v
   Liew CV, 2006, INT J PHARM, V309, P25, DOI 10.1016/ijpharm.2005.10.040
   Matsuda S, 1999, J BIOMED MATER RES, V45, P20, DOI 10.1002/(SICI)1097-4636(199904)45:1<20::AID-JBM3>3.0.CO;2-6
   MATTHEW IR, 1995, BIOMATERIALS, V16, P275, DOI 10.1016/0142-9612(95)93254-B
   MIZRAHI B, 2011, ACTIVE IMPLANTS SCAF, V8, P39
   NARAYANI R, 1994, J MICROENCAPSUL, V11, P69, DOI 10.3109/02652049409040439
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   OSMOND MH, 1995, J PEDIATR-US, V126, P892, DOI 10.1016/S0022-3476(95)70203-2
   Osmond MH, 1999, PEDIATR EMERG CARE, V15, P137, DOI 10.1097/00006565-199904000-00015
   Otani Y, 1996, J BIOMED MATER RES, V31, P157
   Otani Y, 1996, BIOMATERIALS, V17, P1387, DOI 10.1016/0142-9612(96)87279-6
   Rainsford K. D., 2009, Inflammopharmacology, V17, P275, DOI 10.1007/s10787-009-0016-x
   Reece TB, 2001, AM J SURG, V182, p40S, DOI 10.1016/S0002-9610(01)00742-5
   Ryou M, 2006, TECH GASTROINTEST EN, V8, P33, DOI 10.1016/j.tgie.2005.12.007
   Sells L, 1999, PEDIAT EMERG MED REP, V4, P1
   Shefy-Peleg A, ANTIBIOTIC ELU UNPUB
   SIBERT JR, 1981, ARCH DIS CHILD, V56, P225, DOI 10.1136/adc.56.3.225
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2
   Thakur RA, 2008, INT J PHARMACEUT, V364, P87, DOI 10.1016/j.ijpharm.2008.07.033
   Zhang H, 2008, INT J PHARMACEUT, V351, P244, DOI 10.1016/j.ijpharm.2007.10.004
NR 35
TC 8
Z9 8
U1 3
U2 30
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD FEB 11
PY 2014
VL 25
IS 3
BP 224
EP 240
DI 10.1080/09205063.2013.849904
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 286RR
UT WOS:000329486900002
PM 24156311
DA 2018-10-20
ER

PT J
AU Yalcin, O
   Erdem, R
   Ozum, S
AF Yalcin, Orhan
   Erdem, Riza
   Ozum, Songul
TI Origin of the martensitic and austenitic phase transition in
   core-surface smart nanoparticles with size effects and hysteretic
   splitting
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID FERRITE COMPOSITE NANOPARTICLES; EMERY-GRIFFITHS MODEL; NICKEL FERRITE;
   BIOMATERIAL SYSTEM; MAGNETIC-BEHAVIOR; ISING-MODEL; ANTIMICROBIAL
   ACTIVITY; PHOTOCATALYTIC SHELL; FINE PARTICLES; TRANSFORMATION
AB Blume-Emery-Griffiths model is used to study the effects of the bilinear and biquadratic exchange interactions as well as crystal field interaction on the magnetic properties of core-surface smart nanoparticles. From the minimization of the free energy in pair approximation in Kikuchi version, a set of equations for the bond variables and magnetization are derived. Based on the numerical solutions of these equations, magnetization and hysteresis curves are obtained. Besides the first-and second-order phase transitions, martensitic and austenitic phase regions are observed in the phase diagrams of homogeneous and composite nanoparticles and the origin of martensitic transitions (MT)-austenitic transitions (AT) is investigated. It is found that MT-AT occurred for a nonzero biquadratic exchange parameter. On the other hand, nonzero single-ion anisotropy caused the hysteretic splitting in core-surface type nanoparticles. Martensitic and austenitic results of nanoparticles agree with the experimental results in literature. (c) 2014 AIP Publishing LLC.
C1 [Yalcin, Orhan] Nigde Univ, Dept Phys, TR-51240 Nigde, Turkey.
   [Erdem, Riza] Akdeniz Univ, Dept Phys, TR-07058 Antalya, Turkey.
   [Ozum, Songul] Nigde Univ, Inst Sci, TR-51240 Nigde, Turkey.
RP Yalcin, O (reprint author), Nigde Univ, Dept Phys, TR-51240 Nigde, Turkey.
EM o.yalcin@nigde.edu.tr
RI ERDEM, RIZA/C-6996-2016
CR Abou Ghantous M, 2011, J MAGN MAGN MATER, V323, P2504, DOI 10.1016/j.jmmm.2011.05.027
   Babin V, 2003, J APPL PHYS, V94, P4244, DOI 10.1063/1.1604932
   Bakuzis AF, 2004, J MAGN MAGN MATER, V272, pE1161, DOI 10.1016/j.jmmm.2003.12.210
   BERKER AN, 1976, PHYS REV B, V14, P4946, DOI 10.1103/PhysRevB.14.4946
   Bhattacharya K., 2003, MICROSTRUCTURE MARTE
   BLUME M, 1966, PHYS REV, V141, P517, DOI 10.1103/PhysRev.141.517
   BLUME M, 1971, PHYS REV A-GEN PHYS, V4, P1071, DOI 10.1103/PhysRevA.4.1071
   Brailovski V, 2004, PHYS MET METALLOGR+, V97, pS3
   CAPEL HW, 1966, PHYSICA, V32, P966, DOI 10.1016/0031-8914(66)90027-9
   CECH RE, 1956, T AM I MIN MET ENG, V206, P124
   Dhote RP, 2012, COMP MATER SCI, V63, P105, DOI 10.1016/j.commatsci.2012.05.060
   Duman E, 2007, J MAGN MAGN MATER, V309, P40, DOI 10.1016/j.jmmm.2006.06.010
   Ener S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.144305
   Erdinc A, 2002, PHYSICA A, V307, P453, DOI 10.1016/S0378-4371(01)00620-3
   Fraerman AA, 2001, J PHYS-CONDENS MAT, V13, P683, DOI 10.1088/0953-8984/13/4/314
   Frommen C, 2004, J ALLOY COMPD, V377, P232, DOI 10.1016/j.jallcom.2004.01.061
   Funakubu H., 1987, SHAPE MEMORY EFFECT
   Gubbala S, 2006, MATER SCI TECH-LOND, V22, P845, DOI 10.1179/174328406X91096
   Heisenberg W, 1928, Z PHYS, V49, P619, DOI 10.1007/BF01328601
   HOSTON W, 1991, PHYS REV LETT, V67, P1027, DOI 10.1103/PhysRevLett.67.1027
   Kadau K, 2002, COMPUT PHYS COMMUN, V147, P126, DOI 10.1016/S0010-4655(02)00230-8
   KAJIWARA S, 1991, PHILOS MAG A, V63, P625, DOI 10.1080/01418619108213904
   KANEYOSHI T, 1992, J PHYS-CONDENS MAT, V4, pL653, DOI 10.1088/0953-8984/4/49/002
   Kantar E, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40080-9
   Kartopu G., 2010, FABRICATION APPL MET
   Keskin M, 1999, PHYSICA A, V267, P392, DOI 10.1016/S0378-4371(98)00666-9
   KIKUCHI R, 1974, J CHEM PHYS, V60, P1071, DOI 10.1063/1.1681115
   Kim J, 2006, ANGEW CHEM INT EDIT, V45, P7754, DOI 10.1002/anie.200602471
   Kitakami O, 1997, PHYS REV B, V56, P13849, DOI 10.1103/PhysRevB.56.13849
   Krenke T, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174413
   Krenke T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014412
   Leite V. S., 2004, BRAZ J PHYS, V34, P448
   LIN M, 1993, ACTA METALL MATER, V41, P253, DOI 10.1016/0956-7151(93)90356-W
   Manosa L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2830999
   Mutter D, 2011, EUR PHYS J B, V84, P109, DOI 10.1140/epjb/e2011-20661-4
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Perez-Landazabal JI, 2012, J ALLOY COMPD, V536, pS277, DOI 10.1016/j.jallcom.2012.01.015
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Rego LGC, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.144424
   Rosensweig R. E., 1997, FERROHYDRODYNAMICS
   Santamarta R, 2004, SCRIPTA MATER, V50, P1423, DOI 10.1016/j.scriptamat.2004.03.013
   Sasmaz S., 2011, J SUPERCOND NOV MAGN, V24, P757
   SAUL DM, 1974, PHYS REV B, V9, P4964, DOI 10.1103/PhysRevB.9.4964
   STONER EC, 1948, PHILOS TR R SOC S-A, V240, P599, DOI 10.1098/rsta.1948.0007
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Szlaferek A, 2004, PHYS STATUS SOLIDI B, V241, P1312, DOI 10.1002/pssb.200301992
   TSAI JF, 1990, J AM CERAM SOC, V73, P2992, DOI 10.1111/j.1151-2916.1990.tb06706.x
   TU JB, 1994, J MATER SCI, V29, P1662, DOI 10.1007/BF00368942
   Usov NA, 2005, J MAGN MAGN MATER, V290, P727, DOI 10.1016/j.jmmm.2004.11.277
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Waitz T, 2004, ACTA MATER, V52, P5461, DOI 10.1016/j.actamat.2004.08.003
   Waitz T, 2004, ACTA MATER, V52, P137, DOI 10.1016/j.actamat.2003.08.036
   Yalcin O, 2008, ACTA PHYS POL A, V114, P835, DOI 10.12693/APhysPolA.114.835
   Yalcin O., 2013, FERROMAGNETIC RESONA
   Yalcin O., 2012, NANORODS
   Yalcin O., 2012, SMART NANOPARTICLES
   Zaim A, 2013, J MAGN MAGN MATER, V331, P37, DOI 10.1016/j.jmmm.2012.11.018
   Zaim A, 2013, SOLID STATE COMMUN, V158, P76, DOI 10.1016/j.ssc.2012.10.014
   Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
   Zhang W, 2004, APPL PHYS LETT, V84, P4872, DOI 10.1063/1.1762698
   Zhao XQ, 1996, JPN J APPL PHYS 1, V35, P4468, DOI 10.1143/JJAP.35.4468
   Zhao XQ, 1996, NANOSTRUCT MATER, V7, P313, DOI 10.1016/0965-9773(96)00008-6
NR 67
TC 6
Z9 6
U1 0
U2 14
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-8979
EI 1089-7550
J9 J APPL PHYS
JI J. Appl. Phys.
PD FEB 7
PY 2014
VL 115
IS 5
AR 054316
DI 10.1063/1.4864489
PG 7
WC Physics, Applied
SC Physics
GA AB2TV
UT WOS:000331645900085
DA 2018-10-20
ER

PT J
AU Chiono, V
   Mozetic, P
   Boffito, M
   Sartori, S
   Gioffredi, E
   Silvestri, A
   Rainer, A
   Giannitelli, SM
   Trombetta, M
   Nurzynska, D
   Di Meglio, F
   Castaldo, C
   Miraglia, R
   Montagnani, S
   Ciardelli, G
AF Chiono, Valeria
   Mozetic, Pamela
   Boffito, Monica
   Sartori, Susanna
   Gioffredi, Emilia
   Silvestri, Antonella
   Rainer, Alberto
   Giannitelli, Sara Maria
   Trombetta, Marcella
   Nurzynska, Daria
   Di Meglio, Franca
   Castaldo, Clotilde
   Miraglia, Rita
   Montagnani, Stefania
   Ciardelli, Gianluca
TI Polyurethane-based scaffolds for myocardial tissue engineering
SO INTERFACE FOCUS
LA English
DT Article
DE cardiac progenitor cells; myocardial tissue engineering; polyurethane;
   additive manufacturing
ID TYROSINE-BASED POLYURETHANES; ADULT HUMAN HEART; BIOMATERIAL
   APPLICATIONS; STEM-CELLS; IN-VITRO; ELASTOMERS; BEHAVIOR
AB Bi-layered scaffolds with a 0 degrees/90 degrees lay-down pattern were prepared by melt-extrusion additive manufacturing (AM) using a poly(ester urethane) (PU) synthesized from poly(1-caprolactone) diol, 1,4-butandiisocyanate and L-lysine ethyl ester dihydrochloride chain extender. Rheological analysis and differential scanning calorimetry of the starting material showed that compression moulded PU films were in the molten state at a higher temperature than 155 degrees C. The AMprocessing temperature was set at 155 degrees C after verifying the absence of PU thermal degradation phenomena by isothermal thermogravimetry analysis and rheological characterization performed at 165 degrees C. Scaffolds highly reproduced computer-aided design geometry and showed an elastomeric-like behaviour which is promising for applications in myocardial regeneration. PU scaffolds supported the adhesion and spreading of human cardiac progenitor cells (CPCs), whereas they did not stimulate CPC proliferation after 1-14 days culture time. In the future, scaffold surface functionalization with bioactive peptides/proteins will be performed to specifically guide CPC behaviour.
C1 [Chiono, Valeria; Boffito, Monica; Sartori, Susanna; Gioffredi, Emilia; Silvestri, Antonella; Ciardelli, Gianluca] Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy.
   [Mozetic, Pamela; Rainer, Alberto; Giannitelli, Sara Maria; Trombetta, Marcella] Univ Campus Biomed Roma, Tissue Engn Lab, Rome, Italy.
   [Nurzynska, Daria; Di Meglio, Franca; Castaldo, Clotilde; Miraglia, Rita; Montagnani, Stefania] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy.
RP Chiono, V (reprint author), Politecn Torino, Dept Mech & Aerosp Engn, Corso Duca Abruzzi 24, Turin, Italy.
EM valeria.chiono@polito.it
RI Rainer, Alberto/G-8588-2011; Chiono, Valeria/G-3631-2014; Sartori,
   Susanna/C-1277-2010; Boffito, Monica/P-4267-2014
OI Rainer, Alberto/0000-0001-8971-551X; Trombetta,
   Marcella/0000-0002-1357-4885; MONTAGNANI, STEFANIA/0000-0002-7420-372X;
   Mozetic, Pamela/0000-0001-8641-0526; Ciardelli,
   Gianluca/0000-0003-0199-1427; Nurzynska, Daria/0000-0003-1092-6168;
   Boffito, Monica/0000-0001-7637-2001; Castaldo,
   Clotilde/0000-0003-1475-5036; Di Meglio, Franca/0000-0002-9793-9289
FU MIUR (Italian Ministry of Education University and Research)
   [RBFR10L0GK]
FX FIRB 2010 Project 'Bioartificial materials and biomimetic scaffolds for
   a stem cells-based therapy for myocardial regeneration' (grant no.
   RBFR10L0GK) financed by MIUR (Italian Ministry of Education University
   and Research) is acknowledged.
CR Boyle AJ, 2006, CIRCULATION, V114, P339, DOI 10.1161/CIRCULATIONAHA.105.590653
   Castaldo C, 2008, STEM CELLS, V26, P1723, DOI 10.1634/stemcells.2007-0732
   Cesselli D, 2011, AM J PATHOL, V179, P349, DOI 10.1016/j.ajpath.2011.03.036
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Christenson EM, 2005, POLYMER, V46, P11744, DOI 10.1016/j.polymer.2005.08.083
   D'Amario D, 2011, CIRC RES, V108, P857, DOI 10.1161/CIRCRESAHA.111.241380
   DARLAS DF, 2008, POLYM ENG SCI, V48, P519, DOI DOI 10.1002/PEN.20983)
   Di Meglio F, 2010, J MOL CELL CARDIOL, V49, P719, DOI 10.1016/j.yjmcc.2010.05.013
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Forte G, 2008, STEM CELLS, V26, P2093, DOI 10.1634/stemcells.2008-0061
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Gaballa MA, 2006, J HEART LUNG TRANSPL, V25, P946, DOI 10.1016/j.healun.2006.04.008
   GIANNITELLI SM, 2013, ACTA BIOMATER, DOI DOI 10.1016/J.ACTBI0.2013.10.024)
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Liu L. Y., 2012, ISRN NANOTECHNOL, V2012, P11, DOI DOI 10.5402/2012/627420)
   Nurzynska D, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0320-2
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Rainer A, 2012, ANN BIOMED ENG, V40, P966, DOI 10.1007/s10439-011-0465-4
   Rechichi A, 2008, J BIOMED MATER RES A, V84A, P847, DOI 10.1002/jbm.a.31349
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Sartori S, 2013, REACT FUNCT POLYM, V73, P1366, DOI 10.1016/j.reactfunctpolym.2013.01.006
   Silvestri A, 2013, MACROMOL BIOSCI, V13, P984, DOI 10.1002/mabi.201200483
   VILELASILVA ACP, 2011, ADV MATER, V23, P514, DOI DOI 10.1002/ADMA.201003479)
   Vozzi G, 2008, MACROMOL BIOSCI, V8, P60, DOI 10.1002/mabi.200700214
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
NR 26
TC 41
Z9 42
U1 5
U2 41
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2042-8898
EI 2042-8901
J9 INTERFACE FOCUS
JI Interface Focus
PD FEB 6
PY 2014
VL 4
IS 1
SI SI
AR 20130045
DI 10.1098/rsfs.2013.0045
PG 11
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA AC3CI
UT WOS:000332392200003
PM 24501673
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Fadeeva, E
   Deiwick, A
   Chichkov, B
   Schlie-Wolter, S
AF Fadeeva, Elena
   Deiwick, Andrea
   Chichkov, Boris
   Schlie-Wolter, Sabrina
TI Impact of laser-structured biomaterial interfaces on guided cell
   responses
SO INTERFACE FOCUS
LA English
DT Review
DE ultrashort pulse laser structuring; nano- and microsized surface
   topographies; biomaterial-cell interactions; selective cell control
ID ADHESION; SURFACES; TOPOGRAPHY; FEMTOSECOND; DYNAMICS; BEHAVIOR;
   BINDING; SYSTEMS
AB To achieve a perfect integration of biomaterials into the body, tissue formation in contact with the interface has to be controlled. In this connection, a selective cell control is required: fibrotic encapsulation has to be inhibited, while tissue guidance has to be stimulated. As conventional biomaterials do not fulfil this specification, functionalization of the biointerface is under development to mimic the natural environment of the cells. One approach focuses on the fabrication of defined surface topographies. Thereby, ultrashort pulse laser ablation is very beneficial, owing to a large variety of fabricated structures, reduced heat-affected zones, high precision and reproducibility. We demonstrate that nanostructures in platinum and microstructures in silicon selectively control cell behaviour: inhibiting fibroblasts, while stimulating neuronal attachment and differentiation. However, the control of fibroblasts strongly correlates with the created size dimensions of the surface structures. These findings suggest favourable biomaterial interfaces for electronic devices. The mechanisms which are responsible for selective cell control are poorly understood. To give an insight, cell behaviour in dependence of biomaterial interfaces is discussed-including basic research on the role of the extracellular matrix. This knowledge is essential to understand such specific cell responses and to optimize biomaterial interfaces for future biomedical applications.
C1 [Fadeeva, Elena; Deiwick, Andrea; Chichkov, Boris; Schlie-Wolter, Sabrina] Laser Zentrum Hannover eV, D-30419 Hannover, Germany.
   [Chichkov, Boris; Schlie-Wolter, Sabrina] Leibniz Univ Hannover, Inst Quantum Opt, D-30167 Hannover, Germany.
RP Schlie-Wolter, S (reprint author), Laser Zentrum Hannover eV, Hollerithallee 8, D-30419 Hannover, Germany.
EM s.schlie@lzh.de
RI Chichkov, Boris/M-4112-2015
OI Chichkov, Boris/0000-0002-8129-7373
FU German Research Foundation [DFG SFB599]; BMBF
FX This work was partly supported by German Research Foundation Cluster of
   Excellence Rebirth 'From Regenerative Biology to Reconstructive
   Therapy', DFG SFB599 'Sustainable Bioresorbing and Permanent Implants of
   Metallic and Ceramic Materials' and by BMBF project REMEDIS.
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002
   Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chichkov BN, 1996, APPL PHYS A-MATER, V63, P109, DOI 10.1007/BF01567637
   Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Fadeeva E, 2009, CONTACT ANGLE, WETTABILITY AND ADHESION, VOL 6, P163
   Fadeeva E, 2010, J ADHES SCI TECHNOL, V24, P2257, DOI 10.1163/016942410X508000
   Fadeeva E., 2009, PHYS STATUS SOLIDI A, V6, P1348, DOI [10.1002/pssa.200881063, DOI 10.1002/PSSA.200881063)]
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Frantz C, 2011, J CELL SCI, V123, P4195, DOI [10.1242/jcs.023820, DOI 10.1242/JCS.023820)]
   Gaggl A, 2000, BIOMATERIALS, V21, P1067, DOI 10.1016/S0142-9612(00)00002-8
   Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Heino J, 2009, INT J BIOCHEM CELL B, V41, P341, DOI 10.1016/j.biocel.2008.08.021
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359
   Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173
   Koroleva A, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/12/124009
   Kovacs G. T. A., 1994, ENABLING TECHNOLOGIE, P121
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029
   Peto G, 2002, APPL SURF SCI, V186, P7, DOI 10.1016/S0169-4332(01)00769-3
   Schlie Sabrina, 2010, Journal of Biomedical Science & Engineering, V3, P884, DOI 10.4236/jbise.2010.39118
   Schlie S, 2011, P 2 INT C TISS ENG L, P51
   Schlie S, 2012, TISSUE ENG PART C-ME, V18, P688, DOI [10.1089/ten.tec.2011.0635, 10.1089/ten.TEC.2011.0635]
   Schlie S, 2012, J MATER SCI-MATER M, V23, P2813, DOI 10.1007/s10856-012-4737-9
   Schlie S, 2011, PHOTONIC NANOSTRUCT, V9, P159, DOI 10.1016/j.photonics.2010.09.006
   Schlie S, 2010, J BIOMATER APPL, V25, P217, DOI 10.1177/0885328209345553
   Schlie-Wolter S, 2013, EXP CELL RES, V319, P1553, DOI 10.1016/j.yexcr.2013.03.016
   Schlie-Wolter S, 2013, ACS APPL MATER INTER, V5, P1070, DOI 10.1021/am3028487
   SONNENBERG A, 1990, J CELL BIOL, V110, P2145, DOI 10.1083/jcb.110.6.2145
   Stieglitz T, 2004, NEUROPROSTHETICS THE, V2, P475
   Tzu J, 2008, INT J BIOCHEM CELL B, V40, P199, DOI 10.1016/j.biocel.2007.07.015
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
NR 44
TC 12
Z9 12
U1 0
U2 37
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2042-8898
EI 2042-8901
J9 INTERFACE FOCUS
JI Interface Focus
PD FEB 6
PY 2014
VL 4
IS 1
SI SI
AR 20130048
DI 10.1098/rsfs.2013.0048
PG 10
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA AC3CI
UT WOS:000332392200006
PM 24501676
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Zhu, ZZ
   Li, XS
AF Zhu, Zongzhe
   Li, Xinsong
TI Silicone Hydrogels Based on a Novel Amphiphilic
   Poly(2-methyl-2-oxazoline)-b-poly(dimethyl siloxane) Copolymer
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; hydrophilic polymers; silicone hydrogel;
   photopolymerization
ID POLY(ETHYLENE GLYCOL); SURFACE MODIFICATION; PROTEIN ADSORPTION;
   CONTACT-LENSES; POLYMER; POLYOXAZOLINE; CHEMISTRY; DELIVERY
AB A novel amphiphilic hydrogel based on poly(2-methyl-2-oxazoline)-b-poly(dimethyl siloxane) (PMeOx-PDMS) block copolymer was developed. First of all, PMeOx-PDMS macromonomer was synthesized by coupling mono-hydroxylated PMeOx with PDMS followed by end-capping with methacrylate group. The structures of each step were characterized by NMR and titration. After that, silicone hydrogels were prepared by UV-initiated copolymerization of PMeOx-PDMS macromonomer with monomers such as 2-hydroxyethyl methacrylate in the presence of a crosslinker. Measurements of the hydrogels' water contact angle, equilibrium water content, and tensile properties showed that the hydrogels possessed better hydrophilic surface, higher water content, and better ion permeability with the increase of the content of the macromonomer PMeOx-PDMS. Meanwhile, the tensile strength and Young's modulus of the hydrogels decreased slightly. Protein adsorption tests showed that the hydrogels had strong antifouling ability after the incorporation of PMeOx. This newly described hydrogel demonstrated attractive properties to serve as ophthalmic biomaterial. (c) 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014, 131, 39867.
C1 [Zhu, Zongzhe; Li, Xinsong] Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Jiangsu, Peoples R China.
RP Li, XS (reprint author), Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Jiangsu, Peoples R China.
EM lixs@seu.edu.cn
FU National Natural Science Foundation of China [51073036, 51373034];
   Industry-Academic Joint Technological Innovations Project of Jiangsu
   Province, China [BY2010143]
FX This project was support by the National Natural Science Foundation of
   China with the grants no. 51073036, 51373034 and the Industry-Academic
   Joint Technological Innovations Project of Jiangsu Province, China with
   the grant no. BY2010143. The authors thank BianShanshan of the School of
   Chemistry and Chemical Engineering, Fudan University for her help in
   titration tests.
CR Adams N, 2007, ADV DRUG DELIVER REV, V59, P1504, DOI 10.1016/j.addr.2007.08.018
   Antonio L. A., 2002, J BIOMED MATER RES, V63, P319
   Brian T., 1999, OPTICIA, V218, P31
   Cha C, 2010, BIOMATERIALS, V31, P4864, DOI 10.1016/j.biomaterials.2010.02.059
   Chen H, 1999, J APPL POLYM SCI, V72, P1699, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1699::AID-APP6>3.0.CO;2-9
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   Chen H, 2004, BIOMATERIALS, V25, P2273, DOI 10.1016/j.biomaterials.2003.09.023
   CHUJO Y, 1990, MACROMOLECULES, V23, P2693, DOI 10.1021/ma00212a017
   David G, 2008, BIOMACROMOLECULES, V9, P1678, DOI 10.1021/bm800215d
   GODDARD P, 1989, Journal of Controlled Release, V10, P5, DOI 10.1016/0168-3659(89)90013-8
   Guo DJ, 2005, LANGMUIR, V21, P10487, DOI 10.1021/la0514866
   Guo DJ, 2007, COLLOID SURFACE A, V308, P129, DOI 10.1016/j.colsurfa.2007.05.080
   Hoogenboom R, 2009, ANGEW CHEM INT EDIT, V48, P7978, DOI 10.1002/anie.200901607
   Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w
   Keogh P., 1981, U. S. Pat., Patent No. [4,260,725, 4260725]
   Kim J, 2008, BIOMATERIALS, V29, P2259, DOI 10.1016/j.biomaterials.2008.01.030
   Konradi R, 2008, LANGMUIR, V24, P613, DOI 10.1021/la702917z
   KUNZLER J, 1995, J APPL POLYM SCI, V55, P611, DOI 10.1002/app.1995.070550408
   LAI YC, 1997, J APPL POLYM SCI, V66, P1475
   Lawton RA, 2005, COLLOID SURFACE A, V253, P213, DOI 10.1016/j.colsurfa.2004.11.010
   Lemechko P, 2012, REACT FUNCT POLYM, V72, P160, DOI 10.1016/j.reactfunctpolym.2011.12.005
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   Nicolson P. C., 1998, Patent No. [US5760100, 5760100]
   Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X
   Read ML, 2009, J BIOMED MATER RES B, V91B, P662, DOI 10.1002/jbm.b.31442
   Simpson TRE, 2003, POLYMER, V44, P4829, DOI 10.1016/S0032-3861(03)00496-8
   Tanaka K., 1979, US patent, Patent No. 4139548
   Viegas TX, 2011, BIOCONJUGATE CHEM, V22, P976, DOI 10.1021/bc200049d
   Wang X, 2011, ACTA BIOMATER, V7, P4149, DOI 10.1016/j.actbio.2011.07.011
   Zhou J., 2008, [No title captured], Patent No. [WO 2008/116,131, 2008116131]
NR 30
TC 1
Z9 1
U1 5
U2 81
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD FEB 5
PY 2014
VL 131
IS 3
AR 39867
DI 10.1002/app.39867
PG 7
WC Polymer Science
SC Polymer Science
GA AA7TX
UT WOS:000331300900072
DA 2018-10-20
ER

PT J
AU Soares, LGP
   Marques, AMC
   Guarda, MG
   Aciole, JMS
   dos Santos, JN
   Pinheiro, ALB
AF Soares, Luiz Guilherme P.
   Marques, Aparecida Maria C.
   Guarda, Milena G.
   Aciole, Jouber Mateus S.
   dos Santos, Jean Nunes
   Pinheiro, Antonio Luiz B.
TI Influence of the lambda 780 nm laser light on the repair of surgical
   bone defects grafted or not with biphasic synthetic micro-granular
   hydroxylapatite plus Beta-Calcium triphosphate
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Biomaterial; Bone repair; Hydroxyapatite; Laser phototherapy
ID MINERAL TRIOXIDE AGGREGATE; MORPHOGENETIC PROTEINS; RODENT MODEL;
   IN-VIVO; REGENERATION; PHOTOBIOMODULATION; PHOTOTHERAPY; HYDROXYAPATITE;
   IMPLANTS; THERAPY
AB The treatment of bone loss due to different etiologic factors is difficult and many techniques aim to improve repair, including a wide range of biomaterials and, recently, photobioengineering. This work aimed to assess, through histological analysis The aim of this study was to assess, by light microscopy, the repair of bone defects grafted or not with biphasic synthetic micro-granular Calcium hydroxyapatite (HA) + Beta-TCP associated or not with Laser phototherapy - LPT (lambda 780 nm). Forty rats were divided into 4 groups each subdivided into 2 subgroups according to the time of sacrifice (15 and 30 days). Surgical bone defects were made on femur of each animal with a trephine drill. On animals of Clot group the defect was filled only by blood clot, on Laser group the defect filled with the clot was further irradiated. On animals of Biomaterial and Laser + Biomaterial groups the defect was filled by biomaterial and the last one was further irradiated (2780 nm, 70 mW, spot size similar to 0.4 cm(2), 20 J/cm(2)-session, 140 J/cm(2)-treatment) in four points around the defect at 48-h intervals and repeated for 2 weeks. At both 15th and 30th days following sacrifice, samples were taken and analyzed by light microscopy. Many similarities were observed histologically between groups on regards bone reabsorption and neoformation, inflammatory infiltrate and collagen deposition. The criterion degree of maturation, marked by the presence of basophilic lines, indicated that the use of LPT associated with HA + Beta TCP graft, resulted in more advanced stage of bone repair at the end of the experiment. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Soares, Luiz Guilherme P.; Marques, Aparecida Maria C.; Guarda, Milena G.; Aciole, Jouber Mateus S.; Pinheiro, Antonio Luiz B.] Univ Fed Bahia, Ctr Biophoton, Sch Dent, BR-40110150 Salvador, BA, Brazil.
   [Marques, Aparecida Maria C.; Pinheiro, Antonio Luiz B.] Univ Sao Paulo, Natl Inst Opt & Photon, Phys Inst Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil.
   [Pinheiro, Antonio Luiz B.] Univ Camilo Castelo Branco, Nucleo Parque Tecnol Sao Jose Campos, BR-12247004 Sao Jose Dos Campos, SP, Brazil.
   [dos Santos, Jean Nunes] Univ Fed Bahia, Lab Surg Pathol, Sch Dent, BR-40110150 Salvador, BA, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Ctr Biophoton, Sch Dent, Av Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
EM luizguilherme_@hotmail.com; cidamarques77@hotmail.com;
   mileguarda@hotmail.com; jouber_aciole@hotmail.com; jeanpatol@gmail.com;
   albp@ufba.br
RI Sao Carlos Institute of Physics, IFSC/USP/M-2664-2016; Pinheiro, Antonio
   Luiz/A-1962-2008
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
FX We would like to thank the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) for providing financial support for this
   project.
CR Bossini P., 2011, J TISSUE ENG REGEN M, V12, P52
   Franco GR, 2013, INJURY, V44, P908, DOI 10.1016/j.injury.2012.12.022
   Gauthier O, 1999, J MATER SCI-MATER M, V10, P199, DOI 10.1023/A:1008949910440
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MMEM, 2008, LASER MED SCI, V23, P313
   Guzzardella GA, 2003, CLIN ORAL IMPLAN RES, V14, P226, DOI 10.1034/j.1600-0501.2003.00872.x
   KEAVENY TM, 1993, BONE, V7, P285
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Mate-Sanchez V.J.E., 2013, J BIOMED MATER RES A, DOI DOI 10.1002/JBM.A34785
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Oliveira Poliani de, 2012, Rev Bras Ortop, V47, P102, DOI 10.1016/S2255-4971(15)30352-9
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2013, LASER MED SCI, V28, P513, DOI 10.1007/s10103-012-1096-1
   Pinheiro ALB, 2012, LASER MED SCI, V27, P1013, DOI 10.1007/s10103-011-1033-8
   Pinheiro ALB, 2012, LASER MED SCI, V27, P903, DOI 10.1007/s10103-011-1010-2
   Pinheiro ALB, 2011, J BIOMED MATER RES A, V98A, P212, DOI 10.1002/jbm.a.33107
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Pinto K.N., 2013, PHOTOMED LASER SURG, V31, P260
   Rouvillain JL, 2009, KNEE, V16, P392, DOI 10.1016/j.knee.2008.12.015
   Soares LGP, 2014, LASER MED SCI, V29, P1539, DOI 10.1007/s10103-013-1297-2
   Soares Luiz Guilherme P., 2013, Braz. Dent. J., V24, P218, DOI 10.1590/0103-6440201302186
   Tim CR, 2014, LASER MED SCI, V29, P147, DOI 10.1007/s10103-013-1302-9
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Yang C, 2014, J BIOMED MATER RES B, V102, P80, DOI 10.1002/jbm.b.32984
NR 28
TC 8
Z9 10
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD FEB 5
PY 2014
VL 131
BP 16
EP 23
DI 10.1016/j.jphotobiol.2013.12.015
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AE2GA
UT WOS:000333790100002
PM 24463564
DA 2018-10-20
ER

PT J
AU Karacali, O
AF Karacali, O.
TI A Research on Structured Analysis of Biomaterial of Dental Implant in
   Computer Aided Biomechanical Engineering Modelling
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 3rd International Congress on Advances in Applied Physics and Materials
   Science
CY APR 24-28, 2013
CL Antalya, TURKEY
SP Doga Nanobiotech Inc, Mega Technol Serv Inc
ID BEHAVIOR
AB The research explained in this paper is about the mechanical principle applications on regulated form and function, forces, motion of teeth and dental implant influencing the implant length and bone quality in biomechanics engineering modeling in dentistry. The non-linear finite element method was employed as an advanced computer technique of structural stress analysis tool for biomechanics modeling using mechanical, mathematical, and biological definitions and concepts. A finite element model of dental implant with accurate geometry and material properties was developed to make realistic investigations on the implant biomaterial properties and mechanical behavior of new dental implant. The finite element models with non-linear contact elements were used to simulate an interface fixation within the implant system and the sliding function of the non-rigid connector. This research showed that implant design influences force transmission characteristics in pen-implant bone and mechanical signals affect bone tissue differentiation. Hence, it is important to control biomechanical loads on dental implants to maintain osseointegration and to promote early bone implant interface healing. The results of this analysis are helpful for implant biomaterial selection and design for clinical interest.
C1 Istanbul Univ, Fac Engn, Dept Mech Engn, TR-34320 Istanbul, Turkey.
RP Karacali, O (reprint author), Istanbul Univ, Fac Engn, Dept Mech Engn, TR-34320 Istanbul, Turkey.
EM ozdogank@istanbul.edu.tr
RI Karacali, Ozdogan/A-8869-2015
CR [Anonymous], 2013, ANSYS MAN
   Bozkaya D, 2003, J BIOMECH, V36, P1649, DOI 10.1016/S0021-9290(03)00177-5
   Demenko V, 2011, J DENT RES, V90, P1211, DOI 10.1177/0022034511417442
   Deshmukh TR, 2012, COMPUT METHOD BIOMEC, V15, P363, DOI 10.1080/10255842.2010.538385
   Freitas A.C., 2010, IMPLANT DENT, V19, P6
   Jonsdottir SH, 2012, EUR J ORTHODONT, V34, P542, DOI 10.1093/ejo/cjq186
   Koka Pradeep, 2012, Indian J Dent Res, V23, P129, DOI 10.4103/0970-9290.100413
   Tsui WK, 2012, INT J ORAL MAX SURG, V41, P1427, DOI 10.1016/j.ijom.2012.05.011
   Wang RF, 2009, J PROSTHET DENT, V101, P359, DOI 10.1016/S0022-3913(09)60079-2
   Ziegler A, 2005, EUR J ORTHODONT, V27, P333, DOI 10.1093/ejo/cji020
NR 10
TC 0
Z9 0
U1 0
U2 7
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
EI 1898-794X
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD FEB
PY 2014
VL 125
IS 2
BP 186
EP 188
DI 10.12693/APhysPolA.125.186
PG 3
WC Physics, Multidisciplinary
SC Physics
GA AM4LG
UT WOS:000339825400007
OA Bronze
DA 2018-10-20
ER

PT J
AU Misra, RDK
   Nune, C
AF Misra, R. D. K.
   Nune, C.
TI Biological response to self-assembly of preadsorbed proteins at
   biointerfaces: significance, cellular activity and perspective
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Grain size; Protein adsorption; Osteoblast functions
ID INDUCED STRUCTURAL-CHANGES; ADSORPTION; SURFACES; METAL; INTERFACE;
   TITANIUM; ADHESION; PLASMA; CELLS; SPECTROSCOPY
AB Protein adsorption is the first of a complex series of events that regulate cell adhesion and cellular activity and define the hallmark of biological reactions at the biointerface. In this regard, materials with submicrometre to nanometre sized grains by virtue of their high grain boundary length to grain size ratio are excellent vehicles to fundamentally understand self-assembly of preadsorbed proteins and consequent cellular activity. The model protein (albumin) on a nanograined surface had the resemblance of 'leaf-like' in contrast to 'bare branch of a tree' on the coarse grained counterpart with consequent impact on biological functions, for instance, osteoblast response. This raises a fundamental question on the interplay between grain size and surface induced arrangement of plasma proteins into organised structures. It is envisaged that in a given polycrystalline material, the self-assembly of proteins at a biointerface is governed by grain structure because of differences in surface energy and microrheological behaviour that controls the kinetics and thermodynamics of protein adsorption. Furthermore, our capability to synthesise and process biomaterial surfaces with tailored surface morphology and consequently control assembly of proteins provides the possibility of eliciting specific, timely and desirable response from the surrounding cells and tissues necessary for implant efficiency. Studies on the early stages of protein adsorption are expected to impact interfacial processes including neurobiology, where the assembly of soluble proteins as organised structure is potentially considered to be characteristic of neurodegenerative diseases such as Parkinson's and Alzheimer's disease. This is particularly important when the most important relaxation mechanisms such as desorption and conformational changes alter adsorption and are impacted by grain structure and associated surface energy.
C1 [Misra, R. D. K.; Nune, C.] Univ Louisiana Lafayette, Inst Mat Res & Innovat, Ctr Struct & Funct Mat, Biomats & Biomed Engn Res Lab, Lafayette, LA 70504 USA.
RP Misra, RDK (reprint author), Univ Louisiana Lafayette, Inst Mat Res & Innovat, Ctr Struct & Funct Mat, Biomats & Biomed Engn Res Lab, POB 44130, Lafayette, LA 70504 USA.
EM rdm6853@louisiana.edu
FU Center for Structural and Functional Materials, Institute for Materials
   Research and Innovation, University of Louisiana at Lafayette, USA
FX The authors acknowledge support from the Center for Structural and
   Functional Materials, Institute for Materials Research and Innovation,
   University of Louisiana at Lafayette, USA.
CR ALBREKTSSON T, 1987, J PROSTHET DENT, V57, P597, DOI 10.1016/0022-3913(87)90344-1
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Arenas MA, 2000, BRIT CORROS J, V35, P232, DOI 10.1179/000705900101501308
   Baier RE, 1975, APPL CHEM PROTEIN IN
   Bantchev GB, 2003, LANGMUIR, V19, P2673, DOI 10.1021/la0262349
   Blomback B, 1976, PLASMA PROTEINS, P43
   Borsari V, 2005, J BIOMED MATER RES B, V75B, P359, DOI 10.1002/jbm.b.30313
   Brash J. L., 1975, PROTEIN INTERFACES P
   BRASH JL, 1995, PROTEINS INTERFACES, P1
   Caren DT, 1997, LANGMUIR, V13, P3404
   Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   COLLIS JJ, 1992, BIOMATERIALS, V13, P548, DOI 10.1016/0142-9612(92)90107-Y
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   Dhar P, 2006, NANO LETT, V6, P66, DOI 10.1021/nl052027s
   Dhar P, 2007, J PHYS CHEM C, V111, P3607, DOI 10.1021/jp067304d
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   Fischer TM, 2004, J FLUID MECH, V498, P123, DOI 10.1017/S0022112003006608
   FU FN, 1994, APPL SPECTROSC, V48, P1432, DOI 10.1366/0003702944028065
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Grinnell F, 1983, BIOCOMPATIBLE POLYM, P674
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Horbett T. A., 1982, BIOMATERIALS INTERFA
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Hornett T. A., 1996, INTERFACIAL PHENOMEN, P351
   Kasemo B., 1999, ADV DENT RES, V13, P1
   LINDON JN, 1986, BLOOD, V68, P355
   Marchin KL, 2003, LANGMUIR, V19, P9883, DOI 10.1021/la035127r
   MAROUDAS NG, 1977, J CELL PHYSIOL, V90, P511, DOI 10.1002/jcp.1040900314
   Misra RDK, 2013, ACTA BIOMATER, V9, P6245, DOI 10.1016/j.actbio.2012.12.003
   Misra RDK, 2012, METALL MATER TRANS A, V43A, P5286, DOI 10.1007/s11661-012-1360-9
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   Prasad V, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.176001
   Rechenddorff K., 2006, THESIS U AARHUS AARH
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Slack S. M., 1996, BIOMATERIALS SCI INT, P469
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   Williams DF, 1981, BIOCOMPATIBILITY CLI
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P206, DOI 10.1016/0142-9612(88)90085-3
   Willmann G, 1999, ADV ENG MATER, V1, P95
   Wu YQ, 2002, APPL SPECTROSC, V56, P1186, DOI 10.1366/000370202760295449
   YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0
   Yunzhi Y., 2003, J BIOMED MATER RES A, V67A, P344
NR 43
TC 6
Z9 6
U1 0
U2 11
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD FEB
PY 2014
VL 29
IS B1
SI SI
BP B41
EP B48
DI 10.1179/1753555713Y.0000000110
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA AI8EV
UT WOS:000337141500009
DA 2018-10-20
ER

PT J
AU Trinidad, J
   Marco, I
   Arruebarrena, G
   Wendt, J
   Letzig, D
   de Argandona, E
   Goodall, R
AF Trinidad, Javier
   Marco, Inigo
   Arruebarrena, Gurutze
   Wendt, Joachim
   Letzig, Dietmar
   Saenz de Argandona, Eneko
   Goodall, Russell
TI Processing of Magnesium Porous Structures by Infiltration Casting for
   Biomedical Applications
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID CORRODING TUNGSTEN COILS; IN-VIVO CORROSION; FE-MN ALLOYS; VITRO; BONE;
   DEGRADATION; SCAFFOLDS; MG; BIOCOMPATIBILITY; BIOMATERIALS
AB Magnesium and its alloys are currently considered to be a promising metallic biomaterial. The interest in magnesium alloys arises from their biocompatibility, bioabsorbility, and especially from their mechanical properties, which are more compatible to those of human bone than the mechanical properties of other metallic biomaterials, such as stainless steel and titanium. A medical application in which magnesium is gaining interest is regenerative medicine where scaffolds are used to create tissues from cells. For its application in regenerative medicine, the scaffolds have to present a 3D open-cell structure. The main purpose of the present research is to set up the fabrication procedure necessary to manufacture porous magnesium scaffolds; for this the replication (infiltration) process has been used and adapted to process magnesium alloys, processing five different biodegradable magnesium alloys (AZ91E, WE43, ZM20, ZWM200, and ZXM200).
C1 [Trinidad, Javier; Marco, Inigo; Arruebarrena, Gurutze] Mondragon Unibertsitatea, Mech & Mfg Dept, Arrasate Mondragon, Spain.
   [Marco, Inigo; Goodall, Russell] Univ Sheffield, Dept Mat Sci & Engn, Sheffield S1 3JD, S Yorkshire, England.
   [Trinidad, Javier; Letzig, Dietmar] Helmholtz Zentrum Geesthacht, Magnesium Innovat Ctr, D-21502 Geesthacht, Germany.
RP Trinidad, J (reprint author), Mondragon Unibertsitatea, Mech & Mfg Dept, Loramendi 4, Arrasate Mondragon, Spain.
EM jtrinidad@mondragon.edu
OI Wendt, Joachim/0000-0002-6015-0794
FU Department of Industry, Innovation, Trade and Tourism of the Basque
   Government [S-PE12MU012]
FX This work was supported by the Department of Industry, Innovation, Trade
   and Tourism of the Basque Government through the S-PE12MU012 project.
CR ARANDA P, 2000, ARS PHARM, V41, P91
   Bach F. W., 2003, CELLULAR METALS MANU, P215
   Conde Y, 2006, ADV ENG MATER, V8, P795, DOI 10.1002/adem.200600077
   Currey J., 1998, HDB BIOMATERIALS PRO, pA1
   European Technology Platform, 2006, NAN NAN HLTH STRAT R
   Gibson LJ, 1997, CAMBRIDGE SOLID STAT
   Goodall R., 2013, PHYS METALLURGY
   Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Gums JG, 2004, AM J HEALTH-SYST PH, V61, P1569
   Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Hermawan H, 2010, J BIOMED MATER RES A, V93A, P1, DOI 10.1002/jbm.a.32224
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Iannello S, 2001, PANMINERVA MED, V43, P177
   Jamesh M, 2011, CORROS SCI, V53, P645, DOI 10.1016/j.corsci.2010.10.011
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Keaveny TM, 1998, HDB BIOMATERIALS PRO, pA2
   Krause A, 2010, J MATER SCI, V45, P624, DOI 10.1007/s10853-009-3936-3
   Li JN, 2010, BIOMATERIALS, V31, P5782, DOI 10.1016/j.biomaterials.2010.04.023
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lu H, 2007, KEY ENG MATER, V330-332, P1185, DOI 10.4028/www.scientific.net/KEM.330-332.1185
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Peuster M, 2003, BIOMATERIALS, V24, P4057, DOI 10.1016/S0142-9612(03)00274-6
   Peuster M, 2003, J BIOMED MATER RES B, V65B, P211, DOI 10.1002/jbm.b.10561
   Peuster M, 2003, BIOMATERIALS, V24, P393, DOI 10.1016/S0142-9612(02)00352-6
   Singer R. F., 2005, CELLULAR METALS POLY, P77
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Wan CE, 2000, MATER SCI FORUM, V350-3, P359, DOI 10.4028/www.scientific.net/MSF.350-351.359
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Wen GW, 2007, KEY ENG MATER, V330-332, P971, DOI 10.4028/www.scientific.net/KEM.330-332.971
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Wu CT, 2007, J MATER SCI-MATER M, V18, P857, DOI [10.1007/s10856-006-0083-0, 10.1007/S10856-006-0083-0]
   Yamada Y, 1999, J MATER SCI LETT, V18, P1477, DOI 10.1023/A:1006677930532
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
NR 40
TC 15
Z9 17
U1 4
U2 32
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1438-1656
EI 1527-2648
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD FEB
PY 2014
VL 16
IS 2
BP 241
EP 247
DI 10.1002/adem.201300236
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA AB7JE
UT WOS:000331965000017
DA 2018-10-20
ER

PT J
AU Wang, XH
   Schroder, HC
   Grebenjuk, V
   Diehl-Seifert, B
   Mailander, V
   Steffen, R
   Schlossmacher, U
   Muller, WEG
AF Wang, Xiaohong
   Schroeder, Heinz C.
   Grebenjuk, Vladislav
   Diehl-Seifert, Baerbel
   Mailaender, Volker
   Steffen, Renate
   Schlossmacher, Ute
   Mueller, Werner E. G.
TI The Marine Sponge-Derived Inorganic Polymers, Biosilica and
   Polyphosphate, as Morphogenetically Active Matrices/Scaffolds for the
   Differentiation of Human Multipotent Stromal Cells: Potential
   Application in 3D Printing and Distraction Osteogenesis
SO MARINE DRUGS
LA English
DT Article
DE biosilica; polyphosphate; multipotent stromal cells; mesenchymal stem
   cells; alkaline phosphatase; 3D cell/tissue printing; distraction
   osteogenesis
AB The two marine inorganic polymers, biosilica (BS), enzymatically synthesized from ortho-silicate, and polyphosphate (polyP), a likewise enzymatically synthesized polymer consisting of 10 to > 100 phosphate residues linked by high-energy phosphoanhydride bonds, have previously been shown to display a morphogenetic effect on osteoblasts. In the present study, the effect of these polymers on the differential differentiation of human multipotent stromal cells (hMSC), mesenchymal stem cells, that had been encapsulated into beads of the biocompatible plant polymer alginate, was studied. The differentiation of the hMSCs in the alginate beads was directed either to the osteogenic cell lineage by exposure to an osteogenic medium (mineralization activation cocktail; differentiation into osteoblasts) or to the chondrogenic cell lineage by incubating in chondrocyte differentiation medium (triggering chondrocyte maturation). Both biosilica and polyP, applied as Ca2+ salts, were found to induce an increased mineralization in osteogenic cells; these inorganic polymers display also morphogenetic potential. The effects were substantiated by gene expression studies, which revealed that biosilica and polyP strongly and significantly increase the expression of bone morphogenetic protein 2 (BMP-2) and alkaline phosphatase (ALP) in osteogenic cells, which was significantly more pronounced in osteogenic versus chondrogenic cells. A differential effect of the two polymers was seen on the expression of the two collagen types, I and II. While collagen Type I is highly expressed in osteogenic cells, but not in chondrogenic cells after exposure to biosilica or polyP, the upregulation of the steady-state level of collagen Type II transcripts in chondrogenic cells is comparably stronger than in osteogenic cells. It is concluded that the two polymers, biosilica and polyP, are morphogenetically active additives for the otherwise biologically inert alginate polymer. It is proposed that alginate, supplemented with polyP and/or biosilica, is a suitable biomaterial that promotes the growth and differentiation of hMSCs and might be beneficial for application in 3D tissue printing of hMSCs and for the delivery of hMSCs in fractures, surgically created during distraction osteogenesis.
C1 [Wang, Xiaohong; Schroeder, Heinz C.; Grebenjuk, Vladislav; Steffen, Renate; Schlossmacher, Ute; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, D-55128 Mainz, Germany.
   [Diehl-Seifert, Baerbel] NanotecMARIN GmbH, D-55128 Mainz, Germany.
   [Mailaender, Volker] Max Planck Inst Polymer Res, D-55129 Mainz, Germany.
   [Mailaender, Volker] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Med Clin, D-55131 Mainz, Germany.
RP Wang, XH (reprint author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, Duesbergweg 6, D-55128 Mainz, Germany.
EM wang013@uni-mainz.de; hschroed@uni-mainz.de; grebenyu@uni-mainz.de;
   helmut-baerbel.Seifert@t-online.de; volker.mailaender@mpip-mainz.mpg.de;
   steffen@uni-mainz.de; schlossm@uni-mainz.de; wmueller@uni-mainz.de
RI Mailander, Volker/H-3589-2012
OI Mailander, Volker/0000-0001-6583-8136
FU ERC [268476 BIOSILICA, 324564]; European Commission [311848,
   FP7-KBBE-2010-4-266033, PIRSES-GA-2009-246987]; International Human
   Frontier Science Program; German Bundesministerium fur Bildung und
   Forschung; International Bureau (German-Chinese Joint Lab on
   Bio-Nano-Composites) [CHN 09/1AP]; BiomaTiCS research initiative of the
   University Medical Center, Mainz
FX We thank Sandra Ritz (Max-Planck-Institute for Polymer Research, Mainz,
   Germany) for supplying us with the hMSCs, as well as for introducing us
   to the technique of stem cell cultivation. W. E. G. M. is a holder of an
   ERC Advanced Investigator Grant (no. 268476 BIOSILICA), as well as of an
   ERC proof-of-concept grant (no. 324564; Silica-based nanobiomedical
   approaches for treatment of bone diseases). This work was supported by
   grants from the European Commission (no. 311848 "SPECIAL", and
   large-scale integrating project no. FP7-KBBE-2010-4-266033 "BlueGenics",
   as well as European-Chinese Research Staff Exchange Cluster
   PIRSES-GA-2009-246987 "MarBioTec* EU-CN*"), the International Human
   Frontier Science Program, the German Bundesministerium fur Bildung und
   Forschung, International Bureau (no. CHN 09/1AP, German-Chinese Joint
   Lab on Bio-Nano-Composites), and the BiomaTiCS research initiative of
   the University Medical Center, Mainz.
NR 0
TC 27
Z9 29
U1 2
U2 51
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD FEB
PY 2014
VL 12
IS 2
BP 1131
EP 1147
DI 10.3390/md12021131
PG 17
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AG9NC
UT WOS:000335745100032
PM 24566262
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Grunert, P
   Borde, BH
   Hudson, KD
   Macielak, MR
   Bonassar, LJ
   Haartl, R
AF Grunert, Peter
   Borde, Brandon H.
   Hudson, Katherine D.
   Macielak, Michael R.
   Bonassar, Lawrence J.
   Haetl, Roger
TI Annular Repair Using High-Density Collagen Gel
SO SPINE
LA English
DT Article
DE annular repair; intervertebral disc; high-density collagen; disc
   reherniation; disc degeneration; riboflavin cross-linking; needle
   puncture; rat-tail model; T2-relaxation time; animal model
ID INTERVERTEBRAL DISC DEGENERATION; CROSS-LINKING; LUMBAR DISKECTOMY;
   ANULAR DEFECT; FIBROSUS; MODEL; REGENERATION; DEGRADATION; PROGRESSION;
   RIBOFLAVIN
AB Study Design. Animal in vivo study.
   Objective. To test the capability of high-density collagen gel to repair annular defects.
   Summary of Background Data. Annular defects are associated with spontaneous disc herniations and disc degeneration, which can lead to significant morbidity. Persistent annular defects after surgical discectomies can increase reherniation rates. Several synthetic and biological materials have been developed for annular repair. This is the first study to test an injectable biomaterial in vivo.
   Methods. We punctured caudal intervertebral discs in 42 athymic rats, using an 18-gauge needle to create an annular defect. High-density collagen (HDC), either alone or cross-linked with riboflavin (RF), was injected into the defect. There were 4 separate study groups: HDC, HDC cross-linked with either 0.25 mM RF or 0.50 mM RF, and a negative control that was punctured and not treated. The animals were followed for 5 weeks; radiographs were used to assess disc heights and magnetic resonance images were used to evaluate degenerative changes. We developed an algorithm on the basis of T2-relaxation time measurements to assess the size of the nucleus pulposus. Tails were collected for histological analysis to evaluate disc degeneration and measure the cross-sectional area of the nucleus pulposus.
   Results. After 5 weeks, the control and the uncross-linked HDC groups both showed signs of progressive degenerative changes with minimal or no residual nucleus pulposus tissue in the disc space. Cross-linking significantly improved the ability of HDC gels to repair annular defects. The 0.50 mM RF cross-linked group showed only a slight decrease in nuclear tissue when compared with healthy discs, with no signs of intervertebral disc (IVD) degeneration. The annulus fibrosus was partially repaired by a fibrous cap that bridged the defect. Host fibroblasts infiltrated and remodeled the injected collagen.
   Conclusion. HDC is capable of repairing annular defects induced by needle puncture. The stiffness of HDC can be modified by riboflavin cross-linking and seems to positively affect the repair mechanism. These results need to be replicated in a larger animal model.
C1 [Grunert, Peter; Macielak, Michael R.; Haetl, Roger] Weill Cornell Med Coll, Weill Cornell Brain & Spine Inst, Dept Neurol Surg, New York, NY USA.
   [Borde, Brandon H.; Hudson, Katherine D.; Bonassar, Lawrence J.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA.
   [Bonassar, Lawrence J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
RP Haartl, R (reprint author), New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurol Surg, 525 East 68th St,Box 99, New York, NY 10065 USA.
EM roger@hartlmd.net
RI Bonassar, Lawrence/C-2103-2016
OI Bonassar, Lawrence/0000-0003-1094-6433
FU AO Research Fund [F-08-10B]; AOSpine International Hansjorg Wyss Focus
   Award; NFL Medical Charities
FX AO Research Fund grant F-08-10B, the AOSpine International Hansjorg Wyss
   Focus Award 2010, and a grant from NFL Medical Charities funds were
   received to support this work.
CR Ambrossi GLG, 2009, NEUROSURGERY, V65, P574, DOI 10.1227/01.NEU.0000350224.36213.F9
   Borde B.H., 2012, ORTH RES SOC ANN M S
   Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI 10.1089/ten.TEA.2009.0442
   Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z
   Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x
   Carragee EJ, 2006, SPINE, V31, P653, DOI 10.1097/01.brs.0000203714.76250.68
   Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016
   Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432
   Cheng NC, 2013, TISSUE ENG PT A, V19, P484, DOI [10.1089/ten.tea.2012.0384, 10.1089/ten.TEA.2012.0384]
   Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072
   Fazzalari NL, 2001, SPINE, V26, P2575, DOI 10.1097/00007632-200112010-00010
   GUIDRY C, 1985, J CELL SCI, V79, P67
   Gullung Gregory B, 2011, Evid Based Spine Care J, V2, P13, DOI 10.1055/s-0031-1274752
   HAMPTON D, 1989, SPINE, V14, P398, DOI 10.1097/00007632-198904000-00009
   Han B, 2008, SPINE, V33, P1925, DOI 10.1097/BRS.0b013e31817c64a9
   Harriger MD, 1997, J BIOMED MATER RES, V35, P137, DOI 10.1002/(SICI)1097-4636(199705)35:2<137::AID-JBM1>3.0.CO;2-O
   Hashemi H, 2013, OPHTHALMOLOGY, V120, P1515, DOI 10.1016/j.ophtha.2013.01.012
   Jarman-Smith ML, 2004, J MATER SCI-MATER M, V15, P925, DOI 10.1023/B:JMSM.0000036281.47596.cc
   Keorochana G, 2010, SPINE J, V10, P1014, DOI 10.1016/j.spinee.2010.08.013
   Lebow RL, 2011, SPINE, V36, P2147, DOI 10.1097/BRS.0b013e3182054595
   Ledet EH, 2009, SPINE, V34, P1457, DOI 10.1097/BRS.0b013e3181a48554
   Lu DS, 1997, SPINE, V22, P1828, DOI 10.1097/00007632-199708150-00006
   Lu DS, 1997, SPINE, V22, P34
   McGirt MJ, 2009, SPINE, V34, P2044, DOI 10.1097/BRS.0b013e3181b34a9a
   Melrose J, 2008, EUR SPINE J, V17, P1131, DOI 10.1007/s00586-008-0712-z
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Sheikh H, 2009, J NEUROSURG-SPINE, V10, P265, DOI 10.3171/2008.12.SPINE0835
   Staskowski PA, 1998, OTOLARYNG HEAD NECK, V118, P187, DOI 10.1016/S0194-5998(98)80010-7
   Stewart JM, 2009, INVEST OPHTH VIS SCI, V50, P1606, DOI 10.1167/iovs.08-2727
   Tirella A, 2012, MATER LETT, V74, P58, DOI 10.1016/j.matlet.2012.01.036
   Vadala G, 2012, EUR SPINE J, V21, pS20, DOI 10.1007/s00586-012-2235-x
   Yu LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048074
   Zhang HN, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2861
   Zou F, 2013, MOL MED REP, V8, P118, DOI 10.3892/mmr.2013.1450
NR 34
TC 19
Z9 21
U1 3
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0362-2436
EI 1528-1159
J9 SPINE
JI SPINE
PD FEB 1
PY 2014
VL 39
IS 3
BP 198
EP 206
DI 10.1097/BRS.0000000000000103
PG 9
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA AH5ZZ
UT WOS:000336211800017
PM 24253790
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Capasso, C
   Garofalo, M
   Hirvinen, M
   Cerullo, V
AF Capasso, Cristian
   Garofalo, Mariangela
   Hirvinen, Mari
   Cerullo, Vincenzo
TI The Evolution of Adenoviral Vectors through Genetic and Chemical Surface
   Modifications
SO VIRUSES-BASEL
LA English
DT Review
DE gene therapy; adenoviral vectors; genetic modification; chimeric fibers;
   surface modification; pseudotyping; polymers; immunogenicity;
   re-targeting
ID INNATE IMMUNE-RESPONSE; POLYETHYLENE-GLYCOL MODIFICATION; COMPLEMENT
   REGULATORY PROTEINS; HELPER-DEPENDENT ADENOVIRUS; POLYMER-COATED
   ADENOVIRUS; REFRACTORY SOLID TUMORS; GROWTH-FACTOR RECEPTOR; IN-VIVO;
   ONCOLYTIC ADENOVIRUS; RECOMBINANT ADENOVIRUS
AB A long time has passed since the first clinical trial with adenoviral (Ad) vectors. Despite being very promising, Ad vectors soon revealed their limitations in human clinical trials. The pre-existing immunity, the marked liver tropism and the high toxicity of first generation Ad (FG-Ad) vectors have been the main challenges for the development of new approaches. Significant effort toward the development of genetically and chemically modified adenoviral vectors has enabled researchers to create more sophisticated vectors for gene therapy, with an improved safety profile and a higher transduction ability of different tissues. In this review, we will describe the latest findings in the high-speed, evolving field of genetic and chemical modifications of adenoviral vectors, a field in which different disciplines, such as biomaterial research, virology and immunology, co-operate synergistically to create better gene therapy tools for modern challenges.
C1 [Capasso, Cristian; Hirvinen, Mari; Cerullo, Vincenzo] Univ Helsinki, Fac Pharm, Div Pharmaceut Biosci & CDR, Lab Immunovirotherapy,Bioctr 2, Helsinki 00790, Finland.
   [Garofalo, Mariangela] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, I-80131 Naples, Italy.
RP Cerullo, V (reprint author), Univ Helsinki, Fac Pharm, Div Pharmaceut Biosci & CDR, Lab Immunovirotherapy,Bioctr 2, Viikinkaari 5, Helsinki 00790, Finland.
EM cristian.capasso@helsinki.fi; mariangela.garofalo@helsinki.fi;
   mari.hirvinen@helsinki.fi; vincenzo.cerullo@helsinki.fi
RI Garofalo, Mariangela/Q-9469-2018
OI Garofalo, Mariangela/0000-0002-5001-7826; Cerullo,
   Vincenzo/0000-0003-4901-3796
CR Ahn CH, 2004, J CONTROL RELEASE, V97, P567, DOI 10.1016/j.jconrel.2004.04.002
   Alba R, 2012, GENE THER, V19, P109, DOI 10.1038/gt.2011.87
   Alba R, 2010, BLOOD, V116, P2656, DOI 10.1182/blood-2009-12-260026
   Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835
   Appledorn DM, 2008, GENE THER, V15, P1606, DOI 10.1038/gt.2008.114
   Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0
   Belousova N, 2008, J VIROL, V82, P630, DOI 10.1128/JVI.01896-07
   Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320
   Black PC, 2007, UROL ONCOL-SEMIN ORI, V25, P433, DOI 10.1016/j.urolonc.2007.05.011
   Bonsted A, 2006, J GENE MED, V8, P286, DOI 10.1002/jgm.853
   Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445
   Brunetti-Pierri N, 2011, HUM MOL GENET, V20, pR7, DOI 10.1093/hmg/ddr143
   Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031
   Cerullo V, 2012, ONCOIMMUNOLOGY, V1, P979, DOI 10.4161/onci.20172
   Choi JW, 2012, ADV DRUG DELIVER REV, V64, P720, DOI 10.1016/j.addr.2011.12.011
   Coughlan L, 2012, HUM GENE THER, V23, P960, DOI 10.1089/hum.2011.218
   Coughlan L, 2009, J VIROL, V83, P6416, DOI 10.1128/JVI.00445-09
   Croyle MA, 2005, GENE THER, V12, P579, DOI 10.1038/sj.gt.3302441
   Croyle MA, 2002, HUM GENE THER, V13, P1887, DOI 10.1089/104303402760372972
   Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171
   DeWeese TL, 2001, CANCER RES, V61, P7464
   Di BY, 2012, J BIOTECHNOL, V157, P373, DOI 10.1016/j.jbiotec.2011.12.022
   Diaconu I, 2009, HUM GENE THER, V20, P611, DOI 10.1089/hum.2008.108
   Doronin K, 2009, HUM GENE THER, V20, P975, DOI 10.1089/hum.2009.028
   Engesaeter BO, 2005, CANCER GENE THER, V12, P439, DOI 10.1038/sj.cgt.7700808
   Eto Y, 2010, BIOL PHARM BULL, V33, P1540, DOI 10.1248/bpb.33.1540
   Fisher KD, 2010, ADV DRUG DELIVER REV, V62, P240, DOI 10.1016/j.addr.2009.12.003
   FLOMENBERG P, 1994, MOL IMMUNOL, V31, P1277, DOI 10.1016/0161-5890(94)90078-7
   Fu J, 2011, J BIOL CHEM, V286, P17631, DOI 10.1074/jbc.M110.212050
   Gamble Lena J, 2012, J Mol Biochem, V1, P26
   Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698
   Granio O, 2010, HUM GENE THER, V21, P251, DOI 10.1089/hum.2009.056
   Green NK, 2008, J GENE MED, V10, P280, DOI 10.1002/jgm.1121
   Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295
   Grunwald GK, 2013, J NUCL MED, V54, P1450, DOI 10.2967/jnumed.112.115493
   Hall K, 2009, VIROLOGY, V392, P222, DOI 10.1016/j.virol.2009.07.010
   HARA T, 1992, BRIT J HAEMATOL, V82, P368, DOI 10.1111/j.1365-2141.1992.tb06431.x
   Hartman ZC, 2007, VIROLOGY, V358, P357, DOI 10.1016/j.virol.2006.08.041
   Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06
   Hiwasa K, 2012, ANTICANCER RES, V32, P3137
   Hoffman JA, 2003, CANCER CELL, V4, P383, DOI 10.1016/S1535-6108(03)00273-3
   Hofherr SE, 2008, MOL THER, V16, P1276, DOI 10.1038/mt.2008.86
   Hofherr SE, 2007, HUM GENE THER, V18, P837, DOI 10.1089/hum.2007.0051
   Hogg RT, 2011, CANCER GENE THER, V18, P275, DOI 10.1038/cgt.2010.78
   Hogset A, 2002, CANCER GENE THER, V9, P365, DOI 10.1038/sj/cgt/7700447
   Janssen JM, 2013, J GENE MED, V15, P1, DOI 10.1002/jgm.2687
   Jiang H, 2004, MOL THER, V10, P1140, DOI 10.1016/j.ymthe.2004.08.015
   Jonsson MI, 2009, J VIROL, V83, P3816, DOI 10.1128/JVI.02562-08
   KELLY TJ, 1973, J VIROL, V12, P643
   Kiang A, 2006, MOL THER, V14, P588, DOI 10.1016/j.ymthe.2006.03.024
   Kim E, 2003, HUM GENE THER, V14, P1415, DOI 10.1089/104303403769211637
   Kim KH, 2013, GYNECOL ONCOL, V130, P518, DOI 10.1016/j.ygyno.2013.06.003
   Kim KH, 2011, HUM GENE THER, V22, P821, DOI 10.1089/hum.2010.180
   Kim PH, 2011, BIOMATERIALS, V32, P9328, DOI 10.1016/j.biomaterials.2011.08.066
   Kim PH, 2010, BIOMATERIALS, V31, P1865, DOI 10.1016/j.biomaterials.2009.11.043
   King WJ, 2013, STEM CELLS DEV, V22, P679, DOI 10.1089/scd.2012.0379
   Koizumi N, 2006, HUM GENE THER, V17, P264, DOI 10.1089/hum.2006.17.264
   Koski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060032
   Kreppel F, 2008, MOL THER, V16, P16, DOI 10.1038/sj.mt.6300321
   Kritz AB, 2007, MOL THER, V15, P741, DOI 10.1038/mt.sj.6300094
   Kwon OJ, 2013, J CONTROL RELEASE, V169, P257, DOI 10.1016/j.jconrel.2013.03.030
   Lanciotti J, 2003, MOL THER, V8, P99, DOI 10.1016/S1525-0016(03)00139-4
   Law LK, 2005, MOL THER, V12, P599, DOI 10.1016/j.ymthe.2005.05.017
   Leggiero E, 2013, GENE THER, V20, P1124, DOI 10.1038/gt.2013.38
   Lieber A, 1997, J VIROL, V71, P8798
   Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036
   Liu TC, 2008, GENE THER, V15, P877, DOI 10.1038/gt.2008.72
   Maksimenko AV, 2003, J GENE MED, V5, P61, DOI 10.1002/jgm.319
   Matsui H, 2012, BIOMATERIALS, V33, P3743, DOI 10.1016/j.biomaterials.2012.02.011
   Matsui H, 2011, VIRUS RES, V155, P48, DOI 10.1016/j.virusres.2010.08.021
   Mizuguchi H, 2002, GENE THER, V9, P769, DOI 10.1038/sj/gt/3301701
   Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015
   Morral N, 2002, HUM GENE THER, V13, P143, DOI 10.1089/10430340152712692
   Morrison J, 2008, MOL THER, V16, P244, DOI 10.1038/sj.mt.6300363
   Murakami M, 2010, PROSTATE, V70, P362, DOI 10.1002/pros.21070
   Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157
   Muruve DA, 2004, J VIROL, V78, P5966, DOI 10.1128/JVI.78.11.5966-5972.2004
   Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364
   Nakamura T, 2003, J VIROL, V77, P2512, DOI 10.1128/JVI.77.4.2512-2521.2003
   Nazir SA, 2005, J INVEST MED, V53, P292, DOI 10.2310/6650.2005.53605
   Nokisalmi P, 2010, CLIN CANCER RES, V16, P3035, DOI 10.1158/1078-0432.CCR-09-3167
   Palmer Donna J, 2011, Cold Spring Harb Protoc, V2011, P867, DOI 10.1101/pdb.prot5628
   Pandori MW, 2002, VIROLOGY, V299, P204, DOI 10.1006/viro.2002.1510
   Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532
   Pearson S, 2004, NAT BIOTECHNOL, V22, P3, DOI 10.1038/nbt0104-3
   Pesonen S, 2012, INT J CANCER, V130, P1937, DOI 10.1002/ijc.26216
   Piccolo P, 2013, MOL THER, V21, P767, DOI 10.1038/mt.2012.287
   Post DE, 2003, ONCOGENE, V22, P2065, DOI 10.1038/sj.onc.1206464
   Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016
   Raty J K, 2008, Curr Mol Pharmacol, V1, P13
   Rhee EG, 2011, J VIROL, V85, P315, DOI 10.1128/JVI.01597-10
   Rodriguez E, 2013, HUM GENE THER METHOD, V24, P195, DOI 10.1089/hgtb.2012.096
   Rojas JJ, 2012, GENE THER, V19, P453, DOI 10.1038/gt.2011.106
   ROSENBERG SA, 1990, NEW ENGL J MED, V323, P570, DOI 10.1056/NEJM199008303230904
   Sapet C, 2012, PHARM RES-DORDR, V29, P1203, DOI 10.1007/s11095-011-0629-9
   Schowalter DB, 1997, GENE THER, V4, P351, DOI 10.1038/sj.gt.3300398
   Seiler MP, 2007, CURR GENE THER, V7, P297, DOI 10.2174/156652307782151452
   Seregin SS, 2010, BLOOD, V116, P1669, DOI 10.1182/blood-2010-03-276949
   Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005
   Silva AC, 2010, CURR GENE THER, V10, P437
   Singh R, 2008, FASEB J, V22, P3389, DOI 10.1096/fj.08-103275
   Singh R, 2008, ACS NANO, V2, P1040, DOI 10.1021/nn8000565
   Smith TAG, 2003, HUM GENE THER, V14, P777, DOI 10.1089/104303403765255165
   Steegenga WT, 1999, MOL CELL BIOL, V19, P3885
   Suzuki-Kouyama E, 2011, BIOMATERIALS, V32, P1724, DOI 10.1016/j.biomaterials.2010.10.060
   Tang DC, 1997, HUM GENE THER, V8, P2117, DOI 10.1089/hum.1997.8.17-2117
   Teesalu T., 2013, FRONT ONCOL, V3, DOI [10.3389/fonc.2013.00216, DOI 10.3389/FONC.2013.00216]
   THOMAS GP, 1980, CELL, V22, P523
   Thorsteinsson L, 1998, APMIS, V106, P869, DOI 10.1111/j.1699-0463.1998.tb00233.x
   Toietta G, 2002, MOL THER, V5, P204, DOI 10.1006/mthe.2002.0532
   Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352
   Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545
   van de Ven R, 2009, J IMMUNOTHER, V32, P895, DOI 10.1097/CJI.0b013e3181b56deb
   Vetrini F, 2010, VIRUSES-BASEL, V2, P1886, DOI 10.3390/v2091886
   Vetter A, 2013, MOL PHARMACEUT, V10, P606, DOI 10.1021/mp300366f
   Walters CL, 2013, GYNECOL ONCOL, V131, P493, DOI 10.1016/j.ygyno.2013.07.080
   Wang CHK, 2011, BIOMATERIALS, V32, P9536, DOI 10.1016/j.biomaterials.2011.08.069
   Wang IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012085
   Wang WJ, 2005, J NEUROSURG, V103, P1058, DOI 10.3171/jns.2005.103.6.1058
   WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E
   Wohlleber D, 2012, CELL REP, V2, P478, DOI 10.1016/j.celrep.2012.08.001
   Wonganan P, 2011, MOL PHARMACEUT, V8, P78, DOI 10.1021/mp100216h
   Wonganan P, 2010, VIRUSES-BASEL, V2, P468, DOI 10.3390/v2020468
   Wu E, 2003, J VIROL, V77, P7225, DOI 10.1128/JVI.77.13.7225-7235.2003
   Wu HJ, 2005, J VIROL, V79, P3382, DOI 10.1128/JVI.79.6.3382-3390.2005
   Xie M, 2013, INT J NANOMED, V8, P2443, DOI 10.2147/IJN.S46327
   Xiong ZM, 2006, J NUCL MED, V47, P130
   Yamamoto M, 2010, MOL THER, V18, P243, DOI 10.1038/mt.2009.266
   Yang Y, 1996, GENE THER, V3, P412
   Yang Y, 1996, GENE THER, V3, P137
   YANG YP, 1995, J IMMUNOL, V155, P2564
   Yang YP, 1996, J VIROL, V70, P7209
   YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4
   Yao XL, 2012, BIOMACROMOLECULES, V13, P2402, DOI 10.1021/bm300665u
   Yao XL, 2011, MOL THER, V19, P1619, DOI 10.1038/mt.2011.112
   Yilmazer A, 2013, BIOMATERIALS, V34, P1354, DOI 10.1016/j.biomaterials.2012.10.053
   ZAMANIAN M, 1992, EMBO J, V11, P2603, DOI 10.1002/j.1460-2075.1992.tb05325.x
   Zeng Q, 2012, INT J NANOMED, V7, P985, DOI 10.2147/IJN.S27526
   Zhao YG, 2011, MOL CELL BIOCHEM, V353, P93, DOI 10.1007/s11010-011-0778-5
NR 139
TC 19
Z9 19
U1 0
U2 13
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2014
VL 6
IS 2
BP 832
EP 855
DI 10.3390/v6020832
PG 24
WC Virology
SC Virology
GA AG9OH
UT WOS:000335748500010
PM 24549268
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Naghavi, N
   Ghoddusi, J
   Sadeghnia, HR
   Asadpour, E
   Asgary, S
AF Naghavi, Neda
   Ghoddusi, Jamileh
   Sadeghnia, Hamid R.
   Asadpour, Elham
   Asgary, Saeed
TI Genotoxicity and cytotoxicity of mineral trioxide aggregate and calcium
   enriched mixture cements on L929 mouse fibroblast cells
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Biocompatible; Calcium enriched mixture; Cytotoxicity; Genotoxicity;
   Mineral trioxide aggregate
ID PERIODONTAL-LIGAMENT FIBROBLASTS; END FILLING MATERIAL; COMET ASSAY;
   DNA-DAMAGE; ENDODONTIC CEMENT; PORTLAND CEMENTS; WHITE; AGENTS; ORGANS;
   MTA
AB Mineral trioxide aggregate (MTA) has shown good biocompatibility in several studies. In the present study, the genotoxic and cytotoxic effects of calcium enriched mixture (CEM) were evaluated compared with MTA using MTT and single-cell gel (comet) assays with serial ascending concentrations (0 to 1,000 mu g/mL) of tested materials. Cytotoxicity data indicated that there is no significant difference between CEM and MTA at all concentrations except for the full concentration (1,000 mu g/mL); CEM had lower cytotoxicity. Genotoxic effects were more evident with CEM at concentrations of 15.6 and 250 mu g/mL; however, was less than that of MTA at concentrations of 500 and 1,000 mu g/mL. The cytotoxicity and genotoxicity effects of the two experimental groups generally increased with consistency. Under the conditions of this study, CEM is biocompatible in terms of cyto- and genotoxicity. It appears to be an alternative to MTA as an endodontic biomaterial offering several advantages.
C1 [Naghavi, Neda; Ghoddusi, Jamileh] MUMS, Dent Res Ctr, Mashhad, Iran.
   [Sadeghnia, Hamid R.; Asadpour, Elham] MUMS, Neurosci Res Ctr, Dept Pharmacol, Dept New Sci & Technol,Fac Med, Mashhad, Iran.
   [Asgary, Saeed] Shahid Beheshti Univ Med Sci, Iranian Ctr Endodont Res, Tehran, Iran.
RP Ghoddusi, J (reprint author), MUMS, Dent Res Ctr, Mashhad, Iran.
EM ghoddusij@mums.ac.ir
RI Asadpour, Elham/J-6352-2015
OI Asadpour, Elham/0000-0002-6858-5311
FU Mashhad University of Medical Sciences (MUMS), Mashhad, Iran; Iranian
   Center for Endodontic Research, Shahid Beheshti University of Medical
   Sciences, Tehran, Iran
FX This study was fully supported by a grant from Vice Chancellor for
   Research of Mashhad University of Medical Sciences (MUMS), Mashhad, Iran
   and Iranian Center for Endodontic Research, Shahid Beheshti University
   of Medical Sciences, Tehran, Iran. The authors deny any conflict of
   interest related to this study.
CR Asgary S, 2009, J CONSERV DENT, V412, P431
   Asgary S, 2008, J BIOMED MATER RES A, V87A, P706, DOI 10.1002/jbm.a.31678
   Asgary S, 2008, ORAL SURG ORAL MED O, V106, P609, DOI 10.1016/j.tripleo.2008.06.006
   Asgary S, 2008, J ENDODONT, V34, P990, DOI 10.1016/j.joen.2008.05.006
   Asgary S, 2010, ODONTOLOGY, V98, P126, DOI 10.1007/s10266-010-0127-2
   Asgary Saeed, 2007, Iran Endod J, V2, P105
   Asgary S, 2009, AUST ENDOD J, V35, P147, DOI 10.1111/j.1747-4477.2008.00137.x
   Asgary Saeed, 2008, J Oral Sci, V50, P469
   Balto HA, 2004, J ENDODONT, V30, P25, DOI 10.1097/00004770-200401000-00005
   Braz MG, 2006, J ORAL REHABIL, V33, P234, DOI 10.1111/j.1365-2842.2005.01559.x
   Camilleri J, 2005, DENT MATER, V21, P297, DOI 10.1016/j.dental.2004.05.010
   da Silva Glenda N, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V102, pe50, DOI 10.1016/j.tripleo.2006.02.032
   Duarte MAH, 2005, ORAL SURG ORAL MED O, V99, P648, DOI 10.1016/j.tripleo.2004.09.015
   Hartmann A, 2003, MUTAGENESIS, V18, P45, DOI 10.1093/mutage/18.1.45
   Hasan Zarrabi M, 2009, J ORAL SCI, V51, P437
   Hasheminia Mohsen, 2010, Iran Endod J, V5, P151
   Hirschman WR, 2012, J ENDODONT, V38, P385, DOI 10.1016/j.joen.2011.11.012
   Holland Roberto, 2002, Braz Dent J, V13, P23
   Hosseinzadeh H, 2008, DNA CELL BIOL, V27, P657, DOI 10.1089/dna.2008.0767
   Hosseinzadeh H, 2007, DNA CELL BIOL, V26, P841, DOI 10.1089/dna.2007.0631
   Keiser K, 2000, J ENDODONT, V26, P288, DOI 10.1097/00004770-200005000-00010
   Koh ET, 1998, J ENDODONT, V24, P543, DOI 10.1016/S0099-2399(98)80074-5
   Koh ET, 1997, J BIOMED MATER RES, V37, P432, DOI 10.1002/(SICI)1097-4636(19971205)37:3<432::AID-JBM14>3.0.CO;2-D
   Kumaravel TS, 2006, MUTAT RES-GEN TOX EN, V605, P7, DOI 10.1016/j.mrgentox.2006.03.002
   Lessa Fernanda Campos Rosetti, 2010, Braz. Dent. J., V21, P24, DOI 10.1590/S0103-64402010000100004
   Menezes R, 2004, ORAL SURG ORAL MED O, V98, P376, DOI 10.1016/j.tripleo.2004.03.008
   Mitchell PJC, 1999, BIOMATERIALS, V20, P167, DOI 10.1016/S0142-9612(98)00157-4
   Osorio RM, 1998, J ENDODONT, V24, P91, DOI 10.1016/S0099-2399(98)80084-8
   Oviir T, 2006, J ENDODONT, V32, P210, DOI 10.1016/j.joen.2006.10.036
   Parirokh M, 2011, INT ENDOD J, V44, P283, DOI 10.1111/j.1365-2591.2010.01808.x
   Ribeiro DA, 2004, J PERIODONTAL RES, V39, P358, DOI 10.1111/j.1600-0765.2004.00759.x
   Ribeiro DA, 2004, J ENDODONT, V30, P593, DOI 10.1097/01.DON.0000121614.10075.A3
   Ribeiro Daniel Araki, 2005, Braz. oral res., V19, P183, DOI 10.1590/S1806-83242005000300005
   Ribeiro Daniel Araki, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, P258, DOI 10.1016/j.tripleo.2005.02.080
   Ribeiro Daniel Araki, 2004, Braz. oral res., V18, P192, DOI 10.1590/S1806-83242004000300003
   Samiee M, 2010, CLIN ORAL INVEST, V14, P653, DOI 10.1007/s00784-009-0351-8
   Tabarsi B, 2010, INT ENDOD J, V43, P565, DOI 10.1111/j.1365-2591.2010.01711.x
   TORABINEJAD M, 1995, J ENDODONT, V21, P489, DOI 10.1016/S0099-2399(06)80518-2
   TORABINEJAD M, 1995, J ENDODONT, V21, P603, DOI 10.1016/S0099-2399(06)81112-X
   Vajrabhaya LO, 2006, ORAL SURG ORAL MED O, V102, P48
   Zeferino EG, 2010, INT ENDOD J, V43, P843, DOI 10.1111/j.1365-2591.2010.01747.x
NR 41
TC 17
Z9 19
U1 0
U2 7
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD FEB
PY 2014
VL 33
IS 1
BP 64
EP 69
DI 10.4012/dmj.2013-123
PG 6
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA AD7KJ
UT WOS:000333442400011
PM 24492114
OA Bronze
DA 2018-10-20
ER

PT J
AU Osidak, EO
   Osidak, MS
   Akhmanova, MA
   Domogatskii, SP
AF Osidak, E. O.
   Osidak, M. S.
   Akhmanova, M. A.
   Domogatskii, S. P.
TI Collagen-A biomaterial for delivery of growth factors and tissue
   regeneration
SO RUSSIAN JOURNAL OF GENERAL CHEMISTRY
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; DRUG-DELIVERY; ARTIFICIAL SKIN; IN-VITRO;
   IMPLANTABLE COLLAGEN; RELEASE KINETICS; BINDING DOMAIN; LOCAL-DELIVERY;
   SPINAL-FUSION; MATRICES
AB Research on collagen as a carrier for growth factors and cells is an actual field in modern tissue engineering. The progress in this field of research will make possible approaching the problem of regeneration of injured organs and large tissue fragments.
C1 [Osidak, E. O.] Minist Hlth Russian Federat, Fed State Budgetary Inst, Gamaleya Res Inst Epidemiol & Microbiol, Moscow 123098, Russia.
   [Osidak, M. S.] Minist Hlth Russian Federat, Fed State Budgetary Inst, Hematol Res Ctr, Moscow 125167, Russia.
   [Akhmanova, M. A.] Minist Hlth Russian Federat, Fed State Budgetary Inst, Russian Cardiol Res & Prod Ctr, Moscow 121552, Russia.
   [Domogatskii, S. P.] Imtek OOO, Moscow 121552, Russia.
RP Osidak, EO (reprint author), Minist Hlth Russian Federat, Fed State Budgetary Inst, Gamaleya Res Inst Epidemiol & Microbiol, Ul Gamalei 18, Moscow 123098, Russia.
EM egorosidak@gmail.com
CR Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078
   Aishwarya S, 2008, J MICROENCAPSUL, V25, P298, DOI 10.1080/02652040801972004
   Akhmanova M.A., 2011, THESIS
   Andreadis ST, 2006, TRENDS BIOTECHNOL, V24, P331, DOI 10.1016/j.tibtech.2006.05.001
   [Anonymous], 2000, RP651147 MED DAT INT, P29
   Aro HT, 2011, J BONE JOINT SURG AM, V93A, P801, DOI 10.2106/JBJS.I.01763
   Bentz H, 1998, J BIOMED MATER RES, V39, P539, DOI 10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO;2-K
   Berthold A, 1998, EUR J PHARM BIOPHARM, V45, P23, DOI 10.1016/S0939-6411(97)00119-7
   Boden SD, 1998, J SPINAL DISORD, V11, P95
   BOYCE ST, 1992, J BIOMED MATER RES, V26, P547, DOI 10.1002/jbm.820260410
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   Censi R, 2012, J CONTROL RELEASE, V161, P680, DOI 10.1016/j.jconrel.2012.03.002
   Chandran PL, 2004, J BIOMECH ENG-T ASME, V126, P152, DOI 10.1115/1.1688774
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   CHOW AW, 1985, MACROMOLECULES, V18, P793, DOI 10.1021/ma00146a034
   Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241
   Cote MF, 2004, BIOMATERIALS, V25, P3761, DOI 10.1016/j.biomaterials.2003.10.026
   DELUSTRO F, 1986, J BIOMED MATER RES, V20, P109, DOI 10.1002/jbm.820200110
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gao T, 2001, MATERIALWISS WERKST, V32, P953
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   GELMAN RA, 1979, J BIOL CHEM, V254, P1741
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gorham S. D., 1991, BIOMATERIALS, P55
   Grillo H., 1962, J SURG RES, V11, P69
   Hecht BP, 1999, SPINE, V24, P629, DOI 10.1097/00007632-199904010-00004
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   Hsu HP, 2006, J ORTHOP RES, V24, P1660, DOI 10.1002/jor.20204
   Ishikawa T, 2003, ARTIF ORGANS, V27, P147, DOI 10.1046/j.1525-1594.2003.07009.x
   KAMMANN JP, 1994, KLIN MONATSBL AUGENH, V205, P201, DOI 10.1055/s-2008-1045517
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Kim H., 2001, J BIOMED MATER RES, V59, P573
   King WJ, 2012, ADV DRUG DELIVER REV, V64, P1239, DOI 10.1016/j.addr.2012.03.004
   Kobsa S, 2008, PEDIATR RES, V63, P513, DOI 10.1203/PDR.0b013e318165f14d
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Ladewig K, 2011, EXPERT OPIN DRUG DEL, V8, P1175, DOI 10.1517/17425247.2011.588698
   Lanza R, 2000, PRINCIPLES TISSUE EN
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   Lee KY, 2000, NATURE, V408, P998
   LEFEBVRE F, 1992, BIOMATERIALS, V13, P28, DOI 10.1016/0142-9612(92)90091-2
   Lefebvre F, 1996, BIOMATERIALS, V17, P1813, DOI 10.1016/0142-9612(95)00346-0
   Lienemann PS, 2012, ADV DRUG DELIVER REV, V64, P1078, DOI 10.1016/j.addr.2012.03.010
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lin NC, 2012, BIOMATERIALS, V33, P1801, DOI 10.1016/j.biomaterials.2011.11.038
   Ma J., 2011, CLIN EXP OPHTHALMOL, DOI [10.1111/j.1442-9071.2011.02618, DOI 10.1111/J.1442-9071.2011.02618]
   Maehara H, 2010, J ORTHOP RES, V28, P677, DOI 10.1002/jor.21032
   MARKS MG, 1991, J BIOMED MATER RES, V25, P683, DOI 10.1002/jbm.820250510
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   MEADE KR, 1990, BIOMATERIALS, V11, P176, DOI 10.1016/0142-9612(90)90151-F
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   MILANI JK, 1993, AM J OPHTHALMOL, V116, P622, DOI 10.1016/S0002-9394(14)73206-4
   Moriyama T, 2001, TISSUE ENG, V7, P415, DOI 10.1089/10763270152436472
   NA GC, 1986, J BIOL CHEM, V261, P2290
   Nagai N, 2010, J MATER SCI-MATER M, V21, P1891, DOI 10.1007/s10856-010-4054-0
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   Noth U, 2010, ADV DRUG DELIVER REV, V62, P765, DOI 10.1016/j.addr.2010.04.004
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49
   Phillips RJ, 2000, BIOPHYS J, V79, P3350, DOI 10.1016/S0006-3495(00)76566-0
   PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1
   POLAND DE, 1988, J CATARACT REFR SURG, V14, P489, DOI 10.1016/S0886-3350(88)80003-8
   Porter S., 2000, J PHARM SCI, V90, P1
   Princz MA, 2008, J BIOMAT SCI-POLYM E, V19, P1201, DOI 10.1163/156856208785540181
   Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7
   ROSENBLATT J, 1993, J APPL POLYM SCI, V50, P953, DOI 10.1002/app.1993.070500604
   ROSENBLATT J, 1989, J CONTROL RELEASE, V9, P195, DOI 10.1016/0168-3659(89)90088-6
   ROSSLER B, 1995, J MICROENCAPSUL, V12, P49, DOI 10.3109/02652049509051126
   ROYCE PM, 1995, J DERMATOL SCI, V10, P42, DOI 10.1016/0923-1811(95)93713-B
   SCHIMANDLE JH, 1995, SPINE, V20, P1326, DOI 10.1097/00007632-199506000-00002
   Schlapp M, 2003, J PHARM SCI-US, V92, P2145, DOI 10.1002/jps.10460
   SchroederTefft JA, 1997, J CONTROL RELEASE, V48, P29, DOI 10.1016/S0168-3659(97)00055-2
   Sieron AL, 2002, CYTOKINE, V18, P214, DOI 10.1006/cyto.2002.1035
   SINGH M, 1993, P INT S CONTR REL BI, V20, P107
   SINGH MA, 1994, THESIS U MARYLAND BA
   Song S.-Z., 1992, European Patent, Patent No. 92305467
   Stegman S, 1988, J DERMATOL SURG O S1, V14, P39
   STOMPRO BE, 1989, J SURG RES, V46, P413, DOI 10.1016/0022-4804(89)90153-4
   Takeda Y, 2005, J BIOMED MATER RES A, V73A, P133, DOI 10.1002/jbm.a.30257
   Timpl R, 1984, EXTRACELLULAR MATRIX, P159
   Ungaro F, 2006, J CONTROL RELEASE, V113, P128, DOI 10.1016/j.jconrel.2006.04.011
   Vaccaro AR, 2008, SPINE, V33, P2850, DOI 10.1097/BRS.0b013e31818a314d
   Vasita R, 2006, EXPERT REV MED DEVIC, V3, P29, DOI 10.1586/17434440.3.1.29
   Vijaya R.D., 1989, INDIAN J BIOCH BIOPH, V26, P196
   Wallace D., 1988, COLLAGEN BIOTECHNOLO, V3, P118
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Waltraud D., 1977, BIOCHEMISTRY-US, P1
   Wang AY, 2008, BIOMACROMOLECULES, V9, P2929, DOI 10.1021/bm800727z
   Wang NX, 2011, MACROMOL BIOSCI, V11, P321, DOI 10.1002/mabi.201000206
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WEISSMAN BA, 1988, ARCH OPHTHALMOL-CHIC, V106, P1706, DOI 10.1001/archopht.1988.01060140878032
   Wess TJ, 2005, ADV PROTEIN CHEM, V70, P341, DOI 10.1016/S0065-3233(05)70010-3
   Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Wissink MJB, 2000, J CONTROL RELEASE, V67, P141, DOI 10.1016/S0168-3659(00)00202-9
   Yang YF, 2009, TISSUE ENG PT A, V15, P3589, DOI [10.1089/ten.tea.2008.0648, 10.1089/ten.TEA.2008.0648]
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   Zhao YN, 2010, J CONTROL RELEASE, V141, P30, DOI 10.1016/j.jconrel.2009.06.032
NR 104
TC 0
Z9 0
U1 2
U2 10
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1070-3632
EI 1608-3350
J9 RUSS J GEN CHEM+
JI Russ. J. Gen. Chem.
PD FEB
PY 2014
VL 84
IS 2
BP 368
EP 378
DI 10.1134/S107036321402039X
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA AD3QU
UT WOS:000333161700039
DA 2018-10-20
ER

PT J
AU Raj, KR
   Saxena, S
   Kardam, A
   Satsangi, SP
   Srivastava, S
AF Raj, Kumar Rohit
   Saxena, Sachin
   Kardam, Abhishek
   Satsangi, Soami P.
   Srivastava, Shalini
TI Voltammetric speciation of arsenic species in plant biomaterial:
   bioremediation
SO CLEAN TECHNOLOGIES AND ENVIRONMENTAL POLICY
LA English
DT Article
DE Chemical speciation; Arsenic; Square wave anodic stripping voltammetry;
   Leucaena leucocephala
ID ANODIC-STRIPPING VOLTAMMETRY; AQUEOUS-SOLUTIONS; COIR PITH; WATER;
   REMOVAL; SAMPLES; ADSORPTION; AS(III)
AB Environmental pollution, as a consequence of the industrialization process, is one of the major problems that have to be solved and controlled. The heightened awareness regarding the high toxicity and biochemical behavior of the different arsenic species required to develop cost effective technologies for the speciation of arsenic species. Electrochemical techniques are found to be comparatively better tools for arsenic speciation. As (III) is electrochemically stable in the presence of ascorbic acid as supporting electrolyte, while As (V) is electrochemically inactive at the electrode surface. The present piece of work is an attempt to measure the two arsenic species in the elution of arsenic sorbed Leucaena leucocephala seed powder (LLSP), using square wave anodic stripping voltammetry. The strategy employed in this work is based on the determination of As (III) directly, while determining As (V) after reduction with sodium thiosulfate into As (III). The removal percentage of As (III) and As (V) using LLSP biomaterial was 83.18 and 95 %, respectively.
C1 [Raj, Kumar Rohit] Sigachi Ind Pvt Ltd, Res & Dev Lab, Hyderabad 502307, Andhra Pradesh, India.
   [Saxena, Sachin; Satsangi, Soami P.] Dayalbagh Educ Inst, USIC, Remote Instrumentat Lab, Agra 282110, Uttar Pradesh, India.
   [Kardam, Abhishek] Amity Univ, Amity Inst Adv Res & Studies, Noida 201303, India.
   [Srivastava, Shalini] Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282110, Uttar Pradesh, India.
RP Srivastava, S (reprint author), Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282110, Uttar Pradesh, India.
EM dei.smohanm@gmail.com
FU University Grant Commission, New Delhi, India [39-736/2010 (SR)]
FX The authors gratefully acknowledge Prof. V. G. Das, Director and Prof.
   L. D. Khemani, Head, Department of Chemistry, Dayalbagh Educational
   Institute, Dayalbagh, Agra. Authors also gratefully acknowledge
   University Grant Commission, New Delhi, India [Project No. 39-736/2010
   (SR)] for providing financial assistance.
CR Alvarado S, 2008, BIORESOURCE TECHNOL, V99, P8436, DOI 10.1016/j.biortech.2008.02.051
   Anirudhan TS, 2007, CHEMOSPHERE, V66, P60, DOI 10.1016/j.chemosphere.2006.05.031
   Bose U., 2011, International Journal of Chemical Technology, V3, P14
   Brusciotti F, 2007, ELECTROCHIM ACTA, V52, P6644, DOI 10.1016/j.electacta.2007.04.071
   Burriel M, 2006, QUIMICA ANALITICA CU
   DANG HQ, 2004, TALANTA, V64, P269
   Dirilgen N, 2006, ANAL LETT, V39, P127, DOI 10.1080/00032710500464264
   Gong ZL, 2002, TALANTA, V58, P77, DOI 10.1016/S0039-9140(02)00258-8
   HAMAM E, 2002, J PHARM BIOMED ANAL, V30, P651
   He Y, 2007, MICROCHEM J, V85, P265, DOI 10.1016/j.microc.2006.06.012
   Junsomboon J, 2009, CHIANG MAI J SCI, V36, P369
   Kardam Abhishek, 2010, Journal of Water Resource and Protection, V2, P339, DOI 10.4236/jwarp.2010.24039
   Le XC, 2004, ANAL CHEM, V76, p26A, DOI 10.1021/ac041492r
   Mahmood S.A.I., 2011, J TOXICOL ENV HLTH S, V3, P65
   Malik AH, 2009, J HAZARD MATER, V168, P1, DOI 10.1016/j.jhazmat.2009.02.031
   Masson P, 2006, MICROCHIM ACTA, V154, P229, DOI 10.1007/s00604-006-0516-y
   Mays DE, 2009, ANAL CHIM ACTA, V646, P6, DOI 10.1016/j.aca.2009.05.006
   Meng XG, 2003, ACS SYM SER, V835, P70
   Munoz E, 2005, TALANTA, V65, P613, DOI 10.1016/j.talanta.2004.07.034
   Nemade PD, 2007, INDIAN JR ENV PROT, V27, P296
   Patil AK, 2010, E-J CHEM, V7, pS377, DOI 10.1155/2010/314961
   Paul SC, 2008, PAK J ANAL ENV CHEM, V9, P49
   Profumo A, 2005, ANAL CHIM ACTA, V539, P245, DOI 10.1016/j.aca.2005.02.062
   Raj Kumar Rohit, 2010, Journal of Water Resource and Protection, V2, P331, DOI 10.4236/jwarp.2010.24038
   Raj KR, 2013, APPL WATER SCI, V3, P327, DOI 10.1007/s13201-012-0057-y
   Ramesh ST, 2012, APPL WATER SCI, V2, P187, DOI 10.1007/s13201-012-0036-3
   Ramesh S. T., 2011, Electronic Journal of Environmental, Agricultural and Food Chemistry, V10, P2487
   Ramesh ST, 2013, ENVIRON ENG SCI, V30, P74, DOI 10.1089/ees.2012.0192
   Ramesh ST, 2011, ENVIRON ENG MANAG J, V10, P1667, DOI 10.30638/eemj.2011.228
   Ranjan D, 2009, IND ENG CHEM RES, V48, P10180, DOI 10.1021/ie9008771
   Rivas BL, 2010, WATER RES, V44, P5730, DOI 10.1016/j.watres.2010.06.031
   Salaun P, 2007, ANAL CHIM ACTA, V585, P312, DOI 10.1016/j.aca.2006.12.048
   Shao WJ, 2008, HYDROMETALLURGY, V91, P138, DOI 10.1016/j.hydromet.2008.01.005
   Srivastava S, 2013, ENVIRON CHEM LETT, V11, P47, DOI 10.1007/s10311-012-0376-0
   Vahidnia A, 2007, HUM EXP TOXICOL, V26, P823, DOI 10.1177/0960327107084539
   Yeneneh M. A., 2011, J APPL SCI, V11, P3555
   Zlatev R, 2010, ELECTROANAL, V22, P1671, DOI 10.1002/elan.201000090
NR 37
TC 2
Z9 2
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1618-954X
EI 1618-9558
J9 CLEAN TECHNOL ENVIR
JI Clean Technol. Environ. Policy
PD FEB
PY 2014
VL 16
IS 2
BP 377
EP 384
DI 10.1007/s10098-013-0633-3
PG 8
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA AC9PY
UT WOS:000332867800016
DA 2018-10-20
ER

PT J
AU de Olyveira, GM
   dos Santos, ML
   Daltro, PB
   Basmaji, P
   Daltro, GD
   Guastaldi, AC
AF de Olyveira, Gabriel Molina
   dos Santos, Marcio Luiz
   Daltro, Paula Braga
   Basmaji, Pierre
   Daltro, Gildasio de Cerqueira
   Guastaldi, Antonio Carlos
TI Bacterial Cellulose/Chondroitin Sulfate for Dental Materials Scaffolds
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Bacterial Cellulose (Nanoskin); Nanocomposites; Scaffolds; Dental
   Scaffolds Materials
ID CELLULOSE NANOCOMPOSITES; BIOMEDICAL APPLICATIONS
AB Bacterial cellulose (BC) has become established as a remarkably versatile biomaterial and can be used in a wide variety of scientific applications, especially for medical devices. In this work, the bacterial cellulose fermentation process is modified by the addition of chondroitin sulfate (1% w/w) to the culture medium before the bacteria are inoculated. Besides, biomimetic precipitation of calcium phosphate of biological interest from simulated body fluid on bacterial cellulose was studied. Chondroitin sulfate influences in bacterial cellulose were analyzed using transmission infrared spectroscopy (FTIR), XRD (X-ray diffraction) and scanning electron microscopy (SEM). FTIR analysis showed interaction between chondroitin sulfate, bacterial cellulose and calcium phosphate and XRD demonstrated amorphous calcium phosphate and carbonated apatite on bacterial cellulose nanocomposites. SEM images confirmed incorporation of calcium phosphate in bacterial celluloe nanocomposite surface and uniform spherical calcium phosphate particles. Future experiments with cells adhesion and viability are in course.
C1 [de Olyveira, Gabriel Molina; dos Santos, Marcio Luiz; Daltro, Paula Braga; Guastaldi, Antonio Carlos] UNESP, Dept Phys Chem, BR-14800900 Sao Jose Do Rio Preto, Brazil.
   [Basmaji, Pierre] Innovatecs Biotechnol Res & Dev, BR-13560042 Sao Carlos, SP, Brazil.
   [Daltro, Gildasio de Cerqueira] Univ Fed Bahia, Coll Hosp Complex Prof Edgard Santos COM HUPES, BR-40110910 Salvador, BA, Brazil.
RP de Olyveira, GM (reprint author), UNESP, Dept Phys Chem, BR-14800900 Sao Jose Do Rio Preto, Brazil.
RI dos Santos, Marcio/D-9905-2014; Guastaldi, Antonio/O-7379-2014
OI dos Santos, Marcio/0000-0002-3385-7516; Guastaldi,
   Antonio/0000-0002-6433-3555
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Aoki H., 1999, SCI MED APPL HYDROXY, P214
   Aparecida AH, 2009, J MATER SCI-MATER M, V20, P1215, DOI 10.1007/s10856-008-3682-0
   Basmaji P., 2014, J BIOMATER TISS ENG, V4, P1
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Costa L. M. M., 2011, J BIONANOSCIENCE, V5, P167
   DUCHEYNE P, 1988, Journal of Oral Implantology, V14, P325
   Filho L. X., 2013, J NANOSCI NANOTECHNO, V13, P1
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P185, DOI 10.1166/jbt.2012.1044
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P48, DOI 10.1166/jbt.2012.1031
   Million LE, 2008, J BIOMED MATER RES B, V86B, P444, DOI 10.1002/jbm.b.31040
   Olyveira G. M., 2013, J BIOMATER TISS ENG, V2, P31
   Olyveira G. M., 2013, J BIOMEDICAL NANOTEC, V9, P1
   Olyveira GM, 2013, J BIOMATER TISS ENG, V3, P665, DOI 10.1166/jbt.2013.1127
   Ratner D., 1996, BIOMATERIALS SCI INT
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Willians D. F., 1991, CONCISE ENCY MED DEN
   Willians D. F., 1981, BIOCOMPATIBILITY CLI
   Zhbanko R. G., 1966, INFRARED SPECTRA CEL, P325
NR 23
TC 1
Z9 1
U1 1
U2 35
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD FEB
PY 2014
VL 4
IS 2
BP 150
EP 154
DI 10.1166/jbt.2014.1155
PG 5
WC Cell & Tissue Engineering
SC Cell Biology
GA AD0IH
UT WOS:000332917200009
DA 2018-10-20
ER

PT J
AU Shanmugam, G
   Reddy, SMM
   Madhan, B
   Rao, JR
AF Shanmugam, Ganesh
   Reddy, Samala Murali Mohan
   Madhan, Balaraman
   Rao, Jonnalagadda Raghava
TI Method of addition of acetonitrile influences the structure and
   stability of collagen
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE Collagen; Triple helix; Acetonitrile; Denaturation; Circular dichroism
ID TRIPLE-HELIX STABILITY; THERMAL-STABILITY; ORGANIC-SOLVENTS; PEPTIDES;
   HYDROXYPROLINE; STABILIZATION; DENATURATION; GELATIN; TISSUE; MODEL
AB Collagen has been extensively used as a biomaterial in many biomedical applications. Recently, collagen based biomaterials were prepared using organic solvents. In this context, the method of addition of organic solvent described in the present study will be an important contribution in the preparation of collagen-based biomaterials. The effect of acetonitrile on collagen structure and stability was investigated using biophysical methods. Collagen undergoes solvent-induced denaturation with increasing concentration of acetonitrile. It was observed that addition of acetonitrile (50-90%) to a collagen solution in a single shot (method 1) led to precipitation. Contrary, collagen remained in the solution when acetonitrile content was increased to 90% in a collagen solution that had been formerly equilibrated with 20% acetonitrile (method 2). Interestingly, triple helical structure was retained when precipitated collagen, obtained from method 1, was re-dissolved in acetic acid solution. The re-dissolved collagen exhibits comparable melting temperature as that of native collagen. Re-dissolved collagen also showed fibril formation, but with decreased rate. The soluble collagen in 90% acetonitrile, prepared by method 2, is found to be unordered. The above results thus suggest that the method of addition of acetonitrile plays an important role in the folding and unfolding of collagen. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Shanmugam, Ganesh; Reddy, Samala Murali Mohan] CSIR Cent Leather Res Inst, Bioorgan Lab, Madras 600020, Tamil Nadu, India.
   [Madhan, Balaraman] CSIR Cent Leather Res Inst, CHORD, Madras 600020, Tamil Nadu, India.
   [Rao, Jonnalagadda Raghava] CSIR Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Shanmugam, G (reprint author), CSIR Cent Leather Res Inst, Bioorgan Lab, Madras 600020, Tamil Nadu, India.
EM ganesh@clri.res.in
RI Shanmugam, Ganesh/F-3249-2011; Madhan, Balaraman/B-3136-2009
OI Shanmugam, Ganesh/0000-0003-1096-4201; Madhan,
   Balaraman/0000-0002-4198-8452
FU CSIR under a XII plan project; Council of Scientific and Industrial
   Research (CSIR), India
FX This work was supported by CSIR under a XII plan project (Research
   Initiatives for Waterless Tanning, RIWT, CSIR-CLRI communication number:
   1007). One of the authors, S.M.M.R., thanks Council of Scientific and
   Industrial Research (CSIR), India, for financial support as a Junior
   Research Fellowship (JRF). We thank Mr. Arun, Mr. V. Natarajan and Mr.
   R. Sathiesh, Senior Research Fellow, for their experimental help in
   extraction of collagen.
CR Babu IR, 2001, J AM CHEM SOC, V123, P2079, DOI 10.1021/ja002165d
   BACHINGER HP, 1990, MATRIX, V10, P331
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BIANCHI E, 1970, J BIOL CHEM, V245, P3341
   Burck J, 2013, LANGMUIR, V29, P1562
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Chen CC, 2011, ARCH BIOCHEM BIOPHYS, V508, P46, DOI 10.1016/j.abb.2011.01.009
   Chen YS, 2011, BIOPOLYMERS, V96, P60, DOI 10.1002/bip.21470
   Ellender G, 1992, CLIN MATER, V3-4, P201
   GEKKO K, 1983, J BIOCHEM-TOKYO, V94, P199, DOI 10.1093/oxfordjournals.jbchem.a134330
   HART GJ, 1971, BIOCHEM J, V125, P599, DOI 10.1042/bj1250599
   Holmdahl R, 2002, AGEING RES REV, V1, P135, DOI 10.1016/S0047-6374(01)00371-2
   Jariashvili K, 2012, BIOPOLYMERS, V97, P189, DOI 10.1002/bip.21725
   KEEFE J, 1992, Clinical Materials, V9, P155, DOI 10.1016/0267-6605(92)90095-B
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   Mattos C, 2001, CURR OPIN STRUC BIOL, V11, P761, DOI 10.1016/S0959-440X(01)00278-0
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Mu CD, 2007, BIOPOLYMERS, V86, P282, DOI 10.1002/bip.20742
   Paige MF, 2001, MICRON, V32, P341, DOI 10.1016/S0968-4328(00)00037-8
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704
   Prystupa DA, 1996, POLYM GELS NETW, V4, P87, DOI 10.1016/0966-7822(96)00003-2
   RAMACHAN.GN, 1973, BIOCHIM BIOPHYS ACTA, V322, P166, DOI 10.1016/0005-2795(73)90187-6
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   RAMACHANDRAN GN, 1954, NATURE, V174, P269, DOI 10.1038/174269c0
   Ricard-Blum S, 2005, TOP CURR CHEM, V247, P35, DOI 10.1007/b103819
   RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0
   Shanmugam G, 2013, INT J BIOL MACROMOL, V54, P155, DOI 10.1016/j.ijbiomac.2012.12.014
   Shanmugam G, 2009, CHIRALITY, V21, P152, DOI 10.1002/chir.20598
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Shoulders MD, 2009, BIOORG MED CHEM LETT, V19, P3859, DOI 10.1016/j.bmcl.2009.03.168
   SUZUKI E, 1980, INT J BIOL MACROMOL, V2, P54, DOI 10.1016/0141-8130(80)90013-6
   Tamby MC, 2003, AUTOIMMUN REV, V2, P152, DOI 10.1016/S1568-9972(03)00004-1
   Umashankara M, 2003, CHEM COMMUN, P2606, DOI 10.1039/b308581c
   Usha R, 2006, COLLOID SURFACE B, V48, P101, DOI 10.1016/j.colsurfb.2006.01.015
   Usha R, 2004, THERMOCHIM ACTA, V409, P201, DOI 10.1016/S0040-6031(03)00335-6
   Usha R, 1998, J POLYM SCI POL LETT, V37, P1397
   VANDERREST M, 1991, FASEB J, V5, P2814
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Xiong X, 2009, PROCESS BIOCHEM, V44, P1200, DOI 10.1016/j.procbio.2009.06.010
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   Zeugolis DI, 2008, J BIOMAT SCI-POLYM E, V19, P1307, DOI 10.1163/156856208786052344
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhong SP, 2007, MAT SCI ENG C-BIO S, V27, P262, DOI 10.1016/j.msec.2006.05.010
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
NR 47
TC 8
Z9 8
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
EI 1873-3298
J9 PROCESS BIOCHEM
JI Process Biochem.
PD FEB
PY 2014
VL 49
IS 2
BP 210
EP 216
DI 10.1016/j.procbio.2013.11.013
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA AC4NO
UT WOS:000332498200005
DA 2018-10-20
ER

PT J
AU Tsai, YT
   Zhou, J
   Weng, H
   Shen, JH
   Tang, LP
   Hu, WJ
AF Tsai, Yi-Ting
   Zhou, Jun
   Weng, Hong
   Shen, Jinhui
   Tang, Liping
   Hu, Wen-Jing
TI Real- Time Noninvasive Monitoring of In Vivo Infl ammatory Responses
   using a pH Ratiometric Fluorescence Imaging Probe
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE optical probes; near infrared fluorescence; acidosis; biomaterials;
   inflammatory responses
ID FOREIGN-BODY REACTIONS; RAT C6 GLIOMA; INFLAMMATORY RESPONSES; SILICA
   NANOPARTICLES; BIOMATERIAL IMPLANTS; OPTICAL NANOSENSORS;
   CHEMICAL-ANALYSIS; TISSUE RESPONSES; PEBBLE SENSORS; LIVING CELLS
AB It is often difficult to continuously monitor and quantify inflammatory responses in vivo. These dynamic responses however are often accompanied by specific pH changes. A new ratiometric optical pH probe is developed by combining pH-sensitive (CypHer5E) and pH-insensitive (Oyster800) fluorescent dyes into nanoparticles for in vivo optical imaging. By taking the ratio of fluorescence intensities at different wavelengths, these nanosized sensors provide excellent measurement capabilities, and unique mapping, of the continuous in vivo pH changes for three different inflammation models. In each model a strong positive correlation is found between ratiometric pH changes and the corresponding inflammatory response measured by histological analyses. These results indicate that ratiometric imaging can provide a noninvasive, rapid, and highly sensitive optical readout for the pH-ratio changes in vivo. Furthermore this technique may be used to monitor the real-time dynamics of inflammatory processes.
C1 [Tsai, Yi-Ting; Zhou, Jun; Weng, Hong; Shen, Jinhui; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Hu, Wen-Jing] Progenitec Inc, Arlington, TX 76001 USA.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu
FU NIH [R43 GM101776]
FX The authors acknowledge Professor John W. Eaton for his critical review
   of this work. This work is supported by an NIH grant R43 GM101776.
CR Andreev OA, 2007, P NATL ACAD SCI USA, V104, P7893, DOI 10.1073/pnas.0702439104
   Arosio D, 2010, NAT METHODS, V7, P516, DOI [10.1038/NMETH.1471, 10.1038/nmeth.1471]
   Bellocq A, 1998, J BIOL CHEM, V273, P5086, DOI 10.1074/jbc.273.9.5086
   Brasuel M, 2001, ANAL CHEM, V73, P2221, DOI 10.1021/ac0012041
   Cai T, 2007, LANGMUIR, V23, P8663, DOI 10.1021/la700923r
   Cai WB, 2006, NANO LETT, V6, P669, DOI 10.1021/nl052405t
   Carmoa VAS, 2008, NUCL MED COMMUN, V29, P33, DOI 10.1097/MNM.0b013e3282f1bc0d
   Clark HA, 1999, ANAL CHEM, V71, P4837, DOI 10.1021/ac990630n
   DAVIS MH, 1987, BIOCHEM BIOPH RES CO, V149, P40, DOI 10.1016/0006-291X(87)91602-0
   Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199
   Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007
   Gerweck LE, 2006, MOL CANCER THER, V5, P1275, DOI 10.1158/1535-7163.MCT-06-0024
   Hilderbrand SA, 2008, BIOCONJUGATE CHEM, V19, P1635, DOI 10.1021/bc800188p
   Hoet P. M., 2004, J NANOBIOTECHNOL, V2, P12, DOI DOI 10.1186/1477-3155-2-12
   Horisawa E, 2002, PHARMACEUT RES, V19, P132, DOI 10.1023/A:1014260513728
   Jaffer FA, 2007, CIRCULATION, V115, P2292, DOI 10.1161/CIRCULATIONAHA.106.660340
   Ji J, 2000, ANAL CHEM, V72, P3497, DOI 10.1021/ac000080p
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Keyaerts M, 2008, EUR J NUCL MED MOL I, V35, P999, DOI 10.1007/s00259-007-0664-2
   Kim S, 2006, CHEM COMMUN, P2071, DOI 10.1039/b600926c
   Kircher MF, 2004, BIOCONJUGATE CHEM, V15, P242, DOI 10.1021/bc034151d
   La Flamme KE, 2007, BIOMATERIALS, V28, P2638, DOI 10.1016/j.biomaterials.2007.02.010
   Lee H, 2011, BIOCONJUGATE CHEM, V22, P777, DOI 10.1021/bc100584d
   Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   Lindner JR, 2000, CIRCULATION, V102, P2745, DOI 10.1161/01.CIR.102.22.2745
   Mainnemare A, 2004, J DENT RES, V83, P823, DOI 10.1177/154405910408301101
   MARTIN GR, 1994, CANCER RES, V54, P5670
   McNamara KP, 2001, ANAL CHEM, V73, P3240, DOI 10.1021/ac0102314
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Myochin T, 2011, J AM CHEM SOC, V133, P3401, DOI 10.1021/ja1063058
   Nair A, 2011, ACTA BIOMATER, V7, P3887, DOI 10.1016/j.actbio.2011.06.050
   Nair A, 2008, LANGMUIR, V24, P2015, DOI 10.1021/la7025973
   Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074
   Olmez D, 2008, EXP LUNG RES, V34, P501, DOI 10.1080/01902140802271859
   OVERLY CC, 1995, P NATL ACAD SCI USA, V92, P3156, DOI 10.1073/pnas.92.8.3156
   Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8
   PELTON RH, 1986, COLLOID SURFACE, V20, P247, DOI 10.1016/0166-6622(86)80274-8
   PUNNIAMOORTHY A, 1987, J ORAL PATHOL MED, V16, P36, DOI 10.1111/j.1600-0714.1987.tb00674.x
   Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7
   STEEN KH, 1995, J NEUROSCI, V15, P3982
   Sun H, 2006, CHEM MATER, V18, P3381, DOI 10.1021/cm052750j
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748
   Vihola H, 2005, BIOMATERIALS, V26, P3055, DOI 10.1016/j.biomaterials.2004.09.008
   Vijayasekaran S, 1998, BIOMATERIALS, V19, P2255, DOI 10.1016/S0142-9612(98)00128-8
   Wang L, 2005, NANO LETT, V5, P37, DOI 10.1021/nl048417g
   Weng H, 2004, J BIOMAT SCI-POLYM E, V15, P1167, DOI 10.1163/1568562041753106
   Xu H, 2001, ANAL CHEM, V73, P4124, DOI 10.1021/ac0102718
   Yu ZQ, 2005, BASIC CLIN PHARMACOL, V97, P222, DOI 10.1111/j.1742-7843.2005.pto_138.x
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
   Zhou J, 2006, LANGMUIR, V22, P863, DOI 10.1021/la0515773
   Zhou J, 2011, BIOMATERIALS, V32, P9383, DOI 10.1016/j.biomaterials.2011.08.064
   Zhuang HM, 2002, SEMIN NUCL MED, V32, P47, DOI 10.1053/snuc.2002.29278
NR 55
TC 14
Z9 14
U1 5
U2 69
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD FEB
PY 2014
VL 3
IS 2
BP 221
EP 229
DI 10.1002/adhm.201200365
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA AB7DH
UT WOS:000331949000008
PM 23828849
DA 2018-10-20
ER

PT J
AU Lv, FK
   Liu, BL
   Li, WJ
   Jaganathan, GK
AF Lv, Fukou
   Liu, Baolin
   Li, Weijie
   Jaganathan, Ganesh K.
TI Devitrification and recrystallization of nanoparticle-containing
   glycerol and PEG-600 solutions
SO CRYOBIOLOGY
LA English
DT Article
DE Hydroxyapatite nanoparticles; Ice crystal geometry; Phase transition;
   Phase separation; Quenched dispersion; Cryopreservation
ID ICE CRYSTAL-GROWTH; SALMON SALMO-SALAR; AQUEOUS-SOLUTIONS;
   DIMETHYL-SULFOXIDE; MOUSE OOCYTES; WARMING RATE; CRYSTALLIZATION; WATER;
   NUCLEATION; CRYOMICROSCOPY
AB Nanoparticles in solution offer unique electrical, mechanical and thermal properties due to their physical presence and interaction with the state of dispersion. This work is aimed to study the effects of hydroxyapatite (HA) nanoparticles on the devitrification and recrystallization events of two important cryoprotective solutions used in cell and tissue preservation namely glycerol (60% w/w) and PEG-600 (50% w/ w). HA nanoparticles (20, 40 or 60 nm) were incorporated into solutions at the content of 0.1% or 0.5% (w/w), and were studied by differential scanning calorimeter (DSC) and cryomicroscopy. The presence of nanoparticles does not change the glass transition temperatures and melting temperatures of quenched solutions, but significantly affects the behavior of devitrification and recrystallization upon warming. Cryomicroscopic investigation showed the complex interactions among solution type, nanoparticle size and nanoparticle content, which apparently influence ice crystal growth or recrystallization in the quenched dispersions. These findings have significant implications for biomaterial cryopreservation, cryosurgery, and food manufacturing. The complexity of ice crystal growth kinetics in nanoparticle-containing dispersions remains to be poorly understood at the moment. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Lv, Fukou; Liu, Baolin; Li, Weijie; Jaganathan, Ganesh K.] Univ Shanghai Sci & Technol, Inst Biothermal Sci & Technol, Shanghai, Peoples R China.
RP Liu, BL (reprint author), Univ Shanghai Sci & Technol, Inst Biothermal Sci & Technol, Shanghai, Peoples R China.
EM blliuk@163.com
OI Jaganathan, Ganesh K./0000-0003-0972-9263
FU Natural Science Foundation of China [51076108]; Shanghai Dongfang
   Scholars Program;  [20103120110005]
FX This work was supported by the Natural Science Foundation of China
   (Grant No. 51076108), the Doctoral Program (Grant No. 20103120110005)
   and the Shanghai Dongfang Scholars Program.
CR Alizadeh E, 2009, FOOD BIOPROCESS TECH, V2, P257, DOI 10.1007/s11947-008-0157-8
   Baust J, 1997, CRYOBIOLOGY, V34, P373, DOI 10.1006/cryo.1997.2017
   BRONSHTEYN VL, 1995, CRYOBIOLOGY, V32, P1, DOI 10.1006/cryo.1995.1001
   Diller K R, 1970, Cryobiology, V7, P191
   FAHY GM, 1984, CRYOBIOLOGY, V21, P407, DOI 10.1016/0011-2240(84)90079-8
   Gage AA, 1998, CRYOBIOLOGY, V37, P171, DOI 10.1006/cryo.1998.2115
   Gage AA, 2002, CRYOLETTERS, V23, P69
   Gao D, 2000, ILAR J, V41, P187
   Gonda T, 2005, PROG CRYST GROWTH CH, V51, P70, DOI 10.1016/j.pcrysgrow.2005.10.005
   Hagiwara T, 2006, FOOD BIOPHYS, V1, P74, DOI 10.1007/s11483-006-9009-0
   Han X, 2008, MICROFLUID NANOFLUID, V4, P357, DOI 10.1007/s10404-007-0186-z
   Hao B., 2011, J NANOTECHNOLOGY ENG, V2
   Hey JM, 1997, J NON-CRYST SOLIDS, V211, P262, DOI 10.1016/S0022-3093(96)00637-0
   Hey JM, 1998, CRYOBIOLOGY, V37, P119, DOI 10.1006/cryo.1998.2108
   Hey JM, 1996, CRYOBIOLOGY, V33, P205, DOI 10.1006/cryo.1996.0021
   Hoffmann NE, 2002, UROLOGY, V60, P40, DOI 10.1016/S0090-4295(02)01683-7
   Kang HU, 2006, EXP HEAT TRANSFER, V19, P181, DOI 10.1080/08916150600619281
   Kiani H, 2011, TRENDS FOOD SCI TECH, V22, P407, DOI 10.1016/j.tifs.2011.04.011
   Le-Bail A, 2010, FOOD BIOPROCESS TECH, V3, P197, DOI 10.1007/s11947-008-0142-2
   Liu B., 2009, CRYOBIOLOGY, V59, P409
   MAZUR P, 1984, AM J PHYSIOL, V247, pC125
   MAZUR P, 1977, CRYOBIOLOGY, V14, P251, DOI 10.1016/0011-2240(77)90175-4
   Mazur P, 2011, CRYOBIOLOGY, V62, P1, DOI 10.1016/j.cryobiol.2010.10.159
   MEHL P, 1989, THERMOCHIM ACTA, V155, P187, DOI 10.1016/0040-6031(89)87145-X
   MEHL PM, 1990, CRYOBIOLOGY, V27, P378, DOI 10.1016/0011-2240(90)90016-W
   MEHL PM, 1992, THERMOCHIM ACTA, V203, P475, DOI 10.1016/0040-6031(92)85218-K
   MEHL PM, 1993, THERMOCHIM ACTA, V223, P157, DOI 10.1016/0040-6031(93)80130-3
   Mishima O, 1998, NATURE, V396, P329
   Muldrew K, 2001, CRYOBIOLOGY, V42, P182, DOI 10.1006/cryo.2001.2321
   Pegg DE, 2010, CRYOBIOLOGY, V60, pS36, DOI 10.1016/j.cryobiol.2010.02.003
   Petzold G, 2009, FOOD BIOPHYS, V4, P378, DOI 10.1007/s11483-009-9136-5
   Schmidt G, 2003, CURR OPIN COLLOID IN, V8, P103, DOI 10.1016/S1359-0294(03)00008-6
   SCHWARTZ GJ, 1982, CRYOBIOLOGY, V19, P529, DOI 10.1016/0011-2240(82)90182-1
   Sei T, 2002, J CRYST GROWTH, V240, P218, DOI 10.1016/S0022-0248(02)00875-8
   Seki S, 2008, BIOL REPROD, V79, P727, DOI 10.1095/biolreprod.108.069401
   Seki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036058
   Seki S, 2009, CRYOBIOLOGY, V59, P75, DOI 10.1016/j.cryobiol.2009.04.012
   Smith M.J., 1988, HUM REPROD, V3, P795
   Syamaladevi RM, 2012, FOOD BIOPHYS, V7, P57, DOI 10.1007/s11483-011-9243-y
   Teraoka Y, 2002, INT J REFRIG, V25, P218, DOI 10.1016/S0140-7007(01)00082-2
   Uchida T, 2007, J CRYST GROWTH, V299, P125, DOI 10.1016/j.jcrysgro.2006.10.261
   VIGIER G, 1987, J CRYST GROWTH, V84, P309, DOI 10.1016/0022-0248(87)90146-1
   Wang HY, 2009, CRYOBIOLOGY, V59, P83, DOI 10.1016/j.cryobiol.2009.04.013
   Yu SF, 2012, FOOD BIOPROCESS TECH, V5, P391, DOI 10.1007/s11947-011-0526-6
   Yu TH, 2005, CRYOBIOLOGY, V50, P174, DOI 10.1016/j.cryobiol.2005.01.001
NR 45
TC 11
Z9 11
U1 1
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
EI 1090-2392
J9 CRYOBIOLOGY
JI Cryobiology
PD FEB
PY 2014
VL 68
IS 1
BP 84
EP 90
DI 10.1016/j.cryobiol.2013.12.006
PG 7
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA AC0MT
UT WOS:000332190100012
PM 24374134
DA 2018-10-20
ER

PT J
AU Mohamed, KR
   Mousa, SM
   El Bassyouni, GT
AF Mohamed, Khaled R.
   Mousa, Sahar M.
   El Bassyouni, Gehan T.
TI Fabrication of nano structural biphasic materials from phosphogypsum
   waste and their in vitro applications
SO MATERIALS RESEARCH BULLETIN
LA English
DT Article
DE Composites; Nanostructures; Electron microscopy; X-ray diffraction;
   Infrared spectroscopy
ID CALCIUM-PHOSPHATE BIOCERAMICS; ALPHA-TRICALCIUM PHOSPHATE; SOL-GEL
   TECHNIQUE; CRYSTALLINE HYDROXYAPATITE; BIOACTIVITY EVALUATION; DENTIN
   REGENERATION; BONE SUBSTITUTE; CERAMICS; SCAFFOLD; APATITE
AB In this study, a novel process of preparing biphasic calcium phosphate (BCP) is proposed. Also its bioactivity for the utilization of the prepared BCP as a biomaterial is studied. A mixture of calcium hydroxyapatite (HAP) and tricalcium phosphate (beta-TCP) could be obtained by thermal treatment of HAP which was previously prepared from phosphogypsum (PG) waste. The chemical and phase composition, morphology and particle size of prepared samples was characterized by X-ray diffraction (XRD), Infrared spectroscopy (IR), Scanning electron microscopy (SEM) and Transmission electron microscopy (TEM). The bioactivity was investigated by soaking of the calcined samples in simulated body fluid (SBF). Results confirmed that the calcination temperatures played an important role in the formation of calcium phosphate (CP) materials. XRD results indicated that HAP was partially decomposed into beta-TCP. The in vitro data confirmed that the calcined HAP forming BCP besides other phases such as pyrophosphate and silica are bioactive materials. Therefore, BCP will be used as good biomaterials for medical applications. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Mohamed, Khaled R.; El Bassyouni, Gehan T.] Natl Res Ctr, Biomat Dept, Cairo, Egypt.
   [Mousa, Sahar M.] King Abdulaziz Univ, Sci & Art Coll, Dept Chem, Rabigh 21911, Saudi Arabia.
   [Mousa, Sahar M.] Natl Res Ctr, Dept Inorgan Chem, Cairo 11787, Egypt.
   [El Bassyouni, Gehan T.] Taif Univ, Coll Med, Dept Med Phys, At Taif, Saudi Arabia.
RP Mohamed, KR (reprint author), Natl Res Ctr, Biomat Dept, Cairo, Egypt.
EM kh_rezk966@yahoo.com
RI Mousa, Sahar/J-3244-2013
OI El-Bassyouni, Gehan/0000-0001-8438-0570; Mohamed, Khaled
   Rezk/0000-0001-7019-4064; Mousa, Sahar/0000-0003-3790-5084
CR AbdulQader ST, 2013, CERAM INT, V39, P2375, DOI 10.1016/j.ceramint.2012.08.089
   Al-Hwaiti MS, 2010, ACTA GEOCHIM, V29, P261, DOI 10.1007/s11631-010-0455-5
   Ando Y, 2009, NAGOYA J MED SCI, V71, P51
   BLAKESLEE KC, 1971, J AM CERAM SOC, V54, P559, DOI 10.1111/j.1151-2916.1971.tb12207.x
   Boilet L, 2013, CERAM INT, V39, P283, DOI 10.1016/j.ceramint.2012.06.023
   Carrodeguas RG, 2011, ACTA BIOMATER, V7, P3536, DOI 10.1016/j.actbio.2011.06.019
   Chen JD, 2011, MATER LETT, V65, P1923, DOI 10.1016/j.matlet.2011.03.076
   Cheng ZH, 1998, LANGMUIR, V14, P6681, DOI 10.1021/la980339n
   Chu KT, 2013, CERAM INT, V39, P1455, DOI 10.1016/j.ceramint.2012.07.089
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   DUCHEYNE P, 1987, J BIOMED MATER RES-A, V21, P219
   El Kady AA, 2009, CERAM INT, V35, P2933, DOI 10.1016/j.ceramint.2009.03.042
   Elfayoumi MAK, 2010, MAT SCI ENG C-MATER, V30, P509, DOI 10.1016/j.msec.2010.01.012
   Farzadi A, 2011, CERAM INT, V37, P65, DOI 10.1016/j.ceramint.2010.08.021
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Fathi MH, 2009, J CRYST GROWTH, V311, P1392, DOI 10.1016/j.jcrysgro.2008.11.100
   Fleet ME, 2007, BIOMATERIALS, V28, P916, DOI 10.1016/j.biomaterials.2006.11.003
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Hanna AA, 1999, J MATER SCI TECHNOL, V15, P431
   HLAVAY J, 1978, CLAY CLAY MINER, V26, P139, DOI 10.1346/CCMN.1978.0260209
   Hui Y., 2008, T NONFERR METAL SOC, V18, P913
   Jaroenworaluck A, 2007, EUROPEAN CELLS MAT, V14, P67
   Kawata M, 2004, J MATER SCI-MATER M, V15, P817, DOI 10.1023/B:JMSM.0000032823.66093.aa
   Klug H.P., 1997, XRAY DIFFRACTION PRO, P637
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kuriakose TA, 2004, J CRYST GROWTH, V263, P517, DOI 10.1016/j.jcrysgro.2003.11.057
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Li YB, 2007, ACTA BIOMATER, V3, P251, DOI 10.1016/j.actbio.2006.07.003
   Lobo SE, 2010, MATERIALS, V3, P815, DOI 10.3390/ma3020815
   Lukic M, 2011, J EUR CERAM SOC, V31, P19, DOI 10.1016/j.jeurceramsoc.2010.09.006
   Menon P. R., 1995, Proceedings of the 1995 Fourteenth Southern Biomedical Engineering Conference (Cat. No.95TH0703-9), P95, DOI 10.1109/SBEC.1995.514446
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Mohamed KR, 2011, CERAM INT, V37, P3265, DOI 10.1016/j.ceramint.2011.05.121
   MORTIER A, 1989, THERMOCHIM ACTA, V143, P265, DOI 10.1016/0040-6031(89)85065-8
   Mousa S, 2013, MATER RES BULL, V48, P823, DOI 10.1016/j.materresbull.2012.11.067
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Rashchi F, 2000, MINER ENG, V13, P1019, DOI 10.1016/S0892-6875(00)00087-X
   Shuai CJ, 2013, MATER CHARACT, V77, P23, DOI 10.1016/j.matchar.2012.12.009
   Tayibi H, 2009, J ENVIRON MANAGE, V90, P2377, DOI 10.1016/j.jenvman.2009.03.007
   Tonomura A, 2010, ANN BIOMED ENG, V38, P1664, DOI 10.1007/s10439-010-9910-z
   Varma HK, 2005, CERAM INT, V31, P109, DOI 10.1016/j.ceramint.2004.03.041
   Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035
   Veljovic D, 2010, CERAM INT, V36, P595, DOI 10.1016/j.ceramint.2009.09.038
   Viswanath B, 2008, BIOMATERIALS, V29, P4855, DOI 10.1016/j.biomaterials.2008.09.001
   Wu SC, 2011, MATER CHARACT, V62, P526, DOI 10.1016/j.matchar.2011.03.014
   Yang JK, 2009, CONSTR BUILD MATER, V23, P687, DOI 10.1016/j.conbuildmat.2008.02.011
   Zhang HQ, 2011, MATER CHEM PHYS, V126, P642, DOI 10.1016/j.matchemphys.2010.12.067
   Zhoa H., 2008, MATER CHEM PHYS, V111, P265
   Zhou J, 2012, CONSTR BUILD MATER, V34, P114, DOI 10.1016/j.conbuildmat.2012.02.045
   Zyman ZZ, 2008, J MATER SCI-MATER M, V19, P2819, DOI 10.1007/s10856-008-3402-9
NR 52
TC 8
Z9 9
U1 0
U2 33
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0025-5408
EI 1873-4227
J9 MATER RES BULL
JI Mater. Res. Bull.
PD FEB
PY 2014
VL 50
BP 432
EP 439
DI 10.1016/j.materresbull.2013.11.023
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA AB6ST
UT WOS:000331920500073
DA 2018-10-20
ER

PT J
AU Jeon, HJ
   Lee, H
   Kim, GH
AF Jeon, Ho Jun
   Lee, Hyeongjin
   Kim, Geun Hyung
TI Nano-Sized Surface Patterns on Electrospun Microfibers Fabricated Using
   a Modified Plasma Process for Enhancing Initial Cellular Activities
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE electrospun fibers; hierarchical surface pattern; biomaterial
ID TISSUE ENGINEERING APPLICATIONS; NANOFIBER MESHES; DIFFERENTIATION;
   NANOSCALE; PROLIFERATION; ORGANIZATION; SCAFFOLDS; ADHESION; MICRO;
   SHAPE
AB An easy and versatile method of generating a nano-sized patterned surface on a nonwoven mat of electrospun poly(E-caprolactone) (PCL) fibers is described. A nano-sized pattern could be achieved on the surface of the microfiber mat using a modified plasma-treatment method with two nano-sized templates (100 and 800nm). Initial cell attachment and proliferation using osteoblast-like-cells (MG63) were enhanced dramatically compared to a conventional plasma-treated fiber mat. This new type of plasma-treated fiber has high potential as a biomaterial, and can be employed for various tissue engineering applications.
C1 [Jeon, Ho Jun; Lee, Hyeongjin; Kim, Geun Hyung] Sungkyunkwan Univ, Coll Biotechnol & Bioengn, Dept Biomechatron Engn, Suwon, South Korea.
RP Kim, GH (reprint author), Sungkyunkwan Univ, Coll Biotechnol & Bioengn, Dept Biomechatron Engn, Suwon, South Korea.
EM gkimbme@skku.edu
FU National Research Foundation of Korea grant; Ministry of Education,
   Science, and Technology (MEST) [NRF-2012R1A2A2A01017435]; Korean Health
   Technology R&D Project, Ministry of Health & Welfare, Republic of Korea
   [A120942]
FX This research was financially supported by the National Research
   Foundation of Korea grant funded by the Ministry of Education, Science,
   and Technology (MEST) (Grant No. NRF-2012R1A2A2A01017435) and also was
   partially supported by a grant of the Korean Health Technology R&D
   Project, Ministry of Health & Welfare, Republic of Korea (Grant no.
   A120942).
CR Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Chen JP, 2011, ACTA BIOMATER, V7, P234, DOI 10.1016/j.actbio.2010.08.015
   Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043
   CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Hwang IT, 2009, COLLOID SURFACE B, V74, P375, DOI 10.1016/j.colsurfb.2009.08.007
   Jacobs T, 2012, PLASMA CHEM PLASMA P, V32, P1039, DOI 10.1007/s11090-012-9394-8
   Karuri NW, 2006, IEEE T NANOBIOSCI, V5, P273, DOI 10.1109/TNB.2006.886570
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021
   Kumar G, 2012, BIOMATERIALS, V33, P4022, DOI 10.1016/j.biomaterials.2012.02.048
   Lee H, 2013, J MATER CHEM B, V1, P3670, DOI 10.1039/c3tb20424c
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648
   Martins A, 2009, J TISSUE ENG REGEN M, V3, P37, DOI 10.1002/term.132
   Nandakumar A, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015006
   Nandakumar A, 2013, SMALL, V9, P3405, DOI 10.1002/smll.201300220
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Shevach M, 2013, J MATER CHEM B, V1, P5210, DOI 10.1039/c3tb20584c
   Slater JH, 2011, ADV FUNCT MATER, V21, P2876, DOI 10.1002/adfm.201100297
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Yamazoe H, 2008, LANGMUIR, V24, P8402, DOI 10.1021/la801221r
   Yan D, 2013, J BIOMED MATER RES A, V101, P963, DOI 10.1002/jbm.a.34398
   Yildirim ED, 2011, PLASMA PROCESS POLYM, V8, P256, DOI 10.1002/ppap.201000009
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
NR 29
TC 6
Z9 6
U1 0
U2 11
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1612-8850
EI 1612-8869
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD FEB
PY 2014
VL 11
IS 2
BP 142
EP 148
DI 10.1002/ppap.201300144
PG 7
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA AB7GE
UT WOS:000331956700007
DA 2018-10-20
ER

PT J
AU Wang, FJ
   Zheng, Z
   Wang, W
   Gu, ZQ
   Wang, J
   Wang, XL
AF Wang, Fangjie
   Zheng, Zhen
   Wang, Wei
   Gu, Zhenqian
   Wang, Jing
   Wang, Xinling
TI Trypsin-inspired poly(urea-urethane)s containing phenylalanine-lysine
   ethyl ester-phenylalanine units
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Degradation; Poly(urea-urethane); Tri-peptide; Trypsin; Enzymatic
ID TYROSINE-BASED POLYURETHANES; GROWTH-FACTOR DELIVERY; BIOMATERIAL
   APPLICATIONS; AMINO-ACID; SURFACE FUNCTIONALIZATION; SCAFFOLDS;
   CYTOCOMPATIBILITY; PUTRESCINE
AB A novel tri-peptide derivative phenylalanine-lysine ethyl ester-phenylalanine (PLP) was synthesized by carbodiimide hydrochloride (EDC center dot HCl) mediated coupling reaction from phenylalanine and lysine ethyl ester in the presence of NHS. Then PLP was used as a chain extender to synthesize a kind of trypsin-inspired poly(urea-urethane)s (PLP-PU) with polyethylene glycol (PEG) as soft segment and hexamethylene diisocyanate (HDI) as hard segment. Enzymatic degradation tests showed that PLP unit was very sensitive to trypsin in its solution. Experimental results indicated that the degradability was obviously improved by introducing PLP into the main chain of poly(urea-urethane) because the PLP was effectively broken by the action of trypsin in the process of degradation. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Wang, Fangjie; Zheng, Zhen; Wang, Wei; Gu, Zhenqian; Wang, Jing; Wang, Xinling] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
RP Wang, XL (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
EM xlwang@sjtu.edu.cn
FU National Science Fund of China [21274085]; Shanghai Leading Academic
   Discipline Project [B202]
FX This project is supported by the National Science Fund of China
   (21274085) and the Shanghai Leading Academic Discipline Project (No.
   B202)
CR Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017
   Brandon C, 1999, INTRO PROTEIN STRUCT, P159
   Buruiana EC, 2004, J BIOMAT SCI-POLYM E, V15, P781, DOI 10.1163/156856204774196162
   Choi WS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044104
   Fung YS, 2001, ANAL CHEM, V73, P5302, DOI 10.1021/ac010655y
   Gao ZY, 2009, NEW CHEM MAT, V3, P74
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Guelcher SA, 2008, BIOMATERIALS, V29, P1762, DOI 10.1016/j.biomaterials.2007.12.046
   Huang M. N., 2009, J BIOMED SCI ENG, V2, P36
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   Jozwiak AB, 2008, J MATER CHEM, V18, P2240, DOI 10.1039/b719025e
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Leonard JK, 2012, MACROMOLECULES, V45, P677
   Lu HX, 2012, POLYM CHEM-UK, V3, P498, DOI 10.1039/c2py00481j
   Marcos-Fernandez A, 2006, POLYMER, V47, P785, DOI 10.1016/j.polymer.2005.12.007
   MOLLY SS, 2010, MACROMOLECULES, V43, P581
   MORI A, 1985, BIOMATERIALS, V6, P325, DOI 10.1016/0142-9612(85)90088-2
   Nakamura M, 2008, BIOMATERIALS, V29, P2977, DOI 10.1016/j.biomaterials.2008.04.006
   Parrag IC, 2010, J BIOMAT SCI-POLYM E, V21, P843, DOI 10.1163/156856209X446743
   Salacinski HJ, 2003, J BIOMED MATER RES A, V66A, P688, DOI 10.1002/jbm.a.10020
   Sarkar D, 2007, EXPRESS POLYM LETT, V1, P724, DOI 10.3144/expresspolymlett.2007.100
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   Sarkar D, 2007, POLYM DEGRAD STABIL, V92, P1994, DOI 10.1016/j.polymdegradstab.2007.08.003
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Skarja GA, 2001, J BIOMAT SCI-POLYM E, V12, P851, DOI 10.1163/156856201753113060
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Wang H, 2004, LANGMUIR, V20, P1877, DOI 10.1021/la035376f
   Ward J, 2010, BIOMACROMOLECULES, V11, P3093, DOI 10.1021/bm100898p
   Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011
   Woessner J.F., 2000, MATRIX METALLOPROTEI
   Xu XL, 2007, EUR POLYM J, V43, P3187, DOI 10.1016/j.eurpolymj.2007.05.024
   Yue YM, 2008, J APPL POLYM SCI, V6, P3836
   Zhou LJ, 2011, MACROMOLECULES, V44, P857, DOI 10.1021/ma102346a
NR 37
TC 2
Z9 2
U1 2
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
EI 1873-2321
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD FEB
PY 2014
VL 100
BP 86
EP 92
DI 10.1016/j.polymdegradstab.2013.12.007
PG 7
WC Polymer Science
SC Polymer Science
GA AB6UN
UT WOS:000331925100011
DA 2018-10-20
ER

PT J
AU Garcia, AJ
AF Garcia, Andres J.
TI PEG-Maleimide Hydrogels for Protein and Cell Delivery in Regenerative
   Medicine
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Biomaterial; Integrin; RGD; Cell adhesion; Tissue repair
ID ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; FACTOR GENE DELIVERY;
   ISLET TRANSPLANTATION; MYOCARDIAL-INFARCTION; PANCREATIC-ISLETS;
   EXTRACELLULAR-MATRIX; PEPTIDE NANOFIBERS; CONTROLLED-RELEASE; MICHAEL
   ADDITION
AB Protein- and cell-based therapies represent highly promising strategies for regenerative medicine, immunotherapy, and oncology. However, these therapies are significantly limited by delivery considerations, particularly in terms of protein stability and dosing kinetics as well as cell survival, engraftment, and function. Hydrogels represent versatile and robust delivery vehicles for proteins and cells due to their high water content that retains protein biological activity, high cytocompatibility and minimal adverse host reactions, flexibility and tunability in terms of chemistry, structure, and polymerization format, ability to incorporate various biomolecules to convey biofunctionality, and opportunity for minimally invasive delivery as injectable carriers. This review highlights recent progress in the engineering of poly(ethylene glycol) hydrogels cross-linked using maleimide reactive groups for protein and cell delivery.
C1 Georgia Inst Technol, Petit Inst Bioengn & Biosci, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
FU NIH [R01 AR062368, R01 AR062920, DP3 DK094346]; NSF [CBET 0939511];
   Juvenile Diabetes Research Foundation [17-2013-277]
FX AJG is partially supported by the NIH (R01 AR062368, R01 AR062920, DP3
   DK094346), NSF (CBET 0939511) and the Juvenile Diabetes Research
   Foundation (17-2013-277).
CR Alejandro R, 2008, TRANSPLANTATION, V86, P1783, DOI 10.1097/TP.0b013e3181913f6a
   Almeda FQ, 2001, CRIT CARE CLIN, V17, P411, DOI 10.1016/S0749-0704(05)70175-5
   Anversa P, 2013, J CLIN INVEST, V123, P62, DOI 10.1172/JCI63068
   Baldwin SP, 1998, ADV DRUG DELIVER REV, V33, P71, DOI 10.1016/S0169-409X(98)00021-0
   Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649
   Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063
   Brady AC, 2013, TISSUE ENG A
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Centers for Disease Control and Prevention, 2005, NAT DIAB FACT SHEET
   Cheng K, 2004, GENE THER, V11, P1105, DOI 10.1038/sj.gt.3302267
   Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589
   Cheng Y, 2007, WORLD J GASTROENTERO, V13, P2862
   Chiu LLY, 2012, REGEN MED, V7, P523, DOI [10.2217/rme.12.35, 10.2217/RME.12.35]
   Chung IM, 2008, BIOMATERIALS, V29, P2637, DOI 10.1016/j.biomaterials.2008.03.008
   Cittadini A, 2011, EUR J HEART FAIL, V13, P1264, DOI 10.1093/eurjhf/hfr143
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Emamaullee JA, 2007, CELL TRANSPLANT, V16, P1, DOI 10.3727/000000007783464461
   Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103
   Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663
   Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x
   Fu Y, 2011, J BIOMED MATER RES A, V98A, P201, DOI 10.1002/jbm.a.33106
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Hiemstra C, 2007, BIOMACROMOLECULES, V8, P1548, DOI 10.1021/bm061191m
   Hiemstra C, 2007, MACROMOLECULES, V40, P1165, DOI 10.1021/ma062468d
   Hiscox AM, 2008, TISSUE ENG PT A, V14, P433, DOI 10.1089/tea.2007.0099
   Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749
   Hou JY, 2013, STEM CELL REV REP, V9, P326, DOI 10.1007/s12015-012-9421-4
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Hu BH, 2009, BIOMACROMOLECULES, V10, P2194, DOI 10.1021/bm900366e
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Hunt NC, 2013, TISSUE ENG PT A, V19, P905, DOI [10.1089/ten.TEA.2012.0197, 10.1089/ten.tea.2012.0197]
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kim J, 2007, BIOMACROMOLECULES, V8, P3682, DOI 10.1021/bm700756z
   Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139
   Kopecek J, 2012, ANGEW CHEM INT EDIT, V51, P7396, DOI 10.1002/anie.201201040
   Lakey JRT, 2006, METH MOL B, V333, P47
   Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399
   Lee DY, 2007, BIOMATERIALS, V28, P1957, DOI 10.1016/j.biomaterials.2006.12.015
   Leslie-Barbick JE, 2011, BIOMATERIALS, V32, P5782, DOI 10.1016/j.biomaterials.2011.04.060
   Li XY, 2010, CARDIOLOGY, V115, P194, DOI 10.1159/000281840
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Linn T, 2006, CLIN EXP IMMUNOL, V144, P179, DOI 10.1111/j.1365-2249.2006.03066.x
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Malliaras K, 2011, CLIN PHARMACOL THER, V90, P532, DOI 10.1038/clpt.2011.175
   Mathieu E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051991
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Narang AS, 2006, PHARMACOL REV, V58, P194, DOI 10.1124/pr.58.2.6
   Narang AS, 2004, PHARM RES, V21, P15, DOI 10.1023/B:PHAM.0000012147.52900.b8
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Phelps EA, 2015, DRUG DELIV TRANSL RE, V5, P125, DOI 10.1007/s13346-013-0142-2
   Phelps EA, 2013, BIOMATERIALS, V34, P4602, DOI 10.1016/j.biomaterials.2013.03.012
   Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Prokoph S, 2012, BIOMATERIALS, V33, P4792, DOI 10.1016/j.biomaterials.2012.03.039
   Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106
   Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Salimath AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050980
   SAWHNEY AS, 1994, BIOTECHNOL BIOENG, V44, P383, DOI 10.1002/bit.260440317
   Schmidt JJ, 2008, J BIOMED MATER RES A, V87A, P1113, DOI 10.1002/jbm.a.32287
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267
   Shikanov A, 2011, BIOMATERIALS, V32, P2524, DOI 10.1016/j.biomaterials.2010.12.027
   Sigrist S, 2003, CELL TRANSPLANT, V12, P627, DOI 10.3727/000000003108747109
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Smith R.R., 2013, BIOMATTER, V3
   Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]
   Stabler CL, 2007, BIOCONJUGATE CHEM, V18, P1713, DOI 10.1021/bc7002814
   Stendahl JC, 2008, TRANSPLANTATION, V86, P478, DOI 10.1097/TP.0b013e3181806d9d
   Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195
   Su J, 2010, BIOMATERIALS, V31, P308, DOI 10.1016/j.biomaterials.2009.09.045
   Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Vaithilingam V, 2008, CURR OPIN ORGAN TRAN, V13, P633, DOI 10.1097/MOT.0b013e328317a48b
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Weber LM, 2007, CELL TRANSPLANT, V16, P1049, DOI 10.3727/000000007783472336
   Weber LM, 2008, MATRIX BIOL, V27, P667, DOI 10.1016/j.matbio.2008.08.001
   Wilson JT, 2008, NANO LETT, V8, P1940, DOI 10.1021/nl080694q
   Yu HQ, 2006, SOFT MATTER, V2, P343, DOI 10.1039/b517206c
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 97
TC 15
Z9 15
U1 7
U2 55
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD FEB
PY 2014
VL 42
IS 2
SI SI
BP 312
EP 322
DI 10.1007/s10439-013-0870-y
PG 11
WC Engineering, Biomedical
SC Engineering
GA AB7ND
UT WOS:000331976300007
PM 23881112
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rapsch, K
   Bier, FF
   Tadros, M
   von Nickisch-Rosenegk, M
AF Rapsch, Karsten
   Bier, Frank F.
   Tadros, Monier
   von Nickisch-Rosenegk, Markus
TI Identification of Antimicrobial Peptides and Immobilization Strategy
   Suitable for a Covalent Surface Coating with Biocompatible Properties
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID IN-VITRO; BACTERIAL; INFECTIONS; CATHETERS; BIOFILMS; RELEASE; DRUGS;
   VIVO
AB Bacterial accumulation on solid material displays a major source of biomaterial associated infections, cross contamination, and spreading. To overcome these problems, different investigations on surface modifications for the containment of bacterial adhesion have been done. The aim of this research is the development of a rapid and efficient screening procedure to identify and investigate biologically active peptides in an immobilized state in order to produce an antimicrobial surface coating. We figured out that the antimicrobial mode of action is the most important parameter because only peptides with pronounced membrane disruption abilities displayed meaningful activity in an immobilized state. In addition, we highlighted the influence of the coupling reaction chemistry on the activity and amount of the immobilized peptide. Thereupon we developed an optimized antimicrobial surface coating with unrestricted antimicrobial properties by adjusting the immobilization strategy in combination with lowering the necessary peptide amount. Moreover we demonstrated that this antimicrobial surface coating displayed no cytotoxic activity against a eukaryotic cell line and thereby indicates a promising biocompatibility. Furthermore, different antimicrobial peptides obtained either by chemical peptide synthesis or by recombinant DNA technology were used in this study and their activities as well as their potential applications were discussed.
C1 [Rapsch, Karsten; Bier, Frank F.; von Nickisch-Rosenegk, Markus] Fraunhofer Inst Biomed Engn IBMT, Branch Potsdam, D-14476 Potsdam, Germany.
   [Tadros, Monier] Int Lab Biotechnol & Consulting GmbH ILBG, D-14473 Potsdam, Germany.
RP Rapsch, K (reprint author), Fraunhofer Inst Biomed Engn IBMT, Branch Potsdam, Muehlenberg 13, D-14476 Potsdam, Germany.
EM karsten.rapsch@ibmt.fraunhofer.de
FU German Federal Ministry of Education and Research [03IS2201A]; Ministry
   of Economy of the Federal State of Brandenburg
   [ILB80139358/ILB80139359]; EU
FX This work was supported by the German Federal Ministry of Education and
   Research Grant 03IS2201A and the Ministry of Economy of the Federal
   State of Brandenburg Grant ILB80139358/ILB80139359 and was cofinanced by
   the EU, European Funds for Regional Development (EFRE). We gratefully
   acknowledge Simone Aubele, Anne Thomas, and Martina Obry for technical
   assistance.
CR Ando T, 1973, Mol Biol Biochem Biophys, V12, P1
   Appendini P, 2001, J APPL POLYM SCI, V81, P609, DOI 10.1002/app.1476
   Avalos V.I, 2013, BIOINTERPHASES, V8, P22
   Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Bryers JD, 2006, BIOMATERIALS, V27, P5039, DOI 10.1016/j.biomaterials.2006.05.034
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   Clinical and Laboratory Standards Institute, 2006, M100S16CLSI
   Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Etienne O, 2004, ANTIMICROB AGENTS CH, V48, P3662, DOI 10.1128/AAC.48.10.3662-3669.2004
   European Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical M Infectious D, 2003, CLIN MICROBIOL INFEC, V9, pIX, DOI DOI 10.1046/J.1469-0691.2003.00790.X
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0
   Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Hong Y, 2008, LANGMUIR, V24, P5003, DOI 10.1021/la703564q
   Jones JR, 2006, J MATER SCI-MATER M, V17, P989, DOI 10.1007/s10856-006-0434-x
   KAMAL GD, 1991, JAMA-J AM MED ASSOC, V265, P2364, DOI 10.1001/jama.265.18.2364
   Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]
   Mad F. D., 2008, ANTIMICROB AGENTS CH, V52, P1957
   MAGNUSSON KE, 1989, BIOCHEM SOC T, V17, P454, DOI 10.1042/bst0170454
   Matl FD, 2009, J BIOMAT SCI-POLYM E, V20, P1439, DOI 10.1163/092050609X12457418973107
   Onaizi S. A., 2010, BIOTECHNOL ADV, V29, P67
   Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097
   Ramstedt M, 2009, BIOMATERIALS, V30, P1524, DOI 10.1016/j.biomaterials.2008.12.008
   Ravikumar T, 2006, BIOMACROMOLECULES, V7, P2762, DOI 10.1021/bm060476w
   Shukla A, 2010, BIOMATERIALS, V31, P2348, DOI 10.1016/j.biomaterials.2009.11.082
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375
   Soliman W, 2010, J PHYS CHEM B, V114, P11292, DOI 10.1021/jp104024d
   Tadros M., 2009, U.S. Patent, Patent No. [US 7544483 B2, 7544483]
   Tadros M., 2003, World-wide Patent, Patent No. [WO 2003/106485 A1, 2003106485]
   Thornton J, 1996, ANAESTHESIA, V51, P1018, DOI 10.1111/j.1365-2044.1996.tb14994.x
   UTSUGI T, 1991, CANCER RES, V51, P3062
   Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521
NR 42
TC 18
Z9 19
U1 2
U2 52
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD FEB
PY 2014
VL 25
IS 2
BP 308
EP 319
DI 10.1021/bc4004469
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA AB4SH
UT WOS:000331779700014
PM 24372365
DA 2018-10-20
ER

PT J
AU Thomas, NP
   Tran, N
   Tran, PA
   Walters, JL
   Jarrell, JD
   Hayda, RA
   Born, CT
AF Thomas, Nathan P.
   Nhiem Tran
   Tran, Phong A.
   Walters, Jerry L.
   Jarrell, John D.
   Hayda, Roman A.
   Born, Christopher T.
TI Characterization and bioactive properties of zirconia based polymeric
   hybrid for orthopedic applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MECHANICAL-PROPERTIES; NANOPHASE CERAMICS; IN-VITRO; SURFACE; TITANIUM;
   COATINGS; ADHESION; OXIDE; NANOTECHNOLOGY; BIOMATERIAL
AB Zirconia is a transition metal oxide with current applications to orthopedic implants. It has been shown to up-regulate specific genes involved in bio-integration and injury repair. This study examines the effects of zirconia and polydimethylsiloxane (PDMS) hybrids on the proliferation and viability of human primary osteoblast and fibroblast cells. In this study, zirconia-PDMS hybrid coatings were synthesized using a modified sol gel process. The hybrid material was characterized using optical microscopy, scanning electron microscopy, X-ray photoelectron spectroscopy, and contact angle analysis. This study demonstrates that Zr-PMDS surface materials display hydrophobic surface properties coupled with a preferential deposition of polymer near the surface. Primary osteoblast and fibroblast proliferation and viability on hybrid coated surfaces were evaluated via a rapid screening methodology using WST-1 and calcein AM assays. The cells were seed at 5,000 cells per well in 96-well plates coated with various composition of Zr-PDMS hybrids. The results showed increasing cell proliferation with increasing zirconia concentration, which peaked at 90 % v/v zirconia. Proliferation of osteoblasts and fibroblasts displayed similar trends on the hybrid material, although osteoblasts displayed a bi-phasic dose response by the calcein AM assay. The results of this current study show that Zr-PDMS may be used to influence tissue-implant integration, supporting the use of the hybrid as a promising coating for orthopedic trauma implants.
C1 [Thomas, Nathan P.; Nhiem Tran; Tran, Phong A.; Walters, Jerry L.; Jarrell, John D.; Hayda, Roman A.; Born, Christopher T.] Brown Univ, Dept Orthoped, Alpert Med Sch, Providence, RI 02905 USA.
   [Nhiem Tran; Tran, Phong A.; Hayda, Roman A.; Born, Christopher T.] Rhode Isl Hosp, Weiss Ctr Orthopaed Trauma Res, Providence, RI 02905 USA.
   [Jarrell, John D.; Born, Christopher T.] BioIntraface Inc, North Kingstown, RI 02852 USA.
RP Born, CT (reprint author), Brown Univ, Dept Orthoped, Alpert Med Sch, Suite 200,2 Dudley St, Providence, RI 02905 USA.
EM Christopher_Born@brown.edu
RI Tran, Phong/I-4039-2017
OI Tran, Phong/0000-0003-2820-7399; Jarrell, John/0000-0001-8179-9456
FU RIH Orthopedic Foundation; Stein/Bellet Foundation for Orthopedic Trauma
   Research; Vietnam Education Foundation
FX This project was supported in part by the RIH Orthopedic Foundation, the
   Stein/Bellet Foundation for Orthopedic Trauma Research, and the Vietnam
   Education Foundation. The authors would like to thank Mike Platek for
   the help with XPS. SEM and contact angle measurements were performed at
   the Leduc Imaging Facility and the Tripathi Lab, Brown University
   respectively.
CR Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Dalal A, 2012, J BIOMED MATER RES A, V100A, P2147, DOI 10.1002/jbm.a.34122
   Depprich Rita, 2008, Head Face Med, V4, P29, DOI 10.1186/1746-160X-4-29
   Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30
   Jarrell JD, 2010, J BIOMED MATER RES A, V92A, P1094, DOI 10.1002/jbm.a.32435
   Jarrell JD, 2009, J BIOMED MATER RES A, V90A, P272, DOI 10.1002/jbm.a.32093
   Kim S, 2008, ARTHRIT RHEUM-ARTHR, V59, P481, DOI 10.1002/art.23525
   Kohal RJ, 2011, CLIN ORAL IMPLAN RES, V22, P808, DOI 10.1111/j.1600-0501.2010.02067.x
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kuo WH, 2011, BIOMACROMOLECULES, V12, P4348, DOI 10.1021/bm2013185
   Liu XY, 2006, BIOMATERIALS, V27, P3904, DOI 10.1016/j.biomaterials.2006.03.007
   Martin RA, 2012, PHILOS T R SOC A, V370, P1422, DOI 10.1098/rsta.2011.0308
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   Milanesi F, 2010, J PHYS CHEM C, V114, P8287, DOI 10.1021/jp1014669
   Mills KL, 2008, J MATER RES, V23, P37, DOI 10.1557/JMR.2008.0029
   Nakade M, 2004, J MATER SCI, V39, P4131, DOI 10.1023/B:JMSC.0000033393.11687.cf
   Nhiem T, 2011, ACTA BIOMATER, V7, P1298, DOI 10.1016/j.actbio.2010.10.004
   Palmieri A, 2008, CLIN IMPLANT DENT R, V10, P200, DOI 10.1111/j.1708-8208.2007.00078.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sato M, 2004, EXPERT REV MED DEVIC, V1, P105, DOI 10.1586/17434440.1.1.105
   Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003
   Tran N, 2013, BIOMED RES INT, DOI 10.1155/2013/674378
   Tran N, 2009, WIRES NANOMED NANOBI, V1, P336, DOI 10.1002/wnan.23
   Uchida M, 2002, J BIOMED MATER RES, V60, P277, DOI 10.1002/jbm.10071
   Uchida M, 2002, BIOMATERIALS, V23, P313, DOI 10.1016/S0142-9612(01)00110-7
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang GC, 2011, COLLOID SURFACE B, V86, P267, DOI 10.1016/j.colsurfb.2011.04.006
   Wang GC, 2010, ACTA BIOMATER, V6, P990, DOI 10.1016/j.actbio.2009.09.021
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Xia ZC, 2000, J MECH PHYS SOLIDS, V48, P1107, DOI 10.1016/S0022-5096(99)00081-2
   Yamashita D, 2009, DENT MATER J, V28, P461, DOI 10.4012/dmj.28.461
   Young MD, 2014, J BIOMED MATER RES A, V102, P1478, DOI 10.1002/jbm.a.34832
   Yuan L, 2011, MACROMOL BIOSCI, V11, P1031, DOI 10.1002/mabi.201000464
NR 35
TC 4
Z9 4
U1 1
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2014
VL 25
IS 2
BP 347
EP 354
DI 10.1007/s10856-013-5093-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB2NW
UT WOS:000331630400008
PM 24243225
DA 2018-10-20
ER

PT J
AU Floriano, JF
   da Mota, LSLS
   Furtado, EL
   Rossetto, VJV
   Graeff, CFO
AF Floriano, Juliana Ferreira
   Lima Silveira da Mota, Ligia Souza
   Furtado, Edson Luiz
   Vieira Rossetto, Victor Jose
   Graeff, Carlos F. O.
TI Biocompatibility studies of natural rubber latex from different tree
   clones and collection methods
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HEVEA-BRASILIENSIS; COMET ASSAY; NEUTRAL RED; CYTOTOXICITY;
   BIOMATERIALS; GUIDELINES
AB Natural rubber latex (NRL) has several features that make it an excellent biomaterial to promote the growth and repair of tissues, skin and bones. Most of the research with NRL membranes uses a mixture of different clones and chemical preservatives in the collection process. In this study, we compared five clones that produce NRL, seeking to identify their differences in biocompatibility. The clones studied were RRIM 600, PB 235, GT1, PR 255 and IAN 873 commonly found in plantations in Brazil. We did also study the effect of ammonia used during latex collection. NRL membranes were prepared aseptically and sterilized. In the in vitro tests, the membranes remained in direct contact with mouse fibroblasts cells for three periods, 24, 48 and 72 h. In the in vivo tests, the membranes were implanted subcutaneously in rabbits. The results indicated the biocompatibility of the membranes obtained from all clones. Membranes from the clones RRIM 600 and IAN 873 induced greater cell proliferation, suggesting greater bioactivity. It was found that the membranes made from latex that was in contact with ammonia during collection, showed cytotoxic and genotoxic effects in cultures, as well as necrosis, and increased inflammatory cells in the rabbit's tissues close to the implant.
C1 [Floriano, Juliana Ferreira; Graeff, Carlos F. O.] Univ Estadual Paulista, Dept Fis, BR-17033360 Bauru, SP, Brazil.
   [Lima Silveira da Mota, Ligia Souza] Univ Estadual Paulista, Dept Genet, Botucatu, SP, Brazil.
   [Furtado, Edson Luiz] Univ Estadual Paulista, Dept Prod Vegetal, Botucatu, SP, Brazil.
   [Vieira Rossetto, Victor Jose] Univ Estadual Paulista, Dept Cirurgia Pequenos Anim, Botucatu, SP, Brazil.
RP Floriano, JF (reprint author), Univ Estadual Paulista, Dept Fis, Av Luiz Edmundo Carrijo Coube 14-01, BR-17033360 Bauru, SP, Brazil.
EM juli@ibb.unesp.br; graeff@fc.unesp.br
RI Furtado, Edson/Q-1852-2018; Floriano, Juliana Ferreira/D-9207-2014;
   Mota, Ligia/C-4583-2013; FAPESP, CDMF/J-3591-2015; Graeff,
   Carlos/C-6703-2012
OI Furtado, Edson/0000-0002-6924-835X; Mota, Ligia/0000-0003-4513-753X;
   FAPESP, CDMF/0000-0002-4464-0937; Graeff, Carlos/0000-0003-0162-8273;
   Rossetto, Victor/0000-0001-7693-8108
FU CAPES/Nanobiomed; UNESP
FX This work was supported by CAPES/Nanobiomed and UNESP. We thank
   Professor Lui's Fernando Barbisan for his support regarding the
   histological analysis.
CR Agostini DLS, 2008, J THERM ANAL CALORIM, V91, P703, DOI 10.1007/s10973-007-8351-x
   Albertini RJ, 2000, MUTAT RES-REV MUTAT, V463, P111, DOI 10.1016/S1383-5742(00)00049-1
   Albrech J, 2006, HEPATOLOGY, V9, P994
   [Anonymous], 1992, 109936 ISO
   [Anonymous], 2006, 11137 ISO
   Araujo MM, 2012, ACTA CIR BRAS, V27, P566, DOI 10.1590/S0102-86502012000800009
   Balabanian Claudia A C A, 2006, J Oral Sci, V48, P201, DOI 10.2334/josnusd.48.201
   Banerjee B, 2000, MOL IMMUNOL, V37, P789, DOI 10.1016/S0161-5890(00)00095-X
   Barber HD, 2007, J ORAL MAXIL SURG, V65, P748, DOI 10.1016/j.joms.2006.10.042
   Blackley DC, 1997, POLYM LATTICES GLASG
   BORENFREUND E, 1988, TOXICOL IN VITRO, V2, P1, DOI 10.1016/0887-2333(88)90030-6
   Ciapetti G, 1996, BIOMATERIALS, V17, P1259, DOI 10.1016/0142-9612(96)88670-4
   Dulngali S, 1980, PRESERVATIVE SYSTEM
   FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3
   Ferreira M, 2009, BRAZ J PHYS, V39, P564, DOI 10.1590/S0103-97332009000500010
   Frade MAC, 2001, INT J DERMATOL, V40, P238, DOI 10.1046/j.1365-4362.2001.00977-2.x
   Gilbert NE, 1973, J RUBBER RES I MALAY, V3, P365
   Goldsby A, 2003, IMMUNOLOGY
   Hartmann A, 1997, TOXICOL LETT, V90, P183, DOI 10.1016/S0378-4274(96)03847-7
   Hasma H., 1991, Journal of Natural Rubber Research, V6, P105
   IKARASHI Y, 1992, J BIOMED MATER RES, V26, P339, DOI 10.1002/jbm.820260306
   INTERNATIONAL ORGANIZATION FOR STANDARDIZATION-ISO, 1992, 109933 ISO
   International Standardization Organization, 1992, 109935 ISO
   Issa JPM, 2010, ANAT REC, V293, P794, DOI 10.1002/ar.21097
   Mente ED, 2001, ACTA CIR BRAS, V16, P84
   Mrue Fatima, 2004, Mat. Res., V7, P277, DOI 10.1590/S1516-14392004000200010
   Narayanan E, 1973, J RUBBER RES I MALAY, V23, P332
   NARAYANAN R, 1974, Journal of the Rubber Research Institute of Malaysia, V24, P1
   OTHMAN AB, 1993, PLAST RUB COMPOS PRO, V19, P185
   Park J., 2007, BIOMATERIALS INTRO
   Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4
   Ribeiro YLR, 2003, MUTAGENESE AMBIENTAL
   Rippel MM, 2009, J BRAZIL CHEM SOC, V20, P1024, DOI 10.1590/S0103-50532009000600004
   Rogero SO, 2003, ARTIF ORGANS, V27, P424, DOI 10.1046/j.1525-1594.2003.07249.x
   SADER SL, 2000, REV BRASILEIRA CIRUR, V15, P338, DOI DOI 10.1590/S0102-76382000000400008
   Sanchez PA, 2001, ALLERGOL IMMUNOPATH, V5, P212
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P97, DOI 10.1002/term.1
   Souza PG, 2000, PESQUI AGROPECU BRAS, V35, P12
   Stelescu MD, 2013, J APPL POLYM SCI, V128, P2325, DOI 10.1002/app.38231
   Temenoff J. S., 2000, BONE ENG
   Thomazini JA, 1997, ACTA MICROSC, V6, P798
   Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
   Yang C, 2003, BIOSENS BIOELECTRON, V19, P51, DOI 10.1016/S0956-5663(03)00131-3
   Zeller JM, 1993, AORN J, V7, P1284
NR 44
TC 10
Z9 11
U1 0
U2 34
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2014
VL 25
IS 2
BP 461
EP 470
DI 10.1007/s10856-013-5089-9
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB2NW
UT WOS:000331630400020
PM 24202915
DA 2018-10-20
ER

PT J
AU Ruiz, A
   Rathnam, KR
   Masters, KS
AF Ruiz, Amaliris
   Rathnam, Kashmila R.
   Masters, Kristyn S.
TI Effect of hyaluronic acid incorporation method on the stability and
   biological properties of polyurethane-hyaluronic acid biomaterials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID VITRO BLOOD COMPATIBILITY; EPTFE VASCULAR GRAFTS; IN-VITRO;
   PLATELET-ADHESION; CARDIOVASCULAR GRAFT; BACTERIAL ADHESION;
   SHEAR-STRESS; HEPARIN; SURFACE; IMMOBILIZATION
AB The high failure rate of small diameter vascular grafts continues to drive the development of new materials and modification strategies that address this clinical problem, with biomolecule incorporation typically achieved via surface-based modification of various biomaterials. In this work, we examined whether the method of biomolecule incorporation (i.e., bulk versus surface modification) into a polyurethane (PU) polymer impacted biomaterial performance in the context of vascular applications. Specifically, hyaluronic acid (HA) was incorporated into a poly(ether urethane) via bulk copolymerization or covalent surface tethering, and the resulting PU-HA materials characterized with respect to both physical and biological properties. Modification of PU with HA by either surface or bulk methods yielded materials that, when tested under static conditions, possessed no significant differences in their ability to resist protein adsorption, platelet adhesion, and bacterial adhesion, while supporting endothelial cell culture. However, only bulk-modified PU-HA materials were able to fully retain these characteristics following material exposure to flow, demonstrating a superior ability to retain the incorporated HA and minimize enzymatic degradation, protein adsorption, platelet adhesion, and bacterial adhesion. Thus, despite bulk methods rarely being implemented in the context of biomolecule attachment, these results demonstrate improved performance of PU-HA upon bulk, rather than surface, incorporation of HA. Although explored only in the context of PU-HA, the findings revealed by these experiments have broader implications for the design and evaluation of vascular graft modification strategies.
C1 [Ruiz, Amaliris; Masters, Kristyn S.] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.
   [Rathnam, Kashmila R.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA.
   [Masters, Kristyn S.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
RP Masters, KS (reprint author), Univ Wisconsin, Dept Biomed Engn, 1550 Engn Dr 2152, Madison, WI 53706 USA.
EM kmasters@wisc.edu
FU Graduate Engineering Research Scholars Program; W.H. Coulter Foundation
FX Funding for this work was provided by the Graduate Engineering Research
   Scholars Program and the W.H. Coulter Foundation. The authors are also
   grateful for XPS assistance from Jose R. Sanchez-Perez (University of
   Wisconsin-Madison).
CR Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   Bakhshi H, 2013, J BIOMED MATER RES A, V101, P1599, DOI 10.1002/jbm.a.34461
   Begovac PC, 2003, EUR J VASC ENDOVASC, V25, P432, DOI 10.1053/ejvs.2002.1909
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Bosiers M, 2006, J VASC SURG, V43, P313, DOI 10.1016/j.jvs.2005.10.037
   Chuang TW, 2009, BIOMATERIALS, V30, P5341, DOI 10.1016/j.biomaterials.2009.06.029
   DANILICH MJ, 1992, J BIOMAT SCI-POLYM E, V3, P195, DOI 10.1163/156856292X00123
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   Fernandez P, 2007, TISSUE ENG, V13, P1607, DOI 10.1089/ten.2006.0399
   Giudiceandrea A, 1998, EUR J VASC ENDOVASC, V15, P147, DOI 10.1016/S1078-5884(98)80136-6
   GOLDSTONE J, 1974, AM J SURG, V128, P225
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Hoenig MR, 2005, ARTERIOSCL THROM VAS, V25, P1128, DOI 10.1161/01.ATV.0000158996.03867.72
   Hoshi RA, 2013, BIOMATERIALS, V34, P30, DOI 10.1016/j.biomaterials.2012.09.046
   HUBBELL JA, 1992, ANN NY ACAD SCI, V665, P253, DOI 10.1111/j.1749-6632.1992.tb42589.x
   ITO Y, 1986, J BIOMED MATER RES, V20, P1157, DOI 10.1002/jbm.820200808
   Iwasaki K, 2008, CIRCULATION, V118, pS52, DOI 10.1161/CIRCULATIONAHA.107.757369
   Jun HW, 2005, TISSUE ENG, V11, P1133, DOI 10.1089/ten.2005.11.1133
   Kapadia MR, 2008, CIRCULATION, V117, P1873, DOI 10.1161/CIRCULATIONAHA.107.714170
   Kim BN, 2011, J NANOSCI NANOTECHNO, V11, P7065, DOI 10.1166/jnn.2011.4859
   KISHIDA A, 1994, BIOMATERIALS, V15, P848, DOI 10.1016/0142-9612(94)90041-8
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Krijgsman B, 2002, TISSUE ENG, V8, P673, DOI 10.1089/107632702760240580
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Li S, 2011, ANNU REV BIOMED ENG, V13, P451, DOI 10.1146/annurev-bioeng-071910-124733
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Liang RP, 2008, J COLLOID INTERF SCI, V320, P125, DOI 10.1016/j.jcis.2008.01.001
   Lin PH, 2004, J VASC SURG, V39, P1322, DOI 10.1016/j.jvs.2004.01.046
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Martinez-Gutierrez F, 2013, FUTURE MICROBIOL, V8, P403, DOI [10.2217/FMB.13.5, 10.2217/fmb.13.5]
   Mohammad SF, 2000, ASAIO J, V46, pS63, DOI 10.1097/00002480-200011000-00039
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   Nirmala R, 2013, J NANOSCI NANOTECHNO, V13, P4686, DOI 10.1166/jnn.2013.7192
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   Park K, 2000, J BIOMAT SCI-POLYM E, V11, P1121, DOI 10.1163/156856200744228
   Rashid ST, 2004, CELL PROLIFERAT, V37, P351, DOI 10.1111/j.1365-2184.2004.00318.x
   Roohpour N, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015007
   Ruiz A, 2013, J BIOMED MATER RES A, V101, P2870, DOI 10.1002/jbm.a.34597
   Salacinski HJ, 2003, J BIOMED MATER RES A, V66A, P688, DOI 10.1002/jbm.a.10020
   SCHMITT DD, 1986, J VASC SURG, V3, P732, DOI 10.1067/mva.1986.avs0030732
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   STEPHEN M, 1977, SURGERY, V81, P314
   Taite LJ, 2008, J BIOMED MATER RES B, V84B, P108, DOI 10.1002/jbm.b.30850
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   van der Zijpp Y. J., 2003, Archives of Physiology and Biochemistry, V111, P415, DOI 10.3109/13813450312331342274
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   Walluscheck KP, 1996, EUR J VASC ENDOVASC, V12, P321, DOI 10.1016/S1078-5884(96)80251-6
   Walpoth BH, 1998, CIRCULATION, V98, pII319
   Wan M, 2004, J MATER SCI-MATER M, V15, P1079, DOI 10.1023/B:JMSM.0000046389.87287.3f
   Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   Wynne JH, 2011, ACS APPL MATER INTER, V3, P2005, DOI 10.1021/am200250d
   Xu F, 2008, BIOMATERIALS, V29, P150, DOI 10.1016/j.biomaterials.2007.09.028
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   You I, 2011, BIOCONJUGATE CHEM, V22, P1264, DOI 10.1021/bc2000534
NR 61
TC 4
Z9 4
U1 3
U2 39
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2014
VL 25
IS 2
BP 487
EP 498
DI 10.1007/s10856-013-5092-1
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB2NW
UT WOS:000331630400023
PM 24276670
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Meurette, G
   Duchalais, E
   Lehur, PA
AF Meurette, G.
   Duchalais, E.
   Lehur, P-A.
TI Surgical approaches to fecal incontinence in the adult
SO JOURNAL OF VISCERAL SURGERY
LA English
DT Review
DE Anal incontinence; Sphincterorraphy; Sacral neurostimulation; Artificial
   sphincter; Antegrade colonic enema; Intra-sphincteric injection
ID ARTIFICIAL BOWEL SPHINCTER; SACRAL NERVE-STIMULATION; ANTEGRADE
   CONTINENCE ENEMA; INJECTABLE SILICONE BIOMATERIAL; ANAL DYNAMIC
   GRACILOPLASTY; QUALITY-OF-LIFE; ANTERIOR SPHINCTEROPLASTY; GRACILIS
   NEOSPHINCTER; VENTRAL RECTOPEXY; OBSTETRIC TRAUMA
AB Surgical treatment of anal incontinence is indicated only for patients who have failed medical treatment. Sphincterorraphy is suitable in case of external sphincter rupture. In the last decade, sacral nerve stimulation has proven to be a scientifically validated solution when no sphincter lesion has been identified and more recently has also been proposed as an alternative in cases of limited sphincter defect. Anal reconstruction using artificial sphincters is still under evaluation in the literature, while indications for dynamic graciloplasty are decreasing due to its complexity and high morbidity. Less risky techniques involving intra-sphincteric injections are being developed, with encouraging preliminary results that need to be confirmed especially in the medium- and long-term. Antegrade colonic enemas instilled via cecostomy (Malone) can be an alternative to permanent stoma in patients who are well instructed in the techniques of colonic lavage. Stomal diversion is a solution of last resort. (C) 2014 Published by Elsevier Masson SAS.
C1 [Meurette, G.; Duchalais, E.; Lehur, P-A.] Hop Hotel Dieu, CHU Nantes, Inst Malad Appareil Digestif, Clin Chirurg Digest & Endocrinienne, F-44000 Nantes, France.
RP Meurette, G (reprint author), Hop Hotel Dieu, CHU Nantes, Inst Malad Appareil Digestif, Clin Chirurg Digest & Endocrinienne, 1 Pl A Ricordeau, F-44000 Nantes, France.
EM guillaume.meurette@chu-nantes.fr
RI Meurette, Guillaume/M-1419-2015
CR [Anonymous], 2012, TRAITEMENT INCONTINE
   BAETEN CGMI, 1995, NEW ENGL J MED, V332, P1600, DOI 10.1056/NEJM199506153322403
   Chapman AE, 2002, BRIT J SURG, V89, P138, DOI 10.1046/j.1365-2168.2002.02018.x
   Chereau N, 2011, COLORECTAL DIS, V13, pE238, DOI 10.1111/j.1463-1318.2011.02651.x
   CHRISTIANSEN J, 1992, ANN SURG, V215, P383, DOI 10.1097/00000658-199204000-00013
   CHRISTIANSEN J, 1987, LANCET, V2, P244
   Collinson R, 2010, GASTROEN CLIN BIOL, V34, P584, DOI 10.1016/j.gcb.2010.09.007
   Collinson R, 2010, COLORECTAL DIS, V12, P97, DOI 10.1111/j.1463-1318.2009.02049.x
   Damon H, 2006, GASTROEN CLIN BIOL, V30, P37, DOI 10.1016/S0399-8320(06)73076-7
   Damon H, 2013, INCONTINENCE ANALE A
   Darnis B, 2013, DIS COLON RECTUM, V56, P505, DOI 10.1097/DCR.0b013e3182809490
   ENGEL AF, 1994, EUR J SURG, V160, P633
   ENGEL AF, 1994, BRIT J SURG, V81, P1231, DOI 10.1002/bjs.1800810853
   FANG DT, 1984, DIS COLON RECTUM, V27, P720, DOI 10.1007/BF02554596
   FAUCHERON JL, 1994, DIS COLON RECTUM, V37, P979, DOI 10.1007/BF02049308
   FLESHMAN JW, 1991, DIS COLON RECTUM, V34, P1061, DOI 10.1007/BF02050062
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6
   Hawley P, 1985, COLOPROCTOLOGY PELVI, P252
   Jarrett MED, 2004, BRIT J SURG, V91, P1559, DOI 10.1002/bjs.4796
   Karoui S, 2000, DIS COLON RECTUM, V43, P813, DOI 10.1007/BF02238020
   KONSTEN J, 1993, WORLD J SURG, V17, P404, DOI 10.1007/BF01658712
   KORSGEN S, 1995, DIS COLON RECTUM, V38, P1331, DOI 10.1007/BF02049162
   Lehur PA, 1996, LYON CHIR, V92, P251
   Lehur PA, 2010, DIS COLON RECTUM, V53, P1604, DOI 10.1007/DCR.0b013e3181f5d5f7
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub2
   MALONE PS, 1990, LANCET, V336, P1217, DOI 10.1016/0140-6736(90)92834-5
   Malouf AJ, 2000, LANCET, V355, P260, DOI 10.1016/S0140-6736(99)05218-6
   Matzel KE, 2004, LANCET, V363, P1270, DOI 10.1016/S0140-6736(04)15999-0
   Meurette G, 2009, COLORECTAL DIS, V11, P631, DOI 10.1111/j.1463-1318.2008.01633.x
   Oliveira L, 1996, BRIT J SURG, V83, P502, DOI 10.1002/bjs.1800830421
   Portier G, 2011, COLORECTAL DIS, V13, P914, DOI 10.1111/j.1463-1318.2010.02327.x
   Ratto C, 2012, COLORECTAL DIS, V14, pE297, DOI 10.1111/j.1463-1318.2012.03003.x
   Ris F, 2012, COLORECTAL DIS, V14, P1106, DOI 10.1111/j.1463-1318.2011.02904.x
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Teichman JMH, 1998, J UROLOGY, V160, P1278, DOI 10.1016/S0022-5347(01)62515-1
   Teichman JMH, 2003, UROLOGY, V61, P502, DOI 10.1016/S0090-4295(02)02282-3
   Thornton M J, 2004, Colorectal Dis, V6, P470, DOI 10.1111/j.1463-1318.2004.00714.x
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2007, DIS COLON RECTUM, V50, P1497, DOI 10.1007/s10350-007-9001-x
   Wexner SD, 1996, DIS COLON RECTUM, V39, P957, DOI 10.1007/BF02054681
   Wexner SD, 2002, DIS COLON RECTUM, V45, P809, DOI 10.1097/01.DCR.0000017604.54619.64
   Wexner SD, 2010, ANN SURG, V251, P441, DOI 10.1097/SLA.0b013e3181cf8ed0
   WILLIAMS NS, 1991, LANCET, V338, P1166
   Wong MTC, 2011, ANN SURG, V254, P951, DOI 10.1097/SLA.0b013e31823ac2bc
   Wong MTC, 2011, DIS COLON RECTUM, V54, P773, DOI 10.1007/DCR.0b013e3182182689
   Wong MTC, 2011, DIS COLON RECTUM, V54, P425, DOI 10.1007/DCR.0b013e318200f866
   Wong WD, 2002, DIS COLON RECTUM, V45, P1139, DOI 10.1097/01.DCR.0000027038.03012.E3
   Yerkes EB, 2003, J UROLOGY, V169, P320, DOI 10.1097/01.ju.0000041721.26576.92
   YOSHIOKA K, 1989, DIS COLON RECTUM, V32, P39, DOI 10.1007/BF02554724
NR 51
TC 8
Z9 8
U1 1
U2 8
PU ELSEVIER MASSON
PI MILANO
PA VIA PALEOCAPA 7, 20121 MILANO, ITALY
SN 1878-7886
J9 J VISC SURG
JI J. Visc. Surg.
PD FEB
PY 2014
VL 151
IS 1
BP 29
EP 39
DI 10.1016/j.jviscsurg.2013.12.011
PG 11
WC Surgery
SC Surgery
GA AB3VL
UT WOS:000331718200006
PM 24440057
DA 2018-10-20
ER

PT J
AU Evans, SM
   Litzenberger, AL
   Ellenberger, AE
   Maneval, JE
   Jablonski, EL
   Vogel, BM
AF Evans, Stephanie M.
   Litzenberger, Andrew L.
   Ellenberger, Anne E.
   Maneval, Juries E.
   Jablonski, Erin L.
   Vogel, Brandon M.
TI A microfluidic method to measure small molecule diffusion in hydrogels
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Microfluidics; Diffusion; Controlled drug delivery; NMR; Hydrogels; PEG
ID POLY(ETHYLENE GLYCOL) HYDROGELS; LASER-SCANNING MICROSCOPY; PEG
   HYDROGELS; DRUG-DELIVERY; INTERPENETRATING NETWORKS; POLY(VINYL
   ALCOHOL); POLY(ACRYLIC ACID); SOLUTE DIFFUSION; COEFFICIENT; SIZE
AB Drug release from a fluid-contacting biomaterial is simulated using a microfluidic device with a channel defined by solute-loaded hydrogel; as water is pumped through the channel, solute transfers from the hydrogel into the water. Optical analysis of in-situ hydrogels, characterization of the microfluidic device effluent, and NMR methods were used to find diffusion coefficients of several dyes (model drugs) in poly( ethylene glycol) diacrylate (PEG-DA) hydrogels. Diffusion coefficients for methylene blue and sulforhodamine 101 in PEG-DA calculated using the three methods are in good agreement; both dyes are mobile in the hydrogel and elute from the hydrogel at the aqueous channel interface. However, the dye acid blue 22 deviates from typical diffusion behavior and does not release as expected from the hydrogel. Importantly, only the microfluidic method is capable of detecting this behavior.
   Characterizing solute diffusion with a combination of NMR, optical and effluent methods offer greater insight into molecular diffusion in hydrogels than employing each technique individually. The NMR method made precise measurements for solute diffusion in all cases. The microfluidic optical method was effective for visualizing diffusion of the optically active solutes. The optical and effluent methods show potential to be used to screen solutes to determine if they elute from a hydrogel in contact with flowing fluid. Our data suggest that when designing a drug delivery device, analyzing the diffusion from the molecular level to the device level is important to establish a complete picture of drug elution, and microfluidic methods to study such diffusion can play a key role. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Evans, Stephanie M.; Litzenberger, Andrew L.; Ellenberger, Anne E.; Maneval, Juries E.; Jablonski, Erin L.; Vogel, Brandon M.] Bucknell Univ, Dept Chem Engn, Lewisburg, PA 17837 USA.
RP Maneval, JE (reprint author), Bucknell Univ, Dept Chem Engn, Lewisburg, PA 17837 USA.
EM james.maneval@bucknell.edu; erin.jablonski@bucknell.edu;
   brandon.vogel@bucknell.edu
FU Jane W. Griffith Foundation
FX BMV would like to thank the Jane W. Griffith Foundation for a Faculty
   Fellowship.
CR Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f
   Bal T, 2013, J BIOMED MAT RES A
   Bell CL, 1996, BIOMATERIALS, V17, P1203, DOI 10.1016/0142-9612(96)84941-6
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   CANAL T, 1989, J BIOMED MATER RES, V23, P1183, DOI 10.1002/jbm.820231007
   Chen RT, 2012, BIOMACROMOLECULES, V13, P889, DOI 10.1021/bm201802w
   Costin CD, 2003, J CHROMATOGR A, V1013, P77, DOI 10.1016/S0021-9673(03)01101-4
   Cuchiara MP, 2010, BIOMATERIALS, V31, P5491, DOI 10.1016/j.biomaterials.2010.03.031
   Culbertson CT, 2002, TALANTA, V56, P365, DOI 10.1016/S0039-9140(01)00602-6
   Flory Paul J., 1953, FLORY PRINCIPLES POL
   Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Hatch A, 2004, P IEEE, V92, P126, DOI 10.1109/JPROC.2003.820547
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huang GY, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/012001
   Jerschow A, 1997, J MAGN RESON, V125, P372, DOI 10.1006/jmre.1997.1123
   Khoury C, 2003, BIOMED MICRODEVICES, V5, P35, DOI 10.1023/A:1024411332492
   Kosto KB, 2005, BIOPHYS J, V88, P277, DOI 10.1529/biophysj.104.050302
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Lyons JG, 2009, J MECH BEHAV BIOMED, V2, P485, DOI 10.1016/j.jmbbm.2008.12.003
   MATLAB, 2010, IM PROC TOOLB REL
   Oliveira MB, 2013, ANAL CHEM, V85, P2391, DOI 10.1021/ac303405x
   Pelekani C, 2000, CARBON, V38, P1423, DOI 10.1016/S0008-6223(99)00261-4
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 1998, EUR J PHARM BIOPHARM, V46, P15, DOI 10.1016/S0939-6411(97)00113-6
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Peppas NA, 1996, MACROMOLECULES, V29, P8798, DOI 10.1021/ma9613392
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Ray E, 2007, AM J PHYS, V75, P903, DOI 10.1119/1.2752819
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Schultz KM, 2013, SOFT MATTER, V9, P1570, DOI 10.1039/c2sm27303a
   Stringer JL, 1996, J CONTROL RELEASE, V42, P195, DOI 10.1016/0168-3659(96)01457-5
   Watkins AW, 2007, ACTA BIOMATER, V3, P439, DOI 10.1016/j.actbio.2006.11.006
   Watkins AW, 2005, MACROMOLECULES, V38, P1326, DOI 10.1021/ma0475232
   Weber LM, 2009, J BIOMED MATER RES A, V90A, P720, DOI 10.1002/jbm.a.32134
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Yang T, 2013, J POLYM SCI POL CHEM, V51, P1378, DOI 10.1002/pola.26506
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 43
TC 6
Z9 6
U1 3
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2014
VL 35
BP 322
EP 334
DI 10.1016/j.msec.2013.10.035
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA AB2AX
UT WOS:000331596500041
PM 24411384
DA 2018-10-20
ER

PT J
AU Lv, FK
   Liu, BL
   Li, WJ
   Song, XY
AF Lv FuKou
   Liu BaoLin
   Li WeiJie
   Song XiaoYan
TI Effects of nanoparticles on devitrification and recrystallization of
   aqueous glycerol and PEG-600 solutions
SO SCIENCE CHINA-TECHNOLOGICAL SCIENCES
LA English
DT Article
DE nanoparticles; devitrification; recrystallization; ice morphology; ice
   fraction
ID ICE CRYSTALS; CRYSTALLIZATION; CRYOMICROSCOPY; 1,3-BUTANEDIOL;
   TRANSITIONS
AB Nanoparticles in solution offer unique electrical, mechanical and thermal properties due to their physical presence and interaction with the state of dispersion. This work is aimed to study the effects of hydroxyapatite (HA) nanoparticles on the behavior of devitrification and recrystallization of glycerol (60% w/w) and PEG-600 (50% w/w) solutions during warming. HA nanoparticles of different sizes (20, 40, 60 nm) and concentrations (0.1%, 0.5%, w/w) were incorporated into solutions, and were studied by calorimetric analysis coupled with cryomicroscopy. The presence of HA nanoparticles has little effect on the devitrification end temperatures, but affects the devitrification onset temperatures of glycerol and PEG-600 solutions. The investigation with the cryomicroscope observed that the ice morphologies of glycerol and PEG-600 solutions are dendritic and spheric respectively. The ice fraction of glycerol solution containing 0.1% HA with the size of 60 nm decreased to 2/5 of that of the solution without nanoparticles at -45A degrees C. The ice fractions of PEG-600 solutions increased significantly between -64A degrees C and -54A degrees C, and the ice fraction of PEG-600 solution without nanoparticles increased by 92% within the temperature range. The findings have significant implications for biomaterial cryopreservation, cryosurgery, and food manufacturing. The complexity of ice crystal growth kinetics in nanoparticle-containing solutions awaits further study.
C1 [Lv FuKou; Liu BaoLin; Li WeiJie; Song XiaoYan] Shanghai Univ Sci & Technol, Inst Biothermal Sci & Technol, Shanghai 200093, Peoples R China.
RP Liu, BL (reprint author), Shanghai Univ Sci & Technol, Inst Biothermal Sci & Technol, Shanghai 200093, Peoples R China.
EM blliuk@163.com
FU National Natural Science Foundation of China [51076108]; Shanghai
   Dongfang Scholars Program;  [20103120110005]
FX This work was supported by the National Natural Science Foundation of
   China (Grant No. 51076108), the Doctoral Program (Grant No.
   20103120110005) and the Shanghai Dongfang Scholars Program.
CR Diller K R, 1970, Cryobiology, V7, P191
   Gage AA, 2002, CRYOLETTERS, V23, P69
   Gao D, 2000, ILAR J, V41, P18796
   Goff HD, 2003, THERMOCHIM ACTA, V399, P43, DOI 10.1016/S0040-6031(02)00399-4
   Gonda T, 2005, PROG CRYST GROWTH CH, V51, P70, DOI 10.1016/j.pcrysgrow.2005.10.005
   Hagiwara T, 2006, FOOD BIOPHYS, V1, P74, DOI 10.1007/s11483-006-9009-0
   Han X, 2008, MICROFLUID NANOFLUID, V4, P357, DOI 10.1007/s10404-007-0186-z
   Hao B T, 2009, CRYOBIOLOGY, V59, P409
   Kiani H, 2011, TRENDS FOOD SCI TECH, V22, P407, DOI 10.1016/j.tifs.2011.04.011
   Mazur P, 2011, CRYOBIOLOGY, V62, P1, DOI 10.1016/j.cryobiol.2010.10.159
   MEHL P, 1989, THERMOCHIM ACTA, V155, P187, DOI 10.1016/0040-6031(89)87145-X
   MEHL PM, 1990, CRYOBIOLOGY, V27, P378, DOI 10.1016/0011-2240(90)90016-W
   Methl P., 1993, THERMOCHIM ACTA, V223, P157
   Methl P., 1992, THERMOCHIM ACTA, V203, P475
   Muldrew K, 2001, CRYOBIOLOGY, V42, P182, DOI 10.1006/cryo.2001.2321
   Pegg DE, 2010, CRYOBIOLOGY, V60, pS36, DOI 10.1016/j.cryobiol.2010.02.003
   Petzold G, 2009, FOOD BIOPHYS, V4, P378, DOI 10.1007/s11483-009-9136-5
   Schmidt G, 2003, CURR OPIN COLLOID IN, V8, P103, DOI 10.1016/S1359-0294(03)00008-6
   Seki S, 2012, PLOS ONE, V7
   Seki S, 2009, CRYOBIOLOGY, V59, P75, DOI 10.1016/j.cryobiol.2009.04.012
   STEPONKUS PL, 1984, CRYO-LETT, V5, P343
   STEPONKUS PL, 1984, CRYOBIOLOGY, V21, P209, DOI 10.1016/0011-2240(84)90213-X
   Syamaladevi RM, 2012, FOOD BIOPHYS, V7, P57, DOI 10.1007/s11483-011-9243-y
   VIGIER G, 1987, J CRYST GROWTH, V84, P309, DOI 10.1016/0022-0248(87)90146-1
   Yu TH, 2005, CRYOBIOLOGY, V50, P174, DOI 10.1016/j.cryobiol.2005.01.001
NR 25
TC 2
Z9 2
U1 0
U2 7
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7321
EI 1869-1900
J9 SCI CHINA TECHNOL SC
JI Sci. China-Technol. Sci.
PD FEB
PY 2014
VL 57
IS 2
BP 264
EP 269
DI 10.1007/s11431-014-5457-9
PG 6
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA AB2OV
UT WOS:000331632900006
DA 2018-10-20
ER

PT J
AU Nagaoka, H
AF Nagaoka, Hiroyuki
TI Application of a Heme-Binding Protein Eluted from Encapsulated
   Biomaterials to the Catalysis of Enantioselective Oxidation
SO ACS CATALYSIS
LA English
DT Article
DE heme-binding protein; hemophore; asymmetric oxidation; iron
   electron-transfer system; plant HBP; oxygen dependence
ID CYTOCHROME-C PEROXIDASE; SUBSTRATE RECOGNITION; ASYMMETRIC OXIDATION;
   ALPHA-HYDROXYLATION; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE;
   OUTER-MEMBRANE; HEMOPHORE; RESOLUTION; RECEPTOR
AB A protein complex (PX) eluted from an encapsulated pea protein (PP) under aeration can be used as two types of biocatalysts: a polyethylene glycol (PEG) (1000/4000 = 2/1)-aggregated PX (AGPX) and a glutaraldehyde (GA)/compound-modified PX (CMPX). These biocatalysts have the following functional activities: AGPX can catalyze the oxidation of rac-1-(6-methoxynaphthalen-2-yl)ethanol (rac-1) to the corresponding ketone (similar to 95% chemical yield) via the selective oxidation of (S)-(+)-1, leaving highly enantiopure (R)-(-)-1 (>99% ee; similar to 50% chemical yield); CMPX can catalyze the kinetic resolution of (S)-(+)-1 ((S)-naproxen precursor, >99% ee, similar to 50% chemical yield) via the selective oxidation of (R)-(-)-1 to the corresponding ketone. Both reactions occur in the absence of an added cofactor (e.g., NAD(P)) in aqueous media. The specific activities of AGPX and CMPX were determined to be 0.8 +/- 0.03 mU (mean +/- SD) and 0.6 +/- 0.02 mU (mean +/- SD), respectively, and the exact nature of the species engaged in the key reaction was consistent with that of a heme-binding protein (HBP), on the basis of an N-terminal sequence comparison, which showed 93% similarity with a 20.853 kDa hemophore HasA gene product [Pseudomonas fluorescens Pf-S, a plant commensal bacterium]. PP-HBP can be regenerated via successive asymmetric catalytic events using an incorporated iron electron-transfer system (Fe2+ reversible arrow Fe3+) in the presence of oxygen, a process seemingly similar to that utilized by hemoglobin. The use of a raw biomaterial as a PX-catalytic system with an incorporated redox cofactor for asymmetric oxidation overcomes the apparent difficulties in working with pure dehydrogenase enzyme/redox cofactor systems for biotransformation.
C1 Sanyo Shokuhin Co Ltd, R&D, Maebashi, Gumma 3710811, Japan.
RP Nagaoka, H (reprint author), Sanyo Shokuhin Co Ltd, R&D, 555-4 Asakura, Maebashi, Gumma 3710811, Japan.
EM hnagaoka@sanyofoods.co.jp
CR Adam W, 1998, J AM CHEM SOC, V120, P11044, DOI 10.1021/ja981252r
   Afolabi PR, 2001, BIOCHEMISTRY-US, V40, P9799, DOI 10.1021/bi002932l
   Armstrong R. N., 2008, BIOCHEMISTRY-US, V47, P73
   Auld DS, 2008, CELL MOL LIFE SCI, V65, P3961, DOI 10.1007/s00018-008-8593-1
   Barjon C, 2007, J BACTERIOL, V189, P5379, DOI 10.1128/JB.00251-07
   Braun V, 1999, TRENDS BIOCHEM SCI, V24, P104, DOI 10.1016/S0968-0004(99)01359-6
   Chimento DP, 2005, PROTEINS, V59, P240, DOI 10.1002/prot.20416
   Cope LD, 1998, INFECT IMMUN, V66, P4511
   Cwerman H, 2006, J BACTERIOL, V188, P3357, DOI 10.1128/JB.188.9.3357-3364.2006
   Egami H, 2007, J AM CHEM SOC, V129, P8940, DOI 10.1021/ja071916+
   Erman JE, 2002, BBA-PROTEIN STRUCT M, V1597, P193, DOI 10.1016/S0167-4838(02)00317-5
   Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997
   Giles M. N., 2003, BIOPHYS RES COMMUN, V300, P1
   Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1
   Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583
   Izadi-Pruneyre N, 1999, EUR J BIOCHEM, V261, P562, DOI 10.1046/j.1432-1327.1999.00305.x
   Johansson AL, 2013, BIOCHEMISTRY-US, V52, P827, DOI 10.1021/bi301597a
   Kamezawa M., 1996, LIEBIGS ANN, V1996, P167
   Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106
   Landwehr M, 2006, J AM CHEM SOC, V128, P6058, DOI 10.1021/ja061261x
   Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200
   Letoffe S, 2000, J BACTERIOL, V182, P4401, DOI 10.1128/JB.182.16.4401-4405.2000
   Liu XQ, 2009, MICROBIOL-SGM, V155, P2078, DOI 10.1099/mic.0.027201-0
   McDonald AR, 2010, J AM CHEM SOC, V132, P17118, DOI 10.1021/ja1045428
   Nagaoka H., 2003, Current Topics in Nutraceutical Research, V1, P281
   Nagaoka H, 2005, BIOTECHNOL PROGR, V21, P405, DOI 10.1021/bp0496777
   Nagaoka H, 1999, BIOSCI BIOTECH BIOCH, V63, P1991, DOI 10.1271/bbb.63.1991
   Nagaoka H, 2000, BIOSCI BIOTECH BIOCH, V64, P781, DOI 10.1271/bbb.64.781
   Nagaoka H, 2004, BIOTECHNOL PROGR, V20, P128, DOI 10.1021/bp0342046
   Nagaoka H, 2003, BIOTECHNOL PROGR, V19, P1149, DOI 10.1021/bp034059w
   Nagaoka H., 2001, BIOSCI BIOTECH BIOCH, V65, P634
   Nagaoka H, 2012, BIOTECHNOL PROGR, V28, P953, DOI 10.1002/btpr.1580
   Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264
   Ortiz de Montellano P.R., 2004, CYTOCHROME P450 STRU
   Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110
   Prage B. E., 2011, BIOCHEMISTRY-US, V50, P7684, DOI 10.1021/bi2010448 21805999
   Putnam AMAH, 2009, BIOCHEMISTRY-US, V48, P1, DOI 10.1021/bi8020263
   Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237
   Shimizu H, 2001, BIOCHEMISTRY-US, V40, P13483, DOI 10.1021/bi011481h
   Shoji O, 2007, ANGEW CHEM INT EDIT, V46, P3656, DOI 10.1002/anie.200700068
   Sobolov B. S., 1996, J ORG CHEM, V61, P2125, DOI 10.1021/jo951408v
   Thakur VV, 2005, INDIAN J CHEM B, V44, P557
   Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3
   Yosca TH, 2013, SCIENCE, V342, P825, DOI 10.1126/science.1244373
   Zee JM, 2006, BIOCHEM CELL BIOL, V84, P859, DOI 10.1139/O06-201
NR 45
TC 4
Z9 4
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2155-5435
J9 ACS CATAL
JI ACS Catal.
PD FEB
PY 2014
VL 4
IS 2
BP 553
EP 565
DI 10.1021/cs400768x
PG 13
WC Chemistry, Physical
SC Chemistry
GA AA5UB
UT WOS:000331164000023
DA 2018-10-20
ER

PT J
AU Madl, CM
   Mehta, M
   Duda, GN
   Heilshorn, SC
   Mooney, DJ
AF Madl, Christopher M.
   Mehta, Manav
   Duda, Georg N.
   Heilshorn, Sarah C.
   Mooney, David J.
TI Presentation of BMP-2 Mimicking Peptides in 3D Hydrogels Directs Cell
   Fate Commitment in Osteoblasts and Mesenchymal Stem Cells
SO BIOMACROMOLECULES
LA English
DT Article
ID RGD NANOPATTERNED HYDROGELS; ANTERIOR CERVICAL-SPINE; SYNTHETIC PEPTIDE;
   PROGENITOR CELLS; BONE; DIFFERENTIATION; ADHESION; DELIVERY;
   COMPLICATIONS; ACTIVATION
AB Many strategies for controlling the fate of transplanted stem cells rely on the concurrent delivery of soluble growth factors that have the potential to produce undesirable secondary effects in surrounding tissue. Such off target effects could be eliminated by locally presenting growth factor peptide mimics from biomaterial scaffolds to control stem cell fate. Peptide mimics of bone morphogenetic protein 2 (BMP-2) were synthesized by solid phase Fmoc-peptide synthesis and covalently bound to alginate hydrogels via either carbodiimide or sulfhydryl-based coupling strategies. Successful peptide conjugation was confirmed by H-1 NMR spectroscopy and quantified by fluorescently labeling the peptides. Peptides derived from the knuckle epitope of BMP-2, presented from both 2D surfaces and 3D alginate hydrogels, were shown to increase alkaline phosphatase activity in clonally derived murine osteoblasts. Furthermore, when presented in 3D hydrogels, these peptides were shown to initiate Smad signaling, upregulate osteopontin production, and increase mineral deposition with clonally derived murine mesenchymal stem cells. These data suggest that these peptide-conjugated hydrogels may be effective alternatives to local BMP-2 release in directly and spatially eliciting osteogenesis from transplanted or host osteoprogenitors in the future.
C1 [Madl, Christopher M.; Mehta, Manav; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Mehta, Manav; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.
   [Mehta, Manav; Duda, Georg N.] Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
   [Duda, Georg N.] Charite, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany.
   [Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
RI Duda, Georg/H-2085-2016
OI Duda, Georg/0000-0001-7605-3908; Madl, Christopher/0000-0003-3221-5041
FU NIH [R37 DE013033, R01-DK085720]; Harvard College Program for Research
   in Science and Engineering (PRISE); NSF [DMR-0846363]; Einstein
   Foundation Berlin through the Charite-Universitatsmedizin Berlin;
   Berlin-Brandenburg School for Regenerative Therapies [GSC 203]
FX The authors would like to thank Praveen Arany for assistance with
   Western blotting and Shimwoo Lee for assistance with alginate sample
   preparation. This project was supported by funding from the NIH (R37
   DE013033) (to D.J.M.), the Harvard College Program for Research in
   Science and Engineering (PRISE) (to C.M.M.), NSF (DMR-0846363) (to
   S.C.H.), NIH (R01-DK085720) (to S.C.H.), and the award of an Einstein
   Visiting Fellowship by the Einstein Foundation Berlin through the
   Charite-Universitatsmedizin Berlin, Berlin-Brandenburg School for
   Regenerative Therapies GSC 203 (to D.J.M.).
CR Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Colangelo AM, 2008, J NEUROSCI, V28, P2698, DOI 10.1523/JNEUROSCI.5201-07.2008
   Comisar WA, 2006, BIOMATERIALS, V27, P2322, DOI 10.1016/j.biomaterials.2005.10.037
   Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018
   D'Andrea LD, 2005, P NATL ACAD SCI USA, V102, P14215, DOI 10.1073/pnas.0505047102
   de Gorter D. J. J., 2009, ENCY LIFE SCI, P1
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Garrison K., 2007, HLTH TECHNOLOGY ASSE, V11
   Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302
   Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025
   Hsiong S. X., 2009, BIOMACROMOLECULES, V9, P1843
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Kirkwood Keith, 2003, J Oral Implantol, V29, P57, DOI 10.1563/1548-1336(2003)029<0057:IVMSWS>2.3.CO;2
   KUMAGAI H, 1991, BIOCHEM BIOPH RES CO, V177, P74, DOI 10.1016/0006-291X(91)91950-H
   Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003
   Lee JY, 2009, BIOMATERIALS, V30, P3532, DOI 10.1016/j.biomaterials.2009.03.018
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Li JF, 2011, J ORTHOP RES, V29, P1745, DOI 10.1002/jor.21439
   Lin X, 2006, INT J MOL MED, V17, P833
   Manfe V, 2010, J NEUROCHEM, V114, P74, DOI 10.1111/j.1471-4159.2010.06718.x
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019
   Patel G, 1999, J PEPT RES, V53, P68, DOI 10.1111/j.1399-3011.1999.tb01618.x
   Pountos I, 2007, INJURY, V38, pS23, DOI 10.1016/S0020-1383(08)70006-8
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Saito A, 2004, J BIOMED MATER RES A, V70A, P115, DOI 10.1002/jbm.a.30071
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Senta H, 2009, CYTOKINE GROWTH F R, V20, P213, DOI 10.1016/j.cytogfr.2009.05.006
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Sittinger M, 2004, CURR OPIN BIOTECH, V15, P411, DOI 10.1016/j.copbio.2004.08.010
   Smucker JD, 2006, SPINE, V31, P2813, DOI 10.1097/01.brs.0000245863.52371.c2
   Wall ST, 2008, BIOCONJUGATE CHEM, V19, P806, DOI 10.1021/bc700265k
   Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014
NR 39
TC 36
Z9 36
U1 1
U2 63
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2014
VL 15
IS 2
BP 445
EP 455
DI 10.1021/bm401726u
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AA8JQ
UT WOS:000331342200001
PM 24400664
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lai, CY
   Wu, PJ
   Roffler, SR
   Lee, ST
   Hwang, SM
   Wang, SES
   Wang, K
   Hsieh, PCH
AF Lai, Chia Y.
   Wu, Pei J.
   Roffler, Steve R.
   Lee, Sho T.
   Hwang, Shiaw M.
   Wang, Shoei S.
   Wang, Kuan
   Hsieh, Patrick C. H.
TI Clearance Kinetics of Biomaterials Affects Stem Cell Retention and
   Therapeutic Efficacy
SO BIOMACROMOLECULES
LA English
DT Article
ID PERIPHERAL ARTERIAL-DISEASE; HYALURONIC-ACID; HINDLIMB ISCHEMIA;
   TISSUE-INJURY; RAT MODEL; IN-VIVO; REPAIR; ANGIOGENESIS; FLUORESCENCE;
   DIFFERENTIATION
AB The use of biomaterial carriers to improve the therapeutic efficacy of stem cells is known to augment cell delivery, retention, and viability: However, the way that carrier clearance kinetics boosts stem cell delivery and impacts stem cell function remains poorly characterized. In this study, we designed a platform to simultaneously quantify carrier clearance and stem cell retention to evaluate the impact of carrier clearance kinetics on stem cell retention. Additionally, a murine model of hindlimb ischemia was employed to investigate the effects of various cell retention profiles on mitigating peripheral arterial disease. To image the in vivo behaviors of material and cells, we used biotinylated hyaluronan with fluorescently labeled streptavidin and Discosoma sp. Red (Ds-Red)-expressing human mesenchymal stem cells. We found that the retention of transplanted stem cells was closely related to the remaining biomaterial. Furthermore, therapeutic effectiveness was also affected by stem cell retention. These results demonstrate that low-molecular-weight hyaluronan had a slow clearance and high cell retention profile, improving the therapeutic efficacy of human stem cells.
C1 [Lai, Chia Y.; Wu, Pei J.; Roffler, Steve R.; Lee, Sho T.; Hsieh, Patrick C. H.] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.
   [Hwang, Shiaw M.] Food Ind Res & Dev Inst, Hsinchu 300, Taiwan.
   [Wang, Shoei S.] Natl Taiwan Univ & Hosp, Dept Surg, Taipei 100, Taiwan.
   [Wang, Kuan] Acad Sinica, Inst Chem, Taipei 115, Taiwan.
   [Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Inst Clin Med, Tainan 701, Taiwan.
RP Hsieh, PCH (reprint author), Acad Sinica, Inst Biomed Sci, 128 Sec 2,Acad Rd, Taipei 115, Taiwan.
EM phsieh5@gmail.com
RI Roffler, Steve/N-7791-2018; Hsieh, Patrick Ching-Ho/H-5108-2015
OI Wang, Shoei-Shen/0000-0003-3201-4143; Hsieh, Patrick
   C.H./0000-0002-8910-3596
FU National Research Program for Biopharmaceuticals , (NRPB)
   [DOH101-TD-PB-111-TM027, DOH101-TD-PB-111-TM028]; National Science
   Council [NSC 100-2314-B-006-046, NSC101-2325-B-006-013]; National Health
   Research Institutes [NHRI-EX101-10123S1]; Academia Sinica Translational
   Medicine Program; NRPB of Taiwan
FX This work was supported by the National Research Program for
   Biopharmaceuticals (NRPB, DOH101-TD-PB-111-TM027, and
   DOH101-TD-PB-111-TM028), the National Science Council (NSC
   100-2314-B-006-046 and NSC101-2325-B-006-013), the National Health
   Research Institutes (NHRI-EX101-10123S1), and the Academia Sinica
   Translational Medicine Program. We also thank the Taiwan Mouse Clinic,
   funded by the NRPB of Taiwan for technical support in MS operation and
   animal housing.
CR Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Berlier JE, 2003, J HISTOCHEM CYTOCHEM, V51, P1699, DOI 10.1177/002215540305101214
   Burdick J. A., 2011, ADV MATER, V23, P41
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Cha C, 2009, ADV FUNCT MATER, V19, P3056, DOI 10.1002/adfm.200900865
   DE SMEDT SC, 1994, MACROMOLECULES, V27, P141, DOI 10.1021/ma00079a021
   Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008
   Hankey GJ, 2006, JAMA-J AM MED ASSOC, V295, P547, DOI 10.1001/jama.295.5.547
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hung CJ, 2010, CYTOTHERAPY, V12, P455, DOI 10.3109/14653240903555827
   Ishii M, 2011, ARTERIOSCL THROM VAS, V31, P2210, DOI 10.1161/ATVBAHA.111.231100
   Iwase T, 2005, CARDIOVASC RES, V66, P543, DOI 10.1016/j.cardiores.2005.02.006
   Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337
   Joddar B, 2011, BIOMATERIALS, V32, P8404, DOI 10.1016/j.biomaterials.2011.07.083
   Katare R, 2013, ARTERIOSCL THROM VAS, V33, P1872, DOI 10.1161/ATVBAHA.113.301217
   Kawamoto A, 2009, STEM CELLS, V27, P2857, DOI 10.1002/stem.207
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185
   Lin Y. D., 2010, CIRCULATION, V122, P132
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Madonna R, 2013, CIRC RES, V113, P902, DOI 10.1161/CIRCRESAHA.113.301690
   Menasche P, 2008, J MOL CELL CARDIOL, V45, P545, DOI 10.1016/j.yjmcc.2007.11.009
   MEYER K, 1947, PHYSIOL REV, V27, P335
   Napoli C, 2005, P NATL ACAD SCI USA, V102, P17202, DOI 10.1073/pnas.0508534102
   Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6
   Park D, 2012, MOL CELLS, V33, P563, DOI 10.1007/s10059-012-2294-1
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P370, DOI 10.1021/bc00028a015
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565
   Rosova I., 2008, STEM CELLS, V26, P2173
   Sakata H, 2012, BRAIN, V135, P3298, DOI 10.1093/brain/aws259
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Srinivas M, 2010, ADV DRUG DELIVER REV, V62, P1080, DOI 10.1016/j.addr.2010.08.009
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Tang Z. C., 2011, BIOMATERIALS, V3, P275
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   Weinberg MD, 2011, NAT REV CARDIOL, V8, P429, DOI 10.1038/nrcardio.2011.81
   Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110
   Yoon IS, 2011, J BIOSCI BIOENG, V112, P402, DOI 10.1016/j.jbiosc.2011.06.018
NR 43
TC 4
Z9 4
U1 0
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2014
VL 15
IS 2
BP 564
EP 573
DI 10.1021/bm401583b
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AA8JQ
UT WOS:000331342200013
PM 24372561
DA 2018-10-20
ER

PT J
AU Taglietti, A
   Arciola, CR
   D'Agostino, A
   Dacarro, G
   Montanaro, L
   Campoccia, D
   Cucca, L
   Vercellino, M
   Poggi, A
   Pallavicini, P
   Visai, L
AF Taglietti, Angelo
   Arciola, Carla Renata
   D'Agostino, Agnese
   Dacarro, Giacomo
   Montanaro, Lucio
   Campoccia, Davide
   Cucca, Lucia
   Vercellino, Marco
   Poggi, Alessandro
   Pallavicini, Piersandro
   Visai, Livia
TI Antibiofilm activity of a monolayer of silver nanoparticles anchored to
   an amino-silanized glass surface
SO BIOMATERIALS
LA English
DT Article
DE Silver nanoparticles; Anti-infective biomaterials; APTES; Biofilm;
   Staphylococcus epidermidis
ID INFECTION-RESISTANT SURFACES; ANTIBACTERIAL ACTIVITY; COLLOID
   MONOLAYERS; BIOFILM FORMATION; ESCHERICHIA-COLI; IN-SITU; BIOMATERIALS;
   BACTERIA; RELEASE; CAPABILITIES
AB Biofilm production is the crucial pathogenic mechanism of the implant-associated infection and a primary target for new anti-infective strategies. Silver nanoparticles (AgNPs) are attracting interest for their multifaceted potential biomedical applications. As endowed with highest surface/mass ratio and potent antibacterial activity, they can profitably be applied as monolayers at biomaterial surfaces. Desirably, in order to minimize the risks of toxic effects from freely circulating detached nanoparticles, AgNPs should firmly be anchored to the modified biomaterial surfaces. Here we focus on a newly designed glass surface modified with AgNPs and on its antibiofilm properties. Link of a self-assembled monolayer of AgNPs to glass was obtained through preliminary amino-silanization of the glass followed by immersion in an AgNPs colloidal suspension. Static contact angle measure, AFM, TEM, UV-Vis spectroscopy, ICP atomic emission spectroscopy were used for characterization. Antibiofilm activity against the biofilm-producer Staphylococcus epidermidis RP62A was assayed by both CPU method and CLSM. Performances of AgNPs-glasses were: i) excellent stability in aqueous medium; ii) prolonged release and high local concentration of Ag+ without any detaching of AgNPs; iii) strong antibiofilm activity against S. epidermidis RP62A. This AgNPs surface-modification can be applied to a large variety of biomaterials by simply depositing glasslike SiO2 films on their surfaces. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Taglietti, Angelo; D'Agostino, Agnese; Dacarro, Giacomo; Cucca, Lucia; Pallavicini, Piersandro] Univ Pavia, Dept Chem, Inorgan Nanochem Lab, I-27100 Pavia, Italy.
   [Arciola, Carla Renata; Montanaro, Lucio; Campoccia, Davide] Rizzoli Orthopaed Inst, Res Unit Implant Infect, I-40136 Bologna, Italy.
   [Arciola, Carla Renata; Montanaro, Lucio] Univ Bologna, DIMES, Bologna, Italy.
   [Vercellino, Marco; Visai, Livia] Univ Pavia, INSTM UdR Pavia, Dept Mol Med, Ctr Tissue Engn CIT, I-27100 Pavia, Italy.
   [Poggi, Alessandro] Univ Modena & Reggio Emilia, Dept Mother & Child, Pediat Unit, Modena, Italy.
   [Vercellino, Marco; Visai, Livia] IRCCS, Salvatore Maugeri Fdn, Dept Occupat Med Ergon & Disabil, Nanotechnol Lab, Pavia, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it
RI taglietti, angelo/D-7111-2011; Campoccia, Davide/K-5348-2018
OI taglietti, angelo/0000-0003-0141-9201; Campoccia,
   Davide/0000-0002-3336-0219; Pallavicini, Piersandro/0000-0002-5223-0233
FU MIUR, PRIN [prot. 2010FPTBSH_009]; Fondazione Cariplo (Bandi Chiusi)
FX LV would like to acknowledge financial support from MIUR, PRIN 2010
   project entitled "Nanomed" (prot. 2010FPTBSH_009). AT would like to
   acknowledge financial support from Fondazione Cariplo (Bandi Chiusi
   2007, "Superfici vetrose a azione antimicrobica basata sul rilascio
   modulato e controllato di cationi metallici"). We are grateful to Dr. P.
   Vaghi and V. Necchi ("Centro Grandi Strumenti", University of Pavia,
   Pavia, Italy). CRA would like to acknowledge financial support from "5
   per mille" contribution for Health Research to the Rizzoli Orthopaedic
   Institute of Bologna.
CR Agnihotri S, 2013, NANOSCALE, V5, P7328, DOI 10.1039/c3nr00024a
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Aroca RF, 2005, ANAL CHEM, V77, P378, DOI 10.1021/ac048806v
   Bright RM, 1998, LANGMUIR, V14, P5695, DOI 10.1021/la980138j
   Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a
   BUSTAMANTE C, 1992, BIOCHEMISTRY-US, V31, P22, DOI 10.1021/bi00116a005
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Rodriguez-Arguelles MC, 2011, J COLLOID INTERF SCI, V364, P80, DOI 10.1016/j.jcis.2011.08.006
   Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006
   Chen P, 2007, RADIAT PHYS CHEM, V76, P1165, DOI 10.1016/j.radphyschem.2006.11.012
   Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923
   Clauss M, 2010, ACTA BIOMATER, V6, P3791, DOI 10.1016/j.actbio.2010.03.011
   Dacarro G, 2012, DALTON T, V41, P2456, DOI 10.1039/c1dt11373a
   Damm C, 2008, MATER CHEM PHYS, V108, P61, DOI 10.1016/j.matchemphys.2007.09.002
   De Jong WH, 2013, BIOMATERIALS, V34, P8333, DOI 10.1016/j.biomaterials.2013.06.048
   Di Poto A, 2009, BIOMATERIALS, V30, P3158, DOI 10.1016/j.biomaterials.2009.02.038
   Evanoff DD, 2005, CHEMPHYSCHEM, V6, P1221, DOI 10.1002/cphc.200500113
   Flores CY, 2013, ACS APPL MATER INTER, V5, P3149, DOI 10.1021/am400044e
   Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09
   Grabar KC, 1997, ANAL CHEM, V69, P471, DOI 10.1021/ac9605962
   Graf P, 2009, CHEM-EUR J, V15, P5831, DOI 10.1002/chem.200802329
   Greulich C, 2011, ACTA BIOMATER, V7, P3505, DOI 10.1016/j.actbio.2011.05.030
   Guo DW, 2013, BIOMATERIALS, V34, P7884, DOI 10.1016/j.biomaterials.2013.07.015
   Howarter JA, 2006, LANGMUIR, V22, P11142, DOI 10.1021/la061240g
   Kim JS, 2007, J IND ENG CHEM, V13, P718
   Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306
   Lepainteur M, 2013, PEDIATR INFECT DIS J, V32, P622, DOI 10.1097/INF.0b013e318289de0f
   Li Z, 2006, LANGMUIR, V22, P9820, DOI 10.1021/la0622166
   Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n
   Lubick N, 2008, ENVIRON SCI TECHNOL, V42, P8617, DOI 10.1021/es8026314
   Lv YH, 2008, POLYM ADVAN TECHNOL, V19, P1455, DOI 10.1002/pat.1138
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017
   Moores A, 2006, NEW J CHEM, V30, P112
   Neal AL, 2008, ECOTOXICOLOGY, V17, P362, DOI 10.1007/s10646-008-0217-x
   NETZER L, 1983, J AM CHEM SOC, V105, P674, DOI 10.1021/ja00341a087
   Oei JD, 2012, J BIOMED MATER RES B, V100B, P409, DOI 10.1002/jbm.b.31963
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Pallavicini P, 2010, J COLLOID INTERF SCI, V350, P110, DOI 10.1016/j.jcis.2010.06.019
   Peczonka NPW, 2006, J AM CHEM SOC, V128, P12626
   Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Speziale P, 2009, FUTURE MICROBIOL, V4, P1337, DOI [10.2217/fmb.09.102, 10.2217/FMB.09.102]
   Speziale P, 2008, CURR MED CHEM, V15, P3185, DOI 10.2174/092986708786848442
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Taglietti A, 2012, LANGMUIR, V28, P8140, DOI 10.1021/la3003838
   Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794
   Wigginton NS, 2010, ENVIRON SCI TECHNOL, V44, P2163, DOI 10.1021/es903187s
   Wiley B, 2007, ACCOUNTS CHEM RES, V40, P1067, DOI 10.1021/ar7000974
   Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w
   Yliniemi K, 2008, J MATER CHEM, V18, P199, DOI 10.1039/b713313h
   Zhang YW, 2008, J PHYS CHEM C, V112, P2330, DOI 10.1021/jp075436g
   Zhao GQ, 2011, CELL BIOCHEM BIOPHYS, V61, P371, DOI 10.1007/s12013-011-9220-6
NR 57
TC 87
Z9 90
U1 17
U2 146
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 6
BP 1779
EP 1788
DI 10.1016/j.biomaterials.2013.11.047
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA3UD
UT WOS:000331018700001
PM 24315574
DA 2018-10-20
ER

PT J
AU Cameron, AR
   Frith, JE
   Gomez, GA
   Yap, AS
   Cooper-White, JJ
AF Cameron, Andrew R.
   Frith, Jessica E.
   Gomez, Guillermo A.
   Yap, Alpha S.
   Cooper-White, Justin J.
TI The effect of time-dependent deformation of viscoelastic hydrogels on
   myogenic induction and Rac1 activity in mesenchymal stem cells
SO BIOMATERIALS
LA English
DT Article
DE Mesenchymal stem cell; Smooth muscle cell; Creep; Viscoelasticity;
   Hydrogel; Mechanotransduction
ID SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; N-CADHERIN; SUBSTRATE
   ELASTICITY; LINEAGE COMMITMENT; EPITHELIAL-CELLS; GENE-EXPRESSION; FOCAL
   ADHESIONS; DOWN-REGULATION; RHO
AB Cell behaviours within tissues are influenced by a broad array of physical and biochemical microenvironmental factors. Whilst 'stiffness' is a recognised physical property of substrates and tissue microenvironments that influences many cellular behaviours, tissues and their extracellular matrices are not purely rigid but 'viscoelastic' materials, composed of both rigid-like (elastic) and dissipative (viscous) elements. This viscoelasticity results in materials displaying increased deformation with time under the imposition of a defined force or stress, a phenomenon referred to as time-dependent deformation or 'creep'. Previously, we compared the behaviour of human mesenchymal stem cells (hMSCs) on hydrogels tailored to have a constant stiffness, but to display varying levels of creep in response to an applied force. Using polyacrylamide as a model material, we showed that on high-creep hydrogels (HCHs), hMSCs displayed increased proliferation, spread area and differentiation towards multiple lineages, compared to their purely stiff analogue, with a particular propensity for differentiation towards a smooth muscle cell (SMC) lineage. In this present study, we investigate the mechanisms behind this phenomenon and show that hMSCs adhered to HCHs have increased expression of SMC induction factors, including soluble factors, ECM proteins and the cell cell adhesion molecule, N-Cadherin. Further, we identify a key role for Rac1 signalling in mediating this increased N-Cadherin expression. Using a real-time Rac1-FRET biosensor, we confirm increased Rac1 activation on HCHs, an observation that is further supported functionally by observed increases in motility and lamellipodial protrusion rates of hMSCs. Increased Rac1 activity in hMSCs on HCHs provides underlying mechanisms for enhanced commitment towards a SMC lineage and the compensatory increase in spread area (isotonic tension) after a creep-induced loss of cytoskeletal tension on viscoelastic substrates, in contrast to previous studies that have consistently demonstrated up-regulation of RhoA activity with increasing substrate stiffness. Tuning substrate viscoelasticity to introduce varying levels of creep thus equips the biomaterial scientist or engineer with a new tool with which to tune and direct stem cell outcomes. Crown Copyright (C) 2013 Published by Elsevier Ltd. All rights reserved.
C1 [Cameron, Andrew R.; Frith, Jessica E.; Cooper-White, Justin J.] Univ Queensland, Tissue Engn & Microfluid Lab, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia.
   [Gomez, Guillermo A.; Yap, Alpha S.] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, St Lucia, Qld 4072, Australia.
   [Cooper-White, Justin J.] Univ Queensland, Sch Chem Engn, St Lucia, Qld 4072, Australia.
   [Cooper-White, Justin J.] CSIRO, Div Mat Sci & Engn, Clayton, Vic 3168, Australia.
RP Cooper-White, JJ (reprint author), Univ Queensland, Tissue Engn & Microfluid Lab, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia.
EM j.cooperwhite@uq.edu.au
RI Gomez, Guillermo/J-2993-2014; Frith, Jessica/J-6873-2017; McKenzie,
   Warren/J-2137-2014; Yap, Alpha/J-1554-2014
OI Gomez, Guillermo/0000-0002-0494-2404; Frith,
   Jessica/0000-0002-6558-5412; Yap, Alpha/0000-0002-1038-8956; Cameron,
   Andrew/0000-0002-6341-0379; Cooper-White, Justin/0000-0002-1920-8229
FU Australian Research Council [DP 1095429, DP110104446]; Cooperative
   Research Centre for Polymers; School of Chemical Engineering; Australian
   Institute of Bioengineering and Nanotechnology at The University of
   Queensland
FX We gratefully acknowledge Dr Erik Miller for discussions on
   polyacrylamide mechanical testing and Dr Gary Brooke from the Mater
   Medical Research Institute for providing hMSCs. This study was
   financially supported by the Australian Research Council Discovery
   Grants Scheme (DP 1095429 and DP110104446), the Cooperative Research
   Centre for Polymers as well as the School of Chemical Engineering and
   the Australian Institute of Bioengineering and Nanotechnology at The
   University of Queensland. This work was partly performed at the
   Australian National Fabrication Facility, a company established under
   the National Collaborative Research Infrastructure Strategy to provide
   nano- and micro-fabrication facilities for Australia's researchers.
CR Andalib MN, 2013, ACTA BIOMATER, V9, P7737, DOI 10.1016/j.actbio.2013.04.013
   Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293
   Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273
   Ball SG, 2004, INT J BIOCHEM CELL B, V36, P714, DOI 10.1016/j.biocel.2003.10.015
   Beqaj S, 2002, J CELL BIOL, V156, P893, DOI 10.1083/jcb.200107049
   Cameron AR, 2011, BIOMATERIALS, V32, P5979, DOI 10.1016/j.biomaterials.2011.04.003
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2009, BIONANOTECHNOLOGY GL, P35
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dyson JA, 2007, TISSUE ENG, V13, P2891, DOI 10.1089/ten.2007.0124
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ferreira MC, 2008, MOL HUM REPROD, V14, P301, DOI 10.1093/molehr/gan016
   Friedland JC, 2007, J CELL SCI, V120, P3700, DOI 10.1242/jcs.03484
   Frith JE, 2009, TISSUE ENG PART C-ME, V16, P735
   Fujiwara H, 2004, EXP CELL RES, V292, P67, DOI 10.1016/j.yexcr.2003.08.010
   Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gutierrez JA, 1999, AM J PHYSIOL-GASTR L, V277, pG1074, DOI 10.1152/ajpgi.1999.277.5.G1074
   Hudson JE, 2011, STEM CELLS DEV, V20
   INGBER DE, 1993, J CELL SCI, V104, P613
   Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359
   Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002
   Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105
   Keung AJ, 2011, STEM CELLS, V29, P1886, DOI 10.1002/stem.746
   Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598
   Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561
   Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069
   Kocgozlu L, 2012, BIOMATERIALS, V33, P798, DOI 10.1016/j.biomaterials.2011.10.024
   Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520
   Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110
   Lee JS, 2013, BIOCHEM BIOPH RES CO, V435, P696, DOI 10.1016/j.bbrc.2013.05.045
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI DOI 10.1016/S0006-3495(00)76279-5
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Miano JM, 1996, J BIOL CHEM, V271, P7095, DOI 10.1074/jbc.271.12.7095
   Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387
   Murrell M, 2011, BIOPHYS J, V101, P297, DOI 10.1016/j.bpj.2011.05.048
   Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0
   Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938
   NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4
   O'Callaghan CJ, 2000, HYPERTENSION, V36, P319, DOI 10.1161/01.HYP.36.3.319
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pattabiraman PP, 2010, AM J PHYSIOL-CELL PH, V298, pC749, DOI 10.1152/ajpcell.00317.2009
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299
   Raines EW, 2000, ANN NY ACAD SCI, V902, P39
   Ratheesh A, 2012, NAT CELL BIOL, V14, P818, DOI 10.1038/ncb2532
   Rossol-Allisone J, 2009, CELL SIGNAL, V21, P1559, DOI 10.1016/j.cellsig.2009.05.010
   Rowlands A. S., 2008, AM J PHYSIOL-CELL PH, V295, P1037
   Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009
   SCHWARTZ MA, 2002, NAT CELL BIOL, V4, P65
   Shi-wen X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007438
   Suzuki S, 2010, CELLS TISSUES ORGANS, V191, P269, DOI 10.1159/000260061
   Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047
   Tan GK, 2011, BIOMATERIALS, V32, P5600, DOI 10.1016/j.biomaterials.2011.04.033
   Tang AT, 2012, CELL SIGNAL, V24, P1375, DOI 10.1016/j.cellsig.2012.03.005
   Thyberg J, 1997, J HISTOCHEM CYTOCHEM, V45, P837, DOI 10.1177/002215549704500608
   Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002
   Wang CM, 2011, J BIOMED MATER RES B, V97B, P58, DOI 10.1002/jbm.b.31786
   Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200
   Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200
   Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010
   Xiao QZ, 2010, THROMB HAEMOSTASIS, V104, P440, DOI 10.1160/TH09-11-0794
   Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008
   Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898
   Yasuda T, 1996, J CLIN INVEST, V98, P1991, DOI 10.1172/JCI119003
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
NR 70
TC 50
Z9 52
U1 4
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 6
BP 1857
EP 1868
DI 10.1016/j.biomaterials.2013.11.023
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA3UD
UT WOS:000331018700008
PM 24331708
DA 2018-10-20
ER

PT J
AU Kulkarni, M
   O'Loughlin, A
   Vazquez, R
   Mashayekhi, K
   Rooney, P
   Greiser, U
   O'Toole, E
   O'Brien, T
   Malagon, MM
   Pandit, A
AF Kulkarni, M.
   O'Loughlin, A.
   Vazquez, R.
   Mashayekhi, K.
   Rooney, P.
   Greiser, U.
   O'Toole, E.
   O'Brien, T.
   Malagon, Maria M.
   Pandit, A.
TI Use of a fibrin-based system for enhancing angiogenesis and modulating
   inflammation in the treatment of hyperglycemic wounds
SO BIOMATERIALS
LA English
DT Article
DE Gene therapy; Diabetes; Wound healing; Angiogenesis; Inflammation;
   Keratinocyte
ID DIABETIC FOOT ULCERS; OSTEOBLASTIC CELL-DIFFERENTIATION; NITRIC-OXIDE;
   GROWTH-FACTORS; OSTEOGENIC PROTEIN-1; HUMAN KERATINOCYTES; MELLITUS;
   SKIN; PROLIFERATION; FIBROBLASTS
AB The complex pathophysiology of chronic ulceration in diabetic patients is poorly understood; diabetes-related lower limb amputation is a major health issue, which has limited effective treatment regimes in the clinic. This study attempted to understand the complex pathology of hyperglycemic wound healing by showing profound changes in gene expression profiles in wounded human keratinocytes in hyperglycemic conditions compared to normal glucose conditions. In the hyper-secretory wound microenvironment of hyperglycemia, Rab18, a secretory control molecule, was found to be significantly downregulated. Using a biomaterial platform for dual therapy targeting the two distinct pathways, this study aimed to resolve the major dysregulated pathways in hyperglycemic wound healing. To complement Rab18, and promote angiogenesis eNOS was also targeted, and this novel Rab18-eNOS therapy via a dynamically controlled 'fibrin-in-fibrin' delivery system, demonstrated enhanced wound closure, by increasing functional angiogenesis and reducing inflammation, in an alloxan-induced hyperglycemic preclinical ear ulcer model of compromised wound healing. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Kulkarni, M.; Rooney, P.; Greiser, U.; Pandit, A.] Natl Univ Ireland Univ Coll Galway, Network Excellence Funct Biomat, Galway, Ireland.
   [O'Loughlin, A.; Mashayekhi, K.; Greiser, U.; O'Brien, T.] Natl Univ Ireland Univ Coll Galway, Regenerat Med Inst, Galway, Ireland.
   [O'Toole, E.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Cutaneous Res, London, England.
   [Vazquez, R.; Malagon, Maria M.] Univ Cordoba, IMIBIC Reina Sofia Univ Hosp, Dept Cell Biol Physiol & Immunol, Cordoba 14014, Spain.
   [Vazquez, R.; Malagon, Maria M.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Cordoba 14014, Spain.
RP Pandit, A (reprint author), Natl Univ Ireland Univ Coll Galway, Network Excellence Funct Biomat, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI O'Brien, Timothy/N-7112-2014; Malagon, Maria/L-5386-2014; Pandit,
   Abhay/B-6187-2008
OI O'Brien, Timothy/0000-0001-9028-5481; Pandit, Abhay/0000-0002-6292-4933;
   Rooney, Peadar/0000-0003-3119-3928
FU Research Frontier Project, Science Foundation Ireland [06/RFP/ENM005]
FX Tisseel (TM) kits were kindly donated by Baxter Healthcare, Vienna,
   Austria. This research was funded by the Research Frontier Project,
   Science Foundation Ireland, under Grant Number 06/RFP/ENM005. The
   authors acknowledge Gerry McHale, Charles McHale and Michael Schonfeld
   for their assistance with the in vivo studies. The authors also
   acknowledge Dr. Oliver Carroll for assistance in Rab18 plasmid DNA
   expansion, John Butler (MSD) for assistance in Multiplex ELISA and
   Anthony Sloan for linguistic assistance.
CR Acosta JB, 2008, INT WOUND J, V5, P530, DOI 10.1111/j.1742-481X.2008.00457.x
   Bizzarro MJ, 2004, ENCY BIOMATERIALS BI, P1075
   Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x
   Blakytny R, 2009, INT J LOW EXTR WOUND, V8, P95, DOI 10.1177/1534734609337151
   Brandner JM, 2008, DIABETES CARE, V31, P114, DOI 10.2337/dc07-1304
   Breen AM, 2008, BIOMATERIALS, V29, P3143, DOI 10.1016/j.biomaterials.2008.04.020
   Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169
   Burrow JW, 2007, J SURG RES, V140, P90, DOI 10.1016/j.jss.2006.11.010
   CechowskaPasko M, 1996, MOL CELL BIOCHEM, V154, P1, DOI 10.1007/BF00248454
   Dayem MA, 2003, COMP FUNCT GENOM, V4, P47, DOI 10.1002/cfg.239
   Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808
   Deveci M, 2005, BRIT J DERMATOL, V152, P217, DOI 10.1111/J.1365-2133.2004.06329.X
   Dhaunsi GS, 2004, CLIN EXP PHARMACOL P, V31, P46, DOI 10.1111/j.1440-1681.2004.03948.x
   Ennis WJ, 2007, CLIN DERMATOL, V25, P63, DOI 10.1016/j.clindermatol.2006.09.008
   Fard AS, 2007, INT J CLIN PRACT, V61, P1931, DOI 10.1111/j.1742-1241.2007.01534.x
   Galkowska H, 2006, WOUND REPAIR REGEN, V14, P558, DOI 10.1111/j.1743-6109.2006.00155.x
   Garcia Y, 2007, BIOMATERIALS, V28, P175, DOI 10.1016/j.biomaterials.2006.08.037
   Hehenberger K, 1998, J DERMATOL SCI, V16, P144, DOI 10.1016/S0923-1811(97)00042-X
   Hink U, 2001, CIRC RES, V88, pE14
   Isenberg JS, 2005, MICROSURG, V25, P442, DOI 10.1002/micr.20166
   Jazwa Agnieszka, 2010, Genet Vaccines Ther, V8, P6, DOI 10.1186/1479-0556-8-6
   Jeschke MG, 2004, GENE THER, V11, P847, DOI 10.1038/sj.gt.3302229
   Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539
   Kulltarni MM, 2011, MOL PHARMACEUT, V8, P439, DOI 10.1021/mp100295z
   Lan CCE, 2008, BRIT J DERMATOL, V159, P1103, DOI 10.1111/j.1365-2133.2008.08789.x
   Lan CCE, 2009, BRIT J DERMATOL, V160, P1206, DOI 10.1111/j.1365-2133.2009.09089.x
   Li Y, 2010, MOL PHARMACEUT, V7, P254, DOI [10.1021/mp900237f, 10.1021/mp900237t]
   Li Yong-jun, 2007, Chinese Medical Sciences Journal, V22, P232
   Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
   Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121
   Lizarbe TR, 2008, FASEB J, V22, P3207, DOI 10.1096/fj.07-103804
   Lopez-Rivera E, 2005, P NATL ACAD SCI USA, V102, P3685, DOI 10.1073/pnas.0408217102
   Luo JD, 2009, AM J PHYSIOL-ENDOC M, V297, pE525, DOI 10.1152/ajpendo.00308.2009
   LYNCH SE, 1987, P NATL ACAD SCI USA, V84, P7696, DOI 10.1073/pnas.84.21.7696
   Malagon MM, 2009, ANN NY ACAD SCI, V1163, P233, DOI 10.1111/j.1749-6632.2008.03654.x
   Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024
   Mishima Y, 2001, DIABETES RES CLIN PR, V52, P119, DOI 10.1016/S0168-8227(00)00247-3
   Nagoba BS, 2010, INT WOUND J, V7, P153, DOI 10.1111/j.1742-481X.2010.00666.x
   Naguib G, 2004, J INVEST DERMATOL, V123, P87, DOI 10.1111/j.0022-202X.2004.22711.x
   Nakai K, 2003, J DERMATOL SCI, V31, P211, DOI 10.1016/S0923-1811(03)00006-9
   Ochoa O, 2007, VASCULAR, V15, P350, DOI 10.2310/6670.2007.00056
   Pradhan L, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000945
   Schaffer MR, 1997, SURGERY, V121, P513, DOI 10.1016/S0039-6060(97)90105-7
   Schaffer MR, 1997, J IMMUNOL, V158, P2375
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Silva SY, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-26
   Spravchikov N, 2001, DIABETES, V50, P1627, DOI 10.2337/diabetes.50.7.1627
   SPRUGEL KH, 1987, AM J PATHOL, V129, P601
   Stallmeyer B, 2002, NITRIC OXIDE-BIOL CH, V6, P168, DOI 10.1006/niox.2001.0407
   Sun C, 2011, J CELL PHYSL
   Takita H, 1997, EUR J ORAL SCI, V105, P588, DOI 10.1111/j.1600-0722.1997.tb00222.x
   Teixeira AS, 1999, LIFE SCI, V64, P655, DOI 10.1016/S0024-3205(98)00607-9
   Terashi Hiroto, 2005, Int Wound J, V2, P298, DOI 10.1111/j.1742-4801.2005.00148.x
   Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194
   Vazquez-Martinez R, 2008, J CLIN ENDOCR METAB, V93, P2269, DOI 10.1210/jc.2007-1893
   Vazquez-Martinez R, 2007, TRAFFIC, V8, P867, DOI 10.1111/j.1600-0854.2007.00570.x
   Weller RB, 2009, J INVEST DERMATOL, V129, P2335, DOI 10.1038/jid.2009.149
   Witte MB, 2002, BRIT J SURG, V89, P1594, DOI 10.1046/j.1365-2168.2002.02263.x
   Yeh LCC, 1997, ENDOCRINOLOGY, V138, P4181, DOI 10.1210/en.138.10.4181
   Yeh LCC, 2002, J CELL PHYSIOL, V190, P322, DOI 10.1002/jcp.10064
NR 60
TC 20
Z9 21
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 6
BP 2001
EP 2010
DI 10.1016/j.biomaterials.2013.11.003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA3UD
UT WOS:000331018700022
PM 24331702
DA 2018-10-20
ER

PT J
AU Gower, RM
   Boehler, RM
   Azarin, SM
   Ricci, CF
   Leonard, JN
   Shea, LD
AF Gower, R. Michael
   Boehler, Ryan M.
   Azarin, Samira M.
   Ricci, Christine F.
   Leonard, Joshua N.
   Shea, Lonnie D.
TI Modulation of leukocyte infiltration and phenotype in microporous tissue
   engineering scaffolds via vector induced IL-10 expression
SO BIOMATERIALS
LA English
DT Article
DE Inflammation; Immunomodulation; Gene therapy; Flow cytometry; Scaffold;
   Leukocyte
ID EXTRAHEPATIC ISLET TRANSPLANTATION; SPINAL-CORD-INJURY; IN-VIVO;
   MACROPHAGE DEPLETION; POLYMER SCAFFOLDS; GENE DELIVERY; FUNCTIONALIZED
   SCAFFOLD; ALLOGRAFT SURVIVAL; PLASMID DELIVERY; INFLAMMATION
AB Biomaterial scaffolds are central to many tissue engineering strategies as they create a space for tissue growth and provide a support for cell adhesion and migration. However, biomaterial implantation results in unavoidable injury resulting in an inflammatory response, which can impair integration with the host and tissue regeneration. Toward the goal of reducing inflammation, we investigated the hypothesis that a lentiviral gene therapy-based approach to localized and sustained IL-10 expression at a scaffold could modulate the number, relative proportions, and cytokine production of infiltrating leukocyte populations. Flow cytometry was used to quantify infiltration of six leukocyte populations for 21 days following implantation of PLG scaffolds into intraperitoneal fat. Leukocytes with innate immune functions (i.e., macrophages, dendritic cells, neutrophils) were most prevalent at early time points, while T lymphocytes became prevalent by day 14. Reporter gene delivery indicated that transgene expression persisted at the scaffold for up to 28 days and macrophages were the most common leukocyte transduced, while transduced dendritic cells expressed the greatest levels of transgene. IL-10 delivery decreased leukocyte infiltration by 50% relative to controls, increased macrophage IL-10 expression, and decreased macrophage, dendritic cell, and CD4 T cell IFN-gamma expression. Thus, IL-10 gene delivery significantly decreased inflammation following scaffold implant into the intraperitoneal fat, in part by modulating cytokine expression of infiltrating leukocytes. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Gower, R. Michael; Boehler, Ryan M.; Azarin, Samira M.; Ricci, Christine F.; Leonard, Joshua N.; Shea, Lonnie D.] Northwestern Univ, McCormick Sch Engn, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, McCormick Sch Engn, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Inst BioNanotechnol Med IBNAM, Evanston, IL 60208 USA.
   [Leonard, Joshua N.; Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA.
   [Leonard, Joshua N.; Shea, Lonnie D.] Northwestern Univ, Chem Life Proc Inst CLP, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd Tech E136, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009; Leonard, Joshua/B-7649-2009
OI Leonard, Joshua/0000-0003-4359-6126
FU National Institutes of Biomedical Imaging and Bioengineering (NIBIB) at
   the National Institutes of Health (NIH) [R01 EB009910, R01 EB005678, R01
   CA173745]; Northwestern University RHLCCC Flow Cytometry Facility;
   Cancer Center [NCI CA060553]
FX Financial support for this research was provided by the National
   Institutes of Biomedical Imaging and Bioengineering (NIBIB) at the
   National Institutes of Health (NIH) through grant number R01 EB009910,
   R01 EB005678, and R01 CA173745. This work was also supported by the
   Northwestern University RHLCCC Flow Cytometry Facility and a Cancer
   Center Support Grant (NCI CA060553).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Aviles MO, 2011, DRUG DELIV TRANSL RE, V1, P91, DOI 10.1007/s13346-010-0011-1
   Aviles MO, 2010, BIOMATERIALS, V31, P1140, DOI 10.1016/j.biomaterials.2009.10.035
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Boehler RM, 2013, BIOMATERIALS, V34, P5431, DOI 10.1016/j.biomaterials.2013.04.009
   Bottino R, 1998, DIABETES, V47, P316, DOI 10.2337/diabetes.47.3.316
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009
   Dudler J, 2006, TRANSPLANTATION, V82, P1733, DOI 10.1097/01.tp.0000250757.69384.79
   Gibly RF, 2011, BIOMATERIALS, V32, P9677, DOI 10.1016/j.biomaterials.2011.08.084
   Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7
   Graham JG, 2013, TISSUE ENG PT A, V19, P1465, DOI [10.1089/ten.tea.2012.0643, 10.1089/ten.TEA.2012.0643]
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Hidalgo LG, 2002, CRIT REV IMMUNOL, V22, P317
   Holladay C, 2011, MOL THER, V19, P969, DOI 10.1038/mt.2010.311
   Holladay CA, 2012, BIOMATERIALS, V33, P1303, DOI 10.1016/j.biomaterials.2011.10.019
   Hong YS, 2002, J HEART LUNG TRANSPL, V21, P1188, DOI 10.1016/S1053-2498(02)00417-5
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   KAUFMAN DB, 1990, J EXP MED, V172, P291, DOI 10.1084/jem.172.1.291
   Li SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061799
   Lopez-Armada MJ, 2002, ANN RHEUM DIS, V61, P1027, DOI 10.1136/ard.61.11.1027
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Miyoshi H, 1998, J VIROL, V72, P8150
   Montane J, 2011, J CLIN INVEST, V121, P3024, DOI 10.1172/JCI43048
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rives CB, 2009, BIOMATERIALS, V30, P394, DOI 10.1016/j.biomaterials.2008.09.013
   Rossi L, 2008, TRANSPLANTATION, V85, P648, DOI 10.1097/TP.0b013e31816360f3
   Salvay DM, 2010, GENE THER, V17, P1134, DOI 10.1038/gt.2010.79
   Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea
   Staples KJ, 2007, J IMMUNOL, V178, P4779, DOI 10.4049/jimmunol.178.8.4779
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547
   van der Windt DJ, 2008, CELL TRANSPLANT, V17, P1005, DOI 10.3727/096368908786991515
   Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556
   Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44
NR 42
TC 32
Z9 32
U1 3
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 6
BP 2024
EP 2031
DI 10.1016/j.biomaterials.2013.11.036
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA3UD
UT WOS:000331018700024
PM 24309498
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Tsai, YT
   Zhou, J
   Weng, H
   Tang, EN
   Baker, DW
   Tang, LP
AF Tsai, Yi-Ting
   Zhou, Jun
   Weng, Hong
   Tang, Ewin N.
   Baker, David W.
   Tang, Liping
TI Optical imaging of fibrin deposition to elucidate participation of mast
   cells in foreign body responses
SO BIOMATERIALS
LA English
DT Article
DE In vivo imaging; Near infrared fluorescence; Fibrin; Biomaterial;
   Inflammation; Biocompatibility
ID ACUTE INFLAMMATORY RESPONSES; IN-VIVO; MOLECULAR DETERMINANTS; CONTRAST
   AGENT; ALPHA-CHAIN; BIOMATERIALS; THROMBIN; ADHESION; THROMBOEMBOLISM;
   POLYMERIZATION
AB Mast cell activation has been shown to be an initiator and a key determinant of foreign body reactions. However, there is no non-invasive method that can quantify the degree of implant-associated mast cell activation. Taking advantage of the fact that fibrin deposition is a hallmark of mast cell activation around biomaterial implants, a near infrared probe was fabricated to have high affinity to fibrin. Subsequent in vitro testing confirmed that this probe has high affinity to fibrin. Using a subcutaneous particle implantation model, we found significant accumulation of fibrin-affinity probes at the implant sites as early as 15 min following particle implantation. The accumulation of fibrin-affinity probes at the implantation sites could also be substantially reduced if anti-coagulant heparin was administered at the implant sites. Further studies have shown that subcutaneous administration of mast cell activator compound 48/80 - prompted the accumulation of fibrin-affinity probes. However, implant-associated fibrin-affinity probe accumulation was substantially reduced in mice with mast cell deficiency. The results show that our fibrin-affinity probes may serve as a powerful tool to monitor and measure the extent of biomaterial-mediated fibrin deposition and mast cell activation in vivo. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Tsai, Yi-Ting; Zhou, Jun; Weng, Hong; Tang, Ewin N.; Baker, David W.; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Tang, Liping] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu
FU NIH [R43 GM101776]
FX This work was supported by an NIH grant R43 GM101776.
CR Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101
   ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andre P, 2000, P NATL ACAD SCI USA, V97, P13835, DOI 10.1073/pnas.250475997
   Aruva MR, 2006, J NUCL MED, V47, P155
   Aspenberg P, 2004, ACTA ORTHOP SCAND, V75, P93, DOI 10.1080/00016470410001708190
   Botnar RM, 2004, CIRCULATION, V109, P2023, DOI 10.1161/01.CIR.000012703450006.C0
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   Coleman JW, 2002, CLIN EXP IMMUNOL, V129, P4, DOI 10.1046/j.1365-2249.2002.01918.x
   Cooley BC, 2011, ARTERIOSCL THROM VAS, V31, P1351, DOI 10.1161/ATVBAHA.111.225334
   Dorozhkin Sergey V, 2011, Biomatter, V1, P3, DOI 10.4161/biom.1.1.16782
   Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007
   GOMI K, 1990, BLOOD, V75, P1396
   Gray LD, 2011, THROMB RES, V128, P570, DOI 10.1016/j.thromres.2011.04.009
   Hogg PJ, 1996, J BIOL CHEM, V271, P26088, DOI 10.1074/jbc.271.42.26088
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y
   LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044
   Ma ML, 2011, ADV MATER, V23, pH189, DOI 10.1002/adma.201100513
   McCarthy JR, 2009, BIOCONJUGATE CHEM, V20, P1251, DOI 10.1021/bc9001163
   Metz M, 2007, TRENDS IMMUNOL, V28, P234, DOI 10.1016/j.it.2007.03.003
   Neeves KB, 2010, BIOPHYS J, V98, P1344, DOI 10.1016/j.bpj.2009.12.4275
   Overoye-Chan K, 2008, J AM CHEM SOC, V130, P6025, DOI 10.1021/ja800834y
   Pan D, 2008, J AM CHEM SOC, V130, P9186, DOI 10.1021/ja801482d
   Pan DPJ, 2009, CHEM COMMUN, P3234, DOI 10.1039/b902875g
   Pereira M, 2001, ANN NY ACAD SCI, V936, P438
   PEREZ RL, 1995, J IMMUNOL, V154, P1879
   RAMOS BF, 1992, EUR J IMMUNOL, V22, P2381, DOI 10.1002/eji.1830220930
   SIMMONS CA, 1987, J SURG RES, V43, P468, DOI 10.1016/0022-4804(87)90106-5
   Simpson-Haidaris PJ, 2001, ANN NY ACAD SCI, V936, P406
   Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887
   Sohaebuddin SK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-22
   Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Thakur ML, 2000, J NUCL MED, V41, P161
   Valent P, 1998, INT ARCH ALLERGY IMM, V115, P2, DOI 10.1159/000023823
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   Yu DG, 2012, INT J NANOMED, V7, P5725, DOI [10.2147/IJN.S37455, 10.2147/IJN.S29961]
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
   Zhou J, 2012, FREE RADICAL BIO MED, V52, P218, DOI 10.1016/j.freeradbiomed.2011.10.452
   Zhou J, 2011, BIOMATERIALS, V32, P9383, DOI 10.1016/j.biomaterials.2011.08.064
NR 48
TC 8
Z9 8
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 7
BP 2089
EP 2096
DI 10.1016/j.biomaterials.2013.11.040
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0SL
UT WOS:000331502300001
PM 24342726
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Tian, HC
   Liu, JQ
   Wei, DX
   Kang, XY
   Zhang, C
   Du, JC
   Yang, B
   Chen, X
   Zhu, HY
   NuLi, YN
   Yang, CS
AF Tian, Hong-Chang
   Liu, Jing-Quan
   Wei, Dai-Xu
   Kang, Xiao-Yang
   Zhang, Chuan
   Du, Jing-Cheng
   Yang, Bin
   Chen, Xiang
   Zhu, Hong-Ying
   NuLi, Yan-Na
   Yang, Chun-Sheng
TI Graphene oxide doped conducting polymer nanocomposite film for
   electrode-tissue interface
SO BIOMATERIALS
LA English
DT Article
DE Graphene oxide; Conducting polymer; Electrode-tissue interface;
   Microelectrode; Electrochemical deposition; Tissue engineering
ID ELECTRICAL-STIMULATION; NEURAL STIMULATION; NANOTUBES;
   POLY(3,4-ETHYLENEDIOXYTHIOPHENE); ADHESION
AB One of the most significant components for implantable bioelectronic devices is the interface between the microelectrodes and the tissue or cells for disease diagnosis or treatment. To make the devices work efficiently and safely in vivo, the electrode-tissue interface should not only be confined in micro scale, but also possesses excellent electrochemical characteristic, stability and biocompatibility. Considering the enhancement of many composite materials by combining graphene oxide (GO) for its multiple advantages, we dope graphene oxide into poly(3,4-ethylenedioxythiophene) (PEDOT) forming a composite film by electrochemical deposition for electrode site modification. As a consequence, not only the enlargement of efficient surface area, but also the development of impedance, charge storage capacity and charge injection limit contribute to the excellent electrochemical performance. Furthermore, the stability and biocompatibility are confirmed by numerously repeated usage test and cell proliferation and attachment examination, respectively. As electrode-tissue interface, this biomaterial opens a new gate for tissue engineering and implantable electrophysiological devices. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Tian, Hong-Chang; Liu, Jing-Quan; Kang, Xiao-Yang; Zhang, Chuan; Du, Jing-Cheng; Yang, Bin; Chen, Xiang; Zhu, Hong-Ying; Yang, Chun-Sheng] Shanghai Jiao Tong Univ, Natl Key Lab Sci & Technol Micro Nano Fabricat, Shanghai 200030, Peoples R China.
   [Wei, Dai-Xu] Natl Engn Res Ctr Nanotechnol, Shanghai, Peoples R China.
   [NuLi, Yan-Na] Shanghai Jiao Tong Univ, Dept Chem Engn, Shanghai 200030, Peoples R China.
RP Liu, JQ (reprint author), Shanghai Jiao Tong Univ, Natl Key Lab Sci & Technol Micro Nano Fabricat, Shanghai 200030, Peoples R China.
EM jqliu@sjtu.edu.cn
RI Tian, Hong-Chang/E-3580-2015
OI Du, Jingcheng/0000-0002-0322-4566
FU National Natural Science Foundation of China [51035005, 61176104]; 973
   Program [2013CB329401]; Shanghai Municipal Science and Technology
   Commission [11JC1405700, 13511500200]; NDPR Foundation of China
   [9140A26060313JW3385]
FX The authors thank to partly financial support from the National Natural
   Science Foundation of China (No. 51035005, 61176104), 973 Program
   (2013CB329401), Shanghai Municipal Science and Technology Commission
   (No. 11JC1405700, 13511500200), NDPR Foundation of China (No.
   9140A26060313JW3385). The authors are also grateful to the colleagues
   for their essential contribution to this work.
CR Abidian MR, 2010, SMALL, V6, P421, DOI 10.1002/smll.200901868
   Abidian MR, 2006, ADV MATER, V18, P405, DOI 10.1002/adma.200501726
   Asplund M, 2008, BIOINTERPHASES, V3, P83, DOI 10.1116/1.2998407
   Berggren M, 2007, ADV MATER, V19, P3201, DOI 10.1002/adma.200700419
   Chen P, 2013, ADV MATER, V25, P3192, DOI 10.1002/adma.201300515
   Cogan SF, 2004, J NEUROSCI METH, V137, P141, DOI 10.1016/j.jneumeth.2004.02.019
   Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518
   Danielsson P, 2004, J SOLID STATE ELECTR, V8, P809, DOI 10.1007/s10008-004-0549-2
   Dong Y, 2010, BIOMATERIALS, V31, P8921, DOI 10.1016/j.biomaterials.2010.08.001
   Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059
   Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047
   Green RA, 2012, BIOMATERIALS, V33, P5875, DOI 10.1016/j.biomaterials.2012.05.017
   Grill WM, 2009, ANNU REV BIOMED ENG, V11, P1, DOI 10.1146/annurev-bioeng-061008-124927
   Heo C, 2011, BIOMATERIALS, V32, P19, DOI 10.1016/j.biomaterials.2010.08.095
   Kim S, 2009, BIOMED MICRODEVICES, V11, P453, DOI 10.1007/s10544-008-9251-y
   Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]
   Kvarnstrom C, 1999, ELECTROCHIM ACTA, V44, P2739, DOI 10.1016/S0013-4686(98)00405-8
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Liu Y, 2010, LANGMUIR, V26, P6158, DOI 10.1021/la100886x
   Lu Y., 2010, BIOMATERIALS, V22, P3906
   Lu Y, 2009, SENSOR ACTUAT B-CHEM, V137, P334, DOI 10.1016/j.snb.2008.11.036
   Luo XL, 2011, BIOMATERIALS, V32, P5551, DOI 10.1016/j.biomaterials.2011.04.051
   Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020
   Park SY, 2011, ADV MATER, V23, P263
   Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824
   Receveur R. A. M., 2007, J MICROMECH MICROENG, V17, P50
   ROSE TL, 1990, IEEE T BIO-MED ENG, V37, P1118, DOI 10.1109/10.61038
   Rui YF, 2012, BIOMED MICRODEVICES, V14, P367, DOI 10.1007/s10544-011-9613-8
   Ruiz ON, 2011, ACS NANO, V5, P8100, DOI 10.1021/nn202699t
   Ryoo SR, 2010, ACS NANO, V4, P6587, DOI 10.1021/nn1018279
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Sodagar AM, 2009, IEEE T MICROW THEORY, V57, P2565, DOI 10.1109/TMTT.2009.2029957
   Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969
   Venkatraman S, 2011, IEEE T NEUR SYS REH, V19, P307, DOI 10.1109/TNSRE.2011.2109399
   Waltzman SB, 2006, EXPERT REV MED DEVIC, V3, P647, DOI 10.1586/17434440.3.5.647
   Weiland JD, 2008, P IEEE, V96, P1076, DOI 10.1109/JPROC.2008.922589
   Xu YF, 2009, NANO RES, V2, P343, DOI 10.1007/s12274-009-9032-9
   Xu YX, 2010, ACS NANO, V4, P7358, DOI 10.1021/nn1027104
   Yan H, 2009, SYNTHETIC MET, V159, P2225, DOI 10.1016/j.synthmet.2009.07.032
   Yan XB, 2010, ACS APPL MATER INTER, V2, P2521, DOI 10.1021/am100293r
   You B, 2013, CHEM COMMUN, V49, P5016, DOI 10.1039/c3cc41949e
   Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a
   Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068
NR 45
TC 50
Z9 50
U1 9
U2 111
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 7
BP 2120
EP 2129
DI 10.1016/j.biomaterials.2013.11.058
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0SL
UT WOS:000331502300005
PM 24333027
DA 2018-10-20
ER

PT J
AU Nguyen, EH
   Zanotelli, MR
   Schwartz, MP
   Murphy, WL
AF Nguyen, Eric H.
   Zanotelli, Matthew R.
   Schwartz, Michael P.
   Murphy, William L.
TI Differential effects of cell adhesion, modulus and VEGFR-2 inhibition on
   capillary network formation in synthetic hydrogel arrays
SO BIOMATERIALS
LA English
DT Article
DE Angiogenesis; Cell encapsulation; ECM; Growth factors; Hydrogel
ID VISCOELASTIC SHEAR PROPERTIES; GLYCOL) DIACRYLATE HYDROGELS;
   ENDOTHELIAL-CELLS; SIGNAL-TRANSDUCTION; IN-VITRO; ANGIOGENESIS; GROWTH;
   INTEGRIN; COLLAGEN; TUBULOGENESIS
AB Efficient biomaterial screening platforms can test a wide range of extracellular environments that modulate vascular growth. Here, we used synthetic hydrogel arrays to probe the combined effects of Cys-Arg-Gly-Asp-Ser (CRGDS) cell adhesion peptide concentration, shear modulus and vascular endothelial growth factor receptor 2 (VEGFR2) inhibition on human umbilical vein endothelial cell (HUVEC) viability, proliferation and tubulogenesis. HUVECs were encapsulated in degradable poly(ethylene glycol) (PEG) hydrogels with defined CRGDS concentration and shear modulus. VEGFR2 activity was modulated using the VEGFR2 inhibitor SU5416. We demonstrate that synergy exists between VEGFR2 activity and CRGDS ligand presentation in the context of maintaining HUVEC viability. However, excessive CRGDS disrupts this synergy. HUVEC proliferation significantly decreased with VEGFR2 inhibition and increased modulus, but did not vary monotonically with CRGDS concentration. Capillary-like structure (CLS) formation was highly modulated by CRGDS concentration and modulus, but was largely unaffected by VEGFR2 inhibition. We conclude that the characteristics of the ECM surrounding encapsulated HUVECs significantly influence cell viability, proliferation and CLS formation. Additionally, the ECM modulates the effects of VEGFR2 signaling, ranging from changing the effectiveness of synergistic interactions between integrins and VEGFR2 to determining whether VEGFR2 upregulates, downregulates or has no effect on proliferation and CLS formation. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Nguyen, Eric H.; Zanotelli, Matthew R.; Schwartz, Michael P.; Murphy, William L.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Murphy, William L.] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.
   [Murphy, William L.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53706 USA.
RP Murphy, WL (reprint author), Univ Wisconsin, Dept Biomed Engn, 1550 Engn Dr, Madison, WI 53706 USA.
EM wlmurphy@wisc.edu
RI Murphy, William/I-4096-2014
OI Schwartz, Michael/0000-0003-3785-6606
FU National Institutes of Health [NIH R01 HL093282-01A1, NIH R21
   EB016381-01, NIH 1UH2 TR000506-01]; Biotechnology Training Program
   [NIGMS 5T32GM08349]; National Magnetic Resonance Facility at Madison;
   NIH (BRTP/NCRR) [P41RR02301]; NIGMS [P41GM10399]; University of
   Wisconsin; NIH [RR02781, RR08438]; NSF [DMB-8415048, OIA-9977486,
   BIR-9214394]; DOE; USDA; NIH (NCRR) [S100RR027000]
FX The authors would like to acknowledge funding from the National
   Institutes of Health (NIH R01 HL093282-01A1, NIH R21 EB016381-01, NIH
   1UH2 TR000506-01 and the Biotechnology Training Program NIGMS
   5T32GM08349) as well as the UW Madison Graduate Engineering Research
   Scholars program. We would like to thank Justin Williams and David Beebe
   for their assistance with soft lithography techniques. This study made
   use of the National Magnetic Resonance Facility at Madison, which is
   supported by NIH grants P41RR02301 (BRTP/NCRR) and P41GM10399 (NIGMS).
   Additional equipment was purchased with funds from the University of
   Wisconsin, the NIH (RR02781, RR08438), the NSF (DMB-8415048,
   OIA-9977486, BIR-9214394), the DOE, and the USDA. Small angle X-ray
   scattering (SAXS) equipment was purchased with funds from NIH grant
   S100RR027000 (NCRR). Mechanical testing data was obtained using the Ares
   LS2 rheometer at the UW Madison Soft Materials Laboratory. Confocal
   Microscopy images were taken using the Nikon AIR-Si Confocal Microscope
   at the Waisman Center Cellular & Molecular Neuroscience Core facility in
   Madison, WI. Special thanks go to Matt Parlato for assistance with
   mechanical testing techniques and Justin Koepsel for helpful discussions
   and technical instruction throughout the course of these studies.
CR Abaci HE, 2011, AM J PHYSIOL-CELL PH, V301, pC431, DOI 10.1152/ajpcell.00074.2011
   Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200
   Beer AJ, 2008, J NUCL MED, V49, P22, DOI 10.2967/jnumed.107.045864
   Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102
   Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541
   Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3
   Chan RW, 1999, J ACOUST SOC AM, V106, P2008, DOI 10.1121/1.427947
   Charnley M, 2009, INTEGR BIOL-UK, V1, P625, DOI 10.1039/b918172p
   Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076
   Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Funahashi Y, 2011, VASC CELL, V3, DOI DOI 10.1186/2040-2384-2-3.AVAILABLE
   Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Han SW, 2013, CARDIOVASC RES, V98, P73, DOI 10.1093/cvr/cvt019
   Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x
   Hodivala-Dilke K, 2008, CURR OPIN CELL BIOL, V20, P514, DOI 10.1016/j.ceb.2008.06.007
   Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924
   Hudalla GA, 2011, ADV MATER, V23, P5415, DOI 10.1002/adma.201103046
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   Jo BH, 2000, J MICROELECTROMECH S, V9, P76, DOI 10.1109/84.825780
   Jongpaiboonkit L, 2008, BIOMATERIALS, V29, P3346, DOI 10.1016/j.biomaterials.2008.04.040
   Jongpaiboonkit L, 2009, TISSUE ENG PT A, V15, P343, DOI 10.1089/ten.tea.2008.0096
   Jung JP, 2011, INTEGR BIOL-UK, V3, P185, DOI 10.1039/c0ib00112k
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   Khan Zia A., 2005, Angiogenesis, V8, P183, DOI 10.1007/s10456-005-9017-6
   Khoo CP, 2011, TISSUE ENG PART C-ME, V17, P895, DOI [10.1089/ten.TEC.2011.0150, 10.1089/ten.tec.2011.0150]
   King WJ, 2010, J BIOMED MATER RES A, V93A, P1110, DOI 10.1002/jbm.a.32601
   Koepsel JT, 2012, INTEGR BIOL-UK, V4, P1508, DOI 10.1039/c2ib20029e
   Koepsel JT, 2012, INTEGR BIOL-UK, V4, P914, DOI 10.1039/c2ib20055d
   Koepsel JT, 2009, LANGMUIR, V25, P12825, DOI 10.1021/la901938e
   Lafleur MA, 2002, J CELL SCI, V115, P3427
   Le Saux G, 2011, BIOPHYS J, V101, P764, DOI 10.1016/j.bpj.2011.06.064
   Leslie-Barbick JE, 2011, BIOMATERIALS, V32, P5782, DOI 10.1016/j.biomaterials.2011.04.060
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Liu JC, 2008, BIOMACROMOLECULES, V9, P2984, DOI 10.1021/bm800469j
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Mendel DB, 2000, CLIN CANCER RES, V6, P4848
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Murphy JF, 2001, FASEB J, V15, P1667, DOI 10.1096/fj.00-0757fje
   Myers KA, 2011, J CELL BIOL, V192, P321, DOI 10.1083/jcb.201006009
   Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R
   Nelson CM, 2003, J CELL SCI, V116, P3571, DOI 10.1242/jcs.00680
   Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f
   Provenzano P, 2008, BMC MED, V6, DOI DOI 10.1186/1741-7015-6-11.AVAILABLE
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Roberts OL, 2010, J CELL SCI, V123, P3189, DOI 10.1242/jcs.072801
   Sacharidou A, 2010, BLOOD, V115, P5259, DOI 10.1182/blood-2009-11-252692
   Saunders RL, 2010, CELL MOL BIOENG, V3, P60, DOI 10.1007/s12195-010-0112-4
   Schneider BP, 2005, J CLIN ONCOL, V23, P1782, DOI 10.1200/JCO.2005.12.017
   Shamloo A, 2010, LAB CHIP, V10, P3061, DOI 10.1039/c005069e
   Shen CJ, 2011, EXP CELL RES, V317, P1860, DOI 10.1016/j.yexcr.2011.05.006
   Sinkus R, 2005, MAGN RESON IMAGING, V23, P159, DOI 10.1016/j.mri.2004.11.060
   Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882
   Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752
   Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451
   Thibault C, 2007, LANGMUIR, V23, P10706, DOI 10.1021/1a701341j
   Toepke MW, 2013, MACROMOL MATER ENG, V298, P699, DOI 10.1002/mame.201200119
   Xu ZH, 2006, INVEST OPHTH VIS SCI, V47, P4059, DOI 10.1167/iovs.05-1528
   Yamamura N, 2007, TISSUE ENG, V13, P1443, DOI 10.1089/ten.2006.0333
NR 67
TC 33
Z9 33
U1 1
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 7
BP 2149
EP 2161
DI 10.1016/j.biomaterials.2013.11.054
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0SL
UT WOS:000331502300008
PM 24332391
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ho, KKK
   Chen, RX
   Willcox, MDP
   Rice, SA
   Cole, N
   Iskander, G
   Kumar, N
AF Ho, Kitty K. K.
   Chen, Renxun
   Willcox, Mark D. P.
   Rice, Scott A.
   Cole, Nerida
   Iskander, George
   Kumar, Naresh
TI Quorum sensing inhibitory activities of surface immobilized
   antibacterial dihydropyrrolones via click chemistry
SO BIOMATERIALS
LA English
DT Article
DE Surface modification; Dihydropyrrolone; Quorum sensing; Antibacterial;
   Pseudomonas; Staphylococcus
ID DEVICE-ASSOCIATED INFECTIONS; PSEUDOMONAS-AERUGINOSA-LAS; TO-CELL
   COMMUNICATION; STAPHYLOCOCCUS-AUREUS; GENE-EXPRESSION; DELISEA-PULCHRA;
   IN-VIVO; SWARMING MOTILITY; BIOFILM FORMATION; SYSTEMS
AB Device-related infection remains a major barrier to the use of biomaterial implants as life-saving devices. This study aims to examine the effectiveness and mechanism of action of surface attached dihydropyrrolones (DHPs), a quorum sensing (QS) inhibitor, against bacterial colonization. DHPs were covalently attached on glass surfaces via copper-catalyzed azide-alkyne 1,3-dipolar cycloaddition (CuAAC) click reaction. The covalent attachment of DHP surfaces was confirmed by X-ray photoelectron spectroscopy (XPS) and contact angle measurements, and the antimicrobial efficacy of the DHP coatings was assessed by confocal laser scanning microscopy (CLSM) and image analysis. The results demonstrated that covalently bound DHP compounds are effective in reducing the adhesion by up to 97% (p < 0.05) for both Pseudomonas aeruginosa and Staphylococcus aureus. Furthermore, using the green fluorescent protein (Gfp)-based reporter technology, it is demonstrated that surface attached DHPs were able to repress the expression of a lasB-gfp reporter fusion of P. aeruginosa by 72% (p < 0.001) without affecting cell viability. This demonstrates the ability of the covalently bound QS inhibitor to inhibit QS and suggests the existence of a membrane-based pathway(s) for QS inhibition. Hence, strategies based on incorporation of QS inhibitors such as DHPs represent a potential approach for prevention of device-related infections. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Ho, Kitty K. K.; Chen, Renxun; Iskander, George; Kumar, Naresh] Univ New S Wales, Sch Chem, Sydney, NSW 2052, Australia.
   [Willcox, Mark D. P.; Cole, Nerida] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW 2052, Australia.
   [Rice, Scott A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
   [Rice, Scott A.] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW 2052, Australia.
   [Rice, Scott A.] Nanyang Technol Univ, Sch Biol Sci, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore.
RP Kumar, N (reprint author), Univ New S Wales, Sch Chem, Sydney, NSW 2052, Australia.
EM n.kumar@unsw.edu.au
RI Chen, Renxun/G-7015-2014
OI Chen, Renxun/0000-0003-0828-9980; rice, scott/0000-0002-9486-2343; cole,
   nerida/0000-0002-9866-4694
FU Australian Research Council [DP1095159]; Linkage Project Grant
   [LP110200635]
FX This research was supported by the Australian Research Council's
   Discovery Grant (DP1095159) and Linkage Project Grant (LP110200635).
CR Andresen M, 2007, BIOMACROMOLECULES, V8, P2149, DOI 10.1021/bm070304e
   Buckley BR, 2010, CHEM-EUR J, V16, P6278, DOI 10.1002/chem.201000447
   Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003
   Chen RX, 2012, ACTA BIOMATER, V8, P4371, DOI 10.1016/j.actbio.2012.07.029
   Collman JP, 2006, LANGMUIR, V22, P2457, DOI 10.1021/la052947q
   Crescenzi V, 2007, BIOMACROMOLECULES, V8, P1844, DOI 10.1021/bm0700800
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   Davis BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013522
   de Kievit TR, 2002, FEMS MICROBIOL LETT, V212, P101, DOI 10.1016/S0378-1097(02)00735-8
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913
   Gram L, 1996, APPL ENVIRON MICROB, V62, P4284
   Gupta RK, 2011, AM J BIOMED SCI, V3, P116, DOI DOI 10.5099/AJ1102
   Hein CD, 2008, PHARM RES-DORDR, V25, P2216, DOI 10.1007/s11095-008-9616-1
   Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87
   Ho KKK, 2010, BIOFOULING, V26, P913, DOI 10.1080/08927014.2010.531463
   Ho KKK, 2012, ANTIMICROB AGENTS CH, V56, P1138, DOI 10.1128/AAC.05814-11
   Hume EBH, 2005, IMMUNOL CELL BIOL, V83, P294, DOI 10.1111/j.1440-1711.2005.01326.x
   Hume EBH, 2004, BIOMATERIALS, V25, P5023, DOI 10.1016/j.biomaterials.2004.01.048
   Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105
   Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299
   Kjelleberg S, 1997, AQUAT MICROB ECOL, V13, P85, DOI 10.3354/ame013085
   Kjelleberg S, 2002, CURR OPIN MICROBIOL, V5, P254, DOI 10.1016/S1369-5274(02)00325-9
   Kumar N., 2007, WO Patent, Patent No. [WO2007085042, 2007085042]
   Li Y, 2011, CHEM-EUR J, V17, P2656, DOI 10.1002/chem.201001533
   Lintz MJ, 2011, P NATL ACAD SCI USA, V108, P15763, DOI 10.1073/pnas.1112398108
   Lowery CA, 2009, J AM CHEM SOC, V131, P14473, DOI 10.1021/ja9056079
   Manefield M, 1999, MICROBIOL-SGM, V145, P283, DOI 10.1099/13500872-145-2-283
   Mattmann ME, 2008, BIOORG MED CHEM LETT, V18, P3072, DOI 10.1016/j.bmcl.2007.11.095
   Nelson LK, 2009, MICROBIOL-SGM, V155, P2612, DOI 10.1099/mic.0.028464-0
   Oliveira JR, 2012, CARBOHYD POLYM, V87, P240, DOI 10.1016/j.carbpol.2011.07.043
   Prakash S, 2007, ANAL CHEM, V79, P1661, DOI 10.1021/ac061824n
   Pressly ED, 2011, J POLYM SCI POL CHEM, V49, P814, DOI 10.1002/pola.24504
   Qazi S, 2006, INFECT IMMUN, V74, P910, DOI 10.1128/IAI.74.2.910-919.2006
   Quemener D, 2006, CHEM COMMUN, P5051, DOI 10.1039/b611224b
   Rasmussen TB, 2000, MICROBIOL-UK, V146, P3237, DOI 10.1099/00221287-146-12-3237
   SCHULZ A, 1993, ANGEW CHEM INT EDIT, V32, P1610, DOI 10.1002/anie.199316101
   SCHULZE RK, 1990, J VAC SCI TECHNOL A, V8, P2338, DOI 10.1116/1.576760
   Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0
   Stocks SM, 2004, CYTOM PART A, V61A, P189, DOI 10.1002/cyto.a.20069
   Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107
   Tenover FC, 2001, CLIN INFECT DIS, V33, pS108, DOI 10.1086/321834
   Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001
   Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0
   WOLLMAN EW, 1994, J AM CHEM SOC, V116, P4395, DOI 10.1021/ja00089a030
   Wu H, 2001, MICROBIOL-SGM, V147, P1105, DOI 10.1099/00221287-147-5-1105
   Zhu H, 2004, INVEST OPHTH VIS SCI, V45, P1897, DOI 10.1167/iovs.03-0980
NR 49
TC 19
Z9 21
U1 1
U2 76
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 7
BP 2336
EP 2345
DI 10.1016/j.biomaterials.2013.11.072
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0SL
UT WOS:000331502300027
PM 24345737
DA 2018-10-20
ER

PT J
AU Zhu, HJ
   Chen, HB
   Zeng, XW
   Wang, ZY
   Zhang, XD
   Wu, YP
   Gao, YF
   Zhang, JX
   Liu, KW
   Liu, RY
   Cai, LT
   Mei, L
   Feng, SS
AF Zhu, Huijun
   Chen, Hongbo
   Zeng, Xiaowei
   Wang, Zhongyuan
   Zhang, Xudong
   Wu, Yanping
   Gao, Yongfeng
   Zhang, Jinxie
   Liu, Kewei
   Liu, Ranyi
   Cai, Lintao
   Mei, Lin
   Feng, Si-Shen
TI Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA
   nanoparticles for enhanced chemotherapy against multi-drug resistance
SO BIOMATERIALS
LA English
DT Article
DE Biodegradable polymers; Cancer nanotechnology; Controlled release;
   Molecular biomaterial; Nanomedicine; Pharmaceutical nanotechnology
ID POLYETHYLENE-GLYCOL; CONTROLLED-RELEASE; HOLLOW MICROSPHERES;
   CANCER-TREATMENT; BREAST-CANCER; COPOLYMER; SUCCINATE; DOXORUBICIN; PEG;
   NANOMEDICINE
AB We report a strategy to make use of poly(lactic-co-glycolic acid) nanoparticle (PLGA NPs) for co-delivery of docetaxel (DTX) as a model anticancer drug together with vitamin E TPGS. The latter plays a dual role as a pore-forming agent in the nanopartides that may result in smaller particle size, higher drug encapsulation efficiency and faster drug release, and also as a bioactive agent that could inhibit P-glycoprotein to overcome multi-drug resistance of the cancer cells, The DTX-loaded PLGA NPs of 0, 10, 20 and 40% TPGS were prepared by the nanoprecipitation method and then characterized for their size and size distribution, surface morphology, physical status and encapsulation efficiency of the drug in the NPs. All four NPs were found of size ranged 100-120 nm and EE ranged 85-95% at drug loading level around 10%. The in vitro evaluation showed that the 48 h IC50 values of the free DTX and the DTX-loaded PLGA NPs of 0, 10,20% TPGS were 2.619 and 0.474, 0.040, 0.009 mu g/mL respectively, which means that the PLGA NPs formulation could be 5.57 fold effective than the free DTX and that the DTX-loaded PLGA NPs of 10 or 20% TPGS further be 11.85 and 52.7 fold effective than the DTX-loaded PLGA NPs of no TPGS (therefore, 66.0 and 284 fold effective than the free DTX). Xenograft tumor model and immunohistological staining analysis further confirmed the advantages of the strategy of co-delivery of anticancer drugs with TPGS by PLGA NPs. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Zhu, Huijun; Chen, Hongbo; Zeng, Xiaowei; Wang, Zhongyuan; Zhang, Xudong; Wu, Yanping; Gao, Yongfeng; Zhang, Jinxie; Liu, Kewei; Mei, Lin; Feng, Si-Shen] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Zhu, Huijun; Chen, Hongbo; Zeng, Xiaowei; Wang, Zhongyuan; Zhang, Xudong; Wu, Yanping; Gao, Yongfeng; Zhang, Jinxie; Liu, Kewei; Mei, Lin; Feng, Si-Shen] Tsinghua Univ, Shenzhen Grad Sch,Shenzhen Key Lab Chem Biol, Shenzhen Key Lab Gene & Antibody Therapy, Minist Prov Jointly Constructed Base State Key La, Shenzhen 518055, Peoples R China.
   [Zhu, Huijun; Chen, Hongbo; Zeng, Xiaowei; Wang, Zhongyuan; Zhang, Xudong; Wu, Yanping; Gao, Yongfeng; Zhang, Jinxie; Liu, Kewei; Mei, Lin; Feng, Si-Shen] Tsinghua Univ, Shenzhen Grad Sch, Div Life & Hlth Sci, Shenzhen 518055, Peoples R China.
   [Liu, Ranyi] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China.
   [Cai, Lintao] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Shenzhen 518055, Peoples R China.
   [Feng, Si-Shen] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore.
RP Feng, SS (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, Block E5,02-11,4 Engn Dr 4, Singapore 117576, Singapore.
EM mei.lin@sz.tsinghua.edu.cn; chefss@nus.edu.sg
RI Zeng, Xiaowei/A-6506-2015
OI Cai, Lintao/0000-0002-2461-6390
FU National Natural Science Foundation of China [31270019, 51203085,
   81272638]; Program for New Century Excellent Talents in University
   [NCET-11-0275]; Natural Science Foundation of Guangdong Province
   [S2012010010046, S2012040006820]; China Postdoctoral Science Foundation
   [2012M520242]; Science, Technology & Innovation Commission of Shenzhen
   Municipality [JCYJ20120616213729920, JCYJ20120614 191936420,
   KQC201105310021A, JC201005270308A]
FX This work was supported by the National Natural Science Foundation of
   China (No. 31270019, 51203085, 81272638), Program for New Century
   Excellent Talents in University (NCET-11-0275), Natural Science
   Foundation of Guangdong Province (No. S2012010010046, S2012040006820),
   China Postdoctoral Science Foundation (No. 2012M520242) and Science,
   Technology & Innovation Commission of Shenzhen Municipality (No.
   JCYJ20120616213729920, JCYJ20120614 191936420, KQC201105310021A,
   JC201005270308A).
CR Bae SE, 2009, J CONTROL RELEASE, V133, P37, DOI 10.1016/j.jconrel.2008.09.006
   Brigger I, 2002, ADV DRUG DELIV REV, V54, P631
   Buske J, 2012, EUR J PHARM BIOPHARM, V81, P57, DOI 10.1016/j.ejpb.2012.01.009
   Cheng J, 2007, BIOMATERIALS, V28, P869, DOI 10.1016/j.biomaterials.2006.09.047
   Constantinou C, 2008, INT J CANCER, V123, P739, DOI 10.1002/ijc.23689
   Dai XW, 2008, NANOMED-NANOTECHNOL, V4, P49, DOI 10.1016/j.nano.2007.12.002
   Dintaman JM, 1999, PHARMACEUT RES, V16, P1550, DOI 10.1023/A:1015000503629
   Dorai T, 2004, CANCER LETT, V215, P129, DOI 10.1016/j.canlet.2004.07.013
   Gao Y, 2011, ACS NANO, V5, P9788, DOI 10.1021/nn2033105
   Gelperina S, 2005, AM J RESP CRIT CARE, V172, P1487, DOI 10.1164/rccm.200504-613PP
   Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706
   He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065
   Hu CMJ, 2009, CURR DRUG METAB, V10, P836, DOI 10.2174/138920009790274540
   Kang JC, 2007, MOL PHARMACEUT, V4, P104, DOI 10.1021/mp060041n
   Ke CJ, 2012, BIOMATERIALS, V33, P5156, DOI 10.1016/j.biomaterials.2012.03.056
   Ke CJ, 2011, ANGEW CHEM INT EDIT, V50, P8086, DOI 10.1002/anie.201102852
   Kumbar SG, 2006, J NANOSCI NANOTECHNO, V6, P2591, DOI 10.1166/jnn.2006.462
   Lake DE, 2004, DRUGS, V64, P1851, DOI 10.2165/00003495-200464170-00001
   Ma YD, 2010, NANOSCALE RES LETT, V5, P1161, DOI 10.1007/s11671-010-9620-3
   Mitra S, 2001, J CONTROL RELEASE, V74, P317, DOI 10.1016/S0168-3659(01)00342-X
   Mu L, 2002, J CONTROL RELEASE, V80, P129, DOI 10.1016/S0168-3659(02)00025-1
   Neuzil J, 2007, MOL PHARMACOL, V71, P1185, DOI 10.1124/mol.106.030122
   Park W, 2012, BIOMATERIALS, V33, P8848, DOI 10.1016/j.biomaterials.2012.08.042
   Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y
   Reddy LH, 2007, J CONTROL RELEASE, V124, P20, DOI 10.1016/j.jeonrel.2007.08.018
   Sant S, 2005, J CONTROL RELEASE, V107, P203, DOI 10.1016/j.jconrel.2005.02.017
   Schubert MA, 2005, EUR J PHARM BIOPHARM, V61, P77, DOI 10.1016/j.ejpb.2005.03.006
   Tao W, 2013, ACTA BIOMATER, V9, P8910, DOI 10.1016/j.actbio.2013.06.034
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Viswanathan NB, 2001, J MICROENCAPSUL, V18, P783
   Wang JL, 2012, BIOMATERIALS, V33, P6877, DOI 10.1016/j.biomaterials.2012.06.019
   Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050
   Yan F, 2010, NANOMED-NANOTECHNOL, V6, P170, DOI 10.1016/j.nano.2009.05.004
   Yang Y, 2009, BIOMATERIALS, V30, P1947, DOI 10.1016/j.biomaterials.2008.12.044
   Youk HJ, 2005, J CONTROL RELEASE, V107, P43, DOI 10.1016/j.jconrel.2005.05.014
   Zeng XW, 2013, BIOMATERIALS, V34, P6058, DOI 10.1016/j.biomaterials.2013.04.052
   Zhang YQ, 2010, ACTA BIOMATER, V6, P2045, DOI 10.1016/j.actbio.2009.11.035
   Zhang ZP, 2012, NANOMEDICINE-UK, V7, P1645, DOI [10.2217/NNM.12.117, 10.2217/nnm.12.117]
   Zhang ZP, 2012, BIOMATERIALS, V33, P4889, DOI 10.1016/j.biomaterials.2012.03.046
NR 39
TC 115
Z9 123
U1 12
U2 232
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 7
BP 2391
EP 2400
DI 10.1016/j.biomaterials.2013.11.086
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0SL
UT WOS:000331502300033
PM 24360574
DA 2018-10-20
ER

PT J
AU Tan, YN
   Liu, Y
   Grover, L
AF Tan, Yanni
   Liu, Yong
   Grover, Liam
TI Effect of phosphoric acid on the properties of magnesium oxychloride
   cement as a biomaterial
SO CEMENT AND CONCRETE RESEARCH
LA English
DT Article
DE Hydration; Microstructure; Compressive strength; Degradation; MgO
ID MICROSTRUCTURE; MGO-MGCL2-H2O; PHOSPHATES; RESISTANCE; MECHANISM;
   PHASES; PASTES
AB Magnesium oxychloride cement (MOC) has been used in civil engineering for more than 100 years, but its application has been limited by its poor water resistance. This property, however, could be exploited in the formulation of a resorbable orthopaedic biomaterial. In this study, H3PO4 was added to control the degradation process of MOC to provide a predictable and clinically appropriate resorption time. The effects of H3PO4 on the phases, microstructures, mechanical properties, hydration and degradation of MOC have been evaluated. The results revealed that the crystalline phases in MOC before and after adding H3PO4 were the same, but that the needle-like phase 5 (5 Mg(OH)(2) center dot MgCl2 center dot 8H(2)O) crystals were formed more extensively in MOC with H3PO4 than that in MOC without H3PO4. Furthermore, the addition of H3PO4 was shown to retard the hydration process. H3PO4 did significantly improve the water resistance of MOC though its addition resulting in a reduction in compressive strength. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Tan, Yanni] Cent S Univ, Sch Met & Environm, Changsha 410083, Hunan, Peoples R China.
   [Tan, Yanni; Liu, Yong] Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
   [Tan, Yanni; Grover, Liam] Univ Birmingham, Sch Chem Engn, Birmingham B15 2TT, W Midlands, England.
RP Grover, L (reprint author), Univ Birmingham, Sch Chem Engn, Birmingham B15 2TT, W Midlands, England.
EM l.m.grover@bham.ac.uk
RI Grover, Liam/F-2713-2011
OI Grover, Liam/0000-0002-9774-7412
FU China Scholarship council; Central South University; European Regional
   Development Fund (ERDF)
FX The authors acknowledge the financial support to Tan Yanni from the
   China Scholarship council, the postdoctoral research fund and the
   freedom explore program of Central South University. And the universal
   testing machine used in this research was obtained through Birmingham
   Science City, with support from Advantage West Midlands (AWM) and part
   funded by the European Regional Development Fund (ERDF).
CR Aramendia MA, 1999, J COLLOID INTERF SCI, V217, P288, DOI 10.1006/jcis.1999.6380
   Beaudoin JJ, 1975, CHEM CONCER RES, V5, P617
   BILINSKI H, 1984, J AM CERAM SOC, V67, P266
   Chau CK, 2008, MATER STRUCT, V41, P853, DOI 10.1617/s11527-007-9289-y
   Collier NC, 2008, CEMENT CONCRETE RES, V38, P737, DOI 10.1016/j.cemconres.2008.02.012
   Deng DH, 1999, CEMENT CONCRETE RES, V29, P1365
   Deng DH, 2003, CEMENT CONCRETE RES, V33, P1311, DOI 10.1016/S0008-8846(03)00043-7
   Li ZJ, 2007, CEMENT CONCRETE RES, V37, P866, DOI 10.1016/j.cemconres.2007.03.015
   LU HP, 1994, MATER LETT, V20, P217, DOI 10.1016/0167-577X(94)90090-6
   Mathur R, 2009, E-J CHEM, V6, P412, DOI 10.1155/2009/734185
   MATKOVIC B, 1973, NATURE-PHYS SCI, V246, P79, DOI 10.1038/physci246079a0
   MATKOVIC B, 1977, J AM CERAM SOC, V60, P504, DOI 10.1111/j.1151-2916.1977.tb14093.x
   Misra R.M.A.K., 2007, B MATER SCI, V30, P239
   Paxton J.Z., 2012, 9 WORLD BIOM C, V10, P2010
   Rabiee SM, 2010, J MOL STRUCT, V969, P172, DOI 10.1016/j.molstruc.2010.01.068
   TOOPER B, 1966, NATURE, V211, P64, DOI 10.1038/211064a0
   Wang Peiling, 1990, J INORG MATER, V5, P61
   Yunsong J., 2001, MATER LETT, V50, P28
   Zhang C., 1994, J WUHAN UNIV TECHNOL, V9, P51
NR 19
TC 24
Z9 28
U1 9
U2 52
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0008-8846
EI 1873-3948
J9 CEMENT CONCRETE RES
JI Cem. Concr. Res.
PD FEB
PY 2014
VL 56
BP 69
EP 74
DI 10.1016/j.cemconres.2013.11.001
PG 6
WC Construction & Building Technology; Materials Science, Multidisciplinary
SC Construction & Building Technology; Materials Science
GA AA9PD
UT WOS:000331424500008
DA 2018-10-20
ER

PT J
AU Gasik, M
   Keski-Honkola, A
   Bilotsky, Y
   Friman, M
AF Gasik, Michael
   Keski-Honkola, Anu
   Bilotsky, Yeugen
   Friman, Michael
TI Development and optimisation of hydroxyapatite-beta-TCP functionally
   gradated biomaterial
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Hydroxyapatite; Tricalcium phosphate; Sintering; Stress; Scaffold;
   Coating; Optimisation
ID GRADED MATERIALS; BIOMEDICAL APPLICATIONS; POROUS TITANIUM; IMPLANTS;
   COMPOSITES; DEPOSITION; COATINGS; ANATASE; LAYER
AB Use of hydroxyapatite (HAP) for biomaterials is widely established, often in a combination with titanium alloy substrates in orthopaedic and other implants. Porous HAP-based coatings undergo sintering and heat treatment processes to achieve proper level of density yet avoiding undesirable reactions and phase changes. Thermal expansion mismatch between constituents may also lead to cracking of the coating due to excessive thermal stresses. Thus control of mechanical properties and stress state in the coating during the whole processing cycle represents some challenges when trying to combine conflicting objectives.
   In this work a method of optimisation of mechanical behaviour of an FGM biomaterial coating or scaffold composed of HAP and beta-tricalcium phosphate (beta-TCP) is considered. For coating on titanium-based substrates which have anatase (TiO2) top layer, thermodynamic equilibrium was analysed and the "safe" compositional path was found to ensure preservation of original ceramic phases during processing. Experimental studies of HAP-TCP sintering kinetics of different compositions were carried out with dilatometry to obtain true shrinkage curves and thermal expansion functions. These data were integrated with thermo-mechanical calculations of stresses and strains in HAP-beta-TCP FGM during processing, which were optimised with respect to minimal stresses, stresses derivatives and curvatures. The beneficial effect of compositional gradation on behaviour of these materials is shown. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Gasik, Michael; Keski-Honkola, Anu; Bilotsky, Yeugen; Friman, Michael] Aalto Univ Fdn, Sch Chem Technol, FIN-00076 Aalto, Finland.
RP Gasik, M (reprint author), Aalto Univ Fdn, Sch Chem Technol, POB 16200, FIN-00076 Aalto, Finland.
EM michael.gasik@aalto.fi
RI Gasik, Michael/G-2224-2013
OI Gasik, Michael/0000-0002-5782-7987
FU EU [NMP3-CT-2006-026501]; Finnish national innovation agency (Tekes)
FX Authors acknowledge support from the EU FP6 Project "Med-delcoat"
   (NMP3-CT-2006-026501) and from Finnish national innovation agency
   (Tekes).
CR Balamurugan A, 2007, MAT SCI ENG C-BIO S, V27, P162, DOI 10.1016/j.msec.2006.04.006
   Bouazza S, 2010, MATER SCI FORUM, V631-632, P141, DOI 10.4028/www.scientific.net/MSF.631-632.141
   Braem A, 2011, ADV ENG MATER, V13, P509, DOI 10.1002/adem.201100011
   Drnovsek N, 2009, SURF COAT TECH, V203, P1462, DOI 10.1016/j.surfcoat.2008.11.031
   Duan K, 2006, J MATER CHEM, V16, P2309, DOI 10.1039/b517634d
   Gasik M, 2000, COMP MATER SCI, V18, P93, DOI 10.1016/S0927-0256(00)00090-2
   Gasik M., 2009, P 17 PLANS SEM, V1, P1
   Gasik M, 2012, ADV HEALTHC MATER, V1, P117, DOI 10.1002/adhm.201100006
   Gasik M, 2010, MATER SCI FORUM, V631-632, P79, DOI 10.4028/www.scientific.net/MSF.631-632.79
   Gasik MM, 1998, COMP MATER SCI, V13, P42, DOI 10.1016/S0927-0256(98)00044-5
   Gu Wel Yong, 2005, BASIC ORTHOPAEDIC BI
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Henriques B, 2012, J MECH BEHAV BIOMED, V13, P206, DOI 10.1016/j.jmbbm.2012.04.019
   Katakam S., 2003, TRENDS BIOMATER ARTI, V17, P24
   Laonapakul T, 2012, J MECH BEHAV BIOMED, V15, P153, DOI 10.1016/j.jmbbm.2012.05.017
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Miranda M, 2010, INT J MATER RES, V101, P117, DOI 10.3139/146.110247
   Obata A, 2007, MATER TRANS, V48, P313, DOI 10.2320/matertrans.48.313
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   Wu JM, 2004, J AM CERAM SOC, V87, P1635, DOI 10.1111/j.1551-2916.2004.01635.x
   Yasuda HY, 2006, MATER TRANS, V47, P2368, DOI 10.2320/matertrans.47.2368
   Zhang BS, 2002, COMP MATER SCI, V25, P264, DOI 10.1016/S0927-0256(02)00271-9
   Zhao CY, 2010, J BIOMED MATER RES B, V95B, P387, DOI 10.1002/jbm.b.31728
NR 25
TC 11
Z9 11
U1 1
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD FEB
PY 2014
VL 30
BP 266
EP 273
DI 10.1016/j.jmbbm.2013.11.017
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0PF
UT WOS:000331493900027
PM 24361930
DA 2018-10-20
ER

PT J
AU DiRienzo, AL
   Yakacki, CM
   Frensemeier, M
   Schneider, AS
   Safranski, DL
   Hoyt, AJ
   Frick, CP
AF DiRienzo, Amy L.
   Yakacki, Christopher M.
   Frensemeier, Mareike
   Schneider, Andreas S.
   Safranski, David L.
   Hoyt, Anthony J.
   Frick, Carl P.
TI Porous poly(para-phenylene) scaffolds for load-bearing orthopedic
   applications
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Poly(para-phenylenes); Porous biomaterials; Biomedical devices;
   Mechanical behavior; Scanning electron microscopy
ID CRUCIATE LIGAMENT RECONSTRUCTION; EFFECTIVE ELASTIC-MODULI; RIGID
   POLYURETHANE FOAM; MECHANICAL-PROPERTIES; METHACRYLATE COPOLYMERS;
   HYDROXYALKYL ACRYLATE; COMPRESSION BEHAVIOR; SYNTHETIC HYDROGELS;
   CELLULAR MATERIALS; METALLIC IMPLANTS
AB The focus of this study was to fabricate and investigate the mechanical behavior of porous poly(para-phenylene) (PPP) for potential use as a load-bearing orthopedic biomaterial. PPPs are known to have exceptional mechanical properties due to their aromatic backbone; however, the manufacturing and properties of PPP porous structures have not been previously investigated. Tailored porous structures with either small (150-250 mu m) or large (420-500 mu m) pore sizes were manufactured using a powder-sintering/salt-leaching technique. Porosities were systematically varied using 50 to 90 vol%. Micro-computed tomography (mu CT) and scanning electron microscopy (SEM) were used to verify an open-cell structure and investigate pore morphology of the scaffolds. Uniaxial mechanical behavior of solid and porous PPP samples was characterized through tensile and compressive testing. Both modulus and strength decreased with increasing porosity and matched well with foam theory. Porous scaffolds showed a significant decrease in strain-to-failure (<4%) under tensile loading and experienced linear elasticity, plastic deformation, and densification under compressive loading. Over the size ranges tested, pore size did not significantly influence the mechanical behavior of the scaffolds on a consistent basis. These results are discussed in regards to use of porous PPP for orthopedic applications and a prototype porous interbody fusion cage is presented. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [DiRienzo, Amy L.; Hoyt, Anthony J.; Frick, Carl P.] Univ Wyoming, Dept Mech Engn, Laramie, WY 82071 USA.
   [Yakacki, Christopher M.] Univ Colorado Denver, Dept Mech Engn, Denver, CO USA.
   [Frensemeier, Mareike] INM Leibniz Inst New Mat, Funct Surfaces Grp, Saarbrucken, Germany.
   [Schneider, Andreas S.] AG Dillinger Huttenwerke, Dev & Plate Design, Dillingen, Germany.
   [Safranski, David L.] MedShape Inc, Dept Res & Dev, Atlanta, GA USA.
RP Frick, CP (reprint author), Univ Wyoming, Dept Mech Engn, Laramie, WY 82071 USA.
EM cfrick@uwyo.edu
OI Frick, Carl/0000-0002-8202-924X
FU Solvay Specialty Polymers, LLC
FX The authors would like to thank Prof. Robert Guldberg, Prof. R. Dana
   Carpenter, and Angela Lin for their help regarding mu CT imaging and
   analysis using direct transformation methods. The authors gratefully
   acknowledge assistance in porous sample fabrication and mechanical
   testing from Jonathan Schlotthauer and Dustin Bales. The authors would
   also like to thank Eric J. Losty and Jac Corless for their help in
   machining prototype implants. CPF and CMY acknowledge Solvay Specialty
   Polymers, LLC for their financial and material support of this work.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Arora KA, 1998, POLYM ENG SCI, V38, P2055, DOI 10.1002/pen.10375
   BARNES A, 1988, POLYMER, V29, P2191, DOI 10.1016/0032-3861(88)90111-5
   Beutler William J, 2003, Spine J, V3, P289, DOI 10.1016/S1529-9430(03)00061-5
   Bobyn J D, 1992, Clin Orthop Relat Res, P79
   Brand J, 2000, AM J SPORT MED, V28, P761, DOI 10.1177/03635465000280052501
   BREZNY R, 1989, J AM CERAM SOC, V72, P1145, DOI 10.1111/j.1151-2916.1989.tb09698.x
   Burstone CJ, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2009.05.030
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chlopek J, 2005, J MATER SCI-MATER M, V16, P1051, DOI 10.1007/s10856-005-4759-7
   Converse GL, 2010, ACTA BIOMATER, V6, P856, DOI 10.1016/j.actbio.2009.08.004
   Converse GL, 2009, J MECH BEHAV BIOMED, V2, P627, DOI 10.1016/j.jmbbm.2009.07.002
   CORKHILL PH, 1987, POLYMER, V28, P1758, DOI 10.1016/0032-3861(87)90021-8
   Demirhan M, 2000, ARTHROSCOPY, V16, P383, DOI 10.1016/S0749-8063(00)90083-5
   Di Prima MA, 2007, SMART MATER STRUCT, V16, P2330, DOI 10.1088/0964-1726/16/6/037
   Di Prima MA, 2010, MECH MATER, V42, P315, DOI 10.1016/j.mechmat.2009.11.002
   DiPaola CP, 2008, J AM ACAD ORTHOP SUR, V16, P130, DOI 10.5435/00124635-200803000-00004
   Drummond JL, 2008, J DENT RES, V87, P710, DOI 10.1177/154405910808700802
   FOWLKES CW, 1974, INT J FRACTURE, V10, P99, DOI 10.1007/BF00955084
   Frick CP, 2014, J BIOMED MATER RES A, V102, P3122, DOI 10.1002/jbm.a.34982
   FRICKE J, 1988, J NON-CRYST SOLIDS, V100, P169, DOI 10.1016/0022-3093(88)90014-2
   Gibson LJ, 2000, ANNU REV MATER SCI, V30, P191, DOI 10.1146/annurev.matsci.30.1.191
   GIBSON LJ, 1989, MAT SCI ENG A-STRUCT, V110, P1, DOI 10.1016/0921-5093(89)90154-8
   GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P43, DOI 10.1098/rspa.1982.0088
   GOULET RW, 1994, J BIOMECH, V27, P375, DOI 10.1016/0021-9290(94)90014-0
   Gupta N, 2001, J MATER SCI, V36, P4485, DOI 10.1023/A:1017986820603
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Ji SC, 2006, J MATER SCI, V41, P1757, DOI 10.1007/s10853-006-2871-9
   Kabir ME, 2006, MAT SCI ENG A-STRUCT, V429, P225, DOI 10.1016/j.msea.2006.05.133
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   LEDERMAN JM, 1971, J APPL POLYM SCI, V15, P693, DOI 10.1002/app.1971.070150314
   Liu QL, 2004, POLYM ENG SCI, V44, P463, DOI 10.1002/pen.20041
   Liu XWS, 2006, J BONE MINER RES, V21, P1608, DOI 10.1359/JBMR.060716
   MCINTYRE A, 1979, POLYMER, V20, P247, DOI 10.1016/0032-3861(79)90229-5
   MEINECKE EA, 1970, J APPL POLYM SCI, V14, P2239, DOI 10.1002/app.1970.070140905
   Morgan SE, 2006, POLYMER, V47, P2865, DOI 10.1016/j.polymer.2006.02.025
   Noshchenko A, 2011, J BIOMED MATER RES B, V98B, P192, DOI 10.1002/jbm.b.31837
   Noshchenko A, 2011, SPINE, V36, P870, DOI 10.1097/BRS.0b013e3181e6ce16
   Pei XQ, 2012, WEAR, V274, P452, DOI 10.1016/j.wear.2011.09.009
   Poukalova M, 2010, J BIOMECH, V43, P1138, DOI 10.1016/j.jbiomech.2009.12.007
   RAMAKRISHNAN N, 1993, J AM CERAM SOC, V76, P2745, DOI 10.1111/j.1151-2916.1993.tb04011.x
   RAMAKRISHNAN N, 1990, J MATER SCI, V25, P3930, DOI 10.1007/BF00582462
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   RUSCH KC, 1969, J APPL POLYM SCI, V13, P2297, DOI 10.1002/app.1969.070131106
   RUSCH KC, 1970, J APPL POLYM SCI, V14, P1263, DOI 10.1002/app.1970.070140514
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   San Marchi C, 2001, ACTA MATER, V49, P3959, DOI 10.1016/S1359-6454(01)00294-4
   SHELLOCK FG, 1992, JMRI-J MAGN RESON IM, V2, P225, DOI 10.1002/jmri.1880020217
   SHERWOOD JA, 1992, POLYM ENG SCI, V32, P1138, DOI 10.1002/pen.760321611
   Sloten JV, 1998, BIOMATERIALS, V19, P1455, DOI 10.1016/S0142-9612(98)00058-1
   Suh JS, 1998, AM J ROENTGENOL, V171, P1207, DOI 10.2214/ajr.171.5.9798849
   Sun HL, 2002, J APPL POLYM SCI, V86, P1692, DOI 10.1002/app-11070
   Vuorinen AM, 2011, J ADHES DENT, V13, P333, DOI 10.3290/j.jad.a19653
   Vuotinen AM, 2008, DENT MATER, V24, P708, DOI 10.1016/j.dental.2007.07.003
   WAGH AS, 1991, J MATER SCI, V26, P3862, DOI 10.1007/BF01184983
   Walter T.R., 2009, J ENG MAT TECHNOL T, V131
   Wang D, 2007, J POLYM SCI POL PHYS, V45, P173, DOI 10.1002/polb.20796
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
NR 64
TC 10
Z9 10
U1 4
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD FEB
PY 2014
VL 30
BP 347
EP 357
DI 10.1016/j.jmbbm.2013.10.012
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0PF
UT WOS:000331493900035
PM 24374261
DA 2018-10-20
ER

PT J
AU Fiedler, T
   Fisher, M
   Roether, JA
   Belova, IV
   Samtleben, T
   Bernthaler, T
   Murch, GE
   Boccaccini, AR
AF Fiedler, T.
   Fisher, M.
   Roether, J. A.
   Belova, I. V.
   Samtleben, T.
   Bernthaler, T.
   Murch, G. E.
   Boccaccini, A. R.
TI Strengthening mechanism of PDLLA coated titania foam
SO MECHANICS OF MATERIALS
LA English
DT Article
DE Biomaterial; Composite material; Finite element analysis; Micro-computed
   tomography; Micro-structure
ID TISSUE ENGINEERING SCAFFOLDS; COMPOSITE; BIOMATERIALS; COATINGS; STATE
AB This paper addresses the numerical analysis of the mechanical properties of titania foam intended for use in tissue engineering scaffolds. Special focus is given to a PDLLA coating that has been shown to distinctly increase the mechanical strength of the scaffold. Micro-computed tomography (mu CT) data of a real scaffold are obtained and converted into numerical calculation models. Finite element simulations are performed alternately with and without the PDLLA coating. In addition, a strut model containing a single micro-crack is analysed. Numerical results indicate that filling the crack with PDLLA significantly increases the strength of the strut by attenuating stress concentrations. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Fiedler, T.; Fisher, M.; Belova, I. V.; Murch, G. E.] Univ Newcastle, Sch Engn, Callaghan, NSW 2287, Australia.
   [Roether, J. A.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Polymer Mat, D-91058 Erlangen, Germany.
   [Samtleben, T.; Bernthaler, T.] Univ Appl Sci Aalen, Dept Surface Engn & Mat Sci, Fac Mech & Mat Engn, D-73430 Aalen, Germany.
   [Boccaccini, A. R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91058 Erlangen, Germany.
RP Fiedler, T (reprint author), Univ Newcastle, Sch Engn, Callaghan, NSW 2287, Australia.
EM thomas.fiedler@newcastle.edu.au
RI Boccaccini, Aldo/C-7905-2013
OI Fiedler, Thomas/0000-0003-0256-8233
CR CeramTec, 2012, MAT SEL GUID
   Fiedler T, 2012, COMP MATER SCI, V61, P283, DOI 10.1016/j.commatsci.2012.04.043
   Grote K. -H., 2007, DUBBEL TASCHENBUCH M
   Guarino V, 2012, INT MATER REV, V57, P256, DOI 10.1179/0950660812Z.00000000021
   Harrer W, 2012, J EUR CERAM SOC, V32, P27, DOI 10.1016/j.jeurceramsoc.2011.07.019
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Kang YQ, 2011, EUR POLYM J, V47, P1569, DOI 10.1016/j.eurpolymj.2011.05.004
   Kim HJ, 2001, SURF COAT TECH, V139, P75, DOI 10.1016/S0257-8972(00)01132-4
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Li ZS, 2009, ACTA BIOMATER, V5, P2189, DOI 10.1016/j.actbio.2009.02.013
   Liu B, 2008, J MATER SCI-MATER M, V19, P1203, DOI 10.1007/s10856-007-3216-1
   Magnani G, 2010, J EUR CERAM SOC, V30, P769, DOI 10.1016/j.jeurceramsoc.2009.08.002
   Novak S, 2009, J MATER SCI, V44, P1442, DOI 10.1007/s10853-008-2858-9
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Redondo A, 2004, ANNU REV MATER RES, V34, P279, DOI 10.1146/annurev.matsci.34.070503.123908
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Yang GJ, 2012, MATER LETT, V75, P80, DOI 10.1016/j.matlet.2012.01.122
   Yunos DM, 2008, J MATER SCI, V43, P4433, DOI 10.1007/s10853-008-2552-y
   Zhang JY, 2006, T NONFERR METAL SOC, V16, pS453, DOI 10.1016/S1003-6326(06)60232-X
NR 20
TC 4
Z9 4
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-6636
EI 1872-7743
J9 MECH MATER
JI Mech. Mater.
PD FEB
PY 2014
VL 69
IS 1
BP 35
EP 40
DI 10.1016/j.mechmat.2013.09.007
PG 6
WC Materials Science, Multidisciplinary; Mechanics
SC Materials Science; Mechanics
GA AA8NK
UT WOS:000331352000003
DA 2018-10-20
ER

PT J
AU Kundu, B
   Kurland, NE
   Bano, S
   Patra, C
   Engel, FB
   Yadavalli, VK
   Kundu, SC
AF Kundu, Banani
   Kurland, Nicholas E.
   Bano, Subia
   Patra, Chinmoy
   Engel, Felix B.
   Yadavalli, Vamsi K.
   Kundu, Subhas C.
TI Silk proteins for biomedical applications: Bioengineering perspectives
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Silk; Biomedical applications; Films; Scaffolds; Hydrogels
ID MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; TISSUE ENGINEERING
   APPLICATIONS; BIOMIMETIC NANOFIBROUS SCAFFOLDS; PERIPHERAL-NERVE
   REGENERATION; FIBROIN 3D SCAFFOLDS; IN-VITRO EVALUATION; SPIDER SILK;
   CHEMICAL-MODIFICATION; MECHANICAL-PROPERTIES
AB Biomaterials of either natural or synthetic origin are used to fabricate implantable devices, as carriers for bioactive molecules or as substrates to facilitate tissue regeneration. For the design of medical devices it is fundamental to use materials characterized by non-immunogenicity, biocompatibility, slow and/or controllable biodegradability, non-toxicity, and structural integrity. The success of biomaterial-derived biodevices tends to be based on the biomimetic architecture of the materials. Recently, proteins from natural precursors that are essentially structural and functional polymers, have gained popularity as biomaterials. The silks produced by silkworms or spiders are of particular interest as versatile protein polymers. These form the basis for diverse biomedical applications that exploit their unique biochemical nature, biocompatibility and high mechanical strength. This review discusses and summarizes the latest advances in the engineering of silk-based biomaterials, focusing specifically on the fabrication of diverse bio-mimetic structures such as films, hydrogels, scaffolds, nanofibers and nanoparticles; their functionalization and potential for biomedical applications. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Kundu, Banani; Bano, Subia; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Kurland, Nicholas E.; Yadavalli, Vamsi K.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA.
   [Patra, Chinmoy; Engel, Felix B.] Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, D-97054 Erlangen, Germany.
RP Yadavalli, VK (reprint author), Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.
EM vyadavalli@vcu.edu; kundu@hijli.iitkgp.ernet.in
RI Kundu, Banani/O-9320-2016; Engel, Felix/A-1767-2008
OI Kundu, Banani/0000-0003-1251-700X; Engel, Felix/0000-0003-2605-3429;
   Yadavalli, Vamsi/0000-0002-8879-1948; Kundu, Subhas
   C./0000-0002-7170-2291
FU Department of Biotechnology and its Bioinformatics Facility; Department
   of Science and Technology; Council of Scientific Industrial Research
   fellowship; Government of India, New Delhi, India; Alexander von
   Humboldt Foundation
FX We are thankful to Ms. Shilpa Pal and Dr. Joydip Kundu for their
   assistance during the initial write up. The work was financially
   supported by the Department of Biotechnology and its Bioinformatics
   Facility, the Department of Science and Technology (SCK), the Council of
   Scientific Industrial Research fellowship (BK), Government of India, New
   Delhi, India and by a grant from the Alexander von Humboldt Foundation
   (FBE).
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Ahn JS, 2001, J APPL POLYM SCI, V80, P274, DOI 10.1002/1097-4628(20010411)80:2<274::AID-APP1096>3.0.CO;2-G
   Akturk O, 2011, J BIOSCI BIOENG, V112, P279, DOI 10.1016/j.jbiosc.2011.05.014
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arai T, 2002, J APPL POLYM SCI, V84, P1963, DOI 10.1002/app.10491
   Aramwit P, 2010, INT J BIOL MACROMOL, V47, P668, DOI 10.1016/j.ijbiomac.2010.08.015
   Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Baek HS, 2008, SURF COAT TECH, V202, P5794, DOI 10.1016/j.surfcoat.2008.06.154
   Benfenati V, 2010, BIOMATERIALS, V31, P7883, DOI 10.1016/j.biomaterials.2010.07.013
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002
   Bray LJ, 2012, BIOMATERIALS, V33, P3529, DOI 10.1016/j.biomaterials.2012.01.045
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Brown CP, 2011, NANOSCALE, V3, P870, DOI 10.1039/c0nr00752h
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Cai ZX, 2010, INT J MOL SCI, V11, P3529, DOI 10.3390/ijms11093529
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Cassinelli C, 2006, INT J ARTIF ORGANS, V29, P881
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen XD, 2010, BIRTH DEFECTS RES C, V90, P45, DOI 10.1002/bdrc.20171
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Dash BC, 2009, J BIOTECHNOL, V144, P321, DOI 10.1016/j.jbiotec.2009.09.019
   Desai MP, 1997, PHARMACEUT RES, V14, P1568, DOI 10.1023/A:1012126301290
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   FOURNIER A, 1979, BIOCHIMIE, V61, P283, DOI 10.1016/S0300-9084(79)80073-5
   Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603
   Fu CJ, 2009, CHEM COMMUN, P6515, DOI 10.1039/b911049f
   Furuzono T, 2004, J MATER SCI-MATER M, V15, P19, DOI 10.1023/B:JMSM.0000010093.39298.5a
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   Ge Z, 2012, INT J ORAL MAX SURG, V41, P673, DOI 10.1016/j.ijom.2011.11.016
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gotoh Y, 1996, INT J BIOL MACROMOL, V18, P19, DOI 10.1016/0141-8130(95)01039-4
   Gulrajani ML, 2008, J APPL POLYM SCI, V108, P614, DOI 10.1002/app.27584
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hardy JG, 2009, BIOCHEM SOC T, V37, P677, DOI 10.1042/BST0370677
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hirabayashi A, 1990, SEN-I GAKKAISHI, V46, P521
   Ho MP, 2012, APPL SURF SCI, V258, P3948, DOI 10.1016/j.apsusc.2011.12.068
   Hohman MM, 2001, PHYS FLUIDS, V13, P2201, DOI 10.1063/1.1383791
   Hu K, 2006, J BIOACT COMPAT POL, V21, P23, DOI 10.1177/0883911506060455
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Junghans F, 2006, APPL PHYS A-MATER, V82, P253, DOI 10.1007/s00339-005-3432-9
   Kang M, 2007, J NANOSCI NANOTECHNO, V7, P3888, DOI 10.1166/jnn.2007.056
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karve KA, 2011, J MEMBRANE SCI, V383, P44, DOI 10.1016/j.memsci.2011.08.032
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim S, 2012, NAT PHOTONICS, V6, P817, DOI [10.1038/NPHOTON.2012.264, 10.1038/nphoton.2012.264]
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kim UJ, 2005, BIOMATERIALS, V26, P2285
   Kim Y-H, 2007, KEY ENG MATER, V342-343, P73
   Kino R, 2007, J BIOSCI BIOENG, V103, P514, DOI 10.1263/jbb.103.514
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kukreja N, 2008, PHARMACOL RES, V57, P171, DOI 10.1016/.i.phrs.2008.01.012
   Kundu B, 2010, PROG POLYM SCI, V35, P1116, DOI 10.1016/j.progpolymsci.2010.04.004
   Kundu J, 2012, ACTA BIOMATER, V8, P1720, DOI 10.1016/j.actbio.2012.01.004
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Kundu J, 2008, MAT SCI ENG C-BIO S, V28, P1376, DOI 10.1016/j.msec.2008.03.004
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Kurland NE, 2012, MICRON, V43, P116, DOI 10.1016/j.micron.2011.07.017
   Lammel A, 2011, BIOMATERIALS, V32, P2233, DOI 10.1016/j.biomaterials.2010.11.060
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee KH, 2007, INT J BIOL MACROMOL, V41, P168, DOI 10.1016/j.ijbiomac.2007.01.011
   Lee KY, 1999, POLYMER, V40, P4131, DOI 10.1016/S0032-3861(98)00611-9
   Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li TF, 2009, EPILEPSY RES, V84, P238, DOI 10.1016/j.eplepsyres.2009.01.002
   Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Luan XY, 2006, BIOMED MATER, V1, P181, DOI 10.1088/1748-6041/1/4/001
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Mandal BB, 2009, BIOMATERIALS, V30, P5170, DOI 10.1016/j.biomaterials.2009.05.072
   Mandal BB, 2009, BIOMATERIALS, V30, P5019, DOI 10.1016/j.biomaterials.2009.05.064
   Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026
   Mandal BB, 2009, BIOMATERIALS, V30, P2826, DOI 10.1016/j.biomaterials.2009.01.040
   Mao M, 2012, ACTA BIOMATER, V8, P2175, DOI 10.1016/j.actbio.2011.12.025
   Marelli B, 2012, BIOMATERIALS, V33, P102, DOI 10.1016/j.biomaterials.2011.09.039
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Miao YG, 2006, APPL MICROBIOL BIOT, V71, P192, DOI 10.1007/s00253-005-0127-2
   Mieszawska AJ, 2011, ACTA BIOMATER, V7, P3036, DOI 10.1016/j.actbio.2011.04.016
   Mieszawska AJ, 2010, BIOMATERIALS, V31, P8902, DOI 10.1016/j.biomaterials.2010.07.109
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Ming JF, 2012, J APPL POLYM SCI, V125, P2148, DOI 10.1002/app.36354
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MITA K, 1994, J MOL EVOL, V38, P583
   Moreau JE, 2005, TISSUE ENG, V11, P1887, DOI 10.1089/ten.2005.11.1887
   Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Nagai N, 2009, BIOL PHARM BULL, V32, P933, DOI 10.1248/bpb.32.933
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x
   Park K, 1993, BIODEGRADABLE HYDROG, P262
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Patil Y, 2009, INT J PHARM, V367, P195, DOI 10.1016/j.ijpharm.2008.09.039
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Perez-Rigueiro J, 2002, J APPL POLYM SCI, V84, P1431, DOI 10.1002/app.10366
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Ratner B. D., 2004, BIOMATERIALS SCI INT, P864
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Rockwood DN, 2011, ACTA BIOMATER, V7, P144, DOI 10.1016/j.actbio.2010.07.020
   Roohani-Esfahani SI, 2012, ACTA BIOMATER, V8, P302, DOI 10.1016/j.actbio.2011.10.009
   Rujiravanit R, 2003, MACROMOL BIOSCI, V3, P604, DOI 10.1002/mabi.200300027
   Sampaio S, 2011, POLYM INT, V60, P1737, DOI 10.1002/pi.3143
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Seib FP, 2012, BIOMATERIALS, V33, P1017, DOI 10.1016/j.biomaterials.2011.10.063
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   She ZD, 2008, J MATER SCI-MATER M, V19, P3545, DOI 10.1007/s10856-008-3526-y
   Shi PJ, 2012, POWDER TECHNOL, V215-16, P85, DOI 10.1016/j.powtec.2011.09.012
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Sundar S, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014104
   Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018
   Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052
   Tamada Y, 2004, J BIOMAT SCI-POLYM E, V15, P971, DOI 10.1163/1568562041526469
   Tao H, 2012, P NATL ACAD SCI USA, V109, P19584, DOI 10.1073/pnas.1209056109
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Teramoto H, 2005, BIOSCI BIOTECH BIOCH, V69, P845, DOI 10.1271/bbb.69.845
   Teramoto H, 2004, BIOMACROMOLECULES, V5, P1392, DOI 10.1021/bm034537r
   Terry AE, 2004, BIOMACROMOLECULES, V5, P768, DOI 10.1021/bm034381v
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Tsioris K, 2012, ADV FUNCT MATER, V22, P330, DOI 10.1002/adfm.201102012
   Tsioris K, 2011, ADV MATER, V23, P2015, DOI 10.1002/adma.201004771
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   TSUKADA M, 1994, J APPL POLYM SCI, V54, P507, DOI 10.1002/app.1994.070540411
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Vachiraroj N, 2009, INT J BIOL MACROMOL, V45, P470, DOI 10.1016/j.ijbiomac.2009.07.010
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2006, APPL PHYS A-MATER, V82, P205, DOI 10.1007/s00339-005-3437-4
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XL, 2012, BIOMATERIALS, V33, P3411, DOI 10.1016/j.biomaterials.2012.01.011
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Wenk E, 2009, BIOMATERIALS, V30, P2571, DOI 10.1016/j.biomaterials.2008.12.073
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Wu J, 2012, BIOMATERIALS, V33, P1343, DOI 10.1016/j.biomaterials.2011.10.055
   Wu XW, 2012, CYTOTHERAPY, V14, P555, DOI 10.3109/14653249.2011.638914
   Xia YY, 2008, COMPOS SCI TECHNOL, V68, P1471, DOI 10.1016/j.compscitech.2007.10.044
   Xie RJ, 2007, KEY ENG MATER, V342-343, P241, DOI 10.4028/www.scientific.net/KEM.342-343.241
   Yamamoto K, 2007, BIOMATERIALS, V28, P1838, DOI 10.1016/j.biomaterials.2006.11.045
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Yukuhiro K, 1997, INSECT MOL BIOL, V6, P89, DOI 10.1046/j.1365-2583.1997.00161.x
   Zhang F, 2011, INT J BIOL MACROMOL, V48, P474, DOI 10.1016/j.ijbiomac.2011.01.012
   Zhang JE, 2012, P NATL ACAD SCI USA, V109, P11981, DOI 10.1073/pnas.1206210109
   Zhang JF, 2004, BIOTECHNOL LETT, V26, P753, DOI 10.1023/B:BILE.0000024100.49716.3d
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang XZ, 2012, J SHOULDER ELB SURG, V21, P266, DOI 10.1016/j.jse.2011.11.016
   Zhou YS, 2013, INT J BIOL MACROMOL, V53, P88, DOI 10.1016/j.ijbiomac.2012.11.013
   Zhu YR, 2012, MAT SCI ENG C-MATER, V32, P390, DOI 10.1016/j.msec.2011.11.002
   Zou XH, 2010, BIOMATERIALS, V31, P4872, DOI 10.1016/j.biomaterials.2010.02.056
NR 205
TC 142
Z9 147
U1 31
U2 340
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD FEB
PY 2014
VL 39
IS 2
BP 251
EP 267
DI 10.1016/j.progpolymsci.2013.09.002
PG 17
WC Polymer Science
SC Polymer Science
GA AB0VX
UT WOS:000331511300001
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Mattei, G
   Di Patria, V
   Tirella, A
   Alaimo, A
   Elia, G
   Corti, BA
   Paolicchi, A
   Ahluwalia, A
AF Mattei, G.
   Di Patria, V.
   Tirella, A.
   Alaimo, A.
   Elia, G.
   Corti, B. A.
   Paolicchi, A.
   Ahluwalia, A.
TI Mechanostructure and composition of highly reproducible decellularized
   liver matrices
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Extracellular matrix; Decellularization; Biologic three-dimensional
   scaffold; Biomaterial; Tissue engineering
ID TISSUE; STERILIZATION; PERFORMANCE; ALLOGRAFTS; SCAFFOLDS; CULTURE;
   CELLS; GRAFT
AB Despite the increasing number of papers on decellularized scaffolds, there is little consensus on the optimum method of decellularizing biological tissue such that the micro-architecture and protein content of the matrix are conserved as far as possible. Focusing on the liver, the aim of this study was therefore to develop a method for the production of well-characterized and reproducible matrices that best preserves the structure and composition of the native extra cellular matrix (ECM). Given the importance of matrix stiffness in regulating cell response, the mechanical properties of the decellularized tissue were also considered. The testing and analysis framework is based on the characterization of decellularized and untreated samples in the same reproducible initial state (i.e., the equilibrium swollen state). Decellularized ECM (dECM) were characterized using biochemical, histological, mechanical and structural analyses to identify the best procedure to ensure complete cell removal while preserving most of the native ECM structure and composition. Using this method, sterile decellularized porcine ECM with highly conserved intra-lobular micro-structure and protein content were obtained in a consistent and reproducible manner using the equilibrium swollen state of tissue or matrix as a reference. A significant reduction in the compressive elastic modulus was observed for liver dECM with respect to native tissue, suggesting a re-examination of design parameters for ECM-mimicking scaffolds for engineering tissues in vitro. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mattei, G.] Univ Pisa, Dept Civil & Ind Engn, I-56122 Pisa, Italy.
   [Mattei, G.; Di Patria, V.; Alaimo, A.; Elia, G.; Ahluwalia, A.] Univ Pisa, Res Ctr E Piaggio, I-56126 Pisa, Italy.
   [Tirella, A.] IFC, Natl Res Council, I-56124 Pisa, Italy.
   [Corti, B. A.; Paolicchi, A.] Univ Pisa, Dept Translat Res & New Technol Med & Surg, I-56126 Pisa, Italy.
RP Mattei, G (reprint author), Univ Pisa, Res Ctr E Piaggio, Largo Lucio Lazzarino 1, I-56126 Pisa, Italy.
EM giorgio.mattei@centropiaggio.unipi.it
RI Paolicchi, Aldo/K-3946-2018
OI Paolicchi, Aldo/0000-0002-9940-8481; Mattei,
   Giorgio/0000-0003-0441-9653; Ahluwalia, Arti/0000-0001-5370-6750
FU European Union Seventh Framework Programme [304961]
FX The authors are grateful to Stefano Mazzoni and Andrea Pirone for the
   histology preparations and to the abattoir Desideri Luciano S.p.A. Via
   Abruzzi, 2 - Pontedera (Pisa), Italy, for kindly supplying fresh hepatic
   tissue. The work leading to these results has received funding from the
   European Union Seventh Framework Programme (FP7/2007-2013) under grant
   agreement 304961 (ReLiver).
CR Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Burch PT, 2010, ANN THORAC SURG, V90, P1301, DOI 10.1016/j.athoracsur.2010.05.024
   Cebotari S, 2010, ARTIF ORGANS, V34, P206, DOI 10.1111/j.1525-1594.2009.00796.x
   Evans DW, 2013, BIOMECH MODEL MECHAN, V12, P569, DOI 10.1007/s10237-012-0426-3
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Harrison M., 1997, GEN TECHNIQUES CELL
   Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294
   Lang R, 2011, BIOMATERIALS, P1
   LEE LT, 1978, J IMMUNOL METHODS, V19, P69, DOI 10.1016/0022-1759(78)90009-1
   Marchesseau S, 2010, PROG BIOPHYS MOL BIO, V103, P185, DOI 10.1016/j.pbiomolbio.2010.09.005
   Mazzei D, 2010, BIOTECHNOL BIOENG, V106, P127, DOI 10.1002/bit.22671
   Montoya CV, 2009, TISSUE ENG PART C-ME, V15, P191, DOI 10.1089/ten.tec.2008.0372
   Nelson CM, 2005, SEMIN CANCER BIOL, V15, P342, DOI 10.1016/j.semcancer.2005.05.001
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Prasertsung I, 2008, J BIOMED MATER RES B, V85B, P210, DOI 10.1002/jbm.b.30938
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Remlinger NT, 2010, BIOMATERIALS, V31, P3520, DOI 10.1016/j.biomaterials.2010.01.067
   Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196
   Scheffler SU, 2008, CLIN ORTHOP RELAT R, V466, P1810, DOI 10.1007/s11999-008-0288-2
   Serban MA, 2008, METHODS, V45, P93, DOI 10.1016/j.ymeth.2008.01.010
   Sohlenius-Sternbeck AK, 2006, TOXICOL IN VITRO, V20, P1582, DOI 10.1016/j.tiv.2006.06.003
   Tamura Atsutaka, 2002, Stapp Car Crash J, V46, P55
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Vavken P, 2009, J ORTHOP RES, V27, P1612, DOI 10.1002/jor.20932
   Wang YF, 2011, HEPATOLOGY, V53, P293, DOI 10.1002/hep.24012
   Wiegand C, 2009, J BIOMED MATER RES B, V90B, P710, DOI 10.1002/jbm.b.31338
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
NR 30
TC 29
Z9 30
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2014
VL 10
IS 2
BP 875
EP 882
DI 10.1016/j.actbio.2013.10.023
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA2JU
UT WOS:000330921700032
PM 24184179
DA 2018-10-20
ER

PT J
AU Han, F
   Liu, S
   Liu, X
   Pei, Y
   Bai, S
   Zhao, H
   Lu, Q
   Ma, F
   Kaplan, DL
   Zhu, H
AF Han, F.
   Liu, S.
   Liu, X.
   Pei, Y.
   Bai, S.
   Zhao, H.
   Lu, Q.
   Ma, F.
   Kaplan, D. L.
   Zhu, H.
TI Woven silk fabric-reinforced silk nanofibrous scaffolds for regenerating
   load-bearing soft tissues
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk; Dermal substitute; Mechanical properties; Scaffolds; Suture
   retention
ID MESENCHYMAL STEM-CELLS; FIBROIN SCAFFOLDS; IN-VITRO; CARTILAGE; MATRIX;
   BIOMATERIAL; BONE; DIFFERENTIATION; ARCHITECTURE; HYDROGEL
AB Although three-dimensional (3-D) porous regenerated silk scaffolds with outstanding biocompatibility, biodegradability and low inflammatory reactions have promising application in different tissue regeneration, the mechanical properties of regenerated scaffolds, especially suture retention strength, must be further improved to satisfy the requirements of clinical applications. This study presents woven silk fabric-reinforced silk nanofibrous scaffolds aimed at dermal tissue engineering. To improve the mechanical properties, silk scaffolds prepared by lyophilization were reinforced with degummed woven silk fabrics. The ultimate tensile strength, elongation at break and suture retention strength of the scaffolds were significantly improved, providing suitable mechanical properties strong enough for clinical applications. The stiffness and degradation behaviors were then further regulated by different after-treatment processes, making the scaffolds more suitable for dermal tissue regeneration. The in vitro cell culture results indicated that these scaffolds maintained their excellent biocompatibility after being reinforced with woven silk fabrics. Without sacrifice of porous structure and biocompatibility, the fabric-reinforced scaffolds with better mechanical properties could facilitate future clinical applications of silk as matrices in skin repair. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights
C1 [Han, F.; Liu, S.; Liu, X.; Pei, Y.; Bai, S.; Zhao, H.; Lu, Q.] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Han, F.; Ma, F.] Qingdao Univ Sci & Technol, Coll Polymer Sci & Engn, Key Lab Rubber Plast QUST, Minist Educ, Qingdao 266042, Peoples R China.
   [Kaplan, D. L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zhu, H.] Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Lu, Q (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM Lvqiang78@suda.edu.cn; fgma@qust.edu.cn
OI Liu, Xi/0000-0003-4927-8292
FU National Basic Research Program of China (973 Program) [2013CB934400];
   NSFC [21174097]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD); Excellent Youth Foundation of Jiangsu
   Province [BK2012009]; NIH [EB002520]; Ph.D. Programs Foundation of
   Ministry of Education of China [201032011200009]; Key Natural Science
   Foundation of the Jiangsu Higher Education Institutions of China
   [11KGA430002]
FX The authors thank Jiangsu Province Key Laboratory of Stem Cell Research
   for supplying the amniotic fluid stem cells. The authors thank the
   National Basic Research Program of China (973 Program 2013CB934400) and
   NSFC (21174097) for support of this work. They also thank the Priority
   Academic Program Development of Jiangsu Higher Education Institutions
   (PAPD), the Excellent Youth Foundation of Jiangsu Province (BK2012009),
   the NIH (EB002520)), Ph.D. Programs Foundation of Ministry of Education
   of China (201032011200009) and the Key Natural Science Foundation of the
   Jiangsu Higher Education Institutions of China (11KGA430002) for support
   of this work.
CR Agrawal A, 2013, ACTA BIOMATER, V9, P5313, DOI 10.1016/j.actbio.2012.10.011
   Albanna MZ, 2012, J MECH BEHAV BIOMED, V5, P171, DOI 10.1016/j.jmbbm.2011.08.021
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Annaidh AN, 2012, J MECH BEHAV BIOMED, V5, P139, DOI 10.1016/j.jmbbm.2011.08.016
   Cao TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065654
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011
   Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017
   Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Hoganson DM, 2010, BIOMATERIALS, V31, P6730, DOI 10.1016/j.biomaterials.2010.05.019
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kang NH, 2012, CANCER GENE THER, V19, P517, DOI 10.1038/cgt.2012.30
   Khatyr F, 2004, SKIN RES TECHNOL, V10, P96, DOI 10.1111/j.1600-0846.2004.00057.x
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   KWAN MK, 1992, ACTA ORTHOP SCAND, V63, P267, DOI 10.3109/17453679209154780
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Liu HF, 2007, J BIOMED MATER RES B, V82B, P129, DOI 10.1002/jbm.b.30714
   Lu Q, 2008, J MATER SCI-MATER M, V19, P629, DOI 10.1007/s10856-007-3180-9
   Lu Q, 2012, BIOMACROMOLECULES, V13, P826, DOI 10.1021/bm201731e
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Mammadov B, 2012, ACTA BIOMATER, V8, P2077, DOI 10.1016/j.actbio.2012.02.006
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   McCullen SD, 2010, J MATER CHEM, V20, P8776, DOI 10.1039/c0jm01443e
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panas-Perez E, 2013, J MATER SCI-MATER M, V24, P257, DOI 10.1007/s10856-012-4781-5
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Shepherd JH, 2013, J BIOMED MATER RES A, V101, P176, DOI 10.1002/jbm.a.34317
   Shi PJ, 2013, BIOMATERIALS, V34, P5947, DOI 10.1016/j.biomaterials.2013.04.046
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tran RT, 2010, MATERIALS, V3, P1375, DOI 10.3390/ma3021375
   Tutak W, 2013, BIOMATERIALS, V34, P2389, DOI 10.1016/j.biomaterials.2012.12.020
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
NR 47
TC 37
Z9 41
U1 12
U2 105
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2014
VL 10
IS 2
BP 921
EP 930
DI 10.1016/j.actbio.2013.09.026
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA2JU
UT WOS:000330921700037
PM 24090985
DA 2018-10-20
ER

PT J
AU Pedimonte, BJ
   Moest, T
   Luxbacher, T
   von Wilmowsky, C
   Fey, T
   Schlegel, KA
   Greil, P
AF Pedimonte, Birgit Joana
   Moest, Tobias
   Luxbacher, Thomas
   von Wilmowsky, Cornelius
   Fey, Tobias
   Schlegel, Karl Andreas
   Greil, Peter
TI Morphological zeta-potential variation of nanoporous anodic alumina
   layers and cell adherence
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nanoporous alumina; Zeta potential; Isoelectric point; Cell activity
ID ENHANCED OSTEOBLAST ADHESION; NANO-POROUS ALUMINA; IN-VITRO; ISOELECTRIC
   POINTS; PROTEIN ADSORPTION; SOLUTION INTERFACE; SURFACE; OXIDE;
   DIFFERENTIATION; CONSTANTS
AB Nanoscale surface modification of biomedical implant materials offers enhanced biological activity concerning protein adsorption and cell adherence. Nanoporous anodic alumina oxide (AAO) layers were prepared by electrochemical oxidation of thin Al-seed layers in 0.22 M C2H2O4, applying anodization voltages of 20-60 V. The AAO layers are characterized by a mean pore diameter varying from 15 to 40 nm, a mean pore distance of 40-130 nm, a total porosity of similar to 10% and a thickness of 560 +/- 40 nm. Zeta potential and isoelectric point (iep) were derived from streaming potential measurements and correlated to the topology variation of the nanoporous AAO layers. With decreasing pore diameter a shift of iep from similar to 7.9 (pore diameter 40 nm) to similar to 6.7 (pore diameter 15 nm) was observed. Plain alumina layers, however, possess an iep of similar to 9. Compared to the plain alumina surface an enhanced adherence and activity of hFOB cells was observed on the nanoporous AAO after 24 h culture with a maximum at a pore size of 40 nm. The topology-induced change of the electrochemical surface state may have a strong impact on protein adsorption as well as on cell adhesion, which offers a high potential for the development of bioactive AAO coatings on various biomaterial substrates. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights
C1 [Pedimonte, Birgit Joana; Fey, Tobias; Greil, Peter] Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram, D-91054 Erlangen, Germany.
   [Moest, Tobias; von Wilmowsky, Cornelius; Schlegel, Karl Andreas] Univ Erlangen Nurnberg, Fac Med, Dept Oral & Maxillofacial Surg, D-91054 Erlangen, Germany.
   [Luxbacher, Thomas] Anton Paar GmbH, A-8054 Graz, Austria.
RP Pedimonte, BJ (reprint author), Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram, Martens Str 5, D-91054 Erlangen, Germany.
EM Joana.pedimonte@ww.uni-erlangen.de
RI Fey, Tobias/K-9861-2015
OI Fey, Tobias/0000-0002-6217-0035; Luxbacher, Thomas/0000-0002-5472-8203
FU DFG
FX The authors are thankful for experimental support from Renate Kohl
   (Anton Paar GmbH, Graz, Austria) and from the Chair of Electron Devices.
   Financial support from the DFG funded Cluster of Excellence "Engineering
   of advanced materials" is gratefully acknowledged.
CR Bai A, 2008, ELECTROCHIM ACTA, V53, P2258, DOI 10.1016/j.electacta.2007.09.039
   Beaulieu JF, 1997, J HISTOCHEM CYTOCHEM, V31, P1
   Bryers JD, 2004, ASM NEWS, V70, P232
   CONTESCU C, 1993, LANGMUIR, V9, P1754, DOI 10.1021/la00031a024
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   DUNN GA, 1982, CELL BEHAVIOUR, P247
   Ferraz N, 2010, INT J BIOMATER, DOI 10.1155/2010/402715
   Franks GV, 2003, COLLOID SURFACE A, V214, P99, DOI 10.1016/S0927-7757(02)00366-7
   Gultepe E, 2010, ADV DRUG DELIVER REV, V62, P305, DOI 10.1016/j.addr.2009.11.003
   Hartvig RA, 2011, LANGMUIR, V27, P2634, DOI 10.1021/la104720n
   HIEMSTRA T, 1989, J COLLOID INTERF SCI, V133, P91, DOI 10.1016/0021-9797(89)90284-1
   Hunter R.J, 1981, ZETA POTENTIALS COLL
   James R. O., 1982, SURF COLLOID SCI, V12, P119
   Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y
   Karlsson M, 2006, J MATER SCI-MATER M, V17, P1101, DOI 10.1007/s10856-006-0537-4
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   KNOZINGER H, 1978, CATAL REV, V17, P31, DOI 10.1080/03602457808080878
   Lamblet M, 2007, LANGMUIR, V23, P6966, DOI 10.1021/la063104h
   Li P, 1993, THESIS LEIDEN U
   LI PJ, 1990, J NON-CRYST SOLIDS, V119, P112, DOI 10.1016/0022-3093(90)90247-J
   MANASSIDIS I, 1994, J AM CERAM SOC, V77, P335, DOI 10.1111/j.1151-2916.1994.tb07000.x
   Masuda H, 1998, JPN J APPL PHYS 2, V37, pL1340, DOI 10.1143/JJAP.37.L1340
   McNamara L. E., 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/120623
   MOLLER K, 1994, CELL MATER, V4, P263
   Nielsch K, 2002, NANO LETT, V2, P677, DOI [10.1021/nl025537k, 10.1021/n1025537k]
   NORDE W, 1986, J COLLOID INTERF SCI, V112, P447, DOI 10.1016/0021-9797(86)90113-X
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   PARKS GA, 1965, CHEM REV, V65, P177, DOI 10.1021/cr60234a002
   Pedimonte J, 2011, ADV ENG MATER, V13, pB306, DOI 10.1002/adem.201180004
   Poinern GEJ, 2011, MATERIALS, V4, P487, DOI 10.3390/ma4030487
   Price RL, 2003, MED BIOL ENG COMPUT, V41, P372, DOI 10.1007/BF02348445
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Sposito G., 1996, ENV CHEM ALUMINUM
   Sulka G. D., 2008, NANOSTRUCTURED MAT E, P1, DOI DOI 10.1002/9783527621507.CH1
   Sverjensky DA, 1996, GEOCHIM COSMOCHIM AC, V60, P3773, DOI 10.1016/0016-7037(96)00207-4
   Swan EEL, 2005, BIOMATERIALS, V26, P1969, DOI 10.1016/j.biomaterials.2004.07.001
   Teo BK, 2010, METHOD CELL BIOL, V98, P141
   Thompson GE, 1997, THIN SOLID FILMS, V297, P192, DOI 10.1016/S0040-6090(96)09440-0
   Vandrovcova M, 2011, PHYSIOL RES, V60, P403
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   Walpole AR, 2008, J BIOMED MATER RES A, V90, P46
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Xu JL, 2011, BIOL EXTRACELL MATR, P41, DOI 10.1007/978-3-642-16555-9_2
NR 46
TC 16
Z9 17
U1 2
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2014
VL 10
IS 2
BP 968
EP 974
DI 10.1016/j.actbio.2013.09.023
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA2JU
UT WOS:000330921700042
PM 24080316
DA 2018-10-20
ER

PT J
AU Martinez, S
   Kuhn, ML
   Russell, JT
   Holz, RC
   Elgren, TE
AF Martinez, Salette
   Kuhn, Misty L.
   Russell, James T.
   Holz, Richard C.
   Elgren, Timothy E.
TI Acrylamide production using encapsulated nitrile hydratase from
   Pseudonocardia thermophila in a sol-gel matrix
SO JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC
LA English
DT Article
DE Nitrile hydratase; Sol-gels; Enzyme immobilization; Biomaterials; Cobalt
ID ENZYME IMMOBILIZATION; BIOMOLECULES; CONFINEMENT; BIOSENSORS; PROTEINS
AB The cobalt-type nitrile hydratase from Pseudonocardia thermophila JCM 3095 (PtNHase) was successfully encapsulated in tetramethyl orthosilicate sol-gel matrices to produce a PtNHase:sol-gel biomaterial. The PtNHase:sol-gel biomaterial catalyzed the conversion of 600 mM acrylonitrile to acrylamide in 60 min at 35 degrees C with a yields of >90%. Treatment of the biomaterial with proteases confirmed that the catalytic activity is due to the encapsulated enzyme and not surface bound NHase. The biomaterial retained 50% of its activity after being used for a total of 13 consecutive reactions for the conversion of acrylonitrile to acrylamide. The thermostability and long-term storage of the PtNHase:sol-gel are substantially improved compared to the soluble NHase. Additionally, the biomaterial is significantly more stable at high concentrations of methanol (50% and 70%, v/v) as a co-solvent for the hydration of acrylonitrile than native PtNHase. These data indicate that PtNHase:sol-gel biomaterials can be used to develop new synthetic avenues involving nitriles as starting materials given that the conversion of the nitrite moiety to the corresponding amide occurs under mild temperature and pH conditions. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Martinez, Salette; Kuhn, Misty L.; Holz, Richard C.] Loyola Univ, Dept Chem & Biochem, Chicago, IL 60660 USA.
   [Russell, James T.; Elgren, Timothy E.] Hamilton Coll, Dept Chem, Clinton, NY 13323 USA.
   [Holz, Richard C.] Marquette Univ, Dept Chem, Milwaukee, WI 53201 USA.
RP Holz, RC (reprint author), Marquette Univ, Dept Chem, Milwaukee, WI 53201 USA.
EM Richard.holz@marquette.edu; TElgren@Hamilton.edu
FU National Science Foundation [CHE-1058357]; Petroleum Research Fund [ACS
   PRF 50033-ND4]
FX This work was supported by the National Science Foundation (CHE-1058357,
   RCH) and the Petroleum Research Fund (ACS PRF 50033-ND4, RCH). The
   authors gratefully acknowledge Dr. Miguel A. Ballicora and Gregory Rahn
   for assistance with HPLC.
CR Avnir D, 2006, J MATER CHEM, V16, P1013, DOI [10.1039/b512706h, 10.1039/5512706h]
   Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0
   BLYTH DJ, 1995, ANALYST, V120, P2725, DOI 10.1039/an9952002725
   Bornscheuer UT, 2003, ANGEW CHEM INT EDIT, V42, P3336, DOI 10.1002/anie.200301554
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   Dunn B, 1998, ACTA MATER, V46, P737, DOI 10.1016/S1359-6454(97)00254-1
   Eggers DK, 2001, PROTEIN SCI, V10, P250, DOI 10.1110/ps.36201
   Elgren TE, 2005, NANO LETT, V5, P2085, DOI 10.1021/nl0512224
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   Frampton M, 2008, CHEM COMMUN, P5544, DOI 10.1039/b812389f
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Gill I., 2001, CHEM MATER, V13, P3404
   Gong JS, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-142
   Kandimalla VB, 2006, CRIT REV ANAL CHEM, V36, P73, DOI 10.1080/10408340600713652
   Lan EH, 1999, J MATER CHEM, V9, P45, DOI 10.1039/a805541f
   Mitra S, 2007, J BIOL CHEM, V282, P7397, DOI 10.1074/jbc.M604117200
   Miyanaga A, 2004, EUR J BIOCHEM, V271, P429, DOI 10.1046/j.1432-1033.2003.03943.x
   Miyanaga A, 2001, BIOCHEM BIOPH RES CO, V288, P1169, DOI 10.1006/bbrc.2001.5897
   Monton MRN, 2012, CHEM MATER, V24, P796, DOI 10.1021/cm202798e
   Pastor I, 2008, J PHYS CHEM B, V112, P15021, DOI 10.1021/jp805368s
   Pierre AC, 2004, BIOCATAL BIOTRANSFOR, V22, P145, DOI 10.1080/10242420412331283314
   Prasad S, 2010, BIOTECHNOL ADV, V28, P725, DOI 10.1016/j.biotechadv.2010.05.020
   Prepachalova I, 2001, APPL MICROBIOL BIOT, V55, P150
   Serdakowski AL, 2008, TRENDS BIOTECHNOL, V26, P48, DOI 10.1016/j.tibtech.2007.10.007
   Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082
   Smith K, 2002, J AM CHEM SOC, V124, P4247, DOI 10.1021/ja012215u
   Velankar H, 2010, TRENDS BIOTECHNOL, V28, P561, DOI 10.1016/j.tibtech.2010.08.004
   Wang MX, 2005, TOP CATAL, V35, P117, DOI 10.1007/s11244-005-3817-1
   Wei Y, 2001, J NANOSCI NANOTECHNO, V1, P83, DOI 10.1166/jnn.2001.014
   Woodley JM, 2006, BIOCHEM SOC T, V34, P301, DOI 10.1042/BST0340301
   Yamada H, 2001, CHEM REC, V1, P152
   Yamada H, 1996, BIOSCI BIOTECH BIOCH, V60, P1391, DOI 10.1271/bbb.60.1391
   Yamaki T, 1997, J FERMENT BIOENG, V83, P474, DOI 10.1016/S0922-338X(97)83004-8
NR 33
TC 13
Z9 13
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-1177
EI 1873-3158
J9 J MOL CATAL B-ENZYM
JI J. Mol. Catal. B-Enzym.
PD FEB
PY 2014
VL 100
BP 19
EP 24
DI 10.1016/j.molcatb.2013.11.014
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Physical
SC Biochemistry & Molecular Biology; Chemistry
GA AA3XG
UT WOS:000331027900003
DA 2018-10-20
ER

PT J
AU Rosset, P
   Deschaseaux, F
   Layrolle, P
AF Rosset, P.
   Deschaseaux, F.
   Layrolle, P.
TI Cell therapy for bone repair
SO ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH
LA English
DT Review
DE Bone repair; Mesenchymatous stem cells; Cell therapy; Bone tissue
   engineering; Humans
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; FEMORAL-HEAD; AUTOLOGOUS
   MARROW; OSTEONECROSIS; TISSUE; INJECTION; FRACTURE; CYSTS; IMPLANTATION
AB When natural bone repair mechanisms fail, autologous bone grafting is the current standard of care. The osteogenic cells and bone matrix in the graft provide the osteo-inductive and osteo-conductive properties required for successful bone repair. Bone marrow (BM) mesenchymal stem cells (MSCs) can differentiate into osteogenic cells. MSC-based cell therapy holds promise for promoting bone repair. The amount of MSCs available from iliac-crest aspirates is too small to be clinically useful, and either concentration or culture must therefore be used to expand the MSC population. MSCs can be administered alone via percutaneous injection or implanted during open surgery with a biomaterial, usually biphasic hydroxyapatite/beta-calcium-triphosphate granules. Encouraging preliminary results have been obtained inpatients with delayed healing of long bone fractures or avascular necrosis of the femoral head. Bone tissue engineering involves in vitro MSC culturing on biomaterials to obtain colonisation of the biomaterial and differentiation of the cells. The biomaterial-cell construct is then implanted into the zone to be treated. Few published data are available on bone tissue engineering. Much work remains to be done before determining whether this method is suitable for the routine filling of bone tissue defects. Increasing cell survival and promoting implant vascularisation are major challenges. Improved expertise with culturing techniques, together with the incorporation of regulatory requirements, will open the way to high-quality clinical trials investigating the usefulness of cell therapy as a method for achieving bone repair. Cell therapy avoids the drawbacks of autologous bone grafting, preserving the bone stock and diminishing treatment invasiveness. (C) 2013 Published by Elsevier Masson SAS.
C1 [Rosset, P.] Univ Tours, CHU Tours, Hop Trousseau, Serv Chirurg Orthoped 2, F-37044 Tours 09, France.
   [Rosset, P.; Layrolle, P.] Univ Nantes, Fac Med, Inserm U957, Lab Physiopathol Resorpt Osseuse & Therapie Tumeu, Nantes, France.
   [Deschaseaux, F.] Univ Toulouse 3, Etab Francais Sang Pyrenees Mediterranee, UMR CNRS 5273, INSERM,StromaLab,U1031, F-31062 Toulouse, France.
RP Rosset, P (reprint author), Univ Tours, CHU Tours, Hop Trousseau, Serv Chirurg Orthoped 2, F-37044 Tours 09, France.
EM rosset@univ-tours.fr
RI Layrolle, Pierre/K-9257-2015
OI Layrolle, Pierre/0000-0001-9800-5210
FU European Union [241879]
FX We thank the European Union for funding the REBORNE programme, of which
   it is a member (grant #241879), as part of the European Seventh
   Framework Programme for Research (FP7/2007-2013).
CR Asari S, 2009, EXP HEMATOL, V37, P604, DOI 10.1016/j.exphem.2009.01.005
   Ateschrang A, 2009, ARCH ORTHOP TRAUM SU, V129, P97, DOI 10.1007/s00402-008-0699-2
   CONNOLLY JF, 1991, CLIN ORTHOP RELAT R, P259
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Dallari D, 2007, J BONE JOINT SURG AM, V89A, P2413, DOI 10.2106/JBJS.F.01026
   De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753
   Deschaseaux F, 2000, J CELL PHYSIOL, V184, P319, DOI 10.1002/1097-4652(200009)184:3<319::AID-JCP5>3.0.CO;2-N
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Gangji V, 2004, J BONE JOINT SURG AM, V86A, P1153, DOI 10.2106/00004623-200406000-00006
   GARG NK, 1993, ACTA ORTHOP SCAND, V64, P671, DOI 10.3109/17453679308994595
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Gomez-Barrena E, 2011, J CELL MOL MED, V15, P1266, DOI 10.1111/j.1582-4934.2011.01265.x
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Hernigou P, 1999, J BONE JOINT SURG BR, V81B, P349, DOI 10.1302/0301-620X.81B2.8818
   Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215
   Hernigou P, 1997, REV CHIR ORTHOP, V83, P33
   Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455
   Hernigou P, 2009, INDIAN J ORTHOP, V43, P40, DOI 10.4103/0019-5413.45322
   Kim SJ, BMC MUSCULOSKELET DI
   Kitoh Hiroshi, 2009, J Pediatr Orthop, V29, P643, DOI 10.1097/BPO.0b013e3181b2afb2
   Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Mathieu M, 2013, BONE, V53, P391, DOI 10.1016/j.bone.2013.01.005
   Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012
   Morishita T, 2006, ARTIF ORGANS, V30, P115, DOI 10.1111/j.1525-1594.2006.00190.x
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Ochs BG, 2008, J BONE JOINT SURG BR, V90B, P1164, DOI 10.1302/0301-620X.90B9.20425
   Park IH, 2008, FOOT ANKLE INT, V29, P164, DOI 10.3113/FAI.2008.0164
   Petite H, 2011, OSTEOPOROSIS INT, V22, P2017, DOI 10.1007/s00198-011-1614-1
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004
   Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197
   Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907
   Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050
   Wright JG, 2008, J BONE JOINT SURG AM, V90A, P722, DOI 10.2106/JBJS.G.00620
   Yamasaki T, 2010, J BONE JOINT SURG BR, V92B, P337, DOI 10.1302/0301-620X.92B3.22483
   Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098
   Zamzam MM, 2009, INT ORTHOP, V33, P1353, DOI 10.1007/s00264-008-0619-7
   Zhao DW, 2012, BONE, V50, P325, DOI 10.1016/j.bone.2011.11.002
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 42
TC 51
Z9 58
U1 1
U2 41
PU ELSEVIER MASSON
PI MILANO
PA VIA PALEOCAPA 7, 20121 MILANO, ITALY
SN 1877-0568
J9 ORTHOP TRAUMATOL-SUR
JI Orthop. Traumatol.-Surg. Res.
PD FEB
PY 2014
VL 100
IS 1
SU S
BP S107
EP S112
DI 10.1016/j.otsr.2013.11.010
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 304BM
UT WOS:000330720300012
PM 24411717
OA Bronze
DA 2018-10-20
ER

PT J
AU Binan, L
   Ajji, A
   De Crescenzo, G
   Jolicoeur, M
AF Binan, Loic
   Ajji, Abdellah
   De Crescenzo, Gregory
   Jolicoeur, Mario
TI Approaches for Neural Tissue Regeneration
SO STEM CELL REVIEWS AND REPORTS
LA English
DT Article
DE Nerve; Spinal cord; Stem cell; Regeneration; Biomaterial; Scaffold;
   Hydrogel; Electrospinning; Growth factor
ID NERVE-GROWTH-FACTOR; SPINAL-CORD-INJURY; MESENCHYMAL STEM-CELLS; MARROW
   STROMAL CELLS; PROMOTES FUNCTIONAL RECOVERY; RECOMBINANT SPIDER SILK;
   EPI-CORTICAL DELIVERY; DORSAL-ROOT GANGLIA; AXONAL REGENERATION;
   IN-VITRO
AB There is currently no treatment for neurodegenerative diseases such as Parkinson's or Alzheimer's diseases. While spinal cord injury has no treatment either, nerve injuries are being treated with autologous grafts, a procedure that in turn translates into a loss of function in the donor area. The development of therapies for these pathologies has become urgent as population keeps on ageing. A promising direction of investigation is the use of regenerative techniques to re-grow healthy and functional tissue in the injured area. In this review article, various approaches currently investigated to promote neural regeneration are covered. Those include approaches based on (and many times combining) stem cell therapy, scaffolds made of hydrogel, electrospun fibers and conductive materials as well as the use of soluble or non-diffusible growth factors.
C1 [Binan, Loic; Ajji, Abdellah; De Crescenzo, Gregory; Jolicoeur, Mario] Ecole Polytech, Dept Chem Engn, Montreal, PQ H3C 3A7, Canada.
RP Jolicoeur, M (reprint author), Ecole Polytech, Dept Chem Engn, POB 6079, Montreal, PQ H3C 3A7, Canada.
EM loic.binan@polytechnique.org; mario.jolicoeur@polymtl.ca
FU National Sciences and Engineering Research Council of Canada (NSERC);
   New World Laboratories Inc.
FX Authors wish to thank the National Sciences and Engineering Research
   Council of Canada (NSERC) and New World Laboratories Inc. for their
   financial support through a Research and Development Collaborative
   grant.
CR Aizman I, 2009, J NEUROSCI RES, V87, P3198, DOI 10.1002/jnr.22146
   Alhosseini SN, 2012, INT J NANOMED, V7, P25, DOI 10.2147/IJN.S25376
   Alleva E, 2009, NEUROSCI BIOBEHAV R, V33, P525, DOI 10.1016/j.neubiorev.2008.09.004
   ALTMAN J, 1979, J COMP NEUROL, V188, P455, DOI 10.1002/cne.901880308
   [Anonymous], 2012, J Spinal Cord Med, V35, P480, DOI 10.1179/1079026812Z.000000000124
   Arruda JL, 1998, MOL BRAIN RES, V62, P228, DOI 10.1016/S0169-328X(98)00257-5
   Assal Y, 2013, BIOMATERIALS, V34, P3315, DOI 10.1016/j.biomaterials.2013.01.067
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Beduer A, 2012, BIOMATERIALS, V33, P504, DOI 10.1016/j.biomaterials.2011.09.073
   Belisle JM, 2008, LAB CHIP, V8, P2164, DOI 10.1039/b813897d
   Bella AJ, 2009, J SEX MED, V6, P347, DOI 10.1111/j.1743-6109.2008.01194.x
   Bertram JP, 2010, PHARM RES-DORD, V27, P82, DOI 10.1007/s11095-009-0009-x
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730
   Boyd JG, 2003, EXP NEUROL, V183, P610, DOI 10.1016/S0014-4886(03)00183-3
   Brooks DN, 2012, MICROSURG, V32, P1, DOI 10.1002/micr.20975
   Caicco MJ, 2013, J CONTROL RELEASE, V166, P197, DOI 10.1016/j.jconrel.2013.01.002
   Cao JI, 2011, BIOMATERIALS, V32, P3939, DOI 10.1016/j.biomaterials.2011.02.020
   CARONI P, 1990, J CELL BIOL, V110, P1307, DOI 10.1083/jcb.110.4.1307
   Chang Y. J., 2012, NANOMEDICINE
   Chen R, 2010, COLLOID SURFACE B, V79, P315, DOI 10.1016/j.colsurfb.2010.03.043
   Cheng BX, 2011, MOL CELL NEUROSCI, V47, P181, DOI 10.1016/j.mcn.2011.04.002
   Choi Y. K., 2012, LIFE SCI
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032
   Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   Del Gaudio C, 2009, J BIOMED MATER RES A, V89A, P1028, DOI 10.1002/jbm.a.32048
   DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020
   Dey ND, 2010, BEHAV BRAIN RES, V214, P193, DOI 10.1016/j.bbr.2010.05.023
   Di Carlo A, 2009, AGE AGEING, V38, P4, DOI 10.1093/ageing/afn282
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Egawa EY, 2011, BIOMATERIALS, V32, P4737, DOI 10.1016/j.biomaterials.2011.03.033
   Ford B., 2010, PARKINSONS DIS Q A
   GARDETTE R, 1982, J HIRNFORSCH, V23, P415
   Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542
   Grassi Mario, 2005, Current Drug Delivery, V2, P97, DOI 10.2174/1567201052772906
   Han JJ, 2011, BIOMACROMOLECULES, V12, P399, DOI 10.1021/bm101149r
   Han N, 2012, J CONTROL RELEASE, V158, P165, DOI 10.1016/j.jconrel.2011.09.094
   Han Ning, 2011, Front Neuroeng, V4, P2, DOI 10.3389/fneng.2011.00002
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Hansmann F., 2012, CELL TRANSPLANT
   He JT, 2005, DRUG DELIV, V12, P251, DOI 10.1080/10717540500176043
   Heine W, 2004, EXP NEUROL, V189, P231, DOI 10.1016/j.expneurol.2004.06.014
   Herz J, 2012, NEUROBIOL DIS, V45, P1077, DOI 10.1016/j.nbd.2011.12.026
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101
   Huang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039526
   Huang SH, 2011, CURR NANOSCI, V7, P267, DOI 10.2174/157341311794653703
   Huang Y. J., 2012, SMALL
   Huang YJ, 2012, SMALL, V8, P2869, DOI 10.1002/smll.201200715
   Hwang JY, 2013, NANOSCALE, V5, P487, DOI 10.1039/c2nr31581e
   Hwang W., 2012, NEURAL DEV STEM CELL, P149
   Il Cho Y, 2010, ACTA BIOMATER, V6, P4725, DOI 10.1016/j.actbio.2010.06.019
   Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jeong SI, 2008, MACROMOL BIOSCI, V8, P627, DOI 10.1002/mabi.200800005
   Jeong SI, 2008, MACROMOL BIOSCI, V8, P328, DOI 10.1002/mabi.200700107
   Jia C, 2011, NEUROSCIENCE, V177, P335, DOI 10.1016/j.neuroscience.2010.12.039
   Joo NY, 2012, ACTA BIOMATER, V8, P1802, DOI 10.1016/j.actbio.2012.01.026
   Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72
   Kabiri M, 2012, BIOTECHNOL LETT, V34, P1357, DOI 10.1007/s10529-012-0889-4
   Kaka GR, 2012, INT J NEUROSCI, V122, P237, DOI 10.3109/00207454.2011.642037
   Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753
   Keenan TM, 2012, INTEGR BIOL-UK, V4, P1522, DOI 10.1039/c2ib20074k
   Kim HW, 2008, J BIOMED MATER RES A, V87A, P25, DOI 10.1002/jbm.a.31677
   Kobayashi NR, 1997, J NEUROSCI, V17, P9583
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   KREWSON CE, 1995, BRAIN RES, V680, P196, DOI 10.1016/0006-8993(95)00261-N
   Kunze A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026187
   Kwak YD, 2006, STEM CELLS DEV, V15, P381, DOI 10.1089/scd.2006.15.381
   Lee JY, 2012, IEEE T NANOBIOSCI, V11, P15, DOI 10.1109/TNB.2011.2159621
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee YS, 2011, ACTA BIOMATER, V7, P3877, DOI 10.1016/j.actbio.2011.07.013
   Leong W. S., 2012, J TISSUE ENG REGENER
   Lewicka M, 2012, BIOMATERIALS, V33, P7712, DOI 10.1016/j.biomaterials.2012.07.021
   Li BH, 2012, OR SURG OR MED OR PA, V113, pE26, DOI 10.1016/j.tripleo.2011.07.002
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Lin H, 2006, J BIOMED MATER RES A, V79A, P591, DOI 10.1002/jbm.a.30862
   Liu T, 2012, J BIOMED MATER RES A, V100A, P236, DOI 10.1002/jbm.a.33271
   Liu Z, 2011, PEPTIDES, V32, P1244, DOI 10.1016/j.peptides.2011.04.005
   Lowry N, 2012, BIOMATERIALS, V33, P2892, DOI 10.1016/j.biomaterials.2011.12.048
   Luo J, 2009, ACTA NEUROCHIR, V151, P1483, DOI 10.1007/s00701-009-0402-6
   Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014
   Ma QF, 1997, J NEUROSCI, V17, P3644
   Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717
   Ma ZW, 2009, J CHROMATOGR B, V877, P3686, DOI 10.1016/j.jchromb.2009.09.019
   Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001
   Magnaghi V, 2011, J BIOMED MATER RES A, V98A, P19, DOI 10.1002/jbm.a.33091
   Mahoney MJ, 2006, TISSUE ENG, V12, P1915, DOI 10.1089/ten.2006.12.1915
   MAY M, 1991, OTOLARYNG HEAD NECK, V104, P818, DOI 10.1177/019459989110400609
   McKasson MJ, 2008, EXP NEUROL, V211, P585, DOI 10.1016/j.expneurol.2008.02.015
   MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J
   Miao JJ, 2012, J NANOSCI NANOTECHNO, V12, P2387, DOI 10.1166/jnn.2012.5710
   Miller RH, 2006, BRAIN RES, V1091, P258, DOI 10.1016/j.brainres.2006.01.073
   Mohammed JS, 2006, LANGMUIR, V22, P2738, DOI 10.1021/la0525473
   Montastruc JL, 1999, MOVEMENT DISORD, V14, P725, DOI 10.1002/1531-8257(199909)14:5<725::AID-MDS1003>3.0.CO;2-L
   Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102
   Mwizerwa O, 2011, DEV DYNAM, V240, P1402, DOI 10.1002/dvdy.22630
   Nakaji-Hirabayashi T, 2012, BIOCONJUGATE CHEM, V23, P212, DOI 10.1021/bc200481v
   Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055
   Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011
   Ojha SS, 2008, BIOMACROMOLECULES, V9, P2523, DOI 10.1021/bm800551q
   Park JS, 2012, BIOMATERIALS, V33, P7300, DOI 10.1016/j.biomaterials.2012.06.069
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Park S, 2004, NEUROSCI LETT, V359, P99, DOI 10.1016/j.neulet.2004.01.073
   Pawitan Jeanne Adiwinata, 2011, Anat Cell Biol, V44, P256, DOI 10.5115/acb.2011.44.4.256
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Perale G, 2012, J CONTROL RELEASE, V159, P271, DOI 10.1016/j.jconrel.2011.12.025
   Pfister LA, 2007, J BIOMED MATER RES A, V80A, P932, DOI 10.1002/jbm.a.31052
   Puppi D, 2010, ACTA BIOMATER, V6, P1258, DOI 10.1016/j.actbio.2009.08.015
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Rickett TA, 2011, BIOMACROMOLECULES, V12, P57, DOI 10.1021/bm101004r
   Ruiz A, 2008, BIOMATERIALS, V29, P4766, DOI 10.1016/j.biomaterials.2008.08.017
   Sabri F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033242
   Sackett CK, 2011, INT J PHARMACEUT, V418, P104, DOI 10.1016/j.ijpharm.2010.11.048
   Saltzman WM, 1999, PHARMACEUT RES, V16, P232, DOI 10.1023/A:1018824324275
   Sazo REG, 2012, BIOMATERIALS, V33, P8529, DOI 10.1016/j.biomaterials.2012.07.028
   Seyednejad H, 2012, BIOMACROMOLECULES, V13, P3650, DOI 10.1021/bm301101r
   Shanbhag M. S., 2010, BIOMACROMOLECULES
   Sharp KG, 2012, EXP NEUROL, V235, P345, DOI 10.1016/j.expneurol.2012.02.016
   Shen C. C., 2013, J BIOMEDICAL MAT R A
   Shi J, 2010, ACS APPL MATER INTER, V2, P1025, DOI 10.1021/am9007962
   Sirianni RW, 2010, BRAIN RES, V1321, P40, DOI 10.1016/j.brainres.2010.01.041
   Song BB, 2012, BIOMATERIALS, V33, P9105, DOI 10.1016/j.biomaterials.2012.08.060
   Studer L, 2000, J NEUROSCI, V20, P7377
   Subramanian A, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025004
   Sugaya K, 2008, J ALZHEIMERS DIS, V15, P241
   Sulaiman OAR, 2002, GLIA, V37, P206, DOI 10.1002/glia.10022
   Tosi G., 2013, CURRENT MED CHEM
   Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239
   Tzeng SY, 2010, SOFT MATTER, V6, P2208, DOI 10.1039/b923544b
   Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223
   Vincent AM, 2004, NEUROBIOL DIS, V16, P407, DOI 10.1016/j.nbd.2004.03.001
   Wang CY, 2012, J BIOMAT SCI-POLYM E, V23, P167, DOI 10.1163/092050610X545805
   Wang HK, 2012, BIOTECHNOL APPL BIOC, V59, P388, DOI 10.1002/bab.1031
   Wang JX, 2012, J BIOMED MATER RES A, V100A, P632, DOI 10.1002/jbm.a.33291
   Wang SG, 2012, THER DELIV, V3, P1155, DOI 10.4155/TDE.12.103
   Wang Y., 2013, ACTA BIOMATERIALIA
   Wang Y, 2011, PHARM RES-DORDR, V28, P1406, DOI 10.1007/s11095-011-0452-3
   Wang YF, 2012, BIOMATERIALS, V33, P2681, DOI 10.1016/j.biomaterials.2011.12.031
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Xia L, 2013, CHINESE MED J-PEKING, V126, P909, DOI 10.3760/cma.j.issn.0366-6999.20120476
   Xie JW, 2010, ACS NANO, V4, P5027, DOI 10.1021/nn101554u
   Xie JW, 2009, ADV FUNCT MATER, V19, P2312, DOI 10.1002/adfm.200801904
   Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048
   Yao L, 2009, J BIOMED MATER RES B, V90B, P483, DOI 10.1002/jbm.b.31308
   Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3
   Yi X, 2011, NEUROENDOCRINOL LETT, V32, P705
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
   Zuidema JM, 2011, ACTA BIOMATER, V7, P1634, DOI 10.1016/j.actbio.2010.11.039
NR 157
TC 16
Z9 18
U1 2
U2 49
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1550-8943
EI 1558-6804
J9 STEM CELL REV REP
JI Stem Cell Rev. Rep.
PD FEB
PY 2014
VL 10
IS 1
BP 44
EP 59
DI 10.1007/s12015-013-9474-z
PG 16
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
SC Cell Biology; Research & Experimental Medicine
GA AA3LC
UT WOS:000330992900004
PM 24092527
DA 2018-10-20
ER

PT J
AU Kang, SN
   Jeong, CM
   Jeon, YC
   Byon, ES
   Jeong, YS
   Cho, LR
AF Kang, Sun Nyo
   Jeong, Chang Mo
   Jeon, Young Chan
   Byon, Eung-Sun
   Jeong, Yong-Soo
   Cho, Lee-Ra
TI Effects of Mg-ion and Ca-ion Implantations on P-gingivalis and
   F-nucleatum Adhesion
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE bacterial adhesion; ion implantation; calcium; magnesium; non-specific
   bonding
ID PARTIALLY EDENTULOUS PATIENTS; COMMERCIALLY PURE TITANIUM; BACTERIAL
   ADHESION; BONE RESPONSE; IN-VIVO; SURFACES; CALCIUM; BIOMATERIAL;
   MECHANISMS; ATTACHMENT
AB The purpose of this study was to evaluate the effects of ion implantation on Porphyromonas gingivalis (P. gingivalis) and Fusobacterium nucleatum (F. nucleatum) bacterial adhesion. Titanium (Ti) discs of 15 mm diameter and 1 mm in thickness (n = 42, 7 per group) were fabricated. Magnesium (Mg) and calcium (Ca) ions were implanted into the Ti surfaces using a plasma-source ion-implantation method. The roughness, chemistry, morphology, and contact angle of the titanium surfaces were analyzed using scanning electron microscopy, Rutherford back-scattering spectroscopy, Auger electron spectroscopy, and contact angle meter. P. gingivalis and F. nucleatum strains were cultured in anaerobic conditions at 37 degrees C for 72 hours, and all titanium specimens were dipped in the bacterial suspension at 37 degrees C for 24 hours. Specimens were examined at 1,000x magnification using a fluorescence microscope. The number and total area of bacteria in each of 10 separate fields were determined by computer imaging analysis method. The resulting data was analyzed to assess the significance of observed differences based on the method of the surface treatment, ion implantation. The number of P. gingivalis and F. nucleatum attached to the Mg-(927 and 227, respectively) and Ca-ion-implanted (1325 and 231, respectively) surfaces were greater than those attached to the non-implanted surfaces (306 and 98, p <.001). Total area occupied by P. gingivalis adhesion was greater than those of F. nucleatum in the Mg- and Ca-ion-implanted surfaces (p <.001). The types of ion and bacteria did not affect the amount of bacterial adhesion. Ion implantation enhanced the adhesions of P. gingivalis and F. nucleatum. Non-specific bonding derived from the electrostatic force affected by positively charged ions might be the predominant factor in bacterial adhesion. The possibility of specific bonding could not be ruled out in the Ca-ion-implanted surface.
C1 [Kang, Sun Nyo; Jeong, Chang Mo; Jeon, Young Chan] Pusan Natl Univ, Sch Dent, Dept Prosthodont, Pusan, South Korea.
   [Byon, Eung-Sun; Jeong, Yong-Soo] Korea Inst Mat Sci, Mat Proc Div, Chang Won, South Korea.
   [Cho, Lee-Ra] Gangneung Wonju Natl Univ, Coll Dent, Dept Prosthodont, Kangnung, South Korea.
   [Cho, Lee-Ra] Gangneung Wonju Natl Univ, Coll Dent, Res Inst Oral Sci, Kangnung, South Korea.
RP Cho, LR (reprint author), Gangneung Wonju Natl Univ, Coll Dent, Dept Prosthodont, Kangnung, South Korea.
EM lila@gwnu.ac.kr
CR ABBOTT A, 1983, J GEN MICROBIOL, V129, P439
   Albrektsson T, 1994, P 1 EUR WORKSH PER
   Amano A, 1996, INFECT IMMUN, V64, P1631
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Apella MC, 2008, J ARGENT CHEM SOC, V97, P109
   Boks NP, 2009, J COLLOID INTERF SCI, V331, P60, DOI 10.1016/j.jcis.2008.11.025
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   Cardenas C, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2819239
   Cho LR, 2010, CLIN ORAL IMPLAN RES, V21, P848, DOI 10.1111/j.1600-0501.2009.01862.x
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Frojd V, 2008, INT J ORAL MAX SURG, V37, P561, DOI 10.1016/j.ijom.2008.01.020
   Frojd V, 2012, CLIN IMPLANT DENT R, V14, P737, DOI 10.1111/j.1708-8208.2010.00315.x
   Hauslich LB, 2013, CLIN ORAL IMPLAN RES, V24, P49, DOI 10.1111/j.1600-0501.2011.02364.x
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   Hsiao CL, 2009, NUCLEIC ACIDS RES, V37, P3134, DOI 10.1093/nar/gkp119
   Ichikawa T, 2000, INT J ORAL MAX IMPL, V15, P231
   Jeyachandran YL, 2006, BIOMED MATER, V1, pL1, DOI 10.1088/1748-6041/1/1/L01
   Kiejna A, 2006, J PHYS-CONDENS MAT, V18, P4207, DOI 10.1088/0953-8984/18/17/009
   Kim ML, 2012, CLIN ORAL IMPLAN RES, V23, P245, DOI 10.1111/j.1600-0501.2010.02138.x
   KINDER SA, 1993, J BACTERIOL, V175, P840
   Klinge Bjorn, 2005, Dent Clin North Am, V49, P661, DOI 10.1016/j.cden.2005.03.007
   Ko KH, 2012, TISSUE ENG REGEN MED, V9, P137, DOI 10.1007/s13770-012-0137-y
   KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993
   Kuula H, 2004, INT J ORAL MAX IMPL, V19, P803
   LEONHARDT A, 1993, CLIN ORAL IMPLAN RES, V4, P113, DOI 10.1034/j.1600-0501.1993.040301.x
   Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x
   Mei L, 2009, LANGMUIR, V25, P6227, DOI 10.1021/la9000494
   Nayab SN, 2005, BIOMATERIALS, V26, P4717, DOI 10.1016/j.biomaterials.2004.11.044
   Parikh SJ, 2006, LANGMUIR, V22, P8492, DOI 10.1021/la061359p
   Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P1278, DOI 10.1111/j.1600-0501.2010.01944.x
   Pongnarisorn NJ, 2007, CLIN ORAL IMPLAN RES, V18, P114, DOI 10.1111/j.1600-0501.2006.01304.x
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061
   Sul Young-Taeg, 2004, Clin Implant Dent Relat Res, V6, P101, DOI 10.1111/j.1708-8208.2004.tb00032.x
   van Winkelhoff AJ, 2000, CLIN ORAL IMPLAN RES, V11, P511, DOI 10.1034/j.1600-0501.2000.011006511.x
   Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535
   Wan YZ, 2006, SURF COAT TECH, V201, P2904, DOI 10.1016/j.surfcoat.2006.06.004
   Wu-Yuan CD, 1995, J ORAL IMPLANTOL, V21, P207
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 41
TC 2
Z9 2
U1 2
U2 11
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD FEB
PY 2014
VL 11
IS 1
BP 39
EP 46
DI 10.1007/s13770-013-1104-y
PG 8
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA AA0PK
UT WOS:000330797300006
DA 2018-10-20
ER

PT J
AU Suh, JD
   Lim, KT
   Jin, H
   Kim, J
   Choung, PH
   Chung, JH
AF Suh, Je-Duck
   Lim, Ki Taek
   Jin, Hexiu
   Kim, Jangho
   Choung, Pill-Hoon
   Chung, Jong Hoon
TI Effects of Co-Culture of Dental Pulp Stem Cells and Periodontal Ligament
   Stem Cells on Assembled Dual Disc Scaffolds
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE co-culture; assembled dual disc scaffolds; dental pulp stem cells;
   periodontal ligament stem cells; tooth tissue engineering
ID IN-VITRO; BONE-MARROW; PROLIFERATION; FIBROBLASTS; GROWTH; REGENERATION;
   OSTEOPONTIN; EXPRESSION; MATRIX; MODELS
AB The study of cell-to-cell interaction in experimental co-culture systems is very important and relevant to the context of biomaterial scaffolds used for tissue regeneration. In this study, scaffolds, which allow direct and indirect cell-to-cell contact and separation of each cell type, were developed using one of the most utilized biopolymer, poly-D, L-lactide (PDLLA). The assembled scaffold had enough mechanical strength to withstand experiments and maintain its shape. It is separated easily into core and outer portion for further experiments, which could be conducted to examine the effects of co-culture. Co-culture with dental pulp stem cells (DPSCs) and periodontal ligament stem cells (PDLSCs) increased proliferation of both cell types and dentin sialophosphoprotein (DSPP) mRNA expression in co-cultured PDLSCs. In immunohistochemical examination, dentin sialoprotein (DSP) expression in both cell types was up-regulated in co-culture compared to that of mono-culture. The longer the culture period, the more DSP expressions were up-regulated. Osteopontin (OPN) expression in both cell types was also up-regulated in co-culture. Co-culture of dental stem cells improved cell proliferation and osteogenic differentiation. This study demonstrates that biomimetic co-culture method for tooth tissue engineering may be potentially applied to study dental stem cell behavior in tooth regenerative medicine.
C1 [Suh, Je-Duck; Lim, Ki Taek; Jin, Hexiu; Choung, Pill-Hoon] Seoul Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Seoul, South Korea.
   [Suh, Je-Duck; Lim, Ki Taek; Jin, Hexiu; Choung, Pill-Hoon] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul, South Korea.
   [Suh, Je-Duck; Jin, Hexiu; Choung, Pill-Hoon] Seoul Natl Univ, Sch Dent, Tooth Bioengn Natl Res Lab Post BK21, Seoul, South Korea.
   [Lim, Ki Taek; Kim, Jangho; Chung, Jong Hoon] Seoul Natl Univ, Dept Biosyst & Biomat Sci & Engn, Seoul 151921, South Korea.
   [Chung, Jong Hoon] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea.
RP Choung, PH (reprint author), Seoul Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Seoul, South Korea.
EM choungph@snu.ac.kr; jchung@snu.ac.kr
FU Technology Development Program for Korea Institute of Planning and
   Evaluation for Technology in Food, Agriculture, Forestry and Fisheries
   (IPET), Republic of Korea [312031-3]; National Research Foundation of
   Korea (NRF); Korea government (MEST) [2011-0028922]
FX This research was supported by Technology Development Program for Korea
   Institute of Planning and Evaluation for Technology in Food,
   Agriculture, Forestry and Fisheries (IPET), Republic of Korea
   (312031-3), and the National Research Foundation of Korea (NRF) grant
   funded by the Korea government (MEST) (2011-0028922).
CR Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   Bloemen V, 2010, J CELL PHYSIOL, V222, P565, DOI 10.1002/jcp.21971
   Borden M, 2002, J BIOMED MATER RES, V61, P421, DOI 10.1002/jbm.10201
   BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   Buma P, 2004, BIOMATERIALS, V25, P1487, DOI 10.1016/S0142-9612(03)00492-7
   Burger R, 2009, MOL CANCER THER, V8, P26, DOI 10.1158/1535-7163.MCT-08-0149
   Cai XX, 2010, INT J ORAL SCI, V2, P74, DOI 10.4248/IJOS10039
   Croft AP, 2009, EXP NEUROL, V216, P329, DOI 10.1016/j.expneurol.2008.12.010
   Crop MJ, 2010, STEM CELLS DEV, V19, P1843, DOI 10.1089/scd.2009.0368
   Douglas T, 2010, CLIN ORAL IMPLAN RES, V21, P262, DOI 10.1111/j.1600-0501.2009.01818.x
   Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]
   Ferreira CF, 2007, J ORAL REHABIL, V34, P933, DOI 10.1111/j.1365-2842.2007.01785.x
   Gerstenfeld LC, 2003, CONNECT TISSUE RES, V44, P85, DOI 10.1080/03008200390152142
   Geuze RE, 2009, TISSUE ENG PT A, V15, P3669, DOI 10.1089/ten.TEA.2009.0289
   Grant-Tschudy KS, 2005, BIOL REPROD, V72, P814, DOI 10.1095/biolreprod.104.035618
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hendriks J, 2007, J TISSUE ENG REGEN M, V1, P170, DOI 10.1002/term.19
   Hernandez-Guillamon M, 2009, J NEUROSCI RES, V87, P2115, DOI 10.1002/jnr.22034
   Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   James KC, 2007, BIOMATERIALS, V28, P5193
   Jo YY, 2007, TISSUE ENG, V13, P767, DOI 10.1089/ten.2006.0192
   Kacena MA, 2006, BONE, V39, P991, DOI 10.1016/j.bone.2006.05.004
   Kim K, 2010, J DENT RES, V89, P842, DOI 10.1177/0022034510370803
   Ko JA, 2010, INVEST OPHTH VIS SCI, V51, P6286, DOI 10.1167/iovs.09-4753
   Lai N, 2009, TISSUE ENG PT A, V15, P1053, DOI 10.1089/ten.tea.2008.0101
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Lin NH, 2009, PERIODONTOL 2000, V51, P239, DOI 10.1111/j.1600-0757.2009.00303.x
   Mao JJ, 2010, TISSUE ENG PART B-RE, V16, P257, DOI [10.1089/ten.teb.2009.0496, 10.1089/ten.TEB.2009.0496]
   Marten A, 2002, MOL IMMUNOL, V39, P395, DOI 10.1016/S0161-5890(02)00142-6
   Merluzzi S, 2010, BLOOD, V115, P2810, DOI 10.1182/blood-2009-10-250126
   Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100
   Mishra V, 2009, TOXICOL LETT, V186, P104, DOI 10.1016/j.toxlet.2009.01.006
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Modino SAC, 2005, ARCH ORAL BIOL, V50, P255, DOI 10.1016/j.archoralbio.2005.01.002
   Mondrinos MJ, 2006, TISSUE ENG, V12, P717, DOI 10.1089/ten.2006.12.717
   Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004
   Morsczeck C, 2008, CLIN ORAL INVEST, V12, P113, DOI 10.1007/s00784-007-0170-8
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Olivera-Martinez I, 2004, INT J DEV BIOL, V48, P107, DOI 10.1387/ijdb.15272376
   Park JB, 2012, TISSUE ENG REGEN MED, V9, P224, DOI 10.1007/s13770-012-0343-7
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8
   Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302
   Regnier M, 1999, CELL MOL BIOL, V45, P969
   Rincon JC, 2005, J PERIODONTAL RES, V40, P417, DOI 10.1111/j.1600-0765.2005.00823.x
   SANTAVIRTA S, 1990, J BONE JOINT SURG BR, V72, P597
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   SODEK J, 1995, ANN NY ACAD SCI, V760, P223, DOI 10.1111/j.1749-6632.1995.tb44633.x
   Sonoyama W, 2006, PLOS ONE, V1, pe79
   Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1
   Steinhagen J, 2010, TISSUE CELL, V42, P151, DOI 10.1016/j.tice.2010.03.003
   Swierczynski B, 2000, PARASITOL RES, V86, P151, DOI 10.1007/s004360050024
   Terzuoli E, 2010, CLIN CANCER RES, V16, P4207, DOI 10.1158/1078-0432.CCR-10-0156
   Yen AHH, 2008, CELL TISSUE RES, V331, P359, DOI 10.1007/s00441-007-0467-6
   Zahir N, 2004, CURR OPIN GENET DEV, V14, P71, DOI 10.1016/j.gde.2003.12.005
   Zhang WB, 2010, BIOMATERIALS, V31, P7995, DOI 10.1016/j.biomaterials.2010.07.020
NR 58
TC 3
Z9 4
U1 1
U2 14
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD FEB
PY 2014
VL 11
IS 1
BP 47
EP 58
DI 10.1007/s13770-013-1109-6
PG 12
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA AA0PK
UT WOS:000330797300007
DA 2018-10-20
ER

PT J
AU Huang, Y
   Zhu, CL
   Yang, JZ
   Nie, Y
   Chen, CT
   Sun, DP
AF Huang, Yang
   Zhu, Chunlin
   Yang, Jiazhi
   Nie, Ying
   Chen, Chuntao
   Sun, Dongping
TI Recent advances in bacterial cellulose
SO CELLULOSE
LA English
DT Review
DE Bacterial cellulose; Nanobiomaterials; Network architecture;
   Controllable cultivation
ID QUARTZ-CRYSTAL MICROBALANCE; BUBBLE-COLUMN BIOREACTOR; DIFFERENT
   CARBON-SOURCES; ACETOBACTER-XYLINUM; MICROBIAL CELLULOSE;
   GLUCONACETOBACTER-XYLINUS; POLYANILINE NANOCOMPOSITES; STRAIN
   IMPROVEMENT; LIQUID-CRYSTALLINE; VASCULAR GRAFT
AB Bacterial cellulose (BC) produced by some microorganisms has been widely accepted as a multifunctional nano-biomaterial. It is composed of linear glucan molecules attached with hydrogen bonds, which appears similar to plant cellulose. However, when compared with other conventional natural or synthesized counterparts, BC performs better in areas such as biomedicine, functional devices, water treatment, nanofillers, etc. for its distinct superior chemical purity, crystallinity, biocompatibility, and ultrafine network architecture. When BC is incorporated in a material or used as a scaffold, novel features result that are related to BC's intrinsic characteristics mentioned above. This review mainly summarizes the recent developments of the functional products fabricated with BC. Besides, the controllable cultivation conditions should also be discussed for expecting to make a breakthrough in its productivity. We highlight the literatures mainly in last 5 years, exerting ourselves to provide the state-of-the-art opinions in areas wherever are focused on for BC researching.
C1 [Huang, Yang; Zhu, Chunlin; Yang, Jiazhi; Nie, Ying; Chen, Chuntao; Sun, Dongping] Nanjing Univ Sci & Technol, Chemicobiol & Funct Mat Inst, Sch Chem Engn, Nanjing 210094, Jiangsu, Peoples R China.
RP Sun, DP (reprint author), Nanjing Univ Sci & Technol, Chemicobiol & Funct Mat Inst, Sch Chem Engn, Nanjing 210094, Jiangsu, Peoples R China.
EM sundpe301@163.com
FU State 863 Projects [2011AA050701]; Fundamental Research Funds for the
   Central Universities [30920130121001]; Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD, China)
FX We acknowledge the financial support from State 863 Projects
   (2011AA050701), the Fundamental Research Funds for the Central
   Universities (No. 30920130121001), and a Project Funded by the Priority
   Academic Program Development of Jiangsu Higher Education Institutions
   (PAPD, China).
CR Alvarez OM, 2004, WOUNDS, V16, P224
   Amin MCIM, 2012, CARBOHYD POLYM, V88, P465, DOI 10.1016/j.carbpol.2011.12.022
   Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148
   Andrade FK, 2010, ACTA BIOMATER, V6, P4034, DOI 10.1016/j.actbio.2010.04.023
   Astley OM, 2003, INT J BIOL MACROMOL, V32, P28, DOI 10.1016/S0141-8130(03)00022-9
   ATALLA RH, 1984, SCIENCE, V223, P283, DOI 10.1126/science.223.4633.283
   Aveyard R, 2003, ADV COLLOID INTERFAC, V100, P503, DOI 10.1016/S0001-8686(02)00069-6
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Backdahl H, 2011, MAT SCI ENG C-MATER, V31, P14, DOI 10.1016/j.msec.2010.07.010
   Bapiraju K, 2005, AFR J BIOTECHNOL, V3, P618
   Barud HS, 2008, J SOL-GEL SCI TECHN, V46, P363, DOI 10.1007/s10971-007-1669-9
   Basta AH, 2009, J APPL MICROBIOL, V107, P2098, DOI 10.1111/j.1365-2672.2009.04467.x
   Beck-Candanedo S, 2005, BIOMACROMOLECULES, V6, P1048, DOI 10.1021/bm049300p
   Bhatnagar A, 2005, J REINF PLAST COMP, V24, P1259, DOI 10.1177/0731684405049864
   Bielecki S, 2005, BIOPOLYMERS ONLINE, DOI [10.1002/3527600035.bpol5003, DOI 10.1002/3527600035.BP0L5003]
   Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0
   Bodin A, 2007, BIOMACROMOLECULES, V8, P3697, DOI 10.1021/bm070343q
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Brown AJ, 1886, J CHEM SOC, V49, P432, DOI DOI 10.1039/CT8864900432
   Brown EE, 2012, CELLULOSE, V19, P127, DOI 10.1007/s10570-011-9617-9
   Brown RM, 2004, J POLYM SCI POL CHEM, V42, P487, DOI 10.1002/pola.10877
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   Cai Z, 2011, AM SOC MECH ENG, V2
   Cai ZJ, 2011, MATER LETT, V65, P182, DOI 10.1016/j.matlet.2010.09.055
   Cai ZJ, 2011, CURR APPL PHYS, V11, P247, DOI 10.1016/j.cap.2010.07.016
   Carreira P, 2011, BIORESOURCE TECHNOL, V102, P7354, DOI 10.1016/j.biortech.2011.04.081
   CHAN HSO, 1995, J AM CHEM SOC, V117, P8517, DOI 10.1021/ja00138a004
   Chao YP, 2000, BIOTECHNOL BIOENG, V68, P345
   Chen P, 2010, MOL CRYST LIQ CRYST, V519, P169, DOI 10.1080/15421401003613659
   Chen SY, 2010, J APPL POLYM SCI, V117, P8, DOI 10.1002/app.31477
   Chen SY, 2009, POLYM BULL, V63, P283, DOI 10.1007/s00289-009-0088-1
   Chen SY, 2009, J HAZARD MATER, V161, P1355, DOI 10.1016/j.jhazmat.2008.04.098
   Cheng KC, 2011, BIOMACROMOLECULES, V12, P730, DOI 10.1021/bm101363t
   Cheng Kuan-Chen, 2009, J Biol Eng, V3, P12, DOI 10.1186/1754-1611-3-12
   Chiaoprakobkij N, 2011, CARBOHYD POLYM, V85, P548, DOI 10.1016/j.carbpol.2011.03.011
   Choi CN, 2009, KOREAN J CHEM ENG, V26, P136, DOI 10.1007/s11814-009-0021-1
   Conner AH, 1995, SIZE EXCLUSION CHROM, P331
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja W, 2004, CELLULOSE, V11, P403, DOI 10.1023/B:CELL.0000046412.11983.61
   De Olyveira G. M., 2011, J BIOMATER NANOBIOTE, V2, P239
   de Souza FC, 2011, J VOICE, V25, P765, DOI 10.1016/j.jvoice.2010.07.005
   Dong XM, 1998, CELLULOSE, V5, P19, DOI 10.1023/A:1009260511939
   Eichhorn SJ, 2001, J MATER SCI, V36, P2107, DOI 10.1023/A:1017512029696
   El-Saied H, 2008, BIORESOURCES, V3, P1196
   Esguerra M, 2010, J BIOMED MATER RES A, V93A, P140, DOI 10.1002/jbm.a.32516
   Fink H, 2011, J TISSUE ENG REGEN M, V5, P454, DOI 10.1002/term.334
   Fink H, 2010, ACTA BIOMATER, V6, P1125, DOI 10.1016/j.actbio.2009.09.019
   Fujiwara K, 2001, Japanese Patent, Patent No. [01-321164, 01321164]
   Gao C, 2011, CELLULOSE, V18, P1555, DOI 10.1007/s10570-011-9571-6
   Gao CA, 2011, J POROUS MAT, V18, P139, DOI 10.1007/s10934-010-9364-6
   Ge HJ, 2011, APPL BIOCHEM BIOTECH, V165, P1519, DOI 10.1007/s12010-011-9372-2
   George J, 2012, CARBOHYD POLYM, V87, P2031, DOI 10.1016/j.carbpol.2011.10.019
   George J, 2011, INT J BIOL MACROMOL, V48, P50, DOI 10.1016/j.ijbiomac.2010.09.013
   Gimenez J, 2007, J HAZARD MATER, V141, P575, DOI 10.1016/j.jhazmat.2006.07.020
   Gomez H, 2011, J POWER SOURCES, V196, P4102, DOI 10.1016/j.jpowsour.2010.11.002
   Guo J, 2012, CARBOHYD POLYM, V87, P1026, DOI 10.1016/j.carbpol.2011.07.060
   Gusakov AV, 2007, BIOTECHNOL BIOENG, V97, P1028, DOI 10.1002/bit.21329
   Ha JH, 2011, PROCESS BIOCHEM, V46, P1717, DOI 10.1016/j.procbio.2011.05.024
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Hamilton D, 2004, ENCY BIOMATERIALS BI
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Hirai A, 2009, LANGMUIR, V25, P497, DOI 10.1021/la802947m
   Hoenich N, 2006, BIORESOURCES, V1, P270
   HON DNS, 1994, CELLULOSE, V1, P1, DOI 10.1007/BF00818796
   Hong F, 2011, J CHEM TECHNOL BIOT, V86, P675, DOI 10.1002/jctb.2567
   Hu WL, 2011, SENSOR ACTUAT B-CHEM, V159, P301, DOI 10.1016/j.snb.2011.07.014
   Hu WL, 2011, SENSOR ACTUAT B-CHEM, V157, P554, DOI 10.1016/j.snb.2011.05.021
   Hu WL, 2011, J PHYS CHEM B, V115, P8453, DOI 10.1021/jp204422v
   Hu WL, 2011, CELLULOSE, V18, P655, DOI 10.1007/s10570-011-9520-4
   Hu WL, 2010, MATER SCI ENG B-ADV, V170, P88, DOI 10.1016/j.mseb.2010.02.034
   Hu Y, 2011, J BIOMED MATER RES B, V97B, P114, DOI 10.1002/jbm.b.31792
   Hungund BS, 2010, WORLD J MICROB BIOT, V26, P1823, DOI 10.1007/s11274-010-0363-1
   Hungund BS, 2010, AFR J BIOTECHNOL, V9, P5170
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Ishihara M, 2002, ENZYME MICROB TECH, V31, P986, DOI 10.1016/S0141-0229(02)00215-6
   Ishkawa A, 1995, BIOSCI BIOTECH BIOCH, V59, P2259
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Kadam SR, 2006, PROCESS BIOCHEM, V41, P120, DOI 10.1016/j.procbio.2005.06.007
   Kalashnikova I, 2012, BIOMACROMOLECULES, V13, P267, DOI 10.1021/bm201599j
   Keshk SMAS, 2005, AFR J BIOTECHNOL, V4, P478
   Khomenko V, 2005, ELECTROCHIM ACTA, V50, P2499, DOI 10.1016/j.electacta.2004.10.078
   Kim CW, 2006, POLYMER, V47, P5097, DOI 10.1016/j.polymer.2006.05.033
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Kongruang S, 2008, APPL BIOCHEM BIOTECH, V148, P245, DOI 10.1007/s12010-007-8119-6
   Kumagai A, 2011, BIOMACROMOLECULES, V12, P2815, DOI 10.1021/bm2005615
   Kurosumi A, 2009, CARBOHYD POLYM, V76, P333, DOI 10.1016/j.carbpol.2008.11.009
   Lee HJ, 2012, CELLULOSE, V19, P1251, DOI 10.1007/s10570-012-9705-5
   Legnani C, 2008, THIN SOLID FILMS, V517, P1016, DOI 10.1016/j.tsf.2008.06.011
   Liang HW, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.34
   Liang Y, 2009, ELECTROCHEM COMMUN, V11, P1018, DOI 10.1016/j.elecom.2009.03.001
   Liao SS, 2003, SPINE, V28, P1954, DOI 10.1097/01.BRS.0000083240.13332.F6
   Lin YK, 2011, J BIOACT COMPAT POL, V26, P508, DOI 10.1177/0883911511415390
   Liu GG, 2011, J MATER CHEM, V21, P10637, DOI 10.1039/c1jm11432h
   Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317
   Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002
   Marins JA, 2011, CELLULOSE, V18, P1285, DOI 10.1007/s10570-011-9565-4
   Martinez H, 2012, J BIOMED MATER RES A, V100A, P948, DOI 10.1002/jbm.a.34035
   Martinez-Sanz M, 2012, J APPL POLYM SCI, V124, P1398, DOI 10.1002/app.35052
   Martinez-Sanz M, 2011, CARBOHYD POLYM, V85, P228, DOI 10.1016/j.carbpol.2011.02.021
   Martinez-Sanz M, 2011, CELLULOSE, V18, P335, DOI 10.1007/s10570-010-9471-1
   MASAOKA S, 1993, J FERMENT BIOENG, V75, P18, DOI 10.1016/0922-338X(93)90171-4
   Matsuoka M, 1996, BIOSCI BIOTECH BIOCH, V60, P575, DOI 10.1271/bbb.60.575
   Mikami I, 2003, APPL CATAL B-ENVIRON, V44, P79, DOI 10.1016/S0926-3373(03)00021-3
   Mikkelsen D, 2009, J APPL MICROBIOL, V107, P576, DOI 10.1111/j.1365-2672.2009.04226.x
   Mladenova EK, 2011, ENVIRON SCI POLLUT R, V18, P1633, DOI 10.1007/s11356-011-0529-x
   Mormino R, 2003, APPL MICROBIOL BIOT, V62, P503, DOI 10.1007/s00253-003-1377-5
   Muller D, 2012, CELLULOSE, V19, P1645, DOI 10.1007/s10570-012-9754-9
   Muller D, 2011, SYNTHETIC MET, V161, P106, DOI 10.1016/j.synthmet.2010.11.005
   Murugesan S, 2008, CURR TOP MED CHEM, V8, P80
   Nakayama A, 2004, ADV FUNCT MATER, V14, P1124, DOI 10.1002/adfm.200305197
   Nata IF, 2011, RSC ADV, V1, P625, DOI 10.1039/c1ra00153a
   Nata IF, 2010, GREEN CHEM, V12, P1454, DOI 10.1039/c003479g
   Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319
   Oliveira GB, 2003, BIOMATERIALS, V24, P4777, DOI 10.1016/S0142-9612(03)00376-4
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/nnano.2010.155, 10.1038/NNANO.2010.155]
   Olsson RT, 2010, MACROMOLECULES, V43, P4201, DOI 10.1021/ma100217q
   Oshima T, 2008, REACT FUNCT POLYM, V68, P376, DOI 10.1016/j.reactfunctpolym.2007.07.046
   Oshima T, 2011, CARBOHYD POLYM, V83, P953, DOI 10.1016/j.carbpol.2010.09.005
   Padera RF, 2004, BIOMATERIALS SCI, P470
   Peng S, 2012, POLYM BULL, V68, P415, DOI 10.1007/s00289-011-0550-8
   Perepelkin KE, 1997, FIBRE CHEM+, V29, P200, DOI 10.1007/BF02400409
   Pertile RAN, 2012, J BIOMAT SCI-POLYM E, V23, P1339, DOI 10.1163/092050611X581516
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Putra A, 2008, POLYMER, V49, P1885, DOI 10.1016/j.polymer.2008.02.022
   Rambo CR, 2008, MAT SCI ENG C-BIO S, V28, P549, DOI 10.1016/j.msec.2007.11.011
   RANBY BG, 1949, ACTA CHEM SCAND, V3, P649, DOI 10.3891/acta.chem.scand.03-0649
   Rani MU, 2011, J APPL POLYM SCI, V120, P2835, DOI 10.1002/app.33307
   Rani MU, 2011, ANN MICROBIOL, V61, P781, DOI 10.1007/s13213-011-0196-7
   Recouvreux DOS, 2011, MAT SCI ENG C-MATER, V31, P151, DOI 10.1016/j.msec.2010.08.004
   Retegi A, 2010, CELLULOSE, V17, P661, DOI 10.1007/s10570-009-9389-7
   Revol J.F., 1997, US, Patent No. [US 5629055 A, 5629055, 5629055A]
   Revol JF, 1998, J PULP PAP SCI, V24, P146
   Roman M, 2004, BIOMACROMOLECULES, V5, P1671, DOI 10.1021/bm034519+
   Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Saikia CN, 1997, WOOD SCI TECHNOL, V31, P467, DOI 10.1007/s002260050053
   Samir MASA, 2004, MACROMOLECULES, V37, P1386, DOI 10.1021/ma030532a
   Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685
   Sani A, 2010, J CHEM TECHNOL BIOT, V85, P151, DOI 10.1002/jctb.2300
   Shadwick RE, 1999, J EXP BIOL, V202, P3305
   Shaikh FM, 2008, CELLS TISSUES ORGANS, V188, P333, DOI 10.1159/000139772
   Shen W, 2009, CARBOHYD POLYM, V75, P110, DOI 10.1016/j.carbpol.2008.07.006
   Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175
   Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206
   Song HJ, 2009, KOREAN J CHEM ENG, V26, P141, DOI 10.1007/s11814-009-0022-0
   Soykeabkaew N, 2012, COMPOS SCI TECHNOL, V72, P845, DOI 10.1016/j.compscitech.2012.02.015
   SUGIYAMA J, 1985, PLANTA, V166, P161, DOI 10.1007/BF00397343
   Sun D, 2011, TRANS TECH PUBL, P322
   Sun DP, 2010, J ENERG MATER, V28, P85, DOI 10.1080/07370650903222551
   Sun DP, 2007, J WUHAN UNIV TECHNOL, V22, P677, DOI 10.1007/s11595-006-4677-7
   Sun DP, 2010, NANOSCALE, V2, P287, DOI 10.1039/b9nr00158a
   Sun DP, 2010, APPL SURF SCI, V256, P2241, DOI 10.1016/j.apsusc.2009.10.034
   Surma-Slusarska B, 2008, FIBRES TEXT EAST EUR, V16, P69
   Surma-Slusarska B, 2008, FIBRES TEXT EAST EUR, V16, P127
   Sutherland IW, 2001, INT DAIRY J, V11, P663, DOI 10.1016/S0958-6946(01)00112-1
   TASHIRO K, 1991, POLYMER, V32, P1516, DOI 10.1016/0032-3861(91)90435-L
   Timko M, 2004, CZECH J PHYS, V54, pD599, DOI 10.1007/s10582-004-0153-9
   Ul-Islam M, 2012, CARBOHYD POLYM, V88, P596, DOI 10.1016/j.carbpol.2012.01.006
   Vitta S, 2012, CURR SCI INDIA, V102, P1398
   Vitta S, 2010, J APPL PHYS, V108, DOI 10.1063/1.3476058
   Vyjayanthi JP, 2010, WATER ENVIRON RES, V82, P601, DOI 10.2175/106143009X12529484816114
   Wan YZ, 2011, POLYM ADVAN TECHNOL, V22, P2643, DOI 10.1002/pat.1692
   Wan YZ, 2011, SURF COAT TECH, V205, P2938, DOI 10.1016/j.surfcoat.2010.11.006
   Wang HH, 2012, J PHYS CHEM C, V116, P13013, DOI 10.1021/jp301099r
   Wang J, 2010, ACTA BIOMATER, V6, P3004, DOI 10.1016/j.actbio.2010.01.045
   Wang J, 2011, MICRO NANO LETT, V6, P133, DOI 10.1049/mnl.2010.0209
   Wang JP, 2011, J MECH MED BIOL, V11, P285, DOI 10.1142/S0219519411004058
   Wang JP, 2010, J BIOMED MATER RES A, V93A, P753, DOI 10.1002/jbm.a.32591
   Wang Y, 2008, CARBOHYD POLYM, V74, P875, DOI 10.1016/j.carbpol.2008.05.007
   Wanichapichart P, 2012, RADIAT PHYS CHEM, V81, P949, DOI 10.1016/j.radphyschem.2012.02.035
   Webster TJ, 2007, ADV BIOCHEM ENG BIOT, V103, P275, DOI 10.1007/10_021
   Wei B, 2011, CARBOHYD POLYM, V84, P533, DOI 10.1016/j.carbpol.2010.12.017
   White D, 1989, P 10 CELL C
   Williams D. F, 1987, DEF BIOM P CONS C EU, V4
   Wu QJ, 2007, BIOMACROMOLECULES, V8, P3687, DOI 10.1021/bm701061t
   Wu RQ, 2010, CELLULOSE, V17, P399, DOI 10.1007/s10570-009-9388-8
   Wu SQ, 2012, CARBOHYD POLYM, V88, P496, DOI 10.1016/j.carbpol.2011.12.033
   Yang JZ, 2011, J HAZARD MATER, V189, P377, DOI 10.1016/j.jhazmat.2011.02.048
   Yang JZ, 2011, ADV MATER RES-SWITZ, V152-153, P1771, DOI 10.4028/www.scientific.net/AMR.152-153.1771
   Yang JZ, 2009, ELECTROCHIM ACTA, V54, P6300, DOI 10.1016/j.electacta.2009.05.073
   Yang YK, 1998, J FERMENT BIOENG, V85, P312, DOI 10.1016/S0922-338X(97)85681-4
   Yin N, 2011, PROG NAT SCI-MATER, V21, P472, DOI 10.1016/S1002-0071(12)60085-9
   Yin XQ, 2011, POLYM BULL, V67, P401, DOI 10.1007/s00289-010-0388-5
   Yun YS, 2010, MOL CRYST LIQ CRYST, V519, P141, DOI 10.1080/15421401003609897
   ZAAR K, 1979, J CELL BIOL, V80, P773, DOI 10.1083/jcb.80.3.773
   Zhang W, 2011, CARBOHYD POLYM, V86, P1760, DOI 10.1016/j.carbpol.2011.07.015
   Zhang XJ, 2011, SYNTH REACT INORG M, V41, P1141, DOI 10.1080/15533174.2011.591359
   Zhang XJ, 2011, SYNTH REACT INORG M, V41, P997, DOI 10.1080/15533174.2011.591334
   Zhu HX, 2011, CARBOHYD POLYM, V86, P1558, DOI 10.1016/j.carbpol.2011.06.061
   Zimmermann KA, 2011, MAT SCI ENG C-MATER, V31, P43, DOI 10.1016/j.msec.2009.10.007
   Zimmermann T, 2004, ADV ENG MATER, V6, P754, DOI 10.1002/adem.200400097
   Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003
NR 197
TC 89
Z9 94
U1 9
U2 254
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
EI 1572-882X
J9 CELLULOSE
JI Cellulose
PD FEB
PY 2014
VL 21
IS 1
BP 1
EP 30
DI 10.1007/s10570-013-0088-z
PG 30
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA AA0SF
UT WOS:000330807000001
DA 2018-10-20
ER

PT J
AU Mahmoodian, H
   Moradi, O
   Shariatzadeh, B
AF Mahmoodian, Hossein
   Moradi, Omid
   Shariatzadeh, Behnam
TI Grafting chitosan and polyHEMA on carbon nanotubes surfaces: "Grafting
   to" and "Grafting from" methods
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Carbon nanotubes; PolyHEMA; Microwave
ID BIOMEDICAL APPLICATIONS; FUNCTIONALIZATION; POLYMERIZATION; POLYMERS;
   CHITIN; NANOCOMPOSITES; NANOMATERIALS; BIOMATERIAL; CHOLESTEROL;
   BIOSENSORS
AB We report a simple method for engineering chitosan (CS) functionalized multi-walled carbon nanotube (MWCNT) composites with a biomedically important polymer, poly-2-hydroxyethyl methacrylate (polyHEMA), by chemical grafting HEMA monomers via free radical polymerization. Functionalization of CS and polyHEMA occurred in three steps. First, using microwave irradiation, CS was grafted onto the surface and sidewall of the carbon nanotubes. Second, HEMA monomers were grafted onto the polymeric matrix surface. The final step involved free radical polymerization of HEMA monomers. Composite synthesis was confirmed by Fourier transform infrared (FTIR) spectroscopy. Moreover, the presence of polyHEMA on the surface of the CS functionalized carbon nanotubes was confirmed by field emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM) and thermo gravimetric analysis (TGA) analyses. Furthermore, in the aqueous phase, our novel composites exhibited higher dispersibility compared with pristine MWCNTs. Considering the biomedical importance of polyHEMA and CS polymers, we expect these materials to be useful in the pharmaceutical industry as novel biomaterial composites with potential applications in drug delivery. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Mahmoodian, Hossein; Moradi, Omid; Shariatzadeh, Behnam] Islamic Azad Univ, Dept Chem, Shahr e Qods Branch, Tehran, Iran.
RP Mahmoodian, H (reprint author), Islamic Azad Univ, Dept Chem, Shahr e Qods Branch, Tehran, Iran.
EM hossein.mahmoodian@gmail.com
CR Abraham S, 2005, BIOMATERIALS, V26, P4767, DOI 10.1016/j.biomaterials.2005.01.031
   AJAYAN PM, 1994, SCIENCE, V265, P1212, DOI 10.1126/science.265.5176.1212
   Bandaru PR, 2007, J NANOSCI NANOTECHNO, V7, P1239, DOI 10.1166/jnn.2007.307
   Baskaran D, 2005, MACROMOL RAPID COMM, V26, P481, DOI 10.1002/marc.200400564
   Cadotte J., 2005, J NEURAL ENG, V2, P114
   CARBONETTO ST, 1982, SCIENCE, V216, P897, DOI 10.1126/science.7079743
   CARENZA M, 1992, RADIAT PHYS CHEM, V39, P485
   Cho JW, 2005, MACROMOL RAPID COMM, V26, P412, DOI 10.1002/marc.200400492
   De Smedt SC, 2000, PHARMACEUT RES, V17, P113, DOI 10.1023/A:1007548826495
   Demirelli K, 1999, POLYM INT, V48, P1244
   Dhand C, 2008, ANAL BIOCHEM, V383, P194, DOI 10.1016/j.ab.2008.08.039
   Ferreira LM, 1998, RADIAT PHYS CHEM, V52, P207, DOI 10.1016/S0969-806X(98)00141-8
   Guldi DM, 2005, ACCOUNTS CHEM RES, V38, P38, DOI 10.1021/ar040222s
   Homenick CM, 2007, POLYM REV, V47, P265, DOI 10.1080/15583720701271237
   Huang WJ, 2002, NANO LETT, V2, P231, DOI [10.1021/nl010083x, 10.1021/n1010083x]
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5
   Kumar NA, 2008, EUR POLYM J, V44, P579, DOI 10.1016/j.eurpolymj.2007.12.009
   Kumar R., 2004, CHEM REV, V104, P6017
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Li JX, 2006, CHEM-EUR J, V12, P3869, DOI 10.1002/chem.200501314
   Lin Y, 2002, J PHYS CHEM B, V106, P1294, DOI 10.1021/jp013501v
   Liu P, 2005, EUR POLYM J, V41, P2693, DOI 10.1016/j.eurpolymj.2005.05.017
   Mahmoodian H., 2013, POLYM COMPOSITES
   Merkoci A, 2005, TRAC-TREND ANAL CHEM, V24, P826, DOI 10.1016/j.trac.2005.03.019
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   Mourya V.K., 2010, ADV MAT LETT, V1, P11, DOI DOI 10.5185/AMLETT.2010.3108
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Pei XW, 2007, J PHYS CHEM C, V111, P2947, DOI 10.1021/jp0673213
   Punyani S, 2007, J APPL POLYM SCI, V103, P3334, DOI 10.1002/app.25496
   Ramanathan T, 2005, CHEM MATER, V17, P1290, DOI 10.1021/cm048357f
   Riggs JE, 2000, J AM CHEM SOC, V122, P5879, DOI 10.1021/ja9942282
   Riggs JE, 2000, J PHYS CHEM B, V104, P7071, DOI 10.1021/jp0011591
   Roy S, 2006, NANOTECHNOLOGY, V17, pS14, DOI 10.1088/0957-4484/17/4/003
   Sgobba V., 2006, NANOTECHNOLOGY, P329
   Shukla SK, 2013, INT J BIOL MACROMOL, V59, P46, DOI 10.1016/j.ijbiomac.2013.04.043
   Spitalsky Z, 2010, PROG POLYM SCI, V35, P357, DOI 10.1016/j.progpolymsci.2009.09.003
   Srinivasan J, 1999, THEOR CHEM ACC, V101, P426, DOI 10.1007/s002140050460
   Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o
   Trojanowicz M, 2006, TRAC-TREND ANAL CHEM, V25, P480, DOI 10.1016/j.trac.2005.11.008
   Wang CC, 2004, PROG POLYM SCI, V29, P1079, DOI 10.1016/j.progpolymsci.2004.08.001
   Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113
   Wang YB, 2005, CARBON, V43, P1015, DOI 10.1016/j.carbon.2004.11.036
   Yao YL, 2007, ANAL BIOANAL CHEM, V387, P303, DOI 10.1007/s00216-006-0924-1
NR 44
TC 9
Z9 10
U1 3
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD FEB
PY 2014
VL 63
BP 92
EP 97
DI 10.1016/j.ijbiomac.2013.10.030
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 302KQ
UT WOS:000330603800013
PM 24183808
DA 2018-10-20
ER

PT J
AU Yuan, T
   Zhang, L
   Li, KF
   Fan, HS
   Fan, YJ
   Liang, J
   Zhang, XD
AF Yuan, Tun
   Zhang, Li
   Li, Kuifeng
   Fan, Hongsong
   Fan, Yujiang
   Liang, Jie
   Zhang, Xingdong
TI Collagen hydrogel as an immunomodulatory scaffold in cartilage tissue
   engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cartilage tissue engineering; collagen hydrogel; chondrocyte; MHC;
   lymphocytes reaction
ID MESENCHYMAL STEM-CELLS; IMMUNOLOGICAL-PROPERTIES; IN-VIVO; CHONDROGENIC
   DIFFERENTIATION; ALLOGENEIC CHONDROCYTES; TRANSPLANTATION; DEFECTS;
   REPAIR; HOST; ALLOTRANSPLANTATION
AB A collagen type I hydrogel was constructed and used as the scaffold for cartilage tissue engineering. Neonatal rabbit chondrocytes were seeded into the hydrogel, and the constructs were cultured in vitro for 7, 14, and 28 days. The immunomodulatory effect of the hydrogel on seeded chondrocytes was carefully investigated. The expressions of major histocompatibility complex classes I and II of seeded chondrocytes increased with the time, which indicated that the immunogenicity also increased with the time. Meanwhile, the properly designed collagen type I hydrogel could prompt the chondrogenesis of engineered cartilage. The extracellular matrix (ECM) synthesis ability of seeded chondrocytes and the accumulated ECM in the constructs continuously increased with the culture time. Both the isolation and protection, which come from formed ECM and hydrogel scaffold, can effectively control the adverse immunogenicity of seeded chondrocytes and even help to lessen the immunogenicity of the whole engineered cartilage. As the result, the levels of mixed lymphocyte chondrocyte reactions of seed cells and the constructs decreased gradually. The stimulation on allogeneic lymphocytes of the whole constructs was obviously lower than that of the retrieved cells from the constructs. Therefore, properly designed collagen type I hydrogel can give certain immunogenicity-reducing effects on engineered cartilage based on chondrocytes, and it may be a potential immunomodulatory biomaterial in tissue engineering. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 337-344, 2014.
C1 [Yuan, Tun; Zhang, Li; Li, Kuifeng; Fan, Hongsong; Fan, Yujiang; Liang, Jie; Zhang, Xingdong] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Liang, J (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, 29 Wangjiang Rd, Chengdu 610064, Peoples R China.
EM Jie_l88@126.com
FU National Natural Science Foundation of China [31100692]; National
   Science & Technology Pillar Program [2012BAI22B01]; National Project 973
   of China [2011CB606201]
FX Contract grant sponsor: National Natural Science Foundation of China;
   contract grant number: 31100692; Contract grant sponsor: National
   Science & Technology Pillar Program; contract grant number:
   2012BAI22B01; Contract grant sponsor: National Project 973 of China;
   contract grant number: 2011CB606201
CR Appleton CTG, 2007, ARTHRITIS RHEUM, V56, P1854, DOI 10.1002/art.22711
   Blakolmer K, 2000, TRANSPLANTATION, V69, P2330, DOI 10.1097/00007890-200006150-00019
   BOLANO L, 1991, ORTHOPEDICS, V14, P987
   Burrage PS, 2006, FRONT BIOSCI, V11, P529, DOI 10.2741/1817
   Chiang HS, 2009, J FORMOS MED ASSOC, V108, P87, DOI 10.1016/S0929-6646(09)60039-5
   Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Franz S, BIOMATERIALS, V32, P6692
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Jackson D W, 1999, Clin Orthop Relat Res, pS31, DOI 10.1097/00003086-199910001-00005
   Jamali AA, 2005, CLIN ORTHOP RELAT R, P176, DOI 10.1097/01.blo.0000165854.15579.85
   Kim BS, 2004, BIOTECHNOL LETT, V26, P709, DOI 10.1023/B:BILE.0000024093.94151.d8
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Liu H, 2006, J IMMUNOL, V176, P2864, DOI 10.4049/jimmunol.176.5.2864
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Masuoka K, 2005, J BIOMED MATER RES B, V75B, P177, DOI 10.1002/jbm.b.30284
   Mohty M, 2008, CYTOKINE GROWTH F R, V19, P53, DOI 10.1016/j.cytogfr.2007.10.010
   Moskalewski S, 2002, MICROSC RES TECHNIQ, V58, P3, DOI 10.1002/jemt.10110
   Moskalewski S, 2005, ARCH IMMUNOL THER EX, V53, P159
   NIEBAUER GW, 1988, AM J VET RES, V49, P1223
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Revell CM, 2009, TISSUE ENG PART B-RE, V15, P1, DOI 10.1089/ten.teb.2008.0189
   Schulze-Tanzil G, 2009, ANN ANAT, V191, P325, DOI 10.1016/j.aanat.2009.05.003
   Sundelacruz S, 2009, SEMIN CELL DEV BIOL, V20, P646, DOI 10.1016/j.semcdb.2009.03.017
   Swearingen B, 2008, TRANSPLANTATION, V86, P627, DOI 10.1097/TP.0b013e318184ca6a
   Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9
   Watschinger B, 1999, NEPHROL DIAL TRANSPL, V14, P8, DOI 10.1093/ndt/14.1.8
   Whitaker IS, 2008, J PLAST RECONSTR AES, V61, P481, DOI 10.1016/j.bjps.2007.11.019
   Yuan T, 2011, J BIOMED MATER RES A, V98A, P332, DOI 10.1002/jbm.a.33121
   Yuan T, 2011, BIOMATERIALS, V32, P6017, DOI 10.1016/j.biomaterials.2011.04.041
   Yuan T, 2010, BIOTECHNOL PROGR, V26, P1749, DOI 10.1002/btpr.484
   Zheng L, 2010, J BIOMED MATER RES A, V93A, P783, DOI 10.1002/jbm.a.32588
   Zheng L, 2009, TISSUE ENG PT A, V15, P2145, DOI 10.1089/ten.tea.2008.0268
NR 35
TC 40
Z9 43
U1 11
U2 64
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2014
VL 102
IS 2
BP 337
EP 344
DI 10.1002/jbm.b.33011
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 302XW
UT WOS:000330639400016
PM 24000202
DA 2018-10-20
ER

PT J
AU Zhu, L
   Qin, JM
   Yin, XQ
   Ji, L
   Lin, Q
   Qin, ZY
AF Zhu, Li
   Qin, Jinmin
   Yin, Xueqiong
   Ji, Li
   Lin, Qiang
   Qin, Ziyu
TI Direct sulfation of bacterial cellulose with a ClSO3H/DMF complex and
   structure characterization of the sulfates
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE bacterial cellulose; sulfation; ClSO3H; DMF complex
ID IONIC LIQUIDS; ANTICOAGULATION ACTIVITY; MEDICAL APPLICATIONS; MICROBIAL
   CELLULOSE; POLYSACCHARIDES; POLYMERIZATION; DERIVATIZATION; CHLORIDE
AB Bacterial cellulose (BC) is a form of cellulose synthesized by microorganisms, which has unique structure properties and differs from plant cellulose. Up to now, chemical modification of BC has not been studied widely. This paper aims to prepare sodium bacterial cellulose sulfate (SBS) in N,N-dimethylformamide (DMF) with a ClSO3H/DMF complex as the sulfating agent. SBSs with diverse degree of sulfation (DS, 0.04-0.86) were synthesized. The system could change from heterogeneous to homogeneous during the sulfation. Regarding to the DS, the optimal ClSO3H amount and reaction time were 6 mol/mol anhydroglucose unit and 4 h, respectively. DS increased a little when increasing the temperature, while the yield decreased significantly. SBSs with DS>0.24 were soluble in deionized water. Carbon nuclear magnetic resonance spectroscopy revealed that the sulfation prefers to take place in the order of C-6>C-2>C-3. The X-ray diffraction profiles indicated that the crystalline structure of BC was destroyed during sulfation. BC has better reactivity than microcrystalline cellulose in both sulfation and depolymerization processes. SBS is a potential biomaterial. However, BC depolymerized obviously in present sulfation, which forbids application of SBS in material. Moisture of the reaction mixture should be removed as completely as possible to guarantee efficient sulfation and decrease depolymerization. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Zhu, Li; Qin, Jinmin; Yin, Xueqiong; Ji, Li; Qin, Ziyu] Hainan Univ, Hainan Prov Fine Chem Engn Res Ctr, Haikou 570228, Hainan, Peoples R China.
   [Lin, Qiang] Hainan Normal Univ, Minist Educ, Key Lab Trop Med Plant Chem, Haikou 571158, Hainan Province, Peoples R China.
RP Yin, XQ (reprint author), Hainan Univ, Sch Mat & Chem Engn, Haikou 570228, Hainan, Peoples R China.
EM yxq88@hotmail.com
FU National Science Foundation of China [21264007]; Special Project of
   Hainan Social Development [2012SF019]
FX The authors acknowledge the National Science Foundation of China
   (Project No. 21264007), and the Special Project of Hainan Social
   Development (2012SF019) for the financial support.
CR Baumann H, 2000, MACROMOL CHEM PHYSIC, V201, P1950, DOI 10.1002/1521-3935(20001001)201:15<1950::AID-MACP1950>3.0.CO;2-3
   Cai Z, 2010, CELLULOSE, V17, P83, DOI 10.1007/s10570-009-9362-5
   Chen P, 2010, MACROMOL RES, V18, P309, DOI 10.1007/s13233-010-0404-5
   Cheng KC, 2009, CELLULOSE, V16, P1033, DOI 10.1007/s10570-009-9346-5
   Ciechanska D, 2004, FIBRES TEXT EAST EUR, V12, P69
   Czaja W, 2004, CELLULOSE, V11, P403, DOI 10.1023/B:CELL.0000046412.11983.61
   Gericke M, 2012, MOLECULES, V17, P7458, DOI 10.3390/molecules17067458
   Gericke M, 2009, MACROMOL BIOSCI, V9, P343, DOI 10.1002/mabi.200800329
   GEYER U, 1994, INT J BIOL MACROMOL, V16, P343, DOI 10.1016/0141-8130(94)90067-1
   Groth T, 2001, BIOMATERIALS, V22, P2719, DOI 10.1016/S0142-9612(01)00013-8
   Heinze T, 2003, CELLULOSE, V10, P283, DOI 10.1023/A:1025117327970
   Heinze T., 2006, ESTERIFICATION POLYS
   Heinze T, 2010, POLYM SCI TECHNOL SE, P213
   Hoenich N, 2006, BIORESOURCES, V1, P270
   Ifuku S, 2007, BIOMACROMOLECULES, V8, P1973, DOI 10.1021/bm070113b
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Kim HS, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/01/015029
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D., 1998, COMPREHENSIVE CELLUL, VI
   Liebert T., 2010, CELLULOSE SOLVENTS A, V1033, P3, DOI DOI 10.1021/BK-2010-1033
   MCCORMICK CL, 1985, MACROMOLECULES, V18, P2394, DOI 10.1021/ma00154a010
   Oshima T, 2008, REACT FUNCT POLYM, V68, P376, DOI 10.1016/j.reactfunctpolym.2007.07.046
   Philipp B, 1983, CELL CHEM TECHNOL, V17, P443
   Qin Z., CARBOHYDR P IN PRESS, DOI [10.1016/j.carbpol.2013.09.068, DOI 10.1016/J.CARBP0L.2013.09.068]
   Retegi A, 2010, CELLULOSE, V17, P661, DOI 10.1007/s10570-009-9389-7
   Richter R., 2003, CELLULOSE, V10, P133
   Roy D, 2009, CHEM SOC REV, V38, P2046, DOI 10.1039/b808639g
   Saake B, 2002, CARBOHYD POLYM, V48, P7, DOI 10.1016/S0144-8617(01)00191-6
   Schlufter K, 2006, MACROMOL RAPID COMM, V27, P1670, DOI 10.1002/marc.200600463
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tabuchi M, 1998, BIOSCI BIOTECH BIOCH, V62, P1451, DOI 10.1271/bbb.62.1451
   Tokoh C, 1998, CELLULOSE, V5, P249, DOI 10.1023/A:1009211927183
   Wang Y, 2008, CARBOHYD POLYM, V74, P875, DOI 10.1016/j.carbpol.2008.05.007
   Wang ZM, 2007, INT J BIOL MACROMOL, V41, P376, DOI 10.1016/j.ijbiomac.2007.05.007
   Wang ZM, 2009, BIORESOURCE TECHNOL, V100, P1687, DOI 10.1016/j.biortech.2008.09.002
   Yao SJ, 2000, CHEM ENG J, V78, P199, DOI 10.1016/S1385-8947(00)00131-5
   Yin XQ, 2011, POLYM BULL, V67, P401, DOI 10.1007/s00289-010-0388-5
   Yu C., 2010, P 7 NAT C CHIN FUNCT, V1-3, P1339
   Zhang K, 2011, CARBOHYD POLYM, V83, P1659, DOI 10.1016/j.carbpol.2010.10.029
   Zhang K, 2011, POLYMER, V52, P26, DOI 10.1016/j.polymer.2010.11.017
   Zhang K, 2010, CELLULOSE, V17, P427, DOI 10.1007/s10570-009-9375-0
   Zhu SD, 2006, GREEN CHEM, V8, P325, DOI 10.1039/b601395c
NR 42
TC 5
Z9 5
U1 0
U2 45
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-7147
EI 1099-1581
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD FEB
PY 2014
VL 25
IS 2
BP 168
EP 172
DI 10.1002/pat.3218
PG 5
WC Polymer Science
SC Polymer Science
GA AA0PW
UT WOS:000330799100004
DA 2018-10-20
ER

PT J
AU Plotkin, M
   Vaibavi, SR
   Rufaihah, AJ
   Nithya, V
   Wang, J
   Shachaf, Y
   Kofidis, T
   Seliktar, D
AF Plotkin, Marian
   Vaibavi, Srirangam Ramanujam
   Rufaihah, Abdul Jalil
   Nithya, Venkateswaran
   Wang, Jing
   Shachaf, Yonatan
   Kofidis, Theo
   Seliktar, Dror
TI The effect of matrix stiffness of injectable hydrogels on the
   preservation of cardiac function after a heart attack
SO BIOMATERIALS
LA English
DT Article
DE Injectable hydrogel; Myocardial infarction; Minimally invasive;
   Mechanical properties; Matrix modulus
ID STEM-CELL TRANSPLANTATION; MYOCARDIAL-INFARCTION; TISSUE; FIBRIN;
   SCAFFOLDS; REPAIR; STABILIZATION; REGENERATION; PROTEOLYSIS; INJECTION
AB This study compares the effect of four injectable hydrogels with different mechanical properties on the post-myocardial infarction left ventricle (LV) remodeling process. The bioactive hydrogels were synthesized from Tetronic-fibrinogen (TF) and PEG fibrinogen (PF) conjugates; each hydrogel was supplemented with two levels of additional cross-linker to increase the matrix stiffness as measured by the shear storage modulus (G'). Infarcts created by ligating the left anterior descending coronary artery in a rodent model were treated with the hydrogels, and all four treatment groups showed an increase in wall thickness, arterial density, and viable cardiac tissue in the pen-infarct areas of the LV. Echocardiography and hemodynamics data of the PF/TF treated groups showed significant improvement of heart function associated with the attenuated effects of the remodeling process. Multi-factorial regression analysis indicated that the group with the highest modulus exhibited the best rescue of heart function and highest neovascularization. The results of this study demonstrate that multiple properties of an injectable bioactive biomaterial, and notably the matrix stiffness, provide the multifaceted stimulation necessary to preserve cardiac function and prevent adverse remodeling following a heart attack. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Plotkin, Marian; Vaibavi, Srirangam Ramanujam; Seliktar, Dror] Natl Univ Singapore, Nanosci & Nanotechnol Initiat, Singapore 117548, Singapore.
   [Rufaihah, Abdul Jalil; Nithya, Venkateswaran; Wang, Jing; Kofidis, Theo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore.
   [Shachaf, Yonatan; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
   [Kofidis, Theo] Natl Univ Heart Ctr Singapore, Dept Cardiac Thorac &Vasc Surg, Natl Univ Hlth Syst, Singapore 117548, Singapore.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM surtk@nus.edu.sg; dror@bm.technion.ac.il
RI Kofidis, Theodoros/B-9283-2011; Abdul Jalil, Rufaihah/A-4572-2012
OI Kofidis, Theodoros/0000-0002-9623-6450; Abdul Jalil,
   Rufaihah/0000-0002-9764-8668; Seliktar, Dror/0000-0001-6964-8567
FU National Research Foundation (NRF)-Technion-NUS Grant for Regenerative
   Medicine Initiative in Cardiac Restoration Therapy
FX The authors would like to acknowledge funding support from National
   Research Foundation (NRF)-Technion-NUS Grant for Regenerative Medicine
   Initiative in Cardiac Restoration Therapy.
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Barsotti MC, 2011, BIOTECHNOL APPL BIOC, V58, P301, DOI 10.1002/bab.49
   Bastings MMC, 2014, ADV HEALTHC MATER, V3, P70, DOI 10.1002/adhm.201300076
   Burdick JA, 2013, SCI TRANSL MED, V5
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, TISSUE ENG, V10, P403
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Di Napoli P, 2003, AM HEART J, V146, P1105, DOI 10.1016/S0002-8703(03)00445-9
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Grover GN, 2013, ADV MATER, V25, P2937, DOI 10.1002/adma.201205234
   Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049
   Herrick S, 1999, INT J BIOCHEM CELL B, V31, P741, DOI 10.1016/S1357-2725(99)00032-1
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Kofidis T., 2006, ALTERNATIVE CARDIAC
   Koudstaal S, 2013, STEM CELL TRANSL MED, V2, P434, DOI 10.5966/sctm.2013-0001
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lin Y.D., 2012, SCI TRANSL MED, V4
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Nakamuta JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006005
   Pashuck ET, 2012, SCI TRANS MED, V4, p160sr4
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wang HB, 2010, J CELL MOL MED, V14, P1044, DOI 10.1111/j.1582-4934.2010.01046.x
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8
   Weytjens C, 2006, EUR J ECHOCARDIOGR, V7, P411, DOI 10.1016/j.euje.2006.03.009
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Ye ZY, 2011, ADV DRUG DELIVER REV, V63, P688, DOI 10.1016/j.addr.2011.02.007
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang XL, 2010, EXP BIOL MED, V235, P1505, DOI 10.1258/ebm.2010.010175
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
NR 44
TC 32
Z9 34
U1 1
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 5
BP 1429
EP 1438
DI 10.1016/j.biomaterials.2013.10.058
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 295ZY
UT WOS:000330156100009
PM 24268664
DA 2018-10-20
ER

PT J
AU Fan, MR
   Gong, M
   Da, LC
   Bai, L
   Li, XQ
   Chen, KF
   Li-Ling, J
   Yang, ZM
   Xie, HQ
AF Fan, Mei-Rong
   Gong, Mei
   Da, Lin-Cui
   Bai, Lin
   Li, Xiu-Qun
   Chen, Ke-Fei
   Li-Ling, Jesse
   Yang, Zhi-Ming
   Xie, Hui-Qi
TI Tissue engineered esophagus scaffold constructed with porcine small
   intestinal submucosa and synthetic polymers
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE esophagus; tissue engineering; small intestinal mucosa; SIS; PHBHHx;
   PLGA
ID MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; EPITHELIAL-CELLS; CANINE
   MODEL; STEM-CELLS; IN-VIVO; REPAIR; REPLACEMENT;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE); GRAFTS
AB Acellular porcine small intestinal submucosa (SIS) has been successfully used for reconstructing esophagus with half circumferential defects. However, repairing full circumferential esophageal defects with SIS has been restricted due to the latter's poor mechanical properties. In the present study, synthetic polyesters biomaterial poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) and poly(lactide-co-glycolide) (PLGA) have been used to improve the mechanical properties of SIS. Feasibility of SIS/PHBHHx-PLGA composite material scaffold for esophageal tissue engineering has been assessed through a series of testing. The appropriate mixing ratio of PHBHHx and PLGA polymers has been determined as 5: 5 by mechanical testing and in vitro degradation experiment. The morphology of constructed membranous and tubular scaffolds was also characterized. As confirmed by enzyme-linked immunosorbent assay, the contents of VEGF and TGF-beta have respectively reached 657 +/- 18 ng mL(-1) and 130 +/- 4 pg mL(-1) within the SIS/PHBHHx-PLGA specimens. Biocompatibility of the SIS/PHBHHx-PLGA specimens with rat bone marrow mesenchymal stem cells (MSCs) was also evaluated by scanning electron microscopy and a live-dead cell viability assay. Actin filaments of MSCs on the composite materials were labeled. Biological safety of the extract from SIS/PHBHHx-PLGA specimens, measured as hemolysis rate, was all lower than 5%. Compared with SIS and SIS/PHBHHx-PLGA specimens, inflammatory reaction provoked by the PHBHHx-PLGA specimens in rats was however more severe. Our results have suggested that SIS/PHBHHx-PLGA composite material can offer a new approach for esophageal tissue engineering.
C1 [Fan, Mei-Rong; Yang, Zhi-Ming; Xie, Hui-Qi] Sichuan Univ, State Key Lab Biotherapy, Lab Stem Cell & Tissue Engn, Chengdu 610064, Peoples R China.
   [Gong, Mei; Da, Lin-Cui; Bai, Lin; Li, Xiu-Qun; Chen, Ke-Fei; Xie, Hui-Qi] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu 610064, Peoples R China.
   [Li-Ling, Jesse] Sichuan Univ, State Key Lab Biotherapy, Inst Dis Genom & Bioinformat, Chengdu 610064, Peoples R China.
   [Li-Ling, Jesse] Northeastern Univ, Sino Dutch Biomed & Informat Engn Sch, Shenyang, Peoples R China.
RP Xie, HQ (reprint author), Sichuan Univ, State Key Lab Biotherapy, Lab Stem Cell & Tissue Engn, Chengdu 610064, Peoples R China.
EM xiehuiqi@scu.edu.cn
FU National Natural Science Foundation of China [31271058, 81100327];
   National High Technology Research and Development Program of China
   [2012AA020503]
FX This work was jointly supported by the National Natural Science
   Foundation of China (31271058, 81100327) and the National High
   Technology Research and Development Program of China (2012AA020503).
CR Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Beckstead BL, 2005, BIOMATERIALS, V26, P6217, DOI 10.1016/j.biomaterials.2005.04.010
   Bhrany AD, 2006, TISSUE ENG, V12, P319, DOI 10.1089/ten.2006.12.319
   BOSTMAN OM, 1991, J BONE JOINT SURG AM, V73A, P148
   Campodonico F, 2004, EUR UROL, V46, P531, DOI 10.1016/j.eururo.2004.04.019
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Cheng ML, 2011, POLYMER, V52, P1391, DOI 10.1016/j.polymer.2011.01.039
   D'Journo XB, 2008, DIS ESOPHAGUS, V21, P377, DOI 10.1111/j.1442-2050.2008.00849.x
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Doede T, 2009, ARTIF ORGANS, V33, P328, DOI 10.1111/j.1525-1594.2009.00727.x
   Doki Y, 2008, DIS ESOPHAGUS, V21, P132, DOI 10.1111/j.1442-2050.2007.00738.x
   Ferahkose Z, 2008, DIS ESOPHAGUS, V21, P340, DOI 10.1111/j.1442-2050.2007.00781.x
   Fiala R, 2007, EUR UROL, V51, P1702, DOI 10.1016/j.eururo.2007.01.099
   Gallo A, 2006, WORLD J GASTROENTERO, V12, P3237, DOI 10.3748/wjg.v12.i20.3237
   Gaujoux S, 2010, SURGERY, V148, P39, DOI 10.1016/j.surg.2009.12.002
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   ISO, 2002, 109934 ISO
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Kim MS, 2005, INT J BIOL MACROMOL, V36, P54, DOI 10.1016/j/ijbiomac.2005.03.013
   Li XT, 2008, J BIOMED MATER RES A, V87A, P832, DOI 10.1002/jbm.a.31890
   Lopes MF, 2006, J INVEST SURG, V19, P105, DOI 10.1080/08941930600569621
   Luo JC, 2011, BIOMATERIALS, V32, P706, DOI 10.1016/j.biomaterials.2010.09.017
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   Miki H, 1999, ASAIO J, V45, P502, DOI 10.1097/00002480-199909000-00025
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Nakase Y, 2008, J THORAC CARDIOV SUR, V136, P850, DOI 10.1016/j.jtcvs.2008.05.027
   Prokop A, 2008, J PHARM SCI-US, V97, P3518, DOI 10.1002/jps.21270
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Saxena AK, 2010, EUR SURG, V42, P309, DOI 10.1007/s10353-010-0579-1
   Saxena AK, 2009, J PEDIATR SURG, V44, P896, DOI 10.1016/j.jpedsurg.2009.01.019
   Shangguan YY, 2006, BIOMATERIALS, V27, P2349, DOI 10.1016/j.biomaterials.2005.11.024
   Tan B, 2013, J SURG RES, V182, P40, DOI 10.1016/j.jss.2012.07.054
   Tan JY, 2012, BIOTECHNOL BIOENG, V109, P1, DOI 10.1002/bit.23323
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wei RQ, 2009, EXP BIOL MED, V234, P453, DOI 10.3181/0901-RM-5
   Ye C, 2009, BIOMATERIALS, V30, P4401, DOI 10.1016/j.biomaterials.2009.05.001
   Yu BY, 2008, DESALINATION, V234, P204, DOI 10.1016/j.desal.2007.09.087
   Yu XJ, 2012, J MATER SCI-MATER M, V23, P581, DOI 10.1007/s10856-011-4475-4
   Zani A, 2009, SEMIN PEDIATR SURG, V18, P57, DOI 10.1053/j.sempedsurg.2008.10.011
   Zhang F, 2003, PLAST RECONSTR SURG, V112, P565, DOI 10.1097/01.PRS.0000070966.74429.03
   Zhu Y B, 2012, J TISSUE SCI ENG, V3, P2
NR 43
TC 12
Z9 14
U1 4
U2 31
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2014
VL 9
IS 1
AR 015012
DI 10.1088/1748-6041/9/1/015012
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 296OU
UT WOS:000330195300015
PM 24457267
DA 2018-10-20
ER

PT J
AU Kumar, VA
   Martinez, AW
   Caves, JM
   Naik, N
   Haller, CA
   Chaikof, EL
AF Kumar, Vivek A.
   Martinez, Adam W.
   Caves, Jeffrey M.
   Naik, Nisarga
   Haller, Carolyn A.
   Chaikof, Elliot L.
TI Microablation of collagen-based substrates for soft tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE tissue engineering; excimer laser; mesenchymal stem cells; collagen;
   elastin
ID EXCIMER-LASER ABLATION; PROTEIN POLYMER; MECHANICAL-PROPERTIES; VASCULAR
   GRAFTS; SYNTHETIC COLLAGEN; SCAFFOLDS; FIBER; COMPOSITES; NANOFIBERS;
   RESPONSES
AB Noting the abundance and importance of collagen as a biomaterial, we have developed a facile method for the production of a dense fibrillar extracellular matrix mimicking collagen-elastin hybrids with tunable mechanical properties. Through the use of excimer-laser technology, we have optimized conditions for the ablation of collagen lamellae without denaturation of protein, maintenance of fibrillar ultrastructure and preservation of native D-periodicity. Strengths of collagen-elastin hybrids ranged from 0.6 to 13 MPa, elongation at break from 9 to 70% and stiffness from 2.9 to 94 MPa, allowing for the design of a wide variety of tissue specific scaffolds. Further, large (centimeter scale) lamellae can be fabricated and embedded with recombinant elastin to generate collagen-elastin hybrids. Exposed collagen in hybrids act as cell adhesive sites for rat mesenchymal stem cells that conform to ablate waveforms. The ability to modulate these features allows for the generation of a class of biopolymers that can architecturally and physiologically replicate native tissue.
C1 [Kumar, Vivek A.; Caves, Jeffrey M.; Naik, Nisarga; Haller, Carolyn A.; Chaikof, Elliot L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.
   [Kumar, Vivek A.; Caves, Jeffrey M.; Naik, Nisarga; Haller, Carolyn A.; Chaikof, Elliot L.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02215 USA.
   [Kumar, Vivek A.; Martinez, Adam W.; Chaikof, Elliot L.] Emory Univ, Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
RP Kumar, VA (reprint author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.
EM echaikof@bidmc.harvard.edu
OI Kumar, Vivek/0000-0001-7536-9281
FU National Institute of Health [R01HL083867, R01HL60464, R01HL71336]
FX This work was supported by grants from the National Institute of Health:
   R01HL083867, R01HL60464, and R01HL71336. Electron microscopy was
   performed at the Center for Nanoscale Systems at Harvard University, and
   the Wyss Institute of Biologically Inspired Design. The authors have no
   conflicts of interest to disclose.
CR Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Caves JM, 2011, BIOMATERIALS, V32, P5371, DOI 10.1016/j.biomaterials.2011.04.009
   Caves JM, 2010, BIOMATERIALS, V31, P7175, DOI 10.1016/j.biomaterials.2010.05.014
   Caves JM, 2010, ADV MATER, V22, P2041, DOI 10.1002/adma.200903612
   Caves JM, 2010, J BIOMED MATER RES B, V93B, P24, DOI 10.1002/jbm.b.31555
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chollet C, 2010, COLLOID SURFACE B, V75, P107, DOI 10.1016/j.colsurfb.2009.08.024
   Dahlin RL, 2011, TISSUE ENG PART B-RE, V17, P349, DOI [10.1089/ten.teb.2011.0238, 10.1089/ten.TEB.2011.0238]
   Elbischger PJ, 2005, ST HEAL T, V113, P97
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   GLOSSOP ND, 1995, CLIN ORTHOP RELAT R, P72
   Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Krueger RR, 2010, J REFRACT SURG, V26, P749, DOI 10.3928/1081597X-20100921-01
   Kumar VA, 2013, BIOMATER SCI-UK, V1, P1193, DOI [10.1039/c3bm60129c, 10.1039/C3BM60129C]
   Kumar VA, 2013, ACTA BIOMATER, V9, P8067, DOI 10.1016/j.actbio.2013.05.024
   Kurane A, 2007, BIOMATERIALS, V28, P2830, DOI 10.1016/j.biomaterials.2007.02.031
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lapolla W, 2011, J AM ACAD DERMATOL, V64, P936, DOI 10.1016/j.jaad.2009.12.054
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LITVACK F, 1988, AM J CARDIOL, V61, pG81, DOI 10.1016/S0002-9149(88)80038-9
   Matsuda T, 1994, ASAIO J, V40, pM594, DOI 10.1097/00002480-199407000-00068
   Nakayama Y, 1994, ASAIO J, V40, pM590, DOI 10.1097/00002480-199407000-00067
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   PULIAFITO CA, 1985, OPHTHALMOLOGY, V92, P741
   Ravi S, 2013, J BIOMED MATER RES A, V101, P1915, DOI 10.1002/jbm.a.34484
   Ravi S, 2012, BIOMATERIALS, V33, P2431, DOI 10.1016/j.biomaterials.2011.11.055
   Ravi S, 2012, ACTA BIOMATER, V8, P627, DOI 10.1016/j.actbio.2011.10.027
   Sallach RE, 2010, BIOMATERIALS, V31, P779, DOI 10.1016/j.biomaterials.2009.09.082
   Sallach RE, 2009, J BIOMAT SCI-POLYM E, V20, P1629, DOI 10.1163/156856208X386228
   SILVER FH, 1980, J BIOL CHEM, V255, P9427
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Tandon N, 2010, LAB CHIP, V10, P692, DOI 10.1039/b917743d
   Tang H, 2009, ANN BIOMED ENG, V37, P1117, DOI 10.1007/s10439-009-9679-0
   Vacanti JP, 1999, LANCET S1, V354, pSI32
   WANG MC, 1994, BIOMATERIALS, V15, P507
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   Wu XY, 2008, BIOMACROMOLECULES, V9, P1787, DOI 10.1021/bm800012x
   Wu XY, 2005, BIOMACROMOLECULES, V6, P3037, DOI 10.1021/bm0503468
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L
   Zhang YZ, 2007, INT J NANOMED, V2, P623
   Zorlutuna P, 2009, BIOMACROMOLECULES, V10, P814, DOI 10.1021/bm801307y
NR 43
TC 3
Z9 3
U1 0
U2 31
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2014
VL 9
IS 1
AR 011002
DI 10.1088/1748-6041/9/1/011002
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 296OU
UT WOS:000330195300003
PM 24457193
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Vanhercke, T
   El Tahchy, A
   Liu, Q
   Zhou, XR
   Shrestha, P
   Divi, UK
   Ral, JP
   Mansour, MP
   Nichols, PD
   James, CN
   Horn, PJ
   Chapman, KD
   Beaudoin, F
   Ruiz-Lopez, N
   Larkin, PJ
   de Feyter, RC
   Singh, SP
   Petrie, JR
AF Vanhercke, Thomas
   El Tahchy, Anna
   Liu, Qing
   Zhou, Xue-Rong
   Shrestha, Pushkar
   Divi, Uday K.
   Ral, Jean-Philippe
   Mansour, Maged P.
   Nichols, Peter D.
   James, Christopher N.
   Horn, Patrick J.
   Chapman, Kent D.
   Beaudoin, Frederic
   Ruiz-Lopez, Noemi
   Larkin, Philip J.
   de Feyter, Robert C.
   Singh, Surinder P.
   Petrie, James R.
TI Metabolic engineering of biomass for high energy density: oilseed-like
   triacylglycerol yields from plant leaves
SO PLANT BIOTECHNOLOGY JOURNAL
LA English
DT Article
DE triacylglycerol; Nicotiana tabacum; leaf; WRI1; DGAT1; oleosin
ID FATTY-ACID BIOSYNTHESIS; ARABIDOPSIS; ACCUMULATION; LIPIDS; OIL;
   EXPRESSION; CARBOXYLASE; TOBACCO; GENES
AB High biomass crops have recently attracted significant attention as an alternative platform for the renewable production of high energy storage lipids such as triacylglycerol (TAG). While TAG typically accumulates in seeds as storage compounds fuelling subsequent germination, levels in vegetative tissues are generally low. Here, we report the accumulation of more than 15% TAG (17.7% total lipids) by dry weight in Nicotiana tabacum (tobacco) leaves by the co-expression of three genes involved in different aspects of TAG production without severely impacting plant development. These yields far exceed the levels found in wild-type leaf tissue as well as previously reported engineered TAG yields in vegetative tissues of Arabidopsis thaliana and N.tabacum. When translated to a high biomass crop, the current levels would translate to an oil yield per hectare that exceeds those of most cultivated oilseed crops. Confocal fluorescence microscopy and mass spectrometry imaging confirmed the accumulation of TAG within leaf mesophyll cells. In addition, we explored the applicability of several existing oil-processing methods using fresh leaf tissue. Our results demonstrate the technical feasibility of a vegetative plant oil production platform and provide for a step change in the bioenergy landscape, opening new prospects for sustainable food, high energy forage, biofuel and biomaterial applications.
C1 [Vanhercke, Thomas; El Tahchy, Anna; Liu, Qing; Shrestha, Pushkar; Divi, Uday K.; Ral, Jean-Philippe; Singh, Surinder P.; Petrie, James R.] CSIRO, Food Futures Natl Res Flagship, Canberra, ACT, Australia.
   [Zhou, Xue-Rong] CSIRO Plant Ind, Canberra, ACT, Australia.
   [Mansour, Maged P.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia.
   [James, Christopher N.; Horn, Patrick J.; Chapman, Kent D.; Beaudoin, Frederic] Univ N Texas, Ctr Plant Lipid Res, Dept Biol Sci, Denton, TX 76203 USA.
   [Beaudoin, Frederic; Larkin, Philip J.] Rothamsted Res, Dept Biol Chem, Harpenden, Herts, England.
RP Petrie, JR (reprint author), CSIRO, Food Futures Natl Res Flagship, Canberra, ACT, Australia.
EM James.Petrie@csiro.au
RI Vanhercke, Thomas/B-6647-2011; Nichols, Peter/C-5128-2011; Ruiz-Lopez,
   Noemi/C-5895-2008; Divi, Uday/H-8010-2012; Zhou, Xue-Rong/D-4706-2009;
   Liu, Qing/A-1395-2010; Larkin, Philip/A-9468-2008; El tahchy,
   Anna/B-6997-2012; singh, surinder/C-9528-2009; Shrestha,
   Pushkar/A-2728-2010; Divi, Uday/P-2581-2017
OI Vanhercke, Thomas/0000-0003-1397-7622; Ruiz-Lopez,
   Noemi/0000-0002-2169-0210; Zhou, Xue-Rong/0000-0003-3717-2984; Liu,
   Qing/0000-0001-6617-6859; Larkin, Philip/0000-0002-2608-1924; singh,
   surinder/0000-0003-4488-8147; Shrestha, Pushkar/0000-0001-9642-6636;
   Divi, Uday/0000-0003-0905-7567; Horn, Patrick/0000-0002-1057-4708
FU U.S. Department of Energy, BER Division [DE-FG02-09ER64812]; Hoblitzelle
   Foundation; US National Science Foundation [112605]; Biotechnology and
   Biological Sciences Research Council [BBS/E/C/00005207]
FX We would like to thank Nathalie Niesner, Anne Mackenzie, Dawar Hussain,
   Anna Mechanicos, Cheryl Blundell, Luch Hac, Alex Miller, Lina Ma, Lijun
   Tian and Jeni Pritchard for technical assistance. We also thank Dr
   Damien Callahan at Metabolomics Australia, University of Melbourne and
   Dr. Matt Taylor at CSIRO Ecosystem Sciences for assistance with LC-MS,
   Dr. Rosemary White for help with microscopy and Dr. Allan Green for
   helpful discussions and advice. This work was funded by the CSIRO Food
   Futures National Research Flagship, CSIRO Plant Industry and the CSIRO
   Office of the Chief Executive Postdoctoral Fellowship Scheme. LC-MS
   analysis was supported by Bioplatforms Australia Services. Research in
   the UNT Center for Plant Research on oil accumulation in leaves is
   supported by a grant from the U.S. Department of Energy, BER Division,
   DE-FG02-09ER64812. Acquisition of the imaging instruments at UNT was
   made possible, in part, by grants from the Hoblitzelle Foundation and
   the US National Science Foundation (MRI#112605).
CR Andrianov V, 2010, PLANT BIOTECHNOL J, V8, P277, DOI 10.1111/j.1467-7652.2009.00458.x
   Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x
   Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032
   Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x
   Chapman KD, 2013, PLANT SCI, V207, P128, DOI 10.1016/j.plantsci.2013.03.003
   Corrado F., 2008, Mutagenized tobacco plant as seed culture for the production of oil for energetic, industrial and alimentary uses, Patent No. [WO 2008110876, 2008110876, WO/2008/110876]
   CORUZZI G, 1984, EMBO J, V3, P1671, DOI 10.1002/j.1460-2075.1984.tb02031.x
   Dyer J, 2012, INFORM, V23, P193
   Fogher C, 2011, INFORM, V22, P631
   Food and Agriculture Organization, 2003, WORLD AGR 2015 2030
   Gigliotti JC, 2011, FOOD CHEM, V125, P1028, DOI 10.1016/j.foodchem.2010.10.013
   Guelette BS, 2012, J EXP BOT, V63, P3603, DOI 10.1093/jxb/ers028
   Horn PJ, 2012, PLANT CELL, V24, P622, DOI 10.1105/tpc.111.094581
   HORSCH RB, 1985, SCIENCE, V227, P1229
   James CN, 2010, P NATL ACAD SCI USA, V107, P17833, DOI 10.1073/pnas.0911359107
   Kelly AA, 2013, PLANT PHYSIOL, V162, P1282, DOI 10.1104/pp.113.219840
   Klaus D, 2004, PLANTA, V219, P389, DOI 10.1007/s00425-004-1236-3
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mendoza MS, 2005, FEBS LETT, V579, P4666, DOI 10.1016/j.febslet.2005.07.037
   Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342
   Ohlrogge J., 2011, BIOCHEM, V33, P34
   Petrie J., 2012, PLOS ONE, V7
   Rogalski M, 2011, PLANT BIOTECHNOL J, V9, P554, DOI 10.1111/j.1467-7652.2011.00621.x
   Sanjaya, 2013, PLANT CELL, V25, P677, DOI 10.1105/tpc.112.104752
   Sanjaya, 2011, PLANT BIOTECHNOL J, V9, P874, DOI 10.1111/j.1467-7652.2011.00599.x
   Scott RW, 2010, PLANT BIOTECHNOL J, V8, P912, DOI 10.1111/j.1467-7652.2010.00522.x
   Slocombe SP, 2009, PLANT BIOTECHNOL J, V7, P694, DOI 10.1111/j.1467-7652.2009.00435.x
   Stone SL, 2008, P NATL ACAD SCI USA, V105, P3151, DOI 10.1073/pnas.0712364105
   Troncoso-Ponce MA, 2013, PLANT SCI, V205, P13, DOI 10.1016/j.plantsci.2013.01.004
   Vanhercke T, 2013, FEBS LETT, V587, P364, DOI 10.1016/j.febslet.2012.12.018
   Winichayakul S, 2013, PLANT PHYSIOL, V162, P626, DOI 10.1104/pp.113.216820
   Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592
NR 32
TC 98
Z9 102
U1 7
U2 128
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1467-7644
EI 1467-7652
J9 PLANT BIOTECHNOL J
JI Plant Biotechnol. J.
PD FEB
PY 2014
VL 12
IS 2
BP 231
EP 239
DI 10.1111/pbi.12131
PG 9
WC Biotechnology & Applied Microbiology; Plant Sciences
SC Biotechnology & Applied Microbiology; Plant Sciences
GA 295HY
UT WOS:000330108400010
PM 24151938
OA Green Published, Other Gold
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Uzarski, JS
   Van de Walle, AB
   McFetridge, PS
AF Uzarski, Joseph S.
   Van de Walle, Aurore B.
   McFetridge, Peter S.
TI In Vitro Method for Real-Time, Direct Observation of Cell-Vascular Graft
   Interactions under Simulated Blood Flow
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID HUMAN-ENDOTHELIAL-CELLS; VEIN GRAFT; ADHESION; STRESS
AB In the development of engineered vascular grafts, assessing the material's interactive properties with peripheral blood cells and its capacity to endothelialize are important for predicting in vivo graft behavior. Current in vitro techniques used for characterizing cell adhesion at the surface of engineered scaffolds under flow only facilitate a terminal quantification of cell/surface interactions. Here, we present the design of an innovative flow chamber for real-time analysis of blood-biomaterial interactions under controllable hemodynamic conditions. Decellularized human umbilical veins (dHUV) were used as model vascular allografts to characterize platelet, leukocyte, and endothelial cell (EC) adhesion dynamics. Confluent EC monolayers adhered to the lumenal surface of the grafting material were flow conditioned to resist arterial shear stress levels (up to 24 dynes/cm(2)) over a 48h period, and shown to maintain viability over the 1 week assessment period. The basement membrane was imaged while whole blood/neutrophil suspensions were perfused across the HUV surface to quantify cell accumulation. This novel method facilitates live visualization of dynamic events, including cell adhesion, migration, and morphological adaptation at the blood-graft interface on opaque materials, and it can be used for preliminary assessment of clinically relevant biomaterials before implantation.
C1 [Uzarski, Joseph S.; Van de Walle, Aurore B.; McFetridge, Peter S.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
RP McFetridge, PS (reprint author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Biomed Sci Bldg,JG-56,1275 Ctr Dr,POB 116131, Gainesville, FL 32611 USA.
EM pmcfetridge@bme.ufl.edu
OI Van de Walle, Aurore/0000-0003-1579-9145
FU National Institutes of Health [R01-HL088207, R01-HL088207-03S1]
FX The authors would like to acknowledge the National Institutes of Health
   for funding R01-HL088207 and R01-HL088207-03S1. They thank Alan Miles
   for providing flow chamber machining consultation. The authors would
   also like to thank the Electron Microscopy and Bio-imaging Laboratory at
   UF for technical assistance, Christopher Cogle and the UF Clinical and
   Translational Science Institute for their assistance with blood draws.
   They also thank Dr. Cogle for contributing the GFP + HL-60 cells for
   this study.
CR Bacabac RG, 2005, J BIOMECH, V38, P159, DOI 10.1016/j.jbiomech.2004.03.020
   Barthel KU, 2011, INTERACTIVE 3D SURFA
   Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P976, DOI 10.1161/01.ATV.0000162171.30089.f6
   Bulger M. G., 1979, PRINCIPLES STAT
   Butler PJ, 2000, MICROCIRCULATION, V7, P53, DOI 10.1038/sj.mn.7300093
   Daniel J, 2005, ASAIO J, V51, P252, DOI 10.1097/01.MAT.0000160872.41871.7E
   Dardik H, 2006, J AM COLL SURGEONS, V203, P582, DOI 10.1016/j.jamcollsurg.2006.07.003
   ENTE G, 1991, J ROY SOC HEALTH, V111, P138, DOI 10.1177/146642409111100406
   FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488
   HANSON SR, 1985, ARTERIOSCLEROSIS, V5, P595, DOI 10.1161/01.ATV.5.6.595
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kapadia MR, 2008, CIRCULATION, V117, P1873, DOI 10.1161/CIRCULATIONAHA.107.714170
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Mehta D, 1997, INT J CARDIOL, V62, pS55, DOI 10.1016/S0167-5273(97)00214-3
   Michell D. L., 2011, J VIS EXP
   Mollinedo F, 2008, GENE, V419, P16, DOI 10.1016/j.gene.2008.04.015
   Reinhart-King CA, 2008, METHOD ENZYMOL, V443, P25, DOI 10.1016/S0076-6879(08)02002-8
   Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z
   Sarkar S, 2007, J BIOMED MATER RES B, V82B, P100, DOI 10.1002/jbm.b.30710
   Schmidtke DW, 2000, J CELL BIOL, V149, P719, DOI 10.1083/jcb.149.3.719
   Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104
   Tolouei E, 2011, ANN BIOMED ENG, V39, P1403, DOI 10.1007/s10439-010-0239-4
   Tosun Z, 2011, J VASC SURG, V54, P1451, DOI 10.1016/j.jvs.2011.05.050
   Uzarski J. S., 2012, J BIOMED MATER RES A, V101, P123
   Yazdani SK, 2010, J VASC SURG, V51, P174, DOI 10.1016/j.jvs.2009.08.074
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
NR 28
TC 5
Z9 5
U1 0
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD FEB 1
PY 2014
VL 20
IS 2
BP 116
EP 128
DI 10.1089/ten.tec.2012.0771
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 298FX
UT WOS:000330310700003
PM 23679070
OA Green Published
DA 2018-10-20
ER

PT J
AU Bae, MS
   Ohe, JY
   Lee, JB
   Heo, DN
   Byun, W
   Bae, H
   Kwon, YD
   Kwon, IK
AF Bae, Min Soo
   Ohe, Joo-Young
   Lee, Jung Bok
   Heo, Dong Nyoung
   Byun, Wook
   Bae, Hojae
   Kwon, Yong-Dae
   Kwon, Il Keun
TI Photo-cured hyaluronic acid-based hydrogels containing growth and
   differentiation factor 5 (GDF-5) for bone tissue regeneration
SO BONE
LA English
DT Article
DE Photopolymerization; Hyaluronic acid; Hydrogel; Growth and
   differentiation factor 5 (GDF-5); Bone tissue regeneration
ID RECOMBINANT HUMAN GROWTH; BETA-TRICALCIUM PHOSPHATE; SINUS FLOOR
   AUGMENTATION; GOETTINGEN MINIATURE PIG; ENGINEERING APPLICATIONS;
   EXTRACELLULAR-MATRIX; GENE-EXPRESSION; IN-VITRO; PHOTOPOLYMERIZATION;
   SCAFFOLD
AB In this study we describe the generation and influences on in vitro and in vivo osteogenesis of photo-cured hyaluronic acid (HA) hydrogels loaded with growth and differentiation factor 5 (GDF-5). Prior to loading GDF-5, we characterized the release profiles from these hydrogels and tested their respective cell viability, differentiation and in vivo bone regeneration. The results from this testing indicated that GDF-5 was observed to release in a sustained manner from the HA hydrogels I-III. MIT and Live/Dead assays showed that the HA hydrogels I-III have good biocompatibility for use as scaffolds for bone tissue regeneration. In vitro cell tests showed a higher level of MOT3-E1 cell proliferation and differentiation on HA hydrogels I-III than on HA hydrogel 0. Moreover, in vivo animal tests showed that the HA hydrogels I and III had a significant improvement on osteogenesis. Overall, our results suggest that the HA-based hydrogel is a good biomaterial to deliver osteogenic differentiation factors such as GDF-5, and GDF-5 can be useful as an effective alternative to aid new bone formation. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Bae, Min Soo; Lee, Jung Bok; Heo, Dong Nyoung; Byun, Wook; Kwon, Il Keun] Kyung Hee Univ, Dept Maxillofacial Biomed Engn, Sch Dent, Seoul 130701, South Korea.
   [Ohe, Joo-Young; Kwon, Yong-Dae] Kyung Hee Univ, Dept Oral & Maxillofacial Surg, Sch Dent, Seoul 130701, South Korea.
   [Kwon, Yong-Dae; Kwon, Il Keun] Kyung Hee Univ, Inst Oral Biol, Sch Dent, Seoul 130701, South Korea.
   [Bae, Hojae] Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea.
RP Kwon, YD (reprint author), Kyung Hee Univ, Inst Oral Biol, Sch Dent, 1 Hoegi Dong, Seoul 130701, South Korea.
EM yongdae.kwon@gmail.com; kwoni@khu.ac.kr
OI Kwon, Yong-Dae/0000-0001-9620-4814
FU ITI (International Team for Implantology, Basel, Switzerland) research
   grant program [670-2009]; Pioneer Research Center Program [20120000443]
FX This study was supported by the ITI (International Team for
   Implantology, Basel, Switzerland) research grant program (670-2009) and
   grant no. 20120000443 from the Pioneer Research Center Program.
CR Akkouch A, 2011, J BIOMED MATER RES A, V96A, P693, DOI 10.1002/jbm.a.33033
   Bae MS, 2013, CARBOHYD POLYM, V92, P167, DOI 10.1016/j.carbpol.2012.09.044
   Bae MS, 2011, BIOMATERIALS, V32, P8161, DOI 10.1016/j.biomaterials.2011.07.045
   Bot PT, 2008, CURR MED CHEM, V15, P786, DOI 10.2174/092986708783955554
   Bryant SJ, 2001, BIOMATERIALS, V22, P619, DOI 10.1016/S0142-9612(00)00225-8
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Clapper JD, 2008, CHEM MATER, V20, P768, DOI 10.1021/cm702130r
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Emerton KB, 2011, J DENT RES, V90, P1416, DOI 10.1177/0022034511423665
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Garbern JC, 2010, BIOMACROMOLECULES, V11, P1833, DOI 10.1021/bm100318z
   Grant N, 2011, J COLLOID INTERF SCI, V356, P573, DOI 10.1016/j.jcis.2011.01.056
   Gruber RM, 2008, CLIN ORAL IMPLAN RES, V19, P522, DOI 10.1111/j.1600-0501.2007.01494.x
   Gruber RM, 2009, CLIN ORAL IMPLAN RES, V20, P175, DOI 10.1111/j.1600-0501.2008.01628.x
   Gurkan UA, 2011, TISSUE ENG PT A, V17, P417, DOI [10.1089/ten.tea.2010.0193, 10.1089/ten.TEA.2010.0193]
   Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p
   HOTTEN G, 1994, BIOCHEM BIOPH RES CO, V204, P646, DOI 10.1006/bbrc.1994.2508
   Hutchison JB, 2005, CHEM MATER, V17, P4789, DOI 10.1021/cm0504541
   KING SR, 1991, SURGERY, V109, P76
   Koch FP, 2010, CLIN ORAL IMPLAN RES, V21, P1301, DOI 10.1111/j.1600-0501.2010.01949.x
   Kong SW, 2011, BONE, V48, P298, DOI 10.1016/j.bone.2010.09.029
   Kyle S, 2010, BIOMATERIALS, V31, P9395, DOI 10.1016/j.biomaterials.2010.08.051
   Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32
   LEE B, 1994, BIORHEOLOGY, V31, P339
   Lee SJ, 2011, BIOMACROMOLECULES, V12, P306, DOI 10.1021/bm100856g
   Lesley J, 1997, GLYCOCONJUGATE J, V14, P611, DOI 10.1023/A:1018540610858
   LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4
   Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5
   Missirlis D, 2005, LANGMUIR, V21, P2605, DOI 10.1021/la047367s
   Morotome Y, 1998, BIOCHEM BIOPH RES CO, V244, P85, DOI 10.1006/bbrc.1998.8213
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Sena K, 2003, J DENT RES, V82, P166, DOI 10.1177/154405910308200304
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Trochon V, 1996, INT J CANCER, V66, P664, DOI 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4
   Wei HL, 2005, EUR POLYM J, V41, P948, DOI 10.1016/j.eurpolymj.2004.11.041
   Winer I, 2010, CANCER RES, V70, P8674, DOI 10.1158/0008-5472.CAN-10-1917
   YANG BH, 1993, J BIOL CHEM, V268, P8617
   Zhang XZ, 2005, BIOMATERIALS, V26, P3299, DOI 10.1016/j.biomaterials.2004.08.024
NR 40
TC 27
Z9 28
U1 3
U2 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
EI 1873-2763
J9 BONE
JI Bone
PD FEB
PY 2014
VL 59
BP 189
EP 198
DI 10.1016/j.bone.2013.11.019
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 287QZ
UT WOS:000329558600025
PM 24291420
DA 2018-10-20
ER

PT J
AU Kizaki, T
   Ogasahara, T
   Sugita, N
   Mitsuishi, M
AF Kizaki, Toru
   Ogasahara, Toshihiro
   Sugita, Naohiko
   Mitsuishi, Mamoru
TI Ultraviolet-laser-assisted precision cutting of yttria-stabilized
   tetragonal zirconia polycrystal
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE UV laser-assisted precision cutting; UV laser; Yttria-stabilized
   tetragonal zirconia polycrystal; Biomaterial; Difficult-to-cut material
ID CERAMICS; STEEL
AB Yttria-stabilized tetragonal zirconia polycrystal (Y-TZP) is a promising biomaterial for use in dental and femoral implants. The current method for machining Y-TZP involves grinding after sintering. However, the grinding process is time consuming and therefore costly. To resolve these issues, this paper proposes a precision cutting process that utilizes a UV-laser-assisted machining method that requires no expensive cutting tools such as diamond tools. The UV laser is used to heat the Y-TZP, which improves its machinability. First, we performed experiments to determine that the most suitable machining temperature was 600 degrees C. A simulation was then used to determine the optimal distance between the tool edge and the laser spot. Finally, experiments using a UV laser were conducted to confirm the effectiveness of using a UV laser for machining. In these experiments, a Y-TZP sample was cut, and grooves were generated. The carved grooves were 20 mm long, 100 mu m wide, and approximately 10 mu m deep. Cutting without using a UV laser was also performed as a reference experiment. The results show that the use of the laser significantly decreased the number of large cracks from 14 to 3, the specific cutting energy by 35%, and the breakage of the tool edge. These results demonstrate the possibility of enhancing the productivity of Y-TZP products. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Kizaki, Toru; Sugita, Naohiko; Mitsuishi, Mamoru] Univ Tokyo, Sch Engn, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Ogasahara, Toshihiro] Odakyu Elect Railway Co Ltd, Ohno Gen Trains Plant, Minami Ku, Sagamihara, Kanagawa 2520311, Japan.
RP Kizaki, T (reprint author), Univ Tokyo, Sch Engn, Dept Mech Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM kizaki@nml.t.u-tokyo.ac.jp
FU Amada Foundation [AF-2010207]
FX The authors acknowledge the research grant (AF-2010207) awarded by the
   Amada Foundation to conduct this research work.
CR Anderson MC, 2006, P I MECH ENG B-J ENG, V220, P2055, DOI 10.1243/09544054JEM562
   Anderson M, 2006, INT J MACH TOOL MANU, V46, P1879, DOI 10.1016/j.ijmachtools.2005.11.005
   Basu B, 2005, INT MATER REV, V50, P239, DOI 10.1179/174328005X41113
   Chang CW, 2007, INT J MACH TOOL MANU, V47, P452, DOI 10.1016/j.ijmachtools.2006.06.010
   Chryssolouris G, 1997, J MANUF SCI E-T ASME, V119, P766, DOI 10.1115/1.2836822
   Dandekar C.R., 2010, J MANUF SCI E-T ASME, V132
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Dumitrescu P, 2006, INT J MACH TOOL MANU, V46, P2009, DOI 10.1016/j.ijmachtools.2006.01.005
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Hou ZB, 2000, INT J HEAT MASS TRAN, V43, P1679, DOI 10.1016/S0017-9310(99)00271-9
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Larrea A, 2011, J ELECTROCHEM SOC, V158, pB1193, DOI 10.1149/1.3619759
   Masood SH, 2011, INT J MACH TOOL MANU, V51, P450, DOI 10.1016/j.ijmachtools.2011.02.001
   NICOLOSO N, 1992, SENSOR ACTUAT B-CHEM, V8, P253, DOI 10.1016/0925-4005(92)85027-T
   Pfefferkorn FE, 2004, J MANUF SCI E-T ASME, V126, P42, DOI 10.1115/1.1644542
   Rozzi JC, 2000, J MANUF SCI E-T ASME, V122, P666, DOI 10.1115/1.1286556
   Sola D, 2011, APPL SURF SCI, V257, P5413, DOI 10.1016/j.apsusc.2010.09.089
   Stavropoulos P, 2010, International Journal of Nanomanufacturing, V6, P55, DOI 10.1504/IJNM.2010.034772
   THEUNISSEN GSAM, 1992, J MATER SCI, V27, P4429, DOI 10.1007/BF00541576
NR 19
TC 5
Z9 5
U1 0
U2 22
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD FEB
PY 2014
VL 214
IS 2
BP 267
EP 275
DI 10.1016/j.jmatprotec.2013.09.015
PG 9
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 287RR
UT WOS:000329560400013
DA 2018-10-20
ER

PT J
AU Ameer, MA
   Ghoneim, AA
   Fekry, AM
AF Ameer, M. A.
   Ghoneim, A. A.
   Fekry, A. M.
TI Electrochemical and interface analysis of titanium alloy in simulated
   body fluid
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE titanium alloy; electrochemical techniques; inhibition
ID INULIN-TYPE FRUCTANS; CORROSION INHIBITION; BONE MINERALIZATION;
   MILD-STEEL; IMPEDANCE; BEHAVIOR; ELECTROLYTE; ZIRCONIUM; MAGNESIUM;
   COMPOUND
AB The effect of raftiline inulin in presence of Ca2+ on titanium alloy as biomaterial was investigated in simulated body fluid solution at 37 degrees C. The behavior of Ti alloy was studied at different concentrations of inulin with immersion time using electrochemical impedance spectroscopy and potentiodynamic polarization tests. Ti alloy was effectively inhibited by the addition of 0.25% by weight raftiline in presence of 10(-5)m calcium levulinate, which reacts with Ti alloy and forms a protective film on its surface. The results were confirmed by surface examination via scanning electron microscope. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Ameer, M. A.; Ghoneim, A. A.; Fekry, A. M.] Cairo Univ, Fac Sci, Dept Chem, Giza 12613, Egypt.
RP Ameer, MA (reprint author), Cairo Univ, Fac Sci, Dept Chem, Giza 12613, Egypt.
EM mameer_eg@yahoo.com
CR Abrams SA, 2005, AM J CLIN NUTR, V82, P471
   Ameer MA, 2012, INT J ELECTROCHEM SC, V7, P4418
   Ameer MA, 2011, PROG ORG COAT, V71, P343, DOI 10.1016/j.porgcoat.2011.04.001
   Ameer MA, 2010, INT J HYDROGEN ENERG, V35, P11387, DOI 10.1016/j.ijhydene.2010.07.071
   Ameer MA, 2010, MATER CHEM PHYS, V122, P321, DOI 10.1016/j.matchemphys.2010.03.021
   Bosscher D, 2006, INT DAIRY J, V16, P1092, DOI 10.1016/j.idairyj.2005.10.028
   Brunette D. M., 2001, TITANIUM MED MAT SCI, P207
   Cashman K. D., 2002, BR J NUTR, V87, P169
   Fekry AM, 2011, INT J ELECTROCHEM SC, V6, P1342
   Fekry AM, 2010, J APPL ELECTROCHEM, V40, P739, DOI 10.1007/s10800-009-0052-7
   Fekry AM, 2009, ELECTROCHIM ACTA, V54, P7280, DOI 10.1016/j.electacta.2009.07.047
   GIBSON GR, 1995, J NUTR, V125, P1401
   Guillemot F, 2005, EXPERT REV MED DEVIC, V2, P741, DOI 10.1586/17434440.2.6.741
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hosny WM, 2013, INT J ELECTROCHEM SC, V8, P8371
   Ian J., 2003, NUTR RES, V23, P901
   KNITTEL DR, 1984, CORROSION, V40, P9, DOI 10.5006/1.3579296
   Kumar S, 2010, CORROS SCI, V52, P1721, DOI 10.1016/j.corsci.2010.01.008
   Macdonald D. D., 1977, TRANSIENT TECHNIQUES
   Macdonald J. R., 1987, IMPEDANCE SPECTROSCO
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   PATRITO EM, 1994, J ELECTROANAL CHEM, V375, P203, DOI 10.1016/0022-0728(94)03405-2
   Popa MV, 2007, BIOELECTROCHEMISTRY, V71, P126, DOI 10.1016/j.bioelechem.2007.02.007
   PROUD WG, 1993, ELECTROCHIM ACTA, V38, P405, DOI 10.1016/0013-4686(93)85158-U
   Roberfroid MB, 1997, ADV EXP MED BIOL, V427, P211
   Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350
   Souza MEP, 2009, J MATER SCI-MATER M, V20, P549, DOI 10.1007/s10856-008-3623-y
   Tamilselvi S, 2006, ELECTROCHIM ACTA, V52, P839, DOI 10.1016/j.electacta.2006.06.018
   Textor M., 2001, TITANIUM MED, P171
NR 29
TC 1
Z9 1
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD FEB
PY 2014
VL 46
IS 2
BP 65
EP 71
DI 10.1002/sia.5349
PG 7
WC Chemistry, Physical
SC Chemistry
GA 288PN
UT WOS:000329624000002
DA 2018-10-20
ER

PT J
AU Roy, M
   Kusurkar, TS
   Maurya, SK
   Meena, SK
   Singh, SK
   Sethy, N
   Bhargava, K
   Sharma, RK
   Goswami, D
   Sarkar, S
   Das, M
AF Roy, Manas
   Kusurkar, Tejas Sanjeev
   Maurya, Sandeep Kumar
   Meena, Sunil Kumar
   Singh, Sushil Kumar
   Sethy, Niroj
   Bhargava, Kalpana
   Sharma, Raj Kishore
   Goswami, Debabrata
   Sarkar, Sabyasachi
   Das, Mainak
TI Graphene oxide from silk cocoon: a novel magnetic fluorophore for
   multi-photon imaging
SO 3 BIOTECH
LA English
DT Article
DE Bio-imaging; Fluorophore; Graphene oxide; Magnetism; Multi-photon
   imaging; Silk cocoon
ID LAYER GRAPHENE; SINGLE-LAYER; CARBON; NANOTUBES; SHEETS; FILMS
AB In this work, we synthesized graphene oxide from silk cocoon embarking its new dimension as a magnetic fluorophore when compared with its present technical status, which at best is for extracting silk as a biomaterial for tissue engineering applications. We produced graphene oxide by pyrolysing the silk cocoon in an inert atmosphere. The collected raw carbon is oxidized by nitric acid that readily produces multilayer graphene oxide with nano carbon particulates. Structural properties of the graphene oxide were analyzed using scanning electron microscopy, transmission electron microscopy, Fourier transform infrared spectroscopy, and Raman spectroscopy. The oxidized sample shows remarkable fluorescence, multi-photon imaging and magnetic properties. On increasing the excitation wavelength, the fluorescence emission intensity of the graphene oxide also increases and found maximum emission at 380 nm excitation wavelength. On studying the two photon absorption (TPA) property of aqueous graphene oxide using Z-scan technique, we found significant TPA activity at near infrared wavelength. In addition, the graphene oxide shows ferromagnetic behavior at room temperature. The observed fluorescence and magnetic property were attributed to the defects caused in the graphene oxide structure by introducing oxygen containing hydrophilic groups during the oxidation process. Previously silk cocoon has been used extensively in deriving silk-based tissue engineering materials and as gas filter. Here we show a novel application of silk cocoon by synthesizing graphene oxide based magnetic-fluorophore for bio-imaging applications.
C1 [Roy, Manas; Maurya, Sandeep Kumar; Goswami, Debabrata] Indian Inst Technol, Dept Chem, Kanpur 208016, Uttar Pradesh, India.
   [Kusurkar, Tejas Sanjeev; Das, Mainak] Indian Inst Technol, Dept Biol Sci & Bioengn, Bioelect Green Energy Physiol & Sensor Grp, Kanpur 208016, Uttar Pradesh, India.
   [Maurya, Sandeep Kumar; Goswami, Debabrata] Indian Inst Technol, Ctr Laser Technol, Kanpur 208016, Uttar Pradesh, India.
   [Meena, Sunil Kumar] Indian Inst Technol, Dept Elect Engn, Kanpur 208016, Uttar Pradesh, India.
   [Singh, Sushil Kumar] Solid State Phys Lab, Def Res Dev Org, MEMS, Delhi 110054, India.
   [Singh, Sushil Kumar] Solid State Phys Lab, Def Res Dev Org, Photon Div, Delhi 110054, India.
   [Sethy, Niroj; Bhargava, Kalpana] Def Res Dev Org, Def Inst Physiol & Allied Sci, Peptide & Prote Div, Delhi 110054, India.
   [Sharma, Raj Kishore] Univ Delhi, Div Phys Chem, Dept Chem, Electrochem Mat Res Grp, Delhi 110007, India.
   [Sarkar, Sabyasachi] Bengal Engn & Sci Univ, Dept Chem, Bot Garden, Howrah 711103, W Bengal, India.
   [Das, Mainak] Indian Inst Technol, Design Program, Kanpur 208016, Uttar Pradesh, India.
RP Das, M (reprint author), Indian Inst Technol, Dept Biol Sci & Bioengn, Bioelect Green Energy Physiol & Sensor Grp, Kanpur 208016, Uttar Pradesh, India.
EM mainakd@iitk.ac.in
RI Maurya, Sandeep/J-3069-2016; Goswami, Debabrata/A-9347-2009
OI Goswami, Debabrata/0000-0002-2052-0594; Sethy, Niroj/0000-0003-0675-1481
FU IITK [IITK/BSBE/20100206]; CSIR, India [09/092(0670)/2009-EMR-I]; IIT K
   PhD fellowship program
FX The work was supported by IITK start-up grant (IITK/BSBE/20100206) of
   MD. MR is a senior research fellow of CSIR, India (Fellowship Number:
   09/092(0670)/2009-EMR-I). TSK is funded by IIT K PhD fellowship program.
   This work is part of MR's and TSK's doctoral thesis. Authors are
   thankful to MMAE, chemistry, nano-science (DST) of IIT Kanpur for
   TEM/VSM, FT-IR/Raman and SEM/EDAX facilities respectively.
CR ALLEMAND PM, 1991, SCIENCE, V253, P301, DOI 10.1126/science.253.5017.301
   Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872
   Brodie B. C., 1859, PHILOS T R SOC LONDO, V149, P249, DOI DOI 10.1098/RSTL.1859.0013
   Choi EY, 2010, J MATER CHEM, V20, P1907, DOI 10.1039/b919074k
   Dubey P, 2005, PRAMANA-J PHYS, V65, P681, DOI 10.1007/BF03010456
   Eda G, 2011, J MATER CHEM, V21, P11217, DOI 10.1039/c1jm11266j
   Eda G, 2010, ADV MATER, V22, P505, DOI 10.1002/adma.200901996
   Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401
   Ghosh M, 2011, SMALL, V7, P3170, DOI 10.1002/smll.201101158
   Graf D, 2007, NANO LETT, V7, P238, DOI 10.1021/nl061702a
   Guo SJ, 2011, CHEM SOC REV, V40, P2644, DOI 10.1039/c0cs00079e
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kim YH, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.125420
   KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907
   Lu C. H., 2009, ANGEW CHEM, V121, P4879, DOI DOI 10.1002/ANGE.200901479
   Makarova TL, 2004, SEMICONDUCTORS+, V38, P615, DOI 10.1134/1.1766362
   Makarova TL, 2001, NATURE, V413, P716, DOI 10.1038/35099527
   Nag A, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/6/065103
   Nag A, 2009, J PHOTOCH PHOTOBIO A, V206, P188, DOI 10.1016/j.jphotochem.2009.06.007
   NEMANICH RJ, 1979, PHYS REV B, V20, P392, DOI 10.1103/PhysRevB.20.392
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Pan DY, 2010, ADV MATER, V22, P734, DOI 10.1002/adma.200902825
   Qian J, 2012, ANGEW CHEM INT EDIT, V51, P10570, DOI 10.1002/anie.201206107
   RAMIREZ AP, 1994, SCIENCE, V265, P84, DOI 10.1126/science.265.5168.84
   Roy M, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0045-7
   Ruan GD, 2011, ACS NANO, V5, P7601, DOI 10.1021/nn202625c
   Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/NNANO.2010.89, 10.1038/nnano.2010.89]
   Sun ZZ, 2010, NATURE, V468, P549, DOI 10.1038/nature09579
   Tsioris K, 2010, ADV FUNCT MATER, V20, P1083, DOI 10.1002/adfm.200902050
   Wang Y., 2008, NANO LETT, V9, P220
   Xu YX, 2008, J AM CHEM SOC, V130, P5856, DOI 10.1021/ja800745y
   Zhu SJ, 2011, CHEM COMMUN, V47, P6858, DOI 10.1039/c1cc11122a
NR 34
TC 11
Z9 11
U1 2
U2 24
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-5738
EI 2190-572X
J9 3 BIOTECH
JI 3 Biotech
PD FEB
PY 2014
VL 4
IS 1
BP 67
EP 75
DI 10.1007/s13205-013-0128-2
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CM9QO
UT WOS:000358044100008
PM 28324464
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Jadalannagari, S
   Deshmukh, K
   Ramanan, SR
   Kowshik, M
AF Jadalannagari, Sushma
   Deshmukh, Ketaki
   Ramanan, Sutapa Roy
   Kowshik, Meenal
TI Antimicrobial activity of hemocompatible silver doped hydroxyapatite
   nanoparticles synthesized by modified sol-gel technique
SO APPLIED NANOSCIENCE
LA English
DT Article
DE Hydroxyapatite; Silver doping; Antimicrobial activity; Hemocompatibility
AB Silver doped hydroxyapatite (AgxCa100-x (PO4)(6) (OH)(2)) nanorods were synthesized using a modified sol gel method at a low temperature of 100 degrees C. Silver concentration was varied as x = 1, 3 and 5. X-ray diffraction studies showed that the synthesized silver doped hydroxyapatite (Ag-HAp) was fully crystalline with hexagonal structure and an average crystallite size of 25 nm. At all the doping concentrations, the nanoparticles were rod shaped with an average length of 110-180 nm and diameter of 20-25 nm as determined from transmission electron microscopy (TEM) studies. These compounds were tested for their antimicrobial activities against E. coli (MTCC 2345) and S. aureus (MTCC 737). Antimicrobial activity was observed for all the three silver doping concentrations with the highest activity for x = 3, in terms of the zone of inhibition and the percentage reduction in the number of colonies. Hemolysis ratios for x = 1 and 3 Ag-HAp samples were below 2 %, indicating that they are highly hemocompatible and can be a promising biomaterial for tissue engineering applications in orthopedics.
C1 [Jadalannagari, Sushma; Deshmukh, Ketaki; Kowshik, Meenal] Birla Inst Technol & Sci Pilani, Dept Biol Sci, KK Birla Goa Campus, Zuarinagar 403726, Goa, India.
   [Ramanan, Sutapa Roy] Birla Inst Technol & Sci Pilani, Dept Chem Engn, Zuarinagar 403726, Goa, India.
RP Kowshik, M (reprint author), Birla Inst Technol & Sci Pilani, Dept Biol Sci, KK Birla Goa Campus, Zuarinagar 403726, Goa, India.
EM Sushmajp5@gmail.com; Ketaki03@gmail.com; sutapa@goa.bits-pilani.ac.in;
   meenal@goa.bits-pilani.ac.in
CR Babapour A, 2006, NANOTECHNOLOGY, V17, P763, DOI 10.1088/0957-4484/17/3/025
   Bahadir A, 2009, DEFECT DIFFUS FORUM, V283-286, P250, DOI 10.4028/www.scientific.net/DDF.283-286.250
   Bai XA, 2010, ACTA BIOMATER, V6, P2264, DOI 10.1016/j.actbio.2009.12.002
   Borghese R, 2004, APPL ENVIRON MICROB, V70, P6595, DOI 10.1128/AEM.70.11.6595-6602.2004
   BRAGG PD, 1974, CAN J MICROBIOL, V20, P883, DOI 10.1139/m74-135
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Chen YK, 2008, J MATER SCI-MATER M, V19, P3603, DOI 10.1007/s10856-008-3529-8
   Chung RJ, 2006, J BIOMED MATER RES B, V76B, P169, DOI 10.1002/jbm.b.30365
   Diaz M, 2009, J NANOMATER, DOI 10.1155/2009/498505
   Dibrov P, 2002, ANTIMICROB AGENTS CH, V46, P2668, DOI 10.1128/AAC.46.8.2668-2670.2002
   Dragieva I, 1999, NANOSTRUCT MATER, V12, P267, DOI 10.1016/S0965-9773(99)00114-2
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   FURR JR, 1994, J HOSP INFECT, V27, P201, DOI 10.1016/0195-6701(94)90128-7
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Guggenbichler JP, 1999, INFECTION, V27, pS16, DOI 10.1007/BF02561612
   Hyung JJ, 2003, BIOMATERIALS, V24, P4921
   Jadalannagari S, 2011, MAT SCI ENG C-MATER, V31, P1534, DOI 10.1016/j.msec.2011.07.001
   Kim Soo-Hwan, 2011, Korean Journal of Microbiology and Biotechnology, V39, P77
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   Klasen JH, 2006, BURNS, V26, P131
   KRAMER SJ, 1981, CLIN ORTHOP RELAT R, P154
   Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Mo AC, 2008, APPL SURF SCI, V255, P435, DOI 10.1016/j.apsusc.2008.06.083
   Nunez N.V.A., 2009, NANOBIOTECHNOL, V5, P2
   Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x
   Ramanan SR, 2004, MATER LETT, V58, P3320, DOI 10.1016/j.matlet.2004.06.030
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Russell SW, 1996, J AM CERAM SOC, V79, P837, DOI 10.1111/j.1151-2916.1996.tb08514.x
   Sambrook J, 2001, MOL CLONING LAB MANU
   Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006
   SCHREURS WJA, 1982, J BACTERIOL, V152, P7
   Simon V, 2008, J NON-CRYST SOLIDS, V354, P1751, DOI 10.1016/j.jnoncrysol.2007.08.063
   Smith BC, 1999, INFRARED SPECTRAL IN
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Stanic V, 2011, APPL SURF SCI, V257, P4510, DOI 10.1016/j.apsusc.2010.12.113
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   WIESSNER J, 1988, CALCIFIED TISSUE INT, V42, P210, DOI 10.1007/BF02553746
   Woo K. J., 2008, APPL ENVIRON MICROB, V74, P2171
   Xia W, 2010, BIOMED MATER, V5
   Xue WC, 2004, BIOMATERIALS, V25, P415, DOI 10.1016/S0142-9612(03)00545-3
   Yoshiki A, 2010, BIOCONTROL SCI, V15, P15
   Zheng X, 2009, J THERM SPRAY TECHN, V16, P463
NR 44
TC 28
Z9 28
U1 1
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-5509
EI 2190-5517
J9 APPL NANOSCI
JI Appl. Nanosci.
PD FEB
PY 2014
VL 4
IS 2
BP 133
EP 141
DI 10.1007/s13204-013-0197-x
PG 9
WC Nanoscience & Nanotechnology
SC Science & Technology - Other Topics
GA V45VD
UT WOS:000209843200002
OA Other Gold
DA 2018-10-20
ER

PT J
AU Chen, ZT
   Wu, CT
   Gu, WY
   Klein, T
   Crawford, R
   Xiao, Y
AF Chen, Zetao
   Wu, Chengtie
   Gu, Wenyi
   Klein, Travis
   Crawford, Ross
   Xiao, Yin
TI Osteogenic differentiation of bone marrow MSCs by beta-tricalcium
   phosphate stimulating macrophages via BMP2 signalling pathway
SO BIOMATERIALS
LA English
DT Article
DE Macrophage; Immunoreaction; Bone substitute; beta-TCP; Osteogenesis
ID MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2; IN-VITRO; IMPLANT
   SURFACES; IMMUNE-SYSTEM; TISSUE; OSTEOIMMUNOLOGY; PROLIFERATION;
   POLARIZATION; SECRETION
AB Immune reactions play important roles in determining the in vivo fate of bone substitute materials, either in new bone formation or inflammatory fibrous tissue encapsulation. The paradigm for the development of bone substitute materials has been shifted from inert to immunomodulatory materials, emphasizing the importance of immune cells in the material evaluation. Macrophages, the major effector cells in the immune reaction to implants, are indispensable for osteogenesis and their heterogeneity and plasticity render macrophages a primer target for immune system modulation. However, there are very few reports about the effects of macrophages on biomaterial-regulated osteogenesis. In this study, we used beta-tricalcium phosphate (beta-TCP) as a model biomaterial to investigate the role of macrophages on the material stimulated osteogenesis. The macrophage phenotype switched to M2 extreme in response to beta-TCP extracts, which was related to the activation of calcium-sensing receptor (CaSR) pathway. Bone morphogenetic protein 2 (BMP2) was also significantly upregulated by the beta-TCP stimulation, indicating that macrophage may participate in the beta-TCP stimulated osteogenesis. Interestingly, when macrophage-conditioned beta-TCP extracts were applied to bone marrow mesenchymal stem cells (BMSCs), the osteogenic differentiation of BMSCs was significantly enhanced, indicating the important role of macrophages in biomaterial-induced osteogenesis. These findings provided valuable insights into the mechanism of material-stimulated osteogenesis, and a strategy to optimize the evaluation system for the in vitro osteogenesis capacity of bone substitute materials. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Chen, Zetao; Gu, Wenyi; Klein, Travis; Crawford, Ross; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
   [Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Gu, Wenyi] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
RP Wu, CT (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.
EM chengtiewu@mail.sic.ac.cn; yin.xiao@qutedu.au
OI Crawford, Ross/0000-0001-6079-1316; Klein, Travis/0000-0002-6669-7766;
   Xiao, Yin/0000-0003-1785-3491
FU Australian Research Council [DP120103697]; Recruitment Program of Global
   Young Talent, China; Natural Science Foundation of China [81201202,
   31370963]
FX The study was supported by an Australian Research Council Discovery
   Project (DP120103697), Recruitment Program of Global Young Talent, China
   (Dr. Wu) and Natural Science Foundation of China (Grant 81201202 and
   31370963).
CR Ahluwalia A, 2012, CURR MED CHEM, V19, P90, DOI 10.2174/092986712803413944
   Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354
   Bais MV, 2009, BONE, V45, P254, DOI 10.1016/j.bone.2009.04.239
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Chakravorty N, 2012, ACTA BIOMATER, V8, P3516, DOI 10.1016/j.actbio.2012.05.008
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232
   Chappard D, 2010, MICRON, V41, P321, DOI 10.1016/j.micron.2009.12.005
   Chen Z, 2013, J BIOMED A IN PRESS
   De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357
   Fromigue O, 1998, J CELL BIOCHEM, V68, P411, DOI 10.1002/(SICI)1097-4644(19980315)68:4<411::AID-JCB2>3.0.CO;2-T
   Gaasbeek RDA, 2005, BIOMATERIALS, V26, P6713, DOI 10.1016/j.biomaterials.2005.04.056
   Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040
   Honda Y, 2006, BIOCHEM BIOPH RES CO, V345, P1155, DOI 10.1016/j.bbrc.2006.05.013
   Jang BJ, 2008, J VET SCI, V9, P387, DOI 10.4142/jvs.2008.9.4.387
   Lang NP, 2011, CLIN ORAL IMPLAN RES, V22, P349, DOI 10.1111/j.1600-0501.2011.02172.x
   Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6
   Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994
   Lorenzo J, 2000, J CLIN INVEST, V106, P749, DOI 10.1172/JCI11089
   MacLeod RJ, 2007, AM J PHYSIOL-GASTR L, V293, pG403, DOI 10.1152/ajpgi.00119.2007
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Mareddy S, 2007, TISSUE ENG, V13, P819, DOI 10.1089/ten.2006.0180
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Oh SA, 2010, J MATER SCI-MATER M, V21, P3019, DOI 10.1007/s10856-010-4152-z
   Pacifici R, 2010, ARCH BIOCHEM BIOPHYS, V503, P41, DOI 10.1016/j.abb.2010.05.027
   Peiris D, 2007, AM J PHYSIOL-GASTR L, V292, pG753, DOI 10.1152/ajpgi.00225.2006
   Petit A, 2005, BIOMATERIALS, V26, P4416, DOI 10.1016/j.biomaterials.2004.11.019
   Pettit AR, 2008, BONE, V43, P976, DOI 10.1016/j.bone.2008.08.128
   Rokn Ar, 2012, J Dent (Tehran), V9, P35
   Singh S, 2008, STEM CELLS DEV, V17, P245, DOI 10.1089/scd.2007.0146
   Sitasuwan P, 2012, INTEGR BIOL-UK, V4, P651, DOI 10.1039/c2ib20041d
   Soltanoff CS, 2009, CRIT REV EUKAR GENE, V19, P1
   Sullivan DE, 2005, AM J RESP CELL MOL, V32, P342, DOI 10.1165/rcmb.2004-0288OC
   Takayanagi H, 2005, J PERIODONTAL RES, V40, P287, DOI 10.1111/j.1600-0765.2005.00814.x
   Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062
   Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200
   Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035
   WAHL SM, 1990, ANN NY ACAD SCI, V593, P188, DOI 10.1111/j.1749-6632.1990.tb16111.x
   Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646
   Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f
   Wu CT, 2011, ACTA BIOMATER, V7, P1797, DOI 10.1016/j.actbio.2010.12.018
   Xia ZD, 2006, J BIOMED MATER RES A, V79A, P582, DOI 10.1002/jbm.a.30853
   Xiao L, 2012, FRONT BIOSCI-LANDMRK, V17, P2667, DOI 10.2741/4077
   Zhang ML, 2012, J MATER CHEM, V22, P21686, DOI 10.1039/c2jm34395a
   Zhang ML, 2012, J BIOMED MATER RES A, V100A, P2979, DOI 10.1002/jbm.a.34246
   Zhang MY, 2010, J PLAST RECONSTR AES, V63, P227, DOI 10.1016/j.bjps.2008.11.017
   Zheng F, 2010, THESIS OHIO STATE U
NR 57
TC 80
Z9 82
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 5
BP 1507
EP 1518
DI 10.1016/j.biomaterials.2013.11.014
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 295ZY
UT WOS:000330156100016
PM 24268199
DA 2018-10-20
ER

PT J
AU Musson, D
   Street, M
   Dray, M
   Thambayah, A
   Callon, K
   Tuari, D
   Coleman, B
   Cornish, J
AF Musson, David
   Street, Matthew
   Dray, Michael
   Thambayah, Ashvin
   Callon, Karen
   Tuari, Donna
   Coleman, Brendan
   Cornish, Jillian
TI Healing of the bone and tendon interface: an in vivo study using a
   lactoferrin seeded biomaterial scaffold
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Bone-and-Mineral-Research
CY SEP 12-15, 2014
CL Houston, TX
SP Amer Soc Bone & Mineral Res
C1 [Musson, David; Street, Matthew; Thambayah, Ashvin; Callon, Karen; Tuari, Donna; Cornish, Jillian] Univ Auckland, Auckland 1, New Zealand.
   [Dray, Michael] Waikato Dist Hlth Board, Hamilton, New Zealand.
   [Coleman, Brendan] Cty Manukau Dist Hlth Board, Hamilton, New Zealand.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
EI 1523-4681
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD FEB
PY 2014
VL 29
SU 1
MA MO0096
BP S380
EP S380
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CK9ZS
UT WOS:000356598702249
DA 2018-10-20
ER

PT J
AU Bell, S
   Ajami, E
   Davies, JE
AF Bell, Spencer
   Ajami, Elnaz
   Davies, John E.
TI An Improved Mechanical Testing Method to Assess Bone-implant Anchorage
SO Jove-Journal of Visualized Experiments
LA English
DT Article
DE Bioengineering; Issue 84; Mechanical test; bone anchorage; disruption
   test; surface topography; peri-implant bone; bone-implant interface;
   bone-bonding; microtopography; nanotopography
ID IN-VIVO; SURFACE; OSSEOINTEGRATION; INTERFACE; STRENGTH
AB Recent advances in material science have led to a substantial increase in the topographical complexity of implant surfaces, both on a microand a nano-scale. As such, traditional methods of describing implant surfaces -namely numerical determinants of surface roughness -are inadequate for predicting in vivo performance. Biomechanical testing provides an accurate and comparative platform to analyze the performance of biomaterial surfaces. An improved mechanical testing method to test the anchorage of bone to candidate implant surfaces is presented. The method is applicable to both early and later stages of healing and can be employed for any range of chemically or mechanically modified surfaces -but not smooth surfaces. Custom rectangular implants are placed bilaterally in the distal femora of male Wistar rats and collected with the surrounding bone. Test specimens are prepared and potted using a novel breakaway mold and the disruption test is conducted using a mechanical testing machine. This method allows for alignment of the disruption force exactly perpendicular, or parallel, to the plane of the implant surface, and provides an accurate and reproducible means for isolating an exact peri-implant region for testing.
C1 [Bell, Spencer; Ajami, Elnaz; Davies, John E.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A1, Canada.
RP Davies, JE (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A1, Canada.
EM jed.davies@utoronto.ca
FU Biomet 3i; National Sciences and Engineering Research Council of Canada
   (NSERC)
FX The authors would like to thank Biomet 3i for their continued financial
   support, and particularly Randy Goodman for help in the design and
   fabrication of the custom parts. Spencer Bell is a recipient of an
   Industrial Postgraduate Scholarship, provided by the National Sciences
   and Engineering Research Council of Canada (NSERC). We would also like
   to thank Dr. John Brunski for his very valuable feedback during
   manuscript preparation.
CR Branemark R, 1997, BIOMATERIALS, V18, P969, DOI 10.1016/S0142-9612(97)00018-5
   Branemark R, 2011, NANOMED-NANOTECHNOL, V7, P220, DOI 10.1016/j.nano.2010.10.006
   Brunski J B, 1999, Adv Dent Res, V13, P99
   Brunski JB, 2005, OSSEOINTEGRATION BOO, P209
   CURREY JD, 1979, J BIOMECH, V12, P313, DOI 10.1016/0021-9290(79)90073-3
   Davies J.E., 2000, BONE ENG, P1
   Davies JE, 2013, BIOMATERIALS, V34, P3535, DOI 10.1016/j.biomaterials.2013.01.024
   Edwards JT, 1997, J BIOMED MATER RES, V36, P454
   Gotfredsen K, 2000, Clin Implant Dent Relat Res, V2, P120, DOI 10.1111/j.1708-8208.2000.tb00002.x
   Hench L. L., 1972, J BIOMED MAT RES S, V1, P117
   Hong L., J BIOMED MAT RES, V26, P7
   Itala A, 2003, J BIOMED MATER RES A, V67A, P496, DOI 10.1002/jbm.a.10501
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Lekholm U, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X
   MCKEE MD, 1995, ANN NY ACAD SCI, V760, P177, DOI 10.1111/j.1749-6632.1995.tb44629.x
   Mendes VC, 2007, BIOMATERIALS, V28, P4748, DOI 10.1016/j.biomaterials.2007.07.020
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   O'Brien FJ, 2005, J ORTHOP RES, V23, P475, DOI 10.1016/j.orthres.2004.08.005
   Ronold HJ, 2003, BIOMATERIALS, V24, P4559, DOI 10.1016/S0142-9612(03)00256-4
   Skedros JG, 2005, ANAT REC PART A, V286A, P781, DOI 10.1002/ar.a.20214
   Steflik, 1998, J BIOMED MATER RES, P611
   Sul YT, 2010, J R SOC INTERFACE, V7, P81, DOI 10.1098/rsif.2009.0060
   WELSH RP, 1971, J BONE JOINT SURG AM, VA 53, P963, DOI 10.2106/00004623-197153050-00011
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
NR 24
TC 0
Z9 0
U1 0
U2 2
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD FEB
PY 2014
IS 84
AR e51221
DI 10.3791/51221
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CA0JL
UT WOS:000348604100054
PM 24561765
OA Green Published
DA 2018-10-20
ER

PT J
AU Burnett, LR
   Richter, JG
   Rahmany, MB
   Soler, R
   Steen, JA
   Orlando, G
   Abouswareb, T
   Van Dyke, ME
AF Burnett, Luke R.
   Richter, Jillian G.
   Rahmany, Maria B.
   Soler, Roberto
   Steen, Julie A.
   Orlando, Giuseppe
   Abouswareb, Tamer
   Van Dyke, Mark E.
TI Novel keratin (KeraStat (TM)) and polyurethane (Nanosan (R)-Sorb)
   biomaterials are hemostatic in a porcine lethal extremity hemorrhage
   model
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Keratin biomaterials; Nanosan; KeraStat; Hemcon; hemostat; hemorrhage;
   arterial bleeding; swine model
ID ARTERIAL HEMORRHAGE; SWINE MODEL; DRESSINGS; INJURY; AGENTS; INTEGRIN;
   CARE; ADHESION; VOLUME; GAUZE
AB Traumatic injury is the leading cause of death in people aged 44 or less in the US. It is also estimated that 82% of deaths from battlefield hemorrhage may be survivable with better treatment options. In this study, two biomaterial hemostats having disparate mechanisms were evaluated in a large animal lethal hemorrhage model and compared to a commercial product and standard cotton gauze. We hypothesized that the biomaterial with a biologically active mechanism, as opposed to a mechanical mechanism, would be the most effective in this model. Using a published study protocol, the femoral artery in swine was punctured and treated. KeraStat (KeraNetics) and Nanosan (R)-Sorb (SNS Nano) hemostats were compared to a commercial chitosan dressing (second generation Hemcon (R)) and cotton gauze. Both KeraStat and Nanosan increased survival, significantly increased mean arterial pressure (MAP), and significantly decreased shock index compared to both controls. The Hemcon dressing was no different than gauze. Platelet adhesion assays suggested that the KeraStat mechanism of action involves 1 integrin mediated platelet adhesion while Nanosan-Sorb operates similar to one reported mechanism for Hemcon, absorbing fluid and concentrating clotting components. The Nanosan also swelled considerably and created pressure within the wound site even after direct pressure was removed.
C1 [Burnett, Luke R.] KeraNetics LLC, Winston Salem, NC USA.
   [Richter, Jillian G.; Soler, Roberto; Steen, Julie A.; Abouswareb, Tamer] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA.
   [Rahmany, Maria B.; Van Dyke, Mark E.] Wake Forest Sch Med, Dept Orthopaed Surg, Winston Salem, NC USA.
   [Orlando, Giuseppe] Wake Forest Sch Med, Div Surg, Winston Salem, NC USA.
RP Van Dyke, ME (reprint author), Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
EM mvandyk5@vt.edu
RI Soler, Roberto/E-4094-2012
OI Soler, Roberto/0000-0002-1447-670X; Richter, Jillian/0000-0002-2233-1711
FU KeraNetics LLC; SNS Nano
FX Partial funding for this project was provided by KeraNetics LLC and SNS
   Nano.
CR Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Acheson EM, 2005, J TRAUMA, V59, P865, DOI 10.1097/01.ta.0000187655.63698.9f
   Arnaud F, 2009, J VASC SURG, V50, P632, DOI 10.1016/j.jvs.2009.06.010
   BUSH JA, 1955, AM J PHYSIOL, V181, P9
   Clifford C Cloonan, 2004, Mil Med, V169, P8
   Gralnick HR, 1996, THROMB RES, V81, P113, DOI 10.1016/0049-3848(95)00219-7
   Holcomb JB, 1999, J TRAUMA, V47, P233, DOI 10.1097/00005373-199908000-00002
   Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1
   Kheirabadi BS, 2008, J SURG RES, V144, P145, DOI 10.1016/j.jss.2007.02.012
   Kheirabadi BS, 2010, J TRAUMA, V68, P269, DOI 10.1097/TA.0b013e3181c97ef1
   Kheirabadi BS, 2009, J TRAUMA, V67, P450, DOI 10.1097/TA.0b013e3181ac0c99
   Kozen BG, 2008, ACAD EMERG MED, V15, P74, DOI 10.1111/j.1553-2712.2007.00009.x
   Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523
   Littlejohn LF, 2011, ACAD EMERG MED, V18, P340, DOI 10.1111/j.1553-2712.2011.01036.x
   Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618
   Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120
   Peake JB, 2005, NEW ENGL J MED, V352, P219, DOI 10.1056/NEJMp048312
   Pusateri AE, 2003, J TRAUMA, V55, P518, DOI 10.1097/01.TA.0000075336.92129.27
   Ran Y, 2010, PREHOSP DISASTER MED, V25, P584, DOI 10.1017/S1049023X00008797
   Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003
   Sondeen JL, 2003, J TRAUMA, V54, P280, DOI 10.1097/01.TA.0000037431.19185.B4
   Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474
   Ward KR, 2007, J TRAUMA, V63, P276, DOI 10.1097/%A.0b013e3180eea8a5
   Wright JK, 2004, J TRAUMA, V57, P224, DOI 10.1097/01.TA.0000105916.30158.06
NR 24
TC 19
Z9 19
U1 2
U2 37
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2014
VL 28
IS 6
BP 869
EP 879
DI 10.1177/0885328213484975
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 284KX
UT WOS:000329317100007
PM 23594681
DA 2018-10-20
ER

PT J
AU Akkouch, A
   Zhang, Z
   Rouabhia, M
AF Akkouch, Adil
   Zhang, Ze
   Rouabhia, Mahmoud
TI Engineering bone tissue using human dental pulp stem cells and an
   osteogenic collagen-hydroxyapatite-poly
   (L-lactide-co-epsilon-caprolactone) scaffold
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Human dental pulp stem cells; differentiation; biomaterial;
   poly(lactide-co--caprolactone); collagen; hydroxyapatite; bone
   regeneration
ID IN-VITRO; CALCIUM-PHOSPHATE; GENE-EXPRESSION; DIFFERENTIATION; VIVO;
   DEFECTS; REGENERATION; ASSOCIATION; OSTEOBLASTS; POPULATION
AB The aim of this study was to design a new natural/synthetic bioactive bone scaffold for potential use in bone replacement applications. We developed a tri-component osteogenic composite scaffold made of collagen (Coll), hydroxyapatite (HA) and poly(l-lactide-co--caprolactone) (PLCL). This Coll/HA/PLCL composite scaffold was combined with human osteoblast-like cells obtained by differentiation of dental pulp stem cells (DPSCs) to engineer bone tissue invitro. Results show that the 3D Coll/HA/PLCL composite scaffold was highly porous, thereby enabling osteoblast-like cell adhesion and growth. Cultured in the Coll/HA/PLCL scaffold, the osteoblast-like cells expressed different osteogenic genes, produced alkaline phosphatase and formed nodules more than did PLCL alone. Micro-CT analyses revealed a significant (30%) increase of tissue mineralisation on the surface as well as inside of the Coll/HA/PLCL scaffold, thus confirming its effectiveness as a bone regeneration platform.
C1 [Akkouch, Adil; Rouabhia, Mahmoud] Univ Laval, Fac Dent, Grp Rech Ecol Buccale, Quebec City, PQ, Canada.
   [Akkouch, Adil; Zhang, Ze] Univ Laval, Dept Surg, Quebec City, PQ, Canada.
   [Akkouch, Adil; Zhang, Ze] CHUQ, St Francois dAssise Hosp, Res Ctr, Quebec City, PQ, Canada.
RP Rouabhia, M (reprint author), Univ Laval, Fac Med Dent, Grp Rech Ecol Buccale, Quebec City, PQ, Canada.
EM mahmoud.rouabhia@fmd.ulaval.ca
FU Canadian Institutes of Health Research (CIHR); Natural Science and
   Engineering Research Council of Canada (NSERC); Reseau de recherche en
   sante buccodentaire et osseuse du FRSQ
FX Financial support was provided by the Canadian Institutes of Health
   Research (CIHR), the Natural Science and Engineering Research Council of
   Canada (NSERC) and the Reseau de recherche en sante buccodentaire et
   osseuse du FRSQ.
CR Agarwal R, 2009, J NEUROSURG-SPINE, V11, P729, DOI 10.3171/2009.6.SPINE08669
   Akkouch A, 2010, J BIOMED MATER RES A, V92A, P221, DOI 10.1002/jbm.a.32357
   Atari M, 2012, BONE, V50, P930, DOI 10.1016/j.bone.2012.01.005
   Bottino MC, 2011, ACTA BIOMATER, V7, P216, DOI 10.1016/j.actbio.2010.08.019
   Boukhechba F, 2009, J BONE MINER RES, V24, P1927, DOI [10.1359/JBMR.090517, 10.1359/jbmr.090517]
   Calvo MS, 1996, ENDOCR REV, V17, P333, DOI 10.1210/er.17.4.333
   d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121
   d'Aquino R, 2008, STEM CELL REV, V4, P21, DOI 10.1007/s12015-008-9013-5
   Del Bue M, 2008, VET RES COMMUN, V32, pS51, DOI 10.1007/s11259-008-9093-3
   Espitalier F, 2009, BIOMATERIALS, V30, P763, DOI 10.1016/j.biomaterials.2008.10.051
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Gong YH, 2007, ACTA BIOMATER, V3, P531, DOI 10.1016/j.actbio.2006.12.008
   Graham SM, 2010, EXPERT OPIN BIOL TH, V10, P885, DOI 10.1517/14712598.2010.481669
   Granero-Molto F, 2008, EXPERT OPIN BIOL TH, V8, P255, DOI [10.1517/14712598.8.3.255, 10.1517/14712598.8.3.255 ]
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Iohara K, 2006, STEM CELLS, V24, P2493, DOI 10.1634/stemcells.2006-0161
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Kawase T, 2010, J PERIODONTOL, V81, P420, DOI 10.1902/jop.2009.090523
   Lim JI, 2008, BIOTECHNOL LETT, V30, P2085, DOI 10.1007/s10529-008-9808-0
   Mangano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018721
   Mori G, 2011, ANN NY ACAD SCI, V1237, P47, DOI 10.1111/j.1749-6632.2011.06234.x
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nakatsuka R, 2010, ARCH ORAL BIOL, V55, P350, DOI 10.1016/j.archoralbio.2010.03.003
   Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020
   Oliver RC, 1998, J PERIODONTOL, V69, P269, DOI 10.1902/jop.1998.69.2.269
   Park BW, 2009, J ORAL MAXIL SURG, V67, P507, DOI 10.1016/j.joms.2008.08.037
   Park IS, 2009, J BIOMAT SCI-POLYM E, V20, P1645, DOI 10.1163/156856208X386237
   Perry BC, 2008, TISSUE ENG PT C-METH, V14, P149, DOI 10.1089/ten.tec.2008.0031
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813
   Riccio M, 2012, TISSUE ENG PT A, V18, P1006, DOI [10.1089/ten.TEA.2011.0542, 10.1089/ten.tea.2011.0542]
   Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9
   Sculean A, 2008, J PERIODONTOL, V79, P1991, DOI 10.1902/jop.2008.080009 
   Seong JM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/062001
   Shetty Prathibha, 2010, Asian J Transfus Sci, V4, P14, DOI 10.4103/0973-6247.59386
   Vogt S., 2002, European Cells & Materials, V4, P30
   Xie JW, 2004, J BIOMED MATER RES A, V71A, P108, DOI 10.1002/jbm.a.30140
   Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015
NR 39
TC 32
Z9 33
U1 1
U2 31
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2014
VL 28
IS 6
BP 922
EP 936
DI 10.1177/0885328213486705
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 284KX
UT WOS:000329317100012
PM 23640860
DA 2018-10-20
ER

PT J
AU Akagi, H
   Iwata, M
   Ichinohe, T
   Amimoto, H
   Hayashi, Y
   Kannno, N
   Ochi, H
   Fujita, Y
   Harada, Y
   Tagawa, M
   Hara, Y
AF Akagi, Hiroyuki
   Iwata, Munetaka
   Ichinohe, Tomu
   Amimoto, Hirokazu
   Hayashi, Yuuta
   Kannno, Nobuo
   Ochi, Hiroki
   Fujita, Yukihiro
   Harada, Yasuji
   Tagawa, Masahiro
   Hara, Yasushi
TI Hydroxyapatite/poly-L-lactide acid screws have better biocompatibility
   and femoral burr hole closure than does poly-L-lactide acid alone
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Biomaterial; hydroxyapatite; poly-l-lactide; foreign body reaction;
   orthopedics
ID LONG-TERM; INTERNAL-FIXATION; COMPOSITE RODS; BONE-FRACTURES; PIN
   FIXATION; RABBITS; BEHAVIOR; SURGERY
AB Hydroxyapatite (HA)/poly-l-lactide(PLLA) composite biomaterials are available for orthopedic applications, but bioresorption and cell-mediated inflammation in bone cortex are unknown. We conducted an 84-month follow-up study with Beagle dogs that were subjected to implants with either PLLA (left femur) or HA/PLLA (right femur). Histological and radiographic analysis showed that HA/PLLA screws induced significant increases in HA content from 36 months onward and complete burr hole closure at 60 months, whereas PLLA screws did not. Moreover, PLLA screws induced more severe fibrous tissue and histiocyte infiltration. HA/PLLA screws promote earlier burr hole replacement and have superior biocompatibility compared to PLLA screws.
C1 [Akagi, Hiroyuki; Iwata, Munetaka; Ichinohe, Tomu; Amimoto, Hirokazu; Hayashi, Yuuta; Kannno, Nobuo; Harada, Yasuji; Tagawa, Masahiro; Hara, Yasushi] Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Sci, Div Vet Surg, Tokyo 1808602, Japan.
   [Ochi, Hiroki] Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Sci, Div Vet Microbiol, Tokyo 1808602, Japan.
   [Fujita, Yukihiro] Azabu Univ, Sch Vet Med, Lab Vet Surg, Chuou Ku, Sagamihara, Kanagawa, Japan.
RP Hara, Y (reprint author), Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Sci, Div Vet Surg, 1-7-1 Kyonan Cho, Tokyo 1808602, Japan.
EM hara@nvlu.ac.jp
CR BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   DeOrio JK, 2001, FOOT ANKLE INT, V22, P832, DOI 10.1177/107110070102201010
   HARA Y, 1994, J VET MED SCI, V56, P817, DOI 10.1292/jvms.56.817
   HARA Y, 1994, J VET MED SCI, V56, P1041, DOI 10.1292/jvms.56.1041
   Hasegawa S, 2006, BIOMATERIALS, V27, P1327, DOI 10.1016/j.biomaterials.2005.09.003
   Hasegawa Y, 2002, J BIOMED MATER RES, V63, P679, DOI 10.1002/jbm.10388
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ishii S, 2003, J BIOMED MATER RES B, V66B, P539, DOI 10.1002/jbm.b.10027
   Matsusue Y, 1996, CLIN ORTHOP RELAT R, P166
   MATSUSUE Y, 1995, CLIN ORTHOP RELAT R, P246
   Pihlajamaki H, 1998, Surg Technol Int, V7, P395
   Pihlajamaki H, 1992, J BONE JOINT SURG, V74-B, P857
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Saito T, 2004, ANN THORAC SURG, V77, P684, DOI 10.1016/S0003-4975(03)01341-9
   Tatsumi A, 1999, ANN THORAC SURG, V67, P765, DOI 10.1016/S0003-4975(98)01264-8
   TEGNANDER A, 1994, ACTA ORTHOP SCAND, V65, P472, DOI 10.3109/17453679408995495
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   Yasunaga T, 1999, J BIOMED MATER RES, V47, P412, DOI 10.1002/(SICI)1097-4636(19991205)47:3<412::AID-JBM17>3.0.CO;2-B
NR 20
TC 6
Z9 6
U1 1
U2 14
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2014
VL 28
IS 6
BP 954
EP 962
DI 10.1177/0885328213487754
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 284KX
UT WOS:000329317100015
PM 23680818
DA 2018-10-20
ER

PT J
AU Putra, N
   Saleh, R
   Septiadi, WN
   Okta, A
   Hamid, Z
AF Putra, Nandy
   Saleh, Rosari
   Septiadi, Wayan Nata
   Okta, Ashar
   Hamid, Zein
TI Thermal performance of biomaterial wick loop heat pipes with water-base
   Al2O3 nanofluids
SO INTERNATIONAL JOURNAL OF THERMAL SCIENCES
LA English
DT Article
DE Loop heat pipe; Wick; Nanofluids; Biomaterial
ID FLAT EVAPORATOR; ELECTRONICS; FLUID
AB Given the increase of heat flux generated by electronic equipment, particular components of a computer (e.g., the CPU) should always be accompanied with good cooling to achieve optimal operating capability and a high level of reliability. The use of loop heat pipes (LHPs) in the thermal management of electronic cooling is a major alternative solution. Before LHPs are implemented as an alternative cooling method for electronic devices, a quantity of reliability factors should be considered and evaluated, such as wick structure, material, and the type of working fluid. In this case, the pore size distribution of a biomaterial (Collar) that is smaller and more homogeneous than pore size distribution of sintered powder was investigated. The purposes of this experimental study are to examine and analyze the application of a biomaterial (Collar) as a wick on a loop heat pipe and the use of the nanofluid Al2O3 water as a working fluid. The performance of the biomaterial as a wick and nanofluid as a working fluid in LHPs was also investigated in this experiment. The temperature differences between the evaporator and condenser sections with the biomaterial wick were less than that using a sintered copper powder wick, and the use of nanofluids over pure water also resulted in lower temperature differences; i.e., the thermal resistance of the LHP was lowered when using the biomaterial wick and nanofluids. These results make the biomaterial (Collar) and nanofluids attractive as wick and working fluid, respectively, in LHP technology. (C) 2013 Elsevier Masson SAS. All rights reserved.
C1 [Putra, Nandy; Septiadi, Wayan Nata; Okta, Ashar; Hamid, Zein] Univ Indonesia, Dept Mech Engn, Heat Transfer Lab, Depok 16424, Indonesia.
   [Saleh, Rosari] Univ Indonesia, Fak MIPA, Dept Fis, Depok 15426, Indonesia.
RP Putra, N (reprint author), Univ Indonesia, Dept Mech Engn, Heat Transfer Lab, Kampus UI, Depok 16424, Indonesia.
EM nandyputra@eng.ui.ac.id
OI Septiadi, Wayan Nata/0000-0003-3121-9542
FU Directorate of Higher Education Minister of National Education Republic
   of Indonesia; DRPM University of Indonesia
FX The authors would like to thank Directorate of Higher Education Minister
   of National Education Republic of Indonesia and the DRPM University of
   Indonesia for funding this research.
CR Chang YW, 2008, ENERG CONVERS MANAGE, V49, P3398, DOI 10.1016/j.enconman.2008.05.002
   Do KH, 2010, INT J HEAT MASS TRAN, V53, P5888, DOI 10.1016/j.ijheatmasstransfer.2010.07.050
   Kang SW, 2006, APPL THERM ENG, V26, P2377, DOI 10.1016/j.applthermaleng.2006.02.020
   Kang SW, 2009, APPL THERM ENG, V29, P973, DOI 10.1016/j.applthermaleng.2008.05.010
   Kempers R, 2006, APPL THERM ENG, V26, P589, DOI 10.1016/j.applthermaleng.2005.07.004
   Kempers R, 2008, INT J HEAT MASS TRAN, V51, P6039, DOI 10.1016/j.ijheatmasstransfer.2008.04.001
   Kiseev VM, 2010, APPL THERM ENG, V30, P1312, DOI 10.1016/j.applthermaleng.2010.02.010
   Lefevre F, 2012, APPL THERM ENG, V37, P95, DOI 10.1016/j.applthermaleng.2011.11.022
   Leong KC, 1997, J POROUS MAT, V4, P303, DOI 10.1023/A:1009685508557
   Li J, 2010, APPL THERM ENG, V30, P741, DOI 10.1016/j.applthermaleng.2009.12.004
   Li JW, 2010, EXP THERM FLUID SCI, V34, P1403, DOI 10.1016/j.expthermflusci.2010.06.016
   Lin FC, 2011, INT J HEAT MASS TRAN, V54, P4621, DOI 10.1016/j.ijheatmasstransfer.2011.06.015
   Liu ZH, 2010, INT J THERM SCI, V49, P1680, DOI 10.1016/j.ijthermalsci.2010.03.006
   Liu ZH, 2011, ENERG CONVERS MANAGE, V52, P292, DOI 10.1016/j.enconman.2010.07.001
   Maydanik YF, 2005, IEEE T COMPON PACK T, V28, P290, DOI 10.1109/TCAPT.2005.848487
   Maydanik YF, 2005, APPL THERM ENG, V25, P635, DOI 10.1016/j.applthermaleng.2004.07.010
   Maydanik Y, 2011, APPL THERM ENG, V31, P3533, DOI 10.1016/j.applthermaleng.2011.07.008
   Mishra DK, 2010, ADV POWDER TECHNOL, V21, P658, DOI 10.1016/j.apt.2010.07.011
   Pastukhov VG, 2003, APPL THERM ENG, V23, P1125, DOI 10.1016/S1359-4311(03)00046-2
   Putra N, 2012, EXP THERM FLUID SCI, V40, P10, DOI 10.1016/j.expthermflusci.2012.01.007
   Putra Nandy, 2011, 4 INT M ADV THERM ME
   Riehl RR, 2005, APPL THERM ENG, V25, P101, DOI 10.1016/j.applthermaleng.2004.05.010
   Russel MK, 2011, APPL THERM ENG, V31, P69, DOI 10.1016/j.applthermaleng.2010.08.013
   Tang Y, 2010, EXP THERM FLUID SCI, V34, P190, DOI 10.1016/j.expthermflusci.2009.10.016
   Tsai CY, 2004, MATER LETT, V58, P1461, DOI 10.1016/j.matlet.2003.10.009
   Vasiliev L, 2009, INT J HEAT MASS TRAN, V52, P301, DOI 10.1016/j.ijheatmasstransfer.2008.06.016
   Zan K. J., 2004, Heat Transfer-Asian Research, V33, P515, DOI 10.1002/htj.20034
NR 27
TC 16
Z9 16
U1 0
U2 26
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 1290-0729
EI 1778-4166
J9 INT J THERM SCI
JI Int. J. Therm. Sci.
PD FEB
PY 2014
VL 76
BP 128
EP 136
DI 10.1016/j.ijthermalsci.2013.08.020
PG 9
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA 277FN
UT WOS:000328804500012
DA 2018-10-20
ER

PT J
AU Chung, TW
   Lai, DM
   Chen, SD
   Lin, YI
AF Chung, Tze-Wen
   Lai, Dar-Ming
   Chen, Shin-Der
   Lin, Ya-I
TI Poly (epsilon-caprolactone) scaffolds functionalized by grafting NGF and
   GRGD promote growth and differentiation of PC12 cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE NGF; GRGD; PCL scaffolds; PC12 cell; neural tissue engineering
ID HUMAN ENDOTHELIAL-CELLS; TISSUE ENGINEERING APPLICATIONS;
   PERIPHERAL-NERVE REGENERATION; NEURITE OUTGROWTH; NANOMETER-SCALE;
   REPAIR; RGD; GUIDANCE; SURFACE; PROTEINS
AB Poly(epsilon-caprolactone) (PCL) scaffolds functionalized by grafting nerve growth factor (NGF) and Asp-Arg-Gly-Asp (GRGD)(PCL-NGF/GRGD) for neural tissue engineering. The influences of PCL-NGF/GRGD scaffolds on the growth and differentiation of PC12 cells were investigated. The successfully grafting NGF and GRGD into PCL-CS scaffold were verified by FTIR spectra. The densities of GRGD and NGF in the scaffolds were about 2.10x10(-1) mol/cm(2) and 1.51x10(-3) nmol/cm(2). Growths of PC12 cells in PCL-GRGD and PCL/NGF-GRGD scaffolds via MTS measurements were significantly higher (p < 0.01, n = 4) than that in PCL-CS or PCL-NGF ones for three days of cultivation that was consistent with SEM observations. Moreover, the differentiation of PC12 cells, induced by NGF at 50 ng/mL for four days, in PCL-NGF/GRGD scaffolds were qualitatively more numbers and longer outgrowth of neurites than those in PCL-CS, PCL-GRGD, and PCL-NGF ones by SEM observations. The synergistic effects of grafting both NGF and GRGD ligands to PCL-CS scaffolds on the growth and differentiation of PC12 cells provide a new biomaterial for neural tissue engineering. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 315-323, 2014.
C1 [Chung, Tze-Wen; Chen, Shin-Der; Lin, Ya-I] Natl Yunlin Univ Sci & Technol, Dept Chem & Mat Engn, Dou Liu 640, Yun Lin, Taiwan.
   [Lai, Dar-Ming] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Surg, Taipei 10764, Taiwan.
RP Chung, TW (reprint author), Natl Yunlin Univ Sci & Technol, Dept Chem & Mat Engn, Dou Liu 640, Yun Lin, Taiwan.
EM twchung@yuntech.edu.tw
FU NSC of Taiwan, ROC [NSC-100-2221- E-224-007-MY2]
FX This study is supported by NSC of Taiwan, ROC with the project no:
   NSC-100-2221- E-224-007-MY2.
CR Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798
   Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   Chung TW, 2005, J BIOMED MATER RES A, V72A, P213, DOI 10.1002/jbm.a.30225
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   Chung TW, 2011, BIOMATERIALS, V32, P734, DOI 10.1016/j.biomaterials.2010.09.023
   Chung TW, 2010, J MICROENCAPSUL, V27, P514, DOI 10.3109/02652048.2010.484104
   Chung TW, 2010, J MATER SCI-MATER M, V21, P1343, DOI 10.1007/s10856-009-3876-0
   CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S
   DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E
   FUJII DK, 1982, J NEUROSCI, V2, P1157
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Guo Y, 2007, BIOMACROMOLECULES, V8, P3025, DOI 10.1021/bm070266z
   Howe CL, 2003, NEUROSCI LETT, V351, P41, DOI 10.1016/S0304-3940(03)00915-7
   Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
   Huang YC, 2007, J BIOMED MATER RES A, V82A, P842, DOI 10.1002/jbm.a.31036
   KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549
   Kokai LE, 2009, ACTA BIOMATER, V5, P2540, DOI 10.1016/j.actbio.2009.03.009
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Pankajakshan D, 2008, J BIOMED MATER RES B, V87B, P570, DOI 10.1002/jbm.b.31146
   Park KH, 2004, J BIOSCI BIOENG, V97, P374, DOI 10.1263/jbb.97.374
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217
   Sun MZ, 2009, J MATER SCI-MATER M, V20, P1181, DOI 10.1007/s10856-008-3671-3
   Sun WJ, 2009, BIOMATERIALS, V30, P4649, DOI 10.1016/j.biomaterials.2009.05.037
   Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x
   Terzis JK, 1997, J RECONSTR MICROSURG, V13, P215, DOI 10.1055/s-2007-1006407
   Tucker BA, 2005, J COMP NEUROL, V486, P267, DOI 10.1002/cne.20518
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yan QJ, 2012, BIOMED ENG ONLINE, P11
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
NR 33
TC 4
Z9 4
U1 1
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2014
VL 102
IS 2
BP 315
EP 323
DI 10.1002/jbm.a.34693
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 269MT
UT WOS:000328246100002
PM 23468336
DA 2018-10-20
ER

PT J
AU Nectow, AR
   Kilmer, ME
   Kaplan, DL
AF Nectow, Alexander R.
   Kilmer, Misha E.
   Kaplan, David L.
TI Quantifying cellular alignment on anisotropic biomaterial platforms
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cellular alignment; algorithm; NCP criterion; silk; PC-12 cells
ID NERVE GROWTH-FACTOR; NEURITE OUTGROWTH; IN-VITRO; SILK; GUIDANCE; CELLS;
   ORIENTATION; SCAFFOLDS; SUBSTRATE; GRADIENT
AB How do we quantify cellular alignment? Cellular alignment is an important technique used to study and promote tissue regeneration in vitro and in vivo. Indeed, regenerative outcomes are often strongly correlated with the efficacy of alignment, making quantitative, automated assessment an important goal for the field of tissue engineering. There currently exist various classes of algorithms, which effectively address the problem of quantifying individual cellular alignments using Fourier methods, kernel methods, and elliptical approximation; however, these algorithms often yield population distributions and are limited by their inability to yield a scalar metric quantifying the efficacy of alignment. The current work builds on these classes of algorithms by adapting the signal processing methods previously used by our group to study the alignment of cellular processes. We use an automated, ellipse-fitting algorithm to approximate cell body alignment with respect to a silk biomaterial scaffold, followed by the application of the normalized cumulative periodogram criterion to produce a scalar value quantifying alignment. The proposed work offers a generalized method for assessing cellular alignment in complex, two-dimensional environments. This method may also offer a novel alternative for assessing the alignment of cell types with polarity, such as fibroblasts, endothelial cells, and mesenchymal stem cells, as well as nuclei. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 420-428, 2014.
C1 [Nectow, Alexander R.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Kilmer, Misha E.] Tufts Univ, Dept Math, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@Tufts.edu
FU NIH [P41EB002520]
FX Contract grant sponsor: NIH; contract grand number: P41EB002520
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bray MAP, 2010, BIOMATERIALS, V31, P5143, DOI 10.1016/j.biomaterials.2010.03.028
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   Cecchini M, 2007, NANOTECHNOLOGY, V18, P1
   Chien HW, 2009, BIOMATERIALS, V30, P2209, DOI 10.1016/j.biomaterials.2008.12.060
   Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fitzgibbon A, 1999, IEEE T PATTERN ANAL, V21, P476, DOI 10.1109/34.765658
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Haines C, 2010, J NEUROSCI METH, V187, P52, DOI 10.1016/j.jneumeth.2009.12.010
   Hansen PC, 2006, BIT, V46, P41, DOI 10.1007/s10543-006-0042-7
   Heath M., 2002, SCI COMPUTING INTRO
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Karlon WJ, 1999, ANN BIOMED ENG, V27, P712, DOI 10.1114/1.226
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lawrence BD, 2012, ACTA BIOMATER, V8, P3732, DOI 10.1016/j.actbio.2012.06.009
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li GN, 2008, ANN BIOMED ENG, V36, P889, DOI 10.1007/s10439-008-9486-z
   Li GN, 2008, J NEUROSCI METH, V174, P202, DOI 10.1016/j.jneumeth.2008.07.001
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Mandal BB, 2011, TISSUE ENG PT A, V17, P2749, DOI [10.1089/ten.tea.2011.0031, 10.1089/ten.TEA.2011.0031]
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Manjon-Herrera JV, 2005, KMEANS IMAGE SEGMENT
   Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]
   Nectow AR, 2013, J BIOMED MATER RES A, V101, P884, DOI 10.1002/jbm.a.34385
   Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605
   Oliveira AL, 2012, ACTA BIOMATER, V8, P1530, DOI 10.1016/j.actbio.2011.12.015
   Phu D, 2011, TISSUE ENG PT A, V17, P799, DOI [10.1089/ten.tea.2009.0724, 10.1089/ten.TEA.2009.0724]
   Sofia S, 2001, J BIOMED MATER RES, V54, P138
   Song HK, 2006, BIOMATERIALS, V27, P473, DOI 10.1016/j.biomaterials.2005.06.030
   Xu F, 2011, TISSUE ENG PART C-ME, V17, P641, DOI 10.1089/ten.tec.2011.0038
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Zhang YY, 2012, BIOMATERIALS, V33, P2926, DOI 10.1016/j.biomaterials.2012.01.006
NR 39
TC 6
Z9 6
U1 1
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2014
VL 102
IS 2
BP 420
EP 428
DI 10.1002/jbm.a.34713
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 269MT
UT WOS:000328246100014
PM 23520051
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Akram, M
   Ahmed, R
   Shakir, I
   Ibrahim, WAW
   Hussain, R
AF Akram, Muhammad
   Ahmed, Rashid
   Shakir, Imran
   Ibrahim, Wan Aini Wan
   Hussain, Rafaqat
TI Extracting hydroxyapatite and its precursors from natural resources
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Review
ID CALCIUM-PHOSPHATE BIOCERAMICS; NANOCRYSTALLINE HYDROXYAPATITE;
   HEAT-TREATMENT; BOVINE BONE; NANOSIZED HYDROXYAPATITE; FISH BONES;
   EGG-SHELL; WASTE; CARBONATE; EGGSHELL
AB Healing of segmental bone defects remain a difficult problem in orthopedic and trauma surgery. One reason for this difficulty is the limited availability of bone material to fill the defect and promote bone growth. Hydroxyapatite (HA) is a synthetic biomaterial, which is chemically similar to the mineral component of bones and hard tissues in mammals and, therefore, it can be used as a filler to replace damaged bone or as a coating on implants to promote bone in-growth into prosthetic implants when used in orthopedic, dental, and maxillofacial applications. HA is a stoichiometric material with a chemical composition of Ca-10(PO4)(6)(OH)(2), while a mineral component of bone is a non-stoichiometric HA with trace amounts of ions such as Na+, Zn2+, Mg2+, K+, Si2+, Ba2+, F-, CO32-, etc. This review looks at the progress being made to extract HA and its precursors containing trace amount of beneficial ions from biological resources like animal bones, eggshells, wood, algae, etc. Properties, such as particle size, morphology, stoichiometry, thermal stability, and the presence of trace ions are studied with respect to the starting material and recovery method used. This review also highlights the importance of extracting HA from natural resources and gives future directions to the researcher so that HA extracted from biological resources can be used clinically as a valuable biomaterial.
C1 [Akram, Muhammad; Ibrahim, Wan Aini Wan] Univ Teknol Malaysia, Fac Sci, Dept Chem, Utm Johor Bahru 81310, Johor Darul Taz, Malaysia.
   [Ahmed, Rashid] Univ Teknol Malaysia, Fac Sci, Dept Phys, Utm Johor Bahru 81310, Johor Darul Taz, Malaysia.
   [Shakir, Imran] King Saud Univ, Dept Sustainable Energy, Riyadh, Saudi Arabia.
   [Hussain, Rafaqat] Univ Teknol Malaysia, Ibnu Sina Inst Fundamental Sci Studies, Utm Johor Bahru 81310, Johor Darul Taz, Malaysia.
RP Hussain, R (reprint author), Univ Teknol Malaysia, Ibnu Sina Inst Fundamental Sci Studies, Utm Johor Bahru 81310, Johor Darul Taz, Malaysia.
EM rafaqat@kimia.fs.utm.my
OI Hussain, Rafaqat/0000-0003-4810-4776
FU UTM through IDF [UTM. J. 10.01/13. 14/1/128(201105M10019)]
FX Authors would like to acknowledge the financial support from UTM through
   IDF UTM. J. 10.01/13. 14/1/128(201105M10019).
CR Bahrololoom ME, 2009, J CERAM PROCESS RES, V10, P129
   Baig AA, 1996, J COLLOID INTERF SCI, V179, P608, DOI 10.1006/jcis.1996.0255
   Balazsi C, 2007, J EUR CERAM SOC, V27, P1601, DOI 10.1016/j.jeurceramsoc.2006.04.016
   BANKS E, 1977, SCIENCE, V198, P1164, DOI 10.1126/science.929194
   Barakat NAM, 2009, J MATER PROCESS TECH, V209, P3408, DOI 10.1016/j.jmatprotec.2008.07.040
   Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0
   Betancuret ALG, 2013, CURR APPL PHYS, V13, P1383
   Bohner M, 2000, INJURY, V31, pS37
   Boutinguiza M, 2012, MAT SCI ENG C-MATER, V32, P478, DOI 10.1016/j.msec.2011.11.021
   BROWN WE, 1976, ANNU REV MATER SCI, V6, P213, DOI 10.1146/annurev.ms.06.080176.001241
   Cai YL, 2009, THIN SOLID FILMS, V517, P5347, DOI 10.1016/j.tsf.2009.03.071
   Carrodeguas RG, 2011, ACTA BIOMATER, V7, P3536, DOI 10.1016/j.actbio.2011.06.019
   Castro P., 2008, MARINE BIOL
   Chaari K, 2009, MATER CHEM PHYS, V113, P219, DOI 10.1016/j.matchemphys.2008.07.079
   Chaudhuri B, 2013, MATER LETT, V97, P148, DOI 10.1016/j.matlet.2013.01.082
   Coelho TM, 2006, J APPL PHYS, V100, DOI 10.1063/1.2369647
   dePaula SM, 2010, MICRON, V41, P983, DOI 10.1016/j.micron.2010.06.014
   Ribeiro DCD, 2012, MICROSC RES TECHNIQ, V75, P133, DOI 10.1002/jemt.21035
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Feki H. E., 1991, CALCIFIED TISSUE INT, V49, P269
   Ferraro V, 2013, MAT SCI ENG C-MATER, V33, P3111, DOI 10.1016/j.msec.2013.04.003
   Figueiredo M, 2010, CERAM INT, V36, P2383, DOI 10.1016/j.ceramint.2010.07.016
   Gergely G, 2010, CERAM INT, V36, P803, DOI 10.1016/j.ceramint.2009.09.020
   Goloshchapov DL, 2013, CERAM INT, V39, P4539, DOI 10.1016/j.ceramint.2012.11.050
   Gutierres M, 2007, J MATER SCI-MATER M, V18, P2377, DOI 10.1007/s10856-007-3171-x
   Haberko K, 2006, J EUR CERAM SOC, V26, P537, DOI 10.1016/j.jeurceramsoc.2005.07.033
   Habib F, 2012, J CHEM SOC PAKISTAN, V34, P584
   Hench L. L., 1993, ADV SERIES CERAMICS
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hiller JC, 2003, BIOMATERIALS, V24, P5091, DOI 10.1016/S0142-9612(03)00427-7
   Ho WF, 2013, CERAM INT, V39, P6467, DOI 10.1016/j.ceramint.2013.01.076
   Huang YC, 2011, CERAM INT, V37, P1825, DOI 10.1016/j.ceramint.2011.01.018
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9
   Ivankovic H, 2010, J MATER SCI-MATER M, V21, P2711, DOI 10.1007/s10856-010-4115-4
   Ivarez-Lloret P, 2010, CRYS GROWTH DES, V10, P5227
   Jaramillo CD, 2010, REV COLOMB CIENC PEC, V23, P471
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Kannan S, 2006, J MATER CHEM, V16, P286, DOI 10.1039/b511867k
   Kaplan DL, 1998, SCIENCE, V3, P232
   Kim SK, 2006, FOOD RES INT, V39, P383, DOI 10.1016/j.foodres.2005.10.010
   Kim SK, 2001, LIFE SCI J, V11, P97
   Kim YH, 2005, CURR APPL PHYS, V5, P538, DOI 10.1016/j.cap.2005.01.031
   Kongsri S, 2013, CHEM ENG J, V215, P522, DOI 10.1016/j.cej.2012.11.054
   Krishna DSR, 2007, J MATER SCI-MATER M, V18, P1735, DOI 10.1007/s10856-007-3069-7
   Kumar GS, 2012, MATER LETT, V76, P198, DOI 10.1016/j.matlet.2012.02.106
   Kusmanto F, 2008, CHEM ENG J, V139, P398, DOI 10.1016/j.cej.2007.11.041
   Kusrini E, 2012, RADIAT PHYS CHEM, V81, P118, DOI 10.1016/j.radphyschem.2011.10.006
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   LAWTON DM, 1989, J DENT, V17, P21, DOI 10.1016/0300-5712(89)90003-1
   Lee SJ, 2003, MATER LETT, V57, P4570, DOI 10.1016/S0167-577X903)00363-X
   Li SN, 2012, J AM CERAM SOC, V95, P3377, DOI 10.1111/j.1551-2916.2012.05458.x
   Lin FH, 2000, J BIOMED MATER RES, V51, P157, DOI 10.1002/(SICI)1097-4636(200008)51:2<157::AID-JBM3>3.0.CO;2-R
   Lombardi M, 2011, J EUR CERAM SOC, V31, P2513, DOI 10.1016/j.jeurceramsoc.2011.02.017
   Meski S, 2010, J CHEM ENG DATA, V55, P3923, DOI 10.1021/je901070e
   MONROE EA, 1971, J DENT RES, V50, P860, DOI 10.1177/00220345710500041201
   MULYE NV, 1994, DRUG DEV IND PHARM, V20, P2621, DOI 10.3109/03639049409042666
   Murugan R, 2005, CRYST GROWTH DES, V5, P111, DOI 10.1021/cg034227s
   Murugan R, 2006, MATER LETT, V60, P2844, DOI 10.1016/j.matlet.2006.01.104
   Nayar S, 2009, MAT SCI ENG C-BIO S, V29, P1326, DOI 10.1016/j.msec.2008.10.002
   NELSON DGA, 1983, CARIES RES, V17, P200, DOI 10.1159/000260668
   Nirmala R, 2011, J NANOPART RES, V13, P1917, DOI 10.1007/s11051-010-9944-z
   Noh KT, 2010, MATER LETT, V64, P802, DOI 10.1016/j.matlet.2010.01.014
   Ooi CY, 2007, CERAM INT, V33, P1171, DOI 10.1016/j.ceramint.2006.04.001
   Ozawa M, 2002, J AM CERAM SOC, V85, P1315, DOI 10.1111/j.1151-2916.2002.tb00268.x
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Piccirillo C, 2013, MAT SCI ENG C-MATER, V33, P103, DOI 10.1016/j.msec.2012.08.014
   Pramanik N, 2009, INT J BIOMATER, DOI 10.1155/2009/512417
   Pramanik S, 2013, MATERIALS, V6, P65, DOI 10.3390/ma6010065
   Rakmae S, 2013, POLYM-PLAST TECHNOL, V52, P1043, DOI 10.1080/03602559.2013.769580
   Rakmae S, 2012, MAT SCI ENG C-MATER, V32, P1428, DOI 10.1016/j.msec.2012.04.022
   Ramesh S, 2007, SCI TECHNOL ADV MAT, V8, P124, DOI 10.1016/j.stam.2006.11.002
   REJDA BV, 1977, J BIOENG, V1, P93
   Rivera EM, 1999, MATER LETT, V41, P128, DOI 10.1016/S0167-577X(99)00118-4
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Ruksudjarlt A, 2008, CURR APPL PHYS, V8, P270, DOI 10.1016/j.cap.2007.10.076
   Sakka S., 2013, ADV BIOMATERIALS SCI, P23, DOI DOI 10.5772/53088
   Sanosh KP, 2009, MATER LETT, V63, P2100, DOI 10.1016/j.matlet.2009.06.062
   Sellami I, 2000, MATER SCI ENG, V28, P1
   Shaltout AA, 2011, SPECTROCHIM ACTA A, V83, P56, DOI 10.1016/j.saa.2011.07.036
   Shariffuddin JH, 2013, CHEM ENG RES DES, V91, P1693, DOI 10.1016/j.cherd.2013.04.018
   Smolen D, 2013, INT J NANOMED, V8, P653, DOI 10.2147/IJN.S39299
   Sobczak A, 2009, ACTA BIOENG BIOMECH, V11, P23
   Studart AR, 2006, J AM CERAM SOC, V89, P1771, DOI 10.1111/j.1551-2916.2006.01044.x
   Sykaras Nikitas, 2003, J Oral Sci, V45, P57
   Tabrizi BN, 2013, J IND ENG CHEM, DOI [10.1016/j.jiec.2013.03.041, DOI 10.1016/J.JIEC.2013.03.041]
   TAKAGI S, 1987, J DENT RES, V66, P1523, DOI 10.1177/00220345870660100201
   Tampieri A, 2009, J MATER CHEM, V19, P4973, DOI 10.1039/b900333a
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vecchio KS, 2007, ACTA BIOMATER, V3, P910, DOI 10.1016/j.actbio.2007.06.003
   Venkatesan J, 2011, BIOMAD MAT, V6, P12
   Verdelis K, 2007, BONE, V40, P1399, DOI 10.1016/j.bone.2006.12.061
   Villarreal NE, 2012, WATER AIR SOIL POLL, V223, P3643
   Walsh PJ, 2008, CHEM ENG J, V137, P173, DOI 10.1016/j.cej.2007.10.016
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Wu SC, 2013, CERAM INT, V39, P8183, DOI 10.1016/j.ceramint.2013.03.094
   Wu SC, 2011, MATER CHARACT, V62, P1180, DOI 10.1016/j.matchar.2011.09.009
   Xu GF, 2001, J AM CHEM SOC, V123, P2196, DOI 10.1021/ja002537i
   Yoganand CP, 2011, CURR APPL PHYS, V11, P702, DOI 10.1016/j.cap.2010.11.035
   Zhang Y, 2011, J MATER CHEM, V21, P14428, DOI 10.1039/c1jm12544c
NR 103
TC 59
Z9 60
U1 6
U2 109
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD FEB
PY 2014
VL 49
IS 4
BP 1461
EP 1475
DI 10.1007/s10853-013-7864-x
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA 270OI
UT WOS:000328327600002
DA 2018-10-20
ER

PT J
AU Favi, PM
   Yi, SJ
   Lenaghan, SC
   Xia, LJ
   Zhang, MJ
AF Favi, Pelagie M.
   Yi, Sijia
   Lenaghan, Scott C.
   Xia, Lijin
   Zhang, Mingjun
TI Inspiration from the natural world: from bio-adhesives to bio-inspired
   adhesives
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE bio-adhesive; bio-inspiration; biomaterial; biomimetic;
   micro-nanotechnology
ID BARNACLE BALANUS-AMPHITRITE; ATOMIC-FORCE MICROSCOPY; GLUTARALDEHYDE
   TISSUE ADHESIVE; AMPHIBIAN SKIN SECRETIONS; GREEN-ALGA ENTEROMORPHA;
   FROG NOTADEN-BENNETTI; GECKO FOOT-HAIR; PHRAGMATOPOMA-CALIFORNICA;
   ESCHERICHIA-COLI; ATTACHMENT PADS
AB Advances in materials science and engineering through bio-inspiration, at both the micro- and nanoscales, have flourished over recent years. By understanding principles used in nature to produce adhesives and other substances of interest, the field of bio-inspired engineering has emerged as an important area of innovation. In this review, we will focus on bio-adhesives based on three main mechanisms of generating attachment: dry, wet, and chemical adhesion. Dry adhesion, involving micro- to nanoscale filamentous structures, is used by many insects and reptiles to rapidly climb surfaces. Tree frogs and some insects make use of wet adhesion by leveraging capillary forces through the design of attaching structures that increases liquid drainage, and hence increases frictional contact. Finally, chemical adhesion is used by many plants and mollusks, which secrete adhesives composed of proteins, polysaccharides and carbohydrates to generate the strong forces necessary for adhesion. This paper reviews recent discoveries in animal and plant bio-adhesives, and details the mechanisms used in several representative biological systems. We extend the review to include the fundamental principles functioning in each form of adhesion at the micro- and nanoscales. This fast emerging research area has significant implications in the future design of bio-inspired adhesives, and offers further potential for a variety of applications.
C1 [Favi, Pelagie M.; Yi, Sijia; Lenaghan, Scott C.; Xia, Lijin; Zhang, Mingjun] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.
RP Zhang, MJ (reprint author), Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.
EM mjzhang@utk.edu
OI Lenaghan, Scott/0000-0002-7539-1726
FU National Science Foundation [CBET: 0965877, CMMI: 1029953]; Army
   Research Office [W911NF-10-1-0114]; National Institute of Health
   [NIH/NIGMS-IMSD: R25 GM086761]
FX This research was sponsored by the National Science Foundation (CBET:
   0965877, CMMI: 1029953), the Army Research Office (W911NF-10-1-0114),
   and the National Institute of Health (NIH/NIGMS-IMSD: R25 GM086761). The
   authors would like to thank all the sponsors for their financial
   support.
CR Abou B, 2010, J R SOC INTERFACE, V7, P1745, DOI 10.1098/rsif.2010.0075
   Aldred N, 2008, BIOFOULING, V24, P97, DOI 10.1080/08927010801885908
   Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100
   Autumn K, 2006, J EXP BIOL, V209, P3558, DOI 10.1242/jeb.02469
   Autumn K, 2006, J EXP BIOL, V209, P3569, DOI 10.1242/jeb.02486
   Autumn K, 2006, J EXP BIOL, V209, P260, DOI 10.1242/jeb.01980
   Autumn K, 2002, INTEGR COMP BIOL, V42, P1081, DOI 10.1093/icb/42.6.1081
   Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799
   Autumn K, 2000, NATURE, V405, P681
   Bar-Cohen Y, 2006, BIOMIMETICS BIOL INS
   Barlow DE, 2010, LANGMUIR, V26, P6549, DOI 10.1021/la9041309
   Barnes WJP, 2007, MRS BULL, V32, P479, DOI 10.1557/mrs2007.81
   BAUCHHENSS E, 1979, ZOOMORPHOLOGIE, V93, P99, DOI 10.1007/BF00994125
   Baudner BC, 2010, J DRUG TARGET, V18, P752, DOI 10.3109/1061186X.2010.529143
   Bell EC, 1996, J EXP BIOL, V199, P1005
   Beutel RG, 2001, J ZOOL SYST EVOL RES, V39, P177, DOI 10.1046/j.1439-0469.2001.00155.x
   Bhushan B., 2008, NANOTRIBOLOGY NANOME
   Bhushan B, 2008, LOTUS EFFECT ROUGHNE, P995
   Bhushan B, 2007, J ADHES SCI TECHNOL, V21, P1213, DOI 10.1163/156856107782328353
   Bhushan B, 2007, MICROSYST TECHNOL, V13, P71, DOI 10.1007/s00542-006-0256-2
   Bhushan B, 2009, PHILOS T R SOC A, V367, P1445, DOI 10.1098/rsta.2009.0011
   Bitton R, 2006, MACROMOL BIOSCI, V6, P737, DOI 10.1002/mabi.200600073
   Bullock JMR, 2008, J EXP BIOL, V211, P3333, DOI 10.1242/jeb.020941
   Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434
   Callow J, 2006, ULVA SPORE ADHESIVE
   Callow JA, 2000, PLANTA, V211, P641, DOI 10.1007/s004250000337
   Callow JA, 2000, BIOFOULING, V16, P141, DOI 10.1080/08927010009378439
   Carre A, 2009, SUPERHYDROPHOBIC SURFACES, pIX
   Chan EP, 2008, ADV MATER, V20, P711, DOI 10.1002/adma.200701530
   Chen B, 2008, P R SOC A, V464, P1639, DOI 10.1098/rspa.2007.0350
   Cho Hyung Joon, 2008, Biotechnology Journal, V3, P631, DOI 10.1002/biot.200700258
   Chung IM, 2008, BIOMATERIALS, V29, P2637, DOI 10.1016/j.biomaterials.2008.03.008
   Chung JY, 2005, J ROY SOC INTERFACE, V2, P55, DOI 10.1098/rsif.2004.0020
   Clarke BT, 1997, BIOL REV, V72, P365, DOI 10.1017/S0006323197005045
   Clemente CJ, 2008, P R SOC B, V275, P1329, DOI 10.1098/rspb.2007.1660
   Dirks JH, 2010, J R SOC INTERFACE, V7, P587, DOI 10.1098/rsif.2009.0308
   Dodiuk H, 2005, INT J ADHES ADHES, V25, P211, DOI 10.1016/j.ijadhadh.2004.07.003
   Donovan DA, 1997, J EXP BIOL, V200, P1145
   Drechsler P, 2006, J COMP PHYSIOL A, V192, P1213, DOI 10.1007/s00359-006-0150-5
   EDWARDS JS, 1970, PROC R ENTOMOL SOC A, V45, P1
   Eisner T, 2000, P NATL ACAD SCI USA, V97, P6568, DOI 10.1073/pnas.97.12.6568
   EMERSON SB, 1980, BIOL J LINN SOC, V13, P199, DOI 10.1111/j.1095-8312.1980.tb00082.x
   EVANS CM, 1994, J HERPETOL, V28, P499, DOI 10.2307/1564965
   Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638
   Fearing RS, 2007, J ADHES SCI TECHNOL, V21, P1117
   Federle W, 2006, J R SOC INTERFACE, V3, P689, DOI 10.1098/rsif.2006.0135
   Federle W, 2006, J EXP BIOL, V209, P2611, DOI 10.1242/jeb.02323
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Finlay JA, 2002, INTEGR COMP BIOL, V42, P1116, DOI 10.1093/icb/42.6.1116
   Furst W, 2005, ANN THORAC SURG, V79, P1522, DOI 10.1016/j.athoracsur.2004.11.054
   Gao HJ, 2005, MECH MATER, V37, P275, DOI 10.1016/j.mechmat.2004.03.008
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Ge L, 2007, P NATL ACAD SCI USA, V104, P10792, DOI 10.1073/pnas.0703505104
   Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917
   Geiselhardt SF, 2010, J INSECT PHYSIOL, V56, P398, DOI 10.1016/j.jinsphys.2009.11.016
   Gim Y, 2008, BIOTECHNOL PROGR, V24, P1272, DOI [10.1002/btpr.65, 10.1021/bp.65]
   Goldmann AS, 2010, MACROMOL RAPID COMM, V31, P1608, DOI 10.1002/marc.201000193
   Gorb S, 2000, J COMP PHYSIOL A, V186, P821, DOI 10.1007/s003590000135
   Gorb S, 2007, J R SOC INTERFACE, V4, P271, DOI 10.1098/rsif.2006.0164
   Gorb S, 2001, ATTACHMENT DEVICES I
   Gorb SN, 2007, BIOINSPIR BIOMIM, V2, pS117, DOI 10.1088/1748-3182/2/4/S01
   GOWDA DC, 1982, PHYTOCHEMISTRY, V21, P2297, DOI 10.1016/0031-9422(82)85194-7
   Graham L. D., 2006, ADHESIVE SECRETED AU, P207
   Graham LD, 2005, BIOMACROMOLECULES, V6, P3300, DOI 10.1021/bm050335e
   Graham LD, 2010, J BIOMED MATER RES A, V93A, P429, DOI 10.1002/jbm.a.32559
   Gravish N, 2008, J R SOC INTERFACE, V5, P339, DOI 10.1098/rsif.2007.1077
   Haag AP, 2006, MECH PROPERTIES BACT, P1
   Hansen WR, 2005, P NATL ACAD SCI USA, V102, P385, DOI 10.1073/pnas.0408304102
   Hartwig A, 2009, MACROMOL MATER ENG, V294, P363, DOI 10.1002/mame.200900031
   Herget GW, 2001, EUR J CARDIO-THORAC, V19, P4, DOI 10.1016/S1010-7940(00)00613-8
   Hideki T, 2000, J APPL POLYM SCI, V76, P929
   Higgins MJ, 2002, PROTIST, V153, P25, DOI 10.1078/1434-4610-00080
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Holten-Andersen N, 2009, LANGMUIR, V25, P3323, DOI 10.1021/la8027012
   Howard F., 1998, WILBUR ORVILLE BIOGR
   Huang J, 2008, J AM OIL CHEM SOC, V85, P63, DOI 10.1007/s11746-007-1162-1
   Huber G, 2005, P NATL ACAD SCI USA, V102, P16293, DOI 10.1073/pnas.0506328102
   Hui CY, 2007, J ADHES SCI TECHNOL, V21, P1259, DOI 10.1163/156856107782328362
   Hutchinson H, 2008, MECH ENG, V130, P42
   Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157
   Hwang DS, 2010, BIOMATERIALS, V31, P1080, DOI 10.1016/j.biomaterials.2009.10.041
   Hwang DS, 2005, BIOTECHNOL PROGR, V21, P965, DOI 10.1021/bp050014e
   Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004
   Illum L, 2001, INT J PHARM, V222, P109, DOI 10.1016/S0378-5173(01)00708-6
   ISHII S, 1987, APPL ENTOMOL ZOOL, V22, P222, DOI 10.1303/aez.22.222
   Jeong HE, 2010, LANGMUIR, V26, P2223, DOI 10.1021/la904290g
   Kamino K, 2008, MAR BIOTECHNOL, V10, P111, DOI 10.1007/s10126-007-9076-3
   Kamino K, 2006, BIOLOGICAL ADHESIVES, P145, DOI 10.1007/978-3-540-31049-5_8
   Karsten U, 2007, ALGAE CYANOBACTERIA, V11
   Katav T, 2008, J CONTROL RELEASE, V130, P183, DOI 10.1016/j.jconrel.2008.06.002
   Khandeparker L, 2007, INT J ADHES ADHES, V27, P165, DOI 10.1016/j.ijadhadh.2006.03.004
   Khoee S, 2009, J COLLOID INTERF SCI, V336, P872, DOI 10.1016/j.jcis.2009.04.067
   Kim S, 2008, J NANOSCI NANOTECHNO, V8, P4779, DOI 10.1166/jnn.2008.IC45
   Kim TW, 2008, J R SOC INTERFACE, V5, P319, DOI 10.1098/rsif.2007.1078
   Kim TI, 2009, ADV MATER, V21, P2276, DOI 10.1002/adma.200803710
   Koch K, 2009, PROG MATER SCI, V54, P137, DOI 10.1016/j.pmatsci.2008.07.003
   Kosaki A, 1996, JPN J APPL ENTOMOL Z, V40, P47
   Kovacik J, 2012, AMINO ACIDS, V42, P1277, DOI 10.1007/s00726-010-0820-z
   Kuo CFJ, 2006, J APPL POLYM SCI, V102, P5303, DOI 10.1002/app.24827
   Kwaki JS, 2010, INT J PRECIS ENG MAN, V11, P171, DOI [10.1007/s12541-010-0020-5, 10.1007/S12541-010-0020-5]
   Lambuth A., 2006, COATINGS MAT SURFACE
   Langer MG, 2004, P ROY SOC B-BIOL SCI, V271, P2209, DOI 10.1098/rspb.2004.2850
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Lee J, 2009, LANGMUIR, V25, P12449, DOI 10.1021/la9029672
   Lee WF, 2006, J APPL POLYM SCI, V100, P3653, DOI 10.1002/app.23171
   Leggat PA, 2007, ANZ J SURG, V77, P209, DOI 10.1111/j.1445-2197.2007.04020.x
   Lehr CM, 2000, J CONTROL RELEASE, V65, P19, DOI 10.1016/S0168-3659(99)00228-X
   Li LL, 2006, J PHARM SCI-US, V95, P326, DOI 10.1002/jps.20541
   Lin AYM, 2009, ACTA MATER, V57, P4178, DOI 10.1016/j.actamat.2009.05.015
   Lin A. Y. M., 2008, THESIS U CALIFORNIA
   Lohbauer U, 2010, ACTA BIOMATER, V6, P4539, DOI 10.1016/j.actbio.2010.07.002
   May M, 2010, INT J ADHES ADHES, V30, P505, DOI 10.1016/j.ijadhadh.2010.05.002
   Melzer B, 2010, J R SOC INTERFACE, V7, P1383, DOI 10.1098/rsif.2010.0140
   Meyers MA, 2011, J MECH BEHAV BIOMED, V4, P626, DOI 10.1016/j.jmbbm.2010.08.005
   Millar NL, 2009, J SHOULDER ELB SURG, V18, P639, DOI 10.1016/j.jse.2008.12.007
   Mizuhira V, 2004, J ELECTRON MICROSC, V53, P63, DOI 10.1093/jmicro/53.1.63
   Mostaert AS, 2006, J BIOL PHYS, V32, P393, DOI 10.1007/s10867-006-9023-y
   Mostaert AS, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/4/044010
   Mulet ME, 2006, BRIT J OPHTHALMOL, V90, P208, DOI 10.1136/bjo.2005.07.076497
   Northen MT, 2008, ADV MATER, V20, P3905, DOI 10.1002/adma.200801340
   Oz MC, 2000, ANN THORAC SURG, V69, P1376, DOI 10.1016/S0003-4975(00)01194-2
   PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183
   Pardo J., 1990, Protein Expression and Purification, V1, P147, DOI 10.1016/1046-5928(90)90008-M
   Parris N, 2003, J AGR FOOD CHEM, V51, P3892, DOI 10.1021/jf0212183
   Peattie AM, 2007, P NATL ACAD SCI USA, V104, P18595, DOI 10.1073/pnas.0707591104
   Peattie AM, 2007, J R SOC INTERFACE, V4, P1071, DOI 10.1098/rsif.2007.0226
   Peattie AM, 2009, J COMP PHYSIOL B, V179, P231, DOI 10.1007/s00360-008-0310-8
   PERESWETOFFMORATH L, 1995, INT J PHARM, V124, P37, DOI 10.1016/0378-5173(95)00070-Y
   Persson BNJ, 2003, J CHEM PHYS, V119, P11437, DOI 10.1063/1.1621854
   Persson BNJ, 2003, J CHEM PHYS, V118, P7614, DOI 10.1063/1.1562192
   Petrie EM., 2000, HDB ADHESIVES SEALAN
   Pettitt ME, 2004, BIOFOULING, V20, P299, DOI 10.1080/08927010400027068
   Phang I, 2007, NANOS, V1, P35
   Phang IY, 2006, BIOFOULING, V22, P245, DOI 10.1080/08927010600857686
   Plattner VE, 2010, INT J PHARMACEUT, V387, P34, DOI 10.1016/j.ijpharm.2009.11.030
   Prowse MS, 2011, ACTA BIOMATER, V7, P733, DOI 10.1016/j.actbio.2010.09.036
   Puthoff JB, 2010, J EXP BIOL, V213, P3699, DOI 10.1242/jeb.047654
   Qi GY, 2011, J AM OIL CHEM SOC, V88, P271, DOI 10.1007/s11746-010-1666-y
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   ROST K, 1977, PHYTOCHEMISTRY, V16, P1365, DOI 10.1016/S0031-9422(00)88783-X
   Scherge M., 2001, BIOL MICRO NANOTRIBO
   Scholz I, 2009, J EXP BIOL, V212, P155, DOI 10.1242/jeb.019232
   Schulz H, 2008, J DENT, V36, P579, DOI 10.1016/j.jdent.2008.04.010
   Shao H, 2009, MACROMOL BIOSCI, V9, P464, DOI 10.1002/mabi.200800252
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Smith DC, 2004, BIOMATERIALS SCI INT, p573 
   Smith JM, 2006, J COMP PHYSIOL A, V192, P1193, DOI 10.1007/s00359-006-0151-4
   Spierer A, 1997, INVEST OPHTH VIS SCI, V38, P543
   Spotnitz WD, 2008, ORTHOPEDIC BIOL MED
   Spotnitz WD, 2010, CLIN APPL THROMB-HEM, V16, P497, DOI 10.1177/1076029610363589
   Steinbrecher T, 2010, ACTA BIOMATER, V6, P1497, DOI 10.1016/j.actbio.2009.10.003
   Stevens MJ, 2007, LANGMUIR, V23, P5045, DOI 10.1021/la063765e
   Stewart RJ, 2004, J EXP BIOL, V207, P4727, DOI 10.1242/jeb.01330
   Stewart RJ, 2011, ADV COLLOID INTERFAC, V167, P85, DOI 10.1016/j.cis.2010.10.009
   STRAUSBERG RL, 1990, TRENDS BIOTECHNOL, V8, P53, DOI 10.1016/0167-7799(90)90134-J
   Sun CJ, 2005, J BIOL CHEM, V280, P39332, DOI 10.1074/jbc.M508674200
   Suszkiw J., 2009, AGR RES MAGAZINE, V57, P2
   Tian Y, 2006, P NATL ACAD SCI USA, V103, P19320, DOI 10.1073/pnas.0608841103
   Tyler MJ, 2002, USA Patent, Patent No. [WO2002022756, 2002022756]
   Unver O, 2010, IEEE T ROBOT, V26, P131, DOI 10.1109/TRO.2009.2033628
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Vreeland V, 1998, J PHYCOL, V34, P1, DOI 10.1046/j.1529-8817.1998.340001.x
   Waite JH, 1998, MATRIX BIOL, V17, P93, DOI 10.1016/S0945-053X(98)90023-3
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   WALKER G, 1985, J ZOOL, V205, P297, DOI 10.1111/j.1469-7998.1985.tb03536.x
   Waychunas GA, 2008, ELEMENTS, V4, P381, DOI 10.2113/gselements.4.6.381
   Weimer PJ, 2003, APPL MICROBIOL BIOT, V63, P29, DOI 10.1007/s00253-003-1334-3
   Wilker JJ, 2010, ANGEW CHEM INT EDIT, V49, P8076, DOI 10.1002/anie.201003171
   Wilker JJ, 2010, CURR OPIN CHEM BIOL, V14, P276, DOI 10.1016/j.cbpa.2009.11.009
   Wu Y, 2010, J COLLOID INTERF SCI, V344, P533, DOI 10.1016/j.jcis.2009.12.041
   Xia F, 2008, ADV MATER, V20, P2842, DOI 10.1002/adma.200800836
   Xia LJ, 2011, J NANOPART RES, V13, P1029, DOI 10.1007/s11051-010-0091-3
   Yamamoto H, 1996, BIOTECHNOL GENET ENG, V13, P133, DOI 10.1080/02648725.1996.10647926
   Yanik MF, 2009, TRENDS BIOTECHNOL, V27, P1, DOI 10.1016/j.tibtech.2008.10.001
   Yao H, 2006, J MECH PHYS SOLIDS, V54, P1120, DOI 10.1016/j.jmps.2006.01.002
   Yao HM, 2007, J ADHES SCI TECHNOL, V21, P1185, DOI 10.1163/156856107782328326
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
   Zeng HB, 2010, P NATL ACAD SCI USA, V107, P12850, DOI 10.1073/pnas.1007416107
   Zhang MJ, 2008, NANO LETT, V8, P1277, DOI 10.1021/nl0725704
   Zhang Mingjun, 2010, Journal of Nanobiotechnology, V8, P20, DOI 10.1186/1477-3155-8-20
   Zhang XJ, 2009, CHINESE SCI BULL, V54, P1648, DOI [10.1007/s11434-009-0234-z, 10.1007/S11434-009-0234-Z]
   Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200
NR 184
TC 17
Z9 17
U1 10
U2 177
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0169-4243
EI 1568-5616
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PD FEB 1
PY 2014
VL 28
IS 3-4
SI SI
BP 290
EP 319
DI 10.1080/01694243.2012.691809
PG 30
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 254QQ
UT WOS:000327180800006
DA 2018-10-20
ER

PT J
AU Zhang, YL
   Gao, CJ
   Li, XL
   Xu, C
   Zhang, Y
   Sun, ZM
   Liu, Y
   Gao, JP
AF Zhang, Yongli
   Gao, Chunjuan
   Li, Xiulan
   Xu, Chen
   Zhang, Yang
   Sun, Zhiming
   Liu, Yu
   Gao, Jianping
TI Thermosensitive methyl cellulose-based injectable hydrogels for
   post-operation anti-adhesion
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Anti-adhesion; Biomaterial; Methyl cellulose; Chitosan; PEG; Hydrogel
ID HYALURONIC-ACID; GEL; METHYLCELLULOSE; ADHESIONS; TEMPERATURE;
   PREVENTION; CHITOSAN; SURGERY; WATER; SULFATE
AB Thermosensitive methyl cellulose (MC)-based injectable hydrogels for post-operation anti-adhesion were prepared by integrating polyethylene glycol (PEG), carboxymethyl cellulose (CMC) and chitosan sulfate (CS-SO3) with MC sols. The viscosity of the MC-based sols depended on the sol composition, especially the amount of CMC. The gelation temperature of the sols was tuned by adjusting the concentrations of K+ and other components to obtain an MC-based sol that transformed to a gel at body temperature. The composition of the sol also affected the gel strength. Adding PEG decreased the repulsions between the CMC and CS-SO3 macromolecules and thus increased the gel strength. The efficacy of the MC-based injectable hydrogels as barriers for reducing postsurgical adhesions was evaluated using a rat cecal abrasion model. The PEG and CS-SO3 loaded MC-based injectable hydrogels were effective in reducing adhesion formation and reduced adhesiolysis difficulties. (C) 2013 Published by Elsevier Ltd.
C1 [Zhang, Yongli; Sun, Zhiming] Huanhu Hosp, Tianjin 300060, Peoples R China.
   [Gao, Chunjuan; Liu, Yu; Gao, Jianping] Tianjin Univ, Sch Sci, Tianjin 300072, Peoples R China.
   [Li, Xiulan; Zhang, Yang] Tianjin Orthoped Hosp, Tianjin 300211, Peoples R China.
   [Xu, Chen] Beijing 302 Hosp, Beijing 300060, Peoples R China.
RP Sun, ZM (reprint author), Huanhu Hosp, Tianjin 300060, Peoples R China.
EM zmsun@163.com; jianpingg@eyou.com
FU NSFC [50603017]; Science and Technology Developing Plan of the
   Municipality of Tianjin, PR China [06YFGZGX03000]
FX This work was financially supported by the NSFC (50603017) and the
   Science and Technology Developing Plan (06YFGZGX03000) of the
   Municipality of Tianjin, PR China.
CR Al-Musawi J. N. T., 2001, GYNAECOL ENDOSC, V10, P123
   Bain MK, 2012, INT J BIOL MACROMOL, V50, P565, DOI 10.1016/j.ijbiomac.2012.01.025
   Bannikova GE, 2002, APPL BIOCHEM MICRO+, V38, P413, DOI 10.1023/A:1019904131791
   Beck DE, 2003, DIS COLON RECTUM, V46, P1310, DOI 10.1097/01.DCR.0000089117.62296.E4
   Bennett D. A., 2003, J CARDIAC SURG, V18, P494
   Coleman MG, 2000, DIS COLON RECTUM, V43, P1297, DOI 10.1007/BF02237441
   Dhar N, 2012, CARBOHYD POLYM, V87, P101, DOI 10.1016/j.carbpol.2011.07.022
   DIZEREGA GS, 1994, FERTIL STERIL, V61, P219
   ELLIS H, 1982, BRIT J SURG, V69, P241, DOI 10.1002/bjs.1800690502
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Genevieve M., 2006, J SURG RES, V132, P3
   Ha DI, 2006, MACROMOL RES, V14, P87, DOI 10.1007/BF03219073
   HERSHLAG A, 1991, CLIN OBSTET GYNECOL, V34, P395, DOI 10.1097/00003081-199106000-00023
   Holme KR, 1997, CARBOHYD RES, V302, P7, DOI 10.1016/S0008-6215(97)00117-1
   Huang CB, 2012, BIOMATERIALS, V33, P962, DOI 10.1016/j.biomaterials.2011.10.004
   HURTADOPONCE AQ, 1988, BOT MAR, V31, P171, DOI 10.1515/botm.1988.31.2.171
   Kurisawa M, 2000, J CONTROL RELEASE, V69, P127, DOI 10.1016/S0168-3659(00)00297-2
   Lamoutte H., 2006, MAST BIOSURGERY, V12, P1
   Li L, 2001, LANGMUIR, V17, P8062, DOI 10.1021/la010917r
   Liang HF, 2004, BIOMACROMOLECULES, V5, P1917, DOI 10.1021/bm049831
   Lodge AJ, 2008, ANN THORAC SURG, V86, P614, DOI 10.1016/j.athoracsur.2008.04.103
   Menzies P. M., 2006, ANN ROY COLL SURG, V88, P375
   Miao JJ, 2011, BIOMATERIALS, V32, P9557, DOI 10.1016/j.biomaterials.2011.08.080
   Nishimura S, 1998, CARBOHYD RES, V306, P427, DOI 10.1016/S0008-6215(97)10081-7
   Pressato E. B., 2002, P INT M, P491
   Ray F. N., 1994, J AM COLL SURGEONS, V186, P1
   Rodgers K, 1998, FERTIL STERIL, V69, P403, DOI 10.1016/S0015-0282(97)00574-8
   Rodgers Kathleen E, 2003, Spine J, V3, P277, DOI 10.1016/S1529-9430(03)00035-4
   Sampedro JG, 2002, J BACTERIOL, V184, P4384, DOI 10.1128/JB.184.16.4384-4391.2002
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
   Tito WA, 1996, SHACKELFORDS SURG AL, P375
   Trew G, 2006, REV GYNAECOL PERINAT, V6, P47, DOI [10.1016/j.rigapp.2006.02.001, DOI 10.1016/J.RIGAPP.2006.02.001]
   Wells MR, 1997, EXP NEUROL, V146, P395, DOI 10.1006/exnr.1997.6543
   WISEMAN D, 1994, POLYM SITE SPECIFIC, P370
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
   Xu Y, 2004, LANGMUIR, V20, P646, DOI 10.1021/la0356295
   Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
NR 38
TC 17
Z9 21
U1 8
U2 129
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 30
PY 2014
VL 101
BP 171
EP 178
DI 10.1016/j.carbpol.2013.09.001
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 300WN
UT WOS:000330494800021
PM 24299762
DA 2018-10-20
ER

PT J
AU Lai, JY
AF Lai, Jui-Yang
TI Relationship between structure and cytocompatibility of divinyl sulfone
   cross-linked hyaluronic acid
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Hyaluronic acid; Divinyl sulfone; Cross-linker concentration; Molecular
   structure; Cytocompatibility; Retinal pigment epithelium
ID PIGMENT EPITHELIAL-CELLS; TISSUE AUGMENTATION; DELIVERY CARRIERS;
   GELATIN MEMBRANES; HYDROGELS; LINKING; SCAFFOLDS; TRANSPLANTATION;
   FUNCTIONALITY; PERFORMANCE
AB Hyaluronic acid (HA), a carbohydrate polymer naturally found in the eye, has been chemically modified by cross-linking to enhance its performance as a drug carrier. Although the treatment of HA with divinyl sulfone (DVS) is reported, the effects of cross-linker concentration on the biomaterial-mediated retinal pigment epithelial (RPE) cellular responses are yet to be investigated. This paper explores, for the first time, the relationship between molecular structure and cytocompatibility of HA hydrogels cross-linked with DVS of varying concentrations (0-100 mM). The results showed that with increasing DVS concentration, the sulfur content and sulfonyl-bis-ethyl cross-link amount are increased and the mechanical stability and resistance against enzymatic degradation are enhanced, indicating the crucial role of crosslinker in the alteration of structure and property of this polysaccharide biomaterial. The cell viability, pro-inflammatory gene and cytokine expression, and glutamate uptake were suggested to be indicative of cytocompatibility and found to be strongly dependent on the cross-linker concentration. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 33302, Taiwan.
RP Lai, JY (reprint author), Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
EM jylai@mail.cgu.edu.tw
OI Lai, Jui-Yang/0000-0002-9227-8549
FU National Science Council of Republic of China
   [NSC102-2628-B-182-017-MY3]; Chang Gung Memorial Hospital [CMRPD2A0111]
FX This work was supported by Grant NSC102-2628-B-182-017-MY3 from the
   National Science Council of Republic of China and Grant CMRPD2A0111 from
   Chang Gung Memorial Hospital. The author is grateful to Ya-Ting Li
   (Institute of Biochemical and Biomedical Engineering, Chang Gung
   University) for technical assistance.
CR Abe T, 1999, TOHOKU J EXP MED, V189, P179, DOI 10.1620/tjem.189.179
   Bhattacharyya S, 2008, BIOMACROMOLECULES, V9, P505, DOI 10.1021/bm7009976
   Burugapalli K, 2009, J BIOMAT SCI-POLYM E, V20, P1049, DOI [10.1163/156856209X444411, 10.1163/156856209X4444111]
   Collins MN, 2008, J MATER SCI-MATER M, V19, P3335, DOI 10.1007/s10856-008-3476-4
   Collins MN, 2008, J APPL POLYM SCI, V109, P923, DOI 10.1002/app.27631
   Collins MN, 2013, J APPL POLYM SCI, V130, P145, DOI 10.1002/app.39145
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   Ellzy MW, 2003, SPECTROCHIM ACTA A, V59, P867, DOI 10.1016/S1386-1425(02)00239-1
   Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707
   GEBBEN B, 1985, POLYMER, V26, P1737, DOI 10.1016/0032-3861(85)90295-2
   Grasman JM, 2012, ACTA BIOMATER, V8, P4020, DOI 10.1016/j.actbio.2012.07.018
   Hahn SK, 2004, J BIOMAT SCI-POLYM E, V15, P1111, DOI 10.1163/1568562041753115
   Ibrahim S, 2010, J BIOMED MATER RES A, V94A, P355, DOI 10.1002/jbm.a.32704
   Jeng BH, 2004, J CATARACT REFR SURG, V30, P85, DOI 10.1016/S0886-3350(03)00669-2
   Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054058
   Lai JY, 2012, MATERIALS, V5, P1986, DOI 10.3390/ma5101986
   Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753
   Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012
   Lai JY, 2011, J MECH MED BIOL, V11, P967, DOI 10.1142/S0219519411004873
   Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a
   Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085
   Lai JY, 2010, INT J MOL SCI, V11, P5257, DOI 10.3390/ijms11125256
   Lai JY, 2011, J BIOMAT SCI-POLYM E, V22, P277, DOI 10.1163/092050609X12603600753204
   Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980
   Lai JY, 2009, INT J MOL SCI, V10, P3442, DOI 10.3390/ijms10083442
   Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n
   Lai JY, 2005, AM J OPHTHALMOL, V139, P1123, DOI 10.1016/j.ajo.2004.11.052
   Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   McDonald CC, 2002, EYE, V16, P601, DOI 10.1038/sj.eye.6700169
   MIYAMOTO Y, 1994, INVEST OPHTH VIS SCI, V35, P3589
   Murata M, 2005, OPHTHALMOLOGICA, V219, P287, DOI 10.1159/000086113
   Oh EJ, 2008, J BIOMED MATER RES A, V86A, P685, DOI 10.1002/ibm.a.31681
   Sannino A, 2004, BIOMACROMOLECULES, V5, P92, DOI 10.1021/bm0341881
   Singh K, 2012, J MATER SCI-MATER M, V23, P687, DOI 10.1007/s10856-012-4554-1
   SOK DE, 1993, BIOCHEM BIOPH RES CO, V195, P1224, DOI 10.1006/bbrc.1993.2175
   West JD, 2011, CHEM RES TOXICOL, V24, P1457, DOI 10.1021/tx200302w
   Yeom J, 2010, BIOCONJUGATE CHEM, V21, P240, DOI 10.1021/bc9002647
   Yue W, 2012, CARBOHYD POLYM, V89, P709, DOI 10.1016/j.carbpol.2012.03.081
   Zhao X, 2006, J BIOMAT SCI-POLYM E, V17, P419, DOI 10.1163/156856206776374115
NR 45
TC 24
Z9 25
U1 2
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 30
PY 2014
VL 101
BP 203
EP 212
DI 10.1016/j.carbpol.2013.09.060
PG 10
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 300WN
UT WOS:000330494800025
PM 24299766
DA 2018-10-20
ER

PT J
AU Janaswamy, S
AF Janaswamy, Srinivas
TI Encapsulation altered starch digestion: Toward developing starch-based
   delivery systems
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Starch; Encapsulation; Delivery; X-ray diffraction; FT-IR
ID AMYLOSE INCLUSION COMPLEXES; SMALL LIGANDS; DIABETES-MELLITUS;
   CRYSTAL-STRUCTURE; BETA-AMYLOLYSIS; SINGLE-CRYSTALS; GLYCEMIC INDEX;
   CONFORMATION; EPIDEMIC; GRANULES
AB Starch is an abundant biomaterial that forms a vital energy source for humans. Altering its digestion, e.g. increasing the proportions of slowly digestible starch (SOS) and resistant starch (RS), would revolutionize starch utility in addressing a number of health issues related to glucose absorption, glycemic index and colon health. The research reported in this article is based on my hypothesis that water channels present in the B-type starch crystalline matrix, particularly in tuber starches, can embed guest molecules such as nutraceuticals, drugs, flavor compounds and vitamins leading to altered starch digestion. Toward this goal, potato starch has been chosen as the model tuber starch, and ibuprofen, benzocaine, sulfapyridine, curcumin, thymol and ascorbic acid as model guest molecules. X-ray powder diffraction and FT-IR analyses clearly suggest the incorporation of guest molecules in the water channels of potato starch. Furthermore, the in vitro digestion profiles of complexes are intriguing with major variations occurring after 60 min of starch digestion and finally at 120 min. These changes are concomitantly reflected in the SOS and RS amounts, with about 24% decrease in SDS for benzocaine complex and 6% increase in RS for ibuprofen complex, attesting the ability of guest molecule encapsulation in modulating the digestion properties of potato starch. Overall, this research provides an elegant opportunity for the design and development of novel starch-based stable carriers that not only bestow tailored glucose release rates but could also transport health promoting and disease preventing compounds. (C) 2013 Elsevier Ltd. All rights reserved.
C1 Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA.
RP Janaswamy, S (reprint author), Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, 745 Agr Mall Dr, W Lafayette, IN 47907 USA.
EM janaswam@purdue.edu
CR Alberti G, 2004, DIABETES CARE, V27, P1798, DOI 10.2337/diacare.27.7.1798
   Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3
   BULEON A, 1990, INT J BIOL MACROMOL, V12, P25, DOI 10.1016/0141-8130(90)90078-O
   Conde-Petit B, 2006, TRENDS FOOD SCI TECH, V17, P227, DOI 10.1016/j.tifs.2005.11.007
   ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33
   Englyst KN, 2003, BRIT J NUTR, V89, P329, DOI 10.1079/BJN2002786
   GIDLEY MJ, 1988, J AM CHEM SOC, V110, P3820, DOI 10.1021/ja00220a016
   Gunaratne A, 2002, CARBOHYD POLYM, V49, P425, DOI 10.1016/S0144-8617(01)00354-X
   Han XZ, 2006, BIOMACROMOLECULES, V7, P1162, DOI 10.1021/bm050991e
   Heinemann C, 2001, J AGR FOOD CHEM, V49, P1370, DOI 10.1021/jf001079u
   Hickman BE, 2009, J AGR FOOD CHEM, V57, P7005, DOI 10.1021/jf9010164
   Hickman BE, 2009, J AGR FOOD CHEM, V57, P666, DOI 10.1021/jf8030698
   Holmes C., 2005, SUMMARY REPORT EUROP
   IMBERTY A, 1988, BIOPOLYMERS, V27, P1205, DOI 10.1002/bip.360270803
   IMBERTY A, 1988, J MOL BIOL, V201, P365, DOI 10.1016/0022-2836(88)90144-1
   Itthisoponkul T, 2007, CARBOHYD POLYM, V69, P106, DOI 10.1016/j.carbpol.2006.09.012
   Jacobs H, 1998, J AGR FOOD CHEM, V46, P2895, DOI 10.1021/jf980169k
   Janaswamy S, 2013, CARBOHYD POLYM, V94, P209, DOI 10.1016/j.carbpol.2013.01.008
   Janaswamy S, 2012, FOOD FUNCT, V3, P503, DOI 10.1039/c2fo10281a
   JANE JL, 1984, CARBOHYD RES, V132, P105, DOI 10.1016/0008-6215(84)85068-5
   Jenkins DJA, 2002, AM J CLIN NUTR, V76, p266S
   Le Bail P, 2005, INT J BIOL MACROMOL, V35, P1, DOI 10.1016/j.ijbiomac.2004.09.001
   LeRoith D, 2002, AM J MED, V113, p3S
   Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195
   Nuessli J, 2003, INT J BIOL MACROMOL, V33, P227, DOI 10.1016/j.ijbiomac.2003.08.009
   Oakley WG, 1962, T MED SOC LONDON, V78, P16
   Palomer X, 2008, DIABETES OBES METAB, V10, P185, DOI 10.1111/j.1463-1326.2007.00710.x
   Patil S. K., 2012, STRATEGIC REV GLOBAL
   Petersen M, 2008, DIABETES CARE, V31, P596, DOI 10.2337/dc08-9017
   Putaux JL, 2008, MACROMOL SYMP, V273, P1, DOI 10.1002/masy.200851301
   Rondeau-Mouro C, 2004, INT J BIOL MACROMOL, V34, P309, DOI 10.1016/j.ijbiomac.2004.09.002
   Sempertegui F, 2011, PUBLIC HEALTH NUTR, V14, P758, DOI 10.1017/S1368980010002636
   Shamai K, 2003, CARBOHYD POLYM, V54, P363, DOI 10.1016/S0144-8617(03)00192-9
   Shea TB, 2005, J ALZHEIMERS DIS, V7, P297
   Shogren RL, 2006, CARBOHYD POLYM, V64, P444, DOI 10.1016/j.carbpol.2005.12.018
   Song W, 2010, J AGR FOOD CHEM, V58, P9753, DOI 10.1021/jf1011769
   Takahashi Y, 2004, MACROMOLECULES, V37, P6827, DOI 10.1021/ma0490956
   Tian YQ, 2010, CARBOHYD POLYM, V80, P581, DOI 10.1016/j.carbpol.2009.12.010
   Venkataraman R, 2004, AM J CARDIOL, V94, P977, DOI 10.1016/j.amjcard.2004.06.048
   Wang TL, 1998, J EXP BOT, V49, P481, DOI 10.1093/jexbot/49.320.481
   Webb G.P., 2006, DIETARY SUPPLEMENTS
   Wild SH, 2004, DIABETES CARE, V27, P2569, DOI 10.2337/diacare.27.10.2569-a
   Wolever TMS, 2003, NUTR REV, V61, pS40, DOI 10.1301/nr.2003.may.S40-S48
   Wulff G, 2005, J CEREAL SCI, V41, P239, DOI 10.1016/j.jcs.2004.06.002
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 45
TC 8
Z9 11
U1 1
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 30
PY 2014
VL 101
BP 600
EP 605
DI 10.1016/j.carbpol.2013.09.094
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 300WN
UT WOS:000330494800075
PM 24299816
DA 2018-10-20
ER

PT J
AU Li, GC
   Zhang, LZ
   Wang, CP
   Zhao, XY
   Zhu, CL
   Zheng, YH
   Wang, YL
   Zhao, YH
   Yang, YM
AF Li, Guicai
   Zhang, Luzhong
   Wang, Caiping
   Zhao, Xueying
   Zhu, Changlai
   Zheng, Yanhong
   Wang, Yaling
   Zhao, Yahong
   Yang, Yumin
TI Effect of silanization on chitosan porous scaffolds for peripheral nerve
   regeneration
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan porous scaffolds; Silanization; Peripheral nerve regeneration;
   Schwann cells
ID PLURIPOTENT STEM-CELLS; SCHWANN-CELLS; IN-VITRO; IMMOBILIZATION;
   SURFACES; CONDUITS; REPAIR; DIFFERENTIATION; HYDROGELS; FIBERS
AB The aim of this study was to evaluate the feasibility of using 3-aminopropyltriethoxysilane (APTE) silanization treatment for modification and biocompatibility of lyophilized chitosan porous scaffolds. The process is beneficial for biomaterial development due to its low toxicity and simplicity. The silanization treatment with low APTE concentration showed no significant influence on the morphology of chitosan scaffolds, while a skin-like surface was observed for the silanized scaffolds treated with high APTE concentration. The porosity and surface amino densities were increased after silanization whereas the swelling ratio was reduced, and the degradation ratio in PBS and anti-acid degradation properties of the silanized chitosan scaffolds were significantly improved. The in vitro Schwann cells culture demonstrated that the silanized scaffolds with 8% APTE could obviously facilitate the attachment and proliferation of Schwann cells, indicating great potential for the application in peripheral nerve regeneration. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Li, Guicai; Zhang, Luzhong; Wang, Caiping; Zhao, Xueying; Zhu, Changlai; Zheng, Yanhong; Zhao, Yahong; Yang, Yumin] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Peoples R China.
   [Wang, Yaling] Nantong Univ, Coll Chem & Chem Engn, Nantong 226001, Peoples R China.
RP Yang, YM (reprint author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Peoples R China.
EM yangym@ntu.edu.cn
FU Natural Science Research Program of Jiangsu Education Department
   [13KJB310014]; Hi-Tech Research and Development Program of China
   [2012AA020502]; National Natural Science Foundation of China [21242005,
   81130080, 81171457]; Natural Science Foundation of Nantong City
   [BK2012089]; Natural Science Foundation of Jiangsu Province of China
   [BK20130390]; Natural Science Foundation of Nantong University [10Z014]
FX The authors gratefully acknowledge the financial support of the Natural
   Science Research Program of Jiangsu Education Department (No.
   13KJB310014), Hi-Tech Research and Development Program of China (No.
   2012AA020502), National Natural Science Foundation of China (No.
   21242005, 81130080 and 81171457), Natural Science Foundation of Nantong
   City (No. BK2012089), Natural Science Foundation of Jiangsu Province of
   China (No. BK20130390) and the Natural Science Foundation of Nantong
   University (No. 10Z014).
CR Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI 10.1089/ten.TEB.2009.0639
   Baggi L, 1990, Attual Dent, V6, P18
   Busilacchi A, 2013, CARBOHYD POLYM, V98, P665, DOI 10.1016/j.carbpol.2013.06.044
   Byrne EM, 2008, J MATER SCI-MATER M, V19, P3455, DOI 10.1007/s10856-008-3506-2
   Chiono V, 2009, INT REV NEUROBIOL, V87, P173, DOI 10.1016/S0074-7742(09)87009-8
   Gan SH, 2009, BIOMACROMOLECULES, V10, P1238, DOI 10.1021/bm900011h
   Gu Y, 2012, BIOMATERIALS, V33, P6672, DOI 10.1016/j.biomaterials.2012.06.006
   Halliwell CM, 2001, ANAL CHEM, V73, P2476, DOI 10.1021/ac0010633
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Howarter JA, 2006, LANGMUIR, V22, P11142, DOI 10.1021/la061240g
   Hsu SH, 2011, BIOMATERIALS, V32, P3764, DOI 10.1016/j.biomaterials.2011.01.065
   Ichihara S, 2009, TISSUE ENG PART C-ME, V15, P387, DOI 10.1089/ten.tec.2008.0508
   Kim J, 2011, ACS SYM SER, V1062, P141
   Kuo YC, 2013, COLLOID SURFACE B, V103, P595, DOI 10.1016/j.colsurfb.2012.11.001
   Kuo YC, 2013, COLLOID SURFACE B, V102, P405, DOI 10.1016/j.colsurfb.2012.08.061
   Lapin NA, 2009, J PHYS CHEM B, V113, P8776, DOI 10.1021/jp809096m
   Li GC, 2011, BIOMATERIALS, V32, P4691, DOI 10.1016/j.biomaterials.2011.03.025
   Matinlinna Jukka P, 2007, J Contemp Dent Pract, V8, P1
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Nie X., 2013, CELL BIOCH BIOPHYSIC
   Peng L, 2006, J BIOACT COMPAT POL, V21, P207, DOI 10.1177/0883911506065100
   Pettersson J, 2011, NEUROSCI LETT, V500, P41, DOI 10.1016/j.neulet.2011.06.002
   Qu D, 2013, CARBOHYD POLYM, V92, P545, DOI 10.1016/j.carbpol.2012.08.112
   Runge MB, 2010, BIOMATERIALS, V31, P5916, DOI 10.1016/j.biomaterials.2010.04.012
   Salon MCB, 2005, J COLLOID INTERF SCI, V289, P249, DOI 10.1016/j.jcis.2005.03.070
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Wlaszczuk Adam, 2011, Wiad Lek, V64, P208
   Xiao W., 2013, INJURY
   Xu HX, 2011, BIOMATERIALS, V32, P4506, DOI 10.1016/j.biomaterials.2011.02.023
   Yang YM, 2011, EUR J PHARM BIOPHARM, V79, P519, DOI 10.1016/j.ejpb.2011.06.008
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yoshioka T, 2003, BIOMATERIALS, V24, P2889, DOI 10.1016/S0142-9612(03)00127-3
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
   Zhang LZ, 2013, MAT SCI ENG C-MATER, V33, P2626, DOI 10.1016/j.msec.2013.02.024
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
NR 35
TC 25
Z9 26
U1 4
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 30
PY 2014
VL 101
BP 718
EP 726
DI 10.1016/j.carbpol.2013.09.064
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 300WN
UT WOS:000330494800090
PM 24299831
DA 2018-10-20
ER

PT J
AU Miraftab, M
   Masood, R
   Edward-Jones, V
AF Miraftab, M.
   Masood, R.
   Edward-Jones, V.
TI A new carbohydrate-based wound dressing fibre with superior absorption
   and antimicrobial potency
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Absorption; Dressing; Silver; Hybrid; Psyllium
ID SILVER; MANAGEMENT; MODELS
AB Heavily exudating wounds can lead to infection and unnecessary trauma if they are not adequately managed. Manufacturers involved in production and marketing of high absorption silver dressings, besides emphasising high absorptions of their dressings are keen to highlight potent antimicrobial abilities of their products against all kinds of pathogens including MRSA. However, there are little or no credible reports on minimal but potent quantities of silver needed in a dressing to eliminate bacteria spread and growth or how effectively the silver within a dressing is released over time. This paper introduces a new hybrid biomaterial fibre made from polysaccharide-based polymers with inbuilt ability to gel and absorb large quantities of pseudo exudates. Furthermore, it will be reported that the new fibre carries up to six times less silver than it is conventionally used in silver dressings and displays a very slow rate of release whilst maintaining full potency over time against known Gram positive, Gram negative micro-organisms including MRSA. The paper concludes that the developed hybrid fibre has long lasting antimicrobial and gelling properties comparable, if not better, than Acticoat AA and Aquacel Ag, two commercially available silver dressings. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Miraftab, M.] Univ Bolton, Inst Mat Res & Innovat, Bolton BL3 5AB, England.
   [Masood, R.] Natl Text Univ, Faisalabad, Pakistan.
   [Edward-Jones, V.] Manchester Metropolitan Univ, Fac Sci & Engn, Sch Res Enterprise & Innovat, Manchester M1 5GD, Lancs, England.
RP Miraftab, M (reprint author), Univ Bolton, Inst Mat Res & Innovat, Deane Rd, Bolton BL3 5AB, England.
EM m.miraftab@bolton.ac.uk
CR Alloway B.J., 1995, HEAVY METALS SOILS, P324
   Bowler PG, 2004, J BURN CARE REHABIL, V25, P192, DOI 10.1097/01.BCR.0000112331.72232.1B
   Burd A, 2007, WOUND REPAIR REGEN, V15, P94, DOI 10.1111/j.1524-475X.2006.00190.x
   Burrell Robert E, 2003, Ostomy Wound Manage, V49, P19
   Cooper R, 2004, WORLD WIDE WOUNDS
   De SJ, 2003, J CONTROL RELEASE, V89, P101, DOI 10.1016/S0168-3659(03)00098-1
   Dunn K, 2004, BURNS, V30, pS1, DOI 10.1016/j.burns.2004.06.000
   Edwards-Jones V, 2002, J MED MICROBIOL, V51, P50, DOI 10.1099/0022-1317-51-1-50
   Fan LH, 2006, CARBOHYD POLYM, V65, P447, DOI 10.1016/j.carbpol.2006.01.031
   Fischer MH, 2004, CARBOHYD RES, V339, P2009, DOI 10.1016/j.carres.2004.05.023
   Howe PD, 2002, SILVER SILVER COMPOU
   Kalsen HJ, 2000, BURNS, V26, P117
   Keong LC, 2009, INT J MOL SCI, V10, P1300, DOI 10.3390/ijms10031300
   LANDIS SJ, 2008, J PREVENTION HEALING, V21, P531
   MARGARET IP, 2006, J MED MICROBIOL, V55, P59
   MIRAFTAB M, 2011, Patent No. 20110017140201110
   MIRAFTAB M, 2013, J WOUND IN PRESS OCT
   Poon VKM, 2004, BURNS, V30, P140, DOI 10.1016/j.burns.2003.09.030
   Qin Y., 2004, TEXT MAG, V31, P14
   Ryan KJ, 2003, SHERRIS MED MICROBIO
   Samadra C., 1997, J CONTROL RELEASE, V44, P201
   Smith E. A., 1947, SAMPLING ASSAY PRECI
   Stashak T. S., 2004, Clinical Techniques in Equine Practice, V3, P148, DOI 10.1053/j.ctep.2004.08.006
   Thomas S., 2004, ONLINE J WORLD WIDE
   WHITE WC, 2004, WOUND CARE
NR 25
TC 17
Z9 18
U1 1
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 30
PY 2014
VL 101
BP 1184
EP 1190
DI 10.1016/j.carbpol.2013.10.058
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 300WN
UT WOS:000330494800149
PM 24299890
DA 2018-10-20
ER

PT J
AU Bao, L
   Liu, JX
   Shi, F
   Jiang, YY
   Liu, GS
AF Bao, Lei
   Liu, Jingxiao
   Shi, Fei
   Jiang, Yanyan
   Liu, Guishan
TI Preparation and characterization of TiO2 and Si-doped octacalcium
   phosphate composite coatings on zirconia ceramics (Y-TZP) for dental
   implant applications
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Zirconia dental implant; TiO2 coating; Si-doped octacalcium phosphate;
   Biomimetic method
ID LOW-TEMPERATURE DEGRADATION; BIOCOMPATIBILITY; BIOMATERIAL; TITANIUM;
   SILICON
AB In order to prevent the low temperature degradation and improve the bioactivity of zirconia ceramic implants, TiO2 and Si-doped octacalcium phosphate composite coating was prepared on zirconia substrate. The preventive effect on low temperature degradation and surface morphology of the TiO2 layer were studied. Meanwhile, the structure and property changes of the bioactive coating after doping Si were discussed. The results indicate that the dense TiO2 layer, in spite of some microcracks, inhibited the direct contact of the water vapor with the sample's surface and thus prevented the low temperature degradation of zirconia substrates. The acceleration aging test shows that the ratio of the monoclinic phase transition decreased from 10% for the original zirconia substrate to 4% for the TiO2-coated substrate. As to the Si-doped octacalcium phosphate coating prepared by biomimetic method, the main phase composition of the coating was octacalcium phosphate. The morphology of the coating was lamellar-like, and the surface was uniform and continuous with no cracks being observed. It is suggested that Si was added into the coating both through substituting for PO43- and doping as NaSiO3. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Bao, Lei; Liu, Jingxiao; Shi, Fei; Jiang, Yanyan; Liu, Guishan] Dalian Polytech Univ, Sch Text & Mat Engn, Dalian 116034, Peoples R China.
RP Liu, JX (reprint author), Dalian Polytech Univ, Sch Text & Mat Engn, Dalian 116034, Peoples R China.
EM 65786319@qq.com; drliu-shi@dlpu.edu.cn
FU Liaoning Province Doctoral Startup Foundation [20021054]; Liaoning
   Province Ministry Project of Education Grant [202073425]
FX This work was supported by Liaoning Province Doctoral Startup Foundation
   (No. 20021054) and Liaoning Province Ministry Project of Education Grant
   (No. 202073425)
CR CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Chrissanthopoulos A, 2008, VIB SPECTROSC, V48, P118, DOI 10.1016/j.vibspec.2007.11.008
   Frandsen CJ, 2013, MAT SCI ENG C-MATER, V33, P2752, DOI 10.1016/j.msec.2013.02.045
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Habibovic P, 2004, J MATER SCI-MATER M, V15, P373, DOI 10.1023/B:JMSM.0000021104.42685.9f
   Koh YH, 1999, J AM CERAM SOC, V82, P1456
   Lee TH, 2012, J BIOMED MATER RES B, V100B, P1334, DOI 10.1002/jbm.b.32700
   Liu JX, 2004, J MATER SCI TECHNOL, V20, P550
   Liu JX, 2003, THIN SOLID FILMS, V429, P225, DOI 10.1016/S0040-6090(03)00146-9
   Matsko NB, 2011, J STRUCT BIOL, V174, P180, DOI 10.1016/j.jsb.2010.09.025
   Nakamura K, 2010, INT J PROSTHODONT, V23, P299
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Stefanic M, 2012, APPL SURF SCI, V258, P4649, DOI 10.1016/j.apsusc.2012.01.048
   Zhang E, 2009, MAT SCI ENG C-BIO S, V29, P298, DOI 10.1016/j.msec.2008.07.001
   Zou CM, 2007, RARE METAL MAT ENG, V36, P1905
NR 18
TC 6
Z9 7
U1 1
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JAN 30
PY 2014
VL 290
BP 48
EP 52
DI 10.1016/j.apsusc.2013.10.185
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 280VY
UT WOS:000329060100008
DA 2018-10-20
ER

PT J
AU Yavari, SA
   Wauthle, R
   Bottger, AJ
   Schrooten, J
   Weinans, H
   Zadpoor, AA
AF Yavari, S. Amin
   Wauthle, R.
   Bottger, A. J.
   Schrooten, J.
   Weinans, H.
   Zadpoor, A. A.
TI Crystal structure and nanotopographical features on the surface of
   heat-treated and anodized porous titanium biomaterials produced using
   selective laser melting
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Porous biomaterials; Selective laser melting; Anodizing; Nanotubes; Heat
   treatment
ID TOTAL JOINT REPLACEMENT; SIMULATED BODY-FLUID; TIO2 NANOTUBES; APATITE
   FORMATION; IN-VIVO; BIOCOMPATIBILITY EVALUATION; METALLIC BIOMATERIALS;
   MECHANICAL-PROPERTIES; CORTICAL BONE; SCIENCE
AB Porous titanium biomaterials manufactured using additive manufacturing techniques such as selective laser melting are considered promising materials for orthopedic applications where the biomaterial needs to mimic the properties of bone. Despite their appropriate mechanical properties and the ample pore space they provide for bone ingrowth and osseointegration, porous titanium structures have an intrinsically bioinert surface and need to be subjected to surface bio-functionalizing procedures to enhance their in vivo performance. In this study, we used a specific anodizing process to build a hierarchical oxide layer on the surface of porous titanium structures made by selective laser melting of Ti6Al4V ELI powder. The hierarchical structure included both nanotopographical features (nanotubes) and micro-features (micropits). After anodizing, the biomaterial was heat treated in Argon at different temperatures ranging between 400 and 600 degrees C for either 1 or 2 h to improve its bioactivity. The effects of applied heat treatment on the crystal structure of TiO2 nanotubes and the nanotopographical features of the surface were studied using scanning electron microscopy and X-ray diffraction. It was shown that the transition from the initial crystal structure, i.e. anatase, to rutile occurs between 500 and 600 degrees C and that after 2 h of heat treatment at 600 degrees C the crystal structure is predominantly rutile. The nanotopographical features of the surface were found to be largely unchanged for heat treatments carried out at 500 degrees C or below, whereas they were partially or largely disrupted after heat treatment at 600 degrees C. The possible implications of these findings for the bioactivity of porous titanium structures are discussed. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Yavari, S. Amin; Bottger, A. J.; Weinans, H.; Zadpoor, A. A.] Delft Univ Technol TU Delft, Fac Mech Maritime & Mat Engn, NL-2628 CD Delft, Netherlands.
   [Yavari, S. Amin] FT Innovat BV, NL-5831 PW Boxmeer, Netherlands.
   [Wauthle, R.] Katholieke Univ Leuven, Dept Mech Engn, Sect Prod Engn Machine Design & Automat PMA, B-3001 Louvain, Belgium.
   [Wauthle, R.] LayerWise NV, Louvain, Belgium.
   [Schrooten, J.] Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Heverlee, Belgium.
   [Weinans, H.] UMC Utrecht, Dept Orthoped, NL-3584 CX Utrecht, Netherlands.
   [Weinans, H.] UMC Utrecht, Dept Rheumatol, NL-3584 CX Utrecht, Netherlands.
RP Yavari, SA (reprint author), Delft Univ Technol TU Delft, Fac Mech Maritime & Mat Engn, Mekelweg 2, NL-2628 CD Delft, Netherlands.
EM s.aminyavari@tudelft.nl
RI Zadpoor, Amir A/A-8510-2008; Amin Yavari, Saber/E-5360-2017; Amin
   Yavari, Saber/G-9486-2013
OI Amin Yavari, Saber/0000-0003-1677-5751; Amin Yavari,
   Saber/0000-0003-1677-5751; Zadpoor, Amir Abbas/0000-0003-3234-2112
FU research program of the BioMedical Materials Institute [P2.04 BONE-IP];
   Dutch Ministry of Economic Affairs
FX This research forms part of the Project P2.04 BONE-IP of the research
   program of the BioMedical Materials Institute, co-funded by the Dutch
   Ministry of Economic Affairs. The technical supports of Harry Jansen,
   Patrick van Holst, and Ruud Hendrikx (X-Ray facilities) is also
   acknowledged.
CR Balasundaram G, 2008, J BIOMED MATER RES A, V84A, P447, DOI 10.1002/jbm.a.31388
   Barbas A, 2012, J MECH BEHAV BIOMED, V9, P34, DOI 10.1016/j.jmbbm.2012.01.008
   Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463
   Campoli G, 2013, MATER DESIGN, V49, P957, DOI 10.1016/j.matdes.2013.01.071
   Campoli G, 2012, J MECH BEHAV BIOMED, V10, P108, DOI 10.1016/j.jmbbm.2012.02.011
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chong DYR, 2011, J MECH MED BIOL, V11, P55, DOI 10.1142/S0219519410003666
   Crawford GA, 2009, J MATER RES, V24, P1683, DOI 10.1557/JMR.2009.0221
   Crawford GA, 2009, ACTA MATER, V57, P854, DOI 10.1016/j.actamat.2008.10.032
   Cullity B. D., 2001, ELEMENTS XRAY DIFFRA
   Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Diomidis N, 2012, ACTA BIOMATER, V8, P852, DOI 10.1016/j.actbio.2011.09.034
   Duyck J, 2001, CLIN ORAL IMPLAN RES, V12, P207, DOI 10.1034/j.1600-0501.2001.012003207.x
   Fan XP, 2012, J BIOMED MATER RES A, V100A, P3422, DOI 10.1002/jbm.a.34268
   Fang D, 2011, APPL SURF SCI, V257, P6451, DOI 10.1016/j.apsusc.2011.02.037
   Gilbert R., 1991, ASM HDB, V4
   Hanaor DAH, 2011, J MATER SCI, V46, P855, DOI 10.1007/s10853-010-5113-0
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kingham E, 2013, SMALL, V9, P2140, DOI 10.1002/smll.201202340
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Lamolle SF, 2009, J BIOMED MATER RES A, V88A, P581, DOI 10.1002/jbm.a.31898
   Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052
   Lee BH, 2002, J BIOMED MATER RES, V61, P466, DOI 10.1002/jbm.10190
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219
   Noyama Y, 2012, MATER TRANS, V53, P565, DOI 10.2320/matertrans.M2011358
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155
   Poelert S, 2013, P I MECH ENG H, V227, P464, DOI 10.1177/0954411912467884
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Pyka G, 2012, ADV ENG MATER, V14, P363, DOI 10.1002/adem.201100344
   Ramsden JJ, 2007, CIRP ANN-MANUF TECHN, V56, P687, DOI 10.1016/j.cirp.2007.10.001
   Regonini D, 2010, SURF INTERFACE ANAL, V42, P139, DOI 10.1002/sia.3183
   Takadama H, 2001, J BIOMED MATER RES, V55, P185, DOI 10.1002/1097-4636(200105)55:2<185::AID-JBM1005>3.3.CO;2-G
   Takadama H, 2001, J BIOMED MATER RES, V57, P441, DOI 10.1002/1097-4636(20011205)57:3<441::AID-JBM1187>3.0.CO;2-B
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   TURNER CH, 1994, J BONE MINER RES, V9, P87
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   van der Stok J, 2013, TISSUE ENG PT A, V19, P2605, DOI [10.1089/ten.tea.2013.0181, 10.1089/ten.TEA.2013.0181]
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   Vandati A, 2013, J BIOMECH, V46, P1554, DOI 10.1016/j.jbiomech.2013.03.019
   Vandenbroucke B, 2007, RAPID PROTOTYPING J, V13, P196, DOI 10.1108/13552540710776142
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   Varghese OK, 2003, J MATER RES, V18, P156, DOI 10.1557/JMR.2003.0022
   Warnke PH, 2009, TISSUE ENG PART C-ME, V15, P115, DOI 10.1089/ten.tec.2008.0288
   Willie BM, 2010, TISSUE ENG PART C-ME, V16, P1399, DOI [10.1089/ten.tec.2009.0776, 10.1089/ten.TEC.2009.0776]
   Xue W, 2007, ACTA BIOMATER, V3, P1007, DOI 10.1016/j.actbio.2007.05.009
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yavari SA, 2013, MAT SCI ENG C-MATER, V33, P4849, DOI 10.1016/j.msec.2013.08.006
   Zadpoor AA, 2013, APPL MATH MODEL, V37, P5260, DOI 10.1016/j.apm.2012.10.049
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
NR 55
TC 38
Z9 38
U1 4
U2 90
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JAN 30
PY 2014
VL 290
BP 287
EP 294
DI 10.1016/j.apsusc.2013.11.069
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 280VY
UT WOS:000329060100043
DA 2018-10-20
ER

PT J
AU Jacobs, AC
   Blanchard, CE
   Catherman, SC
   Dunman, PM
   Murata, Y
AF Jacobs, Anna C.
   Blanchard, Catlyn E.
   Catherman, Seana C.
   Dunman, Paul M.
   Murata, Yoshihiko
TI An Ribonuclease T2 Family Protein Modulates Acinetobacter baumannii
   Abiotic Surface Colonization
SO PLOS ONE
LA English
DT Article
ID INTENSIVE-CARE-UNIT; BIOFILM FORMATION; ENVIRONMENTAL CONTAMINATION;
   SURVIVAL; CALCOACETICUS; RNASE; RESISTANCE; INFECTION; OUTBREAK;
   BACTERIA
AB Acinetobacter baumannii is an emerging bacterial pathogen of considerable medical concern. The organism's transmission and ability to cause disease has been associated with its propensity to colonize and form biofilms on abiotic surfaces in health care settings. To better understand the genetic determinants that affect biomaterial attachment, we performed a transposon mutagenesis analysis of abiotic surface-colonization using A. baumannii strain 98-37-09. Disruption of an RNase T2 family gene was found to limit the organism's ability to colonize polystyrene, polypropylene, glass, and stainless steel surfaces. DNA microarray analyses revealed that in comparison to wild type and complemented cells, the RNase T2 family mutant exhibited reduced expression of 29 genes, 15 of which are predicted to be associated with bacterial attachment and surface-associated motility. Motility assays confirmed that RNase T2 mutant displays a severe motility defect. Taken together, our results indicate that the RNase T2 family protein identified in this study is a positive regulator of A. baumannii's ability to colonize inanimate surfaces and motility. Moreover, the enzyme may be an effective target for the intervention of biomaterial colonization, and consequently limit the organism's transmission within the hospital setting.
C1 [Jacobs, Anna C.; Blanchard, Catlyn E.; Dunman, Paul M.] Univ Rochester Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.
   [Catherman, Seana C.; Murata, Yoshihiko] Univ Rochester Sch Med & Dent, Div Infect Dis, Dept Med, Rochester, NY USA.
RP Dunman, PM (reprint author), Univ Rochester Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.
EM paul_dunman@urmc.rochester.edu; yoshihiko_murata@urmc.rochester.edu
FU NIDCR NIH HHS [T90 DE021985]
CR Acquati F, 2013, P NATL ACAD SCI USA, V110, P8140, DOI 10.1073/pnas.1222079110
   Andersen KL, 2012, MOL BIOL CELL, V23, P36, DOI 10.1091/mbc.E11-08-0689
   Aygun G, 2002, J HOSP INFECT, V52, P259, DOI 10.1053/jhin.2002.1300
   Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055
   Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09
   de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100
   El Shafie SS, 2004, J HOSP INFECT, V56, P101, DOI 10.1016/j.jhin.2003.09.024
   Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013
   Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10
   GETCHELLWHITE SI, 1989, INFECT CONT HOSP EP, V10, P402
   Grupper M, 2007, INFECT CONT HOSP EP, V28, P293, DOI 10.1086/512629
   Harding CM, 2013, MBIO, V4
   HIRAI Y, 1991, J HOSP INFECT, V19, P191, DOI 10.1016/0195-6701(91)90223-U
   Hood MI, 2010, ANTIMICROB AGENTS CH, V54, P1029, DOI 10.1128/AAC.00963-09
   HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C
   Jacobs AC, 2012, FEMS IMMUNOL MED MIC, V64, P403, DOI 10.1111/j.1574-695X.2011.00926.x
   Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09
   Lappann M, 2010, MED MICROBIOL IMMUN, V199, P173, DOI 10.1007/s00430-010-0149-y
   Levin AS, 2001, INFECT CONT HOSP EP, V22, P717, DOI 10.1086/501852
   Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07
   Luhtala N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041111
   Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002
   Manian FA, 2013, AM J INFECT CONTROL, V41, P384, DOI 10.1016/j.ajic.2012.04.321
   Markogiannakis A, 2008, INFECT CONT HOSP EP, V29, P410, DOI 10.1086/533545
   Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09
   MURRAY BE, 1982, ANN INTERN MED, V96, P176, DOI 10.7326/0003-4819-96-2-176
   Murray EJ, 2009, MICROBIOL-SGM, V155, P1, DOI 10.1099/mic.0.023903-0
   MUSA EK, 1990, J HOSP INFECT, V15, P219, DOI 10.1016/0195-6701(90)90029-N
   Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10
   Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452
   Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148
   Schwartz B, 2007, CANCER RES, V67, P5258, DOI 10.1158/0008-5472.CAN-07-0129
   Shin JH, 2013, PLOS ONE, V8
   Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0
   Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004
NR 35
TC 10
Z9 14
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 28
PY 2014
VL 9
IS 1
AR e85729
DI 10.1371/journal.pone.0085729
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 301CJ
UT WOS:000330510000017
PM 24489668
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Gopi, D
   Kanimozhi, K
   Bhuvaneshwari, N
   Indira, J
   Kavitha, L
AF Gopi, D.
   Kanimozhi, K.
   Bhuvaneshwari, N.
   Indira, J.
   Kavitha, L.
TI Novel banana peel pectin mediated green route for the synthesis of
   hydroxyapatite nanoparticles and their spectral characterization
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE HAP nanoparticles; Banana peels; Pectin; Green template; Antimicrobial
   activity
ID SOL-GEL TECHNIQUE; SILVER NANOPARTICLES; SPECTROSCOPIC CHARACTERIZATION;
   ANTIBACTERIAL ACTIVITY; BIOMEDICAL APPLICATIONS; HYDROTHERMAL SYNTHESIS;
   H-1-NMR SPECTROSCOPY; LEAF EXTRACT; ESTERIFICATION; TEMPLATE
AB Hydroxyapatite [HAP, Ca-10(PO4)(6)(OH)(2)] is the main inorganic component of natural bone and is widely used in various biomedical applications. In this paper, we have reported the synthesis of HAP nanoparticles by banana peel pectin mediated green template method. The pectin extracted from the peels of banana and its various concentrations were exploited in our study to achieve a controlled crystallinity, particle size as well as uniform morphology of HAP. The extracted pectin was characterized by spectral techniques like Fourier transform infrared spectroscopy (FfIR) for the functional group analysis, proton-1 nuclear magnetic resonance spectroscopy (H-1 NMR) and carbon-13 nuclear magnetic resonance spectroscopy (C-13 NMR) for the identification of H and C atoms in the extracted pectin, respectively. The HAP nanoparticles were synthesized using different concentrations of the as-extracted pectin. The purity, crystallinity and morphology of the as-synthesized HAP nanoparticles were evaluated by FTIR, X-ray diffraction (XRD) and scanning electron microscopy (SEM) with energy dispersive X-ray analysis (EDAX) and transmission electron microscopy (TEM), respectively. Moreover the antibacterial activity of HAP nanoparticles was evaluated against the gram positive and negative bacteria like Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli), respectively. The experimental results revealed that the HAP nanoparticles synthesized in the presence of an optimized concentration of pectin are pure, low crystalline, spherical and discrete particles with reduced size. Also, the HAP sample derived in the presence of pectin showed an enhanced antibacterial activity than that of the HAP synthesized in the absence of pectin. Hence, the HAP nanoparticles synthesized using pectin as a green template can act as a good biomaterial for biomedical applications. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Gopi, D.; Kanimozhi, K.; Bhuvaneshwari, N.; Indira, J.] Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
   [Gopi, D.; Kavitha, L.] Periyar Univ, Ctr Nanosci & Nanotechnol, Salem 636011, Tamil Nadu, India.
   [Bhuvaneshwari, N.] Chikkaiah Naicker Coll, Dept Chem, Erode 638004, Tamil Nadu, India.
   [Kavitha, L.] Periyar Univ, Dept Phys, Salem 636011, Tamil Nadu, India.
RP Gopi, D (reprint author), Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
EM dhanaraj_gopi@yahoo.com; louiskavitha@yahoo.co.in
RI Louis, Kavitha/B-9313-2017; Gopi, Dhanaraj/A-9163-2012
OI Louis, Kavitha/0000-0002-8893-2050; Gopi, Dhanaraj/0000-0001-6662-1238
FU Indian Council of Medical Research (ICMR) [2010-08660,
   5/20/11(Bio)/10-NCD-I]; Department of Science and Technology (DST)
   [DST/TSG/NTS/2011/73, SB/EMEQ-185/2013]; Council of Scientific and
   Industrial Research (CSIR), New Delhi, India [01(2547)/11/EMR-II]; ICTP,
   Italy
FX One of the authors D. Gopi acknowledges the major financial support from
   the Indian Council of Medical Research (ICMR, IRIS ID No.: 2010-08660,
   Ref. No.: 5/20/11(Bio)/10-NCD-I), Department of Science and Technology
   (DST, Ref. No.: DST/TSG/NTS/2011/73 and DST-SERB, Ref. No.:
   SB/EMEQ-185/2013), Council of Scientific and Industrial Research (CSIR,
   Ref. No.: 01(2547)/11/EMR-II) New Delhi, India in the form of major
   research projects. Also L. Kavitha acknowledges the financial support
   from ICTP, Italy in the form of Junior Associateship.
CR Abhishek Mathur, 2011, Journal of Chemical and Pharmaceutical Research, V3, P886
   Al-Zoreky NS, 2009, INT J FOOD MICROBIOL, V134, P244, DOI 10.1016/j.ijfoodmicro.2009.07.002
   Azaroff L. V., 1968, ELEMENTS XRAY CRYSTA
   Bae IY, 2009, FOOD HYDROCOLLOID, V23, P1980, DOI 10.1016/j.foodhyd.2009.02.013
   Bankar A, 2010, COLLOID SURFACE A, V368, P58, DOI 10.1016/j.colsurfa.2010.07.024
   Bankar A, 2010, COLLOID SURFACE B, V80, P45, DOI 10.1016/j.colsurfb.2010.05.029
   Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   BODMEIER R, 1994, PHARMACEUT RES, V11, P882, DOI 10.1023/A:1018942127524
   Cao HQ, 2010, J PHYS CHEM C, V114, P18352, DOI 10.1021/jp106078b
   Chanakya HN, 2009, WASTE MANAGE, V29, P1306, DOI 10.1016/j.wasman.2008.09.014
   Chatjigakis AK, 1998, CARBOHYD POLYM, V37, P395, DOI 10.1016/S0144-8617(98)00057-5
   Dharumadurai Dhanasekaran, 2011, Innovative Romanian Food Biotechnology, V8, P26
   Diessens M., 1978, CALCIFIED TISSUE INT, V26, P127
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Edison TJI, 2013, SPECTROCHIM ACTA A, V104, P262, DOI 10.1016/j.saa.2012.11.084
   Ele-Ekouna JP, 2011, CARBOHYD POLYM, V83, P1232, DOI 10.1016/j.carbpol.2010.09.028
   Emaga T.H., 2007, BIORESOURCE TECHNOL, V99, P4346
   Engels C, 2012, FOOD RES INT, V45, P422, DOI 10.1016/j.foodres.2011.11.008
   Fan LH, 2012, CARBOHYD POLYM, V88, P707, DOI 10.1016/j.carbpol.2012.01.021
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Feng NC, 2009, J HAZARD MATER, V164, P1286, DOI 10.1016/j.jhazmat.2008.09.096
   Fisher J.P., 2007, TISSUE ENG
   Gaines R. V., 1997, DANAS NEW MINERALOGY, P1819
   Gilbert U.P.A., 2005, REV MINERAL GEOCHEM, V59, P157
   Gnanasambandam R, 2000, FOOD CHEM, V68, P327, DOI 10.1016/S0308-8146(99)00191-0
   Gopi D, 2008, SPECTROCHIM ACTA A, V70, P1243, DOI 10.1016/j.saa.2008.02.015
   Gopi D, 2013, SPECTROCHIM ACTA A, V107, P196, DOI 10.1016/j.saa.2013.01.052
   Gopi D, 2013, SPECTROCHIM ACTA A, V104, P292, DOI 10.1016/j.saa.2012.11.092
   Gopi D, 2012, SPECTROCHIM ACTA A, V93, P131, DOI 10.1016/j.saa.2012.02.033
   Gopi D, 2012, SPECTROCHIM ACTA A, V92, P194, DOI 10.1016/j.saa.2012.02.069
   Gopi D, 2012, SPECTROCHIM ACTA A, V87, P245, DOI 10.1016/j.saa.2011.11.047
   Gopi D, 2010, SPECTROCHIM ACTA A, V77, P545, DOI 10.1016/j.saa.2010.06.013
   Gopi D, 2009, SPECTROCHIM ACTA A, V74, P282, DOI 10.1016/j.saa.2009.05.021
   Gopi D., 2010, CURR APPL PHYS, V11, P1
   Green DW, 2006, SOFT MATTER, V2, P732, DOI 10.1039/b604786f
   Hokputsa S, 2004, CARBOHYD RES, V339, P753, DOI 10.1016/j.carres.2003.11.022
   Jain P, 2011, AFR J PHARM PHARMACO, V5, P1398, DOI 10.5897/AJPP11.294
   Jindal M, 2013, CARBOHYD POLYM, V93, P386, DOI 10.1016/j.carbpol.2012.12.012
   Karayil S, 1998, J Postgrad Med, V44, P93
   Kim HM, 2003, CURR OPIN SOLID ST M, V7, P289, DOI 10.1016/j.cossms.2003.09.014
   Kim J.H., 1997, J PHARM SCI, V86, P316
   Klug HP, 1954, XRAY DIFFRACTION PRO, P504
   Kohsuke M., 2004, J AM CHEM SOC, V126, P10657
   Kokkonen H, 2008, BIOMACROMOLECULES, V9, P2369, DOI 10.1021/bm800356b
   Koumoulidis GC, 2003, J COLLOID INTERF SCI, V259, P254, DOI 10.1016/S0021-9797(02)00233-3
   Krithika R., 2012, INT J MED RES, V1, P338
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   LeGeros R.Z., 2002, J ORAL IMPLANTOL, V28, P290
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Liu L, 2010, BIORESOURCE TECHNOL, V101, P3268, DOI 10.1016/j.biortech.2009.12.062
   Liu LS, 2004, BIOMATERIALS, V25, P3201, DOI 10.1016/j.biomaterials.2003.10.036
   Miyazaki T, 2003, J MATER SCI-MATER M, V14, P569, DOI 10.1023/A:1024000821368
   Morra M, 2004, BIOMACROMOLECULES, V5, P2094, DOI 10.1021/bm049834q
   Nadagouda MN, 2009, CRYST GROWTH DES, V9, P4979, DOI 10.1021/cg9007685
   Neirynck N, 2004, FOOD HYDROCOLLOID, V18, P949, DOI 10.1016/j.foodhyd.2004.03.004
   Pappas CS, 2004, CARBOHYD POLYM, V56, P465, DOI 10.1016/j.carbpol.2004.03.014
   Patil RS, 2012, SPECTROCHIM ACTA A, V91, P234, DOI 10.1016/j.saa.2012.02.009
   Perrone P, 2002, PHYTOCHEMISTRY, V60, P67, DOI 10.1016/S0031-9422(02)00039-0
   Rao YS, 2013, SPECTROCHIM ACTA A, V103, P156, DOI 10.1016/j.saa.2012.11.028
   Renard CMGC, 1999, CARBOHYD POLYM, V39, P201, DOI 10.1016/S0144-8617(99)00006-5
   Rodriguez-Ambriz SL, 2008, FOOD CHEM, V107, P1515, DOI 10.1016/j.foodchem.2007,10.007
   Rosenbohm C, 2003, CARBOHYD RES, V338, P637, DOI 10.1016/S0008-6215(02)00440-8
   Roudier MP, 2003, CLIN EXP METASTAS, V20, P171, DOI 10.1023/A:1022627421000
   Semde R, 2000, INT J PHARM, V197, P181, DOI 10.1016/S0378-5173(99)00467-6
   SILVERSTEIN RM, 1991, SPECTROMETRIC IDENTI
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sun XM, 2004, ANGEW CHEM INT EDIT, V43, P597, DOI 10.1002/anie.200352386
   Tari NE, 2011, MATER CHEM PHYS, V131, P132, DOI 10.1016/j.matchemphys.2011.07.078
   Wang F, 2005, MATER LETT, V59, P916, DOI 10.1016/j.matlet.2004.08.041
   Wang L, 2007, CARBOHYD POLYM, V68, P740, DOI 10.1016/j.carbpol.2006.08.010
   Wang YJ, 2006, MATER LETT, V60, P1484, DOI 10.1016/j.matlet.2005.11.053
   Winning H, 2007, FOOD HYDROCOLLOID, V21, P256, DOI 10.1016/j.foodhyd.2006.03.017
   Yan L, 2001, INT J INORG MATER, V3, P633, DOI 10.1016/S1466-6049(01)00164-7
   Yao WR, 2011, J AGR FOOD CHEM, V59, P5312, DOI 10.1021/jf200211m
   Zhang LF, 2013, ULTRASON SONOCHEM, V20, P222, DOI 10.1016/j.ultsonch.2012.07.021
NR 75
TC 32
Z9 32
U1 5
U2 76
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD JAN 24
PY 2014
VL 118
BP 589
EP 597
DI 10.1016/j.saa.2013.09.034
PG 9
WC Spectroscopy
SC Spectroscopy
GA 266EE
UT WOS:000328005400079
PM 24095769
DA 2018-10-20
ER

PT J
AU Sadeghi, B
AF Sadeghi, Babak
TI Preparation of ZnO/Ag nanocomposite and coating on polymers for
   anti-infection biomaterial application
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE Nanocomposites; Antibacterial activity; Scanning electron microscopy
   (SEM); X-ray diffraction(XRD)
ID TEMPERATURE MODULATION; CARBON NANOTUBES; CRYSTAL-GROWTH; ZINC-OXIDE;
   NANOPARTICLES; NANORODS; PARTICLES; ROUTE
AB ZnO/Ag nanocomposites coated with polyvinyl chloride (PVC) were prepared by chemical reduction method, for anti-infection biomaterial application. There is a growing interest in attempts in using biomolecular as the templates to grow inorganic nanocomposites in controlled morphology and structure. By optimizing the experiment conditions, we successfully fabricated high yield of ZnO/Ag nanocomposite with full coverage of high-density polyvinyl chloride (PVC) coating. More importantly, ZnO/Ag nanocomposites were shown to significantly inhibit the growth of Staphylococcus aureus in solution. It was further shown that ZnO/Ag nanocomposites induced thiol depletion that caused death of S. aureus. The coatings were fully characterized using techniques such as scanning electron microscopy (SEM), transmission electron microscopy (TEM) and X-ray diffraction (XRD). Most importantly, compared to uncoated metals, the coatings on PVC promoted healthy antibacterial activity. Importantly, compared to ZnO-Ag -uncoated PVC, the ZnO/Ag nanocomposites coated was approximately triplet more effective in preventing bacteria attachment. The result of Thermal Gravimetric Analysis (TGA) indicates that, the ZnO/Ag nanocomposites are chemically stable in the temperature range from 50 to 900 degrees C. This result, for the first time, demonstrates the potential of using ZnO/Ag nanocomposites as a coating material for numerous anti-bacterial applications. (C) 2013 Elsevier B.V. All rights reserved.
C1 Islamic Azad Univ, Dept Chem, Tonekabon Branch, Tonekabon, Iran.
RP Sadeghi, B (reprint author), Islamic Azad Univ, Dept Chem, Tonekabon Branch, Tonekabon, Iran.
EM bsadeghi1177@gmail.com
FU Research vice Presidency of Tonekabon Branch, Islamic Azad University;
   Iran-Nanotechnology Organization (Govt. of Iran)
FX The financial and encouragement support provided by the Research vice
   Presidency of Tonekabon Branch, Islamic Azad University and Executive
   Director of Iran-Nanotechnology Organization (Govt. of Iran).
CR Azahar Ali., 2009, MATER LETT, V63, P2473
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Beydoun D, 1999, J NANOPART RES, V1, P439, DOI 10.1023/A:1010044830871
   Chen CL, 2008, J AM CHEM SOC, V130, P13555, DOI 10.1021/ja805683r
   Chen ZT, 2006, J CRYST GROWTH, V293, P522, DOI 10.1016/j.jcrysgro.2006.05.082
   Dev A, 2006, J PHYS CHEM B, V110, P14266, DOI 10.1021/jp0627291
   Djalali R, 2003, J AM CHEM SOC, V125, P5873, DOI 10.1021/ja0299598
   Fu ZP, 2007, MATER LETT, V61, P4832, DOI 10.1016/j.matlet.2007.03.051
   Ge CQ, 2008, MATER LETT, V62, P2307, DOI 10.1016/j.matlet.2007.11.073
   Grosso D, 2001, ADV MATER, V13, P1085, DOI 10.1002/1521-4095(200107)13:14<1085::AID-ADMA1085>3.0.CO;2-Q
   Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367
   Huang MH, 2001, ADV MATER, V13, P113, DOI 10.1002/1521-4095(200101)13:2<113::AID-ADMA113>3.0.CO;2-H
   Huang XJ, 2004, SENSOR ACTUAT B-CHEM, V99, P444, DOI 10.1016/j.snb.2003.12.013
   Kambayashi M, 2005, CRYST GROWTH DES, V5, P81, DOI 10.1021/cg0499156
   Kryukov A.I., 2000, TEOR EKSP KHIM, V36, P69
   Kulak A. I., 1986, ELECTROCHEMISTRY SEM
   Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x
   Lin HM, 1998, NANOSTRUCT MATER, V10, P465, DOI 10.1016/S0965-9773(98)00087-7
   Liu X, 2004, J APPL PHYS, V95, P3141, DOI 10.1063/1.1646440
   Milne WI, 2004, J MATER CHEM, V14, P933, DOI 10.1039/b314155c
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   O'Regan B, 2000, ADV MATER, V12, P1263, DOI 10.1002/1521-4095(200009)12:17<1263::AID-ADMA1263>3.0.CO;2-T
   Park WI, 2002, APPL PHYS LETT, V80, P4232, DOI 10.1063/1.1482800
   Sadeghi B, 2010, INT J NANO DIMENS, V1, P119, DOI 10.7508/ijnd.2010.02.004
   Sadeghi B, 2011, MICRO NANO LETT, V6, P209, DOI 10.1049/mnl.2011.0036
   Sadeghi B, 2012, SPECTROCHIM ACTA A, V97, P326, DOI 10.1016/j.saa.2012.05.082
   Sadeghi B, 2011, ADV POWDER TECHNOL, V22, P669, DOI 10.1016/j.apt.2010.10.001
   Sadeghi B, 2012, ADV POWDER TECHNOL, V23, P22, DOI 10.1016/j.apt.2010.11.011
   Sadeghi B, 2009, SUPERLATTICE MICROST, V46, P858, DOI 10.1016/j.spmi.2009.10.006
   Sadjadi MAS, 2008, PHYSICA E, V40, P3183, DOI 10.1016/j.physe.2008.05.010
   Senda S, 2004, APPL PHYS LETT, V85, P5679, DOI 10.1063/1.1832733
   Shekhar S., NANOTECHNOLOGY, V22
   Sieber F., 2007, US Patent, Patent No. [7,205,002, 7205002]
   Sone ED, 2004, J AM CHEM SOC, V126, P12756, DOI 10.1021/ja0499344
   Tsukazaki A, 2005, NAT MATER, V4, P42, DOI 10.1038/nmat1284
   Umar AA, 2006, CRYST GROWTH DES, V6, P818, DOI 10.1021/cg050548n
   Wood A, 2001, J PHYS CHEM B, V105, P8810, DOI 10.1021/jp011576t
NR 37
TC 18
Z9 18
U1 1
U2 58
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD JAN 24
PY 2014
VL 118
BP 787
EP 792
DI 10.1016/j.saa.2013.09.022
PG 6
WC Spectroscopy
SC Spectroscopy
GA 266EE
UT WOS:000328005400104
PM 24148529
DA 2018-10-20
ER

PT J
AU Hook, ER
   Owen, OJ
   Bellis, CA
   Holder, JA
   O'Sullivan, DJ
   Barbour, ME
AF Hook, Edward R.
   Owen, Olivia J.
   Bellis, Candice A.
   Holder, James A.
   O'Sullivan, Dominic J.
   Barbour, Michele E.
TI Development of a novel antimicrobial-releasing glass ionomer cement
   functionalized with chlorhexidine hexametaphosphate nanoparticles
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE Nanoparticles; Nanobiomaterials; Antimicrobial; Dentistry
ID PHYSICAL-PROPERTIES; RESTORATIVE MATERIALS; FLUORIDE RELEASE;
   DENTAL-CARIES; ANTIBACTERIAL; MANAGEMENT
AB Background: Glass ionomer cements (GICs) are a class of dental biomaterials. They have a wide range of uses including permanent restorations (fillings), cavity linings, fissure sealants and adhesives. One of the most common reasons for replacing a dental restoration is recurrent bacterial tooth decay around the margins of the biomaterial. Therefore, a dental biomaterial which creates a sustained antimicrobial environment around the restoration would be of considerable clinical benefit. In this manuscript, the formulation of a GIC containing novel antimicrobial nanoparticles composed of chlorhexidine hexametaphosphate at 1, 2, 5, 10 and 20% powder substitution by mass is reported. The aim is to create GICs which contain chlorhexidine-hexametaphosphate nanoparticles and characterize the nanoparticle size, morphology and charge and the release of chlorhexidine and fluoride, tensile strength and morphology of the GICs.
   Results: The GICs released chlorhexidine, which is a broad spectrum antimicrobial agent effective against a wide range of oral bacteria, over the duration of the experiment in a dose-dependent manner. This was not at the expense of other properties; fluoride release was not significantly affected by the substitution of antimicrobial nanoparticles in most formulations and internal structure appeared unaffected up to and including 10% substitution. Diametral tensile strength decreased numerically with substitutions of 10 and 20% nanoparticles but this difference was not statistically significant.
   Conclusion: A series of GICs functionalized with chlorhexidine-hexametaphosphate nanoparticles were created for the first time. These released chlorhexidine in a dose-dependent manner. These materials may find application in the development of a new generation of antimicrobial dental nanomaterials.
C1 [Hook, Edward R.; Owen, Olivia J.; Bellis, Candice A.; Holder, James A.; O'Sullivan, Dominic J.; Barbour, Michele E.] Univ Bristol, Sch Oral & Dent Sci, Bristol BS1 2LY, Avon, England.
   [Holder, James A.] Associated Dent Prod Ltd, Kemdent, Purton SN5 4HT, Wilts, England.
RP Barbour, ME (reprint author), Univ Bristol, Sch Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England.
EM m.e.barbour@bristol.ac.uk
FU Medical Research Council [1380463]
CR Barbour Michele E, 2013, Int J Nanomedicine, V8, P3507, DOI 10.2147/IJN.S50140
   Billington RW, 2006, J DENT, V34, P544, DOI 10.1016/j.jdent.2005.09.008
   Cheng L, 2012, DENT MATER, V28, P573, DOI 10.1016/j.dental.2012.01.006
   Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x
   GRIFFEN AL, 1991, PEDIATR CLIN N AM, V38, P1209
   Holmgren CJ, 2013, BRIT DENT J, V214, P11, DOI 10.1038/sj.bdj.2012.1175
   Hoszek A, 2008, OPER DENT, V33, P696, DOI 10.2341/08-20
   Korkmaz FM, 2013, J PROSTHET DENT, V110, P107, DOI 10.1016/S0022-3913(13)60349-2
   Lim BS, 2013, EUR J ORAL SCI, V121, P211, DOI 10.1111/eos.12033
   Melo MAS, 2013, TRENDS BIOTECHNOL, V31, P459, DOI 10.1016/j.tibtech.2013.05.010
   Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020
   Palmer G, 2004, BIOMATERIALS, V25, P5423, DOI 10.1016/j.biomaterials.2003.12.051
   Randall RC, 1999, J DENT RES, V78, P628, DOI 10.1177/00220345990780020101
   Sanders BJ, 2002, J ORAL REHABIL, V29, P553, DOI 10.1046/j.1365-2842.2002.00876.x
   Sidhu SK, 2011, AUST DENT J, V56, P23, DOI 10.1111/j.1834-7819.2010.01293.x
   Turkun LS, 2008, J ESTHET RESTOR DENT, V20, P29, DOI 10.1111/j.1708-8240.2008.00146.x
   Wang Z, 2013, DENT MATER, V30, pe1
   Yengopal V, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004483.pub2
   Yip HK, 2000, QUINTESSENCE INT, V31, P261
NR 19
TC 19
Z9 20
U1 1
U2 24
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD JAN 23
PY 2014
VL 12
AR 3
DI 10.1186/1477-3155-12-3
PG 9
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA AD4GQ
UT WOS:000333206700001
PM 24456793
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Kumar, S
   Jana, AK
   Maiti, M
   Dhamija, I
AF Kumar, Sandeep
   Jana, Asim K.
   Maiti, Mithu
   Dhamija, Isha
TI Carbodiimide-mediated immobilization of serratiopeptidase on amino-,
   carboxyl-functionalized magnetic nanoparticles and characterization for
   target delivery
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Carrageenan-induced paw edema; Characterization; Direct protein binding;
   Immobilization; Magnetic nanoparticles (MNPs); Serratiopeptidase;
   Nanomedicine
ID INDUCED PAW EDEMA; PROTEOLYTIC-ENZYME SERRAPEPTASE; IRON-OXIDE
   NANOPARTICLES; CROSS-LINKING; DRUG-DELIVERY; RELEASE; STABILIZATION;
   CONJUGATION; STABILITY; PROGRESS
AB A hybrid biomaterial of serratiopeptidase enzyme was prepared with magnetic nanoparticles (MNPs) via carboxyl and amino-functionalization and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) for direct immobilization. The average size of prepared MNPs was found to be 15.05 +/- A 3.06 nm. Attachment of amino and carboxyl groups was confirmed by Fourier transform infrared spectroscopy. X-ray diffraction confirmed the purity and phase integrity of Fe3O4. The MNPs and enzyme-loaded-MNPs (EMNPs) were of saturation magnetization 58 and 50 emu g(-1), respectively. Thermogravimetric analysis of EDC-MNPs and EMNPs showed the presence of organic coating over MNPs. Serratiopeptidase immobilized on amino-functionalized magnetic nanoparticles showed loss of enzyme activity due to crosslinking of enzyme, while serratiopeptidase immobilized on carboxyl-functionalized magnetic nanoparticles was better and gave 115.78 mg protein g(-1) MNPs, enzyme loading 168.32 U g(-1) MNPs at optimized MNPs-to-enzyme ratio 1.0 mg mg(-1). In vitro and in vivo studies showed that EMNPs with magnetic targeting is more effective in drug permeation and reduction in edema than free enzyme.
C1 [Kumar, Sandeep; Jana, Asim K.] Dr BR Ambedkar Natl Inst Technol, Dept Biotechnol, Jalandhar 144011, India.
   [Maiti, Mithu] Dr BR Ambedkar Natl Inst Technol, Dept Chem, Jalandhar 144011, India.
   [Dhamija, Isha] Guru Jambhshwar Univ Sci & Technol, Dept Pharmaceut Sci, Hisar, India.
RP Jana, AK (reprint author), Dr BR Ambedkar Natl Inst Technol, Dept Biotechnol, GT Rd Bye Pass, Jalandhar 144011, India.
EM asimkumarjana@gmail.com
FU Ministry of Human Resource Development (MHRD), Govt. of India
FX Mr. Sandeep Kumar gratefully acknowledges Ministry of Human Resource
   Development (MHRD), Govt. of India for providing the fellowship during
   the study. All authors are highly thankful to Advanced Enzyme
   Technologies Ltd, Mumbai, for providing the enzyme serratiopeptidase.
   All authors are thankful for helping in the analysis of the different
   samples to Sophisticated Analytical Instrumentation Facility (TEM,
   FTIR), Punjab University, Chandigarh; Central Research Facility
   (SEM-EDS), Indian Institute of Technology, Ropar; Institute
   Instrumentation Center (AFM, VSM), Indian Institute of Technology,
   Roorkee. All authors are highly thankful to Prof. Samir Kumar Das,
   Director, National Institute of Technology (NIT), Jalandhar, for
   providing all grants for the study.
CR Al-Khateeb TH, 2008, INT J ORAL MAX SURG, V37, P264, DOI 10.1016/j.ijom.2007.11.011
   [Anonymous], 2003, FOOD CHEM COD VE, P923
   Bi F, 2009, BIOMATERIALS, V30, P5125, DOI 10.1016/j.biomaterials.2009.06.006
   Cao HN, 2009, APPL SURF SCI, V255, P7974, DOI 10.1016/j.apsusc.2009.04.199
   Chen JP, 2012, INT J NANOMED, V7, P5137, DOI 10.2147/IJN.S36197
   Chen JP, 2011, CARBOHYD POLYM, V84, P364, DOI 10.1016/j.carbpol.2010.11.052
   Chen Y, 2011, ANAL BIOANAL CHEM, V399, P2503, DOI 10.1007/s00216-010-4622-7
   Cheon YH, 2000, J MOL CATAL B-ENZYM, V11, P29, DOI 10.1016/S1381-1177(00)00193-4
   Chertok B, 2011, J CONTROL RELEASE, V155, P393, DOI 10.1016/j.jconrel.2011.06.033
   Dandamudi S, 2007, BIOMATERIALS, V28, P4673, DOI 10.1016/j.biomaterials.2007.07.024
   El-Shafey A, 2006, PROTEIN SCI, V15, P429, DOI 10.1110/ps.051685706
   Faraji M, 2010, J IRAN CHEM SOC, V7, P1, DOI 10.1007/BF03245856
   Gao F., 2012, J NANOPART RES, V14, P1, DOI DOI 10.1007/S11051-012-1160-6
   Hong RY, 2009, APPL SURF SCI, V255, P3485, DOI 10.1016/j.apsusc.2008.09.071
   Hsieh HJ, 2000, BIOTECHNOL LETT, V22, P1459, DOI 10.1023/A:1005602812037
   Hu B, 2009, PROCESS BIOCHEM, V44, P1019, DOI 10.1016/j.procbio.2009.05.001
   Hu FX, 2006, BIOMACROMOLECULES, V7, P809, DOI 10.1021/bm050870e
   Huang GJ, 2012, FOOD CHEM TOXICOL, V50, P1485, DOI 10.1016/j.fct.2012.01.041
   Jiang YY, 2009, J MOL CATAL B-ENZYM, V58, P103, DOI 10.1016/j.molcatb.2008.12.001
   Kalkan NA, 2011, J APPL POLYM SCI, V123, P707
   KEE W H, 1989, SMJ Singapore Medical Journal, V30, P48
   Kouassi G. K., 2005, J NANOBIOTECHNOL, V3
   Krukemeyer MG, 2012, J DRUG TARGET, V20, P185, DOI 10.3109/1061186X.2011.622399
   Kumar R, 2010, MATER RES BULL, V45, P1603, DOI 10.1016/j.materresbull.2010.07.017
   Kumar S, 2013, J DRUG TARGET, DOI [10.3109/1061186X. 1062013.1844157, DOI 10.3109/1061186X.1062013.1844157]
   Kumar S, 2013, EUR J PHARM BIOPHARM, DOI [10.1016/j.ejpb.2013.1006.1019, DOI 10.1016/J.EJPB.2013.1006.1019]
   Kumar S, 2010, BIORESOURCE TECHNOL, V101, P6856, DOI 10.1016/j.biortech.2010.03.084
   KV S, 2007, MOL PHARM, V5, P92
   Li B, 2005, BIOMATERIALS, V26, P1487, DOI 10.1016/j.biomaterials.2004.05.004
   Li GY, 2008, J ALLOY COMPD, V466, P451, DOI 10.1016/j.jallcom.2007.11.100
   Liang YY, 2007, COLLOID POLYM SCI, V285, P1193, DOI 10.1007/s00396-007-1672-2
   Liang YY, 2007, BIOMACROMOLECULES, V8, P1480, DOI 10.1021/bm061091g
   Lin YL, 2012, MATER RES BULL, V47, P614, DOI 10.1016/j.materresbull.2011.12.042
   Longhi C, 2008, MICROB PATHOGENESIS, V45, P45, DOI 10.1016/j.micpath.2008.01.007
   Lopez RFV, 2000, INT J PHARM, V200, P127, DOI 10.1016/S0378-5173(00)00365-3
   Mahato RI, 2003, CRIT REV THER DRUG, V20, P153, DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i23.30
   Maheshwari M, 2006, AAPS PHARMSCITECH, V7, pE162
   Majumder AB, 2008, BIOCATAL BIOTRANSFOR, V26, P235, DOI 10.1080/10242420701685601
   Marroquin-Segura R, 2009, J ETHNOPHARMACOL, V124, P639, DOI 10.1016/j.jep.2009.06.004
   Maximov V, 2009, J DRUG DELIV SCI TEC, V19, P311, DOI 10.1016/S1773-2247(09)50066-4
   MAZZONE A, 1990, J INT MED RES, V18, P379, DOI 10.1177/030006059001800506
   Nakamura S, 2003, RESPIROLOGY, V8, P316, DOI 10.1046/j.1440-1843.2003.00482.x
   Namdeo M, 2009, J MOL CATAL B-ENZYM, V59, P134, DOI 10.1016/j.molcatb.2009.02.005
   Nigam S, 2011, J MAGN MAGN MATER, V323, P237, DOI 10.1016/j.jmmm.2010.09.009
   Novak L, 2007, BIOMACROMOLECULES, V8, P1624, DOI 10.1021/bm0612182
   Nowicka AM, 2013, BIOMACROMOLECULES, V14, P828, DOI 10.1021/bm301868f
   Panagariya A, 1999, J Assoc Physicians India, V47, P1170
   Pecova M, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/12/125102
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Petri-Fink A, 2008, EUR J PHARM BIOPHARM, V68, P129, DOI 10.1016/j.ejpb.2007.02.024
   Rath G, 2011, ARTIF CELL BLOOD SUB, V39, P44, DOI 10.3109/10731199.2010.494580
   Ren LL, 2010, J MOL CATAL B-ENZYM, V62, P190, DOI 10.1016/j.molcatb.2009.10.009
   Sadeghi H, 2011, EUR J PHARMACOL, V667, P396, DOI 10.1016/j.ejphar.2011.05.053
   ShiXing W., 2010, J NANOPART RES, V12, P2467
   Shubayev VI, 2009, ADV DRUG DELIVER REV, V61, P467, DOI 10.1016/j.addr.2009.03.007
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Tang TT, 2011, CHEMOSPHERE, V83, P255, DOI 10.1016/j.chemosphere.2010.12.075
   Verma ML, 2013, APPL MICROBIOL BIOT, V97, P23, DOI 10.1007/s00253-012-4535-9
   Vichasilp C, 2012, FOOD CHEM, V134, P1823, DOI 10.1016/j.foodchem.2012.03.086
   Wang N, 2013, J COLLOID INTERF SCI, V395, P50, DOI 10.1016/j.jcis.2012.11.062
   Xu H, 2005, J MAGN MAGN MATER, V293, P514, DOI 10.1016/j.jmmm.2005.01.067
   Yu CC, 2012, BIOCONJUGATE CHEM, V23, P714, DOI 10.1021/bc200396r
   Zheng ZH, 2009, J FIBER BIOENGINEERI, V2, P162
   Zhu H, 2009, J MOL CATAL B-ENZYM, V61, P174, DOI 10.1016/j.molcatb.2009.06.007
   Zhuo Y, 2009, BIOMATERIALS, V30, P2284, DOI 10.1016/j.biomaterials.2009.01.002
   Ziv-Polat O, 2010, BIOMATERIALS, V31, P741, DOI 10.1016/j.biomaterials.2009.09.093
NR 66
TC 8
Z9 9
U1 1
U2 59
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD JAN 22
PY 2014
VL 16
IS 2
BP 1
EP 23
AR 2233
DI 10.1007/s11051-013-2233-x
PG 23
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 298QH
UT WOS:000330338900001
DA 2018-10-20
ER

PT J
AU Zhang, ZS
   Wu, T
   Wang, Q
   Pan, HH
   Tang, RK
AF Zhang, Zhisen
   Wu, Tao
   Wang, Qi
   Pan, Haihua
   Tang, Ruikang
TI Impact of interfacial high-density water layer on accurate estimation of
   adsorption free energy by Jarzynski's equality
SO JOURNAL OF CHEMICAL PHYSICS
LA English
DT Article
ID STEERED MOLECULAR-DYNAMICS; MONTE-CARLO SIMULATIONS; WALLED CARBON
   NANOTUBES; PROTEIN ADSORPTION; NONEQUILIBRIUM SIMULATIONS;
   HYDROXYAPATITE SURFACES; CONFORMATIONAL-CHANGES; STATISTICAL-MECHANICS;
   BINDING AFFINITIES; CELL-ADHESION
AB The interactions between proteins/peptides and materials are crucial to research and development in many biomedical engineering fields. The energetics of such interactions are key in the evaluation of new proteins/peptides and materials. Much research has recently focused on the quality of free energy profiles by Jarzynski's equality, a widely used equation in biosystems. In the present work, considerable discrepancies were observed between the results obtained by Jarzynski's equality and those derived by umbrella sampling in biomaterial-water model systems. Detailed analyses confirm that such discrepancies turn up only when the target molecule moves in the high-density water layer on a material surface. Then a hybrid scheme was adopted based on this observation. The agreement between the results of the hybrid scheme and umbrella sampling confirms the former observation, which indicates an approach to a fast and accurate estimation of adsorption free energy for large biomaterial interfacial systems. (C) 2014 AIP Publishing LLC.
C1 [Zhang, Zhisen; Wu, Tao; Wang, Qi] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310027, Zhejiang, Peoples R China.
   [Zhang, Zhisen; Wu, Tao; Wang, Qi; Tang, Ruikang] Zhejiang Univ, Dept Chem, Hangzhou 310027, Zhejiang, Peoples R China.
   [Pan, Haihua] Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou 310027, Zhejiang, Peoples R China.
   [Zhang, Zhisen; Tang, Ruikang] Zhejiang Univ, Ctr Biomat & Biopathways, Hangzhou 310027, Zhejiang, Peoples R China.
RP Wu, T (reprint author), Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310027, Zhejiang, Peoples R China.
EM tao_wu@zju.edu.cn; qiwang@zju.edu.cn
FU National Natural Science Foundation of China (NNSFC) [21074115,
   21273200]; MOE [J20091551]; Zhejiang University [2011XZZX002,
   2011QNA3014]
FX This work was supported by the National Natural Science Foundation of
   China (NNSFC) (Grant Nos. 21074115 and 21273200), MOE (Grant No.
   J20091551), and the Zhejiang University (Grant Nos. 2011XZZX002 and
   2011QNA3014).
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   Amaro R, 2003, P NATL ACAD SCI USA, V100, P7599, DOI 10.1073/pnas.1331150100
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Bastug T, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2904461
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Bertinetti L, 2007, J PHYS CHEM C, V111, P4027, DOI 10.1021/jp066040s
   Chelli R, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4808037
   Chelli R, 2012, J CHEM THEORY COMPUT, V8, P4040, DOI 10.1021/ct300348w
   Chen X, 2008, BIOMATERIALS, V29, P2423, DOI 10.1016/j.biomaterials.2008.02.002
   Corno M, 2009, LANGMUIR, V25, P2188, DOI 10.1021/la803253k
   Crooks GE, 2000, PHYS REV E, V61, P2361, DOI 10.1103/PhysRevE.61.2361
   Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Daura X, 2010, CHEMPHYSCHEM, V11, P3734, DOI 10.1002/cphc.201000562
   de Graaf J, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3389481
   de Leeuw NH, 2007, CRYSTENGCOMM, V9, P1178, DOI 10.1039/b710974a
   Echeverria I, 2012, J PHYS CHEM B, V116, P10986, DOI 10.1021/jp300527q
   Essex JW, 1997, J PHYS CHEM B, V101, P9663, DOI 10.1021/jp971990m
   Gore J, 2003, P NATL ACAD SCI USA, V100, P12564, DOI 10.1073/pnas.1635159100
   Harding JH, 2006, J MATER CHEM, V16, P1105, DOI 10.1039/b511650c
   Harding JH, 2008, CHEM REV, V108, P4823, DOI 10.1021/cr078278y
   Hauptmann S, 2003, PHYS CHEM CHEM PHYS, V5, P635, DOI 10.1039/b208209h
   Hendrix DA, 2001, J CHEM PHYS, V114, P5974, DOI 10.1063/1.1353552
   Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Hummer G, 2001, J CHEM PHYS, V114, P7330, DOI 10.1063/1.1363668
   Ilan B, 2004, PROTEINS, V55, P223, DOI 10.1002/prot.20038
   Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690
   Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299
   JORGENSEN WL, 1989, CHEM PHYS, V129, P193, DOI 10.1016/0301-0104(89)80004-7
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kang Y, 2010, J PHYS CHEM B, V114, P2869, DOI 10.1021/jp905995s
   Kang Y, 2009, BIOMATERIALS, V30, P2807, DOI 10.1016/j.biomaterials.2009.01.024
   Kato M, 2005, J PHYS CHEM B, V109, P19516, DOI 10.1021/jp0532081
   Kato M, 2006, PROTEINS, V64, P829, DOI 10.1002/prot.21012
   Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657
   Kosztin I, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166379
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   Larsson A, 2007, BIOMACROMOLECULES, V8, P287, DOI 10.1021/bm060685g
   Lua RC, 2005, J PHYS CHEM B, V109, P6805, DOI 10.1021/jp0455428
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Makarucha AJ, 2011, EUR BIOPHYS J BIOPHY, V40, P103, DOI 10.1007/s00249-010-0651-6
   Mijajlovic M, 2013, LANGMUIR, V29, P2919, DOI 10.1021/la3047966
   Minh DDL, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3242285
   Moradi M, 2013, J PHYS CHEM LETT, V4, P1882, DOI 10.1021/jz400816x
   Nicolini P, 2013, J COMPUT CHEM, V34, P1561, DOI 10.1002/jcc.23286
   Nicolini P, 2011, J CHEM THEORY COMPUT, V7, P582, DOI 10.1021/ct100568n
   Nicolini P, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041124
   Oberhofer H, 2005, J PHYS CHEM B, V109, P6902, DOI 10.1021/jp044556a
   Oostenbrink C, 2006, CHEM PHYS, V323, P102, DOI 10.1016/j.chemphys.2005.08.054
   Pan HH, 2007, LANGMUIR, V23, P8972, DOI 10.1021/la700567r
   Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473
   Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311
   Piccinini E, 2008, J CHEM THEORY COMPUT, V4, P173, DOI 10.1021/ct7001896
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Reid JC, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3486196
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rodriguez-Gomez D, 2004, J CHEM PHYS, V120, P3563, DOI 10.1063/1.1642607
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Shen JW, 2008, BIOMATERIALS, V29, P3847, DOI 10.1016/j.biomaterials.2008.06.013
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   Shen JW, 2009, CHEMPHYSCHEM, V10, P1260, DOI 10.1002/cphc.200800836
   Spichty M, 2010, J PHYS CHEM LETT, V1, P1922, DOI 10.1021/jz1005016
   Thyparambil AA, 2012, LANGMUIR, V28, P5687, DOI 10.1021/la300315r
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007
   Wei Y, 2008, LANGMUIR, V24, P6721, DOI 10.1021/la8005772
   WILLNER I, 1993, ADV MATER, V5, P912, DOI 10.1002/adma.19930051206
   Wilson RM, 1999, AM MINERAL, V84, P1406
   Wright LB, 2012, J PHYS CHEM C, V116, P2933, DOI 10.1021/jp209554g
   Yang G, 2012, BIOMATERIALS, V33, P8757, DOI 10.1016/j.biomaterials.2012.08.053
   Ytreberg FM, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3119261
   Ytreberg FM, 2004, J COMPUT CHEM, V25, P1749, DOI 10.1002/jcc.20103
   Zhang DQ, 2006, J AM CHEM SOC, V128, P3019, DOI 10.1021/ja057292u
NR 80
TC 4
Z9 5
U1 1
U2 29
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-9606
EI 1089-7690
J9 J CHEM PHYS
JI J. Chem. Phys.
PD JAN 21
PY 2014
VL 140
IS 3
AR 034706
DI 10.1063/1.4858428
PG 9
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 302OM
UT WOS:000330614400052
PM 25669406
DA 2018-10-20
ER

PT J
AU Zhang, BJ
   He, DY
   Fan, Y
   Liu, N
   Chen, YJ
AF Zhang, Baojie
   He, Dongyang
   Fan, Yu
   Liu, Nan
   Chen, Yijun
TI Oral Delivery of Exenatide via Microspheres Prepared by Cross-Linking of
   Alginate and Hyaluronate
SO PLOS ONE
LA English
DT Article
ID SODIUM ALGINATE; DRUG-DELIVERY; GLUTARALDEHYDE; RELEASE; PEPTIDE;
   NANOPARTICLES; EXENDIN-4; BARRIERS; RECEPTOR; AGONIST
AB Exenatide is an FDA-approved glucose-lowering peptide drug for the treatment of type 2 diabetes by subcutaneous injection. To address the issues on the inconvenience for patient use and the difficulty of oral administration of peptide drugs, chemical cross-linking of two pH-responsive biomaterials, alginate and hyaluronate, was carried out to prepare a new material for the encapsulation of exenatide as a form of microspheres. The exenatide-loaded microspheres exhibited spherical structures with excellent loading and release behaviors in the simulated gastrointestinal tract environments. After oral administration of the microspheres in db/db mice, maximum plasma concentration of exenatide appeared at 4 hours, and blood glucose was effectively reduced to a normal level within 2 hours and maintained for another 4 hours. The bioavailability of the exenatide-loaded microspheres, relative to subcutaneous injection of exenatide, reached 10.2%. Collectively, the present study demonstrated the feasibility of orally delivering exenatide with the new cross-linked biomaterial and formulation, and showed therapeutic potential for clinical applications.
C1 [Zhang, Baojie; He, Dongyang; Fan, Yu; Liu, Nan; Chen, Yijun] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.
   [Zhang, Baojie; He, Dongyang; Fan, Yu; Liu, Nan; Chen, Yijun] China Pharmaceut Univ, Biol Chem Lab, Nanjing, Jiangsu, Peoples R China.
RP Liu, N (reprint author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.
EM liunan0428@aliyun.com; yjchen@cpu.edu.cn
OI chen, yijun/0000-0002-4920-152X
FU Ministry of Education of China; State Administration of Foreign Export
   Affairs of China [111-2-07]; National Science and Technology Major
   Projects of China [2012ZX09103-101-030]; State Key Laboratory of Natural
   Medicines, China Pharmaceutical University [SKLNMZZCX201301]
FX This work was supported by the grants from the "111" Project from the
   Ministry of Education of China, and the State Administration of Foreign
   Export Affairs of China (No: 111-2-07), National Science and Technology
   Major Projects of China (2012ZX09103-101-030) and the Research Project
   of State Key Laboratory of Natural Medicines, China Pharmaceutical
   University (No: SKLNMZZCX201301). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Appel EA, 2012, BIOMATERIALS, V33, P4646, DOI 10.1016/j.biomaterials.2012.02.030
   Bajpai SK, 2004, REACT FUNCT POLYM, V59, P129, DOI 10.1016/j.reactfunctpolym.2004.01.002
   Colinet I, 2009, EUR J PHARM BIOPHARM, V73, P345, DOI 10.1016/j.ejpb.2009.07.008
   Davidovich-Pinhas M, 2010, CARBOHYD POLYM, V79, P1020, DOI 10.1016/j.carbpol.2009.10.036
   Davidson MB, 2005, NAT REV DRUG DISCOV, V4, P713, DOI 10.1038/nrd1828
   Ensign LM, 2012, ADV DRUG DELIVER REV, V64, P557, DOI 10.1016/j.addr.2011.12.009
   Esposito E, 2005, INT J PHARM, V288, P35, DOI 10.1016/j.ijpharm.2004.09.001
   Fasano A, 1998, TRENDS BIOTECHNOL, V16, P152, DOI 10.1016/S0167-7799(97)01170-0
   FEHMANN HC, 1992, MOL CELL ENDOCRINOL, V85, pC39, DOI 10.1016/0303-7207(92)90118-P
   Fundueanu G, 1998, INT J PHARM, V170, P11, DOI 10.1016/S0378-5173(98)00063-5
   Fundueanu G, 1999, BIOMATERIALS, V20, P1427, DOI 10.1016/S0142-9612(99)00050-2
   Gedulin BR, 2008, INT J PHARM, V356, P231, DOI 10.1016/j.ijpharm.2008.01.015
   GOKE R, 1993, J BIOL CHEM, V268, P19650
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Gong NA, 2011, BRIT J PHARMACOL, V163, P399, DOI 10.1111/j.1476-5381.2011.01227.x
   Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003
   Jin CH, 2009, J CONTROL RELEASE, V133, P172, DOI 10.1016/j.jconrel.2008.09.091
   Kim H, 2011, BIOMATERIALS, V32, P1685, DOI 10.1016/j.biomaterials.2010.10.045
   Kulkarni AR, 2000, J CONTROL RELEASE, V63, P97, DOI 10.1016/S0168-3659(99)00176-5
   Li M, 2008, INT J PHARMACEUT, V363, P26, DOI 10.1016/j.ijpharm.2008.07.018
   Liew CV, 2006, INT J PHARM, V309, P25, DOI 10.1016/ijpharm.2005.10.040
   Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a
   Morishita M, 2006, DRUG DISCOV TODAY, V11, P905, DOI 10.1016/j.drudis.2006.08.005
   Nguyen HN, 2011, BIOMATERIALS, V32, P2673, DOI 10.1016/j.biomaterials.2010.12.044
   Norback D, 1998, SCAND J WORK ENV HEA, V14, P366
   Sung HW, 2012, ACCOUNTS CHEM RES, V45, P619, DOI 10.1021/ar200234q
   Yeom CK, 1998, J APPL POLYM SCI, V67, P209, DOI 10.1002/(SICI)1097-4628(19980110)67:2<209::AID-APP3>3.0.CO;2-Y
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   Zeiger E, 2005, MUTAT RES-REV MUTAT, V589, P136, DOI 10.1016/j.mrrev.2005.01.001
NR 29
TC 7
Z9 11
U1 0
U2 32
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 21
PY 2014
VL 9
IS 1
AR e86064
DI 10.1371/journal.pone.0086064
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 297GT
UT WOS:000330244500171
PM 24465870
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Fernandez-Rodriguez, MA
   Rodriguez-Valverde, MA
   Cabrerizo-Vilchez, MA
AF Fernandez-Rodriguez, M. A.
   Rodriguez-Valverde, M. A.
   Cabrerizo-Vilchez, M. A.
TI Selective desorption of organophosphonates on chemically functionalized
   titanium by Direct Laser Patterning
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article; Proceedings Paper
CT 5th International Workshop Bubble and Drop Interfaces
CY MAY 21-24, 2012
CL Krakow, POLAND
DE Titanium; Chemical functionalization; Organophosphonate; Laser
   patterning; Biomaterial engineering
ID SELF-ASSEMBLED MONOLAYERS; NATIVE-OXIDE SURFACE; SILICON; ACIDS
AB Surface functionalization based on organophosphonate molecules and Direct Laser Patterning (DLP) technique both allow to design chemically patterned titanium surfaces devoted to biomaterial engineering. Ultrapolished surfaces of commercially pure titanium were modified with 16-phosphonohexadecanoic acid and octadecylphosphonic acid. The DLP technique with a green pulsed laser was applied to selectively desorb the organophosphonate molecules on the functionalized titanium surfaces. Three regimes of laser ablation were found on the bare titanium surfaces as the ratio between the spot diameter and the interspot distance. Finally, the organophosphonate functionalized titanium surfaces subjected to DLP revealed different wettability domains with minimum impact on the roughness, validated by XPS, AFM and ESEM. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Fernandez-Rodriguez, M. A.; Rodriguez-Valverde, M. A.; Cabrerizo-Vilchez, M. A.] Univ Granada, Fac Sci, Dept Appl Phys, Biocolloid & Fluid Phys Grp, E-18071 Granada, Spain.
RP Rodriguez-Valverde, MA (reprint author), Univ Granada, Fac Sci, Dept Appl Phys, Biocolloid & Fluid Phys Grp, E-18071 Granada, Spain.
EM marodri@ugr.es
RI Fernandez-Rodriguez, Miguel Angel/J-2923-2015; Cabrerizo-Vilchez,
   Miguel/A-3179-2012; Rodriguez-Valverde, Miguel Angel/B-7938-2009
OI Fernandez-Rodriguez, Miguel Angel/0000-0002-9540-1979;
   Cabrerizo-Vilchez, Miguel/0000-0001-8759-1373; Rodriguez-Valverde,
   Miguel Angel/0000-0003-4361-6721
FU "Ministry of Science and Innovation" [MAT2011-23339]; "Junta de
   Andalucia" [P08-FQM-4325, P09-FQM-4698, P10-FQM-5977]
FX This study was supported by the "Ministry of Science and Innovation"
   (project MAT2011-23339) and by the "Junta de Andalucia" (projects
   P08-FQM-4325, P09-FQM-4698 and P10-FQM-5977). Authors thank to J.A.
   Martin-Perez, who masterly polished the titanium samples, and Y.
   Sanchez-Trevino, C.L. Moraila-Martinez and Dr. F.J. Montes Ruiz-Cabello
   for fruitful discussions.
CR Birch W., 2008, DEV SURFACE CONTAMIN, P1
   Butt HJ, 2003, PHYS CHEM INTERFACES
   Conde JC, 2007, APPL PHYS A-MATER, V88, P667, DOI 10.1007/s00339-007-4024-7
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   Danahy MP, 2004, LANGMUIR, V20, P5333, DOI 10.1021/la036084h
   Gawalt ES, 2001, LANGMUIR, V17, P5736, DOI 10.1021/la010649x
   Hanson EL, 2003, J AM CHEM SOC, V125, P16074, DOI 10.1021/ja035956z
   Lawrence J, 2006, SURF COAT TECH, V200, P5581, DOI 10.1016/j.surfcoat.2005.07.107
   Morra M, 2007, EXPERT REV MED DEVIC, V4, P361, DOI 10.1586/17434440.4.3.361
   Shadnam MR, 2004, LANGMUIR, V20, P2667, DOI 10.1021/la0354584
   Tosatti S., 2003, THESIS SWISS FEDERAL
   Wagner CD, 1979, HDB XRAY PHOTOELECTR
   Welsch G., 1994, MAT PROPERTIES HDB
   Wu J., J BIOMED MAT RES A
NR 14
TC 0
Z9 0
U1 3
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
EI 1873-4359
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD JAN 20
PY 2014
VL 441
BP 899
EP 904
DI 10.1016/j.colsurfa.2013.02.047
PG 6
WC Chemistry, Physical
SC Chemistry
GA 283PZ
UT WOS:000329260800116
DA 2018-10-20
ER

PT J
AU Kandasubramanian, B
   Govindaraj, P
AF Kandasubramanian, Balasubramanian
   Govindaraj, Premika
TI Peeling model for cell adhesion on electrospun polymer nanofibres
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE electrospinning; nanofibre; cell adhesion; biocompatibility;
   antibacterial property
ID MEMBRANE-MEMBRANE ADHESION; MOLECULAR CROSS-BRIDGES; DETAILED MECHANICS;
   SEPARATION; DELIVERY; FORCES; STATE
AB Need for controlled drug delivery has gained immense attention over the conventional dosage forms due to improved therapeutic efficacy and reduced toxicity by controlled delivery. Recently, electrospun fibres have gained wide attention particularly for drug delivery systems, tissue engineering and vascular grafts for biomedical application. In the present work, the feasibility of producing fibrous composite of polylactic acid (PLA) and hydroxyapatite with silver nitrate using electrospinning technique was explored to understand the antibacterial property of the dressing. These non-woven fibres were post processed and heat treated with UV radiations. Such heat treatment is known to reduce the ionic silver to silver nanoparticles and also improve the crystalline properties of hydroxyapatite and PLA. Antimicrobial tests show that these fibres have maintained antibacterial properties against Staphylococcos aureus. It was noticed that there was no discolouration in the wound mat. To test the biocompatibility of these fabrics, the electrospun mats were cultured with fibroblasts. The results indicated that the cells attached and proliferated as continuous layers and maintained a healthy morphology. Once the biomaterial is implanted, no control is possible either over the biomaterial characteristics or the healing process. At this point the modelling process takes over. The present study is extended to a mathematical model for a primary step in tissue regeneration-cell adhesion, using a one-dimensional peeling model'.
C1 [Kandasubramanian, Balasubramanian; Govindaraj, Premika] Minist Def, Dept Mat Engn, DIAT DU, Pune, Maharashtra, India.
RP Kandasubramanian, B (reprint author), Minist Def, Dept Mat Engn, DIAT DU, Pune, Maharashtra, India.
EM balask@diat.ac.in
FU Nano project [EPIPR/ER/100 3883/M/01/908/2012/D (RD)/1416]
FX We would like to thank Dr Renuka Gonte for her kind and valuable
   suggestions during the review of the article and Dr Prahlada, vice
   chancellor of Defence Institute of Advanced Technology, for his support
   and encouragement. This work was financially supported by the Nano
   project (EPIPR/ER/100 3883/M/01/908/2012/D (R&D)/1416 Dated:
   28.03.2012).
CR de Velde K. V., 2002, POLYM TEST, V21, P433
   Espinosa-Cristobal LF, 2009, MATER LETT, V63, P2603, DOI 10.1016/j.matlet.2009.09.018
   EVANS EA, 1985, BIOPHYS J, V48, P185, DOI 10.1016/S0006-3495(85)83771-1
   EVANS EA, 1985, BIOPHYS J, V48, P175, DOI 10.1016/S0006-3495(85)83770-X
   Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988
   Kong D, 2008, J THEOR BIOL, V250, P75, DOI 10.1016/j.jtbi.2007.09.028
   Leckband D, 2000, ANNU REV BIOPH BIOM, V29, P1, DOI 10.1146/annurev.biophys.29.1.1
   Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Park JH, 2010, ADV DRUG DELIVER REV, V62, P28, DOI 10.1016/j.addr.2009.10.003
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Song L, 2011, MATER LETT, V65, P974, DOI 10.1016/j.matlet.2010.12.051
   Stevanovic MM, 2012, POLYMER, V53, P2818, DOI 10.1016/j.polymer.2012.04.057
   Tripathi BP, 2011, PROG POLYM SCI, V36, P745
   Zhang LF, 2011, J MEMBRANE SCI, V369, P499, DOI 10.1016/j.memsci.2010.12.032
   Zhang Y, 2013, ADV DRUG DELIVER REV, V65, P104, DOI 10.1016/j.addr.2012.10.003
NR 18
TC 1
Z9 1
U1 1
U2 48
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0169-4243
EI 1568-5616
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PD JAN 17
PY 2014
VL 28
IS 2
BP 171
EP 185
DI 10.1080/01694243.2013.833402
PG 15
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 249MJ
UT WOS:000326781000005
DA 2018-10-20
ER

PT J
AU Qin, GK
   Panilaitis, BJ
   Kaplan, ZSDL
AF Qin, Guokui
   Panilaitis, Bruce J.
   Kaplan, Zhongyuan Sun David L.
TI A cellulosic responsive "living" membrane
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Living membrane; Bacterial cellulose; Co-cultivation; Gene amplifier;
   Positive feedback
ID CYCLIC DIGUANYLIC ACID; ACETOBACTER-XYLINUM; BACTERIAL CELLULOSE;
   GLUCONACETOBACTER-XYLINUS; HIGHER-PLANTS; BIOSYNTHESIS; SYNTHASE;
   INVITRO; SYSTEM
AB Bacterial cellulose has been demonstrated to be a remarkably versatile biomaterial and widely used in biomedical applications due to its unique physical properties. Here we reported for the first time a "living membrane" system based on recombinant Escherichia coli bacterial strains entrapped in cellulosic membranes produced by Gluconacetobacter xylinus. Biologically driven detection and identification of a range of target molecules presents unique challenges, and requires that detection methods are developed to be rapid, specific and sensitive. The compatibility of G. xylinus and recombinant E. coli strains was first investigated for co-cultivation, and the relationship between the number of entrapped E. coli and the level of inducible signal achieved was further explored by fluorescent signal observation in confocal microscopy. Finally to amplify the response to inducers for maximum fluorescent signal, a positive-feedback genetic amplifier was designed within recombinant E. coli strain entrapped in the living cellulosic membrane system, allowing for the detection mechanism to be extremely sensitive and resulting in a significant fluorescent signal from a single receptor binding event. The living membrane system proposed here will create devices of greater complexity in function for applications in biological and chemical detection. (C) 2013 Published by Elsevier Ltd.
C1 [Qin, Guokui; Panilaitis, Bruce J.; Kaplan, Zhongyuan Sun David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Panilaitis, BJ (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM bruce.panilaitis@tufts.edu
RI Qin, Guokui/B-1520-2012
OI Qin, Guokui/0000-0002-2212-1597
FU Army Research Office [58318-LS]
FX We thank Prof. Kaustubh Bhalerao (University of Illinois at
   Urbana-Champaign, USA) for the plasmid pGN68. We would like to
   acknowledge the assistance of Dr. Yinan Lin for SEM studies. This work
   was supported by grants from the Army Research Office (58318-LS).
CR ALONI Y, 1982, P NATL ACAD SCI-BIOL, V79, P6448, DOI 10.1073/pnas.79.21.6448
   Chao YP, 2000, BIOTECHNOL BIOENG, V68, P345
   Charreau H., 2012, RECENT PATENTS NANOT
   Chepurnykh O E, 1994, Gig Sanit, P36
   Dark PM, 2009, CRIT CARE, V13, DOI 10.1186/cc7886
   GRETZ MR, 1989, NATURWISSENSCHAFTEN, V76, P380, DOI 10.1007/BF00366213
   Henderson L W, 1985, Contrib Nephrol, V44, P112
   Hwang JW, 1999, J BIOSCI BIOENG, V88, P183, DOI 10.1016/S1389-1723(99)80199-6
   Kim JS, 2001, APPL BIOCHEM BIOTECH, V91-3, P331, DOI 10.1385/ABAB:91-93:1-9:331
   Kojima S, 1991, ASAIO Trans, V37, P644
   Lee JW, 2001, APPL ENVIRON MICROB, V67, P3970, DOI 10.1128/AEM.67.9.3970-3975.2001
   Ligon B Lee, 2006, Semin Pediatr Infect Dis, V17, P161, DOI 10.1053/j.spid.2006.07.002
   LIN FC, 1985, SCIENCE, V230, P822, DOI 10.1126/science.230.4727.822
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   MAYER R, 1991, P NATL ACAD SCI USA, V88, P5472, DOI 10.1073/pnas.88.12.5472
   Nagai T, 1997, BIOL PHARM BULL, V20, P1082
   Nistala Goutam J, 2010, J Biol Eng, V4, P4, DOI 10.1186/1754-1611-4-4
   Park S. H., 2012, J TISSUE ENG REGENER
   PLUMBRIDGE J, 1995, EMBO J, V14, P3958, DOI 10.1002/j.1460-2075.1995.tb00067.x
   Qin GK, 2011, BIOMATERIALS, V32, P9231, DOI 10.1016/j.biomaterials.2011.06.010
   Qin GK, 2009, BIOMACROMOLECULES, V10, P3227, DOI 10.1021/bm900735g
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Ryu JH, 2001, CHEM-EUR J, V7, P1525, DOI 10.1002/1521-3765(20010401)7:7<1525::AID-CHEM1525>3.0.CO;2-U
   Setyawati MI, 2007, J BIOTECHNOL, V132, P38, DOI 10.1016/j.jbiotec.2007.08.012
   Son HJ, 2001, BIOTECHNOL APPL BIOC, V33, P1, DOI 10.1042/BA20000065
   Thomas S, 2008, J Wound Care, V17, P349
   Upadhyayula VKK, 2012, ANAL CHIM ACTA, V715, P1, DOI 10.1016/j.aca.2011.12.008
   Yadav V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018099
   Yadav V, 2010, APPL ENVIRON MICROB, V76, P6257, DOI 10.1128/AEM.00698-10
NR 30
TC 3
Z9 3
U1 3
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 16
PY 2014
VL 100
SI SI
BP 40
EP 45
DI 10.1016/j.carbpol.2013.06.019
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 295BQ
UT WOS:000330092000007
PM 24188836
DA 2018-10-20
ER

PT J
AU Liu, W
   Shang, LR
   Zheng, FY
   Lu, J
   Qian, JL
   Zhao, YJ
   Gu, ZZ
AF Liu, Wei
   Shang, Luoran
   Zheng, Fuyin
   Lu, Jie
   Qian, Jinglian
   Zhao, Yuanjin
   Gu, Zhongze
TI Photonic Crystal Encoded Microcarriers for Biomaterial Evaluation
SO SMALL
LA English
DT Article
DE microcarriers; photonic crystal; cell culture; multiplex analysis
ID 3-DIMENSIONAL CELL-CULTURE; PARTICLES; MICROPARTICLES; MICROSPHERES;
   LITHOGRAPHY; GENERATION; SCAFFOLDS; BIOASSAYS
C1 [Liu, Wei; Shang, Luoran; Zheng, Fuyin; Lu, Jie; Qian, Jinglian; Zhao, Yuanjin; Gu, Zhongze] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Zhao, Yuanjin; Gu, Zhongze] Inst Southeast Univ Suzhou, Lab Environm & Biosafety Res, Suzhou 215123, Peoples R China.
   [Gu, Zhongze] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China.
RP Zhao, YJ (reprint author), Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
EM yjzhao@seu.edu.cn; gu@seu.edu.cn
RI Zhao, Yuanjin/I-1861-2013
FU National Science Foundation of China [91227124, 21105011, 50925309];
   National Science Foundation of Jiangsu [BK2012735]; Postdoctoral Science
   Foundation of China [2012M520052, 2013T60484]; State Key Laboratory of
   Pharmaceutical Biotechnology of Nanjing University [KF-GN-201201];
   Program for Changjiang Scholars and Innovative Research Team in
   University [IRT1222]
FX This work was supported by the National Science Foundation of China
   (Grant Nos. 91227124, 21105011 and 50925309), the National Science
   Foundation of Jiangsu (Grant No. BK2012735), the Postdoctoral Science
   Foundation of China (Grant Nos. 2012M520052 and 2013T60484), the State
   Key Laboratory of Pharmaceutical Biotechnology of Nanjing University
   (KF-GN-201201 grant) and the Program for Changjiang Scholars and
   Innovative Research Team in University (IRT1222).
CR Appleyard DC, 2011, NAT PROTOC, V6, P1761, DOI 10.1038/nprot.2011.400
   Bae H., 2012, J TISSUE ENG REGEN M, V6, P1
   Chapin SC, 2009, LAB CHIP, V9, P3100, DOI 10.1039/b909959j
   Chen H.-Y., 2010, LANGMUIR, V27, P34, DOI DOI 10.1021/LA101623N
   Choi SW, 2013, ADV HEALTHC MATER, V2, P145, DOI 10.1002/adhm.201200106
   Doshi N, 2009, P NATL ACAD SCI USA, V106, P21495, DOI 10.1073/pnas.0907127106
   Fayazpour F, 2008, ADV FUNCT MATER, V18, P2716, DOI 10.1002/adfm.200800255
   Ge J., 2011, ANGEW CHEM INT EDIT, V50, P1492
   Gu HC, 2013, SMALL, V9, P2266, DOI 10.1002/smll.201203179
   Jin L, 2012, J BIOMED NANOTECHNOL, V8, P1, DOI 10.1166/jbn.2012.1360
   Khademhosseini A, 2013, ADV HEALTHC MATER, V2, P10, DOI 10.1002/adhm.201200444
   Kim J, 2011, SMALL, V7, P1163, DOI 10.1002/smll.201001822
   Kim LN, 2011, LAB CHIP, V11, P48, DOI [10.1039/c0lc00369g, 10.1039/c01c00369g]
   Kristalyn CB, 2011, J COLLOID INTERF SCI, V353, P322, DOI 10.1016/j.jcis.2010.09.057
   Le Clair SV, 2009, J ADHESION, V85, P484, DOI 10.1080/00218460902996374
   Lee H, 2010, NAT MATER, V9, P745, DOI [10.1038/NMAT2815, 10.1038/nmat2815]
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Nichols JE, 2009, BIOMATERIALS, V30, P1071, DOI 10.1016/j.biomaterials.2008.10.041
   Panda P, 2008, LAB CHIP, V8, P1056, DOI 10.1039/b804234a
   Pregibon DC, 2009, ANAL CHEM, V81, P4873, DOI 10.1021/ac9005292
   Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934
   Tumarkin E, 2009, CHEM SOC REV, V38, P2161, DOI 10.1039/b809915b
   Velasco D, 2012, SMALL, V8, P1633, DOI 10.1002/smll.201102464
   Wheeldon I., 2011, NANOTECHNOLOGY, V22
   Wu J, 2013, ACTA BIOMATER, V9, P7410, DOI 10.1016/j.actbio.2013.03.022
   Zhang Y, 2012, MACROMOL RAPID COMM, V33, P296, DOI 10.1002/marc.201100695
   Zhao YJ, 2008, ANAL CHEM, V80, P1598, DOI 10.1021/ac702249a
   Zhao YJ, 2011, J AM CHEM SOC, V133, P8790, DOI 10.1021/ja200729w
   Zhao YJ, 2010, ADV FUNCT MATER, V20, P2970, DOI 10.1002/adfm.201000098
   Zheng WF, 2013, ADV HEALTHC MATER, V2, P95, DOI 10.1002/adhm.201200104
   Zorlutuna P, 2012, ADV MATER, V24, P1782, DOI 10.1002/adma.201104631
NR 33
TC 35
Z9 38
U1 7
U2 96
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1613-6810
EI 1613-6829
J9 SMALL
JI Small
PD JAN 15
PY 2014
VL 10
IS 1
BP 88
EP 93
DI 10.1002/smll.201301253
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 302SE
UT WOS:000330624400010
PM 23861358
DA 2018-10-20
ER

PT J
AU Chang, SH
   Chen, JZ
   Hsiao, SH
   Lin, GW
AF Chang, Shih-Hang
   Chen, Jian-Zhang
   Hsiao, Sou-Hui
   Lin, Guan-Wei
TI Nanohardness, corrosion and protein adsorption properties of CuAlO2
   films deposited on 316L stainless steel for biomedical applications
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE CuAlO2; Surface modification; Nanoindentation; Electrochemical; Protein
   adsorption
ID SURFACE MODIFICATION; CHITOSAN FILMS; CELL-CULTURES; COATINGS; IMPLANTS;
   BIOMATERIALS; 316-L-STAINLESS-STEEL; RESISTANCE; HARDNESS; DIODES
AB This study preliminarily assesses the biomedical applications of CuAlO2 coatings according to nanoindentation, electrochemical, and protein adsorption tests. Nanoindentation results revealed that the surface hardness of 316L stainless steel increased markedly after coating with CuAlO2 films. Electrochemical tests of corrosion potential, breakdown potential, and corrosion current density showed that the corrosion resistance properties of 316L stainless steel are considerably improved by CuAlO2 coatings. Bicinchoninic acid (BCA) protein assay results revealed that the protein adsorption behavior of 316L stainless steel did not exhibit notable differences with or without CuAlO2 coatings. A CuAlO2 coating of 100nm thickness improved the surface nanohardness and corrosion resistance ability of 316L stainless steel. CuAlO2 is a potential candidate for biomaterial coating applications, particularly for surface modification of fine, delicate implants. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Chang, Shih-Hang; Hsiao, Sou-Hui] Natl Ilan Univ, Dept Chem & Mat Engn, Ilan 260, Taiwan.
   [Chen, Jian-Zhang; Lin, Guan-Wei] Natl Taiwan Univ, Grad Inst Appl Mech, Taipei 106, Taiwan.
RP Chang, SH (reprint author), Natl Ilan Univ, 1,Sec 1,Shen Lung Rd, Ilan 260, Taiwan.
EM shchang@niu.edu.tw
RI Chen, Jian Zhang/D-1469-2012
OI Chen, Jian Zhang/0000-0002-1071-2234; Chang,
   Shih-Hang/0000-0002-2262-0396
FU National Science Council (NSC), Taiwan, Republic of China
   [NSC102-2221-E-197006]
FX The authors gratefully acknowledge the financial support for this
   research provided by the National Science Council (NSC), Taiwan,
   Republic of China, under Grants No. NSC102-2221-E-197006.
CR [Anonymous], 1986, ASTM STAND SPEC, pF138
   Ballarre J, 2010, ACTA BIOMATER, V6, P1601, DOI 10.1016/j.actbio.2009.10.015
   Chang SH, 2013, APPL SURF SCI, V282, P735, DOI 10.1016/j.apsusc.2013.06.044
   Chang SH, 2012, SURF COAT TECH, V206, P4959, DOI 10.1016/j.surfcoat.2012.05.121
   Chen CH, 2008, SURF COAT TECH, V202, P2709, DOI 10.1016/j.surfcoat.2007.09.052
   Chi CT, 2013, J ELECTRON MATER, V42, P1242, DOI 10.1007/s11664-013-2573-4
   Chi CT, 2012, J ALLOY COMPD, V544, P111, DOI 10.1016/j.jallcom.2012.08.004
   Chu PK, 2013, THIN SOLID FILMS, V528, P93, DOI 10.1016/j.tsf.2012.07.144
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cieslik M, 2011, CORROS SCI, V53, P296, DOI 10.1016/j.corsci.2010.09.034
   Costa MA, 2000, J MATER SCI-MATER M, V11, P141, DOI 10.1023/A:1008975507654
   D'Anto V, 2009, BIOMATERIALS, V30, P1492, DOI 10.1016/j.biomaterials.2008.12.004
   Dong CJ, 2012, J ALLOY COMPD, V512, P195, DOI 10.1016/j.jallcom.2011.09.062
   Fang M, 2011, APPL SURF SCI, V257, P8330, DOI 10.1016/j.apsusc.2011.03.116
   FRIEDMAN RJ, 1995, J APPL BIOMATER, V6, P231, DOI 10.1002/jab.770060403
   Gurappa I, 2002, SURF COAT TECH, V161, P70, DOI 10.1016/S0257-8972(02)00380-8
   Kawazoe H, 1997, NATURE, V389, P939, DOI 10.1038/40087
   Kim DS, 2007, THIN SOLID FILMS, V515, P5103, DOI 10.1016/j.tsf.2006.10.044
   Kim TN, 1998, SURF COAT TECH, V99, P20, DOI 10.1016/S0257-8972(97)00121-7
   Malheiro VN, 2011, BIOMATERIALS, V32, P6883, DOI 10.1016/j.biomaterials.2011.06.002
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Okazaki Y, 2008, CORROS SCI, V50, P3429, DOI 10.1016/j.corsci.2008.09.002
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Oyen ML, 2006, J BIOMECH, V39, P2699, DOI 10.1016/j.jbiomech.2005.09.011
   Padhy N, 2011, MATER CHEM PHYS, V130, P962, DOI 10.1016/j.matchemphys.2011.08.016
   Ruhi G, 2009, CORROS SCI, V51, P3057, DOI 10.1016/j.corsci.2009.08.037
   Schrooten J, 2000, BIOMATERIALS, V21, P1461, DOI 10.1016/S0142-9612(00)00027-2
   Shan CX, 2008, SURF COAT TECH, V202, P2399, DOI 10.1016/j.surfcoat.2007.08.066
   Shen GX, 2005, THIN SOLID FILMS, V489, P130, DOI 10.1016/j.tsf.2005.05.016
   Sumita M, 2004, MAT SCI ENG C-BIO S, V24, P753, DOI 10.1016/j.msec.2004.08.030
   SUTOW EJ, 1981, BIOCOMPATIBILITY CLI, P45
   Takahashi H, 2011, INT IMMUNOPHARMACOL, V11, P1534, DOI 10.1016/j.intimp.2011.05.010
   TAKAMURA K, 1994, J BIOMED MATER RES, V28, P583, DOI 10.1002/jbm.820280508
   Tang YC, 2006, ACTA BIOMATER, V2, P709, DOI 10.1016/j.actbio.2006.06.003
   Tangpasuthadol V, 2003, CARBOHYD RES, V338, P937, DOI 10.1016/S0008-6215(03)00038-7
   Tiwari SK, 2007, SURF COAT TECH, V201, P7582, DOI 10.1016/j.surfcoat.2007.02.026
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   Wanichapichart P, 2009, SURF COAT TECH, V203, P2531, DOI 10.1016/j.surfcoat.2009.02.069
   Zhou ZF, 2007, CORROS SCI, V49, P830, DOI 10.1016/j.corsci.2006.06.019
NR 39
TC 9
Z9 9
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JAN 15
PY 2014
VL 289
BP 455
EP 461
DI 10.1016/j.apsusc.2013.11.004
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 274WA
UT WOS:000328635700066
DA 2018-10-20
ER

PT J
AU Moglia, RS
   Robinson, JL
   Muschenborn, AD
   Touchet, TJ
   Maitland, DJ
   Cosgriff-Hernandez, E
AF Moglia, Robert S.
   Robinson, Jennifer L.
   Muschenborn, Andrea D.
   Touchet, Tyler J.
   Maitland, Duncan J.
   Cosgriff-Hernandez, Elizabeth
TI Injectable polyMIPE scaffolds for soft tissue regeneration
SO POLYMER
LA English
DT Article
DE PolyMIPE; Tissue engineering; Injectable scaffold
ID BIODEGRADABLE POLYURETHANE SCAFFOLDS; BMP-INDUCED OSTEOGENESIS;
   ENGINEERING SCAFFOLDS; WEIGHT-BEARING; MECHANICAL-PROPERTIES;
   SMOOTH-MUSCLE; BONE; POROSITY; ELASTOMERS; COPOLYMERS
AB Injury caused by trauma, burns, surgery, or disease often results in soft tissue loss leading to impaired function and permanent disfiguration. Tissue engineering aims to overcome the lack of viable donor tissue by fabricating synthetic scaffolds with the requisite properties and bioactive cues to regenerate these tissues. Biomaterial scaffolds designed to match soft tissue modulus and strength should also retain the elastomeric and fatigue-resistant properties of the tissue. Of particular design importance is the interconnected porous structure of the scaffold needed to support tissue growth by facilitating mass transport. Adequate mass transport is especially true for newly implanted scaffolds that lack vasculature to provide nutrient flux. Common scaffold fabrication strategies often utilize toxic solvents and high temperatures or pressures to achieve the desired porosity. In this study, a polymerized medium internal phase emulsion (polyMIPE) is used to generate an injectable graft that cures to a porous foam at body temperature without toxic solvents. These poly(ester urethane urea) scaffolds possess elastomeric properties with tunable compressive moduli (20-200 kPa) and strengths (4-60 kPa) as well as high recovery after the first conditioning cycle (97-99%). The resultant pore architecture was highly interconnected with large voids (0.5-2 mm) from carbon dioxide generation surrounded by water-templated pores (50-300 mu m). The ability to modulate both scaffold pore architecture and mechanical properties by altering emulsion chemistry was demonstrated. Permeability and form factor were experimentally measured to determine the effects of polyMIPE composition on pore interconnectivity. Finally, initial human mesenchymal stem cell (hMSC) cytocompatibility testing supported the use of these candidate scaffolds in regenerative applications. Overall, these injectable polyMIPE foams show strong promise as a biomaterial scaffold for soft tissue repair. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Moglia, Robert S.; Robinson, Jennifer L.; Muschenborn, Andrea D.; Touchet, Tyler J.; Maitland, Duncan J.; Cosgriff-Hernandez, Elizabeth] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
RP Cosgriff-Hernandez, E (reprint author), Texas A&M Univ, Dept Biomed Engn, 5045 Emerging Technol Bldg,3120 TAMU, College Stn, TX 77843 USA.
EM cosgriff.hernandez@bme.tamu.edu
RI Cosgriff-Hernandez, Elizabeth/E-6391-2016
OI Cosgriff-Hernandez, Elizabeth/0000-0002-4701-5600
FU Texas A&M Health Science Center College of Medicine Institute for
   Regenerative Medicine at Scott & White through a grant from NCRR of the
   NIH [P40RR017447]
FX The human mesenchymal stem cells employed in this work were provided by
   the Texas A&M Health Science Center College of Medicine Institute for
   Regenerative Medicine at Scott & White through a grant from NCRR of the
   NIH, Grant #P40RR017447. We would like to thank Prachi Dhavalikar, Megan
   Brooks, and Nicole Cordner for their assistance in data collection.
CR AKIZUKI S, 1986, J ORTHOPAED RES, V4, P379, DOI 10.1002/jor.1100040401
   Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Andrew AB, 1991, J BIOMECH S1, V24, P19
   Barbetta A, 2004, MACROMOLECULES, V37, P3188, DOI 10.1021/ma0359436
   Bear J., 2013, DYNAMICS FLUIDS PORO
   Benhardt H, 2011, MACROMOL BIOSCI, V11, P1020, DOI 10.1002/mabi.201100063
   Botchwey EA, 2003, J BIOMED MATER RES A, V67A, P357, DOI 10.1002/jbm.a.10111
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Busby W, 2001, BIOMACROMOLECULES, V2, P154, DOI 10.1021/bm0000889
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Chandrashekar N, 2006, J BIOMECH, V39, P2943, DOI 10.1016/j.jbiomech.2005.10.031
   Chen J, 1999, J BIOMED MATER RES, V44, P53, DOI 10.1002/(SICI)1097-4636(199901)44:1<53::AID-JBM6>3.0.CO;2-W
   Christenson EM, 2005, POLYMER, V46, P11744, DOI 10.1016/j.polymer.2005.08.083
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   David D, 2009, J POLYM SCI A, V47, P9
   Despois JF, 2005, ACTA MATER, V53, P1381, DOI 10.1016/j.actamat.2004.11.031
   Dhandayuthapani B., 2011, INT J POLYM SCI, V2011
   Duggan M, 2013, J TRAUMA ACUTE CARE, V74, P1462, DOI 10.1097/TA.0b013e31828da937
   Dumas JE, 2013, TISSUE ENG A
   Dumas JE, 2010, ACTA BIOMATER, V6, P2394, DOI 10.1016/j.actbio.2010.01.030
   Dybbs A., 1984, FUNDAMENTALS TRANSPO, V82, P199
   ETTER MC, 1991, J PHYS CHEM-US, V95, P4601, DOI 10.1021/j100165a007
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Garrett P.R., 1993, DEFOAMING THEORY IND
   GEERTSMA J, 1974, SOC PETROL ENG J, V14, P445, DOI 10.2118/4706-PA
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Hacker M, 2007, BIOMATERIALS, V28, P3497, DOI 10.1016/j.biomaterials.2007.04.018
   Hafeman AE, 2007, PMSE PREPR, V97, P546
   Hafeman AE, 2008, PHARM RES-DORDR, V25, P2387, DOI 10.1007/s11095-008-9618-z
   Hafeman AE, 2010, J BIOMAT SCI-POLYM E, V21, P95, DOI 10.1163/156856209X410256
   HAMMOND PT, 1990, MAT SCI ENG A-STRUCT, V126, P281, DOI 10.1016/0921-5093(90)90134-O
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hemmrich K, 2005, BIOMATERIALS, V26, P7025, DOI 10.1016/j.biomaterials.2005.04.065
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Itoh M, 2004, BIOMATERIALS, V25, P2577, DOI 10.1016/j.biomaterials.2003.09.071
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   Jin QM, 2000, J BIOMED MATER RES, V52, P841, DOI 10.1002/1097-4636(20001215)52:4<841::AID-JBM31>3.0.CO;2-3
   Kim BS, 2000, J BIOMECH ENG-T ASME, V122, P210, DOI 10.1115/1.429651
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kruyt MC, 2003, TISSUE ENG, V9, P327, DOI 10.1089/107632703764664792
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Lage J, 1998, TRANSPORT PHENOMENA, V2
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Lepine O, 2005, POLYMER, V46, P9653, DOI 10.1016/j.polymer.2005.07.067
   Lewandrowski KU, 2000, J BIOMAT SCI-POLYM E, V11, P879, DOI 10.1163/156856200744075
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Lumelsky Y, 2009, MACROMOLECULES, V42, P1627, DOI 10.1021/ma802461m
   Marshall AJ, 2005, AICHE J, V51, P1221, DOI 10.1002/aic.10390
   Mistry AS, 2010, J BIOMED MATER RES A, V92A, P451, DOI 10.1002/jbm.a.32371
   Mistry AS, 2009, J BIOMED MATER RES A, V89A, P68, DOI 10.1002/jbm.a.32010
   Moglia RS, 2011, BIOMACROMOLECULES, V12, P3621, DOI 10.1021/bm2008839
   Mullins L, 1957, RUBBER CHEM TECHNOL, V30, P555
   Muschenborn AD, UNPUB
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Peter SJ, 2000, BIOMATERIALS, V21, P1207, DOI 10.1016/S0142-9612(99)00254-9
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Qi HJ, 2005, MECH MATER, V37, P817, DOI 10.1016/j.mechmat.2004.08.001
   Robinson JL, 2013, UNPUB
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Saraf H, 2007, J BIOMECH, V40, P1960, DOI 10.1016/j.jbiomech.2006.09.021
   Scheidegger AE, 1974, PHYS FLOW POROUS MED
   SCHULTZ RJ, 1987, INT ORTHOP, V11, P277, DOI 10.1007/BF00271461
   Spaans CJ, 1998, POLYM BULL, V41, P131, DOI 10.1007/s002890050343
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   TANZI MC, 1994, J MATER SCI-MATER M, V5, P393, DOI 10.1007/BF00058971
   Taylor D, 1998, J ORTHOPAED RES, V16, P163, DOI 10.1002/jor.1100160203
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yeh F, 2003, MACROMOLECULES, V36, P1940, DOI 10.1021/ma0214456
NR 79
TC 15
Z9 15
U1 3
U2 55
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD JAN 14
PY 2014
VL 55
IS 1
SI SI
BP 426
EP 434
DI 10.1016/j.polymer.2013.09.009
PG 9
WC Polymer Science
SC Polymer Science
GA 296TA
UT WOS:000330207100054
PM 24563552
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Boshkovikj, V
   Webb, HK
   Pham, VTH
   Fluke, CJ
   Crawford, RJ
   Ivanova, EP
AF Boshkovikj, Veselin
   Webb, Hayden K.
   Pham, Vy T. H.
   Fluke, Christopher J.
   Crawford, Russell J.
   Ivanova, Elena P.
TI Three-dimensional reconstruction of surface nanoarchitecture from
   two-dimensional datasets
SO AMB EXPRESS
LA English
DT Article
DE Three-dimensional visualization; Scanning electron microscopy; Atomic
   force microscopy; Surface topographical analysis
ID SCANNING-ELECTRON-MICROSCOPY; ATOMIC-FORCE MICROSCOPE; VISUALIZATION;
   ATTACHMENT; IMAGES; CELLS; GPU
AB The design of biomaterial surfaces relies heavily on the ability to accurately measure and visualize the three-dimensional surface nanoarchitecture of substrata. Here, we present a technique for producing three-dimensional surface models using displacement maps that are based on the data obtained from two-dimensional analyses. This technique is particularly useful when applied to scanning electron micrographs that have been calibrated using atomic force microscopy (AFM) roughness data. The evaluation of four different surface types, including thin titanium films, silicon wafers, polystyrene cell culture dishes and dragonfly wings confirmed that this technique is particularly effective for the visualization of conductive surfaces such as metallic titanium. The technique is particularly useful for visualizing surfaces that cannot be easily analyzed using AFM. The speed and ease with which electron micrographs can be recorded, combined with a relatively simple process for generating displacement maps, make this technique useful for the assessment of the surface topography of biomaterials.
C1 [Boshkovikj, Veselin; Webb, Hayden K.; Pham, Vy T. H.; Crawford, Russell J.; Ivanova, Elena P.] Swinburne Univ Technol, Fac Life & Social Sci, Hawthorn, Vic 3122, Australia.
   [Fluke, Christopher J.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia.
RP Ivanova, EP (reprint author), Swinburne Univ Technol, Fac Life & Social Sci, POB 218, Hawthorn, Vic 3122, Australia.
EM eivanova@swin.edu.au
OI Crawford, Russell/0000-0003-1054-5285; Fluke,
   Christopher/0000-0003-0961-2321; Webb, Hayden/0000-0003-2858-0177
FU Australian Research Council (ARC)
FX This study was supported in part by Australian Research Council (ARC).
   Autodesk, Maya are registered trademarks or trademarks of Autodesk,
   Inc., and/or its subsidiaries and/or affiliates in the USA and/or other
   countries.
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BRUNE D, 1997, SURFACE CHARACTERIZA
   Cizmar P, 2008, SCANNING, V30, P381, DOI 10.1002/sca.20120
   Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264
   Crawford RJ, 2012, ADV COLLOID INTERFAC, V179, P142, DOI 10.1016/j.cis.2012.06.015
   Cuijpers VMJI, 2011, TISSUE ENG PART C-ME, V17, P663, DOI 10.1089/ten.tec.2010.0455
   Decuzzi P, 2010, BIOMATERIALS, V31, P173, DOI 10.1016/j.biomaterials.2009.09.018
   Dmitriev K, 2011, ACM SPEC INT GROUP C
   Gentile F, 2010, BIOMATERIALS, V31, P7205, DOI 10.1016/j.biomaterials.2010.06.016
   Hiraiwa A, 2012, METROLOGY INSPECTION
   Hiraiwa A, 2012, J MICRO-NANOLITH MEM, V11, DOI 10.1117/1.JMM.11.4.043010
   Ivanova EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067893
   Jang H, 2012, COMPUT GRAPH FORUM, V31, P1880, DOI 10.1111/j.1467-8659.2012.03068.x
   Joy DC, 1996, MICRON, V27, P247, DOI 10.1016/0968-4328(96)00023-6
   Kang BS, 2009, ACTA BIOMATER, V5, P2222, DOI 10.1016/j.actbio.2009.01.049
   Lu TK, 2009, 35 GRAPH INT C GI 20, P7
   Marschall HU, 2000, J AM CERAM SOC, V83, P223, DOI 10.1111/j.1151-2916.2000.tb01176.x
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Nguyen SHT, 2013, COLLOID SURFACE B, V106, P126, DOI 10.1016/j.colsurfb.2013.01.042
   Nowell JA, 1980, SCANNING ELECTRON MI, V2, P1
   Ostadi H, 2011, NAN IEEE NANO 2011 1, P770, DOI [10.1109/nano.2011.6144402, DOI 10.1109/NANO.2011.6144402]
   Samak D, 2007, CIRP ANN-MANUF TECHN, V56, P149, DOI 10.1016/j.cirp.2007.05.036
   Schatten H, 2011, MICRON, V42, P175, DOI 10.1016/j.micron.2010.08.008
   Schift H, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/35/355301
   Shiramine KI, 2007, J APPL PHYS, V101, DOI 10.1063/1.2434806
   Stout KJ, 1993, PUBLICATION EUR
   Szirmay-Kalos L, 2008, COMPUT GRAPH FORUM, V27, P1567, DOI 10.1111/j.1467-8659.2007.01108.x
   Tabet MF, 1996, THIN SOLID FILMS, V290, P312, DOI 10.1016/S0040-6090(96)08968-7
   Truong VK, 2009, APPL MICROBIOL BIOT, V83, P925, DOI 10.1007/s00253-009-1944-5
   Wang JY, 2008, THIN SOLID FILMS, V517, P656, DOI 10.1016/j.tsf.2008.07.033
   Webb HK, 2012, ROUGHNESS PARAMET ZE
   Zeiger AS, 2013, ACTA BIOMATER, V9, P7354, DOI 10.1016/j.actbio.2013.02.035
NR 32
TC 1
Z9 1
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2191-0855
J9 AMB EXPRESS
JI AMB Express
PD JAN 10
PY 2014
VL 4
AR 3
DI 10.1186/2191-0855-4-3
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CM9SR
UT WOS:000358049800002
PM 24410821
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ayoub, A
   Venditti, RA
   Jameel, H
   Chang, HM
AF Ayoub, Ali
   Venditti, Richard A.
   Jameel, Hasan
   Chang, Hou-Min
TI Effect of Irradiation on the Composition and Thermal Properties of
   Softwood Kraft Lignin and Styrene Grafted Lignin
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE cellulose and other wood products; biomaterials; crosslinking;
   irradiation; lignin; glass transition temperature
ID HYDROCHLORIC ACID LIGNIN; INDUSTRIAL APPLICATIONS; UV-IRRADIATION;
   GAMMA-IRRADIATION; CARBON-FIBERS; POLYMERS; POLYCARBONATE; CHEMISTRY;
   PLASTICS; COPOLYMERIZATION
AB Lignin is an abundant, underutilized natural resource that has potential to be used as a biomaterial but is currently hampered in its use by not being uniform in structure and composition and is thermally unstable due to phenolic group. To address these issues and modify its thermal properties, softwood kraft lignin was modified using gamma-irradiation at low doses with and without styrene present and characterized. Irradiation of kraft lignin alone with gamma-radiation shows an initial decrease in molecular weight due to chain scission up to about 10 kGy followed by an increase in molecular weight due to crosslinking. NMR results indicate a decrease of about 15% in the OH content of the lignin with 30 kGy irradiation. Thermal properties such as T-g, free volume and Delta C-p follow accordingly. Irradiation at very low dosages was determined to facilitate the grafting of styrene monomer to lignin, decreasing the OH content by 23%. This effect increased the hydrophobicity of the material, depressed the value of T-g, increased the Delta C-p, increased the mobility in the liquid state, and made the material more thermally stable relative to the lignin alone, thus improving its processability at high temperatures. Both the irradiation of lignin alone and the grafting of styrene to lignin increased the yield of mass during pyrolysis and the activation energy for mass loss relative to untreated lignin alone. This work has demonstrated that the application of low dosages of gamma-irradiation is a promising method to attach functional molecules onto lignin for use in various applications. (C) 2013 Wiley Periodicals, Inc.
C1 [Ayoub, Ali; Venditti, Richard A.; Jameel, Hasan; Chang, Hou-Min] N Carolina State Univ, Coll Nat Resources, Dept Forest Biomat, Raleigh, NC 27695 USA.
RP Venditti, RA (reprint author), N Carolina State Univ, Coll Nat Resources, Dept Forest Biomat, Raleigh, NC 27695 USA.
EM richard_venditti@ncsu.edu
FU United States Department of Agriculture [1503/2011-0952]; Domtar
   Corporation
FX The authors wish to thank the United States Department of Agriculture
   (Grant number 1503/2011-0952) and Domtar Corporation for their
   sponsorship of this project. We would also like to thank Hasan
   Sadeghifar for his instrumental efforts in the aceto-bromination,
   molecular weight and NMR analysis.
CR ADLER E, 1977, WOOD SCI TECHNOL, V11, P169, DOI 10.1007/BF00365615
   ARGYROPOULOS DS, 1994, J WOOD CHEM TECHNOL, V14, P45, DOI 10.1080/02773819408003085
   Ayoub A, 2012, J APPL POLYM SCI, V124, P1096, DOI 10.1002/app.35094
   Cui CZ, 2013, BIORESOURCES, V8, P864
   Decker C, 2002, MACROMOL RAPID COMM, V23, P1067, DOI 10.1002/marc.200290014
   DURAN N, 1986, J PHOTOCHEM, V35, P209, DOI 10.1016/0047-2670(86)85029-8
   FANTA GF, 1977, J APPL POLYM SCI, V21, P425, DOI 10.1002/app.1977.070210209
   Fisher K, 1987, MACROMOL S, V12, P303
   Gandini A, 2008, MACROMOLECULES, V41, P9491, DOI 10.1021/ma801735u
   Calvo-Flores FG, 2010, CHEMSUSCHEM, V3, P1227, DOI 10.1002/cssc.201000157
   GEMEI MS, 1980, ANGEW MAKROMOL CHEM, V92, P1, DOI 10.1002/apmc.1980.050920101
   Guerra A, 2006, J AGR FOOD CHEM, V54, P5939, DOI 10.1021/jf060722v
   Kadla J., 2002, J APPL POLYM SCI, V86, P1353
   Kadla JF, 2002, CARBON, V40, P2913, DOI 10.1016/S0008-6223(02)00248-8
   Kawamura Y, 2004, ACS SYM SER, V875, P262
   Kobayashi S, 2003, MACROMOL CHEM PHYSIC, V204, P235, DOI 10.1002/macp.200290084
   KOSHIJIMA T, 1968, J POLYM SCI A1, V6, P1431, DOI 10.1002/pol.1968.150060602
   Kubo S, 2005, J POLYM ENVIRON, V13, P97, DOI 10.1007/s10924-005-2941-0
   Lora JH, 2002, J POLYM ENVIRON, V10, P39, DOI 10.1023/A:1021070006895
   Mulhaupt R, 2013, MACROMOL CHEM PHYS, V214, P159, DOI 10.1002/macp.201200439
   Murugan P, 2008, ENERG FUEL, V22, P2720, DOI 10.1021/ef700730u
   Mussatto SI, 2007, CARBOHYD POLYM, V70, P218, DOI 10.1016/j.carbpol.2007.03.02
   Nadji H, 2005, MACROMOL MATER ENG, V290, P1009, DOI 10.1002/mame.200500200
   Nitz H, 2001, MACROMOL MATER ENG, V286, P737, DOI 10.1002/1439-2054(20011201)286:12<737::AID-MAME737>3.0.CO;2-2
   Pandey KK, 1999, J APPL POLYM SCI, V71, P1969, DOI 10.1002/(SICI)1097-4628(19990321)71:12<1969::AID-APP6>3.0.CO;2-D
   Peng B, 2008, NAT NANOTECHNOL, V3, P626, DOI 10.1038/nnano.2008.211
   Philips R. B., 1973, J APPL POLYM SCI, V17, P1443
   PHILLIPS RB, 1972, J APPL POLYM SCI, V16, P1, DOI 10.1002/app.1972.070160101
   PHILLIPS RB, 1971, J APPL POLYM SCI, V15, P2929, DOI 10.1002/app.1971.070151203
   Ramani R, 2000, POLYM DEGRAD STABIL, V69, P347, DOI 10.1016/S0141-3910(00)00081-1
   Sadeghifar H, 2012, IND ENG CHEM RES, V51, P16713, DOI 10.1021/ie301848j
   Sanchez CG, 1999, ANGEW MAKROMOL CHEM, V272, P65
   Stewart D, 2008, IND CROP PROD, V27, P202, DOI 10.1016/j.indcrop.2007.07.008
   SUDO K, 1992, J APPL POLYM SCI, V44, P127, DOI 10.1002/app.1992.070440113
   Thielemans W, 2002, J APPL POLYM SCI, V83, P323, DOI 10.1002/app.2247
   Vignon A, 2013, J APPL POLYM SCI, V127, P4168, DOI 10.1002/app.38024
   Vishtal A, 2011, BIORESOURCES, V6, P3547
   WANG YY, 1990, J POLYM SCI POL PHYS, V28, P1431, DOI 10.1002/polb.1990.090280902
   Wei M, 2006, MACROMOL MATER ENG, V291, P524, DOI 10.1002/mame.200500372
   WU LCF, 1984, J APPL POLYM SCI, V29, P1111, DOI 10.1002/app.1984.070290408
NR 40
TC 9
Z9 9
U1 12
U2 43
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JAN 5
PY 2014
VL 131
IS 1
AR 39743
DI 10.1002/app.39743
PG 10
WC Polymer Science
SC Polymer Science
GA AH6QC
UT WOS:000336254700050
DA 2018-10-20
ER

PT J
AU Chabukswar, VV
   Bhavsar, SV
   Horne, AS
   Dallavalle, S
   Chabukswar, A
   Jagdale, SC
   Mohite, KC
AF Chabukswar, Vasant V.
   Bhavsar, Sanjay V.
   Horne, Amit S.
   Dallavalle, Sabrina
   Chabukswar, Anirudha
   Jagdale, Swati C.
   Mohite, Kakasaheb C.
TI Study of Biological Activity of Conducting Poly(N-Ethylaniline)
   Nanoparticles Doped with Organic Acid
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS
LA English
DT Article
DE Biomaterial; conducting polymers; nanoparticles; photochemical;
   poly-(N-ethylaniline); spectroscopy
ID ACRYLIC-ACID; POLYANILINE; AGGREGATION; COPOLYMER
AB A novel green approach by photocatalytic oxidative polymerization was developed that addresses and resolves current limitations of chemical polymerization of anilines. This process generates nanoparticles of the conducting polymer poly(N-ethylaniline) (PNETA) and poly-(N-methylaniline) (PNMTA) in a single step by using a catalytic amount of the oxidant in the presence of an organic acid such as DL-(+/-)-Tartaric acid. Poly(N-ethylaniline) nanoparticles doped with tartaric acid show exceptional antimicrobial activity at low concentration. Five compounds have been synthesized. Of these, two compounds have been found to exhibit significant activity against Klebsiella pneumoniae. The minimum inhibitory concentration value was observed at 50 mu g/mL. An extremely simple green approach is described that generates bulk quantities of nanoparticles with average diameter 200nm size of the conducting polymer PNETA in one-step photochemical method using a catalytic amount of ammonium persulfate as oxidant in the presence of organic acid dopant, DL-(+/-)-Tartaric acid. The resultant polymer were characterized by UV-visible, FTIR, XRD, and SEM analysis and their antibacterial activity against Klebsiella pneumoniae has been studied. These polymer nanomaterials show a prominent antimicrobial activity against the tested bacteria and therefore have potential applications in biomedical sciences.
C1 [Chabukswar, Vasant V.; Bhavsar, Sanjay V.; Horne, Amit S.] Univ Pune, Dept Chem, Nowrosjee Wadia Coll, Pune 411001, Maharashtra, India.
   [Dallavalle, Sabrina] Univ Milan, Dept Food Environm & Nutr Sci DeFENS, Milan, Italy.
   [Chabukswar, Anirudha; Jagdale, Swati C.] MAEERs Maharashtra Inst Pharm, Pune, Maharashtra, India.
   [Mohite, Kakasaheb C.] Univ Pune, Sch Energy Studies, Pune, Maharashtra, India.
RP Chabukswar, VV (reprint author), Univ Pune, Dept Chem, Nowrosjee Wadia Coll, 19 Joag Path, Pune 411001, Maharashtra, India.
EM vvchabukswar@gmail.com
RI ; of Chem Phy Sciences, InternationalJournal/C-5864-2016
OI Dallavalle, Sabrina/0000-0002-8813-8922; of Chem Phy Sciences,
   InternationalJournal/0000-0003-4314-1308
FU UGC, Nowrosjee Wadia College Pune, BCUD, Pune University; Indian Academy
   of Science Bangalore
FX The authors sincerely acknowledge financial support from UGC, Nowrosjee
   Wadia College Pune, BCUD, Pune University, and Indian Academy of Science
   Bangalore. The authors are very grateful to Dr. Dangat Vijay for
   valuable suggestion and discussion.
CR Athawale AA, 2001, J APPL POLYM SCI, V79, P1994, DOI 10.1002/1097-4628(20010314)79:11<1994::AID-APP1007>3.0.CO;2-R
   Athawale AA, 2002, MATER CHEM PHYS, V73, P106, DOI 10.1016/S0254-0584(01)00338-8
   Bagheri A, 1998, SYNTHETIC MET, V97, P85, DOI 10.1016/S0379-6779(98)00090-3
   Bhumi P., 2013, J COLLOIDS SURF B, V103, P9
   Chabukswar V, 2010, CHEM CHEM TECHOL, V4, P277
   Chabukswar V, 2010, MACROMOL SYMP, V298, P43, DOI 10.1002/masy.201000019
   Chabukswar VV, 2012, J MACROMOL SCI A, V49, P547, DOI 10.1080/10601325.2012.687682
   Chabukswar VV, 2001, SENSOR ACTUAT B-CHEM, V77, P657, DOI 10.1016/S0925-4005(01)00780-8
   Chahukswar V. V., 2012, J MACROMOL SCI CHEM, V49, P547
   Chen S. A., 1993, MACROMOLECULES, V26, P254
   CHEN SA, 1995, MACROMOLECULES, V28, P2858, DOI 10.1021/ma00112a035
   Cullity B. D., 1978, ELEMENTS XRAY DIFFRA
   Das TK, 2012, POLYM-PLAST TECHNOL, V51, P1487, DOI 10.1080/03602559.2012.710697
   DEARMITT C, 1993, POLYMER, V34, P158, DOI 10.1016/0032-3861(93)90299-P
   Ghorbani M, 2012, POLYM-PLAST TECHNOL, V51, P1367, DOI 10.1080/03602559.2012.702362
   Li D, 2006, J AM CHEM SOC, V128, P968, DOI 10.1021/ja056609n
   MACDIARMID AG, 1994, SYNTHETIC MET, V65, P103, DOI 10.1016/0379-6779(94)90171-6
   Mageswari S, 2012, POLYM-PLAST TECHNOL, V51, P1296, DOI 10.1080/03602559.2012.698687
   Mazzanti G, 2000, J ETHNOPHARMACOL, V71, P83, DOI 10.1016/S0378-8741(99)00179-8
   Michira I, 2011, INT J POLYM MATER, V60, P469, DOI 10.1080/00914037.2010.531815
   Paul RK, 1999, SYNTHETIC MET, V104, P189, DOI 10.1016/S0379-6779(99)00063-6
   RIOS JL, 1988, J ETHNOPHARMACOL, V23, P127, DOI 10.1016/0378-8741(88)90001-3
   Roy BC, 1999, SYNTHETIC MET, V100, P233, DOI 10.1016/S0379-6779(98)01505-7
   Singh G., 2010, POLYM-PLAST TECHNOL, V13, P1329
   WEI Y, 1994, MACROMOLECULES, V27, P518, DOI 10.1021/ma00080a028
   Zheng W, 1997, MACROMOLECULES, V30, P7634, DOI 10.1021/ma970933o
NR 26
TC 4
Z9 4
U1 0
U2 38
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0091-4037
EI 1563-535X
J9 INT J POLYM MATER PO
JI Int. J. Polym. Mater. Polym. Biomat.
PD JAN 4
PY 2014
VL 63
IS 1
BP 7
EP 10
DI 10.1080/00914037.2013.769241
PG 4
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA 220UG
UT WOS:000324611800002
DA 2018-10-20
ER

PT J
AU Mathieu, V
   Vayron, R
   Richard, G
   Lambert, G
   Naili, S
   Meningaud, JP
   Haiat, G
AF Mathieu, Vincent
   Vayron, Romain
   Richard, Gilles
   Lambert, Gregory
   Naili, Salah
   Meningaud, Jean-Paul
   Haiat, Guillaume
TI Biomechanical determinants of the stability of dental implants:
   Influence of the bone-implant interface properties
SO JOURNAL OF BIOMECHANICS
LA English
DT Review
DE Bone; Implant; Osseointegration; Biomechanical properties; Stability
ID RESONANCE FREQUENCY-ANALYSIS; FINITE-ELEMENT-ANALYSIS; SHAPED TITANIUM
   IMPLANT; TOTAL HIP-ARTHROPLASTY; WHOLE-BODY VIBRATION; ORAL IMPLANTS;
   IN-VITRO; NUMERICAL-SIMULATION; ENDOSSEOUS IMPLANTS; QUANTITATIVE
   EXPRESSION
AB Dental implants are now widely used for the replacement of missing teeth in fully or partially edentulous patients and for cranial reconstructions. However, risks of failure, which may have dramatic consequences, are still experienced and remain difficult to anticipate. The stability of biomaterials inserted in bone tissue depends on multiscale phenomena of biomechanical (bone-implant interlocking) and of biological (mechanotransduction) natures. The objective of this review is to provide an overview of the biomechanical behavior of the bone-dental implant interface as a function of its environment by considering in silico, ex vivo and in vivo studies including animal models as well as clinical studies. The biomechanical determinants of osseointegration phenomena are related to bone remodeling in the vicinity of the implants (adaptation of the bone structure to accommodate the presence of a biomaterial). Aspects related to the description of the interface and to its space-time multiscale nature will first be reviewed. Then, the various approaches used in the literature to measure implant stability and the bone-implant interface properties in vitro and in vivo will be described. Quantitative ultrasound methods are promising because they are cheap, non invasive and because of their lower spatial resolution around the implant compared to other biomechanical approaches. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Mathieu, Vincent; Vayron, Romain; Naili, Salah] Univ Paris Est, UMR CNRS 8208, Lab Modelisat & Simulat Multi Echelle, F-94010 Creteil, France.
   [Richard, Gilles; Lambert, Gregory] Septodont, F-94100 St Maur Des Fosses, France.
   [Meningaud, Jean-Paul] CHU H Mondor, Serv Chirurg Plast Reconstruct & Esthet, F-94017 Creteil, France.
   [Haiat, Guillaume] Hop Henri Mondor, CNRS, UMR CNRS 8208, Lab Modelisat & Simulat Multi Echelle, F-94010 Creteil, France.
RP Haiat, G (reprint author), Hop Henri Mondor, CNRS, UMR CNRS 8208, Lab Modelisat & Simulat Multi Echelle, 61 Ave Gen Gaulle, F-94010 Creteil, France.
EM guillaume.haiat@univ-paris-est.fr
FU French National Research Agency (ANR) through EMERGENCE program (project
   WaveImplant) [ANR-11-EMMA-039]
FX This work has been supported by French National Research Agency (ANR)
   through EMERGENCE program (project WaveImplant no. ANR-11-EMMA-039).
CR Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x
   ADAMS RD, 1978, J MECH ENG SCI, V20, P93, DOI 10.1243/JMES_JOUR_1978_020_016_02
   Akca K, 2007, HEAD FACE MED, V16, P3
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Albrektsson T, 2008, PERIODONTOL 2000, V47, P15, DOI 10.1111/j.1600-0757.2007.00247.x
   Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P359, DOI 10.1111/j.1600-051X.2007.01047.x
   Andreaus U, 2009, P I MECH ENG H, V223, P589, DOI 10.1243/09544119JEIM559
   Aparicio C, 2006, CLIN ORAL IMPLAN RES, V17, P2, DOI 10.1111/j.1600-0501.2006.01365.x
   Artzi Z, 2003, J PERIODONTOL, V74, P1143, DOI 10.1902/jop.2003.74.8.1143
   Artzi Z, 2003, J PERIODONTOL, V74, P1153, DOI 10.1902/jop.2003.74.8.1153
   Atsumi M, 2007, INT J ORAL MAX IMPL, V22, P743
   Balik A, 2012, J ORAL IMPLANTOL, V38, P491, DOI 10.1563/AAID-JOI-D-10-00127
   Balleri Piero, 2002, Clin Implant Dent Relat Res, V4, P128, DOI 10.1111/j.1708-8208.2002.tb00162.x
   Balshi SF, 2005, INT J ORAL MAX IMPL, V20, P584
   Barewal RM, 2003, INT J ORAL MAX IMPL, V18, P641
   Berglundh T, 2007, CLIN ORAL IMPLAN RES, V18, P147, DOI 10.1111/j.1600-0501.2006.01309.x
   Bernakiewicz M, 2002, J BIOMECH, V35, P61, DOI 10.1016/S0021-9290(01)00163-4
   Bernhardt R, 2012, EUR CELLS MATER, V23, P237, DOI 10.22203/eCM.v023a18
   Bischof M, 2004, CLIN ORAL IMPLAN RES, V15, P529, DOI 10.1111/j.1600-0501.2004.01042.x
   Brunski J B, 1999, Adv Dent Res, V13, P99
   Bunger MH, 2006, EUR CELLS MATER, V12, P81
   Caulier H, 1997, INT J ORAL MAX IMPL, V12, P380
   Chai J Y, 1993, J Prosthodont, V2, P9, DOI 10.1111/j.1532-849X.1993.tb00374.x
   Chang MC, 2003, J BIOMECH, V36, P1209, DOI [10.1016/S0021-9290(03)00113-1, 10.1016/S0021-9290(03)001133-1]
   Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9
   Coelho PG, 2010, J ORAL MAXIL SURG, V68, P1667, DOI 10.1016/j.joms.2010.02.050
   de Almeida MS, 2007, SENSORS-BASEL, V7, P1224, DOI 10.3390/s7071224
   Derhami K, 1995, Int J Oral Maxillofac Implants, V10, P221
   Dong XN, 2006, J BIOMECH ENG-T ASME, V128, P309, DOI 10.1115/1.2187039
   Duyck J, 2006, ARCH ORAL BIOL, V51, P1, DOI 10.1016/j.archoralbio.2005.04.003
   Duyck J, 2007, J CLIN PERIODONTOL, V34, P998, DOI 10.1111/j.1600-051X.2007.01135.x
   Folgado J, 2009, COMPUT METHOD BIOMEC, V12, P135, DOI [10.1080/10255840802546754, 10.1080/10255840903081123]
   Franchi M, 2007, J PERIODONTOL, V78, P879, DOI 10.1902/jop.2007.060280
   Friberg B, 1999, Clin Implant Dent Relat Res, V1, P75, DOI 10.1111/j.1708-8208.1999.tb00095.x
   Geckili O, 2012, J PERIODONTAL RES, V47, P508, DOI 10.1111/j.1600-0765.2011.01462.x
   Geris L, 2004, J BIOMECH, V37, P763, DOI 10.1016/j.jbiomech.2003.09.026
   Ghorayeb SR, 2008, IEEE T ULTRASON FERR, V55, P1256, DOI 10.1109/TUFFC.2008.788
   Gill A, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-3
   Glauser R, 2004, CLIN ORAL IMPLAN RES, V15, P428, DOI 10.1111/j.1600-0501.2004.01036.x
   Glauser Roland, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P47, DOI 10.1111/j.1708-8208.2003.tb00015.x
   Goto T, 2004, BIO-MED MATER ENG, V14, P537
   Haas R, 1999, J ORAL REHABIL, V26, P19, DOI 10.1046/j.1365-2842.1999.00351.x
   Haiat G, 2009, J BIOMECH, V42, P2033, DOI 10.1016/j.jbiomech.2009.06.008
   Harle J, 2001, J MATER SCI-MATER M, V12, P1001, DOI 10.1023/A:1012825519114
   Hecht S, 2011, VET RADIOL ULTRASOUN, V52, P409, DOI 10.1111/j.1740-8261.2011.01809.x
   Heller A L, 1996, J Oral Implantol, V22, P240
   Hellmich C, 2008, ANN BIOMED ENG, V36, P108, DOI 10.1007/s10439-007-9393-8
   Herrero-Climent M, 2012, MED ORAL PATOL ORAL, V17, pE801, DOI 10.4317/medoral.17861
   Heybeli N, 2002, J ULTRAS MED, V21, P1357, DOI 10.7863/jum.2002.21.12.1357
   Hong J, 2012, CLIN ORAL IMPLAN RES, V23, P1193, DOI 10.1111/j.1600-0501.2011.02285.x
   Hsu JT, 2013, INT J ORAL MAX SURG, V42, P276, DOI 10.1016/j.ijom.2012.07.002
   Hsu JT, 2013, INT J ORAL MAX IMPL, V28, P367, DOI 10.11607/jomi.2407
   Hsu SK, 2011, ULTRASOUND MED BIOL, V37, P403, DOI 10.1016/j.ultrasmedbio.2010.12.004
   Huja SS, 1999, BONE, V25, P217, DOI 10.1016/S8756-3282(99)00151-9
   Huwiler MA, 2007, CLIN ORAL IMPLAN RES, V18, P275, DOI 10.1111/j.1600-0501.2007.01336.x
   Ilic S, 2010, BIOMECH MODEL MECHAN, V9, P87, DOI 10.1007/s10237-009-0161-6
   Isidor F, 2006, CLIN ORAL IMPLAN RES, V17, P8, DOI 10.1111/j.1600-0501.2006.01360.x
   Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Karoussis IK, 2004, CLIN ORAL IMPLAN RES, V15, P8, DOI 10.1111/j.1600-0501.2004.00983.x
   Kerner S., 2009, J MATER SCI-MATER M, V10, P707
   Keyak JH, 2003, MED ENG PHYS, V25, P781, DOI 10.1016/S1350-4533(03)00081-X
   Laugier P, 2011, BONE QUANTITATIVE ULTRASOUND, P1, DOI 10.1007/978-94-007-0017-8
   Laz PJ, 2006, J BIOMECH, V39, P2303, DOI 10.1016/j.jbiomech.2005.07.029
   Lee CK, 2009, DENT MATER, V25, P1419, DOI 10.1016/j.dental.2009.07.003
   Lin CL, 2006, J BIOMECH, V39, P453, DOI 10.1016/j.jbiomech.2004.12.020
   Lioubavina-Hack N, 2006, CLIN ORAL IMPLAN RES, V17, P244, DOI 10.1111/j.1600-0501.2005.01201.x
   Liu Q, 2012, BRIT J ORAL MAX SURG, V50, P244, DOI 10.1016/j.bjoms.2011.03.001
   Luo GM, 1999, J BIOMECH, V32, P275, DOI 10.1016/S0021-9290(98)00172-9
   Lynch JE, 2002, REV SCI INSTRUM, V73, P2686, DOI 10.1063/1.1484235
   Markovic A, 2013, CLIN IMPLANT DENT R, V15, P341, DOI 10.1111/j.1708-8208.2011.00415.x
   Mathieu V, 2012, J MECH BEHAV BIOMED, V8, P194, DOI 10.1016/j.jmbbm.2011.12.012
   Mathieu V, 2012, ULTRASOUND MED BIOL, V38, P611, DOI 10.1016/j.ultrasmedbio.2011.12.014
   Mathieu V, 2011, J ACOUST SOC AM, V129, P4062, DOI 10.1121/1.3586788
   Mathieu V, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003131
   Mathieu V, 2011, ULTRASOUND MED BIOL, V37, P262, DOI 10.1016/j.ultrasmedbio.2010.10.008
   Maugis D., 2000, FRICTIONLESS ELASTIC, P236
   Meredith N, 1996, CLIN ORAL IMPLAN RES, V7, P261, DOI 10.1034/j.1600-0501.1996.070308.x
   MERICSKESTERN R, 1995, CLIN ORAL IMPLAN RES, V6, P73
   MEUNIER A, 1988, J ORTHOPAED RES, V6, P770, DOI 10.1002/jor.1100060521
   Michiardi A, 2010, ACTA BIOMATER, V6, P667, DOI 10.1016/j.actbio.2009.08.043
   Nedir R, 2004, CLIN ORAL IMPLAN RES, V15, P150, DOI 10.1111/j.1600-0501.2004.00978.x
   Nedir R, 2004, CLIN ORAL IMPLAN RES, V15, P520, DOI 10.1111/j.1600-0501.2004.01059.x
   Nkenke E, 2003, CLIN ORAL IMPLAN RES, V14, P601, DOI 10.1034/j.1600-0501.2003.00937.x
   Nomura T, 2006, J BIOMED MATER RES B, V77B, P213, DOI 10.1002/jbm.b.30431
   Ogawa T, 2011, CLIN ORAL IMPLAN RES, V22, P302, DOI 10.1111/j.1600-0501.2010.02020.x
   Ogawa T, 2011, J CLIN PERIODONTOL, V38, P180, DOI 10.1111/j.1600-051X.2010.01637.x
   Oh JS, 2012, OR SURG OR MED OR PA, V113, pE35, DOI 10.1016/j.tripleo.2011.07.003
   Orlik J, 2003, MED ENG PHYS, V25, P825, DOI 10.1016/S1350-4533(03)00099-7
   Orsini E, 2012, INT J ORAL MAX IMPL, V27, P383
   Ostman PO, 2006, INT J PROSTHODONT, V19, P77
   PALOU ME, 1987, J PERIODONTOL, V58, P262, DOI 10.1902/jop.1987.58.4.262
   Park KJ, 2012, J ORAL REHABIL, V39, P151, DOI 10.1111/j.1365-2842.2011.02255.x
   Pattijn V, 2007, MED ENG PHYS, V29, P182, DOI 10.1016/j.medengphy.2006.02.010
   Perez MA, 2008, J BIOMECH, V41, P316, DOI 10.1016/j.jbiomech.2007.09.013
   PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108
   Potter HG, 2004, J BONE JOINT SURG AM, V86A, P1947, DOI 10.2106/00004623-200409000-00013
   Quaresma Sergio E T, 2008, J Oral Implantol, V34, P1, DOI 10.1563/1548-1336(2008)34[1:AFEAOT]2.0.CO;2
   Rabel A, 2007, CLIN ORAL INVEST, V11, P257, DOI 10.1007/s00784-007-0115-2
   Raghavendra S, 2005, INT J ORAL MAX IMPL, V20, P425
   Rangert B, 1997, Dent Update, V24, P416
   Riviere J, 2012, J ACOUST SOC AM, V132, pEL202, DOI 10.1121/1.4742138
   Riviere J, 2012, J ACOUST SOC AM, V131, P1922, DOI 10.1121/1.3683251
   Riviere J, 2010, J APPL PHYS, V107, DOI 10.1063/1.3443578
   Ronold HJ, 2003, BIOMATERIALS, V24, P4559, DOI 10.1016/S0142-9612(03)00256-4
   Ronold HJ, 2003, J BIOMED MATER RES A, V67A, P524, DOI 10.1002/jbm.a.10580
   Ronold HJ, 2003, J MATER SCI-MATER M, V14, P843, DOI 10.1023/A:1025622407727
   Ronold HJ, 2002, BIOMATERIALS, V23, P2201, DOI 10.1016/S0142-9612(01)00353-2
   Ronold HJ, 2002, BIOMATERIALS, V23, P4211, DOI 10.1016/S0142-9612(02)00167-9
   Rungsiyakull C, 2010, BIOMATERIALS, V31, P7196, DOI 10.1016/j.biomaterials.2010.05.077
   Salawu OS, 1997, ENG STRUCT, V19, P718, DOI 10.1016/S0141-0296(96)00149-6
   Salonen MAM, 1997, J CLIN PERIODONTOL, V24, P272, DOI 10.1111/j.1600-051X.1997.tb01842.x
   Sansalone V, 2010, J BIOMECH, V43, P1857, DOI 10.1016/j.jbiomech.2010.03.034
   SANSALONE V, 2012, BIOMECHANICS MODELIN, V12, P533
   Scarano A, 2006, CLIN IMPLANT DENT R, V8, P218, DOI 10.1111/j.1708-8208.2006.00022.x
   Schulte W, 1983, Zahnarztl Mitt, V73, P1229
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, P136, DOI 10.1111/j.1708-8208.2005.tb00057.x
   Seong WJ, 2009, J PROSTHET DENT, V101, P306, DOI 10.1016/S0022-3913(09)60062-7
   Shalabi MM, 2007, J MATER SCI-MATER M, V18, P2033, DOI 10.1007/s10856-007-3160-0
   Simon U, 2003, J BIOMECH, V36, P1079, DOI 10.1016/S0021-9290(03)00114-3
   Singhrao SK, 2012, MICROSC RES TECHNIQ, V75, P576, DOI 10.1002/jemt.21094
   Skripitz R, 1998, ACTA ORTHOP SCAND, V69, P315, DOI 10.3109/17453679809000938
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   Sutpideler M, 2004, INT J ORAL MAX IMPL, V19, P819
   Swan CC, 2003, J BIOMECH ENG-T ASME, V125, P25, DOI 10.1115/1.1535191
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   Szmukler-Moncler S, 2000, CLIN ORAL IMPLAN RES, V11, P12, DOI 10.1034/j.1600-0501.2000.011001012.x
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011
   Tate MLK, 2011, J BIOMECH, V44, P304, DOI 10.1016/j.jbiomech.2010.10.019
   Tricio J, 1995, Int J Oral Maxillofac Implants, V10, P43
   Tsai C L, 1992, Chin J Physiol, V35, P21
   Turkyilmaz I, 2006, J ORAL REHABIL, V33, P754, DOI 10.1111/j.1365-2842.2006.01631.x
   Turkyilmaz I., 2007, J CLIN PERIODONTOL, V34, P716, DOI DOI 10.1111/J.1600-051X.2007.01112.X
   Ustun Yakup, 2008, Eur J Dent, V2, P254
   Valderrama P, 2007, J PERIODONTOL, V78, P262, DOI 10.1902/jop.2007.060143
   Vanegas-Acosta JC, 2011, COMPUT METH PROG BIO, V101, P297, DOI 10.1016/j.cmpb.2010.11.007
   VANSTEENBERGHE D, 1995, CLIN ORAL IMPLAN RES, V6, P31, DOI 10.1034/j.1600-0501.1995.060104.x
   Vayron R, 2011, COMPUT METHOD BIOMEC, V14, P139, DOI 10.1080/10255842.2011.593770
   Vayron R., 2013, ULTRASOUND MED UNPUB
   Vayron R, 2013, J BIOMECH, V46, P1162, DOI 10.1016/j.jbiomech.2013.01.003
   Vayron R, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005981
   Vesentini S, 2005, BIOMECH MODEL MECHAN, V3, P224, DOI 10.1007/s10237-004-0064-5
   Viceconti M, 2000, J BIOMECH, V33, P1611, DOI 10.1016/S0021-9290(00)00140-8
   Viceconti M, 2006, J BIOMECH, V39, P1169, DOI 10.1016/j.jbiomech.2005.03.024
   WANG SJ, 1994, J ORTHOP RES, V12, P40, DOI 10.1002/jor.1100120106
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
   Winter W, 2004, J BIOMECH, V37, P1861, DOI 10.1016/j.jbiomech.2004.02.033
   Wolff JL, 1892, LAW BONE REMODELING
   Wu SW, 2012, MED ENG PHYS, V34, P797, DOI 10.1016/j.medengphy.2011.09.021
   Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518
   Yosibash Z, 2007, J BIOMECH, V40, P3688, DOI 10.1016/j.jbiomech.2007.06.017
   Younesi M, 2010, J MECH BEHAV BIOMED, V3, P178, DOI 10.1016/j.jmbbm.2009.08.003
   Zhang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040488
   Zhang XL, 2012, J R SOC INTERFACE, V9, P1697, DOI 10.1098/rsif.2011.0820
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 156
TC 45
Z9 46
U1 1
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD JAN 3
PY 2014
VL 47
IS 1
BP 3
EP 13
DI 10.1016/j.jbiomech.2013.09.021
PG 11
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA AA3QU
UT WOS:000331008200002
PM 24268798
DA 2018-10-20
ER

PT J
AU Ludecke, C
   Jandt, KD
   Siegismund, D
   Kujau, MJ
   Zang, E
   Rettenmayr, M
   Bossert, J
   Roth, M
AF Luedecke, Claudia
   Jandt, Klaus D.
   Siegismund, Daniel
   Kujau, Marian J.
   Zang, Emerson
   Rettenmayr, Markus
   Bossert, Joerg
   Roth, Martin
TI Reproducible Biofilm Cultivation of Chemostat-Grown Escherichia coli and
   Investigation of Bacterial Adhesion on Biomaterials Using a
   Non-Constant-Depth Film Fermenter
SO PLOS ONE
LA English
DT Article
ID TITANIUM THIN-FILMS; SURFACE-ROUGHNESS; NANOSCALE ROUGHNESS; MICROBIAL
   ADHESION; IN-VITRO; QUANTIFICATION; ATTACHMENT; INFECTIONS; TOPOGRAPHY;
   PARAMETERS
AB Biomaterials-associated infections are primarily initiated by the adhesion of microorganisms on the biomaterial surfaces and subsequent biofilm formation. Understanding the fundamental microbial adhesion mechanisms and biofilm development is crucial for developing strategies to prevent such infections. Suitable in vitro systems for biofilm cultivation and bacterial adhesion at controllable, constant and reproducible conditions are indispensable. This study aimed (i) to modify the previously described constant-depth film fermenter for the reproducible cultivation of biofilms at non-depth-restricted, constant and low shear conditions and (ii) to use this system to elucidate bacterial adhesion kinetics on different biomaterials, focusing on biomaterials surface nanoroughness and hydrophobicity. Chemostat-grown Escherichia coli were used for biofilm cultivation on titanium oxide and investigating bacterial adhesion over time on titanium oxide, poly(styrene), poly(tetrafluoroethylene) and glass. Using chemostat-grown microbial cells (single-species continuous culture) minimized variations between the biofilms cultivated during different experimental runs. Bacterial adhesion on biomaterials comprised an initial lag-phase I followed by a fast adhesion phase II and a phase of saturation III. With increasing biomaterials surface nanoroughness and increasing hydrophobicity, adhesion rates increased during phases I and II. The influence of materials surface hydrophobicity seemed to exceed that of nanoroughness during the lag-phase I, whereas it was vice versa during adhesion phase II. This study introduces the non-constant-depth film fermenter in combination with a chemostat culture to allow for a controlled approach to reproducibly cultivate biofilms and to investigate bacterial adhesion kinetics at constant and low shear conditions. The findings will support developing and adequate testing of biomaterials surface modifications eventually preventing biomaterial-associated infections.
C1 [Luedecke, Claudia; Kujau, Marian J.; Zang, Emerson; Roth, Martin] HKI, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.
   [Luedecke, Claudia; Jandt, Klaus D.; Bossert, Joerg] Univ Jena, Fac Phys & Astron, Chair Mat Sci, D-07743 Jena, Germany.
   [Siegismund, Daniel; Rettenmayr, Markus] Univ Jena, Dept Metall Mat, Otto Schott Inst Mat Res OSIM, Jena, Germany.
RP Jandt, KD (reprint author), Univ Jena, Fac Phys & Astron, Chair Mat Sci, Max Wien Pl 1, D-07743 Jena, Germany.
EM k.jandt@uni-jena.de; martin.roth@hki-jena.de
RI Jandt, Klaus/C-8077-2016
OI Jandt, Klaus/0000-0002-7537-5603
FU Excellence Graduate School "Jena School for Microbial Communication";
   Thuringer Ministerium fur Bildung, Wissenschaft und Kultur TMBWK);
   German Excellence Initiative; Deutsche Forschungsgemeinschaft (DFG)
   [INST 275/241-1 FUGG]; Thuringer Ministerium fur Bildung, Wissenschaft
   und Kultur (TMBWK) [62-4264 925/1/10/1/01]
FX This work was supported by the Excellence Graduate School "Jena School
   for Microbial Communication" (JSMC MikroInter supported by the Thuringer
   Ministerium fur Bildung, Wissenschaft und Kultur TMBWK) which is funded
   by the German Excellence Initiative. KDJ gratefully acknowledges,
   furthermore, the partial financial support of the Deutsche
   Forschungsgemeinschaft (DFG), grant reference INST 275/241-1 FUGG, and
   of the Thuringer Ministerium fur Bildung, Wissenschaft und Kultur
   (TMBWK), grant reference 62-4264 925/1/10/1/01. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bakker DP, 2004, MICROBIOL-SGM, V150, P1779, DOI 10.1099/mic.0.26983-0
   Bayoudh S, 2006, MAT SCI ENG C-BIO S, V26, P300, DOI 10.1016/j.msec.2005.10.045
   Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0
   Boland T, 2000, HDB BACTERIAL ADHESI, P29
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   BUCKINGHAMMEYER K, 2003, BIOFILM LAB STEP BY, P31
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Cai KY, 2005, APPL SURF SCI, V250, P252, DOI 10.1016/j.apsusc.2005.01.013
   Chen MY, 2010, BIOCHEM ENG J, V53, P121, DOI 10.1016/j.bej.2010.10.003
   CHRISTENSEN GD, 2000, HDB BACTERIAL ADHESI, P213
   Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315
   de Paz LEC, 2009, APPL ENVIRON MICROB, V75, P1734, DOI 10.1128/AEM.02000-08
   Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   GILBERT P, 1991, J ANTIMICROB CHEMOTH, V27, P550, DOI 10.1093/jac/27.4.550
   Goeres DM, 2009, NAT PROTOC, V4, P783, DOI 10.1038/nprot.2009.59
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Heersink J, 2003, BIOFILM LAB STEP BY, P13
   Hoffman A. S., 2004, INTRO MAT MED, P197
   Honraet K, 2005, J MICROBIOL METH, V63, P287, DOI 10.1016/j.mimet.2005.03.014
   Hope CK, 2012, J APPL MICROBIOL, V113, P601, DOI 10.1111/j.1365-2672.2012.05368.x
   Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   JASS J, 1995, J IND MICROBIOL, V15, P283, DOI 10.1007/BF01569981
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kinniment SL, 1996, J APPL BACTERIOL, V81, P120, DOI 10.1111/j.1365-2672.1996.tb04488.x
   Kinniment SL, 1996, MICROBIOL-SGM, V142, P631, DOI 10.1099/13500872-142-3-631
   LIN FYH, 1993, J COLLOID INTERF SCI, V159, P86, DOI 10.1006/jcis.1993.1300
   Lorite GS, 2011, J COLLOID INTERF SCI, V359, P289, DOI 10.1016/j.jcis.2011.03.066
   Ludecke C, 2013, APPL SURF SCI, V280, P578, DOI 10.1016/j.apsusc.2013.05.030
   Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000
   MAURER R, 1980, J MOL BIOL, V139, P147, DOI 10.1016/0022-2836(80)90302-2
   McBain AJ, 2003, J APPL MICROBIOL, V94, P655, DOI 10.1046/j.1365-2672.2003.01876.x
   MCCOY WF, 1981, CAN J MICROBIOL, V27, P910, DOI 10.1139/m81-143
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Mitik-Dineva Natasa, 2008, Biotechnology Journal, V3, P536, DOI 10.1002/biot.200700244
   Morgan TD, 2001, J APPL MICROBIOL, V91, P47, DOI 10.1046/j.1365-2672.2001.01338.x
   Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2
   Noimark S, 2009, CHEM SOC REV, V38, P3435, DOI 10.1039/b908260c
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   PETERS AC, 1988, BIOTECHNOL BIOENG, V32, P263, DOI 10.1002/bit.260320302
   Peterson WB, 2012, APPL ENVIRON MICROB, V78, P120
   Poncin-Epaillard F, 2013, MAT SCI ENG C-MATER, V33, P1152, DOI 10.1016/j.msec.2012.12.020
   Pratten Jonathan, 2007, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b05s6
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Siegismund D, 2014, ACTA BIOMATER, V10, P267, DOI 10.1016/j.actbio.2013.09.016
   Singh AV, 2013, J NANOSCI NANOTECHNO, V13, P77, DOI 10.1166/jnn.2013.6727
   Stewart PS, 2001, J APPL MICROBIOL, V91, P525, DOI 10.1046/j.1365-2672.2001.01413.x
   Subbiahdoss G, 2011, PLOS ONE, V9
   Taylor JR, 1997, INTRO ERROR ANAL STU
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Webb HK, 2013, BIOFOULING, V29, P163, DOI 10.1080/08927014.2012.757697
   Webb HK, 2012, SCANNING, V34, P257, DOI 10.1002/sca.21002
   WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Zanin ICJ, 2005, J ANTIMICROB CHEMOTH, V56, P324, DOI 10.1093/jac/dki232
NR 59
TC 17
Z9 18
U1 0
U2 35
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 3
PY 2014
VL 9
IS 1
AR e84837
DI 10.1371/journal.pone.0084837
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 286IH
UT WOS:000329460800071
PM 24404192
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zhang, YS
   Cai, X
   Yao, JJ
   Xing, WX
   Wang, LHV
   Xia, YN
AF Zhang, Yu Shrike
   Cai, Xin
   Yao, Junjie
   Xing, Wenxin
   Wang, Lihong V.
   Xia, Younan
TI Non-Invasive and In Situ Characterization of the Degradation of
   Biomaterial Scaffolds by Volumetric Photoacoustic Microscopy
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE blood vessels; inverse opal scaffolds; MTT formazan; photoacoustic
   imaging; regenerative medicine
ID INVERSE OPAL SCAFFOLDS; 3-DIMENSIONAL SCAFFOLDS; GOLD NANOCAGES; PORE
   SIZES; TISSUE; VIVO; TOMOGRAPHY; DESIGN; VITRO; RESOLUTION
AB Degradation is among the most important properties of biomaterial scaffolds, which are indispensable for regenerative medicine. The currently used method relies on the measurement of mass loss across different samples and cannot track the degradation of an individual scaffold insitu. Here we report, for the first time, the use of multiscale photoacoustic microscopy to non-invasively monitor the degradation of an individual scaffold. We could observe alterations to the morphology and structure of a scaffold at high spatial resolution and deep penetration, and more significantly, quantify the degradation of an individual scaffold as a function of time, both invitro and invivo. In addition, the remodeling of vasculature inside a scaffold can be visualized simultaneously using a dual-wavelength scanning mode in a label-free manner. This optoacoustic method can be used to monitor the degradation of individual scaffolds, offering a new approach to non-invasively analyze and quantify biomaterial-tissue interactions in conjunction with the assessment of invivo vascular parameters.
C1 [Zhang, Yu Shrike; Xia, Younan] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Zhang, Yu Shrike; Xia, Younan] Emory Univ, Atlanta, GA 30332 USA.
   [Cai, Xin; Yao, Junjie; Xing, Wenxin; Wang, Lihong V.; Xia, Younan] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
RP Wang, LHV (reprint author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
EM lhwang@seas.wustl.edu; younan.xia@bme.gatech.edu
RI Xia, Younan/E-8499-2011; Zhang, Yu Shrike/H-4885-2013; Wang,
   Lihong/A-7147-2009; yao, junjie/G-9226-2014
OI Zhang, Yu Shrike/0000-0002-0045-0808; Wang, Lihong/0000-0001-9783-4383;
   yao, junjie/0000-0002-2847-5839
FU NIH [DP1 OD000798, R01 EB000712, R01 EB008085, R01 CA140220, R01
   CA157277, R01 CA159959, U54 CA136398]; Washington University in St.
   Louis; Georgia Institute of Technology
FX We thank Prof. James Ballard for careful reading of the manuscript. This
   work was supported by an NIH Director's Pioneer Award (DP1 OD000798) and
   startup funds from Washington University in St. Louis and Georgia
   Institute of Technology (to Y.X.). This work was also sponsored by NIH
   grants (R01 EB000712, R01 EB008085, R01 CA140220, R01 CA157277, R01
   CA159959, and U54 CA136398, to L.V.W.).
CR Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Cai X, 2013, MATER TODAY, V16, P67, DOI 10.1016/j.mattod.2013.03.007
   Cai X, 2013, TISSUE ENG PART C-ME, V19, P196, DOI [10.1089/ten.tec.2012.0326, 10.1089/ten.TEC.2012.0326]
   Cho E. C., 2013, ANGEW CHEM, V125, P1190
   Cho EC, 2013, ANGEW CHEM INT EDIT, V52, P1152, DOI 10.1002/anie.201208096
   Choi SW, 2013, ADV HEALTHC MATER, V2, P145, DOI 10.1002/adhm.201200106
   Choi SW, 2010, LANGMUIR, V26, P19001, DOI 10.1021/la104206h
   Choi SW, 2010, LANGMUIR, V26, P12126, DOI 10.1021/la101519b
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hu S, 2011, OPT LETT, V36, P1134, DOI 10.1364/OL.36.001134
   Janousek L, 2004, TRANSPLANT P, V36, P1099, DOI 10.1016/j.transproceed.2004.04.049
   Jin YD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1042
   Kim C, 2010, BIOMED OPT EXPRESS, V1, P278, DOI 10.1364/BOE.1.000278
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Lee J, 2009, BIOMATERIALS, V30, P4687, DOI 10.1016/j.biomaterials.2009.05.024
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Ma WX, 2011, INT J LEGAL MED, V125, P549, DOI 10.1007/s00414-011-0567-4
   Marquez G, 1998, APPL OPTICS, V37, P798, DOI 10.1364/AO.37.000798
   Maslov K, 2008, OPT LETT, V33, P929, DOI 10.1364/OL.33.000929
   Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074
   Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/nmeth.1483, 10.1038/NMETH.1483]
   Ntziachristos V, 2010, CHEM REV, V110, P2783, DOI 10.1021/cr9002566
   Peyton SR, 2011, BIOTECHNOL BIOENG, V108, P1181, DOI 10.1002/bit.23027
   Razansky D, 2009, NAT PHOTONICS, V3, P412, DOI 10.1038/NPHOTON.2009.98
   SCUDIERO DA, 1988, CANCER RES, V48, P4827
   Shanbhag S, 2005, SMALL, V1, P1208, DOI 10.1002/smll.200500191
   Song KH, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2818045
   Spinelli L, 2004, J BIOMED OPT, V9, P1137, DOI 10.1117/1.1803546
   Stachowiak AN, 2008, J BIOMED MATER RES A, V85A, P815, DOI 10.1002/jbm.a.31661
   Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210
   Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157
   Wang Y, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.061208
   Wang Y, 2011, OPT LETT, V36, P1029, DOI 10.1364/OL.36.001029
   Wang Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3525643
   Wilson K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1627
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yao JJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3594786
   Yao JJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3339953
   Yao JJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3251044
   Zhang HF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2435697
   Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220
   Zhang Y, 2011, ANGEW CHEM INT EDIT, V123, P7497
   Zhang Y, 2012, MACROMOL RAPID COMM, V33, P296, DOI 10.1002/marc.201100695
   Zhang Y, 2012, ADV FUNCT MATER, V22, P121, DOI 10.1002/adfm.201101690
   Zhang Y, 2011, ANGEW CHEM INT EDIT, V50, P7359, DOI 10.1002/anie.201101659
   Zhang Y, 2010, BIOMATERIALS, V31, P8651, DOI 10.1016/j.biomaterials.2010.07.089
   Zhang YS, 2013, SOFT MATTER, V9, P9747, DOI 10.1039/c3sm52063c
   Zhang YS, 2013, THERANOSTICS, V3, P532, DOI 10.7150/thno.5369
   Zhang YS, 2013, MACROMOL RAPID COMM, V34, P485, DOI 10.1002/marc.201200740
NR 52
TC 19
Z9 19
U1 2
U2 69
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1433-7851
EI 1521-3773
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PD JAN 3
PY 2014
VL 53
IS 1
BP 184
EP 188
DI 10.1002/anie.201306282
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 275YI
UT WOS:000328714900023
PM 24130155
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Beilvert, A
   Chaubet, F
   Chaunier, L
   Guilois, S
   Pavon-Djavid, G
   Letourneur, D
   Meddahi-Pelle, A
   Lourdin, D
AF Beilvert, A.
   Chaubet, F.
   Chaunier, L.
   Guilois, S.
   Pavon-Djavid, G.
   Letourneur, D.
   Meddahi-Pelle, A.
   Lourdin, D.
TI Shape-memory starch for resorbable biomedical devices
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Biomaterial; In vivo implantation; Shape-memory; Starch; Extrusion
ID MECHANICAL-PROPERTIES; MACROMOLECULAR ORIENTATION; POTATO STARCH;
   SCAFFOLDS; BEHAVIOR; CRYSTALLINITY; DEGRADATION; MORPHOLOGY; POLYMERS;
   BIOMATERIALS
AB Shape-memory resorbable materials were obtained by extrusion-cooking of potato starch with 20% glycerol under usual conditions. They presented an efficient shape-memory with a high recovery ratio (Rr > 90%).Their recovery could be triggered at 37 C in water. After water immersion at 37 C, the modulus decreased from 1 GPa to 2.4 MPa and remained almost constant over 21 days. Gamma-ray sterilization did not have a dramatic impact on their mechanical properties, despite a large decrease of molecular mass analyzed by asymmetrical flow field-flow fractionation coupled with multi-angle laser light scattering (AFFFF-MALLS). Samples implanted in a rat model exhibited normal tissue integration with a low inflammatory response. Thus, as previously investigated in the case of shape-memory synthetic polymers, natural starch, without chemical grafting, can now be considered for manufacturing innovative biodegradable devices for less-invasive surgery. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Beilvert, A.; Chaunier, L.; Guilois, S.; Lourdin, D.] INRA, Unite Biopolymeres Interact & Assemblages, UR1268, F-44300 Nantes, France.
   [Chaubet, F.; Pavon-Djavid, G.; Letourneur, D.; Meddahi-Pelle, A.] INSERM, Bioengn Cardiovasc & Therapy Team, U698, F-75877 Paris, France.
   [Chaubet, F.; Pavon-Djavid, G.; Letourneur, D.] Univ Paris 13, Sorbonne Paris Cite, Inst Galilee, F-93430 Villetaneuse, France.
   [Meddahi-Pelle, A.] Univ Paris 13, Sorbonne Paris Cite, Inst Univ Technol St Denis, F-93206 St Denis, France.
RP Lourdin, D (reprint author), INRA, Unite Biopolymeres Interact & Assemblages, UR1268, Rue Geraudiere, F-44300 Nantes, France.
EM anne.beilvert@nantes.inra.fr; frederic.chaubet@univ-paris13.fr;
   laurent.chaunier@nantes.inra.fr; sophie.guilois@nantes.inra.fr;
   graciela.pavon@univ-paris13.fr; didier.letourneur@inserm.fr;
   anne.pelle@inserm.fr; denis.lourdin@nantes.inra.fr
RI Didier, letourneur/H-5268-2012; CHAUNIER, Laurent/D-6924-2017; Chaubet,
   Frederic/L-4570-2017
OI Didier, letourneur/0000-0003-2197-9468; CHAUNIER,
   Laurent/0000-0003-0554-8203; Chaubet, Frederic/0000-0001-7375-0425;
   Pavon-Djavid, Graciela/0000-0001-5819-1071
FU French National Research Agency (ANR) [IRMAS-EMMA-007]
FX The authors would like to thank C. Vechambre, A. Buleon, R. Desirest, M.
   de Carvalho, A-L. Reguerre, A. Rolland-Sabate and B. Pontoire (INRA,
   Nantes) and L. Louedec and F. Medjahed (INSERM, Paris) for their
   technical help and helpful discussions. This work has been funded by the
   French National Research Agency (ANR Emergence IRMAS-EMMA-007).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arockianathan PM, 2012, INT J BIOL MACROMOL, V50, P939, DOI 10.1016/j.ijbiomac.2012.02.022
   Bello-Perez LA, 1998, J CEREAL SCI, V27, P267, DOI 10.1006/jcrs.1998.0186
   Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3
   Chaunier L, 2012, FOOD RES INT, V47, P194, DOI 10.1016/j.foodres.2011.05.035
   Chaunier L, 2009, STARCH-STARKE, V61, P116, DOI 10.1002/star.200800074
   Frost K, 2011, CARBOHYD POLYM, V84, P343, DOI 10.1016/j.carbpol.2010.11.042
   Ghosh S, 2008, ACTA BIOMATER, V4, P950, DOI 10.1016/j.actbio.2008.02.001
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Guo BC, 2011, BIOMACROMOLECULES, V12, P1312, DOI 10.1021/bm2000378
   Hayakawa I, 1996, FOOD SCI TECHNOL-LEB, V29, P395
   Kantoglu O, 2002, NUCL INSTRUM METH B, V197, P259, DOI 10.1016/S0168-583X(02)01473-8
   Lan X, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/2/024002
   Lendlein A., 2002, ANGEW CHEM INT EDIT, V41, P2035
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Leng JS, 2011, PROG MATER SCI, V56, P1077, DOI 10.1016/j.pmatsci.2011.03.001
   Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k
   Lopez OV, 2011, J FOOD ENG, V105, P254, DOI 10.1016/j.jfoodeng.2011.02.029
   Lourdin D, 1997, POLYMER, V38, P5401, DOI 10.1016/S0032-3861(97)00082-7
   Lourdin D, 2009, European patent, Patent No. [WO2009130215, 2009130215, WO/2009/130215]
   Martins AM, 2012, J BIOMED MATER RES A, V100A, P599, DOI 10.1002/jbm.a.33261
   Milicevic D, 2012, RADIAT PHYS CHEM, V81, P1361, DOI 10.1016/j.radphyschem.2011.11.037
   Neves NM, 2005, MAT SCI ENG C-BIO S, V25, P195, DOI 10.1016/j.msec.2005.01.009
   Oliveira JT, 2007, J MATER SCI-MATER M, V18, P295, DOI 10.1007/s10856-006-0692-7
   Rodrigues A, 2012, CARBOHYD POLYM, V87, P987, DOI 10.1016/j.carbpol.2011.09.044
   Rolland-Sabate A, 2007, BIOMACROMOLECULES, V8, P2520, DOI 10.1021/bm070024z
   Santos TC, 2010, ACTA BIOMATER, V6, P4314, DOI 10.1016/j.actbio.2010.06.020
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Suljovrujic E, 2007, RADIAT PHYS CHEM, V76, P722, DOI 10.1016/j.radphyschem.2006.02.013
   Tamai H, 2000, CIRCULATION, V102, P399
   TOLLIER MT, 1979, ANN TECHNOL AGR, V28, P1
   Torres FG, 2011, MAT SCI ENG C-MATER, V31, P1737, DOI 10.1016/j.msec.2011.08.004
   vanSoest JJG, 1996, CARBOHYD POLYM, V29, P225, DOI 10.1016/0144-8617(96)00011-2
   Vechambre C, 2011, MACROMOLECULES, V44, P9384, DOI 10.1021/ma202019v
   Vechambre C, 2010, MACROMOLECULES, V43, P9854, DOI 10.1021/ma101704k
   Vechambre C, 2010, MACROMOL MATER ENG, V295, P115, DOI 10.1002/mame.200900191
   Xue LA, 2010, BIOMATERIALS, V31, P8132, DOI 10.1016/j.biomaterials.2010.07.043
   Yakacki CM, 2007, BIOMATERIALS, V28, P2255, DOI 10.1016/j.biomaterials.2007.01.030
   Zhang NZ, 2013, CARBOHYD POLYM, V92, P455, DOI 10.1016/j.carbpol.2012.09.048
NR 40
TC 17
Z9 17
U1 4
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 2
PY 2014
VL 99
BP 242
EP 248
DI 10.1016/j.carbpol.2013.08.015
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 283OM
UT WOS:000329256600030
PM 24274502
DA 2018-10-20
ER

PT J
AU Andersen, T
   Melvik, JE
   Gaserod, O
   Alsberg, E
   Christensen, BE
AF Andersen, Therese
   Melvik, Jan Egil
   Gaserod, Olav
   Alsberg, Eben
   Christensen, Bjorn E.
TI Ionically gelled alginate foams: Physical properties controlled by type,
   amount and source of gelling ions
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Biomaterial; Polysaccharide; Porous; Hydrogel; Gelation; Gelation
   kinetics
ID DRUG-DELIVERY SYSTEMS; CONTROLLED SCAFFOLD DEGRADATION; BIOMEDICAL
   APPLICATIONS; LOADED ALGINATE; SODIUM ALGINATE; BONE-FORMATION;
   STEM-CELLS; IN-VITRO; HYDROGELS; TISSUE
AB A new and flexible method for preparation of dry macroporous alginate foams with the capability of absorbing physiological solutions has been developed, which may find use within areas such as wound healing, cell culture, drug delivery and tissue engineering. The present study demonstrates how the gelation rate of the alginate and degree of ionic crosslinking can be utilized to control the physical foam properties. The rate of released Ca2+/Sr2+ gelling ions available for interaction with the alginate was influenced by the concentration and physical characteristics of CaCO3/SrCO3 particles. The method of preparation of such foams allows, as described herein, tailoring of the pore structure, hydration properties and mechanical integrity in a manner not possible by other techniques. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Andersen, Therese; Melvik, Jan Egil; Gaserod, Olav] FMC BioPolymer AS NovaMatrix, N-1337 Sandvika, Norway.
   [Andersen, Therese; Christensen, Bjorn E.] Norwegian Univ Sci & Technol, NOBIPOL, Dept Biotechnol, N-7034 Trondheim, Norway.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Natl Ctr Regenerat Med, Devis Gen Med Sci, Cleveland, OH 44106 USA.
RP Andersen, T (reprint author), FMC BioPolymer AS NovaMatrix, Ind Veien 33, N-1337 Sandvika, Norway.
EM therese.andersen@fmc.com
RI Christensen, Bjorn E./G-6033-2015
OI Christensen, Bjorn E./0000-0002-1135-9815; Alsberg,
   Eben/0000-0002-3487-4625
CR Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227
   Andersen T, 2012, BIOMACROMOLECULES, V13, P3703, DOI 10.1021/bm301194f
   [Anonymous], 2010, D63810 ASTM INT
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Barbetta A, 2009, BIOMACROMOLECULES, V10, P2328, DOI 10.1021/bm900517q
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   BSI British Standards, 2002, 1372612002 BS EN BSI
   Donati I, 2005, BIOMACROMOLECULES, V6, P1031, DOI 10.1021/bm049306e
   DRAGET K I, 1991, Carbohydrate Polymers, V14, P159
   Draget K. I., 2005, POLYSACCHARIDES POLY, V1, P1
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dvir-Ginzberg M, 2008, FASEB J, V22, P1440, DOI 10.1096/fj.07-9277com
   Fang YP, 2007, J PHYS CHEM B, V111, P2456, DOI 10.1021/jp0689870
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Funami T, 2009, FOOD HYDROCOLLOID, V23, P1746, DOI 10.1016/j.foodhyd.2009.02.014
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Haug A., 1970, ACTA CHEM SCAND, V24, P854
   Hegge AB, 2011, J PHARM SCI-US, V100, P174, DOI 10.1002/jps.22263
   Hegge AB, 2010, J PHARM SCI-US, V99, P3499, DOI 10.1002/jps.22119
   Henderson TMA, 2013, J MATER CHEM B, V1, P2682, DOI 10.1039/c3tb20280a
   Holte O, 2006, PHARMAZIE, V61, P30
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003
   Jain J. P., 2011, BIODEGRADABLE POLYM, P3
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   Kong HJ, 2004, ADV MATER, V16, P1917, DOI 10.1002/adma.200400014
   Kristiansen KA, 2011, CARBOHYD POLYM, V86, P1595, DOI 10.1016/j.carbpol.2011.06.069
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   KUO CK, 2001, MAT RES SOC S P, V662
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Leone G, 2004, J MATER SCI-MATER M, V15, P463, DOI 10.1023/B:JMSM.0000021121.91449.f4
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   Miralles G, 2001, J BIOMED MATER RES, V57, P268, DOI 10.1002/1097-4636(200111)57:2<268::AID-JBM1167>3.0.CO;2-L
   Moe S. T., 1995, FOOD POLYSACCHARIDES, V9, P245
   Morch YA, 2006, BIOMACROMOLECULES, V7, P1471, DOI 10.1021/bm060010d
   Place ES, 2011, TISSUE ENG PT A, V17, P2713, DOI [10.1089/ten.TEA.2011.0059, 10.1089/ten.tea.2011.0059]
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Thornton AJ, 2004, TRANSPLANTATION, V77, P1798, DOI 10.1097/01.tp.0000131152.71117.0e
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   Wee S, 1998, ADV DRUG DELIVERY RE, V4, P267, DOI DOI 10.1016/S0169-409X(97)00124-5
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 53
TC 15
Z9 16
U1 2
U2 81
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 2
PY 2014
VL 99
BP 249
EP 256
DI 10.1016/j.carbpol.2013.08.036
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 283OM
UT WOS:000329256600031
PM 24274503
DA 2018-10-20
ER

PT J
AU Duncan, NA
   Bruehlmann, SB
   Hunter, CJ
   Shao, XX
   Kelly, EJ
AF Duncan, Neil A.
   Bruehlmann, Sabina B.
   Hunter, Christopher J.
   Shao, Xinxin
   Kelly, Elizabeth J.
TI In situ cell-matrix mechanics in tendon fascicles and seeded collagen
   gels: implications for the multiscale design of biomaterials
SO COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING
LA English
DT Article
DE tendon; micromechanics; collagen gel; confocal microscopy; biomaterials;
   cell-matrix
ID SMOOTH-MUSCLE-CELLS; CONFOCAL MICROSCOPY; ANNULUS FIBROSUS;
   BIOMECHANICAL FUNCTION; 3-DIMENSIONAL CULTURE; INTERVERTEBRAL DISC;
   CONNECTIVE TISSUES; CROSS-LINKING; MODEL; FIBRILS
AB Designing biomaterials to mimic and function within the complex mechanobiological conditions of connective tissues requires a detailed understanding of the micromechanical environment of the cell. The objective of our study was to measure the in situ cell-matrix strains from applied tension in both tendon fascicles and cell-seeded type I collagen scaffolds using laser scanning confocal microscopy techniques. Tendon fascicles and collagen gels were fluorescently labelled to simultaneously visualise the extracellular matrix and cell nuclei under applied tensile strains of 5%. There were significant differences observed in the micromechanics at the cell-matrix scale suggesting that the type I collagen scaffold did not replicate the pattern of native tendon strains. In particular, although the overall in situ tensile strains in the matrix were quite similar (approximate to 2.5%) between the tendon fascicles and the collagen scaffolds, there were significant differences at the cell-matrix boundary with visible shear across cell nuclei of >1m measured in native tendon which was not observed at all in the collagen scaffolds. Similarly, there was significant non-uniformity of intercellular strains with relative sliding observed between cell rows in tendon which again was not observed in the collagen scaffolds where the strain environment was much more uniform. If the native micromechanical environment is not replicated in biomaterial scaffolds, then the cells may receive incorrect or mixed mechanical signals which could affect their biosynthetic response to mechanical load in tissue engineering applications. This study highlights the importance of considering the microscale mechanics in the design of biomaterial scaffolds and the need to incorporate such features in computational models of connective tissues.
C1 [Duncan, Neil A.; Bruehlmann, Sabina B.; Hunter, Christopher J.; Shao, Xinxin; Kelly, Elizabeth J.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB T2N 1N4, Canada.
   [Duncan, Neil A.] Univ Calgary, Dept Civil Engn, Calgary, AB T2N 1N4, Canada.
   [Hunter, Christopher J.] Univ Calgary, Dept Mech Engn, Calgary, AB T2N 1N4, Canada.
RP Duncan, NA (reprint author), Univ Calgary, McCaig Inst Bone & Joint Hlth, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.
EM duncan@ucalgary.ca
OI Duncan, Neil/0000-0002-9782-3681
FU Natural Sciences and Engineering Research Council (NSERC); Canadian
   Foundation for Innovation (CFI); Canada Research Chair in Orthopaedic
   Bioengineering
FX This research was supported by the Natural Sciences and Engineering
   Research Council (NSERC), the Canadian Foundation for Innovation (CFI)
   and the Canada Research Chair in Orthopaedic Bioengineering (N.A.D.).
CR Agoram B, 2001, J BIOMECH ENG-T ASME, V123, P362, DOI 10.1115/1.1385843
   Annovazzi L, 2010, J BIOMED MATER RES A, V92A, P254, DOI 10.1002/jbm.a.32352
   Arnoczky SP, 2002, J ORTHOPAED RES, V20, P29, DOI 10.1016/S0736-0266(01)00080-8
   Benjamin M, 2000, INT REV CYTOL, V196, P85
   Bruehlmann SB, 2004, SPINE, V29, P2612, DOI 10.1097/01.brs.0000146465.05972.56
   Bruehlmann SB, 2004, J BIOMECH, V37, P223, DOI 10.1016/S0021-9290(03)00244-6
   Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Buehler MJ, 2010, J COMPUT THEOR NANOS, V7, P1203, DOI 10.1166/jctn.2010.1474
   Butcher JT, 2004, J HEART VALVE DIS, V13, P478
   Butler DL, 1999, CLIN ORTHOP RELAT R, pS324
   Cacho F, 2007, INT J NONLINEAR MECH, V42, P391, DOI 10.1016/j.ijnonlinmec.2007.02.002
   Chandran PL, 2006, J BIOMECH ENG-T ASME, V128, P259, DOI 10.1115/1.2165699
   Chandran PL, 2007, J BIOMECH ENG-T ASME, V129, P137, DOI 10.1115/1.2472369
   Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893
   Desrochers J, 2010, J BIOMECH, V43, P2141, DOI 10.1016/j.jbiomech.2010.03.045
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Fratzl P, 2007, J R SOC INTERFACE, V4, P637, DOI 10.1098/rsif.2007.0218
   Gautieri A, 2010, J CHEM THEORY COMPUT, V6, P1210, DOI 10.1021/ct100015v
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6
   Grytz R, 2009, J MECH BEHAV BIOMED, V2, P522, DOI 10.1016/j.jmbbm.2008.12.009
   Hansen KA, 2002, J BIOMECH ENG-T ASME, V124, P72, DOI 10.1115/1.1427698
   Houssen YG, 2011, J BIOMECH, V44, P2047, DOI 10.1016/j.jbiomech.2011.05.009
   Hunter CJ, 2002, BIOMATERIALS, V23, P1249, DOI 10.1016/S0142-9612(01)00245-9
   KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Krishnan L, 2004, TISSUE ENG, V10, P241, DOI 10.1089/107632704322791880
   Kroon M, 2010, J MECH PHYS SOLIDS, V58, P918, DOI 10.1016/j.jmps.2010.03.005
   Langevin HM, 2004, HISTOCHEM CELL BIOL, V122, P7, DOI 10.1007/s00418-004-0667-z
   Levenberg S, 2004, CURR TOP DEV BIOL, V61, P113, DOI 10.1016/S0070-2153(04)61005-2
   Lo IK, 2002, HISTOL HISTOPATHOL, V17, P523, DOI 10.14670/HH-17.523
   Maceri F, 2012, BIOMECH MODEL MECHAN, V11, P505, DOI 10.1007/s10237-011-0329-8
   Maceri F, 2010, J BIOMECH, V43, P355, DOI 10.1016/j.jbiomech.2009.07.040
   Marino M, 2012, COMPUT METHODS BIOME, DOI .10.1080/10255842
   MIJAILOVICH SM, 1993, J APPL PHYSIOL, V74, P665
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Reese SP, 2010, J BIOMECH, V43, P1394, DOI 10.1016/j.jbiomech.2010.01.004
   Rigozzi S, 2011, J STRUCT BIOL, V176, P9, DOI 10.1016/j.jsb.2011.07.002
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Roeder BA, 2009, J BIOMECH ENG, V131, P137
   Rong Y, 2002, TISSUE ENG, V8, P1037, DOI 10.1089/107632702320934137
   Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3
   Screen HRC, 2008, J MECH BEHAV BIOMED, V1, P51, DOI 10.1016/j.jmbbm.2007.03.002
   Screen HRC, 2006, ACTA BIOMATER, V2, P505, DOI 10.1016/j.actbio.2006.05.008
   Screen HRC, 2010, ADV FUNCT MATER, V20, P738, DOI 10.1002/adfm.200901711
   Screen HRC, 2004, P I MECH ENG H, V218, P109, DOI 10.1243/095441104322984004
   Screen HRC, 2003, BIORHEOLOGY, V40, P361
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   Silver Frederick H., 2006
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Snedeker JG, 2009, CELLS TISSUES ORGANS, V190, P111, DOI 10.1159/000189211
   Snedeker JG, 2009, TISSUE ENG PART C-ME, V15, P485, DOI 10.1089/ten.tec.2008.0612
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332
   Stella JA, 2010, ACTA BIOMATER, V6, P2365, DOI 10.1016/j.actbio.2010.01.001
   Stella JA, 2010, J BIOMED MATER RES A, V93A, P1032, DOI 10.1002/jbm.a.32593
   Tang H, 2009, ANN BIOMED ENG, V37, P1117, DOI 10.1007/s10439-009-9679-0
   Tang Y, 2010, J R SOC INTERFACE, V7, P839, DOI 10.1098/rsif.2009.0390
   Thornton GM, 2002, J ORTHOP RES, V20, P967, DOI 10.1016/S0736-0266(02)00028-1
   Upton ML, 2008, BIOPHYS J, V95, P2116, DOI 10.1529/biophysj.107.126938
   Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
NR 66
TC 9
Z9 10
U1 1
U2 19
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1025-5842
EI 1476-8259
J9 COMPUT METHOD BIOMEC
JI Comput. Methods Biomech. Biomed. Eng.
PD JAN 2
PY 2014
VL 17
IS 1
SI SI
BP 39
EP 47
DI 10.1080/10255842.2012.742075
PG 9
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical
SC Computer Science; Engineering
GA 273MU
UT WOS:000328539900005
PM 23237459
DA 2018-10-20
ER

PT J
AU Lan, Y
   Li, WC
   Guo, R
   Zhang, Y
   Xue, W
   Zhang, YM
AF Lan, Yong
   Li, Weichang
   Guo, Rui
   Zhang, Yi
   Xue, Wei
   Zhang, Yuanming
TI Preparation and characterisation of vancomycin-impregnated gelatin
   microspheres/silk fibroin scaffold
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE gelatin microsphere; silk fibroin; scaffold; vancomycin; antibacterial
   property
ID FIBROBLAST-GROWTH-FACTOR; DRUG DELIVERY-SYSTEM; SILK FIBROIN;
   CONTROLLED-RELEASE; SKIN; ANTIBIOTICS; BIOMATERIAL; FILMS; REGENERATION;
   MEMBRANES
AB A type of antibacterial silk fibroin (SF) scaffold was developed and characterised as a potential functional wound dressing for acute trauma treatment. To achieve this, SF solution was mixed with previously fabricated vancomycin (Vm)-loaded gelatin (G) microspheres, followed by a freeze-drying step. Some physical and antimicrobial properties of the prepared Vm/G/SF scaffolds were investigated and the results demonstrated that the average pore size and porosity of the composite scaffold were 60-80m and 75%, respectively. The compressive stress and compressive modulus of Vm/G/SF scaffold were 140 and 468KPa, respectively. Compared with Vm/G microspheres and Vm/SF scaffold, the Vm/G/SF scaffold has slower release rate of Vm. In addition, the Vm release rate of Vm/G/SF scaffold matched well with the degradation rate of SF scaffold. With respect to the antimicrobial effect, the results showed that the Vm/G/SF scaffold had good antimicrobial activity against Staphylococcus aureus (gram-positive), which is a gram-positive bacteria commonly found in infected wounds.
C1 [Lan, Yong; Li, Weichang; Guo, Rui; Zhang, Yi; Xue, Wei; Zhang, Yuanming] Jinan Univ, Guangdong Higher Educ Inst, Key Lab Biomat, Guangzhou 510632, Guangdong, Peoples R China.
   [Lan, Yong] Jinan Univ, Dept Mat Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China.
   [Li, Weichang; Zhang, Yuanming] Jinan Univ, Dept Chem, Guangzhou 510632, Guangdong, Peoples R China.
   [Guo, Rui; Zhang, Yi; Xue, Wei] Jinan Univ, Dept Biomed Engn, Guangzhou 510632, Guangdong, Peoples R China.
RP Guo, R (reprint author), Jinan Univ, Guangdong Higher Educ Inst, Key Lab Biomat, Guangzhou 510632, Guangdong, Peoples R China.
EM guorui@jnu.edu.cn; tzhangym@jnu.edu.cn
RI Yuanming, Zhang/B-9285-2008; zhang, yuanming/A-9839-2014
FU Natural Science Foundation of Guangdong [S2012040008003]; Guangzhou
   Science and Technology Plan Project [11C32070752]; Key Project of DEGP
   [cxzd1109]; PhD Programmes Foundation of Ministry of Education of China;
   Fundamental Research Funds for the Central Universities [21612327]
FX This study is financially supported by the Natural Science Foundation of
   Guangdong (S2012040008003), Guangzhou Science and Technology Plan
   Project (No. 11C32070752), the Key Project of DEGP (cxzd1109), the PhD
   Programmes Foundation of Ministry of Education of China and the
   Fundamental Research Funds for the Central Universities (21612327).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bin Choy Y, 2008, MACROMOL BIOSCI, V8, P758, DOI 10.1002/mabi.200700316
   Chen DW, 2012, INT J PHARMACEUT, V430, P335, DOI 10.1016/j.ijpharm.2012.04.010
   Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006
   Elsner JJ, 2010, J BIOMED MATER RES B, V93B, P425, DOI 10.1002/jbm.b.31599
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kasoju N, 2012, J BIOMED MATER RES B, V100B, P1854, DOI 10.1002/jbm.b.32753
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Konishi M, 2005, J CONTROL RELEASE, V103, P7, DOI 10.1016/j.conrel.2004.11.014
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Kundu J, 2008, J MATER SCI-MATER M, V19, P2679, DOI 10.1007/s10856-008-3398-1
   Kundu J, 2012, ACTA BIOMATER, V8, P1720, DOI 10.1016/j.actbio.2012.01.004
   Lee OJ, 2012, J BIOMED MATER RES A, V100A, P2018, DOI 10.1002/jbm.a.33308
   Li B, 2010, J CONTROL RELEASE, V145, P221, DOI 10.1016/j.jconrel.2010.04.002
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lu B, 2003, INT J PHARM, V265, P1, DOI 10.1016/S0378-5173(03)00332-6
   Noel SP, 2008, CLIN ORTHOP RELAT R, V466, P1377, DOI 10.1007/s11999-008-0228-1
   Pica K, 2006, J PHARM SCI-US, V95, P1896, DOI 10.1002/jps.20572
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   She HD, 2007, J MATER SCI, V42, P8113, DOI 10.1007/s10853-007-1706-7
   Shepherd J, 2011, BIOMATERIALS, V32, P258, DOI 10.1016/j.biomaterials.2010.08.084
   Spizzirri UG, 2012, J MATER SCI, V47, P3648, DOI 10.1007/s10853-011-6211-3
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wei B, 2011, CARBOHYD POLYM, V84, P533, DOI 10.1016/j.carbpol.2010.12.017
   Wongpanit P, 2007, MACROMOL BIOSCI, V7, P1258, DOI 10.1002/mabi.200700074
   Wongpanit P, 2010, J BIOMAT SCI-POLYM E, V21, P1403, DOI 10.1163/092050609X12517858243706
   Yamada H, 2004, BIOMATERIALS, V25, P467, DOI 10.1016/S0142-9612(03)00540-4
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zhou D, 2012, ARCH PHARM RES, V35, P839, DOI 10.1007/s12272-012-0509-9
   Zhou J, 2012, J BIOMED MATER RES A, V100A, P2295, DOI 10.1002/jbm.a.34170
   Zhou JA, 2011, J MICROENCAPSUL, V28, P99, DOI 10.3109/02652048.2010.534824
   Zhu XH, 2008, TISSUE ENG PT A, V14, P1939, DOI 10.1089/ten.tea.2007.0346
NR 37
TC 10
Z9 10
U1 3
U2 61
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JAN 2
PY 2014
VL 25
IS 1
BP 75
EP 87
DI 10.1080/09205063.2013.836951
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 254RV
UT WOS:000327185600006
PM 24053472
DA 2018-10-20
ER

PT J
AU Kaczmarek, JC
   Tieppo, A
   White, CJ
   Byrne, ME
AF Kaczmarek, James C.
   Tieppo, Arianna
   White, Charles J.
   Byrne, Mark E.
TI Adjusting biomaterial composition to achieve controlled multiple-day
   release of dexamethasone from an extended-wear silicone hydrogel contact
   lens
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE silicone hydrogel contact lenses; drug-eluting contact lens;
   extended-wear contact lens; ocular anti-inflammatory; hydrophobic
   interactions
ID EYE
AB Purpose: To alter the composition and structure of silicone hydrogel contact lenses to achieve controlled release of dexamethasone and evaluate the lens optical and mechanical properties compared to commercial lenses. There is a tremendous need for controlled release of drugs from ocular biomaterials as the majority of ophthalmic drugs are delivered via topical eye drops, which have low bioavailability and patient compliance.Methods: Poly(PDMS-co-TRIS-co-DMA) contact lenses were synthesized with varying PDMS/TRIS:DMA ratios (0.25:1, 0.67:1, 1.5:1) as well as with additional crosslinking monomers. Lenses were characterized via in vitro release studies in a microfluidic device at ocular flowrates and in large well-mixed volumes, optical quality studies over visible wavelengths, mechanical analysis, and determination of polymer volume fraction in the swollen state.Results: Extended and controlled release of therapeutically relevant concentrations of dexamethasone was achieved for multiple day, continuous wear up to 60days at in vitro ocular flowrates. Release was delayed due to a combination of increased hydrophobic to hydrophilic composition and the inclusion of additional structural constraints, both of which decreased the polymer volume fraction in the swollen state. However, decreased mass release rates were at the expense of increased modulus and decreased lens flexibility. All lenses had high optical clarity (approximate to 90% transmittance) and contained highly oxygen permeable siloxane composition similar to those found in commercial silicone hydrogel lenses, but they had poor flexibility for use as soft contact lenses.Conclusions: Based on our results, the lenses described herein likely have too high of a modulus for use as extended-wear, soft contact lenses with drug release. Therefore, other controlled release methods would be better suited for maintaining adequate mechanical properties and achieving controlled and extended release for the duration of wear in soft, silicone hydrogel contact lens biomaterials. However, these biomaterials may find clinical use as more rigid gas permeable contact lenses or inserts.
C1 [Byrne, Mark E.] Auburn Univ, Dept Chem Engn, Biomimet & Biohybrid Mat Lab, Auburn, AL 36849 USA.
   Auburn Univ, Dept Chem Engn, Biomed Devices Lab, Auburn, AL 36849 USA.
   Auburn Univ, Dept Chem Engn, Drug Delivery Lab, Auburn, AL 36849 USA.
RP Byrne, ME (reprint author), Auburn Univ, Dept Chem Engn, Biomimet & Biohybrid Mat Lab, Auburn, AL 36849 USA.
EM byrneme@eng.auburn.edu
RI White, Charles/C-4872-2014
OI White, Charles/0000-0002-2734-3279
FU NSF REU Site in Micro/Nano-Structured Materials, Therapeutics, and
   Devices (EES) [1063107]
FX We acknowledge the NSF REU Site in Micro/Nano-Structured Materials,
   Therapeutics, and Devices (EES Award 1063107) for funding part of this
   research (JCK was an NSF REU Fellow).
CR Douglas JA, 2000, AM J OPHTHALMOL, V130, P469
   Eysteinsson T, 2002, ACTA OPHTHALMOL SCAN, V80, P11, DOI 10.1034/j.1600-0420.2002.800103.x
   Fonn D, 1998, AM J OPTOM PHYSL OPT, V65, P613
   French K, 2005, OPTICIAN, V230, P29
   Ghormley NR, 2005, CONTACT LENS SPECTRU, P20
   Glasson M J, 2006, Cont Lens Anterior Eye, V29, P41, DOI 10.1016/j.clae.2005.12.006
   Hong X, 2001, OPTOMETRY VISION SCI, V78, P872, DOI 10.1097/00006324-200112000-00009
   Jones L, 1996, EYE CONTACT LENS, V22, P258
   Kannurpatti AR, 1998, POLYMER, V39, P213
   Karlgard C C S, 2003, Eye Contact Lens, V29, P83, DOI 10.1097/01.ICL.0000061756.66151.1C
   Karlgard CCS, 2003, INT J PHARM, V257, P141, DOI 10.1016/S0378-5173(03)00124-8
   Kim B, 2002, J BIOMAT SCI-POLYM E, V13, P1271, DOI 10.1163/156856202320893000
   Kim J, 2010, J CONTROL RELEASE, V148, P110, DOI 10.1016/j.jconrel.2010.07.119
   Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X
   Rhee DJ, 2007, PHYS DESK REFERENCE
   Saettone MF, 2002, PHARMATECHNOLOGY, P1
   Schoenwald Ronald D., 1997, P119
   Silicone Hydrogels [Internet]. Silicone Hydrogels.org, 2002, PAP E ED EL MOD SIL
   Tieppo A, 2012, J CONTROL RELEASE, V157, P391, DOI 10.1016/j.jconrel.2011.09.087
   Venkatesh S, 2007, BIOMATERIALS, V28, P717, DOI 10.1016/j.biomaterials.2006.09.007
   White CJ, 2011, J DRUG DELIV SCI TEC, V21, P369, DOI 10.1016/S1773-2247(11)50062-0
   White CJ, 2011, BIOMATERIALS, V32, P5698, DOI 10.1016/j.biomaterials.2011.04.044
   White CJ, 2010, EXPERT OPIN DRUG DEL, V7, P765, DOI 10.1517/17425241003770098
   WINFIELD AJ, 1990, BRIT J OPHTHALMOL, V74, P477, DOI 10.1136/bjo.74.8.477
NR 24
TC 14
Z9 15
U1 0
U2 67
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JAN 2
PY 2014
VL 25
IS 1
BP 88
EP 100
DI 10.1080/09205063.2013.840228
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 254RV
UT WOS:000327185600007
PM 24070140
DA 2018-10-20
ER

PT S
AU Espolov, T
   Ukibayev, J
   Myrzakozha, D
   Perez-Lopez, P
   Ermolaev, Y
AF Espolov, T.
   Ukibayev, J.
   Myrzakozha, D.
   Perez-Lopez, P.
   Ermolaev, Y.
GP SGEM
TI PHYSICAL AND CHEMICAL PROPERTIES AND CRYSTAL STRUCTURE TRANSFORMATION OF
   BEESWAX DURING HEAT TREATMENT
SO GEOCONFERENCE ON NANO, BIO AND GREEN - TECHNOLOGIES FOR A SUSTAINABLE
   FUTURE, VOL I (SGEM 2014)
SE International Multidisciplinary Scientific GeoConference-SGEM
LA English
DT Proceedings Paper
CT 14th International Multidisciplinary Scientific Geoconference (SGEM)
CY JUN 17-26, 2014
CL Albena, BULGARIA
DE Wax; Composite biomaterial; Radiography; Defect structure
AB The object of research is the wax as a waste product of bees in the steppe and mountain areas of Almaty region of Kazakhstan.
   Purpose - to study the structure parameters and the homologous phase composition, morphology waxes of alpine and mountain areas of Kazakhstan and the establishment temperature - dependent patterns of their atomic-crystalline state.
   Methods: radiography, gas chromatography, scanning electron microscopy and chemical methods of separation of multicomponent systems.
   The results obtained in the atomic crystal and molecular structures of beeswax depending on the districts collect materials.
   The technique of obtaining radiographs after dissolving beeswax in benzene, hexane and xylene. Submitted thermo-radiographic study samples obtained.
   Batch analysis thermo-radiographs waxes after treatment with benzene, hexane and xylene showed that their structure is essentially different from the source and closer to the spectra of the crystallized wax melted and due to annihilation of stacking faults waxes native atoms after their dissolution in hexane, benzene and xylene and subsequent their recrystallization.
   The results obtained allow to expand the amount of information on the physicochemical processes and structural transformations in beeswax as a composite of different genesis biomaterial.
   Scope: beekeeping, plant, structural and analytical chemistry, biotechnology and biocomposites.
C1 [Espolov, T.; Ukibayev, J.; Myrzakozha, D.; Perez-Lopez, P.] Kazakh Natl Agr Univ, Alma Ata, Kazakhstan.
   [Ermolaev, Y.] Kazakh Natl Tech Univ, Alma Ata, Kazakhstan.
RP Espolov, T (reprint author), Kazakh Natl Agr Univ, Alma Ata, Kazakhstan.
CR Asakura T, 2001, BIOPOLYMERS, V58, P521, DOI 10.1002/1097-0282(20010415)58:5<521::AID-BIP1027>3.0.CO;2-T
   Dorset D.L., 1983, ACTA CRYSTALLOGR B, V8, P1021
   Dorset DL, 1999, J PHYS D APPL PHYS, V32, P1276, DOI 10.1088/0022-3727/32/11/315
   Kitaygorodsky A. I., 1971, MOL CRYSTALS, P424
   Kotelnikova E.N., 2002, SAINT PETERSBURG MAG, P352
   Zabelkin O.A., 2003, BEEKEEPING, P352
NR 6
TC 0
Z9 0
U1 0
U2 4
PU STEF92 TECHNOLOGY LTD
PI SOFIA
PA 1 ANDREY LYAPCHEV BLVD, SOFIA, 1797, BULGARIA
SN 1314-2704
BN 978-619-7105-20-9
J9 INT MULTI SCI GEOCO
PY 2014
BP 143
EP 149
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BE0JD
UT WOS:000366136600020
DA 2018-10-20
ER

PT S
AU Barney, LE
   Peyton, SR
AF Barney, Lauren E.
   Peyton, Shelly R.
GP IEEE
TI Integrin Binding Uniquely Regulates Tropic Breast Cancer Cell Phenotypes
   in vitro
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE metastasis; tropism; extracellular matrix; integrins
ID METASTASIS; GENES
AB Breast cancer preferentially spreads to the bone, brain, liver, and lung, and this tissue-specific spread (tropism) is not well understood. The diversity of tissue sites often recipient of metastatic colonization suggests a role for the extracellular matrix (ECM) in tropism. We created a biomaterial platform that varies ECM type and composition, inspired by the bone, brain, and lung tissues, in order to study integrin-mediated adhesion and motility phenotypes. We report that bone, brain, and lung tropic breast cancer cells respond to ECM variations uniquely, implicating integrin binding in tropism. We confirmed these phenotypes in other metastatic cell lines, establishing a connection between in vitro phenotype and in vivo fate. We report that integrin-targeting alters the tropic phenotype, and provide insight toward integrins as druggable targets for metastatic disease. In sum, we emphasize the importance of the ECM and engineered microenvironments in order to understand breast cancer spread.
C1 [Barney, Lauren E.; Peyton, Shelly R.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
RP Barney, LE (reprint author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
EM speyton@ecs.umass.edu
CR Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021
   Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6
   Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799
NR 3
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600021
DA 2018-10-20
ER

PT S
AU Choa, R
   Lippens, E
   Mehta, M
   Mooney, DJ
   Lee, K
   Madl, C
AF Choa, Ruth
   Lippens, Evi
   Mehta, Manav
   Mooney, David J.
   Lee, Kangwon
   Madl, Christopher
GP IEEE
TI Hydrogel-based System for Mesenchymal Stem Cell Recruitment
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE mesenchymal stem cells; Thymus-Chemokine-1; alginate hydrogels;
   chemotaxis
AB During the early stages of bone wound healing, mesenchymal stem cells (MSCs) in the bone marrow migrate to an injury site and differentiate into osteoblasts, which actively participate in the bone repair process. We proposed that a biomaterial system which enhances migration of endogenous MSCs may accelerate the tissue healing process. The aims of this study were to 1) identify and characterize an MSC chemoattractant, and 2) quantify the release kinetics of the chemoattractant from alginate hydrogels. Timelapse microscopy of 3D MSC migration was used for real time tracking of cell movement. Quantitative analysis of chemotaxis parameters identified Thymus Chemokine-1 (TCK-1) to be a potent MSC chemoattractant (p-values less than .01 for velocity, directionality, and forward migration index compared to controls). Qualitative receptor staining of MSCs in a transwell membrane assay showed that MSCs which respond chemotactically to gradient of TCK-1 express the TCK-1 cell receptor, CXCR2. An alginate hydrogel was used for controlled release of TCK-1. To characterize the kinetics of this system, an enzyme-linked immunosorbent assay (ELISA) was used to quantify TCK-1 release rates. This approach may be widely applicable to the regeneration of other tissue types and may be more efficient than the current multistep procedures of cell transplantation.
C1 [Choa, Ruth; Lippens, Evi; Mehta, Manav; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Lee, Kangwon] Univ Sci & Technol, Korea Inst Sci & Technol, Seoul, South Korea.
   [Madl, Christopher] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.
RP Choa, R (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
CR Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Krelow J.D., 2009, ADV MATER, V21, P3368
   Lennon DP, 2006, EXP HEMATOL, V34, P1606, DOI 10.1016/j.exphem.2006.07.015
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Orreffo R., 2005, STEM CELL REV, V1, P169
   Tayalia P, 2011, BIOMATERIALS, V32, P2634, DOI 10.1016/j.biomaterials.2010.12.019
   United States Bone and Joint Initiative, 2011, BURD MUSC DIS US
   Zengel P., 2011, BMC CELL BIOL, V12
NR 9
TC 0
Z9 0
U1 2
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600055
DA 2018-10-20
ER

PT S
AU Dooley, K
   Banta, S
AF Dooley, Kevin
   Banta, Scott
GP IEEE
TI Engineering of Functional Proteinaceous Hydrogels for Biotechnology
   Applications
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE protein hydrogels; bioelectrocatalysis; alpha-helix; RTX domain; beta
   roll domain
ID BUILDING-BLOCKS; PEPTIDE; DOMAIN
AB Hydrogels consisting of 3-D cross-linked polymer networks have emerged as interesting scaffolds for a host of applications including drug delivery, tissue engineering, bioelectronics and biosensors. We have used protein engineering to create hydrogels by genetically appending cross-linking domains to globular proteins, which results in proteinacous biomaterials that exhibit bioactivity. Previously, we have investigated alpha-helical leucine zipper appendages for crosslinking. By genetically fusing these helices to the termini of globular proteins, we have created hydrogels with fluorescent proteins, and more interestingly, with enzymes such as laccase, organophosphate hydrolase (OPH) and alcohol dehydrogenase (AdhD). More recently, we have created a hydrogel from three self-assembling dehygrogenases which results in a biomaterial that is also a synthetic metabolic pathway capable of oxidizing methanol to CO2. Now we are exploring the calcium-responsive repeats-in-toxin (RTX) domain as an alternative cross-linker. In the absence of calcium, the RTX domain is unstructured. In calcium rich environments, it reversibly folds into a beta roll structure. By engineering one face of the beta roll to contain leucines, we created an environmentally-responsive cross-linking domain capable of calcium-triggered self-assembly. The folded beta roll contains a second face, which we have also designed to contain leucines. We are currently characterizing this "doubleface" leucine-rich RTX domain and evaluating is mechanical and biophysical properties. The RTX domains represent a truly "smart" cross-linking strategy in that the addition of a specific effector molecule ( calcium) enables the reversible formation of the hydrogel network.
C1 [Dooley, Kevin; Banta, Scott] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
RP Dooley, K (reprint author), Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
EM sbanta@columbia.edu
CR Banta S., 2010, ANNU REV BIOMED ENG, V12, P176
   Blenner MA, 2010, J MOL BIOL, V400, P244, DOI 10.1016/j.jmb.2010.04.056
   Dooley K, 2012, BIOMACROMOLECULES, V13, P1758, DOI 10.1021/bm3002446
   Kim YH, 2013, ANGEW CHEM INT EDIT, V52, P1437, DOI 10.1002/anie.201207423
   Lu HD, 2010, PROTEIN ENG DES SEL, V23, P559, DOI 10.1093/protein/gzq026
   Shur O, 2013, BIOTECHNIQUES, V54, P197, DOI 10.2144/000114010
   Shur O, 2013, PROTEIN ENG DES SEL, V26, P171, DOI 10.1093/protein/gzs092
   Shur O, 2011, PROTEIN SCI, V20, P925, DOI 10.1002/pro.625
   Wheeldon IR, 2008, P NATL ACAD SCI USA, V105, P15275, DOI 10.1073/pnas.0805249105
   Wheeldon IR, 2007, BIOMACROMOLECULES, V8, P2990, DOI 10.1021/bm700858p
   Wheeldon IR, 2009, J MOL BIOL, V392, P129, DOI 10.1016/j.jmb.2009.06.075
NR 11
TC 0
Z9 0
U1 0
U2 5
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600077
DA 2018-10-20
ER

PT S
AU Grasman, JM
   Page, RL
   Dominko, T
   Pins, GD
AF Grasman, Jonathan M.
   Page, Raymond L.
   Dominko, Tanja
   Pins, George D.
GP IEEE
TI Enhancing Cell Recruitment onto Crosslinked Fibrin Microthreads with
   Hepatocyte Growth Factor
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE volumetric muscle loss; hepatocyte growth factor; myoblast migration;
   biomaterial design; tissue engineering
AB Volumetric muscle loss (VML) defects caused by major trauma lead to loss of muscle mass, mobility, and ultimately may result in tissue morbidity. These large-scale injuries destroy native tissue structures such as the basal lamina, which serves as a regenerative template for muscle regeneration. Our approach to the regeneration of VML injuries is to use fibrin microthreads, scaffolds with similar morphology to native muscle, and modulate their mechanical and structural properties to recapitulate cues lost with the destruction of native tissue structures. In this study, we investigated the effect of adsorbing hepatocyte growth factor (HGF) onto crosslinked microthreads on myoblast proliferation and recruitment in an in vitro model designed to mimic in vivo satellite cell recruitment and found that active HGF is released for 1-2 days and is capable of stimulating myoblast migration in both 2D and 3D models. These data suggest that HGF-adsorbed microthreads can recruit myoblasts to the wound site, ultimately leading to an enhanced regenerative response in VML injuries.
C1 [Grasman, Jonathan M.; Page, Raymond L.; Pins, George D.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.
   [Dominko, Tanja] Worcester Polytech Inst, Dept Biol & Biotechnol, Worcester, MA 01609 USA.
   [Grasman, Jonathan M.; Page, Raymond L.; Dominko, Tanja; Pins, George D.] Worcester Polytech Inst, Bioengn Inst, Worcester, MA 01609 USA.
RP Grasman, JM (reprint author), Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.
CR Cornwell KG, 2007, J BIOMED MATER RES A, V82A, P104, DOI 10.1002/jbm.a.31057
   Gal-Levi R, 1998, BBA-MOL CELL RES, V1402, P39, DOI 10.1016/S0167-4889(97)00124-9
   Grasman JM, 2012, ACTA BIOMATER, V8, P4020, DOI 10.1016/j.actbio.2012.07.018
   Miller K. J., 2000, AM J PHYSIOL-CELL PH, V278, P174
   O'Reilly C, 2008, MUSCLE NERVE, V38, P1434, DOI 10.1002/mus.21146
   Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600102
DA 2018-10-20
ER

PT S
AU Koppes, AN
   Carrier, RL
   Oudin, MJ
   Gertler, FB
   Baranov, PY
   Young, MJ
   Miller, MA
   Lauffenburger, DA
AF Koppes, Abigail N.
   Carrier, Rebecca L.
   Oudin, Madeleine J.
   Gertler, Frank B.
   Baranov, Petr Y.
   Young, Michael J.
   Miller, Miles A.
   Lauffenburger, Douglas A.
GP IEEE
TI High-Throughput Screening for Directed Chemotaxis of Retinal Progenitor
   Cells in 3D Hydrogels
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE Retinal Progenitor; Chemotaxis; Hydrogel; High-Throughput Screen
AB This study utilizes high-throughput screening to examine human retinal progenitor cell migration in response to biomaterial and chemokine stimuli. Degenerative diseases of the retina impact millions of people worldwide each year, with no known cure available to date. Implantation of retinal progenitor cells in animal models has shown considerable promise but is limited by extremely low (<5%) levels of integration. We hypothesize that by providing a supportive biomaterial and optimized chemokine concentrations to the subretinal space, directed migration of implanted progenitors could be achieved, aiding cell survival, integration, and differentiation post-implantation. In this work, a high-throughput screen was applied to examine retinal progenitor cell migration in response to two hydrogel compositions (collagen type I, collagen type I: 10% Matrigel (TM)) and three growth factors implicated in migratory cascades: Epidermal Growth Factor (EGF), Fibroblast Growth Factor-2 (FGF-2), and Stromal Cell Derived Factor-1 (SDF-1). After 48 hours, the addition of EGF at various concentrations increased migration in both hydrogel compositions 1.9-2.6-fold compared to chemokine free controls. FGF-2 increased migration 1.4-2.2-fold in collagen gels, however did not impact migration in Matrigel (TM) composites. SDF-1 did not impact migration in Matrigel (TM) composites but increased migration 1.8-3.4-fold in collagen gels with a maximal response at 20 ng/mL. Progenitors penetrate farther in collagen I compared to MatrigelTM composites. These results support the significance of matrix and chemokines to induce migration towards optimizing a rational therapy for retinal degeneration.
C1 [Koppes, Abigail N.; Carrier, Rebecca L.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.
   [Oudin, Madeleine J.; Gertler, Frank B.] MIT, David Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Baranov, Petr Y.; Young, Michael J.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA USA.
   [Baranov, Petr Y.; Young, Michael J.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA.
   [Miller, Miles A.; Lauffenburger, Douglas A.] MIT, Dept Bioengn, Cambridge, MA 02139 USA.
RP Koppes, AN (reprint author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.
CR Benedict KF, 2013, CURR TOP MICROBIOL, V363, P201, DOI 10.1007/82_2012_249
   Miller S, 2013, PNAS, V110, pE2074
   Stumm R., 2007, J MOL ENDOCRINOL, P3
   Tomita M, 2005, STEM CELLS, V23, P1579, DOI 10.1634/stemcells.2005-0111
   Vugler A, 2007, MECH DEVELOP, V124, P807, DOI 10.1016/j.mod.2007.08.002
NR 5
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600144
DA 2018-10-20
ER

PT S
AU Liu, WW
   Chen, S
   Zhang, ZT
   Webster, TJ
AF Liu, Wenwen
   Chen, Su
   Zhang, Zhenting
   Webster, Thomas J.
GP IEEE
TI Antibacterial Properties of TiO2 nanotubes incorporated with ZnO
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE antibacterial properties; titanium; biomaterial; nano zinc oxide
ID TITANIUM SURFACES; ADHESION
AB To obtain desirable Titanium (Ti) implant materials with antibacterial properties, different concentrations of zinc oxide (ZnO) were incorporated into TiO2 nanotubes by a simple hydrothermal treatment. In vitro experiments showed that Streptococcus mutans and Porphyromonas gingivalis were inhibited on ZnO incorporated samples. S. mutants and P. gingivalis densities were reduced on ZnO incorporated nanotube samples compared to controls after 7 days. In summary, results of this study showed that compared to plain TiO2 nanotubes, the incorporated Ti with ZnO in Ti nanotubes provided great antibacterial ability and this should be further studied.
C1 [Liu, Wenwen; Chen, Su; Zhang, Zhenting] Capital Med Univ, Dept Prosthodont, Sch Stomatol, Beijing 100050, Peoples R China.
   [Liu, Wenwen; Webster, Thomas J.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.
RP Liu, WW (reprint author), Capital Med Univ, Dept Prosthodont, Sch Stomatol, Tian Tan Xi Li 4, Beijing 100050, Peoples R China.
CR Eaninwene C, 2008, INT J NANOMEDICINE, V3, P257
   Huo KF, 2013, BIOMATERIALS, V34, P3467, DOI 10.1016/j.biomaterials.2013.01.071
   Karla SB, TIO2 NANOTUBES BONE
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 8
TC 0
Z9 0
U1 1
U2 5
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600158
DA 2018-10-20
ER

PT S
AU Rinaldi, AM
   Black, LD
AF Rinaldi, Anthony M.
   Black, Lauren D., III
GP IEEE
TI Evaluation of Anisotropic Silk Sponges Containing Cardiac ECM for
   Cardiac Tissue Engineering
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE Cardiac Tissue Engineering; Anisotropy; Cell Adhesion
AB Current biomaterials used in cardiac tissue engineering are insufficient due to the lack of pertinent myocardium characteristics like anisotropy and necessary cardiac extracellular matrix (ECM) proteins. In this study, we take advantage silk, a biomaterial, to analyze effects of 0.2 mg/mL, 0.4 mg/mL or 0.6 mg/mL addition of cardiac ECM to 3% wt/v silk solution prior to scaffold formation. We created 200 mu m thick anisotropic and isotropic silk sponges coated with 100 mu g/mL collagen I solution and seeded them with cardiac fibroblasts. The anisotropic scaffolds exhibited an increase in cell spreading, adhesion and cell count as opposed to the isotropic scaffolds. Also, 0.6 mg/mL cardiac ECM incorporation shows increased cell number and spreading compared to the 0.2 mg/mL and 0.4 mg/mL cardiac ECM/silk composite scaffolds. Thus, pore architecture and ECM concentration play significant roles in the creation of optimized silk constructs for cardiac tissue engineering.
C1 [Rinaldi, Anthony M.; Black, Lauren D., III] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Black, Lauren D., III] Tufts Univ, Sch Med, CMDB Program, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA.
RP Rinaldi, AM (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
CR [Anonymous], 2005, SMALL
   Franck D., 2013, PLOS ONE, V8
   Oliveira AL, 2012, ACTA BIOMATER, V8, P1530, DOI 10.1016/j.actbio.2011.12.015
   Omenetto FG, 2010, SCIENCE
   Omenetto FG, 2010, BIOMATERIALS, V31
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Park H, 2011, BIOMATERIALS, V32, P1856, DOI 10.1016/j.biomaterials.2010.11.032
   Rasband WS, 1997, IMAGEJ
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Talukdar S, 2011, BIOMATERIALS, V32
   Talukdar S, 2011, BIOMATERIALS, V32
NR 11
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600218
DA 2018-10-20
ER

PT S
AU Nocera, AD
   Salvatierra, NA
   Cid, MP
AF Diaz Nocera, A.
   Salvatierra, N. A.
   Cid, M. P.
BE Braidot, A
   Hadad, A
TI Printing Collagen 3D Structures
SO VI LATIN AMERICAN CONGRESS ON BIOMEDICAL ENGINEERING (CLAIB 2014)
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 6th Latin American Biomedical Engineering Conference (CLAIB)
CY OCT 29-31, 2014
CL Parana, ARGENTINA
SP Reg Council Biomed Engn Latin America, Argentine Soc Bioengineering, Nacl Univ Entre Rios, Engn Sch, Int Federat Med & Biol Engn, IEEE Engn Med & Biol Soc
DE Biomaterial; Bioprinting; Collagen; Tissue Engineering
ID TISSUE ENGINEERING APPLICATIONS
AB Collagen is a biomaterial with an excellent biocompatibility due to its biodegradability and weak antigenicity. Its main applications in tissue engineering field are in burns -to accelerate wound healing-and drug delivery. Collagen gels and solutions are widely used for building scaffolds or three-dimensional cultures, some of them constructed by three-dimensional bioprinting. This work presents an adaptation of a protocol in order to isolate collagen from bovine tendon and also the development of a three-dimensional bioprinter. The preliminary results we preset are 3D structures constructed by the developed bioprinter, using the collagen obtained from bovine tendon, after application of the proposed protocol. These results are promising as they show the capability of the presented protocol to obtain collagen from bovine tendon and the potential of the bioprinting technique for building biocompatible three-dimensional structures designed by Computer Aided Design (CAD) or replicating anatomical structures from standard medical imagining studies. Further studies are needed in order to assess the mechanical and biochemical properties of the printed structures.
C1 [Diaz Nocera, A.; Salvatierra, N. A.; Cid, M. P.] UNC, FCEFyN, Dept Quim, IIBYT,CONICET, Cordoba, Argentina.
RP Nocera, AD (reprint author), UNC, FCEFyN, Dept Quim, IIBYT,CONICET, Cordoba, Argentina.
EM amdiaz@efn.uncor.edu; nsalvatierra@efn.uncor.edu; manacid@hotmail.com
CR Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9
   Lee V, 2014, TISSUE ENG, V21
   LODISH HB, 2000, MOL CELL BIOL
   Mironov V., 2003, TRENDS BIOTECHNOLOGY, V21
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Ricard-Blum S, 2011, COLLAGEN FAMILY
   Simoes GS, 2014, MEAT SCI, V96, P1460, DOI 10.1016/j.meatsci.2013.10.038
NR 8
TC 1
Z9 1
U1 1
U2 18
PU SPRINGER INT PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 1680-0737
BN 978-3-319-13116-0; 978-3-319-13117-7
J9 IFMBE PROC
PY 2014
VL 49
BP 136
EP 139
DI 10.1007/978-3-319-13117-7_36
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BD8BN
UT WOS:000363767200035
DA 2018-10-20
ER

PT S
AU Guha, S
   Jamal, FI
   Schmalz, K
   Wenger, C
   Meliani, E
AF Guha, S.
   Jamal, F. I.
   Schmalz, K.
   Wenger, Ch.
   Meliani, E.
GP IEEE
TI An 8 GHz CMOS Near Field Bio-sensor Array for Imaging Spatial
   Permittivity Distribution of Biomaterials
SO 2014 IEEE MTT-S INTERNATIONAL MICROWAVE SYMPOSIUM (IMS)
SE IEEE MTT-S International Microwave Symposium
LA English
DT Proceedings Paper
CT IEEE MTT-S International Microwave Symposium (IMS)
CY JUN 01-06, 2014
CL Tampa, FL
SP IEEE MTT S
DE Dielectric permittivity; sensor array; imaging; biosensor; biomaterial
AB In this paper a CMOS biosensor array operating around 8 GHz is presented, for characterizing biomaterials by imaging the spatial distribution of permittivity. The sensor is fabricated in standard 250 nm SiGe BiCMOS process. The sensor operation is based on the frequency shift of cross-coupled oscillator circuit due to capacitance change of the core LC tank. Non-uniform four finger interdigitated capacitor is used as the sensor unit. A four element sensor array system is used in this work for the proof of concept of spatial dielectric imaging. Measured sensitivity is observed to be 22 MHz per unit permittivity change. After first sensitivity tests, the spatial discrimination capability of the array is shown by further testing the array with biomaterials of different permittivity on different sensor units, showing unique frequency shift for individual sensors.
C1 [Guha, S.; Jamal, F. I.; Schmalz, K.; Wenger, Ch.; Meliani, E.] IHP, D-15236 Frankfurt, Oder, Germany.
RP Guha, S (reprint author), IHP, Technol Pk 25, D-15236 Frankfurt, Oder, Germany.
EM guha@ihp-microelectronics.com
CR Asami K, 2002, J NON-CRYST SOLIDS, V305, P268, DOI 10.1016/S0022-3093(02)01110-9
   Chen JZ, 2004, LAB CHIP, V4, P473, DOI 10.1039/b315815b
   Chretiennot T, 2013, IEEE T MICROW THEORY, V61, P972, DOI 10.1109/TMTT.2012.2231877
   Goh S., 2010, P 14 INT C MIN SYST, P1556
   Guha S, 2013, EUR MICROW CONF, P471
   Harris C., 1983, BIOELECTROCHEMISTRY, V11, P14
   Krommenhoek EE, 2006, SENSOR ACTUAT B-CHEM, V115, P384, DOI 10.1016/j.snb.2005.09.028
   PETHIG R, 1987, PHYS MED BIOL, V32, P933, DOI 10.1088/0031-9155/32/8/001
   Tibayrenc P., 2010, PROCESS BIOCHEM, V46, P193
NR 9
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0149-645X
BN 978-1-4799-3869-8
J9 IEEE MTT S INT MICR
PY 2014
PG 4
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA BD7MH
UT WOS:000363283700219
DA 2018-10-20
ER

PT B
AU Biscaia, SI
   Viana, TF
   Almeida, HA
   Bartolo, P
AF Biscaia, S. I.
   Viana, T. F.
   Almeida, H. A.
   Bartolo, P.
BE Jorge, RMN
   Campos, JCR
   Vaz, MAP
   Santos, SM
   Tavares, JMRS
TI Reinforced PCL scaffolds with Eggshell powder
SO BIODENTAL ENGINEERING III
LA English
DT Proceedings Paper
CT 3rd International Conference on Biodental Engineering (BIODENTAL)
CY JUN 22-23, 2014
CL Porto, PORTUGAL
ID COMPOSITES; DEGRADATION; CARBONATE; DEFECTS
AB Hen eggshells (ES), a natural biomaterial from bone-like minerals, has been considered a promising bone substitute to be totally resorbable and biocompatible with good osteoconductivity. The ES represents 11% of the total weight of the egg and it is mainly composed of calcium carbonate (94%), magnesium carbonate (1%), tricalcium phosphate (1%), and organic matter (4%).
   The purpose of this study was to investigate the addition of ES powder on poly(epsilon-caprolactone) (PCL) scaffolds. Morphological and physical analyses were performed to investigate the influence of the ES powder on the properties of the PCL scaffolds.
C1 [Biscaia, S. I.; Viana, T. F.; Almeida, H. A.; Bartolo, P.] Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Leiria, Portugal.
   [Bartolo, P.] Univ Manchester, Sch Mech Civil & Aerosp Engn, Manchester M13 9PL, Lancs, England.
RP Biscaia, SI (reprint author), Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Leiria, Portugal.
RI Almeida, Henrique/D-6275-2012
OI Almeida, Henrique/0000-0002-1367-2290
CR Abdal-hay A, 2013, SOLID STATE SCI, V18, P131, DOI 10.1016/j.solidstatesciences.2012.11.017
   Asghar W, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/47/475601
   Balaz P, 2013, MATER MANUF PROCESS, V28, P343, DOI 10.1080/10426914.2012.709294
   Chen EC, 2007, POLYM DEGRAD STABIL, V92, P1009, DOI 10.1016/j.polymdegradstab.2007.02.019
   Chouzouri G, 2007, ACTA BIOMATER, V3, P745, DOI 10.1016/j.actbio.2007.01.005
   Chuenjitkuntaworn B., 2010, J BIOMEDICAL MAT R A, P242
   Domingos M, 2011, VIRTUAL PHYS PROTOTY, V6, P157, DOI 10.1080/17452759.2011.605839
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   Esfahani S., 2010, BIOMATERIALS, V31, P5498
   Gao Y, 2012, CATAL TODAY, V190, P107, DOI 10.1016/j.cattod.2011.12.004
   Ho WF, 2013, CERAM INT, V39, P6467, DOI 10.1016/j.ceramint.2013.01.076
   Kang J, 2012, J APPL POLYM SCI, V124, pE83, DOI 10.1002/app.35538
   Kim BS, 2014, J BIOMED MATER RES B, V102, P943, DOI 10.1002/jbm.b.33075
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Liu JY, 2011, EXPRESS POLYM LETT, V5, P742, DOI 10.3144/expresspolymlett.2011.72
   Martinez-Abad A, 2013, FOOD CONTROL, V34, P214, DOI 10.1016/j.foodcont.2013.04.025
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Monteiro MSSB, 2013, POLYM TEST, V32, P553, DOI 10.1016/j.polymertesting.2013.01.016
   Mota C, 2015, J TISSUE ENG REGEN M, V9, P174, DOI 10.1002/term.1635
   Ni P, 2014, BIOMATERIALS, V35, P236, DOI 10.1016/j.biomaterials.2013.10.016
   Park JW, 2008, J BIOMED MATER RES A, V87A, P203, DOI 10.1002/jbm.a.31768
   Santos RC, 2014, HIGH VALUE MANUFACTURING: ADVANCED RESEARCH IN VIRTUAL AND RAPID PROTOTYPING, P127
   Sariibrahimoglu K, 2012, J BIOMED MATER RES A, V100A, P712, DOI 10.1002/jbm.a.34009
   Sousa I, 2013, PROCEDIA ENGINEER, V59, P279, DOI 10.1016/j.proeng.2013.05.122
   Wu SC, 2013, CERAM INT, V39, P8183, DOI 10.1016/j.ceramint.2013.03.094
NR 25
TC 1
Z9 1
U1 1
U2 1
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-315-75178-8; 978-1-138-02671-1
PY 2014
BP 151
EP 154
PG 4
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA BD5UK
UT WOS:000361826500027
DA 2018-10-20
ER

PT B
AU Viana, T
   Biscaia, S
   Almeida, HA
   Bartolo, PJ
AF Viana, Tania
   Biscaia, Sara
   Almeida, Henrique A.
   Bartolo, Paulo J.
GP ASME
TI PCL/EGGSHELL SCAFFOLDS FOR BONE REGENERATION
SO PROCEEDINGS OF THE ASME 12TH BIENNIAL CONFERENCE ON ENGINEERING SYSTEMS
   DESIGN AND ANALYSIS - 2014, VOL 1
LA English
DT Proceedings Paper
CT 12th ASME Biennial Conference on Engineering Systems Design and Analysis
   (ESDA2014)
CY JUN 25-27, 2014
CL Copenhagen, DENMARK
SP ASME
ID TISSUE ENGINEERING SCAFFOLDS; CALCIUM-PHOSPHATE CEMENTS; EGGSHELL
   MEMBRANE; CRANIAL DEFECTS; WASTE EGGSHELL; COMPOSITE; CARBONATE;
   CATALYST; BEHAVIOR; POWDER
AB Eggshell (ES) is one of the most common biomaterials in nature. For instance, the ES represents 11% of the total weight of a hen's egg and it is composed of calcium carbonate, magnesium carbonate, tricalcium phosphate and organic matter. Hen ES are also a major waste product of the food industry worldwide. Recently, ES have been used for many applications such as coating pigments for inkjet printing paper, catalyst for biodiesel synthesis, bio-fillers for polymer composites and matrix lipase immobilization. It is also considered a natural biomaterial with high potential for the synthesis of calcium enriched implants that may be applied in tissue engineering applications, such as bone regeneration. The aim of this research regards the production of poly(epsilon-caprolactone) (PCL) scaffolds enriched with hen ES powder for bone regeneration applications, using an extrusion-based process called Dual-Bioextruder. The main objective is to investigate the influence of the addition of ES powder on the PCL matrix. For this purpose the structures were characterised regarding morphological and chemical properties. Morphological images of the PCL scaffolds enriched with hen ES, demonstrated the interconnectivity of the pores within the scaffold and revealed that the addition of the ES powder combined with the screw rotation velocity has a large influence on the resulting filament diameter and consequently on the porosity of the scaffolds.
C1 [Viana, Tania; Biscaia, Sara; Almeida, Henrique A.] Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Marinha Grande, Portugal.
   [Bartolo, Paulo J.] Polytech Inst Leiria, Marinha Grande, Portugal.
   [Bartolo, Paulo J.] Univ Manchester, Manchester M13 9PL, Lancs, England.
RP Viana, T (reprint author), Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Marinha Grande, Portugal.
RI Almeida, Henrique/D-6275-2012
OI Almeida, Henrique/0000-0002-1367-2290
CR Abdal-hay A, 2013, SOLID STATE SCI, V18, P131, DOI 10.1016/j.solidstatesciences.2012.11.017
   Annabi N, 2011, J SUPERCRIT FLUID, V59, P157, DOI 10.1016/j.supflu.2011.06.010
   Arifin A, 2014, MATER DESIGN, V55, P165, DOI 10.1016/j.matdes.2013.09.045
   Arvidson K, 2011, J CELL MOL MED, V15, P718, DOI 10.1111/j.1582-4934.2010.01224.x
   Asghar W., 2012, NANOTECHNOLOGY, V23, P475
   Balaz P, 2013, MATER MANUF PROCESS, V28, P343, DOI 10.1080/10426914.2012.709294
   Bartolo PJ, 2009, VIRTUAL PHYS PROTOTY, V4, P203, DOI 10.1080/17452750903476288
   Bartolo P, 2012, CIRP ANN-MANUF TECHN, V61, P635, DOI 10.1016/j.cirp.2012.05.005
   Bootklad M, 2013, CARBOHYD POLYM, V97, P315, DOI 10.1016/j.carbpol.2013.05.030
   Boschett F, 2008, INT J ARTIF ORGANS, V31, P697
   Cai X, 2013, MATER TODAY, V16, P67, DOI 10.1016/j.mattod.2013.03.007
   Chattopadhyay S, 2012, PROCESS BIOCHEM, V47, P749, DOI 10.1016/j.procbio.2012.02.003
   Chen WC, 2013, BIOMATERIALS, V34, P9917, DOI 10.1016/j.biomaterials.2013.09.002
   Chouzouri G, 2007, ACTA BIOMATER, V3, P745, DOI 10.1016/j.actbio.2007.01.005
   Chuenjitkuntaworn B., 2010, J BIOMEDICAL MAT R A, P242
   Ding CM, 2013, BIOMATERIALS, V34, P6706, DOI 10.1016/j.biomaterials.2013.05.038
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   Elzubair A, 2006, J DENT, V34, P784, DOI 10.1016/j.jdent.2006.03.002
   Engel Y, 2012, MATER TODAY, V15, P478, DOI 10.1016/S1369-7021(12)70217-1
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Gao Y, 2012, CATAL TODAY, V190, P107, DOI 10.1016/j.cattod.2011.12.004
   Ghasemi-Mobarakeh L, 2010, MAT SCI ENG C-MATER, V30, P1129, DOI 10.1016/j.msec.2010.06.004
   Han LH, 2013, BIOMATERIALS, V34, P4251, DOI 10.1016/j.biomaterials.2013.02.051
   Hassan S.B., 2013, J KING SAUD U ENG SC
   Ho WF, 2013, CERAM INT, V39, P6467, DOI 10.1016/j.ceramint.2013.01.076
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Holzwarth JM, 2011, J MATER CHEM, V21, P10243, DOI 10.1039/c1jm10522a
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Jancar J., 1999, ADV POLYM SCI
   Kang J, 2012, J APPL POLYM SCI, V124, pE83, DOI 10.1002/app.35538
   Khan AF, 2014, MAT SCI ENG C-MATER, V35, P245, DOI 10.1016/j.msec.2013.11.013
   Kim BS, 2014, J BIOMED MATER RES B, V102, P943, DOI 10.1002/jbm.b.33075
   Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Liang JZ, 2012, POLYM TEST, V31, P149, DOI 10.1016/j.polymertesting.2011.10.006
   Lu HX, 2011, BIOMATERIALS, V32, P2489, DOI 10.1016/j.biomaterials.2010.12.016
   Martinez-Abad A, 2013, FOOD CONTROL, V34, P214, DOI 10.1016/j.foodcont.2013.04.025
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Mosaddegh E, 2013, ULTRASON SONOCHEM, V20, P1436, DOI 10.1016/j.ultsonch.2013.04.008
   Moura C.S., 2013, HIGH VALUE MANUFACTU, P195
   Ni P, 2014, BIOMATERIALS, V35, P236, DOI 10.1016/j.biomaterials.2013.10.016
   Novitskaya E, 2011, ACTA BIOMATER, V7, P3170, DOI 10.1016/j.actbio.2011.04.025
   Okamoto M, 2013, PROG POLYM SCI, V38, P1487, DOI 10.1016/j.progpolymsci.2013.06.001
   Pascu EI, 2013, MAT SCI ENG C-MATER, V33, P4905, DOI 10.1016/j.msec.2013.08.012
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Santos ARC, 2013, VIRTUAL PHYS PROTOTY, V8, P175, DOI 10.1080/17452759.2013.838825
   Sanzana ES, 2008, ACTA BIOMATER, V4, P1924, DOI 10.1016/j.actbio.2008.04.023
   Sariibrahimoglu K, 2012, J BIOMED MATER RES A, V100A, P712, DOI 10.1002/jbm.a.34009
   Soares MAR, 2013, BIORESOURCE TECHNOL, V148, P293, DOI 10.1016/j.biortech.2013.08.151
   Song MJ, 2013, BIOMATERIALS, V34, P5766, DOI 10.1016/j.biomaterials.2013.04.023
   Tojeira A., 2013, HIGH VALUE MANUFACTU, P221
   Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050
   Wang XF, 2013, MATER TODAY, V16, P229, DOI 10.1016/j.mattod.2013.06.005
   Wei ZK, 2009, BIORESOURCE TECHNOL, V100, P2883, DOI 10.1016/j.biortech.2008.12.039
   Wu SC, 2013, CERAM INT, V39, P8183, DOI 10.1016/j.ceramint.2013.03.094
   Yew MC, 2013, PROG ORG COAT, V76, P1549, DOI 10.1016/j.porgcoat.2013.06.011
   Yoo S, 2009, BIORESOURCE TECHNOL, V100, P6416, DOI 10.1016/j.biortech.2009.06.112
NR 57
TC 0
Z9 0
U1 1
U2 6
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4583-7
PY 2014
AR V001T03A003
PG 6
WC Engineering, Mechanical
SC Engineering
GA BD5GK
UT WOS:000361402800037
DA 2018-10-20
ER

PT B
AU Brooks, VS
   Guo, YB
AF Brooks, V. S.
   Guo, Y. B.
GP ASME
TI MICROSTRUCTURAL AND DYNAMIC MECHANICAL CHARACTERIZATION OF BIODEGRADABLE
   MAGNESIUM-CALCIUM ALLOY FOR ORTHOPEDIC IMPLANTS
SO PROCEEDINGS OF THE ASME 9TH INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE, 2014, VOL 2
LA English
DT Proceedings Paper
CT 9th ASME International Manufacturing Science and Engineering Conference
   (MSEC2014)
CY JUN 09-13, 2014
CL Univ Michigan, Detroit, MI
SP ASME, Mfg Engn Div
HO Univ Michigan
DE Mechanical behavior; Biomaterial; Magnesium-calcium alloy; Biodegradable
   implant
AB Magnesium-Calcium (Mg-Ca) alloy is an emerging metallic biomaterial for manufacturing biodegradable orthopedic implants. However, very few studies have been conducted on mechanical properties of the bi-phase Mg-Ca alloy, especially at the high strain rates often encountered in manufacturing processes. The mechanical properties are critical to design and manufacturing of Mg-Ca implants. The objective of this study is to study the microstructural and mechanical properties of Mg-Ca0.8 (wt %) alloy. Both elastic and plastic behaviors of the Mg-Ca0.8 alloy were characterized at different strains and strain rates in quasi-static tension and compression testing as well as dynamic split-Hopkinson pressure bar (SHPB) testing. It has been shown that Young's modulus of Mg-Ca0.8 alloy in quasi-static compression is much higher than those at high strain rates. Yield strength and ultimate strength of the material are very sensitive to strain rates and increase with strain rate in compression. Strain softening also occurs at large strains in dynamic compression. Furthermore, quasi-static mechanical behavior of the material in tension is very different from that in compression. The stress-strain data was repeatable with reasonable accuracy in both deformation modes. In addition, a set of material constants for the internal state variable plasticity model has been obtained to model the dynamical mechanical behavior of the novel metallic biomaterial.
C1 [Brooks, V. S.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR Aksakal B, 2008, J MATER SCI-MATER M, V19, P2097, DOI 10.1007/s10856-007-3304-2
   Avedesian M. M., 1999, MAGNESIUM MAGNESIUM
   Bammann DJ, 1996, J THEOR APPL MECH, V19, P359
   Cao GP, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2823086
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Denkena B, 2005, P 5 EUSP INT C MONTP
   eFunda Inc, 2008, PROP TYP MAGN ALL
   El-Magd E., 2000, MAGNESIUM ALLOYS THE, P324
   Emley E. F., 1966, PRINCIPLES MAGNESIUM
   Gama B, 2004, APPL MECH REV, V57, P223, DOI DOI 10.1115/1.1704626
   GRIMM MJ, 2009, BIOMEDICAL ENG DESIG, P421
   Guden M, 2005, MATER CHARACT, V54, P399, DOI 10.1016/j.matchar.2005.01.006
   Guo Y.B., 2010, ANN CIRP, V59, P151
   Guo YB, 2005, INT J MECH SCI, V47, P1423, DOI 10.1016/j.ijmecsci.2005.04.015
   Guo YB, 2003, J MATER PROCESS TECH, V142, P72, DOI 10.1016/S0924-0136(03)00462-X
   Hassel T, 2007, P 7 INT C MG ALL THE, P789
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Wessen M., 2004, P 6 INT C MG ALL THE, P501
   Wuth M., 2000, MG ALLOYS THEIR APP, P296
NR 20
TC 0
Z9 0
U1 1
U2 4
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4581-3
PY 2014
AR V002T02A029
PG 7
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA BD5AD
UT WOS:000361249800029
DA 2018-10-20
ER

PT B
AU Smetana, M
   Capova, K
   Strapacova, T
AF Smetana, Milan
   Capova, Klara
   Strapacova, Tatiana
BE Brida, P
   Dubovan, J
   Markovic, M
TI Evaluation of Biomaterial Stress-Corrosion Cracks by Magnetic Sensors
SO 2014 ELEKTRO
LA English
DT Proceedings Paper
CT ELEKTRO 10th International Conference
CY MAY 19-20, 2014
CL Rajecke Teplice, SLOVAKIA
SP Univ Zilina, Fac Elect Engn, AZD Praha s r o Praha CZ, LiV EPI s r o Bratislava SK, SOITRON s r o Bratislava SK, Freescale Polovodice Ceska Republika s r o Roznov Radhostem CZ, Eltodo a s Praha CZ, Scheidt & Bachmann Slovensko s r o Zilina SK, ELMAX ZILINA a s Zilina SK, Panason Ind Devices Slovakia s r o Trstena SK, HUMUSOFT s r o Praha CZ, JONSON CONTROLS Lucenec s r o Odstepny Zavod Namestovo SK, IEEE, Czechoslovakia Sect, Univ Zilina, Communicat Sci Letters, Adv Elect & Elect Engn
DE non-destructive evaluation; inductance sensor; flluxgate magnetometer;
   giant-magneto-resistive sensor; biomaterial cracks
AB The paper deals with identification of real biomaterial's cracks using electromagnetic non-destructive sensing. Advanced types of the magnetic sensors are used for this purpose. New modular eddy current probe is used for the evaluation. Harmonic excitation is used for the eddy currents induction. The real biomaterial stress corrosion cracks are inspected. Gained results are discussed and presented in the paper. The main aim of the article is to compare the sensitivity of the various magnetic sensors at the same conditions.
C1 [Smetana, Milan; Capova, Klara; Strapacova, Tatiana] Univ Zilina, Fac Elect Engn, Dept Electromagnet & Biomed Engn, Zilina 01026, Slovakia.
RP Smetana, M (reprint author), Univ Zilina, Fac Elect Engn, Dept Electromagnet & Biomed Engn, Zilina 01026, Slovakia.
EM milan.smetana@fel.uniza.sk; klara.capova@fel.uniza.sk;
   tatiana.strapacova@fel.uniza.sk
CR Betta G, 2012, IEEE T INSTRUM MEAS, V61, P505, DOI 10.1109/TIM.2011.2161923
   Janousek Ladislav, 2013, Przeglad Elektrotechniczny, V89, P256
   Janousek L., 2012, 2012 Proceedings of the 9th Conference of ELEKTRO (ELEKTRO 2012), P419, DOI 10.1109/ELEKTRO.2012.6225656
   Pernisova V., INT WORKSH EL NOND E
   Reig C., MAGNETIC FIELD SENSO, p7920 
   Ripka P, 2003, SENSOR ACTUAT A-PHYS, V106, P8, DOI 10.1016/S0924-4247(03)00094-3
NR 6
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-3721-9
PY 2014
BP 621
EP 624
PG 4
WC Computer Science, Interdisciplinary Applications; Engineering,
   Electrical & Electronic
SC Computer Science; Engineering
GA BD4RM
UT WOS:000361020800124
DA 2018-10-20
ER

PT S
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
BE Axinte, D
   Clare, A
   Kinnell, P
TI Biodegradation control of magnesium-calcium biomaterial via adjusting
   surface integrity by synergistic cutting-burnishing
SO 2ND CIRP CONFERENCE ON SURFACE INTEGRITY (CSI)
SE Procedia CIRP
LA English
DT Proceedings Paper
CT 2nd CIRP Conference on Surface Integrity (CSI)
CY MAY 28-30, 2014
CL Nottingham, ENGLAND
SP CIRP
DE Magnesium; surface integrity; corrosion; implants
ID MECHANICAL-PROPERTIES; RABBIT MODEL; DEGRADATION; ALLOYS; IMPLANTS;
   MGCA0.8
AB Magnesium-calcium (MgCa) alloys are very promising orthopedic biomaterials with biodegradability and suitable biomechanical properties. However, the high corrosion rate of Mg-based alloys in human body environment remains as a big challenge for their successful development as biomaterials. In this study, synergistic cutting-burnishing was developed to control the degradation rate of the novel MgCa0.8 (wt. %) biomaterial by adjusting surface integrity. In-vitro immersion tests were performed in simulated body fluid to measure degradation kinetics of the processed samples. Morphology and elemental composition of the corroded surface layers were also studied. The synergistic process was successful to control biodegradation rate. This enabling process may manufacture biodegradable MgCa0.8 implants with tailored degradation rate to fit various orthopedic applications. (C) 2014 The Authors. Published by Elsevier B.V.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Drynda A, 2010, J BIOMED MATER RES A, V93A, P763, DOI 10.1002/jbm.a.32582
   Guo YB, 2010, CIRP ANN-MANUF TECHN, V59, P151, DOI 10.1016/j.cirp.2010.03.051
   Guo YB, 2012, CIRP ANN-MANUF TECHN, V61, P583, DOI 10.1016/j.cirp.2012.03.125
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kirkland N.T., 2010, J BIOMEDICAL MAT R B, V95, P9
   Krause A, 2010, J MATER SCI, V45, P624, DOI 10.1007/s10853-009-3936-3
   Thomann M, 2009, MATERIALWISS WERKST, V40, P82, DOI 10.1002/mawe.200800412
   Thomann M, 2010, J BIOMED MATER RES A, V93A, P1609, DOI 10.1002/jbm.a.32639
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
NR 11
TC 10
Z9 10
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2212-8271
J9 PROC CIRP
PY 2014
VL 13
BP 143
EP 149
DI 10.1016/j.procir.2014.04.025
PG 7
WC Engineering, Industrial; Engineering, Manufacturing
SC Engineering
GA BD4GS
UT WOS:000360720300025
OA Other Gold
DA 2018-10-20
ER

PT B
AU Munro, T
   Xing, CH
   Ban, H
   Copeland, C
   Lewis, R
AF Munro, Troy
   Xing, Changhu
   Ban, Heng
   Copeland, Cameron
   Lewis, Randolph
GP ASME
TI PROBING THE MYSTERIES OF SPIDER SILK'S UNCHARACTERISTICALLY HIGH THERMAL
   DIFFUSIVITY
SO PROCEEDINGS OF THE ASME SUMMER HEAT TRANSFER CONFERENCE - 2013, VOL 1
LA English
DT Proceedings Paper
CT ASME Summer Heat Transfer Conference (SHTC)
CY JUL 14-19, 2013
CL Univ Minnesota, Minneapolis, MN
SP ASME, Heat Transfer Div
HO Univ Minnesota
AB Spider silks exhibit excellent strength, stiffness, and toughness simultaneously, a feat unachievable in most synthetic, structural materials. It has recently been reported that the thermal conductivity of dragline silk is comparable to copper, which is uncharacteristically high for a biomaterial. In order to develop a fundamental understanding of the high thermal properties of spider silk, further research must be made to explore how the structure and organization of spider silk proteins affects heat transfer characteristics. Synthetically produced silks created from spider silk proteins obtained from transgenic sources can be used to determine these protein structure effects by varying protein content and process treatments. This initial study determined the thermal properties of synthetic spider silk created from transgenic goat's milk proteins using the transient electrothermal method (TET). Results show that the thermal properties of the synthetic silk are lower than the natural spider silk but vary based on the process treatment, and that the annealing of the gold film coated on the fiber has no effect on the measured thermal properties. These results provide a framework for further research on the protein content effect and its role in thermal properties.
C1 [Munro, Troy; Xing, Changhu; Ban, Heng] Utah State Univ, Mech & Aerosp Engn, Logan, UT 84322 USA.
   [Copeland, Cameron; Lewis, Randolph] Utah State Univ, Biol Engn, Biol, Logan, UT 84322 USA.
RP Munro, T (reprint author), Utah State Univ, Mech & Aerosp Engn, Logan, UT 84322 USA.
CR CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Feng B, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3153464
   Feng X, 2011, ACTA MATER, V59, P1934, DOI 10.1016/j.actamat.2010.11.059
   Feng X., 2012, REV SCI INSTRUM, V83
   Guo J., 2007, J APPL PHYS, V101
   Guo JQ, 2007, APPL PHYS A-MATER, V89, P153, DOI 10.1007/s00339-007-4201-8
   Guo L., 2009, J APPL PHYS, V106
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Huang WW, 2012, J THERM ANAL CALORIM, V109, P1193, DOI 10.1007/s10973-012-2283-9
   Huang XP, 2012, ADV MATER, V24, P1482, DOI 10.1002/adma.201104668
   Kinahan ME, 2011, BIOMACROMOLECULES, V12, P1504, DOI 10.1021/bm1014624
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rengasamy RS, 2005, AUTEX RES J, V5, P30
   Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j
   Wissmann P., 2007, ELECT RESISTIVITY TH, P36
NR 15
TC 0
Z9 0
U1 1
U2 4
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5547-8
PY 2014
AR V001T02A005
PG 6
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA BD4AR
UT WOS:000360414400052
DA 2018-10-20
ER

PT S
AU Winnett, J
   Mallick, KK
AF Winnett, James
   Mallick, Kajal K.
BE Bose, S
   Bandyopadhyay, A
   Narayan, R
TI COMPARATIVE ANALYSIS OF HYDROXYAPATITE AND TITANIUM-BASED BIOSCAFFOLDS
   FABRICATED VIA ADAPTIVE FOAM RETICULATION
SO BIOMATERIALS SCIENCE: PROCESSING, PROPERTIES AND APPLICATIONS IV
SE Ceramic Transactions
LA English
DT Proceedings Paper
CT Materials Science and Technology Conference and Exhibition (MS&T)
CY OCT 27-31, 2013
CL Montreal, CANADA
ID BONE TISSUE REGENERATION; MECHANICAL-PROPERTIES; MEDICAL APPLICATIONS;
   SCAFFOLDS; CERAMICS; MICROSTRUCTURE; BIOMATERIALS; CHEMISTRY; POROSITY
AB Hydroxyapatite, titanium (CP-Ti) and its alloys, in particular titanium-vanadium-aluminium (Ti-6Al-4V), are used as biomaterials due to their structural similarities to native bone, good biocompatibility and inertness in-vivo. It is important to generate porous structures to match the mechanical properties of scaffolds to host tissue and enhance biological activity. Adaptive Foam Reticulation (AFR) has been used to generate such bioscaffolds with enhanced cell behaviour due the generation of macroporous structures with microporous struts that provide routes for cell infiltration as well as attachment sites. For all biomaterials, polyurethane templates of 2 pore sizes (45 and 90 ppi) were coated in water-based biomaterial-slurries containing varying amounts of camphene as a porogen. The resultant macropore sizes related well to the initial template pore size, whilst the camphene produced micropores ranging from 1-10 mu m.
C1 [Winnett, James; Mallick, Kajal K.] Univ Warwick, WMG, Coventry CV4 7AL, W Midlands, England.
RP Winnett, J (reprint author), Univ Warwick, WMG, Coventry CV4 7AL, W Midlands, England.
CR Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cachinho SCP, 2008, J MATER SCI-MATER M, V19, P451, DOI 10.1007/s10856-006-0052-7
   Chen B, 2008, CERAM INT, V34, P359, DOI 10.1016/j.ceramint.2006.10.021
   Chu P. K., 2008, BIOMATERIALS FABRICA
   Cunningham E., 2011, J TISSUE SCI ENG, VS1, P1, DOI DOI 10.4172/2157-7552.S1-001.
   Dabrowski B, 2010, J BIOMED MATER RES B, V95B, P53, DOI 10.1002/jbm.b.31682
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   Fu Q, 2008, J BIOMED MATER RES B, V86B, P125, DOI 10.1002/jbm.b.30997
   Gupta R, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034005
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Jo IH, 2009, MATER LETT, V63, P1702, DOI 10.1016/j.matlet.2009.05.017
   Jones JR, 2009, J MATER SCI-MATER M, V20, P463, DOI 10.1007/s10856-008-3597-9
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Lewis JA, 2006, ADV FUNCT MATER, V16, P2193, DOI 10.1002/adfm.200600434
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Ma P.X., 2005, SCAFFOLDING TISSUE E
   Mahendra A, 2007, INJURY, V38, pS7, DOI 10.1016/S0020-1383(08)70004-4
   Mallick KK, 2012, J BIOMED MATER RES A, V100A, P2948, DOI 10.1002/jbm.a.34238
   Mallick KK, 2009, J AM CERAM SOC, V92, pS85, DOI 10.1111/j.1551-2916.2008.02784.x
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Mikos AG, 2000, ELECTRON J BIOTECHN, V3, P1995
   Miranda P, 2008, J BIOMED MATER RES A, V85A, P218, DOI 10.1002/jbm.a.31587
   Nan BY, 2011, J AM CERAM SOC, V94, P969, DOI 10.1111/j.1551-2916.2010.04257.x
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   SACHS E, 1992, J ENG IND-T ASME, V114, P481
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Salinas AJ, 2007, Z ANORG ALLG CHEM, V633, P1762, DOI 10.1002/zaac.200700278
   Soon YM, 2011, J EUR CERAM SOC, V31, P415, DOI 10.1016/j.jeurceramsoc.2010.09.019
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Yang J, 2011, J EUR CERAM SOC, V31, P2569, DOI 10.1016/j.jeurceramsoc.2010.12.035
NR 35
TC 0
Z9 0
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1042-1122
BN 978-1-118-99523-5; 978-1-118-99520-4
J9 CERAM TRANS
PY 2014
VL 251
BP 73
EP 84
PG 12
WC Materials Science, Ceramics
SC Materials Science
GA BD3WO
UT WOS:000360244700008
DA 2018-10-20
ER

PT B
AU Gilchrist, CL
   Ruch, DS
   Little, D
   Guilak, F
AF Gilchrist, Christopher L.
   Ruch, David S.
   Little, Dianne
   Guilak, Farshid
GP ASME
TI NANO-SCALE AND MICRO-SCALE SUBSTRATE ARCHITECTURES DIRECT COLLAGEN
   ALIGNMENT IN TENDON NEO-TISSUE FORMATION
SO PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE - 2013, PT B
LA English
DT Proceedings Paper
CT 15th American-Society-Mechanical-Engineering Summer Bioengineering
   Conference (SBC2013)
CY JUN 26-29, 2013
CL Sunriver, OR
SP Amer Soc Mech Engn, Bioengineer Div
AB Biomaterial scaffolds that present defined microenvironmental cues (e.g., nano-topography) to cells have shown promise for a variety of tissue engineering applications. However, the specific cues best suited for promoting the formation of aligned, fibrous tissues such as tendon are not fully understood. In this study, we utilize a microphotopatterning (mu PP) model system to precisely arrange scaffold-mimicking microenvironmental cues and investigate their role in the formation of tendon-like neo-tissues. Our data show that scaffold architectural features at both nano- and micro- length scales may be important parameters for directing tendon-like cell organization and the formation of aligned, fibrillar collagen.
C1 [Gilchrist, Christopher L.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27710 USA.
   Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA.
RP Gilchrist, CL (reprint author), Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27710 USA.
CR Baker, 2007, BIOMATERIALS, V28, P1967
   Barber JG, 2011, TISSUE ENG A
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Garrigues NW, 2010, J MATER CHEM, V20, P8962, DOI 10.1039/c0jm01880e
   Kapacce Z, 2008, MATRIX BIOL, V27, P371, DOI 10.1016/j.matbio.2007.11.006
   Moffat KL, 2009, TISSUE ENG PT A, V15, P115, DOI 10.1089/ten.tea.2008.0014
   Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083
NR 7
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5561-4
PY 2014
AR V01BT39A005
PG 2
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA BD2YI
UT WOS:000359389300100
DA 2018-10-20
ER

PT J
AU Pauksch, L
   Franke, J
   Schnettler, R
   Lips, KS
AF Pauksch, Linda
   Franke, Joerg
   Schnettler, Reinhard
   Lips, Katrin S.
TI Synergistic Toxicity of Gentamicin- and Nanosilver-Doped
   Polymethylmethacrylate Bone Cement on Primary Human Osteoclasts
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Cell differentiation; Gentamicin; Osteoclasts; Polymethylmethacrylate;
   Silver nanoparticles; Titanium alloy
ID ENDOPLASMIC-RETICULUM STRESS; SILVER NANOPARTICLES;
   PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; JOINT ARTHROPLASTY;
   OXIDATIVE STRESS; INFECTION; ANTIBACTERIAL; CYTOTOXICITY; CELLS
AB Bacterial colonization of implant surfaces is a feared complication in surgery and orthopedics. Due to the increasing number of periprosthetic infections caused by multidrugresistant microorganisms, new antibacterial coatings for biomaterials must be developed. The excellent antibacterial properties of silver nanoparticles (AgNPs) against multidrugresistant bacteria, for example, have been repeatedly described. For this reason, we tested a nanosilver-doped polymethylmethacrylate (PMMA) bone cement and a nanosilver-coated titanium alloy regarding their influence on osteoclastogenesis of primary human peripheral blood mononuclear cells. Both implant variants did not inhibit osteoclast differentiation. Excellent cell attachment and unaltered podosomal structures were confirmed. Additionally, no induction of oxidative or endoplasmic reticulum stress could be observed. However, PMMA loaded with gentamicin and nanosilver inhibited preosteoclast fusion and further osteoclastogenesis. The material also led to decreased clathrin-dependent endocytosis as well as decreased levels of endoplasmic reticulum stress. Therefore, biomaterial functionalization with AgNPs did not disturb osteoclastogenesis, while addition of gentamicin reduced the cytocompatibility of nanosilver-doped materials towards human osteoclasts. (C) 2015 S. Karger AG, Basel
C1 [Pauksch, Linda; Schnettler, Reinhard; Lips, Katrin S.] Univ Giessen, Lab Expt Trauma Surg, D-35392 Giessen, Germany.
   [Schnettler, Reinhard] Univ Hosp Giessen & Marburg, Dept Trauma Surg, Giessen, Germany.
   [Franke, Joerg] Elbe Hosp Stade, Clin Trauma Surg & Orthoped, Stade, Germany.
RP Lips, KS (reprint author), Univ Giessen, Lab Expt Trauma Surg, Schubertstr 81, D-35392 Giessen, Germany.
EM Katrin.S.Lips@chiru.med.uni-giessen.de
OI Franke, Joerg/0000-0002-0724-1785
FU Federal Ministry of Education and Research [03X0103D]
FX The authors would like to thank Steffi Weghenkel and Ivonne Bergen from
   the Laboratory for Experimental Trauma Surgery, Justus Liebig University
   Giessen, Germany, for their technical assistance. Our special thanks go
   to aap Biomaterials GmbH, Dieburg, Germany, for providing the different
   PMMA and TiAl<INF>6</INF>V<INF>4</INF> samples used in this study. This
   work was financially supported by the Federal Ministry of Education and
   Research (03X0103D).
CR Albers CE, 2013, NANOTOXICOLOGY, V7, P30, DOI 10.3109/17435390.2011.626538
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Arora M, 2013, WORLD J ORTHOP, V4, P67, DOI 10.5312/wjo.v4.i2.67
   Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m
   Chang Y, 2013, BONE JOINT RES, V2, P220, DOI 10.1302/2046-3758.210.2000188
   Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021
   Corisdeo S, 2001, BIOCHEM BIOPH RES CO, V285, P335, DOI 10.1006/bbrc.2001.5127
   Galvez-Lopez R, 2014, DIAGN MICR INFEC DIS, V78, P70, DOI 10.1016/j.diagmicrobio.2013.09.014
   Gasqueres C, 2012, SURF COAT TECH, V206, P3410, DOI 10.1016/j.surfcoat.2012.02.015
   Haase A, 2012, TOXICOL SCI, V126, P457, DOI 10.1093/toxsci/kfs003
   Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P2046, DOI 10.1007/s11999-010-1251-6
   Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008
   Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Kim KJ, 2009, BIOMETALS, V22, P235, DOI 10.1007/s10534-008-9159-2
   Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001
   Kim TH, 2012, J BIOMED MATER RES A, V100A, P1033, DOI 10.1002/jbm.a.34053
   Klein C. L., 2011, JRC SCIENTIFIC AND T
   Lara Humberto H., 2010, Journal of Nanobiotechnology, V8, P1, DOI 10.1186/1477-3155-8-1
   Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3
   Lentino Joseph R, 2004, Curr Infect Dis Rep, V6, P388, DOI 10.1007/s11908-004-0038-x
   Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554
   Lu L, 2008, ANTIVIR THER, V13, P253
   Matar WY, 2010, J BONE JOINT SURG AM, V92A, P36, DOI 10.2106/JBJS.J.01046
   Mohanty S, 2012, NANOMED-NANOTECHNOL, V8, P916, DOI 10.1016/j.nano.2011.11.007
   Moreira DM, 2015, ANGLE ORTHOD, V85, P175, DOI 10.2319/022314-127.1
   Nagafusa T, 2007, CELL BIOL INT, V31, P1150, DOI 10.1016/j.cellbi.2007.03.032
   Narducci P, 2010, EUR J HISTOCHEM, V54, P30, DOI 10.4081/ejh.2010.e6
   Oei JD, 2012, J BIOMED MATER RES B, V100B, P409, DOI 10.1002/jbm.b.31963
   Pauksch L, 2014, ACTA BIOMATER, V10, P439, DOI 10.1016/j.actbio.2013.09.037
   Peyrou M, 2007, TOXICOL SCI, V99, P346, DOI 10.1093/toxsci/kfm152
   Prokopovich P, 2015, J BIOMED MATER RES B, V103, P273, DOI 10.1002/jbm.b.33196
   Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267
   Renaud A, 2012, CAN J SURG, V55, P394, DOI 10.1503/cjs.033610
   Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522
   Takito J, 2012, J CELL SCI, V125, P662, DOI 10.1242/jcs.090886
   Tian XH, 2013, INT J NANOMED, V8, P2129, DOI [10.2147/IJN.S47488, 10.2147/IJN.S45742]
   Wei Q, 2013, INT J MOL SCI, V14, P20983, DOI 10.3390/ijms141020983
   Wright JB, 1998, AM J INFECT CONTROL, V26, P572, DOI 10.1053/ic.1998.v26.a93527
   Zhang BGX, 2014, INT J MOL SCI, V15, P11878, DOI 10.3390/ijms150711878
   Zhang R, 2012, INT J BIOCHEM CELL B, V44, P224, DOI 10.1016/j.biocel.2011.10.019
   Zheng YH, 2012, INT J NANOMED, V7, P875, DOI 10.2147/IJN.S28450
NR 44
TC 1
Z9 1
U1 1
U2 19
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2014
VL 199
IS 5-6
BP 384
EP 392
DI 10.1159/000371341
PG 9
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA CF5UQ
UT WOS:000352623100008
PM 25678413
DA 2018-10-20
ER

PT S
AU Mas-Ayu, H
   Izman, S
   Abdul-Kadir, MR
   Daud, R
   Shah, A
   Yusoff, MFM
   Shamsiah, MW
   Yong, TM
   Kamarul, T
AF Mas-Ayu, H.
   Izman, S.
   Abdul-Kadir, Mohammed Rafiq
   Daud, Rosdi
   Shah, A.
   Yusoff, Mohd Faiz Mohd
   Shamsiah, M. W.
   Yong, T. M.
   Kamarul, T.
BE Kurniawan, D
TI Influence of Carbon Concentrations in Reducing Co and Cr Ions Release in
   Cobalt Based Implant: A Preliminary Report
SO MATERIALS, INDUSTRIAL, AND MANUFACTURING ENGINEERING RESEARCH ADVANCES
   1.1
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 1st International Materials, Industrial, and Manufacturing Engineering
   Conference
CY DEC 04-06, 2013
CL Johor Bahru, MALAYSIA
DE Biomaterial; Thermal oxidation; Co-Cr-Mo alloy; Metal ions release;
   Tissue engineering
ID ALLOY; OXIDATION; MICROSTRUCTURE; LAYER; WEAR
AB The releases of harmful ions from cobalt based alloy to host tissues have raised significant health concerns. Carbon contents in this alloy may influence ions release but has yet investigated. It is hypothesized that carbon contents in this alloy will help the formation of oxide layer during thermal oxidation process and hence reducing the release of Co/Cr ions after implantation. In this study, Co-Cr-Mo alloy with carbon concentrations of 0.03% and 0.24% were oxidized at 1050 degrees C for 3 hours under atmospheric condition. The oxidized substrates were characterized under FESEM and subjected to circulating immersion test in simulated body fluid (SBF) for 21 days. Metal ions release was measured using inductively coupled plasma-mass spectrometry (ICP-MS) at day 0, 7, 14 and 21. Oxidized high carbon samples show denser and a more uniform oxide layer than samples with low carbon contents. It is found that compact oxide structure promotes less metal ions release during immersion.
C1 [Mas-Ayu, H.; Daud, Rosdi; Shah, A.] Univ Malaysia Pahang, Fac Mech Engn, Pekan, Malaysia.
RP Mas-Ayu, H (reprint author), Univ Malaysia Pahang, Fac Mech Engn, Pekan, Malaysia.
EM masszee@ump.edu.my; izman@mail.fkm.utm.my; rafiq@biomedical.utm.my;
   rosdidaud@ump.edu.my; ashah8@live.utm.my; faiz.mohd.yusoff@gmail.com;
   shamey82@gmail.com; yongtzemi@yahoo.co.uk; tkzrea@ummc.edu.my
RI Abdul Kadir, Mohammed/D-1117-2010; Abdullah, Arman Shah/K-7919-2012;
   Daud, Rosdi/K-2508-2016; Tunku Zainol Abidin, Tunku Kamarul
   Zaman/B-9633-2011
OI Abdullah, Arman Shah/0000-0003-0142-6487; Tunku Zainol Abidin, Tunku
   Kamarul Zaman/0000-0002-6028-1313
CR Aoh JN, 2001, WEAR, V250, P611, DOI 10.1016/S0043-1648(01)00668-8
   Blau PJ, 2009, WEAR, V267, P380, DOI 10.1016/j.wear.2008.12.082
   Buscail H, 2012, CORROS ENG SCI TECHN, V47, P404, DOI 10.1179/1743278212Y.0000000007
   Giacchi JV, 2011, MATER CHARACT, V62, P53, DOI 10.1016/j.matchar.2010.10.011
   Izman S, 2012, ADV MATER RES-SWITZ, V399-401, P1564, DOI 10.4028/www.scientific.net/AMR.399-401.1564
   Izman S, 2011, ADV MATER RES-SWITZ, V197-198, P219, DOI 10.4028/www.scientific.net/AMR.197-198.219
   Karaali A, 2005, COMP MATER SCI, V33, P37, DOI 10.1016/j.commatsci.2004.12.025
   Karaali A, 2005, MAT SCI ENG A-STRUCT, V390, P255, DOI 10.1016/j.msea.2004.08.001
   KILNER T, 1982, J BIOMED MATER RES, V16, P63, DOI 10.1002/jbm.820160109
   Lutz J, 2011, SURF COAT TECH, V205, P3043, DOI 10.1016/j.surfcoat.2010.11.017
   Milosev H.-H. S. I., 2003, ELECTROCHIM ACTA, V48, P2767
   Ozturk O, 2006, SURF COAT TECH, V200, P5687, DOI 10.1016/j.surfcoat.2005.08.113
   Varano R, 2006, P I MECH ENG H, V220, P145, DOI 10.1243/09544119JEIM110
   Wang QL, 2010, J BIONIC ENG, V7, P337, DOI 10.1016/S1672-6529(10)60265-X
NR 14
TC 5
Z9 5
U1 1
U2 12
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-936-0
J9 ADV MATER RES-SWITZ
PY 2014
VL 845
BP 462
EP 466
DI 10.4028/www.scientific.net/AMR.845.462
PG 5
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BA8YX
UT WOS:000339040500091
DA 2018-10-20
ER

PT S
AU Tian, HC
   Liu, JQ
   Kang, XY
   Wei, DX
   Zhang, C
   Du, JC
   Yang, B
   Chen, X
   Yang, CS
AF Tian, Hong-Chang
   Liu, Jing-Quan
   Kang, Xiao-Yang
   Wei, Dai-Xu
   Zhang, Chuan
   Du, Jing-Cheng
   Yang, Bin
   Chen, Xiang
   Yang, Chun-Sheng
GP IEEE
TI Poly(3,4-ethylenedioxythiophene)/Graphene Oxide Composite Coating for
   Electrode-Tissue Interface
SO 2014 36TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 36th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society (EMBC)
CY AUG 26-30, 2014
CL Chicago, IL
SP IEEE Engn Medicine & Biol Soc
AB Owing to interacting with the living tissue directly, the electrode-tissue interface largely determines the performance of the whole bioelectronics devices. The miniaturization of biomedical electronic components requires interface materials to possess properties including excellent electrical performance, good biocompatibility and compatibility with microelectronic fabrication process. Considering the unique characteristics and wide applications in biomedical domain of conducting polymer and graphene, composite film consists of poly(3,4-ethylenedioxythiophene) (PEDOT) and graphene oxide (GO) is proposed as electrode-tissue interface in this work. The facilely electrochemically synthesized PEDOT/GO coating on microelectrodes shows low impedance, high charge storage capacity and good biocompatibility to act as electrode-tissue interface. As a result, the composite film is a potential biomaterial as electrode-tissue interface for tissue engineering and further implantable electrophysiological devices.
C1 [Tian, Hong-Chang; Liu, Jing-Quan; Kang, Xiao-Yang; Zhang, Chuan; Du, Jing-Cheng; Yang, Bin; Chen, Xiang; Yang, Chun-Sheng] Shanghai Jiao Tong Univ, Natl Key Lab Sci & Technol Micro Nano Fabricat, Key Lab Thin Film & Microfabricat, Minist Educ,Inst Micronano Sci & Technol, Shanghai 200240, Peoples R China.
   [Wei, Dai-Xu] Natl Engn Res Ctr Nanotechnol, Shanghai 200241, Peoples R China.
RP Liu, JQ (reprint author), Shanghai Jiao Tong Univ, Natl Key Lab Sci & Technol Micro Nano Fabricat, Key Lab Thin Film & Microfabricat, Minist Educ,Inst Micronano Sci & Technol, Shanghai 200240, Peoples R China.
EM jqliu@sjtu.edu.cn
OI Du, Jingcheng/0000-0002-0322-4566
CR Abidian MR, 2010, SMALL, V6, P421, DOI 10.1002/smll.200901868
   Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518
   Green RA, 2012, BIOMATERIALS, V33, P5875, DOI 10.1016/j.biomaterials.2012.05.017
   Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]
   Lu Y., 2010, BIOMATERIALS, V22, P3906
   Qian T, 2013, CHEM COMMUN, V49, P4610, DOI 10.1039/c3cc00276d
NR 6
TC 1
Z9 1
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-7929-0
J9 IEEE ENG MED BIO
PY 2014
BP 1571
EP 1574
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BC1EL
UT WOS:000350044701140
PM 25570271
DA 2018-10-20
ER

PT S
AU Bayrak, ES
   Mehdizadeh, H
   Akar, B
   Somo, SI
   Brey, EM
   Cinar, A
AF Bayrak, Elif S.
   Mehdizadeh, Hamidreza
   Akar, Banu
   Somo, Sami I.
   Brey, Eric M.
   Cinar, Ali
GP IEEE
TI Agent-Based Modeling of Osteogenic Differentiation of Mesenchymal Stem
   Cells in Porous Biomaterials
SO 2014 36TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 36th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society (EMBC)
CY AUG 26-30, 2014
CL Chicago, IL
SP IEEE Engn Medicine & Biol Soc
ID BONE MORPHOGENETIC PROTEIN-2; CHEMOTACTIC MIGRATION; ENDOTHELIAL-CELLS;
   REGENERATION; SCAFFOLDS; PATTERNS; BEHAVIOR; CANCER
AB Mesenchymal stem cells (MSC) have shown promise in tissue engineering applications due to their potential for differentiating into mesenchymal tissues such as osteocytes, chondrocytes, and adipocytes and releasing proteins to promote tissue regeneration. One application involves seeding MSCs in biomaterial scaffolds to promote osteogenesis in the repair of bone defects following implantation. However, predicting in vivo survival and differentiation of MSCs in biomaterials is challenging. Rapid and stable vascularization of scaffolds is required to supply nutrients and oxygen that MSCs need to survive as well as to go through osteogenic differentiation. The objective of this study is to develop an agent-based model and simulator that can be used to investigate the effects of using gradient growth factors on survival and differentiation of MSCs seeded in scaffolds. An agent-based model is developed to simulate the MSC behavior. The effect of vascular endothelial growth factor (VEGF) and bone morphogenic protein-2 (BMP-2) on both survival and osteogenic differentiation is studied. Results showed that the survival ratio of MSCs can be enhanced by increasing VEGF concentration. BMP-2 caused a slight increase on survival ratio. Osteogenesis strongly depends on the VEGF concentration as well because of its effect on vascularization. BMP-2 increased the osteogenic differentiation of MSCs.
C1 [Bayrak, Elif S.; Cinar, Ali] IIT, Dept Chem & Biol Engn, Chicago, IL 60616 USA.
   [Mehdizadeh, Hamidreza] IIT, Chicago, IL 60616 USA.
   [Akar, Banu; Somo, Sami I.; Brey, Eric M.; Cinar, Ali] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
RP Cinar, A (reprint author), IIT, Dept Chem & Biol Engn, Chicago, IL 60616 USA.
EM ebayrak@hawk.iit.edu; hmehdiza@hawk.iit.edu; bakar@hawk.iit.edu;
   ssomo@hawk.iit.edu; brey@iit.edu; cinar@iit.edu
OI Cinar, Ali/0000-0002-1607-9943
CR Abbott RG, 2006, ARTIF LIFE, V12, P617, DOI 10.1162/artl.2006.12.4.617
   Artel A, 2011, TISSUE ENG PT A, V17, P2133, DOI [10.1089/ten.tea.2010.0571, 10.1089/ten.TEA.2010.0571]
   Arvidson K, 2011, J CELL MOL MED, V15, P718, DOI 10.1111/j.1582-4934.2010.01224.x
   Athale C, 2005, J THEOR BIOL, V233, P469, DOI 10.1016/j.jtbi.2004.10.019
   Athale CA, 2006, J THEOR BIOL, V238, P771, DOI 10.1016/j.jtbi.2005.06.029
   Ausk BJ, 2006, J BIOMECH, V39, P2638, DOI 10.1016/j.jbiomech.2005.08.023
   Bailey AM, 2007, ANN BIOMED ENG, V35, P916, DOI 10.1007/s10439-007-9266-1
   D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061
   Deschepper M, 2011, J CELL MOL MED, V15, P1505, DOI 10.1111/j.1582-4934.2010.01138.x
   Druckenbrod NR, 2007, DEV DYNAM, V236, P84, DOI 10.1002/dvdy.20974
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   Finkenzeller G, 2012, MICROVASC RES, V84, P81, DOI 10.1016/j.mvr.2012.03.010
   Jeon O, 2008, TISSUE ENG PT A, V14, P1285, DOI 10.1089/ten.tea.2007.0253
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8
   Lindhorst D, 2010, J BIOMED MATER RES A, V95A, P783, DOI 10.1002/jbm.a.32902
   Lollini PL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-352
   Manassero M, 2013, TISSUE ENG PT A, V19, P1554, DOI [10.1089/ten.tea.2012.0008, 10.1089/ten.TEA.2012.0008]
   MEHDIZADEH H, 2011, AGENTS PRINCIPLE AGE, V7047, P113
   Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047
   Peirce SM, 2004, FASEB J
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Suzuki Y, 2008, J BIOCHEM, V143, P199, DOI 10.1093/jb/mvm215
   Tavassol F, 2011, TISSUE ENG PT A, V17, P1935, DOI [10.1089/ten.TEA.2010.0603, 10.1089/ten.tea.2010.0603]
   Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025
   Walker DC, 2004, IEEE T NANOBIOSCI, V3, P153, DOI 10.1109/TNB.2004.833680
   Yamada Y, 2004, TISSUE ENG, V10, P955, DOI 10.1089/1076327041348284
NR 28
TC 6
Z9 6
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-7929-0
J9 IEEE ENG MED BIO
PY 2014
BP 2924
EP 2927
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BC1EL
UT WOS:000350044702226
PM 25570603
DA 2018-10-20
ER

PT B
AU Miraftab, M
   Masood, R
   Edward-Jones, V
AF Miraftab, M.
   Masood, R.
   Edward-Jones, V.
BE Pal, M
TI Development and Antimicrobial Assessment of a Novel Hybrid Biomaterial
   Fibre Intended for Wound Dressing Applications
SO INTERNATIONAL CONFERENCE ON MATERIAL SCIENCE AND MATERIAL ENGINEERING
   (MSME 2014)
LA English
DT Proceedings Paper
CT International Conference on Material Science and Material Engineering
   (MSME)
CY MAR 15-16, 2014
CL Adv Informat Sci Res Ctr, Chicago, IL
SP DEStech Publicat Inc, Univ East Asia, Univ Mysore, Reitaku Univ
HO Adv Informat Sci Res Ctr
DE Wound dressing; Alginate; Psyllium; antimicrobial
ID SILVER; MANAGEMENT; MODELS
AB Wound dressings containing silver have been commercially marketed for some time now. On the whole, manufacturers are keen to publicize effective antimicrobial activities of their products against all kinds of pathogens including MRSA. However, there are little or no credible reports on minimal but potent quantities of silver needed in a dressing to eliminate bacteria or how effectively the silver within a dressing is released over time. This paper introduces a new hybrid biomaterial fibre made from polysaccharide-based polymers with inbuilt ability to gel and absorb large quantities of pseudo exudates. Furthermore, it will be reported that the new fibre carries up to six times less silver than it is conventionally used in silver dressings and displays a very slow rate of release whilst maintaining full potency over time against known gram positive/gram negative micro-organisms including MRSA. The paper concludes that the developed biomaterial fibre has long lasting antimicrobial and gelling properties comparable, if not better, than Acticoat AA and Aquacel Ag, two commercially available silver dressings.
C1 [Miraftab, M.] Univ Bolton, Insitute Mat Res & Innovat, Bolton BL3 5AB, England.
   [Masood, R.] Natl Text Univ, Faisalabad, Pakistan.
   [Edward-Jones, V.] Manchester Metropolitan Univ, Res Enterprise & Dev, Manchester M15 6BX, Lancs, England.
RP Miraftab, M (reprint author), Univ Bolton, Insitute Mat Res & Innovat, Deane Rd, Bolton BL3 5AB, England.
EM m.iraftab@bolton.ac.uk; rashid44444@yahoo.com; V.E.Jones@mmu.ac.uk
CR Alloway B.J., 1995, HEAVY METALS SOILS, P324
   Bowler PG, 2004, J BURN CARE REHABIL, V25, P192, DOI 10.1097/01.BCR.0000112331.72232.1B
   Burd A, 2007, WOUND REPAIR REGEN, V15, P94, DOI 10.1111/j.1524-475X.2006.00190.x
   Burrell R.E., 2003, OSTOMY WOUND MANAG, P4919
   Cooper R, 2004, WORLDWIDE WOUNDS
   De SJ, 2003, J CONTROL RELEASE, V89, P101, DOI 10.1016/S0168-3659(03)00098-1
   Dunn K, 2004, BURNS, V30, pS1, DOI 10.1016/j.burns.2004.06.000
   Dunn Ken, 2004, ROLE ACTICOAT NANOCR, V30, pS1
   Fan LH, 2006, CARBOHYD POLYM, V65, P447, DOI 10.1016/j.carbpol.2006.01.031
   Howe PD, 2002, SILVER SILVER COMPOU
   Jones-Edward V., 2002, J MED MICROBIOL, V51, P50
   Kalsen H. J., 2000, HIST REV SILVER TREA, V26, P117
   Keong LC, 2009, INT J MOL SCI, V10, P1300, DOI 10.3390/ijms10031300
   Landis Stephan J, 2008, Adv Skin Wound Care, V21, P531, DOI 10.1097/01.ASW.0000323578.87700.a5
   MARGARET IP, 2006, J MED MICROBIOL, V55, P59
   Miraftab M., J WOUNDCARE
   Miraftab M., 2012, patent application, Patent No. [WO2012GB 53011 20121205, 5301120121205]
   Poon VKM, 2004, BURNS, V30, P140, DOI 10.1016/j.burns.2003.09.030
   Qin Yimin, TEXTILE MAGAZINE, P23
   Ryan KJ, 2003, SHERRIS MED MICROBIO
   Samadra C., 1997, J CONTROL RELEASE, V44, P201
   Smith E. A., 1947, SAMPLING ASSAY PRECI, P71
   Ted S., 2004, WOUND MANAGEMENT, V3, P148
   Thomas S., 2004, ONLINE J WORLD WIDE
   White W. C, 2005, AEGIS ENV
NR 25
TC 0
Z9 0
U1 1
U2 1
PU DESTECH PUBLICATIONS, INC
PI LANCASTER
PA 439 DUKE STREET, LANCASTER, PA 17602-4967 USA
BN 978-1-60595-171-3
PY 2014
BP 190
EP 200
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA BC2LC
UT WOS:000351041400027
DA 2018-10-20
ER

PT J
AU Naghiu, MA
   Gorea, M
   Kristaly, F
   Tomoaia-Cotisel, M
AF Naghiu, M. A.
   Gorea, M.
   Kristaly, F.
   Tomoaia-Cotisel, M.
TI A NEW METHOD FOR SYNTHESIS OF FORSTERITE NANOMATERIALS FOR BIOIMPLANTS
SO CERAMICS-SILIKATY
LA English
DT Article
DE Magnesium silicates; Biomaterial; Precipitation method; Particle size;
   Thermal analysis
ID SOL-GEL SYNTHESIS; ENSTATITE MGSIO3; MG2SIO4; POWDERS; CRYSTALLIZATION;
   NANOPOWDERS; PRECURSORS; CERAMICS; PHASE
AB Nanocrystalline forsterite (Mg2SiO4) was synthesized by the precipitation method using Mg(NO3)(2)center dot 6H(2)O, C8H20O4Si (TEOS) and sodium hydroxide as pH regulator as starting materials. The thermal behaviour of the mixture was investigated by a MOM derivatograh. According to DTA results the initial crystallization temperature of the forsterite is about 800 degrees C. The powder calcined at 900 degrees C was characterized by X ray diffraction (XRD). The forsterite was noticed as the main crystalline phase besides of small amounts of periclase (MgO). Polycrystalline forsterite with uniform sized particles and spherical shape is evidenced by electronic microscopy (TEM, SEM). Grain size of forsterite powder according to Counter Coulter-type laser granulometer results is in the range of 10 - 42 nm.
C1 [Naghiu, M. A.; Gorea, M.; Tomoaia-Cotisel, M.] Univ Babes Bolyai, Fac Chem & Chem Engn, Dept Chem Engn, R-3400 Cluj Napoca, Romania.
   [Kristaly, F.] Univ Miskolc, Inst Mineral & Geol, Egyetemvaros, Miskolc, Hungary.
RP Naghiu, MA (reprint author), Univ Babes Bolyai, Fac Chem & Chem Engn, Dept Chem Engn, R-3400 Cluj Napoca, Romania.
EM mgorea@chem.ubbcluj.ro
OI Kristaly, Ferenc/0000-0002-0075-5994
FU UEFISCDI [171/2012]
FX The authors thank the UEFISCDI for financial support through grant
   number 171/2012.
CR Ban T, 1999, J AM CERAM SOC, V82, P22
   BANSAL NP, 1988, J AM CERAM SOC, V71, P666, DOI 10.1111/j.1151-2916.1988.tb06386.x
   BURLITCH JM, 1991, CHEM MATER, V3, P692, DOI 10.1021/cm00016a024
   Douy A, 2002, J SOL-GEL SCI TECHN, V24, P221, DOI 10.1023/A:1015332607551
   ECHEVERRIA LM, 1992, J NON-CRYST SOLIDS, V147, P559, DOI 10.1016/S0022-3093(05)80676-3
   El-Didamony H, 2012, CERAM-SILIKATY, V56, P389
   Gorea M, 2013, CERAM-SILIKATY, V57, P87
   HUANG CM, 1994, J AM CERAM SOC, V77, P2625, DOI 10.1111/j.1151-2916.1994.tb04653.x
   Jones SA, 1999, J SOL-GEL SCI TECHN, V15, P201, DOI 10.1023/A:1008728724009
   KAZAKOS A, 1990, MATER LETT, V9, P405, DOI 10.1016/0167-577X(90)90075-W
   Kharaziha M, 2009, CERAM INT, V35, P2449, DOI 10.1016/j.ceramint.2009.02.001
   Klug H. P., 1974, XRAY DIFFRACTION PRO
   LEE WE, 1987, J AM CERAM SOC, V70, P349, DOI 10.1111/j.1151-2916.1987.tb05007.x
   Lin L, 2008, J ALLOY COMPD, V455, P327, DOI 10.1016/j.jallcom.2007.01.059
   Lin X., 2013, BIOMATERIAL
   lurian A. M., 2013, STUDIA UBB CHEMIA, V58, P141
   MARTIN MHE, 1992, J AM CERAM SOC, V75, P1831, DOI 10.1111/j.1151-2916.1992.tb07204.x
   Mielcarek W, 2004, J EUR CERAM SOC, V24, P3817, DOI 10.1016/j.jeurceramsoc.2003.12.030
   Mitchell MBD, 1999, J SOL-GEL SCI TECHN, V15, P211, DOI 10.1023/A:1008732808079
   Mitchell MBD, 1998, J SOL-GEL SCI TECHN, V13, P359, DOI 10.1023/A:1008696522312
   Naghiu MA, 2013, J MATER SCI TECHNOL, V29, P628, DOI 10.1016/j.jmst.2013.04.007
   Popa M, 2012, STUD U BABES-BOL CHE, V57, P167
   Sanosh KP, 2010, J ALLOY COMPD, V495, P113, DOI 10.1016/j.jallcom.2010.01.097
   Sarve J. F., 1962, J AM CERAM SOC, V55, P152
   Tan GL, 2009, J ALLOY COMPD, V468, P421, DOI 10.1016/j.jallcom.2008.01.051
   Tavangarian F, 2011, MATER LETT, V65, P740, DOI 10.1016/j.matlet.2010.11.014
   Tavangarian F., 2010, CERAMICSSILIKATY, V54, P2
   Xie Y., 2009, ACTA BIOMATER, V5, P6
   Zhenglong L., 2009, J ALLOYS COMPOUNDS, V470
NR 29
TC 3
Z9 3
U1 1
U2 5
PU INST CHEMICAL TECHNOLOGY, DEPT GLASS CERAMICS
PI PRAGUE
PA TECHNICKA 5, PRAGUE 166 28, CZECH REPUBLIC
SN 0862-5468
EI 1804-5847
J9 CERAM-SILIKATY
JI Ceram.-Silik.
PY 2014
VL 58
IS 4
BP 303
EP 307
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA CD2RW
UT WOS:000350927700009
OA DOAJ Gold
DA 2018-10-20
ER

PT B
AU Kapustka, K
   Hajduga, M
   Jedrzejczyk, D
   Was-Solipiwo, J
AF Kapustka, Katarzyna
   Hajduga, Maciej
   Jedrzejczyk, Dariusz
   Was-Solipiwo, Joanna
GP TANGER
TI CORROSION CHANGES OF WELDABLE NITINOLS (NiTi) IN AN ENVIRONMENT OD
   PHYSIOLOGICAL LIQUIDS
SO METAL 2014: 23RD INTERNATIONAL CONFERENCE ON METALLURGY AND MATERIALS
LA English
DT Proceedings Paper
CT 23rd International Conference on Metallurgy and Materials
CY MAY 21-23, 2014
CL Brno, CZECH REPUBLIC
SP TANGER Ltd, VSB Tech Univ Ostrava, Czech Soc New Mat & Technologies, ASM Int, Engn Acad Czech Republic, Mat Res Soc Serbia, Norwegian Co Mat & Technol, French Soc Metallurgy & Mat, Italian Assoc Metallurgy, Austrian Soc Metallurgy & Mat, Portuguese Soc Mat, Mat Informat Soc
DE Corrosion; nitinol; argon envelope; soldering; heat sealing
AB From the large number of available metals with the memory of shape only a few of them found clinical application. Biocompatible orthodontic wires, applied in case of false occlusion reconstruction, are made of intelligent materials and components. The phenomenon origins from the material's property called "shape memory". The alloy deformed plastically in the lower temperature regains its initial shape in the higher temperature. Orthodontic wires, due to their purpose and use, succumb to damage. Hence the exploitation in very demanding conditions of oral cavity makes us search for very efficient reparation system. From the large number available materials with a shape memory only few of them complied with clinical application. It is a result of tough criteria measures implemented to implants - targeting fulfilling biological requirements. Austenitic steels, applied in medicine, belong to metallic biomaterials particularly exposed to damage, due to ongoing processes of corrosion strain. It is connected with its weakest resistance to electrochemical corrosion in environment of organism fluids hence lower susceptibility to self-passivation. The appearance of the foreign matter in the organism stimulates many mechanisms aiming its elimination. So if the foreign substance, in this case the wire, is traced by immunological system, the organism starts production of antibodies of strong oxidizing functions. Antibodies consolidate near the implant and absorb into biomaterial. Defensive reaction of the organism is becoming one of the reasons of degradation of biomaterials. The work is devoted to the influence of corrosion environment on the structure and properties stability of NiTi wires after reparation.
C1 [Kapustka, Katarzyna; Hajduga, Maciej; Jedrzejczyk, Dariusz] Univ Bielsko Biala, Bielsko Biala, Poland.
   [Was-Solipiwo, Joanna] BOSMAL Automot Res & Dev Inst, Bielsko Biala, Poland.
RP Kapustka, K (reprint author), Univ Bielsko Biala, Bielsko Biala, Poland.
EM katarzynakapustka@op.pl
OI Jedrzejczyk, Dariusz/0000-0002-0541-1373
CR Bojarski Z., 1989, METALE PAMIECIA KSZT
   HER-HSIUNGHUANG, 2003, BIOMATERIALS, V24, P3585
   KAPUSTKA K., 2013, MOZLIWOSCI LACZENIA
   KAPUSTKA K., 2013, AGH KRAKOW KRYNICA M, P237
   KAPUSTKA K., 2013, 5564 POL TOW INZ STO
   PLASKOTA T., 2004, 3536 INZ BIOM, V7
   RYDZEWSKA O., 2009, KOROZJA DRUTOW ORTOD
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
NR 8
TC 0
Z9 0
U1 0
U2 0
PU TANGER LTD
PI SLEZSKA
PA KELTICKOVA 62, SLEZSKA, OSTRAVA 710 00, CZECH REPUBLIC
BN 978-80-87294-54-3
PY 2014
BP 831
EP 837
PG 7
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BC2AA
UT WOS:000350641700136
DA 2018-10-20
ER

PT B
AU Vojtech, D
   Kubasek, J
   Capek, J
   Pospisilova, I
AF Vojtech, Dalibor
   Kubasek, Jiri
   Capek, Jaroslav
   Pospisilova, Iva
GP TANGER
TI MAGNESIUM, ZINC AND IRON ALLOYS FOR MEDICAL APPLICATIONS IN
   BIODEGRADABLE IMPLANTS
SO METAL 2014: 23RD INTERNATIONAL CONFERENCE ON METALLURGY AND MATERIALS
LA English
DT Proceedings Paper
CT 23rd International Conference on Metallurgy and Materials
CY MAY 21-23, 2014
CL Brno, CZECH REPUBLIC
SP TANGER Ltd, VSB Tech Univ Ostrava, Czech Soc New Mat & Technologies, ASM Int, Engn Acad Czech Republic, Mat Res Soc Serbia, Norwegian Co Mat & Technol, French Soc Metallurgy & Mat, Italian Assoc Metallurgy, Austrian Soc Metallurgy & Mat, Portuguese Soc Mat, Mat Informat Soc
DE Magnesium; zinc; iron; biomaterial; implant
ID CORROSION BEHAVIOR; STENTS; ZN
AB Biodegradable materials are developed for designing temporary medical implants, like fixation devices for fractured bones or stents. At present, polymeric biomaterials such as poly-lactic acid (PLA) are currently used in these applications. The disadvantage of polymers is a low mechanical strength, hardness and wear resistance that is the main limitation for the use in load-bearing implants. For this reason, extensive research activities are focused on metallic biodegradable materials showing higher strength, hardness, wear resistance and toughness. Among various biodegradable metals, only magnesium, zinc and iron also meet the basic requirement of a good biocompatibility. In the present work, magnesium, zinc and iron based alloys are compared in terms of biocompatibility, mechanical properties and corrosion behavior in the human body environment. Advantages, disadvantages and potential application areas of the three groups of materials are demonstrated.
C1 [Vojtech, Dalibor; Kubasek, Jiri; Capek, Jaroslav; Pospisilova, Iva] Inst Chem Technol, Dept Met & Corros Engn, CR-16628 Prague, Czech Republic.
RP Vojtech, D (reprint author), Inst Chem Technol, Dept Met & Corros Engn, CR-16628 Prague, Czech Republic.
EM Dalibor.Vojtech@vscht.cz
RI Kubasek, Jiri/N-4341-2017
OI Kubasek, Jiri/0000-0001-6008-0127
CR Bowen PK, 2013, ADV MATER, V25, P2577, DOI 10.1002/adma.201300226
   Davis J. R., 2003, HDB MAT MED DEVICES, P1, DOI DOI 10.1361/HMMD2003P001
   DAVIS JR, 1990, ASM HDB PROPERTIES S, V2
   GU X.N., 2010, FRONT MAT SCI CHINA, P111
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006
   Hermawan H., 2012, BIODEGRADABLE METALS, DOI [10.1007/978-3-642-31170-3, DOI 10.1007/978-3-642-31170-3]
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Kubasek J, 2013, T NONFERR METAL SOC, V23, P1215, DOI 10.1016/S1003-6326(13)62586-8
   Kubasek J, 2013, J MATER SCI-MATER M, V24, P1615, DOI 10.1007/s10856-013-4916-3
   Kubasek J, 2013, MAT SCI ENG C-MATER, V33, P2421, DOI 10.1016/j.msec.2013.02.005
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Poinern G. E. J., 2012, AM J BIOMEDICAL ENG, P218
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   Vojtech D, 2011, ACTA BIOMATER, V7, P3515, DOI 10.1016/j.actbio.2011.05.008
   VOJTECH D., 2013, HUTN LISTY, P66
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
NR 18
TC 0
Z9 0
U1 1
U2 14
PU TANGER LTD
PI SLEZSKA
PA KELTICKOVA 62, SLEZSKA, OSTRAVA 710 00, CZECH REPUBLIC
BN 978-80-87294-54-3
PY 2014
BP 1092
EP 1096
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BC2AA
UT WOS:000350641700180
DA 2018-10-20
ER

PT S
AU Johnson, WE
   Koepfli, K
AF Johnson, Warren E.
   Koepfli, Klaus
BE Holt, WV
   Brown, JL
   Comizzoli, P
TI The Role of Genomics in Conservation and Reproductive Sciences
SO REPRODUCTIVE SCIENCES IN ANIMAL CONSERVATION: PROGRESS AND PROSPECTS
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Conservation genetics; Adaptation; Selection; Genomics
ID DETECT CANDIDATE LOCI; PUERTO-RICAN PARROT; LYNX LYNX-PARDINUS;
   WHOLE-GENOME; MICROSATELLITE MARKERS; GENETIC DIVERSITY; TASMANIAN
   DEVIL; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE;
   FUNDAMENTAL-CONCEPTS
AB Genomics, the study of an organism's genome through DNA analyses, is a central part of the biological sciences and is rapidly changing approaches to animal conservation. The genomes of thousands of organisms, including vertebrates, invertebrates, and plants have been sequenced and the results annotated, augmented and refined through the application of new approaches in transcriptomics, proteomics, and metabolomics that enhance the characterization of messenger RNA, proteins, and metabolites. The same computational advances that are catalyzing "-omic" technologies and novel approaches to address fundamental research questions are facilitating bioinformatic analysis and enabling access of primary and derivative data and results in public and private databases (Zhao and Grant. Curr Pharm Biotechnol 12: 293-305, 2011). These tools will be used to provide fundamental advances in our understanding of reproductive biology across vertebrate species and promise to revolutionize our approach to conservation biology.
   The vulnerability of animal populations and their genetic diversity is well documented, as are the myriad of causes and threats to their persistence, including habitat degradation and loss, overexploitation, pollution, invasive alien species, and climate change. Of the 64,283 vertebrates assessed by the International Union for Conservation of Nature in their 2012 Red List of Threatened Species, 7,250 or similar to 11 % are threatened with extinction, a percentage that has been increasing steadily for at least the last decade (www.iucnredlist.org). Among many of these species, important genetic diversity has been lost, thereby increasing their vulnerability as genetically diverse populations have higher fitness, generally are more resilient to environmental challenges, and have more adaptive potential (Reed and Frankham Conserv Biol 17: 230-237, 2003; Luikart et al. Nat Rev Genet 4: 981-994, 2003). In turn, genetic variation within and among populations may be essential to maintaining functional ecosystems, evolutionary process and will impact future food supplies, human health, biomaterial development and geopolitics (Myers and Knoll Proc Natl Acad Sci U S A 98: 5389-5392, 2001; Templeton et al. Proc Natl Acad Sci U S A 98: 5426-5432, 2001). Therefore, conservation of genetic diversity is a social, cultural, scientific, and economic prerogative and is the key to adaptation in the uncertain future of a human-dominated environment. Once lost, genetic resources are nearly impossible to regain, increasing the urgency of fundamental global approaches (e.g. www.cbd.int/sp/targets).
   In this chapter we provide a review of current research and recent advances in biotechnology and genomic approaches for animal conservation and the management of genetic resources, with an emphasis on reproductive sciences. It is intended to provide information and insights for research and to provoke thoughts on how to take advantage of these opportunities.
C1 [Johnson, Warren E.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA.
   [Koepfli, Klaus] Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Washington, VA USA.
RP Johnson, WE (reprint author), Smithsonian Conservat Biol Inst, Natl Zool Pk,1500 Remount Rd, Front Royal, VA 22630 USA.
EM johnsonwe@si.edu
RI Johnson, Warren/D-4149-2016
OI Johnson, Warren/0000-0002-5954-186X
CR Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466
   Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844
   Alminana C, 2012, THERIOGENOLOGY, V77, P717, DOI 10.1016/j.theriogenology.2011.11.009
   Amstislavsky S, 2012, REPROD DOMEST ANIM, V47, P164, DOI 10.1111/j.1439-0531.2011.01886.x
   Andrabi SMH, 2007, ANIM REPROD SCI, V99, P223, DOI 10.1016/j.anireprosci.2006.07.002
   Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253
   Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323
   Aydiner F, 2010, CURR MOL MED, V10, P206, DOI 10.2174/156652410790963349
   Baker CS, 2008, MOL ECOL, V17, P3985, DOI 10.1111/j.1365-294X.2008.03867.x
   Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x
   Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031
   Berthouly C, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-1
   Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087
   Bonin A, 2007, CONSERV BIOL, V21, P697, DOI 10.1111/j.1523-1739.2007.00685.x
   Bott K, 2009, N AM J FISH MANAGE, V29, P1636, DOI 10.1577/M08-211.1
   BROCK MK, 1992, P NATL ACAD SCI USA, V89, P11121, DOI 10.1073/pnas.89.23.11121
   Brosnahan MM, 2010, EQUINE VET J, V42, P658, DOI 10.1111/j.2042-3306.2010.00166.x
   Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1
   Cahill JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003345
   Cain CM, 2011, J MAMMAL, V92, P751, DOI 10.1644/10-MAMM-S-104.1
   Chapman Demian D., 2010, Endangered Species Research, V9, P221, DOI 10.3354/esr00241
   Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664
   Cho YS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3433
   Chocu S, 2012, SYST BIOL REPROD MED, V58, P179, DOI 10.3109/19396368.2012.691943
   Claw KG, 2012, ANNU REV GENOM HUM G, V13, P109, DOI 10.1146/annurev-genom-090711-163745
   COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754
   Comizzoli P, 2009, REPROD DOMEST ANIM, V44, P269, DOI 10.1111/j.1439-0531.2009.01372.x
   DeSalle R, 2004, NAT REV GENET, V75, P04
   Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226
   Dorus S, 2012, SYST BIOL REPROD MED, V58, P218, DOI 10.3109/19396368.2012.700442
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Duran C, 2009, CURR BIOINFORM, V4, P16, DOI 10.2174/157489309787158198
   Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152
   EXCOFFIER L, 1992, GENETICS, V131, P479
   Fan B, 2010, ASIAN AUSTRAL J ANIM, V23, P833, DOI 10.5713/ajas.2010.r.03
   Finlay EK, 2007, BIOLOGY LETT, V3, P449, DOI 10.1098/rsbl.2007.0146
   Fitzpatrick BM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-176
   Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221
   Frankenberg S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-373
   FRANKHAM R, 2002, INTRO CONSERVATION G
   Fujita MK, 2009, CYTOGENET GENOME RES, V127, P261, DOI 10.1159/000295177
   Ganan N, 2010, REPRODUCTION, V139, P275, DOI 10.1530/REP-09-0259
   Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860
   GEYER CJ, 1993, MOL BIOL EVOL, V10, P571
   Govindaraju A, 2012, CELL TISSUE RES, V349, P783, DOI 10.1007/s00441-012-1452-2
   Grado-Ahuir JA, 2011, J ANIM SCI, V89, P1769, DOI 10.2527/jas.2010-3463
   Grant PR, 2010, PHILOS T R SOC B, V365, P1065, DOI 10.1098/rstb.2009.0283
   Grassa CJ, 2011, INT J EVOL BIOL, V2011, P9
   Griffiths AM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-31
   Haig SM, 1995, J HERED, V86, P423, DOI 10.1093/oxfordjournals.jhered.a111616
   Halbert ND, 2007, J HERED, V98, P1, DOI 10.1093/jhered/esl051
   Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0
   Hoffmann B, 2009, VET MICROBIOL, V139, P1, DOI 10.1016/j.vetmic.2009.04.034
   Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611
   Hong CP, 2011, EPIGENOMICS-UK, V3, P73, DOI [10.2217/epi.10.72, 10.2217/ERI.10.72]
   Huang W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-23
   Hughes JF, 2012, ANNU REV GENOM HUM G, V13, P83, DOI 10.1146/annurev-genom-090711-163855
   Hunter N, 1996, ARCH VIROL, V141, P809, DOI 10.1007/BF01718157
   Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891
   Jones KL, 2002, CONSERV BIOL, V16, P789, DOI 10.1046/j.1523-1739.2002.00001.x
   Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x
   Juengel JL, 2011, BIOL REPROD, V85, P113, DOI 10.1095/biolreprod.110.090514
   Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891
   Kidd AG, 2009, MOL ECOL, V18, P1175, DOI 10.1111/j.1365-294X.2009.04100.x
   Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996
   Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620
   Kohn MH, 2006, TRENDS ECOL EVOL, V21, P629, DOI 10.1016/j.tree.2006.08.001
   Kon T, 2007, MOL PHYLOGENET EVOL, V44, P53, DOI 10.1016/j.ympev.2006.12.007
   Kriger KM, 2006, ECOHEALTH, V3, P171, DOI 10.1007/s10393-006-0027-7
   Lacy RC, 2013, ZOO BIOL, V32, P19, DOI 10.1002/zoo.21029
   Lacy Robert C., 2000, Ecological Bulletins, V48, P191
   LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403
   Laval G, 2002, GENET SEL EVOL, V34, P481, DOI 10.1051/gse:2002019
   Li G, 2012, J DAIRY SCI, V95, P6122, DOI 10.3168/jds.2012-5591
   Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231
   Li JY, 2011, MAR BIOTECHNOL, V13, P232, DOI 10.1007/s10126-010-9284-0
   Li Jieying, 2011, MAR BIOTECHNOL, V13, P232, DOI [10.1007/s10126-010-9284-0, DOI 10.1007/S10126-010-9284-0]
   Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696
   Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103
   Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687
   Loire E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r136
   Loukovitis D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016599
   Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226
   Luikart G, 1999, TRENDS ECOL EVOL, V14, P253, DOI 10.1016/S0169-5347(99)01632-8
   Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x
   Luo SJ, 2008, CURR BIOL, V18, P592, DOI 10.1016/j.cub.2008.03.053
   MacHugh DE, 1998, ANIM GENET, V29, P333, DOI 10.1046/j.1365-2052.1998.295330.x
   MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2122, 10.1038/nrmicro2088]
   Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9
   Marshall TC, 2000, ANIM CONSERV, V3, P241, DOI 10.1111/j.1469-1795.2000.tb00109.x
   Mazur P, 2008, BIOL REPROD, V78, P2, DOI 10.1095/biolreprod.107.064113
   McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0
   McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007
   Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072
   Miller KM, 2011, SCIENCE, V331, P214, DOI 10.1126/science.1196901
   Miller W, 2012, P NATL ACAD SCI USA, V109, P14295
   Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109
   Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108
   Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368
   Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009
   MORIN PA, 1991, ZOO BIOL, V10, P341, DOI 10.1002/zoo.1430100408
   Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065
   Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498
   Nakamura Y, 2013, P NATL ACAD SCI USA, V110, P11061, DOI 10.1073/pnas.1302051110
   Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1
   Novak S, 2010, THERIOGENOLOGY, V74, P956, DOI 10.1016/j.theriogenology.2010.04.025
   Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632
   Ogden R, 2008, FISH FISH, V9, P462, DOI 10.1111/j.1467-2979.2008.00305.x
   Oleksyk TK, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-14
   Oliehoek PA, 2006, GENETICS, V173, P483, DOI 10.1534/genetics.105.049940
   Onteru SK, 2011, J ANIM SCI, V89, P988, DOI 10.2527/jas.2010-3236
   Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001
   Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x
   Parma P, 2012, SEX DEV, V6, P7, DOI 10.1159/000332209
   Pharo EA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-80
   Piferrer F, 2012, MAR BIOTECHNOL, V14, P591, DOI 10.1007/s10126-012-9445-4
   Prasad A, 2008, ANIM GENET, V39, P597, DOI 10.1111/j.1365-2052.2008.01772.x
   Primmer CR, 2009, ANN NY ACAD SCI, V1162, P357, DOI 10.1111/j.1749-6632.2009.04444.x
   Pritchard JK, 2000, GENETICS, V155, P945
   Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128
   Pukazhenthi BS, 2004, REPROD FERT DEVELOP, V16, P33, DOI 10.1071/RD03076
   Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x
   Reinartz GE, 1997, PRIMATE CONSERVATION
   Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81
   Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485
   Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416
   Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832
   Ryder OA, 2005, CYTOGENET GENOME RES, V108, P6, DOI 10.1159/000080796
   Sarropoulou E, 2011, COMP BIOCHEM PHYS D, V6, P92, DOI 10.1016/j.cbd.2010.09.003
   Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842
   Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249
   Schopen GCB, 2008, ANIM GENET, V39, P451, DOI 10.1111/j.1365-2052.2008.01736.x
   Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009
   Scott RT, 2010, FERTIL STERIL, V94, P791, DOI 10.1016/j.fertnstert.2010.03.041
   Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x
   Sironen AI, 2010, J ANIM SCI, V88, P821, DOI 10.2527/jas.2009-2426
   Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361
   Soller M, 2006, POULTRY SCI, V85, P2061, DOI 10.1093/ps/85.12.2061
   Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342
   Steiner CC, 2013, ANNU REV ANIM BIOSCI, V1, P261, DOI 10.1146/annurev-animal-031412-103636
   Stella A, 2008, ANIM GENET, V39, P8, DOI 10.1111/j.1365-2052.2007.01662.x
   Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538
   Swanson W.F., 2007, P417
   Swanson WJ, 2011, MOL BIOL EVOL, V28, P1963, DOI 10.1093/molbev/msr026
   Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733
   Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998
   Tapio I, 2010, GENET SEL EVOL, P42
   Templeton A.R., 1986, P105
   Templeton AR, 2001, P NATL ACAD SCI USA, V98, P5426, DOI 10.1073/pnas.091093098
   Teneva A., 2009, BIOTECHNOL ANIM HUSB, V25, P1267
   Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927
   Toro MA, 2009, LIVEST SCI, V120, P174, DOI 10.1016/j.livsci.2008.07.003
   Ungewitter EK, 2013, SEX DEV, V7, P7, DOI 10.1159/000338612
   Vargas A., 2008, International Zoo Yearbook, V42, P190, DOI 10.1111/j.1748-1090.2007.00036.x
   Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI 10.1051/gse:2002009
   Villanueva B, 2004, J ANIM SCI, V82, P1305
   Wang JL, 2003, GENETICS, V163, P429
   Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x
   Wildt DE, 2010, MOL REPROD DEV, V77, P397, DOI 10.1002/mrd.21137
   Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x
   Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588
   Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042
   Zhang BW, 2007, MOL BIOL EVOL, V24, P1801, DOI 10.1093/molbev/msm099
   Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729
   Zhou XM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3708
NR 165
TC 3
Z9 3
U1 5
U2 55
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
EI 2214-8019
BN 978-1-4939-0820-2; 978-1-4939-0819-6
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2014
VL 753
BP 71
EP 96
DI 10.1007/978-1-4939-0820-2_5
D2 10.1007/978-1-4939-0820-2
PG 26
WC Biodiversity Conservation; Reproductive Biology
SC Biodiversity & Conservation; Reproductive Biology
GA BC1SF
UT WOS:000350410000006
PM 25091907
DA 2018-10-20
ER

PT J
AU Lim, DJ
   Andukuri, A
   Vines, JB
   Rahman, SM
   Hwang, PTJ
   Kim, J
   Shalev, A
   Corbett, JA
   Jun, HW
AF Lim, Dong-Jin
   Andukuri, Adinarayana
   Vines, Jeremy B.
   Rahman, Shibli M.
   Hwang, Patrick T. J.
   Kim, Jeonga
   Shalev, Anath
   Corbett, John A.
   Jun, Ho-Wook
TI Enhanced MIN-6 beta cell survival and function on a nitric
   oxide-releasing peptide amphiphile nanomatrix
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nitric oxide; peptide amphiphile; biomimetic; diabetes; beta cells
ID ISLET TRANSPLANTATION; INSULIN-SECRETION; RODENT ISLETS; DYSFUNCTION;
   NANOFIBERS; INTERLEUKIN-1; ANGIOGENESIS; PATHOGENESIS; EXPRESSION;
   LANGERHANS
AB Innovative biomaterial strategies are required to improve islet cell retention, viability, and functionality, and thereby obtain clinically successful outcomes from pancreatic islet cell transplantation. To address this need, we have developed a peptide amphiphile-based nanomatrix that incorporates multifunctional bioactive cues and sustained release of nitric oxide. The goal of this study was to evaluate the effect of this peptide amphiphile nanomatrix on the viability and functionality of MIN-6 islet cells. Additionally, this study provides insight into the role of nitric oxide in islet cell biology, given that conventional nitric oxide donors are unable to release nitric oxide in a controlled, sustained manner, leading to ambiguous results. It was hypothesized that controlled nitric oxide release in synergy with multifunctional bioactive cues would promote islet cell viability and functionality. Nitric oxide-releasing peptide amphiphile nanomatrices within the range of 16.25 mu mol to 130 mu mol were used to analyze MIN-6 cell behavior. Both 32.5 mu mol and 65 mu mol peptide amphiphiles showed improved MIN-6 functionality in response to glucose over a 7-day time period, and the elevated functionality was correlated with both PDX-1 and insulin gene expression. Our results demonstrate that nitric oxide has a beneficial effect on MIN-6 cells in a concentration-dependent manner.
C1 [Lim, Dong-Jin; Andukuri, Adinarayana; Vines, Jeremy B.; Rahman, Shibli M.; Hwang, Patrick T. J.; Jun, Ho-Wook] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
   [Vines, Jeremy B.] Nutech Med Inc, Birmingham, AL USA.
   [Kim, Jeonga] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA.
   [Shalev, Anath] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.
   [Shalev, Anath; Jun, Ho-Wook] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.
   [Corbett, John A.] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA.
RP Jun, HW (reprint author), Univ Alabama Birmingham, Dept Biomed Engn, 806 Shelby Biomed Res Bldg,1825 Univ Blvd, Birmingham, AL 35294 USA.
EM hwjun@uab.edu
FU UAB Diabetes Research Training Center pilot grant [P60 DK-079626];
   American Diabetes Association [1-09-IN-23, 1-09-JF-33, 1-12-BS-99];
   NIDDK [1DP3DK094346-01]; NSF career award [CBET-0952974]; NIH
   [1R03EB017344-01]; American Heart Association [13GRNT17220057]; Wallace
   H Coulter Foundation; Woogok postdoctoral scholarship; Caroline P
   Ireland scholarship; American Heart Association predoctoral fellowship
FX The authors are grateful to Guanlan Xu, who helped to operate the Prism
   7000sequence detection system, and to Eun-Ha Lim, a scientific graphic
   designer who assisted with the graphic summary of this study. The
   authors gratefully acknowledge the MIN-6 cell line provided by Jun-Ichi
   Miyazaki (Osaka University Graduate School of Medicine, Osaka, Japan).
   We also would like to thank Donald F Steiner (Department of
   Biochemistry, University of Chicago, IL, USA) and Wanxing Cui for
   obtaining the MIN-6 cell line. This study was supported by a UAB
   Diabetes Research Training Center pilot grant (P60 DK-079626 to JK),
   grants from the American Diabetes Association (1-09-IN-23 to HWJ;
   1-09-JF-33 and 1-12-BS-99 to JK), NIDDK (1DP3DK094346-01 to HWJ), and an
   NSF career award (CBET-0952974 to HWJ), NIH (1R03EB017344-01 to HWJ),
   and funding from the American Heart Association (13GRNT17220057 to JK),
   the Wallace H Coulter Foundation (to HWJ), a Woogok postdoctoral
   scholarship (to DJL), and a Caroline P Ireland scholarship and American
   Heart Association predoctoral fellowship (both to AA).
CR Anderson JM, 2011, ACS NANO, V5, P9463, DOI 10.1021/nn203247m
   Anderson JM, 2011, ACTA BIOMATER, V7, P675, DOI 10.1016/j.actbio.2010.08.016
   Anderson JM, 2009, ACS NANO, V3, P3447, DOI 10.1021/nn900884n
   Anderson JM, 2009, BIOMACROMOLECULES, V10, P2935, DOI 10.1021/bm9007452
   Andukuri A, 2013, TISSUE ENG PART C-ME, V19, P375, DOI [10.1089/ten.tec.2012.0312, 10.1089/ten.TEC.2012.0312]
   Andukuri A, 2011, ACTA BIOMATER, V7, P225, DOI 10.1016/j.actbio.2010.08.013
   Andukuri A, 2010, NANOMED-NANOTECHNOL, V6, P289, DOI 10.1016/j.nano.2009.09.004
   Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844
   Campbell SC, 2007, BIOCHEM BIOPH RES CO, V353, P1011, DOI 10.1016/j.bbrc.2006.12.127
   Chow LW, 2010, BIOMATERIALS, V31, P6154, DOI 10.1016/j.biomaterials.2010.04.002
   Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73
   CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129
   CORBETT JA, 1995, J EXP MED, V181, P559, DOI 10.1084/jem.181.2.559
   Dimmeler S, 1999, CELL DEATH DIFFER, V6, P964, DOI 10.1038/sj.cdd.4400581
   Ding Y, 1998, BIOCHEM BIOPH RES CO, V251, P699, DOI 10.1006/bbrc.1998.9536
   Golocheikine A, 2010, TRANSPLANTATION, V90, P725, DOI 10.1097/TP.0b013e3181ef8a63
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Jun HW, 2005, ADV MATER, V17, P2612, DOI 10.1002/adma.200500855
   Kitiphongspattana K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1543, DOI 10.1152/ajpendo.00620.2006
   Kushwaha M, 2010, BIOMATERIALS, V31, P1502, DOI 10.1016/j.biomaterials.2009.10.051
   Laffranchi R, 1995, BIOCHEM BIOPH RES CO, V217, P584, DOI 10.1006/bbrc.1995.2815
   Lim DJ, 2011, MICRO NANO LETT, V6, P619, DOI 10.1049/mnl.2011.0026
   Lim DJ, 2011, TISSUE ENG PT A, V17, P399, DOI [10.1089/ten.tea.2010.0151, 10.1089/ten.TEA.2010.0151]
   MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649
   McDaniel ML, 1997, ADV EXP MED BIOL, V426, P313
   MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126
   Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425
   Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Smukler SR, 2002, DIABETES, V51, P3450, DOI 10.2337/diabetes.51.12.3450
   Stendahl JC, 2008, TRANSPLANTATION, V86, P478, DOI 10.1097/TP.0b013e3181806d9d
   Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195
   STEVENS RB, 1994, TRANSPLANT P, V26, P692
   Tambralli A, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/025001
   Tejedo JR, 2001, CELL SIGNAL, V13, P809, DOI 10.1016/S0898-6568(01)00206-6
   XENOS ES, 1994, TRANSPLANTATION, V57, P1208, DOI 10.1097/00007890-199404270-00012
NR 37
TC 4
Z9 4
U1 1
U2 9
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
SU 1
BP 13
EP 21
DI 10.2147/IJN.S50873
PG 9
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA CB9OL
UT WOS:000349961100003
PM 24872700
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Wan, WK
   Bannerman, AD
   Yang, LF
   Mak, H
AF Wan, Wankei
   Bannerman, A. Dawn
   Yang, Lifang
   Mak, Helium
BE Okay, O
TI Poly(Vinyl Alcohol) Cryogels for Biomedical Applications
SO POLYMERIC CRYOGELS: MACROPOROUS GELS WITH REMARKABLE PROPERTIES
SE Advances in Polymer Science
LA English
DT Review; Book Chapter
DE Poly(vinyl alcohol); Physical crosslinking; Cryogel; Medical device;
   Controlled release
ID HEART-VALVE PROSTHESIS; SMALL-ANGLE NEUTRON; LOW-BACK-PAIN;
   POLYVINYL-ALCOHOL; MECHANICAL-PROPERTIES; ARTICULAR-CARTILAGE; POLYMER
   SYSTEMS; DRUG-DELIVERY; INTERVERTEBRAL DISC; CELL COMPATIBILITY
AB Poly(vinyl alcohol) (PVA) is a hydrophilic and biocompatible polymer that can be crosslinked to form a hydrogel. When physically crosslinked using a freeze-thaw cycling process, the product hydrogel or cryogel (PVA-C) possesses unique mechanical properties that can be tuned to closely match those of soft tissues, thus making it an attractive candidate for biomedical and especially medical device applications. We review the freeze-thaw cycling process and processing parameters that impact on the properties of PVA-C and its nanocomposite products. Both the mechanical properties and diffusion properties relevant to biomedical application are discussed. Applications to orthopedic and cardiovascular devices are summarized and discussed. The concept of biomaterial-tissue hybrids that can impart the necessary hemocompatibility to PVA-C for cardiovascular device is introduced and demonstrated.
C1 [Wan, Wankei; Bannerman, A. Dawn; Yang, Lifang; Mak, Helium] Univ Western Ontario, Grad Program Biomed Engn, London, ON N6A 5B9, Canada.
   [Wan, Wankei] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Wan, WK (reprint author), Univ Western Ontario, Grad Program Biomed Engn, London, ON N6A 5B9, Canada.
EM wkwan@uwo.ca
CR Abdel-Mohsen AM, 2011, J POLYM ENVIRON, V19, P1005, DOI 10.1007/s10924-011-0334-0
   Abe H., 1996, DATA BOOK MECH PROPE
   Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c
   Berglund L., 2005, NATURAL FIBERS BIOPO, P819
   Bodugoz-Senturk H, 2009, BIOMATERIALS, V30, P589, DOI 10.1016/j.biomaterials.2008.10.010
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   Briscoe B, 2000, POLYMER, V41, P3851, DOI 10.1016/S0032-3861(99)00550-9
   CASSIDY JJ, 1990, J MATER SCI-MATER M, V1, P69, DOI 10.1007/BF00839071
   Causa F, 2002, J MATER SCI-MATER M, V13, P1277, DOI 10.1023/A:1021143516436
   CHA WI, 1993, MAKROMOL CHEM, V194, P2433
   Chirila TV, 1998, PROG POLYM SCI, V23, P447, DOI 10.1016/S0079-6700(97)00036-1
   Cote P, 2008, SPINE, V33, pS60, DOI 10.1097/BRS.0b013e3181643ee4
   Cote P, 2008, SPINE, V33, pS192, DOI 10.1097/BRS.0b013e3181644616
   Dravida S, 2008, J TISSUE ENG REGEN M, V2, P263, DOI 10.1002/term.91
   Duboeuf F, 2009, MED PHYS, V36, P656, DOI 10.1118/1.3065031
   Eichhorn SJ, 2001, J MATER SCI, V36, P2107, DOI 10.1023/A:1017512029696
   Fergg F, 2001, COLLOID POLYM SCI, V279, P61, DOI 10.1007/s003960000398
   FICEK BJ, 1993, J CONTROL RELEASE, V27, P259, DOI 10.1016/0168-3659(93)90156-Y
   Fink JK, 2011, HDB ENG SPECIALTY TH
   Fromageau J, 2007, IEEE T ULTRASON FERR, V54, P498, DOI 10.1109/TUFFC.2007.273
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   Gordon M, 1999, THESIS U W ONTARIO
   Gu Zheng-Qiu, 1998, Bio-Medical Materials and Engineering, V8, P75
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   GUSEV DG, 1990, MAGN RESON CHEM, V28, P651, DOI 10.1002/mrc.1260280717
   Hassan CM, 2000, MACROMOLECULES, V33, P2472, DOI 10.1021/ma9907587
   Hassan CM, 2000, EUR J PHARM BIOPHARM, V49, P161, DOI 10.1016/S0939-6411(99)00056-9
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   HATAKEYAMA T, 1987, EUR POLYM J, V23, P361, DOI 10.1016/0014-3057(87)90164-9
   HICKEY AS, 1995, J MEMBRANE SCI, V107, P229, DOI 10.1016/0376-7388(95)00119-0
   Holloway JL, 2013, SOFT MATTER, V9, P826, DOI 10.1039/c2sm26763b
   Holloway JL, 2011, ACTA BIOMATER, V7, P2477, DOI 10.1016/j.actbio.2011.02.016
   Hoy D, 2010, BEST PRACT RES CL RH, V24, P155, DOI 10.1016/j.berh.2009.11.002
   Hudson SD, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3050096
   Hui AJ, 1998, THESIS U W ONTARIO
   HYON SH, 1987, Patent No. 4663358
   Jiang HJ, 2004, MED ENG PHYS, V26, P269, DOI 10.1016/j.medengphy.2003.10.007
   Jiang T, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025012
   Joshi A, 2006, BIOMATERIALS, V27, P176, DOI 10.1016/j.biomaterials.2005.06.003
   KANAYA T, 1995, MACROMOLECULES, V28, P3168, DOI 10.1021/ma00113a019
   KANAYA T, 1994, MACROMOLECULES, V27, P5609, DOI 10.1021/ma00098a014
   Kennedy KL, 2011, CURR DRUG DELIV, V8, P534
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Kovacs FM, 2004, SPINE, V29, P206, DOI 10.1097/01.BRS.0000107235.47465.08
   Li JK, 1998, J CONTROL RELEASE, V56, P117, DOI 10.1016/S0168-3659(98)00089-3
   Liu KF, 2011, J MECH BEHAV BIOMED, V4, P440, DOI 10.1016/j.jmbbm.2010.12.005
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Liu Y, 2009, J BIOMED MATER RES B, V90B, P492, DOI 10.1002/jbm.b.31310
   Lozinsky VI, 2007, COLLOID J+, V69, P747, DOI 10.1134/S1061933X07060117
   Lozinsky VI, 2012, COLLOID J+, V74, P319, DOI 10.1134/S1061933X12030088
   Lozinsky VI, 2000, J APPL POLYM SCI, V77, P2017, DOI 10.1002/1097-4628(20000829)77:9<2017::AID-APP18>3.0.CO;2-6
   Lozinsky VI, 1998, ENZYME MICROB TECH, V23, P227, DOI 10.1016/S0141-0229(98)00036-2
   Lozinsky VI, 2002, USP KHIM+, V71, P559
   LOZINSKY VI, 1995, J APPL POLYM SCI, V58, P171, DOI 10.1002/app.1995.070580119
   Lozinsky VI, 1996, J APPL POLYM SCI, V61, P1991, DOI 10.1002/(SICI)1097-4628(19960912)61:11<1991::AID-APP13>3.0.CO;2-2
   Lozinsky VI, 2000, J APPL POLYM SCI, V77, P1822, DOI 10.1002/1097-4628(20000822)77:8<1822::AID-APP20>3.0.CO;2-#
   Mansur HS, 2009, MAT SCI ENG C-BIO S, V29, P1574, DOI 10.1016/j.msec.2008.12.012
   Mathews DT, 2008, J BIOMED MATER RES B, V84B, P531, DOI 10.1002/jbm.b.30901
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P305, DOI 10.1002/jbm.b.30543
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Millon LE, 2006, THESIS U W ONTARIO
   Millon LE, 2007, MACROMOLECULES, V40, P3655, DOI 10.1021/ma062781f
   Millon LE, 2012, J BIOMED MATER RES B, V100B, P1, DOI 10.1002/jbm.b.31860
   Millon LE, 2009, J BIOMED MATER RES B, V90B, P922, DOI 10.1002/jbm.b.31364
   Mohammadi H, 2009, P I MECH ENG H, V223, P697, DOI 10.1243/09544119JEIM493
   Nakaoki T, 2008, J MOL STRUCT, V875, P282, DOI 10.1016/j.molstruc.2007.04.040
   National Toxicology Program, 1998, NATL TOXICOL PROGR T, V474, P1
   Nishinari K, 1996, J CHIM PHYS PCB, V93, P880, DOI 10.1051/jcp/1996930880
   Northwood E, 2007, CLIN BIOMECH, V22, P834, DOI 10.1016/j.clinbiomech.2007.03.008
   Nugent MJD, 2005, J MATER SCI-MATER M, V16, P1149, DOI 10.1007/s10856-005-4722-7
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   OHKURA M, 1992, POLYMER, V33, P3686, DOI 10.1016/0032-3861(92)90656-H
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   Padavan DT, 2011, ACTA BIOMATER, V7, P258, DOI 10.1016/j.actbio.2010.07.038
   Pan YS, 2007, WEAR, V262, P1021, DOI 10.1016/j.wear.2006.10.005
   Pan YS, 2007, J MATER SCI, V42, P5129, DOI 10.1007/s10853-006-1264-4
   Pazos V, 2009, J MECH BEHAV BIOMED, V2, P542, DOI 10.1016/j.jmbbm.2009.01.003
   PEPPAS NA, 1991, J CONTROL RELEASE, V16, P305, DOI 10.1016/0168-3659(91)90007-Z
   PEPPAS NA, 1980, BIOMATERIALS, V1, P158, DOI 10.1016/0142-9612(80)90039-3
   PEPPAS NA, 1996, BIOMATERIALS SCI INT, P60
   Perie DS, 2006, ANN BIOMED ENG, V34, P769, DOI 10.1007/s10439-006-9091-y
   Ratner B. D, 1976, HYDROGELS MEDICAL RE, V31, P1
   Ricciardi R, 2004, MACROMOLECULES, V37, P1921, DOI 10.1021/ma035663q
   Ricciardi R, 2005, MACROMOLECULES, V38, P6629, DOI 10.1021/ma0506031
   Richardson J, 2006, FRONT BIOSCI-LANDMRK, V11, P1042, DOI 10.2741/1862
   Sailaja GS, 2009, ACTA BIOMATER, V5, P1647, DOI 10.1016/j.actbio.2008.12.005
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Shaheen SM, 2002, J CONTROL RELEASE, V81, P367, DOI 10.1016/S0168-3659(02)00085-8
   Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   SUGAWARA T, 1995, J BIOMED MATER RES, V29, P1047, DOI 10.1002/jbm.820290904
   Swieszkowski W, 2006, BIOMATERIALS, V27, P1534, DOI 10.1016/j.biomaterials.2005.08.032
   TADAVARTHY SM, 1975, AM J ROENTGENOL, V125, P609, DOI 10.2214/ajr.125.3.609
   TRIEU H, 1995, POLYMER, V36, P2531, DOI 10.1016/0032-3861(95)91198-G
   URUSHIZAKI F, 1990, INT J PHARM, V58, P135
   VANAARTS.JJ, 1970, EUR POLYM J, V6, P919, DOI 10.1016/0014-3057(70)90026-1
   Vrana NE, 2008, MACROMOL SYMP, V269, P106, DOI 10.1002/masy.200850913
   Wan WK, 2002, J BIOMED MATER RES, V63, P854, DOI 10.1002/jbm.10333
   Wang BH, 2009, SPINE, V34, P2745, DOI 10.1097/BRS.0b013e3181b4abf5
   Wang JH, 2010, MAT SCI ENG C-MATER, V30, P214, DOI 10.1016/j.msec.2009.10.006
   WATASE M, 1983, CRYO-LETT, V4, P197
   WATASE M, 1983, POLYM COMMUN, V24, P52
   Willcox PJ, 1999, J POLYM SCI POL PHYS, V37, P3438
   Wong EYL, 2012, THESIS U W ONTARIO
   YOKOYAMA F, 1986, COLLOID POLYM SCI, V264, P595, DOI 10.1007/BF01412597
   Zajaczkowski MB, 2003, TISSUE ENG, V9, P525, DOI 10.1089/107632703322066705
   Zeng YJ, 2001, J BIOMECH, V34, P533, DOI 10.1016/S0021-9290(00)00219-0
NR 109
TC 21
Z9 21
U1 11
U2 72
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 978-3-319-05846-7; 978-3-319-05845-0
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2014
VL 263
BP 283
EP 321
DI 10.1007/978-3-319-05846-7_8
D2 10.1007/978-3-319-05846-7
PG 39
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA BB9ZO
UT WOS:000348834500009
DA 2018-10-20
ER

PT J
AU Bornes, TD
   Adesida, AB
   Jomha, NM
AF Bornes, Troy D.
   Adesida, Adetola B.
   Jomha, Nadr M.
TI Mesenchymal stem cells in the treatment of traumatic articular cartilage
   defects: a comprehensive review
SO ARTHRITIS RESEARCH & THERAPY
LA English
DT Review
ID MARROW STROMAL CELLS; HUMAN BONE-MARROW; AUTOLOGOUS CHONDROCYTE
   IMPLANTATION; ENHANCES CHONDROGENIC DIFFERENTIATION; RANDOMIZED
   CONTROLLED-TRIAL; FIBROBLAST GROWTH FACTOR-2; OSTEOCHONDRAL LESIONS;
   IN-VIVO; RABBIT MODEL; FEMORAL CONDYLE
AB Articular cartilage has a limited capacity to repair following injury. Early intervention is required to prevent progression of focal traumatic chondral and osteochondral defects to advanced cartilage degeneration and osteoarthritis. Novel cell-based tissue engineering techniques have been proposed with the goal of resurfacing defects with bioengineered tissue that recapitulates the properties of hyaline cartilage and integrates into native tissue. Transplantation of mesenchymal stem cells (MSCs) is a promising strategy given the high proliferative capacity of MSCs and their potential to differentiate into cartilage-producing cells - chondrocytes. MSCs are historically harvested through bone marrow aspiration, which does not require invasive surgical intervention or cartilage extraction from other sites as required by other cell-based strategies. Biomaterial matrices are commonly used in conjunction with MSCs to aid cell delivery and support chondrogenic differentiation, functional extracellular matrix formation and three-dimensional tissue development. A number of specific transplantation protocols have successfully resurfaced articular cartilage in animals and humans to date. In the clinical literature, MSC-seeded scaffolds have filled a majority of defects with integrated hyaline-like cartilage repair tissue based on arthroscopic, histologic and imaging assessment. Positive functional outcomes have been reported at 12 to 48 months post-implantation, but future work is required to assess long-term outcomes with respect to other treatment modalities. Despite relatively positive outcomes, further investigation is required to establish a consensus on techniques for treatment of chondral and osteochondral defects with respect to cell source, isolation and expansion, implantation density, in vitro precultivation, and scaffold composition. This will allow for further optimization of MSC proliferation, chondrogenic differentiation, bioengineered cartilage integration, and clinical outcome.
C1 [Bornes, Troy D.; Adesida, Adetola B.; Jomha, Nadr M.] Univ Alberta, Dept Surg, Lab Stem Cell Biol & Orthopaed Tissue Engn, Edmonton, AB T6G 2E1, Canada.
   [Bornes, Troy D.; Adesida, Adetola B.; Jomha, Nadr M.] Univ Alberta, Dept Surg, Div Orthopaed Surg, Edmonton, AB T6G 2B7, Canada.
RP Adesida, AB (reprint author), Univ Alberta, Dept Surg, Lab Stem Cell Biol & Orthopaed Tissue Engn, Edmonton, AB T6G 2E1, Canada.
EM adesida@ualberta.ca
FU Canadian Institutes of Health Research [125921-1]
CR Acharya C, 2012, J CELL PHYSIOL, V227, P88, DOI 10.1002/jcp.22706
   Adachi N, 2005, J RHEUMATOL, V32, P1615
   Adesida AB, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt100
   Anders S, 2012, INT ORTHOP, V36, P2279, DOI 10.1007/s00264-012-1635-1
   Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030
   Ando W, 2012, EUR CELLS MATER, V24, P292, DOI 10.22203/eCM.v024a21
   Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0
   Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001
   Barbour KE, 2013, MMWR-MORBID MORTAL W, V62, P869
   Bekkers JEJ, 2013, AM J SPORT MED, V41, P2158, DOI 10.1177/0363546513494181
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Buda R, 2010, J BONE JOINT SURG AM, V92A, P2, DOI 10.2106/JBJS.J.00813
   Chang NJ, 2013, OSTEOARTHR CARTILAGE, V21, P1613, DOI 10.1016/j.joca.2013.07.016
   Choi JW, 2013, ARTIF ORGANS, V37, P648, DOI 10.1111/aor.12041
   Darling EM, 2003, ANN BIOMED ENG, V31, P1114, DOI 10.1114/1.1603752
   Dashtdar H, 2013, KNEE SURG SPORTS TRA
   Dashtdar H, 2011, J ORTHOP RES, V29, P1336, DOI 10.1002/jor.21413
   de Vries-van Melle ML, 2014, TISSUE ENG PT A, V20, P23, DOI [10.1089/ten.tea.2013.0080, 10.1089/ten.TEA.2013.0080]
   Deng J, 2013, J MATER SCI-MATER M, V24, P2037, DOI 10.1007/s10856-013-4944-z
   DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x
   DePALMA ANTHONY F., 1966, CLIN ORTHOP RELATED RES, V48, P229
   Dragoo JL, 2007, TISSUE ENG, V13, P1615, DOI 10.1089/ten.2006.0249
   Enea D, 2013, KNEE, V20, P562, DOI 10.1016/j.knee.2013.04.003
   Filardo G, 2013, KNEE, V20, P570, DOI 10.1016/j.knee.2013.05.007
   FURUKAWA T, 1980, J BONE JOINT SURG AM, V62, P79, DOI 10.2106/00004623-198062010-00012
   Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007
   Giannini S, 2013, AM J SPORT MED, V41, P511, DOI 10.1177/0363546512467622
   Giannini S, 2010, INJURY, V41, P1196, DOI 10.1016/j.injury.2010.09.028
   Giannini S, 2009, CLIN ORTHOP RELAT R, V467, P3307, DOI 10.1007/s11999-009-0885-8
   Gigante A, 2011, INT J IMMUNOPATH PH, V24, P69, DOI 10.1177/03946320110241S213
   Gigante A, 2012, ARTHROSC TEC, V1, pE175, DOI 10.1016/j.eats.2012.07.001
   Gille J, 2010, KNEE SURG SPORT TR A, V18, P1456, DOI 10.1007/s00167-010-1042-3
   Gobbi A, 2006, ARTHROSCOPY, V22, P1085, DOI 10.1016/j.arthro.2006.05.016
   Gobbi A, 2011, CARTILAGE, V2, P286, DOI 10.1177/1947603510392023
   Godara P, 2008, J CHEM TECHNOL BIOT, V83, P408, DOI 10.1002/jctb.1918
   Gudas R, 2012, AM J SPORT MED, V40, P2499, DOI 10.1177/0363546512458763
   Guo XM, 2004, TISSUE ENG, V10, P1818, DOI 10.1089/ten.2004.10.1818
   Haleem AM, 2010, CARTILAGE, V1, P253, DOI 10.1177/1947603510366027
   Han SH, 2008, J BIOMED MATER RES A, V87A, P850, DOI 10.1002/jbm.a.31828
   Harrison P. E., 2000, Cell and Tissue Banking, V1, P255, DOI 10.1023/A:1010131729208
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Hori J, 2011, J ORTHOP RES, V29, P531, DOI 10.1002/jor.21267
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Jomha NM, 2012, BIOMATERIALS, V33, P6061, DOI 10.1016/j.biomaterials.2012.05.007
   Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285
   Kamei G, 2013, AM J SPORT MED, V41, P1255, DOI 10.1177/0363546513483270
   Kasemkijwattana Channarong, 2011, Journal of the Medical Association of Thailand, V94, P395
   Khan WS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2448
   Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5
   Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281
   Koga H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2460
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2012, J BONE JOINT SURG AM, V94A, P85
   Kon E, 2011, AM J SPORT MED, V39, P2549, DOI 10.1177/0363546511420688
   Kumai T, 2002, J BONE JOINT SURG BR, V84B, P369, DOI 10.1302/0301-620X.84B3.12373
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   Lai CH, 2010, ULTRASOUND MED BIOL, V36, P1022, DOI 10.1016/j.ultrasmedbio.2010.03.014
   Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311
   Levy YD, 2013, CLIN ORTHOP RELAT R, V471, P231, DOI 10.1007/s11999-012-2556-4
   Li QA, 2011, ARTIF CELL BLOOD SUB, V39, P31, DOI 10.3109/10731191003776769
   Loken S, 2008, KNEE SURG SPORT TR A, V16, P896, DOI 10.1007/s00167-008-0566-2
   Mahmoudifar N, 2010, BIOMATERIALS, V31, P3858, DOI 10.1016/j.biomaterials.2010.01.090
   Malinin T I, 1994, Clin Orthop Relat Res, P18
   Marquass B, 2011, AM J SPORT MED, V39, P1401, DOI 10.1177/0363546511398646
   Marsano A, 2007, OSTEOARTHR CARTILAGE, V15, P48, DOI 10.1016/j.joca.2006.06.009
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Martin JA, 2001, J GERONTOL A-BIOL, V56, pB172, DOI 10.1093/gerona/56.4.B172
   Masuoka K, 2006, J BIOMED MATER RES B, V79B, P25, DOI 10.1002/jbm.30507
   Matsuda C, 2005, CYTOTECHNOLOGY, V47, P11, DOI 10.1007/s10616-005-3751-x
   MAYNE R, 1976, P NATL ACAD SCI USA, V73, P1674, DOI 10.1073/pnas.73.5.1674
   McIlwraith CW, 2011, ARTHROSCOPY, V27, P1552, DOI 10.1016/j.arthro.2011.06.002
   Mizuno S, 2002, J CELL PHYSIOL, V193, P319, DOI 10.1002/jcp.10180
   Mo XT, 2009, BONE, V45, P42, DOI 10.1016/j.bone.2008.07.240
   Mukonoweshuro B, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414534255
   Munir S, 2014, CELL TISSUE RES, V355, P89, DOI 10.1007/s00441-013-1732-5
   Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374
   Naderi-Meshkin H, 2014, CELL BIOL INT, V38, P72, DOI 10.1002/cbin.10181
   Nam EK, 2009, AM J SPORT MED, V37, P274, DOI 10.1177/0363546508325670
   Nam HY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4309
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   NOBLE BS, 1995, BONE, V17, P375, DOI 10.1016/S8756-3282(95)00247-2
   OCEBM Levels of Evidence Working Group, OXF LEV EV 2
   Park J, 2006, J GENE MED, V8, P112, DOI 10.1002/jgm.826
   Pei M, 2009, OSTEOARTHR CARTILAGE, V17, P714, DOI 10.1016/j.joca.2008.11.017
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qi YY, 2012, MOL BIOL REP, V39, P1231, DOI 10.1007/s11033-011-0853-8
   Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Saw KY, 2013, ARTHROSCOPY, V29, P684, DOI 10.1016/j.arthro.2012.12.008
   Saw KY, 2011, ARTHROSCOPY, V27, P493, DOI 10.1016/j.arthro.2010.11.054
   Saw KY, 2009, ARTHROSCOPY, V25, P1391, DOI 10.1016/j.arthro.2009.07.011
   Schinhan M, 2012, J ORTHOP RES, V30, P214, DOI 10.1002/jor.21521
   SCHWARZ RI, 1987, ANN NY ACAD SCI, V498, P172, DOI 10.1111/j.1749-6632.1987.tb23760.x
   Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040
   Shimomura K, 2014, TISSUE ENG A
   Shimomura K, 2010, BIOMATERIALS, V31, P8004, DOI 10.1016/j.biomaterials.2010.07.017
   Solheim E, 2013, KNEE, V20, P287, DOI 10.1016/j.knee.2013.01.001
   Steinwachs M, 2012, CARTILAGE, V3, P5, DOI 10.1177/1947603511415839
   Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461
   Stufkens SA, 2010, J BONE JOINT SURG AM, V92A, P279, DOI 10.2106/JBJS.H.01635
   Tay LX, 2012, AM J SPORT MED, V40, P83, DOI 10.1177/0363546511420819
   Teo BJX, 2013, CLIN ORTHOP RELAT R, V471, P1152, DOI 10.1007/s11999-012-2338-z
   Uematsu K, 2005, BIOMATERIALS, V26, P4273, DOI 10.1016/j.biomaterials.2004.10.037
   Valderrabano V, 2009, AM J SPORT MED, V37, p105S, DOI 10.1177/0363546509351481
   Vinardell T, 2009, ANN BIOMED ENG, V37, P2556, DOI 10.1007/s10439-009-9791-1
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8
   Wakitani S, 2011, J TISSUE ENG REGEN M, V5, P146, DOI 10.1002/term.299
   Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953
   Wegener B, 2010, J BIOMED MATER RES A, V95A, P735, DOI 10.1002/jbm.a.32885
   Williams SK, 2003, J BONE JOINT SURG AM, V85A, P2111, DOI 10.2106/00004623-200311000-00008
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
   World Health Organization Scientific Group, 2003, WHO TECHN REP SER, V919, P24
   Zhang Y, 2012, INT ORTHOP, V36, P1079, DOI 10.1007/s00264-011-1362-z
   Zhao YH, 2013, CHINESE MED J-PEKING, V126, P3130, DOI 10.3760/cma.j.issn.0366-6999.20130212
   Zscharnack M, 2010, AM J SPORT MED, V38, P1857, DOI 10.1177/0363546510365296
NR 121
TC 60
Z9 60
U1 1
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1478-6354
EI 1478-6362
J9 ARTHRITIS RES THER
JI Arthritis Res. Ther.
PY 2014
VL 16
IS 5
AR 432
DI 10.1186/s13075-014-0432-1
PG 19
WC Rheumatology
SC Rheumatology
GA CB8NC
UT WOS:000349885900011
PM 25606595
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Sinha, S
   Pramanik, PC
   Begam, H
   Chanda, A
AF Sinha, Sarmita
   Pramanik, Prabir Chandra
   Begam, Howa
   Chanda, Abhijit
BE Balasubramanian, KR
   Sivapirakasam, SP
   Anand, R
TI Study on the effect of strain rate and temperature on mechanical
   properties of Nitinol
SO DYNAMICS OF MACHINES AND MECHANISMS, INDUSTRIAL RESEARCH
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT 16th International Mechanical Engineering Congress (IMEC)
CY JUN 13-15, 2014
CL Tamil Nadu, INDIA
SP Natl Inst Technol, Dept Mech Engn, Techn Educ Qual Improvement Programme
DE Biomaterial; Super elastic; Nitinol; hysteresis; Heamocompatibility
AB The successful use of Nickel-Titanium (Nitinol) in biomedical applications requires an accurate control of its unique mechanical properties. The purpose of this study is to analyze the effects of a wide range of heat treatments on the mechanical behaviour of Nitinol. We have taken two different grades of Nitinol with different heat treatment history and surface characteristics. Series of tensile tests were performed using universal testing machine to find out various mechanical properties.
C1 [Sinha, Sarmita; Pramanik, Prabir Chandra; Begam, Howa; Chanda, Abhijit] Jadavpur Univ, Sch Biosci & Engn, Kolkata 700032, India.
RP Sinha, S (reprint author), Jadavpur Univ, Sch Biosci & Engn, Kolkata 700032, India.
EM sinha.sarmita@gmail.com; prabirchandra67@gmail.com; howabegam@gmail.com;
   abhijitchanda.biomed@gmail.com
CR Adharapurapu RR, 2010, MAT SCI ENG A-STRUCT, V527, P5255, DOI 10.1016/j.msea.2010.04.076
   Halani PR, 2013, MAT SCI ENG A-STRUCT, V559, P836, DOI 10.1016/j.msea.2012.09.031
   Nayan N, 2009, MAT SCI ENG A-STRUCT, V525, P60, DOI 10.1016/j.msea.2009.07.038
   Pelton AR, 2000, MINIM INVASIV THER, V9, P107, DOI 10.3109/13645700009063057
   Sadiq H., 2010, SMART MAT STRUCT, V19
   Schlun M, 2011, J MATER ENG PERFORM, V20, P684, DOI 10.1007/s11665-010-9790-2
   Shabalovskaya SA, 2013, MAT SCI ENG C-MATER, V33, P127, DOI 10.1016/j.msec.2012.08.018
NR 7
TC 1
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03835-163-4
J9 APPL MECH MATER
PY 2014
VL 592-594
BP 1185
EP 1189
DI 10.4028/www.scientific.net/AMM.592-594.1185
PG 5
WC Engineering, Mechanical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA BC0BL
UT WOS:000348897200223
DA 2018-10-20
ER

PT S
AU Ferreira, JRM
   da Rocha, DN
   Louro, LHL
   da Silva, MHP
AF Muniz Ferreira, Jose Ricardo
   da Rocha, Daniel Navarro
   Leme Louro, Luis Henrique
   Prado da Silva, Marcelo H.
BE Antoniac, I
   Cavalu, S
   Traistaru, T
TI Phosphating of Calcium Carbonate for Obtaining Hydroxyapatite From the
   Ostrich Egg Shell
SO BIOCERAMICS, VOL 25
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 25th Symposium and Annual Meeting of the
   International-Society-for-Ceramics-in-Medicine (ISCM)
CY NOV 07-10, 2013
CL Bucharest, ROMANIA
SP Int Soc Ceram Med
DE Synthesis of Hydroxyapatite; Ostrich Eggshell; Phosphating of Calcium
   Carbonate
AB Hydroxyapatite (HA), the major component of the inorganic portion of bones, may be obtained from different sources for use as biomaterial in the reconstruction of critical bone defects. Among these resources, the eggshell appears as a promising alternative since it is a waste material which may be reused as a source of calcium carbonate after adequate treatment, giving rise to mineral hydroxyapatite. After morphological and physicochemical adjustments allowing its standardization and utilization, hydroxyapatite (HA) may turn into a potentially useful biomaterial for different experimental purposes. This paper aims to present a viable method for obtaining a hydroxyapatite from ostrich eggshell by a wet precipitation process. This phosphating technique with emphasis on the issue of sustainable reuse of disposable materials allows the production of a synthetic crystalline material with characteristics similar to those of bone and tooth. The structural characterization was performed by X-ray diffraction and scanning electron microscopy with field emission gun and energy dispersive X-ray in the Military Institute of Engineering.
C1 [Muniz Ferreira, Jose Ricardo; da Rocha, Daniel Navarro; Leme Louro, Luis Henrique; Prado da Silva, Marcelo H.] IME, Rio De Janeiro, RJ, Brazil.
RP Ferreira, JRM (reprint author), IME, Rio De Janeiro, RJ, Brazil.
EM marceloprado@ime.eb.br
RI Navarro da Rocha, Daniel/C-9386-2018
OI Navarro da Rocha, Daniel/0000-0003-2413-345X
CR Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Dupoirieux L, 1999, BRIT J ORAL MAX SURG, V37, P467, DOI 10.1054/bjom.1999.0041
   Garg A. K., 1999, TISSUE ENG APPL MAXI
   JUNQUEIRA LC, 1982, HISTOLOGIA BASICA
   Kokubo T., 2003, BIOMATERIAL IN PRESS
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   Lynch S.E., 1999, TISSUE ENG APPL MAXI
   Misch CA, 1999, CONT IMPLANT DENT
   Nayak AK, 2010, INT J CHEMTECH RES, V2
   Oliveira D.A., 2009, 2 INT WORKSH ADV CLE
   Saadoun A P, 1999, Pract Periodontics Aesthet Dent, V11, P1063
   Vollmer T.M., 2006, THESIS UFRGS
   Yamamoto M.K, 1994, REV ODONTOL U S PAUL, V8, P281
NR 13
TC 0
Z9 0
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2014
VL 587
BP 69
EP 73
DI 10.4028/www.scientific.net/KEM.587.69
PG 5
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Materials Science
GA BA4RR
UT WOS:000336185000011
DA 2018-10-20
ER

PT S
AU Tonoli, MS
   Beppu, MM
AF Tonoli, Marina S.
   Beppu, Marisa M.
BE Antoniac, I
   Cavalu, S
   Traistaru, T
TI In situ X-ray diffraction study of phase development during hardening of
   beta- tricalcium phosphate bone cements with chitosan
SO BIOCERAMICS, VOL 25
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 25th Symposium and Annual Meeting of the
   International-Society-for-Ceramics-in-Medicine (ISCM)
CY NOV 07-10, 2013
CL Bucharest, ROMANIA
SP Int Soc Ceram Med
DE calcium phosphate cements; biomaterial; chitosan; hardening process
ID CALCIUM-PHOSPHATE; CALCIFICATION
AB The aim of this work was to study the phase transformation during the setting reaction of beta tricalcium phosphate (beta-TCP) and phosphoric acid with chitosan solution added. To follow the kinetics of the phase transformation, two methods were used: x-ray diffraction (XRD) was used to study the phase evolution during the hardening process in real time, and was also used in samples where the reaction was supposedly stopped in different times using acetone, as indicated in literature. The setting reaction occurs so fast that the phase transformation could not be observed, but it was possible to invalidate the second mentioned method for this system, as it induces the final product dicalcium phosphate dihydrate DCPD (brushite) to be converted into his anhydrous form dicalcium phosphate DCP (monetite). The addition of chitosan in order to improve biocompatibility was successfully done, it could be observed that chitosan inhibits brushite crystallization in the first moment of the reaction, but the final product was not affected by it.
C1 [Tonoli, Marina S.; Beppu, Marisa M.] Univ Estadual Campinas, BR-13083852 Campinas, SP, Brazil.
RP Tonoli, MS (reprint author), Univ Estadual Campinas, Caixa Postal 6066, BR-13083852 Campinas, SP, Brazil.
EM marinatonoli@gmail.com; beppu@feq.unicamp.br
RI BEPPU, MARISA/E-1057-2012
CR Aimoli CG, 2007, ARTIF ORGANS, V31, P278, DOI 10.1111/j.1525-1594.2007.00376.x
   Aimoli CG, 2006, COLLOID SURFACE B, V53, P15, DOI 10.1016/j.colsurfb.2006.07.012
   Aimoli CG, 2006, MAT SCI ENG C-BIO S, V26, P78, DOI 10.1016/j.msec.2005.06.037
   [Anonymous], ASTMC26604
   Beppu MM, 2004, KEY ENG MAT, V254-2, P311, DOI 10.4028/www.scientific.net/KEM.254-256.311
   Beppu MM, 2003, MAT SCI ENG C-BIO S, V23, P651, DOI 10.1016/j.msec.2003.08.002
   Bohner M, 2000, J MATER SCI-MATER M, V11, P155, DOI 10.1023/A:1008927624493
   Bohner M., 1993, J MAT SCI MAT MED, V8
   Bohner M, 2007, J MATER CHEM, V17, P3980, DOI 10.1039/b706411j
   Dorozhkin S. V., 2009, MATERIALS, V27, P221
   Dosen A, 2011, AM MINERAL, V96, P368, DOI 10.2138/am.2011.3544
   Galembeck F, 1996, NATO ASI 3 HIGH TECH, V12, P267
   Ginebra M.P., 1996, THESIS U POLITECNICA
   Grover LM, 2005, J MATER CHEM, V15, P4955, DOI 10.1039/b507056m
   JINLONG N, 2001, J MATER SYNTH PROC, V9, P235
   LeGeros R. Z., 1982, J DENT RES, V61, P343
   Rau JV, 2008, ACTA BIOMATER, V4, P1089, DOI 10.1016/j.actbio.2008.01.006
   Tonoli MS, 2006, KEY ENG MAT, V309-311, P845, DOI 10.4028/www.scientific.net/KEM.309-311.845
NR 18
TC 1
Z9 1
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2014
VL 587
BP 109
EP 114
DI 10.4028/www.scientific.net/KEM.587.109
PG 6
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Materials Science
GA BA4RR
UT WOS:000336185000018
DA 2018-10-20
ER

PT S
AU Ion, RM
   Poinescu, AA
   Doncea, SM
AF Ion, Rodica-Mariana
   Poinescu, Aurora Anca
   Doncea, Sanda-Maria
BE Antoniac, I
   Cavalu, S
   Traistaru, T
TI Novel three-component composite materials (hydroxyapatite/polymer
   mixtures) for bone regeneration
SO BIOCERAMICS, VOL 25
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 25th Symposium and Annual Meeting of the
   International-Society-for-Ceramics-in-Medicine (ISCM)
CY NOV 07-10, 2013
CL Bucharest, ROMANIA
SP Int Soc Ceram Med
DE hydroxyapatite/polymer mixtures; chitosan; chitine; collagen;
   carboxmethylcellulose
ID CHITOSAN
AB Biomaterial is a non-drug substance suitable for inclusion in systems which augment or replace the function of body tissues or organs. The nano-hydroxyapatite (HAp) is one of the most applied biomaterial, a popular bone substitute, for coatings and other filler materials due to their ability to promote mineralization. Hydroxyapatite [Ca-10(PO4)(6)(OH)(2)] is one of the most stable forms of calcium phosphate and it occurs in bones as major component (60 to 65%), along with other materials including collagen, chondroitin sulfate, keratin sulfate and lipids.
   In order to improve the bioactivity and mechanical properties of hydroxyapatite, some synthetic and natural polymers (e.g., cellulose, collagen, chitosan, chitine) have been used as excellent candidates for bone/cartilage tissue engineering applications.
   In this paper we propose to synthesize novel three-component composite materials from HAp and cellulose (carboxymethyl cellulose, CMC) with one of the following natural polymers (chitosan (CS), chitine (CT), collagen (CLG), all of them named CX), biocompatible (from CMC) and with excellent antimicrobial activity (from HAp). Similarly to CS, CMC has an extensive network of intra- and inter-molecular hydrogen bonds which makes it insoluble in water or in common organic solvents. To prepare this new composite material, ionic liquids (ILs) have been used as potential green solvents for biopolymers, knowing that 1-butyl-3-methylimidazolium chloride [BMImCl] is able to dissolve up to 10% (w/w) of CMC, and other polysaccharides such as CS. In the studied systems, HAp particles were dispersed uniformly in organic phase, and are present strong chemical interactions between the three phases.. In our case, a highly porous film was prepared and its bioactivity was investigated by in vitro tests in a simulated body fluid (SBF) for 6 months. By ICP-OES, was found a migration of analyzed metals (Fe, Mn, Cr and Ni) in simulated physiological fluids (SBF) analyzed after a period of 6 months, but only in the ppb concentrations range.
   Different system (HAp/CX/CMC) composites with weight ratios of 70/10/20, 70/15/15 and 70/20/10 were prepared. The new composites were characterized by infrared spectroscopy Fourier transformed (FT-IR), scanning electron microscopy (SEM) and ICP-OES.
   Their antimicrobial activity has been tested on Candida albicans, Candida parapsilosis and Staphylococcus aureus, proofing an excellent antimicrobial activity.
C1 [Ion, Rodica-Mariana; Doncea, Sanda-Maria] ICECHIM, Nanomed Res Grp, Bucharest, Romania.
   [Ion, Rodica-Mariana; Poinescu, Aurora Anca; Doncea, Sanda-Maria] Valahia Univ, Mat Engn Fac, Targoviste, Romania.
RP Ion, RM (reprint author), ICECHIM, Nanomed Res Grp, Bucharest, Romania.
EM rodica_ion2000@yahoo.co.uk; poinescua@yahoo.com;
   sandamariadoncea@yahoo.com
OI Ion, Rodica Mariana/0000-0002-9842-3321
CR Bernardi G., 1971, METHOD ENZYMOL, V22, P332
   Chen JD, 2010, COLLOID SURFACE B, V81, P640, DOI 10.1016/j.colsurfb.2010.08.017
   Duri S, 2012, ECS TRANSACTIONS, V50, P573, DOI 10.1149/05011.0573ecst
   El Seoud OA, 2007, BIOMACROMOLECULES, V8, P2629, DOI 10.1021/bm070062i
   Finkenstadt VL, 1998, MACROMOLECULES, V31, P7776, DOI 10.1021/ma9804895
   Hench L. L., 2002, BIOMATERIALS, V19, P1429
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Kajzer W., 2008, J ACHIEVEMENTS MAT M, V31, P247
   Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5
   Liuyun J, 2008, CARBOHYDR POL, V74, P680
   Mututuvari T. M., JBMM34636
   Muzzarelli C, 2002, J INORG BIOCHEM, V92, P89, DOI 10.1016/S0162-0134(02)00486-5
   Pinheiro AG, 2007, POLYM COMPOSITE, V28, P582, DOI 10.1002/pc.20267
   Poinescu AA, 2011, J OPTOELECTRON ADV M, V13, P416
   Poinescu A. A., 2010, P SPIE INT SOC OPTIC, V7821, P1
   Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m
   Teng SH, 2009, J BIOMED MATER RES A, V88A, P569, DOI 10.1002/jbm.a.31897
   Tsioptsias C, 2008, CARBOHYD POLYM, V74, P99, DOI 10.1016/j.carbpol.2008.01.022
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Zhang H, 2009, MOD PHYS LETT B, V23, P3967, DOI 10.1142/S0217984909022071
NR 21
TC 1
Z9 1
U1 2
U2 23
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2014
VL 587
BP 197
EP +
DI 10.4028/www.scientific.net/KEM.587.197
PG 3
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Materials Science
GA BA4RR
UT WOS:000336185000032
DA 2018-10-20
ER

PT S
AU Rimondini, L
   della Valle, C
   Cochis, A
   Azzimonti, B
   Chiesa, R
AF Rimondini, Lia
   della Valle, Cinzia
   Cochis, Andrea
   Azzimonti, Barbara
   Chiesa, Roberto
BE Antoniac, I
   Cavalu, S
   Traistaru, T
TI The biofilm formation onto implants and prosthetic materials may be
   contrasted using Gallium (3(+))
SO BIOCERAMICS, VOL 25
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 25th Symposium and Annual Meeting of the
   International-Society-for-Ceramics-in-Medicine (ISCM)
CY NOV 07-10, 2013
CL Bucharest, ROMANIA
SP Int Soc Ceram Med
DE biomaterials; oral implant; dental materials; oral plaque; oral biofilm;
   functionalized materials; surface modification
ID TRANSITION-METAL GALLIUM; PSEUDOMONAS-AERUGINOSA; IRON-METABOLISM;
   INFECTIONS
AB Bacterial contamination of implanted devices is a common cause of their failure. Microbial contamination of the biomaterials differs from that of natural tissues. In fact, the contamination modalities of medical devices depend on many peculiar factors related to them: the chemistry of the biomaterial, the physical properties of the surface, the design of the medical device, the extension of surgical invasion, and the time of application. The environment and/or the conditions and response of the host also contribute to the development of infection.
   Viruses, fungi, protozoa and bacteria are all involved in biomaterial contamination. They are endogenous commensals of the mouth, not virulent in planktonic form, but pathogens when arranged in biofilm.
   In this paper we review the potency of application of Gallium doping to the surface biomaterials addressed for surgical implantation in order to contrast the bacteria biofilm formation.
C1 [Rimondini, Lia; Cochis, Andrea; Azzimonti, Barbara] Univ Piemonte Orientale Amedeo Avogadro, Via Solaroli 17, I-28100 Novara, Italy.
   [della Valle, Cinzia; Chiesa, Roberto] Politecn Milan, I-20100 Milan, Italy.
RP Rimondini, L (reprint author), Univ Piemonte Orientale Amedeo Avogadro, Via Solaroli 17, I-28100 Novara, Italy.
EM lia.rimondini@med.unipmn.it; cinzia.dellavalle@polimi.it;
   andrea.cochis@med.unipmn.it; barbara.azzimonti@med.unipmn.it;
   roberto.chiesa@polimi.it
RI Chiesa, Roberto/N-2605-2013
OI Chiesa, Roberto/0000-0002-5317-6849; Cochis, Andrea/0000-0003-2455-8239
CR Banin E, 2008, P NATL ACAD SCI USA, V105, P16761, DOI 10.1073/pnas.0808608105
   Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991
   Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x
   Bernstein LR, 1998, PHARMACOL REV, V50, P665
   Chen L, 2011, INT J ORAL SCI, V3, P66, DOI 10.4248/IJOS11022
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Halwani M, 2008, J ANTIMICROB CHEMOTH, V62, P1291, DOI 10.1093/jac/dkn422
   Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783
   Kelson AB, 2013, CURR OPIN PHARMACOL, V13, P707, DOI 10.1016/j.coph.2013.07.001
   Mantareva V, 2011, PHOTOCH PHOTOBIO SCI, V10, P91, DOI 10.1039/b9pp00154a
   Olakanmi O, 2000, INFECT IMMUN, V68, P5619, DOI 10.1128/IAI.68.10.5619-5627.2000
   Olczak T, 2012, ARCH MICROBIOL, V194, P719, DOI 10.1007/s00203-012-0804-3
   Peeters E, 2008, J ANTIMICROB CHEMOTH, V61, P1062, DOI 10.1093/jac/dkn072
   Pickup DM, 2009, J MATER SCI, V44, P1858, DOI 10.1007/s10853-008-3237-2
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   Quirynen M, 2002, CLIN ORAL IMPLAN RES, V13, P1, DOI 10.1034/j.1600-0501.2002.130101.x
   Rimondini L, 2005, J Appl Biomater Biomech, V3, P1
   Seneviratne CJ, 2008, ORAL DIS, V14, P582, DOI 10.1111/j.1601-0825.2007.01424.x
   Sun Y, 2008, WOUND REPAIR REGEN, V16, P805, DOI 10.1111/j.1524-475X.2008.00434.x
   Valappil SP, 2013, DALTON T, V42, P1778, DOI 10.1039/c2dt32235h
   Valappil SP, 2012, ACTA BIOMATER, V8, P1957, DOI 10.1016/j.actbio.2012.01.017
   Yang LA, 2011, INT J ORAL SCI, V3, P74, DOI 10.4248/IJOS11027
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zhu YY, 2013, EXP THER MED, V5, P1001, DOI 10.3892/etm.2013.946
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   Zlowodzki M, 2007, INT ORTHOP, V31, P409, DOI 10.1007/s00264-006-0187-7
NR 26
TC 3
Z9 3
U1 1
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2014
VL 587
BP 315
EP +
DI 10.4028/www.scientific.net/KEM.587.315
PG 3
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Materials Science
GA BA4RR
UT WOS:000336185000052
DA 2018-10-20
ER

PT S
AU Shea, LD
   Woodruff, TK
   Shikanov, A
AF Shea, Lonnie D.
   Woodruff, Teresa K.
   Shikanov, Ariella
BE Yarmush, ML
TI Bioengineering the Ovarian Follicle Microenvironment
SO ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 16
SE Annual Review of Biomedical Engineering
LA English
DT Review; Book Chapter
DE oncofertility; biomaterial; transplantation; oocyte; infertility; tissue
   engineering
ID DEVELOPMENT IN-VITRO; ENCAPSULATED 3-DIMENSIONAL CULTURE; MONOZYGOTIC
   TWINS DISCORDANT; GENE-EXPRESSION PROFILES; MOUSE OOCYTE DEVELOPMENT;
   GROWTH-FACTOR DELIVERY; LONG-TERM CULTURE; FERTILITY PRESERVATION;
   PREANTRAL FOLLICLES; PRIMORDIAL FOLLICLES
AB Chemo- and radiation therapies used to treat cancer can have the unintended effect of making patients infertile. Clinically established fertility preservation methods, such as egg and embryo cryopreservation, are not applicable to all patients, which has motivated the development of strategies that involve ovarian tissue removal and cryopreservation before the first sterilizing treatment. To restore fertility at a later date, the early-stage follicles present in the tissue must be matured to produce functional oocytes, a process that is not possible using existing cell culture technologies. This review describes the application of tissue engineering principles to promote ovarian follicle maturation and produce mature oocytes through either in vitro culture or transplantation. The design principles for these engineered systems are presented, along with identification of emerging opportunities in reproductive biology.
C1 [Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Dept Biomed Engn, McCormick Sch Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Inst BioNanotechnol Med IBNAM, Evanston, IL 60208 USA.
   [Shea, Lonnie D.; Woodruff, Teresa K.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA.
   [Shea, Lonnie D.; Woodruff, Teresa K.] Northwestern Univ, Chem Life Proc Inst CLP, Evanston, IL 60208 USA.
   [Woodruff, Teresa K.] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Evanston, IL 60208 USA.
   [Shea, Lonnie D.; Woodruff, Teresa K.] Northwestern Univ, CRS, Evanston, IL 60208 USA.
   [Shikanov, Ariella] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Shikanov, Ariella] Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu; tkw@northwestern.edu; shikanov@umich.edu
OI Woodruff, Teresa/0000-0002-1197-3399; Shikanov,
   Ariella/0000-0003-0159-6419
FU NIBIB NIH HHS [PL1 EB008542]; NICHD NIH HHS [P50 HD076188, U54 HD041857,
   U54 HD076188]
CR Adamson GD, 2013, FERTIL STERIL, V100, pS42, DOI 10.1016/j.fertnstert.2013.07.1807
   Ahn RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058491
   Amsden B, 1999, BIOTECHNOL BIOENG, V65, P605, DOI 10.1002/(SICI)1097-0290(19991205)65:5<605::AID-BIT14>3.0.CO;2-C
   Anderson RA, 2006, HUM REPROD, V21, P2583, DOI 10.1093/humrep/del201
   Ata B, 2010, BEST PRACT RES CL OB, V24, P101, DOI 10.1016/j.bpobgyn.2009.11.007
   Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035
   Barrett SL, 2007, BIOL REPROD, V76, P949, DOI 10.1095/biolreprod.106.057141
   Bhattacharya P, 2012, TOXICOL APPL PHARM, V261, P227, DOI 10.1016/j.taap.2012.04.009
   Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025
   Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006
   Chin KV, 2002, FERTIL STERIL, V77, P1214, DOI 10.1016/S0015-0282(02)03114-X
   Clement F, 2001, AM J PHYSIOL-ENDOC M, V281, pE35
   CONSTINE LS, 1993, NEW ENGL J MED, V328, P87, DOI 10.1056/NEJM199301143280203
   Cortvrindt R, 1996, HUM REPROD, V11, P2656
   Davis VL, 2006, CANCER, V107, P1690, DOI 10.1002/cncr.22105
   Demeestere I, 2007, ONCOLOGIST, V12, P1437, DOI 10.1634/theoncologist.12-12-1437
   Dolmans MM, 2013, FERTIL STERIL, V99, P1514, DOI 10.1016/j.fertnstert.2013.03.027
   Dolmans MM, 2010, BLOOD, V116, P2908, DOI 10.1182/blood-2010-01-265751
   Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030
   Donnez J, 2013, FERTIL STERIL, V99, P1467, DOI 10.1016/j.fertnstert.2013.03.040
   Duncan FE, 2012, AGING CELL, V11, P1121, DOI 10.1111/j.1474-9726.2012.00866.x
   Duncan FE, 2009, BIOL REPROD, V81, P768, DOI 10.1095/biolreprod.109.077909
   Echenim N, 2005, MATH BIOSCI, V198, P57, DOI 10.1016/j.mbs.2005.05.003
   Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197
   EPPIG JJ, 1977, DEV BIOL, V60, P371, DOI 10.1016/0012-1606(77)90135-X
   EPPIG JJ, 1989, BIOL REPROD, V41, P268, DOI 10.1095/biolreprod41.2.268
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   GOSDEN RG, 1990, HUM REPROD, V5, P499, DOI 10.1093/oxfordjournals.humrep.a137132
   Gosden Roger G, 2005, J Natl Cancer Inst Monogr, P60
   Gosden RG, 2008, REPRODUCTION, V136, P671, DOI 10.1530/REP-08-0099
   Gutierrez CG, 2000, BIOL REPROD, V62, P1322, DOI 10.1095/biolreprod62.5.1322
   Hasegawa A, 2009, J REPROD IMMUNOL, V83, P40, DOI 10.1016/j.jri.2009.09.002
   Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065
   Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052
   Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420
   Hirshfeld-Cytron JE, 2011, HUM REPROD, V26, P2473, DOI 10.1093/humrep/der183
   Hornick JE, 2013, REPRODUCTION, V145, P19, DOI 10.1530/REP-12-0233
   Hornick JE, 2012, HUM REPROD, V27, P1801, DOI 10.1093/humrep/der468
   Hunt P, 2010, CURR BIOL, V20, pR699, DOI 10.1016/j.cub.2010.08.011
   Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454
   Jewgenow K, 2006, THERIOGENOLOGY, V66, P93, DOI 10.1016/j.theriogenology.2006.03.010
   Jin SY, 2010, FERTIL STERIL, V93, P2633, DOI 10.1016/j.fertnstert.2009.10.027
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Kreeger PK, 2006, BIOMATERIALS, V27, P714, DOI 10.1016/j.biomaterials.2005.06.016
   Kreeger PK, 2003, MOL CELL ENDOCRINOL, V205, P1, DOI 10.1016/S0303-7207(03)00209-0
   Krotz SP, 2010, J ASSIST REPROD GEN, V27, P743, DOI 10.1007/s10815-010-9468-6
   Ksiazkiewicz Lucyna Katska, 2006, Reprod Biol, V6, P3
   Lawrence N. D., 2010, LEARNING INFERENCE C
   Lenie S, 2004, BIOL REPROD, V71, P1730, DOI 10.1095/biolreprod.104.028415
   Lenie S, 2008, MUTAT RES-GEN TOX EN, V651, P71, DOI 10.1016/j.mrgentox.2007.10.017
   Lintsen AME, 2005, HUM REPROD, V20, P1867, DOI 10.1093/humrep/deh898
   Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678
   Machluf M, 2003, BIOTECHNOL GENET ENG, V20, P183, DOI 10.1080/02648725.2003.10648043
   Malizia BA, 2009, NEW ENGL J MED, V360, P236, DOI 10.1056/NEJMoa0803072
   Malloch L, 2013, FERTIL STERIL, V100, P1740, DOI 10.1016/j.fertnstert.2013.08.040
   Martinovitch PN, 1938, PROC R SOC SER B-BIO, V125, P232, DOI 10.1098/rspb.1938.0024
   McLaughlin M, 2010, MOL HUM REPROD, V16, P644, DOI 10.1093/molehr/gaq021
   Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535
   Memili E, 2007, REPRODUCTION, V133, P1107, DOI 10.1530/REP-06-0149
   Michelmore KF, 1999, CLIN ENDOCRINOL, V51, P779, DOI 10.1046/j.1365-2265.1999.00886.x
   Michelmore KF, 2000, HUM FERTIL, V3, P96
   Natl. Cancer Inst, 2012, SEER DAT 1973 2010
   Nelson SM, 2007, CURR OPIN OBSTET GYN, V19, P384, DOI 10.1097/GCO.0b013e32825e1d70
   Nieman Carrie L, 2006, J Support Oncol, V4, P171
   Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637
   Nisolle M, 2000, FERTIL STERIL, V74, P122, DOI 10.1016/S0015-0282(00)00548-3
   O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029
   Oktay K, 2013, AM J OBSTET GYNECOL, V209, P77, DOI 10.1016/j.ajog.2013.05.036
   Osborn SM, 1997, HUM REPROD, V12, pP153
   Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023
   Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048
   Pangas SA, 2003, TISSUE ENG, V9, P1013, DOI 10.1089/107632703322495655
   Parrish EM, 2011, REPRODUCTION, V142, P309, DOI 10.1530/REP-10-0481
   Paulose T, 2012, BIRTH DEFECTS RES B, V95, P219, DOI 10.1002/bdrb.21007
   Peddinti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011240
   Poirot CJ, 2007, PEDIATR BLOOD CANCER, V49, P74, DOI 10.1002/pbc.21027
   Purcell SH, 2011, J ASSIST REPROD GEN, V28, P517, DOI 10.1007/s10815-011-9592-y
   Redding GP, 2007, REPRODUCTION, V133, P1095, DOI 10.1530/REP-06-0171
   Reinecke I, 2007, J THEOR BIOL, V247, P303, DOI 10.1016/j.jtbi.2007.03.011
   Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40
   Robker Rebecca L, 2008, Pathophysiology, V15, P115, DOI 10.1016/j.pathophys.2008.04.004
   Rowe SL, 2006, BIOMACROMOLECULES, V7, P2942, DOI 10.1021/bm0602233
   ROY SK, 1993, FERTIL STERIL, V59, P783
   Sasson R, 2003, FASEB J, V17, P1256, DOI 10.1096/fj.02-0740com
   Schover LR, 1999, CANCER, V86, P697, DOI 10.1002/(SICI)1097-0142(19990815)86:4<697::AID-CNCR20>3.0.CO;2-J
   Sharma GT, 2009, ANIM REPROD SCI, V114, P115, DOI 10.1016/j.anireprosci.2008.09.009
   Shikanov Ariella, 2011, J Vis Exp, DOI 10.3791/2695
   Shikanov A, 2011, TISSUE ENG PT A, V17, P3095, DOI [10.1089/ten.tea.2011.0204, 10.1089/ten.TEA.2011.0204]
   Shikanov A, 2011, BIOMATERIALS, V32, P2524, DOI 10.1016/j.biomaterials.2010.12.027
   Shikanov A, 2009, BIOMATERIALS, V30, P5476, DOI 10.1016/j.biomaterials.2009.06.054
   Siegelmann-Danieli N, 2003, ANN SURG ONCOL, V10, P1031, DOI 10.1245/ASO.2003.03.068
   Silber SJ, 2008, HUM REPROD, V23, P1531, DOI 10.1093/humrep/den032
   Silber S, 2010, FERTIL STERIL, V94, P2191, DOI 10.1016/j.fertnstert.2009.12.073
   Silber SJ, 2005, NEW ENGL J MED, V353, P58, DOI 10.1056/NEJMoa043157
   Sittadjody S, 2013, BIOMATERIALS, V34, P2412, DOI 10.1016/j.biomaterials.2012.11.059
   Skinner MK, 2008, MOL REPROD DEV, V75, P1457, DOI 10.1002/mrd.20883
   Smith RM, 2014, TISSUE EN A IN PRESS
   Smitz J, 2010, HUM REPROD UPDATE, V16, P395, DOI 10.1093/humupd/dmp056
   Songsasen N, 2011, REPRODUCTION, V142, P113, DOI 10.1530/REP-10-0442
   Sperling LH, 1996, POLYM ADVAN TECHNOL, V7, P197, DOI 10.1002/(SICI)1099-1581(199604)7:4<197::AID-PAT514>3.0.CO;2-4
   Sriraman V, 2006, MOL ENDOCRINOL, V20, P348, DOI 10.1210/me.2005-0317
   Tagler D, 2013, BIOTECHNOL BIOENG, V110, P3258, DOI 10.1002/bit.24986
   Tagler D, 2012, TISSUE ENG PT A, V18, P1229, DOI [10.1089/ten.TEA.2011.0418, 10.1089/ten.tea.2011.0418]
   TAMBE SS, 1993, STEROIDS, V58, P379, DOI 10.1016/0039-128X(93)90041-K
   TANAKA H, 1984, BIOTECHNOL BIOENG, V26, P53, DOI 10.1002/bit.260260111
   Teissier MP, 2000, HUM REPROD, V15, P2471, DOI 10.1093/humrep/15.12.2471
   Telfer EE, 2013, FERTIL STERIL, V99, P1523, DOI 10.1016/j.fertnstert.2013.03.043
   Ting AY, 2011, HUM REPROD, V26, P2461, DOI 10.1093/humrep/der196
   Tingen C, 2009, MOL HUM REPROD, V15, P795, DOI 10.1093/molehr/gap073
   Tingen CM, 2011, REPRODUCTION, V141, P809, DOI 10.1530/REP-10-0483
   TORRANCE C, 1989, J REPROD FERTIL, V87, P367
   Vanacker J, 2012, BIOMATERIALS, V33, P6079, DOI 10.1016/j.biomaterials.2012.05.015
   Vanselow J, 2010, BIOL REPROD, V82, P289, DOI 10.1095/biolreprod.109.079251
   Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772
   Wang L, 2012, TISSUE ENG PT A, V18, P2000, DOI [10.1089/ten.tea.2011.0663, 10.1089/ten.TEA.2011.0663]
   West ER, 2007, BIOMATERIALS, V28, P4439, DOI 10.1016/j.biomaterials.2007.07.001
   West-Farrell ER, 2009, BIOL REPROD, V80, P432, DOI 10.1095/biolreprod.108.071142
   Wood JR, 2003, J BIOL CHEM, V278, P26380, DOI 10.1074/jbc.M300688200
   Woodruff Teresa K, 2007, Reprod Sci, V14, P6, DOI 10.1177/1933719107309818
   Woodruff TK, 2011, J ASSIST REPROD GEN, V28, P3, DOI 10.1007/s10815-010-9478-4
   Woods DC, 2013, NAT PROTOC, V8, P966, DOI 10.1038/nprot.2013.047
   Xu J, 2013, HUM REPROD, V28, P2187, DOI 10.1093/humrep/det093
   Xu M, 2006, TISSUE ENG, V12, P2739, DOI 10.1089/ten.2006.12.2739
   Xu M, 2006, BIOL REPROD, V75, P916, DOI 10.1095/biolreprod.106.054833
   Xu M, 2011, BIOL REPROD, V84, P689, DOI 10.1095/biolreprod.110.088674
   Xu M, 2009, BIOL REPROD, V81, P587, DOI 10.1095/biolreprod.108.074732
   Xu M, 2009, HUM REPROD, V24, P2531, DOI 10.1093/humrep/dep228
   Yoon SJ, 2006, FERTIL STERIL, V85, P193, DOI 10.1016/j.fertnstert.2005.07.1296
NR 128
TC 48
Z9 49
U1 0
U2 13
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 1523-9829
BN 978-0-8243-3516-8
J9 ANNU REV BIOMED ENG
JI Annu. Rev. Biomed. Eng.
PY 2014
VL 16
BP 29
EP 52
DI 10.1146/annurev-bioeng-071813-105131
PG 24
WC Engineering, Biomedical
SC Engineering
GA BB9LF
UT WOS:000348433000002
PM 24849592
OA Green Accepted
DA 2018-10-20
ER

PT S
AU Bajaj, P
   Schweller, RM
   Khademhosseini, A
   West, JL
   Bashir, R
AF Bajaj, Piyush
   Schweller, Ryan M.
   Khademhosseini, Ali
   West, Jennifer L.
   Bashir, Rashid
BE Yarmush, ML
TI 3D Biofabrication Strategies for Tissue Engineering and Regenerative
   Medicine
SO ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 16
SE Annual Review of Biomedical Engineering
LA English
DT Review; Book Chapter
DE hydrogels; stem cells; scaffolds; bioprinting; photolithography;
   vascularization
ID EMBRYONIC STEM-CELLS; THIOL-ACRYLATE PHOTOPOLYMERS; CLICK-BASED
   HYDROGELS; IN-VITRO; 3-DIMENSIONAL HYDROGELS; POLY(ETHYLENE GLYCOL);
   CROSS-LINKING; COLLAGEN HYDROGEL; VASCULAR NETWORKS; POLYMER SCAFFOLDS
AB Over the past several decades, there has been an ever-increasing demand for organ transplants. However, there is a severe shortage of donor organs, and as a result of the increasing demand, the gap between supply and demand continues to widen. A potential solution to this problem is to grow or fabricate organs using biomaterial scaffolds and a person's own cells. Although the realization of this solution has been limited, the development of new biofabrication approaches has made it more realistic. This review provides an overview of natural and synthetic biomaterials that have been used for organ/tissue development. It then discusses past and current biofabrication techniques, with a brief explanation of the state of the art. Finally, the review highlights the need for combining vascularization strategies with current biofabrication techniques. Given the multitude of applications of biofabrication technologies, from organ/tissue development to drug discovery/screening to development of complex in vitro models of human diseases, these manufacturing technologies can have a significant impact on the future of medicine and health care.
C1 [Bajaj, Piyush; Bashir, Rashid] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
   [Bajaj, Piyush; Bashir, Rashid] Univ Illinois, Micro & Nanotechnol Lab, Urbana, IL 61801 USA.
   [Bashir, Rashid] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.
   [Bajaj, Piyush] Los Alamos Natl Lab, Def Syst & Anal Div, Los Alamos, NM 87545 USA.
   [Schweller, Ryan M.; West, Jennifer L.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   [Khademhosseini, Ali] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Biomed Engn,Dept Med, Cambridge, MA 02139 USA.
   [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Khademhosseini, Ali] Kyung Hee Univ, Sch Dent, Dept Maxillofacial Biomed Engn, Seoul 130701, South Korea.
   [Khademhosseini, Ali] Kyung Hee Univ, Sch Dent, Inst Oral Biol, Seoul 130701, South Korea.
   [Khademhosseini, Ali] King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia.
RP Bajaj, P (reprint author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
EM rbashir@illinois.edu
OI Khademhosseini, Ali/0000-0001-6322-8852
FU NIAID NIH HHS [R01 AI081534, AI081534]; NIAMS NIH HHS [R01 AR057837,
   AR057837]; NIBIB NIH HHS [EB02597]; NHLBI NIH HHS [F32 HL120650,
   F32HL120650]
CR Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI 10.1089/ten.TEB.2009.0639
   Annabi N, 2013, ADV FUNCT MATER, V23, P4950, DOI 10.1002/adfm.201300570
   Arcaute K, 2006, ANN BIOMED ENG, V34, P1429, DOI 10.1007/s10439-006-9156-y
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056
   Bajaj P, 2006, INT J NANOMED, V1, P361
   Bajaj P, 2013, ADV HEALTHC MATER, V2, P450, DOI 10.1002/adhm.201200318
   Bajaj P, 2011, INTEGR BIOL-UK, V3, P897, DOI 10.1039/c1ib00058f
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Barry RA, 2009, ADV MATER, V21, P2407, DOI 10.1002/adma.200803702
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Bryant SJ, 2007, BIOMATERIALS, V28, P2978, DOI 10.1016/j.biomaterials.2006.11.033
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Chan BK, 2012, MACROMOL BIOSCI, V12, P1490, DOI 10.1002/mabi.201200234
   Chan V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00857
   Chan V, 2010, LAB CHIP, V10, P2062, DOI 10.1039/c004285d
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Cho E, 2009, J BIOMED MATER RES A, V90A, P1073, DOI 10.1002/jbm.a.32172
   Compton CC, 1998, J INVEST DERMATOL, V110, P908, DOI 10.1046/j.1523-1747.1998.00200.x
   Cuchiara MP, 2012, ADV FUNCT MATER, V22, P4511, DOI 10.1002/adfm.201200976
   Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056
   Culver JC, 2012, ADV MATER, V24, P2344, DOI 10.1002/adma.201200395
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Dhariwala B, 2004, TISSUE ENG, V10, P1316, DOI 10.1089/1076327042500256
   Lantada AD, 2012, ANNU REV BIOMED ENG, V14, P73, DOI [10.1146/annurev-bioeng-071811-150112, 10.1146/annurev.bioeng-071811-150112]
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   Duoss EB, 2007, ADV MATER, V19, P3485, DOI 10.1002/adma.200701372
   Edalat F, 2012, CURR OPIN BIOTECH, V23, P820, DOI 10.1016/j.copbio.2012.05.007
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fairbanks BD, 2009, MACROMOLECULES, V42, P211, DOI 10.1021/ma801903w
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044
   Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024
   Gill BJ, 2012, CANCER RES, V72, P6013, DOI 10.1158/0008-5472.CAN-12-0895
   Guvendiren M, 2010, BIOMATERIALS, V31, P6511, DOI 10.1016/j.biomaterials.2010.05.037
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   Hammoudi TM, 2010, TISSUE ENG PART C-ME, V16, P1621, DOI [10.1089/ten.tec.2010.0146, 10.1089/ten.TEC.2010.0146]
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Haugen H, 2004, J MATER SCI-MATER M, V15, P343, DOI 10.1023/B:JMSM.0000021099.33619.ac
   He JK, 2013, ADV HEALTHC MATER, V2, P1108, DOI 10.1002/adhm.201200404
   Hess LH, 2011, ADV MATER, V23, P5045, DOI 10.1002/adma.201102990
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hoffmann JC, 2010, SOFT MATTER, V6, P5056, DOI 10.1039/c0sm00140f
   Hong Y, 2011, BIOMATERIALS, V32, P3387, DOI 10.1016/j.biomaterials.2011.01.025
   Hsu YY, 1997, J BIOMED MATER RES, V35, P107, DOI 10.1002/(SICI)1097-4636(199704)35:1<107::AID-JBM11>3.0.CO;2-G
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   Hwang CM, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014105
   Ivanov VV, 2001, POLYM INT, V50, P113, DOI 10.1002/1097-0126(200101)50:1<113::AID-PI594>3.0.CO;2-X
   Jeong JH, 2012, ADV MATER, V24, P58, DOI 10.1002/adma.201103207
   Jin L, 2013, P NATL ACAD SCI USA, V110, P3907, DOI 10.1073/pnas.1301889110
   Jo YS, 2010, J BIOMED MATER RES A, V93A, P870, DOI 10.1002/jbm.a.32580
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kaehr B, 2004, P NATL ACAD SCI USA, V101, P16104, DOI 10.1073/pnas.0407204101
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kang HW, 1999, J BIOACT COMPAT POL, V14, P331, DOI 10.1177/088391159901400404
   Khademhosseini A, 2006, J BIOMED MATER RES A, V79A, P522, DOI 10.1002/jbm.a.30821
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Killops KL, 2008, J AM CHEM SOC, V130, P5062, DOI 10.1021/ja8006325
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim HJ, 2012, TISSUE ENG REGEN MED, V9, P63, DOI 10.1007/s13770-012-0022-8
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Lai JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054058
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lanniel M, 2011, SOFT MATTER, V7, P6501, DOI 10.1039/c1sm05167a
   Lee SJ, 2008, BIOMED MICRODEVICES, V10, P233, DOI 10.1007/s10544-007-9129-4
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Leigh SJ, 2013, BIOMACROMOLECULES, V14, P186, DOI 10.1021/bm3015736
   Lewis JA, 2006, ADV FUNCT MATER, V16, P2193, DOI 10.1002/adfm.200600434
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Liu YX, 2012, MACROMOL BIOSCI, V12, P1034, DOI 10.1002/mabi.201200043
   Lomba M, 2011, MACROMOL BIOSCI, V11, P1505, DOI 10.1002/mabi.201100123
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Martens P, 2001, J PHYS CHEM B, V105, P5131, DOI 10.1021/jp004102n
   Maruo S, 2002, SENSOR ACTUAT A-PHYS, V100, P70, DOI 10.1016/S0924-4247(02)00043-2
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McCall AD, 2013, TISSUE ENG PT A, V19, P2215, DOI [10.1089/ten.tea.2012.0674, 10.1089/ten.TEA.2012.0674]
   Mehrabanian M, 2011, INT J NANOMED, V6, P1651, DOI 10.2147/IJN.S21203
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Melchels FPW, 2009, BIOMATERIALS, V30, P3801, DOI 10.1016/j.biomaterials.2009.03.055
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Miller GA, 2002, J POLYM SCI POL CHEM, V40, P793, DOI 10.1002/pola.10162
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Miller JS, 2010, BIOMATERIALS, V31, P3736, DOI 10.1016/j.biomaterials.2010.01.058
   Mironov V, 2007, J MATER CHEM, V17, P2054, DOI 10.1039/b617903g
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   MIYATA T, 1971, BIOCHIM BIOPHYS ACTA, V229, P672, DOI 10.1016/0005-2795(71)90283-2
   Moon JJ, 2007, BIOMACROMOLECULES, V8, P42, DOI 10.1021/bm060452p
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Musoke-Zawedde P, 2006, BIOMED MATER, V1, P162, DOI 10.1088/1748-6041/1/3/011
   Naito H, 2013, J BIOMED MATER RES A, V101, P2838, DOI 10.1002/jbm.a.34578
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   NEREM RM, 1991, ANN BIOMED ENG, V19, P529, DOI 10.1007/BF02367396
   Neumann T, 2003, MICROVASC RES, V66, P59, DOI 10.1016/S0026-2862(03)00040-2
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Occhetta P, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035002
   Park JS, 2007, J CONTROL RELEASE, V124, P51, DOI 10.1016/j.jconrel.2007,08.030
   Pataky K, 2012, ADV MATER, V24, P391, DOI 10.1002/adma.201102800
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Peng Z., 2010, J MACROMOL SCI B, V50, P340
   Polizzotti BD, 2008, BIOMACROMOLECULES, V9, P1084, DOI 10.1021/bm7012636
   Quirk RA, 2004, CURR OPIN SOLID ST M, V8, P313, DOI 10.1016/j.cossms.2003.12.004
   Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Rydholm AE, 2007, POLYMER, V48, P4589, DOI 10.1016/j.polymer.2007.05.063
   Rydholm AE, 2007, ACTA BIOMATER, V3, P449, DOI 10.1016/j.actbio.2006.12.001
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Schumann P, 2014, J BIOMED MATER RES A, V102, P1652, DOI 10.1002/jbm.a.34826
   Seck TM, 2010, J CONTROL RELEASE, V148, P34, DOI 10.1016/j.jconrel.2010.07.111
   Seidlits SK, 2009, ADV FUNCT MATER, V19, P3543, DOI 10.1002/adfm.200901115
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shepherd JNH, 2011, ADV FUNCT MATER, V21, P47, DOI 10.1002/adfm.201001746
   Shih H, 2012, BIOMACROMOLECULES, V13, P2003, DOI 10.1021/bm300752j
   Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j
   Smay JE, 2002, ADV MATER, V14, P1279, DOI 10.1002/1521-4095(20020916)14:18<1279::AID-ADMA1279>3.0.CO;2-A
   Sodunke TR, 2007, BIOMATERIALS, V28, P4006, DOI 10.1016/j.biomaterials.2007.05.021
   Spikes JD, 1999, PHOTOCHEM PHOTOBIOL, V70, P130, DOI 10.1111/j.1751-1097.1999.tb07980.x
   Sui ZJ, 2007, ADV MATER, V19, P3377, DOI 10.1002/adma.200700092
   Sun JG, 2009, CHINESE SCI BULL, V54, P3154, DOI 10.1007/s11434-009-0240-1
   Suri S, 2009, ACTA BIOMATER, V5, P2385, DOI 10.1016/j.actbio.2009.05.004
   Tekin H, 2012, ADV MATER, V24, P5543, DOI 10.1002/adma.201201805
   Terrones G, 2001, MACROMOLECULES, V34, P8894, DOI 10.1021/ma010678e
   Thomson KS, 2013, TISSUE ENG PT A, V19, P967, DOI 10.1089/ten.tea.2012.0286
   Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/NMAT3404, 10.1038/nmat3404]
   Timko BP, 2009, NANO LETT, V9, P914, DOI 10.1021/nl900096z
   Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com
   US Dep. Health Hum. Serv, 2014, NEED IS REAL DAT DON
   Villar G, 2013, SCIENCE, V340, P48, DOI 10.1126/science.1229495
   Viventi J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000738
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   WARD MD, 1995, ANN BIOMED ENG, V23, P322, DOI 10.1007/BF02584432
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m
   Wylie RG, 2008, J MATER CHEM, V18, P2716, DOI 10.1039/b718431j
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]
   Wylie RG, 2011, BIOMACROMOLECULES, V12, P3789, DOI 10.1021/bm201037j
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Yeh J, 2006, BIOMATERIALS, V27, P5391, DOI 10.1016/j.biomaterials.2006.06.005
   Zellander A, 2013, MAT SCI ENG C-MATER, V33, P3396, DOI 10.1016/j.msec.2013.04.025
   Zhang AP, 2012, ADV MATER, V24, P4266, DOI 10.1002/adma.201202024
   Zhang L, 2012, J BIOMED MATER RES A, V100A, P2717, DOI 10.1002/jbm.a.34194
   Zhang XM, 2012, J BIOMED MATER RES A, V100A, P2960, DOI 10.1002/jbm.a.34243
   Zheng XJ, 2011, LAB CHIP, V11, P3431, DOI 10.1039/c1lc20455f
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899
   Zorlutuna P, 2011, ADV FUNCT MATER, V21, P3642, DOI 10.1002/adfm.201101023
NR 168
TC 170
Z9 173
U1 25
U2 244
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 1523-9829
BN 978-0-8243-3516-8
J9 ANNU REV BIOMED ENG
JI Annu. Rev. Biomed. Eng.
PY 2014
VL 16
BP 247
EP 276
DI 10.1146/annurev-bioeng-071813-105155
PG 30
WC Engineering, Biomedical
SC Engineering
GA BB9LF
UT WOS:000348433000010
PM 24905875
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Broderick, JM
   Kelly, DJ
   Mulhall, KJ
AF Broderick, James M.
   Kelly, Daniel J.
   Mulhall, Kevin J.
TI Optimizing Stem Cell Engineering for Orthopaedic Applications
SO JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
LA English
DT Article
ID ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; MESENCHYMAL STEM;
   REGENERATION
AB Articular cartilage repair remains a significant challenge in orthopaedic surgery and this has led to increased interest in cell-based therapies for cartilage regeneration. Although autologous chondrocyte implantation has been used with reasonable success, there are several disadvantages associated with this technique, such as donor site availability and morbidity, dedifferentiation of the isolated chondrocytes during monolayer expansion, and poor integration of repair tissue into the native cartilage. This has led to a growing interest in the use of mesenchymal stem cells (MSCs) as an alternative cell source. MSCs are easy to isolate and are self-renewing, have a high expansion potential, and are capable of differentiating into several cell lineages, including chondrocytes and osteoblasts. Here, we highlight recent advances in the field of tissue engineering that seek to combine MSCs, biomaterial scaffolds, and chondrogenic signals (the so-called tissue engineering triad) to create functional cartilage tissue replacements.
C1 [Broderick, James M.; Mulhall, Kevin J.] Mater Misericordiae Univ Hosp, Dublin, Ireland.
   [Kelly, Daniel J.] Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Trinity Biomed Sci Inst, Dublin 2, Ireland.
   [Kelly, Daniel J.] Univ Dublin Trinity Coll, Dept Mech & Mfg Engn, Sch Engn, Dublin 2, Ireland.
RP Broderick, JM (reprint author), Mater Misericordiae Univ Hosp, Dublin, Ireland.
OI Kelly, Daniel/0000-0003-4091-0992
CR Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   Huang AH, 2010, EUR CELLS MATER, V19, P72, DOI 10.22203/eCM.v019a08
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Liu YR, 2012, TISSUE ENG PT A, V18, P1531, DOI [10.1089/ten.tea.2011.0575, 10.1089/ten.TEA.2011.0575]
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   Nguyen LH, 2011, BIOMATERIALS, V32, P1327, DOI 10.1016/j.biomaterials.2010.10.009
   Re'em T, 2012, ACTA BIOMATER, V8, P3283, DOI 10.1016/j.actbio.2012.05.014
   Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722
   Thorpe SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060764
   Veronesi F, 2013, J BIOMED MAT RES A
   Ye K, 2013, REGEN MED, V8, P333, DOI [10.2217/RME.13.28, 10.2217/rme.13.28]
NR 11
TC 3
Z9 3
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1067-151X
J9 J AM ACAD ORTHOP SUR
JI J. Am. Acad. Orthop. Surg.
PD JAN
PY 2014
VL 22
IS 1
BP 63
EP 65
DI 10.5435/JAAOS-22-01-63
PG 4
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA CB2IS
UT WOS:000349451200008
PM 24382881
DA 2018-10-20
ER

PT S
AU Liu, P
   Zhong, Y
   Luo, Y
AF Liu, Peng
   Zhong, Yi
   Luo, Yan
BE Tang, F
TI Preparation of PLA and PLGA Magnetic Microspheres with T-Shaped
   Microchannel Reactor
SO MICRO-NANO TECHNOLOGY XV
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 15th Annual Conference of the Chinese-Society-of-Micro-Nano-Technology
   (CSMNT) / 4th International Conference of the
   Chinese-Society-of-Micro-Nano-Technology (CSMNT)
CY NOV 03-06, 2013
CL Tianjin, PEOPLES R CHINA
SP Chinese Soc Micro Nano Technol
DE Biomaterials; Magnetic materials; Composite emulsion; T-Shaped
   microchannel reactor; Monodispersity
ID EMULSIFICATION
AB Monodisperse magnetic microspheres with biomaterial of polylactic acid (PLA) or poly lactic-co-glycolic acid (PLGA) as shell were successfully prepared via T-shaped microchannel reactor in this paper. Hydrophilic ferriferrous oxide (Fe3O4) with highly magnetic responsiveness was obtained by solvothermal method. Aqueous solution of Fe3O4 was then emulsified into a dichloromethane solution of PLA or PLGA to generate water-in-oil (W/O) emulsion. Different stabilizer, i.e. polyvinyl alcohol (PVA), gelatin or gum arabic, was then added into the W/O emulsion for the purpose of more stable system. Subsequently, W/O/W composite emulsion was formed by injecting W/O emulsion into PVA aqueous solution at the T-shaped joint of microchannel reactor. Magnetic microspheres were finally prepared by solvent evaporation in the microchannel. The characteristic functional groups of Fe3O4 were characterized by Fourier transform infrared spectroscopy (FT-IR). The magnetic property was measured with vibrating sample magnetometer (VSM). The morphology of all samples was observed by scanning electron microscopy (SEM). It was found that the magnetic microspheres exhibit a uniform particle size in micro-scale. Therefore, the T-shaped microchannel reactor was expected to create a new approach for fabricating magnetic microspheres.
C1 [Liu, Peng; Zhong, Yi; Luo, Yan] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
RP Luo, Y (reprint author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
EM 2110468@mail.dhu.edu.cn; zhongyi@dhu.edu.cn; luoyan@dhu.edu.cn
CR Fang JH, 2013, MATER LETT, V96, P89, DOI 10.1016/j.matlet.2013.01.016
   Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015
   Kalita H, 2013, POLYM ADVAN TECHNOL, V24, P819, DOI 10.1002/pat.3149
   Ke CJ, 2011, ANGEW CHEM INT EDIT, V123, P8236
   Kobayashi I, 2001, J AM OIL CHEM SOC, V78, P797, DOI 10.1007/s11746-001-0345-5
   Okushima S, 2004, LANGMUIR, V20, P9905, DOI 10.1021/la0480336
   Sugiura S, 2002, IND ENG CHEM RES, V41, P4043, DOI 10.1021/ie0201415
   van der Zwan E, 2009, LANGMUIR, V25, P7320, DOI 10.1021/la900379n
   Zhao C-X, 2013, ADV DRUG DELIV REV
NR 9
TC 1
Z9 1
U1 3
U2 18
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-3-03835-071-2
J9 KEY ENG MATER
PY 2014
VL 609-610
BP 425
EP 429
DI 10.4028/www.scientific.net/KEM.609-610.425
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BB9FX
UT WOS:000348284900071
DA 2018-10-20
ER

PT S
AU Trubitsyn, MA
   Van Dat, D
   Van Thuan, L
   Gabruk, NG
   Oleynikova, II
   Shuteeva, TA
AF Trubitsyn, M. A.
   Van Dat, Doan
   Van Thuan, Le
   Gabruk, N. G.
   Oleynikova, I. I.
   Shuteeva, T. A.
BE Bogdan, A
   Martyushev, N
TI Morphological, Physical and Chemical Characteristics of Biocompatible
   Nano-Sized Carbonate-Substituted Hydroxyapatite
SO HIGH TECHNOLOGY: RESEARCH AND APPLICATIONS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference for Young Scientists on High Technology -
   Research and Applications
CY MAR 26-28, 2014
CL Tomsk Polytechn Univ, Tomsk, RUSSIA
HO Tomsk Polytechn Univ
DE nano-sized hydroxyapatite; modified hydroxyapatite; degree of
   substitution; morphology; specific surface area; biocompatibility;
   electron microscopy
AB Hydroxyapatite and compounds based on it are important and promising inorganic biomaterials that can be used in dentistry and bone surgery due to its biocompatibility with the bone tissue of a living organism. The paper presents the synthesis of carbonate-substituted hydroxyapatite powders and studies their morphology, physical and chemical characteristics and biocompatibility in vivo. The synthetic carbonate-substituted hydroxyapatite are biocompatible, and they do not cause degenerative changes in the surrounding tissues. The result of this research suggests that the carbonate-substituted hydroxyapatite is promising biomaterial for orthopedic and dental prosthetics.
C1 [Trubitsyn, M. A.] Belgorod State Natl Res Univ, 85 Pobeda Str, Belgorod, Russia.
RP Trubitsyn, MA (reprint author), Belgorod State Natl Res Univ, 85 Pobeda Str, Belgorod, Russia.
EM Troubitsin@bsu.edu.ru; datbelgo@mail.ru; thuansphoa27@mail.ru;
   gabruk@bsu.edu.ru; oleynikova@bsu.edu.ru; tatyana.shuteeva@mail.ru
CR Barinov SM, 2010, RUSS CHEM REV+, V79, P13, DOI 10.1070/RC2010v079n01ABEH004098
   Kolobov Y. R., 2007, RU Patent, Patent No. 2342319
   Porter A, 2005, J MATER SCI-MATER M, V16, P899, DOI 10.1007/s10856-005-4424-1
   Precu E., 2006, DETERMINATION STRUCT
   Roveri N, 2008, ADV MATER RES-SWITZ, V47-50, P821, DOI 10.4028/www.scientific.net/AMR.47-50.821
   Troubitsin M. A., 2011, SYNTHESIS ADV MAT BO, P35
NR 6
TC 0
Z9 0
U1 3
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03835-264-8
J9 ADV MATER RES-SWITZ
PY 2014
VL 1040
BP 97
EP +
DI 10.4028/www.scientific.net/AMR.1040.97
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BC0BK
UT WOS:000348897100019
DA 2018-10-20
ER

PT J
AU Andorko, JI
   Tostanoski, LH
   Solano, E
   Mukhamedova, M
   Jewell, CM
AF Andorko, James I.
   Tostanoski, Lisa H.
   Solano, Eduardo
   Mukhamedova, Maryam
   Jewell, Christopher M.
TI Intra-lymph Node Injection of Biodegradable Polymer Particles
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 83; biomaterial; immunology; microparticle;
   nanoparticle; vaccine; adjuvant; lymph node; targeting; polymer
ID VACCINES
AB Generation of adaptive immune response relies on efficient drainage or trafficking of antigen to lymph nodes for processing and presentation of these foreign molecules to T and B lymphocytes. Lymph nodes have thus become critical targets for new vaccines and immunotherapies. A recent strategy for targeting these tissues is direct lymph node injection of soluble vaccine components, and clinical trials involving this technique have been promising. Several biomaterial strategies have also been investigated to improve lymph node targeting, for example, tuning particle size for optimal drainage of biomaterial vaccine particles. In this paper we present a new method that combines direct lymph node injection with biodegradable polymer particles that can be laden with antigen, adjuvant, or other vaccine components. In this method polymeric microparticles or nanoparticles are synthesized by a modified double emulsion protocol incorporating lipid stabilizers. Particle properties (e.g. size, cargo loading) are confirmed by laser diffraction and fluorescent microscopy, respectively. Mouse lymph nodes are then identified by peripheral injection of a nontoxic tracer dye that allows visualization of the target injection site and subsequent deposition of polymer particles in lymph nodes. This technique allows direct control over the doses and combinations of biomaterials and vaccine components delivered to lymph nodes and could be harnessed in the development of new biomaterial-based vaccines.
C1 [Andorko, James I.; Tostanoski, Lisa H.; Solano, Eduardo; Mukhamedova, Maryam; Jewell, Christopher M.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Jewell, CM (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
EM cmjewell@umd.edu
OI Tostanoski, Lisa/0000-0001-9255-5684
FU PhRMA foundation; Research and Scholar Award from the University of
   Maryland, College Park
FX This work was funded in part by the PhRMA foundation and a Research and
   Scholar Award from the University of Maryland, College Park. We thank
   Prof. Darrell Irvine for support of the initial work conducted in the
   completion of "In situ engineering of the lymph node microenvironment
   via intranodal injection of adjuvant-releasing polymer particles."
CR Adamina M, 2010, MOL THER, V18, P651, DOI 10.1038/mt.2009.275
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Bershteyn A, 2008, SOFT MATTER, V4, P1787, DOI 10.1039/b804933e
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Donaldson J. G., 2001, CURRENT PROTOCOLS IM
   Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012
   He Hong, 2010, J Vis Exp, DOI 10.3791/1743
   Hofman F., 2001, CURRENT PROTOCOLS IM
   Holmes K., 2001, CURRENT PROTOCOLS IM
   Irvine D. J., 2011, COMPREHENSIVE BIOMAT
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Johansen P, 2005, EUR J IMMUNOL, V35, P568, DOI 10.1002/eji.200425599
   Johansen P, 2008, P NATL ACAD SCI USA, V105, P5189, DOI 10.1073/pnas.0706296105
   Matheu M. P., 2007, JOVE-J VIS EXP, pe265, DOI DOI 10.3791/265
   Mohanan D, 2010, J CONTROL RELEASE, V147, P342, DOI 10.1016/j.jconrel.2010.08.012
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670
   Reddy ST, 2008, TISSUE ENG PT A, V14, P734
   Ribas A, 2011, CLIN CANCER RES, V17, P2987, DOI 10.1158/1078-0432.CCR-10-3272
   Salmon H, 2011, JOVE-J VIS EXP, DOI 10.3791/3054
   Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105
   Sharrow S. O., 2001, CURRENT PROTOCOLS IM
   Swartz MA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003763
NR 23
TC 14
Z9 14
U1 3
U2 18
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD JAN
PY 2014
IS 83
AR e50984
DI 10.3791/50984
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AZ9DZ
UT WOS:000348513500030
PM 24430972
OA Bronze, Green Published
DA 2018-10-20
ER

PT S
AU Lor Huai, C
   Mim Mim, L
   Naznin, S
AF Lor Huai, Chong
   Mim Mim, Lim
   Naznin, Sultana
BE Sidik, NAC
TI Polycaprolactone(PCL)/Gelatin(Ge)-based Electrospun Nanofibers for
   Tissue engineering and Drug Delivery Application
SO Mechanical and Materials Engineering
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT World Virtual Conference on Advanced Research in Mechanical and
   Materials Engineering
CY MAR 18-22, 2014
CL Kuala Lumpur, MALAYSIA
DE Tissue Engineering; Drug Delivery System; Scaffold;
   Polycaprolactone(PCL); Gelatin(Ge); Electrospinning
ID SCAFFOLD
AB Recent development of tissue engineering has been emphasized on tissue regeneration and repairing in order to solve the limitation of organ and tissue transplantation issues. Biomaterial scaffold, which plays an important role in this development, not only provides a promising alternative in order to improve the efficiency of cell transplantation in tissue engineering but also to deliver cells with growth factors and drugs into injured tissue to increase the survival of cell via drug delivery system. In this study, nanofibers were fabricated through blending of a synthetic polymer, polycaprolactone (PCL) and a natural polymer, Gelatin (Ge) using electrospinning technique. Processing parameters were optimized to determine the most suitable properties of PCL/Ge nanofibers. The surface morphology of PCL/Ge nanofibers were then characterized using Scanning Electron Microscopy (SEM). Six samples of nanofibers from different amount of gelatin mixed with 10% PCL (w/v) were successfully fabricated. Experimental results showed that 18kV of high voltage provided more homogenous and less beaded nanofibers. Meanwhile, the 0.8g of Ge in 10% PCL (w/v) was set as the maximum concentration while 0.2g of Ge in 10% PCL (w/v) was set as the minimum concentration to reduce the bead formation.
C1 [Lor Huai, Chong; Mim Mim, Lim; Naznin, Sultana] Univ Teknol Malaysia, Fac Biosci & Med Engn, Dept Clin Sci, Skudai 81310, Malaysia.
RP Lor Huai, C (reprint author), Univ Teknol Malaysia, Fac Biosci & Med Engn, Dept Clin Sci, Skudai 81310, Malaysia.
EM lorhuai@gmail.com; mimmim1289@gmail.com; naznin@biomedical.utm.my
OI LIM, MIM MIM/0000-0002-2841-0971
CR Ba Linh N. T., 2012, J BIOMATERIALS SCI P, V5, P520
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Chakrapani VY, 2012, J APPL POLYM SCI, V125, P3221, DOI 10.1002/app.36504
   Cho WJ, 2009, J BIOMED MATER RES A, V91A, P400, DOI 10.1002/jbm.a.32264
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Cui WG, 2007, J APPL POLYM SCI, V103, P3105, DOI 10.1002/app.25464
   Feng B, 2012, BIOMACROMOLECULES, V13, P3917, DOI 10.1021/bm3009389
   Gautam S, 2013, MAT SCI ENG C-MATER, V33, P1228, DOI 10.1016/j.msec.2012.12.015
   Jose MV, 2009, POLYMER, V50, P3778, DOI 10.1016/j.polymer.2009.05.035
   Kai D., 2012, NANOTECHNOLOGY, V23
   Kai D, 2011, J BIOMED MATER RES A, V99A, P376, DOI 10.1002/jbm.a.33200
   Kim JH, 2009, MAT SCI ENG C-BIO S, V29, P1725, DOI 10.1016/j.msec.2009.01.023
   Kolbuk D, 2013, EUR POLYM J, V49, P2052, DOI 10.1016/j.eurpolymj.2013.04.036
   Kumar P., 2012, EFFECT COLLECTOR ELE
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Roozbahani F., 2013, J NANOMATER, V2013, P1
   Sultana N., 2013, J NANOMATER, V2013, P1
   Sultana N, 2013, J BIONANOSCI, V7, P169
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
NR 20
TC 0
Z9 0
U1 2
U2 14
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03835-109-2
J9 APPL MECH MATER
PY 2014
VL 554
BP 57
EP 61
DI 10.4028/www.scientific.net/AMM.554.57
PG 5
WC Engineering, Mechanical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA BB9QI
UT WOS:000348561700012
DA 2018-10-20
ER

PT S
AU Cretan, MS
   Stamate, C
AF Cretan, Monica Stamate
   Stamate, Ciprian
BE Nicoara, M
   Opris, C
TI Synthesis and Characterization of PVA-Ketoprofen Cryogel, Biomaterial
   with Extended Drug Release Properties for Cartilage Replacement
SO ADVANCED MATERIALS AND STRUCTURES V
SE Solid State Phenomena
LA English
DT Proceedings Paper
CT 5th International Conference on Advanced Materials and Structures (AMS)
CY OCT 24-25, 2013
CL Timisoara, ROMANIA
SP Politechnica Fdn
DE cryogel; cartilage replacement; drug release system; ketoprofen
ID GELATIN CRYOGELS
AB The present paper aims to study the possibility to modify the properties of polyvinyl alcohol (pva) cryogels prepared in the presence of ketoprofen in order to replace the damaged articular cartilage. Articular cartilage is the most important part of articulation characterized by very low friction, high wear resistance, and poor regenerative qualities. Polyvinyl alcohol is a non-expensive polymer, versatile and adaptable to various needs, with exceptional properties such as water solubility, biocompatibility, non-toxicity and with capability to form hydrogels by chemical or physical methods. The aims of this paper are the synthesis, the physicochemical characterization and analysis of the tribological properties of pva cryogels for cartilage replacement and the introduction of new concept in medication by creating the cryogel like a controlled drug release system. The morphology of the cryogels, the interaction between the pva macromolecular chains and medicament has been studied by Scanning Electronic Microscopy. The gels swelling in physiologic ser have been monitored by gravimetric method in order to evidence the hydrophilic properties. The mechanical properties of the cryogels have been investigated by dynamic mechanical measurements. In conclusion, the biomaterial obtained provides good swelling properties, mechanical resistance and it is ideal for extended drug release implantable systems.
C1 [Cretan, Monica Stamate] Univ Med & Pharm Gr T Popa, Fac Pharm, Str Univ 16, Iasi 700115, Romania.
   [Stamate, Ciprian] Tech Univ Gheorghe Asachi, Mech Fac, Iasi 700050, Romania.
RP Cretan, MS (reprint author), Univ Med & Pharm Gr T Popa, Fac Pharm, Str Univ 16, Iasi 700115, Romania.
EM cretanmonica@yahoo.com; cip101301@gmail.com
CR Bhat S., 2009, EUROPEAN CELLS MAT J, V18, P46
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Srivastava A, 2007, MAT SCI ENG A-STRUCT, V464, P93, DOI 10.1016/j.msea.2007.03.057
   Swieszkowski W, 2006, BIOMATERIALS, V27, P1534, DOI 10.1016/j.biomaterials.2005.08.032
   Tripathi A, 2009, J BIOMED MATER RES A, V90A, P680, DOI 10.1002/jbm.a.32127
NR 5
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1012-0394
BN 978-3-03835-212-9
J9 SOLID STATE PHENOMEN
PY 2014
VL 216
BP 205
EP 209
DI 10.4028/www.scientific.net/SSP.216.205
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BB9AE
UT WOS:000347924100035
DA 2018-10-20
ER

PT S
AU Stamate, C
   Munteanu, C
   Stamate, MC
AF Stamate, Ciprian
   Munteanu, Corneliu
   Stamate, Monica Cretan
BE Nicoara, M
   Opris, C
TI Wear Particle Analysis, the Result of Tribological Phenomena of
   Biomaterials Couplings-Ultra Hight Molecular Weight Polyethylene and
   Magnesium Aluminosilicate Ceramic
SO ADVANCED MATERIALS AND STRUCTURES V
SE Solid State Phenomena
LA English
DT Proceedings Paper
CT 5th International Conference on Advanced Materials and Structures (AMS)
CY OCT 24-25, 2013
CL Timisoara, ROMANIA
SP Politechnica Fdn
DE wear; polyethylene particles; image analyses
AB Joint prosthesis involves the combination in the form of friction couplings of the different materials such as two metals, metal-polymer and polymer-ceramic. This paper aims to analyze the wear particles produced from the friction between two biomaterials: ultra hight molecular weight polyethylene (uhmwpe) and magnesium aluminosilicate ceramic. To obtain the wear particles using a tribometer cetr umt-2 type that can reproduce the wear phenomena of different biomaterials in different humidity conditions and at various speeds of movement. The tests were performed in dry and lubricated friction conditions using saline solution, the best imitating biological conditions. The movement is similar to the friction torques of the hip joint: a semicircular motion of the polymer piece on the circular surface of the ceramic piece. Movement speed chosen is 0.25 m/s. Wear particles obtained were isolated from biomaterial surfaces and studied using scanning electron microscope. The images obtained are analyzed, particle's dimensions are extracted and then imported into autocad can provide information about the shape, size and surface of the particles. In light of these facts, we can say the inflammatory risk of biomaterial particles. In conclusion, the biomaterial particles are very small and the inflammatory rick is reducing to minimum in lubricated conditions.
C1 [Stamate, Ciprian; Munteanu, Corneliu] Tech Univ Gheorghe Asachi, Mech Fac, Bd Dimitrie Mangeron 67, Iasi 700050, Romania.
   [Stamate, Monica Cretan] Univ Med & Pharm Gr T Popa, Fac Pharm, Iasi 700115, Romania.
RP Stamate, C (reprint author), Tech Univ Gheorghe Asachi, Mech Fac, Bd Dimitrie Mangeron 67, Iasi 700050, Romania.
EM cip101301@gmail.com; cornelmun@gmail.com; cretanmonica@yahoo.com
OI STAMATE, Ciprian/0000-0002-1734-9060
CR Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Plumlee K, 2009, WEAR, V267, P710, DOI 10.1016/j.wear.2008.11.028
   Tsukamoto R, 2006, ACTA ORTHOP, V77, P505, DOI 10.1080/17453670610046479
   Walpole AR, 2003, MATERIALWISS WERKST, V34, P1064, DOI 10.1002/mawe.200300707
NR 4
TC 0
Z9 0
U1 0
U2 11
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1012-0394
BN 978-3-03835-212-9
J9 SOLID STATE PHENOMEN
PY 2014
VL 216
BP 226
EP 230
DI 10.4028/www.scientific.net/SSP.216.226
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BB9AE
UT WOS:000347924100039
DA 2018-10-20
ER

PT S
AU Marius, N
   Iulian, A
   Ana, B
AF Marius, Niculescu
   Iulian, Antoniac
   Ana, Blajan
BE Nicoara, M
   Opris, C
TI Metallic biomaterials processing technologies in order to obtain a new
   design for a hip prosthesis femoral component
SO ADVANCED MATERIALS AND STRUCTURES V
SE Solid State Phenomena
LA English
DT Proceedings Paper
CT 5th International Conference on Advanced Materials and Structures (AMS)
CY OCT 24-25, 2013
CL Timisoara, ROMANIA
SP Politechnica Fdn
DE total hip replacement; hip stem design; processing techniques;
   cytoxicity analysis
ID IN-VITRO; ARTHROPLASTY; STEMS
AB The paper presents the processing technology that could be used in order to obtain a new design of a stem component for a hip prosthesis type "lattice beam". This new design was made based on the analysis of the currently successful stems used in clinical practice and on different biomechanical and biomaterials criteria. Metallic biomaterials used for manufacturing different components for hip prosthesis are usually austenitic stainless steel type 316L, Co-Cr alloy and titanium based alloy. In our study, considering the specific design of the stem, stainless steel type 316L with the nominal compositions (% weight): C < 0.03, Cr 17, Ni 14.5, Mo 2.7, Mn < 2.0, Si < 1.0, P < 0.025, S < 0.010, Fe balance is used. Different mechanical processing techniques were used in order to obtain the experimental prototype. According to the well-known limitation of the stainless steel type 316L as biomaterial for long term implants, we propose for the new stem component to use a TiN coating obtained using magnetron sputtering technique. The cytotoxicity studies were performed using a CCl 81 (VERO) stabilized cellular line, in order to analyse the biocompatibility properties. The samples were examined for the development of the cellular culture, in order to compare the results obtained using direct contact method. From the point of view of these tests, it was not observed an essential modification of cells and the cellular morphology is not affected by the presence of the TiN coated metallic samples. In the conclusion, the new geometry proposed for a stem component of cemented hip prosthesis could be made using different mechanical processing techniques and appears to be a potential solution in order to solve the problems related to the stability of the total hip prosthesis, with improved biocompatibility properties due to the TiN coatings.
C1 [Marius, Niculescu] Clin Hosp Colentina, 19-21 Stefan Cel Mare St, Bucharest, Romania.
   [Iulian, Antoniac; Ana, Blajan] Univ Politehn Bucuresti, Bucharest, Romania.
RP Marius, N (reprint author), Clin Hosp Colentina, 19-21 Stefan Cel Mare St, Bucharest, Romania.
EM mariusniculescu@yahoo.com; antoniac.iulian@gmail.com;
   ai.blajan@gmail.com
RI Antoniac, Iulian/D-4802-2014
OI Antoniac, Iulian/0000-0003-0112-3494
CR BARRACK RL, 1992, J BONE JOINT SURG BR, V74, P385
   Bhamra MS, 2006, P I MECH ENG H, V220, P379, DOI 10.1243/095441105X68971
   Braic M, 2006, SURF COAT TECH, V200, P6505, DOI 10.1016/j.surfcoat.2005.11.057
   Braic V, 2011, SURF COAT TECH, V206, P604, DOI 10.1016/j.surfcoat.2011.03.074
   Cristofolini L, 2003, J BIOMECH, V36, P1603, DOI 10.1016/S0021-9290(03)00191-X
   Glassman AH, 2006, CLIN ORTHOP RELAT R, P64, DOI 10.1097/01.blo.0000246541.41951.20
   Hopkinson N, 2006, RAPID MANUFACTURING: AN INDUSTRIAL REVOLUTION FOR THE DIGITAL AGE, P1
   Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7
   Malviya A, 2010, J BONE JOINT SURG AM, V92A, P1675, DOI 10.2106/JBJS.I.01426
   Ostbyhaug PO, 2009, J BONE JOINT SURG BR, V91B, P676, DOI 10.1302/0301-620X.91B5.21749
NR 10
TC 1
Z9 1
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1012-0394
BN 978-3-03835-212-9
J9 SOLID STATE PHENOMEN
PY 2014
VL 216
BP 239
EP 242
DI 10.4028/www.scientific.net/SSP.216.239
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BB9AE
UT WOS:000347924100041
DA 2018-10-20
ER

PT S
AU Balestra, RM
   Ribeiro, AA
   de Oliveira, JC
   Cavaleiro, A
   Oliveira, MV
AF Balestra, Roseli Marins
   Ribeiro, Alexandre Antunes
   de Oliveira, Joao Carlos
   Cavaleiro, Albano
   Oliveira, Marize Varela
BE Castanho, SM
   Acchar, W
   Hotza, D
TI TITANIUM SUBSTRATE SURFACES COATED WITH HYDROXYAPATITE BY MAGNETRON
   SPUTTERING
SO BRAZILIAN CERAMIC CONFERENCE 57
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 57th Brazilian Ceramic Conference (CBC)
CY MAY 19-22, 2013
CL Natal, BRAZIL
SP Elfusa, Mineracao Jundu, Netzsch
DE Titanium; Hydroxyapatite; Magnetron Sputtering; Powder Metallurgy
ID FILMS
AB The deposition of hydroxyapatite coatings on titanium via sputtering techniques has been quite studied on commercial dense substrates, for use as a biomaterial. In this work, porous titanium samples produced by powder metallurgy and commercially dense titanium sheet, used as control, were used as substrates. The coatings were deposited by radio frequency magnetron sputtering using a hydroxyapatite target in argon atmosphere with different deposition times. Samples characterization was performed by Optical Microscopy, Scanning Electron Microscopy/Energy Dispersive Spectroscopy and low-angle X-ray Diffraction. Hydroxyapatite coating depositions were obtained on both titanium substrates. The results indicated the potential of this methodology for titanium substrates with homogeneous hydroxyapatite coatings.
C1 [Balestra, Roseli Marins] Univ Fed Sao Joao Rei UFSJ, Dept Engn Mecan, Praca Santo Antonio 170,Sala 4-24MP, BR-36307352 Sao Jaol Del Rei, MG, Brazil.
   [Ribeiro, Alexandre Antunes; Oliveira, Marize Varela] Inst Nacl Tecnologia, Div Processamento Caracterizacao Mat, Lab Tecnologia Pos, BR-20081312 Rio De Janeiro, Brazil.
   [de Oliveira, Joao Carlos; Cavaleiro, Albano] Univ Coimbra, Dept Engn Mecan, SEG CEMUC, P-3030788 Coimbra, Portugal.
RP Balestra, RM (reprint author), Univ Fed Sao Joao Rei UFSJ, Dept Engn Mecan, Praca Santo Antonio 170,Sala 4-24MP, BR-36307352 Sao Jaol Del Rei, MG, Brazil.
EM roselibalestra@ufsj.edu.br; alexandre.antunes@int.gov.br;
   joao.oliveira@dem.uc.pt; albano.cavaleiro@dem.uc.pt;
   marize.varela@int.gov.br
OI Cavaleiro, Albano/0000-0001-8251-5099; Oliveira, Joao
   Carlos/0000-0002-6218-3098
CR Kim JU, 2011, THIN SOLID FILMS, V520, P793, DOI 10.1016/j.tsf.2011.04.169
   Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020
   Nouri A., 2010, BIOMIMETICS LEARNING
   Ong J, 2009, THIN CALCIUM PHOSPHA, P175
   Ribeiro AA, 2013, APPL SURF SCI, V265, P250, DOI 10.1016/j.apsusc.2012.10.189
   SILVA A. F. L., 2012, THESIS
   Stoica TF, 2008, THIN SOLID FILMS, V516, P8112, DOI 10.1016/j.tsf.2008.04.071
   Yamaguchi T, 2006, NUCL INSTRUM METH B, V249, P723, DOI 10.1016/j.nimb.2006.03.126
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
NR 9
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-3-03835-114-6
J9 MATER SCI FORUM
PY 2014
VL 798-799
BP 472
EP +
DI 10.4028/www.scientific.net/MSF.798-799.472
PG 2
WC Materials Science, Ceramics
SC Materials Science
GA BB9AM
UT WOS:000347955400078
DA 2018-10-20
ER

PT S
AU Wladymyr, JBS
   Nascimento, EP
   Almeida, KV
   Farias, KAS
   Cardoso, MJB
   Meneses, RL
   Fook, MVL
AF Wladymyr, J. B. S.
   Nascimento, E. P.
   Almeida, K., V
   Farias, K. A. S.
   Cardoso, M. J. B.
   Meneses, R. L.
   Fook, M. V. L.
BE Castanho, SM
   Acchar, W
   Hotza, D
TI HYBRID MEMBRANES DEVELOPMENT MADE BY CHITOSAN AND CALCIUM PHOSPHATE
SO BRAZILIAN CERAMIC CONFERENCE 57
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 57th Brazilian Ceramic Conference (CBC)
CY MAY 19-22, 2013
CL Natal, BRAZIL
SP Elfusa, Mineracao Jundu, Netzsch
DE hybrid membranes; chitosan and calcium phosphate
AB Medicine seeks increasingly to treat problems related to bone regeneration and tissue in order to minimize surgical trauma and some bone diseases. The technology advancement in the biomaterials field allows develop materials that assist in reconstructive procedures of body parts and increase treatments improving the life quality of human beings. Due to the biodegradability, biocompatibility and biofunctionality characteristics, chitosan has attracted attention of researchers in order to obtain new materials. Its unique features promote the incorporation of other materials such as calcium phosphate ceramics which are used in this bone replacement and bone regeneration due to submit biocompatibility, bioactivity, osteoconductivity in addition to allowing the bone cells proliferation, collagen and proteins in their surfaces, thus allowing tissue regeneration. This study aimed to develop biodegradable chitosan membranes with 1%, 3% and 5% calcium phosphate for use in bone regeneration. The composites were prepared and Characterized by X-ray diffraction (XRD), Fourier Transform Infrared Spectroscopy (FTIR) and angle contact wettability. The results indicates the composite formation and show an increased crystallinity in the chitosan membrane through the phosphate incorporation, besides confirming the composites hydrophilicity. Preliminary results indicates that the composite is a promising biomaterial.
C1 [Wladymyr, J. B. S.; Nascimento, E. P.; Almeida, K., V; Farias, K. A. S.; Cardoso, M. J. B.; Meneses, R. L.; Fook, M. V. L.] Univ Fed Campina Grande, Mat Engn Acad Unit, CERTBIO, Lab Evaluat & Dev Biomat Northeast, Campina Grande, PB, Brazil.
RP Wladymyr, JBS (reprint author), Univ Fed Campina Grande, Mat Engn Acad Unit, CERTBIO, Lab Evaluat & Dev Biomat Northeast, Campina Grande, PB, Brazil.
EM wladymyrjb@yahoo.com.br; emanueluepb@gmail.com
CR AIMOLI C.G., 2007, THESIS U ESTADUAL CA
   [Anonymous], 1997, CALCULATED ICSD USIN
   Aparecida Anahí Herrera, 2007, Quím. Nova, V30, P892, DOI 10.1590/S0100-40422007000400024
   BARBOSA R.C., 2011, THESIS U FEDERAL CAM
   FUKUMURA H, 2009, MOL NANODYAMICS, V1
   FUKUMURA H, 2009, MOL NANODYAMICS, V2
   HOLANDA A. L., 2011, THESIS U FEDERAL CAM
   Kawachi EY, 2000, QUIM NOVA, V23, P518, DOI 10.1590/S0100-40422000000400015
   KHASANOV S, 1994, THESIS U FEDERAL CAM
   LIMA R., 2010, THESIS U FEDERAL CAM
   OLIVEIRA S.V., 2009, REV ELETRONICA MATER, V4, P11
   PONCIANO J.J., 2010, THESIS U FEDERAL CAM
   RATNER B. D., 2005, INTRO MAT MED
   URAGAMI T., 2006, MAT SCI CHITIN CHITO
NR 14
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-3-03835-114-6
J9 MATER SCI FORUM
PY 2014
VL 798-799
BP 682
EP 686
DI 10.4028/www.scientific.net/MSF.798-799.682
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA BB9AM
UT WOS:000347955400114
DA 2018-10-20
ER

PT J
AU Berezina, N
AF Berezina, Nathalie
TI Biotechnological Transformations - The Future of the Organic Chemistry?
SO CURRENT ORGANIC CHEMISTRY
LA English
DT Article
DE Biocatalysis; biomaterial; biotransfomation; chirality; commodities;
   enantiomer; enzyme; monomer; polymer
ID RING-OPENING POLYMERIZATION; ENZYMATIC SURFACE MODIFICATION; ANTARCTICA
   LIPASE-B; PROCESS INTENSIFICATION; ESCHERICHIA-COLI; CYCLIC OLIGOMERS;
   LACTIC-ACID; POLY(BUTYLENE SUCCINATE); TRIMETHYLENE CARBONATE; MICROBIAL
   FERMENTATION
AB In this critical overview of what kind of organic chemistry is currently performed by biotechnology, the examples of the production of high added value molecules for pharmaceutical industry, of biomaterials and their modification as well as of commodities are discussed. The major strengths as well as weaknesses of this kind of approach in comparison to current organic chemistry achievements are discussed. The prospects of future development and collaborative approach between pure organic synthesis and biotechnological transformations are also developed.
C1 Mat Nova R&D Ctr, B-7822 Ghislenghien, Belgium.
RP Berezina, N (reprint author), Mat Nova R&D Ctr, 1 Rue Foudriers, B-7822 Ghislenghien, Belgium.
EM berezina@materianova.be
FU Walloon region; FEDER European Funds
FX The author is thankful to the Walloon region and FEDER European Funds
   for the financial support.
CR Addidle M., 2012, CLIN MICROBIOL NEWSL, V34, P147
   Agrawal PB, 2008, BIOCATAL BIOTRANSFOR, V26, P412, DOI 10.1080/10242420802332558
   Agrawal PB, 2008, ENZYME MICROB TECH, V42, P473, DOI 10.1016/j.enzmictec.2008.01.016
   Akaraonye E, 2012, BIOTECHNOL J, V7, P293, DOI 10.1002/biot.201100122
   Akaraonye E, 2010, J CHEM TECHNOL BIOT, V85, P732, DOI 10.1002/jctb.2392
   Alves A, 2013, J APPL PHYCOL, V25, P407, DOI 10.1007/s10811-012-9875-4
   Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073
   Asrar J, 2002, J APPL POLYM SCI, V83, P457, DOI 10.1002/app.2253
   Baxendale IR, 2013, J CHEM TECHNOL BIOT, V88, P519, DOI 10.1002/jctb.4012
   Berezina N, 2002, TETRAHEDRON-ASYMMETR, V13, P1953, DOI 10.1016/S0957-4166(02)00442-1
   Berezina N., 2014, CITRIC ACID OCCURREN, P53
   Berezina N, 2007, ADV SYNTH CATAL, V349, P2049, DOI 10.1002/adsc.200700150
   Berezina N, 2013, NEW BIOTECHNOL, V30, P192, DOI 10.1016/j.nbt.2012.05.002
   Berezina N, 2012, BIOTECHNOL J, V7, P304, DOI 10.1002/biot.201100191
   Bhatia A, 2007, KOREA-AUST RHEOL J, V19, P125
   Bisht KS, 1997, MACROMOLECULES, V30, P7735, DOI 10.1021/ma9708858
   Bolivar-Diaz CL, 2013, APPL CATAL B-ENVIRON, V129, P575, DOI 10.1016/j.apcatb.2012.10.004
   Bozell JJ, 2010, GREEN CHEM, V12, P539, DOI 10.1039/b922014c
   Brouk M, 2010, J MOL CATAL B-ENZYM, V66, P72, DOI 10.1016/j.molcatb.2010.03.006
   Brouk M, 2009, FOOD CHEM, V116, P114, DOI 10.1016/j.foodchem.2009.02.020
   Casali M, 2002, BIOTECHNOL BIOENG, V77, P105, DOI 10.1002/bit.10101
   Chanprateep S, 2010, J BIOSCI BIOENG, V110, P621, DOI 10.1016/j.jbiosc.2010.07.014
   Cimini D, 2012, BIOTECHNOL J, V7, P237, DOI 10.1002/biot.201100242
   Conder M.J., 1998, EP Patent, Patent No. [0,532,341, 0532341]
   Cordero OX, 2012, SCIENCE, V337, P1228, DOI 10.1126/science.1219385
   Courtois J, 2009, CURR OPIN MICROBIOL, V12, P261, DOI 10.1016/j.mib.2009.04.007
   Degeest B, 2000, APPL ENVIRON MICROB, V66, P3519, DOI 10.1128/AEM.66.8.3519-3527.2000
   Distel KA, 2005, BIORESOURCE TECHNOL, V96, P617, DOI 10.1016/j.biortech.2004.06.005
   Donelli I, 2010, POLYM DEGRAD STABIL, V95, P1542, DOI 10.1016/j.polymdegradstab.2010.06.011
   Donelli I, 2009, BIOTECHNOL BIOENG, V103, P845, DOI 10.1002/bit.22316
   Du C, 2012, CURR CHEM BIOL, V6, P14, DOI DOI 10.2174/187231312799984394
   Duclohier H, 2007, CHEM BIODIVERS, V4, P1023, DOI 10.1002/cbdv.200790094
   Elboutachfaiti R, 2011, CARBOHYD POLYM, V84, P1, DOI 10.1016/j.carbpol.2010.10.063
   Elboutachfaiti R., 2010, CARBOHYD POLYM, V80, P485
   Erickson B, 2012, BIOTECHNOL J, V7, P176, DOI 10.1002/biot.201100069
   Franks AE, 2009, ENERG ENVIRON SCI, V2, P113, DOI 10.1039/b816445b
   Fu Q, 2003, ANAL CHEM, V75, P191, DOI 10.1021/ac026039z
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Gerrits PJ, 2001, TETRAHEDRON-ASYMMETR, V12, P971, DOI 10.1016/S0957-4166(01)00183-5
   Gross R, 2007, BIOTECHNOL BIOENG, V98, P1123, DOI 10.1002/bit.21547
   Gubitz GM, 2003, CURR OPIN BIOTECH, V14, P577, DOI 10.1016/j.copbio.2003.09.010
   Gustavsson MT, 2005, BIOMACROMOLECULES, V6, P196, DOI 10.1021/bm049588i
   Hessel V, 2009, CHEM ENG TECHNOL, V32, P1655, DOI 10.1002/ceat.200900474
   Hickel A, 2001, BIOTECHNOL BIOENG, V74, P18, DOI 10.1002/bit.1091
   Hilker I, 2006, ANGEW CHEM INT EDIT, V45, P2130, DOI 10.1002/anie.200503496
   Hohn M, 2009, CHEMCATCHEM, V1, P42, DOI 10.1002/cctc.200900110
   HOMANN T, 1990, APPL MICROBIOL BIOT, V33, P121
   Ikunaka M, 2004, CATAL TODAY, V96, P93, DOI 10.1016/j.cattod.2004.06.110
   Jang YS, 2012, BIOTECHNOL J, V7, P186, DOI 10.1002/biot.201100059
   Karmee Sanjib Kumar, 2008, Biotechnology Journal, V3, P104, DOI 10.1002/biot.200700199
   Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434
   Keshavarz T, 2010, CURR OPIN MICROBIOL, V13, P321, DOI 10.1016/j.mib.2010.02.006
   Kircher M, 2012, BIOFUEL BIOPROD BIOR, V6, P240, DOI 10.1002/bbb.1341
   Klein T, 2013, BIOTECHNOL BIOENG, V110, P535, DOI 10.1002/bit.24633
   Kobayashi S, 2001, CHEM REV, V101, P3793, DOI 10.1021/cr990121l
   KOBAYASHI S, 1991, J AM CHEM SOC, V113, P3079, DOI 10.1021/ja00008a042
   Kondo A, 2008, MACROMOL BIOSCI, V8, P533, DOI 10.1002/mabi.200700270
   Kruhne U, 2014, CHEM BIOCHEM ENG Q, V28, P203
   Kumar A, 2000, J AM CHEM SOC, V122, P11767, DOI 10.1021/ja002915j
   Laffend LA, 1997, US Patent, Patent No. 5686276
   Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354
   Li YK, 2013, BIORESOURCE TECHNOL, V149, P333, DOI 10.1016/j.biortech.2013.09.077
   Lopez-Garzon CS, 2014, BIOTECHNOL ADV, V32, P873, DOI 10.1016/j.biotechadv.2014.04.002
   Lopez-Garzon CS, 2014, CHEM ENG J, V235, P52, DOI 10.1016/j.cej.2013.09.017
   Lopez-Garzon CS, 2012, CHEM ENG J, V200, P637, DOI 10.1016/j.cej.2012.06.079
   Luisi PL, 2007, CHEM BIODIVERS, V4, P603, DOI 10.1002/cbdv.200790053
   Mahapatro A, 2004, BIOMACROMOLECULES, V5, P62, DOI 10.1021/bm0342382
   Martelli SM, 2014, RSC POLYM CHEM SER, P349
   Martin GDA, 2010, CURR ORG CHEM, V14, P1
   Matsumura S, 1999, INT J BIOL MACROMOL, V25, P161, DOI 10.1016/S0141-8130(99)00030-6
   Matsuyama A, 2001, J MOL CATAL B-ENZYM, V11, P513, DOI 10.1016/S1381-1177(00)00032-1
   Morlon H, 2012, SCIENCE, V337, P1184, DOI 10.1126/science.1227512
   Musa MM, 2009, CHEMCATCHEM, V1, P89, DOI 10.1002/cctc.200900033
   Naik SN, 2010, RENEW SUST ENERG REV, V14, P578, DOI 10.1016/j.rser.2009.10.003
   Novy V, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-49
   Ohara H, 2003, APPL MICROBIOL BIOT, V62, P474, DOI 10.1007/s00253-003-1383-7
   Okajima S, 2003, BIOMACROMOLECULES, V4, P1514, DOI 10.1021/bm034043u
   Park SJ, 2012, BIOTECHNOL J, V7, P199, DOI 10.1002/biot.201100070
   Peeters J, 2004, BIOMACROMOLECULES, V5, P1862, DOI 10.1021/bm049794q
   Peeters JW, 2005, MACROMOL RAPID COMM, V26, P684, DOI 10.1002/marc.200500011
   Peterman E.A., 1950, U.S. Patent, Patent No. [2,520,255, 2520255]
   Philip S, 2007, J CHEM TECHNOL BIOT, V82, P233, DOI 10.1002/jctb.1667
   Pilarek M, 2013, BIOPROC BIOSYST ENG, V36, P1079, DOI 10.1007/s00449-012-0861-7
   Pollard DJ, 2007, TRENDS BIOTECHNOL, V25, P66, DOI 10.1016/j.tibtech.2006.12.005
   Saimura M, 2008, BIOTECHNOL LETT, V30, P377, DOI 10.1007/s10529-007-9563-7
   Sakai H, 2009, ENERG ENVIRON SCI, V2, P133, DOI 10.1039/b809841g
   Schaetzle O, 2009, ENERG ENVIRON SCI, V2, P96, DOI 10.1039/b815331k
   Schmid A, 2002, CURR OPIN BIOTECH, V13, P359, DOI 10.1016/S0958-1669(02)00336-1
   Schmidt W., 1998, US Patent, Patent No. [5,798,433,, 5798433]
   Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198
   SHIGENO T, 1991, BIOTECHNOL LETT, V13, P427, DOI 10.1007/BF01030995
   Shih IL, 2006, BIORESOURCE TECHNOL, V97, P1148, DOI 10.1016/j.biortech.2004.08.012
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   Singh SK, 2003, J ORG CHEM, V68, P5466, DOI 10.1021/jo0204395
   Srivastava RK, 2006, MACROMOLECULES, V39, P46, DOI 10.1021/ma0518508
   Straathof AJJ, 2014, CHEM REV, V114, P1871, DOI 10.1021/cr400309c
   Straathof AJJ, 2002, CURR OPIN BIOTECH, V13, P548, DOI 10.1016/S0958-1669(02)00360-9
   Su W, 2004, TETRAHEDRON-ASYMMETR, V15, P1275, DOI 10.1016/j.tetasy.2004.03.009
   Sugihara S, 2006, MACROMOL RAPID COMM, V27, P203, DOI 10.1002/marc.200500723
   Tanghe A., 2013, Procede continu de synthese d'oligoesters a partir d'un sel d'ammonium d'un diol et dispositif de mise en oeuvre, Patent No. [BE 2013/0042, 20130042]
   Thakker C, 2012, BIOTECHNOL J, V7, P213, DOI 10.1002/biot.201100061
   Thomsen MH, 2005, APPL MICROBIOL BIOT, V68, P598, DOI 10.1007/s00253-005-0056-0
   Tsuji H, 1999, POLYMER, V40, P6699, DOI 10.1016/S0032-3861(99)00004-X
   Uyama H, 2003, BIOCHEM ENG J, V16, P145, DOI 10.1016/S1369-703X(03)00028-7
   Valepyn E, 2011, BIOCATAL BIOTRANSFOR, V29, P25, DOI 10.3109/10242422.2010.548555
   van Beilen JB, 2002, CURR OPIN BIOTECH, V13, P338, DOI 10.1016/S0958-1669(02)00334-8
   Velasco J, 2000, NAT BIOTECHNOL, V18, P857, DOI 10.1038/78467
   Verstraete W, 2007, ENG LIFE SCI, V7, P117, DOI 10.1002/elsc.200620176
   Vertommen MAME, 2005, J BIOTECHNOL, V120, P376, DOI 10.1016/j.jbiotec.2005.06.015
   Wackett LP, 2004, CURR OPIN BIOTECH, V15, P280, DOI 10.1016/j.copbio.2004.05.003
   Wahlberg J, 2003, BIOMACROMOLECULES, V4, P1068, DOI 10.1021/bm0340725
   Wallace S, 2014, CURR OPIN BIOTECH, V30, P1, DOI 10.1016/j.copbio.2014.03.006
   Waltz E, 2008, NAT BIOTECHNOL, V26, P851, DOI 10.1038/nbt0808-851
   Weber SS, 2012, BIOTECHNOL J, V7, P225, DOI 10.1002/biot.201100065
   Wee YJ, 2006, FOOD TECHNOL BIOTECH, V44, P163
   Wegner J, 2011, CHEM COMMUN, V47, P4583, DOI 10.1039/c0cc05060a
   Weis R, 2004, J MOL CATAL B-ENZYM, V29, P211, DOI 10.1016/j.molcatb.2003.10.006
   Wenda S, 2011, GREEN CHEM, V13, P3007, DOI 10.1039/c1gc15579b
   Werner M, 2014, ANGEW CHEM INT EDIT, V53, P1704, DOI 10.1002/anie.201309301
   Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010
   Willeman WF, 2002, ENZYME MICROB TECH, V30, P200, DOI 10.1016/S0141-0229(01)00467-7
   Xie NZ, 2014, BIOTECHNOL ADV, V32, P615, DOI 10.1016/j.biotechadv.2014.04.001
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yina J., 2005, J CHROMATOGR A, V1090, P68
   Zhang HR, 2012, BIOTECHNOL PROGR, V28, P292, DOI 10.1002/btpr.702
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 126
TC 0
Z9 0
U1 2
U2 25
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1385-2728
EI 1875-5348
J9 CURR ORG CHEM
JI Curr. Org. Chem.
PY 2014
VL 18
IS 24
BP 3120
EP 3130
PG 11
WC Chemistry, Organic
SC Chemistry
GA AZ7BZ
UT WOS:000348374500004
DA 2018-10-20
ER

PT J
AU McLellan, J
   Plevin, S
AF McLellan, Jonathan
   Plevin, Sarah
TI Temporal Release of Growth Factors from Platelet-rich Fibrin (PRF) and
   Platelet-rich Rlasma (PRP) in the Horse: A Comparative in vitro Analysis
SO INTERNATIONAL JOURNAL OF APPLIED RESEARCH IN VETERINARY MEDICINE
LA English
DT Article
DE Keywords
ID PLASMA; REPAIR; LEUKOCYTE; MATRIX; TENDON; BETA; GEL
AB Objectives: To evaluate platelet-rich fibrin (PRF) in horses and compare temporal release of growth factors (OF) to platelet-rich plasma (PRP).
   Study Design: In vitro study Animals: Twelve healthy Thoroughbred geldings <5 years of age
   Methods: PRF was created by centrifugation using a human protocol. PRP was processed using a double spin, tube method. Four groups were created for each horse: immediate analysis of PRP (1) and PRF (2); slow-release analysis of PRP (3) and PRF (4) over 5 days. Concentrations of transforming growth factor beta 1 (TGF beta 1) and platelet derived growth factor BB (PDGF-BB) were analyzed using commercial sandwich ELISAs and significance determined using Wilcoxin signed rank and Kruskal-Wallis tests.
   Results: PRP released more OF than PRF upon immediate quantification (p=0.05). TGF beta 1 was increased at all subsequent time points in PRF compared to PRP (p<0.001), although both methods demonstrated an increased cumulative TGF beta 1 yield compared to immediate analysis (p<0.001). PDGF-BB did not show a temporal increase in yield, but release kinetics differed between PRF and PRP, indicating PRF may trap PDGF-BB, leading to a slower release. PRP gel dissolved by day 5in contrast to PRF clots, which remained solid.
   Conclusions: PRF can be easily procured in the horse using standard laboratory equipment. It may present advantages over PRP by providing a solid fibrin biomaterial allowing steady elusion (Author, pls check this word) of OF over time. This slow release of OF may represent a novel treatment modality for surgical conditions in the horse, and future studies should be undertaken to determine appropriate clinical applications.
C1 [McLellan, Jonathan] Florida Equine Vet Associates, Ocala, FL 34482 USA.
RP McLellan, J (reprint author), 10195 N HWY 27, Ocala, FL 34482 USA.
EM jmclellan@fevaocala.com
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037
   Arguelles D, 2006, RES VET SCI, V81, P237, DOI 10.1016/j.rvsc.2005.12.008
   ARNOCZKY SP, 1988, J BONE JOINT SURG AM, V70A, P1209, DOI 10.2106/00004623-198870080-00012
   Brunner G, 2004, THROMB HAEMOSTASIS, V92, P253, DOI 10.1160/TH04-05-0324
   Carter CA, 2003, EXP MOL PATHOL, V74, P244, DOI 10.1016/S0014-4800(03)00017-0
   Cenni E, 2005, J PERIODONTOL, V76, P323, DOI 10.1902/jop.2005.76.3.323
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Donnelly BP, 2006, AM J VET RES, V67, P1218, DOI 10.2460/ajvr.67.7.1218
   Ehrenfest DMD, 2009, GROWTH FACTORS, V27, P63, DOI 10.1080/08977190802636713
   Everts PAM, 2008, J BIOMED MATER RES A, V85A, P1135, DOI 10.1002/jbm.a.31570
   Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3
   Foster TE, 2009, AM J SPORT MED, V37, P2259, DOI 10.1177/0363546509349921
   Giraldo CE, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-29
   Graziani F, 2006, CLIN ORAL IMPLAN RES, V17, P212, DOI 10.1111/j.1600-0501.2005.2005.01203.x
   Haupt JL, 2006, AM J VET RES, V67, P1595, DOI 10.2460/ajvr.67.9.1595
   Kobayashi M, 2012, BIOLOGICALS, V40, P323, DOI 10.1016/j.biologicals.2012.07.004
   Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Monteiro SO, 2009, AM J VET RES, V70, P277, DOI 10.2460/ajvr.70.2.277
   Nielsen HJ, 2001, VOX SANG, V80, P170, DOI 10.1046/j.1423-0410.2001.00028.x
   O'Connell SM, 2008, WOUND REPAIR REGEN, V16, P749, DOI 10.1111/j.1524-475X.2008.00426.x
   Pietrzak WS, 2005, J CRANIOFAC SURG, V16, P1043, DOI 10.1097/01.scs.0000186454.07097.bf
   ROBERTS AB, 1996, MOL CELLULAR BIOL WO, P275
   Sutter WW, 2004, AM J VET RES, V65, P924, DOI 10.2460/ajvr.2004.65.924
   Thor A, 2007, INT J ORAL MAX SURG, V36, P1164, DOI 10.1016/j.ijom2007.05.023
   Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x
   Visser LC, 2011, AM J VET RES, V72, P699, DOI 10.2460/ajvr.72.5.699
   Visser LC, 2010, VET SURG, V39, P811, DOI 10.1111/j.1532-950X.2010.00739.x
   Zachos TA, 2005, AM J VET RES, V66, P727, DOI 10.2460/ajvr.2005.66.727
   Zumstein MA, 2012, CURR PHARM BIOTECHNO, V13, P1196
NR 34
TC 1
Z9 2
U1 0
U2 6
PU VETERINARY SOLUTIONS LLC
PI APOPKA
PA PO BOX 2083, APOPKA, FL 32704-2083 USA
SN 1542-2666
EI 1559-470X
J9 INT J APPL RES VET M
JI Int. J. Appl. Res. Vet. Med.
PY 2014
VL 12
IS 1
BP 44
EP 53
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA CA0OR
UT WOS:000348617300006
DA 2018-10-20
ER

PT S
AU Guo, FY
   Shen, X
   Pei, XH
   Yang, GS
AF Guo, Fang Yuan
   Shen, Xia
   Pei, Xiao Hong
   Yang, Gen Sheng
BE Hegde, G
TI Synthesis and Characterization of Photocurable Biodegradable Elastomers
SO MATERIALS SCIENCE AND PROCESSING, ENVIRONMENTAL ENGINEERING AND
   INFORMATION TECHNOLOGIES
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT International Conference on Application of Materials Science and
   Environmental Materials (AMSEM)
CY JUL 04-06, 2014
CL Yichang, PEOPLES R CHINA
DE elastomer; ring-opening; UV cross-link
ID DEGRADATION
AB The aim of this study was to synthesize a serious of biodegradable elastomers by photocurable reaction as a potential biomaterial for the delivery of protein drugs. The macromonomers was prepared via ring opening reaction at 140 degrees C later methacrylic acylated at 50 degrees C. The optimal conditions were investigated and the property of the two macromonomer precursors were characterized via GPC and 1H-NMR. The cross-link degree of the elastomers can be adjusted by changing the concentration of photoinitiator (DMPA), furthermore influence the elastomers' degradation rate. It could provide more appropriate choice for the elastomers in application.
C1 [Guo, Fang Yuan; Shen, Xia; Pei, Xiao Hong; Yang, Gen Sheng] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou 310032, Zhejiang, Peoples R China.
RP Guo, FY (reprint author), Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou 310032, Zhejiang, Peoples R China.
EM guofy.2008@hotmail.com; yanggs@zjut.edu.cn
CR Alauzun JG, 2010, BIOMATERIALS, V31, P3471, DOI 10.1016/j.biomaterials.2010.01.069
   Amsden B., 2009, INT J PHARMACEUT, V388, P32
   Amsden BG, 2004, BIOMACROMOLECULES, V5, P2479, DOI 10.1021/bm049578h
   Chapanian R, 2010, EUR J PHARM BIOPHARM, V74, P172, DOI 10.1016/j.ejpb.2009.11.012
   Chapanian R, 2010, J BIOMED MATER RES A, V92A, P830, DOI 10.1002/jbm.a.32422
   Ilagan BG, 2010, J BIOMED MATER RES A, V93A, P211, DOI 10.1002/jbm.a.32482
   Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399
   Serrano MC, 2010, ADV FUNCT MATER, V20, P192, DOI 10.1002/adfm.200901040
   Strohl WR, 2009, CURR OPIN BIOTECH, V20, P668, DOI 10.1016/j.copbio.2009.10.012
NR 9
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03835-270-9
J9 APPL MECH MATER
PY 2014
VL 665
BP 359
EP 362
DI 10.4028/www.scientific.net/AMM.665.359
PG 4
WC Engineering, Environmental; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BB9BZ
UT WOS:000348127000077
DA 2018-10-20
ER

PT B
AU Kivevele, T
   Zhang, M
   Huan, ZJ
AF Kivevele, Thomas
   Zhang, Ming
   Huan, Zhongjie
GP IEEE
TI AIR SOURCE HEAT PUMP SYSTEM FOR DRYING BIOMATERIAL
SO PROCEEDINGS OF THE 2014 11TH INTERNATIONAL CONFERENCE ON THE INDUSTRIAL
   AND COMMERCIAL USE OF ENERGY (ICUE)
LA English
DT Proceedings Paper
CT 11th International Conference on the Industrial and Commercial Use of
   Energy (ICUE)
CY AUG 19-20, 2014
CL Cape Town, SOUTH AFRICA
SP Cape Peninsula Univ Technol, Inst Elect & Elect Engineers, S African Assoc Energy Serv Co, So African Assoc Energy Efficiency, S African Inst Elect Engineers, Assoc Municipal Elect Undertakings, Eskom Demand Side Management, Stellenbosch Univ, Univ Cape Town, N W Univ
ID BANANAS; FRUIT
AB Need for a more economic method of drying biomaterial, from paper to fruit, in South Africa has for long been sought. This paper explains research into an advanced air source heat pump drying (ASHPD) system, designed, manufactured and installed for drying South African fruit and taking into account local climactic conditions. The effect of ambient temperature and condenser fan speed on the coefficient of performance (COP) of the heat pump (HP) was evaluated, also the influence of drying temperature and air velocity analysed. Using banana slices (the sample fruit selected for this study) results indicated the moisture content of bananas produced in Mpumalanga Province averaged 75.5 +/- 1.5% on a wet basis. The COP of the HP was found to be significantly high - an average 4.7. The influence of the evaporator temperature on the COP was important since it assisted in temperature control during the drying process. It was also observed the COP increased with an increase in room temperature. Drying process results indicated for drying South African bananas a possible optimal drying temperature range was 30 - 40 degrees C with 1.5 m/s drying air velocity. Generally, the study demonstrated an ASHPD system was suitable for use in South African climatic conditions. Now South Africa has an opportunity to continue research and to design applications for this green and efficient drying technology - especially for drying biomaterial. This could reduce high energy consumption, something all of South Africa is striving towards.
C1 [Kivevele, Thomas; Zhang, Ming; Huan, Zhongjie] Tshwane Univ Technol, Dept Mech Engn, Pretoria, South Africa.
RP Kivevele, T (reprint author), Tshwane Univ Technol, Dept Mech Engn, Pretoria, South Africa.
CR Beck R. A., 1985, FOOD CHEM NUTR BIOCH
   BOWREY RG, 1980, FOOD TECHNOL AUST, V32, P290
   Chua KJ, 2010, APPL ENERG, V87, P3611, DOI 10.1016/j.apenergy.2010.06.014
   Chua KJ, 2002, DRY TECHNOL, V20, P1579, DOI 10.1081/DRT-120014053
   Chua KJ, 2001, FOOD RES INT, V34, P721, DOI 10.1016/S0963-9969(01)00094-1
   Colak N, 2009, ENERG CONVERS MANAGE, V50, P2187, DOI 10.1016/j.enconman.2009.04.037
   Daghigh R, 2010, INT CONF SYST SCI SI, P404
   Daghigh R, 2010, RENEW SUST ENERG REV, V14, P2564, DOI 10.1016/j.rser.2010.04.004
   Department of Agriculture, 2011, PROF S AFR BAN MARK
   GARCIA R, 1988, INT J FOOD SCI TECH, V23, P73
   Karim MA, 2005, INT J HEAT MASS TRAN, V48, P4914, DOI 10.1016/j.ijheatmasstransfer.2005.04.035
   Kivevele T. T., 2013, P 10 IND COMM US EN, P189
   MEYER JP, 1992, INT J ENERG RES, V16, P13, DOI 10.1002/er.4440160103
   MOWLAH G, 1983, LEBENSM WISS TECHNOL, V16, P103
   Perera CO, 1997, TRENDS FOOD SCI TECH, V8, P75, DOI 10.1016/S0924-2244(97)01013-3
   Prabha TN, 1998, PHYTOCHEMISTRY, V48, P915, DOI 10.1016/S0031-9422(97)00931-X
   Prasertsan S, 1998, DRY TECHNOL, V16, P235, DOI 10.1080/07373939808917401
   Robinson A. A., 1980, FOOD ENG
   Rossi S. J., 1992, DRYING 92 MUJUMDAR A
   Sankat CK, 1996, INT J FOOD SCI TECH, V31, P123, DOI 10.1111/j.1365-2621.1996.332-35.x
   Shi QL, 2008, J FOOD ENG, V87, P74, DOI 10.1016/j.jfoodeng.2007.11.010
   WILLS RBH, 1986, FOOD AUST, V38, P118
NR 22
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-0-9922-0416-7
PY 2014
BP 241
EP 247
PG 7
WC Energy & Fuels; Engineering, Electrical & Electronic; Environmental
   Sciences
SC Energy & Fuels; Engineering; Environmental Sciences & Ecology
GA BB8WY
UT WOS:000347703800031
DA 2018-10-20
ER

PT S
AU Tkachenko, MV
   Kamzin, AS
   Ol'khovik, LP
   Tkachenko, TM
   Keshri, S
AF Tkachenko, M. V.
   Kamzin, A. S.
   Ol'khovik, L. P.
   Tkachenko, T. M.
   Keshri, S.
BE Ovchinnikov, S
   Samardak, A
TI Synthesis and Study of the New Class of Magnetic Bioceramics for
   Biomedical Applications: Mossbauer Studies
SO TRENDS IN MAGNETISM: NANOMAGNETISM
SE Solid State Phenomena
LA English
DT Proceedings Paper
CT 5th Euro-Asian Symposium onTrends in MAGnetism - Nanomagnetism (EASTMAG)
CY SEP 15-21, 2013
CL Vladivostok, RUSSIA
SP Far Eastern Fed Univ, Russian Fdn Basic Res, Dynasty Fdn, Far Eastern Branch Russian Acad Sci, TechnoInfo Ltd Co
DE Hexaferrite; Hydroxyapatite; Hybrid Biocompatible Ceramics;
   Ferrimagnetic Hyperthermia
ID HYDROXYAPATITE; PARTICLES; FERRITE; BONE
AB Magnetic bioceramics based on hydroxyapatite Ca-5(PO4)(3)OH and particles of the M-type hexagonal (barium or calcium) ferrite (taken in proportions 5, 10, 20, 25, 40 and 50 wt % of M-ferrite) with a high bioactivity and magnetic characteristics providing hyperthermal treatment of oncology diseases has been developed and studied. The phase composition, microstructure, and magnetic properties of the synthesized bioceramics have been determined by using electron diffraction patterns, electron microscope micrograms and Mossbauer spectroscopy. It has been shown that the synthesized biomaterial consists of the biocompatible matrix with the apatite structure into which particles of hexagonal ferrite are incorporated. The Mossbauer spectra for all the samples clearly indicates that the particles of hexagonal ferrite are in the ferromagnetic state and small part of particles in paramagnetic state. The magnetic parameters of the synthesized ceramics are substantially higher than those of the bioglass ceramics modified by iron oxides that have been used in medicine, which suggests good potential and effectiveness of application of the created ceramics for medical purposes. Thus, a new class of magnetic bioceramics combining hydroxyapatite Ca-5(PO4)(3)OH, which exhibits good properties in biocompatibility and bioactivity, with particles of the M-type hexagonal ferrite, which possess high magnetic characteristics, has been created.
C1 [Tkachenko, M. V.; Ol'khovik, L. P.] Kharkov Natl Univ, Kharkov, Ukraine.
   [Kamzin, A. S.; Tkachenko, T. M.] Russian Acad Sci, Ioffe Phys Tech Inst, St Petersburg 194021, Russia.
   [Keshri, S.] Birla Inst Technol, Dept Appl Phys, Ranchi, Bihar, India.
RP Tkachenko, MV (reprint author), Kharkov Natl Univ, Kharkov, Ukraine.
EM kamzin@mail.ioffe.ru
OI Tkachenko, Mykola/0000-0003-3174-0290
FU Ministry of Education and Scienct of Ukraine [0112U005918]; Russian
   Foundation for Basic Research [12-02-92690-IND-a]
FX This study was supported by the Ministry of Education and Scienct of
   Ukraine (contract 0112U005918) and the Russian Foundation for Basic
   Research (project 12-02-92690-IND-a).
CR Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Hergt R, 1998, IEEE T MAGN, V34, P3745, DOI 10.1109/20.718537
   Kamzin AS, 1997, J EXP THEOR PHYS+, V84, P788, DOI 10.1134/1.558212
   Kamzin AS, 1996, FIZ TVERD TELA+, V38, P2823
   Kawashita M, 2005, BIOMATERIALS, V26, P2231, DOI 10.1016/j.biomaterials.2004.07.014
   Leventouri T, 2005, BIOMATERIALS, V26, P4924, DOI 10.1016/j.biomaterials.2005.01.017
   Ol'khovik L. P., 2011, Bulletin of the Russian Academy of Sciences. Physics, V75, P281, DOI 10.3103/S1062873810031025
   Ol'khovik LP, 2010, TECH PHYS LETT+, V36, P756, DOI 10.1134/S1063785010080237
   Ol'khovik LP, 2010, LOW TEMP PHYS+, V36, P226, DOI 10.1063/1.3331495
   Ol'khovik L.P., 2010, UA Patent, Patent No. 54514
   Ol'khovik L.P., 2010, UA Patent, Patent No. [48 345, 48345]
   Roca AG, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224002
   Ruiz-Hernandez E, 2006, J BIOMED MATER RES A, V79A, P533, DOI 10.1002/jbm.a.30889
   Rusakov VS, 1999, IZV AKAD NAUK FIZ+, V63, P1389
   Singh RK, 2011, J MAGN MAGN MATER, V323, P330, DOI 10.1016/j.jmmm.2010.09.029
   Singh RK, 2010, CERAM INT, V36, P283, DOI 10.1016/j.ceramint.2009.07.028
   Thorek DLJ, 2006, ANN BIOMED ENG, V34, P23, DOI 10.1007/s10439-005-9002-7
   Zyman Z, 2001, J BIOMED MATER RES, V54, P256, DOI 10.1002/1097-4636(200102)54:2<256::AID-JBM13>3.3.CO;2-2
   Zyman Z, 2004, J MATER SCI-MATER M, V15, P551, DOI 10.1023/B:JMSM.0000026099.74563.db
   Zyman Z.Z., 2007, P INT C FUNCT MAT PA, P503
NR 21
TC 1
Z9 1
U1 1
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1012-0394
BN 978-3-03835-054-5
J9 SOLID STATE PHENOMEN
PY 2014
VL 215
BP 480
EP +
DI 10.4028/www.scientific.net/SSP.215.480
PG 3
WC Physics, Applied; Physics, Condensed Matter
SC Physics
GA BB9BM
UT WOS:000348048400091
DA 2018-10-20
ER

PT S
AU Isik, M
   Niinomi, M
   Cho, K
   Nakai, M
   Hieda, J
   Yilmazer, H
   Horita, Z
   Narushima, T
AF Isik, Murat
   Niinomi, Mitsuo
   Cho, Ken
   Nakai, Masaaki
   Hieda, Junko
   Yilmazer, Hakan
   Horita, Zenji
   Narushima, Takayuki
BE Goto, T
   Fu, Z
   Zhang, L
TI Microstructural analysis of biomedical Co-Cr-Mo alloy subjected to
   high-pressure torsion processing
SO ADVANCED CERAMICS AND NOVEL PROCESSING
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 5th International Symposium on Advance Ceramics (ISAC) / 3rd
   International Symposium on Advanced Synthesis and Processing Technology
   for Materials (ASPT)
CY DEC 09-12, 2013
CL Wuhan, PEOPLES R CHINA
SP Japan Soc Promot Sci, Wuhan Univ Technol, Adv Inst Mat Sci, Ceram Soc Japan, Chinese Ceram Soc, Japan Inst Metals & Mat, Japan Soc Powder & Powder Metallurgy, Peoples Republ China, Minist Educ, Wuhan Univ Technol, State Key Lab Adv Technol Mat Synthesis & Proc, 124th Comm Adv Ceram Mat
DE Co-Cr-Mo alloys; Metallic biomaterial; High-pressure torsion;
   Strain-induced e martensite phase; Vickers hardness; Grain refinement
ID EVOLUTION
AB The effect of high-pressure torsion (HPT) processing on the microstructure and Vickers hardness of Co-Cr-Mo (CCM) alloys were investigated in this study. The microstructure of initial CCM alloy contains equiaxed grains with a grain diameter of approximately 50 mu m and twins. The clear grain boundaries of equiaxed grains and twins disappear after HPT processing at a rotation number, N, of 10. The phase maps of initial CCM alloy and CCM alloy subjected to HPT processing at N = 5 measured by electron backscatter diffraction exhibit that the ratio of. phase decreases from 93.5% to 34.1% and the ratio of e phase increases from 6.5% to 65.9% by applying HPT processing. These results indicate that the e phase is formed by high-strain, which is induced by the HPT processing. The Vickers hardness values on the surfaces of the CCM alloys subjected to HPT processing at N = 1, 5, and 10 increase with increasing the equivalent strain, epsilon(eq). These results suggest that an increase of Vickers hardness is correlated to an increase of the ratio of epsilon phase and the dislocation density, and grain refinement, which are caused by the high-strain induced by HPT processing.
C1 [Isik, Murat] Tohoku Univ, Dept Mat Sci, Sendai, Miyagi 9808579, Japan.
   [Niinomi, Mitsuo; Cho, Ken; Nakai, Masaaki; Hieda, Junko; Yilmazer, Hakan] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi, Japan.
   [Horita, Zenji] Kyushu Univ, Fac Engn, Dept Mat Sci & Engn, Nishi Ku, Fukuoka 8190395, Japan.
   [Narushima, Takayuki] Tohoku Univ, Dept Mat Proc, Sendai, Miyagi 9808579, Japan.
RP Isik, M (reprint author), Tohoku Univ, Dept Mat Sci, Sendai, Miyagi 9808579, Japan.
EM murat@imr.tohoku.ac.jp; niinomi@imr.tohoku.ac.jp;
   k_cho@imr.tohoku.ac.jp; nakai@imr.tohoku.ac.jp; hieda@imr.tohoku.ac.jp;
   hakan@imr.tohoku.ac.jp; horita@zaiko.kyushu-u.ac.jp;
   narut@material.tohoku.ac.jp
FU Grants for Excellent Gradate School; MEXT, Japan; Japan Society for the
   Promotion of Science, and Inamori Grants from the Inamori Foundation,
   Japan [24246111]
FX This study was supported in part by The Grants for Excellent Gradate
   School "Materials Integration Center" and "Materials Science Center",
   MEXT, Japan, Grant-in-Aid for Scientific Research (A) No. 24246111 from
   the Japan Society for the Promotion of Science, and Inamori Grants from
   the Inamori Foundation, Japan.
CR CLEMOW AJT, 1979, J BIOMED MATER RES, V13, P265, DOI 10.1002/jbm.820130208
   Hsu HC, 2003, J MATER PROCESS TECH, V138, P231, DOI 10.1016/S0924-0136(03)00077-3
   Hsu RWW, 2005, MATER CHEM PHYS, V93, P531, DOI 10.1016/j.matchemphys.2005.04.007
   Huang P, 1999, MATER LETT, V39, P244, DOI 10.1016/S0167-577X(99)00021-X
   Ito Y, 2009, MAT SCI ENG A-STRUCT, V503, P32, DOI 10.1016/j.msea.2008.03.055
   Koizumi Y, 2013, ACTA MATER, V61, P1648, DOI 10.1016/j.actamat.2012.11.041
   Mori M, 2010, MAT SCI ENG A-STRUCT, V528, P614, DOI 10.1016/j.msea.2010.09.002
   Yamanaka K, 2009, METALL MATER TRANS A, V40A, P1980, DOI 10.1007/s11661-009-9879-0
   Yilmazer H, 2013, MAT SCI ENG C-MATER, V33, P2499, DOI 10.1016/j.msec.2013.01.056
   Zhilyaev AP, 2008, PROG MATER SCI, V53, P893, DOI 10.1016/j.pmatsci.2008.03.002
   Zhilyaev AP, 2003, ACTA MATER, V51, P753, DOI 10.1016/S1359-6454(02)00466-4
NR 11
TC 0
Z9 0
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-3-03835-130-6
J9 KEY ENG MATER
PY 2014
VL 616
BP 263
EP 269
DI 10.4028/www.scientific.net/KEM.616.263
PG 7
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA BB8ZR
UT WOS:000347883400046
DA 2018-10-20
ER

PT J
AU Ju, RK
   Wen, YJ
   Gou, RB
   Wang, Y
   Xu, QY
AF Ju, Rongkai
   Wen, Yujun
   Gou, Rongbin
   Wang, Ying
   Xu, Qunyuan
TI The Experimental Therapy on Brain Ischemia by Improvement of Local
   Angiogenesis With Tissue Engineering in the Mouse
SO CELL TRANSPLANTATION
LA English
DT Article
DE Hyaluronic acid (HA) hydrogel; Poly(lactic-co-glycolic acid) (PLGA);
   Neural stem cells (NSCs); Angiogenesis; Ischemic stroke
ID ENDOTHELIAL GROWTH-FACTOR; NEURAL STEM-CELLS; FOCAL CEREBRAL-ISCHEMIA;
   HYALURONIC-ACID HYDROGEL; PROMOTES ANGIOGENESIS; EXPERIMENTAL STROKE;
   RECEPTOR ANTIBODY; VASCULAR NICHE; IN-VITRO; VEGF
AB Neural restoration has proven to be difficult after brain stroke, especially in its chronic stage. This is mainly due to the generation of an unpropitious niche in the injured area, including loss of vascular support but production of numerous inhibitors against neuronal regeneration. Reconstruction of a proper niche for promoting local angiogenesis, therefore, should be a key approach for neural restoration after stroke. In the present study, a new biomaterial composite that could be implanted in the injured area of the brain was created for experimental therapy of brain ischemia in the mouse. This composite was made using a hyaluronic acid (HA)-based biodegradable hydrogel scaffold, mixed with poly(lactic-co-glycolic acid) (PLGA) microspheres containing vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang1), two factors that stimulate angiogenesis. In addition, the antibody of Nogo receptor (NgR-Ab), which can bind to multiple inhibitory myelin proteins and promote neural regeneration, was covalently attached to the hydrogel, making the hydrogel more bioactive and suitable for neural survival. This composite (HA PLGA) was implanted into the mouse model with middle cerebral artery occlusion (MCAO) to explore a new approach for restoration of brain function after ischemia. A good survival and proliferation of human umbilical artery endothelial cells (HUAECs) and neural stem cells (NSCs) were seen on the HA hydrogel with PLGA microspheres in vitro. This new material was shown to have good compatibility with the brain tissue and inhibition to gnosis and inflammation after its implantation in the normal or ischemic brain of mice. Particularly, good angiogenesis was found around the implanted HA PLGA hydrogel, and the mouse models clearly showed a behavioral improvement. The results in this present study indicate, therefore, that the HA PLGA hydrogel is a promising material, which is able to induce angiogenesis in the ischemic region by releasing VEGF and Ang1, thus creating a suitable niche for neural restoration in later stages of stroke. This manuscript is published as part of the International Association of Neurorestoratology (IANR) special issue of Cell Transplantation.
C1 [Ju, Rongkai; Wen, Yujun; Gou, Rongbin; Wang, Ying; Xu, Qunyuan] Capital Med Univ, Beijing Ctr Neural Regenerat & Repair, Beijing Inst Brain Disorders, Dept Neurobiol,Key Lab Neurodegenerat Dis,Minist, Beijing 100069, Peoples R China.
RP Xu, QY (reprint author), Capital Med Univ, Beijing Ctr Neural Regenerat & Repair, Beijing Inst Brain Disorders, Dept Neurobiol,Key Lab Neurodegenerat Dis,Minist, 10 Xitoutiao, Beijing 100069, Peoples R China.
EM xuqy@ccmu.edu.cn
FU National Nature Science Foundation of China [81070977, 81200931,
   81271388]; Capital Medical University Key Laboratory Research
   [2011SJZS05, 2012SJZS03]; National Basic Research Program of China
   [2012CBA01307]
FX This work was supported by National Nature Science Foundation of China
   (No. 81070977, No. 81200931, No. 81271388), Capital Medical University
   Key Laboratory Research (No. 2011SJZS05, No. 2012SJZS03), and National
   Basic Research Program of China (No. 2012CBA01307). The authors declare
   no conflicts of interest.
CR Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Chu K, 2005, NEUROSCI RES, V53, P384, DOI 10.1016/j.neures.2005.08.010
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012
   Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710
   ERIKSDOTTERNILSSON M, 1986, J NEUROSCI METH, V17, P275, DOI 10.1016/0165-0270(86)90128-7
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   George ML, 2000, CLIN CANCER RES, V6, P3147
   Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014
   Hansen TM, 2008, CURR NEUROVASC RES, V5, P236, DOI 10.2174/156720208786413433
   Henderson RD, 2000, STROKE, V31, P128, DOI 10.1161/01.STR.31.1.128
   Herz J, 2012, NEUROBIOL DIS, V45, P1077, DOI 10.1016/j.nbd.2011.12.026
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F
   Khan AA, 2011, INT J NANOMED, V6, P1069, DOI 10.2147/IJN.S15054
   Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163
   KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794
   Li MZ, 2011, GLIA, V59, P108, DOI 10.1002/glia.21080
   Liu XS, 2007, J CEREBR BLOOD F MET, V27, P564, DOI 10.1038/sj.jcbfm.9600371
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   McKhann GM, 2002, ANN NEUROL, V52, P133, DOI 10.1002/ana.10313
   Nakagomi N, 2009, STEM CELLS, V27, P2185, DOI 10.1002/stem.161
   Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006
   Pan LJ, 2009, J NEUROSCI RES, V87, P3207, DOI 10.1002/jnr.22142
   Pan WH, 2006, EXP NEUROL, V198, P222, DOI 10.1016/j.expneurol.2005.11.020
   Peirce SM, 2004, AM J PHYSIOL-HEART C, V286, pH918, DOI 10.1152/ajpheart.00833.2003
   Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   Shen FX, 2011, J CEREBR BLOOD F MET, V31, P2343, DOI 10.1038/jcbfm.2011.97
   Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505
   Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026
   Shin SH, 2013, PHARM RES-DORDR, V30, P2157, DOI 10.1007/s11095-013-1076-6
   Su H, 2009, INT J CARDIOL, V133, P191, DOI 10.1016/j.ijcard.2007.12.034
   Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977
   Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622
   Taguchi A, 2007, EUR J NEUROSCI, V26, P126, DOI 10.1111/j.1460-9568.2007.05640.x
   TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6
   Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108
   Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025
   Tomita Y, 2005, J CEREBR BLOOD F MET, V25, P858, DOI 10.1038/sj.jcbfm.9600077
   Wang Y, 2011, PHARM RES-DORDR, V28, P1406, DOI 10.1007/s11095-011-0452-3
   Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298
   Yang JP, 2010, J INVEST SURG, V23, P149, DOI 10.3109/08941930903469482
   Yang JP, 2009, NEUROSCI LETT, V461, P212, DOI 10.1016/j.neulet.2009.06.060
   Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369
   Zhao H, 2011, HUM GENE THER, V22, P207, DOI 10.1089/hum.2010.111
NR 53
TC 15
Z9 18
U1 2
U2 16
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2014
VL 23
SU 1
BP S83
EP S95
DI 10.3727/096368914X684998
PG 13
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA AY9KT
UT WOS:000347869500010
PM 25302948
OA Bronze
DA 2018-10-20
ER

PT J
AU Bianchera, A
   Salomi, E
   Pezzanera, M
   Ruwet, E
   Bettini, R
   Elviri, L
AF Bianchera, Annalisa
   Salomi, Enrico
   Pezzanera, Matteo
   Ruwet, Elisabeth
   Bettini, Ruggero
   Elviri, Lisa
TI Chitosan Hydrogels for Chondroitin Sulphate Controlled Release: An
   Analytical Characterization
SO JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY
LA English
DT Article
ID ARTIFICIAL EXTRACELLULAR-MATRIX; MESENCHYMAL STEM-CELLS;
   CHITOSAN/CHONDROITIN SULFATE; POLYELECTROLYTE COMPLEXES; TISSUE
   REGENERATION; HYALURONIC-ACID; GROWTH-FACTOR; GLUCOSAMINE; CHONDROCYTES;
   EXPRESSION
AB This paper provides an analytical characterization of chitosan scaffolds obtained by freeze-gelation toward the uptake and the controlled release of chondroitin sulphate (CS), as cartilage repair agent, under different pH conditions. Scanning electron microscopy (SEM), attenuated total reflectance-Fourier transforminfrared spectroscopy (ATR-FTIR), and liquid chromatography-UV spectrophotometry (LC-UV) techniques were exploited to obtain qualitative and quantitative descriptions of polymer and drug behaviour in the biomaterial. As for morphology, SEM analysis allowed the evaluation of scaffold porosity in terms of pore size and distribution both at the surface (Feret diameter 58 + 19 mu m) and on the cross section (Feret diameter 106 + 51 mu m). LC and ATR-FTIR evidenced a pH-dependent CS loading and release behaviour, strongly highlighting the role of electrostatic forces on chitosan/chondroitin sulphate interactions.
C1 [Bianchera, Annalisa; Salomi, Enrico; Pezzanera, Matteo; Ruwet, Elisabeth; Bettini, Ruggero; Elviri, Lisa] Univ Parma, Dept Pharm, I-43124 Parma, Italy.
RP Elviri, L (reprint author), Univ Parma, Dept Pharm, Parco Area Sci 27-A, I-43124 Parma, Italy.
EM lisa.elviri@unipr.it
RI Bettini, Ruggero/O-2693-2013
OI Bettini, Ruggero/0000-0002-3857-7476
CR Abarrategi A, 2010, J BIOMED MATER RES A, V95A, P1132, DOI 10.1002/jbm.a.32912
   Ahmed TAE, 2010, TISSUE ENG PART B-RE, V16, P305, DOI [10.1089/ten.teb.2009.0590, 10.1089/ten.TEB.2009.0590]
   BASSLEER C, 1992, INT J TISSUE REACT, V14, P231
   Busilacchi A, 2013, CARBOHYD POLYM, V98, P665, DOI 10.1016/j.carbpol.2013.06.044
   Calamia V, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4040
   Chen WB, 2005, J BIOMED MATER RES A, V75A, P128, DOI 10.1002/jbm.a.30393
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Derfoul A, 2007, OSTEOARTHR CARTILAGE, V15, P646, DOI 10.1016/j.joca.2007.01.014
   Fajardo AR, 2011, COLLOID POLYM SCI, V289, P1739, DOI 10.1007/s00396-011-2497-6
   Fajardo AR, 2010, CARBOHYD POLYM, V80, P934, DOI 10.1016/j.carbpol.2010.01.009
   Henson FMD, 2012, AM J VET RES, V73, P306, DOI 10.2460/ajvr.73.2.306
   Huang HJ, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035008
   Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208
   Jou CH, 2008, POLYM ADVAN TECHNOL, V19, P377, DOI 10.1002/pat.1020
   Kobo M, 2009, LIFE SCI, V85, P477, DOI [10.1016/j.lfs.2009.08.005, 10.1016/j.lfs.209.08.005]
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Liang N, 2012, INT J PHARMACEUT, V423, P480, DOI 10.1016/j.ijpharm.2011.12.004
   Lippiello L, 2003, OSTEOARTHR CARTILAGE, V11, P335, DOI 10.1016/S1063-4584(03)00026-8
   Lippiello L, 2000, CLIN ORTHOP RELAT R, P229
   Lovu M, 2008, OSTEOARTHR CARTILAGE, V16, pS14, DOI 10.1016/j.joca.2008.06.008
   Martel-Pelletier J, 2010, OSTEOARTHR CARTILAGE, V18, pS7, DOI 10.1016/j.joca.2010.01.015
   Mi FL, 2006, J BIOMED MATER RES A, V76A, P1, DOI 10.1002/jbm.a.30298
   Mi FL, 2006, J AGR FOOD CHEM, V54, P3290, DOI 10.1021/jf0529868
   Muzzarelli RAA, 2012, CARBOHYD POLYM, V89, P723, DOI 10.1016/j.carbpol.2012.04.057
   Park YJ, 2000, J CONTROL RELEASE, V67, P385, DOI 10.1016/S0168-3659(00)00232-7
   Peng CK, 2006, J APPL POLYM SCI, V99, P2091, DOI 10.1002/app.22730
   Piai JF, 2010, J MOL LIQ, V156, P28, DOI 10.1016/j.molliq.2010.05.017
   Piai JF, 2009, ACTA BIOMATER, V5, P2601, DOI 10.1016/j.actbio.2009.03.035
   PIPITONE VR, 1991, DRUG EXP CLIN RES, V17, P3
   Romani AA, 2008, BIOMED PHARMACOTHER, V62, P491, DOI 10.1016/j.biopha.2008.07.010
   Romani A. A., 2013, ADV BIOMATERIALS SCI
   Ronca F, 1998, OSTEOARTHR CARTILAGE, V6, P14, DOI 10.1016/S1063-4584(98)80006-X
   Ruffell B, 2011, J BIOL CHEM, V286, P19179, DOI 10.1074/jbc.M110.200790
   Schindeler A, 2013, CELL REPROGRAM, V15, P101, DOI 10.1089/cell.2012.0054
   Schwartz Z, 2011, AM J VET RES, V72, P42, DOI 10.2460/ajvr.72.1.42
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Senkoylu A, 2001, J BIOACT COMPAT POL, V16, P136, DOI 10.1106/3EH5-2R73-RC4V-Y9L7
   Shea JE, 2005, ADV DRUG DELIVER REV, V57, P945, DOI 10.1016/j.addr.2004.12.017
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Varghese S, 2007, OSTEOARTHR CARTILAGE, V15, P59, DOI 10.1016/j.joca.2006.06.008
   Yagoubi N., 1996, Annales Pharmaceutiques Francaises, V54, P126
   Yao HB, 2010, ANGEW CHEM INT EDIT, V49, P10127, DOI 10.1002/anie.201004748
   Yeh MK, 2011, ACTA BIOMATER, V7, P3804, DOI 10.1016/j.actbio.2011.06.026
   Yuan NY, 2008, DESALINATION, V234, P166, DOI 10.1016/j.desal.2007.09.083
NR 44
TC 8
Z9 8
U1 0
U2 18
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-8865
EI 2090-8873
J9 J ANAL METHODS CHEM
JI J. Anal. Methods Chem.
PY 2014
AR 808703
DI 10.1155/2014/808703
PG 8
WC Chemistry, Analytical; Engineering, Civil
SC Chemistry; Engineering
GA AY8TS
UT WOS:000347826900001
PM 25614850
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Fangel, R
   Bossini, PS
   Renno, AC
   Granito, RN
   Wang, CC
   Nonaka, KO
   Driusso, P
   Parizotto, NA
   Oishi, J
AF Fangel, Renan
   Bossini, Paulo S.
   Renno, Ana Claudia
   Granito, Renata N.
   Wang, Charles C.
   Nonaka, Keico O.
   Driusso, Patricia
   Parizotto, Nivaldo A.
   Oishi, Jorge
TI Biomechanical properties: effects of low-level laser therapy and
   Biosilicate (R) on tibial bone defects in osteopenic rats
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Biomaterial; Biomechanical properties; Bone healing; Low-level laser
   therapy; Osteopenia
ID INORGANIC BOVINE BONE; IN-VITRO; 830-NM LASER; REPAIR; OSTEOPOROSIS;
   IRRADIATION; DIFFERENTIATION; PROLIFERATION; EXPRESSION; FRACTURES
AB Purpose: The aim of this study was to investigate the effects of laser therapy and Biosilicate (R) on the biomechanical properties of bone callus in osteopenic rats.
   Methods: Fifty female Wistar rats were equally divided into 5 groups (n=10/group): osteopenic rats with intact tibiae (SC); osteopenic rats with unfilled and untreated tibial bone defects (OC); osteopenic rats whose bone defects were treated with Biosilicate (R) (B); osteopenic rats whose bone defects were treated with 830-nm laser, at 120 J/cm(2) (L120) and osteopenic rats whose bone defects were treated with Biosilicate (R) and 830-nm laser, at 120 J/cm(2) (BL120). Ovariectomy (OVX) was used to induce osteopenia. A non-critical bone defect was created on the tibia of the osteopenic animals 8 weeks after OVX. In Biosilicate (R) groups, bone defects were completely filled with the biomaterial. For the laser therapy, an 830-nm laser, 120 J/cm(2) was used. On day 14 postsurgery, rats were euthanized, and tibiae were removed for biomechanical analysis.
   Results: Maximal load and energy absorption were higher in groups B and BL120, according to the indentation test. Animals submitted to low-level laser therapy (LLLT) did not show any significant biomechanical improvement, but the association between Biosilicate (R) and LLLT was shown to be efficient to enhance callus biomechanical properties. Conversely, no differences were found between study groups in the bending test.
   Conclusions: Biosilicate (R) alone or in association with low level laser therapy improves biomechanical properties of tibial bone callus in osteopenic rats.
C1 [Fangel, Renan; Bossini, Paulo S.; Granito, Renata N.; Wang, Charles C.; Driusso, Patricia; Parizotto, Nivaldo A.] Fed Univ Sao Carlos UFSCar, Dept Physiotherapy, Sao Carlos, SP, Brazil.
   [Renno, Ana Claudia] Fed Univ Sao Paulo UNIFESP, Dept Biosci, Santos, SP, Brazil.
   [Nonaka, Keico O.] Fed Univ Sao Carlos UFSCar, Dept Biol, Sao Carlos, SP, Brazil.
   [Oishi, Jorge] Fed Univ Sao Carlos UFSCar, Dept Stat, Sao Carlos, SP, Brazil.
RP Driusso, P (reprint author), Univ Fed Sao Carlos, Dept Physiotherapy, Rod Washington Luiz,Km 235, BR-13565208 Sao Carlos, SP, Brazil.
EM pdriusso@ufscar.br
RI Granito, Renata/F-3407-2014; Bossini, Paulo/G-2333-2014; Renno, Ana
   Claudia/C-1266-2015; Parizotto, Nivaldo/D-5347-2014
OI Parizotto, Nivaldo/0000-0003-1774-9053
FU Brazilian funding agency Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - CAPES
FX This work was funded by the Brazilian funding agency Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - CAPES. CAPES is a
   foundation within the Ministry of Education (MEC).
CR Adachi JD, 2010, MAYO CLIN PROC, V85, P806, DOI 10.4065/mcp.2010.0082
   Pinheiro ALB, 2013, LASER MED SCI, V28, P815, DOI 10.1007/s10103-012-1166-4
   Bossini PS, 2011, J TISSUE ENG REGEN M, V5, P229, DOI 10.1002/term.309
   Bultink IEM, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0328-0
   Buravlev EA, 2013, LASER MED SCI, V28, P785, DOI 10.1007/s10103-012-1155-7
   Calixto RFE, 2007, IMPLANT DENT, V16, P260, DOI 10.1097/ID.0b013e3180500b95
   Comelekoglu U, 2007, CLIN RHEUMATOL, V26, P380, DOI 10.1007/s10067-006-0367-2
   Diniz JS, 2009, LASER MED SCI, V24, P347, DOI 10.1007/s10103-008-0568-9
   Fangel R, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3598847
   Fazil M, 2013, EXPERT OPIN DRUG DEL, V10, P1123, DOI 10.1517/17425247.2013.785518
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Granito RN, 2011, J BIOMED MATER RES B, V97B, P139, DOI 10.1002/jbm.b.31795
   Granito RN, 2009, J MATER SCI-MATER M, V20, P2521, DOI 10.1007/s10856-009-3824-z
   KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I
   Kamali F, 2007, J PHOTOCH PHOTOBIO B, V88, P11, DOI 10.1016/j.jphotobiol.2007.04.010
   Ke HZ, 1998, BONE, V23, P249, DOI 10.1016/S8756-3282(98)00102-1
   Lirani-Galvao AP, 2006, PHOTOMED LASER SURG, V24, P735, DOI 10.1089/PHO.2006.2003
   Liu XC, 2007, PHOTOMED LASER SURG, V25, P487, DOI 10.1089/pho.2006.2075
   Luger EJ, 1998, LASER SURG MED, V22, P97, DOI 10.1002/(SICI)1096-9101(1998)22:2<97::AID-LSM5>3.0.CO;2-R
   Matsumoto MA, 2009, LASER MED SCI, V24, P195, DOI 10.1007/s10103-008-0544-4
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Muniz Renno AC, 2006, LASER MED SCI, V21, P202, DOI 10.1007/s10103-006-0396-8
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Ozawa Y, 1998, BONE, V22, P347, DOI 10.1016/S8756-3282(97)00294-9
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   Pretel H, 2007, LASER SURG MED, V39, P788, DOI 10.1002/lsm.20585
   Renno ACM, 2007, PHOTOMED LASER SURG, V25, P275, DOI 10.1089/pho.2007.2055
   Renno ACM, 2006, PHOTOMED LASER SURG, V24, P202, DOI 10.1089/pho.2006.24.202
   Renno ACM, 2009, PHOTOMED LASER SURG, V12, P124
   Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161
   Tim CR, 2014, LASER MED SCI, V29, P147, DOI 10.1007/s10103-013-1302-9
NR 31
TC 5
Z9 5
U1 0
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2014
VL 12
IS 3
BP 271
EP 277
DI 10.5301/jabfm.5000198
PG 7
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA AY4NB
UT WOS:000347554200020
PM 24700268
DA 2018-10-20
ER

PT S
AU Klocke, F
   Schwade, M
   Klink, A
AF Klocke, Fritz
   Schwade, Max
   Klink, Andreas
BE Larkiola, J
TI Fundamental Analysis of the Process Conditions During Electro Discharge
   Machining of Biodegradable Magnesium
SO MATERIAL FORMING ESAFORM 2014
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 17th Conference of the
   European-Scientific-Association-on-Material-Forming (ESAFORM)
CY MAY 07-09, 2014
CL Espoo, FINLAND
SP European Sci Assoc Mat Forming, VTT
DE EDM; Sinking-EDM; Single Discharge; Process Monitoring
AB Magnesium is one of the most promising materials for the application as degradable biomaterial for load bearing implants due to the initial stability and extraordinary biocompatibility. But up until now magnesium degrades too fast before the ingrowing bone can support itself. One possible approach is the application of an interconnecting channel structure. This design increases the surface area to promote bone regeneration and gives the bone the possibility to build a supporting structure throughout the implant. In combination with a surface modification which increases the corrosion resistance the bone can regain enough stability to support itself before the implant has dissolved noticeably. Due to the low process forces EDM is very suited for the machining of the necessary filigree structures. But up until now there are no standard technologies for the machining of this material available. Therefore a fundamental analysis of the material specific influence of magnesium on the EDM process is necessary. In this paper the machining of three different magnesium alloys are compared to the machining of a tool steel. Due to the numerous influencing factors and their interdependencies it is normally not possible to analyze the impact of each input parameter of a typical EDM technology on the continuous process separately making the correlation of input and output parameters very difficult. Therefore the electrical signals are recorded during the machining process to identify and monitor the resulting discharge conditions and frequency. These results are compared to the fundamental influence of the material derived from single discharge experiments in which the boundary conditions are constant to a large extent. By this method the material removal rate as well as the resulting surface roughness of the continuous process can be linked to the material dependent process conditions. As a result technologies for the machining of new materials can be developed and optimized based on fundamental knowledge.
C1 [Klocke, Fritz; Schwade, Max; Klink, Andreas] Rhein Westfal TH Aachen, Lab Machine Tools & Prod Engn WZL, Aachen, Germany.
RP Schwade, M (reprint author), Rhein Westfal TH Aachen, Lab Machine Tools & Prod Engn WZL, Aachen, Germany.
EM f.klocke@wzl.rwth-aachen.de; m.schwade@wzl.rwth-aachen.de;
   a.klink@wzl.rwth-aachen.de
CR Altpeter F, 2004, J MATER PROCESS TECH, V149, P147, DOI 10.1016/j.jmatprotec.2003.10.033
   GU X.N., 2010, FRONT MAT SCI CHINA, P111
   Klocke F, 2007, FERTIGUNGSVERFAHREN
   Kunieda M., 2005, CIRP ANN-MANUF TECHN, V54, P64, DOI DOI 10.1016/S0007-8506(07)60020-1
   Nasab M. B., 2009, TRENDS BIOMATER ARTI, V24, P69
   Witte F., 2009, CURRENT OPINION SOLI, V12, P63
NR 6
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-3-03835-106-1
J9 KEY ENG MATER
PY 2014
VL 611-612
BP 773
EP 780
DI 10.4028/www.scientific.net/KEM.611-612.773
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA BB8TP
UT WOS:000347481000099
DA 2018-10-20
ER

PT B
AU de Viteri, VS
   Igartua, A
   Bayon, R
   Barandika, G
   Perez-Jorge, C
   Esteban, J
   Martinez, M
AF de Viteri, Virginia Saenz
   Igartua, Amaya
   Bayon, Raquel
   Barandika, Gotzone
   Perez-Jorge, Conchita
   Esteban, Jaime
   Martinez, Marta
GP IEEE
TI Tribocorrosion and antibacterial behaviour of TiO2 coatings obtained by
   PEO technique
SO 2014 IEEE INTERNATIONAL SYMPOSIUM ON MEDICAL MEASUREMENTS AND
   APPLICATIONS (MEMEA)
SE IEEE International Symposium on Medical Measurements and Applications
   Proceedings-MeMeA
LA English
DT Proceedings Paper
CT 9th IEEE International Symposium on Medical Measurements and
   Applications (IEEE MeMeA)
CY JUN 11-12, 2014
CL Univ Lisbon, ISCTE, Lisbon, PORTUGAL
SP IEEE, IEEE Instrumentat & Measurement Soc
HO Univ Lisbon, ISCTE
DE Plasma Electrolytic Oxidation; iodine; titanium; tribocorrosion;
   antibacterial
ID PLASMA ELECTROLYTIC OXIDATION; BACTERIAL ADHESION; TI-6AL-4V ALLOY;
   TITANIUM; GROWTH; FILMS
AB Ti6Al4V (grade 5) is the implant material of choice to be used in stems of hip joint implants due to its good mechanical properties, biocompatibility and its good corrosion resistance. However, it presents poor wear resistance. This effect with the exposure of biomaterial to the body fluids that induce corrosion damage lead to irreversible material degradation, called tribocorrosion process. Another problem present in prostheses is the high risk of bacterial infection. In this work, Plasma Electrolytic Oxidation technique was used to develop TiO2 coatings with high wear resistance and antibacterial properties were developed. Microstructural and chemical characterization has been carried out. Tribocorrosion behavior was analyzed in simulated body fluid, and bacterial adhesion study was performed.
C1 [de Viteri, Virginia Saenz; Igartua, Amaya; Bayon, Raquel] IK4 TEKNIKER, Tribol Unit, Eibar, Spain.
   [Barandika, Gotzone] Univ Basque Country, Dept Inorgan Chem, Vitoria, Spain.
   [Perez-Jorge, Conchita; Esteban, Jaime; Martinez, Marta] IIS Fundac Jimnez Diaz, Dept Clin Microbiol, Madrid, Spain.
RP de Viteri, VS (reprint author), IK4 TEKNIKER, Tribol Unit, Eibar, Spain.
EM virginia.saenzdeviteri@tekniker.es
RI Barandika, Gotzone/N-2157-2014; Esteban, Jaime/S-6554-2018
OI Barandika, Gotzone/0000-0002-6771-6586; Esteban,
   Jaime/0000-0002-8971-3167
FU FUNCOAT [CSD2008- 0023]; Spanish Government; MEC; GV/ EJ; European
   Social
FX Authors thanks to EMAITEK Project, financed by the Basque Country;
   FUNCOAT ( CSD2008- 0023) CONSOLIDER Project, financed by the Spanish
   Government, under contract; and SGIker for their technical support (
   MEC, GV/ EJ, European Social Fund)
CR Al-Radha ASD, 2012, J DENT, V40, P146, DOI 10.1016/j.jdent.2011.12.006
   Chandra A, 2011, J MECH BEHAV BIOMED, V4, P1990, DOI 10.1016/j.jmbbm.2011.06.018
   Han E., 2007, CURR APPL PHYS, P23
   Han Y, 2003, SURF COAT TECH, V168, P249, DOI 10.1016/S0257-8972(03)00016-1
   Kinnari TJ, 2008, J BIOMED MATER RES A, V86A, P760, DOI 10.1002/jbm.a.31643
   Mabbouxa F., 2004, COLLOID SURFACES B, P199
   Matykina E, 2007, ELECTROCHIM ACTA, V53, P1987, DOI 10.1016/j.electacta.2007.08.074
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Perez-Tanoira R., 2012, WIDELY ONLINE LIB, DOI [10.1002/ibm.a.34090, DOI 10.1002/IBM.A.34090]
   SANTAVIRTA S, 1992, ACTA ORTHOP SCAND, V63, P225, DOI 10.3109/17453679209154831
   Shirai T, 2011, ACTA BIOMATER, V7, P1928, DOI 10.1016/j.actbio.2010.11.036
   Wang YM, 2004, MATER LETT, V58, P1907, DOI 10.1016/j.matlet.2003.11.026
   Yao ZP, 2008, APPL SURF SCI, V254, P4084, DOI 10.1016/j.apsusc.2007.12.062
   Yerokhin AL, 2000, SURF COAT TECH, V130, P195, DOI 10.1016/S0257-8972(00)00719-2
NR 14
TC 0
Z9 0
U1 4
U2 9
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-2921-4
J9 IEEE INT SYM MED MEA
PY 2014
BP 289
EP 292
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BB8JS
UT WOS:000346747000054
DA 2018-10-20
ER

PT J
AU Barenghi, R
   Beke, S
   Romano, I
   Gavazzo, P
   Farkas, B
   Vassalli, M
   Brandi, F
   Scaglione, S
AF Barenghi, Rossella
   Beke, Szabolcs
   Romano, Ilaria
   Gavazzo, Paola
   Farkas, Balazs
   Vassalli, Massimo
   Brandi, Fernando
   Scaglione, Silvia
TI Elastin-Coated Biodegradable Photopolymer Scaffolds for Tissue
   Engineering Applications
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; GRAFTS; STENTS; STEREOLITHOGRAPHY;
   PROLIFERATION; POLYPEPTIDE; BIOMATERIAL; INHIBITION; RETENTION
AB One of the main open issues in modern vascular surgery is the nonbiodegradability of implants used for stent interventions, which can lead to small caliber-related thrombosis and neointimal hyperplasia. Some new, resorbable polymeric materials have been proposed to substitute traditional stainless-steel stents, but so far they were affected by poor mechanical properties and low biocompatibility. In this respect, a new material, polypropylene fumarate (PPF), may be considered as a promising candidate to implement the development of next generation stents, due to its complete biodegradability, and excellent mechanical properties and the ease to be precisely patterned. Besides all these benefits, PPF has not been tested yet for vascular prosthesis, mainly because it proved to be almost inert, while the ability to elicit a specific biological function would be of paramount importance in such critical surgery applications. Here, we propose a biomimetic functionalization process, aimed at obtaining specific bioactivation and thus improved cell-polymer interaction. Porous PPF-based scaffolds produced by deep-UV photocuring were coated by elastin and the functionalized scaffolds were extensively characterized, revealing a stable bound between the protein and the polymer surface. Both 3T3 and HUVEC cell lines were used for in vitro tests displaying an enhancement of cells adhesion and proliferation on the functionalized scaffolds.
C1 [Barenghi, Rossella; Scaglione, Silvia] Natl Res Council Italy CNR, IEIIT Inst, I-16149 Genoa, Italy.
   [Beke, Szabolcs; Romano, Ilaria; Farkas, Balazs; Brandi, Fernando] IIT, Dept Nanophys, I-16163 Genoa, Italy.
   [Gavazzo, Paola; Vassalli, Massimo] Natl Res Council Italy CNR, IBF Inst, I-16149 Genoa, Italy.
   [Brandi, Fernando] Natl Res Council Italy CNR, INO Inst, I-56124 Pisa, Italy.
RP Scaglione, S (reprint author), Natl Res Council Italy CNR, IEIIT Inst, Via Marini 6, I-16149 Genoa, Italy.
EM silvia.scaglione@ieiit.cnr.it
RI Scaglione, Silvia/B-7124-2014; Vassalli, Massimo/F-6762-2011
OI Scaglione, Silvia/0000-0002-9464-3554; Vassalli,
   Massimo/0000-0002-3063-4376; Brandi, Fernando/0000-0003-2717-3748
FU Italian Ministry of Education and Research (MIUR) through the PRIN
   "Innovative Chemical Methodologies for Smart Biomaterials" project
   [2010L9SH3 K_006]; European Community (FP7-NMP-EU-China) [604263]
FX The authors thank Roberto Utzeri (ISMAC-CNR) for FTIR analysis and Alice
   Scarpellini (IIT) for SEM images. This work has been supported by the
   Italian Ministry of Education and Research (MIUR) through the PRIN
   "Innovative Chemical Methodologies for Smart Biomaterials" project
   (Project 2010L9SH3 K_006) and partially by the European Community
   (FP7-NMP-2013-EU-China) Grant agreement no. 604263 (NEUROSCAFFOLDS).
CR Bandiera A, 2010, J BIOTECHNOL, V150, pS440, DOI 10.1016/j.jbiotec.2010.09.627
   Beke S, 2012, J R SOC INTERFACE, V9, P3017, DOI 10.1098/rsif.2012.0300
   BEKE S, 2013, LASER PHYS, V23
   Bekele S, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-20
   Blit PH, 2011, BIOMATERIALS, V32, P5790, DOI 10.1016/j.biomaterials.2011.04.067
   Bracalello A, 2011, BIOMACROMOLECULES, V12, P2957, DOI 10.1021/bm2005388
   Brandi F, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054007
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Dutoya S, 2000, BIOMATERIALS, V21, P1521, DOI 10.1016/S0142-9612(99)00274-4
   Garg S, 2010, J AM COLL CARDIOL, V56, pS1, DOI 10.1016/j.jacc.2010.06.007
   Garg S, 2010, J AM COLL CARDIOL, V56, pS43, DOI 10.1016/j.jacc.2010.06.008
   Imbert E, 1998, BIOMATERIALS, V19, P2285, DOI 10.1016/S0142-9612(98)00137-9
   Inoue T, 2009, CIRC J, V73, P615, DOI 10.1253/circj.CJ-09-0059
   Ito S, 1998, ANGIOLOGY, V49, P289, DOI 10.1177/000331979804900407
   Jordan S. W., 2007, J VASC SURG, V45, P104
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Lan PX, 2009, J MATER SCI-MATER M, V20, P271, DOI 10.1007/s10856-008-3567-2
   Lee JW, 2009, MICROELECTRON ENG, V86, P1451, DOI 10.1016/j.mee.2008.12.052
   Mathews A, 2012, J TISSUE ENG REGEN M, V6, P451, DOI 10.1002/term.449
   McClure MJ, 2010, ACTA BIOMATER, V6, P2422, DOI 10.1016/j.actbio.2009.12.029
   Naito Y, 2011, ADV DRUG DELIVER REV, V63, P312, DOI 10.1016/j.addr.2011.03.001
   Pennesi G, 2011, CURR PHARM BIOTECHNO, V12, P151, DOI 10.2174/138920111794295684
   Rnjak J, 2009, BIOMATERIALS, V30, P6469, DOI 10.1016/j.biomaterials.2009.08.017
   Rotmans JI, 2006, CAN J CARDIOL, V22, P1113, DOI 10.1016/S0828-282X(06)70946-1
   Sbrana F, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/4/046007
   Scaglione S., 2013, P SPIE, V8792
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sukmana I, 2010, BIOMATERIALS, V31, P5091, DOI 10.1016/j.biomaterials.2010.02.076
   Vassalli M, 2013, LANGMUIR, V29, P15898, DOI 10.1021/la403311x
   Waterhouse A, 2011, TISSUE ENG PART B-RE, V17, P93, DOI [10.1089/ten.teb.2010.0432, 10.1089/ten.TEB.2010.0432]
   Williamson MR, 2007, BIOMATERIALS, V28, P5307, DOI 10.1016/j.biomaterials.2007.08.019
   Wilson BD, 2011, ANN BIOMED ENG, V39, P337, DOI 10.1007/s10439-010-0142-z
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Yu H, 2003, J VASC SURG, V38, P557, DOI 10.1016/S0741-5214(03)00334-3
NR 34
TC 4
Z9 5
U1 1
U2 21
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 624645
DI 10.1155/2014/624645
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AX5TD
UT WOS:000346989400001
PM 25405204
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Hassanzadeh, M
AF Hassanzadeh, Masoumeh
BE Ranzi, E
   KohseHoinghaus, K
TI Unique Marine Organism: Identification of some Methods for Biomaterial
   Production
SO ICONBM: INTERNATIONAL CONFERENCE ON BIOMASS, PTS 1 AND 2
SE Chemical Engineering Transactions
LA English
DT Proceedings Paper
CT International Conference on BioMass (iconBM 2014)
CY MAY 04-07, 2014
CL Florence, ITALY
SP Italian Assoc Chem Engn
ID CIONA-INTESTINALIS; CELLULOSE; ASCIDIANS; BIOFUELS
AB In this work, one dominant species of tunicates in Scandinavian Ocean called Ciona intestinalis has been investigated by extraction and characterization of its cellulose, oil, and amino acids. Potential applications have been evaluated for production of pure crystalline cellulose, biodiesel, and by analysis of amino acid composition of the samples. Pure tunicate cellulose (IC) has been prepared via chemical treatment, using acid, alkali, and the subsequent bleaching. The cellulose percentage, and yield for the chemically pure cellulose obtained were around 96% and 54% respectively. Oil extraction has been done using petroleum ether as the extraction solvent, and then chemical structure and fatty acid composition of the obtained oil have been characterized by NMR (Nuclear Magnetic Resonance Spectroscopy), FTIR (Fourier Transform Infrared Spectroscopy), and GC-MS (Gas Chromatography-Mass Spectrometry). Tunicate's oil has shown high content of free fatty acids together with very low content of glycerol, the latter being the common oil from vegetable origins. Moreover, the composition profile of Tunicate fatty acids seems to be similar to fish oil. However, amino acid composition has shown similarity to egg albumin, implying tunicate to have the capability to be considered as other marine organisms' feed in the near future.
C1 KTH Royal Inst Technol, Sch Chem Sci & Engn, Dept Fiber & Polymer Technol, SE-10044 Stockholm, Sweden.
RP Hassanzadeh, M (reprint author), KTH Royal Inst Technol, Sch Chem Sci & Engn, Dept Fiber & Polymer Technol, SE-10044 Stockholm, Sweden.
EM mashas@kth.se
CR Bratu A, 2013, UNIV POLITEH BUCHAR, V75, P23
   Caponio F, 2011, J FOOD COMPOS ANAL, V24, P1117, DOI 10.1016/j.jfca.2011.01.019
   Carver C.E., 2006, BIOL SYNOPSIS SOLITA, V2746
   GUNNARSSON T, 1986, SOIL BIOL BIOCHEM, V18, P595, DOI 10.1016/0038-0717(86)90081-7
   JACKSON AD, 1993, DEV COMP IMMUNOL, V17, P97, DOI 10.1016/0145-305X(93)90020-Q
   Kimura Satoshi, 2007, P217, DOI 10.1007/978-1-4020-5380-1_13
   LEWIS JC, 1950, J BIOL CHEM, V186, P23
   Okamoto Takashi, 1996, Wood Research, V83, P27
   Palkovits R, 2010, ANGEW CHEM INT EDIT, V49, P4336, DOI 10.1002/anie.201002061
   Pirani S, 2013, CARBOHYD POLYM, V93, P357, DOI 10.1016/j.carbpol.2012.06.063
   Sasakura Y, 2005, P NATL ACAD SCI USA, V102, P15134, DOI 10.1073/pnas.0503640102
   Siqueira G, 2010, POLYMERS-BASEL, V2, P728, DOI 10.3390/polym2040728
   SMITH MJ, 1971, COMP BIOCHEM PHYSIOL, V40, P615, DOI 10.1016/0305-0491(71)90136-2
   van den Berg O, 2007, BIOMACROMOLECULES, V8, P1353, DOI 10.1021/bm061104q
   VANDAELE Y, 1992, BIOL CELL, V76, P87, DOI 10.1016/0248-4900(92)90198-A
   Yang F., 2012, BIOTECHNOL BIOFUELS, V5, P1
   Zhang D., 2013, INT J POLYM SCI, V2013, P1, DOI DOI 10.1109/TC.2013.223
NR 17
TC 0
Z9 0
U1 0
U2 3
PU AIDIC SERVIZI SRL
PI MILANO
PA VIA GIUSEPPE COLOMBO 81/A, MILANO, MI 20133, ITALY
SN 1974-9791
BN 978-88-95608-28-0
J9 CHEM ENGINEER TRANS
PY 2014
VL 37
BP 385
EP 390
DI 10.3303/CET1437065
PG 6
WC Engineering, Chemical
SC Engineering
GA BB8GO
UT WOS:000346540000065
DA 2018-10-20
ER

PT S
AU Palaniappan, N
   Inwati, GK
   Singh, M
AF Palaniappan, N.
   Inwati, Gajendra Kumar
   Singh, Man
GP IOP
TI Biomaterial Co-Cr-Mo Alloys Nano Coating Calcium Phosphate Orthopedic
   Treatment
SO 2ND INTERNATIONAL CONFERENCE ON STRUCTURAL NANO COMPOSITES (NANOSTRUC
   2014)
SE IOP Conference Series-Materials Science and Engineering
LA English
DT Proceedings Paper
CT 2nd International Conference on Structural Nano Composites (NANOSTRUC)
CY MAY 20-21, 2014
CL Madrid, SPAIN
DE implant; Cr; Co; Mo alloys; Ca-phosphate coating; SEM; corrosion;
   nanostructures
AB The modern study a thermal martensitic transformation of biomedical Co-Cr-Mo alloys and ultimately offers large elongation to failure while maintaining high strength. In the future study, structural evolution and dislocation slip as an elementary process in the martensitic transformation in Co-Cr-Mo alloys were investigated to reveal the origin of their enhanced phase stability due to nitrogen addition and coating of calcium phosphate specimens with and without nitrogen addition were prepared. The N-doped alloys had a single-phase matrix, whereas the N-free alloys had a duplex microstructure. Irrespective of the nitrogen content, dislocations frequently dissociated into Shockley partial dislocations with stacking faults. The Nano range coating of calcium phosphate function as obstacles to the glide of partial dislocations and consequently significantly affect the kinetics of the martensitic transformation. As a result, the formation of marten site plays a crucial role in plastic deformation and wear behavior, the developed nanostructures modification associated with nitrogen addition must be a promising strategy for highly durable orthopedic implants.
C1 [Palaniappan, N.; Inwati, Gajendra Kumar; Singh, Man] Cent Univ Gujarat, Gandhinagar, Gujarat, India.
RP Palaniappan, N (reprint author), Cent Univ Gujarat, Gandhinagar, Gujarat, India.
EM palaniappancecri@rediffmail.com
CR Grecu Michaela, 2011, REV CHEM, V62
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Ievlev VM, 2013, RUSS CHEM REV+, V82, P131, DOI 10.1070/RC2013v082n02ABEH004331
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V36, P9519
   Overgaard Soren, ACTA ORTHOP SCAND, V71, P1
   Park Jiu H, 2005, SURF COAT TECH, V195
   Ricardo Luiz Perez Teixeira. Geralda Cristina Duraes de Godoy, 2004, MAT RES, V7
   Ueda K., 2007, MAT T, V48, P307
NR 8
TC 0
Z9 0
U1 0
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1757-8981
J9 IOP CONF SER-MAT SCI
PY 2014
VL 64
AR UNSP 012026
DI 10.1088/1757-899X/64/1/012026
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Materials Science, Composites
SC Science & Technology - Other Topics; Materials Science
GA BB8JQ
UT WOS:000346741500027
OA Other Gold
DA 2018-10-20
ER

PT S
AU Hristu, R
   Tofail, SAM
   Stanciu, SG
   Tranca, DE
   Stanciu, GA
AF Hristu, Radu
   Tofail, Syed A. M.
   Stanciu, Stefan G.
   Tranca, Denis E.
   Stanciu, George A.
BE Jaworski, M
   Marciniak, M
TI Hydroxyapatite Surface Charge Investigated by Scanning Probe Microscopy
SO 2014 16TH INTERNATIONAL CONFERENCE ON TRANSPARENT OPTICAL NETWORKS
   (ICTON)
SE International Conference on Transparent Optical Networks-ICTON
LA English
DT Proceedings Paper
CT 16th International Conference on Transparent Optical Networks (ICTON)
CY JUL 06-10, 2014
CL Graz, AUSTRIA
SP IEEE, IEEE Photon Soc, Light Tec, Agilent Technologies, Cerebra InformationsSysteme GmbH, IEEE Austria Sect, Inst Engn & Technol, Natl Inst Telecommunicat, IIIE Media Event, ML11, GRAZ, Osterreichischer Verband Elektrotechnik, IEEE Photon Soc, Raiffeisen Meine Bank, GRAZ Stadt, Graz Univ Technology, TEST
DE hydroxyapatite; surface charge; scanning probe microscopy; scattering
   near field optical microscopy
ID ELECTRON-BEAM; OPTICAL MICROSCOPY; CONTRAST
AB It is well known that electrical properties such as local electrostatic charge distribution at biomaterial surface plays a significant role in biological interactions. The methods currently employed in measuring surface charge in biomaterials such as zeta potential or potentiostatic titration, however, can only measure global charge distribution in macroscopic and colloidal state of biomaterials. By using scanning probe microscopy techniques we investigated the surface charge domains placed on the hydroxyapatite surface. Scattering near field optical microscopy (s-SNOM) was used to image electrostatic charge trapped at pre-existing and irradiation induced defects within these domains, while phase imaging in atomic force microscopy was used to image the carbon contamination. The two techniques can be used for nanoscale imaging.
C1 [Hristu, Radu; Stanciu, Stefan G.; Tranca, Denis E.; Stanciu, George A.] Univ Politehn Bucuresti, Ctr Microscopy Microanl & Informat Proc, 313 Splaiul Independentei, Bucharest 060042, Romania.
   [Tofail, Syed A. M.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland.
RP Hristu, R (reprint author), Univ Politehn Bucuresti, Ctr Microscopy Microanl & Informat Proc, 313 Splaiul Independentei, Bucharest 060042, Romania.
EM stanciu@physics.pub.ro
RI Tranca, Denis/C-8429-2015; Tranca, Denis/N-4518-2014; Tranca,
   Denis/P-6928-2018
OI Tranca, Denis/0000-0002-1966-8348; 
FU UEFISCDI [PN-II-PT-PCCA-2011-3.2-1162]; European Commission [EC
   NMP4-SL-2008-212533 -BioElectricSurface]; Sectoral Operational Programme
   Human Resources Development [20072013]; Ministry of European Funds
   through the Financial Agreement [POSDRU/159/1.5/S/132397]
FX This work was suported by the UEFISCDI PN-II-PT-PCCA-2011-3.2-1162
   Research Grant and by the European Commission (EC NMP4-SL-2008-212533
   -BioElectricSurface). This publication reflects the views only of the
   authors, and the Commission cannot be held responsible for any use,
   which may be made of the information contained therein. The work has
   also been funded by the Sectoral Operational Programme Human Resources
   Development 20072013 of the Ministry of European Funds through the
   Financial Agreement POSDRU/159/1.5/S/132397.
CR Aronov D, 2008, SURF COAT TECH, V202, P2093, DOI 10.1016/j.surfcoat.2007.08.060
   Aronov D, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196481
   Hristu R, 2014, MICROSC MICROANAL, V20, P586, DOI 10.1017/S1431927614000191
   Itoh S, 2006, CALCIFIED TISSUE INT, V78, P133, DOI 10.1007/s00223-005-0213-6
   Plecenik T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3567532
   Renoud R, 2002, J PHYS-CONDENS MAT, V14, P231, DOI 10.1088/0953-8984/14/2/310
   Robin S, 2011, LANGMUIR, V27, P14968, DOI 10.1021/la203491q
   Rykaczewski K, 2008, ULTRAMICROSCOPY, V108, P989, DOI 10.1016/j.ultramic.2008.04.006
   Stanciu G.A., 2012, P 14 INT C TRANSP OP
   Stevens-Kalceff MA, 2007, MICROSC RES TECHNIQ, V70, P195, DOI 10.1002/jemt.20399
   Tranca DE, 2014, OPT EXPRESS, V22, P1687, DOI 10.1364/OE.22.001687
   VAEZIRAVANI M, 1993, APPL PHYS LETT, V62, P1044, DOI 10.1063/1.108789
NR 12
TC 0
Z9 0
U1 0
U2 9
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2162-7339
BN 978-1-4799-5601-2
J9 INT C TRANS OPT NETW
PY 2014
PG 4
WC Engineering, Electrical & Electronic; Telecommunications
SC Engineering; Telecommunications
GA BB8GC
UT WOS:000346516400061
DA 2018-10-20
ER

PT S
AU Esa, F
   Tasirin, SM
   Rahman, NA
AF Esa, Faezah
   Tasirin, Siti Masrinda
   Rahman, Norliza Abd
BE Chin, NL
   Man, HC
   Talib, RA
TI Overview of Bacterial Cellulose Production and Application
SO 2ND INTERNATIONAL CONFERENCE ON AGRICULTURAL AND FOOD ENGINEERING (CAFE
   2014) - NEW TRENDS FORWARD
SE Agriculture and Agricultural Science Procedia
LA English
DT Proceedings Paper
CT 2nd International Conference on Agricultural and Food Engineering (CAFE)
CY DEC 01-03, 2014
CL Kuala Lumpur, MALAYSIA
DE Bacterial cellulose; acetobacter xylinum; fermentation; composite
   material
ID NATA-DE-COCO; ACETOBACTER-XYLINUM; GLUCONACETOBACTER-XYLINUS; COMPOSITE
   MEMBRANES; EPSILON-POLYLYSINE; CULTURE-MEDIA; IN-SITU; NANOFIBERS;
   HANSENII; FILM
AB Bacterial cellulose (BC), produced by aerobic bacteria received ample of attention due to its unique physiochemical properties compared to plant cellulose. Intense researches on BC mainly focus on biosynthetic process to achieve low-cost preparation and high cellulose production. BC has been used as biomaterial for medical field, electrical instrument and food ingredient. However, BC alone has limited capabilities to fulfil current demand on high-performance biomaterials. Hence, BC composite has been introduced to enhance BC properties through addition of reinforcement materials. This review discusses current knowledge in fermentation process and potential application of BC including its application in food industry. (C) 2014 The Authors. Published by Elsevier B.V.
C1 [Esa, Faezah; Tasirin, Siti Masrinda; Rahman, Norliza Abd] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Chem & Proc Engn, Bangi 43600, Selangor, Malaysia.
RP Esa, F (reprint author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Chem & Proc Engn, Bangi 43600, Selangor, Malaysia.
EM faey_z@yahoo.com.my
CR Arrieta MP, 2014, POLYM DEGRAD STABIL, V107, P139, DOI 10.1016/j.polymdegradstab.2014.05.010
   Bootten TJ, 2008, CARBOHYD RES, V343, P221, DOI 10.1016/j.carres.2007.11.008
   BORZANI W, 1995, BIOTECHNOL LETT, V17, P1271, DOI 10.1007/BF00128400
   Brown A.J., 1988, CHEM SOC, V49, P432
   Budhiono A, 1999, CARBOHYD POLYM, V40, P137, DOI 10.1016/S0144-8617(99)00050-8
   Cakar F, 2014, CARBOHYD POLYM, V106, P7, DOI 10.1016/j.carbpol.2014.01.103
   CANNON RE, 1991, CRIT REV MICROBIOL, V17, P435, DOI 10.3109/10408419109115207
   Carreira P, 2011, BIORESOURCE TECHNOL, V102, P7354, DOI 10.1016/j.biortech.2011.04.081
   Castro C, 2011, CARBOHYD POLYM, V84, P96, DOI 10.1016/j.carbpol.2010.10.072
   Chawla PR, 2009, FOOD TECHNOL BIOTECH, V47, P107
   Chen P, 2010, MACROMOL RES, V18, P309, DOI 10.1007/s13233-010-0404-5
   Correa MJ, 2010, FOOD RES INT, V43, P780, DOI 10.1016/j.foodres.2009.11.016
   Dahman Y, 2010, APPL BIOCHEM BIOTECH, V162, P1647, DOI 10.1007/s12010-010-8946-8
   Dahman Y, 2009, J NANOSCI NANOTECHNO, V9, P5105, DOI 10.1166/jnn.2009.1466
   El-Saied H, 2004, POLYM-PLAST TECHNOL, V43, P797, DOI 10.1081/PPT-120038065
   Fernandes SCM, 2009, GREEN CHEM, V11, P2023, DOI 10.1039/b919112g
   Festucci-Buselli Reginaldo A., 2007, Braz. J. Plant Physiol., V19, P1, DOI 10.1590/S1677-04202007000100001
   Gadim TDO, 2014, ACS APPL MATER INTER, V6, P7864, DOI 10.1021/am501191t
   Gao C, 2014, FOOD HYDROCOLLOID, V36, P204, DOI 10.1016/j.foodhyd.2013.09.015
   Gayathry G, 2014, INDIAN J FIBRE TEXT, V39, P93
   Gomes FP, 2013, BIOMASS BIOENERG, V55, P205, DOI 10.1016/j.biombioe.2013.02.004
   Hu Y, 2013, BIOMACROMOLECULES, V14, P3444, DOI 10.1021/bm400744a
   Jagannath A, 2008, WORLD J MICROB BIOT, V24, P2593, DOI 10.1007/s11274-008-9781-8
   Keshk S, 2006, ENZYME MICROB TECH, V40, P4, DOI 10.1016/j.enzmictec.2006.07.037
   Keshk S.M., 2014, BIOPROCES BIOTECHNIQ, V4, P2
   Kim J, 2011, J POLYM RES, V18, P739, DOI 10.1007/s10965-010-9470-9
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Kurosumi A, 2009, CARBOHYD POLYM, V76, P333, DOI 10.1016/j.carbpol.2008.11.009
   Lin DH, 2014, BIORESOURCE TECHNOL, V151, P113, DOI 10.1016/j.biortech.2013.10.052
   Lin SB, 2011, J FOOD PROCESS ENG, V34, P1363, DOI 10.1111/j.1745-4530.2009.00533.x
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Maria LCS, 2010, POLIMEROS, V20, P72, DOI 10.1590/S0104-14282010005000001
   Meng N, 2009, APPL CLAY SCI, V42, P667, DOI 10.1016/j.clay.2008.06.016
   Mesomya W., 2006, J SCI TECHNOL, V28, P23
   Montealegre C.M., 2012, CONTINUOUS BIOETHANO
   Moosavi-Nasab M, 2011, IRAN J BIOTECHNOL, V9, P94
   Muangman Pornprom, 2011, J Am Col Certif Wound Spec, V3, P16, DOI 10.1016/j.jcws.2011.04.001
   Nguyen VT, 2008, FOOD MICROBIOL, V25, P471, DOI 10.1016/j.fm.2008.01.004
   Octave S, 2009, BIOCHIMIE, V91, P659, DOI 10.1016/j.biochi.2009.03.015
   Park JK, 2003, BIOTECHNOL BIOPROC E, V8, P83, DOI 10.1007/BF02940261
   Perez CD, 2013, J FOOD ENG, V116, P162, DOI 10.1016/j.jfoodeng.2012.11.004
   Rivas B, 2004, INT J FOOD MICROBIOL, V97, P93, DOI 10.1016/j.ijfoodmicro.2004.05.006
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Saibuatong OA, 2010, CARBOHYD POLYM, V79, P455, DOI 10.1016/j.carbpol.2009.08.039
   Sani A, 2010, J CHEM TECHNOL BIOT, V85, P151, DOI 10.1002/jctb.2300
   Santos SM, 2015, CARBOHYD POLYM, V116, P173, DOI 10.1016/j.carbpol.2014.03.064
   Shah N, 2013, CARBOHYD POLYM, V98, P1585, DOI 10.1016/j.carbpol.2013.08.018
   Sheykhnazari S, 2011, CARBOHYD POLYM, V86, P1187, DOI 10.1016/j.carbpol.2011.06.011
   Shi QS, 2013, CELL CHEM TECHNOL, V47, P503
   Sonia A, 2013, J FOOD ENG, V118, P78, DOI 10.1016/j.jfoodeng.2013.03.020
   Sun RC, 2009, BIORESOURCES, V4, P452
   Suppakul P, 2010, J FOOD ENG, V98, P207, DOI 10.1016/j.jfoodeng.2009.12.027
   Tang XZ, 2012, CRIT REV FOOD SCI, V52, P426, DOI 10.1080/10408398.2010.500508
   Tanskul S, 2013, CARBOHYD POLYM, V92, P421, DOI 10.1016/j.carbpol.2012.09.017
   Tazi N, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-61
   Ul-Islam M, 2012, CARBOHYD POLYM, V88, P596, DOI 10.1016/j.carbpol.2012.01.006
   Ummartyotin S, 2012, IND CROP PROD, V35, P92, DOI 10.1016/j.indcrop.2011.06.025
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Wu J, 2014, CARBOHYD POLYM, V102, P762, DOI 10.1016/j.carbpol.2013.10.093
   Wu JM, 2012, CARBOHYD POLYM, V90, P116, DOI 10.1016/j.carbpol.2012.05.003
   Wu SC, 2008, J MOL CATAL B-ENZYM, V54, P103, DOI 10.1016/j.molcatb.2007.12.021
   Yan ZY, 2008, CARBOHYD POLYM, V74, P659, DOI 10.1016/j.carbpol.2008.04.028
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
   Zeng XB, 2011, CARBOHYD POLYM, V85, P506, DOI 10.1016/j.carbpol.2011.02.034
   Zhang XJ, 2013, SYNTH REACT INORG M, V43, P907, DOI 10.1080/15533174.2012.750674
   Zhao QZ, 2009, FOOD HYDROCOLLOID, V23, P2168, DOI 10.1016/j.foodhyd.2009.04.007
   Zhou T, 2013, EXPRESS POLYM LETT, V7, P756, DOI 10.3144/expresspolymlett.2013.73
   Zhu HX, 2010, FOOD SCI BIOTECHNOL, V19, P1479, DOI 10.1007/s10068-010-0211-y
NR 68
TC 48
Z9 48
U1 5
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2210-7843
J9 AGRIC AGRIC SCI PROC
PY 2014
VL 2
BP 113
EP 119
DI 10.1016/j.aaspro.2014.11.017
PG 7
WC Agriculture, Multidisciplinary; Food Science & Technology
SC Agriculture; Food Science & Technology
GA BB8CL
UT WOS:000346363800016
OA Other Gold
DA 2018-10-20
ER

PT J
AU Palmer, JA
   Abberton, KM
   Mitchell, GM
   Morrison, WA
AF Palmer, Jason A.
   Abberton, Keren M.
   Mitchell, Geraldine M.
   Morrison, Wayne A.
TI Macrophage Phenotype in Response to Implanted Synthetic Scaffolds: An
   Immunohistochemical Study in the Rat
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Biomaterials; Foreign body response; Macrophage phenotype;
   Polycaprolactone; Rat model
ID FOREIGN-BODY REACTION; SCAVENGER RECEPTOR CD163; IN-VITRO; INFLAMMATORY
   RESPONSE; BIOLOGIC SCAFFOLDS; TISSUE-RESPONSE; BIOMATERIALS; EXPRESSION;
   BIODEGRADATION; ACTIVATION
AB Macrophages predominate among the cells that directly interact with biomaterials and are key orchestrators of host-biomaterial interactions. However, the macrophage response to synthetic scaffolds in particular has not been well studied. The aim of this study was therefore to characterise the macrophage response to several synthetic scaffolds in the rat using immunohistological techniques for a panel of markers of macrophage subclass or activation, including ED1 (CD68), ED2 (CD163), CD80, mannose receptor and inducible nitric oxide synthase (iNOS). Materials were implanted subcutaneously and collected after 6-8 weeks during the chronic phase of the host response. Unmodified polycaprolactone scaffolds uniquely demonstrated a total lack of both macrophage adherence to surfaces and a wider foreign body response compared to scaffolds composed of poly( lactic-co-glycolic acid) (PLGA) and polyurethanes (PURs), with those macrophages present having a clear M2 (MR+, CD80-, iNOS-) phenotype. PLGA scaffolds displayed an M1-dominant (CD80+, iNOS+, MR-) response with substantial foreign body giant cell (FBGC) formation, whilst PUR scaffold FBGCs had a more mixed M1 (CD80+, iNOS+) and M2 (MR+) phenotype. The study also identified that the use of the ED1 antibody in the rat as a pan-macrophage marker is problematic as there is a separate and substantial ED2-positive macrophage population that it does not label, both in response to biomaterials and in normal tissues. The biomaterial-dependent nature of activation for both macrophages and FBGCs was confirmed, and nuanced M1/ M2 phenotypes were described. (C) 2014 S. Karger AG, Basel
C1 [Palmer, Jason A.; Abberton, Keren M.; Mitchell, Geraldine M.; Morrison, Wayne A.] Univ Melbourne, St Vincents Hosp, OBrien Inst, Melbourne, Vic, Australia.
   [Palmer, Jason A.; Abberton, Keren M.; Mitchell, Geraldine M.; Morrison, Wayne A.] Univ Melbourne, St Vincents Hosp, Dept Surg, Melbourne, Vic, Australia.
   [Palmer, Jason A.; Abberton, Keren M.; Mitchell, Geraldine M.; Morrison, Wayne A.] Australian Catholic Univ, Fac Hlth Sci, Melbourne, Vic, Australia.
RP Palmer, JA (reprint author), OBrien Inst, 42 Fitzroy St, Fitzroy, Vic 3065, Australia.
EM jpalmer@obi.edu.au
FU Victorian State Government's Department of State Development, Business
   and Innovation's Operational Infrastructure Support Program
FX The authors wish to acknowledge the contributions of Dr. Aurora Messina,
   Dr. Tristan Croll, Sue McKay and the staff of the Experimental Medical
   and Surgical Research Unit at St. Vincent's Hospital. The work was
   supported by the Victorian State Government's Department of State
   Development, Business and Innovation's Operational Infrastructure
   Support Program.
CR Ahn M, 2012, BRAIN RES, V1445, P11, DOI 10.1016/j.brainres.2012.01.045
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Baker SC, 2011, MACROMOL BIOSCI, V11, P618, DOI 10.1002/mabi.201000415
   BEELEN RHJ, 1987, TRANSPLANT P, V19, P3166
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Byers BA, 2006, J BIOMED MATER RES A, V76A, P646, DOI 10.1002/jbm.a.30549
   Cao Y, 2006, J BIOMAT SCI-POLYM E, V17, P369, DOI 10.1163/156856206776374142
   Cao Y, 2006, BIOMATERIALS, V27, P2854, DOI 10.1016/j.biomaterials.2005.12.015
   Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236
   DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Hagerty RD, 2000, J BIOMED MATER RES, V49, P489, DOI 10.1002/(SICI)1097-4636(20000315)49:4<489::AID-JBM7>3.0.CO;2-2
   Hamid ZAA, 2010, BIOMATERIALS, V31, P6454, DOI 10.1016/j.biomaterials.2010.05.008
   Hespanhol RC, 2005, J HISTOCHEM CYTOCHEM, V53, P35, DOI 10.1369/jhc.4A6384.2005
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   HONDA H, 1990, IMMUNOLOGY, V70, P272
   Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kidd KR, 2002, J BIOMED MATER RES, V59, P682, DOI 10.1002/jbm.10032
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6
   Liu XH, 2012, MACROMOL BIOSCI, V12, P911, DOI 10.1002/mabi.201100466
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Maniecki MB, 2006, IMMUNOBIOLOGY, V211, P407, DOI 10.1016/j.imbio.2006.05.019
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Matthews KE, 2006, STEM CELLS DEV, V15, P40, DOI 10.1089/scd.2006.15.40
   McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7
   Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171
   MOHANTY M, 1992, BIOMATERIALS, V13, P651, DOI 10.1016/0142-9612(92)90123-6
   Mueller CK, 2011, INT J ORAL MAX SURG, V40, P401, DOI 10.1016/j.ijom.2010.10.025
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015
   Poon CJ, 2013, ACTA BIOMATER, V9, P5609, DOI 10.1016/j.actbio.2012.11.003
   Rhodes NP, 2005, J MATER SCI-MATER M, V16, P1207, DOI 10.1007/s10856-005-4730-7
   Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Seyednejad H, 2012, BIOMATERIALS, V33, P4309, DOI 10.1016/j.biomaterials.2012.03.002
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Stout RD, 2010, J LEUKOCYTE BIOL, V87, P19, DOI 10.1189/jlb.0509311
   Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008
   van Luyn MJA, 2001, BIOMATERIALS, V22, P1385, DOI 10.1016/S0142-9612(00)00295-7
   van Putten SM, 2013, ACTA BIOMATER, V9, P6502, DOI 10.1016/j.actbio.2013.01.022
   VINCE DG, 1991, BIOMATERIALS, V12, P731, DOI 10.1016/0142-9612(91)90021-2
   Wiggenhauser PS, 2012, CELL TISSUE RES, V347, P747, DOI 10.1007/s00441-011-1226-2
   Yang ZF, 2005, INT IMMUNOL, V17, P1391, DOI 10.1093/intimm/dxh316
NR 53
TC 11
Z9 11
U1 2
U2 27
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2014
VL 199
IS 2-3
BP 169
EP 183
DI 10.1159/000363693
PG 15
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA AW4FG
UT WOS:000346235900008
PM 25412799
DA 2018-10-20
ER

PT S
AU Lopes, MS
   Jardini, AL
   Filho, RM
AF Lopes, Milena S.
   Jardini, Andre L.
   Filho, Rubens M.
BE Bardone, E
   Bravi, M
   Keshavarz, T
TI Synthesis and Characterizations of Poly (Lactic Acid) by Ring-Opening
   Polymerization for Biomedical Applications
SO IBIC2014: 4TH INTERNATIONAL CONFERENCE ON INDUSTRIAL BIOTECHNOLOGY
SE Chemical Engineering Transactions
LA English
DT Proceedings Paper
CT 4th International Conference on Industrial Biotechnology (IBIC2014)
CY JUN 08-11, 2014
CL Rome, ITALY
SP Italian Assoc Chem Engn
ID POLY(LACTIC ACID); SCAFFOLDS; PLA
AB The development of biomaterials for application in medicine is one of the great challenges of research in material science. The poly (a-hydroxy acids) are the principal biodegradable and bioresorbable polymers used in tissue engineering. Among the biomaterials (biopolynners) used in the medical field, the poly (lactic acid) (PLA) has received significant attention. It is produced from lactic acid, a naturally occurring organic acid that can be produced by fermentation. The attractive price and commercial availability of lactic acid are important reasons for PLA development. PLA and its copolymers are being used in biomedical area in the form of implants or devices due to its excellent biocompatibility and biodegradability. In this study, lactide was synthesized and Poly lactic acid produced. The objective of this study was to investigate the PLA production in laboratory scale. Characterization by FTIR of the lactide and PLA production was made to confirm the polymerization and a possible use as biomaterial.
C1 [Lopes, Milena S.; Jardini, Andre L.; Filho, Rubens M.] Univ Estadual Campinas, UNICAMP, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
RP Lopes, MS (reprint author), Univ Estadual Campinas, UNICAMP, Sch Chem Engn, POB 6066, BR-13083970 Campinas, SP, Brazil.
EM mil_savioli@hotmail.com
RI Jardini, Andre Luiz/N-9963-2016
OI Jardini, Andre Luiz/0000-0002-9381-9335
CR Auras R, 2004, MACROMOL BIOSCI, V4, P835, DOI 10.1002/mabi.200400043
   BENICEWICZ BC, 1991, J BIOACT COMPAT POL, V6, P64, DOI 10.1177/088391159100600106
   Bouapao L., 2007, POLYMER, V50, P4007
   Cheng Y, 2009, FRONT CHEM CHINA, V4, P259, DOI DOI 10.1007/S11458-009-0092-X
   Davis SS, 1996, CURR OPIN COLLOID IN, V1, P660, DOI 10.1016/S1359-0294(96)80105-1
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.3.CO;2-5
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Fukushima K, 2008, J POLYM SCI POL CHEM, V46, P3714, DOI 10.1002/pola.22712
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005
   Hu J., 2012, BIOMATERIALS, V31, P7971
   Lim LT, 2008, PROG POLYM SCI, V33, P820, DOI 10.1016/j.progpolymsci.2008.05.004
   Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092
   Nikolic L, 2010, SENSORS-BASEL, V10, P5063, DOI 10.3390/s100505063
   Lopes MS, 2012, PROCEDIA ENGINEER, V42, P1402, DOI 10.1016/j.proeng.2012.07.534
   Valonen PK, 2010, BIOMATERIALS, V31, P2193, DOI 10.1016/j.biomaterials.2009.11.092
   Yamane H, 2003, POLYMER, V44, P2569, DOI 10.1016/S0032-3861(03)00092-2
   Yoo DK, 2006, MACROMOL RES, V14, P510, DOI 10.1007/BF03218717
NR 18
TC 6
Z9 6
U1 1
U2 13
PU AIDIC SERVIZI SRL
PI MILANO
PA VIA GIUSEPPE COLOMBO 81/A, MILANO, MI 20133, ITALY
SN 1974-9791
BN 978-88-95608-29-7
J9 CHEM ENGINEER TRANS
PY 2014
VL 38
BP 331
EP 336
DI 10.3303/CET1438056
PG 6
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA BB8GK
UT WOS:000346539600057
DA 2018-10-20
ER

PT S
AU Wallace, GQ
   Pashaee, F
   Hou, R
   Tabatabei, M
   Lagugne-Labarthet, F
AF Wallace, Gregory Q.
   Pashaee, Farshid
   Hou, Renjie
   Tabatabei, Mohammadali
   Lagugne-Labarthet, Francois
BE Andrews, DL
   Nunzi, JM
   Ostendorf, A
TI Plasmonic nanostructures for enhanced Raman spectroscopy: SERS and TERS
   of thiolated monolayers
SO NANOPHOTONICS V
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Nanophotonics V
CY APR 13-17, 2014
CL Brussels, BELGIUM
SP SPIE, Brussels Photon Team, Fonds Wetenschappelijk Onderzoek
DE Surface-enhanced Raman spectroscopy (SERS); Nanosphere lithography;
   Finite difference time domain; Tip-enhanced Raman spectroscopy (TERS);
   Surface specificity
ID NANOSPHERE LITHOGRAPHY; ARRAY
AB Although discovered 40 years ago, the interest in surface enhanced Raman spectroscopy (SERS) for a variety of applications in the fields of material and biomaterial has been revived over the past decade mostly due to a better control over the fabrication methods of nanoscale metallic structures. Metallic structures prepared by bottom-up or top-down methods can be tailored for a variety of applications in order to benefit from the best conditions for surface enhancement. SERS platforms made by nanosphere lithography are for example very versatile platforms that show a detection limit in the femtomolar range. Although quantitative measurements are difficult to perform in Raman spectroscopy, the plasmon-mediated enhancement by the metallic nanostructures are of great interest to improve the detection of analytes traces at surfaces. The extension of SERS to tip-enhanced Raman spectroscopy (TERS) is also very valuable to improve spatial resolution of Raman measurements and to yield surface signals, thus making TERS spectroscopy a surface specific technique. Herein we review SERS and TERS measurements of a model molecule (nitrothiophenol) adsorbed onto gold surfaces.
C1 [Wallace, Gregory Q.; Pashaee, Farshid; Hou, Renjie; Tabatabei, Mohammadali; Lagugne-Labarthet, Francois] Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada.
RP Wallace, GQ (reprint author), Univ Western Ontario, Dept Chem, 1151 Richmond St, London, ON N6A 5B7, Canada.
RI Lagugne-Labarthet, Francois/U-3835-2017
OI Lagugne-Labarthet, Francois/0000-0001-9882-9367
CR Galarreta BC, 2010, J PHYS CHEM C, V114, P19952, DOI 10.1021/jp108584t
   Haynes CL, 2001, J PHYS CHEM B, V105, P5599, DOI 10.1021/jp010657m
   HULTEEN JC, 1995, J VAC SCI TECHNOL A, V13, P1553, DOI 10.1116/1.579726
   Marquestaut N, 2008, LANGMUIR, V24, P11313, DOI 10.1021/la801697u
   Pashaee F, 2013, J PHYS CHEM C, V117, P15639, DOI 10.1021/jp403157v
   Wallace G. Q., 2013, CAN J CHEM, V91, P1
   Wu DY, 2011, CHEM COMMUN, V47, P2520, DOI 10.1039/c0cc05302c
   Xie W, 2013, J AM CHEM SOC, V135, P1657, DOI 10.1021/ja309074a
NR 8
TC 0
Z9 0
U1 1
U2 10
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-1-62841-074-7
J9 PROC SPIE
PY 2014
VL 9126
AR 912610
DI 10.1117/12.2054391
PG 4
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA BB8BE
UT WOS:000346237300015
DA 2018-10-20
ER

PT B
AU Ghinea, R
   Pecho, O
   Herrera, LJ
   Ionescu, AM
   Cardona, JD
   Sanchez, MP
   Paravina, RD
   Perez, MD
AF Ghinea, Razvan
   Pecho, Oscar
   Javier Herrera, Luis
   Maria Ionescu, Ana
   de la Cruz Cardona, Juan
   Purificacion Sanchez, Maria
   Paravina, Rade D.
   del Mar Perez, Maria
BE Ortuno, F
   Rojas, I
TI Predictive algorithms for determination of reflectance data from
   quantity of pigments within experimental dental resin composites
SO PROCEEDINGS IWBBIO 2014: INTERNATIONAL WORK-CONFERENCE ON BIOINFORMATICS
   AND BIOMEDICAL ENGINEERING, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 2nd International Work-Conference on Bioinformatics and Biomedical
   Engineering (IWBBIO)
CY APR 07-09, 2014
CL Granada, SPAIN
SP Univ Granada, IEEE Computat Intelligence Soc, Spanish Chapter, BioMed Central, e Health Business Dev BULL Espana S A
DE experimental dental resin composites; MNLR modelling; inorganic
   pigments; reflectance
ID MECHANICAL-PROPERTIES; CAMPHORQUINONE; REGRESSION
AB Being able to estimate (predict) the final spectrum of reflectance of a biomaterial, especially when the final color and appearance are fundamental for their clinical success (as is the case of dental resin composites), could be a very useful tool for the industrial development of these type of materials.. Objective: Development of predictive models which enable the determination of the reflectance spectrum of experimental dental resin composites based on type and quantity of pigments used in their chemical formulation. Materials and Methods: 49 types of experimental dental resin composites were formulated as a mixture of organic matrix, inorganic filler, photo activator and other components in minor quantities (accelerator, inhibitor, fluorescent agent and 4 types of pigments). All samples underwent an artificial chromatic aging, and their reflectance spectrum was measured using a spectroradiometer. A Multiple Nonlinear Regression Model (MNLR) was used to predict the values of the Reflectance Factors values in the visible range (380nm-780nm), before and after aging, from % Pigment (%P1, %P2, %P3 and %P4) within the formulation. Results. The average value of the prediction error of the model was 3.46% (SD: 1.82) across all wavelengths for samples before aging and 3.54% (SD: 1.17) for samples after aging. Conclusion: Within the framework of this pilot study, the nonlinear predictive models developed allow the prediction, with a high degree of accuracy, of the reflectance spectrum of the experimental dental resin composites.
C1 [Ghinea, Razvan; Pecho, Oscar; Maria Ionescu, Ana; de la Cruz Cardona, Juan; del Mar Perez, Maria] Univ Granada, Dept Opt, Campus Fuentenueva S-N, E-18071 Granada, Spain.
   [Javier Herrera, Luis] Univ Granada, Dept Comp Architecture & Comp Technol, Granada 18071, Spain.
   [Purificacion Sanchez, Maria] Univ Granada, Dept Inorgan Chem, Granada 18071, Spain.
   [Ghinea, Razvan; Paravina, Rade D.; del Mar Perez, Maria] Univ Texas, Sch Dent, Houston Ctr Biomat & Biomimet, Dept Restorat Dent & Prosthodont, Houston, TX 77054 USA.
RP Ghinea, R (reprint author), Univ Granada, Dept Opt, Campus Fuentenueva S-N, E-18071 Granada, Spain.
EM rghinea@ugr.es; opey@correo.ugr.es; jherrera@ugr.es; anaionescu@ugr.es;
   cardona@ugr.es; mpsansan@ugr.es; rade.paravina@uth.tmc.edu;
   mmperez@ugr.es
RI Herrera, Luis/L-2392-2014
OI Herrera, Luis/0000-0003-3220-9389
CR [Anonymous], 2013, 489222013 ISO 2
   [Anonymous], 2000, 74912000 ISO
   Atai M, 2004, DENT MATER, V20, P663, DOI 10.1016/j.dental.2003.08.008
   BANERJEE KS, 1971, TECHNOMETRICS, V13, P895, DOI 10.2307/1266967
   Calheiros FC, 2008, DENT MATER, V24, P1164, DOI 10.1016/j.dental.2008.01.006
   CIE (International Commission on Illumination), 2004, TECHNICAL REPORT
   Cramer NB, 2011, J DENT RES, V90, P402, DOI 10.1177/0022034510381263
   FRANK IE, 1993, TECHNOMETRICS, V35, P109, DOI 10.2307/1269656
   Ghinea R. H., 2010, DEV LINEAR MODEL PRE
   Golden RM, 1997, J MATH PSYCHOL, V41, P287, DOI 10.1006/jmps.1997.1164
   Herrera LJ, 2010, APPL OPTICS, V49, P422, DOI 10.1364/AO.49.000422
   Johnston WM, 2009, J DENT, V37, pE2, DOI 10.1016/j.jdent.2009.03.011
   Park MY, 2007, DENT MATER, V23, P731, DOI 10.1016/j.dental.2006.06.028
   Sadowsky SJ, 2006, J PROSTHET DENT, V96, P433, DOI 10.1016/j.prosdent.2006.09.018
   Schneider LFJ, 2012, DENT MATER, V28, P392, DOI 10.1016/j.dental.2011.11.014
   Schneider LFJ, 2009, DENT MATER, V25, P369, DOI 10.1016/j.dental.2008.08.003
   Schunn C. D., 2005, PSYCHOL KOGNITION RE
   Wee AG, 2005, DENT MATER, V21, P665, DOI 10.1016/j.dental.2004.09.003
   Zandinejad AA, 2006, DENT MATER, V22, P382, DOI 10.1016/j.dental.2005.04.027
NR 19
TC 1
Z9 1
U1 0
U2 2
PU COPICENTRO GRANADA S L
PI GRANADA
PA AV ANDALUCIA, 38, GRANADA, GRANADA 18014, SPAIN
BN 978-84-15814-84-9
PY 2014
BP 66
EP 76
PG 11
WC Engineering, Biomedical; Medical Informatics
SC Engineering; Medical Informatics
GA BB8CY
UT WOS:000346381500007
DA 2018-10-20
ER

PT J
AU Liu, DX
   Gu, JJ
   Li, Z
   Zhang, YF
   Zhang, W
   Liu, QL
   Zhang, D
AF Liu, Dingxin
   Gu, Jiajun
   Li, Zhuo
   Zhang, Yafeng
   Zhang, Wang
   Liu, Qinglei
   Zhang, Di
TI The study on the dragonfly's wings and the structural colors
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE biomaterial; interface; nanobioscience; nanostructure; optical
ID LIGHT-SCATTERING; SCALES; BUTTERFLIES; INTERFERENCE; COLORATION; INSECTS
AB The authors observed the surface and transection of dragonflies and demonstrated that the surface of dragonflies is a submicrometer multilayer system. The authors showed that the different colors of wing are attributed to multilayer interference, which is confirmed by a finite-difference time domain simulation.
C1 [Liu, Dingxin; Gu, Jiajun; Li, Zhuo; Zhang, Wang; Liu, Qinglei; Zhang, Di] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
   [Zhang, Yafeng] Fudan Univ, Dept Phys & Surface Phys Lab, Shanghai 200433, Peoples R China.
RP Gu, JJ (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
EM gujiajunn@sjtu.edu.cn; zhangdi@sjtu.edu.cn
RI ZHANG, Wang/E-7470-2010
FU National Natural Science Foundation of China [51271116, 51171110];
   National Basic Research Program of China (973 Program) [2012CB619600];
   Shanghai Science and Technology Committee [10JC1407600]
FX This study was supported by the National Natural Science Foundation of
   China (Grant Numbers 51271116 and 51171110), the National Basic Research
   Program of China (973 Program, Grant Number 2012CB619600) and the
   Shanghai Science and Technology Committee (Grant Number 10JC1407600).
CR Anderson TF, 1942, J APPL PHYS, V13, P748, DOI 10.1063/1.1714827
   Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92
   Berthier Serge, 2006, Insect Science, V13, P145, DOI 10.1111/j.1744-7917.2006.00077.x
   Brink DJ, 1999, APPL OPTICS, V38, P5282, DOI 10.1364/AO.38.005282
   Dong BQ, 2010, OPT EXPRESS, V18, P14430, DOI 10.1364/OE.18.014430
   GHIRADELLA H, 1972, SCIENCE, V178, P1214, DOI 10.1126/science.178.4066.1214
   Gralak B, 2001, OPT EXPRESS, V9, P567, DOI 10.1364/OE.9.000567
   Hooper IR, 2006, OPT EXPRESS, V14, P4891, DOI 10.1364/OE.14.004891
   LAND MF, 1972, PROGR BIOPHYSICS MOL, V24, P77, DOI DOI 10.1016/0079-6107(72)90004-1
   Large MCJ, 2007, PHYSICA B, V394, P229, DOI 10.1016/j.physb.2006.12.016
   Liu F, 2009, OPT EXPRESS, V17, P16183, DOI 10.1364/OE.17.016183
   Mason CW, 1926, J PHYS CHEM-US, V30, P383, DOI 10.1021/j150261a009
   McPhedran R. C., 2003, PHYSICA B, V338, P183
   Plattner L, 2004, J ROY SOC INTERFACE, V1, P49, DOI 10.1098/rsif.2004.0006
   Prum RO, 1998, NATURE, V396, P28, DOI 10.1038/23838
   Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431
   Richard O. P., 2004, J EXP BIOL, V207, P3999
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   Shevtsova E, 2011, P NATL ACAD SCI USA, V108, P668, DOI 10.1073/pnas.1017393108
   Stavenga DG, 2006, OPT EXPRESS, V14, P4880, DOI 10.1364/OE.14.004880
   Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794
   Watanabe K, 2005, JPN J APPL PHYS 2, V44, pL48, DOI 10.1143/JJAP.44.L48
NR 22
TC 1
Z9 1
U1 2
U2 21
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2014
VL 3
IS 4
BP 193
EP 198
DI 10.1680/bbn.14.00003
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AW6GQ
UT WOS:000346368300002
DA 2018-10-20
ER

PT J
AU Markhoff, J
   Mick, E
   Mitrovic, A
   Pasold, J
   Wegner, K
   Bader, R
AF Markhoff, Jana
   Mick, Enrico
   Mitrovic, Aurica
   Pasold, Juliane
   Wegner, Katharina
   Bader, Rainer
TI Surface Modifications of Dental Ceramic Implants with Different Glass
   Solder Matrices: In Vitro Analyses with Human Primary Osteoblasts and
   Epithelial Cells
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID TITANIUM SURFACES; ZIRCONIA CERAMICS; GENE-EXPRESSION; OSSEOINTEGRATION;
   BEHAVIOR; PROLIFERATION; FIBROBLASTS; TOPOGRAPHY; ADHESION; BIOMATERIAL
AB Ceramic materials show excellent esthetic behavior, along with an absence of hypersensitivity, making them a possible alternative implant material in dental surgery. However, their surface properties enable only limited osseointegration compared to titanium implants. Within this study, a novel surface coating technique for enhanced osseointegration was investigated biologically and mechanically. Specimens of tetragonal zirconia polycrystal (TZP) and aluminum toughened zirconia (ATZ) were modified with glass solder matrices in two configurations which mainly consisted of SiO2, Al2O3, K2O, and Na2O. The influence on human osteoblastic and epithelial cell viability was examined by means of a WST-1 assay as well as live/dead staining. A C1CP-ELISA was carried out to verify procollagen type I production. Uncoated/sandblasted ceramic specimens and sandblasted titanium surfaces were investigated as a reference. Furthermore, mechanical investigations of bilaterally coated pellets were conducted with respect to surface roughness and adhesive strength of the different coatings. These tests could demonstrate a mechanically stable implant coating with glass solder matrices. The coated ceramic specimens show enhanced osteoblastic and partly epithelial viability and matrix production compared to the titanium control. Hence, the new glass solder matrix coating could improve bone cell growth as a prerequisite for enhanced osseointegration of ceramic implants.
C1 [Markhoff, Jana; Mick, Enrico; Pasold, Juliane; Wegner, Katharina; Bader, Rainer] Univ Med Rostock, Res Lab Biomech & Implant Technol, Dept Orthopaed, D-18057 Rostock, Germany.
   [Mitrovic, Aurica] ZM Praezisionsdentaltech GmbH, D-18055 Rostock, Germany.
RP Markhoff, J (reprint author), Univ Med Rostock, Res Lab Biomech & Implant Technol, Dept Orthopaed, Doberaner Str 142, D-18057 Rostock, Germany.
EM jana.markhoff@med.uni-rostock.de
OI Ekat, Katharina/0000-0003-2423-201X
FU German Ministry for Economy (BMWi) via Zentrales Innovations programm
   Mittelstand (ZIM)
FX The content of the proposed paper was developed within the framework of
   a project funded by the German Ministry for Economy (BMWi) via Zentrales
   Innovations programm Mittelstand (ZIM). Furthermore, the authors kindly
   thank DOT GmbH (Rostock, Germany) for conditioning the titanium
   cylinders for adhesive testing. The authors also thank Dental Creativ
   Management GmbH(Rostock, Germany) for supplying the glass solders,
   Metoxit AG (Thayngen, Switzerland) for supplying the ceramic specimens,
   and the EMZ, University Medicine Rostock, for enabling FESEM analysis.
CR Aldini NN, 2002, J BIOMED MATER RES, V61, P282, DOI 10.1002/jbm.10162
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   Bachle M, 2007, CLIN ORAL IMPLAN RES, V18, P53, DOI 10.1111/j1600-0501.2006.01292.x
   Baharloo B, 2005, J BIOMED MATER RES A, V74A, P12, DOI 10.1002/jbm.a.30321
   Depprich Rita, 2008, Head Face Med, V4, P29, DOI 10.1186/1746-160X-4-29
   Gahlert M, 2010, CLIN IMPLANT DENT R, V12, P297, DOI 10.1111/j.1708-8208.2009.00168.x
   Gong SH, 2013, J ADV PROSTHODONT, V5, P416, DOI 10.4047/jap.2013.5.4.416
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Hempel U, 2010, CLIN ORAL IMPLAN RES, V21, P174, DOI 10.1111/j.1600-0501.2009.01797.x
   Herrero-Climent M, 2013, J MATER SCI-MATER M, V24, P2047, DOI 10.1007/s10856-013-4935-0
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Hopp M., 2010, Tech. Rep. DE102009051655B3, Patent No. 102009051655
   Kohal RJ, 2009, CLIN ORAL IMPLAN RES, V20, P1265, DOI 10.1111/j.1600-0501.2009.01735.x
   Kubies D, 2011, PHYSIOL RES, V60, P95
   Le Guehennec L, 2008, ACTA BIOMATER, V4, P535, DOI 10.1016/j.actbio.2007.12.002
   Lochner K, 2011, INT J MOL MED, V28, P1055, DOI 10.3892/ijmm.2011.778
   Marchi J, 2010, J BIOMED MATER RES B, V94B, P305, DOI 10.1002/jbm.b.31652
   Marchi J, 2010, INT J APPL CERAM TEC, V7, P139, DOI 10.1111/j.1744-7402.2009.02388.x
   Marrelli M, 2013, INT J DENT, V2013
   Mick E, 2013, MATERIALS, V6, P4001, DOI 10.3390/ma6094001
   Mustafa K, 2005, BIOMATERIALS, V26, P373, DOI 10.1016/j.biomaterials.2004.02.037
   Nishimoto SK, 2008, INT J ORAL MAX IMPL, V23, P675
   Noro A, 2013, J BIOMED MATER RES B, V101B, P355, DOI 10.1002/jbm.b.32846
   Oliva A, 1998, BIOMATERIALS, V19, P1019, DOI 10.1016/S0142-9612(97)00249-4
   Pae A, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025005
   Raffaelli L, 2008, J BIOMED MATER RES A, V86A, P959, DOI 10.1002/jbm.a.31693
   Raisanen L, 2000, J BIOMED MATER RES, V49, P79
   Rocchietta I, 2009, CLIN ORAL IMPLAN RES, V20, P844, DOI 10.1111/j.1600-0501.2009.01727.x
   Rompen E, 2006, CLIN ORAL IMPLAN RES, V17, P55, DOI 10.1111/j.1600-0501.2006.01367.x
   Sammons RL, 2005, CLIN ORAL IMPLAN RES, V16, P657, DOI 10.1111/j.1600-0501.2005.01168.x
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   Torricelli P, 2001, BIOMATERIALS, V22, P2535, DOI 10.1016/S0142-9612(00)00444-0
NR 33
TC 0
Z9 0
U1 0
U2 7
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 742180
DI 10.1155/2014/742180
PG 7
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AW4ZO
UT WOS:000346286200001
PM 25295270
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Nair, M
   Krishnan, A
AF Nair, Manitha
   Krishnan, Amit
TI Antibiotic Releasing Biodegradable Scaffolds for Osteomyelitis
SO CURRENT DRUG DELIVERY
LA English
DT Article
DE Bacterial internalization; biodegradable scaffolds; osteomyelitis;
   staphylococcus aureus
ID RESISTANT STAPHYLOCOCCUS-AUREUS; CALCIUM-PHOSPHATE NANOPARTICLES;
   GENTAMICIN-COLLAGEN SPONGE; PHASE-COMPOSITION CONTROL; DRUG-DELIVERY
   KINETICS; IN-VITRO RELEASE; METHICILLIN-RESISTANT; HYDROXYAPATITE
   BLOCKS; SURGICAL DEBRIDEMENT; BONE-CEMENT
AB Osteomyelitis is characterized by progressive inflammatory bone degeneration. In the management of chronic osteomyelitis, it is necessary to remove the infected bone tissue followed by implantation of an antibiotic releasing biomaterial that can release antibiotic locally for long periods of time. The main carrier used in clinics for this application is polymethylmethacrylate (PMMA) (Eg. Septopal beads). However, major drawback is the need of an additional surgery to remove the beads after therapy, as PMMA is not biodegradable. This necessitates the requirement of biodegradable carrier systems that can release antibiotics and simultaneously support debrided bone formation. This review summarizes biodegradable carrier systems that have been reported for the localised treatment and prophylaxis of osteomyelitis.
C1 [Nair, Manitha; Krishnan, Amit] Amrita Vishwa Vidyapeetham Univ, Amrita Ctr Nanosci & Mol Med, Amrita Inst Med Sci & Res Ctr, Cochin 682041, Kerala, India.
RP Nair, M (reprint author), Amrita Vishwa Vidyapeetham Univ, Amrita Ctr Nanosci & Mol Med, Amrita Inst Med Sci & Res Ctr, Cochin 682041, Kerala, India.
EM manithanair@aims.amrita.edu
FU Department of Science and Technology, India
FX The authors would like to acknowledge Department of Science and
   Technology, India for financial support.
CR ALBREKTSSON T, 1982, ACTA ORTHOP SCAND, V53, P757, DOI 10.3109/17453678208992288
   Albu M.G., 2011, COLLAGEN GELS MATRIC
   Alexander EH, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-5
   Alexander EH, 2001, APPL MICROBIOL BIOT, V56, P361, DOI 10.1007/s002530100703
   Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2
   Anagnostakos K, 2006, ACTA ORTHOP, V77, P628, DOI 10.1080/174453670610012719
   BAKER AS, 1988, J BONE JOINT SURG AM, V70A, P1551, DOI 10.2106/00004623-198870100-00015
   Bang K, 1998, SCAND J PLAST RECONS, V32, P129, DOI 10.1080/02844319850158732
   BAYSTON R, 1982, J BONE JOINT SURG BR, V64, P460
   Bost KL, 1999, J INFECT DIS, V180, P1912, DOI 10.1086/315138
   Brady R., 2009, CLIN MICROBIOL NEWSL, V28, P65
   Breen A, 2009, TISSUE ENG PART B-RE, V15, P201, DOI [10.1089/ten.teb.2008.0527, 10.1089/ten.TEB.2008.0527]
   Brin YS, 2009, J BIOMAT SCI-POLYM E, V20, P1081, DOI 10.1163/156856209X444439
   Brin YS, 2008, J CONTROL RELEASE, V131, P121, DOI 10.1016/j.jconrel.2008.07.022
   Carek PJ, 2001, AM FAM PHYSICIAN, V63, P2413
   Cevher E, 2006, INT J PHARM, V317, P127, DOI 10.1016/j.ijpharm.2006.03.014
   Changez M, 2005, BIOMATERIALS, V26, P2095, DOI 10.1016/j.biomaterials.2004.06.008
   Changez M, 2004, BIOMATERIALS, V25, P139, DOI 10.1016/S0142-9612(03)00466-6
   Changez M, 2003, BIOMATERIALS, V24, P527, DOI 10.1016/S0142-9612(02)00364-2
   Chen AM, 1999, CLIN ORTHOP RELAT R, P239
   Cierny G, 1985, CONT ORTHOP, V10, P17, DOI DOI 10.1097/01.BLO.0000088564.81746.62
   Dankert J., 1996, CRC CRIT R BIOCOMP, V2, P219
   Dax S.L., 1997, ANTIBACTERIAL CHEMOT
   Desai TA, 2013, THER DELIV, V4, P643, DOI [10.4155/TDE.13.33, 10.4155/tde.13.33]
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Elizabeth E, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/11/115101
   Ellington JK, 1999, MICROB PATHOGENESIS, V26, P317, DOI 10.1006/mpat.1999.0272
   Fang TL, 2012, J BIOMED MATER RES B, V100B, P1803, DOI 10.1002/jbm.b.32747
   FITZGERALD RH, 1984, ORTHOP CLIN N AM, V15, P537
   Fraimow Henry S, 2009, Semin Plast Surg, V23, P90, DOI 10.1055/s-0029-1214161
   Franklin T.J., 1989, BIOCH ANTIMICROBIAL
   Garcia EJ, 2013, ORTHOPEDICS, V36, pE986, DOI 10.3928/01477447-20130724-11
   GARVIN KL, 1994, J BONE JOINT SURG AM, V76A, P1500, DOI 10.2106/00004623-199410000-00009
   Gitelis Steven, 2002, J Orthop Surg (Hong Kong), V10, P53
   Gittens RA, 2013, ACTA BIOMATER, V9, P6268, DOI 10.1016/j.actbio.2012.12.002
   GRECO F, 1991, J BIOMED MATER RES, V25, P39, DOI 10.1002/jbm.820250104
   Gursel I, 2001, BIOMATERIALS, V22, P73, DOI 10.1016/S0142-9612(00)00170-8
   HENRY SL, 1995, CLIN PHARMACOKINET, V29, P36, DOI 10.2165/00003088-199529010-00005
   Hou TY, 2008, TISSUE ENG PT A, V14, P1173, DOI 10.1089/ten.tea.2007.0159
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   IPSEN T, 1991, ACTA ORTHOP SCAND, V62, P592, DOI 10.3109/17453679108994503
   ITOKAZU M, 1995, J APPL BIOMATER, V6, P167, DOI 10.1002/jab.770060304
   Itokazu M, 1998, Bull Hosp Jt Dis, V57, P125
   ITOKAZU M, 1994, CLIN MATER, V17, P173, DOI 10.1016/0267-6605(94)90033-7
   Itokazu M, 1997, J MED MICROBIOL, V46, P779, DOI 10.1099/00222615-46-9-779
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Jia WT, 2010, ACTA BIOMATER, V6, P812, DOI 10.1016/j.actbio.2009.09.011
   Jia WT, 2010, ANTIMICROB AGENTS CH, V54, P170, DOI 10.1128/AAC.01122-09
   Jiang JL, 2012, INFLAMM RES, V61, P207, DOI 10.1007/s00011-011-0402-x
   Joosten U, 2005, BIOMATERIALS, V26, P5251, DOI 10.1016/j.biomaterials.2005.01.001
   Kanellakopoulou K, 2009, INT J ANTIMICROB AG, V33, P354, DOI 10.1016/j.ijantimicag.2008.09.008
   Karr JC, 2011, J AM PODIAT MED ASSN, V101, P146, DOI 10.7547/1010146
   Katanec B., 2004, COLLEGIUM ANTROPOL, V1, P331
   Kaul G, 2002, PHARM RES-DORDR, V19, P1061, DOI 10.1023/A:1016486910719
   Kaya M, 2012, OR SURG OR MED OR PA, V113, P340, DOI 10.1016/j.tripleo.2011.03.032
   Kendall RW, 1996, CLIN ORTHOP RELAT R, P273
   Kent ME, 2006, ORTHOPEDICS, V29, P599
   Kilian O, 2009, J BIOMED MATER RES B, V90B, P210, DOI 10.1002/jbm.b.31275
   Kluin OS, 2013, EXPERT OPIN DRUG DEL, V10, P341, DOI 10.1517/17425247.2013.751371
   Krasko MY, 2007, J CONTROL RELEASE, V117, P90, DOI 10.1016/j.jconrel.2006.10.010
   Krasko MY, 2005, BIOMACROMOLECULES, V6, P1877, DOI 10.1021/bm049228v
   Lalidou F., 2014, SURG TECHNOL INT, VXXIV
   LAURENCIN C, 1990, J BIOMED MATER RES, V24, P1463, DOI 10.1002/jbm.820241105
   Lazzarini L, 2004, J BONE JOINT SURG AM, V86A, P2305, DOI 10.2106/00004623-200410000-00028
   Letsch R, 1993, Aktuelle Traumatol, V23, P324
   Liu SJ, 2002, J BIOMED MATER RES, V63, P807, DOI 10.1002/jbm.10406
   Lu WJ, 2013, EXP THER MED, V5, P253, DOI 10.3892/etm.2012.762
   Mader J.T., 1992, CLIN INFECT DIS
   Mader JT, 2002, CLIN ORTHOP RELAT R, P58, DOI 10.1097/01.blo.0000030070.92399.4d
   Mader JT, 1997, CLIN INFECT DIS, V25, P1303, DOI 10.1086/516149
   Martinez-Aguilar G, 2003, PEDIATR INFECT DIS J, V22, P593
   Mendel V, 2005, ARCH ORTHOP TRAUM SU, V125, P363, DOI 10.1007/s00402-004-0774-2
   Nair MB, 2011, CURR OPIN BIOTECH, V22, P721, DOI 10.1016/j.copbio.2011.02.005
   Nelson CL, 1997, J ORTHOPAED RES, V15, P249, DOI 10.1002/jor.1100150214
   Nelson CL, 2002, J ORTHOPAED RES, V20, P643, DOI 10.1016/S0736-0266(01)00133-4
   Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885
   Orhan Z, 2006, J BONE JOINT SURG BR, V88B, P270, DOI 10.1302/0301-620X.88B2.16328
   Pacheco H, 2014, J BIOMED MATER RES A, V102, P4213, DOI 10.1002/jbm.a.35092
   Panduranga K.R., 1995, J BIOMAT SCI-POLYM E, V7, P623
   Pelczar M.J., 1999, MICROBIOLOGY CONCEPT
   PELTIER LF, 1959, AM J SURG, V97, P311, DOI 10.1016/0002-9610(59)90305-8
   REDL H, 1983, BIOMATERIALS, V4, P29, DOI 10.1016/0142-9612(83)90066-2
   Roberts R, 2014, J BIOMED MATER RES B, V102, P667, DOI 10.1002/jbm.b.33045
   Rossi S, 2004, J ANTIMICROB CHEMOTH, V54, P1013, DOI 10.1093/jac/dkh477
   RUSSELL AD, 1996, UNDERSTANDING ANTIBA
   Saito T, 2002, J BIOMED MATER RES, V63, P245, DOI 10.1002/jbm.10179
   SCHMIDT C, 1995, J CONTROL RELEASE, V37, P83, DOI 10.1016/0168-3659(95)00067-I
   Shi PJ, 2010, J BIOMED MATER RES A, V93A, P1020, DOI 10.1002/jbm.a.32598
   Shirtliff ME, 2002, CLIN ORTHOP RELAT R, P239
   Somayaji SN, 2008, INFECT IMMUN, V76, P5120, DOI 10.1128/IAI.00228-08
   Speziale P, 2009, FUTURE MICROBIOL, V4, P1337, DOI [10.2217/fmb.09.102, 10.2217/FMB.09.102]
   Tan HX, 2008, APPL SURF SCI, V255, P353, DOI 10.1016/j.apsusc.2008.06.085
   Tang H, 2009, ARCH ORTHOP TRAUM SU, V129, P1301, DOI 10.1007/s00402-008-0782-8
   Tang Shanhua, 2006, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V20, P758
   Tofuku K, 2012, EUR SPINE J, V21, P2027, DOI 10.1007/s00586-012-2435-4
   Turesin F, 2001, J BIOMAT SCI-POLYM E, V12, P195, DOI 10.1163/156856201750180924
   Uskokovic V, 2014, J PHARM SCI-US, V103, P567, DOI 10.1002/jps.23824
   Uskokovic V, 2013, MAT SCI ENG C-MATER, V33, P3362, DOI 10.1016/j.msec.2013.04.023
   Uskokovic V, 2013, J BIOMED MATER RES A, V101, P1416, DOI 10.1002/jbm.a.34426
   Uskokovic V, 2013, J BIOMED MATER RES A, V101, P1427, DOI 10.1002/jbm.a.34437
   Virto MR, 2007, BIOMATERIALS, V28, P877, DOI 10.1016/j.biomaterials.2006.09.045
   WacholDrewek Z, 1996, BIOMATERIALS, V17, P1733, DOI 10.1016/0142-9612(96)87654-X
   WALDVOGEL FA, 1970, NEW ENGL J MED, V282, P198, DOI 10.1056/NEJM197001222820406
   Widaa A., 2012, PLOS ONE, V7
   WILSON KJ, 1988, J ORTHOPAED RES, V6, P279, DOI 10.1002/jor.1100060216
   Wininger DA, 1996, ANTIMICROB AGENTS CH, V40, P2675, DOI 10.1128/AAC.40.12.2675
   Wright JA, 2010, INT J MED MICROBIOL, V300, P193, DOI 10.1016/j.ijmm.2009.10.003
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Wu TY, 2013, J MATER CHEM B, V1, P3304, DOI [10.1039/C3TB20261E, 10.1039/c3tb20261e]
   Xie ZP, 2013, ANTIMICROB AGENTS CH, V57, P3293, DOI 10.1128/AAC.00284-13
   Xing JC, 2013, TISSUE ENG PT A, V19, P255, DOI [10.1089/ten.TEA.2012.0262, 10.1089/ten.tea.2012.0262]
   Yagmurlu MF, 1999, J BIOMED MATER RES, V46, P494
   Yang CC, 2013, MAT SCI ENG C-MATER, V33, P2203, DOI 10.1016/j.msec.2013.01.038
   Yu BG, 1996, J CONTROL RELEASE, V39, P65, DOI 10.1016/0168-3659(95)00139-5
   Zaffe D, 2005, J MATER SCI-MATER M, V16, P789, DOI 10.1007/s10856-005-3574-5
   Zelken J, 2007, CLIN ORTHOP RELAT R, P190, DOI 10.1097/BLO.0b013e3180ca9521
   Zilberman Meital, 2010, Handb Exp Pharmacol, P299, DOI 10.1007/978-3-642-00477-3_11
NR 117
TC 6
Z9 6
U1 1
U2 18
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1567-2018
EI 1875-5704
J9 CURR DRUG DELIV
JI Curr. Drug Deliv.
PY 2014
VL 11
IS 6
BP 687
EP 700
DI 10.2174/1567201811666140414120002
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AW0EJ
UT WOS:000345962900003
PM 24730438
DA 2018-10-20
ER

PT J
AU Ren, X
   Zhang, QW
   Liu, KW
   Li, HL
   Zhou, JG
AF Ren, Xiang
   Zhang, Qingwei
   Liu, Kewei
   Li, Ho-lung
   Zhou, Jack G.
TI Modeling of pneumatic valve dispenser for printing viscous biomaterials
   in additive manufacturing
SO RAPID PROTOTYPING JOURNAL
LA English
DT Article
DE 3D printing; Additive manufacturing; Pneumatic valve dispenser
ID 2-PHOTON POLYMERIZATION; CHITOSAN SCAFFOLDS; TISSUE SCAFFOLDS;
   FABRICATION; SYSTEM; LIQUIDS
AB Purpose - The purpose of this paper is establishing a general mathematical model and theoretical design rules for 3D printing of biomaterials. Additive manufacturing of biomaterials provides many opportunities for fabrication of complex tissue structures, which are difficult to fabricate by traditional manufacturing methods. Related problems and research tasks are raised by the study on biomaterials' 3D printing. Most researchers are interested in the materials studies; however, the corresponded additive manufacturing machine is facing some technical problems in printing user-prepared biomaterials. New biomaterials have uncertainty in physical properties, such as viscosity and surface tension coefficient. Therefore, the 3D printing process requires lots of trials to achieve proper printing parameters, such as printing layer thickness, maximum printing line distance and printing nozzle's feeding speed; otherwise, the desired computer-aided design (CAD) file will not be printed successfully in 3D printing.
   Design/methodology/approach - Most additive manufacturing machine for user-prepared bio-material use pneumatic valve dispensers or extruder as printing nozzle, because the air pressure activated valve can print many different materials, which have a wide range of viscosity. We studied the structure inside the pneumatic valve dispenser in our 3D heterogeneous printing machine, and established mathematical models for 3D printing CAD structure and fluid behaviors inside the dispenser during printing process.
   Findings - Based on theoretical modeling, we found that the bio-material's viscosity, surface tension coefficient and pneumatic valve dispenser's dispensing step time will affect the final structure directly. We verified our mathematical model by printing of two kinds of self-prepared biomaterials, and the results supported our modeling and theoretical calculation.
   Research limitations/implications - For a certain kinds of biomaterials, the mathematical model and design rules will have unique solutions to the functions and equations. Therefore, each biomaterial's physical data should be collected and input to the model for specified solutions. However, for each user-made 3D printing machine, the core programming code can be modified to adjust the parameters, which follows our mathematical model and the related CAD design rules.
   Originality - This study will provide a universal mathematical method to set up design rules for new user-prepared biomaterials in 3D printing of a CAD structure.
C1 [Ren, Xiang; Zhang, Qingwei; Liu, Kewei; Li, Ho-lung; Zhou, Jack G.] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Zhou, JG (reprint author), Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
EM zhoug@drexel.edu
OI Ren, Xiang/0000-0002-8882-6362
FU National Science Foundation (NSF) [CMMI-0700139]
FX The authors are grateful for the support from National Science
   Foundation (NSF) on award number CMMI-0700139. The authors would also
   like to thank Dr Moses Noh's Lab-On-Chip & BioMEMS Lab and Dr Ying Sun's
   Complex Fluids and Multiphase Transport Lab for their equipment usage.
CR Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Chang R, 2008, TISSUE ENG PT A, V14, P41, DOI 10.1089/ten.a.2007.0004
   Cumpston BH, 1999, NATURE, V398, P51
   Currie I. G., 2002, FUNDAMENTAL MECH FLU
   Lantada AD, 2012, ANNU REV BIOMED ENG, V14, P73, DOI [10.1146/annurev-bioeng-071811-150112, 10.1146/annurev.bioeng-071811-150112]
   Geisler C.G., 2011, THERMOSENSITIVE PHOT
   Geng L, 2005, RAPID PROTOTYPING J, V11, P90, DOI 10.1108/13552540510589458
   Kalpakjian S., 2008, MANUFACTURING PROCES
   Khalil S, 2005, RAPID PROTOTYPING J, V11, P9, DOI 10.1108/13552540510573347
   Khalil S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128729
   Kim GH, 2009, APPL PHYS A-MATER, V94, P781, DOI 10.1007/s00339-008-4959-3
   Lee H, 2011, CARBOHYD POLYM, V85, P817, DOI 10.1016/j.carbpol.2011.04.001
   Lu L, 2010, RAPID PROTOTYPING J, V16, P365, DOI 10.1108/13552541011065768
   Mironov V, 2009, VIRTUAL PHYS PROTOTY, V4, P63, DOI 10.1080/17452750802657202
   PELOFSKY AH, 1966, J CHEM ENG DATA, V11, P394, DOI 10.1021/je60030a031
   SCHONHORN H, 1967, J CHEM ENG DATA, V12, P524, DOI 10.1021/je60035a016
   Serbin J, 2003, OPT LETT, V28, P301, DOI 10.1364/OL.28.000301
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Snyder J.E., 2011, BIOFABRICATION, V3, P9
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Visconti RP, 2010, EXPERT OPIN BIOL TH, V10, P409, DOI 10.1517/14712590903563352
NR 21
TC 7
Z9 7
U1 4
U2 29
PU EMERALD GROUP PUBLISHING LIMITED
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1355-2546
EI 1758-7670
J9 RAPID PROTOTYPING J
JI Rapid Prototyping J.
PY 2014
VL 20
IS 6
BP 434
EP 443
DI 10.1108/RPJ-03-2013-0025
PG 10
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA AW2IE
UT WOS:000346110600002
DA 2018-10-20
ER

PT J
AU Yang, J
   Wang, S
   Lee, JH
AF Yang, Jaechang
   Wang, Semyung
   Lee, Jong-Hyun
TI Photovoltaic Detection of Hydrogen Peroxide Employing Potassium
   Ferricyanide as a Catalyst in the Chemiluminescence of Luminol
SO SENSORS AND MATERIALS
LA English
DT Article
DE hydrogen peroxide; photovoltaic detection; luminol; chemiluminescence;
   potassium ferricyanide
AB A photovoltaic measurement system is fabricated to detect hydrogen peroxide (H2O2) in a solution based on the chemiluminescence of luminol with potassium ferricyanide and potassium hydroxide as catalysts. A silicon-based positive/intrinsic/negative (PIN) photodiode is employed to quantitatively measure the chemiluminescent light generated from luminol (5-amino-2, 3-dihydro-1, 4-phthalazinedione). Instead of the mixture of luminol and catalysts (MLC) contained in water, the MLC is prepared in powder form enabling H2O2 detectability at high concentration intended for agricultural applications. Unlike horseradish peroxidase (HRP), potassium ferricyanide (non-biomaterial) can be stored for a longer period at room temperature without being denatured and without any sophisticated equipment for cooling. For various H2O2 concentrations, the peak value, integration value and maximum slope of the output voltage are measured and are discussed in terms of complexity, linearity and measurement speed.
C1 [Yang, Jaechang; Wang, Semyung; Lee, Jong-Hyun] GIST, Sch Mechatron, Kwangju 500712, South Korea.
   [Lee, Jong-Hyun] GIST, Dept Med Syst Engn, Kwangju 500712, South Korea.
RP Lee, JH (reprint author), GIST, Sch Mechatron, Kwangju 500712, South Korea.
EM jonghyun@gist.ac.kr
FU Institute of Medical System Engineering (iMSE) in GIST, Korea
FX This research was supported by a grant from the Institute of Medical
   System Engineering (iMSE) in GIST, Korea.
CR AIZAWA M, 1984, ANAL LETT PT B, V17, P555, DOI 10.1080/00032718408066489
   Bruno D. W., 1994, Aquaculture International, V2, P10, DOI 10.1007/BF00118529
   Byun HongJu, 2003, Journal of the Korean Society for Horticultural Science, V44, P859
   Cho IH, 2009, J BIOENVIRONMENT CON, V18, P297
   Hosono H, 2007, SENSOR MATER, V19, P191
   Kim Hyung-Il, 2003, Journal of the Korean Physical Society, V42, P336
   Luo FB, 2009, MICROCHIM ACTA, V165, P23, DOI 10.1007/s00604-008-0091-5
   Ozaki K, 2009, J PLANT PHYSIOL, V166, P569, DOI 10.1016/j.jplph.2008.08.007
   Rameshkumar P, 2013, J APPL ELECTROCHEM, V43, P1005, DOI 10.1007/s10800-013-0589-3
   Sudakin Daniel L., 2003, Toxicological Reviews, V22, P83, DOI 10.2165/00139709-200322020-00003
   Tensha K., 2006, B YAMAGUCHI PREF FIS, V4, P167
   Vanninen I, 1998, CROP PROT, V17, P547, DOI 10.1016/S0261-2194(98)00060-X
   Wang Q, 2009, MICROCHIM ACTA, V167, P153, DOI 10.1007/s00604-009-0236-1
   Yan ZK, 2013, MICROCHIM ACTA, V180, P145, DOI 10.1007/s00604-012-0916-0
   Yang JC, 2008, JPN J APPL PHYS, V47, P6943, DOI 10.1143/JJAP.47.6943
   Zhang KY, 2010, MICROCHIM ACTA, V171, P139, DOI 10.1007/s00604-010-0409-y
   Zhang Y, 2011, BIOPROC BIOSYST ENG, V34, P215, DOI 10.1007/s00449-010-0463-1
   Zheng J., 2012, ADV OPTICAL MAT, V24, P194
NR 18
TC 0
Z9 0
U1 1
U2 11
PU MYU, SCIENTIFIC PUBLISHING DIVISION
PI TOKYO
PA 1-23-3-303 SENDAGI, TOKYO, 113-0022, JAPAN
SN 0914-4935
J9 SENSOR MATER
JI Sens. Mater.
PY 2014
VL 26
IS 9
BP 677
EP 686
PG 10
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA AW4BN
UT WOS:000346226600003
DA 2018-10-20
ER

PT S
AU Xie, MB
   Li, Y
   Li, JS
   Chen, AZ
   Zhao, Z
   Li, G
AF Xie, Mao-Bin
   Li, Yi
   Li, Jia-Shen
   Chen, Ai-Zheng
   Zhao, Zheng
   Li, Gang
BE Li, Y
   Xin, JH
   Yoon, KJ
   Li, JS
TI Biomedical Applications of Silk Fibroin
SO TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, 2014, VOLS
   1 AND 2
SE Textile Bioengineering and Informatics Symposium Proceedings
LA English
DT Proceedings Paper
CT 7th Textile Bioengineering and Informatics Symposium (TBIS 2014) / 5th
   Asian Protective Clothing Conference (APCC 2014)
CY AUG 06-08, 2014
CL Hong Kong Polytechn Univ, Hong Kong, PEOPLES R CHINA
SP Inst Text & Cloth, Text Bioengineer & Informat Soc, Hong Kong Res Inst Text & Apparel, SDL ATLAS, Beijing Inst Fash Technol, Aimer Human Engn Res Ctr, Guangdong Hong Kong Int Text Engn Joint Res Ctr, Res Ctr Environm Impact Assessment Text & Apparel, Shaanxi Prov Res Ctr Apparel Engn & Technol, Text Biofunct Mat Ind Technol Innovat Union, Hong Kong Polytechn Univ, Xian Polytechn Univ
HO Hong Kong Polytechn Univ
DE Silk Fibroin; Biomaterial; Wound Healing; Drug Delivery; Tissue
   Engineering
ID TISSUE ENGINEERING APPLICATIONS; BOMBYX-MORI; DRUG-DELIVERY; SURFACE
   MODIFICATION; SCAFFOLDS; FABRICATION; BIOMATERIAL; PROTEIN; FIBERS;
   DIFFERENTIATION
AB In order to seek a natural protein biomaterial alternative with enough mechanical strength for developing demands of biomedical materials, silk fibroin is under reviewed due to its growing attention in biomedicine. Silk fibroin is an insoluble protein produced by the larvae of Bombyx mori, spiders, and other insects. Remarkable properties such as biocompatibility, biodegradable, oxygen and water vapor permeability, and excellent mechanical strength make silk fibroin an ideal biomaterial for biomedical applications. This paper firstly elaborates the chemistry, structure and these unique properties of silk fibroin, and then reviews different silk fibroin-based biomaterials used in biomedicine including hydrogels, nanoparticles, nanofibers, films and scaffolds follow by several emerging advanced silk fibroin-based biomedical products such as micro-needles, implantable electronic devices, resorbable screws and plates.
C1 [Xie, Mao-Bin; Li, Yi; Li, Jia-Shen; Chen, Ai-Zheng; Zhao, Zheng; Li, Gang] Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
RP Li, Y (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
EM yi.li@polyu.edu.hk
RI LI, YI/G-4421-2012; XIE, Maobin/A-1487-2013; Li, Jiashen/E-8571-2015
OI LI, YI/0000-0002-2092-4505; XIE, Maobin/0000-0001-9082-4510; 
CR Asakura T, 2013, PROG NUCL MAG RES SP, V69, P23, DOI 10.1016/j.pnmrs.2012.08.001
   Aznar CS, 2012, BIOELECTROCHEMISTRY, V85, P36
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Calabrese R, 2012, BIOMATERIALS, V33, P7375, DOI 10.1016/j.biomaterials.2012.06.043
   Chen CH, 2014, MATERIALS, V7, P2104, DOI 10.3390/ma7032104
   Chen L, 2014, INT J BIOL MACROMOL, V65, P1, DOI 10.1016/j.ijbiomac.2014.01.003
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   DeMuth PC, 2014, ADV HEALTHC MATER, V3, P47, DOI 10.1002/adhm.201300139
   Diab T, 2012, J MECH BEHAV BIOMED, V11, P123, DOI 10.1016/j.jmbbm.2011.11.007
   Dutta S, 2013, BIOPOLYMERS, V99, P326, DOI 10.1002/bip.22168
   Elakkiya T, 2014, POLYM INT, V63, P100, DOI 10.1002/pi.4499
   Farokhi M, 2014, MAT SCI ENG C-MATER, V35, P401, DOI 10.1016/j.msec.2013.11.023
   Gautam S, 2013, J MATER SCI, V49, P1076
   Gautam S, 2014, J MATER SCI, V49, P1076, DOI 10.1007/s10853-013-7785-8
   Ghorbanian L, 2013, INT J BIOL MACROMOL, V58, P275, DOI 10.1016/j.ijbiomac.2013.04.004
   Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   Gu ZP, 2013, INT J BIOL MACROMOL, V58, P121, DOI 10.1016/j.ijbiomac.2013.03.059
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Higuchi A, 2000, CYTOTECHNOLOGY, V34, P165, DOI 10.1023/A:1008130223190
   Ho MP, 2012, APPL SURF SCI, V258, P3948, DOI 10.1016/j.apsusc.2011.12.068
   Horan RL, 2009, HERNIA, V13, P189, DOI 10.1007/s10029-008-0459-9
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Jiang J, 2013, BIOTECHNOL LETT, V35, P657, DOI 10.1007/s10529-012-1121-2
   Kazemimostaghim M, 2014, POWDER TECHNOL, V254, P488, DOI 10.1016/j.powtec.2014.01.060
   Kimoto M, 2014, DEV BIOL, V386, P64, DOI 10.1016/j.ydbio.2013.12.002
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lawrence BD, 2012, J VIS EXP, V62, pe3646, DOI DOI 10.3791/3646
   Lee KB, 2003, J PHARM SCI, V92, P933, DOI 10.1002/jps.10556
   Ling SJ, 2014, PHYS CHEM CHEM PHYS, V16, P7741, DOI 10.1039/c4cp00556b
   Liu L, 2014, RSC ADV, V4, P14304, DOI 10.1039/c4ra01284d
   Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Ma L, 2013, PESTIC BIOCHEM PHYS, V107, P391, DOI 10.1016/j.pestbp.2013.10.008
   Mandal BB, 2009, BIOMATERIALS, V30, P5170, DOI 10.1016/j.biomaterials.2009.05.072
   Mazzi S, 2014, J THERM ANAL CALORIM, V116, P1337, DOI 10.1007/s10973-013-3631-0
   Mhuka V, 2013, INT J BIOL MACROMOL, V52, P305, DOI 10.1016/j.ijbiomac.2012.09.010
   Ming JF, 2014, J CRYST GROWTH, V386, P154, DOI 10.1016/j.jcrysgro.2013.09.050
   Ming JF, 2012, J APPL POLYM SCI, V125, P2148, DOI 10.1002/app.36354
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Nawalakhe R, 2012, J FIBER BIOENG INFO, V5, P227
   Numata K, 2014, MACROMOL BIOSCI, V14, P799, DOI 10.1002/mabi.201300482
   Perrone GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4385
   Polo CL, 2014, J NANOSCI NANOTECHNO, V14, P15
   Rajkhowa R, 2000, J APPL POLYM SCI, V77, P2418, DOI 10.1002/1097-4628(20000912)77:11<2418::AID-APP10>3.3.CO;2-H
   Rajkhowa R, 2010, J FIBER BIOENGINEERI, V2, P202
   Reddy N, 2010, INT J BIOL MACROMOL, V46, P419, DOI 10.1016/j.ijbiomac.2010.02.013
   Rnjak-Kovacina J, 2014, ADV FUNCT MATER, V24, P2188, DOI 10.1002/adfm.201302901
   Samal SK, 2013, ACTA BIOMATER, V9, P8192, DOI 10.1016/j.actbio.2013.05.027
   Selmin F, 2014, POLYM ADVAN TECHNOL, V25, P532, DOI 10.1002/pat.3282
   Sheikh FA, 2013, J BIOMED MAT RES A, V00A, P000
   Sheikh FA, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-303
   Shen Y, 2014, BIOMED MATER, V9, P15
   Subia B, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/3/035103
   Subia B, 2014, INTEGR BIOL-UK, V6, P203, DOI 10.1039/c3ib40184g
   Suzuki Y, 2014, BIOMACROMOLECULES, V15, P104, DOI 10.1021/bm401346h
   Taddei P, 2013, MACROMOL BIOSCI, V13, P1492, DOI 10.1002/mabi.201300156
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   Teuschl AH, 2014, ACTA BIOMATER, V10, P2506, DOI 10.1016/j.actbio.2014.02.012
   Tsioris K, 2012, ADV FUNCT MATER, V22, P330, DOI 10.1002/adfm.201102012
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Wang SD, 2009, BIOMACROMOLECULES, V10, P2240, DOI 10.1021/bm900416b
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Xie MB, 2013, TEXT BIOENG INFORM S, P247
   Xie R., 2008, J FIBER BIOENG INFO, V1, P73
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yang YJ, 2014, BIOMACROMOLECULES, V15, P1390, DOI 10.1021/bm500001n
   Yin GB, 2008, TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1 AND 2, P659, DOI 10.3993/tbis2008108
   Yoon H, 2013, MACROMOL RES, V22, P297
   Zhang KH, 2013, MACROMOL MATER ENG, V298, P565, DOI 10.1002/mame.201200038
   Zhang Q, 2010, J FIBER BIOENG INFO, V3, P1, DOI DOI 10.1109/ICMTMA.2010.531
   Zhang YP, 2010, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2010/683962
   Zhao HS, 2014, J STRUCT BIOL, V186, P420, DOI 10.1016/j.jsb.2014.02.009
   Zhao Z, 2013, TEXT BIOENG INFORM S, P143
   Zhao Z, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0736-5
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 80
TC 1
Z9 1
U1 0
U2 16
PU TEXTILE BIOENGINEERING & INFORMATICS SOCIETY LTD
PI HONG KONG SAR
PA TBIS 2010 SECRETARIAT MN104, HONG KONG POLYTECHNIC UNIV, HONG KONG SAR,
   0000, PEOPLES R CHINA
SN 1942-3438
J9 TEXT BIOENG INFORM S
PY 2014
BP 207
EP 218
PG 12
WC Materials Science, Textiles
SC Materials Science
GA BB7XZ
UT WOS:000346105500030
DA 2018-10-20
ER

PT J
AU Benni, S
   Avramoglou, T
   Hlawaty, H
   Mora, L
AF Benni, Safiya
   Avramoglou, Thierry
   Hlawaty, Hanna
   Mora, Laurence
TI Dynamic Contact Angle Analysis of Protein Adsorption on Polysaccharide
   Multilayer's Films for Biomaterial Reendothelialization
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID SURFACE MODIFICATION; ENDOTHELIAL-CELLS; DEXTRAN SULFATE;
   POLYELECTROLYTE; FIBROBLASTS; POLYSTYRENE; ADHESION; BEHAVIOR
AB Atherosclerosis is a major cardiovascular disease. One of the side effects is restenosis. The aim of this work was to study the coating of stents by dextran derivates based polyelectrolyte's multilayer (PEM) films in order to increase endothelialization of injured arterial wall after stent implantation. Films were composed with diethylaminoethyl dextran (DEAE) as polycation and dextran sulphate (DS) as polyanion. One film was composed with 4 bilayers of (DEAE-DS)(4) and was labeled D-. The other film was the same as D-but with an added terminal layer of DEAE polycation: (DEAE-DS)(4) -DEAE (labeled D+). The dynamic adsorption/desorption of proteins on the films were characterized by dynamic contact angle (DCA) and atomic force microscopy (AFM). Human endothelial cell (HUVEC) adhesion and proliferation were quantified and correlated to protein adsorption analyzed by DCA for fibronectin, vitronectin, and bovine serum albumin (BSA). Our results showed that the endothelial cell response was optimal for films composed of DS as external layer. Fibronectin was found to be the only protein to exhibit a reversible change in conformation after desorption test. This behavior was only observed for (DEAE-DS)(4) films. (DEAE-DS)(4) films could enhance HUVEC proliferation in agreement with fibronectin ability to easily change from conformation.
C1 [Benni, Safiya; Avramoglou, Thierry; Mora, Laurence] Univ Paris 13, Inst Galilee, LVTS, INSERM,U1148,Sorbonne Paris Cite, F-93430 Villetaneuse, France.
   [Hlawaty, Hanna] Univ Paris 13, UFR SMBH, LVTS, INSERM,U1148,Sorbonne Paris Cite, F-93000 Bobigny, France.
RP Mora, L (reprint author), Univ Paris 13, Inst Galilee, LVTS, INSERM,U1148,Sorbonne Paris Cite, F-93430 Villetaneuse, France.
EM laurence.mora@univ-paris13.fr
OI Hlawaty, Hanna/0000-0002-4758-0941
CR Alves CM, 2010, SOFT MATTER, V6, P4135, DOI 10.1039/c002972f
   Bordji K, 1996, BIOMATERIALS, V17, P491, DOI 10.1016/0142-9612(96)82723-2
   Bouafsoun A, 2007, MAT SCI ENG C-BIO S, V27, P709, DOI 10.1016/j.msec.2006.06.038
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   ELFERINK JGR, 1995, CHEM-BIOL INTERACT, V95, P203, DOI 10.1016/0009-2797(94)03360-9
   Hindlet P., 2005, PHARMACOL CLIN, V24, P40
   Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360
   Lin WC, 2005, COLLOID SURFACE B, V44, P143, DOI 10.1016/j.colsurfb.2005.06.010
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Meredith JE, 1997, TRENDS CELL BIOL, V7, P146, DOI 10.1016/S0962-8924(97)01002-7
   Mhamdi L, 2006, MAT SCI ENG C-BIO S, V26, P273, DOI 10.1016/j.msec.2005.10.049
   Miao YH, 2008, COLLOID SURFACE B, V66, P299, DOI 10.1016/j.colsurfb.2008.07.002
   Muller C, 2011, ANAL BIOANAL CHEM, V400, P679, DOI 10.1007/s00216-010-4613-8
   Noh H, 2008, BIOMATERIALS, V29, P2033, DOI 10.1016/j.biomaterials.2008.01.017
   Nolte A, 2013, J BIOMATER APPL, V28, P84, DOI 10.1177/0885328212437610
   Pribat F. Bourdery, 2004, Journal de Pharmacie Clinique, V23, P253
   Rapuano BE, 2004, J ORTHOP RES, V22, P353, DOI 10.1016/S0736-0266(03)00180-3
   Rupp F, 2002, J BIOMED MATER RES, V62, P567, DOI 10.1002/jbm.10198
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   Thomas JJ, 2010, INT J PHARMACEUT, V389, P195, DOI 10.1016/j.ijpharm.2010.01.011
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Xie AF, 2002, MACROMOLECULES, V35, P1805, DOI 10.1021/ma011293z
   Yu DG, 2007, COLLOID SURFACE B, V54, P222, DOI 10.1016/j.colsurfb.2006.10.026
   Zeerleder S, 2002, THROMB RES, V105, P441, DOI 10.1016/S0049-3848(02)00041-5
NR 26
TC 1
Z9 1
U1 0
U2 12
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 679031
DI 10.1155/2014/679031
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AU7KU
UT WOS:000345780200001
PM 25276808
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Tan, AW
   Tay, LL
   Chua, KH
   Ahmad, R
   Akbar, SA
   Pingguan-Murphy, B
AF Tan, Ai Wen
   Tay, Lelia
   Chua, Kien Hui
   Ahmad, Roslina
   Akbar, Sheikh Ali
   Pingguan-Murphy, Belinda
TI Proliferation and stemness preservation of human adipose-derived stem
   cells by surface-modified in situ TiO2 nanofibrous surfaces
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE titania; nanofibers; thermal oxidation; stem cells; pluripotency
ID DIFFERENTIAL REGULATION; CELLULAR-RESPONSE; TITANIUM; NANOTUBES;
   EXPRESSION; SUBSTRATE; GROWTH; REGENERATION; OSTEOBLASTS; FABRICATION
AB Two important criteria of an ideal biomaterial in the field of stem cells research are to regulate the cell proliferation without the loss of its pluripotency and to direct the differentiation into a specific cell lineage when desired. The present study describes the influence of TiO2 nanofibrous surface structures on the regulation of proliferation and stemness preservation of adipose-derived stem cells (ADSCs). TiO2 nanofiber arrays were produced in situ onto Ti-6Al-4V substrate via a thermal oxidation process and the successful fabrication of these nanostructures was confirmed by field emission scanning electron microscopy (FESEM), energy dispersive spectrometer (EDS), X-ray diffractometer (XRD), and contact angle measurement. ADSCs were seeded on two types of Ti-6Al-4V surfaces (TiO2 nanofibers and flat control), and their morphology, proliferation, and stemness expression were analyzed using FESEM, AlamarBlue assay, flow cytometry, and quantitative real-time polymerase chain reaction (qRT-PCR) after 2 weeks of incubation, respectively. The results show that ADSCs exhibit better adhesion and significantly enhanced proliferation on the TiO2 nanofibrous surfaces compared to the flat control surfaces. The greater proliferation ability of TiO2 nanofibrous surfaces was further confirmed by the results of cell cycle assay. More importantly, TiO2 nanofibrous surfaces significantly upregulate the expressions of stemness markers Sox-2, Nanog3, Rex-1, and Nestin. These results demonstrate that TiO2 nanofibrous surfaces can be used to enhance cell adhesion and proliferation while simultaneously maintaining the stemness of ADSCs, thereby representing a promising approach for their potential application in the field of bone tissue engineering as well as regenerative therapies.
C1 [Tan, Ai Wen; Pingguan-Murphy, Belinda] Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia.
   [Tay, Lelia; Chua, Kien Hui] Natl Univ Malaysia, Dept Physiol, Fac Med, Kuala Lumpur, Malaysia.
   [Ahmad, Roslina] Univ Malaya, Dept Mech Engn, Kuala Lumpur, Malaysia.
   [Akbar, Sheikh Ali] Ohio State Univ, Dept Mat Sci & Engn, Columbus, OH 43210 USA.
RP Pingguan-Murphy, B (reprint author), Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia.
EM bpingguan@um.edu.my
RI AHMAD, ROSLINA/B-9612-2010; Akbar, Sheikh/J-6170-2013; CHUA, KEK
   HENG/B-5261-2010; Pingguan-Murphy, Belinda/B-8332-2010; Tan, Ai
   Wen/I-6408-2015
OI AHMAD, ROSLINA/0000-0001-9038-8632; Akbar, Sheikh/0000-0003-3567-274X;
   Pingguan-Murphy, Belinda/0000-0001-5567-1141; 
FU High Impact Research Grant - Higher Education of Malaysia
   [UM.C/HIR/MOHE/ENG/44]; University of Malaya [PV 102/2012A]
FX The authors gratefully acknowledge support by a High Impact Research
   Grant (UM.C/HIR/MOHE/ENG/44) funded by the Higher Education of Malaysia
   and Postgraduate Research Fund (PV 102/2012A) from the University of
   Malaya.
CR Bauer S, 2008, ACTA BIOMATER, V4, P1576, DOI 10.1016/j.actbio.2008.04.004
   Blanco R, 2013, ISRN BIOMARKERS, V2013
   Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005
   Brammer KS, 2011, ACTA BIOMATER, V7, P683, DOI 10.1016/j.actbio.2010.09.022
   Chen XY, 2012, ADV ENG MATER, V14, pB216, DOI 10.1002/adem.201180073
   Chen XM, 2000, JNCI-J NATL CANCER I, V92, P1999, DOI 10.1093/jnci/92.24.1999
   Cheng D, 2013, J GEN VIROL, V94, P326, DOI 10.1099/vir.0.046052-0
   DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dinan B, 2013, CERAM INT, V39, P5949, DOI 10.1016/j.ceramint.2012.12.004
   Fatimah SS, 2013, MICROVASC RES, V86, P21, DOI 10.1016/j.mvr.2012.12.004
   Fatimah SS, 2012, J BIOSCI BIOENG, V114, P220, DOI 10.1016/j.jbiosc.2012.03.021
   Frandsen CJ, 2014, MAT SCI ENG C-MATER, V37, P332, DOI 10.1016/j.msec.2014.01.014
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Hashemi SM, 2011, BIOMATERIALS, V32, P7363, DOI 10.1016/j.biomaterials.2011.06.048
   Hou YH, 2013, INT J NANOMED, V8, P3619, DOI 10.2147/IJN.S38992
   Hu Y, 2012, BIOMATERIALS, V33, P3515, DOI 10.1016/j.biomaterials.2012.01.040
   Hui CK, 2012, BIOTECHNOL BIOPROC E, V17, P1306, DOI 10.1007/s12257-012-0354-1
   Kaitainen S, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025009
   Lai M, 2012, COLLOID SURFACE B, V97, P211, DOI 10.1016/j.colsurfb.2012.04.029
   Lee H, 2010, J NANOMATER, V2010
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Li D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066623
   Lim JY, 2011, J ORTHOP RES, V29, P1627, DOI 10.1002/jor.21441
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   Logan N., 2013, STEM CELLS INT, V2013
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Lu DY, 2014, BIOMATERIALS, V35, P3945, DOI 10.1016/j.biomaterials.2014.01.066
   McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623
   Motemani Y, 2014, APPL SURF SCI, V292, P626, DOI 10.1016/j.apsusc.2013.12.022
   Nava MM, 2012, J BIOMED BIOTECHNOL, V2012, DOI DOI 10.1155/2012/797410
   Oh S, 2006, MAT SCI ENG C-BIO S, V26, P1301, DOI 10.1016/j.msec.2005.08.014
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Pittrof A, 2012, ACTA BIOMATER, V8, P2639, DOI 10.1016/j.actbio.2012.03.040
   Ravichandran R, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015001
   Schreml S, 2009, CYTOTHERAPY, V11, P947, DOI 10.3109/14653240903204322
   Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200
   Tamura RE, 2012, CURR MOL MED, V12, P634
   Tan AW, 2014, CERAM INT, V40, P8301, DOI 10.1016/j.ceramint.2014.01.032
   Tan AW, 2012, CERAM INT, V38, P4421, DOI 10.1016/j.ceramint.2012.03.002
   Tan AW, 2013, J MATER SCI, V48, P8337, DOI 10.1007/s10853-013-7659-0
   Taylor BK, 2000, AM J PHYSIOL-LUNG C, V278, pL1062
   Wang XD, 2013, J MATER RES, V28, P270, DOI 10.1557/jmr.2012.356
   Wu KC, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/5/054401
   Yu JS, 2014, BIOMATERIALS, V35, P3516, DOI 10.1016/j.biomaterials.2014.01.015
   Zhang D, 2013, BIOMATERIALS, V34, P3962, DOI 10.1016/j.biomaterials.2013.02.029
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 50
TC 4
Z9 4
U1 0
U2 15
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 5389
EP 5401
DI 10.2147/IJN.S72659
PG 13
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AU7IP
UT WOS:000345774500001
PM 25473278
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Erfani-Moghadam, V
   Nomani, A
   Zamani, M
   Yazdani, Y
   Najafi, F
   Sadeghizadeh, M
AF Erfani-Moghadam, Vahid
   Nomani, Alireza
   Zamani, Mina
   Yazdani, Yaghoub
   Najafi, Farhood
   Sadeghizadeh, Majid
TI A novel diblock copolymer of (monomethoxy poly [ethylene glycol]-oleate)
   with a small hydrophobic fraction to make stable micelles/polymersomes
   for curcumin delivery to cancer cells
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE anticancer agent; nanocarrier; encapsulation; bioavailability;
   apoptosis; critical micelle concentration
ID AMPHIPHILIC BLOCK-COPOLYMERS; IN-VITRO; POLYMERSOMES; THERAPY;
   SUPPRESSES; APOPTOSIS; PATHWAYS; VESICLES; VIVO
AB Curcumin is a potent natural anticancer agent, but its effectiveness is limited by properties such as very low solubility, high rate of degradation, and low rate of absorption of its hydrophobic molecules in vivo. To date, various nanocarriers have been used to improve the bioavailability of this hydrophobic biomaterial. This study investigates the encapsulation of curcumin in a novel nanostructure of monomethoxy poly(ethylene glycol)-oleate (mPEG-OA) and its anticancer effect. Tests were done to determine the critical micelle concentration (CMC), encapsulation efficiency, drug-loading efficiency, and cytotoxicity (against U87MG brain carcinoma cells and HFSF-PI3 cells as normal human fibroblasts) of some nanodevice preparations. The results of fluorescence microscopy and cell-cycle analyses indicated that the in vitro bioavailability of the encapsulated curcumin was significantly greater than that of free curcumin. Cytotoxicity evaluations showed that half maximal inhibitory concentrations of free curcumin and curcumin-loaded mPEG-OA for the U87MG cancer cell line were 48 mu M and 24 mu M, respectively. The Annexin-V-FLUOS assay was used to quantify the apoptotic effect of the prepared nanostructures. Apoptosis induction was observed in a dose-dependent manner after curcumin-loaded mPEG-OA treatments. Two common self-assembling structures, micelles and polymersomes, were observed by atomic force microscopy and dynamic light scattering, and the abundance of each structure was dependent on the concentration of the diblock copolymer. The mPEG-OA micelles had a very low CMC (13.24 mu M or 0.03 g/L). Moreover, atomic force microscopy and dynamic light scattering showed that the curcumin-loaded mPEG-OA polymersomes had very stable structures, and at concentrations 1,000 times less than the CMC, at which the micelles disappear, polymersomes were the dominant structures in the dispersion with a reduced size distribution below 150 nm. Overall, the results from these tests revealed that this nanocarrier can be considered as an appropriate drug delivery system for delivering curcumin to cancer cells.
C1 [Erfani-Moghadam, Vahid; Sadeghizadeh, Majid] Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran, Iran.
   [Nomani, Alireza] Zanjan Univ Med Sci, Dept Pharmaceut, Fac Pharm, Zanjan, Iran.
   [Zamani, Mina; Sadeghizadeh, Majid] Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, Tehran, Iran.
   [Yazdani, Yaghoub] Golestan Univ Med Sci, Infect Dis Res Ctr, Gorgan, Golestan, Iran.
   [Yazdani, Yaghoub] Golestan Univ Med Sci, Lab Sci Res Ctr, Gorgan, Golestan, Iran.
   [Najafi, Farhood] Inst Color Sci & Technol, Dept Resin & Addit, Tehran, Iran.
   [Erfani-Moghadam, Vahid] Golestan Univ Med Sci, Fac Adv Med Technol, Dept Biotechnol, Gorgan, Iran.
RP Sadeghizadeh, M (reprint author), Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, Tehran 14115154, Iran.
EM arnomani@zums.ac.ir; sadeghma@modares.ac.ir
RI Yazdani, Yaghoub/I-2343-2016
OI Yazdani, Yaghoub/0000-0003-4005-3521; Nomani,
   Alireza/0000-0003-0028-5870; Erfani-Moghadam, Vahid/0000-0002-6723-5766
FU Faculty of Biological Sciences, Tarbiat Modares University, Tehran,
   Iran; INSF; Zanjan University of Medical Sciences
FX This project was supported by grants from the Faculty of Biological
   Sciences, Tarbiat Modares University, Tehran, Iran and the INSF
   (www.insf.gov.ir). We also acknowledge financial support from the Zanjan
   University of Medical Sciences for this research. We would like to
   express our special thanks to Dr Majid Erfani-Moghadam for his generous
   assistance in manuscript preparation.
CR Adams ML, 2003, J PHARM SCI, V92, P1343, DOI 10.1002/jps.10397
   Antonietti M, 2003, ADV MATER, V15, P1323, DOI 10.1002/adma.200300010
   Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167
   Babaei E, 2012, INT IMMUNOPHARMACOL, V12, P226, DOI 10.1016/j.intimp.2011.11.015
   Darvishi MH, 2013, INT J PHARMACEUT, V456, P408, DOI 10.1016/j.ijpharm.2013.08.069
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Discher DE, 2006, ANNU REV BIOMED ENG, V8, P323, DOI 10.1146/annurev.bioeng.8.061505.095838
   Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016
   Gou ML, 2011, NANOSCALE, V3, P1558, DOI 10.1039/c0nr00758g
   Hamidi M, 2012, MACROMOL BIOSCI, V12, P144, DOI 10.1002/mabi.201100193
   Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4
   Hillmyer MA, 1996, MACROMOLECULES, V29, P6994, DOI 10.1021/ma960774t
   Karmakar S, 2007, NEUROCHEM RES, V32, P2103, DOI 10.1007/s11064-007-9376-z
   Karmakar S, 2006, NEUROSCI LETT, V407, P53, DOI 10.1016/j.neulet.2006.08.013
   Levine DH, 2008, METHODS, V46, P25, DOI 10.1016/j.ymeth.2008.05.006
   Ma ZS, 2008, J BIOMED MATER RES A, V86A, P300, DOI 10.1002/jbm.a.31584
   Mimeault M, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-31
   Mirgani MT, 2014, INT J NANOMED, V9, P403, DOI 10.2147/IJN.S48136
   Pearson RT, 2013, SMART MAT DRUG DELIV, V1, P179
   Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x
   Robinson BR, 2005, DYNAMICS SURFACTANT, V125, P299
   Sahu A, 2008, ACTA BIOMATER, V4, P1752, DOI 10.1016/j.actbio.2008.04.021
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Song L, 2011, COLLOID SURFACE A, V390, P25, DOI 10.1016/j.colsurfa.2011.08.031
   Tong R, 2007, POLYM REV, V47, P345, DOI 10.1080/15583720701455079
   VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503
   Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9
   Xiong XB, 2012, ACTA BIOMATER, V8, P2017, DOI 10.1016/j.actbio.2012.03.006
   Yallapu MM, 2012, DRUG DISCOV TODAY, V17, P71, DOI 10.1016/j.drudis.2011.09.009
   Zana Raoul, 2005, DYNAMICS SURFACTANT, V125, P1
NR 30
TC 12
Z9 13
U1 1
U2 17
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 5541
EP 5554
DI 10.2147/IJN.S63762
PG 14
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AU7JO
UT WOS:000345777000001
PM 25489242
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Leszczak, V
   Popat, KC
AF Leszczak, Victoria
   Popat, Ketul C.
TI Direct co-culture of endothelial and smooth muscle cells on
   poly(epsilon-caprolactone) nanowire surfaces
SO RSC ADVANCES
LA English
DT Article
ID VASCULAR TISSUE; NITRIC-OXIDE; POLYCAPROLACTONE; INHIBITION; COLLAGEN;
   MODEL; PROLIFERATION; EXPRESSION; GRAFTS; STRESS
AB Current cardiovascular implants cause restenosis, calcification and thrombosis due to insufficient integration with native tissue. A thorough understanding of the interaction between the cells and the biomaterial involved is fundamental in a successful implant that promotes healing and tissue regeneration. In this study, we have developed collagen-immobilized nanostructured surfaces from poly(3-caprolactone) for the growth and maintenance of co-cultures of endothelial and smooth muscle cells. Cell adhesion, morphology and differentiation were investigated using microscopy and western blotting. The results presented here indicate that collagenimmobilized nanostructured surfaces may be good interfaces for use in cardiovascular applications and warrant further investigation.
C1 [Leszczak, Victoria; Popat, Ketul C.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
   [Popat, Ketul C.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
RP Popat, KC (reprint author), Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
EM ketul.popat@colostate.edu
OI Popat, Ketul C./0000-0002-2417-7789
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health under Award [5-R21-AR057341-02]
FX Research reported in this publication was supported by the National
   Institute of Arthritis and Musculoskeletal and Skin Diseases of the
   National Institutes of Health under Award Number 5-R21-AR057341-02. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR [Anonymous], 1994, BIDIRECTIONAL ELECT
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Chiu JJ, 2007, BLOOD, V110, P519, DOI 10.1182/blood-2006-08-040097
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   de Valence S, 2012, BIOMATERIALS, V33, P38, DOI 10.1016/j.biomaterials.2011.09.024
   DICHEK DA, 1989, CIRCULATION, V80, P1347, DOI 10.1161/01.CIR.80.5.1347
   Fillinger MF, 1997, J SURG RES, V67, P169, DOI 10.1006/jsre.1996.4978
   Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2
   Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035
   Jeong SI, 2007, BIOMATERIALS, V28, P1115, DOI 10.1016/j.biomaterials.2006.10.025
   JONES PA, 1979, P NATL ACAD SCI USA, V76, P1882, DOI 10.1073/pnas.76.4.1882
   Leszczak V., 2014, J BIOMED NA IN PRESS
   Leszczak V, 2014, J FUNCT BIOMATER, V5, P58, DOI 10.3390/jfb5020058
   Leszczak V, 2013, J BIOMAT SCI-POLYM E, V24, P1529, DOI 10.1080/09205063.2013.777228
   Liu YX, 2012, ACS APPL MATER INTER, V4, P1378, DOI 10.1021/am201648f
   O'Brien B, 2009, ACTA BIOMATER, V5, P945, DOI 10.1016/j.actbio.2008.11.012
   ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455
   Owens G. K., 2004, MOL REGULATION VASCU
   Parker T, 2010, CURR PHARM DESIGN, V16, P3978, DOI 10.2174/138161210794454897
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Rossello Ricardo A, 2010, Commun Integr Biol, V3, P53
   Sakurai S, 1999, AM J PATHOL, V154, P23, DOI 10.1016/S0002-9440(10)65246-7
   Shirota T, 2003, BIOMATERIALS, V24, P2295, DOI 10.1016/S0142-9612(03)00042-5
   Vernon SM, 1997, AM J PHYSIOL-CELL PH, V272, pC582
   Wenger A, 2004, TISSUE ENG, V10, P1536, DOI 10.1089/1076327042500283
   Williamson MR, 2006, TISSUE ENG, V12, P45, DOI 10.1089/ten.2006.12.45
   Wu HC, 2007, BIOMATERIALS, V28, P1385, DOI 10.1016/j.biomaterials.2006.11.012
   Wulf K, 2011, J BIOMED MATER RES B, V98B, P89, DOI 10.1002/jbm.b.31836
   Zhu YB, 2009, MAT SCI ENG C-BIO S, V29, P1046, DOI 10.1016/j.msec.2008.09.004
   ZIEGLER T, 1995, ANN BIOMED ENG, V23, P216, DOI 10.1007/BF02584424
   Zuckerbraun BS, 2007, AM J PHYSIOL-CELL PH, V292, pC824, DOI 10.1152/ajpcell.00592.2005
NR 31
TC 0
Z9 0
U1 0
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 101
BP 57929
EP 57934
DI 10.1039/c4ra09416f
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU5MP
UT WOS:000345651600076
DA 2018-10-20
ER

PT J
AU Chen, Y
   Sun, ZH
   Li, YY
   Hong, YL
AF Chen, Ying
   Sun, Zhihui
   Li, Yanyan
   Hong, Youliang
TI Rapid osteogenic differentiation of mesenchymal stem cells on
   hydroxyapatite nanocrystal clusters-oriented nanotopography
SO RSC ADVANCES
LA English
DT Article
ID BONE; MESOCRYSTALS; ATTACHMENT; NANOSCALE; LITHOGRAPHY; PHENOTYPE;
   SUBSTRATE; SURFACES; ADHESION; NUCLEUS
AB Although it has been well demonstrated that specific nanotopographies alone can direct the fate decision of stem cells, there is still a huge gap, and at the same time, denotes a large challenge to translate this concept into clinical trials. Herein, we reported on using a kind of clinically relative biomaterial, hydroxyapatite, to prepare a kind of specific nanotopography constructed by the randomly oriented hydroxyapatite nanocrystal clusters, through high temperature water vapour treatment of the plasma-sprayed hydroxyapatite slices. Cell experiments demonstrated that bone-marrow mesenchymal stem cells could exert a strong adhesive tension on the nanocrystal clusters-oriented topography, and the formed strong intracytoskeletal stress in turn promoted cells to osteogenic differentiation rapidly; the differentiation process was associated with, but faster than, the model of osteoblastic differentiation. Therefore, our work reported here extremely shortened the gap from the concepts of mechanotransduction, i.e., extracellular physical forces sponsored from materials features can induce mechanochemical conversion to alter the fate decision of stem cells, to the clinical trials.
C1 [Chen, Ying; Hong, Youliang] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
   [Sun, Zhihui; Li, Yanyan] Jilin Univ, Hosp 1, Dept Pharm, Changchun 130012, Peoples R China.
RP Hong, YL (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM hyl@scu.edu.cn
FU National Natural Science Foundation of China [31170928]
FX This work was supported by the National Natural Science Foundation of
   China (Grant 31170928).
CR Alvarez-Barreto JF, 2011, J TISSUE ENG REGEN M, V5, P464, DOI 10.1002/term.338
   Berridge M. J., 2012, CELL SIGNALLING BIOL, DOI [10.1042/csb000100, DOI 10.1042/CSB000100]
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2004, EXP CELL RES, V295, P387, DOI 10.1016/j.yexcr.2004.02.004
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Escudero ND, 2007, BONE, V40, pS7, DOI 10.1016/j.bone.2006.12.022
   Gentile F, 2010, BIOMATERIALS, V31, P7205, DOI 10.1016/j.biomaterials.2010.06.016
   Giachelli C M, 2005, Orthod Craniofac Res, V8, P229, DOI 10.1111/j.1601-6343.2005.00345.x
   Hatakeyama H, 2007, BIOMATERIALS, V28, P3632, DOI 10.1016/j.biomaterials.2007.04.019
   Heimann RB, 1997, J THERM SPRAY TECHN, V6, P145, DOI 10.1007/s11666-997-0005-9
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hong YL, 2010, MAT SCI ENG R, V70, P225, DOI 10.1016/j.mser.2010.06.010
   Hu XL, 2008, ADV FUNCT MATER, V18, P880, DOI 10.1002/adfm.200700671
   HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562
   Itano N, 2003, P NATL ACAD SCI USA, V100, P5181, DOI 10.1073/pnas.0531397100
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kuo SW, 2012, BIOMATERIALS, V33, P5013, DOI 10.1016/j.biomaterials.2012.03.080
   Li JF, 2011, J ORTHOP RES, V29, P1745, DOI 10.1002/jor.21439
   Manzanares M. V., 2009, NAT REV MOL CELL BIO, V10, P778, DOI DOI 10.1038/NRM2786
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   McNamara L. E., 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/120623
   Meili R, 2010, MOL BIOL CELL, V21, P405, DOI 10.1091/mbc.E09-08-0703
   Molnar P, 2007, BIOTECHNOL PROGR, V23, P265, DOI 10.1021/bp060302q
   Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Paletta JRJ, 2010, J MATER SCI-MATER M, V21, P1363, DOI 10.1007/s10856-009-3947-2
   Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957
   Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969
   Prat A. G., 1996, AM J PHYSIOL, V270
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Schofer D., 2011, PLOS ONE, V6
   Simon P, 2012, ANGEW CHEM INT EDIT, V51, P10776, DOI 10.1002/anie.201204583
   Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007
   Song RQ, 2010, ADV MATER, V22, P1301, DOI 10.1002/adma.200901365
   Stamenovic D, 2009, SOFT MATTER, V5, P1137, DOI 10.1039/b806442c
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165
   Zhang CG, 2000, J BIOMED MATER RES, V50, P267, DOI 10.1002/(SICI)1097-4636(200005)50:2<267::AID-JBM22>3.0.CO;2-7
NR 46
TC 2
Z9 2
U1 0
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 101
BP 58019
EP 58026
DI 10.1039/c4ra10027a
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU5MP
UT WOS:000345651600088
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Yao, NJ
   Wang, F
   Li, WD
   Jiang, SX
AF Zhang, Yin
   Yao, Nengjian
   Wang, Fei
   Li, Wenda
   Jiang, Shengxiang
TI A novel in situ self foaming method for the synthesis of porous calcium
   metaphosphate biomaterials
SO RSC ADVANCES
LA English
DT Article
ID HYDROXYAPATITE SCAFFOLDS; TRICALCIUM PHOSPHATE; BONE; DEGRADATION;
   CERAMICS; COMBINATION; FABRICATION; COMPOSITE; POWDERS; GROWTH
AB Porous calcium metaphosphate (CMP) ceramics were manufactured using an in situ self-foaming method. The porous CMP ceramics with different porosities and strengths, and the preparation process and the properties of the resulting material were studied. Under the conditions of a low molding pressure (<= 2.0 MPa) or low heating rate (<= 0.5 degrees C min(-1)), green specimens synthesized using only Ca(H2PO4)(2) center dot H2O (MCPM) or Ca(H2PO4)(2) (MCPA) as raw materials can be fabricated into porous bioceramics without deformation and without pore-forming agents. In this study, MCPA specimens were molded at a pressure of 80.0 MPa and the heating rate was controlled at 0.5 degrees C min(-1). The synthetic biomaterial showed a porosity of 38.0% and a strength of 48.0 MPa.
C1 [Zhang, Yin; Yao, Nengjian; Wang, Fei; Li, Wenda; Jiang, Shengxiang] Nanjing Tech Univ, Coll Mat Sci & Engn, Nanjing 210009, Jiangsu, Peoples R China.
   [Zhang, Yin] Nanjing Haoqi Adv Mat Co,Ltd, Nanjing 211300, Jiangsu, Peoples R China.
RP Zhang, Y (reprint author), Nanjing Tech Univ, Coll Mat Sci & Engn, 5 Xinmofan Rd, Nanjing 210009, Jiangsu, Peoples R China.
EM zhang.512@njtech.edu.cn
FU Priority Academic Program Development of Jiangsu Higher Education
   Institutions and "12th Five-Year Plan" [2011BAE30B01]
FX This project was funded by the Priority Academic Program Development of
   Jiangsu Higher Education Institutions and "12th Five-Year Plan" to
   support science and technology key project (no. 2011BAE30B01).
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Bitou M, 2008, POLYM DEGRAD STABIL, V93, P1081, DOI 10.1016/j.polymdegradstab.2008.03.014
   Caceres T, 2007, WATER RES, V41, P4497, DOI 10.1016/j.watres.2007.06.025
   Chiara R., 2013, J EUR CERAM SOC, V33, P1553
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Correa J, 2003, ENVIRON INT, V29, P459, DOI 10.1016/S0160-4120(03)00002-3
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Engin NO, 1999, J EUR CERAM SOC, V19, P2569
   FUJIU T, 1990, J AM CERAM SOC, V73, P85, DOI 10.1111/j.1151-2916.1990.tb05095.x
   Han JC, 2010, J EUR CERAM SOC, V30, P53, DOI 10.1016/j.jeurceramsoc.2009.08.018
   Hsu FY, 1999, BIOMATERIALS, V20, P1931
   Hu J, 2001, J MATER SCI LETT, V20, P85, DOI 10.1023/A:1006735319725
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Jin HH, 2010, POLYM DEGRAD STABIL, V95, P1856, DOI 10.1016/j.polymdegradstab.2010.04.025
   Koh YH, 2006, J AM CERAM SOC, V89, P3646, DOI 10.1111/j.1551-2916.2006.01311.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee YM, 2001, J BIOMED MATER RES, V54, P216, DOI 10.1002/1097-4636(200102)54:2<216::AID-JBM8>3.0.CO;2-C
   Alves HLR, 2008, J MATER SCI-MATER M, V19, P2241, DOI 10.1007/s10856-007-3329-6
   Lu J. X., 1997, BIOCERAMICS, V10, P583
   MCINTOSH AO, 1956, ANAL CHEM, V28, P1424, DOI 10.1021/ac60117a019
   NEREM RM, 1991, ANN BIOMED ENG, V19, P529, DOI 10.1007/BF02367396
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Omelon S, 2008, MATER RES BULL, V43, P68, DOI 10.1016/j.materresbull.2007.02.015
   Park EK, 2004, BIOMATERIALS, V25, P3403, DOI 10.1016/j.biomaterials.2003.10.031
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Popovic L, 2005, J RAMAN SPECTROSC, V36, P2, DOI 10.1002/jrs.1253
   Potoczek M, 2008, MATER LETT, V62, P1055, DOI 10.1016/j.matlet.2007.07.043
   Potoczek M, 2009, CERAM INT, V35, P2249, DOI 10.1016/j.ceramint.2008.12.006
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Sanchez-Salcedo S, 2008, CHEM ENG J, V137, P62, DOI 10.1016/j.cej.2007.09.01
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   TenHuisen KS, 1999, J AM CERAM SOC, V82, P2813
   TIENEN TG, 2002, BIOMATERIALS, V23, P1731
   Veljovic D, 2009, CERAM INT, V35, P1407, DOI 10.1016/j.ceramint.2008.07.007
   Wang J, 2010, J MOL CATAL A-CHEM, V320, P62, DOI 10.1016/j.molcata.2010.01.004
   Xiao-Feng L., 2010, CHINESE J INORG CHEM, V8, P1404
   Yang YF, 2008, POLYM DEGRAD STABIL, V93, P1838, DOI 10.1016/j.polymdegradstab.2008.07.007
   Zhang Y, 2006, KEY ENG MAT, V317-318, P723, DOI 10.4028/www.scientific.net/KEM.317-318.723
   Zhang Y, 2012, J AM CERAM SOC, V95, P147, DOI 10.1111/j.1551-2916.2011.04859.x
NR 40
TC 5
Z9 5
U1 1
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 104
BP 60007
EP 60016
DI 10.1039/c4ra11097h
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU5NO
UT WOS:000345654000046
DA 2018-10-20
ER

PT J
AU Paska, OM
   Pacurariu, C
   Muntean, SG
AF Paska, Oana Maria
   Pacurariu, Cornelia
   Muntean, Simona Gabriela
TI Kinetic and thermodynamic studies on methylene blue biosorption using
   corn-husk
SO RSC ADVANCES
LA English
DT Article
ID GRANULAR ACTIVATED CARBON; LOW-COST ADSORBENTS; AQUEOUS-SOLUTION; BASIC
   DYE; ADSORPTION-ISOTHERMS; CATIONIC DYES; WOOD SAWDUST; OLIVE POMACE;
   LEAF POWDER; WASTE-WATER
AB A low-cost waste biomass derived from corn plant (husk) was tested as an alternative to other expensive treatment options, for the removal of methylene blue (MB), from aqueous solutions. The effects of different experimental parameters, such as biosorbent dosage, dye concentration, contact time, and temperature, on the adsorption process were investigated. An optimum value of discoloration was observed at pH 6.0 and 2 g L-1 biomass dosage. The amount of dye removed per adsorbent unit decreased with increasing adsorbent dosage, temperature, and increased with increasing contact time, and concentration. Experimental data were modeled using first-order, pseudo-second-order, Elovich, and intraparticle diffusion kinetics models. The adsorption kinetics of MB could be described by the pseudo-second order reaction model. The experimental data were fitted to: Langmuir, Freundlich, Temkin, Redlich-Peterson, Toth, and Sips isotherm models and the best fitting was obtained with the Sips model. The thermodynamic parameters (Delta H degrees, Delta S degrees and Delta G degrees) obtained revealed that MB adsorption is a spontaneous, exothermic and physical process. The obtained results indicated that corn husk as a low-cost biomaterial is an attractive candidate for the removal of basic dye MB from aqueous solutions.
C1 [Paska, Oana Maria; Pacurariu, Cornelia] Politehn Univ Timisoara, Fac Ind Chem & Environm Engn, Timisoara 300006, Romania.
   [Muntean, Simona Gabriela] Romanian Acad, Inst Chem Timisoara, Timisoara 300223, Romania.
RP Muntean, SG (reprint author), Romanian Acad, Inst Chem Timisoara, 24 Mihai Viteazul, Timisoara 300223, Romania.
EM sgmuntean@acad-icht.tm.edu.ro
RI Muntean, Simona/B-9008-2011
FU inside POSDRU Romania [POSDRU 107/1.5/S/77265]; European Social Fund -
   Investing in People; Program 2 of the Institute of Chemistry Timisoara
   of Romanian Academy [2.3]
FX This work was partially supported by the strategic grant POSDRU
   107/1.5/S/77265, inside POSDRU Romania 2007-2013 co-financed by the
   European Social Fund - Investing in People. This work was supported by
   Program 2 of the Institute of Chemistry Timisoara of Romanian Academy
   (Research Project 2.3.).
CR Ahmad A, 2009, J HAZARD MATER, V170, P357, DOI 10.1016/j.jhazmat.2009.04.087
   Akar ST, 2011, CHEM ENG J, V168, P125, DOI 10.1016/j.cej.2010.12.049
   Akar ST, 2009, DESALINATION, V249, P757, DOI 10.1016/j.desal.2008.09.012
   Akar T, 2008, BIORESOURCE TECHNOL, V99, P3057, DOI 10.1016/j.biortech.2007.06.029
   Akar T, 2009, J HAZARD MATER, V166, P1217, DOI 10.1016/j.jhazmat.2008.12.029
   Aksu Z, 2007, CHEM ENG J, V127, P177, DOI 10.1016/j.cej.2006.09.014
   ALzaydien Atef S, 2009, American Journal of Environmental Sciences, V5, P197, DOI 10.3844/ajessp.2009.197.208
   Asgher M, 2010, ECOL ENG, V36, P1660, DOI 10.1016/j.ecoleng.2010.07.003
   Banat F, 2007, BIORESOURCE TECHNOL, V98, P3017, DOI 10.1016/j.biortech.2006.10.023
   Barka N, 2011, J TAIWAN INST CHEM E, V42, P320, DOI 10.1016/j.jtice.2010.07.004
   BARL B, 1991, J SCI FOOD AGR, V56, P195, DOI 10.1002/jsfa.2740560209
   Batzias FA, 2007, J HAZARD MATER, V149, P8, DOI 10.1016/j.jhazmat.2007.03.043
   Belala Z, 2011, DESALINATION, V271, P80, DOI 10.1016/j.desal.2010.12.009
   Bhattacharyya KG, 2005, DYES PIGMENTS, V65, P51, DOI 10.1016/j.dyepig.2004.06.016
   Boeriu CG, 2004, IND CROP PROD, V20, P205, DOI 10.1016/j.indcrop.2004.04.022
   Bulut Y, 2006, DESALINATION, V194, P259, DOI 10.1016/j.desal.2005.10.032
   Chowdhury S, 2011, COLLOID SURFACE B, V84, P520, DOI 10.1016/j.colsurfb.2011.02.009
   Crank J., 1979, MATH DIFFUSION
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Delval F, 2006, BIORESOURCE TECHNOL, V97, P2173, DOI 10.1016/j.biortech.2005.09.022
   Deniz F, 2011, DESALINATION, V270, P199, DOI 10.1016/j.desal.2010.11.046
   Dogan M, 2007, DYES PIGMENTS, V75, P701, DOI 10.1016/j.dyepig.2006.07.023
   Ferrero F, 2007, J HAZARD MATER, V142, P144, DOI 10.1016/j.jhazmat.2006.07.072
   Fiorentin LD, 2010, CHEM ENG J, V163, P68, DOI 10.1016/j.cej.2010.07.043
   Garg VK, 2004, DYES PIGMENTS, V63, P243, DOI 10.1016/j.dyepig.2004.03.005
   Gong RM, 2008, DESALINATION, V230, P220, DOI 10.1016/j.desal.2007.12.002
   Gong RM, 2007, BIORESOURCE TECHNOL, V98, P1319, DOI 10.1016/j.biortech.2006.04.034
   Gurses A, 2006, J HAZARD MATER, V131, P217, DOI 10.1016/j.jhazmat.2005.09.036
   Hamdaoui O, 2007, J HAZARD MATER, V147, P381, DOI 10.1016/j.jhazmat.2007.01.021
   Hamdaoui O, 2007, J HAZARD MATER, V147, P401, DOI 10.1016/j.jhazmat.2007.01.023
   Hameed BH, 2008, J HAZARD MATER, V158, P499, DOI 10.1016/j.jhazmat.2008.01.098
   Hameed BH, 2008, J HAZARD MATER, V158, P65, DOI 10.1016/j.jhazmat.2008.01.034
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P183, DOI 10.1205/095758298529326
   Hu ZH, 2010, J HAZARD MATER, V173, P292, DOI 10.1016/j.jhazmat.2009.08.082
   Jirekar D. B., 2014, Oriental Journal of Chemistry, V30, P1263, DOI 10.13005/ojc/300342
   Kara S, 2007, DESALINATION, V212, P282, DOI 10.1016/j.desal.2006.09.022
   Khaled A, 2009, DESALINATION, V238, P210, DOI 10.1016/j.desal.2008.02.014
   Khan T, 2010, ADSORPT SCI TECHNOL, V28, P657, DOI 10.1260/0263-6174.28.7.657
   Kumar R, 2011, DESALINATION, V265, P112, DOI 10.1016/j.desal.2010.07.040
   Liu Y, 2010, J ENVIRON SCI-CHINA, V22, P486, DOI 10.1016/S1001-0742(09)60134-0
   Mahmood R., 2013, AFR J PURE APPL CHEM, V7, P173
   Monash P, 2010, KOREAN J CHEM ENG, V27, P1184, DOI 10.1007/s11814-010-0177-8
   Nakanishi K, 1977, INFRARED ABSORPTION
   Nethaji S, 2013, INT J ENVIRON SCI TE, V10, P231, DOI 10.1007/s13762-012-0112-0
   Ofomaja AE, 2008, BIORESOURCE TECHNOL, V99, P5411, DOI 10.1016/j.biortech.2007.11.018
   Oladoja NA, 2008, DESALINATION, V227, P190, DOI 10.1016/j.desal.2007.06.025
   Ong ST, 2007, BIORESOURCE TECHNOL, V98, P2792, DOI 10.1016/j.biortech.2006.05.011
   Osasona I., 2013, British Journal of Applied Science & Technology, V3, P1006
   Padmesh I. V. N., 2006, Bioremediation Journal, V10, P37, DOI 10.1080/10889860600842746
   Patil Satish, 2011, International Journal of Environmental Sciences, V1, P711
   Pavan FA, 2008, J HAZARD MATER, V150, P703, DOI 10.1016/j.jhazmat.2007.05.023
   Reddy MCS, 2012, J HAZARD MATER, V203, P118, DOI 10.1016/j.jhazmat.2011.11.083
   Royer B, 2009, J HAZARD MATER, V164, P1213, DOI 10.1016/j.jhazmat.2008.09.028
   Singh R, 2005, CARBOHYD POLYM, V62, P57, DOI 10.1016/j.carbpol.2005.07.011
   Thangamani KS, 2007, BIORESOURCE TECHNOL, V98, P1265, DOI 10.1016/j.biortech.2006.05.010
   Vadivelan V, 2005, J COLLOID INTERF SCI, V286, P90, DOI 10.1016/j.jcis.2005.01.007
   Vijayaraghavan K, 2006, J HAZARD MATER, V133, P304, DOI 10.1016/j.jhazmat.2005.10.016
   Wang SB, 2005, CHEMOSPHERE, V60, P1401, DOI 10.1016/j.chemosphere.2005.01.091
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yan TG, 2013, BIORESOURCES, V8, P4722
   Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013
   Zulfikar M. A., 2013, International Journal of ChemTech Research, V5, P1671
NR 62
TC 27
Z9 27
U1 3
U2 21
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 107
BP 62621
EP 62630
DI 10.1039/c4ra10504d
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU5PY
UT WOS:000345660300076
DA 2018-10-20
ER

PT J
AU Deepachitra, R
   Ramnath, V
   Sastry, TP
AF Deepachitra, R.
   Ramnath, V.
   Sastry, T. P.
TI Graphene oxide incorporated collagen-fibrin biofilm as a wound dressing
   material
SO RSC ADVANCES
LA English
DT Article
ID IN-VIVO; GELATIN COMPOSITES; DRUG-DELIVERY; CELLULAR GROWTH; CHROME
   SHAVINGS; HYDROGELS; PROTEIN; CANCER; SKIN; CYTOTOXICITY
AB Functionalized graphene oxide offers many advantages as a biomaterial in various biomedical applications. In the present study, graphene oxide (GO) was incorporated in the collagen-fibrin composite film (CFGO) and used as wound dressing material in both in vitro and in vivo studies. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay using NIH 3T3 cells revealed that CFGO film is biocompatible. CFGO was also used as a wound dressing material on the experimental wounds of rats. Histopathological, biochemical and hematology studies have shown that the CFGO treated wounds healed faster than control and CF treated wounds. Based on the results, CFGO can be used as a wound dressing material in small and large animals.
C1 [Deepachitra, R.; Ramnath, V.; Sastry, T. P.] Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
RP Sastry, TP (reprint author), Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
EM sastrytp@hotmail.com
FU Department of Science and Technology (DST)
FX R. Deepachitra gratefully acknowledges the financial support provided by
   the Department of Science and Technology (DST).
CR Adam J., 1999, NEW ENGL J MED, V341, P738
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bidgoli Sepideh Arbabi, 2013, Acta Med Iran, V51, P203
   Bilgen G, 1999, TURK J VET ANIM SCI, V23, P483
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Bryan N, 2012, EUR CELLS MATER, V24, P249, DOI 10.22203/eCM.v024a18
   Cabeza LF, 1998, WASTE MANAGE, V18, P211, DOI 10.1016/S0956-053X(98)00032-4
   Chung C, 2013, ACCOUNTS CHEM RES, V46, P2211, DOI 10.1021/ar300159f
   Compton OC, 2010, SMALL, V6, P711, DOI 10.1002/smll.200901934
   Elson LA, 1933, BIOCHEM J, V27, P1824, DOI 10.1042/bj0271824
   Enoch S, 2008, SURGERY, V26, P31, DOI DOI 10.1016/J.MPSUR.2007.11.005
   Fonseca MJ, 1996, BBA-BIOMEMBRANES, V1279, P259
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Gengler R. Y. N., 2009, SMALL, V6, P35
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Gollavelli G, 2012, BIOMATERIALS, V33, P2532, DOI 10.1016/j.biomaterials.2011.12.010
   Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007
   Hu WB, 2011, ACS NANO, V5, P3693, DOI 10.1021/nn200021j
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Khullar P, 2012, J PHYS CHEM C, V116, P8834, DOI 10.1021/jp300585d
   Kim J, 2010, J AM CHEM SOC, V132, P8180, DOI 10.1021/ja102777p
   Lichtenberg D, 2000, BBA-BIOMEMBRANES, V1508, P1, DOI 10.1016/S0304-4157(00)00004-6
   Lu BG, 2012, NANOSCALE, V4, P2978, DOI 10.1039/c2nr11958g
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   MORGAN PW, 1994, VET SURG, V23, P494, DOI 10.1111/j.1532-950X.1994.tb00511.x
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Muruthy N., 2001, MACROMOL S, V172, P49
   Nagai T, 2004, INT J FOOD SCI TECH, V39, P239, DOI 10.1111/j.1365-2621.2004.00777.x
   Natarajan N, 2005, J MACROMOL SCI PURE, VA42, P945, DOI 10.1081/MA-200063188
   Noorjahan SE, 2004, J BIOMED MATER RES B, V71B, P305, DOI 10.1002/jbm.b.30094
   Noorjahan SE, 2004, J POLYM SCI POL CHEM, V42, P2241, DOI 10.1002/pola.20055
   Noorlander ML, 2002, J HISTOCHEM CYTOCHEM, V50, P1469, DOI 10.1177/002215540205001106
   Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49
   Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]
   Peng C, 2010, SMALL, V6, P1686, DOI 10.1002/smll.201000560
   Ramnath V, 2012, J MATER SCI-MATER M, V23, P3083, DOI 10.1007/s10856-012-4765-5
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Ruiz ON, 2011, ACS NANO, V5, P8100, DOI 10.1021/nn202699t
   Sadowska M, 2003, FOOD CHEM, V81, P257, DOI 10.1016/S0308-8146(02)00420-X
   SASTRY TP, 1990, J BIOACT COMPAT POL, V5, P430, DOI 10.1177/088391159000500405
   Sastry TP, 1998, J APPL POLYM SCI, V68, P1109, DOI 10.1002/(SICI)1097-4628(19980516)68:7<1109::AID-APP8>3.0.CO;2-J
   Sathian J, 2003, J BIOMED MATER RES A, V65A, P435, DOI 10.1002/jbm.a.10489
   SCHILLER S, 1961, J BIOL CHEM, V236, P983
   Sun ZC, 2013, NANOSCALE, V5, P6857, DOI 10.1039/c3nr01573d
   Swarnalatha S, 2009, J CHEM TECHNOL BIOT, V84, P751, DOI 10.1002/jctb.2108
   Thubagere A, 2010, ACS NANO, V4, P3611, DOI 10.1021/nn100389a
   TROWBRIDGE JM, 2002, GLYCOBIOLOGY, V12, P117, DOI DOI 10.1093/GLYCOB/CWF066
   Turcheniuk K, 2014, RSC ADV, V4, P865, DOI 10.1039/c3ra46307a
   Venkatesan P, 2011, BIOMATERIALS, V32, P3794, DOI 10.1016/j.biomaterials.2011.01.027
   Wang CC, 2008, J BIOMED MATER RES A, V84A, P1006, DOI 10.1002/jbm.a.31482
   Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6
   Wang TG, 2004, J NEUROCHEM, V88, P939, DOI 10.1046/j.1471-4159.2003.02242.x
   WOESSNER JF, 1962, BIOCHEM J, V83, P304, DOI 10.1042/bj0830304
   Yang K, 2012, BIOMATERIALS, V33, P2206, DOI 10.1016/j.biomaterials.2011.11.064
   Yang K, 2011, ACS NANO, V5, P516, DOI 10.1021/nn1024303
   Yang YQ, 2013, MATER TODAY, V16, P365, DOI 10.1016/j.mattod.2013.09.004
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
NR 58
TC 18
Z9 18
U1 3
U2 63
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 107
BP 62717
EP 62727
DI 10.1039/c4ra10150b
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU5PY
UT WOS:000345660300091
DA 2018-10-20
ER

PT J
AU More, P
   Patil, A
   Salunkhe, R
AF More, Pallavi
   Patil, Amol
   Salunkhe, Rajashri
TI Natural surfactant mediated phytosynthesis and solvatochromic
   fluorescence of 2-aminobenzamide derivatives
SO RSC ADVANCES
LA English
DT Article
ID SOLUBILITY ENHANCEMENT; ANTIBACTERIAL ACTIVITY; ORGANIC-CHEMISTRY;
   ANTHRANILIC ACID; WATER; SYSTEM; DESIGN; SILVER; NANOPARTICLES;
   CATALYSIS
AB A green synthesis and intriguing solvatochromic behaviour of 2-aminobenzamide derivatives in varying solvents has been investigated. The biomaterial in the form of an aqueous extract of mesocarp of the fruit of the Balanites roxburghii plant as a natural surfactant reaction medium has been employed for phytosynthesis with quantitative yield at 60 degrees C. The reaction proceeds effortlessly in a short reaction time with easy product formation. The fluorescence property of some synthesized compounds was studied, along with the interesting solvatochromic behaviour of 2-amino-N-benzylbenzamide.
C1 [More, Pallavi; Patil, Amol; Salunkhe, Rajashri] Shivaji Univ, Dept Chem, Kolhapur 416004, Maharashtra, India.
RP Salunkhe, R (reprint author), Shivaji Univ, Dept Chem, Kolhapur 416004, Maharashtra, India.
EM rsschem1@gmail.com
FU Department of Science Technology and University; Department of Science
   Technology, New Delhi, India
FX We gratefully acknowledge the financial support from the Department of
   Science Technology and University Grants Commission for FIST and SAP
   respectively. One of the authors Pallavi More thanks the Department of
   Science Technology, New Delhi, India for the award of PURSE fellowship.
   We also express our thanks to Prof. Dr S. R. Patil, Department of
   Chemistry, Shivaji University, Kolhapur for useful discussion regarding
   the fluorescence spectroscopic studies.
CR Andrade LH, 2006, J MOL CATAL B-ENZYM, V38, P84, DOI 10.1016/j.molcatb.2005.11.009
   Bahrami K, 2010, GREEN CHEM, V12, P1237, DOI 10.1039/c000047g
   Barge M, 2014, RSC ADV, V4, P31177, DOI 10.1039/c4ra04387a
   Basabe-Desmonts L, 2007, CHEM SOC REV, V36, P993, DOI 10.1039/b609548h
   BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468
   Capobianco ML, 2012, MOLECULES, V17, P910, DOI 10.3390/molecules17010910
   COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050
   Deshmukh V. N., 2011, INT J PHARM LIFE SCI, V1, P318
   Dharmaraja J, 2013, SPECTROCHIM ACTA A, V114, P607, DOI 10.1016/j.saa.2013.05.043
   Fonseca AM, 2009, J MOL CATAL B-ENZYM, V57, P78, DOI 10.1016/j.molcatb.2008.06.022
   Gawande MB, 2013, CHEM SOC REV, V42, P5522, DOI 10.1039/c3cs60025d
   Gu YL, 2013, CHEM SOC REV, V42, P9550, DOI 10.1039/c3cs60241a
   Ikejiri M, 2012, ORG LETT, V14, P4406, DOI 10.1021/ol301901e
   JAIN DC, 1987, PHYTOCHEMISTRY, V26, P2223, DOI 10.1016/S0031-9422(00)84687-7
   Kaniskan N., 2012, ARKIVOC, Vviii, P198
   Kim YH, 2005, B KOR CHEM SOC, V26, P47
   Kumar A.M., 2011, ADV BIORESEARCH, V2, P122
   Kumar D, 2013, RSC ADV, V3, P15157, DOI 10.1039/c3ra41038b
   Kumar V, 2009, J CHEM TECHNOL BIOT, V84, P151, DOI 10.1002/jctb.2023
   Lipshutz BH, 2012, ALDRICHIM ACTA, V45, P3
   Liu JZ, 2013, DRUG DISCOV THER, V7, P144, DOI 10.5582/ddt.2013.v7.4.144
   Liu QF, 2009, CATAL LETT, V131, P485, DOI 10.1007/s10562-009-9926-x
   Lutz R, 2005, J DISPER SCI TECHNOL, V26, P535, DOI 10.1081/DIS-200057627
   Mabkhot YN, 2014, INT J MOL SCI, V15, P5115, DOI 10.3390/ijms15035115
   Mahadavi M., 2012, SYNLETT, V23, P2521
   MAHATO SB, 1982, PHYTOCHEMISTRY, V21, P959, DOI 10.1016/S0031-9422(00)82400-0
   Manabe K, 2001, J AM CHEM SOC, V123, P10101, DOI 10.1021/ja016338q
   Manley P. W., 2004, BIOCHIM BIOPHYS ACTA, V17, P1697
   Manley PW, 2002, J MED CHEM, V45, P5687, DOI 10.1021/jm020899q
   MENGER FM, 1975, J ORG CHEM, V40, P3803, DOI 10.1021/jo00913a051
   Rai D, 2011, INDIAN J CHEM B, V50, P931
   Sanderson K, 2011, NATURE, V469, P18, DOI 10.1038/469018a
   Saxena A, 2010, DIG J NANOMATER BIOS, V5, P427
   Song WL, 2003, IND ENG CHEM RES, V42, P949, DOI 10.1021/ie020618c
   Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937
   STAIGER RP, 1959, J ORG CHEM, V24, P1214, DOI 10.1021/jo01091a013
   Suzuki K, 2005, BIOORGAN MED CHEM, V13, P4014, DOI 10.1016/j.bmc.2005.03.053
   TANI J, 1979, J MED CHEM, V22, P95, DOI 10.1021/jm00187a021
   Vemula V. R., 2010, INT J PHARM SCI REV, V5, P41
   Verma A., 2012, ACS MED CHEM LETT, V4, P32
   Wessig P, 2008, J ORG CHEM, V73, P4452, DOI 10.1021/jo800341k
   Xia B, 2013, J ORG CHEM, V78, P1994, DOI 10.1021/jo301942g
   Yadav J.S., 2001, TETRAHEDRON-ASYMMETR, V12, P3381
   Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976
NR 44
TC 1
Z9 1
U1 0
U2 4
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 108
BP 63039
EP 63047
DI 10.1039/c4ra09514f
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU6GJ
UT WOS:000345701500031
DA 2018-10-20
ER

PT J
AU Mendoza-Novelo, B
   Lona-Ramos, MC
   Gonzalez-Garcia, G
   Castellano, LE
   Delgado, J
   Cuellar-Mata, P
   Flores-Moreno, JM
   Vargas, J
   Gutierrez, JA
   Avila, EE
   Mata-Mata, JL
AF Mendoza-Novelo, Birzabith
   Lona-Ramos, Maria C.
   Gonzalez-Garcia, Gerardo
   Castellano, Laura E.
   Delgado, Jorge
   Cuellar-Mata, Patricia
   Mauricio Flores-Moreno, J.
   Vargas, Juan
   Alfredo Gutierrez, J.
   Avila, Eva E.
   Mata-Mata, Jose L.
TI Incorporation of silica particles into decellularized tissue biomaterial
   and its effect on macrophage activation
SO RSC ADVANCES
LA English
DT Article
ID IN-VITRO; MESOPOROUS SILICA; OSTEOGENIC DIFFERENTIATION; ENGINEERING
   SCAFFOLDS; ENDOTHELIAL-CELLS; IMMUNE-RESPONSE; DRUG-DELIVERY;
   STEM-CELLS; NANOPARTICLES; POLARIZATION
AB This paper describes an optimized procedure to incorporate silica particles by hydrolysis/ polycondensation of sodium silicate into pericardial (ECM) matrix scaffolds and elucidates the effect of the biocomposites on the in vitro response of macrophages by assessment of the secretion of signaling molecules. Variables (concentration, pH, time) of the sol-gel process allow a gradual incorporation of silica into the ECM scaffolds as confirmed by gravimetry, FT-IR, SEM and EDX microanalysis. The SiO2 incorporation increases the resistance to in vitro degradation but does not alter either the denaturation temperature or content of free amines of non-crosslinked ECM fibrous scaffolds, however, the properties of oligourethane-crosslinked scaffolds are not modified after silica incorporation. Despite the fact that cell viability is gradually decreased for the ECM materials crosslinked with oligourethane and functionalized with silica, murine RAW264.7 macrophages are able to secrete b-FGF, TGF-beta 1 and VEGF. Secretion of growth factors by RAW264.7 macrophages after 6 h of culture on scaffolds containing silica was lower but it was sustained for 24 h as compared to cells cultured on silica-free materials. Human peripheral blood macrophages cultured with materials containing silica show a higher production of IL-6, IL-10 or TNF-alpha than with the silica-free counterparts but in a time-dependent manner from one to four days of culture. Results suggest that stimulation of macrophages is induced by silica particles deposited onto the ECM fibrous network, which represents an opportunity to control the cell response to decellularized tissue-derived biomaterials through strategies intended to stimulate cells via signaling molecules secreted by macrophages.
C1 [Mendoza-Novelo, Birzabith; Lona-Ramos, Maria C.; Delgado, Jorge] Univ Guanajuato, DCI, Dept Ingn Quim Elect & Biomed, Leon 37150, Mexico.
   [Gonzalez-Garcia, Gerardo; Alfredo Gutierrez, J.; Mata-Mata, Jose L.] Univ Guanajuato, DCNE, Dept Quim, Guanajuato 36050, Mexico.
   [Castellano, Laura E.] Univ Guanajuato, DCS, Dept Ciencias Aplicadas Trabajo, Leon 37150, Mexico.
   [Cuellar-Mata, Patricia; Avila, Eva E.] Univ Guanajuato, DCNE, Dept Biol, Guanajuato 36050, Mexico.
   [Mauricio Flores-Moreno, J.] Ctr Invest Opt AC, Leon 37150, Mexico.
   [Vargas, Juan] IPN, Unidad Profes Interdisciplinaria Ingn, Silao De La Victoria 36275, Mexico.
RP Mendoza-Novelo, B (reprint author), Univ Guanajuato, DCI, Dept Ingn Quim Elect & Biomed, Loma Bosque 103, Leon 37150, Mexico.
EM b.mendozanovelo@ugto.mx
RI Mendoza-Novelo, Birzabith/M-8588-2016
OI Mendoza-Novelo, Birzabith/0000-0001-6604-395X; Avila, Eva
   E./0000-0003-2011-688X
FU Consejo Nacional de Ciencia y Tecnologia (Mexico) [CB2011/164440]; Fund
   Convocatoria Interinstitucional CIO-UG
FX We thank to Julio C. Martinez and Mayra C. Rodriguez (UG) for technical
   assistance with fibroblast culture and to Rossana F. Vargas and Prof.
   Juan V. Cauich (Centro de Investigacion Cientifica de Yucatan) for
   technical assistance and facilities with SEM and DSC analyses. GGG
   thanks to MC Dora A. Huerta Q. for technical assistance with SEM
   analysis at LANNBIO Cinvestavunidad Merida Yucatan. This research was
   supported by the Consejo Nacional de Ciencia y Tecnologia (Mexico)
   through the project CB2011/164440 and the Fund Convocatoria
   Interinstitucional CIO-UG 2013.
CR Angelopoulou A, 2012, MATER LETT, V74, P50, DOI 10.1016/j.matlet.2012.01.054
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Augustine R, 2014, RSC ADV, V4, P51528, DOI 10.1039/c4ra07361d
   Balaure PC, 2013, INT J PHARMACEUT, V441, P555, DOI 10.1016/j.ijpharm.2012.10.045
   Ballotta V, 2014, BIOMATERIALS, V35, P4919, DOI 10.1016/j.biomaterials.2014.03.002
   Battiston KG, 2014, BIOMATERIALS, V35, P4465, DOI 10.1016/j.biomaterials.2014.02.023
   Bonilla CEP, 2014, MAT SCI ENG C-MATER, V40, P418, DOI 10.1016/j.msec.2014.04.024
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen S, 2011, J MATER CHEM, V21, P10942, DOI 10.1039/c1jm10829h
   Cicuendez M, 2014, J MATER CHEM B, V2, P3469, DOI 10.1039/c4tb00106k
   Colilla M, 2013, BIOMATER SCI-UK, V1, P114, DOI 10.1039/c2bm00085g
   Coradin T, 2004, SPECTROSC-INT J, V18, P567, DOI 10.1155/2004/356207
   Day RM, 2005, J BIOMED MATER RES A, V73A, P73, DOI 10.1002/jbm.a.30262
   Desimone MF, 2010, ACTA BIOMATER, V6, P3998, DOI 10.1016/j.actbio.2010.05.014
   Dohle E, 2014, EUR CELLS MATER, V27, P149, DOI 10.22203/eCM.v027a12
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Grotheer V, 2013, BIOMATERIALS, V34, P7314, DOI 10.1016/j.biomaterials.2013.06.012
   Han PP, 2013, BIOMATER SCI-UK, V1, P379, DOI 10.1039/c2bm00108j
   He QJ, 2010, MICROPOR MESOPOR MAT, V131, P314, DOI 10.1016/j.micromeso.2010.01.009
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu L., 2011, J NANOSCI LETT, V1, P1
   Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010
   Kajahn Jennifer, 2012, Biomatter, V2, P226, DOI 10.4161/biom.22855
   Kasper J, 2013, ARCH TOXICOL, V87, P1053, DOI 10.1007/s00204-012-0876-5
   Lee KH, 2009, BIOMATERIALS, V30, P3444, DOI 10.1016/j.biomaterials.2009.03.002
   Lee S, 2011, BIOMATERIALS, V32, P9434, DOI 10.1016/j.biomaterials.2011.08.042
   Link T, 2013, RSC ADV, V3, P11140, DOI 10.1039/c2ra22352j
   Maciel J, 2012, ACTA BIOMATER, V8, P3669, DOI 10.1016/j.actbio.2012.06.010
   Mao ZW, 2013, BIOMATER SCI-UK, V1, P896, DOI 10.1039/c3bm00137g
   Mebert AM, 2013, J BIOMATER TISS ENG, V3, P108, DOI 10.1166/jbt.2013.1069
   Mendoza-Novelo B, 2014, J MATER CHEM B, V2, P2874, DOI 10.1039/c3tb21832e
   Mendoza-Novelo B, 2013, MATER LETT, V106, P369, DOI 10.1016/j.matlet.2013.05.088
   Mendoza-Novelo B, 2013, MAT SCI ENG C-MATER, V33, P2392, DOI 10.1016/j.msec.2013.02.001
   Mendoza-Novelo B, 2011, ACTA BIOMATER, V7, P1241, DOI 10.1016/j.actbio.2010.11.017
   Mu QX, 2014, CHEM REV, V114, P7740, DOI 10.1021/cr400295a
   Muller WEG, 2013, BIOMATER SCI-UK, V1, P669, DOI 10.1039/c3bm00001j
   Quignard S, 2014, BIOMATER SCI-UK, V2, P484, DOI 10.1039/c3bm60214a
   Quignard S, 2012, BIOMATERIALS, V33, P4431, DOI 10.1016/j.biomaterials.2012.03.004
   Rajabi-Zeleti S, 2014, BIOMATERIALS, V35, P970, DOI 10.1016/j.biomaterials.2013.10.045
   Ren L, 2001, J NON-CRYST SOLIDS, V285, P116, DOI 10.1016/S0022-3093(01)00441-0
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rodrigues AI, 2012, ACTA BIOMATER, V8, P3765, DOI 10.1016/j.actbio.2012.05.025
   Rong Y, 2013, ENVIRON TOXICOL PHAR, V36, P921, DOI 10.1016/j.etap.2013.08.007
   Schlossmacher U, 2013, RSC ADV, V3, P11185, DOI 10.1039/c3ra23341c
   Shirosaki Y, 2005, BIOMATERIALS, V26, P485, DOI 10.1016/j.biomaterials.2004.02.056
   Alvarez GS, 2014, J MATER CHEM B, V2, P4660, DOI 10.1039/c4tb00327f
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Tomoaia G, 2014, MAT SCI ENG C-MATER, V37, P37, DOI 10.1016/j.msec.2013.12.027
   Vargas GE, 2013, J MATER SCI-MATER M, V24, P1261, DOI 10.1007/s10856-013-4892-7
   Wang J, 2014, BIOMATERIALS, V35, P466, DOI 10.1016/j.biomaterials.2013.09.060
   Wang XP, 2013, ACTA BIOMATER, V9, P7480, DOI 10.1016/j.actbio.2013.03.031
   Wiens M, 2010, BIOMATERIALS, V31, P7716, DOI 10.1016/j.biomaterials.2010.07.002
   Wu CT, 2011, J MATER CHEM, V21, P18300, DOI 10.1039/c1jm12770e
   Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k
   Yun HS, 2011, ACTA BIOMATER, V7, P2651, DOI 10.1016/j.actbio.2011.02.014
   Zhai WY, 2013, ACTA BIOMATER, V9, P8004, DOI 10.1016/j.actbio.2013.04.024
   Zhai WY, 2012, J BIOMED MATER RES B, V100B, P1397, DOI 10.1002/jbm.b.32711
   Zhang HY, 2012, J AM CHEM SOC, V134, P15790, DOI 10.1021/ja304907c
NR 61
TC 2
Z9 2
U1 0
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 108
BP 63457
EP 63465
DI 10.1039/c4ra08984g
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU6GJ
UT WOS:000345701500082
DA 2018-10-20
ER

PT S
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
BE Dornfeld, D
   Helu, M
TI Finite Element Simulation and Experimental Validation of Residual
   Stresses in High Speed Dry Milling of Biodegradable Mg-Ca Alloys
SO 6TH CIRP INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE CUTTING (HPC2014)
SE Procedia CIRP
LA English
DT Proceedings Paper
CT 6th CIRP International Conference on High Performance Cutting (HPC)
CY JUN 23-25, 2014
CL Univ Calif, Berkeley & Davis Campuses, Berkeley, CA
SP CIRP
HO Univ Calif, Berkeley & Davis Campuses
DE Residua stess; dry cutting; magnesium alloy; implants
ID MACHINED LAYER; SURFACE; MODEL; TOOL; TEMPERATURE; GEOMETRY
AB Magnesium-Calcium (Mg-Ca) alloys have become attractive biodegradable orthopedic biomaterials recently. Residual stresses are proven to be very influential on the degradation rate of an Mg-Ca implant in the human body. Due to the time and cost reasons, development of finite element models to predict residual stress profiles in cutting of Mg-Ca implants is highly desirable. In this study, a finite element simulation model of orthogonal cutting without explicit chip formation has been developed by using the plowing depth approach in order to predict process-induced residual stresses in high speed dry cutting of Mg-Ca0.8 (wt %) alloy using diamond tools. Mechanical properties of Mg-Ca0.8 biomaterial at high strain rates and large strains were determined using the split-Hopkinson pressure bar test. The internal state variable (ISV) plasticity model has been implemented to model the dynamic material behavior under cutting regimes. The residual stress evolution and effects of plowing speed and plowing depth on residual stress profiles are studied. Residual stress measurements were also performed utilizing the X-ray diffraction technique for validation purposes. (C) 2014 Elsevier B.V.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR Bach F. W., 2007, P 7 INT C MG ALL THE, P1076
   Bammann D. J., 1996, THEORETICAL APPL MEC, P359
   Bammann DJ, 1993, STRUCTURAL CRASHWORT, P1
   Brinksmeier E, 2000, ANN CIRP, V31, P491
   DENKENA B, 2007, ANN CIRP, V56, P113, DOI DOI 10.1016/J.CIRP.2007.05.029
   Ee KC, 2005, INT J MECH SCI, V47, P1611, DOI [10.1016/j.ijmecsci.2005.06.001, 10.1016/j.ijmensci.2005.06.001]
   Fang FZ, 2007, J MATER PROCESS TECH, V184, P407, DOI 10.1016/j.jmatprotec.2006.12.007
   Grzesik W, 2003, INT J MACH TOOL MANU, V43, P1311, DOI 10.1016/S0890-6955(03)00160-3
   Guo YB, 2009, CIRP ANN-MANUF TECHN, V58, P81, DOI 10.1016/j.cirp.2009.03.110
   Guo YB, 2005, TRANS N AMER MANUFAC, V33, P469
   Hashimoto F., 2006, ANN CIRP, V55, P81
   Jacobus K, 2001, J MANUF SCI E-T ASME, V123, P537, DOI 10.1115/1.1372197
   Jacobus K, 2000, J MANUF SCI E-T ASME, V122, P20, DOI 10.1115/1.538906
   Jawahir IS, 2011, CIRP ANN-MANUF TECHN, V60, P603, DOI 10.1016/j.cirp.2011.05.002
   Liu CR, 2000, INT J MECH SCI, V42, P1069, DOI 10.1016/S0020-7403(99)00042-9
   Ozel T, 2007, INT J ADV MANUF TECH, V35, P255, DOI 10.1007/s00170-006-0720-2
   Outeiro JC, 2006, INT J MACH TOOL MANU, V46, P1786, DOI 10.1016/j.ijmachtools.2005.11.013
   Palmer W. B., 1963, P 4 INT MACH TOOL DE, P61
   Salahshoor M, 2011, INT J MACH TOOL MANU, V51, P579, DOI 10.1016/j.ijmachtools.2011.04.004
   Sasahara H, 2004, INT J MACH TOOL MANU, V44, P815, DOI 10.1016/j.ijmachtools.2004.01.002
   Sasahara H, 1996, J MATER PROCESS TECH, V62, P448, DOI 10.1016/S0924-0136(96)02451-X
   Schulze V, 2010, CIRP ANN-MANUF TECHN, V59, P117, DOI 10.1016/j.cirp.2010.03.064
   Spear H. E., 1994, SYNTHETIC DIAMOND EM
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   Zong WJ, 2007, INT J ADV MANUF TECH, V32, P666, DOI 10.1007/s00170-005-0388-z
NR 25
TC 1
Z9 1
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2212-8271
J9 PROC CIRP
PY 2014
VL 14
BP 281
EP 286
DI 10.1016/j.procir.2014.03.062
PG 6
WC Engineering, Industrial
SC Engineering
GA BB7ES
UT WOS:000345439400049
OA Other Gold
DA 2018-10-20
ER

PT J
AU Qi, C
   Zhu, YJ
   Lu, BQ
   Ding, GJ
   Sun, TW
   Chen, F
   Wu, J
AF Qi, Chao
   Zhu, Ying-Jie
   Lu, Bing-Qiang
   Ding, Guan-Jun
   Sun, Tuan-Wei
   Chen, Feng
   Wu, Jin
TI Microwave-assisted rapid synthesis of magnesium phosphate hydrate
   nanosheets and their application in drug delivery and protein adsorption
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID BETA-TRICALCIUM PHOSPHATE; HYDROTHERMAL SYNTHESIS; MESOPOROUS SILICA;
   BONE REGENERATION; PHOSPHORUS SOURCE; CALCIUM; NANOSTRUCTURES;
   FABRICATION; MATRICES; RELEASE
AB Magnesium phosphate biomaterial, as an alternative to well-known calcium phosphate biomaterials, is an excellent candidate for biomedical applications, owing to its outstanding biocompatibility and biodegradability. Herein, we report a simple strategy for the rapid synthesis of magnesium phosphate hydrate nanosheets (MPHSs) using the microwave-assisted hydrothermal method. This method is facile, rapid, surfactant-free and environmentally friendly. The product shows an excellent ability to promote osteoblast MC-3T3 adhesion and spreading, which indicates high biocompatibility. Moreover, the as-prepared MPHSs are explored for potential applications in the loading and release of the anticancer drug and protein adsorption, using docetaxel as a model anticancer drug and hemoglobin (Hb) as a model protein. The experiments indicate that the as-prepared MPHSs have a relatively high protein adsorption capacity and a high ability to damage tumor cells after loading docetaxel. Thus, the as-prepared MPHSs are promising for applications in various biomedical fields such as drug delivery and protein adsorption.
C1 [Qi, Chao; Zhu, Ying-Jie; Lu, Bing-Qiang; Ding, Guan-Jun; Sun, Tuan-Wei; Chen, Feng; Wu, Jin] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Zhu, YJ (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM y.j.zhu@mail.sic.ac.cn
RI Qi, Chao/N-5957-2015; Chen, Feng/D-6406-2012; CHEN, Feng/E-4310-2016
OI Chen, Feng/0000-0002-1162-1684; CHEN, Feng/0000-0002-1162-1684
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [51172260, 51302294];
   Science and Technology Commission of Shanghai [12ZR1452100]
FX Financial support from the National Basic Research Program of China (973
   Program, no. 2012CB933600), the National Natural Science Foundation of
   China (51172260, 51302294), and Science and Technology Commission of
   Shanghai (12ZR1452100) is gratefully acknowledged.
CR Andersson J, 2004, CHEM MATER, V16, P4160, DOI 10.1021/cm0401490
   Bhakta G, 2005, BIOMATERIALS, V26, P2157, DOI 10.1016/j.biomaterials.2004.06.039
   Bichler KH, 2002, INT J ANTIMICROB AG, V19, P488, DOI 10.1016/S0924-8579(02)00088-2
   Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077
   Jia JF, 2010, J R SOC INTERFACE, V7, P1171, DOI 10.1098/rsif.2009.0559
   Klammert U, 2011, ACTA BIOMATER, V7, P3469, DOI 10.1016/j.actbio.2011.05.022
   Klammert U, 2010, J MATER SCI-MATER M, V21, P2947, DOI 10.1007/s10856-010-4148-8
   Lu JX, 2011, J MATER SCI-MATER M, V22, P607, DOI 10.1007/s10856-011-4228-4
   Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972
   Mestres G, 2011, ACTA BIOMATER, V7, P1853, DOI 10.1016/j.actbio.2010.12.008
   Paul W, 2007, J MATER SCI-MATER M, V18, P699, DOI 10.1007/s10856-006-0005-1
   Qi C, 2013, CHEM-EUR J, V19, P5332, DOI 10.1002/chem.201203886
   Qi C, 2012, J MATER CHEM, V22, P22642, DOI 10.1039/c2jm35280j
   Qi C, 2012, MATER LETT, V85, P71, DOI 10.1016/j.matlet.2012.06.106
   Rude RK, 2003, CALCIFIED TISSUE INT, V72, P32, DOI 10.1007/s00223-001-1091-1
   SALIMI MH, 1985, LANGMUIR, V1, P119, DOI 10.1021/la00061a019
   Tamimi F, 2011, ACTA BIOMATER, V7, P2678, DOI 10.1016/j.actbio.2011.02.007
   Tavares DDS, 2013, J APPL ORAL SCI, V21, P37, DOI 10.1590/1678-7757201302138
   Wang SP, 2013, MICROPOR MESOPOR MAT, V179, P172, DOI 10.1016/j.micromeso.2013.06.005
   Wei J, 2010, BIOMATERIALS, V31, P1260, DOI 10.1016/j.biomaterials.2009.11.005
   Xue WC, 2008, J MATER SCI-MATER M, V19, P2669, DOI 10.1007/s10856-008-3395-4
   Yang Q, 2005, CHEM MATER, V17, P5999, DOI 10.1021/cm051198v
   Zhao XY, 2013, CRYSTENGCOMM, V15, P206, DOI 10.1039/c2ce26315g
   Zhou H, 2013, MAT SCI ENG C-MATER, V33, P4288, DOI 10.1016/j.msec.2013.06.034
   Zhu YJ, 2014, CHEM REV, V114, P6462, DOI 10.1021/cr400366s
NR 25
TC 12
Z9 12
U1 2
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 48
BP 8576
EP 8586
DI 10.1039/c4tb01473a
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AU3QT
UT WOS:000345529400014
DA 2018-10-20
ER

PT J
AU Nakaji-Hirabayashi, T
   Kitano, H
AF Nakaji-Hirabayashi, T.
   Kitano, H.
TI Interleukin-10 chimeric protein to protect transplanted neural
   progenitor cells from immune responses
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID EPIDERMAL-GROWTH-FACTOR; STEM-CELLS; PARKINSONS-DISEASE;
   DOPAMINERGIC-NEURONS; SELECTIVE EXPANSION; NERVOUS-SYSTEM; RAT MODEL;
   SURVIVAL; DIFFERENTIATION; POLYPEPTIDES
AB The provision of adhesive scaffolding and protection from inflammatory responses are important for enhancing graft survival. We previously developed a functional hydrogel that significantly enhances the survival of cells transplanted into the midbrain striatum. Although graft survival reached approximately 40% using this hydrogel, the survival of transplanted cells required further enhancements because it ultimately produced a decrease in the number of transplanted cells. Therefore, we developed a hydrogel system that can locally prevent the inflammatory response. This hydrogel was modified by the addition of the interleukin 10 chimeric protein (IL10CP), which is selectively released from the hydrogel when triggered by an inflammatory response. This design protects transplanted cells from inflammatory response, while other host cells remain unaffected. The IL10 domains are selectively released from the hydrogel, which act locally on the immune cells to prevent the inflammatory response without the administration of an immune suppressor. The selective release of IL10 domains from the hydrogel and their activity to prevent immune responses were evaluated using various approaches. Moreover, the ability of the IL10CP-modified hydrogel to protect cells was investigated using an in vitro co-culture with activated microglia. The IL10 incorporated into the hydrogel was selectively released by the activity of matrix-metalloproteinase 9 (MMP9), and the neural progenitor cells encapsulated in the IL10CP-immobilized hydrogel were protected from activated microglia by the release of IL10s from the hydrogel by the MMP9, produced by the activated microglia. These results show that the IL10CP-modified hydrogel will be useful as a biomaterial for improving the survival of transplanted cells.
C1 [Nakaji-Hirabayashi, T.] Toyama Univ, Frontier Res Core Life Sci, Toyama 9308555, Japan.
   [Kitano, H.] Toyama Univ, Grad Sch Sci & Engn, Dept Appl Chem, Toyama 9308555, Japan.
RP Nakaji-Hirabayashi, T (reprint author), Toyama Univ, Frontier Res Core Life Sci, 3190 Gofuku, Toyama 9308555, Japan.
EM nakaji@ctg.u-toyama.ac.jp
CR Agari T., 2002, NEUROSCI RES, V69, P698
   Arimoto T, 2007, NEUROBIOL AGING, V28, P894, DOI 10.1016/j.neurobiolaging.2006.04.011
   Armstrong RJE, 2000, CELL TRANSPLANT, V9, P139, DOI 10.1177/096368970000900202
   Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x
   Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119
   Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/23455
   Kim DE, 2006, RADIOLOGY, V241, P822, DOI 10.1148/radiol.2413050466
   Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200
   Lepore A C, 2006, Neuroscience, V142, P287, DOI 10.1016/j.neuroscience.2005.12.067
   Marchionini DM, 2003, J COMP NEUROL, V464, P172, DOI 10.1002/cne.10785
   Nakaii-Hirabayashi T, 2008, BIOCONJUGATE CHEM, V19, P516, DOI 10.1021/bc700355t
   Nakaji-Hirabayashi T, 2012, J TISSUE ENG REGEN M, V6, P322
   Nakaji-Hirabayashi T, 2008, BIOMATERIALS, V29, P4403, DOI 10.1016/j.biomaterials.2008.07.048
   Nakaji-Hirabayashi T, 2007, BIOMATERIALS, V28, P3517, DOI 10.1016/j.biomaterials.2007.04.022
   Nakaji-Hirabayashi T, 2013, BIOCONJUGATE CHEM, V24, P1798, DOI 10.1021/bc400005m
   Nakaji-Hirabayashi T, 2012, BIOCONJUGATE CHEM, V23, P212, DOI 10.1021/bc200481v
   Nakaji-Hirabayashi T, 2009, BIOCONJUGATE CHEM, V20, P102, DOI 10.1021/bc800331t
   Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649
   Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137
   Thomas JG, 1997, APPL BIOCHEM BIOTECH, V66, P197, DOI 10.1007/BF02785589
   Wang F, 2011, NEUROSCI RES, V71, P92, DOI 10.1016/j.neures.2011.05.019
   Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001
NR 22
TC 4
Z9 4
U1 1
U2 3
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 48
BP 8598
EP 8607
DI 10.1039/c4tb01413h
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AU3QT
UT WOS:000345529400016
DA 2018-10-20
ER

PT J
AU Ma, MC
   Xu, XJ
   Shi, LL
   Li, LD
AF Ma, Mingchao
   Xu, Xinjun
   Shi, Leilei
   Li, Lidong
TI Organic field-effect transistors with a low driving voltage using
   albumin as the dielectric layer
SO RSC ADVANCES
LA English
DT Article
ID THIN-FILM TRANSISTORS; PROTEIN MOLECULES; PERFORMANCE; MOISTURE; POLYMER
AB Solution-processed organic field-effect transistors (OFETs) were fabricated based on a hygroscopic biomaterial, egg-white albumin, as the gate dielectric and poly(3-hexylthiophene) as the semiconductor. With increasing humidity, such OFETs can show improved performance exhibiting a very low driving voltage, together with enhanced carrier mobility and suppressed off-state current.
C1 [Ma, Mingchao; Xu, Xinjun; Shi, Leilei; Li, Lidong] Univ Sci & Technol Beijing, State Key Lab Adv Met & Mat, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
RP Xu, XJ (reprint author), Univ Sci & Technol Beijing, State Key Lab Adv Met & Mat, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
EM xuxj@mater.ustb.edu.cn; lidong@mater.ustb.edu.cn
RI Li, Lidong/D-7077-2011
OI Shi, Leilei/0000-0002-9427-4357
FU National Natural Science Foundation of China [51273020]; Fundamental
   Research Funds for the Central Universities [FRF-SD-12-005B]; Research
   Fund for the Doctoral Program of Higher Education of China
   [20130006110007]; State Key Lab for Advanced Metals and Materials
   [2012-ZD05]
FX This work is supported by the National Natural Science Foundation of
   China (51273020), the Fundamental Research Funds for the Central
   Universities (FRF-SD-12-005B), Research Fund for the Doctoral Program of
   Higher Education of China (20130006110007), and the State Key Lab for
   Advanced Metals and Materials (2012-ZD05).
CR Arias AC, 2010, CHEM REV, V110, P3, DOI 10.1021/cr900150b
   Capelli R, 2011, ORG ELECTRON, V12, P1146, DOI 10.1016/j.orgel.2011.04.005
   Chang JW, 2011, ADV MATER, V23, P4077, DOI 10.1002/adma.201102124
   Chen HJ, 2012, ADV MATER, V24, P4618, DOI 10.1002/adma.201201318
   Chua LL, 2005, NATURE, V434, P194, DOI 10.1038/nature03376
   Di CA, 2008, ADV MATER, V20, P1286, DOI 10.1002/adma.200701812
   Gelinck G, 2010, ADV MATER, V22, P3778, DOI 10.1002/adma.200903559
   HILL TL, 1956, J PHYS CHEM-US, V60, P1593, DOI 10.1021/j150545a035
   HILL TL, 1956, J PHYS CHEM-US, V60, P358, DOI 10.1021/j150537a026
   Hoshino S, 2004, J APPL PHYS, V95, P5088, DOI 10.1063/1.1691190
   Kaihovirta N, 2010, ADV FUNCT MATER, V20, P2605, DOI 10.1002/adfm.201000586
   Kim YS, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3299022
   Knipp D, 2007, J APPL PHYS, V101, DOI 10.1063/1.2432369
   Ko SH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345202
   Komoda T, 2003, JPN J APPL PHYS 1, V42, P3662, DOI 10.1143/JJAP.42.3662
   Leveque J. L., 2005, BIOENGINEERING SKIN, P18
   Livingston J. D., 1999, ELECT PROPERTIES ENG, P39
   Lu GH, 2014, ADV MATER, V26, P2359, DOI 10.1002/adma.201305320
   Mai CK, 2013, ANGEW CHEM INT EDIT, V52, P12874, DOI 10.1002/anie.201307667
   Mao LK, 2013, ORG ELECTRON, V14, P1170, DOI 10.1016/j.orgel.2013.02.010
   Park J, 2010, MOL CRYST LIQ CRYST, V531, P14, DOI 10.1080/15421406.2010.495928
   Shea PB, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2115077
   Shi LL, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862198
   Singh B, 2006, J APPL PHYS, V100, DOI 10.1063/1.2220488
   Sirringhaus H, 1998, SCIENCE, V280, P1741, DOI 10.1126/science.280.5370.1741
   Wang CL, 2012, CHEM REV, V112, P2208, DOI 10.1021/cr100380z
   Wang CH, 2011, ADV MATER, V23, P1630, DOI 10.1002/adma.201004071
   Wen YG, 2011, CHEM REV, V111, P3358, DOI 10.1021/cr1001904
   Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727
   Yumusak C, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3278592
   Zhou B, 2011, IEEE ELECTR DEVICE L, V32, P1549, DOI 10.1109/LED.2011.2164612
NR 31
TC 5
Z9 5
U1 1
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 102
BP 58720
EP 58723
DI 10.1039/c4ra11833b
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU2PQ
UT WOS:000345460800079
DA 2018-10-20
ER

PT J
AU Volodina, KV
   Solov'eva, NL
   Vinogradov, VV
   Sobolev, VE
   Vinogradov, AV
   Vinogradov, VV
AF Volodina, K. V.
   Solov'eva, N. L.
   Vinogradov, Vasiliy V.
   Sobolev, V. E.
   Vinogradov, Alexander V.
   Vinogradov, Vladimir V.
TI A synergistic biocomposite for wound healing and decreasing scar size
   based on sol-gel alumina
SO RSC ADVANCES
LA English
DT Article
ID THERMAL-STABILITY; DELIVERY; CHLORHEXIDINE; DRESSINGS; SCAFFOLD; MATRIX
AB The synthesis of new biocomposites exhibiting a synergistic effect is a promising step in the healing of acute and chronic wounds. In the present study we have combined four materials: chlorhexidine digluconate as a antimicrobial agent, lidocaine as a painkiller, chymotrypsin as a necrolytic agent, and sol-gel processed alumina as a carrier for the sustained delivery of drugs and as an established wound healer. Composites were synthesized and characterized for surface morphology, crystalline structure and in vitro drug release. In vivo wound healing efficacy was assessed using a full thickness excision wound model in Wistar rats. The main result, was that a marked decrease in scar size was observed because of the wound healing composite, in fact the area of the scar in the test group of rats was 2.4 times smaller than that in the control group. Wound closure analysis revealed that complete epithelialization was observed after 15 +/- 1 days using the biocomposite, whereas this took 17 +/- 1 days and 19 +/- 1 days using the healing solution alone or pure alumina gel, respectively. It was concluded that the synergistic combination of healing drugs, with sol-gel alumina as dressing material, provides a highly attractive biomaterial for the treatment of surface wounds, burns and foot ulcers.
C1 [Volodina, K. V.; Vinogradov, Vasiliy V.; Sobolev, V. E.; Vinogradov, Alexander V.; Vinogradov, Vladimir V.] ITMO Univ, Lab Solut Chem Adv Mat & Technol, St Petersburg 197101, Russia.
   [Volodina, K. V.] Ivanovo State Univ Chem & Technol, Ivanovo 153000, Russia.
   [Solov'eva, N. L.] Ivanovo State Med Acad, Ivanovo 153012, Russia.
RP Vinogradov, VV (reprint author), ITMO Univ, Lab Solut Chem Adv Mat & Technol, St Petersburg 197101, Russia.
EM Vinogradoffs@mail.ru
RI Vinogradov, Vladimir/H-1166-2014; Vinogradov, Alexandr/I-8294-2017
OI Vinogradov, Vladimir/0000-0002-5081-4876
CR Agarwal A, 2012, BIOMATERIALS, V33, P6783, DOI 10.1016/j.biomaterials.2012.05.068
   Barbe C, 2004, ADV MATER, V16, P1959, DOI 10.1002/adma.200400771
   Ben-Knaz R, 2010, ADV FUNCT MATER, V20, P2324, DOI 10.1002/adfm.200902393
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x
   Garcia-Esteo F, 2005, HISTOL HISTOPATHOL, V20, P53, DOI 10.14670/HH-20.53
   Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153
   James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x
   Kerstein M. D., 1994, AM J SURG, V167, P2
   Lee YH, 2012, EXP DIABETES RES, DOI 10.1155/2012/504693
   Li HY, 2011, NAT NANOTECHNOL, V6, P645, DOI [10.1038/nnano.2011.153, 10.1038/NNANO.2011.153]
   Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.1440-1711.2004.01286.x
   Macheras P, 2006, MODELING BIOPHARMACE
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Musset JH, 1998, PHARM PRACTICE, P176
   Newton PM, 2004, INFLAMMATION, V28, P207, DOI 10.1023/B:IFLA.0000049045.41784.59
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Perumal S, 2014, EUR J PHARM SCI, V52, P26, DOI 10.1016/j.ejps.2013.10.006
   Poinern GEJ, 2010, J BIOMED NANOTECHNOL, V6, P497, DOI 10.1166/jbn.2010.1148
   Rutenberg A, 2013, CHEM COMMUN, V49, P5636, DOI 10.1039/c3cc41696h
   Vinogradov AV, 2014, PHYS CHEM CHEM PHYS, V16, P10614, DOI 10.1039/c4cp00969j
   Vinogradov VV, 2014, J MATER CHEM B, V2, P2868, DOI 10.1039/c3tb21643h
NR 23
TC 5
Z9 5
U1 3
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 105
BP 60445
EP 60450
DI 10.1039/c4ra09015b
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU5OE
UT WOS:000345655600002
DA 2018-10-20
ER

PT S
AU Wanyonyi, WC
   Onyari, JM
   Shiundu, PM
AF Wanyonyi, Wycliffe Chisutia
   Onyari, John Mmari
   Shiundu, Paul Mwanza
BE Salame, C
   Aillerie, M
   Papageorgas, P
TI Adsorption of Congo Red Dye from Aqueous Solutions Using Roots of
   Eichhornia crassipes: Kinetic and Equilibrium Studies
SO TECHNOLOGIES AND MATERIALS FOR RENEWABLE ENERGY, ENVIRONMENT AND
   SUSTAINABILITY (TMREES14 - EUMISD)
SE Energy Procedia
LA English
DT Proceedings Paper
CT International Conference on Technologies and Materials for Renewable
   Energy, Environment and Sustainability (TMREES)
CY APR 10-13, 2014
CL Beirut, LEBANON
SP Euro Mediterranean Inst Sustainable Dev
DE Adsorption; Congo red; Eichhornia crassipes; Isotherm; Kinetics
ID METHYLENE-BLUE; REMOVAL
AB Adsorption of Congo red (CR) from aqueous solution using dried roots of Eichhornia crassipes was studied. Batch experiments were carried out for sorption kinetics and isotherms. Experimental results obtained showed that adsorption process was highly dependent on contact time, adsorbent dosage, initial dye concentration and particle size. The sorption equilibrium for Congo red dye by E. crassipes (roots) was reached within 90 minutes and adsorption efficiency of up to 96% achieved. The sorption kinetics followed a pseudo-second-order kinetic model while Freundlich isotherm model was best applicable for obtaining the equilibrium parameters. These results demonstrate that roots of E. crassipes are effective, environmentally friendly and low-cost biomaterial for dye removal from aqueous dye solutions and industrial effluents. (C) 2014 Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). Selection and peer-review under responsibility of the Euro-Mediterranean Institute for Sustainable Development (EUMISD)
C1 [Wanyonyi, Wycliffe Chisutia; Onyari, John Mmari; Shiundu, Paul Mwanza] Univ Nairobi, Sch Phys Sci, Dept Chem, Nairobi, Kenya.
RP Wanyonyi, WC (reprint author), Univ Nairobi, Sch Phys Sci, Dept Chem, POB 30197-00100, Nairobi, Kenya.
EM wchisutia@yahoo.com
OI Onyari, john Mmari/0000-0002-7289-6550
CR Chanzu HA, 2012, J POLYM ENVIRON, V20, P665, DOI 10.1007/s10924-012-0479-5
   Cheung WH, 2009, BIORESOURCE TECHNOL, V100, P1143, DOI 10.1016/j.biortech.2008.07.071
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Crini G, 2008, DYES PIGMENTS, V77, P415, DOI 10.1016/j.dyepig.2007.07.001
   Dizge N, 2008, J HAZARD MATER, V150, P737, DOI 10.1016/j.jhazmat.2007.05.027
   dos Santos AB, 2007, BIORESOURCE TECHNOL, V98, P2369, DOI 10.1016/j.biortech.2006.11.013
   Freundlich H. M. F., 1907, J PHYS CHEM-US, V57, P385, DOI DOI 10.1021/JE900585T
   Gao JF, 2010, J HAZARD MATER, V174, P215, DOI 10.1016/j.jhazmat.2009.09.039
   Hameed BH, 2009, J HAZARD MATER, V162, P939, DOI 10.1016/j.jhazmat.2008.05.120
   Hu TL, 2001, BIORESOURCE TECHNOL, V77, P93, DOI 10.1016/S0960-8524(00)00124-3
   Hu ZH, 2010, J HAZARD MATER, V173, P292, DOI 10.1016/j.jhazmat.2009.08.082
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Limousin G, 2007, APPL GEOCHEM, V22, P249, DOI 10.1016/j.apgeochem.2006.09.010
   Nemchi F, 2012, ADSORPT SCI TECHNOL, V30, P81, DOI 10.1260/0263-6174.30.1.81
   Pavan FA, 2008, DYES PIGMENTS, V76, P64, DOI 10.1016/j.dyepig.2006.08.027
   Purkait MK, 2007, J HAZARD MATER, V145, P287, DOI 10.1016/j.jhazmat.2006.11.021
   Ren TZ, 2013, ADSORPT SCI TECHNOL, V31, P535, DOI 10.1260/0263-6174.31.6.535
   Sanchez N, 2012, ADSORPT SCI TECHNOL, V30, P881, DOI 10.1260/0263-6174.30.10.881
   Wanyonyi WC, 2013, B ENVIRON CONTAM TOX, V91, P362, DOI 10.1007/s00128-013-1053-0
   Wijetunga S., 2008, BIORESOURCE TECHNOL, V99, P3692
   Zhang WJ, 2011, B ENVIRON CONTAM TOX, V87, P86, DOI 10.1007/s00128-011-0304-1
NR 21
TC 30
Z9 31
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2014
VL 50
BP 862
EP 869
DI 10.1016/j.egypro.2014.06.105
PG 8
WC Energy & Fuels
SC Energy & Fuels
GA BB7FA
UT WOS:000345440100105
OA Other Gold
DA 2018-10-20
ER

PT J
AU Zein, R
   Hidayat, DA
   Elfia, M
   Nazarudin, N
   Munaf, E
AF Zein, Rahmiana
   Hidayat, Dian Arrisujaya
   Elfia, Mega
   Nazarudin, Nazris
   Munaf, Edison
TI Sugar palm Arenga pinnata Merr (Magnoliophyta) fruit shell as
   biomaterial to remove Cr(III), Cr(VI), Cd(II) and Zn(II) from aqueous
   solution
SO JOURNAL OF WATER SUPPLY RESEARCH AND TECHNOLOGY-AQUA
LA English
DT Article
DE aqueous solution; Arenga pinnata; biosorption; Fourier transform
   infrared spectroscopy; scanning electron microscope; toxic metals
ID WASTE-WATER; HEAVY-METAL; BIOSORPTION; ADSORPTION; ADSORBENT; ALGAE;
   IONS
AB The removal of toxic heavy metals Cr(III), Cr(VI), Cd(II) and Zn(II) from aqueous solution by sugar palm (Arenga pinnata) fruit shell has been examined. Adsorption factors consisted of solution of pH, mass of biosorbent as well as initial metal concentration. The Langmuir isotherm was used to study the adsorption mechanism. Moreover, characterization of sugar palm fruit shell was investigated using Fourier transform infrared spectroscopy and surface morphology was checked using scanning electron microscope. The removal percentage at maximum conditions were: 0.28, 0.52, 0.43 and 0.58 mg g(-1) for Cr(III), Cr(VI), Cd(II) and Zn(II), respectively. Desorption study was carried out by using nitric acid at a range of pH 1-4. This work shows that the performance of biosorption of metals by A. pinnata has many advantages, such as good removal and deremoval efficiencies.
C1 [Zein, Rahmiana; Hidayat, Dian Arrisujaya; Elfia, Mega; Nazarudin, Nazris; Munaf, Edison] Andalas Univ, Fac Math & Nat Sci, Dept Chem, Analyt Environm Chem Lab, Padang 25163, Indonesia.
RP Zein, R (reprint author), Andalas Univ, Fac Math & Nat Sci, Dept Chem, Analyt Environm Chem Lab, Padang 25163, Indonesia.
EM rzein@fmipa.unand.ac.id
OI Arrisujaya, Dian/0000-0002-9053-756X
FU Andalas University BOPTN research fund from the Directorate General of
   Higher Education of the Ministry of Education and Culture of the
   Republic of Indonesia
FX This research was supported by Andalas University BOPTN research fund
   academic year 2012, from the Directorate General of Higher Education of
   the Ministry of Education and Culture of the Republic of Indonesia.
CR Aguado J, 2009, J HAZARD MATER, V163, P213, DOI 10.1016/j.jhazmat.2008.06.080
   Ahmad R, 2005, WATER QUAL RES J CAN, V40, P462
   Ali I, 2010, SEP PURIF REV, V39, P95, DOI 10.1080/15422119.2010.527802
   Andrade AD, 2005, PROCESS BIOCHEM, V40, P1931, DOI 10.1016/j.procbio.2004.07.007
   Cao J, 2010, BIORESOURCE TECHNOL, V101, P2558, DOI 10.1016/j.biortech.2009.10.069
   Cordero B., 2004, ENV CHEM, V1, P180
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   Demirbas A, 2008, J HAZARD MATER, V157, P220, DOI 10.1016/j.jhazmat.2008.01.024
   ENZMINGER JD, 1987, J HAZARD MATER, V14, P83, DOI 10.1016/0304-3894(87)87007-3
   Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042
   Guo J, 2012, CURR MICROBIOL, V65, P350, DOI 10.1007/s00284-012-0164-x
   Ishak MR, 2012, J THERM ANAL CALORIM, V109, P981, DOI 10.1007/s10973-011-1785-1
   Kok K. H., 2002, PAK J BIOL SCI, V5, P474
   Munaf E, 1997, ENVIRON TECHNOL, V18, P359, DOI 10.1080/09593331808616549
   Munaf E., 1994, HAZARDOUS WASTE CONT
   Naik C., 2012, ENVIRON SCI POLLUT R, V19, P3005
   Pennesi C, 2012, J APPL PHYCOL, V24, P1495, DOI 10.1007/s10811-012-9808-2
   Pennesi C, 2012, WATER ENVIRON RES, V84, P9, DOI 10.2175/106143011X12989211841296
   Sari A, 2010, SEP SCI TECHNOL, V45, P463, DOI 10.1080/01496390903526642
   Silva AC, 2004, CHEMOSPHERE, V55, P207, DOI 10.1016/j.chemosphere.2003.10.013
   Tien CJ, 2002, PROCESS BIOCHEM, V38, P605, DOI 10.1016/S0032-9592(02)00183-8
   Volesky B, 1990, BIOSORPTION METALS
   Volesky B, 2007, WATER RES, V41, P4017, DOI 10.1016/j.watres.2007.05.062
   Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002
   Zein R., 2011, J HAZARD MATER, V181, P52
NR 25
TC 2
Z9 2
U1 2
U2 10
PU IWA PUBLISHING
PI LONDON
PA ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H0QS, ENGLAND
SN 0003-7214
EI 1365-2087
J9 J WATER SUPPLY RES T
JI J. Water Supply Res Technol.-Aqua
PY 2014
VL 63
IS 7
BP 553
EP 559
DI 10.2166/aqua.2014.120
PG 7
WC Engineering, Civil; Water Resources
SC Engineering; Water Resources
GA AT7MU
UT WOS:000345122400004
DA 2018-10-20
ER

PT J
AU Hedia, HS
   Fouda, N
AF Hedia, Hassan S.
   Fouda, Noha
TI Improved Stress Shielding of a Coated Cemented Hip Stem by Functionally
   Graded Materials
SO MATERIALS TESTING
LA English
DT Article
DE Materials testing; finite element analysis; FGM; hip replacement;
   coating; stress shielding; interface shear stress
ID FINITE-ELEMENT-ANALYSIS; FATIGUE NOTCH FACTOR; HYDROXYAPATITE COATINGS;
   SHEAR-STRENGTH; DENTAL IMPLANT; FEMUR; DESIGN; BONE; ENDOPROSTHESIS;
   OPTIMIZATION
AB Surfaces are the primary contact zones between a biomaterial and its host organism. Surface treatment or coating provides a means to fulfill demanding structural and mechanical requirements of the prostheses. As well as, a number of studies have been performed on functionally graded materials (FGM) and their suitability for use as the biomaterial of choice in various prostheses. This study investigates the effect of utilizing the two concepts of FGM and coating, in designing new hip stem material. The results of this study concluded that the optimal FGM cemented stem is consisting of titanium at the upper stem layers graded to collagen at lower stem layers. The optimal functionally graded stem coated with collagen reduced the stress shielding by 51 % compared to homogenous titanium stem coated with collagen. However, this optimal graded stem coated with hydroxyapatite showed a reduction of stress shielding by 57 % compared to homogenous titanium stem coated with hydroxyapatite.
C1 [Hedia, Hassan S.] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia.
   [Fouda, Noha] Mansoura Univ, Fac Engn, Mansoura, Egypt.
RP Hedia, HS (reprint author), King Abdulaziz Univ, Vice President Off, POB 80200, Jeddah 21589, Saudi Arabia.
EM hassanhedia87@yahoo.com
RI Fouda, Noha/Q-3612-2018
OI Fouda, Noha/0000-0002-1206-7486
FU Deanship of Scientific Research (DSR), King Abdulaziz University,
   Jeddah, Saudi Arabia [135-004-D1433]; DSR
FX This project was funded by the Deanship of Scientific Research (DSR),
   King Abdulaziz University, Jeddah, Saudi Arabia, under grant No.
   (135-004-D1433). The authors gratefully acknowledge the DSR for the
   technical and financial support.
CR Bareil R. P., 2010, MATERIALS, V3, P1863, DOI [10.3390/ma3031863, DOI 10.3390/MA3031863]
   Darimont GL, 2002, BIOMATERIALS, V23, P2569, DOI 10.1016/S0142-9612(01)00392-1
   Hedia HS, 2006, J BIOMED MATER RES B, V79B, P42, DOI 10.1002/jbm.30509
   Hedia H. S., 1996, THESIS LEEDS U LEEDS
   Hedia H. S., 2006, INT C PROD ENG DES D, P205
   Hedia HS, 1996, BIO-MED MATER ENG, V6, P199
   Hedia HS, 1996, BIO-MED MATER ENG, V6, P135
   Hedia HS, 2005, J BIOMED MATER RES B, V75B, P74, DOI 10.1002/jbm.b.30275
   Hedia HS, 2004, INT J MECH MATER DES, V1, P329, DOI DOI 10.1007/S10999-005-3307-4
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Jonkers I, 2008, J BIOMECH, V41, P3405, DOI 10.1016/j.jbiomech.2008.09.011
   KANG YK, 1993, J BIOMED ENG, V15, P497, DOI 10.1016/0141-5425(93)90065-7
   Kim YH, 2012, J ARTHROPLASTY, V27, P559, DOI 10.1016/j.arth.2011.06.020
   KUIPER JH, 1992, RECENT ADVANCES IN COMPUTER METHODS IN BIOMECHANICS & BIOMEDICAL ENGINEERING, P76
   Kuiper JH, 1997, J BIOMECH ENG-T ASME, V119, P166, DOI 10.1115/1.2796076
   Lawson MC, 2010, CLIN ORTHOP RELAT R, V468, P2081, DOI 10.1007/s11999-010-1266-z
   Lee JH, 2011, THIN SOLID FILMS, V519, P4618, DOI 10.1016/j.tsf.2011.01.004
   Narayanan R, 2007, MATER CHEM PHYS, V106, P406, DOI 10.1016/j.matchemphys.2007.06.026
   Niinomi M., 2006, ENCY BIOMATERIALS BI
   Okada M, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064103
   Ou KL, 2011, J MECH BEHAV BIOMED, V4, P618, DOI 10.1016/j.jmbbm.2011.02.001
   Race A, 2011, J ARTHROPLASTY, V26, P289, DOI 10.1016/j.arth.2010.02.004
   ROHLMANN A, 1983, J BIOMECH, V16, P727, DOI 10.1016/0021-9290(83)90082-9
   Sam Z, 2006, SURF COAT TECH, V200, P6350, DOI 10.1016/j.surfcoat.2005.11.033
   Svehla M, 2002, J ARTHROPLASTY, V17, P304, DOI 10.1054/arth.2002.30410
   Taylor ME, 1996, MED ENG PHYS, V18, P122, DOI 10.1016/1350-4533(95)00031-3
   Weinrauch PC, 2007, J ARTHROPLASTY, V22, P394, DOI 10.1016/j.arth.2006.04.010
   Xie JH, 2008, SURF COAT TECH, V202, P2960, DOI 10.1016/j.surfcoat.2007.10.040
   Yang J, 2007, J BIOMECH, V40, P2377, DOI 10.1016/j.jbiomech.2006.11.019
   Zhang S, 2007, ENG FRACT MECH, V74, P1884, DOI 10.1016/j.engfracmech.2006.04.021
NR 30
TC 1
Z9 1
U1 1
U2 7
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 0025-5300
J9 MATER TEST
JI Mater. Test.
PY 2014
VL 56
IS 11-12
BP 1021
EP 1028
DI 10.3139/120.110667
PG 8
WC Materials Science, Characterization & Testing
SC Materials Science
GA AT7QF
UT WOS:000345131900017
DA 2018-10-20
ER

PT J
AU Bahl, S
   Suwas, S
   Chatterjee, K
AF Bahl, Sumit
   Suwas, Satyam
   Chatterjee, Kaushik
TI The control of crystallographic texture in the use of magnesium as a
   resorbable biomaterial
SO RSC ADVANCES
LA English
DT Article
ID SIMULATED BODY-FLUID; AZ31 MG ALLOY; CORROSION BEHAVIOR; GRAIN-SIZE;
   TITANIUM; BIOCOMPATIBILITY; DIFFERENTIATION; IMPLANTS
AB Magnesium and its alloys are an emerging class of resorbable materials for orthopedic and cardiovascular applications. The typical strategy underlying the development of these materials involves the control of material processing routes and the addition of alloying elements. Crystallographic texture is known to control bulk mechanical as well as surface properties. However, its role in determining the properties of magnesium for implant materials has not been well studied. In this work, an extruded rod of pure magnesium was cut in multiple directions to generate samples with different textures. It was found that texture significantly affected the strength and ductility of magnesium. Corrosion rates in Hank's solution decreased with the increased presence of low energy basal planes at the surface. In vitro cell studies revealed that changes in texture did not induce cytotoxicity. Thus, the control of texture in magnesium based implants could be used to tailor the mechanical properties and the resorption rates without compromising cytocompatibility. This study elucidates the importance of texture in the use of magnesium as a resorbable biomaterial.
C1 [Bahl, Sumit; Suwas, Satyam; Chatterjee, Kaushik] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
RP Chatterjee, K (reprint author), Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
EM kchatterjee@materials.iisc.ernet.in
OI Chatterjee, Kaushik/0000-0002-7204-2926; Bahl, Sumit/0000-0002-9471-5001
FU Department of Atomic Energy-Board of Research in Nuclear Sciences
   (DAE-BRNS); Ramanujan fellowship from Department of Science and
   Technology (DST), India
FX This work was funded by the Department of Atomic Energy-Board of
   Research in Nuclear Sciences (DAE-BRNS). K. C. was financially supported
   by the Ramanujan fellowship from Department of Science and Technology
   (DST), India. Authors gratefully acknowledge Prof. Subodh Kumar and Mr
   George Raphael for assistance with the corrosion studies and Mr R.
   Deshpande for help with AAS.
CR Argade GR, 2012, CORROS SCI, V58, P145, DOI 10.1016/j.corsci.2012.01.021
   Bahl S, 2014, RSC ADV, V4, P38078, DOI 10.1039/c4ra05440g
   Bostman O, 1996, J TRAUMA, V41, P846, DOI 10.1097/00005373-199611000-00013
   Byer CM, 2010, SCRIPTA MATER, V62, P536, DOI 10.1016/j.scriptamat.2009.12.017
   Chapuis A, 2011, ACTA MATER, V59, P1986, DOI 10.1016/j.actamat.2010.11.064
   del Valle JA, 2006, ACTA MATER, V54, P4247, DOI 10.1016/j.actamat.2006.05.018
   Fu BQ, 2009, APPL SURF SCI, V255, P9348, DOI 10.1016/j.apsusc.2009.07.034
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Hoseini M, 2014, J BIOMED MATER RES A, V102, P3631, DOI 10.1002/jbm.a.35028
   Hoseini M, 2009, CORROS SCI, V51, P3064, DOI 10.1016/j.corsci.2009.08.017
   Hutchinson WB, 2010, SCRIPTA MATER, V63, P737, DOI 10.1016/j.scriptamat.2010.05.047
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kleiner S, 2004, MAT SCI ENG A-STRUCT, V379, P258, DOI 10.1016/j.msea.2004.02.020
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Li RW, 2014, J BIOMED MATER RES A, V102, P4346, DOI 10.1002/jbm.a.35111
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Manivasagam G, 2014, MATER SCI TECH-LOND, V30, P515, DOI 10.1179/1743284713Y.0000000500
   O'Brien B, 2009, ACTA BIOMATER, V5, P945, DOI 10.1016/j.actbio.2008.11.012
   Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027
   Song GL, 2010, ELECTROCHEM COMMUN, V12, P1009, DOI 10.1016/j.elecom.2010.05.011
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Xin RL, 2011, MATER DESIGN, V32, P4548, DOI 10.1016/j.matdes.2011.04.031
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Zhang EL, 2008, MAT SCI ENG A-STRUCT, V497, P111, DOI 10.1016/j.msea.2008.06.019
   Zhao LC, 2010, CORROS SCI, V52, P2228, DOI 10.1016/j.corsci.2010.03.008
NR 29
TC 3
Z9 3
U1 1
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 99
BP 55677
EP 55684
DI 10.1039/c4ra08484e
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA AT5QT
UT WOS:000344997800001
DA 2018-10-20
ER

PT J
AU Robles, L
   Storrs, R
   Lamb, M
   Alexander, M
   Lakey, JRT
AF Robles, Lourdes
   Storrs, Rick
   Lamb, Morgan
   Alexander, Michael
   Lakey, Jonathan R. T.
TI Current Status of Islet Encapsulation
SO CELL TRANSPLANTATION
LA English
DT Review
DE Cell encapsulation; Islets; Stem cells; Xenotransplantation; Cell
   engineering
ID EMBRYONIC STEM-CELLS; MICROENCAPSULATED PORCINE ISLETS; BIOARTIFICIAL
   ENDOCRINE PANCREAS; BIOHYBRID ARTIFICIAL PANCREAS; IMMUNOCOMPETENT
   DIABETIC MICE; PROLONGS XENOGRAFT SURVIVAL; INSULIN-PRODUCING CELLS;
   ALGINATE-PLL CAPSULES; LONG-TERM FUNCTION; IN-VIVO FUNCTION
AB Cell encapsulation is a method of encasing cells in a semipermeable matrix that provides a permeable gradient for the passage of oxygen and nutrients, but effectively blocks immune-regulating cells from reaching the graft, preventing rejection. This concept has been described as early as the 1930s, but it has exhibited substantial achievements over the last decade. Several advances in encapsulation engineering, chemical purification, applications, and cell viability promise to make this a revolutionary technology. Several obstacles still need to be overcome before this process becomes a reality, including developing a reliable source of islets or insulin-producing cells, determining the ideal biomaterial to promote graft function, reducing the host response to the encapsulation device, and ultimately a streamlined, scaled-up process for industry to be able to efficiently and safely produce encapsulated cells for clinical use. This article provides a comprehensive review of cell encapsulation of islets for the treatment of type 1 diabetes, including a historical perspective, current research findings, and future studies.
C1 [Robles, Lourdes; Lamb, Morgan; Alexander, Michael; Lakey, Jonathan R. T.] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA.
   [Storrs, Rick] Islet Sheet Med, San Francisco, CA USA.
   [Lakey, Jonathan R. T.] Univ Calif Irvine, Irvine, CA USA.
RP Lakey, JRT (reprint author), Univ Calif Irvine, 333 City Blvd West,Suite 700, Orange, CA 92868 USA.
EM jlakey@uci.edu
CR Abbah SA, 2008, J MATER SCI-MATER M, V19, P2113, DOI 10.1007/s10856-006-0013-1
   Addae C, 2012, DIFFERENTIATION, V83, P233, DOI 10.1016/j.diff.2012.03.001
   Alejandro R, 2008, TRANSPLANTATION, V86, P1783, DOI 10.1097/TP.0b013e3181913f6a
   Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107
   ALTMAN JJ, 1984, T AM SOC ART INT ORG, V30, P382
   Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063
   Baruch L, 2009, BIOMED MICRODEVICES, V11, P1103, DOI 10.1007/s10544-009-9327-3
   Basta G, 2011, DIABETES CARE, V34, P2406, DOI 10.2337/dc11-0731
   Berman DM, 2009, AM J TRANSPLANT, V9, P91, DOI 10.1111/j.1600-6143.2008.02489.x
   Bisceglie V., 1993, Z KREBSFORSCHUNG, V40, P122
   Black SP, 2006, BIOCHEM BIOPH RES CO, V340, P236, DOI 10.1016/j.bbrc.2005.11.180
   Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100
   Brendel M. D., 2001, INT ISLET TRANSPLANT, V9, P1
   Bromberg JS, 2007, AM J TRANSPLANT, V7, P2217, DOI 10.1111/j.1600-6143.2007.01957.x
   Bunger CM, 2005, BIOMATERIALS, V26, P2353, DOI 10.1016/j.biomaterials.2004.07.017
   Calafiore R, 2006, DIABETES CARE, V29, P137, DOI 10.2337/diacare.29.01.06.dc05-1270
   Calafiore R, 2004, BIOTECHNOL APPL BIOC, V39, P159, DOI 10.1042/BA20030151
   Centers for Disease Control and Prevention, 2012, DIAB PUBL HLTH RES
   Check E, 2002, NATURE, V419, P5, DOI 10.1038/419005b
   Chhabra P, 2011, J TRANSPLANT, DOI 10.1155/2011/637692
   CLAYTON HA, 1992, TRANSPLANTATION, V54, P558
   COLE DR, 1992, DIABETOLOGIA, V35, P231, DOI 10.1007/BF00400922
   Cornolti R, 2009, CELL TRANSPLANT, V18, P195, DOI 10.3727/096368909788341252
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   De Vos P, 1999, DIABETES, V48, P1381, DOI 10.2337/diabetes.48.7.1381
   de Vos P, 2002, J BIOMED MATER RES, V62, P430, DOI 10.1002/jbm.10345
   de Vos P, 2002, DIABETOLOGIA, V45, P159, DOI 10.1007/s00125-001-0729-x
   DeVos P, 1997, DIABETOLOGIA, V40, P262
   Diabetes UK, 2012, STAT NAT 2012, P1
   Souza Yngrid Ellyn Dias Maciel de, 2011, Arq. Gastroenterol., V48, P146, DOI 10.1590/S0004-28032011000200011
   Dickson BC, 2003, TRANSPLANTATION, V75, P599, DOI 10.1097/01.TP.0000048226.28357.0D
   DIONNE KE, 1993, DIABETES, V42, P12, DOI 10.2337/diabetes.42.1.12
   Dong HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050265
   Dufrane D, 2006, BIOMATERIALS, V27, P3201, DOI 10.1016/j.biomaterials.2006.01.028
   Dufrane D, 2006, TRANSPLANTATION, V81, P1345, DOI 10.1097/01.tp.0000208610.75997.20
   Dufrane D, 2010, TRANSPLANTATION, V90, P1054, DOI 10.1097/TP.0b013e3181f6e267
   Duvivier-Kali VF, 2004, AM J TRANSPLANT, V4, P1991, DOI 10.1111/j.1600-6143.2004.00628.x
   Elliott R. B., 2011, INT PANCR ISL TRANSP
   Elliott R. B., 2010, 70 SCI SESS AM DIAB
   Elliott RB, 2005, TRANSPL P, V37, P3505, DOI 10.1016/j.transproceed.2005.09.038
   Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x
   FAN MY, 1990, DIABETES, V39, P519, DOI 10.2337/diabetes.39.4.519
   Figliuzzi M, 2005, BIOMATERIALS, V26, P5640, DOI 10.1016/j.biomaterials.2005.02.019
   Foster JL, 2007, TRANSPLANTATION, V83, P1440, DOI 10.1097/01.tp.0000264555.46417.7d
   FRITSCHY WM, 1991, DIABETOLOGIA, V34, P542, DOI 10.1007/BF00400270
   Gao Q, 2010, AM J TRANSPLANT, V10, P1588, DOI 10.1111/j.1600-6143.2010.03151.x
   Garkavenko O, 2004, J CLIN MICROBIOL, V42, P5353, DOI 10.1128/JCM.42.11.5353-5356.2004
   GATES RJ, 1977, LANCET, V2, P1257
   Gotfredsen C F, 1990, Diabetes Res, V15, P157
   Grose S, 2007, NAT MED, V13, P390, DOI 10.1038/nm0407-390b
   Hering B., 1999, GRAFT, V2, P12
   Hirotani S, 1999, CELL TRANSPLANT, V8, P399, DOI 10.1177/096368979900800409
   IWATA H, 1994, J BIOMED MATER RES, V28, P1003, DOI 10.1002/jbm.820280905
   IWATA H, 1994, J BIOMED MATER RES, V28, P1201, DOI 10.1002/jbm.820281010
   JAIN K, 1995, TRANSPLANTATION, V59, P319, DOI 10.1097/00007890-199502150-00002
   Kadam Sachin, 2010, Rev Diabet Stud, V7, P168, DOI 10.1900/RDS.2010.7.168
   Kerby A, 2013, CYTOTHERAPY, V15, P192, DOI 10.1016/j.jcyt.2012.10.018
   Khanna O, 2010, J BIOMED MATER RES A, V95A, P632, DOI 10.1002/jbm.a.32883
   Kin T, 2002, PANCREAS, V25, P94, DOI 10.1097/01.MPA.0000015216.27722.72
   King Aileen, 2003, Diabetes Technol Ther, V5, P653, DOI 10.1089/152091503322250677
   Knippenberg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036857
   Kobayashi T, 2003, TRANSPLANTATION, V75, P619, DOI 10.1097/01.TP.0000053749.36365.7E
   Kobayashi T, 2006, CELL TRANSPLANT, V15, P359, DOI 10.3727/000000006783981954
   Korbutt GS, 2004, DIABETOLOGIA, V47, P1810, DOI 10.1007/s00125-004-1531-3
   Krishnamurthy N. V., 2011, Critical Reviews in Biomedical Engineering, V39, P473, DOI 10.1615/CritRevBiomedEng.v39.i6.10
   Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393
   Kuhtreiber W M, 1993, ASAIO J, V39, pM247
   Kumagai-Braesch M, 2013, CELL TRANSPLANT, V22, P1137, DOI 10.3727/096368912X657486
   LACY PE, 1991, SCIENCE, V254, P1782, DOI 10.1126/science.1763328
   Langlois G, 2009, ACTA BIOMATER, V5, P3433, DOI 10.1016/j.actbio.2009.05.029
   Lanza RP, 1999, TRANSPLANTATION, V67, P1105, DOI 10.1097/00007890-199904270-00004
   LANZA RP, 1991, P NATL ACAD SCI USA, V88, P11100, DOI 10.1073/pnas.88.24.11100
   LANZA RP, 1993, TRANSPLANTATION, V56, P1067, DOI 10.1097/00007890-199311000-00003
   LANZA RP, 1992, ENDOCRINOLOGY, V131, P637, DOI 10.1210/en.131.2.637
   Lee DY, 2007, BIOMATERIALS, V28, P1957, DOI 10.1016/j.biomaterials.2006.12.015
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee SH, 2009, TRANSPLANTATION, V87, P983, DOI 10.1097/TP.0b013e31819c86ea
   Lembert N, 2005, CELL TRANSPLANT, V14, P97, DOI 10.3727/000000005783983232
   Leung A, 2008, J MICROENCAPSUL, V25, P387, DOI 10.1080/02652040802008857
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Ludwig B, 2010, P NATL ACAD SCI USA, V107, P12623, DOI 10.1073/pnas.1005098107
   LUM ZP, 1991, DIABETES, V40, P1511, DOI 10.2337/diabetes.40.11.1511
   Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866
   MAKI T, 1991, TRANSPLANTATION, V51, P43, DOI 10.1097/00007890-199101000-00006
   Maki T, 1996, DIABETES, V45, P342, DOI 10.2337/diabetes.45.3.342
   Matveyenko AV, 2010, AM J PHYSIOL-ENDOC M, V299, pE713, DOI 10.1152/ajpendo.00279.2010
   MAZAHERI R, 1991, TRANSPLANTATION, V51, P750, DOI 10.1097/00007890-199104000-00002
   MONACO AP, 1991, ANN SURG, V214, P339, DOI 10.1097/00000658-199109000-00016
   Moya ML, 2010, J SURG RES, V160, P208, DOI 10.1016/j.jss.2009.06.003
   Muthyala S, 2011, ACTA BIOMATER, V7, P2153, DOI 10.1016/j.actbio.2011.01.036
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   O'Sullivan ES, 2010, DIABETOLOGIA, V53, P937, DOI 10.1007/s00125-009-1653-8
   Ohyama T, 1998, TRANSPLANT P, V30, P3433, DOI 10.1016/S0041-1345(98)01091-4
   Omer A, 2005, TRANSPLANTATION, V79, P52, DOI 10.1097/01.TP.0000149340.37865.46
   Omer A, 2003, DIABETES, V52, P69, DOI 10.2337/diabetes.52.1.69
   Orive G, 2002, TRENDS BIOTECHNOL, V20, P382, DOI 10.1016/S0167-7799(02)02037-1
   OSHEA GM, 1986, DIABETES, V35, P943, DOI 10.2337/diabetes.35.8.943
   OSHEA GM, 1984, BIOCHIM BIOPHYS ACTA, V804, P133, DOI 10.1016/0167-4889(84)90107-1
   Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236
   Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282
   Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   PETRUZZO P, 1991, TRANSPLANT INT, V4, P200, DOI 10.1007/BF00649103
   Prevost P, 1997, ANN NY ACAD SCI, V831, P344
   Prochorov AV, 2008, ADV MED SCI-POLAND, V53, P240, DOI 10.2478/v10039-008-0045-5
   Qi M, 2008, ARTIF CELL BLOOD SUB, V36, P403, DOI 10.1080/10731190802369755
   Qi Z, 2010, BIOMATERIALS, V31, P4026, DOI 10.1016/j.biomaterials.2010.01.088
   Ricci M, 2005, J CONTROL RELEASE, V107, P395, DOI 10.1016/j.jconrel.2005.06.023
   Safley Susan A, 2008, J Diabetes Sci Technol, V2, P760
   SCHARP DW, 1994, DIABETES, V43, P1167, DOI 10.2337/diabetes.43.9.1167
   Schneider S, 2005, DIABETES, V54, P687, DOI 10.2337/diabetes.54.3.687
   Schneider S, 2003, ARTIF ORGANS, V27, P1053, DOI 10.1046/j.1525-1594.2003.07159.x
   Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004
   Scobie L, 2009, CURR OPIN ORGAN TRAN, V14, P175, DOI 10.1097/MOT.0b013e328327984d
   Shapiro AMJ, 2003, IMMUNOL REV, V196, P219, DOI 10.1046/j.1600-065X.2003.00085.x
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   SIEBERS U, 1993, INT J ARTIF ORGANS, V16, P96
   Sigrist S, 2003, J VASC RES, V40, P359, DOI 10.1159/000072700
   SOONSHIONG P, 1992, TRANSPLANTATION, V54, P769, DOI 10.1097/00007890-199211000-00001
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   Sorenby AK, 2006, TRANSPLANTATION, V82, P393, DOI 10.1097/01.tp.0000228912.62374.44
   Storrs R, 2001, ANN NY ACAD SCI, V944, P252
   Street C. N., 2003, CAN J DIABETES, V27, P262
   Su J, 2010, BIOMATERIALS, V31, P308, DOI 10.1016/j.biomaterials.2009.09.045
   Sun A M, 1992, ASAIO J, V38, P125, DOI 10.1097/00002480-199204000-00012
   Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929
   Suzuki K, 1998, TRANSPLANTATION, V66, P21, DOI 10.1097/00007890-199807150-00004
   Sweet IR, 2008, J CELL MOL MED, V12, P2644, DOI 10.1111/j.1582-4934.2008.00322.x
   Tarantal AF, 2009, TRANSPLANTATION, V88, P38, DOI 10.1097/TP.0b013e3181a9ee6c
   Tatarkiewicz K, 1997, Ann Transplant, V2, P20
   Tatarkiewicz K, 2001, DIABETOLOGIA, V44, P646, DOI 10.1007/s001250051672
   Thanos CG, 2009, EXPERT OPIN BIOL TH, V9, P29, DOI 10.1517/14712590802630666 
   Trivedi N, 2001, TRANSPLANTATION, V71, P203, DOI 10.1097/00007890-200101270-00006
   Tuch BE, 2009, DIABETES CARE, V32, P1887, DOI 10.2337/dc09-0744
   Tze WJ, 1998, TRANSPLANT P, V30, P477, DOI 10.1016/S0041-1345(97)01363-8
   U.S. Department of Health and Human Services, 2012, ORG DON
   Vaithilingam V, 2010, AM J TRANSPLANT, V10, P1961, DOI 10.1111/j.1600-6143.2010.03209.x
   Vaithilingam Vijayaganapathy, 2011, Rev Diabet Stud, V8, P51, DOI 10.1900/RDS.2011.8.51
   Valdes-Gonzalez R, 2010, CLIN EXP IMMUNOL, V162, P537, DOI 10.1111/j.1365-2249.2010.04273.x
   Valdes-Gonzalez RA, 2005, EUR J ENDOCRINOL, V153, P419, DOI 10.1530/eje.1.01982
   Wang T, 2008, TRANSPLANTATION, V85, P331, DOI 10.1097/TP.0b013e3181629c25
   Wang WJ, 2002, TRANSPLANTATION, V73, P122, DOI 10.1097/00007890-200201150-00023
   WU ZG, 1988, INT J PANCREATOL, V3, P91
   Xin ZL, 2005, WORLD J GASTROENTERO, V11, P5714, DOI 10.3748/wjg.v11.i36.5714
   Yang H, 1997, TRANSPLANTATION, V64, P28, DOI 10.1097/00007890-199707150-00006
   Zhi ZI, 2012, DIABETOLOGIA, V55, P1081, DOI 10.1007/s00125-011-2431-y
   Zhou D, 1998, AM J PHYSIOL-CELL PH, V274, pC1356, DOI 10.1152/ajpcell.1998.274.5.C1356
   Zhou MH, 1998, CHINESE MED J-PEKING, V111, P394
   Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1
NR 150
TC 6
Z9 6
U1 1
U2 26
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2014
VL 23
IS 11
BP 1321
EP 1348
DI 10.3727/096368913X670949
PG 28
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA AT3IC
UT WOS:000344827900001
PM 23880554
OA Bronze
DA 2018-10-20
ER

PT J
AU Jones, CH
   Hakansson, AP
   Pfeifer, BA
AF Jones, Charles H.
   Hakansson, Anders P.
   Pfeifer, Blaine A.
TI Biomaterials at the interface of nano- and micro-scale vector-cellular
   interactions in genetic vaccine design
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID ATTENUATED SALMONELLA-TYPHIMURIUM; MINICIRCLE DNA VECTORS; TARGETING
   ENZYME/PRODRUG THERAPY; INTERFERON-REGULATORY FACTORS; ADAPTIVE
   IMMUNE-RESPONSES; EXPRESSION IN-VIVO; MAMMALIAN-CELLS; TRANSGENE
   EXPRESSION; ESCHERICHIA-COLI; PLASMID DNA
AB The development of safe and effective vaccines for the prevention of elusive infectious diseases remains a public health priority. Immunization, characterized by adaptive immune responses to specific antigens, can be raised by an array of delivery vectors. However, current commercial vaccination strategies are predicated on the retooling of archaic technology. This review will discuss current and emerging strategies designed to elicit immune responses in the context of genetic vaccination. Selected strategies at the biomaterial-biological interface will be emphasized to illustrate the potential of coupling both fields towards a common goal.
C1 [Jones, Charles H.; Pfeifer, Blaine A.] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
   [Hakansson, Anders P.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.
   [Hakansson, Anders P.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA.
RP Pfeifer, BA (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
EM blainepf@buffalo.edu
RI Hakansson, Anders/H-8190-2014
OI Hakansson, Anders/0000-0002-2834-6009
FU NIH [AI088485, DC013554]; SUNY-Buffalo Schomburg fellowship
FX The authors recognize support from NIH awards AI088485 (BAP) and
   DC013554 (APH) and a SUNY-Buffalo Schomburg fellowship (CHJ).
CR Abdul-Wahid A, 2007, VACCINE, V25, P8372, DOI 10.1016/j.vaccine.2007.10.012
   Akin D, 2007, NAT NANOTECHNOL, V2, P441, DOI 10.1038/nnano.2007.149
   Al-Mariri A, 2002, INFECT IMMUN, V70, P1915, DOI 10.1128/IAI.70.4.1915-1923.2002
   Alam S, 2010, EXPERT REV VACCINES, V9, P731, DOI [10.1586/erv.10.64, 10.1586/ERV.10.64]
   Anderson ED, 1996, MOL MAR BIOL BIOTECH, V5, P105
   Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089
   Baban Chwanrow K, 2010, Bioeng Bugs, V1, P385, DOI 10.4161/bbug.1.6.13146
   Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005
   Barouch DH, 2004, IMMUNOL REV, V202, P266, DOI 10.1111/j.0105-2896.2004.00200.x
   Bartolome A, 2010, VET MICROBIOL, V141, P81, DOI 10.1016/j.vetmic.2009.08.006
   Bergman PJ, 2003, CLIN CANCER RES, V9, P1284
   Blume S, 2000, SCIENCE, V288, P1593, DOI 10.1126/science.288.5471.1593
   Boyle JS, 1998, NATURE, V392, P408
   Bramson JL, 2003, VACCINE, V21, P1363, DOI 10.1016/S0264-410X(02)00694-1
   BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836
   Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027
   Castagliuolo I, 2005, GENE THER, V12, P1070, DOI 10.1038/sj.gt.3302493
   Castaldello A, 2010, J CELL PHYSIOL, V224, P702, DOI 10.1002/jcp.22169
   Chams V, 1999, FEBS LETT, V448, P28, DOI 10.1016/S0014-5793(99)00333-6
   Chart H, 2000, J APPL MICROBIOL, V89, P1048, DOI 10.1046/j.1365-2672.2000.01211.x
   Chatel JM, 2008, GENE THER, V15, P1184, DOI 10.1038/gt.2008.59
   Chatellard P, 2007, BIOTECHNOL BIOENG, V96, P106, DOI 10.1002/bit.21172
   Chen CK, 2013, BIOMATERIALS, V34, P9688, DOI 10.1016/j.biomaterials.2013.08.063
   Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126
   Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0
   Cheng CC, 2014, MOL MED REP, V9, P2239, DOI 10.3892/mmr.2014.2065
   Cho HJ, 2011, BIOMATERIALS, V32, P4621, DOI 10.1016/j.biomaterials.2011.03.004
   Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]
   Coban C, 2005, J LEUKOCYTE BIOL, V78, P647, DOI 10.1189/jlb.1104627
   COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698
   Corr M, 1997, J IMMUNOL, V159, P4999
   Courvalin P, 1995, CR ACAD SCI III-VIE, V318, P1207
   Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   De Geest BG, 2012, ACS NANO, V6, P2136, DOI 10.1021/nn205099c
   Delogu G, 2000, INFECT IMMUN, V68, P3097, DOI 10.1128/IAI.68.6.3097-3102.2000
   Dietrich G, 1998, NAT BIOTECHNOL, V16, P181, DOI 10.1038/nbt0298-181
   Ehreth J, 2003, VACCINE, V21, P596, DOI 10.1016/S0264-410X(02)00623-0
   El-Sayed A, 2013, MOL THER, V21, P1118, DOI 10.1038/mt.2013.54
   Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139
   Estcourt MJ, 2002, INT IMMUNOL, V14, P31, DOI 10.1093/intimm/14.1.31
   Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774
   Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334
   Ferreira SA, 2013, NANOMED-NANOTECHNOL, V9, P159, DOI 10.1016/j.nano.2012.06.001
   Flingai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00354
   Flo J, 2000, IMMUNOLOGY, V100, P259, DOI 10.1046/j.1365-2567.2000.00041.x
   GARMORY HS, 2003, GENET VACCINES THER, V1, P2, DOI DOI 10.1186/1479-0556-1-2
   Geissler M, 1997, J IMMUNOL, V158, P1231
   Gorringe Andrew R, 2012, Hum Vaccin Immunother, V8, P174, DOI 10.4161/hv.18500
   Grillot-Courvalin C, 2002, CELL MICROBIOL, V4, P177, DOI 10.1046/j.1462-5822.2002.00184.x
   Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862
   Grodeland G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080008
   Gujrati V, 2014, ACS NANO, V8, P1525, DOI 10.1021/nn405724x
   Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927
   Gurunathan S, 1998, J IMMUNOL, V161, P4563
   Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006
   Hamaji Y, 2007, BIOSCI BIOTECH BIOCH, V71, P874, DOI 10.1271/bbb.60502
   Hidaka A, 2007, BIOSCI BIOTECH BIOCH, V71, P2921, DOI 10.1271/bbb.70284
   Higgins DE, 1999, MOL MICROBIOL, V31, P1631, DOI 10.1046/j.1365-2958.1999.01272.x
   Hinton HJ, 2008, CURR TOP MICROBIOL, V319, P1
   Hoare M, 2005, BIOTECHNOL PROGR, V21, P1577, DOI 10.1021/bp050190n
   Holmstrom F, 2013, J IMMUNOL, V190, P1113, DOI 10.4049/jimmunol.1201497
   Huang LF, 2013, NAT BIOTECHNOL, V31, P350, DOI 10.1038/nbt.2537
   HUANG MTF, 1990, NUCLEIC ACIDS RES, V18, P937, DOI 10.1093/nar/18.4.937
   Huckriede A, 2003, METHOD ENZYMOL, V373, P74
   Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Jones CH, 2014, P NATL ACAD SCI USA, V111, P12360, DOI 10.1073/pnas.1411355111
   Jones CH, 2013, MOL PHARMACEUT, V10, P4301, DOI 10.1021/mp4003927
   Jones CH, 2013, MOL PHARMACEUT, V10, P4082, DOI 10.1021/mp400467x
   Jones CH, 2013, MOL PHARMACEUT, V10, P1138, DOI 10.1021/mp300666s
   Jones KS, 2008, BIOTECHNOL PROGR, V24, P807, DOI [10.1002/btpr.10, 10.1021/bp.10]
   Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708
   Keswani RK, 2013, MOL PHARMACEUT, V10, P1725, DOI 10.1021/mp300561y
   KETLEY JM, 1993, FEMS MICROBIOL LETT, V111, P15
   Kim JJ, 1997, NAT BIOTECHNOL, V15, P641
   Kim SJ, 2003, VIROLOGY, V314, P84, DOI 10.1016/S0042-6822(03)00417-3
   Ko HJ, 2005, INFECT IMMUN, V73, P5666, DOI 10.1128/IAI.73.9.5666-5674.2005
   Kojima Y, 2002, VACCINE, V20, P2857, DOI 10.1016/S0264-410X(02)00238-4
   Kong W, 2012, P NATL ACAD SCI USA, V109, P19414, DOI 10.1073/pnas.1217554109
   Kumar P, 2011, CURR GENE THER, V11, P144, DOI 10.2174/156652311794940782
   Kumar P, 2013, CURR OPIN IMMUNOL, V25, P373, DOI 10.1016/j.coi.2013.03.011
   Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112
   Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432
   Laner A, 2005, GENE THER, V12, P1559, DOI 10.1038/sj.gt.3302576
   LANIER LL, 1995, J IMMUNOL, V154, P97
   Lee ES, 2008, ANGEW CHEM INT EDIT, V47, P2418, DOI 10.1002/anie.200704121
   Leifert JA, 2004, IMMUNOL REV, V199, P40, DOI 10.1111/j.0105-2896.2004.0135.x
   Li HS, 2007, CHINESE MED J-PEKING, V120, P496
   Li WJ, 2008, VACCINE, V26, P3282, DOI 10.1016/j.vaccine.2008.03.081
   Li ZM, 1999, INFECT IMMUN, V67, P4780
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998
   Liu TY, 2013, BIOMACROMOLECULES, V14, P2798, DOI 10.1021/bm400626w
   Loukinov D, 2006, J CELL BIOCHEM, V98, P1037, DOI 10.1002/jcb.20953
   Lu JM, 2013, MOL THER, V21, P954, DOI 10.1038/mt.2013.33
   Lu JM, 2012, MOL THER, V20, P2111, DOI 10.1038/mt.2012.65
   Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016
   Luke JM, 2011, GENE THER, V18, P334, DOI 10.1038/gt.2010.149
   Luke J, 2009, VACCINE, V27, P6454, DOI 10.1016/j.vaccine.2009.06.017
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   MacGregor RR, 2000, J INFECT DIS, V181, P406, DOI 10.1086/315199
   Maniar LEG, 2013, MOL THER, V21, P131, DOI 10.1038/mt.2012.244
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Maue AC, 2004, VACCINE, V23, P769, DOI 10.1016/j.vaccine.2004.07.019
   Mendoza RB, 1997, J IMMUNOL, V159, P5777
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Mora-Solano C, 2014, J MATER CHEM B, V2, P2409, DOI 10.1039/c3tb21549k
   Moser C, 2013, EXPERT REV VACCINES, V12, P779, DOI 10.1586/14760584.2013.811195
   Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091
   Mulligan MJ, 2006, AIDS RES HUM RETROV, V22, P678, DOI 10.1089/aid.2006.22.678
   Murugaiah C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081817
   Muthumani K, 2002, VACCINE, V20, P1999, DOI 10.1016/S0264-410X(02)00086-5
   Narayanan K, 2013, ANAL BIOCHEM, V439, P142, DOI 10.1016/j.ab.2013.04.010
   Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478
   Ning JF, 2009, VACCINE, V27, P1127, DOI 10.1016/j.vaccine.2008.11.075
   Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7
   Nobiron I, 2000, VET MICROBIOL, V76, P129, DOI 10.1016/S0378-1135(00)00238-8
   O'Hagan D, 2001, J VIROL, V75, P9037, DOI 10.1128/JVI.75.19.9037-9043.2001
   O'Hagan DT, 2012, VACCINE, V30, P4341, DOI 10.1016/j.vaccine.2011.09.061
   Osborn MJ, 2011, MOL THER, V19, P450, DOI 10.1038/mt.2010.249
   Palffy R, 2011, EXP BIOL MED, V236, P177, DOI 10.1258/ebm.2010.010277
   Parsa S, 2008, J BIOTECHNOL, V137, P59, DOI 10.1016/j.jbiotec.2008.07.1815
   Pasetti MF, 2003, J VIROL, V77, P5209, DOI 10.1128/JVI.77.9.5209-5217.2003
   Puffer EB, 2007, ACS CHEM BIOL, V2, P252, DOI 10.1021/cb600489g
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611
   Qin LH, 1997, HUM GENE THER, V8, P2019, DOI 10.1089/hum.1997.8.17-2019
   Qiu L, 2013, J VIROL METHODS, V188, P108, DOI 10.1016/j.jviromet.2012.12.007
   Radford KJ, 2002, GENE THER, V9, P1455, DOI 10.1038/sj.gt.3301812
   Ramanathan MP, 2009, VACCINE, V27, P4370, DOI 10.1016/j.vaccine.2009.01.137
   Ramsey JD, 2010, J CONTROL RELEASE, V144, P39, DOI 10.1016/j.jconrel.2010.01.031
   Ratto-Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045840
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Rivas-Aravena A, 2013, BIOL RES, V46, P407, DOI 10.4067/S0716-97602013000400012
   Robert-Guroff M, 2007, CURR OPIN BIOTECH, V18, P546, DOI 10.1016/j.copbio.2007.10.010
   Rosenthal JA, 2013, CURR OPIN BIOTECHN C, V28, P51
   Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]
   Sadler K, 2002, J PEPT RES, V60, P150, DOI 10.1034/j.1399-3011.2002.21009.x
   Sasaki S, 2002, J VIROL, V76, P6652, DOI 10.1128/JVI.76.13.6652-6659.2002
   Sasaki T, 2006, CANCER SCI, V97, P649, DOI 10.1111/j.1349-7006.2006.00221.x
   SCHAFFNER W, 1980, P NATL ACAD SCI-BIOL, V77, P2163, DOI 10.1073/pnas.77.4.2163
   Schmidt C, 2013, NAT BIOTECHNOL, V31, P957, DOI 10.1038/nbt.2733
   Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402
   Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443
   Shata MT, 2000, MOL MED TODAY, V6, P66, DOI 10.1016/S1357-4310(99)01633-0
   Shedlock DJ, 2014, VACCINES, V2, P196, DOI 10.3390/vaccines2020196
   Shen H, 2004, MICROBIOL IMMUNOL, V48, P329, DOI 10.1111/j.1348-0421.2004.tb03514.x
   Singarapu K, 2013, J BIOMED MATER RES A, V101, P1857, DOI 10.1002/jbm.a.34483
   SIZEMORE DR, 1995, SCIENCE, V270, P299, DOI 10.1126/science.270.5234.299
   Song MY, 2011, J IMMUNOTHER, V34, P297, DOI 10.1097/CJI.0b013e318210ed0e
   Song RJ, 2007, MOL THER, V15, P1007, DOI 10.1038/mt.sj.6300129
   Spies B, 2003, J IMMUNOL, V171, P5908, DOI 10.4049/jimmunol.171.11.5908
   Stritzker J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-94
   Su Yan, 2013, Sheng Wu Gong Cheng Xue Bao, V29, P458
   Takeshita F, 2006, J VIROL, V80, P6218, DOI 10.1128/JVI.00121-06
   Tobias J, 2008, VACCINE, V26, P743, DOI 10.1016/j.vaccine.2007.12.009
   Tsuji T, 1997, EUR J IMMUNOL, V27, P782, DOI 10.1002/eji.1830270329
   Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261
   Ulmer JB, 2006, TRENDS MOL MED, V12, P216, DOI 10.1016/j.molmed.2006.03.007
   Unal CM, 2011, SEMIN IMMUNOPATHOL, V33, P395, DOI 10.1007/s00281-010-0231-y
   van Pijkeren JP, 2010, HUM GENE THER, V21, P405, DOI 10.1089/hum.2009.022
   Vecino WH, 2002, IMMUNOL LETT, V82, P197, DOI 10.1016/S0165-2478(02)00043-3
   Vyas SP, 2010, METHODS MOL BIOL, V605, P177, DOI 10.1007/978-1-60327-360-2_12
   Wan C, 2010, VET IMMUNOL IMMUNOP, V137, P47, DOI 10.1016/j.vetimm.2010.04.008
   Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476
   Wang Y, 2012, NAT STRUCT MOL BIOL, V19, P1044, DOI 10.1038/nsmb.2377
   Williams JA, 2009, BIOTECHNOL ADV, V27, P353, DOI 10.1016/j.biotechadv.2009.02.003
   Williman J, 2008, VACCINE, V26, P5153, DOI 10.1016/j.vaccine.2008.03.084
   Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009
   WU TC, 1995, P NATL ACAD SCI USA, V92, P11671, DOI 10.1073/pnas.92.25.11671
   Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt.1211
   Xu FF, 2003, VACCINE, V21, P644, DOI 10.1016/S0264-410X(02)00573-X
   Xu HQ, 2010, J GENE MED, V12, P97, DOI 10.1002/jgm.1412
   Xu L, 2002, HUM GENE THER, V13, P469, DOI 10.1089/10430340252792594
   Yang SC, 2008, BIOCONJUGATE CHEM, V19, P1164, DOI 10.1021/bc700442g
   Yao WJ, 2013, MOL PHARMACEUT, V10, P2904, DOI 10.1021/mp4000053
   Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499
NR 182
TC 5
Z9 5
U1 0
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 46
BP 8053
EP 8068
DI 10.1039/c4tb01058b
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA AT5NQ
UT WOS:000344990000003
PM 29887986
DA 2018-10-20
ER

PT J
AU Sayin, E
   Baran, ET
   Hasirci, V
AF Sayin, Esen
   Baran, Erkan Turker
   Hasirci, Vasif
TI Protein-based materials in load-bearing tissue-engineering applications
SO REGENERATIVE MEDICINE
LA English
DT Review
DE biomaterial; load bearing; protein; regeneration; scaffold; tissue
   engineering
ID SILK FIBROIN SCAFFOLDS; MECHANICAL-PROPERTIES; COLLAGEN SCAFFOLDS;
   STEM-CELLS; BIOMEDICAL APPLICATIONS; REGENERATIVE MEDICINE; FREEFORM
   FABRICATION; COMPOSITE SCAFFOLDS; CHONDROITIN SULFATE;
   ARTICULAR-CARTILAGE
AB Proteins such as collagen and elastin are robust molecules that constitute nanocomponents in the hierarchically organized ultrastructures of bone and tendon as well as in some of the soft tissues that have load-bearing functions. In the present paper, the macromolecular structure and function of the proteins are reviewed and the potential of mammalian and non-mammalian proteins in the engineering of load-bearing tissue substitutes are discussed. Chimeric proteins have become an important structural biomaterial source and their potential in tissue engineering is highlighted. Processing of proteins challenge investigators and in this review rapid prototyping and microfabrication are proposed as methods for obtaining precisely defined custom-built tissue engineered structures with intrinsic microarchitecture.
C1 [Sayin, Esen; Hasirci, Vasif] METU, Dept Biotechnol, Ankara, Turkey.
   [Sayin, Esen; Baran, Erkan Turker; Hasirci, Vasif] METU Ctr Excellence Biomat & Tissue Engn, BIOMATEN, TR-06800 Ankara, Turkey.
   [Hasirci, Vasif] METU, Dept Biol Sci, Ankara, Turkey.
RP Baran, ET (reprint author), METU Ctr Excellence Biomat & Tissue Engn, BIOMATEN, TR-06800 Ankara, Turkey.
EM erkantur@metu.edu.tr
RI Baran, Erkan/B-1055-2016; Baran, Erkan/Q-8482-2017
OI Baran, Erkan/0000-0002-0563-6943; Baran, Erkan/0000-0002-0563-6943
FU METU [BAP-07.02.2013.101]; Scientific and Technological Research Council
   of Turkey (TUBITAK) [2232]
FX The authors acknowledge the support by METU through project
   BAP-07.02.2013.101. ET Baran gratefully acknowledges the Scientific and
   Technological Research Council of Turkey (TUBITAK) for the Post Doctoral
   2232 BIDEP-TUBITAK Fellowship. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript.
CR Achilli M, 2012, MACROMOL MATER ENG, V297, P724, DOI 10.1002/mame.201100363
   Albertson AE, 2014, J MECH BEHAV BIOMED, V29, P225, DOI 10.1016/j.jmbbm.2013.09.002
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2012, J PEDIATR SURG, V47, P17, DOI 10.1016/j.jpedsurg.2011.10.013
   Baker S, 2012, MAT SCI ENG C-MATER, V32, P215, DOI 10.1016/j.msec.2011.10.021
   Balaji S, 2012, POLYM ADVAN TECHNOL, V23, P500, DOI 10.1002/pat.1905
   Balint E, 2012, J BIOMED MATER RES A, V100A, P195, DOI 10.1002/jbm.a.33260
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bhattacharjee M, 2012, ACTA BIOMATER, V8, P3313, DOI 10.1016/j.actbio.2012.05.023
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Bracalello A, 2011, BIOMACROMOLECULES, V12, P2957, DOI 10.1021/bm2005388
   Burck J, 2013, LANGMUIR, V29, P1562
   Caves JM, 2011, BIOMATERIALS, V32, P5371, DOI 10.1016/j.biomaterials.2011.04.009
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Chen CH, 2014, MATERIALS, V7, P2104, DOI 10.3390/ma7032104
   Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011
   Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017
   Choi BH, 2010, BIOMATERIALS, V31, P8980, DOI 10.1016/j.biomaterials.2010.08.027
   de Moraes MA, 2012, MACROMOL BIOSCI, V12, P1253, DOI 10.1002/mabi.201200060
   Dhandayuthapani B, 2010, J BIOMED MATER RES B, V94B, P264, DOI 10.1002/jbm.b.31651
   Dravida S, 2008, J TISSUE ENG REGEN M, V2, P263, DOI 10.1002/term.91
   Eberli D, 2009, METHODS, V47, P109, DOI 10.1016/j.ymeth.2008.10.014
   Enea D, 2011, J MATER SCI-MATER M, V22, P1569, DOI 10.1007/s10856-011-4336-1
   Engelhardt EM, 2011, BIOMATERIALS, V32, P3969, DOI 10.1016/j.biomaterials.2011.02.012
   Gauvin R, 2012, BIOMATERIALS, V33, P3824, DOI 10.1016/j.biomaterials.2012.01.048
   Gentleman E, 2006, ANN BIOMED ENG, V34, P726, DOI 10.1007/s10439-005-9058-4
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gomes S, 2011, SOFT MATTER, V7, P4964, DOI 10.1039/c1sm05024a
   Haider M, 2008, PHARM RES, V25, P692, DOI 10.1007/s11095-007-9282-8
   Han JJ, 2011, BIOMACROMOLECULES, V12, P399, DOI 10.1021/bm101149r
   Hendriks FM, 2006, MED ENG PHYS, V28, P259, DOI 10.1016/j.medengphy.2005.07.001
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hwang W, 2009, LANGMUIR, V25, P12682, DOI 10.1021/la9015993
   Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406
   Kew SJ, 2012, ACTA BIOMATER, V8, P3723, DOI 10.1016/j.actbio.2012.06.018
   Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002
   Kilic C, 2014, BIOMATER SCI-UK, V2, P318, DOI 10.1039/c3bm60194c
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020
   Koria P, 2011, P NATL ACAD SCI USA, V108, P1034, DOI 10.1073/pnas.1009881108
   Kurland NE, 2014, ADV MATER, V26, P4431, DOI 10.1002/adma.201400777
   Lai ES, 2011, ACTA BIOMATER, V7, P2448, DOI 10.1016/j.actbio.2011.03.012
   Lee W, 2009, BIOMATERIALS, V30, P1587, DOI 10.1016/j.biomaterials.2008.12.009
   Levett PA, 2014, ACTA BIOMATER, V10, P214, DOI 10.1016/j.actbio.2013.10.005
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li LQ, 2011, BIOMACROMOLECULES, V12, P2302, DOI 10.1021/bm200373p
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Mandal BB, 2010, ACTA BIOMATER, V6, P360, DOI 10.1016/j.actbio.2009.08.035
   Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051
   McKenna KA, 2012, ACTA BIOMATER, V8, P225, DOI 10.1016/j.actbio.2011.08.001
   McManus M, 2007, BIOMED MATER, V2, P257, DOI 10.1088/1748-6041/2/4/008
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Merrett K, 2009, BIOMATERIALS, V30, P5403, DOI 10.1016/j.biomaterials.2009.06.016
   Meyer M, 2010, MAT SCI ENG C-MATER, V30, P1266, DOI 10.1016/j.msec.2010.07.005
   Mieszawska AJ, 2010, CHEM MATER, V22, P5780, DOI 10.1021/cm101940u
   Miwa H, 1993, ASAIO J, V39, P273
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nayak S, 2012, CELL TISSUE RES, V347, P783, DOI 10.1007/s00441-011-1269-4
   Ner Y, 2009, POLYMER, V50, P5828, DOI 10.1016/j.polymer.2009.09.017
   Ni M, 2012, J ORTHOP RES, V30, P613, DOI 10.1002/jor.21559
   Pallela R, 2011, J BIOMED MATER RES A, V100, P486
   Pataquiva-Mateus AY, 2012, J BIOMED MATER RES B, V100B, P862, DOI 10.1002/jbm.b.32650
   Rahman MM, 2012, POLYM INT, V62, P79
   Reno F, 2012, J MATER SCI-MATER M, V23, P565, DOI 10.1007/s10856-011-4519-9
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   Rothamel D, 2005, CLIN ORAL IMPLAN RES, V16, P369, DOI 10.1111/j.1600-0501.2005.01108.x
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Saha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080004
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Seib FP, 2012, BIOMATERIALS, V33, P1017, DOI 10.1016/j.biomaterials.2011.10.063
   Shah A, 2008, PEDIATR RES, V63, P535, DOI 10.1203/PDR.0b013e31816bdf54
   Shin H, 2012, BIOMATERIALS, V33, P3143, DOI 10.1016/j.biomaterials.2011.12.050
   Silva SS, 2012, GREEN CHEM, V14, P1463, DOI 10.1039/c2gc16535j
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, P1451
   Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027
   Tanaka Y, 2011, BIOMATERIALS, V32, P3358, DOI 10.1016/j.biomaterials.2010.11.011
   Taylor PM, 2006, BIOMATERIALS, V27, P2733, DOI 10.1016/j.biomaterials.2005.12.003
   Tejeda-Montes E, 2012, ACTA BIOMATER, V8, P998, DOI 10.1016/j.actbio.2011.09.005
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Um IC, 2004, INT J BIOL MACROMOL, V34, P107, DOI 10.1016/j.ijbiomac.2004.03.011
   Uquillas JA, 2012, J MECH BEHAV BIOMED, V15, P176, DOI 10.1016/j.jmbbm.2012.06.012
   Van Lonkhuyzen DR, 2007, GROWTH FACTORS, V25, P295, DOI 10.1080/08977190701803752
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Wang XG, 2011, J MECH BEHAV BIOMED, V4, P922, DOI 10.1016/j.jmbbm.2011.04.009
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wei W, 2011, MAT SCI ENG C-MATER, V31, P1602, DOI 10.1016/j.msec.2011.07.013
   Werkmeister JA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012002
   Werten MWT, 2009, BIOMACROMOLECULES, V10, P1106, DOI 10.1021/bm801299u
   Xia ZM, 2013, ACTA BIOMATER, V9, P7308, DOI 10.1016/j.actbio.2013.03.038
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134
   Yu QZ, 2014, J BIOMED MATER RES A, V102, P3828, DOI 10.1002/jbm.a.35051
   Zeugolis DI, 2008, J BIOMED MATER RES B, V85B, P343, DOI 10.1002/jbm.b.30952
   Zhang L, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045012
   Zou XH, 2010, BIOMATERIALS, V31, P4872, DOI 10.1016/j.biomaterials.2010.02.056
NR 103
TC 9
Z9 9
U1 4
U2 42
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PY 2014
VL 9
IS 5
BP 687
EP 701
DI 10.2217/RME.14.52
PG 15
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA AS8YE
UT WOS:000344530100011
PM 25372082
DA 2018-10-20
ER

PT J
AU Jayakumar, GC
   Usharani, N
   Kawakami, K
   Rao, JR
   Nair, BU
AF Jayakumar, Gladstone Christopher
   Usharani, Nagarajan
   Kawakami, Kohsaku
   Rao, Jonnalagadda Raghava
   Nair, Balachandran Unni
TI Preparation of antibacterial collagen-pectin particles for
   biotherapeutics
SO RSC ADVANCES
LA English
DT Article
ID POLY(LACTIDE-CO-GLYCOLIDE) MICROPARTICLES
AB Biomaterial microparticles have versatile applications in biomedical formulations in site specific targeting treatment due to their size. There are many types of particulate formulations available in the pharmaceutical industry. But still it is difficult to produce protein solid particles due to their high sensitivity to heat. In this study, collagen-pectin microparticles (solid aerosol) are prepared using an electrospray method under ambient temperature and pressure conditions in a single step process. Pectin is used as a stabilizing and natural antiglycation agent for diabetic wound treatment. Collagen molecules can form various structures and aggregation states in solutions. During microparticle preparation, the electrospray method might affect the particle morphology. The significance of particle morphology was investigated using various analytical techniques. The effect of acetic acid concentration was monitored by viscosity, conductivity, differential scanning calorimetry (DSC), X-ray diffraction (XRD) and Fourier transform infrared spectroscopic (FTIR) measurements. The surface modifications of the microparticles were studied using scanning electron microscopy (SEM) and atomic force microscopy (AFM). The optimized results indicate that the collagen-pectin microparticles are obtained by electrospraying collagen dissolved in 50-80% acetic acid with 0.25% NaCl. Collagen-pectin microparticles are obtained which measure less than 150 mu m in size when sprayed using a 0.65 mm sized nozzle. The prepared microparticles were also tested for antimicrobial activity to ensure high efficiency use during wound infection. Thus, the collagen-pectin microparticles prepared can potentially be used as biomedical particles for clinical applications including wound healing and lung regeneration for diabetic patients.
C1 [Jayakumar, Gladstone Christopher; Rao, Jonnalagadda Raghava; Nair, Balachandran Unni] CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
   [Usharani, Nagarajan] CSIR, Cent Leather Res Inst, CHORD, Madras 600020, Tamil Nadu, India.
   [Jayakumar, Gladstone Christopher; Kawakami, Kohsaku] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan.
RP Jayakumar, GC (reprint author), CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
EM clrichem@lycos.com
CR Bowler P G, 1999, J Wound Care, V8, P499
   Chen Y. S., 1980, Proceedings of the 1980 Custom Integrated Circuits Conference, P63
   Clopeau 8 M., 1994, J AEROSOL SCI, V25, P1021
   Cristina B., 2007, BIOINTERPHASES, V4, pMR17
   Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004
   FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315
   Ganan-Calvo AM, 1997, J AEROSOL SCI, V28, P249, DOI 10.1016/S0021-8502(96)00433-8
   Gupta A. K., 2012, J NAT PRODUCTS, V2, P250
   Halbert A R, 1992, Australas J Dermatol, V33, P75, DOI 10.1111/j.1440-0960.1992.tb00083.x
   Jayakumar G. C., 2013, BIOACTIVE CARBOHYDRA, V2, P119
   Jayakumar G. C., 2012, CARBOHYD POLYM, V345, P2213
   Jayakumar GC, 2010, CARBOHYD RES, V345, P2213, DOI 10.1016/j.carres.2010.07.041
   Jayasinghe SN, 2004, NANOTECHNOLOGY, V15, P1519, DOI 10.1088/0957-4484/15/11/025
   JEFFERY H, 1993, PHARMACEUT RES, V10, P362, DOI 10.1023/A:1018980020506
   Jinkeun K., 2005, B KOREAN CHEM SOC, V26, P1083
   Kawakami K, 2010, AAPS PHARMSCITECH, V11, P1202, DOI 10.1208/s12249-010-9498-5
   Pornsak S., 2003, SILPAKORN U SCI TECH, V3, P206
   Raghavan K. V., 2014, RSC ADV, V4, P23642
   Rodrigo M.M., 2012, DRY TECHNOL, V30, P935
   Sai KP, 2001, COMP BIOCHEM PHYS B, V128, P81
   Usharani N., 2014, CHEM PHARM BULL, V62, P422
   Usharani N., 2013, INT J BIOL MACROMOL, V61, P404
   Usharani N., 2014, J MICROSC-OXFORD, V253, P2
   Usharani N, 2014, BIOPOLYMERS, V101, P903, DOI 10.1002/bip.22473
   YAN CH, 1994, J CONTROL RELEASE, V32, P231, DOI 10.1016/0168-3659(94)90233-X
   Zhang SL, 2011, MOL PHARMACEUT, V8, P807, DOI 10.1021/mp100401d
NR 26
TC 8
Z9 8
U1 0
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 81
BP 42846
EP 42854
DI 10.1039/c4ra07683d
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA AS8WI
UT WOS:000344525500011
DA 2018-10-20
ER

PT J
AU Schaap-Oziemlak, AM
   Kuhn, PT
   van Kooten, TG
   van Rijn, P
AF Schaap-Oziemlak, Aneta M.
   Kuhn, Philipp T.
   van Kooten, Theo G.
   van Rijn, Patrick
TI Biomaterial-stem cell interactions and their impact on stem cell
   response
SO RSC ADVANCES
LA English
DT Review
ID SELF-ASSEMBLED MONOLAYERS; HUMAN HEMATOPOIETIC STEM; MESENCHYMAL STEM;
   BONE-MARROW; ADIPOSE-TISSUE; FUNCTIONAL-GROUPS; PROGENITOR CELLS;
   SUBSTRATE STIFFNESS; IN-VITRO; OSTEOGENIC DIFFERENTIATION
AB In this review, current research in the field of biomaterial properties for directing stem cells are discussed and placed in a critical perspective. Regenerative medicine, in which stem cells play a crucial role, has become an interdisciplinary field between cell biology and materials science. New insights are generated, different approaches to determine material features and stem cell properties are implemented, but also many misconceptions exist. According to the current state-of-the-art and combined with basic principles from two different disciplines the topic is critically addressed. We take into account what seem to be the most important material properties and their influence towards stem cells but also the various stem cells available with respect to their origin, tissue source and culturing conditions.
C1 [Schaap-Oziemlak, Aneta M.; Kuhn, Philipp T.; van Kooten, Theo G.; van Rijn, Patrick] Univ Groningen, Univ Med Ctr Groningen, WJ Kolff Inst Biomed Engn & Mat Sci, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP van Kooten, TG (reprint author), Univ Groningen, Univ Med Ctr Groningen, WJ Kolff Inst Biomed Engn & Mat Sci, Dept Biomed Engn, FB40,A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM p.van.rijn@umcg.nl
RI van Rijn, Patrick/B-3792-2014
OI van Rijn, Patrick/0000-0002-2208-5725
FU Graduate School of Medical Sciences (GSMS) of the University of
   Groningen (RuG); University Medical Center Groningen (UMCG)
FX PTK and PvR gratefully acknowledge the Graduate School of Medical
   Sciences (GSMS) of the University of Groningen (RuG) and University
   Medical Center Groningen (UMCG) for financial support.
CR Abe H., 1996, DATA BOOK MECH PROPE
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Bass H., 2001, HDB ELASTIC PROPERTI
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Blasiak J, 2004, CHEM-BIOL INTERACT, V149, P137, DOI 10.1016/j.cbi.2004.08.002
   Brocher J, 2013, STEM CELL RES, V11, P1393, DOI 10.1016/j.scr.2013.07.008
   Brower J., 2012, ADV SKIN WOUND CARE, V24, P524
   Bucaro MA, 2012, ACS NANO, V6, P6222, DOI 10.1021/nn301654e
   Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930
   Chen WLK, 2011, ADV DRUG DELIVER REV, V63, P269, DOI 10.1016/j.addr.2011.01.004
   Choi JS, 2012, BIOMATERIALS, V33, P4460, DOI 10.1016/j.biomaterials.2012.03.010
   Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200
   Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   DeSimone D. W., 2013, EXTRACELLULAR MATRIX
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dzierzak E, 2002, IMMUNOL REV, V187, P126, DOI 10.1034/j.1600-065X.2002.18711.x
   Elman JS, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-1
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Ferreira MSV, 2012, BIOMATERIALS, V33, P6987, DOI 10.1016/j.biomaterials.2012.06.029
   Ferreira MV, 2012, J MATER SCI-MATER M, V23, P109, DOI 10.1007/s10856-011-4483-4
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Fitchmun MI, 1998, ANAL BIOCHEM, V265, P1, DOI 10.1006/abio.1998.2877
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Genzer J, 2008, LANGMUIR, V24, P2294, DOI 10.1021/la7033164
   Genzer J, 2012, ANNU REV MATER RES, V42, P435, DOI 10.1146/annurev-matsci-070511-155050
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Hao L., 2014, J MATER CHEM B, P4794
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Inoue H, 2014, EMBO J, V33, P409, DOI 10.1002/embj.201387098
   Irwin EE, 2011, BIOMATERIALS, V32, P6912, DOI 10.1016/j.biomaterials.2011.05.058
   Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jang M, 2013, BIOMATERIALS, V34, P3571, DOI 10.1016/j.biomaterials.2013.01.073
   Jansen BJH, 2010, STEM CELLS DEV, V19, P481, DOI 10.1089/scd.2009.0288
   Jin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050880
   Kang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094888
   Kassem M, 2004, BASIC CLIN PHARMACOL, V95, P209, DOI 10.1111/j.1742-7843.2004.pto950502.x
   Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60
   Kroupova J, 2006, J BIOMED MATER RES B, V76B, P315, DOI 10.1002/jbm.b.30366
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lentz RD, 2008, J ENVIRON QUAL, V37, P2293, DOI 10.2134/jeq2007.0574
   Li XM, 2014, J BIOMED MATER RES A, V102, P1092, DOI 10.1002/jbm.a.34774
   Lopez-Garcia MD, 2010, ANN BIOMED ENG, V38, P2485, DOI 10.1007/s10439-010-0015-5
   MacQueen L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0179
   Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615
   Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262
   Mendicino M, 2014, CELL STEM CELL, V14, P141, DOI 10.1016/j.stem.2014.01.013
   Mierczynska A, 2012, SOFT MATTER, V8, P8399, DOI 10.1039/c2sm25221j
   Musah S, 2012, ACS NANO, V6, P10168, DOI 10.1021/nn3039148
   Niemeyer P, 2010, TISSUE ENG PT A, V16, P33, DOI [10.1089/ten.tea.2009.0190, 10.1089/ten.TEA.2009.0190]
   Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085
   Ofek G, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127262
   Palchesko RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051499
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Patino JMR, 2007, CURR OPIN COLLOID IN, V12, P187, DOI 10.1016/j.cocis.2007.06.003
   Pendleton C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058198
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Raic A, 2014, BIOMATERIALS, V35, P929, DOI 10.1016/j.biomaterials.2013.10.038
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Rippon H., 2004, CELL PROLIFERAT, P23
   Roemeling-van Rhijn M., 2013, J STEM CELL RES THER, P20780
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   SAMBROOK J, 1982, MOL CLONING
   Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278
   Shin YN, 2008, APPL SURF SCI, V255, P293, DOI 10.1016/j.apsusc.2008.06.173
   Steinert AF, 2012, STEM CELL TRANSL MED, V1, P237, DOI 10.5966/sctm.2011-0036
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takahashi K, 2013, DEVELOPMENT, V140, P2457, DOI 10.1242/dev.092551
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Tsimbouri P, 2014, J CELL BIOCHEM, V115, P380, DOI 10.1002/jcb.24673
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Vacanti C, 2006, J CELL MOL MED, V1, P569
   Vuoristo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076205
   Wade RJ, 2012, MATER TODAY, V15, P454, DOI 10.1016/S1369-7021(12)70197-9
   Wang PY, 2012, RSC ADV, V2, P12857, DOI 10.1039/c2ra21557h
   Wang PY, 2012, ACTA BIOMATER, V8, P519, DOI 10.1016/j.actbio.2011.09.030
   Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192
   Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Witkowska-Zimny M, 2012, ACTA BIOCHIM POL, V59, P261
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Yang JJ, 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1640, DOI 10.1002/TERM.1640]
   Zhai JL, 2013, CURR OPIN COLLOID IN, V18, P257, DOI 10.1016/j.cocis.2013.03.002
   Zhang W, 2013, J DENT RES, V92, P1136, DOI 10.1177/0022034513507581
   Zhang ZL, 2009, BONE MARROW TRANSPL, V43, P69, DOI 10.1038/bmt.2008.260
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 113
TC 19
Z9 19
U1 1
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 95
BP 53307
EP 53320
DI 10.1039/c4ra07915a
PG 14
WC Chemistry, Multidisciplinary
SC Chemistry
GA AS6RL
UT WOS:000344390000093
DA 2018-10-20
ER

PT J
AU Yuan, X
   He, B
   Lv, Z
   Luo, SX
AF Yuan, Xiao
   He, Bin
   Lv, Zi
   Luo, Suxin
TI Fabrication of self-assembling peptide nanofiber hydrogels for
   myocardial repair
SO RSC ADVANCES
LA English
DT Review
ID TISSUE-ENGINEERING SCAFFOLDS; IMPROVES CARDIAC-FUNCTION; NATIVE CHEMICAL
   LIGATION; ISCHEMIC-HEART-DISEASE; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR;
   REGENERATIVE MEDICINE; PROGENITOR CELLS; ENDOTHELIAL-CELLS; DESIGNED
   PEPTIDE
AB Myocardial infarction (MI) has become widely spread in clinical medicine, and results in massive loss of myocardium, ventricular remodeling and ultimately heart failure. Many strategies for repairing injured myocardium are under extensive investigation with some early encouraging effects, but cannot effectively prevent disease progression and heart failure. Cardiac tissue engineering has emerged as an increasingly important approach to repair infarcted myocardium. Self-assembling peptide nanofiber hydrogels are regarded as tailored biomaterial scaffolds with the aim to develop cardiac tissue engineering. Their fabrication is based on the principle of molecular self-assembly which allows tailoring of the biological features (e. g. modification with functional motifs and controlled release of signal molecules) of supramolecular structures for cell behaviors and tissue regeneration. This review will outline the potential of combinational treatments of peptide nanofiber hydrogels with cells, growth factors, or both together in myocardial repair.
C1 [Yuan, Xiao; Luo, Suxin] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing, Peoples R China.
   [He, Bin] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped, Chongqing, Peoples R China.
   [Lv, Zi] Sichuan Univ, West China Sch Med, Chengdu 610064, Peoples R China.
RP Luo, SX (reprint author), Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing, Peoples R China.
EM luosuxin0204@163.com
FU National Natural Science Foundation of China (NSFC) [81270210]; Nature
   Science Foundation of Chongqing (CSTC) [2012JJA0911]
FX S. X. Luo was supported by National Natural Science Foundation of China
   (NSFC, 81270210) and the Nature Science Foundation of Chongqing (CSTC,
   2012JJA0911). We apologize to all the scientists whose work we could not
   cite due to space restrictions.
CR Altunbas A, 2012, TOP CURR CHEM, V310, P135, DOI 10.1007/128_2011_206
   Andukuri A, 2010, NANOMED-NANOTECHNOL, V6, P289, DOI 10.1016/j.nano.2009.09.004
   Anversa P, 2000, CIRC RES, V86, P121, DOI 10.1161/01.RES.86.2.121
   Aulisa L, 2009, BIOMACROMOLECULES, V10, P2694, DOI 10.1021/bm900634x
   Bangalore S, 2013, CIRCULATION, V127, P769, DOI 10.1161/CIRCULATIONAHA.112.131961
   Boopathy AV, 2014, BIOMATERIALS, V35, P8103, DOI 10.1016/j.biomaterials.2014.05.082
   Boopathy AV, 2014, METHODS MOL BIOL, V1141, P159, DOI 10.1007/978-1-4939-0363-4_10
   Botchwey EA, 2003, J BIOMED MATER RES A, V67A, P357, DOI 10.1002/jbm.a.10111
   Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Choh SY, 2011, BIOMACROMOLECULES, V12, P1126, DOI 10.1021/bm101451k
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0
   Collier JH, 2003, BIOCONJUGATE CHEM, V14, P748, DOI 10.1021/bc034017t
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Cui XJ, 2010, TOHOKU J EXP MED, V222, P281, DOI 10.1620/tjem.222.281
   Daskalopoulos E., 2013, EUR HEART J, V34, pP3292
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dhandayuthapani B, 2010, J BIOMED MATER RES B, V94B, P264, DOI 10.1002/jbm.b.31651
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Dominguez-Rodriguez A, 2014, WORLD J CARDIOL, V6, P100, DOI 10.4330/wjc.v6.i3.100
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   Dvir T, 2011, NANO LETT, V11, P4411, DOI 10.1021/nl2025882
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Fleischer S, 2013, CURR OPIN BIOTECH, V24, P664, DOI 10.1016/j.copbio.2012.10.016
   Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007
   Frederick JR, 2010, CIRCULATION, V122, pS107, DOI [10.1161/C1RCULATIONAHA.109.930404, 10.1161/CIRCULATIONAHA.109.930404]
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026
   Goldsmith EC, 2013, AM J PHYSIOL-CELL PH, V304, pC393, DOI 10.1152/ajpcell.00347.2012
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   Greenfield MA, 2010, LANGMUIR, V26, P3641, DOI 10.1021/la9030969
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Guo HD, 2010, BIOCHEM BIOPH RES CO, V399, P42, DOI 10.1016/j.bbrc.2010.07.031
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hartgerink JD, 2001, CURR OPIN SOLID ST M, V5, P355, DOI 10.1016/S1359-0286(01)00019-5
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   He B, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.13
   He B, 2014, RSC ADV, V4, P23610, DOI 10.1039/c4ra01826e
   Hockaday LA, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035005
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hosseinkhani H, 2013, CHEM REV, V113, P4837, DOI 10.1021/cr300131h
   Hou TY, 2014, BIOMATERIALS, V35, P5689, DOI 10.1016/j.biomaterials.2014.03.079
   Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONHA.106.639831
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Hurley JR, 2010, AM J PHYSIOL-CELL PH, V299, pC444, DOI 10.1152/ajpcell.00572.2009
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498
   JUCKER M, 1991, J NEUROSCI RES, V28, P507, DOI 10.1002/jnr.490280407
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Jung JP, 2010, BIOPOLYMERS, V94, P49, DOI 10.1002/bip.21326
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Lin YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003841
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Lindenauer PK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f521
   Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004
   Liu JP, 2010, MACROMOL BIOSCI, V10, P1164, DOI 10.1002/mabi.200900450
   Liu YC, 2013, BIOTECHNOL ADV, V31, P688, DOI 10.1016/j.biotechadv.2012.10.003
   Loo Y, 2012, BIOTECHNOL ADV, V30, P593, DOI 10.1016/j.biotechadv.2011.10.004
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   Luo ZL, 2012, CHEM SOC REV, V41, P4736, DOI 10.1039/c2cs15360b
   Luo ZL, 2011, BIOMATERIALS, V32, P2013, DOI 10.1016/j.biomaterials.2010.11.049
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MacPhee CE, 2004, CURR OPIN SOLID ST M, V8, P141, DOI 10.1016/j.cossms.2004.01.010
   Martinez-Ramos C, 2014, TISSUE ENG PART C-ME, V20, P817, DOI 10.1089/ten.tec.2013.0489
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   Mihardja SS, 2013, BIOMATERIALS, V34, P8869, DOI 10.1016/j.biomaterials.2013.07.028
   Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570
   Nam YJ, 2013, NAT MED, V19, P413, DOI 10.1038/nm.3147
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Ou LL, 2011, J CELL MOL MED, V15, P1310, DOI 10.1111/j.1582-4934.2010.01086.x
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Palmer LC, 2008, ACCOUNTS CHEM RES, V41, P1674, DOI 10.1021/ar8000926
   Paramonov SE, 2005, MACROMOLECULES, V38, P7555, DOI 10.1021/ma0514065
   Plotkin M, 2014, BIOMATERIALS, V35, P1429, DOI 10.1016/j.biomaterials.2013.10.058
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Prat-Vidal C, 2014, INT J CARDIOL, V174, P654, DOI 10.1016/j.ijcard.2014.04.181
   Radhakrishnan J, 2014, BIOTECHNOL ADV, V32, P449, DOI 10.1016/j.biotechadv.2013.12.010
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Ravichandran R, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/38/385102
   Rufaihah AJ, 2013, BIOMATERIALS, V34, P8195, DOI 10.1016/j.biomaterials.2013.07.031
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Salem AK, 2002, J BIOMED MATER RES, V61, P212, DOI 10.1002/jbm.10195
   Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001410
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Soler-Botija C, 2014, AM J TRANSL RES, V6, P291
   Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139
   Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046
   Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Tokunaga M, 2010, J MOL CELL CARDIOL, V49, P972, DOI 10.1016/j.yjmcc.2010.09.015
   Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018
   Tuan RS, 2013, NAT REV RHEUMATOL, V9, P74, DOI 10.1038/nrrheum.2012.235
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Velichko YS, 2008, J PHYS CHEM B, V112, P2326, DOI 10.1021/jp074420n
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   Welt FGP, 2013, CIRC-HEART FAIL, V6, P99, DOI 10.1161/CIRCHEARTFAILURE.112.972273
   Wu DQ, 2009, ACS APPL MATER INTER, V1, P319, DOI 10.1021/am8000456
   Wu J, 2012, ADV FUNCT MATER, V22, P3815, DOI 10.1002/adfm.201103147
   Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619
   Yacoub Magdi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS133, DOI 10.1038/ncpcardio0401
   Yang YL, 2009, NANO TODAY, V4, P193, DOI 10.1016/j.nantod.2009.02.009
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhao F, 2009, CHEM SOC REV, V38, P883, DOI 10.1039/b806410p
   Zhao XJ, 2006, CHEM SOC REV, V35, P1105, DOI 10.1039/b511336a
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
NR 143
TC 9
Z9 10
U1 3
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 96
BP 53801
EP 53811
DI 10.1039/c4ra08582e
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA AS7YW
UT WOS:000344468800052
DA 2018-10-20
ER

PT J
AU Siegismund, D
   Schroeter, A
   Ludecke, C
   Undisz, A
   Jandt, KD
   Roth, M
   Rettenmayr, M
   Schuster, S
   Germerodt, S
AF Siegismund, Daniel
   Schroeter, Anja
   Luedecke, Claudia
   Undisz, Andreas
   Jandt, Klaus D.
   Roth, Martin
   Rettenmayr, Markus
   Schuster, Stefan
   Germerodt, Sebastian
TI Discrimination between random and non-random processes in early
   bacterial colonization on biomaterial surfaces: application of point
   pattern analysis
SO BIOFOULING
LA English
DT Article
DE bacterial colonization; point-pattern analysis; bacterial adhesion;
   biofilm; biomaterials; image processing
ID ORAL STREPTOCOCCAL ADHESION; SELF-ASSEMBLED MONOLAYERS; BIOFILM
   FORMATION; PSEUDOMONAS-AERUGINOSA; HYDROPHOBIC SURFACES;
   SPATIAL-PATTERNS; NANOSCALE ROUGHNESS; MICROBIAL ADHESION; ADHERING
   BACTERIA; IMAGE-ANALYSIS
AB The dynamics of adhesion and growth of bacterial cells on biomaterial surfaces play an important role in the formation of biofilms. The surface properties of biomaterials have a major impact on cell adhesion processes, eg the random/noncooperative adhesion of bacteria. In the present study, the spatial arrangement of Escherichia coli on different biomaterials is investigated in a time series during the first hours after exposure. The micrographs are analyzed via an image processing routine and the resulting point patterns are evaluated using second order statistics. Two main adhesion mechanisms can be identified: random adhesion and non-random processes. Comparison with an appropriate null-model quantifies the transition between the two processes with statistical significance. The fastest transition to non-random processes was found to occur after adhesion on PTFE for 2-3 h. Additionally, determination of cell and cluster parameters via image processing gives insight into surface influenced differences in bacterial micro-colony formation.
C1 [Siegismund, Daniel; Luedecke, Claudia; Undisz, Andreas; Jandt, Klaus D.; Rettenmayr, Markus] Univ Jena, Otto Schott Inst Mat Res OSIM, Jena, Germany.
   [Siegismund, Daniel; Schroeter, Anja; Schuster, Stefan; Germerodt, Sebastian] Univ Jena, Dept Bioinformat, Jena, Germany.
   [Luedecke, Claudia; Roth, Martin] HKI, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.
RP Germerodt, S (reprint author), Univ Jena, Dept Bioinformat, Jena, Germany.
EM sebastian.germerodt@uni-jena.de
RI Jandt, Klaus/C-8077-2016
OI Jandt, Klaus/0000-0002-7537-5603
FU Jena School for Microbial Communication (JSMC/MikroInter) - DFG; State
   of Thuringia
FX This work was supported by the Jena School for Microbial Communication
   (JSMC/MikroInter) funded by the DFG and the State of Thuringia. Fruitful
   discussions with J. Schleicher and M. Foge are gratefully acknowledged.
CR Azevedo NF, 2007, APPL ENVIRON MICROB, V73, P3423, DOI 10.1128/AEM.00047-07
   Baddeley A, 2005, J STAT SOFTW, V12, P1
   Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   Bell ML, 2004, BIOSTATISTICS, V5, P633, DOI 10.1093/biostatistics/kxh014
   Beloin C, 2008, PLOS BIOL, V6, P1549, DOI 10.1371/journal.pbio.0060167
   Boks NP, 2008, LANGMUIR, V24, P12990, DOI 10.1021/la801824c
   Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0
   Boks NP, 2009, J COLLOID INTERF SCI, V331, P60, DOI 10.1016/j.jcis.2008.11.025
   BOS R, 1994, J MICROBIOL METH, V20, P289, DOI 10.1016/0167-7012(94)90053-1
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Busscher HJ, 2012, PLOS PATHOGENS, P8
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952
   Gibiansky ML, 2010, SCIENCE, V330, P197, DOI 10.1126/science.1194238
   Giraldez MJ, 2010, OPTOMETRY VISION SCI, V87, pE426, DOI 10.1097/OPX.0b013e3181da8656
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Grivet M, 1999, J MICROBIOL METH, V38, P33, DOI 10.1016/S0167-7012(99)00074-3
   Gu H, 2013, LANGMUIR, V29, P11145, DOI 10.1021/la402608z
   Gustafson D. E., 1979, Proceedings of the 1978 IEEE Conference on Decision and Control Including the 17th Symposium on Adaptive Processes, P761
   HAMILTON MA, 1995, BIOMETRICAL J, V37, P393, DOI 10.1002/bimj.4710370403
   Hsu LC, 2013, APPL ENVIRON MICROB, V79, P2703, DOI 10.1128/AEM.03436-12
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   JAMES GA, 1995, J BACTERIOL, V177, P907, DOI 10.1128/jb.177.4.907-915.1995
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x
   Ludecke C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084837
   Ludecke C, 2013, APPL SURF SCI, V280, P578, DOI 10.1016/j.apsusc.2013.05.030
   Mc Quarrie D. A., 1975, STAT MECH
   Medilanski E, 2002, BIOFOULING, V18, P193, DOI 10.1080/08927010290011370
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   Parreira P, 2011, J BIOMED MATER RES A, V99A, P344, DOI 10.1002/jbm.a.33178
   Perni S, 2013, SOFT MATTER, V9, P1844, DOI 10.1039/c2sm26828k
   Ploux L, 2007, COLLOID SURFACE B, V57, P174, DOI 10.1016/j.colsurfb.2007.01.018
   Ponche A, 2010, P I MECH ENG H, V224, P1471, DOI 10.1243/09544119JEIM900
   Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65
   RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172
   Schillinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037583
   Schleicher J, 2011, J ARID ENVIRON, V75, P270, DOI 10.1016/j.jaridenv.2010.10.003
   Siegismund D, 2014, ACTA BIOMATER, V10, P267, DOI 10.1016/j.actbio.2013.09.016
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   SJOLLEMA J, 1990, FEMS MICROBIOL LETT, V69, P263
   SJOLLEMA J, 1990, COLLOID SURFACE, V47, P337, DOI 10.1016/0166-6622(90)80082-F
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Taylor JR, 1997, INTRO ERROR ANAL STU
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   van der Mei HC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002821
   VANDERMEI HC, 1993, J GEN MICROBIOL, V139, P937, DOI 10.1099/00221287-139-5-937
   Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x
   Wiegand T, 2006, J ECOL, V94, P825, DOI 10.1111/j.1365-2745.2006.01113.x
   Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06
   Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155
NR 55
TC 2
Z9 3
U1 2
U2 28
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0892-7014
EI 1029-2454
J9 BIOFOULING
JI Biofouling
PY 2014
VL 30
IS 9
BP 1023
EP 1033
DI 10.1080/08927014.2014.958999
PG 11
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA AS5OO
UT WOS:000344320100001
PM 25329612
DA 2018-10-20
ER

PT J
AU Wang, C
   Lyu, GJ
   Yang, GH
   Chen, JC
   Jiang, WK
AF Wang, Chao
   Lyu, Gaojin
   Yang, Guihua
   Chen, Jiachuan
   Jiang, Weikun
TI Characterization and Hydrothermal Conversion of Lignin Produced from
   Corncob Acid Hydrolysis Residue
SO BIORESOURCES
LA English
DT Article
DE Corncob acid hydrolysis residue; Enzymatic/mild acidolysis lignin;
   Hydrothermal conversion; Phenolic compounds
ID ALKALI LIGNIN; WATER; DEPOLYMERIZATION; LIQUEFACTION; DEGRADATION;
   PYROLYSIS; ETHANOL; BIOMASS
AB Lignin is one of the main components of corncob acid hydrolysis residue (CAHR). It can be used as a feedstock for biomaterial and biochemical production via biorefining. In this study, CAHR lignin was extracted, and enzymatic/mild acidolysis lignin (EMAL) was produced to ensure efficient lignin recovery. Next, hydrothermal conversion of the EMAL was carried out. The influences of process conditions including the temperature, time, and mass ratio of deionized water to EMAL on the hydrothermal conversion were thoroughly investigated to quantify analysis of the aromatics. EMAL produced from CAHR had a structure of the G-S-H type, in which the p-hydroxyphenyl unit was the primary structural unit, followed by the guaiacyl structural unit. The syringyl structural unit was less common. The yields (wt. %) of phenol, guaiacol, and 4-ethyl-phenol reached maxima of 1.26%, 0.75%, and 1.16%, respectively, at a reaction temperature of 310 degrees C and time of 30 min with a mass ratio of 80:1.
C1 [Wang, Chao; Lyu, Gaojin; Yang, Guihua; Chen, Jiachuan; Jiang, Weikun] Qilu Univ Technol, Key Lab Pulp & Paper Sci & Technol, Minist Educ, Jinan 250353, Shandong, Peoples R China.
RP Lyu, GJ (reprint author), Qilu Univ Technol, Key Lab Pulp & Paper Sci & Technol, Minist Educ, Jinan 250353, Shandong, Peoples R China.
EM gaojinlv@qlu.edu.cn; ygh2626@126.com
FU National Science Foundation of China [31170547, 31270627, 31370580,
   31270626]; Natural Science Foundation of Shandong Province [ZR2010CM065,
   ZR2011CM011]; Outstanding Young Scientist Award Fund of Shandong
   province [BS2013NJ014]; Director Fund of KLPPST [08031334]
FX The authors are grateful for the financial support from the National
   Science Foundation of China (Grant Nos. 31170547, 31270627, 31370580,
   31270626), the Natural Science Foundation of Shandong Province (Grant
   Nos. ZR2010CM065, ZR2011CM011), the Outstanding Young Scientist Award
   Fund of Shandong province (BS2013NJ014), and the Director Fund of KLPPST
   (No. 08031334).
CR [Anonymous], 1975, T9WD75 TAPPI
   [Anonymous], 1988, T222OM88 TAPPI
   [Anonymous], 1999, T203CM99 TAPPI
   Bozell JJ, 2010, SCIENCE, V329, P522, DOI 10.1126/science.1191662
   Cheng SN, 2012, POLYM DEGRAD STABIL, V97, P839, DOI 10.1016/j.polymdegradstab.2012.03.044
   Cox BJ, 2012, BIORESOURCE TECHNOL, V118, P584, DOI 10.1016/j.biortech.2012.05.012
   Crestini C, 1997, J AGR FOOD CHEM, V45, P1212, DOI 10.1021/jf960568k
   Dizhbite T, 2011, J ANAL APPL PYROL, V90, P126, DOI 10.1016/j.jaap.2010.11.004
   FAIX O, 1991, HOLZFORSCHUNG, V45, P21, DOI 10.1515/hfsg.1991.45.s1.21
   Gosselink R. J., 2011, BIORESOURCE TECHNOL, V106, P173
   Sobrino FH, 2010, RENEW SUST ENERG REV, V14, P772, DOI 10.1016/j.rser.2009.10.021
   Hoekman SK, 2011, ENERG FUEL, V25, P1802, DOI 10.1021/ef101745n
   Huang YQ, 2012, J ANAL APPL PYROL, V93, P153, DOI 10.1016/j.jaap.2011.10.011
   Jin YQ, 2011, BIORESOURCE TECHNOL, V102, P3581, DOI 10.1016/j.biortech.2010.10.050
   Kleinert M, 2008, ENERG FUEL, V22, P1371, DOI 10.1021/ef700631w
   Lou R, 2011, APPL ENERG, V88, P316, DOI 10.1016/j.apenergy.2010.06.028
   Pandey MP, 2011, CHEM ENG TECHNOL, V34, P29, DOI 10.1002/ceat.201000270
   Pinkowska H, 2012, CHEM ENG J, V187, P410, DOI 10.1016/j.cej.2012.01.092
   Toor SS, 2011, ENERGY, V36, P2328, DOI 10.1016/j.energy.2011.03.013
   Wahyudiono Sasaki M., 2008, CHEM ENG PROCESS, V47, P1609
   Wu S. B., 2006, FORESTRY STUDIES CHI, V8, P34
   Yang GH, 2013, CURR ORG CHEM, V17, P1589, DOI 10.2174/13852728113179990068
   Ye YY, 2012, J ANAL APPL PYROL, V94, P190, DOI 10.1016/j.jaap.2011.12.005
   Yuan ZS, 2010, BIORESOURCE TECHNOL, V101, P9308, DOI 10.1016/j.biortech.2010.06.140
NR 24
TC 10
Z9 10
U1 0
U2 12
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2014
VL 9
IS 3
BP 4596
EP 4607
PG 12
WC Materials Science, Paper & Wood
SC Materials Science
GA AS3NG
UT WOS:000344184300071
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Namvar, F
   Jawaid, M
   Tahir, PM
   Mohamad, R
   Azizi, S
   Khodavandi, A
   Rahman, HS
   Nayeri, MD
AF Namvar, Farideh
   Jawaid, Mohammad
   Tahir, Paridah Md
   Mohamad, Rosfarizan
   Azizi, Susan
   Khodavandi, Alireza
   Rahman, Heshu Sulaiman
   Nayeri, Majid Dehghan
TI Potential Use of Plant Fibres and their Composites for Biomedical
   Applications
SO BIORESOURCES
LA English
DT Article
DE Fibres; Polymers; Biocomposites; Biomedical applications
ID REINFORCED COMPOSITES; NATURAL FIBERS; HYBRID COMPOSITES;
   MECHANICAL-PROPERTIES; BIO-COMPOSITES; NANOCELLULOSE; BIOMATERIALS;
   CELLULOSE; BEHAVIOR
AB Plant-based fibers such as flax, jute, sisal, hemp, and kenaf have been frequently used in the manufacturing of biocomposites. Natural fibres possess a high strength to weight ratio, non-corrosive nature, high fracture toughness, renewability, and sustainability, which give them unique advantages over other materials. The development of biocomposites by reinforcing natural fibres has attracted attention of scientists and researchers due to environmental benefits and improved mechanical performance. Manufacturing of biocomposites from renewable sources is a challenging task, involving metals, polymers, and ceramics. Biocomposites are already utilized in biomedical applications such as drug/gene delivery, tissue engineering, orthopedics, and cosmetic orthodontics. The first essential requirement of materials to be used as biomaterial is its acceptability by the human body. A biomaterial should obtain some important common properties in order to be applied in the human body either for use alone or in combination. Biocomposites have potential to replace or serve as a framework allowing the regeneration of traumatized or degenerated tissues or organs, thus improving the patients' quality of life. This review paper addresses the utilization of plant fibres and its composites in biomedical applications and considers potential future research directed at environment-friendly biodegradable composites for biomedical applications.
C1 [Namvar, Farideh; Jawaid, Mohammad; Tahir, Paridah Md; Mohamad, Rosfarizan; Nayeri, Majid Dehghan] Univ Putra Malaysia, Inst Trop Forestry & Forest Prod INTROP, Upm Serdang 43400, Selangor, Malaysia.
   [Namvar, Farideh] Islamic Azad Univ, Mashhad Branch, Mashhad, Iran.
   [Mohamad, Rosfarizan] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Serdang 43400, Malaysia.
   [Azizi, Susan] Univ Putra Malaysia, Fac Chem, Serdang 43400, Malaysia.
   [Khodavandi, Alireza] Islamic Azad Univ, Gachsaran Branch, Dept Paramed Sci, Gachsaran, Iran.
   [Rahman, Heshu Sulaiman] Univ Putra Malaysia, Fac Vet Med, Dept Pathol & Microbiol, Serdang 43400, Malaysia.
   [Jawaid, Mohammad] King Saud Univ, Coll Engn, Dept Chem Engn, Riyadh 11421, Saudi Arabia.
RP Namvar, F (reprint author), Univ Putra Malaysia, Inst Trop Forestry & Forest Prod INTROP, Upm Serdang 43400, Selangor, Malaysia.
EM farideh.namvar@gmail.com
RI Jawaid, Mohammad/E-2116-2011
OI Jawaid, Mohammad/0000-0001-5348-5740; Khodavandi,
   Alireza/0000-0001-9498-9822; MD. TAHIR, PARIDAH/0000-0002-2961-6031;
   Mohamad, Rosfarizan/0000-0001-5672-1905
CR Abraham E, 2011, CARBOHYD POLYM, V86, P1468, DOI 10.1016/j.carbpol.2011.06.034
   Aggerholm S., 2013, WIPO patent, Patent No. [WO/2013/148399, 2437616]
   Ambrose CG, 2004, ANN BIOMED ENG, V32, P171, DOI 10.1023/B:ABME.0000007802.59936.fc
   Asokan P, 2012, REV ADV MATER SCI, V30, P254
   Barthelat F, 2007, PHILOS T R SOC A, V365, P2907, DOI 10.1098/rsta.2007.0006
   Bhatnagar A, 2005, J REINF PLAST COMP, V24, P1259, DOI 10.1177/0731684405049864
   Biagiotti J, 2004, J NAT FIBERS, V1, P37, DOI DOI 10.1300/J395V01N02_04
   Bledzki A., 2010, COMPOS SCI TECHNOL, V70, P1
   Bodros E, 2007, COMPOS SCI TECHNOL, V67, P462, DOI 10.1016/j.compscitech.2006.08.024
   Chandramohan D, 2011, ACTA BIOENG BIOMECH, V13, P77
   Cheng G., 2010, China Patent, Patent No. [CN 101703317, 102677504]
   Cherian BM, 2010, CARBOHYD POLYM, V81, P720, DOI 10.1016/j.carbpol.2010.03.046
   Cheung HY, 2009, COMPOS PART B-ENG, V40, P655, DOI 10.1016/j.compositesb.2009.04.014
   Corbie T., 2001, Life cycle assessment of biofibres replacing glass fibres as reinforcement in plastics, V33, P267, Patent No. 0818184
   Cottenceau J. P., 1998, European Patent EP, Patent No. [0818184, 101703317]
   Cullen Richard K., 2013, Journal of Composites, DOI 10.1155/2013/416501
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Daunton C., 2012, WOUND MANAGEMENT, V20
   Dhandayuthapani B, 2011, INT J POLYM SCI, DOI 10.1155/2011/290602
   DiGregorio BE, 2009, CHEM BIOL, V16, P1, DOI 10.1016/j.chembiol.2009.01.001
   Eichhorn SJ, 2009, J MATER SCI, V45, P1, DOI DOI 10.1007/S10853-009-3874-0
   Everitt N. M., 2013, C PAPERS MAT SCI, DOI [10.1155/2013/141204, DOI 10.1155/2013/141204]
   Flory A., 2013, DEV GREEN BINDER SYS
   Garcia M. I., 2007, J APPL POLYM SCI, V107, P2994
   Giri J, 2013, NEPAL J ONLINE, V9, P81, DOI [10.3126/bibechana.v9i0.7179, DOI 10.3126/BIBECHANA.V9I0.7179]
   GOLDSTEIN SA, 1991, J BIOMECH, V24, P135, DOI 10.1016/0021-9290(91)90384-Y
   Hin T. S., 2004, ENG MAT BIOMEDICAL A, DOI [10.1142/5673, DOI 10.1142/5673]
   Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667
   Jawaid M, 2011, CARBOHYD POLYM, V86, P1, DOI 10.1016/j.carbpol.2011.04.043
   Joshi SV, 2004, COMPOS PART A-APPL S, V35, P371, DOI 10.1016/j.compositesa.2003.09.016
   Kabir M., 2011, P 1 INT POSTGR C ENG
   Kalia S, 2011, INT J POLYM SCI, DOI 10.1155/2011/837875
   Kalia S, 2009, POLYM ENG SCI, V49, P1253, DOI 10.1002/pen.21328
   Kutz M., 2003, STANDARD HDB BIOMEDI, P1
   Lund S. S., 2008, U.S Patent US, Patent No. [20090234459, 2002054998]
   Majeed K, 2013, MATER DESIGN, V46, P391, DOI 10.1016/j.matdes.2012.10.044
   Mao Z., 2012, China Patent CN, Patent No. [102715804, 1461827]
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Milanese AC, 2011, PROCEDIA ENGINEER, V10, DOI 10.1016/j.proeng.2011.04.335
   Mohanty A. K., 2002, J POLYM ENVIRON, V10, P18
   Morgan C, 2013, ANGIOGENESIS, V16, P493, DOI 10.1007/s10456-013-9341-1
   Mueller D., 2004, INT NONWOVENS J, V13, P31
   Mukhopadhyay S, 2009, J THERMOPLAST COMPOS, V22, P135, DOI 10.1177/0892705708091860
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Oksman K, 2003, COMPOS SCI TECHNOL, V63, P1317, DOI 10.1016/S0266-3538(03)00103-9
   Patel N. R., 2012, INT J EMERGING TECHN, V2, P91
   Puglia D., 2005, J NATURAL FIBERS, V1
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Ratner B. D., 2004, BIOMATERIALS SCI MUL
   Romanzini D, 2012, MATER RES-IBERO-AM J, V15, P415, DOI [10.1590/S1516-14392012000300012, 10.1590/S1516-14392012005000050]
   Sarasini F, 2013, J POLYM ENVIRON, V21, P881, DOI 10.1007/s10924-013-0594-y
   Strandqvist M, 2012, Patent No. [CN102665510, 102715983]
   Taniguchi K., 2006, WIPO patent, Patent No. [W0/2002/054998, 2013148399]
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Ticoalu A, 2010, P SO REG ENG C 2010
   Verma D., 2013, J MAT ENV SCI, V4, P263
   Wirawan R, 2009, SAINS MALAYS, V38, P531
   Wu TM, 2006, POLYM DEGRAD STABIL, V91, P2198, DOI 10.1016/j.polymdegradstab.2006.01.004
   Xiang Q., 2012, China Patent CN, Patent No. [102715983, 102715804]
   Xue Q., 2012, China Patent CN, Patent No. [102677504, 102665510]
   Yang HS, 2006, POLYM TEST, V25, P668, DOI 10.1016/j.polymertesting.2006.03.013
   Yu G, 2003, China Patent CN, Patent No. [1461827, 1609336]
   Zhou S., 2006, China Patent, Patent No. [CN 1609336, 20090234459]
   Zhu JC, 2013, MATERIALS, V6, P5171, DOI 10.3390/ma6115171
NR 64
TC 7
Z9 8
U1 0
U2 20
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2014
VL 9
IS 3
BP 5688
EP 5706
PG 19
WC Materials Science, Paper & Wood
SC Materials Science
GA AS3NG
UT WOS:000344184300157
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Hiebl, B
   Hopperdietzel, C
   Hunigen, H
   Dietze, K
   Jung, F
   Niehues, SM
AF Hiebl, B.
   Hopperdietzel, C.
   Huenigen, H.
   Dietze, K.
   Jung, F.
   Niehues, S. M.
TI Tissue reaction induced by implanted venous access ports in adult
   patients after infection of the implantation site
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Encapsulation; infection; central venous access system; biomaterial
ID SOFT-TISSUE; FOLLOW-UP; COMPLICATIONS; DEVICES; TITANIUM; SYSTEMS;
   CHEMOTHERAPY; MALIGNANCIES; BIOMATERIAL; EXPERIENCE
AB Implantable long-term central venous port systems (CVPS) are widely used as a permanent means of accessing the vascular system for intravenous delivery of drugs, parenteral nutrition, blood transfusion, and blood sampling. These systems allow easy and repetitive puncture without causing much damage to the vessels. However, the body foreign surface of CVPS induces an inflammatory response with varying intensity (depending on the implant materials) that leads to formation of a fibrous tissue capsule around the implant. This study was designed to investigate the influence of bacterial infection on the tissue reaction induced by implanted CVPS in adult patients. 20 patients (9 women, 11 men, 58 +/- 14 yrs of age) were included in this study. These patients received explantation of a polysulfone based CVPS (ChemoSite (TM), Covidien, Mansfield, USA) due to port related infections (patients with bacterial infections at the implantation site: group A, 5 men, 1 women) or to other reasons such as termination of treatment, thrombosis, or CVPS dysfunction (patients without bacterial infections, group B, 6 men, 8 women) 299.9 +/- 261.2 days after CVPS implantation. A sample of the encapsulating tissue covering the CVPS together with surrounding tissue (at least 1x1 cm(2)) was placed in a small container with fixing agent, a buffered neutral 4% formalin solution (pH 7). Histological sections of the samples were prepared for light microscopic analysis after paraffin embedding. Sections of 3 mu m were cut and stained with haematoxylin and eosin, Weigert's elastic stain, and Heidenhain's azan stain. There was no difference in thickness, collagen and elastin content, or cell and capillary density of the fibrous capsule between both groups. Due to the wound healing reaction involving angiogenesis and fibroblast activation cell density and number of capillaries in the capsule tissue of all patients showed a positive correlation (r = 0.45, p < 0.05). However, the study demonstrated that at the end of the foreign body reaction the artificial tissue layer which covers the CVPS after implantation due to foreign body reaction shows only low reactivity towards infections.
C1 [Hiebl, B.] Univ Halle Wittenberg, Ctr Med Basic Res, D-06108 Halle, Saale, Germany.
   [Jung, F.] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Teltow, Germany.
   [Jung, F.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Teltow, Germany.
   [Hopperdietzel, C.; Huenigen, H.; Dietze, K.] Free Univ Berlin, Inst Vet Anat, Fac Vet Med, Berlin, Germany.
   [Niehues, S. M.] Charite, Dept Radiol, D-13353 Berlin, Germany.
RP Hiebl, B (reprint author), Univ Halle Wittenberg, Ctr Med Basic Res, D-06108 Halle, Saale, Germany.
EM bernhard.hiebl@medizin.uni-halle.de
RI Jung, Friedrich/L-1301-2013
OI Jung, Friedrich/0000-0001-8098-7180; Hiebl, Bernhard/0000-0002-6450-0675
CR Al-Banna NA, 2013, CLIN HEMORHEOL MICRO, V55, P423, DOI 10.3233/CH-131780
   BARRIOS CH, 1992, ONCOLOGY, V49, P474
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   Biffi R, 1998, ANN ONCOL, V9, P767, DOI 10.1023/A:1008392423469
   Boersma RS, 2008, ANN ONCOL, V19, P433, DOI 10.1093/annonc/mdm350
   Bouza E, 2002, CLIN MICROBIOL INFEC, V8, P265, DOI 10.1046/j.1469-0691.2002.00385.x
   Bow EJ, 1999, J CLIN ONCOL, V17, P1267, DOI 10.1200/JCO.1999.17.4.1267
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   BROTHERS TE, 1988, SURG GYNECOL OBSTET, V166, P295
   Gebauer B, 2009, EUR J RADIOL, V69, P517, DOI 10.1016/j.ejrad.2007.10.018
   Groebli Y, 1999, PANMINERVA MED, V41, P89
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KEUNG YK, 1994, CANCER, V73, P2832, DOI 10.1002/1097-0142(19940601)73:11<2832::AID-CNCR2820731128>3.0.CO;2-V
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Kock HJ, 1998, WORLD J SURG, V22, P12, DOI 10.1007/s002689900342
   Lemmers NWM, 1996, J CLIN ONCOL, V14, P2916, DOI 10.1200/JCO.1996.14.11.2916
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   MCNAMARA A, 1981, BIOMATERIALS, V2, P33, DOI 10.1016/0142-9612(81)90085-5
   Mulisch M, 2010, MIKROSKOPISCHE TECHN
   Paquay YCGJ, 1996, BIOMATERIALS, V17, P1251, DOI 10.1016/0142-9612(96)84946-5
   Prantl L., 2014, CLIN HEMORHEOL MICRO, DOI [10.3233/CH-141812.25, DOI 10.3233/CH-141812.25]
   RAAF JH, 1994, SUPPORT CARE CANCER, V2, P335, DOI 10.1007/BF00344046
   Rosengren A, 1998, J MATER SCI-MATER M, V9, P415, DOI 10.1023/A:1013239731256
   SARIEGO J, 1993, AM J SURG, V165, P249, DOI 10.1016/S0002-9610(05)80520-3
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   Teichgraber UKM, 2011, EUR RADIOL, V21, P1224, DOI 10.1007/s00330-010-2045-7
   THERIN M, 1991, J MATER SCI-MATER M, V2, P1, DOI 10.1007/BF00701681
   Vescia S, 2008, ANN ONCOL, V19, P9, DOI 10.1093/annonc/mdm272
   WOOD N K, 1970, Journal of Biomedical Materials Research, V4, P1, DOI 10.1002/jbm.820040102
   Yildizeli B, 2004, J Vasc Access, V5, P174
NR 32
TC 1
Z9 2
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2014
VL 58
IS 1
BP 107
EP 113
DI 10.3233/CH-141881
PG 7
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA AS3GP
UT WOS:000344165900009
PM 25227193
DA 2018-10-20
ER

PT J
AU Braune, S
   Walter, M
   Schulze, F
   Lendlein, A
   Jung, F
AF Braune, S.
   Walter, M.
   Schulze, F.
   Lendlein, A.
   Jung, F.
TI Changes in platelet morphology and function during 24 hours of storage
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Platelet; platelet function; platelet rich plasma; whole blood; platelet
   aging; platelet storage; hemocompatibility; biomaterials
ID ALPHA-GRANULE PROTEINS; FUNCTION ANALYZER; VASCULAR-DISEASE;
   BLEEDING-TIME; BLOOD; MICROPARTICLES; HEMOSTASIS; BIOMATERIALS;
   AGGREGATION; COLLECTION
AB For in vitro studies assessing the interaction of platelets with implant materials, common and standardized protocols for the preparation of platelet rich plasma (PRP) are lacking, which may lead to non-matching results due to the diversity of applied protocols. Particularly, the aging of platelets during prolonged preparation and storage times is discussed to lead to an underestimation of the material thrombogenicity. Here, we study the influence of whole blood-and PRP-storage times on changes in platelet morphology and function.
   Blood from apparently healthy subjects was collected according to a standardized protocol and examined immediately after blood collection, four hours and twenty four hours later. The capability of platelets to adhere and form stable aggregates (PFA100, closure time) was examined in sodium citrate anticoagulated whole blood (WB) using the agonists equine type I collagen and epinephrine bitartrate (collagen/epinephrine) as well as equine type I collagen and adenosine-5'-diphosphate (collagen/ADP). Circulating platelets were quantified at each time point. Morphology of platelets and platelet aggregates were visualized microscopically and measured using an electric field multi-channel counting system (CASY). The percentage of activated platelets was assessed by means of P-selectin (CD62P) expression of circulating platelets. Furthermore, platelet factor 4 (PF4) release was measured in platelet poor plasma (PPP) at each time point.
   Whole blood PFA100 closure times increased after stimulation with collagen/ADP and collagen/epinephrine. Twenty four hours after blood collection, both parameters were prolonged pathologically above the upper limit of the reference range. Numbers of circulating platelets, measured in PRP, decreased after four hours, but no longer after twenty four hours. Mean platelet volumes (MPV) and platelet large cell ratios (P-LCR, 12 fL - 40 fL) decreased over time. Immediately after blood collection, no debris or platelet aggregates could be visualized microscopically. After four hours, first debris and very small aggregates occurred. After 24 hours, platelet aggregates and also debris progressively increased. In accordance to this, the CASY system revealed an increase of platelet aggregates (up to 90 mu m diameter)with increasing storage time.
   The percentage of CD62P positive platelets and PF4 increased significantly with storage time in resting PRP. When soluble ADP was added to stored PRP samples, the number of activatable platelets decreased significantly over storage time. The present study reveals the importance of a consequent standardization in the preparation of WB and PRP. Platelet morphology and function, particularly platelet reactivity to adherent or soluble agonists in their surrounding milieu, changed rapidly outside the vascular system. This knowledge is of crucial interest, particularly in the field of biomaterial development for cardiovascular applications, and may help to define common standards in the in vitro hemocompatibility testing of biomaterials.
C1 [Braune, S.; Walter, M.; Schulze, F.; Lendlein, A.; Jung, F.] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Braune, S.; Walter, M.; Schulze, F.; Lendlein, A.; Jung, F.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
   [Braune, S.; Walter, M.; Lendlein, A.] Univ Potsdam, Inst Chem, Potsdam, Germany.
RP Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM friedrich.jung@hzg.de
RI Lendlein, Andreas/K-9553-2013; Braune, Steffen/D-2315-2015; Jung,
   Friedrich/L-1301-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Jung,
   Friedrich/0000-0001-8098-7180
CR BACH R, 1994, THROMB RES, V74, pS55
   BERG B, 1981, REFERENCE VALUES LAB, P55
   Braune S, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-33
   Braune S, 2013, CLIN HEMORHEOL MICRO, V54, P235, DOI 10.3233/CH-131729
   BROWN AS, 1994, EUR J CLIN INVEST, V24, P9, DOI 10.1111/j.1365-2362.1994.tb02419.x
   CAPITANIO AM, 1985, BIOCHIM BIOPHYS ACTA, V839, P161, DOI 10.1016/0304-4165(85)90033-9
   Cattaneo M, 2013, J THROMB HAEMOST, V11, P1183, DOI 10.1111/jth.12231
   Devine DV, 2010, CLIN LAB MED, V30, P475, DOI 10.1016/j.cll.2010.02.002
   Erlandsen SL, 2001, J HISTOCHEM CYTOCHEM, V49, P809, DOI 10.1177/002215540104900702
   Favaloro EJ, 2010, CLIN CHEM LAB MED, V48, P579, DOI 10.1515/CCLM.2010.121
   Favaloro EJ, 2008, SEMIN THROMB HEMOST, V34, P709, DOI 10.1055/s-0029-1145254
   Ferroni P, 2012, THROMB HAEMOSTASIS, V108, P1109, DOI 10.1160/TH12-08-0550
   Francis J, 1999, PLATELETS, V10, P132, DOI 10.1080/09537109976194
   GEORGE JN, 1990, BLOOD, V76, P859
   GROTEMEYER KH, 1993, THROMB RES, V71, P397, DOI 10.1016/0049-3848(93)90164-J
   Hayward CPM, 2009, SEMIN THROMB HEMOST, V35, P127, DOI 10.1055/s-0029-1220320
   Italiano JE, 2010, CURR OPIN HEMATOL, V17, P578, DOI 10.1097/MOH.0b013e32833e77ee
   Jennings I, 2008, J CLIN PATHOL, V61, P950, DOI 10.1136/jcp.2008.057174
   Jensen EA, 2008, CLIN CHEM LAB MED, V46, P225, DOI 10.1515/CCLM.2008.053
   Jung F, 2013, CLIN HEMORHEOL MICRO, V53, P97, DOI 10.3233/CH-2012-1579
   Jung F., 2011, MRS BULL, V35, P607
   Kalb ML, 2009, PLATELETS, V20, P7, DOI 10.1080/09537100802364076
   KAPLAN KL, 1979, BLOOD, V53, P604
   Kehrel BE, 2013, TRANSFUS MED HEMOTH, V40, P73, DOI 10.1159/000350469
   KINLOUGHRATHBONE RL, 1995, THROMB HAEMOSTASIS, V74, P958
   Klinger MHF, 1996, ANN HEMATOL, V73, P103, DOI 10.1007/s002770050210
   Knehtl M, 2013, INT J ARTIF ORGANS, V36, P717, DOI 10.5301/ijao.5000239
   Koscielny J, 2005, SEMIN THROMB HEMOST, V31, P464, DOI 10.1055/s-2005-916682
   KUNDU SK, 1995, SEMIN THROMB HEMOST, V21, P106
   Latza R, 2000, INFUS THER TRANSFUS, V27, P94
   Lima-Oliveira G., 2014, J MED BIOCHEM, P1
   Lindl T, 2005, ATLA-ALTERN LAB ANIM, V33, P591
   Lippi G, 2012, SEMIN THROMB HEMOST, V38, P565, DOI 10.1055/s-0032-1315961
   Mackie I, 2013, INT J LAB HEMATOL, V35, P1, DOI 10.1111/ijlh.12004
   MARTIN JF, 1983, THROMB RES, V32, P443, DOI 10.1016/0049-3848(83)90255-4
   MISSELWITZ F, 1987, THROMB RES, V46, P233, DOI 10.1016/0049-3848(87)90285-4
   Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003
   Reinhart WH, 2013, CLIN HEMORHEOL MICRO, V53, P71, DOI 10.3233/CH-2012-1577
   Shrivastava M, 2009, TRANSFUS APHER SCI, V41, P105, DOI 10.1016/j.transci.2009.07.002
   Sikara MP, 2010, BLOOD, V115, P713, DOI 10.1182/blood-2009-03-206367
   Siljander PRM, 2011, THROMB RES, V127, pS30, DOI 10.1016/S0049-3848(10)70152-3
   THOMSON JM, 1983, CLIN LAB HAEMATOL, V5, P413
   Van der Zee PM, 2006, CLIN CHEM, V52, P657, DOI 10.1373/clinchem.2005.057414
   Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011
   Wenzel F, 2012, PLATELETS, V23, P150, DOI 10.3109/09537104.2011.599897
NR 45
TC 13
Z9 13
U1 1
U2 13
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2014
VL 58
IS 1
BP 159
EP 170
DI 10.3233/CH-141876
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA AS3GP
UT WOS:000344165900013
PM 25227196
DA 2018-10-20
ER

PT J
AU Kruger, A
   Mayer, A
   Roch, T
   Schulz, C
   Lendlein, A
   Jung, F
AF Krueger, Anne
   Mayer, Anke
   Roch, Toralf
   Schulz, Christian
   Lendlein, Andreas
   Jung, Friedrich
TI Angiogenically stimulated alternative monocytes maintain their
   pro-angiogenic and non-inflammatory phenotype in long-term co-cultures
   with HUVEC
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Angiogenically stimulated alternative monocytes; endothelialization;
   biomaterials; hemocompatible surface
ID ENDOTHELIAL GROWTH-FACTOR; POLY(N-BUTYL ACRYLATE) NETWORKS; PROGENITOR
   CELLS; ESSENTIAL MEDIATORS; OXIDATIVE STRESS; VEIN GRAFT; IN-VITRO;
   BIOMATERIALS; ADHESION; MONOCYTES/MACROPHAGES
AB Angiogenically stimulated alternative monocytes (aMO2) could be established as cellular release system accelerating the endothelialization of polymers rendering their surfaces hemocompatibility in a short-term study. However, for their clinical application it is essential that aMO2 do not switch back to the MO1 state sustaining their capability as cellular release system over an extended period of time.
   We explored whether aMO2 can maintain their differentiation state over 21 days in a mono-and in a co-culture with HUVEC. In comparison, the influence of recombinant VEGF-A(165) on the endothelialization of biomaterials was assessed including endothelial cell (HUVEC) density, organisation of the endothelial cytoskeleton, cytokine secretion profile and release of prostacyclin, thromboxane A2 and matrix metalloproteinases.
   In mono-culture aMO2 secreted high amounts of VEGF and other growth factors/cytokines. Co-cultured with HUVEC, aMO2 accelerated the formation of a confluent HUVEC monolayer. Furthermore, no pro-inflammatory cytokines were found, neither in aMO2-mono, nor in co-cultures with HUVEC indicating that the majority of the aMO2 remained stable in their aMO2 state during the 21 days of cultivation.
   In contrast, the addition of recombinant VEGF-A(165) instead of the co-culture with aMO2 resulted in the formation of stress fibres, dissociated marginal filament bands, and a detachment of HUVEC. In addition, the profile of bioactive agents of HUVEC (e. g. prostacyclin, thromboxane A2, matrix metalloproteinases, IFN-gamma and TNF-alpha) was influenced by the VEGF-A(165) treatment inducing the detachment of HUVEC.
   In conclusion, in co-culture with HUVEC aMO2 remained stable in their type 2 state over 21 days confirming the suitability of aMO2 as biological release system for the endothelialization of biomaterial surfaces with constant release of angiogenic factors but without secretion of pro-inflammatory cytokines over three weeks. Therefore, this endothelialization approach seems to be appropriate to improve the hemocompatibility of cardiovascular implant materials in vitro, and proved to be superior to the use of recombinant VEGF-A(165).
C1 [Krueger, Anne; Mayer, Anke; Roch, Toralf; Schulz, Christian; Lendlein, Andreas; Jung, Friedrich] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Krueger, Anne; Mayer, Anke; Roch, Toralf; Schulz, Christian; Lendlein, Andreas; Jung, Friedrich] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
   [Roch, Toralf; Lendlein, Andreas; Jung, Friedrich] Helmholtz Virtual Inst Multifunct Biomat Med, Teltow, Germany.
   [Roch, Toralf; Lendlein, Andreas; Jung, Friedrich] Helmholtz Virtual Inst Multifunct Biomat Med, Berlin, Germany.
RP Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de; friedrich.jung@hzg.de
RI Lendlein, Andreas/K-9553-2013; Jung, Friedrich/L-1301-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Jung,
   Friedrich/0000-0001-8098-7180; Roch, Toralf/0000-0003-2948-8700
FU Bundesministerium fur Bildung und Forschung (BMBF) [0315696A]
FX The authors thank Stefanie Dietze and Angela Ritschel for assistance and
   the Bundesministerium fur Bildung und Forschung (BMBF, project number
   0315696A "Poly4Bio") for funding this study.
CR ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Avci-Adali M, 2011, EUR CELLS MATER, V21, P157, DOI 10.22203/eCM.v021a13
   Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010
   Butler D, 2011, NATURE, V477, P260, DOI 10.1038/477260a
   Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118
   Fadini GP, 2012, CLIN HEMORHEOL MICRO, V50, P293, DOI 10.3233/CH-2011-1437
   Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358
   Forte A, 2014, CLIN SCI, V127, P615, DOI 10.1042/CS20140131
   Funahashi Y, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-2
   Hao Q, 2009, AM J PHYSIOL-CELL PH, V296, pC821, DOI 10.1152/ajpcell.00504.2008
   Hoepken S, 2009, CLIN HEMORHEOL MICRO, V43, P157, DOI 10.3233/CH-2009-1230
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kruger A, 2012, CLIN HEMORHEOL MICRO, V52, P283, DOI 10.3233/CH-2012-1605
   Li BW, 2013, CLIN HEMORHEOL MICRO, V54, P345, DOI 10.3233/CH-121647
   Li S, 2011, ANNU REV BIOMED ENG, V13, P451, DOI 10.1146/annurev-bioeng-071910-124733
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Maulucci G, 2010, BIOPHYS J, V98, p576A, DOI 10.1016/j.bpj.2009.12.3131
   Mayer A, 2011, CLIN HEMORHEOL MICRO, V49, P423, DOI 10.3233/CH-2011-1492
   Mayer A, 2010, CLIN HEMORHEOL MICRO, V46, P217, DOI 10.3233/CH-2010-1348
   Mayer A, 2012, ACTA BIOMATER, V8, P4253, DOI 10.1016/j.actbio.2012.08.011
   Mayer A, 2012, ARTIF ORGANS, V36, pE28, DOI 10.1111/j.1525-1594.2011.01410.x
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Menu P, 2012, BIO-MED MATER ENG, V22, P17, DOI 10.3233/BME-2012-0685
   Miller-Kasprzak E, 2007, ARCH IMMUNOL THER EX, V55, P247, DOI 10.1007/s00005-007-0027-5
   Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894
   Monahan TS, 2009, SEMIN VASC SURG, V22, P216, DOI 10.1053/j.semvascsurg.2009.10.003
   Munzel T, 2010, EUR HEART J, V31, P2741, DOI 10.1093/eurheartj/ehq396
   Ozaki CK, 2007, J VASC SURG, V45, p92A, DOI 10.1016/j.jvs.2007.02.032
   Pernagallo S, 2012, ADV HEALTHC MATER, V1, P646, DOI 10.1002/adhm.201200130
   Piret G, 2011, SOFT MATTER, V7, P8642, DOI 10.1039/c1sm05838j
   Prasad CK, 2008, ACTA BIOMATER, V4, P182, DOI 10.1016/j.actbio.2007.05.012
   Pries A. R., 2006, V176, P1
   Re F, 2010, J BIOTECHNOL, V156, P341
   Rocher C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084009
   Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661
   Saeidnia S, 2013, TOXICOL APPL PHARM, V273, P442, DOI 10.1016/j.taap.2013.09.031
   Stannard AK, 2007, ARTERIOSCL THROM VAS, V27, P494, DOI 10.1161/01.ATV.000025309.38699.6c
   Stoltz JF, 1999, J MAL VASCUL, V24, P99
   Tan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077112
   Trescher K, 2013, J BIOTECHNOL, V166, P58, DOI 10.1016/j.jbiotec.2013.04.012
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774
   Vouret-Craviari V, 2002, J CELL SCI, V115, P2475
   Wischke C, 2013, EUR J PHARM BIOPHARM, V84, P288, DOI 10.1016/j.ejpb.2013.01.025
   Wu KK, 1996, ANNU REV MED, V47, P315
NR 46
TC 1
Z9 1
U1 1
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2014
VL 58
IS 1
BP 229
EP 240
DI 10.3233/CH-141875
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA AS3GP
UT WOS:000344165900019
PM 25227195
DA 2018-10-20
ER

PT J
AU Routray, W
   Orsat, V
   Gariepy, Y
AF Routray, Winny
   Orsat, Valerie
   Gariepy, Yvan
TI Effect of Different Drying Methods on the Microwave Extraction of
   Phenolic Components and Antioxidant Activity of Highbush Blueberry
   Leaves
SO DRYING TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 19th International Drying Symposium (IDS)
CY AUG 24-27, 2014
CL Lyon, FRANCE
DE Antioxidant activity; Blueberry leaf; Drying; Drying rate; Phenolic
   compound
ID GRAPE POMACE; PLANT-EXTRACTS; BAY LEAVES; ANTHOCYANINS; CAPACITY;
   STABILITY; STRAWBERRIES; PARAMETERS; VEGETABLES; RETENTION
AB In the last few decades, researchers have found blueberry leaves to be an interesting source of different phenolic compounds, and drying is an important part of their postharvest and sample preparation processes. In the current study, blueberry leaves were dried using microwave-assisted hot air drying or hot air drying alone at 45, 60, and 75 degrees C to 10-15% wet basis. Corresponding drying characteristics were determined by fitting the moisture ratio obtained in each case with eight theoretical and semitheoretical models for hot air and microwave drying stages. It was observed that best fitting drying models for blueberry leaves depended not only on the nature of the biomaterial but also on the method of drying and the temperature of drying. Phenolic content, monomeric anthocyanin content, and the corresponding antioxidant activity in terms of 2,2-diphenyl-1-picrylhydrazyl (DPPH) inhibition activity and ferric reducing ability of plasma (FRAP) activity were evaluated for the leaf extract obtained following microwave extraction of the dried samples obtained using the above-mentioned drying methods and were compared to the corresponding bioactive compositional characteristics of freeze-dried blueberry leaves. It was observed that the freeze-dried sample had the highest content of total phenolics and total monomeric anthocyanins along with high antioxidant activity. Furthermore, extracts obtained from the microwave-dried leaf samples obtained with a drying temperature of 60 degrees C had highest total phenolic content and highest total monomeric anthocyanin content among all other drying methods and the extract had an antioxidant activity similar to the freeze-dried blueberry leaf samples, implying that microwave drying at 60 degrees C is a potential alternative to freeze drying for preservation of the phenolic components and antioxidant activity of dried blueberry leaves.
C1 [Routray, Winny; Orsat, Valerie; Gariepy, Yvan] McGill Univ, Dept Bioresource Engn, Ste Anne De Bellevue, PQ H9X 3V9, Canada.
RP Routray, W (reprint author), McGill Univ, Dept Bioresource Engn, Macdonald Campus,21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.
EM routrayw@yahoo.com
RI Orsat, Valerie/L-4875-2015
OI Routray, Winny/0000-0003-3761-7592
FU Natural Sciences and Engineering Research Council of Canada
FX The authors acknowledge financial support from the Natural Sciences and
   Engineering Research Council of Canada.
CR ADAMS GDJ, 1991, DRY TECHNOL, V9, P891, DOI 10.1080/07373939108916727
   Akpinar EK, 2006, J FOOD ENG, V77, P864, DOI 10.1016/j.jfoodeng.2005.08.014
   Alibas I, 2009, DRY TECHNOL, V27, P1266, DOI 10.1080/07373930903267773
   Asami DK, 2003, J AGR FOOD CHEM, V51, P1237, DOI 10.1021/jf020635c
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6
   Chatterjee A, 2004, MOL CELL BIOCHEM, V265, P19, DOI 10.1023/B:MCBI.0000044310.92444.ec
   Chen YG, 2013, DRY TECHNOL, V31, P1114, DOI 10.1080/07373937.2013.775587
   Cyboran S, 2013, FOOD BIOPHYS, V8, P321, DOI 10.1007/s11483-013-9309-0
   Del B C., 2012, J AGR FOOD CHEM, V60, P9298
   Demir V, 2004, BIOSYST ENG, V88, P325, DOI 10.1016/j.biosystemseng.2004.04.005
   Doymaz, 2013, HEAT MASS TRANSFER, V49, P835
   Doymaz, 2006, J FOOD ENG, V77, P559
   Doymaz I, 2006, J FOOD ENG, V74, P370, DOI 10.1016/j.jfoodeng.2005.03.009
   Doymaz I, 2009, J FOOD PROCESS ENG, V32, P112, DOI 10.1111/j.1745-4530.2007.00205.x
   Dudonne S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r
   Duy JC, 1999, THESIS ACADIA U WOLF
   Ehlenfeldt MK, 2001, J AGR FOOD CHEM, V49, P2222, DOI 10.1021/jf0013656
   Gabriel C, 1998, CHEM SOC REV, V27, P213, DOI 10.1039/a827213z
   Giusti M. M., 2005, HDB FOOD ANAL CHEM P
   Grace MH, 2009, PHYTOMEDICINE, V16, P406, DOI 10.1016/j.phymed.2009.02.018
   Gunhan T, 2005, ENERG CONVERS MANAGE, V46, P1667, DOI 10.1016/j.enconman.2004.10.001
   Hellstrom J, 2013, J FOOD COMPOS ANAL, V31, P12, DOI 10.1016/j.jfca.2013.02.010
   Hoch WA, 2001, TREE PHYSIOL, V21, P1
   Hokkanen J, 2009, J AGR FOOD CHEM, V57, P9437, DOI 10.1021/jf9022542
   Keinanen M, 1996, J AGR FOOD CHEM, V44, P2724, DOI 10.1021/jf960168x
   Kelebek H, 2013, J SCI FOOD AGR, V93, P2963, DOI 10.1002/jsfa.6125
   Khanal RC, 2010, FOOD RES INT, V43, P1464, DOI 10.1016/j.foodres.2010.04.018
   Kratchanova M, 2004, CARBOHYD POLYM, V56, P181, DOI 10.1016/j.carbpol.2004.01.009
   Kubrakova IV, 2008, INORG MATER+, V44, P1509, DOI 10.1134/S0020168508140069
   Larrauri JA, 1997, J AGR FOOD CHEM, V45, P1390, DOI 10.1021/jf960282f
   Martineau LC, 2006, PHYTOMEDICINE, V13, P612, DOI 10.1016/j.phymed.2006.08.005
   Matsuo Y, 2010, FOOD CHEM, V121, P1073, DOI 10.1016/j.foodchem.2010.01.052
   Midilli A, 2003, ENERG CONVERS MANAGE, V44, P1111, DOI 10.1016/S0196-8904(02)00099-7
   Miliauskas G, 2004, FOOD CHEM, V85, P231, DOI 10.1016/j.foodchem.2003.05.007
   Mishra DK, 2008, J FOOD SCI, V73, pE9, DOI 10.1111/j.1750-3841.2007.00598.x
   Mujumdar A, 2006, HDB IND DRYING
   Nemes S. M., 2012, PRACTICAL METHODS LI
   Neto CC, 2007, MOL NUTR FOOD RES, V51, P652, DOI 10.1002/mnfr.200600279
   Orsat V, 2007, FOOD BIOPROD PROCESS, V85, P255, DOI 10.1205/fbp07019
   Ozdemir M, 1999, J FOOD ENG, V42, P225, DOI 10.1016/S0260-8774(99)00126-0
   Ozsen D, 2013, FOOD BIOPROCESS TECH, V6, P2261, DOI 10.1007/s11947-012-0910-x
   Park YJ, 2011, J FOOD SCI, V76, pM101, DOI 10.1111/j.1750-3841.2010.01974.x
   Piljac-Zegarac J, 2009, J MED FOOD, V12, P608, DOI 10.1089/jmf.2008.0081
   Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698
   Proestos C, 2008, LWT-FOOD SCI TECHNOL, V41, P652, DOI 10.1016/j.lwt.2007.04.013
   Raghavan GSV, 2001, DRY TECHNOL, V19, P405, DOI 10.1081/DRT-100102913
   Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025
   Routray W., 2012, IND CROP PROD, V58, P36
   Routray W, 2014, PHYS CHEM LIQ, V52, P209, DOI 10.1080/00319104.2013.812022
   Routray W, 2012, FOOD BIOPROCESS TECH, V5, P409, DOI 10.1007/s11947-011-0573-z
   Routray W, 2011, COMPR REV FOOD SCI F, V10, P303, DOI 10.1111/j.1541-4337.2011.00164.x
   Silva EM, 2007, SEP PURIF TECHNOL, V55, P381, DOI 10.1016/j.seppur.2007.01.008
   SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144
   Soysal Y, 2004, BIOSYST ENG, V89, P167, DOI 10.1016/j.biosystemseng.2004.07.008
   Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945
   Therdthai N, 2009, J FOOD ENG, V91, P482, DOI 10.1016/j.jfoodeng.2008.09.031
   Tseng A, 2012, J FOOD SCI, V77, pH192, DOI 10.1111/j.1750-3841.2012.02840.x
   Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973
   Venkatachalapathy K, 1999, DRY TECHNOL, V17, P837, DOI 10.1080/07373939908917573
   Vivekananda Mandal, 2007, Pharmacognosy Reviews, V1, P7
   Vyas P, 2013, J AGR FOOD CHEM, V61, P7769, DOI 10.1021/jf401158a
   Waterhouse A. L., 2005, HDB FOOD ANAL CHEM P
   Wojdylo A, 2009, J AGR FOOD CHEM, V57, P1337, DOI 10.1021/jf802507j
   Yaldiz O, 2001, DRY TECHNOL, V19, P583, DOI 10.1081/DRT-100103936
NR 65
TC 16
Z9 16
U1 2
U2 33
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0737-3937
EI 1532-2300
J9 DRY TECHNOL
JI Dry. Technol.
PY 2014
VL 32
IS 16
BP 1888
EP 1904
DI 10.1080/07373937.2014.919002
PG 17
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA AS1TL
UT WOS:000344064100002
DA 2018-10-20
ER

PT J
AU Diez-Pascual, AM
   Diez-Vicente, AL
AF Diez-Pascual, Ana M.
   Diez-Vicente, Angel L.
TI Effect of TiO2 nanoparticles on the performance of polyphenylsulfone
   biomaterial for orthopaedic implants
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID THERMOMECHANICAL BEHAVIOR; ANTIBACTERIAL PROPERTIES;
   MECHANICAL-PROPERTIES; NANOCOMPOSITES; MEMBRANES; TITANIUM;
   BIONANOCOMPOSITES; COMPOSITES; POLYSULFONES; NANOTUBES
AB Nanocomposites of biocompatible polyphenylsulfone (PPSU) and titanium dioxide (TiO2) nanoparticles have been prepared via ultrasonication and solution casting. Their structure, surface morphology, water uptake, thermal, mechanical, tribological and antibacterial properties have been investigated in detail. FT-IR analysis revealed the existence of strong hydrogen bonding interactions between the sulfone group of PPSU and the hydroxyl moieties of the nanoparticles, which were homogenously dispersed within the matrix without adding coupling agents. The incorporation of TiO2 reduced the water absorption and increased the thermal stability of the polymer under both inert and oxidative conditions. Furthermore, the nanocomposites exhibited greatly enhanced mechanical performance (storage and Young's moduli, tensile strength and toughness, glass transition and heat distortion temperature) compared to neat PPSU, confirming the formation of a strong nanofiller-matrix interface necessary for an efficient load transfer. Moreover, their tensile properties were retained after exposure to several cycles of steam sterilization or to simulated body fluid (SBF) at physiological temperature. Outstanding improvements in the tribological performance under both dry and SBF conditions were also attained, demonstrating the suitability of these nanoparticles for providing wear resistance to the matrix. The nanocomposites exhibited inhibition against both Gram-positive and Gram-negative bacteria with and without UV illumination, which was progressively enhanced with increasing TiO2 loading. These biomaterials are very promising for use in biomedical applications like orthopaedic and trauma implants.
C1 [Diez-Pascual, Ana M.] Univ Alcala de Henares, Fac Biol Environm Sci & Chem, Analyt Chem Phys Chem & Chem Engn Dept, E-28871 Alcala De Henares, Spain.
   [Diez-Pascual, Ana M.] CSIC, ICTP, Inst Polymer Sci & Technol, E-28006 Madrid, Spain.
   [Diez-Vicente, Angel L.] Airbus Operat SL, Madrid 28906, Spain.
RP Diez-Pascual, AM (reprint author), Univ Alcala de Henares, Fac Biol Environm Sci & Chem, Analyt Chem Phys Chem & Chem Engn Dept, E-28871 Alcala De Henares, Spain.
EM am.diez@uah.es
FU Ministerio de Economia y Competitividad (MINECO); EU
FX Dr Ana Diez-Pascual wishes to acknowledge the Ministerio de Economia y
   Competitividad (MINECO) for the "Ramon y Cajal" Senior Research
   Fellowship co-financed by the EU.
CR Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004
   Alexander L. E., 1969, XRAY DIFFRACTION MET
   Ashokkumar M, 2013, PROG BIOMATER, V2, P1, DOI [10.1186/2194-0517-2-2, DOI 10.1186/2194-0517-2-2]
   Barnard AS, 2008, ACS NANO, V2, P2237, DOI 10.1021/nn800446w
   Belfer S, 2000, J MEMBRANE SCI, V172, P113, DOI 10.1016/S0376-7388(00)00316-1
   Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205
   CALLEJA FJB, 1985, ADV POLYM SCI, V66, P117
   Chang L, 2006, WEAR, V260, P869, DOI 10.1016/j.wear.2005.04.002
   Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535
   Colthup N. B., 1990, INTRO INFRARED RAMAN
   Dalai S, 2014, B MATER SCI, V37, P371, DOI 10.1007/s12034-014-0680-3
   Diez-Pascual AM, 2014, ACS APPL MATER INTER, V6, P10132, DOI 10.1021/am501610p
   Diez-Pascual AM, 2014, ACS APPL MATER INTER, V6, P9822, DOI 10.1021/am502261e
   Diez-Pascual AM, 2014, INT J MOL SCI, V15, P10950, DOI 10.3390/ijms150610950
   Diez-Pascual AM, 2014, J MATER CHEM B, V2, P3065, DOI 10.1039/c3tb21800g
   Diez-Pascual AM, 2014, ACS APPL MATER INTER, V6, P3729, DOI 10.1021/am500171x
   Diez-Pascual AM, 2013, COMPOS PART A-APPL S, V54, P10, DOI 10.1016/j.compositesa.2013.06.018
   Diez-Pascual AM, 2013, MATERIALS, V6, P3171, DOI 10.3390/ma6083171
   Diez-Pascual AM, 2012, PROG MATER SCI, V57, P1106, DOI 10.1016/j.pmatsci.2012.03.003
   Diez-Pascual AM, 2010, CARBON, V48, P3500, DOI 10.1016/j.carbon.2010.05.050
   Duan YJ, 2009, J MACROMOL SCI B, V48, P604, DOI 10.1080/00222340902837899
   El-Hibri M. Jj, 2000, POLYM CONTAINING SUL
   Forati T, 2014, POLYM ADVAN TECHNOL, V25, P322, DOI 10.1002/pat.3243
   Gaur MS, 2013, J THERM ANAL CALORIM, V111, P743, DOI 10.1007/s10973-012-2357-8
   Gonzalez-Benito J, 2013, EUR POLYM J, V49, P1747, DOI 10.1016/j.eurpolymj.2013.04.023
   HANKS JH, 1949, P SOC EXP BIOL MED, V71, P196
   Jaszkiewicz A, 2013, J APPL POLYM SCI, V130, P3175, DOI 10.1002/app.39562
   Jones PJ, 2011, J APPL POLYM SCI, V121, P2945, DOI 10.1002/app.33852
   Jose AJ, 2013, APPL CLAY SCI, V71, P64, DOI 10.1016/j.clay.2012.11.003
   Jose AJ, 2012, INT J POLYM MATER, V61, P544, DOI 10.1080/00914037.2011.593065
   Kubacka A, 2012, TITANIUM DIOXIDE POL, P119
   Li JF, 2009, APPL SURF SCI, V255, P4725, DOI 10.1016/j.apsusc.2008.07.139
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Mallakpour S, 2013, J CHIL CHEM SOC, V58, P1603, DOI 10.4067/S0717-97072013000100022
   Mital G. S., 2011, CHINESE SCI BULL, V56, P1639
   Molnar G, 2005, POLYM DEGRAD STABIL, V89, P410, DOI 10.1016/j.polymdegradstab.2005.01.031
   Murayama T, 1978, DYNAMIC MECH ANAL PO
   Naffakh M, 2014, J MATER CHEM B, V2, P4509, DOI 10.1039/c4tb00557k
   Nayak L, 2011, POLYM BULL, V67, P1029, DOI 10.1007/s00289-011-0479-y
   Neal AL, 2008, ECOTOXICOLOGY, V17, P362, DOI 10.1007/s10646-008-0217-x
   Nyquist R. A., 1971, INFRARED SPECTRA INO, P214
   Perego C, 2010, SOLID STATE SCI, V12, P989, DOI 10.1016/j.solidstatesciences.2009.07.021
   Richards H.L., 2012, J SURF ENG MAT ADV T, V2, P183, DOI DOI 10.4236/JSEMAT.2012.223029
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Sayes CM, 2006, TOXICOL SCI, V92, P174, DOI 10.1093/toxsci/kfj197
   Schank K., 1988, CHEM SULPHONES SULPH, P54
   Touloukian Y. S., 1970, THERMOPHYSICAL PROPE, V2, P208
   Van der Bruggen B, 2009, J APPL POLYM SCI, V114, P630, DOI 10.1002/app.30578
   VANKREVELEN DW, 1975, POLYMER, V16, P615, DOI 10.1016/0032-3861(75)90157-3
   Visai L, 2011, INT J ARTIF ORGANS, V34, P929, DOI 10.5301/ijao.5000050
   Wang HT, 2009, FIBER POLYM, V10, P1, DOI 10.1007/s12221-009-0001-4
   Wang M, 1998, J BIOMED MATER RES, V42, P577, DOI 10.1002/(SICI)1097-4636(19981215)42:4<577::AID-JBM14>3.0.CO;2-2
   WELLINGHOFF ST, 1978, J APPL POLYM SCI, V22, P2025, DOI 10.1002/app.1978.070220723
   Williams D. F., 1973, IMPLANTS SURG, P173
   Wu GP, 2008, APPL SURF SCI, V254, P7080, DOI 10.1016/j.apsusc.2008.05.221
   Wu JY, 2014, NANOMED-NANOTECHNOL, V10, P1097, DOI 10.1016/j.nano.2014.01.002
   Yang YN, 2007, J MEMBRANE SCI, V288, P231, DOI 10.1016/j.memsci.2006.11.019
   Zhang MY, 2012, WATER RES, V46, P2077, DOI 10.1016/j.watres.2012.01.015
NR 58
TC 20
Z9 20
U1 4
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 43
BP 7502
EP 7514
DI 10.1039/c4tb01101e
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA AS0TZ
UT WOS:000343992700004
DA 2018-10-20
ER

PT J
AU Robert-Nicoud, G
   Donno, R
   Cadman, CJ
   Alexander, MR
   Tirelli, N
AF Robert-Nicoud, Ghislaine
   Donno, Roberto
   Cadman, Christopher J.
   Alexander, Morgan R.
   Tirelli, Nicola
TI Surface modification of silicone via colloidal deposition of amphiphilic
   block copolymers
SO POLYMER CHEMISTRY
LA English
DT Article
ID IMPLANTABLE GLUCOSE SENSORS; HYDROPHOBIC RECOVERY; BACTERIAL ATTACHMENT;
   PROTEIN ADSORPTION; CELL-ADHESION; POLY(DIMETHYLSILOXANE); POLYMERS;
   BIOCOMPATIBILITY; HYDROGELS; COATINGS
AB We report here on a method to functionalize silicone surfaces, which is based on the deposition of silicone-containing amphiphilic block copolymers from a colloidal water-ethanol dispersion. Using crosslinked silicones (Sylgard 184) as substrates, copolymers composed of two poly(glycerol monomethacrylate) (PGMMA) terminal blocks and a central poly(dimethylsiloxane) (PDMS) block can be effectively deposited when the PDMS content is >= 46 wt%. (>= 65 mol%); the deposition provides smooth and stable surfaces, which significantly affected the protein adsorption behaviour of the substrate, suggesting a possible application in biomaterial coating. In air, the block copolymer surface films underwent a reorganization, which differs from the classical hydrophobic recovery of silicones and may be related to a disordered folding of lamellar structures. This led to a predominant surface coverage by thin, possibly monomolecular layers, which displayed a non-restructuring polar surface. However, as a consequence of the reorganization also larger aggregates were produced, albeit in relatively small numbers; these aggregates underwent a progressive hydrophobization (in this case a hydrophobic recovery) and probably dominated the contact angle behaviour of the material. In summary, the colloidal deposition of amphiphilic silicone-based block copolymers successfully modifies the surface properties of silicone substrates; however, attention must paid to reorganization phenomena in order to maximize the stability of the coating.
C1 [Robert-Nicoud, Ghislaine; Donno, Roberto; Tirelli, Nicola] Univ Manchester, Inst Inflammat & Repair, Sch Med, Manchester M13 9PT, Lancs, England.
   [Cadman, Christopher J.] Univ Manchester, Sch Pharm, Manchester M13 9PT, Lancs, England.
   [Alexander, Morgan R.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
   [Tirelli, Nicola] Univ Manchester, Sch Mat, Manchester M13 9PT, Lancs, England.
RP Tirelli, N (reprint author), Univ Manchester, Inst Inflammat & Repair, Sch Med, Oxford Rd, Manchester M13 9PT, Lancs, England.
EM nicola.tirelli@manchester.ac.uk
RI Tirelli, Nicola/P-7210-2014; Tirelli, Nicola/P-3604-2018; Alexander,
   Morgan/C-2506-2009
OI Tirelli, Nicola/0000-0002-4879-3949; Tirelli,
   Nicola/0000-0002-4879-3949; Alexander, Morgan/0000-0001-5182-493X;
   Donno, Roberto/0000-0003-3175-2742
FU EPSRC [EP/F019750/1]; Engineering and Physical Sciences Research Council
   [EP/F019750/1]
FX Dr Christopher Cadman and Dr Roberto Donno gratefully acknowledge EPSRC
   for PhD studentships, the latter in the framework of the EPSRC-funded
   North West Nanoscience Doctoral Training Centre (NoWNano DTC). Finally,
   the authors wish to also acknowledge the support from the EPSRC grant
   EP/F019750/1 (A coordinated open-access centre for comprehensive
   materials analysis) to perform XPS measurements.
CR Abbasi F, 2003, J POLYM SCI POL PHYS, V41, P2145, DOI 10.1002/polb.10559
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Beamson G., 2000, XPS POLYM DATABASE
   Campbell DJ, 1999, J CHEM EDUC, V76, P1205
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   Clifford CA, 2005, APPL SURF SCI, V252, P1915, DOI 10.1016/j.apsusc.2005.08.090
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Everaert EP, 1996, J ADHES SCI TECHNOL, V10, P351, DOI 10.1163/156856196X00751
   FreijLarsson C, 1996, BIOMATERIALS, V17, P2199, DOI 10.1016/0142-9612(96)00050-6
   Galler N, 2011, APPL PHYS B-LASERS O, V104, P931, DOI 10.1007/s00340-011-4664-3
   Geelhood SJ, 2007, J BIOMED MATER RES B, V81B, P251, DOI 10.1002/jbm.b.30660
   Giacomelli C, 2007, MACROMOLECULES, V40, P2148, DOI 10.1021/ma062562u
   Goncalves IC, 2011, J MATER SCI-MATER M, V22, P2053, DOI 10.1007/s10856-011-4381-9
   Haigh R, 2000, BIOMATERIALS, V21, P735, DOI 10.1016/S0142-9612(99)00245-8
   Hao XJ, 2010, BIOMATERIALS, V31, P8153, DOI 10.1016/j.biomaterials.2010.07.065
   HARDING JW, 1945, P CAMB PHILOS SOC, V41, P16
   Hillborg H, 2004, LANGMUIR, V20, P785, DOI 10.1021/la035552k
   Hillborg H, 1998, POLYMER, V39, P1991, DOI 10.1016/S0032-3861(97)00484-9
   Hook AL, 2013, ADV MATER, V25, P2542, DOI 10.1002/adma.201204936
   Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316
   Hsu HL, 2010, ADV MATER, V22, P2177, DOI 10.1002/adma.200903413
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Johnson C, 2010, MACROMOL SYMP, V291-292, P314, DOI 10.1002/masy.201050537
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Lawrence EL, 2005, MED ENG PHYS, V27, P443, DOI 10.1016/j.medengphy.2004.12.013
   Lee S, 2004, MACROMOLECULES, V37, P8349, DOI 10.1021/ma049076w
   Li M, 2012, LANGMUIR, V28, P16408, DOI 10.1021/la303438t
   Lopez AI, 2011, BIOMATERIALS, V32, P4336, DOI 10.1016/j.biomaterials.2011.02.056
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   Mequanint K, 2006, BIOMACROMOLECULES, V7, P883, DOI 10.1021/bm0507047
   Merel P, 1998, APPL SURF SCI, V136, P105, DOI 10.1016/S0169-4332(98)00319-5
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   O'Hare LA, 2007, SURF INTERFACE ANAL, V39, P926, DOI 10.1002/sia.2634
   Olah A, 2005, APPL SURF SCI, V239, P410, DOI 10.1016/j.apsusc.2004.06.005
   Patrucco E, 2009, BIOMACROMOLECULES, V10, P3130, DOI 10.1021/bm900856r
   QUINN KJ, 1988, BRIT POLYM J, V20, P25, DOI 10.1002/pi.4980200106
   Rambarran T, 2012, MACROMOLECULES, V45, P2276, DOI 10.1021/ma202785x
   Rimmer S, 2007, BIOMATERIALS, V28, P5319, DOI 10.1016/j.biomaterials.2007.08.028
   Robert-Nicoud G, 2013, POLYM CHEM-UK, V4, P3458, DOI 10.1039/c3py00273j
   Roberts R. F., 1980, Surface and Interface Analysis, V2, P5, DOI 10.1002/sia.740020103
   Rozada R, 2013, NANO RES, V6, P216, DOI 10.1007/s12274-013-0298-6
   Sam SS, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-412
   Seo JH, 2008, BIOMATERIALS, V29, P1367, DOI 10.1016/j.biomaterials.2007.11.039
   Seo JH, 2011, SOFT MATTER, V7, P2968, DOI 10.1039/c0sm01292k
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Sneddon I. N., 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   SODERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386, DOI 10.1016/0021-9797(80)90463-4
   Tugulu S, 2009, MACROMOL SYMP, V279, P103, DOI 10.1002/masy.200950516
   UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871
   Wan F, 2012, ACS APPL MATER INTER, V4, P4557, DOI 10.1021/am300912w
   Wang C, 2008, BIOMACROMOLECULES, V9, P561, DOI 10.1021/bm701102y
   Wang JJ, 2011, J MATER SCI-MATER M, V22, P2651, DOI 10.1007/s10856-011-4452-y
   Wolfram Dolores, 2004, J Autoimmun, V23, P81
   Wu MH, 2009, SURF INTERFACE ANAL, V41, P11, DOI 10.1002/sia.2964
   Wu ZQ, 2012, COLLOID SURFACE B, V96, P37, DOI 10.1016/j.colsurfb.2012.03.016
   Wu ZG, 2009, LAB CHIP, V9, P1500, DOI 10.1039/b901651a
   Yu K, 2006, SOFT MATTER, V2, P705, DOI 10.1039/b602880m
   Zhang ZY, 2011, COLLOID SURFACE B, V88, P85, DOI 10.1016/j.colsurfb.2011.06.019
NR 61
TC 5
Z9 5
U1 2
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PY 2014
VL 5
IS 23
BP 6687
EP 6701
DI 10.1039/c4py00941j
PG 15
WC Polymer Science
SC Polymer Science
GA AS6LG
UT WOS:000344374500009
OA Bronze
DA 2018-10-20
ER

PT J
AU Rubert, M
   Li, YF
   Dehli, J
   Taskin, MB
   Besenbacher, F
   Chen, ML
AF Rubert, Marina
   Li, Yan-Fang
   Dehli, Jeppe
   Taskin, Mehmet Berat
   Besenbacher, Flemming
   Chen, Menglin
TI Dexamethasone encapsulated coaxial electrospun PCL/PEO hollow
   microfibers for inflammation regulation
SO RSC ADVANCES
LA English
DT Article
ID FOREIGN-BODY RESPONSE; GLUCOCORTICOID-RECEPTOR; CONTROLLED-RELEASE;
   SCAFFOLDS; DELIVERY; FIBERS; DRUG; MECHANISMS; NANOFIBERS; SURFACES
AB One of the major challenges in the field of biomaterials is to develop strategies to regulate the innate host inflammatory response. Coaxial electrospun PCL/PEO hollow fibers containing dexamethasone were evaluated for a local delivery of dexamethasone to reduce adverse inflammation responses often resulting from biomaterial implantation. Core-shell PCL/PEO hollow fibers with a highly porous surface were successfully developed using coaxial electrospinning. The release of dexamethasone exhibited a burst release during the first 0.5-3 h followed by a sustained release over more than 12 days. In vitro study showed that the dexamethasone encapsulated coaxial PCL/PEO hollow fibers significantly reduced cell proliferation of LPS-stimulated macrophages and meanwhile significantly decreased the mRNA expression levels of the pro-inflammatory cytokines TNF-alpha and IL-1 beta. The dexamethasone encapsulated coaxial PCL/PEO hollow microfibers are promising biomaterials for implantation to combat the acute inflammation responses which take place during first 24-48 h after biomaterial implantation and meanwhile to regulate possible hostile chronic inflammations, thus increasing the efficacy and longevity of the implants in vivo.
C1 [Rubert, Marina; Li, Yan-Fang; Dehli, Jeppe; Taskin, Mehmet Berat; Besenbacher, Flemming; Chen, Menglin] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark.
   [Li, Yan-Fang] Cent China Normal Univ, Inst Nanosci & Nanotechnol, Wuhan 430079, Peoples R China.
RP Chen, ML (reprint author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark.
EM menglin@inano.au.dk
RI Rubert, Marina/A-3935-2010; Li, Yanfang/I-9370-2016
OI Li, Yanfang/0000-0002-1487-365X; Chen, Menglin/0000-0002-2721-651X;
   Taskin, Mehmet Berat/0000-0002-4836-1097
FU Danish Council for Strategic Research; Lundbeck Foundation; Carlsberg
   Foundation
FX We gratefully acknowledge the Danish Council for Strategic Research for
   the funding to the ElectroMed Project at the iNANO Center, and the
   Lundbeck Foundation and the Carlsberg Foundation for their financial
   support. Marina Rubert and Yan-Fang Li contributed equally.
CR Almawi WY, 2002, J LEUKOCYTE BIOL, V71, P9
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Bognitzki M, 2001, ADV MATER, V13, P70, DOI 10.1002/1521-4095(200101)13:1<70::AID-ADMA70>3.3.CO;2-8
   Bridges Amanda W, 2008, J Diabetes Sci Technol, V2, P984
   Casper CL, 2004, MACROMOLECULES, V37, P573, DOI 10.1021/ma0351975
   Cui WG, 2006, BIOMACROMOLECULES, V7, P1623, DOI 10.1021/bm060057z
   Dalton PD, 2013, BIOMATER SCI-UK, V1, P171, DOI 10.1039/c2bm00039c
   Dawes GJS, 2010, J MATER SCI-MATER M, V21, P215, DOI 10.1007/s10856-009-3846-6
   Dror Y, 2007, SMALL, V3, P1064, DOI 10.1002/smll.200600536
   Ghag AK, 2014, BIOMATER SCI-UK, V2, P233, DOI 10.1039/c3bm60188a
   Gugutkov D, 2013, BIOMATER SCI-UK, V1, P1065, DOI 10.1039/c3bm60124b
   Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5
   Ito T, 2007, BIOMATERIALS, V28, P1778, DOI 10.1016/j.biomaterials.2006.12.012
   Ji W., 2010, PHARM RES, V28, P1259
   Jiang HL, 2005, J CONTROL RELEASE, V108, P237, DOI 10.1016/j.jconrel.2005.08.006
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Li YF, 2014, NANOSCALE, V6, P3392, DOI 10.1039/c3nr06197c
   Man ZT, 2014, BIOMATERIALS, V35, P5250, DOI 10.1016/j.biomaterials.2014.03.031
   Moghe AK, 2008, POLYM REV, V48, P353, DOI 10.1080/15583720802022257
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Nakatani Y, 2013, BIOL PHARM BULL, V36, P592
   Rujitanaroj PO, 2014, BIOMATER SCI-UK, V2, P843, DOI 10.1039/c3bm60245a
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Saraf A, 2010, J CONTROL RELEASE, V143, P95, DOI 10.1016/j.jconrel.2009.12.009
   Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010
   Srouji S, 2010, TISSUE ENG PART A, V17, P269
   Vacanti NM, 2012, BIOMACROMOLECULES, V13, P3031, DOI 10.1021/bm300520u
   Wang XH, 2009, J ENDOCRINOL, V200, P35, DOI 10.1677/JOE-08-0340
   Webber MJ, 2012, BIOMATERIALS, V33, P6823, DOI 10.1016/j.biomaterials.2012.06.003
   Worz A, 2012, J MATER CHEM, V22, P19547, DOI 10.1039/c2jm30820g
   Yoon JJ, 2003, BIOMATERIALS, V24, P2323, DOI 10.1016/S0142-9612(03)00024-3
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
NR 33
TC 7
Z9 7
U1 1
U2 51
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 93
BP 51537
EP 51543
DI 10.1039/c4ra08358j
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA AS6QK
UT WOS:000344387400063
DA 2018-10-20
ER

PT J
AU Panja, S
   Nayak, S
   Ghosh, SK
   Selvakumar, M
   Chattopadhyay, S
AF Panja, S.
   Nayak, S.
   Ghosh, S. K.
   Selvakumar, M.
   Chattopadhyay, S.
TI Self-assembly of a biodegradable branched PE-PCL-b-PEC amphiphilic
   polymer: synthesis, characterization and targeted delivery of
   doxorubicin to cancer cells
SO RSC ADVANCES
LA English
DT Article
ID BLOCK-COPOLYMER MICELLES; ANTICANCER DRUG-DELIVERY; PH-SENSITIVE
   MICELLES; TRIBLOCK COPOLYMERS; NANOPARTICLES; RELEASE; CARRIER;
   FUNCTIONALIZATION; BIOMATERIAL; CARBONATE)
AB A novel biodegradable branched block copolymer was synthesized by the ring-opening polymerization of ethylene carbonate using pre-synthesized four-armed pentaerythretol poly(epsilon-caprolactone) (PE-PCL) as a macro initiator. Folic acid was conjugated with the end-group of the block copolymer and self-assembled in water to form polymer micelles (PMs). The very low critical micelle concentration of the block copolymer suggests its potential application in advanced drug delivery systems. The PMs are spherical in shape and have an average size of 80 nm, which is suitable for the delivery of drugs. The hydrophobicity of pentaerythretol poly(epsilon-caprolactone) and its branched structure can accommodate high amounts of doxorubicin. Compared with a blank sample, PMs containing encapsulated doxorubicin show a much higher cytotoxicity towards HeLa cells. A high rate of release of doxorubicin in vitro at pH 5.0 shows that the system is responsive to pH. Confocal laser scanning microscopy showed that the doxorubicin-loaded PMs were internalized into the HeLa cells.
C1 [Panja, S.; Selvakumar, M.; Chattopadhyay, S.] Indian Inst Technol, Ctr Rubber Technol, Kharagpur 721302, W Bengal, India.
   [Nayak, S.; Ghosh, S. K.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Chattopadhyay, S (reprint author), Indian Inst Technol, Ctr Rubber Technol, Kharagpur 721302, W Bengal, India.
EM santanuchat71@yahoo.com
FU UGC, New Delhi
FX SP is grateful to the UGC, New Delhi for sponsoring a fellowship. We
   acknowledge Mithu Baidya and Somnath Maji for their valuable
   suggestions.
CR Chan P, 2007, BIOMATERIALS, V28, P540, DOI 10.1016/j.biomaterials.2006.08.046
   Chang LL, 2012, BIOMACROMOLECULES, V13, P3301, DOI 10.1021/bm301086c
   Chen JI, 2013, MACROMOL BIOSCI, V13, P623, DOI 10.1002/mabi.201200396
   Chen JC, 2014, RSC ADV, V4, P9684, DOI 10.1039/c3ra47026a
   Chen S, 2008, BIOMACROMOLECULES, V9, P2578, DOI 10.1021/bm800371n
   Chen T, 2012, ACS APPL MATER INTER, V4, P5766, DOI 10.1021/am301223n
   Cheng YX, 2012, BIOMACROMOLECULES, V13, P2163, DOI 10.1021/bm300823y
   Esfandiar A. K. S. Behravesh, 2002, BIOMACROMOLECULES, V3, P153
   Fan JQ, 2012, BIOMACROMOLECULES, V13, P4126, DOI 10.1021/bm301424r
   Feng H, 2006, BIOMACROMOLECULES, V7, P3069, DOI 10.1021/bm060568l
   Gaucher G, 2005, J CONTROL RELEASE, V109, P169, DOI 10.1016/j.jconrel.2005.09.034
   Hao Y, 2014, J MATER CHEM B, V2, P4237, DOI 10.1039/c4tb00334a
   Hu XL, 2008, J POLYM SCI POL CHEM, V46, P1852, DOI 10.1002/pola.22530
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Ishida T, 2005, J CONTROL RELEASE, V105, P305, DOI 10.1016/j.jconrel.2005.04.003
   Jin Y, 2011, BIOMACROMOLECULES, V12, P3460, DOI 10.1021/bm200956u
   Kelsch A, 2012, BIOMACROMOLECULES, V13, P4179, DOI 10.1021/bm301453g
   Li LY, 2010, BIOMACROMOLECULES, V11, P1882, DOI 10.1021/bm1004383
   Li Y, 2011, POLYMER, V52, P3304, DOI 10.1016/j.polymer.2011.05.049
   Li YY, 2006, BIOMACROMOLECULES, V7, P2956, DOI 10.1021/bm060080k
   Licciardi Y. T. M., 2005, BIOMACROMOLECULES, V6, P1085
   Lin WJ, 2014, J MATER CHEM B, V2, P4008, DOI 10.1039/c3tb21694b
   Liu Q, 2012, INT J PHARMACEUT, V430, P350, DOI 10.1016/j.ijpharm.2012.04.008
   Mi Y, 2011, BIOMATERIALS, V32, P4058, DOI 10.1016/j.biomaterials.2011.02.022
   Murat Acemoglu F. N., 1997, J CONTROL RELEASE, V49, P263
   Panja S, 2013, LANGMUIR, V29, P12530, DOI 10.1021/la401811c
   Park SH, 2008, MACROMOLECULES, V41, P6486, DOI 10.1021/ma800562s
   Pasut G, 2007, PROG POLYM SCI, V32, P933, DOI 10.1016/j.progpolymsci.2007.05.008
   Patil YB, 2009, BIOMATERIALS, V30, P859, DOI 10.1016/j.biomaterials.2008.09.056
   Prabaharan M, 2009, MACROMOL BIOSCI, V9, P515, DOI 10.1002/mabi.200800269
   Prateek Singh U. G., 2008, BIOCONJUGATE CHEM, V19, P2239
   Shim WS, 2006, MACROMOL BIOSCI, V6, P179, DOI 10.1002/mabi.200500182
   Sulistio A, 2011, BIOMACROMOLECULES, V12, P3469, DOI 10.1021/bm200604h
   Sun J, 2009, POLYMER, V50, P455, DOI 10.1016/j.polymer.2008.11.015
   Szebeni J, 2005, TOXICOLOGY, V216, P106, DOI 10.1016/j.tox.2005.07.023
   Unger F, 2007, J CONTROL RELEASE, V117, P312, DOI 10.1016/j.jconrel.2006.11.003
   Vincent Pourcelle S. D., 2007, BIOMACROMOLECULES, V8, P3977
   Wang DL, 2011, BIOMACROMOLECULES, V12, P1370, DOI 10.1021/bm200155t
   Wang YP, 2014, RSC ADV, V4, P24810, DOI 10.1039/c4ra03566f
   Wang Y, 2010, BIOMACROMOLECULES, V11, P3531, DOI 10.1021/bm101013s
   Wenjun Du Z. X., 2008, BIOCONJUGATE CHEM, V19, P2492
   Xu ZG, 2012, ACS APPL MATER INTER, V4, P3424, DOI 10.1021/am300877v
   Yang YQ, 2013, ACTA BIOMATER, V9, P7679, DOI 10.1016/j.actbio.2013.05.006
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Yu L, 2013, BIOMATER SCI-UK, V1, P411, DOI 10.1039/c2bm00159d
   Yue J, 2012, SOFT MATTER, V8, P7426, DOI 10.1039/c2sm25456e
   Zhang CQ, 2014, ACS APPL MATER INTER, V6, P5212, DOI 10.1021/am5005267
   Zhang JX, 2006, J BIOMED MATER RES A, V76A, P773, DOI 10.1002/jbm.a.30604
   Zhou YF, 2009, CHEM COMMUN, P1172, DOI 10.1039/b814560c
   Zhu FX, 2014, POLYMER, V55, P2977, DOI 10.1016/j.polymer.2014.05.010
NR 50
TC 9
Z9 9
U1 2
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 93
BP 51766
EP 51775
DI 10.1039/c4ra08351b
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA AS6QK
UT WOS:000344387400095
DA 2018-10-20
ER

PT S
AU Cho, EH
   Boico, A
   Wisniewski, NA
   Gant, R
   Helton, KL
   Brown, NL
   Register, JK
   Vo-Dinh, T
   Schroeder, T
   Klitzman, B
AF Cho, Eugenia H.
   Boico, Alina
   Wisniewski, Natalie A.
   Gant, Rebecca
   Helton, Kristen L.
   Brown, Nga L.
   Register, Janna K.
   Vo-Dinh, Tuan
   Schroeder, Thies
   Klitzman, Bruce
BE Lee, LP
   Rogers, JA
   Yun, SHA
TI Microvascular Integration into Porous PolyHEMA Scaffold
SO BIOINSPIRED, BIOINTEGRATED, BIOENGINEERED PHOTONIC DEVICES II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Bioinspired, Biointegrated, Bioengineered Photonic Devices
   II
CY FEB 01-02, 2014
CL San Francisco, CA
SP SPIE, SAMSUNG
DE biocompatibility; vascularization; mass transport; foreign body response
AB Biomaterials elicit foreign body responses when implanted into living tissue. While biocompatibility has been improved, the fundamental aspects of tissue responses to biomaterials and their in vivo evaluation remain poorly appreciated. Here, we quantified vascularization of porous poly2-hydroxyethylmethacrylate (polyHEMA) with 40 and 80 mu m nominal pore sizes at various time points after implantation in rat subcutis. Solid polyHEMA, silicone, and cotton materials were also studied for comparison. We observed vascularization into the material one week after implantation for both 40 and 80 mu m porous polyHEMA. The rate of vascularization was greater in 80 mu m polyHEMA, with higher vascular density in the material and adjacent tissues one week and one month post-implantation. The vascular density inside 80 mu m polyHEMA reached a maximum one month after implantation. In 40 mu m polyHEMA, the vascular density increased gradually over the two months following implantation. After two months, vascularization in the material was similar for both 40 and 80 mu m polyHEMA. Notably, despite similar levels of vascularization inside both porous materials at two months, the 80 mu m polyHEMA elicited greater vascularization in the critical 100 mu m margin of tissue around the implant, compared to other materials. In all materials except 80 mu m polyHEMA, we observed a narrow margin of significantly reduced vascularity at the implant-tissue interface. We conclude that implanted 80 mu m polyHEMA encourages vascularization, underscoring the importance of rigorous evaluation metrics to assess long-term performance of implanted biomaterials and guide future biomaterial optimization.
C1 [Cho, Eugenia H.; Boico, Alina; Brown, Nga L.; Register, Janna K.; Vo-Dinh, Tuan; Schroeder, Thies; Klitzman, Bruce] Duke Univ, Durham, NC 27710 USA.
   [Wisniewski, Natalie A.; Gant, Rebecca; Helton, Kristen L.] PROFUSA Corp, San Francisco, CA USA.
RP Cho, EH (reprint author), Duke Univ, Durham, NC 27710 USA.
EM klitz@duke.edu
RI Cho, Eugenia/G-2342-2015
OI Cho, Eugenia/0000-0001-5448-7895
FU Defense Advanced Research Projects Agency [W911NF-11-1-0119,
   HR0011-13-2-0003]; Fitzpatrick Institute for Photonics; Robert Jones
   Fund, Duke University
FX Funding: Supported in part by Defense Advanced Research Projects Agency
   grant numbers W911NF-11-1-0119 and HR0011-13-2-0003, the Fitzpatrick
   Institute for Photonics and the Robert Jones Fund, Duke University. The
   content of the information does not necessarily reflect the position or
   the policy of the Government, and no official endorsement should be
   inferred.
CR Ruckh T. T., 2013, ANAL CHEM
   Wang XD, 2013, ANAL CHEM, V85, P487, DOI 10.1021/ac303159b
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
NR 3
TC 1
Z9 1
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9871-7
J9 PROC SPIE
PY 2014
VL 8958
AR UNSP 89580B
DI 10.1117/12.2037950
PG 4
WC Biophysics; Engineering, Biomedical; Optics
SC Biophysics; Engineering; Optics
GA BB4XL
UT WOS:000343461700003
DA 2018-10-20
ER

PT J
AU Sokic, S
   Christenson, MC
   Larson, JC
   Appel, AA
   Brey, EM
   Papavasiliou, G
AF Sokic, S.
   Christenson, M. C.
   Larson, J. C.
   Appel, A. A.
   Brey, E. M.
   Papavasiliou, G.
TI Evaluation of MMP substrate concentration and specificity for
   neovascularization of hydrogel scaffolds
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID POLY(ETHYLENE GLYCOL) HYDROGELS; BIOMIMETIC PEGDA HYDROGELS; CLEAVAGE
   SITE PRESENTATION; CELL-MIGRATION; IN-VITRO; GROWTH; DEGRADATION;
   VASCULARIZATION; ANGIOGENESIS; INVASION
AB Controlled vascular response in scaffolds following implantation remains a significant clinical challenge. A critical biomaterial design criterion is the synchronization of the rates of scaffold degradation and vascularized tissue formation. Matrix metalloproteinases (MMPs) are key enzymes that regulate neovascularization and extracellular matrix remodelling. Synthetic protease-sensitive hydrogels offer controllable environments for investigating the role of matrix degradation on neovascularization. In this study, PEG hydrogels containing MMP-sensitive peptides with increased catalytic activity for MMPs expressed during neovascularization were investigated. Scaffolds were functionalized with MMP-2-, MMP-14- or general collagenase-sensitive peptides and with varying peptide concentration using crosslinkers containing one (SSite) or multiple (TSite) repeats of each protease-sensitive sequence. Increasing peptide concentration enhanced the degradation kinetics of scaffolds functionalized with MMP-specific sequences while 80% of the collagenase-sensitive scaffolds remained upon exposure to MMP-2 and MMP-14. In vitro neovascularization was consistent with in vivo tissue invasion with significantly increased invasion occurring within SSite MMP-specific as compared to collagenase-sensitive hydrogels and with further invasion in TSite as compared to SSite hydrogels regardless of peptide specificity. All scaffolds supported in vivo neovascularization; however, this was not dependent on peptide specificity. These findings demonstrate that peptide concentration and specificity regulate in vivo scaffold degradation, neovascularization and matrix remodelling.
C1 [Sokic, S.; Christenson, M. C.; Larson, J. C.; Appel, A. A.; Brey, E. M.; Papavasiliou, G.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Appel, A. A.; Brey, E. M.] Edward Hines Vet Adm Med Ctr, Res Serv, Hines, IL USA.
RP Sokic, S (reprint author), IIT, Dept Biomed Engn, 3255 South Dearborn St,Wishnick Hall Room 314, Chicago, IL 60616 USA.
EM papavasiliou@iit.edu
FU National Heart, Lung, and Blood Institute of the National Institutes of
   Health [R21HL094916]; Veterans Administration; Illinois Institute of
   Technology Educational Research Initiative Fund
FX This research was supported by the financial support of the National
   Heart, Lung, and Blood Institute of the National Institutes of Health
   (Award Number R21HL094916), the Veterans Administration and the Illinois
   Institute of Technology Educational Research Initiative Fund. The
   authors would like to thank the laboratory of Professor David Venerus in
   the Department of Chemical and Biological Engineering at the Illinois
   Institute of Technology for providing access for mechanical testing of
   our samples as well as the laboratory of Professor Joseph Orgel in the
   College of Science and Letters at the Illinois Institute of Technology
   for access to HPLC for peptide purification.
CR Bracher M, 2013, BIOMATERIALS, V34, P6797, DOI 10.1016/j.biomaterials.2013.05.057
   Brey EM, 2002, MICROVASC RES, V63, P279, DOI 10.1006/mvre.2002.2395
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066
   DeKosky BJ, 2010, TISSUE ENG PART C-ME, V16, P1533, DOI 10.1089/ten.tec.2009.0761
   Kraehenbuehl TP, 2009, BIOMATERIALS, V30, P4318, DOI 10.1016/j.biomaterials.2009.04.057
   Lee SH, 2005, BIOTECHNOL PROGR, V21, P1736, DOI 10.1021/bp0502429
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Nagase N., 1996, BIOPOLYMERS, V40, P399
   Nakatsu MN, 2003, LAB INVEST, V83, P1873, DOI 10.1097/01.LAB.0000107160.81875.33
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Saik JE, 2011, ACTA BIOMATER, V7, P133, DOI 10.1016/j.actbio.2010.08.018
   Sokic S, 2012, TISSUE ENG PT A, V18, P2477, DOI [10.1089/ten.tea.2012.0173, 10.1089/ten.TEA.2012.0173]
   Sokic S, 2012, ACTA BIOMATER, V8, P2213, DOI 10.1016/j.actbio.2012.03.017
   Sounni NE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00111
   Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273
   Turturro MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058897
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
NR 25
TC 9
Z9 9
U1 3
U2 28
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 10
BP 1343
EP 1354
DI 10.1039/c4bm00088a
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA AQ7XP
UT WOS:000343034000004
PM 28553543
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rooney, MK
   Woodhouse, KA
AF Rooney, M. K.
   Woodhouse, K. A.
TI Decreased tissue factor expression with increased CD11b upregulation on
   elastin-based biomaterial coatings
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID LEUKOCYTE ACTIVATION; NEUTROPHIL ADHESION; POLYSTYRENE BEADS;
   PLATELET-ADHESION; WHOLE-BLOOD; P-SELECTIN; IN-VIVO; FIBRINOGEN;
   COMPLEMENT; FLOW
AB Elastin-like polypeptide (ELP) coatings have been shown to have non-thrombogenic properties both in vitro and in vivo. In this work, we expand our understanding of this phenomenon by investigating the interaction of these coatings with leukocytes. Citrated whole blood was exposed to a shear rate of 300 s(-1) for 2 hours at 37 degrees C on ELP1- and ELP4-coated polyethylene terephthalate (Mylar T) surfaces in a cone and plate device. Scanning electron microscopy and flow cytometry were used to measure leukocyte activation and platelet-leukocyte aggregation in response to the ELP1 and ELP4 coatings on the surface and in the bulk, respectively. Surface analysis showed little leukocyte activity on the surface of uncoated positive controls. Both the tissue factor (TF) expression (indicative of leukocyte activation) and CD61 expression (indicative of platelet-leukocyte aggregates), in the bulk were decreased by 40% and 20%, respectively, with the ELP coating of Mylar T, while a two- to three-fold increase in CD11b upregulation (indicative of leukocyte activation) for ELP1 and ELP4 was determined. Two of three bulk markers indicated that ELP-coated Mylar T decreased the leukocyte response compared to the uncoated Mylar T, while the third, CD11b, indicated an increase in leukocyte response to the ELP coatings.
C1 [Rooney, M. K.; Woodhouse, K. A.] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
RP Rooney, MK (reprint author), Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
EM kim.woodhouse@queensu.ca
FU Science Foundation Ireland (SFI) [07/SRC/B1163]; Natural Sciences and
   Engineering Research Council (NSERC); Queen's University
FX Funding for this project was provided by Science Foundation Ireland
   (SFI) (07/SRC/B1163), Natural Sciences and Engineering Research Council
   (NSERC), and Queen's University. The authors would like to thank Dr
   Lillicrap's research group (Queen's University) for their assistance in
   blood collection and Mr Matt Gordon (Queen's University) for his
   expertise in flow cytometry. They would also like to thank Dr Brian
   Amsden for his support.
CR BACH R, 1990, P NATL ACAD SCI USA, V87, P6995, DOI 10.1073/pnas.87.18.6995
   BAINTON DF, 1987, J EXP MED, V166, P1641, DOI 10.1084/jem.166.6.1641
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   Bournazos S, 2008, ARTERIOSCL THROM VAS, V28, pE2, DOI 10.1161/ATVBAHA.107.153387
   CELI A, 1994, P NATL ACAD SCI USA, V91, P8767, DOI 10.1073/pnas.91.19.8767
   Chang X., 2012, J BIOMATER APPL, V0, P1
   Darling R. C., 1971, SURGERY, P472
   Defife KM, 1999, J BIOMAT SCI-POLYM E, V10, P1063, DOI 10.1163/156856299X00685
   Egorina EM, 2008, BLOOD, V111, P1208, DOI 10.1182/blood-2007-08-107698
   Eilertsen KE, 2004, BLOOD COAGUL FIBRIN, V15, P521, DOI 10.1097/00001721-200409000-00001
   ElHabbal MH, 1995, CARDIOVASC RES, V30, P676, DOI 10.1016/0008-6363(95)00069-0
   Eriksson C, 2001, J LAB CLIN MED, V137, P296, DOI 10.1067/mlc.2001.114066
   FAN ST, 1991, J CLIN INVEST, V87, P50, DOI 10.1172/JCI115000
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Gorbet M. B., 2006, HEMOSTASIS THROMBOSI, P751
   Gorbet MB, 2005, J BIOMED MATER RES A, V74A, P511, DOI 10.1002/jbm.a.30354
   Gorbet MB, 2003, J BIOMED MATER RES A, V67A, P792, DOI 10.1002/jbm.a.10155
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S
   Hathcock JJ, 2006, ARTERIOSCL THROM VAS, V26, P1729, DOI 10.1161/01.ATV.0000229658.76797.30
   Ito S, 1998, ANGIOLOGY, V49, P289, DOI 10.1177/000331979804900407
   Jaisson S, 2006, CHEM BIOL, V13, P149, DOI 10.1016/j.chembiol.2005.11.005
   Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   Kuijper PHM, 1997, BLOOD, V89, P2131
   LORANT DE, 1993, J CLIN INVEST, V92, P559, DOI 10.1172/JCI116623
   Lwaleed BA, 2006, J PATHOL, V208, P327, DOI 10.1002/path.1871
   Lytle BW, 2004, NEW ENGL J MED, V351, P2262, DOI 10.1056/NEJMp048238
   MORGAN BP, 1994, EUR J CLIN INVEST, V24, P219, DOI 10.1111/j.1365-2362.1994.tb01078.x
   Peerschke EIB, 1998, IMMUNOBIOLOGY, V199, P239, DOI 10.1016/S0171-2985(98)80030-2
   REPO H, 1995, J IMMUNOL METHODS, V185, P65, DOI 10.1016/0022-1759(95)00105-J
   Ross M. H., 2006, HISTOLOGY, P247
   SEMERARO N, 1983, IMMUNOLOGY, V50, P529
   SHEPPARD JI, 1994, J BIOMED MATER RES, V28, P1175, DOI 10.1002/jbm.820281008
   Skarja GA, 1997, J BIOMED MATER RES, V34, P427, DOI 10.1002/(SICI)1097-4636(19970315)34:4<427::AID-JBM4>3.3.CO;2-R
   Srokowski EM, 2011, J BIOMAT SCI-POLYM E, V22, P41, DOI 10.1163/092050609X12578498935594
   Srokowski E. M., 2013, J BIOMED MATER RES A, P1
   Tedesco F., 1999, MOL IMMUNOL, V36, P26
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   TURITTO VT, 1980, MICROVASC RES, V19, P352, DOI 10.1016/0026-2862(80)90054-0
   VROMAN L, 1980, BLOOD, V55, P156
   Walpoth BH, 2005, EXPERT REV MED DEVIC, V2, P647, DOI 10.1586/17434440.2.6.647
   Waterhouse A, 2011, TISSUE ENG PART B-RE, V17, P93, DOI [10.1089/ten.teb.2010.0432, 10.1089/ten.TEB.2010.0432]
   Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   Zhong D, 2013, BIOMATERIALS, V34, P294, DOI 10.1016/j.biomaterials.2012.09.060
NR 49
TC 0
Z9 0
U1 2
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 10
BP 1377
EP 1383
DI 10.1039/c4bm00099d
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA AQ7XP
UT WOS:000343034000007
DA 2018-10-20
ER

PT J
AU Wei, WL
   Xu, C
   Gao, N
   Ren, JS
   Qu, XG
AF Wei, Weili
   Xu, Can
   Gao, Nan
   Ren, Jinsong
   Qu, Xiaogang
TI Opposing enantiomers of tartaric acid anchored on a surface generate
   different insulin assemblies and hence contrasting cellular responses
SO CHEMICAL SCIENCE
LA English
DT Article
ID AMYLOID FIBRIL FORMATION; NERVE GROWTH-FACTOR; PROTEIN ADSORPTION;
   DESIGNING MATERIALS; ADHESION BEHAVIOR; MASS-SPECTROMETRY; NEURITE
   FORMATION; FACTOR-II; CELLS; PROLIFERATION
AB Chirality plays a pivotal role in biomolecule recognition, which is one of the key aspects of cell responses to a biomaterial surface. Generally, the effects of the properties of a biomaterial surface on cellular responses are modulated by adsorbed proteins. Surface chemistry, such as charge and hydrophobicity, has a profound effect on protein adsorption. Nevertheless, chirality has been seldom considered in biomaterial surface chemistry. Herein, using the classical biogenic chiral molecules, D-and L-tartaric acid, assembled into monolayers as a model chiral surface, we reported for the first time that surface chirality modulated insulin assembly, including the dynamics of adsorption, kinetics of the conformational transition and fibril formation, on D-and L-surfaces and determined the cellular effect of insulin on neuronal PC12 cells. On the D-surface, insulin retained its bioactivity; however, on the L-surface, insulin formed amyloid fibrils with lost bioactivity. Previous reports have demonstrated that insulin can act as growth and neuronal differentiation factors. The chiral surfaces that were preassembled with insulin exhibited contrasting cellular behaviours in proliferation and differentiation. High proliferation and a high differentiation rate were observed for PC12 cells on the insulin-adsorbed D-surface, whereas neither proliferation nor differentiation were observed for PC12 cells on the insulin-adsorbed L-surface. Since protein surface adsorption is ubiquitous for tissue engineering and cell adhesion, our work provides new insights into engineering novel biomaterials by taking into account surface chirality. Surface chirality is important and may determine cell fate on a chiral surface.
C1 [Wei, Weili; Xu, Can; Gao, Nan; Ren, Jinsong; Qu, Xiaogang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resource Utilizat, Lab Chem Biol,Div Biol Inorgan Chem, Changchun 130022, Jilin, Peoples R China.
RP Qu, XG (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resource Utilizat, Lab Chem Biol,Div Biol Inorgan Chem, Changchun 130022, Jilin, Peoples R China.
EM xqu@ciac.ac.cn
RI Qu, xiaogang/M-9472-2016; Wei, Weili/F-8112-2018
OI Wei, Weili/0000-0001-6363-3591
FU 973 Project [2011CB936004, 2012CB720602]; NSFC [21210002, 91213302,
   21303179]
FX This work was supported by the 973 Project (2011CB936004, 2012CB720602),
   and NSFC (21210002, 91213302, 21303179).
CR Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Benson K, 2014, MACROMOL BIOSCI, V14, P793, DOI 10.1002/mabi.201300485
   Bruce IJ, 2005, LANGMUIR, V21, P7029, DOI 10.1021/la050553t
   Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Dai B, 2013, P NATL ACAD SCI USA, V110, P8543, DOI 10.1073/pnas.1220711110
   DIKIC I, 1994, CURR BIOL, V4, P702, DOI 10.1016/S0960-9822(00)00155-X
   El-Gindi J, 2012, ANGEW CHEM INT EDIT, V51, P3716, DOI 10.1002/anie.201109144
   Evers F, 2010, PHYS CHEM CHEM PHYS, V12, P4375, DOI 10.1039/b925134k
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004
   Guo SL, 2006, BIOMACROMOLECULES, V7, P1630, DOI 10.1021/bm0600724
   HANEIN D, 1994, SCIENCE, V263, P1413, DOI 10.1126/science.8128221
   Hatakeyama H, 2005, BIOMATERIALS, V26, P5167, DOI 10.1016/j.biomaterials.2004.11.061
   Hatakeyama H, 2006, BIOMATERIALS, V27, P5069, DOI 10.1016/j.biomaterials.2006.05.019
   Howson SE, 2012, NAT CHEM, V4, P31, DOI 10.1038/nchem.1206
   Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LEVINE H, 1993, PROTEIN SCI, V2, P404
   Li YY, 2011, ANGEW CHEM INT EDIT, V50, P5860, DOI 10.1002/anie.201008206
   Li Z, 2013, ADV HEALTHC MATER, V2, P1377, DOI 10.1002/adhm.201200402
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Nettleton EJ, 2000, BIOPHYS J, V79, P1053, DOI 10.1016/S0006-3495(00)76359-4
   Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983
   Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200
   OKUSA H, 1994, LANGMUIR, V10, P3577, DOI 10.1021/la00022a034
   PARKER JL, 1989, J PHYS CHEM-US, V93, P6121, DOI 10.1021/j100353a034
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   RECIOPINTO E, 1984, P NATL ACAD SCI-BIOL, V81, P2562, DOI 10.1073/pnas.81.8.2562
   RECIOPINTO E, 1986, J NEUROSCI, V6, P1211
   Reichhart C, 2009, LANGMUIR, V25, P1047, DOI 10.1021/la802905s
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Secundo F, 2013, CHEM SOC REV, V42, P6250, DOI 10.1039/c3cs35495d
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smith MI, 2007, BIOPHYS J, V93, P2143, DOI 10.1529/biophysj.107.105338
   Sun TL, 2007, J AM CHEM SOC, V129, P1496, DOI 10.1021/ja0686155
   Tito P, 2000, J MOL BIOL, V303, P267, DOI 10.1006/jmbi.2000.4142
   Vreeland WN, 2002, CURR OPIN BIOTECH, V13, P87, DOI 10.1016/S0958-1669(02)00292-6
   Wang X, 2011, ADV FUNCT MATER, V21, P3276, DOI 10.1002/adfm.201101032
   Xia YH, 2011, NANOSCALE, V3, P1374, DOI 10.1039/c0nr00903b
   Xiang S, 2012, ANALYST, V137, P1669, DOI 10.1039/c2an15983j
   Zako T., 2008, BIOPHYS J, V96, P3331
   Zhou F, 2012, COLLOID SURFACE B, V90, P97, DOI 10.1016/j.colsurfb.2011.10.016
   Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200
NR 47
TC 11
Z9 11
U1 6
U2 43
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2041-6520
EI 2041-6539
J9 CHEM SCI
JI Chem. Sci.
PY 2014
VL 5
IS 11
BP 4367
EP 4374
DI 10.1039/c4sc01386g
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA AQ7NK
UT WOS:000343004300032
DA 2018-10-20
ER

PT J
AU Rao, L
   Ma, Y
   Zhuang, MJ
   Luo, TJ
   Wang, YY
   Hong, A
AF Rao, Lei
   Ma, Yi
   Zhuang, Manjiao
   Luo, Tianjie
   Wang, Yayu
   Hong, An
TI Chitosan-decorated selenium nanoparticles as protein carriers to improve
   the in vivo half-life of the peptide therapeutic BAY 55-9837 for type 2
   diabetes mellitus
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE BAY 55-9837; selenium nanoparticles; clearance; half-life; type 2
   diabetes
ID CYCLASE-ACTIVATING POLYPEPTIDE; ADENYLATE-CYCLASE; BIOPHARMACEUTICAL
   BENCHMARKS; DRUG-DELIVERY; TOXICITY; CELLS; AGONISTS; RELEASE; SYSTEM;
   SERUM
AB Purpose: As a potential protein therapeutic for type 2 diabetes mellitus (T2DM), BAY 55-9837 is limited by poor stability and a very short half-life in vivo. The purpose of this study was to construct a novel nanostructured biomaterial by conjugating BAY 55-9837 to chitosan-decorated selenium nanoparticles (CS-SeNPs) to prolong the in vivo half-life of BAY 55-9837 by reducing its renal clearance rate.
   Materials and methods: BAY 55-9837-loaded CS-SeNPs (BAY-CS-SeNPs) were prepared, and their surface morphology, particle size, zeta potential, and structure were characterized. The stability, protein-loading rate, and in vitro release of BAY 55-9837 from CS-SeNPs were also quantified. Additionally, a sensitive high-performance liquid chromatography (HPLC) assay was developed for the quantification of BAY 55-9837 in mouse plasma. Thereafter, mice were injected via the tail vein with either BAY 55-9837 or BAY-CS-SeNPs, and the plasma concentration of BAY 55-9837 was determined via our validated HPLC method at different time intervals postinjection. Relevant in vivo pharmacokinetic parameters (half-life, area under the curve from time 0 to last sampling point, observed clearance) were then calculated and analyzed.
   Results: BAY-CS-SeNPs were successfully synthesized, with diameters of approximately 200 nm. BAY-CS-SeNPs displayed good stability with a high protein-loading rate, and the release process of BAY 55-9837 from the CS-SeNPs lasted for over 70 hours, with the cumulative release reaching 78.9%. Moreover, the conjugation of CS-SeNPs to BAY 55-9837 significantly reduced its renal clearance to a rate of 1.56 mL/h and extended its half-life to 20.81 hours.
   Conclusion: In summary, our work provides a simple method for reducing the renal clearance rate and extending the half-life of BAY 55-9837 in vivo by utilizing CS-SeNPs as nanocarriers.
C1 [Rao, Lei; Ma, Yi; Zhuang, Manjiao; Luo, Tianjie; Wang, Yayu; Hong, An] Jinan Univ, Dept Cell Biol, Inst Med Biol, Guangdong Prov Key Lab Bioengn Med,Natl Engn Res, Guangzhou 510632, Guangdong, Peoples R China.
RP Hong, A (reprint author), Jinan Univ, Dept Cell Biol, Inst Med Biol, 601 Huangpu West Ave, Guangzhou 510632, Guangdong, Peoples R China.
EM anhong0881@163.com
FU NSFC [81373314]; Doctoral Program of Higher Education of China
   [20124401120012]; Natural Science Foundation of Guangdong Province
   [S2012010008756]; Special Fund for Subject Construction of Guangdong
   Province [2012KJCX0015]; Cooperation Project in Industry, Education and
   Research of Guangdong Province [2010B090400544]; National Technical
   Innovation Fund for Medium and Small-Size Enterprise, China
   [11C26214413218]; National 863 Project [2006AA02Z125]; Major Science and
   Technology Projects of Guangdong Province [2007B060310212]; National
   Project for Significant New Drug Development of the Ministry of Science
   and Technology of China [2012ZX09202301]; Ministry of Education in China
FX This work was supported by the grants from the NSFC (No 81373314), the
   Doctoral Program of Higher Education of China (No 20124401120012), the
   Natural Science Foundation of Guangdong Province (No S2012010008756),
   Special Fund for Subject Construction of Guangdong Province (No
   2012KJCX0015), the Cooperation Project in Industry, Education and
   Research of Guangdong Province and Ministry of Education in China (No
   2010B090400544), and the National Technical Innovation Fund for Medium
   and Small-Size Enterprise, China (No 11C26214413218). We also gratefully
   acknowledge financial support from the National 863 Project
   (2006AA02Z125), the Major Science and Technology Projects of Guangdong
   Province (2007B060310212), and the National Project for Significant New
   Drug Development of the Ministry of Science and Technology of China
   (2012ZX09202301). We would also like to thank Professor Tianfeng Chen
   from the Materials Chemistry Department of Jinan University for the
   FT-IR analysis.
CR ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
   Bertrand G, 1996, BRIT J PHARMACOL, V117, P764, DOI 10.1111/j.1476-5381.1996.tb15256.x
   Borboni P, 1999, ENDOCRINOLOGY, V140, P5530, DOI 10.1210/en.140.12.5530
   Charrois GJR, 2004, BBA-BIOMEMBRANES, V1663, P167, DOI 10.1016/j.bbamem.2004.03.006
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m
   Gao XY, 2002, ADV MATER, V14, P290, DOI 10.1002/1521-4095(20020219)14:4<290::AID-ADMA290>3.0.CO;2-U
   Gates B, 2002, ADV FUNCT MATER, V12, P219, DOI 10.1002/1616-3028(200203)12:3<219::AID-ADFM219>3.0.CO;2-U
   Imani M, 2010, AAPS PHARMSCITECH, V11, P1268, DOI 10.1208/s12249-010-9494-9
   Kljai K, 2001, BIOL TRACE ELEM RES, V83, P223, DOI 10.1385/BTER:83:3:223
   Lee C, 2013, INT J NANOMED, V8, P2975, DOI 10.2147/IJN.S48197
   Li YH, 2011, BIOMATERIALS, V32, P9068, DOI 10.1016/j.biomaterials.2011.08.001
   Liu W, 2012, ACS NANO, V6, P6578, DOI 10.1021/nn202452c
   Makhluf SBD, 2008, SMALL, V4, P1453, DOI 10.1002/smll.200701308
   MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x
   MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9
   MIYATA A, 1990, BIOCHEM BIOPH RES CO, V170, P643, DOI 10.1016/0006-291X(90)92140-U
   Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a
   Navarro-Alarcon M, 1999, SCI TOTAL ENVIRON, V228, P79, DOI 10.1016/S0048-9697(99)00034-0
   Pan CQ, 2007, J PHARMACOL EXP THER, V320, P900, DOI 10.1124/jpet.106.112276
   Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Singh Y, 2012, PHARM RES-DORDR, V29, P2377, DOI 10.1007/s11095-012-0763-z
   Torres SK, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1236-3
   Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729
   Tsutsumi M, 2002, DIABETES, V51, P1453, DOI 10.2337/diabetes.51.5.1453
   Walsh G, 2000, NAT BIOTECHNOL, V18, P831, DOI 10.1038/78720
   Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917
   Wang HL, 2007, FREE RADICAL BIO MED, V42, P1524, DOI 10.1016/j.freeradbiomed.2007.02.013
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Winzell MS, 2007, PEPTIDES, V28, P1805, DOI 10.1016/j.peptides.2007.04.024
   Yu B, 2012, INORG CHEM, V51, P8956, DOI 10.1021/ic301050v
   Yung SL, 2003, J BIOL CHEM, V278, P10273, DOI 10.1074/jbc.M211945200
   Zhang ES, 2005, LIFE SCI, V76, P1099, DOI 10.1016/j.lfs.2004.08.015
   Zhang SY, 2004, MATER LETT, V58, P2590, DOI 10.1016/j.matlet.2004.03.031
   Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007
NR 36
TC 11
Z9 11
U1 6
U2 52
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 4819
EP 4828
DI 10.2147/IJN.S67871
PG 10
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AQ9JI
UT WOS:000343167900001
PM 25378923
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Khandelwal, PC
   Agrawal, SS
   Namboothiry, MAG
   Gundiah, N
AF Khandelwal, Pranav C.
   Agrawal, Suchi S.
   Namboothiry, Manoj A. G.
   Gundiah, Namrata
TI Fabrication of a novel biomaterial with enhanced mechanical and
   conducting properties
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID POLY(VINYL ALCOHOL); THIN-FILMS; PEDOT-PSS; NETWORKS
AB Conducting polymers have the combined advantages of metal conductivity with ease in processing and biocompatibility; making them extremely versatile for biosensor and tissue engineering applications. However, the inherent brittle property of conducting polymers limits their direct use in such applications which generally warrant soft and flexible material responses. Addition of fillers increases the material compliance, but is achieved at the cost of reduced electrical conductivity. To retain suitable conductivity without compromising the mechanical properties, we fabricate an electroactive blend (dPEDOT) using low grade PEDOT: PSS as the base conducting polymer with polyvinyl alcohol as filler and glycerol as a dopant. Bulk dPEDOT films show a thermally stable response till 110 degrees C with over seven fold increase in room temperature conductivity as compared to 0.002 S cm(-1) for pristine PEDOT: PSS. We characterize the nonlinear stress-strain response of dPEDOT, well described using a Mooney-Rivlin hyperelastic model, and report elastomer-like moduli with ductility similar to fives times its original length. Dynamic mechanical analysis shows constant storage moduli over a large range of frequencies with corresponding linear increase in tan(delta). We relate the enhanced performance of dPEDOT with the underlying structural constituents using FTIR and AFM microscopy. These data demonstrate specific interactions between individual components of dPEDOT, and their effect on surface topography and material properties. Finally, we show biocompatibility of dPEDOT using fibroblasts that have comparable cell morphologies and viability as the control, which make dPEDOT attractive as a biomaterial.
C1 [Khandelwal, Pranav C.; Agrawal, Suchi S.; Gundiah, Namrata] Indian Inst Sci, Dept Mech Engn, Bangalore 560012, Karnataka, India.
   [Khandelwal, Pranav C.; Namboothiry, Manoj A. G.] Indian Inst Sci Educ & Res, Coll Engn Trivandrum Campus, Sch Phys, Thiruvananthapuram 695016, Kerala, India.
RP Gundiah, N (reprint author), Indian Inst Sci, Dept Mech Engn, Bangalore 560012, Karnataka, India.
EM namrata@mecheng.iisc.ernet.in
OI Namboothiry, Manoj/0000-0002-7805-1962
FU Department of Science (DST) and Technology for the Ramanujan fellowship
   [RJN-42]; DST [DST/TM/SERI/2k11/73(G)]; Ministry of Human Resources and
   Development, Government of India, through Indian Institute of Science
   Education and Research, Thiruvananthapuram;  [MERC/91]
FX 3T3 cells used in this study were obtained from Prof. P. Kondaiah's
   laboratory (IISc) for which we are grateful. We thank folks in the
   Biomechanics lab for help with various aspects of the study. We thank Dr
   Girish Kunte (CeNSE) for help with FTIR experiments and Prof Praveen
   Ramamurthy (IISc) for discussions. NG acknowledges Department of Science
   (DST) and Technology for the Ramanujan fellowship (RJN-42) and research
   grant (MERC/91) that supported this work. MAGN acknowledges DST for
   generous funding through the research project (DST/TM/SERI/2k11/73(G))
   and Ministry of Human Resources and Development, Government of India,
   through Indian Institute of Science Education and Research,
   Thiruvananthapuram.
CR Ahmad F, 2013, J ADV RES, V4, P155, DOI 10.1016/j.jare.2012.05.001
   Attia G, 2013, INT J ELECTROCHEM SC, V8, P5672
   Babu AR, 2014, EXP MECH, V54, P1177, DOI 10.1007/s11340-014-9895-x
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Chen CH, 2012, J APPL POLYM SCI, V125, P3134, DOI 10.1002/app.36474
   Chen CH, 2011, SYNTHETIC MET, V161, P2259, DOI 10.1016/j.synthmet.2011.08.031
   Choi JW, 2004, SYNTHETIC MET, V141, P293, DOI 10.1016/S0379-6779(03)00419-3
   Collazos-Castro JE, 2010, BIOMATERIALS, V31, P9244, DOI 10.1016/j.biomaterials.2010.08.057
   Ghosh S, 2001, SYNTHETIC MET, V121, P1321, DOI 10.1016/S0379-6779(00)01523-X
   Heraeus C. P. D., 2010, CLEVIOS TM P VP 4083
   Hidawati EN, 2011, INT J CHEM ENV ENG, V2, P309
   Karagkiozaki V, 2013, BBA-GEN SUBJECTS, V1830, P4294, DOI 10.1016/j.bbagen.2012.12.019
   Khandelwal P. K., 2014, THESIS INDIAN I SCI
   Kirchmeyer S, 2005, J MATER CHEM, V15, P2077, DOI 10.1039/b417803n
   Lang U, 2009, ADV FUNCT MATER, V19, P1215, DOI 10.1002/adfm.200801258
   Lang U, 2009, SYNTHETIC MET, V159, P473, DOI 10.1016/j.synthmet.2008.11.005
   Luo SC, 2008, LANGMUIR, V24, P8071, DOI 10.1021/la800333g
   Nardes AM, 2007, ADV MATER, V19, P1196, DOI 10.1002/adma.200602575
   Okuzaki H, 2003, MACROMOL RAPID COMM, V24, P261, DOI 10.1002/marc.200390038
   Ouyang J, 2004, POLYMER, V45, P8443, DOI 10.1016/j.polymer.2004.10.001
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Rodriguez AB, 2011, J MATER CHEM, V21, P19324, DOI 10.1039/c1jm13107a
   Romyen N, 2013, J MATER SCI-MATER EL, V24, P2897, DOI 10.1007/s10854-013-1188-0
   Sheha E, 2013, PHYS SCRIPTA, V88, DOI 10.1088/0031-8949/88/03/035701
   Suarez-Vargas J., 2014, REV LATINAM METAL MA, V35
   Vieyres A, 2013, MACROMOLECULES, V46, P889, DOI 10.1021/ma302563z
   Yang XM, 2010, RADIAT PHYS CHEM, V79, P606, DOI 10.1016/j.radphyschem.2009.12.017
   Zhang XT, 2010, J MATER CHEM, V20, P5080, DOI 10.1039/c0jm00050g
NR 28
TC 2
Z9 2
U1 0
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 42
BP 7327
EP 7333
DI 10.1039/c4tb01029a
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA AQ7ZD
UT WOS:000343038600004
DA 2018-10-20
ER

PT J
AU Patel, SP
   Vaishya, R
   Yang, XY
   Pal, D
   Mitra, AK
AF Patel, Sulabh P.
   Vaishya, Ravi
   Yang, Xiaoyan
   Pal, Dhananjay
   Mitra, Ashim K.
TI Novel Thermosensitive Pentablock Copolymers for Sustained Delivery of
   Proteins in the Treatment of Posterior Segment Diseases
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
DE Block copolymers; controlled drug delivery; in situ gelling system;
   intravitreal; ocular delivery; pentablock copolymers; posterior segment;
   sol-gel transition; sustained drug delivery; thermosensitive gel
ID PEG-PCL-PEG; TRIBLOCK COPOLYMER; AQUEOUS-SOLUTIONS; PLGA; DEGRADATION;
   INJECTION; COMPLICATIONS; BEVACIZUMAB; PEPTIDES; HYDROGEL
AB Biodegradable and injectable in situ thermosensitive hydrogels were investigated for sustained delivery of protein therapeutics in the treatment of ocular posterior segment neovascular diseases. A series of triblock (TB, polycaprolactone- polyethylene glycol-polycaprolactone (PCL-PEG-PCL), B-A-B) and pentablock copolymers (PBCs) (polylactic acid (PLA)-PCL-PEG-PCL-PLA (C-B-A-B-C) and PEG-PCL-PLA-PCL-PEG (A-B-C-B-A)) were synthesized and evaluated for their thermosensitive behavior. Effects of molecular weight, hydrophobicity and block arrangement on polymer crystallinity, sol-gel transition, micelle size, viscosity and in vitro drug release were examined. Results from sol-gel transition studies demonstrated that aqueous solutions of block copolymers can immediately transform to hydrogel upon exposure to physiological temperature. PBC provide significantly longer sustained release (more than 20 days) of IgG relative to TB copolymers. Moreover, kinematic viscosity of aqueous solution at 25 degrees C for A-B-C-B-A type of PBCs was noticeably lower than the TB (B-A-B) copolymers and other PBCs with C-B-A-B-C block arrangements suggesting desired syringe-ability. The presence of PLA blocks in PBCs (C-B-A-B-C and A-B-C-B-A) significantly reduces crystallinity. Hence, it is anticipated that PBCs will have a faster rate of degradation relative to PCL-PEG-PCL based TB copolymers. PBCs also exhibited excellent cell viability and biocompatibility on ARPE-19 (human retinal pigment epithelial cell line) and RAW-264.7 (mouse macrophage cells), likely rendering it safe for ocular applications. Owing to biodegradability, thermosensitivity, ease of handling and biocompatibility PBC hydrogels can be considered as promising biomaterial for sustained delivery of protein therapeutics to the back of the eye.
C1 [Patel, Sulabh P.; Vaishya, Ravi; Yang, Xiaoyan; Pal, Dhananjay; Mitra, Ashim K.] Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64108 USA.
RP Mitra, AK (reprint author), Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64108 USA.
EM mitraa@umkc.edu
RI Vaishya, Ravi/F-6498-2016
OI Vaishya, Ravi/0000-0002-7909-5019
FU NIH [R01 EY09171-14, RO1 EY10659-12]
FX This study was supported by NIH R01 EY09171-14 and NIH RO1 EY10659-12.
CR Barot M, 2013, FUTURE MED CHEM, V5, P301, DOI [10.4155/FMC.12.206, 10.4155/fmc.12.206]
   Bock F, 2007, INVEST OPHTH VIS SCI, V48, P2545, DOI 10.1167/iovs.06-0570
   Gong CY, 2009, ACTA BIOMATER, V5, P3358, DOI 10.1016/j.actbio.2009.05.025
   Gou ML, 2010, J BIOMED MATER RES A, V93A, P219, DOI 10.1002/jbm.a.32546
   Houchin ML, 2008, J PHARM SCI-US, V97, P2395, DOI 10.1002/jps.21176
   Huang MH, 2004, POLYMER, V45, P8675, DOI 10.1016/j.polymer.2004.10.054
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jager RD, 2004, RETINA-J RET VIT DIS, V24, P676, DOI 10.1097/00006982-200410000-00002
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Kulkarni AD, 2005, ADV DRUG DELIVER REV, V57, P1994, DOI 10.1016/j.addr.2005.09.003
   Lee DS, 2001, MACROMOL RAPID COMM, V22, P587, DOI 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8
   Liu CB, 2008, J BIOMED MATER RES B, V84B, P165, DOI 10.1002/jbm.30858
   Peyman GA, 2009, RETINA-J RET VIT DIS, V29, P875, DOI 10.1097/IAE.0b013e3181a94f01
   Prabhu A, 1998, J BIOMED MATER RES, V42, P655, DOI 10.1002/(SICI)1097-4636(19981215)42:4<655::AID-JBM23>3.3.CO;2-2
   Sampat KM, 2010, CURR OPIN OPHTHALMOL, V21, P178, DOI 10.1097/ICU.0b013e328338679a
   Singh S, 2007, INT J PHARM, V341, P68, DOI 10.1016/j.ijpharm.2007.03.054
   Alforja MS, 2011, JPN J OPHTHALMOL, V55, P425, DOI 10.1007/s10384-011-0038-y
   Van Tomme SR, 2008, INT J PHARM, V355, P1, DOI 10.1016/j.ijpharm.2008.01.057
   Zhang Y, 2012, J CONTROL RELEASE, V162, P119, DOI 10.1016/j.jconrel.2012.04.022
NR 20
TC 11
Z9 11
U1 4
U2 36
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8665
EI 1875-5305
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PY 2014
VL 21
IS 11
BP 1185
EP 1200
DI 10.2174/092986652111141001122054
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AR0DF
UT WOS:000343235900011
PM 25315374
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lee, HV
   Hamid, SBA
   Zain, SK
AF Lee, H. V.
   Hamid, S. B. A.
   Zain, S. K.
TI Conversion of Lignocellulosic Biomass to Nanocellulose: Structure and
   Chemical Process
SO SCIENTIFIC WORLD JOURNAL
LA English
DT Review
ID IONIC LIQUID PRETREATMENT; TEMPO-MEDIATED OXIDATION;
   ENZYMATIC-HYDROLYSIS; CORN STOVER; SUGARCANE BAGASSE; SOLID ACID;
   ETHANOL-PRODUCTION; MICROFIBRILLATED CELLULOSE; NANOCRYSTALLINE
   CELLULOSE; CATALYTIC CONVERSION
AB Lignocellulosic biomass is a complex biopolymer that is primary composed of cellulose, hemicellulose, and lignin. The presence of cellulose in biomass is able to depolymerise into nanodimension biomaterial, with exceptional mechanical properties for biocomposites, pharmaceutical carriers, and electronic substrate's application. However, the entangled biomass ultrastructure consists of inherent properties, such as strong lignin layers, low cellulose accessibility to chemicals, and high cellulose crystallinity, which inhibit the digestibility of the biomass for cellulose extraction. This situation offers both challenges and promises for the biomass biorefinery development to utilize the cellulose from lignocellulosic biomass. Thus, multistep biorefinery processes are necessary to ensure the deconstruction of noncellulosic content in lignocellulosic biomass, while maintaining cellulose product for further hydrolysis into nanocellulose material. In this review, we discuss the molecular structure basis for biomass recalcitrance, reengineering process of lignocellulosic biomass into nanocellulose via chemical, and novel catalytic approaches. Furthermore, review on catalyst design to overcome key barriers regarding the natural resistance of biomass will be presented herein.
C1 [Lee, H. V.; Hamid, S. B. A.; Zain, S. K.] Univ Malaya, IPS, Nanotechnol & Catalysis Res Ctr NANOCAT, Kuala Lumpur 50603, Malaysia.
RP Lee, HV (reprint author), Univ Malaya, IPS, Nanotechnol & Catalysis Res Ctr NANOCAT, 3rd Floor,Block A, Kuala Lumpur 50603, Malaysia.
EM leehweivoon@um.edu.my
RI ABD HAMID, SHARIFAH BEE/B-9749-2010
OI ABD HAMID, SHARIFAH BEE/0000-0002-5104-3938
FU Ministry of Higher Education Malaysia for Fundamental Research Grant
   Scheme (FRGS) [FP056-2013B]; High Impact Research (University of Malaya)
   [HIR F-000032]
FX The authors are grateful for cordial support from Ministry of Higher
   Education Malaysia for Fundamental Research Grant Scheme (FRGS, Project
   number: FP056-2013B) and High Impact Research (University of Malaya)
   (HIR F-000032).
CR Abdel-Halim ES, 2011, CARBOHYD POLYM, V86, P988, DOI 10.1016/j.carbpol.2011.05.051
   Abraham E, 2011, CARBOHYD POLYM, V86, P1468, DOI 10.1016/j.carbpol.2011.06.034
   Agbor VB, 2011, BIOTECHNOL ADV, V29, P675, DOI 10.1016/j.biotechadv.2011.05.005
   Alila S, 2013, IND CROP PROD, V41, P250, DOI 10.1016/j.indcrop.2012.04.028
   Melero JA, 2012, ENERG ENVIRON SCI, V5, P7393, DOI 10.1039/c2ee21231e
   Bai W, 2009, CELLULOSE, V16, P455, DOI 10.1007/s10570-009-9277-1
   Biao H., PREPARATION NANOCELL
   Bozell JJ, 2011, J AGR FOOD CHEM, V59, P9232, DOI 10.1021/jf201850b
   Brinchi L, 2013, CARBOHYD POLYM, V94, P154, DOI 10.1016/j.carbpol.2013.01.033
   Brodeur Gary, 2011, Enzyme Res, V2011, P787532, DOI 10.4061/2011/787532
   Cabiac A, 2011, APPL CATAL A-GEN, V402, P1, DOI 10.1016/j.apcata.2011.05.029
   Chen WS, 2011, CARBOHYD POLYM, V83, P1804, DOI 10.1016/j.carbpol.2010.10.040
   Chundawat SPS, 2011, ENERG ENVIRON SCI, V4, P973, DOI 10.1039/c0ee00574f
   Cybulska I, 2012, BIORESOURCE TECHNOL, V118, P30, DOI 10.1016/j.biortech.2012.05.073
   Correia JAD, 2013, BIORESOURCE TECHNOL, V139, P249, DOI 10.1016/j.biortech.2013.03.153
   de Campos A, 2013, CELLULOSE, V20, P1491, DOI 10.1007/s10570-013-9909-3
   Dutta S, 2012, RSC ADV, V2, P12575, DOI 10.1039/c2ra20922e
   FAN LT, 1980, BIOTECHNOL BIOENG, V22, P177, DOI 10.1002/bit.260220113
   Feng G., 2013, PRETREATMENT TECHNIQ, V115, P339, DOI DOI 10.1007/978-3-642-32735-3_15
   Fu DB, 2011, BIORESOURCE TECHNOL, V102, P7008, DOI 10.1016/j.biortech.2011.04.049
   Gindl W, 2004, APPL PHYS A-MATER, V79, P2069, DOI 10.1007/s00339-004-2864-y
   Grabber J. H., 2003, P CSSA ANN M LIGN FO, V45, P820
   Gullon P., 2010, The Open Agriculture Journal, V4, P135
   Guo F, 2012, PROG ENERG COMBUST, V38, P672, DOI 10.1016/j.pecs.2012.04.001
   Habibi Y, 2014, CHEM SOC REV, V43, P1519, DOI 10.1039/c3cs60204d
   Harmsen P, 2010, LIT REV PHYS CHEM PR
   Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027
   Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016
   [黄海 Huang Hai], 2013, [南京农业大学学报, Journal of Nanjing Agricultural University], V36, P1
   Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386
   [张帆 Zhang Fan], 2011, [石油化工, Petrochemical Technology], V40, P43
   Jiang F, 2013, CARBOHYD POLYM, V95, P32, DOI 10.1016/j.carbpol.2013.02.022
   JIMENEZ A, 1988, CHEM ENG J BIOCH ENG, V37, pB1, DOI 10.1016/0300-9467(88)80011-X
   Kamiya Y., 2013, COMPREHENSIVE INORGA, VII, P185
   Karimi K., 2013, BIOFUEL TECHNOLOGIES, P53, DOI DOI 10.1007/978-3-642-34519-7_3
   Khalil HPSA, 2012, CARBOHYD POLYM, V87, P963, DOI 10.1016/j.carbpol.2011.08.078
   Ko FK, 2004, NATO SCI SER II MATH, V169, P1, DOI 10.1007/978-1-4020-2550-1_1
   Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g
   Lai DM, 2011, ENERG ENVIRON SCI, V4, P3552, DOI 10.1039/c1ee01526e
   Lange J.-P., 2010, SUSTAINABLE DEV PROC, P171
   Lange J.P., 2007, CATALYSIS RENEWABLES
   Lanzafame P, 2012, CATAL TODAY, V179, P178, DOI 10.1016/j.cattod.2011.07.018
   Lavoine N, 2012, CARBOHYD POLYM, V90, P735, DOI 10.1016/j.carbpol.2012.05.026
   Lee JW, 2011, BIORESOURCE TECHNOL, V102, P5884, DOI 10.1016/j.biortech.2011.02.048
   Lee SH, 2009, BIOTECHNOL BIOENG, V102, P1368, DOI 10.1002/bit.22179
   Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066
   Li JH, 2012, CARBOHYD POLYM, V90, P1609, DOI 10.1016/j.carbpol.2012.07.038
   Li RJ, 2009, CARBOHYD POLYM, V76, P94, DOI 10.1016/j.carbpol.2008.09.034
   Limayem A, 2012, PROG ENERG COMBUST, V38, P449, DOI 10.1016/j.pecs.2012.03.002
   Lin L. Q., 2014, SCI TECHNOLOGY REV, V32, P56
   Lin YC, 2009, ENERG ENVIRON SCI, V2, P68, DOI 10.1039/b814955k
   Liu CG, 2006, CARBOHYD RES, V341, P2550, DOI 10.1016/j.carres.2006.07.017
   Liu HB, 2010, J PHYS CHEM B, V114, P4293, DOI 10.1021/jp9117437
   Liu L, 2009, BIORESOURCE TECHNOL, V100, P5865, DOI 10.1016/j.biortech.2009.06.048
   Liu ZS, 2012, BIORESOURCE TECHNOL, V119, P224, DOI 10.1016/j.biortech.2012.05.107
   Lopez-Linares JC, 2013, IND CROP PROD, V50, P525, DOI 10.1016/j.indcrop.2013.08.028
   Mandal A, 2011, CARBOHYD POLYM, V86, P1291, DOI 10.1016/j.carbpol.2011.06.030
   McDonough T. J., 1992, CHEM ORGANOSOLY DELI
   McIntosh S, 2010, BIORESOURCE TECHNOL, V101, P6718, DOI 10.1016/j.biortech.2010.03.116
   Metzger JO, 2009, NATURWISSENSCHAFTEN, V96, P279, DOI 10.1007/s00114-008-0479-4
   MIRON J, 1982, EUR J APPL MICROBIOL, V15, P83, DOI 10.1007/BF00499511
   Misono M, 2001, CHEM COMMUN, P1141, DOI 10.1039/b102573m
   Moe ST, 2012, ENRGY PROCED, V20, P50, DOI 10.1016/j.egypro.2012.03.007
   Mood SH, 2013, RENEW SUST ENERG REV, V27, P77, DOI 10.1016/j.rser.2013.06.033
   Mora-Pale M, 2011, BIOTECHNOL BIOENG, V108, P1229, DOI 10.1002/bit.23108
   Morales-delaRosa S, 2012, CHEM ENG J, V181, P538, DOI 10.1016/j.cej.2011.11.061
   Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025
   Palkovits R, 2011, CHEM COMMUN, V47, P576, DOI 10.1039/c0cc02263b
   Pedersen M, 2010, NEW BIOTECHNOL, V27, P739, DOI 10.1016/j.nbt.2010.05.003
   Peng BL, 2011, CAN J CHEM ENG, V89, P1191, DOI 10.1002/cjce.20554
   Perego C, 2010, CHEM ENG J, V161, P314, DOI 10.1016/j.cej.2010.01.036
   Perez J., 2002, International Microbiology, V5, P53
   Quievy N, 2010, POLYM DEGRAD STABIL, V95, P306, DOI 10.1016/j.polymdegradstab.2009.11.020
   Quiroz-Castañeda Rosa E, 2011, Biotecnol Apl, V28, P205
   Ramos LP, 2003, QUIM NOVA, V26, P863, DOI 10.1590/S0100-40422003000600015
   Refaat AA, 2012, COMPREHENSIVE RENEWABLE ENERGY, VOL 5: BIOMASS AND BIOFUEL PRODUCTION, P217, DOI 10.1016/B978-0-08-087872-0.00518-7
   Rinaldi R, 2009, ENERG ENVIRON SCI, V2, P610, DOI 10.1039/b902668a
   Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769
   Saito T, 2007, BIOMACROMOLECULES, V8, P2485, DOI 10.1021/bm0703970
   Sanchez O., 2011, DELIGNIFICATION PROC
   Morais JPS, 2013, CARBOHYD POLYM, V91, P229, DOI 10.1016/j.carbpol.2012.08.010
   Saratale G. D., 2012, African Journal of Biotechnology, V11, P1002
   Sathitsuksanoh N, 2012, CELLULOSE, V19, P1161, DOI 10.1007/s10570-012-9719-z
   Satyamurthy P, 2013, ENZYME MICROB TECH, V52, P20, DOI 10.1016/j.enzmictec.2012.09.002
   Sills DL, 2011, BIORESOURCE TECHNOL, V102, P1389, DOI 10.1016/j.biortech.2010.09.035
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7
   Sun ZY, 2011, BIORESOURCE TECHNOL, V102, P10929, DOI 10.1016/j.biortech.2011.09.071
   Tadesse H, 2011, ENERG ENVIRON SCI, V4, P3913, DOI 10.1039/c0ee00667j
   Taherdanak M, 2014, FUEL, V115, P714, DOI 10.1016/j.fuel.2013.07.094
   Tian JA, 2011, CHEM ENG TECHNOL, V34, P482, DOI 10.1002/ceat.201000409
   Tian J, 2010, CELLULOSE, V17, P587, DOI 10.1007/s10570-009-9391-0
   Tonoli GHD, 2012, CARBOHYD POLYM, V89, P80, DOI 10.1016/j.carbpol.2012.02.052
   Wang HY, 2012, J ENVIRON SCI-CHINA, V24, P473, DOI 10.1016/S1001-0742(11)60795-X
   Wendy PQN, 2012, J CLEAN PROD, V34, P57, DOI 10.1016/j.jclepro.2012.04.004
   Wettstein SG, 2012, CURR OPIN CHEM ENG, V1, P218, DOI 10.1016/j.coche.2012.04.002
   Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P1959, DOI 10.1016/j.biortech.2005.01.010
   Xiong R, 2012, CELLULOSE, V19, P1189, DOI 10.1007/s10570-012-9730-4
   Xiong Y, 2014, CHEM ENG J, V235, P349, DOI 10.1016/j.cej.2013.09.031
   Xu JL, 2010, BIORESOURCE TECHNOL, V101, P2900, DOI 10.1016/j.biortech.2009.12.015
   Yan YJ, 1996, BIORESOURCE TECHNOL, V57, P269, DOI 10.1016/S0960-8524(96)00103-4
   Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116
   Yang HP, 2006, ENERG FUEL, V20, P388, DOI 10.1021/ef0580117
   Yang PF, 2011, CHINESE J CATAL, V32, P716, DOI 10.1016/S1872-2067(10)60232-X
   Yi Zheng, 2009, International Journal of Agricultural and Biological Engineering, V2, P51, DOI 10.3965/j.issn.1934-6344.2009.03.051-068
   Yin DL, 2011, BIORESOURCE TECHNOL, V102, P5183, DOI 10.1016/j.biortech.2011.01.079
   Zavrel M, 2009, BIORESOURCE TECHNOL, V100, P2580, DOI 10.1016/j.biortech.2008.11.052
   Zhang CB, 2013, CELLULOSE, V20, P127, DOI 10.1007/s10570-012-9839-5
   Zhang Q, 2013, RENEW ENERG, V60, P127, DOI 10.1016/j.renene.2013.04.012
   Zhang ZY, 2012, BIORESOURCE TECHNOL, V120, P149, DOI 10.1016/j.biortech.2012.06.035
   Zhao JQ, 2013, CARBOHYD POLYM, V97, P695, DOI 10.1016/j.carbpol.2013.05.050
   Zhao J, 2011, BIOCHEM ENG J, V56, P158, DOI 10.1016/j.bej.2011.06.002
   Zhao XB, 2009, APPL MICROBIOL BIOT, V82, P815, DOI 10.1007/s00253-009-1883-1
   Zheng Y, 2013, APPL ENERG, V105, P1, DOI 10.1016/j.apenergy.2012.11.070
   Zhou CH, 2011, CHEM SOC REV, V40, P5588, DOI 10.1039/c1cs15124j
   Zhu L, 2008, BIORESOURCE TECHNOL, V99, P3817, DOI 10.1016/j.biortech.2007.07.033
NR 116
TC 29
Z9 30
U1 12
U2 131
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 1537-744X
J9 SCI WORLD J
JI Sci. World J.
PY 2014
AR 631013
DI 10.1155/2014/631013
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AR2WU
UT WOS:000343449400001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Shahabi, S
   Najafi, F
   Majdabadi, A
   Hooshmand, T
   Nazarpak, MH
   Karimi, B
   Fatemi, SM
AF Shahabi, Sima
   Najafi, Farhood
   Majdabadi, Abbas
   Hooshmand, Tabassom
   Nazarpak, Masoumeh Haghbin
   Karimi, Batool
   Fatemi, Seyyed Mostafa
TI Effect of Gamma Irradiation on Structural and Biological Properties of a
   PLGA-PEG-Hydroxyapatite Composite
SO SCIENTIFIC WORLD JOURNAL
LA English
DT Article
ID MOLECULAR-WEIGHT; MECHANICAL-PROPERTIES; SURFACE MODIFICATION; RAY
   IRRADIATION; ION IRRADIATION; FT-RAMAN; RADIATION; MICROSPHERES; BONE;
   DEGRADATION
AB Gamma irradiation is able to affect various structural and biological properties of biomaterials In this study, a composite of Hap/PLGA-PEG and their ingredients were submitted to gamma irradiation doses of 25 and 50 KGy. Various properties such as molecular weight (GPC), thermal behavior (DSC), wettability (contact angle), cell viability (MTT assay), and alkaline phosphatase activity were studied for the composites and each of their ingredients. The results showed a decrease in molecular weight of copolymer with no change in the glass transition and melting temperatures after gamma irradiation. In general gamma irradiation can increase the activation energy Delta H of the composites and their ingredients. While gamma irradiation had no effect on the wettability of copolymer samples, there was a significant decrease in contact angle of hydroxyapatite and composites with increase in gamma irradiation dose. This study showed an increase in biocompatibility of hydroxyapatite with gamma irradiation with no significant effect on cell viability in copolymer and composite samples. In spite of the fact that no change occurred in alkaline phosphatase activity of composite samples, results indicated a decrease in alkaline phosphatase activity in irradiated hydroxyapatites. These effects on the properties of PLGA-PEG-hydroxyapatite can enhance the composite application as a biomaterial.
C1 [Shahabi, Sima; Hooshmand, Tabassom; Fatemi, Seyyed Mostafa] Univ Tehran Med Sci, Sch Dent, Dept Dent Biomat, Tehran, Iran.
   [Najafi, Farhood] Inst Color Sci & Technol, Dept Resin & Addit, Tehran, Iran.
   [Majdabadi, Abbas] Univ Tehran Med Sci, Sch Dent, Laser Res Ctr Dent, Tehran, Iran.
   [Nazarpak, Masoumeh Haghbin] Amirkabir Univ Technol, NTRC, Tehran, Iran.
   [Karimi, Batool] Iranian Ctr Med Laser Res, ACECR Tehran Med Sci Branch, Tehran, Iran.
RP Fatemi, SM (reprint author), Univ Tehran Med Sci, Sch Dent, Dept Dent Biomat, End North Kargar St, Tehran, Iran.
EM fatemi_m@razi.tums.ac.ir
RI Hooshmand, Tabassom/N-2949-2018
OI Hooshmand, Tabassom/0000-0002-4552-6861; Shahabi,
   Sima/0000-0001-7666-3204
CR Albano C, 2006, MOL CRYST LIQ CRYST, V448, P243, DOI 10.1080/15421400500403283
   Alothman OY, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-95
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Bittner B, 1999, J CONTROL RELEASE, V59, P23, DOI 10.1016/S0168-3659(98)00170-9
   Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h
   CHAPIRO A, 1988, NUCL INSTRUM METH B, V32, P111, DOI 10.1016/0168-583X(88)90191-7
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Colaco R., 2006, MATER SCI FORUM, V514-516, P1054
   Dadbin S, 2014, POLYM INT, V63, P1063, DOI 10.1002/pi.4611
   Dorati R, 2008, AAPS PHARMSCITECH, V9, P718, DOI 10.1208/s12249-008-9103-3
   Dorati R, 2012, J BIOMAT SCI-POLYM E, V23, P2223, DOI 10.1163/156856211X613915
   Eslaminejad Mohamadreza Baghaban, 2010, Iranian Journal of Biotechnology, V8, P234
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Girija EK, 2008, J CERAM SOC JPN, V116, P320, DOI 10.2109/jcersj2.116.320
   Gorna K, 2003, POLYM DEGRAD STABIL, V79, P465, DOI 10.1016/S0141-3910(02)00362-2
   Guo XY, 2007, J BIOMED MATER RES A, V82A, P1022, DOI 10.1002/jbm.a.31200
   HAUSBERGER AG, 1995, PHARMACEUT RES, V12, P851, DOI 10.1023/A:1016256903322
   Herrero-Vanrell R, 2001, ADV DRUG DELIVER REV, V52, P5, DOI 10.1016/S0169-409X(01)00200-9
   Ignjatovic N., 2007, MATER SCI FORUM, P497
   JACOBS GP, 1995, J BIOMATER APPL, V10, P59, DOI 10.1177/088532829501000104
   Jo SY, 2012, RADIAT PHYS CHEM, V81, P846, DOI 10.1016/j.radphyschem.2012.03.013
   Kawasaki Y, 2010, J BIOMED MATER RES B, V92B, P161, DOI 10.1002/jbm.b.31502
   Kizil R, 2002, J AGR FOOD CHEM, V50, P3912, DOI 10.1021/jf011652p
   Kizil R, 2007, J SCI FOOD AGR, V87, P1244, DOI 10.1002/jsfa.2830
   Kohane DS, 2006, J BIOMED MATER RES A, V77A, P351, DOI 10.1002/jbm.a.30654
   Kubisz L, 2003, INT J BIOL MACROMOL, V33, P89, DOI 10.1016/S0141-8130(03)00071-0
   Milicevic D, 2010, NUCL INSTRUM METH B, V268, P2744, DOI 10.1016/j.nimb.2010.06.036
   Montanari L, 1998, J CONTROL RELEASE, V56, P219, DOI 10.1016/S0168-3659(98)00082-0
   Montanari L, 2003, J CONTROL RELEASE, V90, P281, DOI 10.1016/S0168-3659(03)00153-6
   Nechifor CD, 2009, ROM J PHYS, V54, P349
   Parthiban SP, 2008, NUCL INSTRUM METH B, V266, P911, DOI 10.1016/j.nimb.2008.02.026
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sagari ARA, 2008, NUCL INSTRUM METH B, V266, P2515, DOI 10.1016/j.nimb.2008.03.069
   Sayyah S. M., 2003, INT J POLYM MATER PO, V52, P1059
   Sen M, 2003, NUCL INSTRUM METH B, V208, P480, DOI 10.1016/S0168-583X(03)01111-X
   Sintzel MB, 1997, DRUG DEV IND PHARM, V23, P857, DOI 10.3109/03639049709148693
   Sonkawade RG, 2010, INDIAN J PURE AP PHY, V48, P453
   Suljovrujic E., 2003, RADIAT PHYS CHEM, V67, P375
   Takeuchi N, 2011, DENT MATER J, V30, P730, DOI 10.4012/dmj.2011-075
   Thanigaiarul K, 2013, CERAM INT, V39, P3027, DOI 10.1016/j.ceramint.2012.09.081
   VOLLAND C, 1994, J CONTROL RELEASE, V31, P293, DOI 10.1016/0168-3659(94)90012-4
   Yildirim Y, 2014, RADIAT PHYS CHEM, V96, P69, DOI 10.1016/j.radphyschem.2013.08.016
   You F., 2013, SCI WORLD J, V2013
NR 43
TC 7
Z9 7
U1 1
U2 9
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1537-744X
J9 SCI WORLD J
JI Sci. World J.
PY 2014
AR 420616
DI 10.1155/2014/420616
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AR4NM
UT WOS:000343563500001
PM 25574485
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Mirzasadeghi, A
   Narayanan, SS
   Ng, MH
   Sanaei, R
   Cheng, CH
   Bajuri, MY
   Shukur, MH
AF Mirzasadeghi, Alireza
   Narayanan, Sri Subanesh
   Ng, Min Hwei
   Sanaei, Reza
   Cheng, Chen Hui
   Bajuri, Mohd Yazid
   Shukur, Mohammad Hassan
TI Intramedullary cement osteosynthesis (IMCO): A pilot study in sheep
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Intramedullary cement osteosynthesis (IMCO); calcium phosphate cement
   (CPC); biomaterial; fracture; impending fracture; osteoporosis; internal
   fixation
ID BONE-CEMENT; BIOCOMPATIBILITY; FRACTURES; FIXATION
AB The application of bone substitutes and cements has a long standing history in augmenting fractures as a complement to routine fracture fixation techniques. Nevertheless, such use is almost always in conjunction with definite means of fracture fixation such as intramedullary pins or bone plates. The idea of using biomaterials as the primary fixation bears the possibility of simultaneous fixation and bone enhancement. Intramedullary recruitment of bone cements is suggested in this study to achieve this goal. However, as the method needs primary testings in animal models before human implementation, and since the degree of ambulation is not predictable in animals, this pilot study only evaluates the outcomes regarding the feasibility and safety of this method in the presence of primary bone fixators. A number of two sheep were used in this study. Tibial transverse osteotomies were performed in both animals followed by external skeletal fixation. The medullary canals, which have already been prepared by removing the marrow through proximal and distal drill holes, were then injected with calcium phosphate cement (CPC). The outcomes were evaluated postoperatively by standard survey radiographs, morphology, histology and biomechanical testings. Healing processes appeared uncomplicated until week four where one bone fracture recurred due to external fixator failure. The results showed 56% and 48% cortical thickening, compared to the opposite site, in the fracture site and proximal and distal diaphyses respectively. This bone augmentative effect resulted in 264% increase in bending strength of the fracture site and 148% increase of the same value in the adjacent areas of diaphyses. In conclusion, IMCO, using CPC in tibia of sheep, is safe and biocompatible with bone physiology and healing. It possibly can carry the osteopromotive effect of the CPCs to provide a sustained source of bone augmentation throughout the diaphysis. Although the results must be considered preliminary, this method has possible advantages over conventional methods of bone fixation at least in bones with compromised quality (i.e. osteoporosis and bone cysts), where rigid metal implants may jeopardize eggshell cortices.
C1 [Mirzasadeghi, Alireza] Taylors Univ, Sch Med, Dept Orthoped, Hosp Sungai Buloh, Sungai Buloh 47000, Selangor, Malaysia.
   [Narayanan, Sri Subanesh; Bajuri, Mohd Yazid; Shukur, Mohammad Hassan] Univ Kebangsaan Malaysia, Natl Univ Malaysia, Med Ctr UKMMC, Dept Orthoped & Traumatol, Kuala Lumpur 56000, Malaysia.
   [Ng, Min Hwei] Univ Kebangsaan Malaysia, Natl Univ Malaysia, Med Ctr UKMMC, Tissue Engeenering Ctr, Kuala Lumpur 56000, Malaysia.
   [Sanaei, Reza; Cheng, Chen Hui] Univ Putra Malaysia, Dept Veterinay Clin Studies, Serdang 43400, Selangor, Malaysia.
RP Mirzasadeghi, A (reprint author), Taylors Univ, Sch Med, Dept Orthoped, Hosp Sungai Buloh, Level 9D, Sungai Buloh 47000, Selangor, Malaysia.
EM alireza.mirzasadeghi@taylors.edu.my
OI Chen, Hui Cheng/0000-0003-3717-0831
CR Benzel EC, 1995, BIOMECHANICS SPINE S
   Buckwalter J.A., 2005, TUREKS ORTHOPAEDICS, P28
   Cohen M S, 1997, AORN J, V65, P958, DOI 10.1016/S0001-2092(06)62978-5
   Completo A, 2008, KNEE, V15, P227, DOI 10.1016/j.knee.2008.01.008
   Elizabeth P.F., 1998, J BONE JOINT SURG AM, V80, P1112
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   Jamsa T, 1998, BONE, V23, P155, DOI 10.1016/S8756-3282(98)00076-3
   JOHNSON RW, 1968, CLIN ORTHOP RELAT R, P5
   KUZMA AB, 1991, J AM ANIM HOSP ASSOC, V27, P239
   Lind P. J., 1989, Journal of the Association of Avian Veterinarians, V3, P203, DOI 10.2307/27670893
   Link DP, 2008, J BIOMED MATER RES A, V87A, P760, DOI 10.1002/jbm.a.31831
   Lobenhoffer P, 2002, J ORTHOP TRAUMA, V16, P143, DOI 10.1097/00005131-200203000-00001
   Mitzner E, 2009, MATER RES-IBERO-AM J, V12, P447, DOI 10.1590/S1516-14392009000400013
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/8756-3282(95)00026-A
   PUTNEY DL, 1983, J AM ANIM HOSP ASSOC, V19, P773
   Saffar Kaveh Pour Akbar, 2009, American Journal of Applied Sciences, V6, P463
   Simpson D, 2004, INJURY, V35, P913, DOI 10.1016/S0020-1383(03)00109-8
   Theiss F, 2005, BIOMATERIALS, V26, P4383, DOI 10.1016/j.biomaterials.2004.11.056
   Varner KE, 2005, AM J SPORT MED, V33, P1071, DOI 10.1177/0363546504271968
NR 20
TC 4
Z9 4
U1 0
U2 9
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2014
VL 24
IS 6
BP 2177
EP 2186
DI 10.3233/BME-141029
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ7NW
UT WOS:000343005700032
PM 25226916
DA 2018-10-20
ER

PT J
AU Ye, X
   Wang, Z
   Zhang, XH
   Zhou, M
   Cai, L
AF Ye, Xia
   Wang, Ze
   Zhang, Xianghua
   Zhou, Ming
   Cai, Lan
TI Hemocompatibility research on the micro-structure surface of a bionic
   heart valve
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Hemocompatibility; micro-structure surface; polyurethane; periodic
   space; bionic heart valve
ID NANOCRYSTALLINE DIAMOND; MECHANICAL-PROPERTIES; COMPATIBILITY;
   TRANSPARENT
AB In order to study how the geometric parameters and shape of the micro-structure surface of a bionic heart valve affects hemocompatibility, mastoid micro-structures with different periodic space were fabricated using a femtosecond laser on a polyurethane (PU) surface. The apparent contact angles of droplets on the micro-structure surfaces were measured to characterize their wettability. Then a series of blood compatibility experiments, including platelet adhesion, dynamic coagulation and hemolysis were completed. The experimental results showed that the micr-ostructure on the biomaterial surface helped improve its hydrophobicity and hemocompatibility. Also, the periodic space affected not only the hydrophobicity but also the hemocompatibility of the biomaterial. With the increasing of the periodic space, the apparent contact angle increased, the number of platelet adhesion decreased, the dynamic clotting time became longer and the hemolysis ratio reduced. In addition, the shape of the micro-structure also affected the hemocompatibility of the biomaterial.
C1 [Ye, Xia; Wang, Ze; Zhang, Xianghua] Jiangsu Univ Technol, Sch Mech Engn, Changzhou 213001, Jiangsu, Peoples R China.
   [Zhou, Ming; Cai, Lan] Jiangsu Univ, Ctr Photon Fabricat, Zhenjiang 212013, Jiangsu, Peoples R China.
RP Ye, X (reprint author), Jiangsu Univ Technol, Sch Mech Engn, Changzhou 213001, Jiangsu, Peoples R China.
EM yexia@jsut.edu.cn
FU Natural Science foundation of Jiangsu Province [BK2010203]; Key
   Laboratory Opening foundation of Jiangsu Province [GZ201109]; Jiangsu
   Overseas Research & Training Program for University Prominent Young &
   Middle-aged Teachers and Presidents
FX This research is supported by the Natural Science foundation of Jiangsu
   Province (BK2010203) and the Key Laboratory Opening foundation of
   Jiangsu Province (GZ201109) and Jiangsu Overseas Research & Training
   Program for University Prominent Young & Middle-aged Teachers and
   Presidents.
CR All N., 2006, THIN SOLID FILMS, V515, P59
   BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   Cao LL, 2010, FARADAY DISCUSS, V146, P57, DOI 10.1039/c003392h
   Cho KL, 2010, J PHYS CHEM C, V114, P11228, DOI 10.1021/jp103479k
   Ebert D, 2012, J COLLOID INTERF SCI, V368, P584, DOI 10.1016/j.jcis.2011.09.049
   Hung JM, 2012, PHYSCS PROC, V32, P696, DOI 10.1016/j.phpro.2012.03.620
   Hung JM, 2011, APPL SURF SCI, V257, P5508, DOI 10.1016/j.apsusc.2010.12.134
   Im M, 2010, SOFT MATTER, V6, P1401, DOI 10.1039/b925970h
   Jung YC, 2009, ACS NANO, V3, P4155, DOI 10.1021/nn901509r
   Krzysztof J., 2007, DIAM RELAT MATER, V16, P1004
   Leng YX, 2006, SURF COAT TECH, V201, P1012, DOI 10.1016/j.surfcoat.2006.01.024
   Narayan RJ, 2006, DIAM RELAT MATER, V15, P1935, DOI 10.1016/j.diamond.2006.08.024
   Xu LB, 2012, ACS APPL MATER INTER, V4, P1118, DOI 10.1021/am201750h
   Ye X, 2009, APPL SURF SCI, V255, P6686, DOI 10.1016/j.apsusc.2009.02.068
   Zhang JH, 2011, ADV MATER RES-SWITZ, V230-232, P420, DOI 10.4028/www.scientific.net/AMR.230-232.420
NR 15
TC 0
Z9 0
U1 1
U2 17
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2014
VL 24
IS 6
BP 2361
EP 2369
DI 10.3233/BME-141049
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ7NW
UT WOS:000343005700052
PM 25226936
DA 2018-10-20
ER

PT J
AU Putnam, AJ
AF Putnam, Andrew J.
TI The instructive role of the vasculature in stem cell niches
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID MICROVASCULAR ENDOTHELIAL-CELLS; GROWTH-FACTOR DELIVERY; MARROW STROMAL
   CELLS; MESENCHYMAL STEM; HEMATOPOIETIC STEM; BONE-MARROW; IN-VIVO;
   SELF-RENEWAL; PROGENITOR CELLS; CAPILLARY MORPHOGENESIS
AB An important hallmark of many adult stem cell niches is their proximity to the vasculature in vivo, a feature common to neural stem cells (NSCs), mesenchymal stem cells (MSCs) from bone marrow, adipose, and other tissues, hematopoietic stem cells (HSCs), and many tumor stem cells. This review summarizes key studies supporting the vasculature's instructive role in adult stem cell niches, and the putative underlying molecular mechanisms by which blood vessels in these niches exert control over progenitor cell fates. The importance of the perivascular niche for pathology, notably tumor metastasis and dormancy, is also highlighted. Finally, the implications of the perivascular regulation of stem and progenitor cells on biomaterial design and the impact on future research directions are discussed.
C1 Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Putnam, AJ (reprint author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
EM putnam@umich.edu
OI Putnam, Andrew/0000-0002-1262-4377
FU National Heart, Lung, and Blood Institute of the National Institutes of
   Health [R01HL085339, R01HL118259]
FX The author gratefully acknowledges financial support from the National
   Heart, Lung, and Blood Institute of the National Institutes of Health
   under award numbers R01HL085339 and R01HL118259.
CR Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027
   Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389
   Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437
   Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444
   Beckermann BM, 2008, BRIT J CANCER, V99, P622, DOI 10.1038/sj.bjc.6604508
   Blocki A, 2013, STEM CELLS DEV, V22, P2347, DOI 10.1089/scd.2012.0415
   Bordignon C, 2006, NATURE, V441, P1100, DOI 10.1038/nature04962
   Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001
   Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791
   Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Caplan AI, 2010, TISSUE ENG PT A, V16, P2415, DOI 10.1089/ten.TEA.2010.0216
   Carreira BP, 2010, STEM CELLS, V28, P1219, DOI 10.1002/stem.444
   Carrion B, 2013, EXP CELL RES, V319, P2964, DOI 10.1016/j.yexcr.2013.09.007
   Carrion B, 2010, BIOTECHNOL BIOENG, V107, P1020, DOI 10.1002/bit.22891
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057
   Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039
   Conway A, 2014, STEM CELLS, V32, P1220, DOI 10.1002/stem.1650
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Dardik A, 2005, J VASC SURG, V41, P321, DOI 10.1016/j.jvs.2004.11.016
   Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012
   Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27
   Franses JW, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001542
   FRIEDENSTEIN AJ, 1978, EXP HEMATOL, V6, P440
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767
   Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390
   Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963
   Grainger SJ, 2013, TISSUE ENG PT A, V19, P1209, DOI [10.1089/ten.tea.2012.0281, 10.1089/ten.TEA.2012.0281]
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224
   Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338
   Holst J, 2010, NAT BIOTECHNOL, V28, P1123, DOI 10.1038/nbt.1687
   Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Indraccolo S, 2009, CANCER RES, V69, P1314, DOI 10.1158/0008-5472.CAN-08-2791
   Infanger DW, 2013, ANNU REV BIOMED ENG, V15, P29, DOI 10.1146/annurev-bioeng-071811-150028
   Jackson WM, 2010, EXPERT OPIN BIOL TH, V10, P505, DOI 10.1517/14712591003610606
   Jeon JS, 2014, INTEGR BIOL-UK, V6, P555, DOI 10.1039/c3ib40267c
   Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015
   Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje
   Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279
   Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026
   Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57
   Kniazeva E, 2011, TISSUE ENG PT A, V17, P905, DOI [10.1089/ten.tea.2010.0275, 10.1089/ten.TEA.2010.0275]
   Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108
   Kobel S, 2011, CURR OPIN BIOTECH, V22, P690, DOI 10.1016/j.copbio.2011.07.001
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Kokovay E, 2006, J CEREBR BLOOD F MET, V26, P545, DOI 10.1038/sj.jcbfm.9600214
   Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   KOLLER MR, 1993, BIOTECHNOL BIOENG, V42, P909, DOI 10.1002/bit.260420802
   Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612
   Lee HJ, 2013, DIFFERENTIATION, V86, P92, DOI 10.1016/j.diff.2013.06.004
   Lee J, 2012, P NATL ACAD SCI USA, V109, P19638, DOI 10.1073/pnas.1208384109
   Lee ST, 2010, BIOMATERIALS, V31, P1219, DOI 10.1016/j.biomaterials.2009.10.054
   Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762
   Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5
   Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mason S, 2014, J DENT RES, V93, P55, DOI 10.1177/0022034513510530
   Mathieu C, 2008, MOL CELL NEUROSCI, V38, P569, DOI 10.1016/j.mcn.2008.05.005
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Moore MAS, 2012, NAT MED, V18, P1613, DOI 10.1038/nm.2992
   Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447
   NEHLS V, 1995, HISTOCHEM CELL BIOL, V104, P459, DOI 10.1007/BF01464336
   Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100
   Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048
   RAFII S, 1994, BLOOD, V84, P10
   RAFII S, 1995, BLOOD, V86, P3353
   Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Scotti C, 2013, P NATL ACAD SCI USA, V110, P3997, DOI 10.1073/pnas.1220108110
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505
   Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026
   Shin JW, 2014, CELL STEM CELL, V14, P81, DOI 10.1016/j.stem.2013.10.009
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Singh RK, 2013, BIOMATERIALS, V34, P9331, DOI 10.1016/j.biomaterials.2013.08.016
   Song JH, 2010, BLOOD, V115, P2592, DOI 10.1182/blood-2009-01-200071
   Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364
   Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025
   TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Urschel K, 2012, CLIN HEMORHEOL MICRO, V50, P143, DOI 10.3233/CH-2011-1450
   Vazin T, 2010, TRENDS BIOTECHNOL, V28, P117, DOI 10.1016/j.tibtech.2009.11.008
   Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009
   Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220
   Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969
   Wong KHK, 2012, ANNU REV BIOMED ENG, V14, P205, DOI [10.1146/annurev-bioeng-071811-150052, 10.1146/annurev.bioeng-071811-150052]
   Yeon JH, 2012, LAB CHIP, V12, P2815, DOI [10.1039/c2lc40131b, 10.1039/C2LC40131B]
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
   Zhang QZ, 2012, J DENT RES, V91, P1011, DOI 10.1177/0022034512461016
   Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109
   Zhou J, 2014, ARTERIOSCL THROM VAS, V34, P2191, DOI 10.1161/ATVBAHA.114.303422
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 126
TC 10
Z9 9
U1 1
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 11
BP 1562
EP 1573
DI 10.1039/c4bm00200h
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA AQ7XR
UT WOS:000343034200003
PM 25530848
OA Green Accepted
DA 2018-10-20
ER

PT J
AU McCreedy, DA
   Wilems, TS
   Xu, H
   Butts, JC
   Brown, CR
   Smith, AW
   Sakiyama-Elbert, SE
AF McCreedy, D. A.
   Wilems, T. S.
   Xu, H.
   Butts, J. C.
   Brown, C. R.
   Smith, A. W.
   Sakiyama-Elbert, S. E.
TI Survival, differentiation, and migration of high-purity mouse embryonic
   stem cell-derived progenitor motor neurons in fibrin scaffolds after
   sub-acute spinal cord injury
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID PROMOTE LOCOMOTOR RECOVERY; STEM/PROGENITOR CELLS; CONTROLLED-RELEASE;
   GROWTH-FACTOR; TRANSGENIC ENRICHMENT; FUNCTIONAL RECOVERY; PRECURSOR
   CELLS; RAT; TRANSPLANTATION; OLIGODENDROCYTES
AB Embryonic stem (ES) cells can be differentiated into many neural cell types that hold great potential in cell replacement therapies following spinal cord injury (SCI). Coupling stem cell transplantation with biomaterial scaffolds can produce a unified combination therapy with several potential advantages including enhanced cell survival, greater transplant retention, reduced scarring, and improved integration at the transplant/host interface. Undesired cell types, however, are commonly present in ES-cell derived cultures due to the limited efficiency of most ES cell induction protocols. Heterogeneous cell populations can confound the interaction between the biomaterial and specific neural populations leading to undesired outcomes. In particular, biomaterial scaffolds may enhance tumor formation by promoting survival and proliferation of undifferentiated ES cells that can persist after induction. Methods for purification of specific ES cell-derived neural populations are necessary to recognize the full potential of combination therapies involving biomaterials and ES cell-derived neural populations. We previously developed a method for enriching ES cell-derived progenitor motor neurons (pMNs) induced from mouse ES cells via antibiotic selection and showed that the enriched cell populations are depleted of pluripotent stem cells. In this study, we demonstrate the survival and differentiation of enriched pMNs within three dimensional (3D) fibrin scaffolds in vitro and when transplanted into a sub-acute dorsal hemisection model of SCI into neurons, oligodendrocytes and astrocytes.
C1 [McCreedy, D. A.; Wilems, T. S.; Xu, H.; Butts, J. C.; Brown, C. R.; Smith, A. W.; Sakiyama-Elbert, S. E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63112 USA.
RP McCreedy, DA (reprint author), Washington Univ, Dept Biomed Engn, St Louis, MO 63112 USA.
EM sakiyama@wustl.edu
RI Sakiyama-Elbert, Shelly/A-6753-2008
OI Sakiyama-Elbert, Shelly/0000-0003-4832-5851
FU NIH RO1 grant [5R01NS051454]; NSF GRFP [DGE-1143954]
FX The authors were funded by the NIH RO1 grant 5R01NS051454. Support was
   provided for Dylan McCreedy by the NSF GRFP DGE-1143954.
CR Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029
   Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303
   BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   BANIK NL, 1982, NEUROCHEM RES, V7, P1465, DOI 10.1007/BF00965089
   Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099
   Bozkurt G, 2010, NEUROSURGERY, V67, P1733, DOI 10.1227/NEU.0b013e3181f9af35
   Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536
   Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exner.2002.7981
   Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8
   Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   Erceg S, 2010, STEM CELLS, V28, P1541, DOI 10.1002/stem.489
   Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB
   Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Iwata A, 2006, TISSUE ENG, V12, P101, DOI 10.1089/ten.2006.12.101
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126
   Liu XZ, 1997, J NEUROSCI, V17, P5395
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   McCreedy DA, 2014, BIOTECHNOL BIOENG, V111, P2041, DOI 10.1002/bit.25260
   McCreedy DA, 2012, STEM CELL RES, V8, P368, DOI 10.1016/j.scr.2011.12.003
   Meijer DH, 2012, NAT REV NEUROSCI, V13, P819, DOI 10.1038/nrn3386
   Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756
   Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108
   Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042
   Patel V, 2010, J NEUROTRAUM, V27, P789, DOI 10.1089/neu.2008.0809
   QUITSCHKE WW, 1989, J BIOL CHEM, V264, P9539
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Schumacher PA, 2000, J NEUROCHEM, V74, P1646, DOI 10.1046/j.1471-4159.2000.0741646.x
   SEILERTUYNS A, 1984, P NATL ACAD SCI-BIOL, V81, P2980, DOI 10.1073/pnas.81.10.2980
   Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245
   Smith AW, 2013, BIOMATERIALS, V34, P6559, DOI 10.1016/j.biomaterials.2013.05.050
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774
NR 44
TC 29
Z9 29
U1 1
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 11
BP 1672
EP 1682
DI 10.1039/c4bm00106k
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AQ7XR
UT WOS:000343034200012
PM 25346848
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Bang, LT
   Othman, R
AF Le Thi Bang
   Othman, Radzali
TI AGING TIME AND SYNTHESIS PARAMETERS OF NANOCYSTALLINE SINGLE PHASE
   HYDROXYAPATITE PRODUCED BY A PRECIPITATION METHOD
SO CERAMICS-SILIKATY
LA English
DT Article
DE Hydroxyapatite; Aging time; Calcinations; Phase purity; Biomaterial
ID THERMAL-STABILITY; NANOCRYSTALLINE HYDROXYAPATITE; ROUTE; BONE;
   TEMPERATURE; SCAFFOLDS
AB Hydroxyapatite (HA) is the major inorganic component in hard tissue of the human body, such as dental and bone. However, there is a great challenge to produce high purity phase HA with nano-size particles. In this research work, precipitation method is a successful route to synthesize purity nanocrystalite hydroxyapatite (HA) at low temperature. The effects of stirring speed and aging time during the precipitation process on the formation of nanocrystalline HA were investigated. The results indicated that the stoichiometric pure HA powders with nano-sized, rod-like particles of about 8.7 - 20.7 nm in width and 44.2 - 107.0 nm in length were successfully produced. In order to study the thermal stability, as-prepared HA powders were calcined at different temperatures of 850, 1000 and 1200 degrees C for 1 hour It was concluded that purity HA had excellent thermal stability up to 1200 degrees C when the aging time is prolonged to 24 hours.
C1 [Le Thi Bang; Othman, Radzali] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Nibong Tebal 14300, Penang, Malaysia.
   [Le Thi Bang] Univ Malaya, Ctr Adv Mfg & Mat Proc, Dept Mech Engn, Kuala Lumpur 50603, Malaysia.
RP Bang, LT (reprint author), Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Nibong Tebal 14300, Penang, Malaysia.
EM lebang@um.edu.my
FU Japan International Cooperation Agency (JICA); Ministry of Higher
   Education Malaysia
FX This study was in part supported by the AUN/SEED-Net project under the
   Japan International Cooperation Agency (JICA) and by the Ministry of
   Higher Education Malaysia grants.
CR Afshar A, 2003, MATER DESIGN, V24, P197, DOI 10.1016/S0261-3069(03)00003-7
   Bianco A, 2009, MATER RES BULL, V44, P345, DOI 10.1016/j.materresbull.2008.05.013
   Binnaz H., 2009, DIG J NANOMATER BIOS, V4, P73
   Cabrera JL, 2011, J NANOSCI NANOTECHNO, V11, P5555, DOI 10.1166/jnn.2011.3433
   Donadel K, 2005, J AM CERAM SOC, V88, P2230, DOI 10.1111/j.1551-2916.2005.00433.x
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Feng W, 2005, MATER LETT, V59, P916, DOI DOI 10.1016/J.MATLET.2004.08.041
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Iwasaki T, 2013, INT J MOL SCI, V14, P9365, DOI 10.3390/ijms14059365
   Joyce Y, 2007, BIOMATERIALS
   Kothapalli C, 2004, ACTA MATER, V52, P5655, DOI 10.1016/j.actamat.2004.08.027
   Koumoulidis GC, 2003, J COLLOID INTERF SCI, V259, P254, DOI 10.1016/S0021-9797(02)00233-3
   Lazic S, 2001, THERMOCHIM ACTA, V374, P13, DOI 10.1016/S0040-6031(01)00453-1
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Maria V. R., 2005, J MATER CHEM, V15, P1509
   Meejoo S, 2006, THERMOCHIM ACTA, V447, P115, DOI 10.1016/j.tca.2006.04.013
   Miller F.A, 2004, COURSE NOTES INTERPR, P300
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Padmanabhan SK, 2009, PARTICUOLOGY, V7, P466, DOI 10.1016/j.partic.2009.06.008
   Ramanan SR, 2004, MATER LETT, V58, P3320, DOI 10.1016/j.matlet.2004.06.030
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rhee SH, 2002, BIOMATERIALS, V23, P1147, DOI 10.1016/S0142-9612(01)00229-0
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Saeri MR, 2003, MATER LETT, V57, P4064, DOI 10.1016/S0167-577X(03)00266-0
   Shinnosuke O., 2010, ACTA BIOMATER, V6, P591
   Tang XL, 2005, MATER LETT, V59, P3841, DOI 10.1016/j.matlet.2005.06.060
   Xie ML, 2010, ACTA BIOMATER, V6, P3665, DOI 10.1016/j.actbio.2010.03.034
   Yang ZW, 2004, MATER LETT, V58, P3586, DOI 10.1016/j.matlet.2004.06.046
NR 28
TC 2
Z9 2
U1 0
U2 1
PU INST CHEMICAL TECHNOLOGY, DEPT GLASS CERAMICS
PI PRAGUE
PA TECHNICKA 5, PRAGUE 166 28, CZECH REPUBLIC
SN 0862-5468
EI 1804-5847
J9 CERAM-SILIKATY
JI Ceram.-Silik.
PY 2014
VL 58
IS 2
BP 157
EP 164
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA AQ4AY
UT WOS:000342735800012
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zilm, ME
   Staruch, M
   Jain, M
   Wei, M
AF Zilm, M. E.
   Staruch, M.
   Jain, M.
   Wei, Mei
TI An intrinsically magnetic biomaterial with tunable magnetic properties
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID IRON-OXIDE NANOPARTICLES; PHOSPHATE-GLASSES; SUBSTITUTED HYDROXYAPATITE;
   CANCER-THERAPY; SPECTROSCOPY; FLUORAPATITE; PARTICLE; IONS
AB Many magnetic materials lack intrinsic biocompatibility and require surface functionalization for in vivo applications. In this study, we fabricated an intrinsically biocompatible, biodegradable magnetic material through iron substitution into hydroxyapatite (FeHA) via ion-exchange. Controlling the oxidation state of iron in the ion exchange solution resulted in 'tunable' magnetic properties. Superparamagnetic behavior was observed in Fe(2+)HA and Fe(2+3+)HA and paramagnetism in Fe(3+)HA. FeHA powders were characterized using field emission scanning electron microscopy (FESEM), X-ray diffraction (XRD), Fourier transform infra-red (FTIR) and X-ray photoelectron spectroscopy (XPS) with no detection of iron oxide phases. The as-synthesized HA and Fe(2+3+)HA samples were characterized in vitro using MC3T3-E1 cells. Cellular proliferation of Fe(2+3+)HA was found comparable to HA, while our cytotoxicity results from a lactate dehydrogenase assay showed Fe(2+3+)HA to be less toxic than pure HA, a widely used implantable biomaterial. Thus, these results collectively suggest that we have fabricated a magnetic biomaterial with intrinsic biocompatibility.
C1 [Zilm, M. E.; Staruch, M.; Jain, M.; Wei, Mei] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06268 USA.
RP Wei, M (reprint author), Univ Connecticut, Dept Mat Sci & Engn, 97 N Eagleville Rd,Unit 3136, Storrs, CT 06268 USA.
EM meiwei@engr.uconn.edu
RI Staruch, Margo/M-9260-2015
OI Staruch, Margo/0000-0003-3088-2553; Jain, Menka/0000-0002-2264-6895
FU NSF [CBET-1133883, CBET-1347130, DMR 1310149]; NSF GK-12 program
   [0947869]
FX The authors would like to thank NSF grants (CBET-1133883 and
   CBET-1347130) and the NSF GK-12 program (0947869) for their support. For
   magnetic measurements, author MJ would like to thank the support from
   the NSF grant (DMR 1310149). The authors would also like to thank Dr.
   Heng Zhang for his aid in XPS experiments.
CR Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005
   Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067
   Ernsting MJ, 2013, J CONTROL RELEASE, V172, P782, DOI 10.1016/j.jconrel.2013.09.013
   Fortune WB, 1938, IND ENG CHEM, V10, P0060, DOI 10.1021/ac50118a004
   Goya GF, 2008, CURR NANOSCI, V4, P1, DOI 10.2174/157341308783591861
   Gross K.A., 2002, EUR CELLS MATER, V3, P114
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Hou C., 2009, BIOMATERIALS, V20, P1
   Huang J, 2010, ACS NANO, V4, P7151, DOI 10.1021/nn101643u
   Hughes S, 2005, MED ENG PHYS, V27, P754, DOI 10.1016/j.medengphy.2005.04.006
   Hughes S, 2007, J BIOMECH, V40, pS96, DOI 10.1016/j.jbiomech.2007.03.002
   Issa B, 2013, INT J MOL SCI, V14, P21266, DOI 10.3390/ijms141121266
   Jiang M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224107
   Khachani M, 2010, APPL CATAL A-GEN, V388, P113, DOI 10.1016/j.apcata.2010.08.043
   Kim DK, 2003, CHEM MATER, V15, P1617, DOI 10.1021/cm021349j
   Kolhatkar AG, 2013, INT J MOL SCI, V14, P15977, DOI 10.3390/ijms140815977
   Korzenski MB, 1999, J SOLID STATE CHEM, V147, P390, DOI 10.1006/jssc.1999.8392
   Kramer E. R., 2012, J MATER SCI, V48, P665
   Lee J, 2008, SMALL, V4, P143, DOI 10.1002/smll.200700456
   Lee Y, 2005, ADV FUNCT MATER, V15, P503, DOI 10.1002/adfm.200400187
   Li Y, 2012, J MATER SCI, V47, P754, DOI 10.1007/s10853-011-5851-7
   Liu ZL, 2004, J MAGN MAGN MATER, V283, P258, DOI 10.1016/j.jmmm.2004.05.031
   Marasinghe GK, 1997, J NON-CRYST SOLIDS, V222, P144, DOI 10.1016/S0022-3093(97)00393-1
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   Motskin M, 2009, BIOMATERIALS, V30, P3307, DOI 10.1016/j.biomaterials.2009.02.044
   Nath S, 2009, CHEM MATER, V21, P1761, DOI 10.1021/cm8031863
   Panseri S., 2012, J NANOBIOTECHNOL, V10
   POSNER AS, 1958, ACTA CRYSTALLOGR, V11, P308, DOI 10.1107/S0365110X58000815
   REGNIER P, 1994, AM MINERAL, V79, P809
   Ribeiro CC, 2006, BIOMATERIALS, V27, P1749, DOI 10.1016/j.biomaterials.2005.09.043
   Salim MA, 2001, J NON-CRYST SOLIDS, V289, P185, DOI 10.1016/S0022-3093(01)00727-X
   Silva AKA, 2013, ACS NANO, V7, P4954, DOI 10.1021/nn400269x
   Soenen SJH, 2011, BIOMATERIALS, V32, P195, DOI 10.1016/j.biomaterials.2010.08.075
   Song YN, 2002, INORG CHEM, V41, P5778, DOI 10.1021/ic025688q
   Tampieri A, 2011, TRENDS BIOTECHNOL, V29, P526, DOI 10.1016/j.tibtech.2011.04.011
   TANIZAWA Y, 1990, J CHEM SOC FARADAY T, V86, P1071, DOI 10.1039/ft9908601071
   Thomas CR, 2010, J AM CHEM SOC, V132, P10623, DOI 10.1021/ja1022267
   Wei M, 2003, J MATER SCI-MATER M, V14, P311, DOI 10.1023/A:1022975730730
   Wu H.-C., 2007, NONOTECHNOLOGY, V18, P9
   Wu HC, 2010, ADV FUNCT MATER, V20, P67, DOI 10.1002/adfm.200901108
   Yu DH, 2007, J PHYS CHEM C, V111, P14394, DOI 10.1021/jp072893o
   Yu X., 2013, BIOMED RES INT, V2013, P1
   Yu XY, 1997, J NON-CRYST SOLIDS, V215, P21, DOI 10.1016/S0022-3093(97)00022-7
   Yuan Y, 2010, BIOMATERIALS, V31, P730, DOI 10.1016/j.biomaterials.2009.09.088
   Zakaria SM, 2013, TISSUE ENG PART B-RE, V19, P431, DOI [10.1089/ten.teb.2012.0624, 10.1089/ten.TEB.2012.0624]
NR 45
TC 12
Z9 12
U1 0
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 41
BP 7176
EP 7185
DI 10.1039/c4tb00925h
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AQ4KA
UT WOS:000342763700011
DA 2018-10-20
ER

PT J
AU Keremidarska, M
   Radeva, E
   Pramatarova, L
   Krasteva, N
AF Keremidarska, Milena
   Radeva, Ekaterina
   Pramatarova, Lilyana
   Krasteva, Natalia
TI ALTERATION IN MORPHOLOGY AND CYTOSKELETON ORGANISATION OF MESENCHYMAL
   STEM CELLS CULTURED ON PLASMA MODIFIED POLYMER FILMS
SO COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES
LA English
DT Article
DE mesenchymal stem cells; plasma modification; cell morphology
ID SURFACES; BONE; BIOMATERIALS; ATTACHMENT; ADHESION; ALLOY
AB Cell morphology and organisation of actin cytoskeleton are closely related to all essential for cells processes including adhesion, growth and differentiation. Therefore, both cell characteristics can be used to assess the tissue compatibility of a biomaterial. Many approaches have been used to modify biomaterials surface in order to improve their interactions with cells. In the present work, we have modified the surface of a synthetic polymer, plasma polymerised hexamethyldisiloxane (PPHMDS) using two approaches: treatment in ammonia plasma and plasma deposition of detonation nanodiamond (DND) particles, and have studied the alteration in cell morphology, adhesion and actin cytoskeleton organisation in rat mesenchymal stem cells (rMSCs) in order to assess suitability of plasma modified polymer films as cell adhesion substrata for tissue engineering application.
C1 [Keremidarska, Milena; Krasteva, Natalia] Bulgarian Acad Sci, Inst Biophys & Biomed Engn, BU-1113 Sofia, Bulgaria.
   [Radeva, Ekaterina; Pramatarova, Lilyana] Bulgarian Acad Sci, Georgi Nadjakov Inst Solid State Phys, BU-1784 Sofia, Bulgaria.
RP Keremidarska, M (reprint author), Bulgarian Acad Sci, Inst Biophys & Biomed Engn, Acad G Bonchev St,Bl 21, BU-1113 Sofia, Bulgaria.
EM m_keremidarska@abv.bg; nataly@bio21.bas.bg
OI Radeva, Ekaterina/0000-0001-5543-252X; Keremidarska-Markova,
   Milena/0000-0001-9385-6593
FU Bulgarian Science Fund [DFNI BO-18]
FX This work was supported by Bulgarian Science Fund, Grant No DFNI BO-18.
CR Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brett P. M., 2013, STEM CELLS INT, DOI [10.1155/2013/361637, DOI 10.1155/2013/361637]
   Dobson KR, 1999, CALCIFIED TISSUE INT, V65, P411, DOI 10.1007/s002239900723
   Guo YY, 2013, INT J MOL MED, V31, P689, DOI 10.3892/ijmm.2013.1249
   Kommireddy DS, 2006, BIOMATERIALS, V27, P4296, DOI 10.1016/j.biomaterials.2006.03.042
   Krasteva NA, 2010, J PHYS CONF SER, V253, DOI 10.1088/1742-6596/253/1/012079
   Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Marcotte L, 2008, IRBM, V29, P77, DOI 10.1016/j.rbmret.2007.11.019
   Pramatarova L., 2011, BIOMIMETICS, P271
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   TAKATSUKA K, 1995, J BIOMED MATER RES, V29, P157, DOI 10.1002/jbm.820290204
   Wakatsuki T, 2003, BIOPHYS CHEM, V100, P593, DOI 10.1016/S0301-4622(02)00308-3
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Yoshinari M, 2006, BIOMED RES-TOKYO, V27, P29, DOI 10.2220/biomedres.27.29
NR 15
TC 1
Z9 1
U1 0
U2 6
PU PUBL HOUSE BULGARIAN ACAD SCI
PI SOFIA
PA ACADEMICIAN G BONCEV ST, 1113 SOFIA, BULGARIA
SN 1310-1331
J9 CR ACAD BULG SCI
JI C. R. Acad. Bulg. Sci.
PY 2014
VL 67
IS 8
BP 1113
EP 1118
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ2GC
UT WOS:000342602800011
DA 2018-10-20
ER

PT J
AU Bernards, M
   He, Y
AF Bernards, Matthew
   He, Yi
TI Polyampholyte polymers as a versatile zwitterionic biomaterial platform
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE polyampholytes; mixed charge; nonfouling; multifunctional
ID TRANSFER RADICAL POLYMERIZATION; NONSPECIFIC PROTEIN ADSORPTION;
   SELF-ASSEMBLED MONOLAYERS; CONJUGATION CAPACITY; FILM THICKNESS;
   BLOOD-PLASMA; BRUSHES; HYDROGELS; SURFACES; IMMOBILIZATION
AB Polyampholyte polymers are a subclass of zwitterionic materials that are composed of mixtures of charged monomer subunits. These materials have properties that mimic those of the more widely characterized zwitterionic polymers as long as their polymer chemistry has been well controlled. In particular, overall neutral polyampholyte polymers have been shown to have resistance to nonspecific protein adsorption and protein conjugation capability. This has been demonstrated for both polymer brush and hydrogel-based platforms. In this review, our recent work demonstrating these characteristics will be summarized and placed into the broader context of zwitterionic materials.
C1 [Bernards, Matthew] Univ Missouri, Dept Chem Engn, Columbia, MO 65211 USA.
   [Bernards, Matthew] Univ Missouri, Dept Bioengn, Columbia, MO 65211 USA.
   [He, Yi] Zhejiang Univ, Dept Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China.
RP Bernards, M (reprint author), Univ Missouri, Dept Chem Engn, Columbia, MO 65211 USA.
EM bernardsm@missouri.edu
OI Bernards, Matthew/0000-0002-5234-1910
FU National Natural Science Foundation of China [31350110223]; Scientific
   Research Fund of the Zhejiang Provincial Education Department
   [Y201329422]
FX This research was supported in part by a grant from the National Natural
   Science Foundation of China through [grant number 31350110223];
   Scientific Research Fund of the Zhejiang Provincial Education Department
   through [grant number Y201329422].
CR ALFREY T, 1950, J AM CHEM SOC, V72, P1864, DOI 10.1021/ja01160a532
   Azzaroni O, 2006, ANGEW CHEM INT EDIT, V45, P1770, DOI 10.1002/anie.200503264
   Bernards MT, 2008, MACROMOLECULES, V41, P4216, DOI 10.1021/ma800185y
   Cao B, 2013, ADV HEALTHC MATER, V2, P1096, DOI 10.1002/adhm.201200359
   Carr L, 2010, LANGMUIR, V26, P14793, DOI 10.1021/la1028004
   Carr LR, 2011, BIOMATERIALS, V32, P961, DOI 10.1016/j.biomaterials.2010.09.067
   Chang Y., 2009, LANGMUIR, V26, P3522
   Chen SF, 2008, ADV MATER, V20, P335, DOI 10.1002/adma.200701164
   Chen SF, 2006, LANGMUIR, V22, P8186, DOI 10.1021/la061012m
   Chen SF, 2009, BIOMATERIALS, V30, P5892, DOI 10.1016/j.biomaterials.2009.07.001
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Cui JW, 2014, SOFT MATTER, V10, P2656, DOI 10.1039/c3sm53056f
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dobbins SC, 2012, J PHYS CHEM B, V116, P14346, DOI 10.1021/jp307588b
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   Hoffman AS, 1999, J BIOMAT SCI-POLYM E, V10, P1011, DOI 10.1163/156856299X00658
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Hu H, 2012, J MATER CHEM, V22, P15362, DOI 10.1039/c2jm32720a
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Jiang H, 2011, LANGMUIR, V27, P11575, DOI 10.1021/la202101q
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Li GZ, 2010, MACROMOLECULES, V43, P14, DOI 10.1021/ma902029s
   Li LY, 2007, J BIOMAT SCI-POLYM E, V18, P1415, DOI 10.1163/156856207782246795
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   Mi L, 2010, BIOMATERIALS, V31, P2919, DOI 10.1016/j.biomaterials.2009.12.038
   Nowinski AK, 2014, LANGMUIR, V30, P1864, DOI 10.1021/la404980g
   Nowinski AK, 2012, J AM CHEM SOC, V134, P6000, DOI 10.1021/ja3006868
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Sanjuan S, 2008, MACROMOLECULES, V41, P8721, DOI 10.1021/ma8018798
   Sanjuan S, 2008, J POLYM SCI POL CHEM, V46, P4305, DOI 10.1002/pola.22726
   Schroeder ME, 2013, BIOMACROMOLECULES, V14, P3112, DOI 10.1021/bm4007369
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Tah T, 2012, COLLOID SURFACE B, V93, P195, DOI 10.1016/j.colsurfb.2012.01.004
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Vaisocherova H, 2008, ANAL CHEM, V80, P7894, DOI 10.1021/ac8015888
   Vaisocherova H, 2009, BIOSENS BIOELECTRON, V24, P1924, DOI 10.1016/j.bios.2008.09.035
   Yang W, 2008, LANGMUIR, V24, P9211, DOI 10.1021/la801487f
   Yang W, 2009, LANGMUIR, V25, P11911, DOI 10.1021/la9015788
   Zhang Z, 2006, BIOMACROMOLECULES, V7, P3311, DOI 10.1021/bm060750m
   Zhao C, 2011, LANGMUIR, V27, P4906, DOI 10.1021/la200061h
   Zurick KM, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40069
NR 43
TC 12
Z9 13
U1 6
U2 83
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2014
VL 25
IS 14-15
SI SI
BP 1479
EP 1488
DI 10.1080/09205063.2014.938976
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AP8CA
UT WOS:000342304500003
PM 25050648
DA 2018-10-20
ER

PT J
AU Pauthe, E
   Van Tassel, PR
AF Pauthe, Emmanuel
   Van Tassel, Paul R.
TI Layer-by-layer films as biomaterials: bioactivity and mechanics
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE nanofilm; biomaterial; layer-by-layer; polyelectrolyte; chemical
   cross-linking
ID POLYELECTROLYTE MULTILAYER FILMS; CELL-ADHESION; CROSS-LINKING;
   IN-VITRO; BIOMEDICAL APPLICATIONS; THIN-FILMS; DELIVERY; TISSUE;
   ELASTICITY; SURFACES
AB Layer-by-layer (LbL) assembly offers a facile approach toward biomaterials of nanoscale thickness. Bioactivity may be realized through incorporation of biomolecular species within the film architecture, and film mechanics may be controlled through post-formation chemical cross-linking steps. This short review focuses on recent efforts toward the simultaneous control of LbL film bioactive and mechanical properties, with a particular focus on approaches yielding cellular outcomes dependent on both of these properties. Challenges and opportunities toward the independent control of film rigidity and bioactivity are highlighted.
C1 [Pauthe, Emmanuel] Univ Cergy Pontoise, Dept Biol, ERRMECe, I Mat, F-95302 Cergy Pontoise, France.
   [Van Tassel, Paul R.] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.
RP Van Tassel, PR (reprint author), Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.
EM paul.vantassel@yale.edu
RI Van Tassel, Paul/D-1087-2017
FU National Science Foundation [CBET-0756323, CBET-1066994]
FX The authors acknowledge funding from the National Science Foundation
   through CBET-0756323 and CBET-1066994.
CR Almodovar J, 2013, LAB CHIP, V13, P1562, DOI 10.1039/c3lc41407h
   Bechler SL, 2013, BIOMATERIALS, V34, P226, DOI 10.1016/j.biomaterials.2012.09.010
   Benkirane-Jessel N, 2005, ADV FUNCT MATER, V15, P648, DOI 10.1002/adfm.200400129
   Benkirane-Jessel N, 2004, ADV MATER, V16, P1507, DOI 10.1002/adma.200306613
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Blacklock J, 2010, BIOMATERIALS, V31, P7167, DOI 10.1016/j.biomaterials.2010.06.002
   Blacklock J, 2010, J PHYS CHEM B, V114, P5283, DOI 10.1021/jp100486h
   Boudou T, 2011, MACROMOL BIOSCI, V11, P77, DOI 10.1002/mabi.201000301
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116
   Chaubaroux C, 2012, BIOMACROMOLECULES, V13, P2128, DOI 10.1021/bm300529a
   Chen AA, 2009, BIOMATERIALS, V30, P1113, DOI 10.1016/j.biomaterials.2008.10.055
   Crouzier T, 2011, BIOMATERIALS, V32, P7543, DOI 10.1016/j.biomaterials.2011.06.062
   Crouzier T, 2011, ADV MATER, V23, pH111, DOI 10.1002/adma.201004637
   Crouzier T, 2010, SMALL, V6, P651, DOI 10.1002/smll.200901728
   Crouzier T, 2009, SMALL, V5, P598, DOI 10.1002/smll.200800804
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Etienne O, 2005, BIOMACROMOLECULES, V6, P726, DOI 10.1021/bm049425u
   Flessner RM, 2011, CHEM COMMUN, V47, P550, DOI 10.1039/c0cc02926b
   Francius G, 2006, MICROSC RES TECHNIQ, V69, P84, DOI 10.1002/jemt.20275
   Gand Adeline, 2014, Biomatter, V4, pe28823, DOI 10.4161/biom.28823
   Gribova V, 2012, CHEM MATER, V24, P854, DOI 10.1021/cm2032459
   Guillot R, 2013, BIOMATERIALS, V34, P5737, DOI 10.1016/j.biomaterials.2013.03.067
   Hammond PT, 2011, AICHE J, V57, P2928, DOI 10.1002/aic.12769
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   Harris JJ, 1999, J AM CHEM SOC, V121, P1978, DOI 10.1021/ja9833467
   He LM, 2012, J MATER CHEM, V22, P13187, DOI 10.1039/c2jm32332j
   Hillberg AL, 2009, BIOMATERIALS, V30, P4463, DOI 10.1016/j.biomaterials.2009.05.026
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   IWASAKI S, 1995, J BIOL CHEM, V270, P5476, DOI 10.1074/jbc.270.10.5476
   Jessel N, 2006, P NATL ACAD SCI USA, V103, P8618, DOI 10.1073/pnas.0508246103
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Jewell CM, 2008, ADV DRUG DELIVER REV, V60, P979, DOI 10.1016/j.addr.2008.02.010
   Keeney M, 2013, BIOMACROMOLECULES, V14, P794, DOI 10.1021/bm3018559
   Larkin AL, 2010, BIOMACROMOLECULES, V11, P2788, DOI 10.1021/bm100867h
   Liu XH, 2008, ADV MATER, V20, P4148, DOI 10.1002/adma.200800881
   Logeart-Avramoglou D, 2006, ANAL BIOCHEM, V349, P78, DOI 10.1016/j.ab.2005.10.030
   Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052
   Macdonald ML, 2010, BIOMACROMOLECULES, V11, P2053, DOI 10.1021/bm100413w
   Manna U, 2013, ADV MATER, V25, P6405, DOI 10.1002/adma.201302561
   Mehrotra S, 2010, LANGMUIR, V26, P12794, DOI 10.1021/la101689z
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Min J, 2014, BIOMATERIALS, V35, P2507, DOI 10.1016/j.biomaterials.2013.12.009
   Nadiri A, 2007, SMALL, V3, P1577, DOI 10.1002/smll.200700115
   Olenych SG, 2005, BIOMACROMOLECULES, V6, P3252, DOI 10.1021/bm050298r
   Pavlukhina S, 2011, ADV DRUG DELIVER REV, V63, P822, DOI 10.1016/j.addr.2011.03.017
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Phelps JA, 2011, LANGMUIR, V27, P1123, DOI 10.1021/la104156c
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   Picart C, 2005, ADV FUNCT MATER, V15, P1771, DOI 10.1002/adfm.200400588
   Picart C, 2008, CURR MED CHEM, V15, P685, DOI 10.2174/092986708783885219
   Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X
   Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Ricotti L, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/031001
   Saurer EM, 2013, BIOMACROMOLECULES, V14, P1696, DOI 10.1021/bm4005222
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Schneider A, 2007, BIOMED MATER, V2, pS45, DOI 10.1088/1748-6041/2/1/S07
   Schneider A, 2007, BIOMACROMOLECULES, V8, P139, DOI 10.1021/bm060765k
   Schuetz P, 2003, ADV FUNCT MATER, V13, P929, DOI 10.1002/adfm.200304483
   Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328
   Seo J, 2009, BIOMACROMOLECULES, V10, P2254, DOI 10.1021/bm900439r
   Shah NJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005576
   Shah NJ, 2012, ADV MATER, V24, P1445, DOI 10.1002/adma.201104475
   Sun XJ, 2011, TISSUE ENG PT A, V17, P2369, DOI [10.1089/ten.tea.2011.0027, 10.1089/ten.TEA.2011.0027]
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Vodouhe C, 2006, BIOMATERIALS, V27, P4149, DOI 10.1016/j.biomaterials.2006.03.024
   Vrana NE, 2014, J MATER CHEM B, V2, P999, DOI 10.1039/c3tb21304h
   Wittmer CR, 2008, BIOMATERIALS, V29, P4082, DOI 10.1016/j.biomaterials.2008.06.027
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Wood KC, 2006, P NATL ACAD SCI USA, V103, P10207, DOI 10.1073/pnas.0602884103
   Wu C, 2013, ADV FUNCT MATER, V23, P66, DOI 10.1002/adfm.201201042
   Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613
NR 78
TC 2
Z9 2
U1 1
U2 58
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2014
VL 25
IS 14-15
SI SI
BP 1489
EP 1501
DI 10.1080/09205063.2014.921096
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AP8CA
UT WOS:000342304500004
PM 24894809
DA 2018-10-20
ER

PT J
AU Jhong, JF
   Sin, MC
   Kung, HH
   Chinnathambi, A
   Alharbi, SA
   Chang, Y
AF Jhong, Jheng-Fong
   Sin, Mei-Chan
   Kung, Hsiao-Han
   Chinnathambi, Arunachalam
   Alharbi, Sulaiman Ali
   Chang, Yung
TI Hemocompatibility of pseudozwitterionic polymer brushes with a
   systematic well-defined charge-bias control
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE hemocompatibility; mixed charge; pseudozwitterionization; atom transfer
   radical polymerization; charge bias
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; BLOOD COMPATIBILITY;
   ZWITTERIONIC MATERIALS; PLATELET-ADHESION; COPOLYMER BRUSHES; SURFACES;
   PLASMA; PHOSPHORYLCHOLINE; RESISTANCE
AB In this study, a pseudozwitterionic surface bearing positively and negatively mixed charged moieties was developed as a potential hemocompatible material for biomedical applications. In this work, hemocompatility of pseudozwitterionic surface prepared from copolymerization of negatively charged 3-sulfopropyl methacrylate (SA) and positively charged [2-(methacryloyloxy) ethyl] trimethylammonium (TMA) was delineated. Mixed charge distribution in the prepared poly(TMA-co-SA)-grafted surface can be controlled by regulating TMA and SA monomer ratios via surface-initiated atom transfer radical polymerization. The effects of grafting composition and charge bias variations on blood compatibility of poly(TMA-co-SA)-grafted surface were reported. The protein adsorption on different poly(TMA-co-SA)-grafted surfaces from human plasma protein (fibrinogen, HSA, and gamma-globulin) solutions was evaluated using an enzyme-linked immunosorbent assay. Blood platelet adhesion and time measurements on plasma clotting were conducted to determine the platelet activation on the grafted surface. It was found that the protein resistance and anti-blood cell adhesion of prepared surface can be precisely controlled by controlling the charge balance of TMA/SA compositions. In addition, different charge bias variations on the poly (TMA-co-SA)-grafted surface would induce electrostatic interactions between plasma proteins and prepared surfaces which lead to adsorptions of interfacial protein and blood cells, plasma clotting, and blood cell hemolysis. Results from this study suggest that the hemocompatility of mixed charged poly(TMA-co-SA)-grafted surface depends on the charge bias level. This provides a great potential for designing biomaterial with unique surface chemical structure which could be used in contact with human blood.
C1 [Jhong, Jheng-Fong; Sin, Mei-Chan; Kung, Hsiao-Han; Chang, Yung] Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan 320, Taiwan.
   [Jhong, Jheng-Fong; Sin, Mei-Chan; Kung, Hsiao-Han; Chang, Yung] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan 320, Taiwan.
   [Chinnathambi, Arunachalam; Alharbi, Sulaiman Ali; Chang, Yung] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
RP Chang, Y (reprint author), Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan 320, Taiwan.
EM ychang@cycu.edu.tw
RI Chinnathambi, Arunachalam/E-7808-2016
OI Chinnathambi, Arunachalam/0000-0002-7126-8421
FU Center-of-Excellence (COE) Program on Membrane Technology from Ministry
   of Education (MOE), R.O.C.; project of Outstanding Professor Research
   Program in the Chung Yuan Christian University, Taiwan
   [CYCU-00RD-RA002-11,757]; Ministry of Science and Technology
   [100-2628-E-033-001-MY3, 102-2221-E-033-009-MY3]
FX The authors would like to acknowledge the Center-of-Excellence (COE)
   Program on Membrane Technology from the Ministry of Education (MOE),
   R.O.C., the project of Outstanding Professor Research Program in the
   Chung Yuan Christian University, Taiwan (CYCU-00RD-RA002-11,757), and
   the Ministry of Science and Technology (100-2628-E-033-001-MY3 and
   102-2221-E-033-009-MY3) for their financial support. Deanship of
   Scientific Research, College of Science Research Center, King Saud
   University, and Kingdom of Saudi Arabia are also acknowledged. Yung
   Chang thanks the King Saud University, Riyadh, Kingdom of Saudi Arabia,
   for the Visiting Professorship.
CR Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Bernards MT, 2008, MACROMOLECULES, V41, P4216, DOI 10.1021/ma800185y
   Brault ND, 2012, BIOMACROMOLECULES, V13, P589, DOI 10.1021/bm3001217
   Chang Y, 2006, LANGMUIR, V22, P2222, DOI 10.1021/la052692v
   Chang Y, 2007, BIOMACROMOLECULES, V8, P122, DOI 10.1021/bm060739m
   Chang Y, 2013, ADV FUNCT MATER, V23, P1100, DOI 10.1002/adfm.201201386
   Chang Y, 2011, ACS APPL MATER INTER, V3, P1228, DOI 10.1021/am200055k
   Chang Y, 2010, BIOMACROMOLECULES, V11, P1101, DOI 10.1021/bm100093g
   Chang Y, 2010, LANGMUIR, V26, P3522, DOI 10.1021/la903172j
   Chang Y, 2009, BIOMACROMOLECULES, V10, P2092, DOI 10.1021/bm900208u
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Chen SF, 2008, ADV MATER, V20, P335, DOI 10.1002/adma.200701164
   Dabkowska M, 2012, J COLLOID INTERF SCI, V366, P105, DOI 10.1016/j.jcis.2011.09.030
   He Y, 2008, LANGMUIR, V24, P10358, DOI 10.1021/la8013046
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Hucknall A, 2009, ADV MATER, V21, P2441, DOI 10.1002/adma.200900383
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 2005, ANAL BIOANAL CHEM, V381, P534, DOI 10.1007/s00216-004-2805-9
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Kwak D, 2005, J BIOMED MATER RES A, V74A, P69, DOI 10.1002/jbm.a.30365
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Mi L, 2010, BIOMATERIALS, V31, P2919, DOI 10.1016/j.biomaterials.2009.12.038
   Michael J, 2011, FUNDAMENTALS MED PHY
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Shih YJ, 2012, BIOMACROMOLECULES, V13, P2849, DOI 10.1021/bm3008764
   Shih YJ, 2010, LANGMUIR, V26, P17286, DOI 10.1021/la103186y
   Sin MC, 2014, ACS APPL MATER INTER, V6, P861, DOI 10.1021/am4041256
   Storey K. B., 2004, FUNCTIONAL METABOLIS
   Tokumasu F, 2012, EXP PARASITOL, V131, P245, DOI 10.1016/j.exppara.2012.03.005
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Unsworth LD, 2005, LANGMUIR, V21, P1036, DOI 10.1021/la047672d
   Yu B, 2009, BIOMACROMOLECULES, V10, P950, DOI 10.1021/bm8014945
   Yusa SI, 2005, BIOMACROMOLECULES, V6, P663, DOI 10.1021/bm0495553
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   Zhang Z, 2006, BIOMACROMOLECULES, V7, P3311, DOI 10.1021/bm060750m
   Zhang Z, 2006, LANGMUIR, V22, P10072, DOI 10.1021/la062175d
NR 41
TC 4
Z9 4
U1 3
U2 22
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2014
VL 25
IS 14-15
SI SI
BP 1558
EP 1572
DI 10.1080/09205063.2014.921754
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AP8CA
UT WOS:000342304500009
PM 24894872
DA 2018-10-20
ER

PT J
AU Joslin, JM
   Neufeld, BH
   Reynolds, MM
AF Joslin, J. M.
   Neufeld, B. H.
   Reynolds, Melissa M.
TI Correlating S-nitrosothiol decomposition and NO release for modified
   poly(lactic-co-glycolic acid) polymer films
SO RSC ADVANCES
LA English
DT Article
ID NITRIC-OXIDE RELEASE; BIOMEDICAL APPLICATIONS; PHOTOCHEMICAL RELEASE;
   MODIFIED XEROGELS; NITROSOGLUTATHIONE; BIOMATERIALS; NITROSATION;
   POLYESTERS; CHEMISTRY; MECHANISM
AB This study marks the first parallel measurements where S-nitrosothiol behaviour is directly correlated to nitric oxide (NO) release for an established polymer system under exposure conditions that are specific to S-nitrosothiol decomposition (i.e. heat, light, pH). These methods are intended to be applied to confirm the NO source in any biomaterial system.
C1 [Joslin, J. M.; Neufeld, B. H.; Reynolds, Melissa M.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
   [Reynolds, Melissa M.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
RP Reynolds, MM (reprint author), Colorado State Univ, Dept Chem, 1872 Campus Delivery, Ft Collins, CO 80523 USA.
EM melissa.reynolds@colostate.edu
FU Colorado State University; Department of Defense Congressionally
   Directed Medical Research Program (DOD-CDMPRP); Boettcher Foundation's
   Webb-Waring Biomedical Research Program
FX We would like to acknowledge Colorado State University and the
   Department of Defense Congressionally Directed Medical Research Program
   (DOD-CDMPRP) for financial support. This research was supported by funds
   from the Boettcher Foundation's Webb-Waring Biomedical Research Program.
   We would like to further acknowledge Dr Vinod Damodaran for providing
   the PLGH-cysteine material for these studies.
CR BARNETT DJ, 1994, J CHEM SOC PERK T 2, P1131, DOI 10.1039/p29940001131
   Bohl KS, 2000, BIOMATERIALS, V21, P2273, DOI 10.1016/S0142-9612(00)00153-8
   Coneski PN, 2011, POLYM CHEM-UK, V2, P906, DOI 10.1039/c0py00269k
   Coneski PN, 2010, BIOMACROMOLECULES, V11, P3208, DOI 10.1021/bm1006823
   Damodaran VB, 2012, J MATER CHEM, V22, P5990, DOI 10.1039/c2jm16554f
   Feelisch M, 1996, METHODS NITRIC OXIDE
   Frost MC, 2005, J BIOMED MATER RES A, V72A, P409, DOI 10.1002/jbm.a.30275
   Frost MC, 2004, J AM CHEM SOC, V126, P1348, DOI 10.1021/ja039466i
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   Grossi L, 2002, CHEM-EUR J, V8, P380, DOI 10.1002/1521-3765(20020118)8:2<380::AID-CHEM380>3.3.CO;2-G
   Hrabie JA, 2002, CHEM REV, V102, P1135, DOI 10.1021/cr000028t
   Jen MC, 2012, ADV FUNCT MATER, V22, P239, DOI 10.1002/adfm.201101707
   Johnson TA, 2010, NITRIC OXIDE-BIOL CH, V22, P30, DOI 10.1016/j.niox.2009.11.002
   Joslin JM, 2013, RSC ADV, V3, P15035, DOI 10.1039/c3ra41988f
   Joslin JM, 2012, ACS APPL MATER INTER, V4, P1126, DOI 10.1021/am201807c
   Li Y, 2010, MOL PHARMACEUT, V7, P254, DOI [10.1021/mp900237f, 10.1021/mp900237t]
   MATHEWS WR, 1993, J PHARMACOL EXP THER, V267, P1529
   Riccio DA, 2012, CHEM SOC REV, V41, P3731, DOI 10.1039/c2cs15272j
   Riccio DA, 2012, ACS APPL MATER INTER, V4, P796, DOI 10.1021/am201443r
   Riccio DA, 2011, CHEM MATER, V23, P1727, DOI 10.1021/cm102510q
   Riccio DA, 2009, BIOMATERIALS, V30, P4494, DOI 10.1016/j.biomaterials.2009.05.006
   Seabra AB, 2005, BIOMACROMOLECULES, V6, P2512, DOI 10.1021/bm050216z
   Seabra AB, 2008, ARTIF ORGANS, V32, P262, DOI 10.1111/j.1525-1594.2008.00540.x
   Seabra AB, 2010, J MATER CHEM, V20, P1624, DOI 10.1039/b912493b
   SEXTON DJ, 1994, PHOTOCHEM PHOTOBIOL, V59, P463, DOI 10.1111/j.1751-1097.1994.tb05065.x
   Singh RJ, 1996, J BIOL CHEM, V271, P18596, DOI 10.1074/jbc.271.31.18596
   STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444
   Stasko NA, 2008, BIOMACROMOLECULES, V9, P834, DOI 10.1021/bm7011746
   Varu VN, 2009, VASC ENDOVASC SURG, V43, P121, DOI 10.1177/1538574408322752
   Williams D. L. H., 2004, NITROSATION REACTION
   Williams DLH, 1999, ACCOUNTS CHEM RES, V32, P869, DOI 10.1021/ar9800439
   Wood PD, 1996, PHOTOCHEM PHOTOBIOL, V64, P518, DOI 10.1111/j.1751-1097.1996.tb03099.x
   Zhelyaskov VR, 1998, PHOTOCHEM PHOTOBIOL, V67, P282, DOI 10.1111/j.1751-1097.1998.tb05200.x
NR 33
TC 5
Z9 5
U1 0
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 79
BP 42039
EP 42043
DI 10.1039/c4ra04817b
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA AP6BD
UT WOS:000342161600046
DA 2018-10-20
ER

PT J
AU Monteiro, N
   Martins, A
   Pires, R
   Faria, S
   Fonseca, NA
   Moreira, JN
   Reisa, RL
   Neves, NM
AF Monteiro, Nelson
   Martins, Albino
   Pires, Ricardo
   Faria, Susana
   Fonseca, Nuno A.
   Moreira, Joao N.
   Reisa, Rui L.
   Neves, Nuno M.
TI Immobilization of bioactive factor-loaded liposomes on the surface of
   electrospun nanofibers targeting tissue engineering
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; FIBRIN ENCAPSULATED LIPOSOMES; IN-VITRO;
   DELIVERY-SYSTEM; DRUG-DELIVERY; STEALTH LIPOSOMES; FIBROUS SCAFFOLDS;
   BONE REGENERATION; RELEASE; DIFFERENTIATION
AB Electrospun nanofiber meshes (NFM), due to their morphology and fibrous structure, are extensively proposed as biomedical devices, for tissue engineering on scaffolds and also as drug delivery systems. Liposomes are nanoparticles prepared from a biologically derived material (phospholipid), which are already in clinical use as a drug release device. Liposomes may be combined with biomaterial scaffolds to promote a local and sustained delivery of loaded bioactive agents. The main objective of the present study is to evaluate the efficacy of dexamethasone (Dex)-loaded liposomes immobilized on the surface of electrospun polycaprolactone (PCL) NFM for promoting the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs). The in vitro release profile demonstrates a sustained release of Dex over 21 days, after an initial burst release over 12 h. Biological assays show that Dex-loaded liposomes immobilized on the surface of electrospun PCL NFMs do not exhibit any cytotoxic effect, being able to successfully promote the osteogenic differentiation of hBMSCs. We herein validate the concept of using liposomes immobilized on the surface of a nanostructured fibrous system to be used as an advanced cell carrier device with autonomous release of growth/differentiation factors relevant for tissue engineering and regenerative medicine strategies.
C1 [Monteiro, Nelson; Martins, Albino; Pires, Ricardo; Reisa, Rui L.; Neves, Nuno M.] Univ Minho, European Inst Excellence Tissue Engn & Regenerat, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   [Monteiro, Nelson; Martins, Albino; Pires, Ricardo; Reisa, Rui L.; Neves, Nuno M.] ICVS 3Bs, PT Govt Associate Lab, Braga, Portugal.
   [Faria, Susana] Univ Minho, Res CMAT, Dept Math Sci & Technol, P-4800058 Guimaraes, Portugal.
   [Fonseca, Nuno A.; Moreira, Joao N.] Univ Coimbra, FFUC Fac Pharm, CNC Ctr Neurosci & Cell Biol, P-3000 Coimbra, Portugal.
RP Monteiro, N (reprint author), Univ Minho, European Inst Excellence Tissue Engn & Regenerat, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM nelson.monteiro@dep.uminho.pt; amartins@dep.uminho.pt;
   rpires@dep.uminho.pt; sfaria@math.uminho.pt; nuno.a.c.fonseca@gmail.com;
   jmoreira@ff.uc.pt; rgreis@dep.uminho.pt; nuno@dep.uminho.pt
RI Faria, Susana/C-2176-2015; Group, 3Bs/E-4374-2012; Martins,
   Albino/C-8432-2012; Pires, Ricardo/A-1595-2009; Moreira, Joao
   Nuno/F-3180-2010; Neves, Nuno/B-4685-2008
OI Faria, Susana/0000-0001-8014-9902; Group, 3Bs/0000-0002-5195-3456;
   Martins, Albino/0000-0003-3868-0251; Pires, Ricardo/0000-0002-9197-0138;
   Moreira, Joao Nuno/0000-0003-3449-0522; Neves, Nuno/0000-0003-3041-0687;
   Fonseca, Nuno A. C./0000-0003-4970-7288; Reis, Rui
   L./0000-0002-4295-6129
FU Portuguese Foundation for Science and Technology [SFRH/BD/62465/2009,
   SFRH/BPD/70669/2010, SFRH/BPD/39333/2007, PTDC/EME-MFE/2008]; FIND BIND
   project [NMP4-SL-2009-229292]; MaxBone project
   [PTDC/SAU-ENB/115179/2009/FCOMP-01-0124-FEDER-015729]
FX The authors thank the Portuguese Foundation for Science and Technology
   for the Ph.D. grant of N. S. Monteiro (SFRH/BD/62465/2009), the Post-Doc
   grants of A. Martins (SFRH/BPD/70669/2010) and R. A. Pires
   (SFRH/BPD/39333/2007), and the OsteoGraphy project (PTDC/EME-MFE/2008).
   This work was partly supported by the FIND & BIND (NMP4-SL-2009-229292)
   and MaxBone (PTDC/SAU-ENB/115179/2009/FCOMP-01-0124-FEDER-015729)
   projects.
CR Ami D, 2008, BBA-MOL CELL RES, V1783, P98, DOI 10.1016/j.bbamcr.2007.08.003
   Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bhardwaj U, 2010, INT J PHARMACEUT, V388, P181, DOI 10.1016/j.ijpharm.2010.01.003
   Bolgen N, 2007, J BIOMED MATER RES B, V81B, P530, DOI 10.1002/jbm.b.30694
   Cao HQ, 2010, J CONTROL RELEASE, V144, P203, DOI 10.1016/j.jconrel.2010.02.003
   Choi JS, 2007, J BIOACT COMPAT POL, V22, P508, DOI 10.1177/0883911507081101
   Chung TW, 2006, INT J PHARM, V311, P122, DOI 10.1016/j.ijpharm.2005.12.038
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Darain F, 2011, SOFT MATER, V9, P64, DOI 10.1080/1539445X.2010.520797
   Delorme Bruno, 2007, V140, P67
   Duarte ARC, 2009, ACTA BIOMATER, V5, P2054, DOI 10.1016/j.actbio.2009.01.047
   Ghag AK, 2014, BIOMATER SCI-UK, V2, P233, DOI 10.1039/c3bm60188a
   Giannoni P, 2003, BIOTECHNOL BIOENG, V83, P121, DOI 10.1002/bit.10639
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   HRISTOVA K, 1995, MACROMOLECULES, V28, P7693, DOI 10.1021/ma00127a015
   Huang DM, 2005, FASEB J, V19, P2014, DOI 10.1096/fj.05-4288fje
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kim TG, 2008, MACROMOL RAPID COMM, V29, P1231, DOI 10.1002/marc.200800094
   Kulkarni M, 2010, TRENDS BIOTECHNOL, V28, P28, DOI 10.1016/j.tibtech.2009.10.003
   Liu Y, 2012, SOFT MATTER, V8, P4517, DOI 10.1039/c2sm25092f
   Longobardi L, 2006, J BONE MINER RES, V21, P626, DOI 10.1359/JBMR.051213
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lynge ME, 2013, BIOMATER SCI-UK, V1, P1181, DOI 10.1039/c3bm60107b
   Martins A, 2008, INT MATER REV, V53, P257, DOI 10.1179/174328008X353547
   Martins A, 2010, BIOMATERIALS, V31, P5875, DOI 10.1016/j.biomaterials.2010.04.010
   Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648
   Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t
   Meyenburg S, 2000, J CONTROL RELEASE, V69, P159, DOI 10.1016/S0168-3659(00)00295-9
   Mickova A, 2012, BIOMACROMOLECULES, V13, P952, DOI 10.1021/bm2018118
   Monteiro N, 2012, J TISSUE ENG REGEN M, V6, P33
   Monteiro N, 2015, J TISSUE ENG REGEN M, V9, P1056, DOI 10.1002/term.1817
   Moreira JN, 2002, PHARMACEUT RES, V19, P265, DOI 10.1023/A:1014434732752
   MORI M, 1994, J POLYM SCI POL CHEM, V32, P1683, DOI 10.1002/pola.1994.080320910
   Mourtas S, 2011, COLLOID SURFACE B, V84, P214, DOI 10.1016/j.colsurfb.2011.01.002
   Park JS, 2009, TISSUE ENG PT A, V15, P2163, DOI 10.1089/ten.tea.2008.0532
   Poulsson AHC, 2009, LANGMUIR, V25, P3718, DOI 10.1021/la801820s
   Pulavendran S, 2011, BIOTECHNOL BIOPROC E, V16, P393, DOI 10.1007/s12257-009-3155-4
   Ruggeri F, 2013, SOFT MATTER, V9, P8862, DOI 10.1039/c3sm50603g
   Santo VE, 2012, J TISSUE ENG REGEN M, V6, P330
   Santo VE, 2012, NANOMEDICINE-UK, V7, P1045, DOI [10.2217/NNM.12.78, 10.2217/nnm.12.78]
   Schofer MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025462
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   Shimada K, 2000, INT J PHARMACEUT, V203, P255, DOI 10.1016/S0378-5173(00)00466-X
   Smith LA, 2008, SOFT MATTER, V4, P2144, DOI 10.1039/b807088c
   Tan Q, 2011, INT J NANOMED, V6, P929, DOI 10.2147/IJN.S18753
   Teo WE, 2009, COMPOS SCI TECHNOL, V69, P1804, DOI 10.1016/j.compscitech.2009.04.015
   Thire RMSM, 2007, MACROMOL SYMP, V258, P38, DOI 10.1002/masy.200751205
   Torchilin V, 2003, LIPOSOMES PRACTICAL
   TYLLIANAKIS PE, 1993, APPL BIOCHEM BIOTECH, V38, P15, DOI 10.1007/BF02916409
   Wang G, 2011, MOL PHARMACEUT, V8, P1025, DOI 10.1021/mp200028w
   Wang SS, 2008, DRUG DELIV, V15, P149, DOI [10.1080/10717540801952456, 10.1080/10717540801952456 ]
   Wang YY, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/054112
   Yousefi A., 2008, SCI PHARM, V77, P453
   Yu XH, 2014, BIOMATER SCI-UK, V2, P242, DOI 10.1039/c3bm60173k
   Zhang SF, 2009, PHARM RES-DORDR, V26, P1561, DOI 10.1007/s11095-009-9897-z
NR 57
TC 17
Z9 17
U1 2
U2 38
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 9
BP 1195
EP 1209
DI 10.1039/c4bm00069b
PG 15
WC Materials Science, Biomaterials
SC Materials Science
GA AO7GC
UT WOS:000341519500006
DA 2018-10-20
ER

PT J
AU Gouveia, RM
   Jones, RR
   Hamley, IW
   Connon, CJ
AF Gouveia, Ricardo M.
   Jones, Roanne R.
   Hamley, Ian W.
   Connon, Che J.
TI The bioactivity of composite Fmoc-RGDS-collagen gels
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID FIBROBLAST CONTRACTION; PEPTIDE-AMPHIPHILES; FIBRIL FORMATION;
   CELL-ADHESION; TISSUE; BIOMATERIALS; INTEGRIN; SCAFFOLDS; HYDROGELS;
   GROWTH
AB The incorporation of small bioactive peptide motifs within robust hydrogels constitutes a facile procedure to chemically functionalise cell and tissue scaffolds. In this study, a novel approach to utilise Fmoc-linked peptide amphiphiles comprising the bio-functional cell-adhesion RGDS motif within biomimetic collagen gels was developed. The composite scaffolds thus created were shown to maintain the mechanical properties of the collagen gel while presenting additional bio-activity. In particular, these materials enhanced the adhesion and proliferation of viable human corneal stromal fibroblasts by 300% compared to non-functionalised gels. Furthermore, the incorporation of Fmoc-RGDS nanostructures within the collagen matrix significantly suppressed gel shrinkage resulting from the contractile action of encapsulated fibroblasts once activated by serum proteins. These mechanical and biological properties demonstrate that the incorporation of peptide amphiphiles provides a suitable and easy method to circumvent specific biomaterial limitations, such as cell-derived shrinkage, for improved performance in tissue engineering and regenerative medicine applications.
C1 [Gouveia, Ricardo M.; Jones, Roanne R.; Hamley, Ian W.; Connon, Che J.] Univ Reading, Sch Chem Food Biosci & Pharm, Reading RG6 6AD, Berks, England.
RP Gouveia, RM (reprint author), Univ Reading, Sch Chem Food Biosci & Pharm, Reading RG6 6AD, Berks, England.
EM che.connon@gmail.com
RI Hamley, Ian/D-1643-2009; Connon, Che/B-3128-2012
OI Hamley, Ian/0000-0002-4549-0926; Connon, Che/0000-0001-8264-6531;
   Gouveia, Ricardo/0000-0002-2968-1298
FU BBSRC [BB/I008187/1]; Biotechnology and Biological Sciences Research
   Council [BB/I008187/1, BB/I008187/2]
FX We are grateful to the BBSRC (grant number BB/I008187/1) for financial
   support. We kindly acknowledge M. Leyland, Royal Berkshire Hospital for
   supplying the post-mortem corneal rings.
CR Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Brown RA, 2002, EXP CELL RES, V274, P310, DOI 10.1006/excr.2002.5471
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Castelletto V, 2011, SOFT MATTER, V7, P11405, DOI 10.1039/c1sm06550e
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Cheng G, 2011, SOFT MATTER, V7, P1326, DOI 10.1039/c0sm00408a
   Cooper TP, 2011, ACTA BIOMATER, V7, P1072, DOI 10.1016/j.actbio.2010.11.008
   Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200
   Garcia-Gareta E, 2013, BIORESEARCH OPEN ACC, V2, P412, DOI 10.1089/biores.2013.0043
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gouveia RM, 2013, J MATER CHEM B, V1, P6157, DOI 10.1039/c3tb21031f
   Hadjipanayi E, 2009, J TISSUE ENG REGEN M, V3, P77, DOI 10.1002/term.136
   Hamley IW, 2012, CHEM REV, V112, P5147, DOI 10.1021/cr3000994
   HARPER PA, 1980, J CELL BIOL, V87, P755, DOI 10.1083/jcb.87.3.755
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hsu WC, 2000, INVEST OPHTH VIS SCI, V41, P2404
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jayawarna V, 2009, ACTA BIOMATER, V5, P934, DOI 10.1016/j.actbio.2009.01.006
   Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200
   Jones RR, 2012, STEM CELL RES, V8, P403, DOI 10.1016/j.scr.2012.01.001
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kagami S, 1999, J AM SOC NEPHROL, V10, P779
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Lee SY, 2003, BIOMATERIALS, V24, P5049, DOI 10.1016/S0142-9612(03)00411-3
   Liebmann T., 2007, BMC BIOTECHNOL, P7
   Lin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085672
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mahler A, 2006, ADV MATER, V18, P1365, DOI 10.1002/adma.200501765
   Mason TG, 2000, J RHEOL, V44, P917, DOI 10.1122/1.551113
   MASUR SK, 1993, INVEST OPHTH VIS SCI, V34, P2690
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   Mi SL, 2012, TISSUE ENG PT A, V18, P373, DOI [10.1089/ten.tea.2011.0194, 10.1089/ten.TEA.2011.0194]
   Patterson JM, 2011, EUR UROL, V60, P856, DOI 10.1016/j.eururo.2011.07.045
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Qi W., 2007, NEW J PHYS, V9, P428
   Sarin V, 2005, J PHYSIOL-LONDON, V564, P603, DOI 10.1113/jphysiol.2005.083238
   Sarrazy V, 2014, CARDIOVASC RES, V102, P407, DOI 10.1093/cvr/cvu053
   Schopferer M, 2009, J MOL BIOL, V388, P133, DOI 10.1016/j.jmb.2009.03.005
   Sottile J, 1998, J CELL SCI, V111, P2933
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Thornton K, 2009, BIOCHEM SOC T, V37, P660, DOI 10.1042/BST0370660
   Tuin A, 2012, EUR CELLS MATER, V24, P320, DOI 10.22203/eCM.v024a23
   von der Mark K, 2013, PROG MATER SCI, V58, P327, DOI 10.1016/j.pmatsci.2012.09.002
   Wang YQ, 2013, COLLOID SURFACE B, V104, P163, DOI 10.1016/j.colsurfb.2012.11.038
   Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Xin XJ, 2004, J BIOMAT SCI-POLYM E, V15, P1223, DOI 10.1163/1568562041753025
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 51
TC 18
Z9 18
U1 1
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 9
BP 1222
EP 1229
DI 10.1039/c4bm00121d
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA AO7GC
UT WOS:000341519500008
DA 2018-10-20
ER

PT J
AU Tao, W
   Zeng, XW
   Zhang, JX
   Zhu, HJ
   Chang, DF
   Zhang, XD
   Gao, YF
   Tang, J
   Huang, LQ
   Mei, L
AF Tao, Wei
   Zeng, Xiaowei
   Zhang, Jinxie
   Zhu, Huijun
   Chang, Danfeng
   Zhang, Xudong
   Gao, Yongfeng
   Tang, Jiao
   Huang, Laiqiang
   Mei, Lin
TI Synthesis of cholic acid-core
   poly(epsilon-caprolactone-ran-lactide)-b-poly(ethylene glycol) 1000
   random copolymer as a chemotherapeutic nanocarrier for liver cancer
   treatment
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID DOCETAXEL-LOADED NANOPARTICLES; STAR-SHAPED POLYMER; DRUG-DELIVERY;
   BLOCK-COPOLYMERS; CELLULAR INTERNALIZATION; IN-VITRO; BIOMEDICAL
   APPLICATIONS; TARGETED NANOPARTICLES; DIBLOCK COPOLYMER; PEG
AB A star-shaped random copolymer, cholic acid functionalized poly(e-caprolactone-ran-lactide)-b-poly-(ethylene glycol) 1000 (CA-(PCL-ran-PLA)-b-PEG(1k)), was synthesized by a core-first approach involving three stages of chemical reactions, and was characterized by hydrogen-1 nuclear magnetic resonance (H-1 NMR), gel permeation chromatography and thermogravimetric analysis. The docetaxel-loaded nanoparticles (NPs) were prepared by a modified nano-precipitation method. The formation and characterization of these NPs were confirmed through dynamic light scattering, zeta potential measurements, field emission scanning electron microscopy, and transmission electron microscopy. The in vitro release profiles indicated that CA-(PCL-ran-PLA)-b-PEG(1k) NPs had excellent sustained and controlled drug release properties. Both confocal laser scanning microscope and flow cytometric results showed that the coumarin-6 loaded CA-(PCL-ran-PLA)-b-PEG(1k) NPs had the highest cellular uptake efficiency compared with PEG(1k)-b-(PCL-ran-PLA) NPs and CA-(PCL-ran-PLA) NPs in human hepatic carcinoma cells. The docetaxel-loaded CA-(PCL-ran-PLA)-b-PEG(1k) NPs were also proved to have the highest drug loading content, encapsulation efficiency, and the best anti-tumor efficacy both in vitro and in vivo. In conclusion, the star-shaped CA-(PCL-ran-PLA)-b-PEG(1k) copolymer was successfully synthesized and could be used as a promising drug-loaded biomaterial for liver cancer chemotherapy.
C1 [Tao, Wei; Zeng, Xiaowei; Zhang, Jinxie; Zhu, Huijun; Zhang, Xudong; Gao, Yongfeng; Huang, Laiqiang; Mei, Lin] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Tao, Wei; Zeng, Xiaowei; Zhang, Jinxie; Zhu, Huijun; Chang, Danfeng; Zhang, Xudong; Gao, Yongfeng; Huang, Laiqiang; Mei, Lin] Tsinghua Univ, Minist Prov Jointly Constructed Base State Key La, Shenzhen Key Lab Chem Biol, Shenzhen Key Lab Gene & Antibody Therapy, Shenzhen 518055, Peoples R China.
   [Tao, Wei; Zeng, Xiaowei; Zhang, Jinxie; Zhu, Huijun; Chang, Danfeng; Zhang, Xudong; Gao, Yongfeng; Huang, Laiqiang; Mei, Lin] Tsinghua Univ, Grad Sch Shenzhen, Div Life & Hlth Sci, Shenzhen 518055, Peoples R China.
   [Chang, Danfeng] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China.
   [Tang, Jiao] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.
RP Mei, L (reprint author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
EM huanglq@sz.tsinghua.edu.cn; mei.lin@sz.tsinghua.edu.cn
RI Zeng, Xiaowei/A-6506-2015
OI Tao, Wei/0000-0001-8818-5326; Tao, Wei/0000-0002-4277-3728
FU National Natural Science Foundation of China [31270019, 51203085];
   Natural Science Foundation of Guangdong Province [S2012010010046,
   S2012040006820]; Science, Technology & Innovation Commission of Shenzhen
   Municipality [JCYJ20120616213729920, JCYJ20120614191936420,
   KQC201105310021A, JC201005270308A]; Program for New Century Excellent
   Talents in University [NCET-11-0275]
FX The authors are grateful for financial support from the National Natural
   Science Foundation of China (no. 31270019, 51203085), the Natural
   Science Foundation of Guangdong Province (no. S2012010010046,
   S2012040006820), the Science, Technology & Innovation Commission of
   Shenzhen Municipality (no. JCYJ20120616213729920, JCYJ20120614191936420,
   KQC201105310021A, JC201005270308A), and the Program for New Century
   Excellent Talents in University (NCET-11-0275).
CR Aw MS, 2014, BIOMATER SCI-UK, V2, P10, DOI 10.1039/c3bm60196j
   Bawarski WE, 2008, NANOMED-NANOTECHNOL, V4, P273, DOI 10.1016/j.nano.2008.06.002
   Buxton DB, 2009, NANOMEDICINE-UK, V4, P331, DOI 10.2217/NNM.09.8
   Claesson H, 2002, POLYMER, V43, P3511, DOI 10.1016/S0032-3861(02)00073-3
   Colilla M, 2013, BIOMATER SCI-UK, V1, P114, DOI 10.1039/c2bm00085g
   Csiszar E, 2013, CARBOHYD POLYM, V94, P927, DOI 10.1016/j.carbpol.2013.02.026
   de Espinosa LM, 2013, MACROMOL RAPID COMM, V34, P1381, DOI 10.1002/marc.201300472
   Delplace V, 2014, POLYM CHEM-UK, V5, P1529, DOI 10.1039/c3py01384g
   Ding JX, 2013, J CONTROL RELEASE, V169, P193, DOI 10.1016/j.jconrel.2012.12.006
   Duan XP, 2013, SMALL, V9, P1521, DOI 10.1002/smll.201201390
   Fokong S, 2012, J CONTROL RELEASE, V163, P75, DOI 10.1016/j.jconrel.2012.05.007
   Fu HL, 2007, J BIOMED MATER RES A, V81A, P186, DOI 10.1002/jbm.a.30924
   Fujii K, 2009, BIOCONJUGATE CHEM, V20, P1553, DOI 10.1021/bc900094g
   Hu KL, 2009, J CONTROL RELEASE, V134, P55, DOI 10.1016/j.jconrel.2008.10.016
   Huang LQ, 2011, INTEGR BIOL-UK, V3, P993, DOI 10.1039/c1ib00026h
   Inglis AJ, 2010, SOFT MATTER, V6, P82, DOI 10.1039/b920806m
   Kelleher SM, 2014, BIOMATER SCI-UK, V2, P410, DOI 10.1039/c3bm60218d
   Kim DG, 2012, J POLYM SCI POL CHEM, V50, P3618, DOI 10.1002/pola.26151
   Li TH, 2011, MACROMOL BIOSCI, V11, P1570, DOI 10.1002/mabi.201100147
   Liu YL, 2007, ANAL CHEM, V79, P2221, DOI 10.1021/ac061578f
   Loo YH, 2012, J CONTROL RELEASE, V160, P48, DOI 10.1016/j.jconrel.2012.01.041
   Lozano R, 2013, LANCET, V381, P628, DOI 10.1016/S0140-6736(12)61728-0
   Lv MQ, 2013, J APPL POLYM SCI, V128, P332, DOI 10.1002/app.38173
   Ma D, 2013, MACROMOL RAPID COMM, V34, P548, DOI 10.1002/marc.201200742
   Ma YD, 2010, POLYMER, V51, P5952, DOI 10.1016/j.polymer.2010.10.029
   Maeda H, 2012, P JPN ACAD B-PHYS, V88, P53, DOI 10.2183/pjab.88.53
   Mao ZW, 2013, BIOMATER SCI-UK, V1, P896, DOI 10.1039/c3bm00137g
   Mei L, 2013, J CONTROL RELEASE, V172, pE55, DOI 10.1016/j.jconrel.2013.08.114
   Mei L, 2013, ADV DRUG DELIVER REV, V65, P880, DOI 10.1016/j.addr.2012.11.005
   Mei L, 2009, NANOSCALE RES LETT, V4, P1530, DOI 10.1007/s11671-009-9431-6
   Mi Y, 2012, BIOMATERIALS, V33, P7519, DOI 10.1016/j.biomaterials.2012.06.100
   Nabid MR, 2011, POLYMER, V52, P2799, DOI 10.1016/j.polymer.2011.04.054
   Newland B, 2013, BIOMATER SCI-UK, V1, P556, DOI 10.1039/c3bm60030k
   Onyuksel H, 2009, CANCER LETT, V274, P327, DOI 10.1016/j.canlet.2008.09.041
   Shi JJ, 2011, ACCOUNTS CHEM RES, V44, P1123, DOI 10.1021/ar200054n
   Swinarew A, 2011, MACROMOL SYMP, V308, P8, DOI 10.1002/masy.201151002
   Synatschke CV, 2013, NACHR CHEM, V61, P1008, DOI 10.1002/nadc.201390313
   Tan BH, 2013, POLYM CHEM-UK, V4, P1250, DOI 10.1039/c2py20823g
   Tao W, 2013, ACTA BIOMATER, V9, P8910, DOI 10.1016/j.actbio.2013.06.034
   Valencia PM, 2011, BIOMATERIALS, V32, P6226, DOI 10.1016/j.biomaterials.2011.04.078
   Vollrath A, 2012, MACROMOL RAPID COMM, V33, P1791, DOI 10.1002/marc.201200329
   Wagner E, 2013, BIOMATER SCI-UK, V1, P804, DOI 10.1039/c3bm60071h
   Wan YM, 2014, POLYM CHEM-UK, V5, P1720, DOI 10.1039/c3py01281f
   Wang J, 2013, J MATER CHEM B, V1, P2324, DOI 10.1039/c3tb20100g
   Yallapu MM, 2010, J COLLOID INTERF SCI, V351, P19, DOI 10.1016/j.jcis.2010.05.022
   Yang CM, 2013, J BIOMED NANOTECHNOL, V9, P1617, DOI 10.1166/jbn.2013.1646
   Yang Y, 2013, POLYM CHEM-UK, V4, P2651, DOI 10.1039/c3py00049d
   Yue YN, 2013, BIOMATER SCI-UK, V1, P152, DOI 10.1039/c2bm00030j
   Yue ZG, 2013, J MATER CHEM B, V1, P3239, DOI 10.1039/c3tb20406e
   Zeng XW, 2013, BIOMATERIALS, V34, P6058, DOI 10.1016/j.biomaterials.2013.04.052
   Zhang CN, 2012, BIOMATERIALS, V33, P2187, DOI 10.1016/j.biomaterials.2011.11.045
   Zhang YQ, 2010, ACTA BIOMATER, V6, P2045, DOI 10.1016/j.actbio.2009.11.035
   Zou T, 2007, J BIOMED MATER RES B, V82B, P400, DOI 10.1002/jbm.b.30745
NR 53
TC 24
Z9 24
U1 3
U2 47
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 9
BP 1262
EP 1274
DI 10.1039/c4bm00134f
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA AO7GC
UT WOS:000341519500012
DA 2018-10-20
ER

PT J
AU Pence, JC
   Gonnerman, EA
   Bailey, RC
   Harley, BAC
AF Pence, Jacquelyn C.
   Gonnerman, Emily A.
   Bailey, Ryan C.
   Harley, Brendan A. C.
TI Strategies to balance covalent and non-covalent biomolecule attachment
   within collagen-GAG biomaterials
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; GROWTH-FACTOR ACTIVITY; CROSS-LINKING;
   GLYCOSAMINOGLYCAN SCAFFOLDS; IN-VITRO; EXTRACELLULAR-MATRIX; FACTOR
   SUPPLEMENTATION; TENOCYTE BIOACTIVITY; WOUND CONTRACTION;
   PERIPHERAL-NERVES
AB Strategies to integrate instructive biomolecular signals into a biomaterial are becoming increasingly complex and bioinspired. While a large majority of reports still use repeated treatments with soluble factors, this approach can be prohibitively costly and difficult to translate in vivo for applications where spatial control over signal presentation is necessary. Recent efforts have explored the use of covalent immobilization of biomolecules to the biomaterial, via both bulk (ubiquitous) as well as spatially-selective light-based crosslinking, as a means to both enhance stability and bioactivity. However, little is known about how processing conditions during immobilization impact the degree of unintended non-covalent interactions, or fouling, that takes place between the biomaterial and the biomolecule of interest. Here we demonstrate the impact of processing conditions for bulk carbodiimide (EDC) and photolithography-based benzophenone (BP) crosslinking on specific attachment vs. fouling of a model protein (concanavalin A, ConA) within collagen-glycosaminoglycan (CG) scaffolds. Collagen source significantly impacts the selectivity of biomolecule immobilization. EDC crosslinking intensity and ligand concentration significantly impacted selective immobilization. For benzophenone photoimmobilization we observed that increased UV exposure time leads to increased ConA immobilization. Immobilization efficiency for both EDC and BP strategies was maximal at physiological pH. Increasing ligand concentration during immobilization process led to enhanced immobilization for EDC chemistry, no impact on BP immobilization, but significant increases in non-specific fouling. Given recent efforts to covalently immobilize biomolecules to a biomaterial surface to enhance bioactivity, improved understanding of the impact of crosslinking conditions on selective attachment versus non-specific fouling will inform the design of instructive biomaterials for applications across tissue engineering.
C1 [Pence, Jacquelyn C.; Gonnerman, Emily A.; Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Bailey, Ryan C.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
RP Pence, JC (reprint author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
EM bharley@illinois.edu
OI Bailey, Ryan/0000-0003-1021-4267; Harley, Brendan/0000-0001-5458-154X
FU National Science Foundation [1105300]; National Institute of Arthritis
   and Musculoskeletal and Skin Diseases of the National Institutes of
   Health [R03 AR062811]; Chemical and Biomolecular Engineering Dept.;
   Institute for Genomic Biology at the University of Illinois at
   Urbana-Champaign
FX The authors would like to acknowledge Aurora Alsop (UIUC) for assistance
   with BP-photopatterning. This material is based upon work supported by
   the National Science Foundation under grant no. 1105300. Research
   reported in this publication was supported by the National Institute of
   Arthritis and Musculoskeletal and Skin Diseases of the National
   Institutes of Health under Award numbers R03 AR062811. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health. We
   are grateful for additional funding for this study provided by the
   Chemical and Biomolecular Engineering Dept. (BAH) and the Institute for
   Genomic Biology (BAH) at the University of Illinois at Urbana-Champaign.
CR Alsop A. T., 2014, ACTA BIOMAT IN PRESS
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Caliari S. R., 2014, TISSUE ENG PART A, DOI [10.1089/ten.TEA.2013.0400, DOI 10.1089/TEN.TEA.2013.0400]
   Caliari SR, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400252
   Caliari SR, 2014, ADV HEALTHC MATER, V3, P1086, DOI 10.1002/adhm.201300646
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Capito RM, 2006, OSTEOARTHR CARTILAGE, V14, P1203, DOI 10.1016/j.joca.2006.06.001
   Chiu LLY, 2011, J TISSUE ENG REGEN M, V5, P69, DOI 10.1002/term.292
   Cornwell KG, 2007, J BIOMED MATER RES A, V82A, P104, DOI 10.1002/jbm.a.31057
   Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Getgood AMJ, 2012, KNEE, V19, P422, DOI 10.1016/j.knee.2011.03.011
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Harley BAC, 2008, CHEM ENG J, V137, P102, DOI 10.1016/j.cej.2007.09.009
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Haugh MG, 2010, TISSUE ENG PART C-ME, V16, P887, DOI 10.1089/ten.TEC.2009.0422
   Holland TA, 2004, J CONTROL RELEASE, V94, P101, DOI 10.1016/j.jconrel.2003.09.007
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   Hudalla GA, 2011, ADV MATER, V23, P5415, DOI 10.1002/adma.201103046
   Hudalla GA, 2011, INTEGR BIOL-UK, V3, P832, DOI 10.1039/c1ib00021g
   Hudalla GA, 2011, ADV FUNCT MATER, V21, P1754, DOI 10.1002/adfm.201002468
   Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008
   Lim JJ, 2013, BIOMATERIALS, V34, P5007, DOI 10.1016/j.biomaterials.2013.03.037
   Lyons FG, 2014, CLIN ORTHOP RELAT R, V472, P1318, DOI 10.1007/s11999-013-3438-0
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Osborne CS, 1998, MED BIOL ENG COMPUT, V36, P129, DOI 10.1007/BF02522870
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Rossetto VJV, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-39
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   SILVER FH, 1978, THROMB RES, V13, P267, DOI 10.1016/0049-3848(78)90014-2
   SODERSTROM KO, 1987, HISTOCHEMISTRY, V87, P557, DOI 10.1007/BF00492470
   Soller EC, 2012, BIOMATERIALS, V33, P4783, DOI 10.1016/j.biomaterials.2012.03.068
   Toh CR, 2009, LANGMUIR, V25, P8894, DOI 10.1021/la9019537
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   Vickers SM, 2010, J ORTHOP RES, V28, P1184, DOI 10.1002/jor.21113
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Wu JM, 2011, J MATER SCI-MATER M, V22, P107, DOI 10.1007/s10856-010-4176-4
   Wu SF, 2011, BIOMATERIALS, V32, P1317, DOI 10.1016/j.biomaterials.2010.10.006
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yannas IV, 1975, POLYM PREPR AM CH PC, V16, P209
   Zhang YY, 2005, BJU INT, V96, P1120, DOI 10.1111/j.1464-410X.2005.05741.x
NR 58
TC 6
Z9 6
U1 0
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 9
BP 1296
EP 1304
DI 10.1039/c4bm00193a
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA AO7GC
UT WOS:000341519500015
PM 25147727
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ye, H
   Tong, JS
   Wu, JZ
   Xu, X
   Wu, SJ
   Tan, BT
   Shi, MJ
   Wang, JG
   Zhao, WB
   Jiang, H
   Jin, S
AF Ye, Hui
   Tong, Jiansong
   Wu, Jianzhang
   Xu, Xia
   Wu, Shenjie
   Tan, Botao
   Shi, Mengjing
   Wang, Jianguang
   Zhao, Weibo
   Jiang, Heng
   Jin, Sha
TI Preclinical evaluation of recombinant human IFN alpha(2)b-containing
   magnetoliposomes for treating hepatocellular carcinoma
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE recombinant human interferon-alpha(2)b; magnetoliposome; hepatocellular
   carcinoma
ID MAGNETIC FE3O4 NANOPARTICLES; PROGRAMMED CELL-DEATH; INTERFERON-ALPHA;
   IFN-ALPHA; ANTITUMOR-ACTIVITY; DRUG-DELIVERY; CANCER CELLS; PHASE-I;
   APOPTOSIS; DIFFERENTIATION
AB Magnetoliposomes are phospholipid vesicles encapsulating magnetic nanoparticles that can be used to encapsulate therapeutic drugs for delivery into specific organs. Herein, we developed magnetoliposomes containing recombinant human IFN alpha(2)b, designated as MIL, and evaluated this combination's biological safety and therapeutic effect on both cellular and animal hepatocellular carcinoma models. Our data showed that MIL neither hemolyzed erythrocytes nor affected platelet-aggregation rates in blood. Nitroblue tetrazolium-reducing testing showed that MIL did not change the absolute numbers or phagocytic activities of leukocytes. Acutetoxicity testing also showed that MIL had no devastating effect on mice behaviors. All the results indicated that the nanoparticles could be a safe biomaterial. Pharmacokinetic analysis and tissue-distribution studies showed that MIL maintained stable and sustained drug concentrations in target organs under a magnetic field, helped to increase bioavailability, and reduced administration time. MIL also dramatically inhibited the growth of hepatoma cells. Targeting of MIL in the livers of nude mice bearing human hepatocellular carcinoma showed that MIL significantly reduced the tumor size to 38% of that of the control group. Further studies proved that growth inhibition of cells or tumors was due to apoptosis-signaling pathway activation by human IFN alpha(2)b.
C1 [Ye, Hui; Wang, Jianguang] Wenzhou Med Univ, Sch Basic Med Sci, Wenzhou 325035, Zhejiang, Peoples R China.
   [Ye, Hui; Tong, Jiansong] Scripps Res Inst, Dept Cellular & Mol Biol, La Jolla, CA 92037 USA.
   [Wu, Jianzhang] Wenzhou Med Univ, Pharmaceut Coll, Wenzhou 325035, Zhejiang, Peoples R China.
   [Xu, Xia] Zhejiang Univ, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.
   [Wu, Shenjie; Shi, Mengjing; Zhao, Weibo; Jiang, Heng; Jin, Sha] Wenzhou Med Univ, Sch Clin Med Sci 1, Wenzhou 325035, Zhejiang, Peoples R China.
   [Tan, Botao] Lishui Univ, Sch Med, Lishui, Peoples R China.
RP Ye, H (reprint author), Wenzhou Med Univ, Sch Basic Med Sci, Wenzhou 325035, Zhejiang, Peoples R China.
EM huiye1109@gmail.com
FU China Scholarship Council [201208330266]; Natural Science Foundation of
   Zhejiang Province, PRC [Y4110029, Y4090379]; Natural Science Foundation
   of Wenzhou Science Technology Bureau, Zhejiang, PRC [Y20100018]
FX This work was partly supported by grants from the China Scholarship
   Council (201208330266), the Natural Science Foundation of Zhejiang
   Province, PRC (Y4110029 and Y4090379), and the Natural Science
   Foundation of Wenzhou Science Technology Bureau, Zhejiang, PRC
   (Y20100018). We appreciate Dr Matthew Wheeler at the Scripps Institute
   for editing the manuscript.
CR Amendola V, 2011, J MATER CHEM, V21, P3803, DOI 10.1039/c0jm03863f
   Azzimonti B, 2004, HISTOPATHOLOGY, V45, P560, DOI 10.1111/j.1365-2559.2004.02000.x
   Breitenstein S, 2009, BRIT J SURG, V96, P975, DOI 10.1002/bjs.6731
   Bukowski R, 2002, J CLIN ONCOL, V20, P3841, DOI 10.1200/JCO.2002.02.051
   Carvalho A, 2013, MAGN RESON IMAGING, V31, P610, DOI 10.1016/j.mri.2012.10.024
   Chua CW, 2011, INT J HEPATOL, V2011, P1
   Cinti C, 2011, PLOS ONE, V6, P17132
   Colletier Jacques-Philippe, 2002, BMC Biotechnol, V2, P9, DOI 10.1186/1472-6750-2-9
   Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534
   EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0
   Galor A, 2010, BRIT J OPHTHALMOL, V94, P551, DOI 10.1136/bjo.2008.153197
   Garcia-Jimeno S, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-452
   HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0
   Jahnke A, 2007, J VET MED A, V54, P599, DOI 10.1111/j.1439-0442.2007.01002.x
   Jing HM, 2010, INT J NANOMED, V5, P999, DOI 10.2147/IJN.S14957
   Kawaguchi E, 2008, COLLOID SURFACE B, V62, P130, DOI 10.1016/j.colsurfb.2007.09.027
   Kim MJ, 2011, J NANOSCI NANOTECHNO, V11, P889, DOI 10.1166/jnn.2011.3267
   Le Buanec H, 2011, P NATL ACAD SCI USA, V108, P18995, DOI 10.1073/pnas.1113301108
   Lesinski GB, 2008, CANCER RES, V68, P8351, DOI 10.1158/0008-5472.CAN-08-0426
   Matsui W, 2003, BRIT J HAEMATOL, V121, P251, DOI 10.1046/j.1365-2141.2003.04255.x
   Mejias R, 2011, BIOMATERIALS, V32, P2938, DOI 10.1016/j.biomaterials.2011.01.008
   OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O
   Rudel T, 1999, HERZ, V24, P236, DOI 10.1007/BF03044967
   Satthaporn S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-32
   Shinohara N, 2012, JPN J CLIN ONCOL, V42, P113, DOI 10.1093/jjco/hyr176
   Singal AK, 2010, ALIMENT PHARM THER, V32, P851, DOI 10.1111/j.1365-2036.2010.04414.x
   Singh R, 2011, J BIOMED NANOTECHNOL, V7, P489, DOI 10.1166/jbn.2011.1324
   Solomon M, 2011, CURR OPIN PEDIATR, V23, P215, DOI 10.1097/MOP.0b013e32834456a5
   Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05
   Wang BX, 2011, J INTERF CYTOK RES, V31, P545, DOI 10.1089/jir.2010.0158
   Wang CL, 2011, INT J NANOMED, V6, P1929, DOI 10.2147/IJN.S24707
   Wang J, 2010, INT J NANOMED, V5, P861, DOI 10.2147/IJN.S13662
   Wang YS, 2002, ADV DRUG DELIVER REV, V54, P547, DOI 10.1016/S0169-409X(02)00027-3
   Xu DW, 2000, BLOOD, V96, P4313
   Xuan CY, 2010, BLOOD, V115, P2864, DOI 10.1182/blood-2009-10-250555
   Yamamoto-Yamaguchi Y, 2003, ANTICANCER RES, V23, P2537
   Yang E, 1996, BLOOD, V88, P386
   Yang JD, 2010, INFECT DIS CLIN N AM, V24, P899, DOI 10.1016/j.idc.2010.07.004
   Yi TL, 2011, ONCOTARGET, V2, P1155
   Yuen MF, 2002, J CLIN GASTROENTEROL, V35, P272, DOI 10.1097/01.MCG.0000024791.18323.99
NR 40
TC 5
Z9 5
U1 1
U2 11
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 4533
EP 4550
DI 10.2147/IJN.S67228
PG 18
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AP5OY
UT WOS:000342129700001
PM 25288882
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bavbek, AB
   Ozcan, M
   Eskitascioglu, G
AF Bavbek, Andac Barkin
   Oezcan, Mutlu
   Eskitascioglu, Gurcan
TI Radioactive potential of zirconium-dioxide used for dental applications
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Radioactivity; XRF; Zirconium-dioxide
ID IN-VITRO EVALUATION; STABILIZED ZIRCONIA; CERAMICS; BIOMATERIAL;
   RADIATION; IMPLANTS; POWDERS
AB Purpose: The purpose of this study was to investigate the possible radioactive potential of zirconium dioxide (ZrO2) dental ceramics. Such information is necessary since they became an integral part of routine prosthetic rehabilitations and devoid of scientific information about their radioactivity creates some concern in the dental community.
   Methods: Four different types of commercial ZrO2 ceramics, namely Lava, Cercon, ICE Zirkon, and Everest Bio ZS were investigated before and after the sintering process. Sintering temperatures were applied according to each manufacturer's instructions. The compositions of the presintered and sintered specimens were analyzed using x-ray fluorescence spectrometer (XRF). Concentrations of the elements and compounds were also measured by this method. Determination of radioactivity continued with gamma-spectrometry measurements and gross alpha/beta analyses.
   Results: The activity of gamma and gross alpha/beta was below minimum detection limits (MDL) for presintered and sintered ZrO2. The MDLs of gross alpha/beta counting system were 0.02 Bq/g and 0.01 Bq/g for alpha and beta radioactivity, respectively. The sintering process played only a minor role in the composition of the compounds.
   Conclusions: Radioactivity of the ZrO2 ceramics studied showed negligible radionuclide activity that can be considered lower than many hazardous radioactive appliances in our environment.
C1 [Bavbek, Andac Barkin; Eskitascioglu, Gurcan] Yuzuncu Yil Univ, Fac Dent, Dept Prosthodont, TR-65080 Van, Turkey.
   [Oezcan, Mutlu] Univ Zurich, Ctr Dent & Oral Med, Dent Mat Unit, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Zurich, Switzerland.
RP Bavbek, AB (reprint author), Yuzuncu Yil Univ, Fac Dent, Dept Prosthodont, TR-65080 Van, Turkey.
EM bavbekab@yahoo.com
CR Akagawa Y, 1998, J PROSTHET DENT, V80, P551, DOI 10.1016/S0022-3913(98)70031-9
   [Anonymous], 2007, SAF REP SER INT AT E, V51
   [Anonymous], DOE FUND HDB NUCL PH, V1
   Anusavice K J, 1992, Adv Dent Res, V6, P82
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Christensen GJ, 2009, J AM DENT ASSOC, V140, P1036, DOI 10.14219/jada.archive.2009.0316
   Conrad HJ, 2007, J PROSTHET DENT, V98, P389, DOI 10.1016/S0022-3913(07)60124-3
   Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Gilmore GR, 2008, PRACTICAL GAMMA RAY, P39
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Lazar DRR, 2008, DENT MATER, V24, P1676, DOI 10.1016/j.dental.2008.04.002
   Liang XJ, 2008, J UNIV SCI TECHNOL B, V15, P764, DOI 10.1016/S1005-8850(08)60284-4
   LINDELL B, 1987, B WORLD HEALTH ORGAN, V65, P139
   Mackert J R Jr, 1992, Adv Dent Res, V6, P90
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Papanagiotou HP, 2006, J PROSTHET DENT, V96, P154, DOI 10.1016/j.prosdent.2006.08.004
   PAPASTEFANOU C, 1987, RADIAT PROT DOSIM, V19, P49
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Porstendorfer J, 1996, J BIOMED MATER RES, V32, P663, DOI 10.1002/(SICI)1097-4636(199612)32:4<663::AID-JBM20>3.0.CO;2-D
   Schmalz G., 2008, BIOCOMPATIBILITY DEN, P183
   Sickafus KE, 1999, J NUCL MATER, V274, P66, DOI 10.1016/S0022-3115(99)00041-0
   TINKER RA, 1995, J RADIOAN NUCL CH AR, V193, P329, DOI 10.1007/BF02039890
   Vagkopoulou T, 2009, INT J ESTHET DENT, V4, P130
   Veronese I, 2006, J ENVIRON RADIOACTIV, V91, P15, DOI 10.1016/j.jenvrad.2006.08.002
   Willmann G, 1998, ORTHOPEDICS, V21, P173
NR 27
TC 1
Z9 1
U1 0
U2 7
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2014
VL 12
IS 1
BP 35
EP 40
DI 10.5301/JABFM.2012.9341
PG 6
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA AP7LC
UT WOS:000342257800005
PM 22865573
DA 2018-10-20
ER

PT J
AU Bai, SM
   Zhang, WM
   Lu, Q
   Ma, QH
   Kaplanad, DL
   Zhu, HS
AF Bai, ShuMeng
   Zhang, WenMin
   Lu, Qiang
   Ma, QuanHong
   Kaplanad, David L.
   Zhu, Hesun
TI Silk nanofiber hydrogels with tunable modulus to regulate nerve stem
   cell fate
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID SELF-ASSEMBLY PROCESS; NEURAL TISSUE; MECHANICAL-PROPERTIES;
   EXTRACELLULAR-MATRIX; HIPPOCAMPAL-NEURONS; SPIDER SILK; SPINAL-CORD;
   FIBROIN; DIFFERENTIATION; SCAFFOLDS
AB Reconstruction of damaged nerves remains a significant unmet challenge in clinical medicine. To foster improvements, the control of neural stem cell (NSC) behaviors, including migration, proliferation and differentiation, is a critical factor to consider. Topographical and mechanical stimulations based on the control of biomaterial features are promising approaches, which are usually studied separately. The synergy between topography and mechanical rigidity could offer new insights into the control of neural cell fate if they could be utilized concurrently in studies. To achieve this need, silk fibroin self-assembled nanofibers with a beta-sheet-enriched structure are formed into hydrogels. Stiffness is tuned using different annealing processes to enable mechanical control without impacting the nanofiber topography. Compared with nonannealed nanofibers, NSCs on methanol annealed nanofibers with stiffness similar to that of nerve tissues differentiate into neurons with the restraint of glial differentiation, without the influence of specific differentiation biochemical factors. These results demonstrate that combining topographic and mechanical cues provides the control of nerve cell behaviors, with potential for neurogenerative repair strategies.
C1 [Bai, ShuMeng; Lu, Qiang; Kaplanad, David L.] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Bai, ShuMeng; Lu, Qiang; Kaplanad, David L.] Soochow Univ, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Suzhou 215123, Peoples R China.
   [Zhang, WenMin; Ma, QuanHong] Soochow Univ, Affiliated Hosp 2, Inst Neurosci, Jiangsu Key Lab Translat Res & Therapy Neuro Psyc, Suzhou 215123, Peoples R China.
   [Lu, Qiang] Soochow Univ, Coll Med, Jiangsu Prov Key Lab Stem Cell Res, Suzhou 215006, Peoples R China.
   [Kaplanad, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zhu, Hesun] Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Lu, Q (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM Lvqiang78@suda.edu.cn; h999.judy@gmail.com
FU National Basic Research Program of China (973 Program) [2013CB934400,
   2012CB22302]; NSFC [21174097, 81272106]; Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD); Excellent
   Youth Foundation of Jiangsu Province [BK2012009]; Youth Foundation of
   Jiangsu Province [BK20140397]; NIH [P41 EB002520]; Key Natural Science
   Foundation of the Jiangsu Higher Education Institutions of China
   [11KGA430002]; National Programme on Key Basic Research Project
   [2013CB945602]; National Natural Science Foundation of China [31171313,
   81271424]; Research Fund for the Doctoral Program of Higher Education of
   China [20113201120018]; Soochow University Start up foundation
   [Q421500110]
FX We thank grants from the National Basic Research Program of China (973
   Program 2013CB934400, 2012CB22302), and NSFC (21174097, 81272106) for
   support of this work. We also thank grants from the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD), the
   Excellent Youth Foundation of Jiangsu Province (BK2012009), the Youth
   Foundation of Jiangsu Province (BK20140397), the NIH (P41 EB002520), and
   the Key Natural Science Foundation of the Jiangsu Higher Education
   Institutions of China (11KGA430002) for support of this work. We thank
   grants to Quan-hong Ma from the National Programme on Key Basic Research
   Project (2013CB945602), the National Natural Science Foundation of China
   (31171313, 81271424), Research Fund for the Doctoral Program of Higher
   Education of China (20113201120018) and Soochow University Start up
   foundation (Q421500110).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bai S, 2013, ACTA BIOMATER, V9, P7806, DOI 10.1016/j.actbio.2013.04.033
   Benfenati V, 2012, ADV FUNCT MATER, V22, P1871, DOI 10.1002/adfm.201102310
   Callahan LAS, 2013, BIOMATERIALS, V34, P9089, DOI 10.1016/j.biomaterials.2013.08.028
   Eng G, 2013, P NATL ACAD SCI USA, V110, P4551, DOI 10.1073/pnas.1300569110
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037
   Georgiou M, 2013, BIOMATERIALS, V34, P7335, DOI 10.1016/j.biomaterials.2013.06.025
   Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t
   Giobbe GG, 2012, BIOTECHNOL BIOENG, V109, P3119, DOI 10.1002/bit.24571
   Gong ZG, 2010, SOFT MATTER, V6, P1217, DOI 10.1039/b913510c
   Gong ZG, 2009, CHEM COMMUN, P7506, DOI 10.1039/b914218e
   Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047
   Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144
   Han F, 2014, ACTA BIOMATER, V10, P921, DOI 10.1016/j.actbio.2013.09.026
   Hensley K, 2010, J ALZHEIMERS DIS, V21, P1, DOI 10.3233/JAD-2010-1414
   Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435
   Hronik-Tupaj M, 2013, J BIOMED MATER RES A, V101, P2559, DOI 10.1002/jbm.a.34565
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Joddar B, 2013, J BIOTECHNOL, V168, P218, DOI 10.1016/j.jbiotec.2013.04.021
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Kong H, 2008, J CELL SCI, V121, P4029, DOI 10.1242/jcs.035758
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033
   Lee J, 2012, P NATL ACAD SCI USA, V109, P19638, DOI 10.1073/pnas.1208384109
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Li YC, 2014, BIOMATERIALS, V35, P1192, DOI 10.1016/j.biomaterials.2013.10.066
   Li YC, 2012, ACTA BIOMATER, V8, P3035, DOI 10.1016/j.actbio.2012.04.036
   Lu GZ, 2014, COLLOID SURFACE B, V120, P28, DOI 10.1016/j.colsurfb.2014.03.027
   Lu Q, 2012, BIOMACROMOLECULES, V13, P826, DOI 10.1021/bm201731e
   Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787
   Mawad D, 2012, ADV FUNCT MATER, V22, P2692, DOI 10.1002/adfm.201102373
   Meamar R, 2013, J CLIN NEUROSCI, V20, P1659, DOI 10.1016/j.jocn.2013.04.024
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Neirinckx V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064723
   Numata K, 2014, MACROMOL BIOSCI, V14, P799, DOI 10.1002/mabi.201300482
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Prewitz MC, 2013, NAT METHODS, V10, P788, DOI [10.1038/nmeth.2523, 10.1038/NMETH.2523]
   Purcell EK, 2012, BIOMACROMOLECULES, V13, P3427, DOI 10.1021/bm301220k
   Qu J, 2013, J BIOMED MATER RES A, V101, P2667, DOI 10.1002/jbm.a.34551
   Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shibuya S., 2009, CELL ADHES MIGR, V3, P1
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Stabenfeldt SE, 2011, ACTA BIOMATER, V7, P4102, DOI 10.1016/j.actbio.2011.07.026
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Volpato FZ, 2013, BIOMATERIALS, V34, P4945, DOI 10.1016/j.biomaterials.2013.03.057
   Wei GJ, 2013, INT J NANOMED, V8, P3217, DOI 10.2147/IJN.S43681
   Wittmer CR, 2011, ADV FUNCT MATER, V21, P4232, DOI 10.1002/adfm.201100755
   Xie H, 2013, ACTA BIOMATER, V9, P7845, DOI 10.1016/j.actbio.2013.04.038
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yao DY, 2012, BIOMACROMOLECULES, V13, P3723, DOI 10.1021/bm301197h
   Yoo J, 2013, J CELL BIOCHEM, V114, P743, DOI 10.1002/jcb.24427
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhao YH, 2013, BIO-MED MATER ENG, V23, P545, DOI 10.3233/BME-130775
NR 70
TC 20
Z9 21
U1 15
U2 60
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 38
BP 6590
EP 6600
DI 10.1039/c4tb00878b
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AP4WJ
UT WOS:000342079900016
PM 25530851
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lopez, C
   Carmona, JU
   Giraldo, CE
   Alvarez, ME
AF Lopez, C.
   Carmona, J. U.
   Giraldo, C. E.
   Alvarez, M. E.
TI Bacteriostatic effect of equine pure platelet-rich plasma and other
   blood products against methicillin-sensitive Staphylococcus aureus
SO VETERINARY AND COMPARATIVE ORTHOPAEDICS AND TRAUMATOLOGY
LA English
DT Article
DE Growth factor; leukocyte-reduced platelet concentrate; platelet factor
   4; wound infection
ID GROWTH-FACTOR-BETA; ANTIMICROBIAL ACTIVITY; IN-VITRO; HORSES; GEL;
   OSTEOMYELITIS; INFECTION; ELISA
AB Objectives: 1) To evaluate the bacteriostatic in vitro effect of pure platelet-rich plasma (P-PRP), pure platelet-rich gel (P-PRG), leukocyte-poor gel (LPG), platelet-poor plasma (PPP), and heat inactivated plasma (IP) against methicillin-sensitive Staphylococcus aureus (MSSA) over a period of 24 hours. 2) To determine the degradation of platelet factor-4 (PF-4), transforming growth factor beta 1 (TGF-beta(1)), and platelet-derived growth factor isoform BB (PDGF-BB) in these equine blood components. 3) To establish correlations between platelet and leukocyte counts, PF-4 concentrations, and MSSA growth.
   Methods: Fourteen horses were used. Blood components were obtained by a manual protocol. Every blood component was mixed with MSSA and Muller-Hinton Broth and cultured at 37 C for 24 hours. Samples for the determination of bacterial growth (colony-forming units) and PF-4, TGF-beta(1) and PDGF-BB concentrations were taken at one, four, eight, 12 and 24 hours.
   Results: The bacterial growth was significantly (p = 0.01) inhibited for P-PRP, P-PRG, LPG and PPP in comparison with IP and, the positive control group during the first 12 hours. The P-PRG had higher and sustained TGF-beta(1) and PDGF-BB concentrations over time in comparison with the other blood components.
   Clinical significance: The plasma complement could be one of the most responsible components of the in vitro bacteriostatic effect of P-PRP, P-PRG, LPG and PPP against MSSA. Additionally, P-PRG was the better biomaterial because it had an acceptable bacteriostatic effect and the highest concentration of growth factors.
C1 [Lopez, C.; Carmona, J. U.; Giraldo, C. E.; Alvarez, M. E.] Univ Caldas, Dept Salud Anim, Grp Invest Terapia Regenerat, Manizales, Colombia.
RP Carmona, JU (reprint author), Univ Caldas, Dept Salud Anim, Calle 65,26-10, Manizales, Colombia.
EM carmona@ucaldas.edu.co
OI LOPEZ, CATALINA/0000-0003-4954-1601; Carmona, Jorge
   U./0000-0002-6917-8451
FU Vicerrectoria de Investigaciones y Postgrados of the Universidad de
   Caldas, Manizales, Colombia [1295210]
FX This research was supported by a research grant (No 1295210) of the
   Vicerrectoria de Investigaciones y Postgrados of the Universidad de
   Caldas, Manizales, Colombia.
CR Alsousou J, 2013, PLATELETS, V24, P173, DOI 10.3109/09537104.2012.684730
   Alvarez ME, 2011, ARCH MED VET, V43, P155, DOI 10.4067/S0301-732X2011000200008
   Alvarez ME, 2010, EQUINE VET J, V42, P63, DOI 10.2746/042516409X455221
   Anitua E, 2012, CLIN EXP DERMATOL, V37, P652, DOI 10.1111/j.1365-2230.2011.04303.x
   Arguelles D, 2008, VET REC, V162, P208, DOI 10.1136/vr.162.7.208
   Arguelles D, 2006, RES VET SCI, V81, P237, DOI 10.1016/j.rvsc.2005.12.008
   Bielecki TM, 2007, J BONE JOINT SURG BR, V89B, P417, DOI 10.1302/0301-620X.89B3.18491
   Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001
   Burnouf T, 2013, TRANSFUSION, V53, P138, DOI 10.1111/j.1537-2995.2012.03668.x
   Burton S, 2008, CAN VET J, V49, P797
   Carmona JU, 2007, J EQUINE VET SCI, V27, P167, DOI 10.1016/j.jevs.2007.02.007
   Carmona JU, 2013, REC PAT REG MED, V3, P148
   Chen LH, 2013, J DIABETES RES, DOI 10.1155/2013/269527
   Cieslik-Bielecka A, 2009, TRANSFUS APHER SCI, V41, P9, DOI 10.1016/j.transci.2009.05.006
   Delesalle C, 2008, EQUINE VET J, V40, P326, DOI 10.2746/042516408X293583
   Donnelly BP, 2006, AM J VET RES, V67, P1218, DOI 10.2460/ajvr.67.7.1218
   Drago L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-47
   GILBERT P, 1987, J ANTIMICROB CHEMOTH, V20, P147, DOI 10.1093/jac/20.2.147
   Giraldo CE, 2013, BMC VET RES, V12, P9
   Haenni M, 2010, J VET DIAGN INVEST, V22, P953, DOI 10.1177/104063871002200617
   Hnasko R, 2011, BIOCHEM BIOPH RES CO, V410, P726, DOI 10.1016/j.bbrc.2011.06.005
   IngleFehr JE, 1997, VET SURG, V26, P7, DOI 10.1111/j.1532-950X.1997.tb01456.x
   Klinger MHF, 2002, J INTERF CYTOK RES, V22, P913, DOI 10.1089/10799900260286623
   LEDUR A, 1995, J IMMUNOL METHODS, V186, P171, DOI 10.1016/0022-1759(95)00184-C
   Lopez C, 2010, ARCH MED VET, V42, P209, DOI 10.4067/S0301-732X2010000300013
   MACDONALD DG, 1994, EQUINE VET J, V26, P323, DOI 10.1111/j.2042-3306.1994.tb04394.x
   Maciel FB, 2012, BURNS, V38, P1058, DOI 10.1016/j.burns.2012.02.029
   Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x
   Moojen DJF, 2008, J ORTHOP RES, V26, P404, DOI 10.1002/jor.20519
   Moor AN, 2009, WOUND REPAIR REGEN, V17, P832, DOI 10.1111/j.1524-475X.2009.00547.x
   Payne WG, 2003, J APPL RES, V3, P35
   Penha-Goncalves MN, 1997, DNA SEQUENCE, V7, P375, DOI 10.3109/10425179709034059
   Schraw T, 2005, TRANSFUSION, V45, P717, DOI 10.1111/j.1537-2995.2005.04243.x
   Shenkman B, 1999, PLATELETS, V10, P36, DOI 10.1080/09537109976338
   Sutter WW, 2004, AM J VET RES, V65, P924, DOI 10.2460/ajvr.2004.65.924
   Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524.6533.2002
   Taylor AH, 2010, EQUINE VET J, V42, P213, DOI 10.2746/042516409X480403
   Wang HF, 2013, INT WOUND J, V10, P105, DOI 10.1111/j.1742-481X.2012.00951.x
   Xiong YQ, 2002, J INFECT DIS, V185, P348, DOI 10.1086/338514
   Yavuz SS, 2013, J HOSP INFECT, V85, P206, DOI 10.1016/j.jhin.2013.07.010
   Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4
   Yount NY, 2004, ANTIMICROB AGENTS CH, V48, P4395, DOI 10.1128/AAC.48.11.4395-4404.2004
   Yuan T, 2008, TRANSFUS APHER SCI, V38, P167, DOI 10.1016/j.transci.2008.01.006
NR 43
TC 7
Z9 7
U1 1
U2 8
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0932-0814
J9 VET COMP ORTHOPAED
JI Vet. Comp. Orthop. Traumatol.
PY 2014
VL 27
IS 5
BP 372
EP 378
DI 10.3415/VCOT-14-04-0054
PG 7
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA AP4GN
UT WOS:000342035300008
PM 25088784
DA 2018-10-20
ER

PT J
AU Roch, T
   Schulz, C
   Jung, F
   Ma, N
   Lendlein, A
AF Roch, Toralf
   Schulz, Christian
   Jung, Friedrich
   Ma, Nan
   Lendlein, Andreas
TI Interaction of poly(ether imide) films with early immune mechanisms
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Immuno-compatibility; endotoxins; biomaterial; poly(ether imide);
   cardiovascular implants
ID COMPLEMENT ACTIVATION; ENDOTHELIAL-CELLS; BIOMATERIALS; COAGULATION;
   POLYSTYRENE; INDUCTION; IMPLANTS; SURFACES; PATTERN; SEPSIS
AB With the worldwide increase of atherosclerosis, the need for new engineered patient specific implants such as stents or vascular grafts is still emerging. Recently, very smooth poly(ether imide) (PEI) films were, based on their hemocompatibility and compatibility with endothelial cells, suggested as potential biomaterial for cardiovascular applications. In atherosclerosis, immune mechanisms such as complement activation, but also cellular responses such as monocytes and neutrophils activation, can mediate the inflammatory response. Therefore, it is important that the implant material itself does not trigger the inflammatory response. Early immune mechanisms - e.g. macrophage activation, complement induction, generation of reactive oxygen species (ROS), and the secretion of inflammatory cytokines by leukocytes - could potentiate the inflammatory responses, and may thereby alter endothelial cells behaviour or facilitate platelet activation. Therefore, it is important to evaluate the immuno-compatibility of PEI-films.
   The PEI-films were fabricated from commercially available PEI, which was dissolved in dichloromethane and pulled out on a cleaned, smooth glass surface and subsequently, solvent residues were removed during the drying procedure.
   Using a murine macrophage reporter cell line possible material bound microbial contaminations and material intrinsic immunostimulatory properties were investigated. The macrophages were viable after adhering on the PEI-films and did not show signs of activation, indicating that the used PEI-film was free of microbial contaminations. To determine whether PEI-films induced complement activation, the release of C5a in pooled human plasma was analyzed. The detected C5a levels did not differ between PEI-films and tissue culture plates (TCP), which served as control material. Furthermore, in whole human blood, the generation of ROS as well as the cytokine production were investigated by flow cytometry and by multiplex bead arrays, respectively. The production of IL-6 and TNF-alpha as well as the generation of ROS by immune cells of the whole blood was not induced upon contact with PEI-films.
   The immunological evaluation of PEI-films revealed that no substantial activation of the investigated early immune mechanisms occurred. Altogether, this data demonstrate that PEI is immuno-compatible and from that perspective may be a suitable biomaterial for cardiovascular applications.
C1 [Roch, Toralf; Schulz, Christian; Jung, Friedrich; Ma, Nan; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Regenerat Therapies, Inst Biomaterial Sci & Berlin Brandenburg, D-14513 Teltow, Germany.
   [Roch, Toralf; Jung, Friedrich; Ma, Nan; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Biomat Med, Teltow, Germany.
   [Roch, Toralf; Jung, Friedrich; Ma, Nan; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Biomat Med, Berlin, Germany.
RP Roch, T (reprint author), Helmholtz Zentrum Geesthacht, Ctr Regenerat Therapies, Inst Biomaterial Sci & Berlin Brandenburg, Kantstr 55, D-14513 Teltow, Germany.
EM toralf.roch@hzg.de; andreas.lendlein@hzg.de
RI Jung, Friedrich/L-1301-2013; Lendlein, Andreas/K-9553-2013
OI Jung, Friedrich/0000-0001-8098-7180; Lendlein,
   Andreas/0000-0003-4126-4670; Roch, Toralf/0000-0003-2948-8700
FU German Federal Ministry of Education and Research (BMBF) [0315696A]
FX The authors thank Ruth Hesse, Anja Muller-Heyn, and Angelika Ritschel
   for the technical support and the German Federal Ministry of Education
   and Research (BMBF) for funding within project number 0315696A
   ,,Poly4Bio BB".
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202
   BERG B, 1981, REFERENCE VALUES LAB, P55
   Braune S, 2010, CLIN HEMORHEOL MICRO, V46, P239, DOI 10.3233/CH-2010-1351
   Butler D, 2011, NATURE, V477, P260, DOI 10.1038/477260a
   EKDAHL KN, 1993, J COLLOID INTERF SCI, V158, P121, DOI 10.1006/jcis.1993.1236
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grasbeck R., 1981, REFERENCE VALUES LAB
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kader KN, 2007, J BIOMED MATER RES B, V83B, P138, DOI 10.1002/jbm.b.30777
   Lange M, 2012, MACROMOL RAPID COMM, V33, P1487, DOI 10.1002/marc.201200426
   Lendlein A, 2011, INT J ARTIF ORGANS, V34, P71, DOI 10.5301/IJAO.2011.6422
   Lumadue JA, 1996, AM J CLIN PATHOL, V106, P795
   Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952
   NAGATA S, 1987, J ALLERGY CLIN IMMUN, V80, P24, DOI 10.1016/S0091-6749(87)80186-0
   Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854
   Opal SM, 2010, CONTRIB NEPHROL, V167, P14, DOI 10.1159/000315915
   Roch T, 2012, CLIN HEMORHEOL MICRO, V52, P375, DOI 10.3233/CH-2012-1612
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   Schulz C, 2012, CLIN HEMORHEOL MICRO, V52, P267, DOI 10.3233/CH-2012-1604
   Seifu DG, 2013, NAT REV CARDIOL, V10, P410, DOI 10.1038/nrcardio.2013.77
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Toda M, 2008, BIOMATERIALS, V29, P407, DOI 10.1016/j.biomaterials.2007.10.005
   Vijayakumar R., 2012, EUROPEAN J PARENTERA, V17, P4
   Wischke C, 2013, EUR J PHARM BIOPHARM, V84, P288, DOI 10.1016/j.ejpb.2013.01.025
   Wischke C, 2012, J CONTROL RELEASE, V164, P299, DOI 10.1016/j.jconrel.2012.06.034
NR 30
TC 4
Z9 4
U1 1
U2 6
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2014
VL 57
IS 2
BP 203
EP 212
DI 10.3233/CH-141831
PG 10
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA AP2TH
UT WOS:000341927400013
PM 24584324
DA 2018-10-20
ER

PT J
AU Yao, ZT
   Xia, MS
   Li, HY
   Chen, T
   Ye, Y
   Zheng, H
AF Yao, Zhitong
   Xia, Meisheng
   Li, Haiyan
   Chen, Tao
   Ye, Ying
   Zheng, Hao
TI Bivalve Shell: Not an Abundant Useless Waste but a Functional and
   Versatile Biomaterial
SO CRITICAL REVIEWS IN ENVIRONMENTAL SCIENCE AND TECHNOLOGY
LA English
DT Review
DE biomaterial; bivalve shell; calcium carbonate; filler; mineralization;
   organic matrix
ID OYSTER-PINCTADA-FUCATA; WATER MUSSEL AMBLEMA; OSTEOBLASTS MAINTAINED
   INVITRO; ALKALINE-PHOSPHATASE ACTIVITY; SCANNING-ELECTRON-MICROSCOPY;
   JAPANESE PEARL OYSTER; SOLID BASE CATALYST; BIODIESEL PRODUCTION;
   PRISMATIC LAYER; MATRIX PROTEIN
AB Bivalve shells, available in abundance, have no eminent use and are commonly regarded as waste. Their improper disposal causes a significant level of environmental concern and also results in a waste of natural resources. Bivalve shell is formed by biomineralization and consists mainly of CaCO3 with a small amount of organic matrix, giving it a potential for use as raw material. Recycling shell waste could potentially eliminate the disposal problem, and also turn an otherwise useless waste into high value-added products. The present paper first describes the microstructure and physicochemical properties of bivalve shell, then focuses on its current applications. Finally, the current status of bivalve shell studies and directions for future research are considered.
C1 [Yao, Zhitong] Hangzhou Dianzi Univ, Coll Mat Sci & Environm Engn, Hangzhou 310018, Zhejiang, Peoples R China.
   [Xia, Meisheng; Chen, Tao; Ye, Ying; Zheng, Hao] Zhejiang Univ, Dept Ocean Sci & Engn, Hangzhou 310058, Zhejiang, Peoples R China.
   [Li, Haiyan] Zhejiang Univ, Zhoushan Ocean Res Inst, Zhoushan, Peoples R China.
RP Yao, ZT (reprint author), Hangzhou Dianzi Univ, Coll Mat Sci & Environm Engn, Hangzhou 310018, Zhejiang, Peoples R China.
EM sxyzt@126.com; msxia@zju.edu.cn
FU Zhejiang Provincial Natural Science Foundation of China [LQ13B070005];
   Marine Scientific Research Foundation of Zhejiang University
   [2012HY001B]; Key Laboratory for Solid Waste Management and Environment
   Safety Open Fund [SWMES 2011-07]; Scientific Research Foundation of
   Hangzhou Dianzi University [KYS205612029]
FX We gratefully acknowledge financial support from the Zhejiang Provincial
   Natural Science Foundation of China (Grant no. LQ13B070005), Marine
   Scientific Research Foundation of Zhejiang University (Grant no.
   2012HY001B), the Key Laboratory for Solid Waste Management and
   Environment Safety Open Fund (Grant no. SWMES 2011-07), and Scientific
   Research Foundation of Hangzhou Dianzi University (Grant no.
   KYS205612029).
CR ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531
   Ahmad H. A., 2003, Journal of Applied Poultry Research, V12, P509
   ALBECK S, 1993, J AM CHEM SOC, V115, P11691, DOI 10.1021/ja00078a005
   Almeida MJ, 2001, J BIOMED MATER RES, V57, P306, DOI 10.1002/1097-4636(200111)57:2<306::AID-JBM1172>3.0.CO;2-H
   Alvarez E, 2012, PEDOSPHERE, V22, P152, DOI 10.1016/S1002-0160(12)60002-2
   Asaoka S, 2009, BIORESOURCE TECHNOL, V100, P4127, DOI 10.1016/j.biortech.2009.03.075
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Azizi H, 2009, POLYM COMPOSITE, V30, P1743, DOI 10.1002/pc.20685
   Bae DH, 2006, ARCH PHARM RES, V29, P298, DOI 10.1007/BF02968574
   BEEDHAM GE, 1958, Q J MICROSC SCI, V99, P181
   Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019
   BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776
   Boey PL, 2011, FUEL, V90, P2353, DOI 10.1016/j.fuel.2011.03.002
   Boggild OB, 1930, K DAN VIDENSK SELSK, V9, P233
   Bolan NS, 2003, ADV AGRON, V78, P215, DOI 10.1016/S0065-2113(02)78006-1
   Boro J, 2012, RENEW SUST ENERG REV, V16, P904, DOI 10.1016/j.rser.2011.09.011
   Bowerbank J. S., 1844, T MICROSC SOC LONDON, V1, P123
   Bureau of Fisheries Ministry of Agriculture., 2011, CHIN FISH YB 2011
   CAMPRASSE S, 1990, Clinical Materials, V5, P235, DOI 10.1016/0267-6605(90)90022-N
   CARTER JG, 1975, LETHAIA, V8, P315, DOI 10.1111/j.1502-3931.1975.tb00936.x
   CATALANO CR, 1994, J FOOD PROTECT, V57, P587, DOI 10.4315/0362-028X-57.7.587
   Chang F, 2007, FOOD CHEM, V104, P1171, DOI 10.1016/j.foodchem.2007.01.032
   Checa A, 2000, TISSUE CELL, V32, P405, DOI 10.1054/tice.2000.0129
   Checa AG, 2005, BIOMATERIALS, V26, P6404, DOI 10.1016/j.biomaterials.2005.04.016
   Checa AG, 2011, J STRUCT BIOL, V176, P330, DOI 10.1016/j.jsb.2011.09.011
   Checa AG, 2009, J STRUCT BIOL, V167, P261, DOI 10.1016/j.jsb.2009.06.009
   Chen B, 2005, J METASTAB NANOCRYST, V23, P83, DOI 10.4028/www.scientific.net/JMNM.23.83
   Chen B, 2004, CERAM INT, V30, P2011, DOI 10.1016/j.ceramint.2003.12.169
   Cheng P. Y., 2009, THESIS KAOHSIUNG MAR
   Cheon S. M., 2003, J KOREAN CERAM SOC, V40, P1235
   Choi YM, 2006, FOOD CONTROL, V17, P695, DOI 10.1016/j.foodcont.2005.04.005
   Chong MH, 2006, J APPL POLYM SCI, V99, P1583, DOI 10.1002/app.22484
   Chou J, 2010, ENVIRON POLLUT, V158, P2230, DOI 10.1016/j.envpol.2010.02.015
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   Currey JD, 2001, P ROY SOC B-BIOL SCI, V268, P107, DOI 10.1098/rspb.2000.1337
   Di Serio M, 2008, ENERG FUEL, V22, P207, DOI 10.1021/ef700250g
   Effiong G. S., 2009, AM EURASIAN J AGRON, V2, P144
   Etelaaho P, 2011, POLYM COMPOSITE, V32, P464, DOI 10.1002/pc.21065
   Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860
   FAO, 2010, YB FISH AQ STAT 2008
   FAO, 2011, GLOB AQ PROD 1950 20
   Feng QL, 2000, J MATER SCI, V35, P3337, DOI 10.1023/A:1004843900161
   FINKELSTEIN AD, 1993, J DAIRY SCI, V76, P582, DOI 10.3168/jds.S0022-0302(93)77378-6
   Freer A., 2009, CRYST GROWTH DES, V10, P344
   de Alvarenga RAF, 2012, J ENVIRON MANAGE, V106, P102, DOI 10.1016/j.jenvman.2012.04.017
   Funabashi M, 2010, J POLYM ENVIRON, V18, P85, DOI 10.1007/s10924-010-0166-3
   Gilbert PUPA, 2011, P NATL ACAD SCI USA, V108, P11350, DOI 10.1073/pnas.1107917108
   Glover EA, 2010, J MOLLUS STUD, V76, P157, DOI 10.1093/mollus/eyp054
   Gryglewicz S, 1999, BIORESOURCE TECHNOL, V70, P249, DOI 10.1016/S0960-8524(99)00042-5
   GUINOTTE F, 1991, POULTRY SCI, V70, P583, DOI 10.3382/ps.0700583
   Hashidate Y. T., 1993, P 33 JAP NAT C GEOT, P869
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   Hu SY, 2011, BIOMASS BIOENERG, V35, P3627, DOI 10.1016/j.biombioe.2011.05.009
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   JACKSON AP, 1990, J MATER SCI, V25, P3173, DOI 10.1007/BF00587670
   Jipa S, 2010, POLYM BULL, V64, P783, DOI 10.1007/s00289-009-0213-1
   JOZEWICZ W, 1987, ENVIRON SCI TECHNOL, V21, P664, DOI 10.1021/es00161a007
   Jung JH, 2005, KOREAN J CHEM ENG, V22, P566, DOI 10.1007/BF02706644
   Jung JH, 2000, KOREAN J CHEM ENG, V17, P585, DOI 10.1007/BF02707171
   Jung JH, 2007, J IND ENG CHEM, V13, P512
   Jung SH, 2012, FUEL PROCESS TECHNOL, V96, P265, DOI 10.1016/j.fuproc.2011.12.039
   Kaplan DL, 1998, CURR OPIN SOLID ST M, V3, P232, DOI 10.1016/S1359-0286(98)80096-X
   Kawashima A, 2009, BIORESOURCE TECHNOL, V100, P696, DOI 10.1016/j.biortech.2008.06.049
   KINNER JA, 1981, POULTRY SCI, V60, P761, DOI 10.3382/ps.0600761
   Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200
   Kouzu M., 2006, J JPN I ENERGY, V85, P135
   Kouzu M, 2008, APPL CATAL A-GEN, V334, P357, DOI 10.1016/j.apcata.2007.10.023
   Kurunczi S, 2001, MIKROCHIM ACTA, V137, P41, DOI 10.1007/s006040170026
   Kusterko S. K., 2006, VALORIZACAO RESIDUOS
   Kwon HB, 2004, RESOUR CONSERV RECY, V41, P75, DOI 10.1016/j.resconrec.2003.08.005
   Lee CH, 2008, WASTE MANAGE, V28, P2702, DOI 10.1016/j.wasman.2007.12.005
   Lee G. H., 1998, P 33 JAP NAT C GEOT, P423
   Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372
   LEVIN M, 1978, J WATER POLLUT CON F, V50, P1377
   Li H. Y., 2013, J CENT S U IN PRESS
   Li HY, 2012, J HAZARD MATER, V217, P256, DOI 10.1016/j.jhazmat.2012.03.028
   [李海晏 Li Haiyan], 2012, [硅酸盐学报, Journal of the Chinese Silicate Society], V40, P1671
   [李海晏 Li Haiyan], 2012, [功能材料, Journal of Functional Materials], V43, P1519
   [李花帅 Li Huashuai], 2012, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V27, P1
   Lim B. P., 2009, EUR J SCI RES, V33, P347
   Lin AYM, 2008, ACTA BIOMATER, V4, P131, DOI 10.1016/j.actbio.2007.05.005
   Lin AYM, 2009, J MECH BEHAV BIOMED, V2, P607, DOI 10.1016/j.jmbbm.2009.04.003
   Lin CY, 2006, FUEL, V85, P1743, DOI 10.1016/j.fuel.2006.03.010
   Liu J., 1992, MATER RES SOC S P, V255, P9
   Liu XJ, 2008, FUEL, V87, P216, DOI 10.1016/j.fuel.2007.04.013
   Lopez E, 2000, TISSUE CELL, V32, P95, DOI 10.1054/tice.1999.0091
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Granados ML, 2007, APPL CATAL B-ENVIRON, V73, P317, DOI 10.1016/j.apcatb.2006.12.017
   Lopez-Urionabarrenechea A, 2011, FUEL PROCESS TECHNOL, V92, P253, DOI 10.1016/j.fuproc.2010.05.008
   LUTTS A, 1960, ARCH INT PHYS BIOCH, V68, P829, DOI 10.3109/13813456009075173
   MacDonald J, 2010, CRYST GROWTH DES, V10, P1243, DOI 10.1021/cg901263p
   MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0
   MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286
   Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200
   Meher LC, 2006, RENEW SUST ENERG REV, V10, P248, DOI 10.1016/j.rser.2004.09.002
   Mihara Y., 2008, J CERAM SOC JPN, V116, ps1
   Miyaji Y., 2000, P COAST GEOT ENG PRA, P675
   Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657
   Monagheddu M, 1999, ENVIRON SCI TECHNOL, V33, P2485, DOI 10.1021/es9809206
   MORSE DE, 1993, MATER RES SOC SYMP P, V292, P59
   Moutahir-Belqasmi F, 2001, J MATER SCI-MATER M, V12, P1, DOI 10.1023/A:1026759431595
   Mustata F, 2012, COMPOS PART B-ENG, V43, P702, DOI 10.1016/j.compositesb.2011.11.047
   Nakatani N, 2009, BIORESOURCE TECHNOL, V100, P1510, DOI 10.1016/j.biortech.2008.09.007
   National Bureau of Statistics of the People's Republic of China, 2010, CHIN STAT YB 2010
   Oikawa K, 2000, J HEALTH SCI, V46, P98
   Okouchi S., 1996, INORG MATER, V261, P111
   Okouchi S., 1995, J ANTIBACTERIAL ANTI, V26, P109
   Oliveira DV, 2012, SCI WORLD J, DOI 10.1100/2012/765909
   Park WH, 2008, ECOL ENG, V34, P50, DOI 10.1016/j.ecoleng.2008.05.014
   PEARSON J, 1987, APPL ENVIRON MICROB, V53, P2060
   PETERSON GR, 1984, J AM OIL CHEM SOC, V61, P1593, DOI 10.1007/BF02541639
   PETIT H, 1980, TISSUE CELL, V12, P13, DOI 10.1016/0040-8166(80)90049-X
   PETIT H, 1978, TISSUE CELL, V10, P619, DOI 10.1016/0040-8166(78)90050-2
   PETIT H, 1980, TISSUE CELL, V12, P581, DOI 10.1016/0040-8166(80)90046-4
   PETIT H, 1979, TISSUE CELL, V11, P633, DOI 10.1016/0040-8166(79)90020-X
   PHILLIPS DJH, 1985, MAR ECOL PROG SER, V21, P251, DOI 10.3354/meps021251
   ROLAND DA, 1986, WORLD POULTRY SCI J, V42, P166, DOI 10.1079/WPS19860013
   Roland Sr D. A., 1999, FEEDSTUFFS, V71, P18
   SALEUDDIN ASM, 1983, MOLLUSCA, V4, P199
   Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3
   Sawai J, 1996, J CHEM ENG JPN, V29, P251, DOI 10.1252/jcej.29.251
   Sawai J, 1996, J CHEM ENG JPN, V29, P627, DOI 10.1252/jcej.29.627
   Sawai J, 2001, INT J FOOD MICROBIOL, V71, P211, DOI 10.1016/S0168-1605(01)00619-5
   SAWAI J, 1995, J CHEM ENG JPN, V28, P556, DOI 10.1252/jcej.28.556
   Schaffer T. E., CHEM MAT, V9, P1731
   Shanks B., 2004, NRELSR51036244
   Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472
   Shono M, 2008, BIOSCI BIOTECH BIOCH, V72, P2761, DOI 10.1271/bbb.80267
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   Solidum J. N., 2011, 5 INT C BIOINF BIOM
   Song F, 2003, BIOMATERIALS, V24, P3623, DOI 10.1016/S0142-9612(03)00215-1
   SOUTHAM G, 1987, J FOOD PROTECT, V50, P103, DOI 10.4315/0362-028X-50.2.103
   Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391
   Suppes GJ, 2004, APPL CATAL A-GEN, V257, P213, DOI 10.1016/j.apcata.2003.07.010
   Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319
   Suzuki M, 2007, BIOSCI BIOTECH BIOCH, V71, P1735, DOI 10.1271/bbb.70140
   TAYLOR JD, 1969, CALC TISS RES, V3, P274, DOI 10.1007/BF02058669
   Tongamp W, 2008, WASTE MANAGE, V28, P484, DOI 10.1016/j.wasman.2007.01.022
   Tongamp W, 2009, J MATER CYCLES WASTE, V11, P32, DOI 10.1007/s10163-008-0216-2
   Tsai HC, 2011, BIORESOURCE TECHNOL, V102, P7802, DOI 10.1016/j.biortech.2011.06.036
   Tsai W. T., 2009, J ENV ENG MANAGE, V19, P165
   Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072
   Van Gerpen J, 2005, FUEL PROCESS TECHNOL, V86, P1097, DOI 10.1016/j.fuproc.2004.11.005
   Watabe N., 1988, MOLLUSCA, V11, P69
   WATABE N, 1976, MECHANISMS MINERALIZ, P283
   WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G
   WEINER S, 1976, P NATL ACAD SCI USA, V73, P2541, DOI 10.1073/pnas.73.8.2541
   Yamada M., 2005, Journal of the Society of Materials Science, Japan, V54, P1117, DOI 10.2472/jsms.54.1117
   Yan ZG, 2008, CHEMBIOCHEM, V9, P1093, DOI 10.1002/cbic.200700553
   Yan ZG, 2011, ACTA OCEANOL SIN, V30, P87, DOI 10.1007/s13131-011-0094-7
   Yang CM, 1996, HAZARD WASTE HAZARD, V13, P445, DOI 10.1089/hwm.1996.13.445
   Yang EI, 2005, CEMENT CONCRETE RES, V35, P2175, DOI 10.1016/j.cemconres.2005.03.016
   Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cpbp.2006.03.004
   Yoon GL, 2003, WASTE MANAGE, V23, P825, DOI 10.1016/S0956-053X(02)00159-9
   Yoon H, 2004, WASTE MANAGE RES, V22, P158, DOI 10.1177/0734242X04042456
   Yuangsawad R., 2011, 21 THAI I CHEM ENG A
   Yusof AM, 2004, J RADIOANAL NUCL CH, V259, P119, DOI 10.1023/B:JRNC.0000015816.16869.6f
   Zhang J, 2011, J APPL POLYM SCI, V119, P3560, DOI 10.1002/app.33037
NR 158
TC 21
Z9 21
U1 2
U2 34
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1064-3389
EI 1547-6537
J9 CRIT REV ENV SCI TEC
JI Crit. Rev. Environ. Sci. Technol.
PY 2014
VL 44
IS 22
BP 2502
EP 2530
DI 10.1080/10643389.2013.829763
PG 29
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA AP1GW
UT WOS:000341817100002
DA 2018-10-20
ER

PT J
AU Svensson, S
   Forsberg, M
   Hulander, M
   Vazirisani, F
   Palmquist, A
   Lausmaa, J
   Thomsen, P
   Trobos, M
AF Svensson, Sara
   Forsberg, Magnus
   Hulander, Mats
   Vazirisani, Forugh
   Palmquist, Anders
   Lausmaa, Jukka
   Thomsen, Peter
   Trobos, Margarita
TI Role of nanostructured gold surfaces on monocyte activation and
   Staphylococcus epidermidis biofilm formation
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nanotopography; staphylococci; host defense; bacteria; zymosan;
   macrophage
ID PSEUDOMONAS-AERUGINOSA; BIOMATERIAL SURFACES; INCREASED OSTEOBLAST;
   PROTEIN ADSORPTION; BACTERIAL ADHESION; BETA-2 INTEGRIN;
   GENE-EXPRESSION; NANOMETER-SCALE; GLASS SURFACES; KAPPA-B
AB The role of material surface properties in the direct interaction with bacteria and the indirect route via host defense cells is not fully understood. Recently, it was suggested that nanostructured implant surfaces possess antimicrobial properties. In the current study, the adhesion and biofilm formation of Staphylococcus epidermidis and human monocyte adhesion and activation were studied separately and in coculture in different in vitro models using smooth gold and well-defined nanostructured gold surfaces. Two polystyrene surfaces were used as controls in the monocyte experiments. Fluorescent viability staining demonstrated a reduction in the viability of S. epidermidis close to the nanostructured gold surface, whereas the smooth gold correlated with more live biofilm. The results were supported by scanning electron microscopy observations, showing higher biofilm tower formations and more mature biofilms on smooth gold compared with nanostructured gold. Unstimulated monocytes on the different substrates demonstrated low activation, reduced gene expression of pro- and anti-inflammatory cytokines, and low cytokine secretion. In contrast, stimulation with opsonized zymosan or opsonized live S. epidermidis for 1 hour significantly increased the production of reactive oxygen species, the gene expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), IL-6, and IL-10, as well as the secretion of TNF-alpha, demonstrating the ability of the cells to elicit a response and actively phagocytose prey. In addition, cells cultured on the smooth gold and the nanostructured gold displayed a different adhesion pattern and a more rapid oxidative burst than those cultured on polystyrene upon stimulation. We conclude that S. epidermidis decreased its viability initially when adhering to nanostructured surfaces compared with smooth gold surfaces, especially in the bacterial cell layers closest to the surface. In contrast, material surface properties neither strongly promoted nor attenuated the activity of monocytes when exposed to zymosan particles or S. epidermidis.
C1 [Svensson, Sara; Forsberg, Magnus; Hulander, Mats; Vazirisani, Forugh; Palmquist, Anders; Thomsen, Peter; Trobos, Margarita] Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, SE-40530 Gothenburg, Sweden.
   [Svensson, Sara; Forsberg, Magnus; Hulander, Mats; Vazirisani, Forugh; Palmquist, Anders; Lausmaa, Jukka; Thomsen, Peter; Trobos, Margarita] BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden.
   [Lausmaa, Jukka] SP Tech Res Inst Sweden, Boras, Sweden.
RP Svensson, S (reprint author), Univ Gothenburg, Inst Clin Sci, Dept Biomat, Box 412, SE-40530 Gothenburg, Sweden.
EM sara.svensson@biomaterials.gu.se
RI Palmquist, Anders/D-2171-2014
OI Thomsen, Peter/0000-0003-3910-6665
FU BIOMATCELL Vinn Excellence Center of Biomaterials and Cell Therapy;
   VINNOVA; Vastra Gotaland Region; Swedish Research Council
   [K2012-52X-09495-25-3]; Hjalmar Svensson Foundation; IngaBritt and Arne
   Lundberg Foundation; Adlerbertska Foundation
FX The authors would like to acknowledge the Center for Cellular Imaging at
   the Sahlgrenska Academy, University of Gothenburg, for the use of CLSM
   equipment and for the support of the staff, and the Electron Microscopy
   Unit, University of Gothenburg, where the SEM was performed. Financial
   support was obtained from the BIOMATCELL Vinn Excellence Center of
   Biomaterials and Cell Therapy, supported by VINNOVA and the Vastra
   Gotaland Region, the Swedish Research Council (grant
   K2012-52X-09495-25-3), the Hjalmar Svensson Foundation, IngaBritt and
   Arne Lundberg Foundation, and the Adlerbertska Foundation.
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0
   Braem A, 2013, J BIOMED MAT RES A
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Collie AMB, 2011, J BIOMED MATER RES A, V96A, P162, DOI 10.1002/jbm.a.32963
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   DEFORGE LE, 1991, BIOCHEM BIOPH RES CO, V174, P18, DOI 10.1016/0006-291X(91)90478-P
   Eisler R, 2003, INFLAMM RES, V52, P487, DOI 10.1007/s00011-003-1208-2
   Ercan B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295102
   Ferraz N, 2010, INT J BIOMATER, V2010, DOI DOI 10.1155/2010/402715
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   HAZUDA DJ, 1988, J BIOL CHEM, V263, P8473
   Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395
   Hulander M, 2013, COLLOID SURFACE B, V110, P261, DOI 10.1016/j.colsurfb.2013.04.010
   Hulander M, 2011, INT J NANOMED, V6, P2653, DOI 10.2147/IJN.S24578
   Jancinova V, 2006, REDOX REP, V11, P110, DOI 10.1179/135100006X116592
   Kiener PA, 1997, J EXP MED, V185, P1511, DOI 10.1084/jem.185.8.1511
   Kimling J, 2006, J PHYS CHEM B, V110, P15700, DOI 10.1021/jp061667w
   Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004
   Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021
   Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006
   Lindblad M, 1997, BIOMATERIALS, V18, P1059, DOI 10.1016/S0142-9612(97)00029-X
   Lundgren AO, 2008, NANO LETT, V8, P3989, DOI 10.1021/nl802543g
   Machado MC, 2012, INT J NANOMED, V7, P3741, DOI 10.2147/IJN.S28191
   MARTINEZMARTINEZ L, 1993, J MED MICROBIOL, V39, P196, DOI 10.1099/00222615-39-3-196
   Mitik-Dineva N, 2009, BIOFOULING, V25, P621, DOI 10.1080/08927010903012773
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Mohiuddin M, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-394
   Tran N, 2012, CHEMPHYSCHEM, V13, P2481, DOI 10.1002/cphc.201200091
   Nilsdotter-Augustinsson A, 2005, APMIS, V113, P361, DOI 10.1111/j.1600-0463.2005.apm_113508.x
   Omar O, 2010, J MATER SCI-MATER M, V21, P969, DOI 10.1007/s10856-009-3915-x
   Omar OM, 2011, BIOMATERIALS, V32, P374, DOI 10.1016/j.biomaterials.2010.09.011
   PEREZ RL, 1995, J IMMUNOL, V154, P1879
   Puckett SD, 2010, ACTA BIOMATER, V6, P2352, DOI 10.1016/j.actbio.2009.12.016
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Rezzonico R, 2000, BLOOD, V95, P3868
   Rezzonico R, 2001, BLOOD, V97, P2932, DOI 10.1182/blood.V97.10.2932
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406
   Sheng YJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2804425
   Smith LL, 2007, INT J NANOMED, V2, P383
   Steiner G, 2007, ANAL CHEM, V79, P1311, DOI 10.1021/ac061341j
   Suska F, 2005, BIOMATERIALS, V26, P519, DOI 10.1016/j.biomaterials.2004.02.066
   Suska F, 2008, J BIOMED MATER RES A, V85A, P888, DOI 10.1002/jbm.a.31575
   Suska F, 2010, J BIOMED MATER RES B, V92B, P86, DOI 10.1002/jbm.b.31492
   Wagner VE, 2004, J BIOMED MATER RES A, V69A, P79, DOI 10.1002/jbm.a.20115
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
NR 55
TC 19
Z9 19
U1 2
U2 24
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 775
EP 794
DI 10.2147/IJN.S51465
PG 20
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AP0VE
UT WOS:000341782800001
PM 24550671
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ware, T
   Jennings, AR
   Bassampour, ZS
   Simon, D
   Son, DY
   Voit, W
AF Ware, Taylor
   Jennings, Abby R.
   Bassampour, Zahra S.
   Simon, Dustin
   Son, David Y.
   Voit, Walter
TI Degradable, silyl ether thiol-ene networks
SO RSC ADVANCES
LA English
DT Article
ID POLYMERS; ELECTRONICS; BIOMATERIAL; CHEMISTRY; SYSTEMS
AB A system of multifunctional silyl ether containing alkene and thiol monomers are synthesized and polymerized into uniform degradable networks with widely tunable thermomechanical properties. The glass transition temperature of the hydrolytically unstable networks can be controlled between -60 degrees C and 40 degrees C. Near total degradation is observed and the rate of degradation is controlled to occur between hours and months. Dynamic mechanical analysis, mass loss, uniaxial compression testing, multinuclear NMR spectroscopy, and gas chromatography-mass spectrometry are utilized to characterize the degradation of these networks. Importantly, this system of materials allows for rapid hydrolytic degradation that is not preceded by swelling. These degradable polymers are demonstrated to be compatible with microfabrication techniques, namely photolithography. As a demonstration, partially biodegradable cortical electrodes were fabricated and electrochemically characterized on silyl ether substrates.
C1 [Ware, Taylor; Simon, Dustin; Voit, Walter] Univ Texas Dallas, Dept Mat Sci & Engn, Richardson, TX 75080 USA.
   [Jennings, Abby R.; Bassampour, Zahra S.; Son, David Y.] So Methodist Univ, Ctr Drug Discovery Design & Delivery CD4, Dept Chem, Dallas, TX 75275 USA.
RP Voit, W (reprint author), Univ Texas Dallas, Dept Mat Sci & Engn, 800 West Campbell RD,RL 3, Richardson, TX 75080 USA.
EM dson@mail.smu.edu; walter.voit@utdallas.edu
RI Ware, Taylor/A-7130-2017
OI Ware, Taylor/0000-0001-7996-7393
FU NSF Graduate Research Fellowship; Texas Biomedical Device Center at The
   University of Texas at Dallas; DARPA Young Faculty Award Program;
   Southern Methodist University; Texas Space Grant Consortium Graduate
   Fellowship
FX THW would like to acknowledge support from the NSF Graduate Research
   Fellowship. In addition, this work was supported by funding from the
   Texas Biomedical Device Center at The University of Texas at Dallas and
   the DARPA Young Faculty Award Program. The authors thank Southern
   Methodist University for support of this work. A. Jennings was partially
   supported by a Texas Space Grant Consortium Graduate Fellowship. THW, WV
   and DS would like to thank Keith Hearon, Radu Reit and Jonathan Reeder
   for thoughtful discussions, suggestions for future work and adjacent
   research with similar polymer systems that have helped to clarify and
   strengthen this effort.
CR Bruning K., 1999, ORGANOMET CHEM, V575, P153
   Cook WD, 2010, MACROMOL SYMP, V291-292, P50, DOI 10.1002/masy.201050507
   Gitto SP, 1995, MACROMOLECULES, V28, P8887, DOI 10.1021/ma00130a030
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Harris JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066011
   Hoyle CE, 2010, CHEM SOC REV, V39, P1355, DOI 10.1039/b901979k
   Hwang SW, 2014, ADV MATER, V26, P3905, DOI 10.1002/adma.201306050
   Jennings AR, 2013, CHEM COMMUN, V49, P3467, DOI 10.1039/c3cc39152c
   Kade MJ, 2010, J POLYM SCI POL CHEM, V48, P743, DOI 10.1002/pola.23824
   Kim C, 1998, SYNTHESIS-STUTTGART, P105
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Nair DP, 2010, POLYMER, V51, P4383, DOI 10.1016/j.polymer.2010.07.027
   Parrott MC, 2010, J AM CHEM SOC, V132, P17928, DOI 10.1021/ja108568g
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Subbaroyan J, 2005, J NEURAL ENG, V2, P103, DOI 10.1088/1741-2560/2/4/006
   Tien LW, 2013, ADV FUNCT MATER, V23, P3185, DOI 10.1002/adfm.201203716
   Wang M, 2001, BIOMACROMOLECULES, V2, P1206, DOI 10.1021/bm010093s
   Ware T, 2013, J BIOMED MATER RES B, V102, P1
   Wei HY, 2007, J POLYM SCI POL CHEM, V45, P822, DOI 10.1002/pola.21844
   Weinberg JM, 1998, MACROMOLECULES, V31, P15, DOI 10.1021/ma971168g
NR 23
TC 9
Z9 10
U1 1
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 75
BP 39991
EP 40002
DI 10.1039/c4ra06997h
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA AP0TY
UT WOS:000341779000055
DA 2018-10-20
ER

PT J
AU Qi, SY
   Huang, YL
   Li, YD
   Cai, P
   Kim, SI
   Seo, HJ
AF Qi, Shuyun
   Huang, Yanlin
   Li, Yadong
   Cai, Peiqing
   Kim, Sun Il
   Seo, Hyo Jin
TI Probe spectrum measurements of Eu3+ ions as a relevant tool for
   monitoring in vitro hydroxyapatite formation in a new borate biomaterial
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID RARE-EARTH IONS; TRICALCIUM SILICATE; BIOACTIVE CERAMICS; LUMINESCENCE
   PROPERTIES; CALCIUM METABORATE; APATITE FORMATION; CRYSTAL; CELLS;
   SCAFFOLD; DIFFERENTIATION
AB CaB2O4 powders and ceramics were prepared by the conventional solid-state reaction. In vitro hydroxyapatite (HA) mineralization was investigated by soaking the samples in simulated body fluid (SBF) for various time periods. X-ray diffraction and structural refinements, scanning electron microscopy and X-ray energy-dispersive spectra measurements were applied to investigate apatite formation before and after immersion in SBF. HA can easily form flower-like nanostructures with nano-needles even when soaked in SBF for several hours. The in vitro bioactivity of CaB2O4 was attributed to easy formation of B-OH groups in the CaB2O4 structure when soaked in SBF solutions. In the process of mineralization, the luminescence evolution of Eu3+ ions, a well-known structural probe, was detected by photoluminescence spectra and photoluminescence decay curves. This suggested that the process of mineralization can be monitored by the luminescence intensity of Eu3+ ions in the mineralization products. The current study will open up a new and simple in vivo avenue for in situ monitoring of hydroxyapatite conversion using a fiber luminescence spectrometer.
C1 [Qi, Shuyun; Huang, Yanlin; Li, Yadong] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
   [Cai, Peiqing; Kim, Sun Il; Seo, Hyo Jin] Pukyong Natl Univ, Dept Phys, Pusan 608737, South Korea.
   [Cai, Peiqing; Kim, Sun Il; Seo, Hyo Jin] Pukyong Natl Univ, Ctr Marine Integrated Biomed Technol, Pusan 608737, South Korea.
RP Huang, YL (reprint author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
EM huang@suda.edu.cn; hjseo@pknu.ac.kr
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT & Future Planning
   [NRF-2013R1A1A2009154]; Priority Academic Program Development of Jiangsu
   Higher Education Institutions (PAPD), China
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Science, ICT & Future Planning (NRF-2013R1A1A2009154) and by
   the Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD), China.
CR Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   Alves NM, 2010, J MATER CHEM, V20, P2911, DOI 10.1039/b910960a
   Baran A, 2013, OPT MATER, V35, P2107, DOI 10.1016/j.optmat.2013.05.030
   BLASSE G, 1973, CHEM PHYS LETT, V20, P573, DOI 10.1016/0009-2614(73)80504-4
   Body S., 2009, MINERALOGIA, V40, P85
   Brown R.F., 2008, J BIOMED MATER RES A, V88, P392
   Cheng XL, 2009, STRUCT CHEM, V20, P221, DOI 10.1007/s11224-009-9405-4
   Devirian TA, 2003, CRIT REV FOOD SCI, V43, P219, DOI 10.1080/10408690390826491
   Dzondo-Gadet M, 2002, BIOL TRACE ELEM RES, V85, P23, DOI 10.1385/BTER:85:1:23
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   Feng ZQ, 2011, J ALLOY COMPD, V509, P7087, DOI 10.1016/j.jallcom.2011.04.003
   Ferreira RAS, 2006, J LUMIN, V121, P561, DOI 10.1016/j.jlumin.2005.12.044
   Fisher H., 2002, DENT MATER, V18, P12
   Fujimoto Y, 2012, CRYST GROWTH DES, V12, P142, DOI 10.1021/cg200885h
   GorllerWalrand C, 1996, HANDB PHYSI, V23, P121, DOI 10.1016/S0168-1273(96)23006-5
   Gou ZG, 2004, J EUR CERAM SOC, V24, P93, DOI 10.1016/S0955-2219(03)00320-0
   Gou ZR, 2005, J EUR CERAM SOC, V25, P1507, DOI 10.1016/j.jeurceramsoc.2004.05.029
   Graeve OA, 2010, BIOMATERIALS, V31, P4259, DOI 10.1016/j.biomaterials.2010.02.009
   Hafezi-Ardakani M, 2011, CERAM INT, V37, P175, DOI 10.1016/j.ceramint.2010.08.034
   Han X, 2007, J MATER SCI-MATER M, V18, P1837, DOI 10.1007/s10856-007-3053-2
   Hao JH, 2004, APPL PHYS LETT, V85, P3720, DOI 10.1063/1.1808876
   He Y, 2014, J MATER CHEM B, V2, P2220, DOI 10.1039/c4tb00146j
   Huang HS, 2014, MATER RES BULL, V49, P88, DOI 10.1016/j.materresbull.2013.08.010
   Huang JL, 2009, LUMINESCENCE, V24, P363, DOI 10.1002/bio.1116
   Huang YL, 2012, MATER LETT, V84, P107, DOI 10.1016/j.matlet.2012.06.051
   JUDD BR, 1962, PHYS REV, V127, P750, DOI 10.1103/PhysRev.127.750
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 2004, J MATER SCI-MATER M, V15, P99, DOI 10.1023/B:JMSM.0000011809.36275.0c
   KOKUBO T, 1993, J MATER SCI-MATER M, V4, P1, DOI 10.1007/BF00122969
   Larson A. C, 1994, 86748 LAUR LOS AL NA
   Lin KL, 2004, MATER LETT, V58, P2109, DOI 10.1016/j.matlet.2004.01.008
   Liu X, 2009, J MATER SCI-MATER M, V20, P365, DOI 10.1007/s10856-008-3582-3
   Lu HX, 2010, J BIOMATER APPL, V25, P39, DOI 10.1177/0885328209342469
   Lu W, 2010, J BIOMATER APPL, V26, P637
   MACHIDA K, 1980, INORG CHEM, V19, P983, DOI 10.1021/ic50206a038
   MANN S, 1988, NATURE, V334, P692, DOI 10.1038/334692a0
   MAREZIO M, 1963, ACTA CRYSTALLOGR, V16, P390, DOI 10.1107/S0365110X63001031
   MAREZIO M, 1969, ACTA CRYSTALL B-STRU, VB 25, P965, DOI 10.1107/S0567740869003256
   Meis C, 2000, J PHYS CHEM A, V104, P5380, DOI 10.1021/jp000096j
   Miake Y, 1995, J DENT RES, V74, P1756, DOI 10.1177/00220345950740110701
   Murray FJ, 1998, BIOL TRACE ELEM RES, V66, P331, DOI 10.1007/BF02783146
   Ni SY, 2006, J BIOMED MATER RES A, V76A, P196, DOI 10.1002/jbm.a.30525
   Nielsen FH, 2004, BIOFACTORS, V20, P161, DOI 10.1002/biof.5520200305
   OFELT GS, 1962, J CHEM PHYS, V37, P511, DOI 10.1063/1.1701366
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Oonishi H., 2000, J BIOMED MATER RES, V51, P7
   Peng WW, 2011, J ENDODONT, V37, P1240, DOI 10.1016/j.joen.2011.05.035
   PIRIOU B, 1987, J LUMIN, V39, P97, DOI 10.1016/0022-2313(87)90036-6
   Poort SHM, 1997, J PHYS CHEM SOLIDS, V58, P1451, DOI 10.1016/S0022-3697(97)00010-3
   Ramaswamy Y, 2008, BIOMATERIALS, V29, P4392, DOI 10.1016/j.biomaterials.2008.08.006
   Ramaswamy Y, 2008, ACTA BIOMATER, V4, P1487, DOI 10.1016/j.actbio.2008.04.014
   Ramaswamy Y, 2009, ACTA BIOMATER, V5, P3192, DOI 10.1016/j.actbio.2009.04.028
   Salinas AJ, 2013, RSC ADV, V3, P11116, DOI 10.1039/c3ra00166k
   Skaudzius R, 2014, J LUMIN, V147, P290, DOI 10.1016/j.jlumin.2013.11.051
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   Takada A, 1997, PHYS CHEM MINER, V24, P423, DOI 10.1007/s002690050056
   Vallet-Regi M, 2011, CHEM SOC REV, V40, P596, DOI 10.1039/c0cs00025f
   Wu CT, 2008, ACTA BIOMATER, V4, P343, DOI 10.1016/j.actbio.2007.08.010
   Wu CT, 2007, J MATER SCI-MATER M, V18, P857, DOI [10.1007/s10856-006-0083-0, 10.1007/S10856-006-0083-0]
   Wu CT, 2007, J BIOMATER APPL, V21, P251, DOI 10.1177/0885328206062360
   Wu CT, 2010, ACTA BIOMATER, V6, P2237, DOI 10.1016/j.actbio.2009.12.022
   Wu CT, 2010, ACTA BIOMATER, V6, P820, DOI 10.1016/j.actbio.2009.09.025
   Wu CT, 2009, J R SOC INTERFACE, V6, P159, DOI 10.1098/rsif.2008.0274
   Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019
   Xia Z, 2014, J MATER CHEM B, V2, P1998, DOI 10.1039/c3tb21595d
   Xu MC, 2013, BIOMATER SCI-UK, V1, P933, DOI 10.1039/c3bm60028a
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Yao AH, 2007, J AM CERAM SOC, V90, P303, DOI 10.1111/j.1551-2916.2006.01358.x
   Zachariasen WH, 1931, P NATL ACAD SCI USA, V17, P617, DOI 10.1073/pnas.17.11.617
   Zhang ML, 2010, J MATER SCI-MATER M, V21, P1169, DOI 10.1007/s10856-010-3985-9
   Zhao WN, 2014, SOLID STATE COMMUN, V178, P42, DOI 10.1016/j.ssc.2013.10.022
   Zhao WY, 2007, J MATER SCI-MATER M, V18, P917, DOI 10.1007/s10856-006-0069-y
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
   Zhong C, 2012, J MATER CHEM, V22, P6080, DOI 10.1039/c2jm15610e
   Zhou YH, 2012, ACTA BIOMATER, V8, P2307, DOI 10.1016/j.actbio.2012.03.012
NR 75
TC 19
Z9 19
U1 4
U2 34
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 37
BP 6387
EP 6396
DI 10.1039/c4tb00871e
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AO6JS
UT WOS:000341457500025
DA 2018-10-20
ER

PT J
AU Akash, MSH
   Rehman, K
   Chen, SQ
AF Akash, Muhammad Sajid Hamid
   Rehman, Kanwal
   Chen, Shuqing
TI Pluronic F127-Based Thermosensitive Gels for Delivery of Therapeutic
   Proteins and Peptides
SO POLYMER REVIEWS
LA English
DT Review
DE Pluronic; thermosensitive gel; proteinous drugs; therapeutic proteins;
   sustained delivery
ID TYPE-2 DIABETES-MELLITUS; HUMAN GROWTH-HORMONE; INTERLEUKIN-1 RECEPTOR
   ANTAGONIST; BIOLOGICAL RESPONSE MODIFIERS; UNSATURATED FATTY-ACIDS;
   NONVIRAL GENE DELIVERY; BLOOD-BRAIN-BARRIER; DRUG-DELIVERY;
   BLOCK-COPOLYMERS; CONTROLLED-RELEASE
AB Pluronic F127 block copolymer (PF127) has been recognized as an important biomaterial used for the efficient delivery of therapeutic proteins and peptides against various incurable diseases and thereby has gained increasing attention of pharmaceutical researchers. The aim of the present article is to highlight the biopharmaceutical significance of PF127-based thermosensitive gels for sustained delivery of therapeutic proteins and peptides. In this article, we have discussed various approaches adopted by several researchers for sustained release of different proteins and peptides from PF127-based thermosensitive gels. Incorporation of therapeutic proteins and peptides in PF127-based thermosensitive gels have shown to increase thermostability, biocompatibility, bioavailability, and therapeutic effects of these therapeutic agents. Summarizing various studies which have used PF127 as thermosensitive gel for controlled release of therapeutic proteins and peptides with no known toxicity, we conclude that PF127 continues to show its prospective effects for sustained delivery of therapeutic proteins and peptides. Taken together, we can expect a promising future of PF127 as polymer therapeutic for significant clinical outcomes of therapeutic proteins and peptides.
C1 [Akash, Muhammad Sajid Hamid; Rehman, Kanwal; Chen, Shuqing] Zhejiang Univ, Inst Pharmacol Toxicol & Biochem Pharmaceut, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China.
   [Akash, Muhammad Sajid Hamid] Govt Coll Univ Faisalabad, Coll Pharm, Fac Pharmaceut Sci, Faisalabad, Pakistan.
   [Rehman, Kanwal] Zhejiang Univ, Sch Med & Publ Hlth, Dept Toxicol, Hangzhou 310058, Zhejiang, Peoples R China.
RP Akash, MSH (reprint author), Zhejiang Univ, Inst Pharmacol Toxicol & Biochem Pharmaceut, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China.
EM sajidakash@gmail.com; chenshuqing@zju.edu.cn
RI Rehman, Kanwal/P-7727-2014; Akash, Muhammad Sajid Hamid/C-3477-2018
OI Rehman, Kanwal/0000-0001-7873-6681; Akash, Muhammad Sajid
   Hamid/0000-0002-9446-5233; Chen, Shuqing/0000-0002-0792-3735
FU National Major Projects for Science and Technology Development of
   Ministry Science and Technology of China [2012ZX09506001-004]; China
   Scholarship Council; Higher Education Commission of Pakistan
FX This work was financially supported by the grant (2012ZX09506001-004)
   from National Major Projects for Science and Technology Development of
   Ministry Science and Technology of China. The first two authors
   acknowledge China Scholarship Council to provide scholarships for their
   PhD studies in Zhejiang University, China. The first two authors also
   acknowledge the Higher Education Commission of Pakistan for providing
   partial support to the PhD studies of Muhammad Sajid Hamid Akash and
   Kanwal Rehman.
CR Agueros M, 2010, J CONTROL RELEASE, V145, P2, DOI 10.1016/j.jconrel.2010.03.012
   Ahmed F, 2006, DRUG DEVELOP RES, V67, P4, DOI 10.1002/ddr.20062
   Ahn JS, 2005, POLYM INT, V54, P842, DOI 10.1002/pi.1780
   Akash MSH, 2011, J MED PLANTS RES, V5, P6885, DOI 10.5897/JMPR11.1425
   Akash MSH, 2014, NUTRITION, V30, P1128, DOI 10.1016/j.nut.2014.02.011
   Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Akash MSH, 2014, PHARM DEV TECHNOL, V19, P278, DOI 10.3109/10837450.2013.775158
   Akash MSH, 2013, PHARM RES-DORDR, V30, P2951, DOI 10.1007/s11095-013-1118-0
   Akash MSH, 2013, CURR DIABETES REV, V9, P387, DOI 10.2174/15733998113099990069
   Akash MSH, 2013, CURR DIABETES REV, V9, P286, DOI 10.2174/15733998113099990062
   Akash MSH, 2013, EUR J PHARMACOL, V701, P87, DOI 10.1016/j.ejphar.2013.01.008
   Akash MSH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055925
   Akash MSH, 2013, J CELL BIOCHEM, V114, P525, DOI 10.1002/jcb.24402
   Akash MSH, 2012, PHARM RES-DORDR, V29, P3475, DOI 10.1007/s11095-012-0843-0
   Akash MSH, 2012, J PHARM SCI-US, V101, P1647, DOI 10.1002/jps.23057
   Azzam Tony, 2004, Current Drug Delivery, V1, P165, DOI 10.2174/1567201043479902
   Barichello JM, 1999, INT J PHARMACEUT, V183, P125, DOI 10.1016/S0378-5173(99)00090-3
   Barichello JM, 1999, INT J PHARM, V184, P189, DOI 10.1016/S0378-5173(99)00119-2
   Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013
   Batrakova EV, 2004, J CONTROL RELEASE, V100, P389, DOI 10.1016/j.jconrel.2004.09.002
   Batrakova EV, 1998, PHARMACEUT RES, V15, P850, DOI 10.1023/A:1011964213024
   Baum C, 2006, HUM GENE THER, V17, P253, DOI 10.1089/hum.2006.17.253
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Brockmeier SL, 2002, INFECT IMMUN, V70, P481, DOI 10.1128/IAI.70.2.481-490.2002
   Bromberg L, 1998, J PHYS CHEM B, V102, P10736, DOI 10.1021/jp983162e
   Bromberg L, 2006, CURR OPIN COLLOID IN, V11, P217, DOI 10.1016/j.cocis.2006.07.001
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Cen XD, 2006, PEPTIDES, V27, P836, DOI 10.1016/j.peptides.2005.08.015
   Cheaburu CN, 2013, J APPL POLYM SCI, V127, P3340, DOI 10.1002/app.37789
   Chiappetta DA, 2007, EUR J PHARM BIOPHARM, V66, P303, DOI 10.1016/j.ejpb.2007.03.022
   Cho CW, 2000, BIOTECHNOL APPL BIOC, V32, P21, DOI 10.1042/BA20000022
   Choi JS, 2010, J BIOMED MATER RES A, V95A, P564, DOI 10.1002/jbm.a.32848
   Chun KW, 2005, BIOMATERIALS, V26, P3319, DOI 10.1016/j.biomaterials.2004.07.055
   Chung HJ, 2008, J CONTROL RELEASE, V127, P22, DOI 10.1016/j.jconrel.2007.12.008
   Clark MA, 2001, ADV DRUG DELIVER REV, V50, P81, DOI 10.1016/S0169-409X(01)00149-1
   Coeshott CM, 2004, VACCINE, V22, P2396, DOI 10.1016/j.vaccine.2003.11.064
   Cohn D, 2006, BIOMATERIALS, V27, P1718, DOI 10.1016/j.biomaterials.2005.10.035
   Croy SR, 2006, CURR PHARM DESIGN, V12, P4669, DOI 10.2174/138161206779026245
   Croy SR, 2005, J PHARM SCI-US, V94, P2345, DOI 10.1002/jps.20301
   Croy SR, 2004, J CONTROL RELEASE, V95, P161, DOI 10.1016/j.jconrel.2003.11.003
   Csaba Noemi, 2006, Expert Opin Drug Deliv, V3, P463, DOI 10.1517/17425247.3.4.463
   Csaba N, 2009, ADV DRUG DELIVER REV, V61, P140, DOI 10.1016/j.addr.2008.09.005
   DANKO I, 1994, GENE THER, V1, P114
   Das N, 2012, PHARM DEV TECHNOL, V17, P363, DOI 10.3109/10837450.2010.542164
   Das N, 2010, PHARM DEV TECHNOL, V15, P192, DOI [10.3109/10837450903085442, 10.1080/10837450903085442]
   de Jong SJ, 2000, MACROMOLECULES, V33, P3680, DOI 10.1021/ma992067g
   Dufes C, 2004, PHARM RES, V21, P101, DOI 10.1023/B:PHAM.0000012156.65125.01
   Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106
   Fang JY, 2009, J BIOMAT SCI-POLYM E, V20, P1031, DOI 10.1163/156856209X444493
   Feldman LJ, 1997, GENE THER, V4, P189, DOI 10.1038/sj.gt.3300382
   Fonseca V., 2006, INSULIN, V1, P51
   Fusco S, 2006, J BIOACT COMPAT POL, V21, P149, DOI 10.1177/0883911506063207
   Gariepy E. R., 2004, EUR J PHARM BIOPHARM, V58, P409
   Garverick HA, 1997, J DAIRY SCI, V80, P995, DOI 10.3168/jds.S0022-0302(97)76025-9
   Gebhart CL, 2002, BIOCONJUGATE CHEM, V13, P937, DOI 10.1021/bc025504w
   Ghilzai NMK, 2003, DRUG DEV IND PHARM, V29, P253, DOI 10.1081/DDC-120018199
   Gong C, 2013, CURR MED CHEM, V20, P79
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guo DD, 2009, BIOMATERIALS, V30, P4777, DOI 10.1016/j.biomaterials.2009.05.051
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Hennink WE, 2004, INT J PHARM, V277, P99, DOI 10.1016/j.ijpharm.2003.02.002
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hiemstra C, 2007, J CONTROL RELEASE, V122, P71, DOI 10.1016/j.jconrel.2007.06.011
   Hsu SH, 2009, CHEM PHARM BULL, V57, P453, DOI 10.1248/cpb.57.453
   Hwang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067495
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong B, 2012, ADV DRUG DELIVER REV, V64, P154, DOI 10.1016/j.addr.2012.09.012
   JOHNSTON TP, 1992, PHARMACEUT RES, V9, P425, DOI 10.1023/A:1015815624334
   Kabanov A, 2005, ADV GENET, V53, P231, DOI 10.1016/S0065-2660(05)53009-8
   Kabanov AV, 2003, ADV DRUG DELIVER REV, V55, P151, DOI 10.1016/S0169-409X(02)00176-X
   Kabanov AV, 2002, CRIT REV THER DRUG, V19, P1, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i1.10
   Kabanov AV, 2004, CURR PHARM DESIGN, V10, P1355, DOI 10.2174/1381612043384826
   Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P223, DOI 10.1016/S0169-409X(02)00018-2
   Kang ML, 2007, VACCINE, V25, P4602, DOI 10.1016/j.vaccine.2007.03.038
   Katakam M, 1997, INT J PHARM, V152, P53, DOI 10.1016/S0378-5173(97)04920-X
   Katakam M, 1997, J CONTROL RELEASE, V49, P21, DOI 10.1016/S0168-3659(97)01648-9
   Kim EY, 2002, INT J PHARMACEUT, V233, P159, DOI 10.1016/S0378-5173(01)00933-4
   Kim MR, 2002, J CONTROL RELEASE, V80, P69, DOI 10.1016/S0168-3659(01)00557-0
   Kissel T, 2002, ADV DRUG DELIVER REV, V54, P99, DOI 10.1016/S0169-409X(01)00244-7
   Krupka TM, 2007, EXP BIOL MED, V232, P950
   Kwon GS, 2003, CRIT REV THER DRUG, V20, P357, DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i5.20
   Kwon SH, 2007, ARCH PHARM RES, V30, P1138, DOI 10.1007/BF02980249
   Lee JB, 2004, MACROMOL BIOSCI, V4, P957, DOI 10.1002/mabi.200400073
   Lee SY, 2007, J BIOMAT SCI-POLYM E, V18, P1335, DOI 10.1163/156856207782177855
   Lee SY, 2007, J CONTROL RELEASE, V119, P313, DOI 10.1016/j.jconrel.2007.03.007
   Lemieux P, 2000, GENE THER, V7, P986, DOI 10.1038/sj.gt.3301189
   Lim DW, 2000, MACROMOL RAPID COMM, V21, P464, DOI 10.1002/(SICI)1521-3927(20000501)21:8<464::AID-MARC464>3.0.CO;2-#
   Lin HR, 2000, J CONTROL RELEASE, V69, P379, DOI 10.1016/S0168-3659(00)00329-1
   Liu Y, 2007, J CONTROL RELEASE, V117, P387, DOI 10.1016/j.jconrel.2006.11.024
   Liu Y, 2009, EUR J PHARM SCI, V37, P306, DOI 10.1016/j.ejps.2009.02.022
   Lu DM, 2007, EXPERT REV VACCINES, V6, P213, DOI 10.1586/14760584.6.2.213
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   March K. L., 1995, HUM GENE THER, V6, P45
   Mata JP, 2005, J COLLOID INTERF SCI, V292, P548, DOI 10.1016/j.jcis.2005.06.013
   Mayol L, 2011, BIOMACROMOLECULES, V12, P28, DOI 10.1021/bm1008958
   Meilander NJ, 2003, J CONTROL RELEASE, V88, P321, DOI 10.1016/S0168-3659(03)00007-5
   Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7
   Meyers PJ, 1997, VET REC, V140, P249, DOI 10.1136/vr.140.10.249
   Mishra S, 2004, EUR J CELL BIOL, V83, P97, DOI 10.1078/0171-9335-00363
   Moreno E., 2013, INT J PHARMACEUT, V459, P1
   Morishita M, 2001, INT J PHARM, V212, P289, DOI 10.1016/S0378-5173(00)00615-3
   Mumper J., 1998, ADV DRUG DELIVER REV, V30, P151
   Na DH, 2006, PHARM DEV TECHNOL, V11, P513, DOI 10.1080/10837450600941053
   Nasir F, 2014, DRUG DEV IND PHARM, V40, P1503, DOI 10.3109/03639045.2013.831441
   Niu GG, 2009, J CONTROL RELEASE, V138, P49, DOI 10.1016/j.jconrel.2009.04.026
   Nof M, 2002, J BIOMED MATER RES, V59, P349, DOI 10.1002/jbm.1251
   Park JS, 2002, J BIOMED MATER RES, V59, P144, DOI 10.1002/jbm.1227
   Perez C, 2002, J PHARM PHARMACOL, V54, P301, DOI 10.1211/0022357021778448
   Pillai O, 2003, J CONTROL RELEASE, V89, P127, DOI 10.1016/S0168-3659(03)00094-4
   Pisal SS, 2004, INT J PHARM, V270, P37, DOI 10.1016/j.ijpharm.2003.10.005
   Prashar D, 2011, LANGMUIR, V27, P13091, DOI 10.1021/la203271u
   Quick DJ, 2004, J CONTROL RELEASE, V96, P341, DOI 10.1016/j.jconrel.2004.01.021
   Quick DJ, 2003, PHARM RES, V20, P1730, DOI 10.1023/B:PHAM.0000003368.66471.6a
   Serno T, 2011, ADV DRUG DELIVER REV, V63, P1086, DOI 10.1016/j.addr.2011.08.003
   Shachaf Y, 2010, BIOMATERIALS, V31, P2836, DOI 10.1016/j.biomaterials.2009.12.050
   Sinha VR, 2005, CRIT REV THER DRUG, V22, P535, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i6.20
   Slager J, 2003, ADV DRUG DELIVER REV, V55, P549, DOI 10.1016/S0169-409X(03)00042-5
   Sosnik A, 2005, BIOMATERIALS, V26, P7425, DOI 10.1016/j.biomaterials.2005.05.086
   Sosnik A, 2004, BIOMATERIALS, V25, P2851, DOI 10.1016/j.biomaterials.2003.09.057
   Spitzenberger TJ, 2007, J CEREBR BLOOD F MET, V27, P1033, DOI 10.1038/sj.jcbfm.9600414
   Strappe PM, 2005, EUR J PHARM BIOPHARM, V61, P126, DOI 10.1016/j.ejpb.2005.06.006
   Stratton LP, 1997, J PHARM SCI, V86, P1006, DOI 10.1021/js970034d
   Sullivan Vincent J, 2006, Expert Opin Drug Deliv, V3, P87, DOI 10.1517/17425247.3.1.87
   Sung SJ, 2003, BIOL PHARM BULL, V26, P492
   Swanson-Biearman B, 2001, J TOXICOL-CLIN TOXIC, V39, P81, DOI 10.1081/CLT-100102885
   Todoroff J, 2013, EUR J PHARM BIOPHARM, V84, P40, DOI 10.1016/j.ejpb.2012.11.020
   Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P6039, DOI 10.1073/pnas.0931428100
   Trentin D, 2005, J CONTROL RELEASE, V102, P263, DOI 10.1016/j.jconrel.2004.09.029
   Walter E, 1999, J CONTROL RELEASE, V61, P361, DOI 10.1016/S0168-3659(99)00151-0
   WANG PL, 1995, INT J PHARM, V113, P73, DOI 10.1016/0378-5173(94)00179-9
   Wang XQ, 2013, CRIT REV THER DRUG, V30, P411, DOI 10.1615/CritRevTherDrugCarrierSyst.2013007362
   Wang Y, 2006, COLLOID POLYM SCI, V285, P233, DOI 10.1007/s00396-006-1541-4
   Wenzel JGW, 2002, J CONTROL RELEASE, V85, P51, DOI 10.1016/S0168-3659(02)00271-7
   WESTERINK MAJ, 2002, VACCINE, V20, P711
   Yoo HS, 2005, J CONTROL RELEASE, V103, P235, DOI 10.1016/j.jconrel.2004.11.033
   Yoo HS, 2007, J BIOMAT SCI-POLYM E, V18, P1429, DOI 10.1163/156856207782246803
   Yu L, 2010, BIOMACROMOLECULES, V11, P2169, DOI 10.1021/bm100549q
   Zaiss AK, 2005, CURR GENE THER, V5, P323, DOI 10.2174/1566523054065039
NR 138
TC 17
Z9 17
U1 3
U2 55
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1558-3724
EI 1558-3716
J9 POLYM REV
JI Polym. Rev.
PY 2014
VL 54
IS 4
BP 573
EP 597
DI 10.1080/15583724.2014.927885
PG 25
WC Polymer Science
SC Polymer Science
GA AO9CX
UT WOS:000341654300001
DA 2018-10-20
ER

PT J
AU Qiu, KY
   Netravali, AN
AF Qiu, Kaiyan
   Netravali, Anil N.
TI A Review of Fabrication and Applications of Bacterial Cellulose Based
   Nanocomposites
SO POLYMER REVIEWS
LA English
DT Review
DE bacterial cellulose; nanocomposites; mechanical properties;
   biocompatibility; fabrication methods; BC applications
ID OPTICALLY TRANSPARENT COMPOSITES; SUGAR-CANE MOLASSES;
   ACETOBACTER-XYLINUM; BIOMEDICAL APPLICATIONS; MICROBIAL CELLULOSE;
   CARBON SOURCE; SURFACE MODIFICATION; AGITATED CULTURE; MEMBRANES;
   AEROGELS
AB Bacterial cellulose (BC) is a unique nanofibrous biomaterial which can have applications in many engineering fields. BC possesses excellent mechanical properties and biocompatibility and can be engineered in various forms from nano to macro scales. BC based nanocomposites can be manipulated to improve their properties and/or functionalities. Such materials can be categorized as high-strength materials as well as materials for plant biomimicking, biomedical, electrically conductive, catalysis, optical, luminescent, proton conductive, separating, antimicrobial, thermo-responsive, and other applications. The review presented here focuses on various fabrication methods used and novel applications of BC based nanocomposites that are expected to be commercialized.
C1 [Qiu, Kaiyan] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.
   [Netravali, Anil N.] Cornell Univ, Fiber Sci Program, Ithaca, NY USA.
RP Qiu, KY (reprint author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.
EM kaiyan.qiu@gmail.com; ann2@cornell.edu
RI Qiu, Kaiyan/Q-1342-2018
OI Qiu, Kaiyan/0000-0002-3138-0275
CR Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Bae S, 2004, BIOTECHNOL PROGR, V20, P1366, DOI 10.1021/bp0498490
   Bae SO, 2005, APPL MICROBIOL BIOT, V67, P45, DOI 10.1007/s00253-004-1723-2
   Barud HS, 2008, MAT SCI ENG C-BIO S, V28, P515, DOI 10.1016/j.msec.2007.05.001
   Bielecki S., 2002, BIOPOLYMERS, V5, P37, DOI 10.1002/3527600035.bpol5003
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Brown EE, 2007, BIOMACROMOLECULES, V8, P3074, DOI 10.1021/bm700448x
   Brown RM, 1996, J MACROMOL SCI PURE, VA33, P1345, DOI 10.1080/10601329608014912
   Cai Z, 2010, CELLULOSE, V17, P83, DOI 10.1007/s10570-009-9362-5
   CANNON RE, 1991, CRIT REV MICROBIOL, V17, P435, DOI 10.3109/10408419109115207
   Chen LF, 2013, ADV MATER, V25, P4746, DOI 10.1002/adma.201204949
   Cheng KC, 2009, CELLULOSE, V16, P1033, DOI 10.1007/s10570-009-9346-5
   Choi YJ, 2004, J CHEM TECHNOL BIOT, V79, P79, DOI 10.1002/jctb.942
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja W, 2004, CELLULOSE, V11, P403, DOI 10.1023/B:CELL.0000046412.11983.61
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Dobre LM, 2012, CHEM PAP, V66, P144, DOI 10.2478/s11696-011-0086-2
   Dubey V, 2005, J MEMBRANE SCI, V251, P131, DOI 10.1016/j.memsci.2004.11.009
   Evans BR, 2003, BIOSENS BIOELECTRON, V18, P917, DOI 10.1016/S0956-5663(02)00212-9
   Fang B, 2009, TISSUE ENG PT A, V15, P1091, DOI 10.1089/ten.tea.2008.0110
   Fernandes SCM, 2009, GREEN CHEM, V11, P2023, DOI 10.1039/b919112g
   Fink HP, 2001, PROG POLYM SCI, V26, P1473, DOI 10.1016/S0079-6700(01)00025-9
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Gindl W, 2004, COMPOS SCI TECHNOL, V64, P2407, DOI 10.1016/j.compscitech.2004.05.001
   Goelzer FDE, 2009, MAT SCI ENG C-BIO S, V29, P546, DOI 10.1016/j.msec.2008.10.013
   Grande CJ, 2009, MAT SCI ENG C-BIO S, V29, P1098, DOI 10.1016/j.msec.2008.09.024
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   Gutierrez J, 2012, J COLLOID INTERF SCI, V377, P88, DOI 10.1016/j.jcis.2012.03.075
   Haimer E, 2010, MACROMOL SYMP, V294-II, P64, DOI 10.1002/masy.201000008
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Hong F, 2008, CARBOHYD POLYM, V72, P545, DOI 10.1016/j.carbpol.2007.09.015
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Hsieh YC, 2008, CELLULOSE, V15, P507, DOI 10.1007/s10570-008-9206-8
   Hu WL, 2011, CARBOHYD POLYM, V83, P1575, DOI 10.1016/j.carbpol.2010.10.016
   Hu Y, 2010, BIOMACROMOLECULES, V11, P1727, DOI 10.1021/bm100060v
   Hungund B. S., 2010, J MICROBIAL BIOCH TE, V2, P127, DOI DOI 10.4172/1948-5948.1000037
   Ifuku S, 2007, BIOMACROMOLECULES, V8, P1973, DOI 10.1021/bm070113b
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Ishihara M, 2002, ENZYME MICROB TECH, V31, P986, DOI 10.1016/S0141-0229(02)00215-6
   Jagannath A, 2008, WORLD J MICROB BIOT, V24, P2593, DOI 10.1007/s11274-008-9781-8
   Juntaro J, 2008, ADV MATER, V20, P3122, DOI 10.1002/adma.200703176
   Kang YJ, 2012, ACS NANO, V6, P6400, DOI 10.1021/nn301971r
   Katepetch C, 2011, CARBOHYD POLYM, V86, P162, DOI 10.1016/j.carbpol.2011.04.024
   KAUSHAL R, 1951, BIOCHEM J, V48, P618, DOI 10.1042/bj0480618
   Keshk S, 2006, APPL MICROBIOL BIOT, V72, P291, DOI 10.1007/s00253-005-0265-6
   Keshk SMAS, 2006, AFR J BIOTECHNOL, V5, P1519
   Keshk SMAS, 2005, AFR J BIOTECHNOL, V4, P478
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Kurosumi A, 2009, CARBOHYD POLYM, V76, P333, DOI 10.1016/j.carbpol.2008.11.009
   Lee KY, 2011, CELLULOSE, V18, P595, DOI 10.1007/s10570-011-9525-z
   Liang HW, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.34
   Liebner F, 2012, ACS SYM SER, V1107, P57
   Lin SP, 2013, CELLULOSE, V20, P2191, DOI 10.1007/s10570-013-9994-3
   Lina F, 2011, BIOMEDICAL ENGINEERING - FRONTIERS AND CHALLENGES, P249
   Maeda H, 2006, J MATER SCI, V41, P5646, DOI 10.1007/s10853-006-0297-z
   Martinez-Sanz M, 2011, CELLULOSE, V18, P335, DOI 10.1007/s10570-010-9471-1
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Muller D, 2012, CELLULOSE, V19, P1645, DOI 10.1007/s10570-012-9754-9
   Nakagaito AN, 2005, APPL PHYS A-MATER, V80, P93, DOI 10.1007/s00339-004-2932-3
   Nakayama A, 2004, ADV FUNCT MATER, V14, P1124, DOI 10.1002/adfm.200305197
   Netravali A.N., 2013, US, Patent No. [8541001 B2, 8541001]
   Nogi M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2191667
   Nogi M, 2008, ADV MATER, V20, P1849, DOI 10.1002/adma.200702559
   Numata Y, 2009, POLYM J, V41, P524, DOI 10.1295/polymj.PJ2009035
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/nnano.2010.155, 10.1038/NNANO.2010.155]
   Park WI, 2007, MACROMOL SYMP, V249, P289, DOI 10.1002/masy.200750347
   Pestland J. A., 1993, US Patent, Patent No. 5207826
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Phisalaphong M, 2008, J APPL POLYM SCI, V107, P3419, DOI 10.1002/app.27411
   Pommet M, 2008, BIOMACROMOLECULES, V9, P1643, DOI 10.1021/bm800169g
   Portal O, 2009, WOUNDS, V21, P1
   Premjet S, 2007, SEN-I GAKKAISHI, V63, P193
   Qiu K., 2014, RECENT ADV ADHESION, P193
   Qiu KY, 2012, J MATER SCI, V47, P6066, DOI 10.1007/s10853-012-6517-9
   Ramana KV, 2000, WORLD J MICROB BIOT, V16, P245, DOI 10.1023/A:1008958014270
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Russler A, 2012, CELLULOSE, V19, P1337, DOI 10.1007/s10570-012-9728-y
   Saddler JN, 1998, FOREST PRODUCTS BIOTECHNOLOGY, P183
   Saska S, 2012, J MATER CHEM, V22, P22102, DOI 10.1039/c2jm33762b
   Schlufter K, 2010, MACROMOL SY, V294-II, P117, DOI 10.1002/masy.200900054
   Schlufter K, 2006, MACROMOL RAPID COMM, V27, P1670, DOI 10.1002/marc.200600463
   Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6
   SHIBAZAKI H, 1993, J APPL POLYM SCI, V50, P965, DOI 10.1002/app.1993.070500605
   Siripong P., 2012, AFR J BIOTECHNOL, V11, P1433
   Stoica-Guzun A, 2007, NUCL INSTRUM METH B, V265, P434, DOI 10.1016/j.nimb.2007.09.036
   Stoica-Guzun A, 2013, IND CROP PROD, V50, P414, DOI 10.1016/j.indcrop.2013.07.063
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tang WH, 2010, WORLD J MICROB BIOT, V26, P125, DOI 10.1007/s11274-009-0151-y
   TARR H. L. A., 1931, CANADIAN JOUR RES, V4, P372
   Touzel JP, 2003, J AGR FOOD CHEM, V51, P981, DOI 10.1021/jf020200p
   Trovatti E, 2013, J RENEW MATER, V1, P28, DOI 10.7569/JRM.2012.634104
   Wan WK, 2006, ACS SYM SER, V938, P221
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Wang B, 2013, SMALL, V9, P2399, DOI 10.1002/smll.201300692
   Wang JH, 2010, MAT SCI ENG C-MATER, V30, P214, DOI 10.1016/j.msec.2009.10.006
   Watanabe K, 1998, CELLULOSE, V5, P187, DOI 10.1023/A:1009272904582
   Weimer PJ, 2000, J AGR FOOD CHEM, V48, P1727, DOI 10.1021/jf991372y
   Whitney SEC, 2006, AM J BOT, V93, P1402, DOI 10.3732/ajb.93.10.1402
   Wu ZY, 2013, ANGEW CHEM INT EDIT, V52, P2925, DOI 10.1002/anie.201209676
   Yamanaka S, 2000, CELLULOSE, V7, P213, DOI 10.1023/A:1009208022957
   Yang JZ, 2011, J HAZARD MATER, V189, P377, DOI 10.1016/j.jhazmat.2011.02.048
   Yang JZ, 2009, ELECTROCHIM ACTA, V54, P6300, DOI 10.1016/j.electacta.2009.05.073
   Yang ZH, 2012, CARBOHYD POLYM, V88, P173, DOI 10.1016/j.carbpol.2011.11.080
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
   Zhang DY, 2005, CHEM COMMUN, P2735, DOI 10.1039/b501933h
   Zhang HY, 2011, ADV MATER RES-SWITZ, V152-153, P978, DOI 10.4028/www.scientific.net/AMR.152-153.978
   Zhou PP, 2012, IND ENG CHEM RES, V51, P5743, DOI 10.1021/ie300395q
NR 111
TC 32
Z9 35
U1 8
U2 114
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1558-3724
EI 1558-3716
J9 POLYM REV
JI Polym. Rev.
PY 2014
VL 54
IS 4
BP 598
EP 626
DI 10.1080/15583724.2014.896018
PG 29
WC Polymer Science
SC Polymer Science
GA AO9CX
UT WOS:000341654300002
DA 2018-10-20
ER

PT J
AU Bahl, S
   Suwas, S
   Chatterjee, K
AF Bahl, Sumit
   Suwas, Satyam
   Chatterjee, Kaushik
TI The importance of crystallographic texture in the use of titanium as an
   orthopedic biomaterial
SO RSC ADVANCES
LA English
DT Article
ID COMMERCIALLY PURE TITANIUM; MECHANICAL-PROPERTIES; CORROSION BEHAVIOR;
   ROLLING TEXTURES; ORIENTED GROWTH; TI; MICROSTRUCTURE; HYDROXYAPATITE;
   TI-6AL-4V; EVOLUTION
AB Crystallographic texture is perceived to play an important role in controlling material properties. However, the influence of texture in modulating the properties of biomedical materials has not been well investigated. In this work, commercially pure titanium (cp-Ti) was processed through six different routes to generate a variety of textures. The effect of texture on mechanical properties, corrosion behavior, cell proliferation and osteogenesis was characterized for potential use in orthopedic applications. The presence of closely packed, low-energy crystallographic planes at the material surface was influenced by the volume fraction of the components in the overall texture, thereby influencing surface energy and corrosion behavior. Texture modulated osteoblast proliferation through variations in surface water wettability. It also affected mineralization by possibly influencing the coherency between the substrate and calcium phosphate deposits. This study demonstrates that crystallographic texture can be an important tool in improving the properties of biomaterials to achieve the enhanced performance of biomedical implants.
C1 [Bahl, Sumit; Suwas, Satyam; Chatterjee, Kaushik] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
RP Chatterjee, K (reprint author), Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
EM kchatterjee@materials.iisc.ernet.in
OI Bahl, Sumit/0000-0002-9471-5001; Chatterjee, Kaushik/0000-0002-7204-2926
FU Department of Atomic Energy-Board of Research in Nuclear Sciences
   (DAE-BRNS), India; Ramanujan Fellowship from the Department of Science
   and Technology (DST), India
FX This work was funded by the Department of Atomic Energy-Board of
   Research in Nuclear Sciences (DAE-BRNS), India. K. C. gratefully
   acknowledges support through the Ramanujan Fellowship from the
   Department of Science and Technology (DST), India. The authors
   acknowledge the Defense Metallurgical Research Laboratory (DMRL,
   Hyderabad, India) for providing cp-Ti pan cakes. Authors thank Prof.
   Subodh Kumar and Mr George Rapheal for their assistance with the
   corrosion studies and Mr Sasidhara for his assistance with tensile
   tests.
CR [Anonymous], 2011, ORTHOPEDIC IMPLANTS
   Bahl S, 2014, MATER TECHNOL, V29, pB64, DOI 10.1179/1753555713Y.0000000118
   Balakrishnan A., 2008, TRENDS BIOMATER ARTI, V22, P54
   Balyanov A, 2004, SCRIPTA MATER, V51, P225, DOI 10.1016/j.scriptamat.2004.04.011
   Chatterjee K, 2011, BIOMATERIALS, V32, P1361, DOI 10.1016/j.biomaterials.2010.10.043
   Cowin S., 1987, HDB BIOENGINEERING
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gurao NP, 2013, METALL MATER TRANS A, V44A, P1497, DOI 10.1007/s11661-012-1484-y
   Gurao NP, 2009, MAT SCI ENG A-STRUCT, V504, P24, DOI 10.1016/j.msea.2008.11.053
   HOEPPNER DW, 1994, WEAR, V173, P189, DOI 10.1016/0043-1648(94)90272-0
   HONG L, 1992, Journal of Biomedical Materials Research, V26, P7, DOI 10.1002/jbm.820260103
   Hoseini M, 2014, J BIOMED MATER RES A, V102, P3631, DOI 10.1002/jbm.a.35028
   Hoseini M, 2009, CORROS SCI, V51, P3064, DOI 10.1016/j.corsci.2009.08.017
   Huiskes R, 1993, Acta Orthop Belg, V59 Suppl 1, P118
   INAGAKI H, 1991, Z METALLKD, V82, P779
   INAGAKI H, 1992, Z METALLKD, V83, P40
   INAGAKI H, 1990, Z METALLKD, V81, P282
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   KAIBYSHEV OA, 1981, J MATER SCI, V16, P2501, DOI 10.1007/BF01113587
   Kim SK, 2002, METALL MATER TRANS A, V33, P1051, DOI 10.1007/s11661-002-0206-2
   Kumar S, 2014, RSC ADV, V4, P19086, DOI 10.1039/c4ra00875h
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lutjering G, 1998, MAT SCI ENG A-STRUCT, V243, P32, DOI 10.1016/S0921-5093(97)00778-8
   Mao CB, 1999, J CRYST GROWTH, V206, P308, DOI 10.1016/S0022-0248(99)00315-2
   Mao CB, 1998, J MATER CHEM, V8, P2795, DOI 10.1039/a801384e
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Pascuet MI, 2001, J MOL CATAL A-CHEM, V167, P165, DOI 10.1016/S1381-1169(00)00503-3
   PETERS M, 1984, METALL TRANS A, V15, P1597, DOI 10.1007/BF02657799
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rad AT, 2013, COLLOID SURFACE B, V103, P200, DOI 10.1016/j.colsurfb.2012.10.027
   Sato K, 1999, SENSOR ACTUAT A-PHYS, V73, P122, DOI 10.1016/S0924-4247(98)00270-2
   Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   Steinemann S., 1985, BIOL BIOMECHANICAL P, P409
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Suwas S, 2002, Z METALLKD, V93, P928, DOI 10.3139/146.020928
   Suwas S, 2002, Z METALLKD, V93, P918, DOI 10.3139/146.020918
   Suwas S., 2012, J INDIAN I SCI, V88, P151
   Union O. E., 2010, HLTH GLANCE EUROPE
   VEIS A, 1981, CHEM BIOL MINERALIZE, P617
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   VOGLER EA, 1988, BIOPHYS J, V53, P759, DOI 10.1016/S0006-3495(88)83156-4
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Williams D. F., 1977, P INT S RETR AN ORTH
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   Yapici GG, 2003, SCRIPTA MATER, V49, P1021, DOI 10.1016/S1359-6462(03)00484-6
NR 47
TC 15
Z9 15
U1 0
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 72
BP 38078
EP 38087
DI 10.1039/c4ra05440g
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA AO6IZ
UT WOS:000341455200018
DA 2018-10-20
ER

PT J
AU Kopaczynska, M
   Sobieszczanska, B
   Ulatowska-Jarza, A
   Holowacz, I
   Buzalewicz, I
   Wasyluk, L
   Tofail, SAM
   Bialy, D
   Wawrzynska, M
   Podbielska, H
AF Kopaczynska, Marta
   Sobieszczanska, Beata
   Ulatowska-Jarza, Agnieszka
   Holowacz, Iwona
   Buzalewicz, Igor
   Wasyluk, Lukasz
   Tofail, Syed A. M.
   Bialy, Dariusz
   Wawrzynska, Magdalena
   Podbielska, Halina
TI Photoactivated titania-based nanomaterials for potential application as
   cardiovascular stent coatings
SO BIOCYBERNETICS AND BIOMEDICAL ENGINEERING
LA English
DT Article
DE Cardiovascular stent; Photoactive coating; Endothelial cells; Surface
   charge; Biocompatibility
ID IN-VITRO; WATER; PHOTOCATALYSIS; HYDROLYSIS; ADSORPTION; ADHESION;
   DAMAGE; CELLS; VIVO
AB Intravascular stenting of atherosclerotic coronary arteries is a life-saving, widely used procedure in interventional cardiology. Adverse clinical outcomes such as restenosis highlight the importance of meeting the excellent biocompatibility by cardiovascular implants. Many attempts have been made to improve the safety profile of implant surface. We for the first time developed the photoactive intravascular titania-based nanomaterials for the application as cardiovascular stent coating. Photoactive biomaterial deposited on the cardiovascular stent surface demonstrated promising features, making it an excellent substrate for endothelial cells growth and proliferation. The biocompatibility of these coatings has been compared with 316L stainless steel surfaces typically used in commercial coronary stents production. The results of the study proved that the innovative titania-based coatings have better biocompatibility characteristics than the 316L stainless steel and in regard of its antithrombotic potential provided protection against restenosis. Furthermore, the titania coating supported endothelial cells attachment and proliferation, and induced prolonged plasma recalcification time in comparison with stainless steel surface. Innovative photoactive titania coating can be an important factor to prevent the process of the restenosis in the place of implantation. (C) 2014 Nalecz Institute of Biocybernetics and Biomedical Engineering. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
C1 [Kopaczynska, Marta; Ulatowska-Jarza, Agnieszka; Holowacz, Iwona; Buzalewicz, Igor; Podbielska, Halina] Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland.
   [Sobieszczanska, Beata] Wroclaw Univ Technol, Dept Microbiol, PL-50370 Wroclaw, Poland.
   [Bialy, Dariusz] Wroclaw Univ Technol, Dept & Clin Cardiol, PL-50370 Wroclaw, Poland.
   [Wawrzynska, Magdalena] Wroclaw Univ Technol, Dept Emergency Med, PL-50370 Wroclaw, Poland.
   [Tofail, Syed A. M.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland.
   [Wasyluk, Lukasz] Balton Sp Zoo, Warsaw, Poland.
RP Kopaczynska, M (reprint author), Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.
EM marta.kopaczynska@pwr.wroc.pl
RI Podbielska, Halina/A-7311-2012
OI Podbielska, Halina/0000-0001-7162-8530; Buzalewicz,
   Igor/0000-0002-9774-4625
FU European Community's Seventh Framework Programme (FP7) [212533]
FX The BioElectricSurface research leading to these results has received
   funding from the European Community's Seventh Framework Programme
   (FP7/2008-2011) under grant agreement no 212533. This communication
   reflects the views only of authors, and the Commission cannot be held
   responsible for any use which may be made of the information contained
   therein.
CR [Anonymous], 2011, IMAGE PROCESSING ANA
   BENNETT JM, 1989, APPL OPTICS, V28, P3303, DOI 10.1364/AO.28.003303
   BRINKER CJ, 1988, J NON-CRYST SOLIDS, V100, P31, DOI 10.1016/0022-3093(88)90005-1
   Buvailo AI, 2011, ACS APPL MATER INTER, V3, P528, DOI 10.1021/am1011035
   Castro AL, 2009, J SOLID STATE CHEM, V182, P1838, DOI 10.1016/j.jssc.2009.04.020
   Chai F, 2010, J BIOMED MATER RES A, V92A, P754, DOI 10.1002/jbm.a.32399
   Dittmar K., 2009, THESIS
   DOEUFF S, 1987, J NON-CRYST SOLIDS, V89, P206, DOI 10.1016/S0022-3093(87)80333-2
   Fine E, INT J NANOMEDICINE
   Fine E, 2009, INT J NANOMED, V4, P91
   Fox KAA, 2010, EUR HEART J, V31, P2755, DOI 10.1093/eurheartj/ehq326
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Gumy D, 2006, SOL ENERGY, V80, P1376, DOI 10.1016/j.solener.2005.04.026
   Haenle M, 2011, J MATER SCI-MATER M, V22, P381, DOI 10.1007/s10856-010-4204-4
   Ince NH, 2000, WATER RES, V34, P4169, DOI 10.1016/S0043-1354(00)00194-9
   Kim S, 2013, WATER RES, V47, P4403, DOI 10.1016/j.watres.2013.05.009
   Kim TY, 2011, J NANOSCI NANOTECHNO, V11, P1551, DOI 10.1166/jnn.2011.3339
   Li CX, 2010, DALTON T, V39, P10692, DOI 10.1039/c0dt00448k
   Li QN, 2009, BIOMATERIALS, V30, P4708, DOI 10.1016/j.biomaterials.2009.05.015
   Li YL, 2004, J COLLOID INTERF SCI, V275, P488, DOI 10.1016/j.jcis.2004.02.060
   Liu L, 2010, J PHOTOCH PHOTOBIO B, V98, P207, DOI 10.1016/j.jphotobiol.2010.01.005
   Maitz MF, 2003, J BIOMATER APPL, V17, P303, DOI 10.1177/088532803033178
   Mikhalovska L, 2011, J BIOMED MATER RES B, V96B, P333, DOI 10.1002/jbm.b.31772
   Nakajima S, 2004, J BIOL CHEM, V279, P46674, DOI 10.1074/jbc.M406070200
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Strachan T, 1999, CANC GENETICS HUMAN
   Tseng YH, 2013, BBA-GEN SUBJECTS, V1830, P3787, DOI 10.1016/j.bbagen.2013.03.022
   Yla-Herttuala S, 2011, THROMB HAEMOSTASIS, V106, P1, DOI 10.1160/TH10-12-0784
NR 28
TC 4
Z9 4
U1 4
U2 22
PU PWN-POLISH SCIENTIFIC PUBL
PI WARSAW
PA UL KS TROJDENA 4, WARSAW, 02-109, POLAND
SN 0208-5216
J9 BIOCYBERN BIOMED ENG
JI Biocybern. Biomed. Eng.
PY 2014
VL 34
IS 3
BP 189
EP 197
DI 10.1016/j.bbe.2014.03.005
PG 9
WC Engineering, Biomedical
SC Engineering
GA AO1KZ
UT WOS:000341072300007
DA 2018-10-20
ER

PT J
AU Brittain, SB
   Gohil, SV
   Nair, LS
AF Brittain, Sarah B.
   Gohil, Shalini V.
   Nair, Lakshmi S.
TI Statins as Bioactive Molecules to Support Bone Regeneration
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Article
DE Bone regeneration; local delivery; osteogenic; scaffolds; statin
ID BIOMATERIAL OG-PLG; IN-VITRO; OSTEOBLAST DIFFERENTIATION; MORPHOGENETIC
   PROTEIN-2; MC3T3-E1 CELLS; GRAFT SUBSTITUTES; IMPLANT SURFACES;
   SIMVASTATIN; EXPRESSION; BMP-2
AB Statins are currently used as an effective cholesterol-lowering medication through inhibition of the mevalonate pathway, but recent studies show their potential for bone repair. The bone anabolic effects of statins have been largely attributed to their ability to enhance BMP-2 expression in osteoblast cells. In vitro studies have demonstrated that statins can increase the expression of osteogenic and angiogenic markers such as alkaline phosphatase, vascular endothelial growth factor, and osteocalcin in cells. In vivo, statins have been shown to promote significant new bone growth when injected systemically or locally in combination with a scaffold. The potential anabolic effects of statins on bone make them attractive candidates to support bone regeneration. Since the molecular pathways by which statins induce osteoblast differentiation are still unclear, further investigations are required to elucidate the detailed cellular signaling mechanisms involved to determine the type of statin, optimal dose and mode of delivery to effectively utilize their anabolic effect. This also warrants the development of novel vehicles to locally deliver statins for the desired time periods to support optimal tissue regeneration in vivo.
C1 [Brittain, Sarah B.; Gohil, Shalini V.; Nair, Lakshmi S.] UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.
   [Nair, Lakshmi S.] UConn Hlth, Raymond & Beverly Sackler Ctr Biomed Biol Phys &, Inst Regenerat Engn, Farmington, CT 06030 USA.
   [Nair, Lakshmi S.] Univ Connecticut, Inst Mat Sci, Dept Chem Mat & Biomol Engn, Storrs, CT 06269 USA.
RP Nair, LS (reprint author), UConn Hlth, Ctr Farmington, Inst Regenerat Engn, Raymond & Beverly Sackler Ctr Biomed Biol Phys &, Farmington, CT 06030 USA.
EM nair@uchc.edu
FU U.S Army Medical research and Materiel Command, Maryland
   [W81XWH-10-1-0653]
FX This work was supported by the U.S Army Medical research and Materiel
   Command, Maryland [W81XWH-10-1-0653].
CR Alam S, 2009, ORAL SURG ORAL MED O, V107, P22, DOI 10.1016/j.tripleo.2008.06.025
   Amini AA, 2011, CURR MED CHEM, V18, P1220
   Amini AA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024105
   Axelrad TW, 2008, J BONE JOINT SURG BR, V90B, P1617, DOI 10.1302/0301-620X.90B12.20975
   Ayukawa Y, 2009, ORAL SURG ORAL MED O, V107, P336, DOI 10.1016/j.tripleo.2008.07.013
   Bae MS, 2011, BIOMATERIALS, V32, P8161, DOI 10.1016/j.biomaterials.2011.07.045
   Barrios-Gonzalez J, 2010, APPL MICROBIOL BIOT, V85, P869, DOI 10.1007/s00253-009-2239-6
   Buday L., 2012, ENCY CANC, P3176
   Budiraharjo R, 2013, J BIOMAT SCI-POLYM E, V24, P645, DOI 10.1080/09205063.2012.703949
   Burks Martin V, 2010, J Long Term Eff Med Implants, V20, P277
   Chen PY, 2010, NUTR RES, V30, P191, DOI 10.1016/j.nutres.2010.03.004
   Cho KJ, 2011, MOL CELL BIOL, V31, P1110, DOI 10.1128/MCB.00989-10
   Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002
   Dhandayuthapani B., 2011, INT J POLYM SCI, V2011
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   ENDO A, 1976, J ANTIBIOT, V29, P1346, DOI 10.7164/antibiotics.29.1346
   ENDO A, 1977, EUR J BIOCHEM, V77, P31, DOI 10.1111/j.1432-1033.1977.tb11637.x
   Fukui T, 2012, J BONE MINER RES, V27, P1118, DOI 10.1002/jbmr.1558
   Garrett IR, 2007, J ORTHOP RES, V25, P1351, DOI 10.1002/jor.20391
   Garrett IR, 2001, CURR PHARM DESIGN, V7, P715, DOI 10.2174/1381612013397762
   Ghosh-Choudhury N, 2007, J BIOL CHEM, V282, P4983, DOI 10.1074/jbc.M606706200
   Grasser W. A., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P53
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Gutierrez GE, 2006, OSTEOPOROSIS INT, V17, P1033, DOI 10.1007/s00198-006-0079-0
   Hu M, 2011, AFR J BIOTECHNOL, V10, P7330
   Hu XF, 2012, BIOMATERIALS, V33, P8082, DOI 10.1016/j.biomaterials.2012.07.057
   Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229
   Jeon JH, 2008, J PERIODONTOL, V79, P1457, DOI [10.1902/jop.2008.080004, 10.1902/jop.2008.080004 ]
   Kanazawa I, 2009, AM J PHYSIOL-ENDOC M, V296, pE139, DOI 10.1152/ajpendo.90677.2008
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   Kraiwattanapong C, 2005, SPINE, V30, P1001, DOI 10.1097/01.brs.0000160997.91502.3b
   Kugel A, 2011, PROG ORG COAT, V72, P222, DOI 10.1016/j.porgcoat.2011.07.004
   Lv Q., 2011, BIODEGRADABLE POLYM
   Maeda T, 2003, ENDOCRINOLOGY, V144, P681, DOI 10.1210/en.2002.220682
   Maeda T, 2004, J CELL BIOCHEM, V92, P458, DOI 10.1002/jcb.20072
   Maeda T, 2001, BIOCHEM BIOPH RES CO, V280, P874, DOI 10.1006/bbrc.2000.4232
   Maritz FJ, 2001, ARTERIOSCL THROM VAS, V21, P1636, DOI 10.1161/hq1001.097781
   Merrell JG, 2009, CLIN EXP PHARMACOL P, V36, P1149, DOI 10.1111/j.1440-1681.2009.05216.x
   Moon JH, 2011, METABOLISM, V60, P930, DOI 10.1016/j.metabol.2010.08.013
   Mukozawa A, 2011, CLIN ORAL IMPLAN RES, V22, P1327, DOI 10.1111/j.1600-0501.2010.02135.x
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nakashima A, 2005, J BIOL CHEM, V280, P37660, DOI 10.1074/jbc.M504612200
   Ohnaka K, 2001, BIOCHEM BIOPH RES CO, V287, P337, DOI 10.1006/bbrc.2001.5597
   Sato N, 2012, NEURODEGENER DIS, V10, P305, DOI 10.1159/000334534
   Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x
   Skoglund B, 2002, J BONE MINER RES, V17, P2004, DOI 10.1359/jbmr.2002.17.11.2004
   Skoglund B, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-98
   Stephan SJ, 2010, LARYNGOSCOPE, V120, P895, DOI 10.1002/lary.20624
   Sugiyama M, 2000, BIOCHEM BIOPH RES CO, V271, P688, DOI 10.1006/bbrc.2000.2697
   Tan HC, 2013, BIOTECHNOL BIOENG, V110, P969, DOI 10.1002/bit.24756
   Tashjian AH, 2008, J BONE MINER RES, V23, P803, DOI 10.1359/JBMR.080208
   Thatte S, 2005, J BIOACT COMPAT POL, V20, P585, DOI 10.1177/0883911505059549
   Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112
   Verma S, 2011, BIODEGRADABLE POLYM, P555
   von Stechow D, 2003, BMC MUSCULOSKELET DI, V4, DOI 10.1186/1471-2474-4-8
   Wadagaki R, 2011, ANN BIOMED ENG, V39, P1872, DOI 10.1007/s10439-011-0327-0
   Walter MS, 2014, J BIOMATER APPL, V28, P897, DOI 10.1177/0885328213486364
   Wang JW, 2007, OSTEOPOROSIS INT, V18, P1641, DOI 10.1007/s00198-007-0412-2
   Weivoda MM, 2011, ENDOCRINOLOGY, V152, P3113, DOI 10.1210/en.2011-0016
   Whang KM, 2005, J BIOMED MATER RES A, V74A, P237, DOI 10.1002/jbm.a.30309
   Whang KM, 2005, J BIOMED MATER RES A, V74A, P247, DOI 10.1002/jbm.a.30370
   Wong RWK, 2005, BRIT J ORAL MAX SURG, V43, P46, DOI 10.1016/j.bjoms.2004.08.014
   Wong RWK, 2003, BRIT J ORAL MAX SURG, V41, P244, DOI 10.1016/S0266-4356(03)00081-0
   Yang F, 2011, ORAL SURG ORAL MED O, V111, P551, DOI 10.1016/j.tripleo.2010.06.018
   Yin H, 2012, J BIOMED MATER RES A, V100A, P2991, DOI 10.1002/jbm.a.34228
   Yoshii T, 2012, J TISSUE ENG REGEN M
NR 68
TC 2
Z9 4
U1 0
U2 5
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PY 2014
VL 21
IS 25
BP 2980
EP 2988
DI 10.2174/0929867321666140601202933
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA AO0MQ
UT WOS:000341004200012
PM 24934344
DA 2018-10-20
ER

PT J
AU Liu, YQ
   Cai, DM
   Yang, J
   Wang, YJ
   Zhang, X
   Yin, SL
AF Liu, Yunqi
   Cai, Dongmei
   Yang, Jing
   Wang, Yujie
   Zhang, Xi
   Yin, Shengli
TI In vitro hemocompatibility evaluation of poly (4-hydroxybutyrate)
   scaffold
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Biomaterial; poly-4-hydroxybutyrate; hemocompatibility; tissue
   engineering; scaffold
ID BLOOD COMPATIBILITY; TISSUE; POLYHYDROXYALKANOATES; BIOCOMPATIBILITY;
   VIVO
AB The biosynthetic thermoplastic poly-4-hydroxybutyrate (P4HB) possesses favorable tensile strength and elongation performance and has been studied as a new implantable polymer material for medical uses. However, its hemocompatibility has not been tested to confirm its applicability to tissue engineering. In this study, a series of experiments was performed that included erythrocyte hemolysis tests, dynamic blood coagulation tests, platelet adhesion tests, effects on blood coagulation, Wright staining, and adsorption of erythrocytes, leukocytes, platelets, and plasma proteins. The results were compared with control tests on polyvinyl chloride (PVC), a biomaterial in current use, to evaluate the relative in vitro hemocompatibility of P4HB. The degree of hemolysis in the presence of P4HB was 1.9 +/- 0.2%. The absorbance-time curve for blood clotting declined slowly and smoothly. There were no differences in the test values of Factor XII, activated partial thromboplastin time (APTT), or fibrin degradation products (FDPs) among whole blood samples exposed to P4HB or PVC and the blank control groups (P > .05). Adsorption of platelets and globulin was similar in samples exposed to P4HB and PVC (P > .05), but the adsorption of erythrocytes, leukocytes, and albumin to P4HB was higher (P < .05). In conclusion, P4HB compares favorably with PVC in terms of blood compatibility, except for a higher affinity for erythrocytes and leukocytes. The findings indicate that P4HB, an alternate scaffolding material with advantageous properties, is generally acceptable for bioengineering use.
C1 [Liu, Yunqi; Cai, Dongmei; Zhang, Xi; Yin, Shengli] Sun Yat Sen Univ, Dept Cardiac Surg, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China.
   [Yang, Jing] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Dept Pediat Dent, Guangzhou 510080, Guangdong, Peoples R China.
   [Yang, Jing] Guangdong Prov Key Lab Stomatol, Guangzhou, Guangdong, Peoples R China.
   [Wang, Yujie] Guangdong Univ Technol, Sch Environm Sci & Engn, Guangzhou, Guangdong, Peoples R China.
RP Yin, SL (reprint author), Sun Yat Sen Univ, Dept Cardiac Surg, Affiliated Hosp 1, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.
EM yshengl03-@163.com
FU Guangdong Science and Technology Department, Guangdong, China
   [2010B080701036]
FX Funding was provided by the Guangdong Science and Technology Department,
   Guangdong, China (grant # 2010B080701036). The authors gratefully
   acknowledge the expert assistance of Dr. Guifu Wu and other researchers
   in Cardiology and the Key Laboratory on Assisted Circulation of the
   First Affiliated Hospital, Sun Yat-sen University.
CR Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Andree B, 2013, TISSUE ENG PART B-RE, V19, P279, DOI [10.1089/ten.teb.2012.0583, 10.1089/ten.TEB.2012.0583]
   [Anonymous], 2006, 1099342009 EN ISO
   [Anonymous], 2005, ANN BOOK ASTM STAND, P309
   Bunger CM, 2007, J ENDOVASC THER, V14, P725, DOI 10.1583/1545-1550(2007)14[725:ABSBOP]2.0.CO;2
   Chanard J, 2010, NEPHROL THER, V6, P158, DOI 10.1016/j.nephro.2009.10.006
   Chandra PS, 1991, BLOOD COMPATIBLE MAT, P136
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen XY, 2010, J BIOMED MATER RES B, V92B, P447, DOI 10.1002/jbm.b.31534
   Chen ZF, 2009, J BIOMAT SCI-POLYM E, V20, P1451, DOI 10.1163/092050609X12457419007621
   COOL DE, 1985, J BIOL CHEM, V260, P3666
   Deeken CR, 2013, ISRN SURG, V2013, DOI DOI 10.1155/2013/238067
   Favaloro EJ, 2011, PATHOLOGY, V43, P682, DOI 10.1097/PAT.0b013e32834bf5f4
   Gao WQ, 2013, INT J CLIN EXP MED, V6, P259
   Gao Y, 2010, BIOMACROMOLECULES, V11, P3102, DOI 10.1021/bm100906m
   Hanson SR, 2004, INTRO MAT MED, P367
   Hein S, 1997, FEMS MICROBIOL LETT, V153, P411, DOI 10.1016/S0378-1097(97)00282-6
   Kanezaki S, 2003, J BIOMAT SCI-POLYM E, V14, P469, DOI 10.1163/156856203766652075
   Kim IC, 1999, J APPL POLYM SCI, V74, P2046, DOI 10.1002/(SICI)1097-4628(19991121)74:8<2046::AID-APP20>3.0.CO;2-3
   Kirkizlar O, 2007, INT UROL NEPHROL, V39, P651, DOI 10.1007/s11255-006-9096-3
   Knight RL, 2008, P I MECH ENG H, V222, P129, DOI 10.1243/09544119JEIM230
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Li LH, 2001, BIOMATERIALS, V22, P2595, DOI 10.1016/S0142-9612(00)00222-2
   Liu YQ, 2014, J BIOMATER APPL, V28, P1105, DOI 10.1177/0885328213499806
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   McGann CL, 2013, MACROMOL CHEM PHYS, V214, P203, DOI 10.1002/macp.201200412
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   Nair C S Bhaskaran, 2011, Asian J Transfus Sci, V5, P18, DOI 10.4103/0973-6247.75972
   Pan JY, 2009, BIOMATERIALS, V30, P2975, DOI 10.1016/j.biomaterials.2009.02.005
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Sevastianov VI, 2003, J BIOMAT SCI-POLYM E, V14, P1029, DOI 10.1163/156856203769231547
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Somers P, 2009, TISSUE ENG PT A, V15, P3597, DOI [10.1089/ten.tea.2008.0690, 10.1089/ten.TEA.2008.0690]
   Stamm C, 2004, ANN THORAC SURG, V78, P2084, DOI 10.1016/j.athoracsur.2004.03.106
   Stock U A, 2001, J Long Term Eff Med Implants, V11, P249
   Williams SF, 2013, BIOMED ENG-BIOMED TE, V58, P439, DOI 10.1515/bmt-2013-0009
   Xu JL, 2012, J MATER SCI-MATER M, V23, P2839, DOI 10.1007/s10856-012-4755-7
   Yamazoe H, 2010, J BIOMAT SCI-POLYM E, V21, P647, DOI 10.1163/156856209X434665
   Zorio E, 2008, CURR MED CHEM, V15, P923, DOI 10.2174/092986708783955455
NR 39
TC 10
Z9 12
U1 0
U2 6
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2014
VL 7
IS 5
BP 1233
EP 1243
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AO3SD
UT WOS:000341254800005
PM 24995078
DA 2018-10-20
ER

PT J
AU Engelke, W
   Fuentes, R
   Beltran, V
AF Engelke, Wilfried
   Fuentes, Ramon
   Beltran, Victor
TI Sinus floor augmentation using miniscrew and in situ hardening
   biomaterial: method and case report
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Bone grafting; maxillary sinus; sinus augmentation; endoscopy
ID MAXILLARY SINUS; IMPLANT; PERFORATIONS; MEMBRANE; GRAFTS
AB Sinus floor augmentation in case of severe pneumatization is a challenge for surgical management. We present a low invasive endoscopically assisted technique facilitating the stabilization of augmentation material in the subantral space. The technique consists of (1) trepanation of the lateral sinus wall with tunnelling of the sinus membrane and creation of the subantral space, (2) subantroscopically assisted insertion of a mini screw, (3) precise stepwise placement of in situ hardening graft material with antroscopic control. Based on a case example, details of the procedure are presented. The technique provides a minimally invasive treatment for difficult and instable augmentation sites.
C1 [Engelke, Wilfried; Beltran, Victor] Univ Gottingen, Sch Dent, Dept Oral & Maxillofacial Surg, D-37073 Gottingen, Germany.
   [Fuentes, Ramon; Beltran, Victor] Univ La Frontera, Sch Dent, CIMOFIR Res Ctr, Temuco 4781176, Chile.
RP Beltran, V (reprint author), Univ La Frontera, Sch Dent, CIMOFIR Res Ctr, Claro Solar 115 420, Temuco 4781176, Chile.
EM victor.beltran@ufrontera.cl
FU Degradable Solution Company, Schlieren, Switzerland; Universidad de La
   Frontera, Temuco, Chile
FX This study was supported in part by Degradable Solution Company,
   Schlieren, Switzerland and the Universidad de La Frontera, Temuco,
   Chile.
CR Acocella A, 2009, J ORAL IMPLANTOL, V35, P37, DOI 10.1563/1548-1336-35.1.37
   Becker ST, 2008, CLIN ORAL IMPLAN RES, V19, P1285, DOI 10.1111/j.1600-0501.2008.01612.x
   Beltran V, 2012, J ORAL MAXIL SURG, V70, pE1, DOI 10.1016/j.joms.2011.09.011
   Engelke W, 1997, CLIN ORAL IMPLAN RES, V8, P527, DOI 10.1034/j.1600-0501.1997.080612.x
   Engelke W, 2003, INT J ORAL MAX IMPL, V18, P135
   Gacic B, 2009, ORAL SURG ORAL MED O, V108, P844, DOI 10.1016/j.tripleo.2009.07.026
   Iwai T, 2012, J CRANIOFAC SURG, V23, pE295, DOI 10.1097/SCS.0b013e318252f1cf
   MOMTAHENI DM, 1994, ORAL SURG ORAL MED O, V78, P14, DOI 10.1016/0030-4220(94)90110-4
   Tabrizi R, 2012, J CRANIOFAC SURG, V23, P767, DOI 10.1097/SCS.0b013e31824dbd19
   Testori T, 2008, INT J PERIODONT REST, V28, P9
   Wiltfang J, 2000, ORAL SURG ORAL MED O, V89, P288, DOI 10.1016/S1079-2104(00)70090-4
NR 11
TC 0
Z9 0
U1 0
U2 0
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2014
VL 7
IS 6
BP 1607
EP 1610
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AO3SL
UT WOS:000341255900017
PM 25035787
DA 2018-10-20
ER

PT J
AU Wood, NJ
   Maddocks, SE
   Grady, HJ
   Collins, AM
   Barbour, ME
AF Wood, Natalie J.
   Maddocks, Sarah E.
   Grady, Helena J.
   Collins, Andrew M.
   Barbour, Michele E.
TI Functionalization of ethylene vinyl acetate with antimicrobial
   chlorhexidine hexametaphosphate nanoparticles
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE EVA; biomaterial; polymer
ID SHORT-TERM CATHETERIZATION; SUSTAINED-RELEASE VARNISH; BIOFILM
   FORMATION; GANCICLOVIR IMPLANT; URETHRAL CATHETER; URINARY CATHETERS;
   ORAL ENVIRONMENT; COPOLYMER MATRIX; DRUG-RELEASE; IN-VITRO
AB Ethylene vinyl acetate (EVA) is in widespread use as a polymeric biomaterial with diverse applications such as intravitreal devices, catheters, artificial organs, and mouthguards. Many biomaterials are inherently prone to bacterial colonization, as the human body is host to a vast array of microbes. This can lead to infection at the biomaterial's site of implantation or application. In this study, EVA was coated with chlorhexidine (CHX) hexametaphosphate (HMP) nanoparticles (NPs) precipitated using two different reagent concentrations: CHX-HMP- 5 (5 mM CHX and HMP) and CHX-HMP-0.5 (0.5 mM CHX and HMP). Data gathered using dynamic light scattering, transmission electron microscopy, and atomic force microscopy indicated that the NPs were polydisperse, similar to 40-80 nm in diameter, and aggregated in solution to form clusters of similar to 140-200 nm and some much larger aggregates of 4-5 mu M. CHX-HMP-5 formed large deposits on the polymer surface discernible using scanning electron microscopy, whereas CHX-HMP-0.5 did not. Soluble CHX was released by CHX-HMP-5 NP-coated surfaces over the experimental period of 56 days. CHX-HMP-5 NPs prevented growth of methicillin-resistant Staphylococcus aureus when applied to the polymer surfaces, and also inhibited or prevented growth of Pseudomonas aeruginosa with greater efficacy when the NP suspension was not rinsed from the polymer surface, providing a greater NP coverage. This approach may provide a useful means to treat medical devices fabricated from EVA to render them resistant to colonization by pathogenic microorganisms.
C1 [Wood, Natalie J.; Grady, Helena J.; Barbour, Michele E.] Univ Bristol, Sch Oral & Dent Sci, Bristol BS1 2LY, Avon, England.
   [Wood, Natalie J.; Grady, Helena J.; Collins, Andrew M.] Univ Bristol, Bristol Ctr Funct Nanomat, Bristol BS1 2LY, Avon, England.
   [Wood, Natalie J.] Univ Bristol, Sch Chem, Ctr Organised Matter Chem, Bristol BS1 2LY, Avon, England.
   [Maddocks, Sarah E.] Cardiff Metropolitan Univ, Sch Hlth Sci, Cardiff, S Glam, Wales.
RP Barbour, ME (reprint author), Univ Bristol, Sch Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England.
EM m.e.barbour@bristol.ac.uk
FU Engineering and Physical Sciences Research Council; University of
   Bristol; Cardiff Metropolitan University; Engineering and Physical
   Sciences Research Council [1224976]
FX The authors gratefully acknowledge Data Plastics Ltd. (Witney, UK) for
   supplying the EVA, and the Engineering and Physical Sciences Research
   Council, the University of Bristol and Cardiff Metropolitan University
   for funding this research.
CR Arnold RR, 2008, J BIOMED MATER RES B, V86B, P506, DOI 10.1002/jbm.b.31049
   Barbour ME, 2007, COLLOID SURFACE A, V307, P116, DOI 10.1016/j.colsurfa.2007.05.010
   Barbour Michele E, 2013, Int J Nanomedicine, V8, P3507, DOI 10.2147/IJN.S50140
   Bratlie KM, 2012, ADV HEALTHC MATER, V1, P267, DOI 10.1002/adhm.201200037
   Charles NC, 2002, AM J OPHTHALMOL, V133, P273, DOI 10.1016/S0002-9394(01)01307-1
   Cho YW, 2003, J BIOMAT SCI-POLYM E, V14, P963, DOI 10.1163/156856203322381447
   Christoforidis JB, 2012, MEDIAT INFLAMM, DOI 10.1155/2012/126463
   Dinato RC, 2014, J SCI MED S IN PRESS
   Helbling IM, 2014, PHARM RES-DORDR, V31, P795, DOI 10.1007/s11095-013-1201-6
   Kiser PF, 2012, AIDS REV, V14, P62
   Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003
   Lete I, 2013, EUR J CONTRACEP REPR, V18, P234, DOI 10.3109/13625187.2013.801954
   Lin DM, 2003, DENT MATER, V19, P589, DOI 10.1016/S0109-5641(02)00109-4
   Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X
   Neto HP, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-193
   Nostro A, 2013, APPL MICROBIOL BIOT, V97, P9515, DOI 10.1007/s00253-013-5196-z
   Ogawa T, 2012, INT J ORAL SCI, V4, P14, DOI 10.1038/ijos.2012.13
   Park JH, 2003, J BIOMAT SCI-POLYM E, V14, P951, DOI 10.1163/156856203322381438
   Pickard R, 2012, LANCET, V380, P1927, DOI 10.1016/S0140-6736(12)61380-4
   Segev G, 2013, J VET INTERN MED, V27, P39, DOI 10.1111/j.1939-1676.2012.01027.x
   Shane TS, 2003, AM J OPHTHALMOL, V136, P649, DOI 10.1016/S0002-9394(03)00333-7
   Shapur NK, 2012, J ENDOUROL, V26, P26, DOI 10.1089/end.2011.0140
   Stickler DJ, 2008, NAT CLIN PRACT UROL, V5, P598, DOI 10.1038/ncpuro1231
   Tallury P, 2007, DENT MATER, V23, P404, DOI 10.1016/j.dental.2006.02.011
   Tenke P, 2014, CURR OPIN INFECT DIS, V27, P102, DOI 10.1097/QCO.0000000000000031
   Thurman AR, 2013, IN J WOMENS HEALTH, V5, P695, DOI 10.2147/IJWH.S34030
   Williamson JC, 2000, AM J OPHTHALMOL, V129, P554, DOI 10.1016/S0002-9394(99)00479-1
   Zelichenko G, 2013, J ENDOUROL, V27, P333, DOI 10.1089/end.2012.0193
NR 28
TC 8
Z9 8
U1 1
U2 25
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 4145
EP 4152
DI 10.2147/IJN.S65343
PG 8
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AN8QY
UT WOS:000340870200001
PM 25206305
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Easton, CD
   Bullock, AJ
   Gigliobianco, G
   McArthur, SL
   MacNeil, S
AF Easton, C. D.
   Bullock, A. J.
   Gigliobianco, G.
   McArthur, S. L.
   MacNeil, S.
TI Application of layer-by-layer coatings to tissue scaffolds - development
   of an angiogenic biomaterial
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; SITU ATR-FTIR; POLYELECTROLYTE MULTILAYERS;
   EXTRACELLULAR-MATRIX; SURFACE MODIFICATION; HEPARIN; FILM; DEPOSITION;
   BINDING; PH
AB Tissue engineered materials aimed at wound care typically underperform due to poor engrafting to the wound bed. The need for such materials will continue to intensify as a result of an ageing population and an increase in patients suffering from vascular problems. Here we describe the development of an angiogenic coating strategy employing a combination of plasma phase deposition of acrylic acid and layer-by-layer (LBL) chemistry using polyethyleneimine and poly(acrylic acid) for the immobilization of heparin and Vascular Endothelial Growth Factor (VEGF). The formation of the coating and its ability to immobilize heparin was examined by Quartz Crystal Microbalance with Dissipation. X-ray Photoelectron Spectroscopy (XPS) and Atomic Force Microscopy were used to confirm that these coatings retained a significant amount of heparin on the surface when applied to a flat substrate. The coating strategy was transferred to 2 different tissue scaffold architectures: a commercially available non-biodegradable polypropylene mesh, and a biodegradable electrospun poly(lactic-co-glycolic acid) (PLGA) scaffold. XPS confirmed that the coating was successfully applied to the scaffolds and that a similar amount of heparin was immobilized. In vitro testing showed that while HDMEC readily attached to the PLGA scaffold, they were inhibited from adhering and forming proliferative colonies where heparin alone was attached to the LBL coated PLGA scaffold. However, after dip coating with VEGF, the heparin coated scaffold supported both attachment and colony growth of HDMEC; no such colony formation occurred in the absence of VEGF.
C1 [Easton, C. D.] CSIRO Mfg Flagship, Clayton, Vic 3168, Australia.
   [Bullock, A. J.; Gigliobianco, G.; MacNeil, S.] Univ Sheffield, Kroto Res Inst, Dept Mat Engn, Sheffield S3 7HQ, S Yorkshire, England.
   [McArthur, S. L.] Swinburne Univ Technol, Fac Engn & Ind Sci, Biotact Engn Grp, IRIS, Hawthorn, Vic 3122, Australia.
RP MacNeil, S (reprint author), Univ Sheffield, Kroto Res Inst, Dept Mat Engn, Broad Lane, Sheffield S3 7HQ, S Yorkshire, England.
EM s.macneil@sheffield.ac.uk
RI McArthur, Sally/B-6848-2008
OI McArthur, Sally/0000-0002-4914-6989; Easton,
   Christopher/0000-0002-1981-3779; Bullock, Anthony/0000-0003-0579-3997
CR Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Brouwer KM, 2013, ORGANOGENESIS, V9, P161, DOI 10.4161/org.25587
   Cantini M, 2012, SOFT MATTER, V8, P5575, DOI 10.1039/c2sm25413a
   Chen YS, 2004, J APPL POLYM SCI, V93, P2014, DOI 10.1002/app.20663
   Chung HJ, 2006, PHARM RES, V23, P1835, DOI 10.1007/s11095-006-9039-9
   de Aguiar CBNM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-31
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Demirdogen B, 2010, GROWTH FACTORS, V28, P426, DOI 10.3109/08977194.2010.508456
   Elzbieciak M, 2009, COLLOID SURFACE A, V343, P89, DOI 10.1016/j.colsurfa.2009.01.034
   Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336
   Gengenbach TR, 1998, J POLYM SCI POL CHEM, V36, P985, DOI 10.1002/(SICI)1099-0518(19980430)36:6<985::AID-POLA14>3.0.CO;2-H
   Gilmore L, 2013, BIOTECHNOL BIOENG, V110, P296, DOI 10.1002/bit.24598
   Gupta K, 1997, EXP CELL RES, V230, P244, DOI 10.1006/excr.1996.3421
   HOUCK KA, 1992, J BIOL CHEM, V267, P26031
   Huang YS, 2013, J POLYM SCI POL CHEM, V51, P5230, DOI 10.1002/pola.26953
   Karlovsky ME, 2005, UROLOGY, V66, P469, DOI 10.1016/j.urology.2005.03.006
   Kim TG, 2009, BIOMACROMOLECULES, V10, P1532, DOI 10.1021/bm900116r
   KLEBE RJ, 1982, J CELL PHYSIOL, V112, P5, DOI 10.1002/jcp.1041120103
   Kovacevic D, 2002, LANGMUIR, V18, P5607, DOI 10.1021/la025639q
   LATERRA J, 1983, J CELL BIOL, V96, P112, DOI 10.1083/jcb.96.1.112
   Lin QK, 2011, J BIOMED MATER RES A, V96A, P132, DOI 10.1002/jbm.a.32820
   Liu GM, 2008, J PHYS CHEM B, V112, P3333, DOI 10.1021/jp710600f
   Lode A, 2008, J BIOMED MATER RES A, V86A, P749, DOI 10.1002/jbm.a.31581
   Lundin M, 2010, LANGMUIR, V26, P3242, DOI 10.1021/la902968h
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Mao ZW, 2005, BIOCONJUGATE CHEM, V16, P1316, DOI 10.1021/bc049755b
   Marchesan S, 2013, COLLOID SURFACE B, V108, P313, DOI 10.1016/j.colsurfb.2013.03.018
   MITCHELL DF, 1994, SURF INTERFACE ANAL, V21, P44, DOI 10.1002/sia.740210107
   Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684
   Muller M, 1998, MACROMOL RAPID COMM, V19, P333
   Muller M, 2001, MACROMOL RAPID COMM, V22, P390, DOI 10.1002/1521-3927(20010301)22:6<390::AID-MARC390>3.0.CO;2-B
   Muller M, 2006, BIOMACROMOLECULES, V7, P1285, DOI 10.1021/bm050631r
   Niepel MS, 2009, BIOMATERIALS, V30, P4939, DOI 10.1016/j.biomaterials.2009.06.014
   Pandiyaraj KN, 2009, MAT SCI ENG C-BIO S, V29, P796, DOI 10.1016/j.msec.2008.07.013
   PARK JE, 1993, MOL BIOL CELL, V4, P1317
   Porter AM, 2011, AM J PHYSIOL-CELL PH, V301, pC1086, DOI 10.1152/ajpcell.00090.2011
   Porter AM, 2011, BIOMACROMOLECULES, V12, P242, DOI 10.1021/bm101220b
   Robinson DE, 2008, ADV MATER, V20, P1166, DOI 10.1002/adma.200702586
   Robinson DE, 2012, BIOMATERIALS, V33, P1007, DOI 10.1016/j.biomaterials.2011.10.042
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Salim M, 2009, ELECTROPHORESIS, V30, P1877, DOI 10.1002/elps.200800619
   SANANTONIO JD, 1992, J CELL PHYSIOL, V150, P8
   Schoeler B, 2003, MACROMOLECULES, V36, P5258, DOI 10.1021/ma034018g
   Sharkawi T, 2011, J BIOMED MATER RES A, V98A, P80, DOI 10.1002/jbm.a.33099
   Shen LY, 2012, ACS APPL MATER INTER, V4, P4476, DOI 10.1021/am301118f
   Singh S, 2011, BIOMATERIALS, V32, P2059, DOI 10.1016/j.biomaterials.2010.11.038
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Tan QG, 2003, BIOMATERIALS, V24, P4699, DOI 10.1016/S0142-9612(03)00363-6
   Tang DW, 2010, BIOMATERIALS, V31, P9320, DOI 10.1016/j.biomaterials.2010.08.058
   Taylor L, 2014, POLYM INT, V63, P127, DOI 10.1002/pi.4567
   Tsai WB, 2009, ACTA BIOMATER, V5, P3467, DOI 10.1016/j.actbio.2009.05.034
   Weiss T, 2010, J BIOL CHEM, V285, P33867, DOI 10.1074/jbc.M110.141366
   Winters JC, 2006, BJU INT, V98, P70, DOI 10.1111/j.1464-410X.2006.06309.x
   Yoon JJ, 2006, J BIOMED MATER RES A, V79A, P934, DOI 10.1002/jbm.a.30843
   Zieris A, 2011, J CONTROL RELEASE, V156, P28, DOI 10.1016/j.jconrel.2011.06.042
NR 55
TC 9
Z9 9
U1 3
U2 45
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 34
BP 5558
EP 5568
DI 10.1039/c4tb00448e
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AN4VK
UT WOS:000340586500007
DA 2018-10-20
ER

PT J
AU Oliveira, MB
   Luz, GM
   Mano, JF
AF Oliveira, M. B.
   Luz, G. M.
   Mano, J. F.
TI A combinatorial study of nanocomposite hydrogels: on-chip
   mechanical/viscoelastic and pre-osteoblast interaction characterization
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID DYNAMIC-MECHANICAL ANALYSIS; BIOACTIVE GLASS; BONE TISSUE; COMPOSITE
   SCAFFOLDS; VISCOELASTIC PROPERTIES; CHITOSAN MEMBRANES; IN-VITRO;
   POLYMER; COLLAGEN; NANOPARTICLES
AB Nanocomposite hydrogels were prepared in a combinatorial way with chitosan, bioglass nanoparticles (BG-NPs) and distinct amounts of crosslinker (genipin), in a total of 30 formulations. Such miniaturized hydrogels were prepared by dispensing the precursor solutions in wettable spots previously patterned onto superhydrophobic surfaces. The chips were used as platforms to analyze the biomaterials on-chip both for mechanical/viscoelastic and cell-biomaterial interactions. We adapted a mechanical dynamic analyzer (DMA) in order to perform the in situ totally unconfined solid-state rheological characterization of biomaterials under physiological-like conditions. We concluded that the viscoelastic properties of the hydrogels are dependent on the three factors studied. Besides influencing biomaterials' mechanical properties, bioglass fillers also confer bioactivity. We immersed the chips with 20 distinct biomaterial formulations in a cell suspension of MC3T3-E1 pre-osteoblasts and quantified - using image analysis compatible with the maintenance of the integrity of the chip - selective cell adhesion after 1 day of cell culture, as well as cell proliferation and cell morphology at day 3. Linear regression studies showed that for the range of conditions studied herein, neither cell adhesion nor proliferation depended directly on the biomaterials' mechanical/viscoelastic properties. Rather, cell proliferation was favoured in the presence of an intermediate amount of BGNPs (12.5% w/w) for all chitosan/genipin conditions, especially in softer hydrogels (2% (w/v) chitosan, 2.5% (w/w) genipin). This hit-spotted condition also favoured cell spreading. Interestingly, the elastic modulus measured for this formulation meets the values reported for the granulation tissue occurring during bone regeneration, where fibroblasts produce collagen. We believe that this approach will facilitate the complete on-chip rapid study of miniaturized biomaterials, in order to get more adequate formulations to be used in tissue engineering or other biomedical applications.
C1 [Oliveira, M. B.; Luz, G. M.; Mano, J. F.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4806909 Taipas, Guimaraes, Portugal.
   [Oliveira, M. B.; Luz, G. M.; Mano, J. F.] ICVS 3Bs PT Govt Associate Lab, Braga, Guimaraes, Portugal.
RP Mano, JF (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
EM jmano@dep.uminho.pt
RI Oliveira, Mariana/H-6933-2017; Mano, Joao/A-4418-2009; Group,
   3Bs/E-4374-2012
OI Oliveira, Mariana/0000-0002-6104-6075; Mano, Joao/0000-0002-2342-3765;
   Group, 3Bs/0000-0002-5195-3456
FU FCT - Fundacao para a Ciencia e para a Tecnologia [SFRH/BD/71396/2010,
   SFRH/BPD/91681/2012]; FEDER through the program Operacional Factores de
   Competitividade - COMPETE; FCT [PTDC/FIS/115048/2009,
   PTDC/CTM-Bio/1814/2012]
FX The authors acknowledge the financial support from the FCT - Fundacao
   para a Ciencia e para a Tecnologia through the Ph.D. and Post-Doctoral
   grants with the references SFRH/BD/71396/2010 and SFRH/BPD/91681/2012.
   We also acknowledge the financial support of the FEDER through the
   program Operacional Factores de Competitividade - COMPETE and from the
   FCT - under the projects PTDC/FIS/115048/2009 and
   PTDC/CTM-Bio/1814/2012.
CR Abdel-Sayed P, 2014, BIOMATERIALS, V35, P1890, DOI 10.1016/j.biomaterials.2013.11.048
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Alves NM, 2010, J MATER CHEM, V20, P2911, DOI 10.1039/b910960a
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Burdick JA, 2011, NAT METHODS, V8, P915, DOI 10.1038/nmeth.1745
   Caridade SG, 2013, J MECH BEHAV BIOMED, V20, P173, DOI 10.1016/j.jmbbm.2012.11.012
   Claes LE, 2009, CLIN ORTHOP RELAT R, V467, P1964, DOI 10.1007/s11999-009-0752-7
   Claes LE, 1998, CLIN ORTHOP RELAT R, pS132
   Correlo VM, 2009, J BIOMED MATER RES A, V91A, P489, DOI 10.1002/jbm.a.32221
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Duarte ARC, 2009, MAT SCI ENG C-MATER, V29, P2110, DOI 10.1016/j.msec.2009.04.012
   Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gentile P, 2012, J BIOMED MATER RES A, V100A, P2654, DOI 10.1002/jbm.a.34205
   Ghosh S, 2008, ACTA BIOMATER, V4, P950, DOI 10.1016/j.actbio.2008.02.001
   Guedes RM, 2006, J BIOMECH, V39, P49, DOI 10.1016/j.jbiomech.2004.11.005
   Heinemann S, 2007, INT J MATER RES, V98, P603, DOI 10.3139/146.101519
   Hong ZK, 2010, J BIOMED MATER RES A, V95A, P747, DOI 10.1002/jbm.a.32898
   Hong Z, 2009, J BIOMED MATER RES A, V88A, P304, DOI 10.1002/jbm.a.31848
   Ina K, 2005, EXP MOL PATHOL, V79, P244, DOI 10.1016/j.yexmp.2005.08.003
   Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9
   Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001
   LAKES RS, 1979, J BIOMECH, V12, P657, DOI 10.1016/0021-9290(79)90016-2
   Lei B, 2012, J BIOMED MATER RES B, V100B, P967, DOI 10.1002/jbm.b.32659
   Leong PL, 2008, ACTA BIOMATER, V4, P1569, DOI 10.1016/j.actbio.2008.02.030
   Lin S, 2011, PHARM RES-DORDR, V28, P1422, DOI 10.1007/s11095-011-0378-9
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   Luz GM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/054104
   Luz GM, 2012, LANGMUIR, V28, P6970, DOI 10.1021/la300667g
   Luz GM, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494014
   Luz GM, 2011, MATER LETT, V65, P296, DOI 10.1016/j.matlet.2010.09.056
   Luz GM, 2010, COMPOS SCI TECHNOL, V70, P1777, DOI 10.1016/j.compscitech.2010.05.013
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mano JF, 2008, MACROMOL BIOSCI, V8, P69, DOI 10.1002/mabi.200700139
   Misra SK, 2008, BIOMATERIALS, V29, P1750, DOI 10.1016/j.biomaterials.2007.12.040
   Moorcroft CI, 2001, CLIN BIOMECH, V16, P776, DOI 10.1016/S0268-0033(01)00079-1
   Mota J, 2012, ACTA BIOMATER, V8, P4173, DOI 10.1016/j.actbio.2012.06.040
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Neto AI, 2011, SOFT MATTER, V7, P4147, DOI 10.1039/c1sm05169e
   Oliveira MB, 2013, SMALL, V9, P768, DOI 10.1002/smll.201201436
   Oliveira MB, 2013, ANAL CHEM, V85, P2391, DOI 10.1021/ac303405x
   Oliveira MB, 2011, SOFT MATTER, V7, P6426, DOI 10.1039/c0sm01302a
   Oliveira N. M., 2010, APPL PHYS EXPRESS, V3
   Paul DR, 2008, POLYMER, V49, P3187, DOI 10.1016/j.polymer.2008.04.017
   Poon B, 2008, INT J SOLIDS STRUCT, V45, P6018, DOI 10.1016/j.ijsolstr.2008.07.021
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rojo FJ, 2010, J BIOMED MATER RES B, V95B, P414, DOI 10.1002/jbm.b.31732
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Salgado CL, 2012, INTEGR BIOL-UK, V4, P318, DOI 10.1039/c2ib00170e
   Sasaki N., 2012, VISCOELASTIC PROPERT
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Silva SS, 2010, CRIT REV BIOTECHNOL, V30, P200, DOI 10.3109/07388551.2010.505561
   Simon CG, 2004, MACROMOL RAPID COMM, V25, P2003, DOI 10.1002/marc.200400395
   Sowmya S, 2011, TRENDS BIOMATER ARTI, V25, P1
   Srinivasan S, 2012, CARBOHYD POLYM, V87, P274, DOI 10.1016/j.carbpol.2011.07.058
   Stafford CM, 2004, NAT MATER, V3, P545, DOI 10.1038/nmat1175
   Tweedie CA, 2005, ADV MATER, V17, P2599, DOI 10.1002/adma.200501142
   Xu HHK, 2007, J BIOMED MATER RES B, V81B, P116, DOI 10.1002/jbm.b.30644
NR 59
TC 12
Z9 12
U1 0
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 34
BP 5627
EP 5638
DI 10.1039/c4tb00437j
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA AN4VK
UT WOS:000340586500015
DA 2018-10-20
ER

PT J
AU Kang, HM
   Wen, C
   Hwang, YS
   Shih, YRV
   Kar, M
   Seo, SW
   Varghese, S
AF Kang, Heemin
   Wen, Cai
   Hwang, Yongsung
   Shih, Yu-Ru V.
   Kar, Mrityunjoy
   Seo, Sung Wook
   Varghese, Shyni
TI Biomineralized matrix-assisted osteogenic differentiation of human
   embryonic stem cells
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID PHOSPHATE CERAMIC COMPOSITION; ENGINEERING BONE TISSUE;
   CALCIUM-PHOSPHATE; INVITRO BEHAVIOR; MINERAL COATINGS;
   MICROENVIRONMENTS; PROLIFERATION; BIOMATERIALS; INTERFACE; SCAFFOLDS
AB The physical and chemical properties of a matrix play an important role in determining various cellular behaviors, including lineage specificity. We demonstrate that the differentiation commitment of human embryonic stem cells (hESCs), both in vitro and in vivo, can be solely achieved through synthetic biomaterials. hESCs cultured using mineralized synthetic matrices mimicking a calcium phosphate (CaP)-rich bone environment differentiated into osteoblasts in the absence of any osteogenic inducing supplements. When implanted in vivo, these hESC-laden mineralized matrices contributed to ectopic bone tissue formation. In contrast, cells within the corresponding non-mineralized matrices underwent either osteogenic or adipogenic fate depending upon the local cues present in the microenvironment. To our knowledge, this is the first demonstration where synthetic matrices are shown to induce terminal cell fate specification of hESCs exclusively by biomaterial-based cues both in vitro and in vivo. Technologies that utilize tissue specific cell-matrix interactions to control stem cell fate could be a powerful tool in regenerative medicine. Such approaches can be used as a tool to advance our basic understanding and assess the translational potential of stem cells.
C1 [Kang, Heemin; Wen, Cai; Hwang, Yongsung; Shih, Yu-Ru V.; Kar, Mrityunjoy; Seo, Sung Wook; Varghese, Shyni] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Kang, Heemin; Varghese, Shyni] Univ Calif San Diego, Mat Sci & Engn Program, La Jolla, CA 92093 USA.
   [Wen, Cai] Southeast Univ, Sch Chem & Chem Engn, Nanjing 210018, Jiangsu, Peoples R China.
   [Seo, Sung Wook] Sungkyunkwan Univ, Sch Med, Dept Orthopaed Surg, Seoul 135710, South Korea.
RP Varghese, S (reprint author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr,Mail Code 0412, La Jolla, CA 92093 USA.
EM svarghese@ucsd.edu
OI Kar, Mrityunjoy/0000-0002-7910-9580
FU National Institutes of Health (NIH) [1 R01 AR063184-01A1]; California
   Institute of Regenerative Medicine (CIRM) [RN2-00945, RT2-01889]
FX Authors gratefully acknowledge the financial support from National
   Institutes of Health and California Institute of Regenerative Medicine
   (NIH, Grant 1 R01 AR063184-01A1; CIRM, RN2-00945 and RT2-01889). We also
   thank Dr Ameya Phadke and Dr Manando Nakasaki for valuable discussions.
CR Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041
   Autefage H, 2009, J BIOMED MATER RES B, V91B, P706, DOI 10.1002/jbm.b.31447
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Barradas AMC, 2013, INTEGR BIOL-UK, V5, P920, DOI 10.1039/c3ib40027a
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518
   Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014
   Both SK, 2011, J TISSUE ENG REGEN M, V5, P180, DOI 10.1002/term.303
   Bryant SJ, 2007, BIOMATERIALS, V28, P2978, DOI 10.1016/j.biomaterials.2006.11.033
   Cameron K, 2013, J BIOMED MATER RES A, V101, P13, DOI 10.1002/jbm.a.34261
   Chang CW, 2013, BIOMATERIALS, V34, P912, DOI 10.1016/j.biomaterials.2012.10.020
   Choi S, 2013, BIOTECHNOL J, V8, P496, DOI 10.1002/biot.201200204
   Chou YF, 2005, BIOMATERIALS, V26, P285, DOI 10.1016/j.biomaterials.2004.02.030
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hwang NS, 2013, TISSUE ENG PT A, V19, P1723, DOI [10.1089/ten.TEA.2013.0064, 10.1089/ten.tea.2013.0064]
   Hwang YS, 2011, REGEN MED, V6, P505, DOI [10.2217/RME.11.38, 10.2217/rme.11.38]
   Hwang YS, 2010, J MATER CHEM, V20, P345, DOI 10.1039/b917142h
   Lee JS, 2011, ADV MATER, V23, P4279, DOI 10.1002/adma.201100060
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Levi B, 2012, P NATL ACAD SCI USA, V109, P20379, DOI 10.1073/pnas.1218052109
   Lim JI, 2009, MICRON, V40, P756, DOI 10.1016/j.micron.2009.04.002
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   Marolt D, 2012, P NATL ACAD SCI USA, V109, P8705, DOI 10.1073/pnas.1201830109
   Maxian SH, 1998, J BIOMED MATER RES, V40, P171, DOI 10.1002/(SICI)1097-4636(199805)40:2<171::AID-JBM1>3.0.CO;2-I
   Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x
   Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008
   Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202
   Phadke A, 2013, EUR CELLS MATER, V25, P114, DOI 10.22203/eCM.v025a08
   Phadke A, 2012, MACROMOL BIOSCI, V12, P1022, DOI 10.1002/mabi.201100289
   Phadke A, 2010, BIOMACROMOLECULES, V11, P2060, DOI 10.1021/bm100425p
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   Roberts SJ, 2011, BIOMATERIALS, V32, P4393, DOI 10.1016/j.biomaterials.2011.02.047
   Shih YRV, 2014, P NATL ACAD SCI USA, V111, P990, DOI 10.1073/pnas.1321717111
   Smith LA, 2010, BIOMATERIALS, V31, P5526, DOI 10.1016/j.biomaterials.2010.03.065
   Song GD, 2013, BIOMATERIALS, V34, P2167, DOI 10.1016/j.biomaterials.2012.12.010
   Sottile V, 2003, CLONING STEM CELLS, V5, P149, DOI 10.1089/153623003322234759
   Suarez-Gonzalez D, 2012, BIOMATERIALS, V33, P713, DOI 10.1016/j.biomaterials.2011.09.095
   Vaquette C, 2013, BIOMATERIALS, V34, P5538, DOI 10.1016/j.biomaterials.2013.03.088
   Wen L, 2012, BIOCHEM BIOPH RES CO, V424, P439, DOI 10.1016/j.bbrc.2012.06.128
   Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zhu ST, 2009, CELL STEM CELL, V4, P416, DOI 10.1016/j.stem.2009.04.001
NR 51
TC 16
Z9 16
U1 2
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 34
BP 5676
EP 5688
DI 10.1039/c4tb00714j
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA AN4VK
UT WOS:000340586500020
PM 25114796
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Fazal, A
   Rafique, U
AF Fazal, Aliya
   Rafique, Uzaira
TI Mechanistic study of Cd adsorption through esterification and
   acetylation of novel biosorbent Gallus Domesticus chemically modified
   biomaterial for heavy metal
SO JOURNAL OF WATER REUSE AND DESALINATION
LA English
DT Article
DE biosorption; kinetics; modification; thermodynamics
ID AQUEOUS-SOLUTION; CHEMISORPTION; KINETICS; CARBON
AB The inevitable expansion of industries for development is at the cost of release of industrial pollutants into the natural reservoirs of the environment. Biosorption is becoming an important component in the integrated approach to the treatment of aqueous effluents. The adsorption properties of Gallus Domesticus are determined as a function of batch operating conditions including contact time, solution initial concentration and temperature. Metal ion fixed Fourier transform infrared spectroscopy spectrum depicted amine, alcohol, carboxyl, and carbonate ion as active sites for metal sorption. Augmentation of removal capacity to 5 and 17% is tailored by esterification and acetylation of different surface functional groups of the base matrix. Kinetics is dissected through diffusion-based kinetic models, and best fit was figured out for Elovich equation. The thermodynamic relationship draws that enthalpy (Delta H degrees 45.48 KJ/mol) and entropy (Delta S degrees 153.32 J/mol K) are positive and entropy of the system is much larger than enthalpy. Results propose alteration of domestic waste into economical adsorbent for commercialization with no processing in the efficient removal of cadmium from wastewater.
C1 [Fazal, Aliya] Quaid E Azam Univ Campus, Natl Ctr Phys, Islamabad 44000, Pakistan.
   [Rafique, Uzaira] Fatima Jinnah Women Univ, Dept Environm Sci, Rawalpindi 46000, Pakistan.
RP Fazal, A (reprint author), Quaid E Azam Univ Campus, Natl Ctr Phys, Islamabad 44000, Pakistan.
EM aliyafazal38@yahoo.com
CR Abia A. A., 2007, Tsinghua Science and Technology, V12, P485, DOI 10.1016/S1007-0214(07)70072-X
   Aliya F., 2012, J WATER SUSTAINABILI, V2, P259
   Alkan M, 2007, MICROPOR MESOPOR MAT, V101, P388, DOI 10.1016/j.micromeso.2006.12.007
   Andal NM, 2010, E-J CHEM, V7, P967, DOI 10.1155/2010/605285
   Asma S., 2005, SEP PURIF TECHNOL, V45, P25
   Atef S. A., 2009, INT J PHYS SCI, V4, P172
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Boehm HP, 2008, ADSORPTION BY CARBONS, P301, DOI 10.1016/B978-008044464-2.50017-1
   Clark R.N., 1995, AGU REFERENCE SHELF, V3, P178
   Davila-Jimenez MM, 2005, COLLOID SURFACE A, V254, P107, DOI 10.1016/j.colsurfa.2004.11.022
   Gabriela H. P., 2006, MINER ENG, V19, P380
   Hameed BH, 2008, J HAZARD MATER, V159, P574, DOI 10.1016/j.jhazmat.2008.02.054
   Ilkay H. G., 2011, J HAZARD MATER, V186, P416
   IPCS, 2005, CADM CADM CHLOR CADM, V0020
   Kannan K., 2001, DYES PIGMENTS, V51, P25
   Kumar PS, 2010, BRAZ J CHEM ENG, V27, P347, DOI 10.1590/S0104-66322010000200013
   Laura L., 2005, BIOINORG CHEM APPL, V3, P29
   LOW MJD, 1960, CHEM REV, V60, P267, DOI 10.1021/cr60205a003
   MA QY, 1995, ENVIRON SCI TECHNOL, V29, P1118, DOI 10.1021/es00004a034
   MARQUES AM, 1991, APPL MICROBIOL BIOT, V35, P406
   Ozcan A, 2005, J HAZARD MATER, V124, P200, DOI 10.1016/j.hazmat.2005.05.007
   Paul A, 1997, COMPOS SCI TECHNOL, V57, P67, DOI 10.1016/S0266-3538(96)00109-1
   Renmin G., 2005, DYES PIGMENTS, V67, P175
   Sparks D.L., 1989, KINETICS SOIL CHEM P
   Teng H, 1999, IND ENG CHEM RES, V38, P292, DOI 10.1021/ie980107j
   Vimal C. S., 2007, CHEM ENG J, V132, P267
   Wanna S., 2009, SONGKLANAKARIN J SCI, V31, P547
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yang HD, 2003, SCI TOTAL ENVIRON, V304, P391, DOI 10.1016/S0048-9697(02)00584-3
NR 29
TC 0
Z9 0
U1 0
U2 3
PU IWA PUBLISHING
PI LONDON
PA ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H0QS, ENGLAND
SN 2220-1319
J9 J WATER REUSE DESAL
JI J. Water Reuse Desalin.
PY 2014
VL 4
IS 2
BP 76
EP 84
DI 10.2166/wrd.2013.033
PG 9
WC Engineering, Environmental; Water Resources
SC Engineering; Water Resources
GA AN8ZJ
UT WOS:000340894600003
OA Bronze
DA 2018-10-20
ER

PT J
AU de Souza, MR
   Oliveira, NTC
   Kuromoto, NK
   Marino, CEB
AF de Souza, Mariana Rossi
   Oliveira, Nilson T. C.
   Kuromoto, Neide Kazue
   Marino, Claudia E. B.
TI Growth and electrochemical stability of self-organized TiO2 nanotubes on
   Ti-2 grade and orthopedic Ti6Al4V alloy for biomedical application
SO MATERIA-RIO DE JANEIRO
LA English
DT Article
DE biomaterial; self-organized TiO2 nanotubes layer; electrochemical
   behavior
ID ANODIC-OXIDATION; SURFACES; MEDIA; HYDROXYAPATITE; TITANIUM; ARRAYS;
   FILMS
AB Titanium and its alloys are biomaterials used in endosseous implants, due to desirable mechanical properties, high corrosion resistance and biocompatibility. Using electrochemical anodization technique these materials can be recovered with self-organized TiO2 nanotubes layer resulting in increased specific surface area and probable bioactivity improvement. This research aimed determine potentiostatic anodization parameters to obtain self-organized TiO2 nanotubes layer with reproducibility and ideal diameters for probable bioactive response on Ti - 2 grade (ASTM F67) and Ti6Al4V (ASTM F136) orthopedic alloy and evaluation the electrochemical stability behavior in simulated body fluid media. The self-organized nanotubes layer were obtained by potentiostatic electrochemical method in electrolyte containing fluoride ions, H3PO4/HF for Ti 2 grade and H3PO4/NH4F for Ti6Al4V alloy, the applied potentials were 15 V, 20 V and 25 V for 30, 60 and 90 minutes, for both materials. For morphologic characterization were employed scanning electron microscopy SEM and the Image J software for nanodiameter measurements. The nanoestructure electrochemical stability was evaluated by open circuit potential after immersion for 15, 30 and 60 days in artificial blood plasma, into an electrochemical cell, using SCE (saturated calomel electrode) as reference electrode, in PBS ((phosphate buffered saline) solution electrolyte for 90 minutes. The ideal anodization parameters were 15 V and 20 V for 1 hour and a reproducible, uniform and homogeneous self-organized nanotubes layer were obtained with ideal diameters that probably improve the implant superficial bioactivity with 80 and 120 nm respectively, according to the literature. Open-circuit potentials from metal/oxide system obtained on both materials are stable with potentials in range of -0.031 V to -0,183 V indicating good stability of nanoestructures in simulated body fluid. Nanotubes layer as a superficial treatment is viable with high reproducibility, low cost and electrochemical stability in simulated body fluid media.
C1 [de Souza, Mariana Rossi; Kuromoto, Neide Kazue; Marino, Claudia E. B.] UFPR, Programa Posgrad Ciencias & Engn Mat PIPE, Curitiba, Parana, Brazil.
   [Oliveira, Nilson T. C.] Univ Fed Sao Carlos, Depto Eng Mat, Sao Carlos, SP, Brazil.
   [Kuromoto, Neide Kazue] UFPR, Depto Fis, Curitiba, Parana, Brazil.
   [Marino, Claudia E. B.] UFPR, Depto Eng Mecan, Lab Biomat & Eletroquim, Curitiba, Parana, Brazil.
RP de Souza, MR (reprint author), UFPR, Programa Posgrad Ciencias & Engn Mat PIPE, Curitiba, Parana, Brazil.
EM mariana.rossi.souza@gmail.com; ntco@yahoo.com; kuromoto@fisica.ufpr.br;
   claudiamarino@ufpr.br
RI MARINO, CLAUDIA/H-8169-2017; Oliveira, Nilson/G-4429-2015
OI MARINO, CLAUDIA/0000-0003-2660-4577; Kuromoto, Neide
   Kazue/0000-0001-8032-5523
FU PIPE-UFPR; Capes
FX The authors are grateful to the Capes for the scholarship, PIPE-UFPR for
   the financial support and CCDMUFSCAR and CME-UFPR for the SEM analysis.
CR An SH, 2012, MAT SCI ENG C-MATER, V32, P2516, DOI 10.1016/j.msec.2012.07.034
   Bauer S, 2006, ELECTROCHEM COMMUN, V8, P1321, DOI 10.1016/j.elecom.2006.05.030
   Frandsen C. J., 2013, INT J BIOMATER, V2013
   Karpagavalli R, 2007, J BIOMED MATER RES A, V83A, P1087, DOI 10.1002/jbm.a.31447
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Marino CEB, 2006, ELECTROCHIM ACTA, V51, P6580, DOI 10.1016/j.electacta.2006.04.051
   Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Pittrof A, 2011, ACTA BIOMATER, V7, P424, DOI 10.1016/j.actbio.2010.09.028
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Regonini D, 2013, MAT SCI ENG R, V74, P377, DOI 10.1016/j.mser.2013.10.001
   Sanchez-Tovar R, 2013, ELECTROCHEM COMMUN, V26, P1, DOI 10.1016/j.elecom.2012.09.041
   SCHMUKI P., 2011, ANGEWANDTE CHEM INTE, V50, P2904
   Simka W, 2011, ELECTROCHIM ACTA, V56, P9831, DOI 10.1016/j.electacta.2011.08.049
   Souto RM, 2003, BIOMATERIALS, V24, P4213, DOI 10.1016/S0142-9612(03)00362-4
   Yang H, 2013, INT J MOL SCI, V14, P244, DOI 10.3390/ijms14010244
   Zhou Y, 2010, T NONFERR METAL SOC, V20, P2320, DOI 10.1016/S1003-6326(10)60648-6
   Zwilling V, 1999, ELECTROCHIM ACTA, V45, P921, DOI 10.1016/S0013-4686(99)00283-2
NR 18
TC 3
Z9 3
U1 2
U2 31
PU UNIV FED RIO DE JANEIRO, LAB HIDROGENIO
PI RIO DE JANEIRO RJ
PA CIDADE UNIV, ILHA DO FUNDAO, BLOCO I 2000, S L I 146, RIO DE JANEIRO RJ,
   CEP21941-972, BRAZIL
SN 1517-7076
J9 MATERIA-BRAZIL
JI Materia
PY 2014
VL 19
IS 1
BP 53
EP 60
DI 10.1590/S1517-70762014000100008
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA AN2RJ
UT WOS:000340432700008
OA DOAJ Gold
DA 2018-10-20
ER

PT B
AU Wiria, FE
   Tay, BY
   Chandrasekaran, M
   Zhang, SX
   Maleksaeedi, S
   He, ZM
AF Wiria, Florencia Edith
   Tay, Bee Yen
   Chandrasekaran, Margam
   Zhang, Su Xia
   Maleksaeedi, Saeed
   He, Zeming
BE Kai, CC
   Yee, YW
   Jen, TM
   Erjia, L
TI 3D PRINTING OF CUSTOMIZED BIOMEDICAL SCAFFOLDS AND IMPLANTS
SO PROCEEDINGS OF THE 1ST INTERNATIONAL CONFERENCE ON PROGRESS IN ADDITIVE
   MANUFACTURING
LA English
DT Proceedings Paper
CT 1st International Conference on Progress in Additive Manufacturing
CY MAY 26-28, 2014
CL Nanyang Execut Ctr, Singapore, SINGAPORE
SP Nanyang Technol Univ
HO Nanyang Execut Ctr
ID RAPID PROTOTYPING TECHNIQUES; BONE INGROWTH; TISSUE; DEGRADATION;
   CHALLENGES; CARTILAGE
AB Powder-bed 3D printing (3DP) is a versatile additive manufacturing technique that uses ink binder deposition to bind loose powder particles together. This paper evaluates the work using powder-bed 3DP technology as a low-cost manufacturing system to print non-proprietary materials for biomedical scaffold and implant applications. The work presents development of suitable binder-powder feedstock coupled with the suitable printing and post-processing methodologies for respective biomaterial.
C1 [Wiria, Florencia Edith; Tay, Bee Yen; Zhang, Su Xia; Maleksaeedi, Saeed; He, Zeming] Singapore Inst Mfg Technol, 71 Nanyang Dr, Singapore 638075, Singapore.
   [Chandrasekaran, Margam] Bioscaffold Int Pte Ltd, Singapore 117525, Singapore.
RP Wiria, FE (reprint author), Singapore Inst Mfg Technol, 71 Nanyang Dr, Singapore 638075, Singapore.
CR [Anonymous], 1993, 62321993 BS EN
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Bartolo PJ, 2009, VIRTUAL PHYS PROTOTY, V4, P203, DOI 10.1080/17452750903476288
   ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Kawanishi M, 2004, MAT SCI ENG C-BIO S, V24, P431, DOI 10.1016/j.msec.2003.11.008
   Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008
   Lutjering G., 2007, TITANIUM
   Maleksaeedi S, 2013, PROC CIRP, V5, P158, DOI 10.1016/j.procir.2013.01.032
   Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Sato T, 2004, MAT SCI ENG C-BIO S, V24, P365, DOI 10.1016/j.msec.2003.12.010
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Wiria FE, 2010, MATER DESIGN, V31, pS101, DOI 10.1016/j.matdes.2009.12.050
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
NR 18
TC 0
Z9 0
U1 0
U2 29
PU RESEARCH PUBLISHING SERVICES
PI SINGAPORE
PA NO 83 GENTING LANE, #08-01, GENTING BUILDING, SINGAPORE, 349568,
   SINGAPORE
BN 978-981-09-0446-3
PY 2014
BP 411
EP +
DI 10.3850/978-981-09-0446-3_069
PG 2
WC Cell & Tissue Engineering; Engineering, Manufacturing; Materials
   Science, Multidisciplinary
SC Cell Biology; Engineering; Materials Science
GA BB0YY
UT WOS:000340850500065
DA 2018-10-20
ER

PT B
AU Wu, Y
   Yu, X
   Fuh, JYH
   Wong, YS
   Sun, J
AF Wu, Y.
   Yu, X.
   Fuh, J. Y. H.
   Wong, Y. S.
   Sun, J.
BE Kai, CC
   Yee, YW
   Jen, TM
   Erjia, L
TI FABRICATION OF POLYCAPROLACTONE SCAFFOLDS USING AN E-JET 3D PRINTING
   SYSTEM
SO PROCEEDINGS OF THE 1ST INTERNATIONAL CONFERENCE ON PROGRESS IN ADDITIVE
   MANUFACTURING
LA English
DT Proceedings Paper
CT 1st International Conference on Progress in Additive Manufacturing
CY MAY 26-28, 2014
CL Nanyang Execut Ctr, Singapore, SINGAPORE
SP Nanyang Technol Univ
HO Nanyang Execut Ctr
DE E-jetting; polycaprolactone (PCL); 3D printing
ID NANOFIBROUS SCAFFOLDS
AB The electrohydrodynamic jetting (or E-jetting) 3D printing system developed in-house is used as a fiber-based fabrication approach which applies electrical voltage between a nozzle and a substrate to deposit fibers onto the substrate layer by layer. PCL (polycaprolactone) is chosen as biomaterial of scaffolds because of its bio-compatibility and bio-degradability. This study focused on the fiber characteristics impacted by two main parameters, solution dispensing feed rate and plotting speed, to optimize filament diameter, filament formation and stability. Scaffolds fabricated with 70wt% PCL with size of 30x30mm and pore size of 300x300 mu m were investigated and characterized.
C1 [Wu, Y.; Yu, X.; Fuh, J. Y. H.; Wong, Y. S.; Sun, J.] Natl Univ Singapore, Dept Mech Engn, Singapore S117575, Singapore.
RP Wu, Y (reprint author), Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore S117575, Singapore.
EM mpefuhyh@nus.edu.sg
CR Averous L, 2000, POLYMER, V41, P4157, DOI 10.1016/S0032-3861(99)00636-9
   Chiu JB, 2005, J BIOMED NANOTECHNOL, V1, P115, DOI 10.1166/jbn.2005.018
   Hong JK, 2010, ACTA BIOMATER, V6, P4734, DOI 10.1016/j.actbio.2010.07.003
   Li J. L., 2013, J BIOMEDICAL MAT R B
   Liao I., 2006, ALIGNED CORE SHELL N
   Moffat K. L., 2008, TISSUE ENG PART A, V15, P115
   Park JU, 2007, NAT MATER, V6, P782, DOI 10.1038/nmat1974
   Tamayol A, 2013, BIOTECHNOL ADV, V31, P669, DOI 10.1016/j.biotechadv.2012.11.007
   Thomas V, 2006, J BIOMAT SCI-POLYM E, V17, P969, DOI 10.1163/156856206778366022
   Xie JW, 2010, NANOSCALE, V2, P923, DOI 10.1039/c0nr00192a
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 11
TC 0
Z9 0
U1 1
U2 12
PU RESEARCH PUBLISHING SERVICES
PI SINGAPORE
PA NO 83 GENTING LANE, #08-01, GENTING BUILDING, SINGAPORE, 349568,
   SINGAPORE
BN 978-981-09-0446-3
PY 2014
BP 434
EP 440
DI 10.3850/978-981-09-0446-3_058
PG 7
WC Cell & Tissue Engineering; Engineering, Manufacturing; Materials
   Science, Multidisciplinary
SC Cell Biology; Engineering; Materials Science
GA BB0YY
UT WOS:000340850500069
DA 2018-10-20
ER

PT S
AU Putra, N
   Septiadi, WN
   Saleh, R
   Koestoer, RA
   Prakoso, SP
AF Putra, Nandy
   Septiadi, Wayan Nata
   Saleh, Rosari
   Koestoer, Raldi Artono
   Prakoso, Suhendro Purbo
BE Li, D
   Zheng, D
   Shi, J
TI The Effect of CuO-water Nanofluid and Biomaterial Wick On Loop Heat Pipe
   Performance
SO MATERIALS RESEARCH AND APPLICATIONS, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Advanced Material and Manufacturing Science
   (ICAMMS 2012)
CY DEC 20-21, 2012
CL Beijing, PEOPLES R CHINA
SP Int Res Assoc Informat & Comp Sci, Sci Technol Press, Beijing Xinyongshun Acad Exchange LTD
DE loop heat pipe; wick; biomaterial; nano fluid
ID THERMAL PERFORMANCE; ELECTRONIC EQUIPMENT
AB The determinants of heat pipe performances are its wick and working fluid, instead of controlled by the material, dimension, and the shape of heat pipe. This study aimed to determine the effect of using nano-fluid on the performance of Loop heat pipes (LHP) with CuO-water nanofluid that using biomaterials wick. LHP was made of 8 mm diameter copper pipe, with the diameter of evaporator and the condenser was 20 mm respectively and the length of the heat pipe was 100 mm. The wick was made of biomaterials Collaria Tabulate and the working fluid was CuO-water nanofluids where the CuO nanoparticles were synthesized by sol-gel method. The characteristic of the Tabulate Collaria biomaterial as a wick in LHP was also investigated in this experiment. The results of the experiments showed that the temperature differences between the evaporator and condenser sections with the biomaterial wick and CuO-water nanofluid were less than those using pure water. These results make the biomaterial (Collar) and nanofluids are attractive both as wick and working fluid in LHP technology.
C1 [Putra, Nandy; Septiadi, Wayan Nata; Koestoer, Raldi Artono] Univ Indonesia, Dept Mech Engn, Heat Transfer Lab, Kampus Baru Ul Depok, Depok 16424, Indonesia.
   [Saleh, Rosari; Prakoso, Suhendro Purbo] Univ Indonesia, Dept Phys, Depok, Indonesia.
RP Putra, N (reprint author), Univ Indonesia, Dept Mech Engn, Heat Transfer Lab, Kampus Baru Ul Depok, Depok 16424, Indonesia.
EM nandyputra@eng.ui.ac.id
OI Septiadi, Wayan Nata/0000-0003-3121-9542
FU DRPM University of Indonesia [UT 2012]
FX The authors would like to thank the DRPM University of Indonesia for
   funding this research through Hibah Riset Utama UT 2012.
CR Chang YW, 2008, ENERG CONVERS MANAGE, V49, P3398, DOI 10.1016/j.enconman.2008.05.002
   Do Kyu Hyung, 2010, INT J HEAT MASS TRAN, V53, P5888
   Harris Jamie M., 2008, Mammalian Species, P1, DOI 10.1644/815.1
   Kang SW, 2006, APPL THERM ENG, V26, P2377, DOI 10.1016/j.applthermaleng.2006.02.020
   Kang SW, 2009, APPL THERM ENG, V29, P973, DOI 10.1016/j.applthermaleng.2008.05.010
   Kaya T, 2006, INT J HEAT MASS TRAN, V49, P3211, DOI 10.1016/j.ijheatmasstransfer.2006.01.028
   Kempers R, 2008, INT J HEAT MASS TRAN, V51, P6039, DOI 10.1016/j.ijheatmasstransfer.2008.04.001
   Lefevre Frederic, 2011, APPL THERM ENG, P1
   Leong KC, 1997, J POROUS MAT, V4, P303, DOI 10.1023/A:1009685508557
   Li JW, 2010, EXP THERM FLUID SCI, V34, P1403, DOI 10.1016/j.expthermflusci.2010.06.016
   Liu ZH, 2010, INT J THERM SCI, V49, P1680, DOI 10.1016/j.ijthermalsci.2010.03.006
   Liu ZH, 2011, ENERG CONVERS MANAGE, V52, P292, DOI 10.1016/j.enconman.2010.07.001
   Mishra DK, 2010, ADV POWDER TECHNOL, V21, P658, DOI 10.1016/j.apt.2010.07.011
   Ochterbeck J. M., HEAT PIPE, P1182
   Putra N, 2012, EXP THERM FLUID SCI, V40, P10, DOI 10.1016/j.expthermflusci.2012.01.007
   Putra N, 2011, EXP THERM FLUID SCI, V35, P1274, DOI 10.1016/j.expthermflusci.2011.04.015
   Putra Nandy, 2011, 4 INT M ADV THERM ME
   Putra Nandy, INT J THERMAL UNPUB
   Reay D, 2006, HEAT PIPE THEORY DES
   Saleh Rosari, 2012, INT J THERM IN PRESS
   Tang Y, 2010, EXP THERM FLUID SCI, V34, P190, DOI 10.1016/j.expthermflusci.2009.10.016
   Vasiliev LL, 2008, APPL THERM ENG, V28, P266, DOI 10.1016/j.applthermaleng.2006.02.023
   Vasiliev Leonard L, 2005, APPL THERM ENG, V25, P1
   Vasiliev L, 2009, INT J HEAT MASS TRAN, V52, P301, DOI 10.1016/j.ijheatmasstransfer.2008.06.016
   Vasiliev LL, 2005, APPL THERM ENG, V25, P1, DOI 10.1016/j.applthermaleng.2003.12.004
   Wang JC, 2011, INT J THERM SCI, V50, P97, DOI 10.1016/j.ijthermalsci.2010.07.001
   Weibel JA, 2010, INT J HEAT MASS TRAN, V53, P4204, DOI 10.1016/j.ijheatmasstransfer.2010.05.043
   Weng Ying-Che, 2011, APPL ENERG, V88, P1825
   Yu BM, 2002, INT J HEAT MASS TRAN, V45, P2983, DOI 10.1016/S0017-9310(02)00014-5
   Zan K.J., 2004, HEAT TRANSFER ASIAN, V33
NR 30
TC 3
Z9 3
U1 1
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-993-3
J9 ADV MATER RES-SWITZ
PY 2014
VL 875-877
BP 356
EP +
DI 10.4028/www.scientific.net/AMR.875-877.356
PG 3
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BA9HW
UT WOS:000339412000068
DA 2018-10-20
ER

PT J
AU Johansson, P
   Jimbo, R
   Kjellin, P
   Currie, F
   Chrcanovic, BR
   Wennerberg, A
AF Johansson, Par
   Jimbo, Ryo
   Kjellin, Per
   Currie, Fredrik
   Chrcanovic, Bruno Ramos
   Wennerberg, Ann
TI Biomechanical evaluation and surface characterization of a nano-modified
   surface on PEEK implants: a study in the rabbit tibia
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE polyether ether ketone; hydroxyapatite; removal torque; nanotopography
ID ANTERIOR CERVICAL DISKECTOMY; BEARING ORTHOPEDIC IMPLANTS; IN-VIVO
   EVALUATION; BONE RESPONSE; CALCIUM-PHOSPHATE; INTERBODY FUSION;
   TISSUE-REACTIONS; COATED IMPLANTS; PEDICLE SCREWS; HYDROXYAPATITE
AB Polyether ether ketone (PEEK) is today frequently used as a biomaterial in different medical operations due to its excellent mechanical and chemical properties. However, the untreated surface of PEEK is bioinert and hydrophobic, and it does not osseointegrate in its pure form. The aim of this study was to evaluate a unique nano-modified surface of PEEK with respect to osseointegration. Forty-eight threaded, non-cutting PEEK implants were inserted bilaterally in the tibia of 24 rabbits. Half of the implants (n=24) were coated with nanocrystalline hydroxyapatite (test) and the remaining implants (n=24) were left uncoated (control). Half of the animals (n=12) were euthanized after 3 weeks of healing and the remaining (n=12) after 12 weeks. The implant retention was measured with a removal torque apparatus. Surface analysis was performed with interferometry, scanning electron microscopy, and X-ray photon spectroscopy to relate the removal torque to the applied surface. The test implants revealed a significantly higher retention after 3 weeks (P=0.05) and 12 weeks (P=0.028) compared to controls. The result of the present study proves that the addition of nanocrystalline hydroxyapatite coating to PEEK surfaces significantly increases its removal torque and biocompatibility.
C1 [Johansson, Par; Jimbo, Ryo; Chrcanovic, Bruno Ramos; Wennerberg, Ann] Malmo Univ, Fac Odontol, Dept Prosthodont, S-20506 Malmo, Sweden.
   [Kjellin, Per; Currie, Fredrik] Promimic AB, Gothenburg, Sweden.
RP Johansson, P (reprint author), Malmo Univ, Fac Odontol, Dept Prosthodont, S-20506 Malmo, Sweden.
EM par.johansson@mah.se
RI Chrcanovic, Bruno/A-1278-2014
OI Chrcanovic, Bruno/0000-0002-3460-3374
FU Swedish Knowledge Foundation
FX This study was supported by grants received from the Swedish Knowledge
   Foundation.
CR Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   Aksakal B, 2013, EUR J ORTHOP SURG TR
   Albrektsson T, 1998, J ORAL MAXIL SURG, V56, P1312, DOI 10.1016/S0278-2391(98)90616-4
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266
   Barkarmo S, 2013, J BIOMED MATER RES A, V101, P465, DOI 10.1002/jbm.a.34358
   Bonfante EA, 2012, INT J BIOMATER, V2012
   Cheng ZP, 2012, OR SURG OR MED OR PA, V113, pE48, DOI 10.1016/j.tripleo.2011.07.008
   Cutler AR, 2006, J NEUROSURG-SPINE, V5, P534, DOI 10.3171/spi.2006.5.6.534
   Eom TG, 2012, OR SURG OR MED OR PA, V114, P411, DOI 10.1016/j.oooo.2011.10.036
   Evans SL, 1998, BIOMATERIALS, V19, P1329, DOI 10.1016/S0142-9612(97)00217-2
   HAY JN, 1989, POLYMER, V30, P489, DOI 10.1016/0032-3861(89)90019-0
   Hermida JC, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-57
   Katzer A, 2002, BIOMATERIALS, V23, P1749, DOI 10.1016/S0142-9612(01)00300-3
   Khoury J, 2013, NUCL INSTRUM METH B, V307, P630, DOI 10.1016/j.nimb.2012.11.087
   Kulkarni AG, 2007, SPINE J, V7, P205, DOI 10.1016/j.spinee.2006.03.002
   Kurtz SM, 2012, PDL HANDB SER, P1
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Lee JH, 2013, ACTA BIOMATER, V9, P6177, DOI 10.1016/j.actbio.2012.11.030
   Manders PJD, 2006, CLIN ORAL IMPLAN RES, V17, P548, DOI 10.1111/j.1600-0501.2006.01263.X
   Meirelles L, 2008, J BIOMED MATER RES A, V87A, P299, DOI 10.1002/jbm.a.31744
   Meirelles L, 2008, INT J ORAL MAX IMPL, V23, P641
   Munir G, 2011, J R SOC INTERFACE, V8, P678, DOI 10.1098/rsif.2010.0548
   Nakahara I, 2012, J ORTHOP RES, V30, P1618, DOI 10.1002/jor.22115
   Nieminen T, 2008, J BIOMED MATER RES A, V84A, P377, DOI 10.1002/jbm.a.31310
   Niu CC, 2010, J SPINAL DISORD TECH, V23, P310, DOI 10.1097/BSD.0b013e3181af3a84
   Park DS, 2010, J BIOMED MATER RES B, V94B, P353, DOI 10.1002/jbm.b.31658
   Park YS, 2005, INT J ORAL MAX IMPL, V20, P31
   Ponnappan RK, 2009, SPINE J, V9, P263, DOI 10.1016/j.spinee.2008.08.002
   Rabiei A, 2013, J BIOMED MATER RES A, V101, P2621, DOI 10.1002/jbm.a.34557
   Reigstad O, 2011, J BIOMED MATER RES B, V99B, P14, DOI 10.1002/jbm.b.31866
   Rokkum M, 2003, J BONE JOINT SURG BR, V85B, P440, DOI 10.1302/0301-620X.85B3.12834
   Sanden B, 2001, EUR SPINE J, V10, P334, DOI 10.1007/s005860100291
   Svanborg LM, 2011, INT J ORAL MAX SURG, V40, P308, DOI 10.1016/j.ijom.2010.10.010
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Ulrich D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050044
   Walter J, 2010, EUR SPINE J, V19, P1004, DOI 10.1007/s00586-009-1265-5
   Wang HR, 2013, J SPINAL DISORD TECH, V26, pE286, DOI 10.1097/BSD.0b013e31828679b3
   Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331
   Wennerberg A, 2011, INT J ORAL MAX IMPL, V26, P1161
   Williams D, 2008, MED DEVICE TECHNOL, V19, P10
   Williams David, 2008, Med Device Technol, V19, P10
   Wong KL, 2009, BIOMATERIALS, V30, P3810, DOI 10.1016/j.biomaterials.2009.04.016
   Yang GL, 2010, INT J ORAL MAX IMPL, V25, P669
   Yildirim OS, 2006, SPINE, V31, pE215, DOI 10.1097/01.brs.0000210221.00778.c7
   Yildirim OS, 2005, MED ENG PHYS, V27, P221, DOI 10.1016/j.medengphy.2004.10.006
   Zhang Haijun, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P468
NR 47
TC 13
Z9 13
U1 4
U2 25
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 3903
EP 3911
DI 10.2147/IJN.S60387
PG 9
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AN5BO
UT WOS:000340604300001
PM 25152620
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Gumel, AM
   Annuar, MSM
   Ishak, KA
   Ahmad, N
AF Gumel, A. M.
   Annuar, M. S. M.
   Ishak, K. A.
   Ahmad, N.
TI Carbon Nanofibers-Poly-3-hydroxyalkanoates Nanocomposite:
   Ultrasound-Assisted Dispersion and Thermostructural Properties
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID MECHANICAL-PROPERTIES; BIO-NANOCOMPOSITES; NANOTUBES; FUNCTIONALIZATION;
   POLYMERIZATION; POLYURETHANE; COMPOSITES; MORPHOLOGY; POLYMERS
AB The conductivity and high surface-to-volume ratio of carbon nanofibers (CNFs) composited with the medium-chain-length poly-3-hydroxyalkanoate (mcl-PHA) have attracted much attention as smart biomaterial. However, poor CNF dispersion leads to tactoid agglomerated composite with poor crystallite morphology resulting in inferior thermomechanical properties. We employed acoustic sonication to enhance the construction of exfoliated PHA/CNFs nanocomposites. The effects of CNF loading and the insonation variables (power intensity, frequency, and time) on the stability and microscopic morphology of the nanocomposites were studied. Sonication improved the dispersion of CNFs into the polymer matrix, thereby improving the physical morphology, crystallinity, and thermomechanical properties of the nanocomposites. For example, compositing the polymer with 10% w/w CNF resulted in 66% increase in crystallite size, 46% increase in micromolecular elastic strain, and 17% increase in lattice strain. Nevertheless, polymer degradation was observed following the ultrasound exposure. The constructed bionanocomposite could potentially be applied for organic electroconductive materials, biosensors and stimuli-responsive drug delivery devices.
C1 [Gumel, A. M.; Annuar, M. S. M.; Ishak, K. A.] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia.
   [Ahmad, N.] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur 50603, Malaysia.
RP Gumel, AM (reprint author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia.
EM gumel@um.edu.my
RI MOHAMAD ANNUAR, MOHAMAD SUFFIAN/B-9031-2010; GUMEL, AHMAD
   MOHAMMED/E-9906-2011; Ahmad, Noraini/H-5346-2011; ISHAK, KHAIRUL
   ANWAR/E-3907-2018
OI MOHAMAD ANNUAR, MOHAMAD SUFFIAN/0000-0003-3387-0160; GUMEL, AHMAD
   MOHAMMED/0000-0002-2998-4088; Ahmad, Noraini/0000-0002-1174-4748; ISHAK,
   KHAIRUL ANWAR/0000-0003-4433-8874
FU University of Malaya [BK014-2014, RG024-2012A, UM.C/625/1/HIR/MOHE/05,
   PV036-2012A]
FX We acknowledged University of Malaya for providing the research Grants
   nos. BK014-2014, RG024-2012A, UM.C/625/1/HIR/MOHE/05, and PV036-2012A.
CR Atieh MA, 2010, BIOINORG CHEM APPL, DOI 10.1155/2010/603978
   Belin T, 2005, MAT SCI ENG B-SOLID, V119, P105, DOI 10.1016/j.mseb.2005.02.046
   Carli LN, 2011, COMPOS PART A-APPL S, V42, P1601, DOI 10.1016/j.compositesa.2011.07.007
   CULLITY BD, 1969, ELEMENTS XRAY DIFFRA
   Dean K. M., 2012, CHARACTERIZATION TEC, V3
   Estevez-Martinez Y., 2013, J NANOMATER, V2013, P38
   Gumel A., 2013, INT J CHEM REACT ENG, V11, P609
   Gumel AM, 2013, J POLYM ENVIRON, V21, P580, DOI 10.1007/s10924-012-0527-1
   Gumel AM, 2013, ULTRASON SONOCHEM, V20, P937, DOI 10.1016/j.ultsonch.2012.09.015
   Gumel AM, 2012, POLYM DEGRAD STABIL, V97, P1224, DOI 10.1016/j.polymdegradstab.2012.05.041
   Gumel AM, 2013, J APPL POLYM SCI, V129, P3079, DOI 10.1002/app.39006
   Harding S., 2013, ENCY BIOPHYSICS, P1123
   Ishida H, 2000, CHEM MATER, V12, P1260, DOI 10.1021/cm990479y
   Johansson C., 2011, NANOCOMPOSITES BIODE, P348
   Lai MD, 2004, POLYM INT, V53, P1479, DOI 10.1002/pi.1566
   Leconte Y, 2007, J COLLOID INTERF SCI, V313, P511, DOI 10.1016/j.jcis.2007.05.010
   Lee EC, 2004, POLYM ENG SCI, V44, P1773, DOI 10.1002/pen.20179
   Mason T, 2002, APPL SONOCHEMISTRY U
   McGill R. A., 2003, [No title captured], Patent No. [US 6,660,343 B2, 6660343]
   Misra SK, 2010, ACTA BIOMATER, V6, P735, DOI 10.1016/j.actbio.2009.09.023
   Mohod AV, 2011, ULTRASON SONOCHEM, V18, P727, DOI 10.1016/j.ultsonch.2010.11.002
   Morales-Teyssier O, 2006, MACROMOL MATER ENG, V291, P1547, DOI 10.1002/mame.200600323
   Mote V. D., 2012, J THEORETICAL APPL P, V6, P1, DOI DOI 10.1186/2251-7235-6-6
   Musil J, 2013, VACUUM, V87, P96, DOI 10.1016/j.vacuum.2012.02.023
   Nerkar M, 2013, J POLYM ENVIRON, V21, P24, DOI 10.1007/s10924-012-0525-3
   Nieto A, 2012, CARBON, V50, P4068, DOI 10.1016/j.carbon.2012.04.054
   Ong YT, 2011, SEP PURIF TECHNOL, V76, P419, DOI 10.1016/j.seppur.2010.11.013
   Pandey JK, 2005, POLYM DEGRAD STABIL, V88, P234, DOI 10.1016/j.polymdegradstab.2004.09.013
   Park C, 2002, CHEM PHYS LETT, V364, P303, DOI 10.1016/S0009-2614(02)01326-X
   Poli A, 2011, ARCHAEA, DOI 10.1155/2011/693253
   Qian YQ, 2012, POLYMER, V53, P5060, DOI 10.1016/j.polymer.2012.09.008
   Qian Y, 2011, ACS APPL MATER INTER, V3, P3709, DOI 10.1021/am2008954
   Randriamahefa S, 2003, BIOMACROMOLECULES, V4, P1092, DOI 10.1021/bm034104o
   Ray S., 2006, BIODEGRADABLE POLYM
   Ray SS, 2005, PROG MATER SCI, V50, P962, DOI 10.1016/j.pmatsci.2005.05.002
   Rhim JW, 2013, PROG POLYM SCI, V38, P1629, DOI 10.1016/j.progpolymsci.2013.05.008
   Sanchez-Garcia MD, 2010, COMPOS SCI TECHNOL, V70, P1095, DOI 10.1016/j.compscitech.2010.02.015
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Shan GF, 2011, COLLOID POLYM SCI, V289, P1005, DOI 10.1007/s00396-011-2412-1
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Tan KH, 2012, INT J ELECTROCHEM SC, V7, P3765
   Vidhate S, 2012, POLYM ENG SCI, V52, P1367, DOI 10.1002/pen.23084
   Vinayan BP, 2012, J MATER CHEM, V22, P9949, DOI 10.1039/c2jm16294f
   Yang JH, 2009, MACROMOLECULES, V42, P7016, DOI 10.1021/ma901266u
   Yun SI, 2010, POLYM BULL, V64, P99, DOI 10.1007/s00289-009-0173-5
   Yun SI, 2008, POLYM BULL, V61, P267, DOI 10.1007/s00289-008-0936-4
   Zak AK, 2011, SOLID STATE SCI, V13, P251, DOI 10.1016/j.solidstatesciences.2010.11.024
   Zhang R, 2012, COMPOS PART A-APPL S, V43, P547, DOI 10.1016/j.compositesa.2012.01.005
   Zhijiang C., 2011, CURRENT APPL PHYS, V11, P247
   Ziegler KJ, 2005, J AM CHEM SOC, V127, P1541, DOI 10.1021/ja044537e
NR 50
TC 5
Z9 5
U1 1
U2 21
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-4110
EI 1687-4129
J9 J NANOMATER
JI J. Nanomater.
PY 2014
AR 264206
DI 10.1155/2014/264206
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AN2MC
UT WOS:000340418400001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Chung, RJ
   Wu, HY
AF Chung, Ren-Jei
   Wu, Huan-Yu
TI Study of C3S/Nano-HAp/Collagen Composite Bone Cement
SO CURRENT NANOSCIENCE
LA English
DT Article
DE Bone cement; collagen; in vitro study; in vivo study; nano
   hydroxyapatite particle; tricalcium silicate
ID CALCIUM-PHOSPHATE CEMENT
AB Composite bone cement composed of tricalcium silicate (Ca3SiO5, C3S), hydroxyapatite particle (nano-HAp) and collagen was prepared and investigated in this study. We synthesized C3S through a solid-state reaction and modified it by adding zinc oxide (ZnO) in order to stabilize the C3S phase during preparation. In order to achieve proper setting time and better powder characteristics, a series of different molar ratio of ZnO to CaCO3 precursors were tested. An optimized composition, Zn02.5Ca2.75SiO5, was chosen for further studies. Zn0.25Ca2.75SiO5 powder was mixed with 10 wt% NaH2PO4 solution with the liquid to powder (L/P) ratio of 2: 5. The setting time was measured to be within one hour, and the pH value maintained between 8 and 10. Furthermore, 5 wt% nano-HAp particle and 2 wt% type I collagen were mixed to comprise the composite bone cement. The set product had a compressive strength up to 85 MPa. The set materials were further tested in vitro by culturing the mouse fibroblast cell line L929. Through the cytotoxicity tests (MTT) of the extracts in medium, the results revealed that the set matter had a good biocompatibility. When the cells were directly seeded onto the material, the cells attached well and would out-stretch their pseudopodia through SEM observation. The results of in vivo test through subcutaneous implantation in rat showed that the material was well biocompatible with neovessel formation. The results indicate that this novel composite bone cement exhibits good properties and biocompatibility as well as a desirable biomaterial.
C1 [Chung, Ren-Jei; Wu, Huan-Yu] Natl Taipei Univ Technol Taipei Tech, Dept Chem Engn & Biotechnol, Taipei 10608, Taiwan.
RP Chung, RJ (reprint author), Natl Taipei Univ Technol Taipei Tech, Dept Chem Engn & Biotechnol, Taipei 10608, Taiwan.
EM rjchung@ntut.edu.tw
FU National Science Council of the Republic of China [NSC
   101-2622-E-027-026-CC3, NSC 102-2221-E-027-009]
FX The authors are grateful for the part sponsor of this research by the
   National Science Council of the Republic of China, under Grant No. NSC
   101-2622-E-027-026-CC3 and NSC 102-2221-E-027-009.
CR Cardoso DA, 2012, J BIOMED MATER RES B, V100B, P2316, DOI 10.1002/jbm.b.32794
   Chen CC, 2009, J ENDODONT, V35, P1288, DOI 10.1016/j.joen.2009.05.036
   Chung R.J., 2003, J MED BIOL ENG, V23, P199
   Dalby MJ, 2002, BIOMATERIALS, V23, P569, DOI 10.1016/S0142-9612(01)00139-9
   Ding SJ, 2009, J MATER CHEM, V19, P1183, DOI 10.1039/b819033j
   FRASER RDB, 1983, J MOL BIOL, V167, P497, DOI 10.1016/S0022-2836(83)80347-7
   Gandolfi MG, 2009, ORAL SURG ORAL MED O, V108, pE39, DOI 10.1016/j.tripleo.2009.07.039
   Ginebra MP, 2012, ADV DRUG DELIVER REV, V64, P1090, DOI 10.1016/j.addr.2012.01.008
   Hench LL, 2002, J INORG MATER, V17, P897
   Jaeblon T, 2010, J AM ACAD ORTHOP SUR, V18, P297, DOI 10.5435/00124635-201005000-00006
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   Lin JHC, 2012, J MED BIOL ENG, V32, P201, DOI [10.5405/jmbe.894, 10.5405/jmbe.889]
   Lin Q, 2011, MAT SCI ENG C-MATER, V31, P629, DOI 10.1016/j.msec.2010.11.021
   Liu-Snyder P, 2008, CURR NANOSCI, V4, P111, DOI 10.2174/157341308783591799
   Mestres G, 2012, ACTA BIOMATER, V8, P1169, DOI 10.1016/j.actbio.2011.11.021
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   O'Hara RM, 2012, ACTA BIOMATER, V8, P4043, DOI 10.1016/j.actbio.2012.07.003
   Olmo IF, 2001, CEMENT CONCRETE RES, V31, P1213
NR 18
TC 1
Z9 1
U1 2
U2 17
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4137
EI 1875-6786
J9 CURR NANOSCI
JI Curr. Nanosci.
PY 2014
VL 10
IS 2
BP 212
EP 216
DI 10.2174/1573413709666131129000945
PG 5
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics; Materials Science
GA AN0QM
UT WOS:000340289100009
DA 2018-10-20
ER

PT J
AU Shokuhfar, T
   Hamlekhan, A
   Chang, JY
   Choi, CK
   Sukotjo, C
   Friedrich, C
AF Shokuhfar, Tolou
   Hamlekhan, Azhang
   Chang, Jen-Yung
   Choi, Chang Kyoung
   Sukotjo, Cortino
   Friedrich, Craig
TI Biophysical evaluation of cells on nanotubular surfaces: the effects of
   atomic ordering and chemistry
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nanotubes; osteoblasts; titanium dioxide
ID MESENCHYMAL STEM-CELLS; IN-VITRO; TIO2 NANOTUBES; MC3T3-E1
   PREOSTEOBLAST; OSTEOBLAST ADHESION; TITANIA NANOTUBES; MODEL SURFACES;
   ATTACHMENT; CYTOSKELETAL; DIFFERENTIATION
AB After the implantation of a biomaterial in the body, the first interaction occurs between the cells in contact with the biomaterial surface. Therefore, evaluating the cell-substrate interface is crucial for designing a successful implant. In this study, the interaction of MC3T3 osteoblasts was studied on commercially pure and alloy (Ti6Al4V) Ti surfaces treated with amorphous and crystalline titanium dioxide nanotubes. The results indicated that the presence of nanotubes increased the density of osteoblast cells in comparison to bare surfaces (no nanotubes). More importantly, our finding shows that the chemistry of the substrate affects the cell density rather than the morphology of the cells. A novel approach based on the focused ion beam technique was used to investigate the biophysical cell-substrate interaction. The analysis revealed that portions of the cells migrated inside the crystalline nanotubes. This observation was correlated with the super hydrophilic properties of the crystalline nanotubes.
C1 [Shokuhfar, Tolou; Hamlekhan, Azhang; Chang, Jen-Yung; Choi, Chang Kyoung; Friedrich, Craig] Michigan Technol Univ, Dept Mech Engn Engn Mech, Multi Scale Technol Inst, Houghton, MI 49931 USA.
   [Shokuhfar, Tolou] Univ Illinois, Dept Phys, Chicago, IL 60680 USA.
   [Shokuhfar, Tolou] Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60680 USA.
   [Sukotjo, Cortino] Univ Illinois, Dept Restorat Dent, Comprehens Dent Implant Ctr, Coll Dent, Chicago, IL USA.
RP Shokuhfar, T (reprint author), Michigan Technol Univ, Dept Mech Engn Engn Mech, Multi Scale Technol Inst, 815 RL Smith Bldg,1400 Townsend Dr, Houghton, MI 49931 USA.
EM tshokuhf@mtu.edu
CR Azhang Hamlekhan AB, 2014, OPTIMIZATION ANODI S
   Bauer S, 2008, ACTA BIOMATER, V4, P1576, DOI 10.1016/j.actbio.2008.04.004
   Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h
   Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Brunette D. M., 2001, TITANIUM MED
   Butt A., 2014, J ORAL IMPLANTOL
   Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507
   Dalton BA, 1998, J BIOMAT SCI-POLYM E, V9, P781, DOI 10.1163/156856298X00154
   Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088
   Doroudian G, 2013, BIOCHEM BIOPH RES CO, V430, P1040, DOI 10.1016/j.bbrc.2012.11.120
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Ghicov A, 2009, CHEM COMMUN, P2791, DOI 10.1039/b822726h
   Gongadze E, 2013, MINI-REV MED CHEM, V13, P194
   Hamlekhan A, 2014, PLOS ONE, V9, P1
   Hazan R, 2009, J PHYS SCI, V20, P35
   Lee J, 2012, J CLIN PERIODONTOL, V39, P781, DOI 10.1111/j.1600-051X.2012.01905.x
   Leser V, 2009, J MICROSC-OXFORD, V233, P309, DOI 10.1111/j.1365-2818.2009.03121.x
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Luckey H. A, 1983, TITANIUM ALLOYS SURG
   Macak JM, 2005, J BIOMED MATER RES A, V75A, P928, DOI 10.1002/jbm.a.30501
   Massia S. P., 1999, TISSUE ENG VASCULAR
   Nourmohammadzadeh M, 2013, ANAL CHEM, V85, P11240, DOI 10.1021/ac401297v
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Patel SB, 2014, J MATER CHEM B, V2, P3597, DOI 10.1039/c3tb21731k
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Rabiee S, 2009, BIOTECHNOL BIOPROC E, V14, P1, DOI [10.1007/s12257-008-0089-1, 10.1007/S12257-008-0089-1]
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257
   Shin DH, 2011, NANOTECHNOLOGY, V22, P1
   Shinde VR, 2005, APPL SURF SCI, V245, P407, DOI 10.1016/j.apsusc.2004.10.036
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Takebe J, 2000, J BIOMED MATER RES, V51, P398, DOI 10.1002/1097-4636(20000905)51:3<398::AID-JBM14>3.0.CO;2-#
   Tami AE, 2003, BIORHEOLOGY, V40, P577
   Tan AW, 2012, CERAM INT, V38, P4421, DOI 10.1016/j.ceramint.2012.03.002
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893
   WAPNER KL, 1991, CLIN ORTHOP RELAT R, P12
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   Yu WQ, 2010, ORAL DIS, V16, P624, DOI 10.1111/j.1601-0825.2009.01643.x
NR 47
TC 26
Z9 26
U1 0
U2 11
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 3737
EP 3748
DI 10.2147/IJN.S67344
PG 12
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AM8ZT
UT WOS:000340169400001
PM 25143725
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Hu, GF
   Wang, H
   Yao, XC
   Bi, DW
   Zhu, G
   Tang, SC
   Wei, J
   Yang, LL
   Tong, PJ
   Xiao, LW
AF Hu, Gangfeng
   Wang, Hui
   Yao, Xiaocong
   Bi, Dawei
   Zhu, Gang
   Tang, Songchao
   Wei, Jie
   Yang, Lili
   Tong, Peijian
   Xiao, Luwei
TI Development of nanofluorapatite polymer-based composite for bioactive
   orthopedic implants and prostheses
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nanofluorapatite; bioactive composites; cell behavior; orthopedic
   implants
ID IN-VITRO; CALCIUM-PHOSPHATE; GLASS-CERAMICS; FLUORAPATITE; FLUORIDE;
   HYDROXYAPATITE; OSTEOBLASTS; RESPONSES; CELLS; DIFFERENTIATION
AB Fluorapatite with low solubility is a promising biomaterial due to its structure, which is similar to hydroxyapatite. In this study a bioactive composite of nanofluorapatite (n-FA) and polyamide 12 (PA12) was fabricated. The results revealed that the mechanical properties (such as compressive strength and elastic modulus), hydrophilicity, and antibacterial properties of n-FA/PA12 composite were obviously improved by adding n-FA into PA12 as compared with PA12. In addition, cell proliferation of MC3T3-E1 cells cultured on n-FA/PA12 composite was significantly higher than with PA12, and alkaline phosphatase activity of MC3T3-E1 cells on the n-FA/PA12 composite was expressed at obviously higher levels as compared with PA12. The results suggest that n-FA/PA12 composite could support cell proliferation and differentiation, showing good cytocompatibility. Histological evaluation indicates that n-FA/PA12 composite enhances the efficiency of new bone formation with the introduction of n-FA into PA12, and the quantity of the newly formed bone for n-FA/PA12 composite is significantly higher than with PA12. In conclusion, n-FA/PA12 composite exhibits good biocompatibility and osteogenesis, which might be used for various orthopedic prostheses and dental implants.
C1 [Hu, Gangfeng; Wang, Hui; Yao, Xiaocong; Bi, Dawei; Zhu, Gang] First Peoples Hosp Xiaoshang, Hangzhou 311200, Zhejiang, Peoples R China.
   [Hu, Gangfeng; Tang, Songchao; Wei, Jie] E China Univ Sci & Technol, Minist Educ, Key Lab Ultrafine Mat, Shanghai, Peoples R China.
   [Yang, Lili] Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Surg, Shanghai, Peoples R China.
   [Tong, Peijian; Xiao, Luwei] Zhejiang Tradit Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China.
RP Yao, XC (reprint author), First Peoples Hosp Xiaoshang, Shixinnan Rd 199, Hangzhou 311200, Zhejiang, Peoples R China.
EM hugf1111@163.com; biomaterbone@163.com
OI tong, peijian/0000-0003-0948-8674
FU Hangzhou Science and Technology Bureau [20110733Q30]; National Natural
   Science Foundation of China [81271705, 83171383, 51173041]; Key Medical
   Program of Science and Technology Development of Shanghai [12nm0500400,
   12441903600]; Key Projects of Basic Research of Science and Technology
   Development of Shanghai [12JC1411302]
FX The authors appreciate financial support by the Hangzhou Science and
   Technology Bureau (No. 20110733Q30), the National Natural Science
   Foundation of China (Nos. 81271705, 83171383, and 51173041), the Key
   Medical Program of Science and Technology Development of Shanghai (No.
   12nm0500400, 12441903600), and Key Projects of Basic Research of Science
   and Technology Development of Shanghai (No. 12JC1411302).
CR Azami M, 2011, CERAM INT, V37, P2007, DOI 10.1016/j.ceramint.2011.02.025
   Bandyopadhyay-Ghosh S, 2007, J BIOMED MATER RES A, V80A, P175, DOI 10.1002/jbm.a.30878
   Bhadang KA, 2010, ACTA BIOMATER, V6, P1575, DOI 10.1016/j.actbio.2009.10.029
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Brauer DS, 2010, ACTA BIOMATER, V6, P3275, DOI 10.1016/j.actbio.2010.01.043
   Breaker RR, 2012, CARIES RES, V46, P78, DOI 10.1159/000336397
   Busch S, 2001, CHEM MATER, V13, P3260, DOI 10.1021/cm0110728
   Chen YM, 2005, BIOMATERIALS, V26, P1205, DOI 10.1016/j.biomaterials.2004.04.027
   Colombo P, 2010, J AM CERAM SOC, V293, P805
   Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032
   Huang D, 2012, J R SOC INTERFACE, V9, P1450, DOI 10.1098/rsif.2011.0782
   Kansal I, 2010, J MATER CHEM, V21, P16247
   Khan AS, 2013, MAT SCI ENG C-MATER, V33, P3458, DOI 10.1016/j.msec.2013.04.029
   Kheradmanfard M, 2010, J ALLOY COMPD, V504, P41
   Kim FM, 2011, J DENT RES, V90, P1171, DOI 10.1177/0022034511418828
   Kushwaha M, 2012, DENT MATER, V28, P252, DOI 10.1016/j.dental.2011.10.010
   Li JN, 2010, BIOMATERIALS, V31, P5782, DOI 10.1016/j.biomaterials.2010.04.023
   Li JJ, 2011, CARBOHYD POLYM, V85, P885, DOI 10.1016/j.carbpol.2011.04.015
   Liu J, 2010, TISSUE ENG PT A, V16, P2977, DOI [10.1089/ten.tea.2009.0632, 10.1089/ten.TEA.2009.0632]
   Nordquist WD, 2011, J ORAL IMPLANTOL, V37, P43, DOI 10.1563/AAID-JOI-D-10-00165
   Ohno M, 2013, J ORAL IMPLANTOL, V39, P154, DOI 10.1563/AAID-JOI-D-10-00175
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Qu YL, 2010, INT J NANOMED, V5, P429
   Sahoo NG, 2013, NANOMEDICINE-UK, V8, P639, DOI [10.2217/NNM.13.44, 10.2217/nnm.13.44]
   Seong JM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/062001
   Simon P, 2005, J MATER CHEM, V15, P4992, DOI 10.1039/b504977f
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Takagi S, 2010, J RES NATL INST STAN, V115, P267
   VROUWENVELDER WCA, 1994, BIOMATERIALS, V15, P97, DOI 10.1016/0142-9612(94)90257-7
   Wang HY, 2011, ADV MATER RES-SWITZ, V306-307, P63, DOI 10.4028/www.scientific.net/AMR.306-307.63
   Yang L, 2010, BIOMATERIALS, V31, P2976, DOI 10.1016/j.biomaterials.2010.01.002
   Yoon BH, 2005, BIOMATERIALS, V26, P2957, DOI 10.1016/j.biomaterials.2004.07.062
NR 34
TC 4
Z9 4
U1 0
U2 16
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 3875
EP 3884
DI 10.2147/IJN.S65682
PG 10
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AM9AC
UT WOS:000340170500003
PM 25143735
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Maji, K
   Dasgupta, S
AF Maji, Kanchan
   Dasgupta, Sudip
TI Hydroxyapatite-Chitosan and Gelatin Based Scaffold for Bone Tissue
   Engineering
SO TRANSACTIONS OF THE INDIAN CERAMIC SOCIETY
LA English
DT Article
DE Hydroxyapatite; Chitosan; Gelatin; Composite scaffold
ID COMPOSITE; SURGERY; GROWTH
AB Bone tissue engineering, using a porous scaffold material to induce the formation of bone from the surrounding tissues has some distinct advantages over autografting and allografting, and it is a rapidly growing alternative approach to heal damaged bone tissue. The current study focuses on fabrication and characterization of hydroxyapatite and natural biopolymer composite for improved bone repair and regeneration. The porous composite scaffold containing hydroxyapatite (HAp), chitosan and gelatin having 3D network of interconnected pores with an average pore size of 150 mu m was fabricated using freeze drying method. Glutaraldehyde was used as a cross linker between chitosan and gelatin. Characteristic IR band for (-C=N-) group observed in IR study of the prepared scaffold indicated the crosslinking ability of glutaraldehyde with chitosan and gelatin. Total porosity in the scaffold varied between 60 and 70% as determined by Archimedes principle and depended on the solids loading of the scaffold. Microstructural analysis using field emission scanning electron microscopy (FESEM) showed an interconnected porous network in the scaffold where HAp nanoparticles were found to be dispersed in the biopolymer matrix. Thick bone like apatite layer deposition was observed on the surface of the scaffold on immersing it into simulated body fluid (SBF) at 37 degrees C for 7 days. The developed scaffold exhibited a compressive strength of 1.75 MPa which is close to the lower limit of compressive strength of spongy bone. These types of composite scaffolds find application as efficient biomaterial for natural bone tissue regeneration and bone tissue engineering.
C1 [Maji, Kanchan; Dasgupta, Sudip] Natl Inst Technol, Dept Ceram Engn, Rourkela, India.
RP Dasgupta, S (reprint author), Natl Inst Technol, Dept Ceram Engn, Rourkela, India.
EM dasguptas@nitrkl.ac.in
OI , kanchan/0000-0002-2362-9886
FU Department of Ceramic Engineering at NIT-Rourkela
FX The authors acknowledge the Department of Ceramic Engineering at
   NIT-Rourkela for providing necessary supports to carry out above
   research work.
CR Bigi A, 2002, J BIOMED MATER RES, V59, P709, DOI 10.1002/jbm.10045
   Cooke F W, 1992, Clin Orthop Relat Res, P135
   DAFTARI TK, 1994, SPINE, V19, P904, DOI 10.1097/00007632-199404150-00007
   Hae-Won K., 2005, J BIOMED MATER RES, V72, P136
   Itoh S, 2005, BIO-MED MATER ENG, V15, P29
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Liao SS, 2004, J BIOACT COMPAT POL, V19, P117, DOI 10.1177/0883911504042643
   Masanori K. B., 2004, BIOMATERIALS, V25, P63, DOI DOI 10.1016/S0142-9612(03)00472-1
   Mathew M, 2001, J RES NATL INST STAN, V106, P1035, DOI 10.6028/jres.106.054
   MEYER JL, 1978, CALC TISS RES, V25, P59, DOI 10.1007/BF02010752
   Myung C. C., 2003, BIOMATERIALS, V24, P2853
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Stoch A, 1999, J MOL STRUCT, V511, P287, DOI 10.1016/S0022-2860(99)00170-2
   Tai K, 2006, NANO LETT, V6, P2520, DOI 10.1021/nl061877k
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F
   Yasuda Y., 2006, J MAT T, V47, P2368
   Zhang SM, 2003, J MATER SCI-MATER M, V14, P641, DOI 10.1023/A:1024083309982
NR 22
TC 8
Z9 8
U1 2
U2 25
PU INDIAN CERAMIC SOC
PI KOLKATA
PA CENTRAL GLASS & CERAMIC RES INST, KOLKATA, 700 032, INDIA
SN 0371-750X
EI 2165-5456
J9 T INDIAN CERAM SOC
JI Trans. Indian Ceram. Soc.
PY 2014
VL 73
IS 2
SI SI
BP 110
EP 114
DI 10.1080/0371750X.2014.922424
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA AM8MJ
UT WOS:000340129400008
DA 2018-10-20
ER

PT S
AU Zahra, N
   Fayyaz, M
   Iqbal, W
   Irfan, M
   Alam, S
AF Zahra, N.
   Fayyaz, M.
   Iqbal, W.
   Irfan, M.
   Alam, S.
BE Qaisar, S
   Khan, AN
   Mukhtar, EA
TI A process for the development of strontium hydroxyapatite
SO 13TH INTERNATIONAL SYMPOSIUM ON ADVANCED MATERIALS (ISAM 2013)
SE IOP Conference Series-Materials Science and Engineering
LA English
DT Proceedings Paper
CT 13th International Symposium on Advanced Materials (ISAM)
CY SEP 23-27, 2013
CL Islamabad, PAKISTAN
SP Inst Space Technol, Amber Chem Ind Ltd, Ap Ways, Askari Bank Ltd, Engn Horizons, Forward Enterprises, Hamdard Fdn, Higher Educ Commiss, M S OVETEK, Natl Bank Pakistan, Natl Talent Pool, Pakistan Sci Fdn, Peoples Steel Mills Ltd, Profess Syst Ltd
ID TRICALCIUM PHOSPHATE; SUBSTITUTED HYDROXYAPATITE; BEHAVIOR; TEMPERATURE
AB A procedure for the preparation of Strontium Hydroxyapatite is adapted to produce high purity and better homogeneity ceramic with good Crystallinity. The strontium substituted bone cement has potential for use in orthopedic surgeries. Ionic Strontium (Sr) in humans shares the same physiological pathway as calcium and can be deposited in the mineral structure of the bone. In the present study, a novel concept of preparing Sr-contained Hydroxyapatite bone cement by using a precipitation method is proposed to get an ideal biomaterial that possesses potential degradability and more excellent pharmacological effect. Chemical analysis, Fourier Transform Infra Red analysis and Thermogravimetric/Differential Scanning Calorimetric studies were conducted on prepared Strontium Hydroxyapatite sample to characterize the incorporation of 15% Sr2+ into the crystal lattice of Hydroxyapatite. Strontium was quantitatively incorporated into Hydroxyapatite where its substitution for calcium provoked a linear shift of the infrared absorption bands of the hydroxyl and phosphate groups. Thus, the formation of Sr-HAp was confirmed by Chemical Analysis, FT-IR and TGA/DSC results.
C1 [Zahra, N.; Fayyaz, M.; Iqbal, W.; Irfan, M.; Alam, S.] Pakistan Inst Technol Minerals & Adv Engn Mat, Lahore, Pakistan.
RP Zahra, N (reprint author), Pakistan Inst Technol Minerals & Adv Engn Mat, PCSIR Labs Complex, Lahore, Pakistan.
EM naseem.zahra1981@gmail.com
CR Acchar W, 2008, MAT SCI ENG C-BIO S, V28, P248, DOI 10.1016/j.msec.2006.12.011
   Ahmed S., 2008, BANGLADESH J SCI IND, V43, P501
   Bigi Boanini E, 2007, INORG CHIM ACTA, V360, P1009
   Black R J, 1990, CLIN MAT, P251
   Boevski I., 2007, J U CHEM TECH METALL, V42, P419
   Fu Y.F., 2005, J ORAL TISSUE ENG, V2, P76
   Gibson R, 2002, J MATER SCI-MATER M, V13, P685
   Habib F, 2012, J CHEM SOC PAKISTAN, V34, P584
   Jegou Saint-Jean S., 2005, J MATER SCI-MATER M, V16, P993
   Joice T, 2009, PHYS CHEM CHEM PHYS, DOI [10.1039/b802841a, DOI 10.1039/B802841A]
   Kannan S, 2005, J SOLID STATE CHEM, V178, P3190, DOI 10.1016/j.jssc.2005.08.003
   Kim HW, 2004, J MATER SCI-MATER M, V15, P1129, DOI 10.1023/B:JMSM.0000046395.76435.60
   Kim TG, 2005, INORG CHEM, V44, P9895, DOI 10.1021/ic051013m
   Komarneni S, 2002, PURE APPL CHEM, V74, P1537, DOI 10.1351/pac200274091537
   Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y
   Landi E, 2006, J EUR CERAM SOC, V26, P2593, DOI 10.1016/j.jeurceramsoc.2005.06.040
   Lazic S, 2001, THERMOCHIM ACTA, V374, P13, DOI 10.1016/S0040-6031(01)00453-1
   LeGeros R Z, 1993, INTRO BIOCERMAICS DE
   Li MO, 2008, J MATER SCI-MATER M, V19, P797, DOI 10.1007/s10856-007-3213-4
   Ozturk M, 2009, IRAN J ENVIRON HEALT, V6, P73
   Paul W, 2006, AM J BIOCH BIOTECHNO, V2, P41, DOI DOI 10.3844/AJBBSP.2006.41.48
   Prokopiev O, 2006, MAT SCI ENG A-STRUCT, V431, P218, DOI 10.1016/j.msea.2006.05.158
   Ryu HS, 2006, J MATER RES, V21, P428, DOI 10.1557/JMR.2006.0049
   Simon V, 2005, J OPTOELECTRON ADV M, V7, P2823
   Vogel I. R., 1961, TXB QUANTITATIVE INO
   Xu W, 2006, MATER LETT, V60, P1575, DOI 10.1016/j.matlet.2005.11.072
NR 26
TC 1
Z9 1
U1 0
U2 10
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1757-8981
J9 IOP CONF SER-MAT SCI
PY 2014
VL 60
AR 012056
DI 10.1088/1757-899X/60/1/012056
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BA9MV
UT WOS:000339568300056
OA Other Gold
DA 2018-10-20
ER

PT S
AU Rahmanian, R
   Moghaddam, NS
   Haberland, C
   Dean, D
   Miller, M
   Elahinia, M
AF Rahmanian, Rasool
   Moghaddam, Narges Shayesteh
   Haberland, Christoph
   Dean, David
   Miller, Michael
   Elahinia, Mohammad
BE Goulbourne, NC
   Naguib, HE
TI Load Bearing and Stiffness Tailored NiTi Implants Produced by Additive
   Manufacturing: A Simulation Study
SO BEHAVIOR AND MECHANICS OF MULTIFUNCTIONAL MATERIALS AND COMPOSITES 2014
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Behavior and Mechanics of Multifunctional Materials and
   Composites
CY MAR 10-12, 2014
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers
DE Porous NiTi; Modeling
ID SHAPE-MEMORY ALLOY; POROUS NITI; IN-VIVO; BONE; BIOCOMPATIBILITY;
   FABRICATION; DIFFUSION; POROSITY; MODEL
AB Common metals for stable long-term implants (e.g. stainless steel, Titanium and Titanium alloys) are much stiffer than spongy cancellous and even stiffer than cortical bone. When bone and implant are loaded this stiffness mismatch results in stress shielding and as a consequence, degradation of surrounding bony structure can lead to disassociation of the implant. Due to its lower stiffness and high reversible deformability, which is associated with the superelastic behavior, NiTi is an attractive biomaterial for load bearing implants. However, the stiffness of austenitic Nitinol is closer to that of bone but still too high. Additive manufacturing provides, in addition to the fabrication of patient specific implants, the ability to solve the stiffness mismatch by adding engineered porosity to the implant. This in turn allows for the design of different stiffness profiles in one implant tailored to the physiological load conditions. This work covers a fundamental approach to bring this vision to reality. At first modeling of the mechanical behavior of different scaffold designs are presented as a proof of concept of stiffness tailoring. Based on these results different Nitinol scaffolds can be produced by additive manufacturing.
C1 [Rahmanian, Rasool; Moghaddam, Narges Shayesteh; Haberland, Christoph; Elahinia, Mohammad] Univ Toledo, 2801 W Bancroft St,MS 312, Toledo, OH 43606 USA.
   [Rahmanian, Rasool; Moghaddam, Narges Shayesteh; Haberland, Christoph; Elahinia, Mohammad] Ohio State Univ, Dept Plast Surg, Columbus, OH 43212 USA.
RP Rahmanian, R (reprint author), Univ Toledo, 2801 W Bancroft St,MS 312, Toledo, OH 43606 USA.
EM rasool.rahmanian@gmail.com
CR Bahraminasab M, 2012, MATER DESIGN, V42, P459, DOI 10.1016/j.matdes.2012.05.046
   Bansiddhi A, 2008, ACTA BIOMATER, V4, P773, DOI 10.1016/j.actbio.2008.02.009
   Boyd JG, 1996, INT J PLASTICITY, V12, P805, DOI 10.1016/S0749-6419(96)00030-7
   Chu CL, 2004, MAT SCI ENG A-STRUCT, V366, P114, DOI 10.1016/j.msea.2003.08.118
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Elahinia MH, 2012, PROG MATER SCI, V57, P911, DOI 10.1016/j.pmatsci.2011.11.001
   Gepreel MAH, 2013, J MECH BEHAV BIOMED, V20, P407, DOI 10.1016/j.jmbbm.2012.11.014
   Gjunter V., 1995, SUPERELASTIC SHAPE M, P15
   Greiner C, 2005, ACTA BIOMATER, V1, P705, DOI 10.1016/j.actbio.2005.07.005
   Huang HH, 2003, BIOMATERIALS, V24, P3585, DOI 10.1016/S0142-9612(03)00188-1
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008
   Li BY, 1999, SCI CHINA SER E, V42, P94, DOI 10.1007/BF02917064
   Li H, 2011, J BIOMED MATER RES A, V99A, P544, DOI 10.1002/jbm.a.33198
   Li YH, 2002, MATER LETT, V57, P448, DOI 10.1016/S0167-577X(02)00809-1
   Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Neurohr AJ, 2011, ACTA BIOMATER, V7, P1862, DOI 10.1016/j.actbio.2010.11.038
   Qidwai MA, 2000, INT J NUMER METH ENG, V47, P1123, DOI 10.1002/(SICI)1097-0207(20000228)47:6<1123::AID-NME817>3.0.CO;2-N
   Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   VANRIETBERGEN B, 1993, J BIOMECH, V26, P369, DOI 10.1016/0021-9290(93)90001-U
   Yousaf MN, 2001, P NATL ACAD SCI USA, V98, P5992, DOI 10.1073/pnas.101112898
   Zhu SL, 2008, MAT SCI ENG C-BIO S, V28, P1271, DOI 10.1016/j.msec.2007.11.010
NR 25
TC 3
Z9 3
U1 3
U2 24
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9984-4
J9 PROC SPIE
PY 2014
VL 9058
AR UNSP 905814
DI 10.1117/12.2048948
PG 8
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA BA9EZ
UT WOS:000339327700026
DA 2018-10-20
ER

PT S
AU Luo, L
   Jiang, ZY
   Wei, DB
   He, XF
AF Luo, Liang
   Jiang, Zhengyi
   Wei, Dongbin
   He, Xiaofeng
BE Jiang, Z
   Han, J
TI Surface Modification of Titanium and Its Alloys for Biomedical
   Application
SO ADVANCES IN MATERIALS AND MATERIALS PROCESSING IV, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 4th International Conference on Advances in Materials and Manufacturing
   (ICAMMP 2013)
CY DEC 18-19, 2013
CL Kunming, PEOPLES R CHINA
SP Univ Wollongong, NE Univ, Univ Sci & Technol Beijing, Hong Kong Ind Res Inst
DE Surface modification; Titanium; Titanium alloy; Medical engineering
ID MECHANICAL-PROPERTIES; DIAMOND FILMS; TI IMPLANTS; BIOMATERIALS;
   ROUGHNESS
AB Titanium and its alloys have excellent properties and are promising biomaterial in medical engineering field. A bioactive surface on a Ti substrate is a prerequisite for great performance and long service life of implants. Based on the mechanism for inducing cell/tissue responses, three kinds of methods, namely morphological, physicochemical and biochemical methods, are reviewed in this paper. Hybrid methods that integrate individual methods or have additional functions are also discussed.
C1 [Luo, Liang; Jiang, Zhengyi] Univ Wollongong, Wollongong, NSW 2522, Australia.
   [Wei, Dongbin] Univ Technol, Sydney, NSW 2007, Australia.
   [He, Xiaofeng] Huzhong Univ Sci & Technol, Wuhan 430074, Peoples R China.
RP Luo, L (reprint author), Univ Wollongong, Wollongong, NSW 2522, Australia.
EM ll895@uowmail.edu.au; jiang@uow.edu.au; Dongbin.Wei@uts.edu.au;
   hexiaofeng_hust@163.com
FU China Scholarships Council and International Postgraduate Tuition Award
   (IPTA) [201206160011]; University of Wollongong
FX The research is supported by the CSC scholarship (201206160011) from
   China Scholarships Council and International Postgraduate Tuition Award
   (IPTA) from University of Wollongong.
CR Amjad Z., 1998, CALCIUM PHOSPHATES B
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   ASM International, 2009, MAT COAT MED DEV CAR
   Assender H, 2002, SCIENCE, V297, P973, DOI 10.1126/science.1074955
   Bandyopadhyay A, 2010, ACTA BIOMATER, V6, P1640, DOI 10.1016/j.actbio.2009.11.011
   Chandra L, 1996, DIAM RELAT MATER, V5, P674, DOI 10.1016/0925-9635(95)00431-9
   Coelho TM, 2007, J APPL PHYS, V101, DOI 10.1063/1.2718866
   de Jonge LT, 2008, PHARM RES-DORDR, V25, P2357, DOI 10.1007/s11095-008-9617-0
   Donachie J. M. J., 2000, TITANIUM TECHNICAL G
   Han CM, 2011, THIN SOLID FILMS, V519, P8074, DOI 10.1016/j.tsf.2011.06.013
   Kakehi S., 2006, J ORAL TISSUE ENG, V4, P77
   Krischok S, 2007, SURF SCI, V601, P3856, DOI 10.1016/j.susc.2007.04.060
   Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008
   Lee SH, 2006, J BIOMATER APPL, V20, P195, DOI 10.1177/0885328206050518
   Liu A., 2005, PREPARATION NANOHYDR
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Silva TSN, 2009, ACTA CIR BRAS, V24, P200, DOI 10.1590/S0102-86502009000300007
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Qi L, 2007, MATER LETT, V61, P2191, DOI 10.1016/j.matlet.2006.08.076
   Rats D, 1995, THIN SOLID FILMS, V270, P177, DOI 10.1016/0040-6090(95)06913-5
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Santos E, 2007, MATER CHEM PHYS, V102, P92, DOI 10.1016/j.matchemphys.2006.11.010
   Xia W, 2012, J BIOMED MATER RES B, V100B, P82, DOI 10.1002/jbm.b.31925
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Zhang YM, 2004, J BIOMED MATER RES A, V68A, P383, DOI 10.1002/jbm.a.20063
   Zhong ZY, 2000, ADV MATER, V12, P206, DOI 10.1002/(SICI)1521-4095(200002)12:3<206::AID-ADMA206>3.0.CO;2-5
   Zou L.M., 2011, MAT REV, P82
NR 27
TC 2
Z9 2
U1 0
U2 17
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03835-014-9
J9 ADV MATER RES-SWITZ
PY 2014
VL 887-888
BP 1115
EP +
DI 10.4028/www.scientific.net/AMR.887-888.1115
PG 3
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BA8YW
UT WOS:000339036900224
DA 2018-10-20
ER

PT S
AU Malathi, S
   Hegde, G
   Srinivas, T
   Roy, UM
AF Malathi, S.
   Hegde, Gopalkrishna
   Srinivas, T.
   Roy, Ugra Mohan
BE Sirisoonthorn, S
TI Analysis of an Integrated Optic Micro Racetrack Resonator based
   Biosensor
SO INTERNATIONAL CONFERENCE ON EXPERIMENTAL MECHANICS 2013 AND TWELFTH
   ASIAN CONFERENCE ON EXPERIMENTAL MECHANICS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT International Conference on Experimental*
CY NOV 25-27, 2013
CL Bangkok, THAILAND
SP Natl Met Mat Technol Ctr, Natl Sci Technol Dev Agency, Minist Sci Technol, Chulalongkorn Univ, King Mongkuts Univ Technol North Bangkok, King Mongkuts Univ Technol Thonburi, Suranaree Univ Technol, Thammasat Univ, Asian Soc Expt Mech, Japan Soc Expt Mech, Opt Photon Soc Singapore, Soc Expt Mech
DE Integrated Optics; Micro Racetrack Resonator; Biosensor; Coupling -
   coefficient
AB Silicon-On- Insulator (SOI) technology has huge potential in fabricating compact devices for various applications such as integrated optic waveguides, directional couplers, resonators etc. In this work, we present the analysis of a biosensor based on an integrated optic racetrack resonator, interrogated by a bus waveguide. The biomaterial is applied as a cladding layer. Here we analyze the coupling between the resonator and the bus waveguide, and its dependence on the bio layer. In traditional analysis, the effective refractive index and resonator total path length are the factors influencing the resonant wavelength. Our analysis shows that all parametric values decrease with increase in waveguide width and spacing. The inclusion of waveguide mode overlap and perturbation in coupled mode equation results in enhanced resonator sensitivity of an order of magnitude
C1 [Malathi, S.; Roy, Ugra Mohan] MS Ramaiah Sch Adv Studies, Peenya Ind Area, Bangalore 560058, Karnataka, India.
   [Hegde, Gopalkrishna] Indian Inst Sci, Ctr Nano Sci & Engn, Bangalore 560012, Karnataka, India.
   [Srinivas, T.] Indian Inst Sci, Dept Elect Commun Engn, Bangalore 560012, Karnataka, India.
RP Malathi, S (reprint author), MS Ramaiah Sch Adv Studies, Peenya Ind Area, Bangalore 560058, Karnataka, India.
EM malathi@msrsas.org
CR de Vos K., 2010, THESIS GHENT U
   Guo Wei, 2012, OPTICS COMMUNICATION
   Haus Hermann H., 1991, P IEEE, V79
   HUNSPERGER RG, 1977, APPL OPTICS, V16, P1026, DOI 10.1364/AO.16.001026
   Liu Ye, 2005, OPTICAL ENG, V44
NR 5
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-1-62841-288-8
J9 PROC SPIE
PY 2014
VL 9234
AR UNSP 923410
DI 10.1117/12.2049043
PG 4
WC Engineering, Mechanical; Mechanics; Optics
SC Engineering; Mechanics; Optics
GA BA8WO
UT WOS:000338923500035
DA 2018-10-20
ER

PT J
AU Dwivedi, P
   Bhat, S
   Nayak, V
   Kumar, A
AF Dwivedi, Priyanka
   Bhat, Sumrita
   Nayak, Vijayashree
   Kumar, Ashok
TI Study of Different Delivery Modes of Chondroitin Sulfate Using
   Microspheres and Cryogel Scaffold for Application in Cartilage Tissue
   Engineering
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS
LA English
DT Article
DE Cartilage tissue engineering; chondroitin sulfate; cryogels; delivery
   mode; microspheres
ID HUMAN ARTICULAR CHONDROCYTES; AGAROSE-GELATIN CRYOGELS; IN-VITRO;
   MECHANICAL-PROPERTIES; MATRIX ELASTICITY; GROWTH; BIOMATERIAL; CELLS;
   HYALURONAN; HYDROGEL
AB This study focuses on the development of an efficient delivery modes designed for chondroitin sulfate (CS) for application in cartilage tissue engineering. Novel three -dimensional (3-D) scaffold fabricated from natural polymers such as chitosan and gelatin blended with chondroitin sulfate (CGC) were synthesized using cryogelation technology. Other methods to deliver CS were also tried, which included incorporation into microparticles for sustained release and embedding the CS loaded microparticles in CG (chitosan-gelatin) cryogel scaffold. Novel CGC scaffolds were characterized by rheology, scanning electron microscopy (SEM), and mechanical assay. Scaffolds exhibited compression modulus of 50 KPa confirming the utility of these scaffolds for cartilage tissue engineering. Primary goat chondrocytes were used for the in vitro testing of all the delivery modes. So this study shows that CS microparticles when given freely with matrix (chitosan -gelatin) or embedded into scaffold has potential to enhance chondrocyte proliferation together with improved matrix production than in control without microspheres.
C1 [Dwivedi, Priyanka; Nayak, Vijayashree] Birla Inst Technol, Dept Biol Sci, Pilani, Rajasthan, India.
   [Bhat, Sumrita; Kumar, Ashok] Indian Inst Technol Kanpur, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
RP Kumar, A (reprint author), Indian Inst Technol Kanpur, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
EM ashokkum@iitk.ac.in
RI Kumar, Ashok/G-8515-2015
FU Department of Biotechnology (DBT), Ministry of Science and Technology;
   Board of Research in Nuclear Sciences (BRNS), Government of India,
   Department of Atomic Energy (DAE)
FX The authors acknowledge the financial support from Department of
   Biotechnology (DBT), Ministry of Science and Technology, Board of
   Research in Nuclear Sciences (BRNS), Government of India, Department of
   Atomic Energy (DAE).
CR Amrutkar JR, 2009, AAPS PHARMSCITECH, V10, P670, DOI 10.1208/s12249-009-9253-y
   ASTON JE, 1986, J BONE JOINT SURG BR, V68, P29
   Austin K., 2007, MMG 445 BASIC BIOTEC, V3, P62
   Baeurle SA, 2009, POLYMER, V50, P1805, DOI 10.1016/j.polymer.2009.01.066
   Banerjee I, 2009, INT J BIOMATER, DOI 10.1155/2009/143659
   BASSLEER C, 1992, INT J TISSUE REACT, V14, P231
   Bhat S, 2013, MACROMOL BIOSCI, V13, P827, DOI 10.1002/mabi.201200484
   Bhat S, 2011, J R SOC INTERFACE, V8, P540, DOI 10.1098/rsif.2010.0455
   Brown KE, 1998, ARTHRITIS RHEUM, V41, P2185, DOI 10.1002/1529-0131(199812)41:12<2185::AID-ART13>3.3.CO;2-3
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Cai DZ, 2007, CHINESE MED J-PEKING, V120, P197
   Choi SM, 2013, INT J POLYM MATER PO, V62, P384, DOI 10.1080/00914037.2012.710862
   CONTE A, 1995, ARZNEIMITTEL-FORSCH, V45-2, P918
   Davis HE, 2011, ANN BIOMED ENG, V39, P1, DOI 10.1007/s10439-010-0135-y
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Goodstone NJ, 2004, TISSUE ENG, V10, P621, DOI 10.1089/107632704323061979
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Hedaoo RK, 2013, POLYM-PLAST TECHNOL, V52, P243, DOI 10.1080/03602559.2012.745555
   Henrotin Y, 2010, THER ADV MUSCULOSKEL, V2, P335, DOI 10.1177/1759720X10383076
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Imada K, 2010, BIOL PHARM BULL, V33, P410, DOI 10.1248/bpb.33.410
   Ingavle GC, 2012, J MATER SCI-MATER M, V23, P157, DOI 10.1007/s10856-011-4499-9
   Jain E, 2009, J MATER SCI-MATER M, V20, P173, DOI 10.1007/s10856-008-3504-4
   Jayan S, 2009, HYGIEA, V1, P17
   Jiang T, 2011, J BIOMED MATER RES B, V97B, P355, DOI 10.1002/jbm.b.31822
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Kim K. K., 2006, MICROSPHERES DRUG DE
   Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020
   KO CS, 2007, J MED BIOL ENG, V27, P7
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Li JS, 2005, J BIOMATER APPL, V19, P253, DOI 10.1177/0885328205047219
   Liu Y, 2013, POLYM-PLAST TECHNOL, V52, P1154, DOI 10.1080/03602559.2013.798818
   Machado CB, 2007, BIOMED MATER, V2, P124, DOI 10.1088/1748-6041/2/2/010
   Mahmood TA, 2004, EXP CELL RES, V301, P179, DOI 10.1016/j.yexcr.2004.07.027
   Maxwell AS, 2014, INT J POLYM MATER PO, V63, P123, DOI 10.1080/00914037.2013.769257
   Minas T, 1997, ORTHOPEDICS, V20, P525
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Nair R., 2011, J PHARM SCI TECHNOL, V3, P563
   OBEID EMH, 1994, J BONE JOINT SURG BR, V76B, P315
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Ruffell B, 2011, J BIOL CHEM, V286, P19179, DOI 10.1074/jbc.M110.200790
   Salmah H, 2012, POLYM-PLAST TECHNOL, V51, P86, DOI 10.1080/03602559.2011.618156
   Schuh E, 2010, TISSUE ENG PT A, V16, P1281, DOI [10.1089/ten.tea.2009.0614, 10.1089/ten.TEA.2009.0614]
   SCHWARTZ NB, 1975, CONNECT TISSUE RES, V3, P115, DOI 10.3109/03008207509152169
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Singh D, 2013, INT J BIOL SCI, V9, P521, DOI 10.7150/ijbs.4962
   Singh D, 2010, INT J BIOL SCI, V6, P371
   Srivastava A, 2007, MAT SCI ENG A-STRUCT, V464, P93, DOI 10.1016/j.msea.2007.03.057
   Stuart K, 2008, BIOPOLYMERS, V89, P841, DOI 10.1002/bip.21024
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Swamy BY, 2013, INT J POLYM MATER PO, V62, P700, DOI 10.1080/00914037.2013.769229
   Tan HP, 2009, ACTA BIOMATER, V5, P328, DOI 10.1016/j.actbio.2008.07.030
   Tripathi A, 2011, MACROMOL BIOSCI, V11, P22, DOI 10.1002/mabi.201000286
   Tripathi A, 2009, J BIOMED MATER RES A, V90A, P680, DOI 10.1002/jbm.a.32127
   Uebelhart D, 2008, OSTEOARTHR CARTILAGE, V16, pS19, DOI 10.1016/j.joca.2008.06.006
   Vishnoi T, 2013, J MATER SCI-MATER M, V24, P447, DOI 10.1007/s10856-012-4795-z
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   WISSEMANN KW, 1985, IN VITRO CELL DEV B, V21, P391
   Wu CH, 2010, J MATER SCI-MATER M, V21, P725, DOI 10.1007/s10856-009-3889-8
   Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289
   Zhang JX, 2007, AM J CHINESE MED, V35, P183, DOI 10.1142/S0192415X07004722
NR 64
TC 6
Z9 6
U1 1
U2 22
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0091-4037
EI 1563-535X
J9 INT J POLYM MATER PO
JI Int. J. Polym. Mater. Polym. Biomat.
PY 2014
VL 63
IS 16
BP 859
EP 872
DI 10.1080/00914037.2014.886223
PG 14
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA AL2XK
UT WOS:000338988700007
DA 2018-10-20
ER

PT J
AU Langowska, K
   Kowal, J
   Palivan, CG
   Meier, W
AF Langowska, Karolina
   Kowal, Justyna
   Palivan, Cornelia G.
   Meier, Wolfgang
TI A general strategy for creating self-defending surfaces for controlled
   drug production for long periods of time
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID PROTEIN-POLYMER NANOREACTORS; TRIBLOCK COPOLYMER VESICLES; MEDICAL
   APPLICATIONS; COVALENT ATTACHMENT; REDUCTIVE AMINATION; BACTERIAL
   ADHESION; BONE-CEMENT; THERAPY; BIOMATERIAL; INFECTION
AB Infections associated with bacterial adhesion and subsequent biofilm formation constitute a grave medical issue for which conventional antibiotic therapies remain ineffective. Here, we introduce a new strategy employing nanotechnology to create smart surfaces with self-defending properties that result in controlled drug production and controlled release for long periods of time. Self-defending surfaces on solid supports are prepared by immobilizing polymer nanoreactors containing an encapsulated biocatalyst that can convert non-antibiotic substrates to an abiotic drug. For medical applications and biosensing, the immobilization method must fulfill specific criteria, and these were achieved by an immobilization strategy based on Schiff base formation between aldehyde groups on the outer surface of nanoreactors and amino groups on the solid support surface, followed by reductive amination. The resulting self-defending surfaces allow control of drug production at a specific rate for a specific period of time by adding predetermined amounts of substrate to the outer medium, minimization of dosages and therefore systemic toxicity, and limitation of the immune response. Such self-defending surfaces producing drugs offer a versatile strategy for the development of smart surfaces with improved stability and efficacy (by changing the biocatalyst) to serve as biosensors, antifouling surfaces, or smart packages.
C1 [Langowska, Karolina; Kowal, Justyna; Palivan, Cornelia G.; Meier, Wolfgang] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
RP Meier, W (reprint author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.
EM wolfgang.meier@unibas.ch
FU Swiss National Science Foundation; National Research Program 62;
   University of Basel
FX We acknowledge the Swiss National Science Foundation, National Research
   Program 62 and the University of Basel for financial support. KL thanks
   B. Steeb from Biozentrum, University of Basel for providing E. coli XL
   Gold cells, and E. Bieler from the Zentrum fur Mikroskopie, University
   of Basel (ZMB) for TEM measurements. Experimental assistance from G.
   Persy and D. Vasquez from the University of Basel is gratefully
   acknowledged. We thank Dr B.A. Goodman for editing the manuscript. R.
   Pfalzberger is gratefully acknowledged for the artwork.
CR Arlett JL, 2011, NAT NANOTECHNOL, V6, P203, DOI 10.1038/nnano.2011.44
   Bohmler J, 2011, J PHYS CHEM C, V115, P11102, DOI 10.1021/jp201377n
   Broz P, 2005, J CONTROL RELEASE, V102, P475, DOI 10.1016/j.jconrel.2004.10.014
   BUNETEL L, 1989, CLIN PHARMACOKINET, V17, P291, DOI 10.2165/00003088-198917040-00006
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dathe M, 2001, FEBS LETT, V501, P146, DOI 10.1016/S0014-5793(01)02648-5
   De Hoog HPM, 2010, NANOSCALE, V2, P709, DOI 10.1039/b9nr00325h
   De Oliveira H, 2012, WIRES NANOMED NANOBI, V4, P525, DOI 10.1002/wnan.1183
   De Vocht C, 2009, J CONTROL RELEASE, V137, P246, DOI 10.1016/j.jconrel.2009.03.020
   DESS DB, 1983, J ORG CHEM, V48, P4155, DOI 10.1021/jo00170a070
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Dobrunz D, 2012, LANGMUIR, V28, P15889, DOI 10.1021/la302724m
   Domes S, 2010, LANGMUIR, V26, P6927, DOI 10.1021/la904175u
   Egli S, 2011, J AM CHEM SOC, V133, P4476, DOI 10.1021/ja110275f
   El-Harouny MA, 2010, ANDROLOGIA, V42, P92, DOI 10.1111/j.1439-0272.2009.00961.x
   Friedman R. J., 2000, HDB BACTERIAL ADHESI
   Graff A, 2010, MACROMOL CHEM PHYS, V211, P229, DOI 10.1002/macp.200900517
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Grzelakowski M, 2009, SMALL, V5, P2545, DOI 10.1002/smll.200900603
   Gunawan P, 2011, ACS NANO, V5, P10033, DOI 10.1021/nn2038725
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   Huang NP, 2002, LANGMUIR, V18, P252, DOI 10.1021/la0109563
   Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002
   Kaper HJ, 2003, J BIOMAT SCI-POLYM E, V14, P313, DOI 10.1163/156856203321478847
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kim KT, 2010, NANOSCALE, V2, P844, DOI 10.1039/b9nr00409b
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   Konradi R, 2008, LANGMUIR, V24, P613, DOI 10.1021/la702917z
   Langowska K, 2013, CHEM COMMUN, V49, P128, DOI 10.1039/c2cc36345c
   Li F, 2008, LANGMUIR, V24, P76, DOI 10.1021/la702546b
   Li SL, 2004, LANGMUIR, V20, P7917, DOI 10.1021/la049035t
   LoPresti C, 2009, J MATER CHEM, V19, P3576, DOI 10.1039/b818869f
   Minelli EB, 2011, ANAEROBE, V17, P380, DOI 10.1016/j.anaerobe.2011.03.013
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   Najer A, 2013, NANOMEDICINE-UK, V8, P425, DOI [10.2217/NNM.13.11, 10.2217/nnm.13.11]
   Nardin C, 2000, CHEM COMMUN, P1433, DOI 10.1039/b004280n
   Nardin C, 2000, LANGMUIR, V16, P1035, DOI 10.1021/la990951u
   Ofek I, 2003, FEMS IMMUNOL MED MIC, V38, P181, DOI 10.1016/S0928-8244(03)00228-1
   Ohm C, 2012, J MATER CHEM, V22, P19343, DOI 10.1039/c2jm90126a
   Palivan CG, 2012, CHEM SOC REV, V41, P2800, DOI 10.1039/c1cs15240h
   Pallarola D, 2010, LANGMUIR, V26, P13684, DOI 10.1021/la100486g
   Penner MJ, 1999, J ARTHROPLASTY, V14, P209, DOI 10.1016/S0883-5403(99)90128-6
   Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1016/S0378-1097(98)00151-7
   Rakhmatullina E, 2008, LANGMUIR, V24, P6254, DOI 10.1021/la8003068
   Ranquin A, 2005, NANO LETT, V5, P2220, DOI 10.1021/nl051523d
   Ruhaak LR, 2010, PROTEOMICS, V10, P2330, DOI 10.1002/pmic.200900804
   Sato S, 2004, TETRAHEDRON, V60, P7899, DOI 10.1016/j.tet.2004.06.045
   Schnitzler T, 2012, ACCOUNTS CHEM RES, V45, P1419, DOI 10.1021/ar200211a
   Simons H, 1999, BIOTECHNOL TECH, V13, P365, DOI 10.1023/A:1008975600792
   Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007
   Speicher A, 1996, J PRAK CHEM-CHEM ZTG, V338, P588, DOI 10.1002/prac.199633801112
   Staples JK, 2012, CHEM SCI, V3, P3387, DOI 10.1039/c2sc20729j
   Tanner P, 2013, NANO LETT, V13, P2875, DOI 10.1021/nl401215n
   van Dongen SFM, 2009, CHEM-EUR J, V15, P1107, DOI 10.1002/chem.200802114
   Vecitis CD, 2010, ACS NANO, V4, P5471, DOI 10.1021/nn101558x
   Vorndran E, 2012, J BIOMATER APPL, V26, P581, DOI 10.1177/0885328210376996
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Xie D, 2007, CHEM-EUR J, V13, P3346, DOI 10.1002/chem.200601361
   Yang M, 2005, J AM CHEM SOC, V127, P15107, DOI 10.1021/ja052713t
   Zhang XY, 2012, J POLYM SCI POL CHEM, V50, P2293, DOI 10.1002/pola.26000
NR 64
TC 19
Z9 19
U1 2
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 29
BP 4684
EP 4693
DI 10.1039/c4tb00277f
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AL3DC
UT WOS:000339004600010
DA 2018-10-20
ER

PT J
AU Novotny, J
   Yurenko, YP
   Kulhanek, P
   Marek, R
AF Novotny, Jan
   Yurenko, Yevgen P.
   Kulhanek, Petr
   Marek, Radek
TI Tailoring the properties of quadruplex nucleobases for biological and
   nanomaterial applications
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID BASIS-SETS; GUANINE QUARTETS; NUCLEIC-ACIDS; FORCE-FIELD; DNA; ENERGY;
   HYDRATION; DENSITY; MODEL; SUBSTITUTION
AB Guanine DNA quadruplexes are interesting and important biological objects because they represent potential targets for regulatory drugs. Their use as building blocks for biomaterial applications is also being investigated. This contribution reports the in silico design of artificial building blocks derived from xanthine. Methods of quantum chemistry were used to evaluate the properties of xanthine structures relative to those containing guanine, the natural reference used. Tailoring the xanthine core showed that the base stacking and the ion coordination were significantly enhanced in the designed systems, while the ion-transport properties were not affected. Our study suggests that the 9-deaza-8-haloxanthine bases (where the halogen is fluorine or chlorine) are highly promising candidates for the development of artificial quadruplexes and quadruplex-active ligands.
C1 [Novotny, Jan; Yurenko, Yevgen P.; Kulhanek, Petr; Marek, Radek] Masaryk Univ, CEITEC Cent European Inst Technol, CZ-62500 Brno, Czech Republic.
   [Novotny, Jan; Kulhanek, Petr; Marek, Radek] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, CZ-62500 Brno, Czech Republic.
   [Marek, Radek] Masaryk Univ, Fac Sci, Dept Chem, CZ-62500 Brno, Czech Republic.
RP Marek, R (reprint author), Masaryk Univ, CEITEC Cent European Inst Technol, Kamenice 5-A4, CZ-62500 Brno, Czech Republic.
EM rmarek@chemi.muni.cz
RI Yurenko, Yevgen/I-8022-2012; Novotny, Jan/D-7676-2012; Marek,
   Radek/D-6929-2012; Kulhanek, Petr/D-6884-2012
OI Yurenko, Yevgen/0000-0003-3925-0384; Novotny, Jan/0000-0002-1203-9549;
   Marek, Radek/0000-0002-3668-3523; Kulhanek, Petr/0000-0002-4152-6514
FU project "CEITEC - the Central European Institute of Technology" from the
   European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; program
   Center CERIT Scientific Cloud part of the Operational Program Research
   and Development for Innovations [CZ. 1.05/3.2.00/08.0144]
FX This work was supported by the project "CEITEC - the Central European
   Institute of Technology" (CZ.1.05/1.1.00/02.0068) from the European
   Regional Development Fund. Access to the CERIT-SC computing and storage
   facilities provided under the program Center CERIT Scientific Cloud,
   part of the Operational Program Research and Development for
   Innovations, reg. no. CZ. 1.05/3.2.00/08.0144 is highly appreciated.
CR AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8
   Alberti P, 2006, ORG BIOMOL CHEM, V4, P3383, DOI 10.1039/b605739j
   Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428
   BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098
   Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]
   Case DA, 2010, AMBER 11
   Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589
   EICHKORN K, 1995, CHEM PHYS LETT, V240, P283, DOI 10.1016/0009-2614(95)00621-A
   Gray RD, 2012, METHODS, V57, P47, DOI 10.1016/j.ymeth.2012.04.006
   Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495
   Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344
   Guerra CF, 2011, CHEM-EUR J, V17, P12612, DOI 10.1002/chem.201102234
   Haudecoeur R, 2013, J AM CHEM SOC, V135, P550, DOI 10.1021/ja310056y
   Hud NV, 1996, BIOCHEMISTRY-US, V35, P15383, DOI 10.1021/bi9620565
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614
   Kaucher MS, 2006, J AM CHEM SOC, V128, P38, DOI 10.1021/ja056888e
   Kaushik M, 2011, CURR MOL MED, V11, P744, DOI 10.2174/156652411798062421
   KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799
   Largy E, 2013, GUANINE QUARTETS: STRUCTURE AND APPLICATION, P248, DOI 10.1039/9781849736954-00248
   Lech CJ, 2013, NUCLEIC ACIDS RES, V41, P2034, DOI 10.1093/nar/gks1110
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Lutz PB, 2013, PHYS CHEM CHEM PHYS, V15, P9397, DOI 10.1039/c3cp51077h
   MARCUS Y, 1991, J CHEM SOC FARADAY T, V87, P2995, DOI 10.1039/ft9918702995
   Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n
   Nikan M, 2009, J ORG CHEM, V74, P5211, DOI 10.1021/jo9001245
   Novotny J, 2012, J PHYS CHEM LETT, V3, P1788, DOI 10.1021/jz300559w
   Paragi G, 2013, GUANINE QUARTETS: STRUCTURE AND APPLICATION, P179, DOI 10.1039/9781849736954-00179
   Parkinson GN, 2013, GUANINE QUARTETS: STRUCTURE AND APPLICATION, P237, DOI 10.1039/9781849736954-00237
   Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782
   PINNAVAIA TJ, 1978, J AM CHEM SOC, V100, P3625, DOI 10.1021/ja00479a070
   SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204
   Spindler L, 2013, GUANINE QUARTETS: STRUCTURE AND APPLICATION, pV, DOI 10.1039/9781849736954-FP005
   Sproviero M, 2014, CHEM SCI, V5, P788, DOI 10.1039/c3sc52625a
   Sun HJ, 2013, ANALYST, V138, P856, DOI 10.1039/c2an36564b
   Swart M, 2006, MOL SIMULAT, V32, P471, DOI 10.1080/08927020600631270
   Swart M, 2007, EUR J INORG CHEM, P3646, DOI 10.1002/ejic.200700228
   Szolomajer J, 2011, NEW J CHEM, V35, P476, DOI 10.1039/c0nj00612b
   van Mourik T, 2005, CHEM-EUR J, V11, P6064, DOI 10.1002/chem.200500198
   Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F
   Weigend F, 2006, PHYS CHEM CHEM PHYS, V8, P1057, DOI 10.1039/b515623h
   Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a
   Yurenko YP, 2014, PHYS CHEM CHEM PHYS, V16, P2072, DOI 10.1039/c3cp53875c
NR 43
TC 13
Z9 13
U1 1
U2 38
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2014
VL 16
IS 29
BP 15241
EP 15248
DI 10.1039/c4cp00541d
PG 8
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA AL5KY
UT WOS:000339173700023
PM 24939211
DA 2018-10-20
ER

PT J
AU Can, E
   Bucak, S
   Kinaci, E
   Calikogly, AC
   Kose, GT
AF Can, Erde
   Bucak, Seyda
   Kinaci, Emre
   Calikogly, Ayse Ceren
   Kose, Gamze Torun
TI Polybutylene Succinate (PBS) - Polycaprolactone (PCL) Blends
   Compatibilized with Poly(ethylene oxide)-block-poly( propylene
   oxide)-block-poly(ethylene oxide) (PEO-PPO-PEO) Copolymer for
   Biomaterial Applications
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE Biomaterial; Compatibilizer; Cytotoxicity; PBS; PCL; Polymer blend
ID STARCH/SYNTHETIC POLYMER BLENDS; POLY(BUTYLENE SUCCINATE);
   MECHANICAL-PROPERTIES; BIODEGRADABLE BLENDS; THERMAL-PROPERTIES;
   IN-VITRO; MORPHOLOGY; SCAFFOLDS; ACID); POLY(EPSILON-CAPROLACTONE)
AB This study reports the preparation and characterization of Polybutylene Succinate (PBS)-Polycaprolactone (PCL) melt blends (10-40 wt.% PCL) in the presence of a compatibilizer, in order to explore their potential use as a biomaterial. The thermal transitions, as well as the crystallinity of the polymer blends were analyzed by Differential Scanning Calorimetry, the thermomechanical properties were analyzed via Dynamic Mechanical Analysis and phase morphologies were characterized by Scanning Electron Microscopy. Degradation profiles of the blends were analyzed in PBS buffer solution at pH 7.4 at 37 degrees C via pH measurements. Cytotoxicity of the PBS/PCL films were tested by MTS assay.
C1 [Can, Erde; Bucak, Seyda; Kinaci, Emre] Yeditepe Univ, Dept Chem Engn, Fac Engn & Architecture, TR-34755 Istanbul, Turkey.
   [Calikogly, Ayse Ceren; Kose, Gamze Torun] Yeditepe Univ, Dept Genet & Bioengn, Fac Engn & Architecture, TR-34755 Istanbul, Turkey.
   [Kose, Gamze Torun] METU, BIOMATEN Ctr Excellence Biomat & Tissue Engn, Ankara, Turkey.
RP Can, E (reprint author), Yeditepe Univ, Dept Chem Engn, Fac Engn & Architecture, TR-34755 Istanbul, Turkey.
EM erde.can@yeditepe.edu.tr
OI TORUN KOSE, GAMZE/0000-0003-0997-1404
FU Yeditepe University; Turkish Ministry of Industrial Affairs through
   SANTEZ Project [00155.STZ.2007-2.]
FX This work is supported by Yeditepe University and Turkish Ministry of
   Industrial Affairs through SANTEZ Project 00155.STZ.2007-2.
CR Cao A, 2002, POLYMER, V43, P671, DOI 10.1016/S0032-3861(01)00658-9
   Chao H.S., 2010, WASTE MANAGE, V31, P475
   Chen S.S., 2010, THESIS S CHINA U TEC
   Chen ZCC, 2008, J BIOMAT SCI-POLYM E, V19, P693, DOI 10.1163/156856208784089580
   Chiono V, 2009, MAT SCI ENG C-MATER, V29, P2174, DOI 10.1016/j.msec.2009.04.020
   Dean K, 2007, J APPL POLYM SCI, V103, P802, DOI 10.1002/app.25149
   Dell'Erba R, 2001, POLYMER, V42, P7831, DOI 10.1016/S0032-3861(01)00269-5
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   Ibrahim NA, 2010, POLYM-PLAST TECHNOL, V49, P1571, DOI 10.1080/03602559.2010.512337
   Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057
   Lee B.T., 2014, J BIOMATER SCI POL E, V25, P150
   Li HY, 2005, MACROMOL BIOSCI, V5, P433, DOI 10.1002/mabi.200400183
   Liang JZ, 2013, J MACROMOL SCI B, V52, P964, DOI 10.1080/00222348.2012.746572
   Maglio G, 2004, MACROMOL CHEM PHYSIC, V205, P946, DOI 10.1002/macp.200300150
   Mani R, 2001, EUR POLYM J, V37, P515, DOI 10.1016/S0014-3057(00)00155-5
   Fernandez JM, 2010, J BIOMAT SCI-POLYM E, V21, P1297, DOI 10.1163/092050609X12517190417632
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Nayak PL, 2008, POLYM-PLAST TECHNOL, V47, P600, DOI 10.1080/03602550802059402
   Nguyen TH, 2013, J BIOMAT SCI-POLYM E, V24, P1692, DOI 10.1080/09205063.2013.792642
   Linh NTB, 2013, J BIOMAT SCI-POLYM E, V24, P520, DOI 10.1080/09205063.2012.697696
   Nugroho P, 2001, MACROMOL MATER ENG, V286, P316, DOI 10.1002/1439-2054(20010501)286:5<316::AID-MAME316>3.3.CO;2-E
   Olabarrieta I., 2002, INT J POLYM MATER, V51, P275
   Oliveira JT, 2011, J BIOMAT SCI-POLYM E, V22, P773, DOI 10.1163/092050610X494604
   Park JW, 2003, POLYMER, V44, P4341, DOI 10.1016/S0032-3861(03)00346-X
   Reddy MM, 2012, MACROMOL MATER ENG, V297, P455, DOI 10.1002/mame.201100203
   Salerno A, 2012, J SUPERCRIT FLUID, V67, P114, DOI 10.1016/j.supflu.2012.03.016
   Sen A, 2002, MAT SCI ENG A-STRUCT, V338, P60, DOI 10.1016/S0921-5093(02)00077-1
   Sen A, 2000, POLYMER, V41, P9177, DOI 10.1016/S0032-3861(00)00300-1
   Shen TF, 2013, J MACROMOL SCI A, V50, P547, DOI 10.1080/10601325.2013.781463
   Shinoda H, 2003, POLYM DEGRAD STABIL, V80, P241, DOI 10.1016/S0141-3910(02)00404-4
   Soccio M, 2012, REACT FUNCT POLYM, V72, P856, DOI 10.1016/j.reactfunctpolym.2012.08.002
   Su SK, 2010, POLYM-PLAST TECHNOL, V49, P1361, DOI 10.1080/03602559.2010.512322
   Todo M, 2007, ENG FRACT MECH, V74, P1872, DOI 10.1016/j.engfracmech.2006.05.021
   Vilay V, 2013, POLYM-PLAST TECHNOL, V52, P768, DOI 10.1080/03602559.2013.763350
   Wang J, 2012, POLYM TEST, V31, P39, DOI 10.1016/j.polymertesting.2011.09.005
   Webb K., 1998, J BIOMED MATER RES, V41, P42
   Yao QQ, 2012, J BIOMAT SCI-POLYM E, V23, P1755, DOI 10.1163/092050611X597780
NR 37
TC 8
Z9 8
U1 5
U2 36
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0360-2559
EI 1525-6111
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PY 2014
VL 53
IS 11
BP 1178
EP 1193
DI 10.1080/03602559.2014.886119
PG 16
WC Polymer Science
SC Polymer Science
GA AL3TB
UT WOS:000339051000010
DA 2018-10-20
ER

PT J
AU Huang, R
   Han, Y
   Lu, SM
AF Huang, Run
   Han, Yong
   Lu, Shemin
TI Enhanced osteoblast functions and bactericidal effect of Ca and Ag
   dual-ion implanted surface layers on nanograined titanium alloys
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID SILVER NANOPARTICLES; IN-VITRO; GENE-EXPRESSION; STAINLESS-STEEL;
   BONE-FORMATION; OSTEOGENIC DIFFERENTIATION; TI-25NB-3MO-3ZR-2SN ALLOY;
   FETAL OSTEOBLASTS; CELL-CYCLE; GRAIN
AB To endow a Ti-based implant with enhanced osteogenic activity and antibacterial property, we herein modified nano-grained (NG) and coarse-grained (CG) Ti surface layers by the implantation of Ca and/or Ag ions, which were derived by surface mechanical attrition treatment (SMAT). The cellular adhesion, proliferation, differentiation (as marked by the osteogenesis-related gene expression, ALP activity and specific protein content) and extracellular matrix mineralization of hFOB1.19 osteoblasts, as well as the bacterial adhesion of Staphylococcus aureus and Escherichia coli on as-SMATed and different ion-implanted surfaces, were also investigated. The obtained results show that Ca and/or Ag ion implantation almost does not significantly alter the surface roughness and topography of the SMATed layers; moreover, it has little influence on the microstructure of the SMAT-achieved Ti nanograins. Furthermore, the implanted Ca and Ag are in the form of CaTiO3 and metallic Ag nanoparticles (NPs), respectively, and are embedded tightly in the Ti matrix. Significant enhancements of osteoblast functions are exhibited on the NG and ion-implanted NG surfaces compared to the CG and ion-implanted CG surfaces, which is related to the grain size and hydrophilicity of the surfaces. Although the Ca and Ag dual-ion implanted CG surface can simultaneously enhance the osteogenic activity and antibacterial properties compared to the CG surface, the enhancement of dual functions is more pronounced on the dual-ion implanted NG surface because the NG surface is more beneficial to the implantation of Ag and Ca ions compared to the CG surface. Although surface chemistry and hydrophilicity are responsible for the various antibacterial properties of the surfaces, the Ag NPs in the ion-implanted surfaces play a dominant role in the bactericidal ability compared to the hydrophilicity. Our study provides a promising means for designing biomaterial surfaces such that their osteoblast functions and antibacterial activity are perfectly balanced.
C1 [Huang, Run; Han, Yong] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
   [Lu, Shemin] Xi An Jiao Tong Univ, Coll Med, Dept Genet & Mol Biol, Xian 710061, Peoples R China.
RP Han, Y (reprint author), Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
EM yonghan@mail.xjtu.edu.cn
RI Lu, Shemin/M-3350-2018
OI Lu, Shemin/0000-0001-8250-850X
FU National Basic Research Program (973 Program) of China [2012CB619103];
   National Natural Science Foundation of China [51071120, 51371137]
FX We acknowledge the National Basic Research Program (973 Program) of
   China (Grant number 2012CB619103), and the National Natural Science
   Foundation of China (Grant number 51071120, 51371137) for financially
   supporting this work. The authors are also grateful to Prof. Yizhao Wan
   at Tianjin University for his help in the preparation of Ca and Ag
   ion-implanted samples.
CR Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Cao HL, 2013, ACTA BIOMATER, V9, P5100, DOI 10.1016/j.actbio.2012.10.017
   Cao HL, 2011, BIOMATERIALS, V32, P693, DOI 10.1016/j.biomaterials.2010.09.066
   Chai HW, 2011, J MATER SCI-MATER M, V22, P2525, DOI 10.1007/s10856-011-4427-z
   Dupin JC, 2000, PHYS CHEM CHEM PHYS, V2, P1319, DOI 10.1039/a908800h
   Ewald A, 2011, ACTA BIOMATER, V7, P4064, DOI 10.1016/j.actbio.2011.06.049
   Faghihi S, 2007, BIOMATERIALS, V28, P3887, DOI 10.1016/j.biomaterials.2007.05.010
   Fiedler J, 2011, INT J ARTIF ORGANS, V34, P882, DOI 10.5301/ijao.5000022
   Flores CY, 2013, ACS APPL MATER INTER, V5, P3149, DOI 10.1021/am400044e
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   HANAWA T, 1995, MATER T JIM, V36, P438, DOI 10.2320/matertrans1989.36.438
   Hanawa T, 1996, CORROS SCI, V38, P2061, DOI 10.1016/S0010-938X(96)89124-4
   Hanawa T, 1998, J MATER SCI-MATER M, V9, P89, DOI 10.1023/A:1008847014938
   Huang R, 2014, MAT SCI ENG C-MATER, V35, P144, DOI 10.1016/j.msec.2013.10.037
   Huang R, 2013, COLLOID SURFACE B, V111, P232, DOI 10.1016/j.colsurfb.2013.06.007
   Huang R, 2013, J ALLOY COMPD, V554, P1, DOI 10.1016/j.jallcom.2012.09.045
   Jinno T, 2004, J ARTHROPLASTY, V19, P102, DOI 10.1016/j.arth.2003.10.001
   Kaciulis S, 1999, APPL SURF SCI, V151, P1, DOI 10.1016/S0169-4332(99)00267-6
   Kaciulis S, 1998, J ELECTRON SPECTROSC, V95, P61, DOI 10.1016/S0368-2048(98)00202-3
   Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q
   Kim DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083363
   Kim SH, 2009, IFMBE PROC, V23, P2009
   Ko KH, 2012, TISSUE ENG REGEN MED, V9, P137, DOI 10.1007/s13770-012-0137-y
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Levard C, 2012, ENVIRON SCI TECHNOL, V46, P6900, DOI 10.1021/es2037405
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Liu XY, 2005, SURF COAT TECH, V191, P43, DOI 10.1016/j.surfcoat.2004.08.118
   Liu Y, 2005, BIOPHYS CHEM, V117, P39, DOI 10.1016/j.bpc.2005.04.015
   Lu K, 2004, MAT SCI ENG A-STRUCT, V375, P38, DOI 10.1016/j.msea.2003.10.261
   Marsich E, 2013, ACTA BIOMATER, V9, P5088, DOI 10.1016/j.actbio.2012.10.002
   Misra RDK, 2013, ACTA BIOMATER, V9, P6245, DOI 10.1016/j.actbio.2012.12.003
   Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Nayab SN, 2007, BIOMATERIALS, V28, P38, DOI 10.1016/j.biomaterials.2006.08.032
   Nayab SN, 2007, J BIOMED MATER RES A, V83A, P296, DOI 10.1002/jbm.a.31218
   Nayab SN, 2005, BIOMATERIALS, V26, P4717, DOI 10.1016/j.biomaterials.2004.11.044
   Necula BS, 2012, ACTA BIOMATER, V8, P4191, DOI 10.1016/j.actbio.2012.07.005
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Park JW, 2007, BIOMATERIALS, V28, P3306, DOI 10.1016/j.biomaterials.2007.04.007
   Park JW, 2009, ACTA BIOMATER, V5, P3272, DOI 10.1016/j.actbio.2009.04.038
   PARK JW, 2008, J BIOMED MATER RES A, V86, P117
   Pereni CI, 2006, COLLOID SURFACE B, V48, P143, DOI 10.1016/j.colsurfb.2006.02.004
   Posternak M, 2013, J PHYS CHEM C, V117, P26013, DOI 10.1021/jp406817k
   Rautray TR, 2011, PROG MATER SCI, V56, P1137, DOI 10.1016/j.pmatsci.2011.03.002
   Ren L, 2012, MAT SCI ENG C-MATER, V32, P1204, DOI 10.1016/j.msec.2012.03.009
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648
   Shinonaga Y, 2012, ACTA BIOMATER, V8, P1388, DOI 10.1016/j.actbio.2011.09.017
   Sul YT, 2002, INT J ORAL MAX IMPL, V17, P625
   Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019
   Valerio P, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045011
   Venkatsurya PKC, 2012, MAT SCI ENG C-MATER, V32, P330, DOI 10.1016/j.msec.2011.10.036
   Viereck V, 2002, J CELL BIOCHEM, V86, P348, DOI 10.1002/jcb.10220
   Vinals F, 1999, MOL CELL BIOL, V19, P2763
   Wan YZ, 2007, VACUUM, V81, P1114, DOI 10.1016/j.vacuum.2006.12.011
   Wang CY, 2004, BIOMATERIALS, V25, P2949, DOI 10.1016/j.biomaterials.2003.09.088
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Wu X, 2002, ACTA MATER, V50, P2075, DOI 10.1016/S1359-6454(02)00051-4
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Yu ZT, 2006, MAT SCI ENG A-STRUCT, V438, P391, DOI 10.1016/j.msea.2005.12.079
   Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675
   Zhao CL, 2011, J NANOPART RES, V13, P645, DOI 10.1007/s11051-010-0061-9
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhuang LF, 2012, J BIOMED MATER RES A, V100A, P125, DOI 10.1002/jbm.a.33247
NR 69
TC 15
Z9 16
U1 3
U2 46
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 28
BP 4531
EP 4543
DI 10.1039/c4tb00124a
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA AK7ZD
UT WOS:000338646000016
DA 2018-10-20
ER

PT S
AU Talib, M
   Covington, JA
   Bolarinwa, A
AF Talib, Marina
   Covington, James A.
   Bolarinwa, Aminat
BE Mohamed, AA
   Idris, FM
   Wood, AKBH
TI Characterization of Fabricated Three Dimensional Scaffolds of
   Bioceramic-Polymer Composite via Microstereolithography Technique
SO ADVANCING NUCLEAR RESEARCH AND ENERGY DEVELOPMENT
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Nuclear Science, Technology and Engineering Conference
   (iNuSTEC)
CY SEP 30-OCT 02, 2013
CL Kuala Lumpur, MALAYSIA
SP Minist Environm & Green Technol, Minist Sci Technol & Innovat, Malaysian Nucl Agcy, Malaysian Nucl Soc, Univ Tenaga Nas, Univ Teknologi MARA, Univ Islam Antarabangsa Malaysia, Univ Kebangsaan Malaysia, Univ Malaya, Univ Teknologi Malaysia, Univ Malaysia Pahang, Minist Energy, Green Technology & Water, Int Atom Energy Agcy
DE Biomaterial; microstereolithography; calcium pyrophospate; tissue
   engineering
AB Microstereolithography is a method used for rapid prototyping of polymeric and ceramic components. This technique converts a computer-aided design (CAD) to a three dimensional (3D) model, and enables layer per layer fabrication curing a liquid resin with UV-light or laser source. The aim of this project was to formulate photocurable polymer reinforced with synthesized calcium pyrophosphate (CPP), and to fabricate a 3D scaffolds with optimum mechanical properties for specific tissue engineering applications. The photocurable ceramic suspension was prepared with acrylate polyester, multifunctional acrylate monomer with the addition of 50-70wt% of CPP, photoinitiators and photoinhibitors. The 3D structure of disc (5 mm height x 4 mm diameter) was successfully fabricated using Envisiontec Perfactory3 (R). They were then sintered at high temperature for polymer removal, to obtain a ceramic of the desired porosity. The density increased to more than 35% and the dimensional shrinkage after sintering were 33%. The discs were then subjected compressive measurement, biodegradation and bioactivity test. Morphology and CPP content of the sintered polymer was investigated with SEM and XRD, respectively. The addition of CPP coupled with high temperature sintering, had a significant effect on the compressive strength exhibited by the bioceramic. The values are in the range of cancellous bone (2-4 MPa). In biodegradation and bioactivity test, the synthesized CPP induced the formation of apatite layer and its nucleation onto the composite surface.
C1 [Talib, Marina] Agensi Nuklear Malaysia, Kajang 43000, Selangor, Malaysia.
   [Covington, James A.] Univ Warwick, Sch Engn, Coventry CV4 7AL, W Midlands, England.
   [Bolarinwa, Aminat] Univ Birmingham, Sch Chem Engn, Birmingham B15 2TT, W Midlands, England.
RP Talib, M (reprint author), Agensi Nuklear Malaysia, Kajang 43000, Selangor, Malaysia.
RI Covington, James/Q-1934-2018
OI Covington, James/0000-0003-1307-6488
FU Engineering and Physical Sciences Research Council; Public Service
   Department of Malaysia
FX The authors would like to thank the Engineering and Physical Sciences
   Research Council for support of this work through of a research grant
   and Public Service Department of Malaysia for the fellowship..
CR Baroli B., 2009, BLOOD, V98, P1317
   Fisher J.P., 2006, DESIGN
   Gbureck U, 2008, J MATER SCI-MATER M, V19, P1559, DOI 10.1007/s10856-008-3373-x
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Melchels FPW, 2008, J CONTROL RELEASE, V132, pE71, DOI 10.1016/j.jconrel.2008.09.066
   Nguyen LH, 2005, ADV FUNCT MATER, V15, P209, DOI 10.1002/adfm.200400212
   Pattanayak D.K., 2007, ENGINEERING, V27, P684
   Zhi-hua Z., 2007, T NONFERR METAL SOC, V17, P394
   Zissi J.C.A. S., 1996, MICROSYST TECHNOL, V2, P97
NR 9
TC 1
Z9 1
U1 1
U2 14
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1216-3
J9 AIP CONF PROC
PY 2014
VL 1584
BP 129
EP 135
DI 10.1063/1.4866118
PG 7
WC Physics, Applied; Physics, Nuclear
SC Physics
GA BA8HZ
UT WOS:000338127400022
OA Bronze
DA 2018-10-20
ER

PT J
AU Thomas, AM
   Seidlits, SK
   Goodman, AG
   Kukushliev, TV
   Hassani, DM
   Cummings, BJ
   Anderson, AJ
   Shea, LD
AF Thomas, Aline M.
   Seidlits, Stephanie K.
   Goodman, Ashley G.
   Kukushliev, Todor V.
   Hassani, Donna M.
   Cummings, Brian J.
   Anderson, Aileen J.
   Shea, Lonnie D.
TI Sonic hedgehog and neurotrophin-3 increase oligodendrocyte numbers and
   myelination after spinal cord injury
SO INTEGRATIVE BIOLOGY
LA English
DT Article
ID MULTIPLE-CHANNEL BRIDGES; NEURAL PROGENITOR CELLS; IN-VITRO;
   INDUCED-DIFFERENTIATION; LOCOMOTOR RECOVERY; PRECURSOR CELLS; SOX2
   EXPRESSION; GENE DELIVERY; BRAIN-INJURY; AXON GROWTH
AB Spinal cord injury (SCI) results in loss of sensory and motor function below the level of injury and has limited available therapies. Multiple channel bridges have been investigated as a means to create a permissive environment for regeneration, with channels supporting axonal growth through the injury. Bridges support robust axon growth and myelination. Here, we investigated the cell types that myelinate axons in the bridges and whether over-expression of trophic factors can enhance myelination. Lentivirus encoding for neurotrophin-3 (NT3), sonic hedgehog (SHH) and the combination of these factors was delivered from bridges implanted into a lateral hemisection defect at T9/T10 in mice, and the response of endogenous progenitor cells within the spinal cord was investigated. Relative to control, the localized, sustained expression of these factors significantly increased growth of regenerating axons into the bridge and enhanced axon myelination 8 weeks after injury. SHH decreased the number of Sox2(+) cells and increased the number of Olig2(+) cells, whereas NT3 alone or in combination with SHH enhanced the numbers of GFAP(+) and Olig2(+) cells relative to control. For delivery of lentivirus encoding for either factor, we identified cells at various stages of differentiation along the oligodendrocyte lineage (e.g., O4(+), GalC(+)). Expression of NT3 enhanced myelination primarily by infiltrating Schwann cells, whereas SHH over-expression substantially increased myelination by oligodendrocytes. These studies further establish biomaterial-mediated gene delivery as a promising tool to direct activation and differentiation of endogenous progenitor cells for applications in regenerative medicine.
C1 [Thomas, Aline M.] Northwestern Univ, Dept Biomed Engn, McCormick Sch Engn, Evanston, IL 60208 USA.
   [Seidlits, Stephanie K.; Goodman, Ashley G.; Kukushliev, Todor V.; Shea, Lonnie D.] Northwestern Univ, McCormick Sch Engn, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Seidlits, Stephanie K.; Shea, Lonnie D.] Northwestern Univ, Inst BioNanotechnol Med IBNAM, Chicago, IL 60611 USA.
   [Hassani, Donna M.] Northwestern Univ, Weinberg Coll Arts & Sci, Dept Psychol, Evanston, IL USA.
   [Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Dept Phys Med & Rehabil, Irvine, CA USA.
   [Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.
   [Cummings, Brian J.; Anderson, Aileen J.] Sue & Bill Gross Stem Cell Ctr, Irvine, CA USA.
   [Cummings, Brian J.; Anderson, Aileen J.] Inst Memory Impairments & Neurol Disorders MIND, Irvine, CA USA.
   [Shea, Lonnie D.] Northwestern Univ, Ctr Reprod Sci, Evanston, IL USA.
   [Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
   [Shea, Lonnie D.] Northwestern Univ, Chem Life Proc Inst CLP, Evanston, IL USA.
RP Shea, LD (reprint author), Northwestern Univ, McCormick Sch Engn, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009; Cummings, Brian/C-9180-2012
OI Cummings, Brian/0000-0003-3628-5290
FU NIH [RO1 EB005678, R21 EB006520, RO1 EB003806, R01 CA173745, F32
   NS081961]; NCI CCSG [P30 CA060553]
FX This work was supported by the NIH (RO1 EB005678, R21 EB006520, RO1
   EB003806, R01 CA173745, F32 NS081961 (SKS)). In vivo bioluminescence
   imaging work was performed at the Northwestern University Center for
   Advanced Molecular Imaging generously supported by NCI CCSG P30 CA060553
   awarded to the Robert H. Lurie Comprehensive Cancer Center. Confocal
   microscopy was performed at the Northwestern University Biological
   Imaging Facility. Technical support for animal studies from the
   Northwestern University Center for Comparative Medicine.
CR Abdellatif AA, 2006, J NEUROSCI RES, V84, P553, DOI 10.1002/jnr.20968
   Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009
   Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x
   Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004
   Bambakidis NC, 2009, J NEUROSURG-SPINE, V10, P171, DOI 10.3171/2008.10.SPI08231
   Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x
   Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195
   Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014
   BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0
   Beauparlant J, 2013, BRAIN, V136, P3347, DOI 10.1093/brain/awt204
   Binder E, 2011, J NEUROSCI, V31, P6379, DOI 10.1523/JNEUROSCI.0129-11.2011
   Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008
   Bonner JF, 2010, J NEUROSCI RES, V88, P1182, DOI 10.1002/jnr.22288
   Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x
   Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8
   Cassiani-Ingoni R, 2006, EXP NEUROL, V201, P349, DOI 10.1016/j.expneurol.2006.04.030
   Chen J, 2005, EUR J NEUROSCI, V22, P1895, DOI 10.1111/j.1460-9568.2005.04348.x
   De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252
   Engel U, 1996, GLIA, V16, P16, DOI 10.1002/(SICI)1098-1136(199601)16:1<16::AID-GLIA3>3.0.CO;2-9
   Foret A, 2010, J NEUROCHEM, V112, P762, DOI 10.1111/j.1471-4159.2009.06500.x
   Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1
   Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628
   Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033
   Hor CHH, 2010, CELL ADHES MIGR, V4, P1, DOI 10.4161/cam.4.1.9914
   Hughes SM, 2002, MOL THER, V5, P16, DOI 10.1006/mthe.2001.0512
   Kumar S, 1998, J NEUROSCI RES, V54, P754, DOI 10.1002/(SICI)1097-4547(19981215)54:6<754::AID-JNR3>3.0.CO;2-K
   Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983
   Lee HJ, 2013, J NEUROSCI RES, V91, P196, DOI 10.1002/jnr.23151
   Li GL, 1999, ACTA NEUROPATHOL, V98, P473, DOI 10.1007/s004010051112
   Lowry N, 2008, EXP NEUROL, V209, P510, DOI 10.1016/j.expneurol.2007.09.031
   Lowry N, 2012, BIOMATERIALS, V33, P2892, DOI 10.1016/j.biomaterials.2011.12.048
   Magnus T, 2007, J NEUROSCI RES, V85, P2126, DOI 10.1002/jnr.21368
   Marshall CAG, 2005, J NEUROSCI, V25, P7289, DOI 10.1523/JNEUROSCI.1924-05.2005
   McTigue DM, 2006, J NEUROPATH EXP NEUR, V65, P406, DOI 10.1097/01.jnen.0000218447.32320.52
   McTigue DM, 1998, J NEUROSCI, V18, P5354
   Merchan P, 2007, MOL CELL NEUROSCI, V36, P355, DOI 10.1016/j.mcn.2007.07.012
   Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581
   Neri M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010145
   Park J. Y., 2009, STEM CELLS, V27, P2645
   Powers BE, 2012, J NEUROSCI, V32, P5120, DOI 10.1523/JNEUROSCI.0002-12.2012
   Rossignol S, 2006, PHILOS T R SOC B, V361, P1647, DOI 10.1098/rstb.2006.1889
   Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009
   Shin SJ, 2010, BIOMATERIALS, V31, P4353, DOI 10.1016/j.biomaterials.2010.02.013
   Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905
   Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523
   Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006
   Thomas AM, 2013, J CONTROL RELEASE, V170, P421, DOI 10.1016/j.jconrel.2013.06.013
   Thomas AM, 2013, BIOMATERIALS, V34, P2213, DOI 10.1016/j.biomaterials.2012.12.002
   Tuinstra H. M., 2014, TISSUE ENG A
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   Wang YP, 2011, J NEUROSCI, V31, P6053, DOI 10.1523/JNEUROSCI.5524-09.2011
   Wu CL, 2009, BIOCHEM BIOPH RES CO, V385, P112, DOI 10.1016/j.bbrc.2009.04.145
   Wu JH, 2010, INVEST OPHTH VIS SCI, V51, P2986, DOI 10.1167/iovs.09-4151
   Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101
   Yamazaki Y, 2010, NEUROSCIENTIST, V16, P11, DOI 10.1177/1073858409334425
   Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005
   Yang Y, 2011, DEV BIOL, V350, P127, DOI 10.1016/j.ydbio.2010.11.028
   Yang Y, 2009, TISSUE ENG PT A, V15, P3283, DOI [10.1089/ten.tea.2009.0081, 10.1089/ten.TEA.2009.0081]
   Zhu GF, 1999, DEV BIOL, V215, P118, DOI 10.1006/dbio.1999.9431
NR 59
TC 25
Z9 27
U1 1
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1757-9694
EI 1757-9708
J9 INTEGR BIOL-UK
JI Integr. Biol.
PY 2014
VL 6
IS 7
BP 694
EP 705
DI 10.1039/c4ib00009a
PG 12
WC Cell Biology
SC Cell Biology
GA AK3BS
UT WOS:000338298200005
PM 24873988
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Liu, W
   Wu, ZQ
   Wang, YY
   Tang, ZC
   Du, J
   Yuan, L
   Li, D
   Chen, H
AF Liu, Wei
   Wu, Zhaoqiang
   Wang, Yanyun
   Tang, Zengchao
   Du, Jun
   Yuan, Lin
   Li, Dan
   Chen, Hong
TI Controlling the biointerface of electrospun mats for clot lysis: an
   engineered tissue plasminogen activator link to a lysine-functionalized
   surface
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID ADSORPTION
AB Controlling the interface of biomaterials that take advantage of the natural fibrinolytic or clot-dissolving capacity of the body is attractive for preventing clot formation on an implanted biomaterial. Here, we engineer the interface of a biopolymer electrospun fiber mat with a serine protease of the tissue plasminogen activator (t-PA), aiming to simulate fibrinolytic functions of the body. The method is based on the one-step electrospinning aqueous solution of poly(vinyl alcohol) (PVA) and lysine ligand-modified PVA (PVA-Lys), in which the epsilon-amino and carboxyl groups of the lysine ligands were free. These electrospun mats showed good resistance to non-specific protein adsorption of fibrinogen and excellent biocompatibility with L929 cells using the MTT assay. A highly specific tethering of t-PA was facilitated by the lysine-functionalized surface through molecular recognition of t-PA to the lysine ligands. Moreover, the t-PA anchorage to the PVA/PVA-Lys mats can be easily released by plasminogen displacement when exposed to plasma, and can efficiently lyse the formed-clot in an in vitro plasma assay. In particular, the quantities of t-PA tethered on the mats could easily be regulated by simply varying the blend ratio of PVA and PVA-Lys in the electrospinning process. Collectively, considering the advantages of simplicity, controllability and biocompatibility, this approach is expected to be useful for the construction of a biointerface for blood-contacting devices.
C1 [Liu, Wei; Wu, Zhaoqiang; Wang, Yanyun; Tang, Zengchao; Du, Jun; Yuan, Lin; Li, Dan; Chen, Hong] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
RP Wu, ZQ (reprint author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, 199 Renai Rd, Suzhou 215123, Peoples R China.
EM wzqwhu@suda.edu.cn; chenh@suda.edu.cn
RI Li, Dan/R-8422-2016; chen, Hong/L-6932-2013
OI Li, Dan/0000-0002-1141-8838; , Lin/0000-0001-6966-8584
FU National Science Fund for Distinguished Young Scholars [21125418];
   National Natural Science Foundation of China [21174098, 21204055,
   21334004]; Natural Science Foundation of the Jiangsu Higher Education
   Institutions of China [13KJA430006]; Project of Scientific and
   Technologic Infrastructure of Suzhou [SZS201207]
FX This work was supported by the National Science Fund for Distinguished
   Young Scholars (21125418), the National Natural Science Foundation of
   China (21174098, 21204055 and 21334004), the Natural Science Foundation
   of the Jiangsu Higher Education Institutions of China (13KJA430006) and
   the Project of Scientific and Technologic Infrastructure of Suzhou
   (SZS201207).
CR Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Liu XL, 2010, COLLOID SURFACE B, V79, P452, DOI 10.1016/j.colsurfb.2010.05.011
   Majerus P., 1993, GOODMAN GILMANNS PHA
   Novak K., 2005, DRUG FACTS COMPARISO, P217
   Pan CJ, 2014, J MATER CHEM B, V2, P892, DOI 10.1039/c3tb21403f
NR 5
TC 5
Z9 5
U1 1
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 27
BP 4272
EP 4279
DI 10.1039/c4tb00488d
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA AK0SH
UT WOS:000338124900007
DA 2018-10-20
ER

PT S
AU Dannbatta, MS
   Izman, S
   Hermawan, H
   Kurniawan, D
AF Dannbatta, M. S.
   Izman, S.
   Hermawan, H.
   Kurniawan, D.
BE Pramujati, B
TI Effect of Heat Treatment on Microstructure Homogeneity of Zn-3Mg Alloy
SO ADVANCES IN APPLIED MECHANICS AND MATERIALS
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT International Conference on Mechanical Engineering (ICOME 2013)
CY SEP 19-21, 2013
CL Mataram, INDONESIA
SP BKS-TM, PT Graha Elektro Tama, LINTECH, Dinamika Energitama Nusantara, Citilink, PT Pelabuhan Indonesia III PERSERO
DE Zinc alloy; biomaterials; heat treatment; dendritic; homogenity
ID CORROSION PROPERTIES; MECHANICAL-PROPERTIES; POLYCAPROLACTONE; BEHAVIOR
AB The Zn based alloy has a high potential to be the next generation of biodegradable implant material. Development of this biomaterial involves casting process which often associated with various defects. In this study, Zn-3Mg alloy was prepared using conventional casting method and followed by homogenization treatment (370 degrees C for 10hr) with the aim to improve the microstructure uniformity. Microscopic images show that as-cast Zn-3Mg alloy consists of segregated Zn-rich structure of star-like dendritic shape and eutectic mixture of Mg2Zn11 phase. It is observed that after the heat treatment process thissegregation has been dispersed well and results in a more uniform microstructure of Zn-3Mg alloy with low fraction of casting defects.
C1 [Dannbatta, M. S.; Izman, S.; Kurniawan, D.] Univ Teknol Malaysia, Fac Mech Engn, Skudai, Malaysia.
   [Hermawan, H.] Univ Teknol Malaysia, Fac Biosci & Med Engn, Skudai, Malaysia.
RP Dannbatta, MS (reprint author), Univ Teknol Malaysia, Fac Mech Engn, Skudai, Malaysia.
EM murifestac@yahoo.com; izman@fkm.utm.my;
   hendra.hermawan@biomedical.utm.my; denni@utm.my
RI sudin, izman/A-6746-2015; Kurniawan, Denni/C-2703-2008; Hermawan,
   Hendra/G-5892-2010
OI Kurniawan, Denni/0000-0002-4179-0454; Hermawan,
   Hendra/0000-0002-5596-9949
FU Ministry of Higher Education, Malaysia; Universiti Teknologi Malaysia
   through Research University [05H27]
FX Financial support from the Ministry of Higher Education, Malaysia and
   Universiti Teknologi Malaysia through Research University Grant (No.
   05H27) is acknowledged.
CR Biljana B, 2011, CORROS SCI, V53, P409
   Bowen PK, 2013, ADV MATER, V10, P20
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gu XN, 2011, MATER SCI ENG B-ADV, V176, P1778, DOI 10.1016/j.mseb.2011.05.032
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hambidge KM, 2007, J NUTR, V137, P1101
   Hosking NC, 2007, CORROS SCI, V49, P3669, DOI 10.1016/j.corsci.2007.03.032
   Huan ZG, 2010, J MATER SCI-MATER M, V21, P2623, DOI 10.1007/s10856-010-4111-8
   Karamis MB, 2007, MATER LETT, V61, P944, DOI 10.1016/j.matlet.2006.06.016
   Kotah K, 2004, J HIGH PRESSURE I JA, V42, P207
   Kurniawan D, 2011, P I MECH ENG H, V225, P1015, DOI 10.1177/0954411911413059
   Nor FM, 2012, P I MECH ENG H, V226, P693, DOI 10.1177/0954411912452988
   Prasad BK, 2004, WEAR, V257, P1137, DOI 10.1016/j.wear.2004.07.006
   Vojtech D, 2011, ACTA BIOMATER, V7, P3515, DOI 10.1016/j.actbio.2011.05.008
   Wang X, 2007, T NONFERR METAL SOC, V17, pS122
   Yan XQ, 2013, MATER DESIGN, V45, P440, DOI 10.1016/j.matdes.2012.09.033
   Zhang E, 2008, MAT SCI ENG A-STRUCT, V488, P102, DOI 10.1016/j.msea.2007.10.056
   Zhang EL, 2010, ACTA BIOMATER, V6, P1756, DOI 10.1016/j.actbio.2009.11.024
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
NR 19
TC 0
Z9 0
U1 1
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-990-2
J9 APPL MECH MATER
PY 2014
VL 493
BP 777
EP +
DI 10.4028/www.scientific.net/AMM.493.777
PG 3
WC Engineering, Mechanical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA BA8DH
UT WOS:000337986500130
DA 2018-10-20
ER

PT J
AU Brennan-Pierce, EP
   MacAskill, I
   Price, RB
   Lee, JM
AF Brennan-Pierce, Ellen P.
   MacAskill, Ian
   Price, Richard B.
   Lee, J. Michael
TI Riboflavin-sensitized photo-crosslinking of collagen using a dental
   curing light
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Collagen; crosslink; riboflavin; photo-oxidation; dental curing light
ID DYE-MEDIATED PHOTOOXIDATION; TISSUE SEALANT; VISIBLE-LIGHT; KERATOCONUS;
   BIOMATERIALS; BACTERIA; CORNEA
AB BACKGROUND: Photo-crosslinking of biomolecules such as collagen and fibrinogen is an emerging area of research interest. The use of a small dental curing light with a non-toxic photosensitizer represents a novel, practical approach to periodontal wound treatment.
   OBJECTIVE: This study evaluated the effects of riboflavin-sensitized photo-oxidation using a dental curing light on two collagenous biomaterials, as a preliminary step towards developing a medical technology for wound closure/healing.
   METHODS: A collagenous biomaterial (DBP) and type I collagen gels were treated by this photo-oxidative technique and characterized by hydrothermal isometric tension (HIT) analysis, amino acid analysis, SDS-PAGE, and rheology.
   RESULTS: HIT analysis suggested that dental curing light exposure for 300 s with riboflavin produced heavily crosslinked DBP. Dental curing light exposure for 300 s with riboflavin also showed a reduction in lysine concentration of DBP. SDS-PAGE showed that dental curing light exposure for 30 or 300 s with riboflavin resulted in crosslinked collagen gels. Dental curing light exposure for 30 s with riboflavin yielded a collagen gel with the strongest rheological characteristics.
   CONCLUSIONS: This novel approach to wound treatment has potential for wide adoption and clinical use, particularly because dental curing lights, riboflavin, and collagen biomaterials are all used clinically, but not yet combined together as one technology for broad application.
C1 [Brennan-Pierce, Ellen P.; Lee, J. Michael] Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada.
   [MacAskill, Ian; Price, Richard B.] Dalhousie Univ, Fac Dent, Dept Clin Dent Sci, Halifax, NS B3H 3J5, Canada.
RP Lee, JM (reprint author), Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada.
EM michael.lee@dal.ca
OI Price, Richard/0000-0001-6479-1436
FU Natural Sciences and Engineering Research Council of Canada;
   Collaborative Research and Training Experience Program (NSERC CREATE:
   Biomedic)
FX The authors would like to thank Dr. Allan Paulson and David Mackenzie,
   from the Department of Process Engineering and Applied Science,
   Dalhousie University, for use of their rheometry facilities and advice
   regarding rheometry. We thank Thomas Haenel for performing the dental
   curing light integrating sphere measurements and Jonathan McDade for
   assistance with DBP preparation. Reynaldo Interior at the Hospital for
   Sick Children, Toronto, performed amino acid analysis. Dr. Frances
   Cozens, Department of Chemistry, Dalhousie University, provided valuable
   discussion around photochemistry. This work was partially funded by a
   grant to JML from the Natural Sciences and Engineering Research Council
   of Canada and a personnel award to EPB-P from a Collaborative Research
   and Training Experience Program (NSERC CREATE: Biomedic).
CR Ariganello MB, 2009, J HEART VALVE DIS, V18, P187
   BERNSTEIN PH, 1980, J BIOL CHEM, V255, P414
   Blay J, 2010, J BIOMED MATER RES B, V93B, P367, DOI 10.1002/jbm.b.31591
   Bouillaguet S, 2008, DENT MATER, V24, P1070, DOI 10.1016/j.dental.2007.12.004
   Chan BP, 2005, J SURG RES, V124, P274, DOI 10.1016/j.jss.2004.09.019
   Edwards AM, 2001, J PHOTOCH PHOTOBIO B, V63, P126, DOI 10.1016/S1011-1344(01)00209-3
   Elvin CM, 2010, BIOMATERIALS, V31, P8323, DOI 10.1016/j.biomaterials.2010.07.032
   Elvin CM, 2009, BIOMATERIALS, V30, P2059, DOI 10.1016/j.biomaterials.2008.12.059
   Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020
   Feuerstein O, 2004, PHOTOCHEM PHOTOBIOL, V80, P412, DOI 10.1562/0031-8655(2004)080<0412:PEOVLO>2.0.CO;2
   Hardwick CC, 2004, PHOTOCHEM PHOTOBIOL, V80, P609, DOI 10.1562/2004-04-14-TSN-139.1
   KATO Y, 1994, PHOTOCHEM PHOTOBIOL, V59, P343, DOI 10.1111/j.1751-1097.1994.tb05045.x
   Kremer I, 1996, ISRAEL J MED SCI, V32, P1243
   Lauto A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-47
   Lee JM, 1996, J MATER SCI-MATER M, V7, P531, DOI 10.1007/BF00122176
   LEE JM, 1995, MED ENG PHYS, V17, P115, DOI 10.1016/1350-4533(95)91882-H
   MOORE MA, 1994, J BIOMED MATER RES, V28, P611, DOI 10.1002/jbm.820280511
   Moore MA, 1998, ANN THORAC SURG, V66, pS245, DOI 10.1016/S0003-4975(98)01118-7
   Nair PNR, 2004, CRIT REV ORAL BIOL M, V15, P348, DOI 10.1177/154411130401500604
   National Center for Biotechnology Information Reference Database, COLL ALPH 1 2 CHAIN
   National Center for Biotechnology Information Reference Database, COLL ALPH 1 1 CHAIN
   Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039
   Ruane PH, 2004, TRANSFUSION, V44, P877, DOI 10.1111/j.1537-2995.2004.03355.x
   Sando L, 2010, J BIOMED MATER RES A, V95A, P901, DOI 10.1002/jbm.a.32913
   Soukos NS, 2005, ANTIMICROB AGENTS CH, V49, P1391, DOI 10.1128/AAC.49.4.1391-1396.2005
   Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182
   Straight R. C., 1985, SINGLET OXYGEN, P91
   TU SC, 1973, J BIOL CHEM, V248, P6339
   Velvart P, 2005, J ENDODONT, V31, P4, DOI 10.1097/01.DON.000014532.08454.5c
   Wells SM, 1998, BIORHEOLOGY, V35, P399, DOI 10.1016/S0006-355X(99)80019-5
   Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   Wollensak G, 2006, CURR OPIN OPHTHALMOL, V17, P356, DOI 10.1097/01.icu.0000233954.86723.25
   Xu XY, 2008, J AM CHEM SOC, V130, P703, DOI 10.1021/ja077102a
   Yang PG, 2012, LASER SURG MED, V44, P163, DOI 10.1002/lsm.21137
NR 35
TC 2
Z9 2
U1 2
U2 18
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2014
VL 24
IS 4
BP 1659
EP 1671
DI 10.3233/BME-140979
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ7XD
UT WOS:000337913300002
PM 24948451
DA 2018-10-20
ER

PT B
AU Biscaia, S
   Viana, T
   Almeida, HA
   Bartolo, PJ
AF Biscaia, S.
   Viana, T.
   Almeida, H. A.
   Bartolo, P. J.
BE Bartolo, PJD
   DeLemos, ACS
   Pereira, AMH
   Mateus, AJD
   Ramos, C
   DosSantos, C
   Oliveira, D
   Pinto, E
   Craveiro, F
   Bartolo, HMCDTG
   Almeia, HD
   Sousa, I
   Matias, JM
   Durao, L
   Gaspar, M
   Alves, NMF
   Carreira, P
   Ferreira, T
   Marques, T
TI Biofabrication of three-dimensional scaffolds of polycaprolactone with
   eggshell powder for bone regeneration
SO HIGH VALUE MANUFACTURING: ADVANCED RESEARCH IN VIRTUAL AND RAPID
   PROTOTYPING
LA English
DT Proceedings Paper
CT 6th International Conference on Advanced Research in Virtual and
   Physical Prototyping (VRatP)
CY OCT 01-05, 2013
CL Leiria, PORTUGAL
SP Polytechn Inst Leiria, Ctr Rapid & Sustainable Prod Dev
ID CALCIUM-CARBONATE; PCL SCAFFOLDS; WASTE; PERFORMANCE; COMPOSITES
AB Hen eggshells (ES), a natural biomaterial from bone-like minerals, have been considered as promising bone substitutes to be totally resorbable and biocompatible with good osteoconductivity. The purpose of this study was to investigate the addition of untreated and treated (by different methods) ES powder on poly(e-caprolactone) (PCL). Scaffolds were produced using an extrusion-based process called Dual-Bioextruder, which is based on the extrusion of thin filaments of low melting point biomaterials in a layer-by-layer fashion. Morphological and chemical analyses were performed to investigate the influence of ES powder on the PCL properties.
C1 [Biscaia, S.; Viana, T.; Almeida, H. A.; Bartolo, P. J.] Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Leiria, Portugal.
RP Biscaia, S (reprint author), Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Leiria, Portugal.
RI Almeida, Henrique/D-6275-2012
OI Almeida, Henrique/0000-0002-1367-2290
CR AIST, SPECTR DAT ORG COMP
   Asghar W, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/47/475601
   Balaz P, 2013, MATER MANUF PROCESS, V28, P343, DOI 10.1080/10426914.2012.709294
   Bartolo PJ, 2009, VIRTUAL PHYS PROTOTY, V4, P203, DOI 10.1080/17452750903476288
   Bartolo P, 2012, CIRP ANN-MANUF TECHN, V61, P635, DOI 10.1016/j.cirp.2012.05.005
   Bartolo PJ, 2008, ADV PROCESSES FABRIC
   Bootklad M, 2013, CARBOHYD POLYM, V97, P315, DOI 10.1016/j.carbpol.2013.05.030
   Chattopadhyay S, 2012, PROCESS BIOCHEM, V47, P749, DOI 10.1016/j.procbio.2012.02.003
   Chuenjitkuntaworn B., 2010, J BIOMEDICAL MAT R A, P242
   Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031
   Domingos M, 2011, VIRTUAL PHYS PROTOTY, V6, P157, DOI 10.1080/17452759.2011.605839
   Domingos M, 2009, INT J BIOMATER, DOI 10.1155/2009/239643
   Durmus E, 2008, J BIOMED MATER RES B, V86B, P82, DOI 10.1002/jbm.b.30990
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   Elzubair A, 2006, J DENT, V34, P784, DOI 10.1016/j.jdent.2006.03.002
   Gao Y, 2012, CATAL TODAY, V190, P107, DOI 10.1016/j.cattod.2011.12.004
   Ghasemi-Mobarakeh L, 2010, MAT SCI ENG C-MATER, V30, P1129, DOI 10.1016/j.msec.2010.06.004
   Giannatsis J, 2009, INT J ADV MANUF TECH, V40, P116, DOI 10.1007/s00170-007-1308-1
   Ho WF, 2013, CERAM INT, V39, P6467, DOI 10.1016/j.ceramint.2013.01.076
   Hutmacher D. W., 2004, TRENDS BIOTECHNOL, V22, P355
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Kang X, 2012, J APPL POLYM SCI, V124, pE83
   Khalil S, 2005, RAPID PROTOTYPING J, V11, P9, DOI 10.1108/13552540510573347
   Kumar G. S., CERAMICS INT
   Martinez-Abad A, 2013, FOOD CONTROL, V34, P214, DOI 10.1016/j.foodcont.2013.04.025
   Mota C, 2011, MATERIALS, V4, P527, DOI 10.3390/ma4030527
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   Park JW, 2008, J BIOMED MATER RES A, V87A, P203, DOI 10.1002/jbm.a.31768
   Ren JW, 2012, CHEM IND CHEM ENG Q, V18, P221, DOI 10.2298/CICEQ110919063R
   Sariibrahimoglu K, 2012, J BIOMED MATER RES A, V100A, P712, DOI 10.1002/jbm.a.34009
   Sousa I, 2013, PROCEDIA ENGINEER, V59, P279, DOI 10.1016/j.proeng.2013.05.122
   Tavangar A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-1
   Toro P, 2007, MATER LETT, V61, P4347, DOI 10.1016/j.matlet.2007.01.102
   Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050
   Viana T, 2013, PROCEDIA ENGINEER, V59, P255, DOI 10.1016/j.proeng.2013.05.119
   Wu SC, 2013, CERAM INT, V39, P8183, DOI 10.1016/j.ceramint.2013.03.094
   Yoo S, 2009, BIORESOURCE TECHNOL, V100, P6416, DOI 10.1016/j.biortech.2009.06.112
NR 37
TC 0
Z9 0
U1 0
U2 2
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-315-81741-5
PY 2014
BP 171
EP 176
PG 6
WC Engineering, Manufacturing
SC Engineering
GA BA7YH
UT WOS:000337900800029
DA 2018-10-20
ER

PT B
AU Sousa, I
   Mendes, A
   Bartolo, PJ
   Vaz, D
AF Sousa, I.
   Mendes, A.
   Bartolo, P. J.
   Vaz, D.
BE Bartolo, PJD
   DeLemos, ACS
   Pereira, AMH
   Mateus, AJD
   Ramos, C
   DosSantos, C
   Oliveira, D
   Pinto, E
   Craveiro, F
   Bartolo, HMCDTG
   Almeia, HD
   Sousa, I
   Matias, JM
   Durao, L
   Gaspar, M
   Alves, NMF
   Carreira, P
   Ferreira, T
   Marques, T
TI Bovine collagen extraction for tissue engineering applications
SO HIGH VALUE MANUFACTURING: ADVANCED RESEARCH IN VIRTUAL AND RAPID
   PROTOTYPING
LA English
DT Proceedings Paper
CT 6th International Conference on Advanced Research in Virtual and
   Physical Prototyping (VRatP)
CY OCT 01-05, 2013
CL Leiria, PORTUGAL
SP Polytechn Inst Leiria, Ctr Rapid & Sustainable Prod Dev
ID SURFACE MODIFICATION; ACID
AB This paper aims to obtain PCL scaffolds bioactivators to be used as support matrices for the development of human tissues. PCL is a biomaterial widely used in the biomedical field, due to its biocompatibility, mechanical strength and biodegradability. However, it is hydrophobic, so cell adhesion is difficult. To solve this problem, a coating of PCL scaffolds with collagen was used, since collagen is a hydrophilic protein present in the formation of various tissues, this way improving cell adhesion.
C1 [Sousa, I.; Mendes, A.; Bartolo, P. J.] Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Leiria, Portugal.
   [Vaz, D.] Polytech Inst Leiria, Leiria, Portugal.
RP Sousa, I (reprint author), Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Leiria, Portugal.
OI Barroso de Moura Cipreste Vaz, Daniela/0000-0001-7562-4676
FU Portuguese National Science Foundation (FCT) [UI 4044
   (Pest/OE/EME/UI4044/2011)]
FX This work was funded by the Portuguese National Science Foundation
   (FCT), through the "Strategic Project UI 4044 (Pest/OE/EME/UI4044/2011).
CR Atala A, 2007, J TISSUE ENG REGEN M, V1, P83, DOI 10.1002/term.18
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Dobkowski J, 1999, J BIOMED MATER RES, V47, P234, DOI 10.1002/(SICI)1097-4636(199911)47:2<234::AID-JBM14>3.0.CO;2-X
   Mei N., 2005, J BIOMARIALS APPL, V19, P235
   Rest Michel, 1980, SEPARATION COLLAGEN, P191
   Sell SA, 2009, ADV DRUG DELIVER REV, V61, P1007, DOI 10.1016/j.addr.2009.07.012
   Singh P, 2011, FOOD CHEM, V124, P97, DOI 10.1016/j.foodchem.2010.05.111
   Wu W, 2007, BRIT J ORAL MAX SURG, V45, P272, DOI 10.1016/j.bjoms.2006.09.004
   Zhang F, 2001, BIOMATERIALS, V22, P1541, DOI 10.1016/S0142-9612(00)00310-0
NR 10
TC 0
Z9 0
U1 0
U2 0
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-315-81741-5
PY 2014
BP 177
EP 181
PG 5
WC Engineering, Manufacturing
SC Engineering
GA BA7YH
UT WOS:000337900800030
DA 2018-10-20
ER

PT B
AU Loaiza, M
   Rezende, RA
   da Silva, JVL
   Bartolo, PJ
   Sabino, MA
AF Loaiza, M.
   Rezende, R. A.
   da Silva, J. V. L.
   Bartolo, P. J.
   Sabino, M. A.
BE Bartolo, PJD
   DeLemos, ACS
   Pereira, AMH
   Mateus, AJD
   Ramos, C
   DosSantos, C
   Oliveira, D
   Pinto, E
   Craveiro, F
   Bartolo, HMCDTG
   Almeia, HD
   Sousa, I
   Matias, JM
   Durao, L
   Gaspar, M
   Alves, NMF
   Carreira, P
   Ferreira, T
   Marques, T
TI Chitosan microlayer on the photografting modified surface of PLA, PCL
   and PLA/PCL bioextruder scaffolds
SO HIGH VALUE MANUFACTURING: ADVANCED RESEARCH IN VIRTUAL AND RAPID
   PROTOTYPING
LA English
DT Proceedings Paper
CT 6th International Conference on Advanced Research in Virtual and
   Physical Prototyping (VRatP)
CY OCT 01-05, 2013
CL Leiria, PORTUGAL
SP Polytechn Inst Leiria, Ctr Rapid & Sustainable Prod Dev
ID POLYCAPROLACTONE
AB Polylactic (PLA), Polycaprolactone (PCL) and blend of Polylactid/Polycaprolactone (PLA/PCL) scaffolds constructs composed by layers of microsized filaments (0/90. lay-down pattern), with a diameter of around 400 m and interfilament distance of around 200 m and 10 layers, were produced using a melt extrusion-based additive manufacturing technique. The range composition of these blends used for scaffolding was PLA/PCL [% w/w]= 100/0, 90/10, 80/20, 0/100; and also a graft PLA with maleic anhydride was incorporate as compatibilizer to blend PLA/PLA-g-AM/PCL= 80/10/10 [% w/w]. All polymer blends were prepared using solvent casting technique to avoid thermal degradation during blending. These blends were characterized using Differential Scanning Calorimetric (DSC) to know about compatibility and thermal properties to construct the scaffolds by melt extrusion-additive manufacturing technique.
   In general, one of the limitations to the use of PLA, PLC or PLA/PCL polymer blends as an ideal biomaterial with great biocompatibility is their high hydrofobicity. To improve the hydrofilicity and biocompatibility, after the scaffolds built, a chitosan microlayer was grafted onto scaffolds surface through the combination of photooxidation in hydrogen peroxide/UV exposition.
   Photo-oxidation of these surfaces modification was evaluated using Attenuated Total Reflectance-Fourier Transformed Infrared (ATR-FTIR). After the activation of the scaffolds surface, they were immersed into a chitosan solution, and finally morphologically evaluated using scanning electron microscopy.
   Results show that the surface modificationwas more effective in all blends with PLA phase, and the microlayer of chitosan showed good adhesion to the same cases, allowing infer their biocompatible character.
C1 [Loaiza, M.; Sabino, M. A.] Univ Simon Bolivar, Grp B5IDA, Dept Quim, Caracas, Venezuela.
   [Loaiza, M.] Univ Nacl Expt Francisco Miranda, Dept Quim, Punto Fijo, Venezuela.
   [Rezende, R. A.; da Silva, J. V. L.; Sabino, M. A.] Ctr Tecnol Informacao Renato Archer, Div Tecnol 3D, Campinas, SP, Brazil.
   [Bartolo, P. J.] Zona Ind, Inst Politecn Leiria, Ctr Desenvolvimento Rapido & Sustentado Prod, Leiria, Portugal.
RP Loaiza, M (reprint author), Univ Simon Bolivar, Grp B5IDA, Dept Quim, Caracas, Venezuela.
FU Research Foundation of the State of Sao Paulo (FAPESP) Brazil
   [2010/20763-0, 2012/19302-4]
FX Authors want to acknowledgements at: CDRsP Center for Rapid and
   Sustainable Product Development, IPLLeiria, Portugal. Universidad
   Nacional Experimental Francisco de Miranda, UNEFM, Falccn- Venezuela.
   The Research Foundation of the State of Sao Paulo (FAPESP) Brazil, for
   the scholarship funding process No.: 2010/20763-0 and 2012/19302-4.
   Also, Simcn Bolivar University (USB) for sabbatical year of Prof. M.
   Sabino (Caracas-Venezuela).
CR Bikiaris D.N., 2013, POLYM DEGRA IN PRESS
   Brito Y, 2008, J APPL POLYM SCI, V110, P3848, DOI 10.1002/app.28883
   Castillo RV, 2009, PROG POLYM SCI, V34, P516, DOI 10.1016/j.progpolymsci.2009.03.002
   Chaim IA, 2012, J TISSUE ENG REGEN M, V6, P272, DOI 10.1002/term.430
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Hayashi Y, 2012, ADV FOOD NUTR RES, V65, P107, DOI 10.1016/B978-0-12-416003-3.00006-8
   Kundu J, 2013, BIOFABRICATION: MICRO- AND NANO-FABRICATION, PRINTING, PATTERNING, AND ASSEMBLIES, P23
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Perez RA, 2013, ADV DRUG DELIVER REV, V65, P471, DOI 10.1016/j.addr.2012.03.009
   Rezende RA, 2013, PROC CIRP, V5, P276, DOI 10.1016/j.procir.2013.01.054
   Sabino MA, 2007, POLYM DEGRAD STABIL, V92, P986, DOI 10.1016/j.polymdegradstab.2007.03.010
   Sangsanoh P, 2010, EUR POLYM J, V46, P428, DOI 10.1016/j.eurpolymj.2009.10.029
   Singh M, 2013, BIOMATERIALS SCI INT, P1138
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Zhu YB, 2002, BIOMATERIALS, V23, P4889, DOI 10.1016/S0142-9612(02)00247-8
NR 16
TC 0
Z9 0
U1 0
U2 21
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-315-81741-5
PY 2014
BP 183
EP 187
PG 5
WC Engineering, Manufacturing
SC Engineering
GA BA7YH
UT WOS:000337900800031
DA 2018-10-20
ER

PT B
AU Almeida, RS
   d'Avila, MA
   Martinez, DST
   Alves, OL
AF Almeida, R. S.
   d'Avila, M. A.
   Martinez, D. S. T.
   Alves, O. L.
BE Bartolo, PJD
   DeLemos, ACS
   Pereira, AMH
   Mateus, AJD
   Ramos, C
   DosSantos, C
   Oliveira, D
   Pinto, E
   Craveiro, F
   Bartolo, HMCDTG
   Almeia, HD
   Sousa, I
   Matias, JM
   Durao, L
   Gaspar, M
   Alves, NMF
   Carreira, P
   Ferreira, T
   Marques, T
TI Nanocomposite polycaprolactone/Carbon Nanotube processed by
   electrospinning applying of AC
SO HIGH VALUE MANUFACTURING: ADVANCED RESEARCH IN VIRTUAL AND RAPID
   PROTOTYPING
LA English
DT Proceedings Paper
CT 6th International Conference on Advanced Research in Virtual and
   Physical Prototyping (VRatP)
CY OCT 01-05, 2013
CL Leiria, PORTUGAL
SP Polytechn Inst Leiria, Ctr Rapid & Sustainable Prod Dev
AB Poly (e-caprolactone) (PCL) has been widely used as a biomaterial in recent years. Its biocompatibility and good thermo-mechanical properties are the main features that lead to the selection of these materials for biomedical and pharmaceutical applications. The aim of this work was the processing and characterization of PCL/carbon nanotube (CNT) fibers mats with diameters in the nano and micrometer scale by electrospinning, combining the application of an Alternating Current (AC) and Direct Current (DC) aiming the formation of oriented fibers and control of the jet flow stability in order to determine process parameters and compare the effects of different frequencies during processing. The samples were characterized by Scanning Electron Microscopy (SEM), where the influence of frequency on the average diameter of fibers was observed. The interaction between PCL and carbon nanotube (NTC) was assessed by FTIR.
C1 [Almeida, R. S.; d'Avila, M. A.] Univ Estadual Campinas, UNICAMP, Sch Mech Engn, Campinas, SP, Brazil.
   [Martinez, D. S. T.; Alves, O. L.] Univ Estadual Campinas, Inst Chem, UNICAMP, Campinas, Brazil.
RP Almeida, RS (reprint author), Univ Estadual Campinas, UNICAMP, Sch Mech Engn, Campinas, SP, Brazil.
RI Alves, Oswaldo/J-7124-2012
OI Alves, Oswaldo/0000-0002-1518-2092
CR Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Costa RGF, 2012, POLIMEROS, V22, P178, DOI 10.1590/S0104-14282012005000018
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Ishii Y, 2008, MATER LETT, V62, P3370, DOI 10.1016/j.matlet.2008.03.038
   Kessick R, 2004, POLYMER, V45, P2981, DOI 10.1016/j.polymer.2004.02.056
   Lee H, 2009, APPL PHYS A-MATER, V97, P559, DOI 10.1007/s00339-009-5371-3
   Ochanda FO, 2012, J APPL POLYM SCI, V123, P1112, DOI 10.1002/app.34583
   Ramaswamy S, 2011, POLYMER, V52, P3183, DOI 10.1016/j.polymer.2011.05.023
   Sarkar S, 2007, MACROMOL RAPID COMM, V28, P1034, DOI 10.1002/marc.200700053
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   Yellampalli S., 2011, CARBON NANOTUBES POL
   Yijun L., 2012, J WUHAN UNIV TECHNOL, V27, P207
   Zhang DH, 2006, J PHYS CHEM B, V110, P12910, DOI 10.1021/jp061628k
NR 13
TC 1
Z9 1
U1 0
U2 12
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-315-81741-5
PY 2014
BP 217
EP 219
PG 3
WC Engineering, Manufacturing
SC Engineering
GA BA7YH
UT WOS:000337900800037
DA 2018-10-20
ER

PT B
AU Lima, LL
   Zavaglia, CAC
   Bavaresco, VP
   Pinto, E
   Bartolo, PJS
   Gomes, JMR
AF Lima, L. L.
   Zavaglia, C. A. C.
   Bavaresco, V. P.
   Pinto, E.
   Bartolo, P. J. S.
   Gomes, J. M. R.
BE Bartolo, PJD
   DeLemos, ACS
   Pereira, AMH
   Mateus, AJD
   Ramos, C
   DosSantos, C
   Oliveira, D
   Pinto, E
   Craveiro, F
   Bartolo, HMCDTG
   Almeia, HD
   Sousa, I
   Matias, JM
   Durao, L
   Gaspar, M
   Alves, NMF
   Carreira, P
   Ferreira, T
   Marques, T
TI Photopolymerization kinetics of 2-Hydroxyethyl Methacrylate (pHEMA)
   hydrogels, effect of different crosslinked agent
SO HIGH VALUE MANUFACTURING: ADVANCED RESEARCH IN VIRTUAL AND RAPID
   PROTOTYPING
LA English
DT Proceedings Paper
CT 6th International Conference on Advanced Research in Virtual and
   Physical Prototyping (VRatP)
CY OCT 01-05, 2013
CL Leiria, PORTUGAL
SP Polytechn Inst Leiria, Ctr Rapid & Sustainable Prod Dev
ID CARTILAGE; SCAFFOLDS
AB The photopolymerization kinect of 2-Hydroxyethyl Methacrylate (pHEMA) copolymerized with 1-Vinyl-2-Pyrrolidinone hydrogels was performad using the mu STLG mm (Micro Stereo-thermal-lithography multi-material) machine. In this study was used two differents crosslinked agent, and interaction time were varied to obtain the optimal parameters to photopolimerization the hydrogels. The kinect study improves to guarantee the uniformity in material curing, refleting consequently on mechanical resistance, and thus avoiding possible dimensional errors in the built part. Many works and studies were realized using pHEMA hydrogels, because this biomaterial have biocompatibility and similar mechanical resistance of soft tissues.
C1 [Lima, L. L.; Zavaglia, C. A. C.] Univ Estadual Campinas, UNICAMP, INCT Biofabris, Campinas, SP, Brazil.
   [Bavaresco, V. P.] Univ Estadual Campinas, CTC, Campinas, SP, Brazil.
   [Pinto, E.; Bartolo, P. J. S.] Ctr Rapid & Sustainable Prod Dev, Leiria, Portugal.
   [Gomes, J. M. R.] Univ Minho, CIICS, Dept Mech Engn, Guimaraes, Portugal.
RP Lima, LL (reprint author), Univ Estadual Campinas, UNICAMP, INCT Biofabris, Campinas, SP, Brazil.
CR Andrzejewska E, 2001, PROG POLYM SCI, V26, P605, DOI 10.1016/S0079-6700(01)00004-1
   [Anonymous], 2011, CURRENT APPL PHYS, V11, P945
   Bartolo PJ, 2011, STEREOLITHOGRAPHY: MATERIALS, PROCESSES AND APPLICATIONS, P1
   Bartolo PJ, 2003, RAPID PROTOTYPING J, V9, P150, DOI 10.1108/13552540310477454
   Bavaresco VP, 2008, WEAR, V265, P269, DOI 10.1016/j.wear.2007.10.009
   Bryant SJ, 2008, PHARM RES-DORDR, V25, P2379, DOI 10.1007/s11095-008-9619-y
   Chua C. K., 2003, RAPID PROTOTYPING PR, P420
   Ejaz M, 2011, POLYMER, V52, P5262, DOI 10.1016/j.polymer.2011.09.018
   Fouassier J.P., 1995, PHOTOINICIATION PHOT
   Horak D, 2008, POLYMER, V49, P2046, DOI 10.1016/j.polymer.2008.02.041
   Kishida A, 2002, HYDROGELS BIOMEDICAL, P13
   Kubinova S, 2009, BIOMATERIALS, V30, P4601, DOI 10.1016/j.biomaterials.2009.05.007
   Magalhaes J., 2012, SYNTHESIS CHARACTERI, P157
   Noorani R, 2006, RAPID PROTOTYPING PR, P377
   Orefice R. L., 2006, BIOMATERIALS FUNDAME, P538
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Stucker B. E, 2007, LAYER BASED ADDITIVE, P32
   Zhou B, 2011, J MECH BEHAV BIOMED, V4, P1336, DOI 10.1016/j.jmbbm.2011.05.002
NR 18
TC 1
Z9 1
U1 0
U2 5
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-315-81741-5
PY 2014
BP 315
EP 317
PG 3
WC Engineering, Manufacturing
SC Engineering
GA BA7YH
UT WOS:000337900800054
DA 2018-10-20
ER

PT J
AU Loeffelbein, DJ
   Rohleder, NH
   Eddicks, M
   Baumann, C
   Stoeckelhuber, M
   Wolff, KD
   Drecoll, E
   Steinstraesser, L
   Hennerbichler, S
   Kesting, MR
AF Loeffelbein, Denys J.
   Rohleder, Nils H.
   Eddicks, Matthias
   Baumann, ClaudiaM.
   Stoeckelhuber, Mechthild
   Wolff, Klaus-D.
   Drecoll, Enken
   Steinstraesser, Lars
   Hennerbichler, Simone
   Kesting, Marco R.
TI Evaluation of Human Amniotic Membrane as a Wound Dressing for
   Split-Thickness Skin-Graft Donor Sites
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID DEVELOPING-COUNTRIES; CORNEAL; BURN; REEPITHELIALIZATION;
   TRANSPLANTATION; PROLIFERATION; MYOFIBROBLAST; REGENERATION;
   FIBROBLASTS; SUPPRESSION
AB Human amniotic membrane (HAM) has been used as a biomaterial in various surgical procedures and exceeds some qualities of common materials. We evaluated HAM as wound dressing for split-thickness skin-graft (STSG) donor sites in a swine model (Part A) and a clinical trial (Part B). Part A: STSG donor sites in 4 piglets were treated with HAM or a clinically used conventional polyurethane (PU) foil (n = 8 each). Biopsies were taken on days 5, 7, 10, 20, 40, and 60 and investigated immunohistochemically for alpha-smooth muscle actin (alpha SMA: wound contraction marker), von Willebrand factor (vWF: angiogenesis), Ki-67 (cell proliferation), and laminin (basement membrane integrity). Part B: STSG donor sites in 45 adult patients (16 female/29 male) were treated with HAM covered by PU foam, solely by PU foam, or PU foil/paraffin gauze (n = 15 each). Part A revealed no difference in the rate of wound closure between groups. HAM showed improved esthetic results and inhibitory effects on cicatrization. Angioneogenesis was reduced, and basement membrane formation was accelerated in HAM group. Part B: no difference in reepithelialization/infection rate was found. HAM caused less ichor exudation and less pruritus. HAM has no relevant advantage over conventional dressings but might be a cost-effective alternative.
C1 [Loeffelbein, Denys J.; Rohleder, Nils H.; Baumann, ClaudiaM.; Stoeckelhuber, Mechthild; Wolff, Klaus-D.; Kesting, Marco R.] Tech Univ Munich, Dept Oral & Maxillofacial Surg, D-81675 Munich, Germany.
   [Eddicks, Matthias] Univ Munich, Fac Vet Med, Clin Swine, D-85764 Oberschleissheim, Germany.
   [Drecoll, Enken] Tech Univ Munich, Dept Pathol, D-81675 Munich, Germany.
   [Steinstraesser, Lars] Carl von Ossietzky Univ Oldenburg, European Med Sch, Dept Plast Reconstruct & Aesthet Surg, D-26122 Oldenburg, Germany.
   [Hennerbichler, Simone] Red Cross Blood Transfus Serv Upper Austria, Austrian Cluster Tissue Regenerat, A-4017 Linz, Austria.
RP Rohleder, NH (reprint author), Tech Univ Munich, Dept Oral & Maxillofacial Surg, Ismaninger Str 22, D-81675 Munich, Germany.
EM rohleder@mkg.med.tum.de
RI Eddicks, Matthias/K-7669-2014
OI Rohleder, Nils/0000-0002-7905-2924
FU Medical Faculty of the Ruhr University Bochum (FoRUM) [F321/01]
FX This work was supported by the Medical Faculty of the Ruhr University
   Bochum (FoRUM, F321/01). The results are part of the HAM research by Dr.
   Kesting awarded with the Scientific Prize of the German Association of
   Oral and Maxillofacial Surgery 2011 (results published for the first
   time in this paper) and are part of doctoral theses presented by C. M.
   Baumann and J. Teichmann for fulfillment of their doctoral degree at the
   Technische Universitat Munchen.
CR Ahn JI, 2007, ARTIF ORGANS, V31, P711, DOI 10.1111/j.1525-1594.2007.00441.x
   Andree C, 2001, PLAST RECONSTR SURG, V107, P97, DOI 10.1097/00006534-200101000-00015
   Andriessen Monique P., 1998, Journal of Pathology, V186, P192, DOI 10.1002/(SICI)1096-9896(1998100)186:2<192::AID-PATH163>3.0.CO;2-X
   BENNETT JP, 1980, LANCET, V1, P1153
   Branski LK, 2008, BURNS, V34, P393, DOI 10.1016/j.burns.2007.06.007
   DAVIS JW, 1910, J HOPKINS MED J, V15, P307
   Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x
   Druecke D, 2004, WOUND REPAIR REGEN, V12, P518, DOI 10.1111/j.1067-1927.2004.012504.x
   Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001
   FAULK WP, 1980, LANCET, V1, P1156
   Fraser JF, 2009, BURNS, V35, P998, DOI 10.1016/j.burns.2009.01.003
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Hennerbichler Simone, 2007, Cell and Tissue Banking, V8, P1, DOI 10.1007/s10561-006-9002-3
   Horch RE, 2013, J CELL MOL MED, V17, P1197, DOI 10.1111/jcmm.12130
   Kanyshkova TG, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1, DOI 10.1023/A:1002817226110
   Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794
   KNAGGS HE, 1994, J INVEST DERMATOL, V102, P89, DOI 10.1111/1523-1747.ep12371738
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Kopp J, 2006, J CELL MOL MED, V10, P157, DOI 10.1111/j.1582-4934.2006.tb00297.x
   Kubo M, 2001, INVEST OPHTH VIS SCI, V42, P1539
   KUCAN JO, 1982, ANN PLAS SURG, V8, P523, DOI 10.1097/00000637-198206000-00012
   Ladin Daniel A., 1995, Wound Repair and Regeneration, V3, P6, DOI 10.1046/j.1524-475X.1995.30106.x
   Laurent R., CELL TISSUE IN PRESS
   Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4
   Lo V, 2009, INT J DERMATOL, V48, P935, DOI 10.1111/j.1365-4632.2009.04173.x
   Loeffelbein DJ, 2012, J BIOMED MATER RES B, V100B, P1245, DOI 10.1002/jbm.b.32689
   Maral T, 1999, BURNS, V25, P625, DOI 10.1016/S0305-4179(99)00072-8
   Meller D, 2011, DTSCH ARZTEBL INT, V108, P243, DOI 10.3238/arztebl.2011.0243
   MUIR IFK, 1990, BRIT J PLAST SURG, V43, P61, DOI 10.1016/0007-1226(90)90046-3
   PISERCHIA NE, 1981, TROP GEOGR MED, V33, P235
   Ramakrishnan KM, 1997, BURNS, V23, pS33, DOI 10.1016/S0305-4179(97)90099-1
   Rolfo A, 2014, AGING MALE, V17, P94, DOI 10.3109/13685538.2014.896894
   Rommel N, 2013, BRIT J ORAL MAX SURG, V51, pE224, DOI 10.1016/j.bjoms.2013.01.016
   Shimizu T, 1997, DERMATOLOGY, V195, P224, DOI 10.1159/000245947
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   Splichal I, 2001, FOLIA MICROBIOL, V46, P345, DOI 10.1007/BF02815625
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   Usui ML, 2005, WOUND REPAIR REGEN, V13, P468, DOI 10.1111/j.1067-1927.2005.00067.x
   WALKER AB, 1977, J PEDIATR SURG, V12, P391, DOI 10.1016/0022-3468(77)90015-X
   Wolbank S, 2009, J TISSUE ENG REGEN M, V3, P651, DOI 10.1002/term.207
   Yates CC, 2009, WOUND REPAIR REGEN, V17, P34, DOI 10.1111/j.1524-475X.2008.00439.x
   YOUNG CMA, 1980, MICROVASC RES, V20, P182, DOI 10.1016/0026-2862(80)90006-0
NR 42
TC 15
Z9 17
U1 0
U2 7
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 572183
DI 10.1155/2014/572183
PG 12
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AJ6UT
UT WOS:000337832400001
PM 25003117
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Kainz, B
   Oprzeska-Zingrebe, EA
   Toca-Herrera, JL
AF Kainz, Birgit
   Oprzeska-Zingrebe, Ewa A.
   Toca-Herrera, Jose L.
TI Biomaterial and cellular properties as examined through atomic force
   microscopy, fluorescence optical microscopies and spectroscopic
   techniques
SO BIOTECHNOLOGY JOURNAL
LA English
DT Review
DE Biological systems; Microscopy; Scanning probe microscopy; Soft matter;
   Spectroscopy
ID SUPPORTED LIPID-BILAYERS; LIVING CELLS; ADHESION FORCES; VERSATILE TOOL;
   COMBINED AFM; RAMAN; POLYELECTROLYTES; ORGANIZATION; RESOLUTION;
   MECHANICS
AB Colloids, polymers, gels, and biological materials are widely used for numerous technological applications. The design, fabrication, and understanding of the physico-chemical properties of such (bio) materials, however, represent a challenge for scientists and technologists. This review is a concise update of the latest achievements in surface and bulk analytical techniques applied to biomaterials and soft matter systems. Specific emphasis is devoted to their structural, mechanical, surface, and chemical properties. The review introduces the basics of atomic force microscopy (AFM) and discusses its combination with optical microscopies and spectroscopic techniques. In particular, we report the AFM combination with fluorescence, confocal microscopy, stimulated emission depletion, Raman, and infrared spectroscopy. The review highlights the impact and the potential applications of the combination of such experimental techniques on current problems and questions related to material and polymer science, cell biology, biochemical engineering, and protein chemistry. This review is an accessible introduction to AFM for the newcomer and a source of new experimental information for the experienced researcher.
C1 [Kainz, Birgit] Croma Pharma GmbH Leobendorf, Korneuburg, Austria.
   [Oprzeska-Zingrebe, Ewa A.; Toca-Herrera, Jose L.] Univ Nat Resources & Life Sci Vienna BOKU, Inst Biophys, Dept Nanobiotechnol, A-1190 Vienna, Austria.
RP Toca-Herrera, JL (reprint author), Univ Nat Resources & Life Sci Vienna BOKU, Inst Biophys, Dept Nanobiotechnol, Muthgasse 11, A-1190 Vienna, Austria.
EM jose.toca-herrera@boku.ac.at
FU IGS Program of the Federal Ministry for Science and Research (Austria)
FX EAOZ thanks the IGS Program of the Federal Ministry for Science and
   Research (Austria) for financial support. The authors thank Dr. K.
   Melzak for Fig. 2A.
CR Alessandrini A, 2005, MEAS SCI TECHNOL, V16, pR65, DOI 10.1088/0957-0233/16/6/R01
   AMBROSE EJ, 1956, NATURE, V178, P1194, DOI 10.1038/1781194a0
   Ando T, 2013, ANNU REV BIOPHYS, V42, P393, DOI 10.1146/annurev-biophys-083012-130324
   Arrondo JLR, 1998, CHEM PHYS LIPIDS, V96, P53, DOI 10.1016/S0009-3084(98)00080-2
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Benoit M, 2002, CELLS TISSUES ORGANS, V172, P174, DOI 10.1159/000066964
   Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025
   Borkovec M, 2012, ADV COLLOID INTERFAC, V179, P85, DOI 10.1016/j.cis.2012.06.005
   Bornschlogl T, 2011, METHODS MOL BIOL, V783, P233, DOI 10.1007/978-1-61779-282-3_13
   Brackmann C, 2011, J RAMAN SPECTROSC, V42, P586, DOI 10.1002/jrs.2778
   Brown AEX, 2009, BIOPHYS J, V96, P1952, DOI 10.1016/j.bpj.2008.11.032
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Cheng JX, 2002, BIOPHYS J, V83, P502, DOI 10.1016/S0006-3495(02)75186-2
   Cialla D, 2009, J RAMAN SPECTROSC, V40, P240, DOI 10.1002/jrs.2123
   Dazzi A, 2008, ULTRAMICROSCOPY, V108, P635, DOI 10.1016/j.ultramic.2007.10.008
   Dazzi A, 2007, ULTRAMICROSCOPY, V107, P1194, DOI 10.1016/j.ultramic.2007.01.018
   Deckert-Gaudig T, 2011, CURR OPIN CHEM BIOL, V15, P719, DOI 10.1016/j.cbpa.2011.06.020
   Deckert-Gaudig T, 2010, PHYS CHEM CHEM PHYS, V12, P12040, DOI 10.1039/c003316b
   Delcea M, 2010, SMALL, V6, P2858, DOI 10.1002/smll.201001478
   DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0
   Dufrene YF, 2004, NAT REV MICROBIOL, V2, P451, DOI 10.1038/nrmicro905
   Dufrene YF, 2013, NANOSCALE, V5, P4094, DOI 10.1039/c3nr00340j
   Elfick APD, 2010, ANAL BIOANAL CHEM, V396, P45, DOI 10.1007/s00216-009-3223-9
   Etchegoin PG, 2008, PHYS CHEM CHEM PHYS, V10, P6079, DOI 10.1039/b809196j
   Felts JR, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4793229
   Flores SM, 2009, NANOSCALE, V1, P40, DOI 10.1039/b9nr00156e
   Franz CM, 2008, CELL MOL BIOENG, V1, P289, DOI 10.1007/s12195-008-0037-3
   Friedrichs J, 2010, NAT PROTOC, V5, P1353, DOI 10.1038/nprot.2010.89
   Giancoli D. C., 2010, PHYSIK
   Harke B., 2012, OPT NANOSCOPY, V1, P3, DOI DOI 10.1186/2192-2853-1-3
   Hecht E, 2012, ANALYST, V137, P5208, DOI 10.1039/c2an36001b
   Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999
   HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780
   Hemley I. W., 2007, INTRO SOFT MATTER SY
   Henderson E, 1993, Neuroimage, V1, P145, DOI 10.1006/nimg.1993.1007
   Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871
   Horton M., 2000, Single Molecules, V1, P135, DOI 10.1002/1438-5171(200006)1:2<135::AID-SIMO135>3.0.CO;2-S
   Hugel T, 2001, MACROMOL RAPID COMM, V22, P989, DOI 10.1002/1521-3927(20010901)22:13<989::AID-MARC989>3.0.CO;2-D
   Ichimura T., 2010, SURFACE ENHANCED RAM
   Inaba T, 2011, LANGMUIR, V27, P12515, DOI 10.1021/la2033548
   Jalili N, 2004, MECHATRONICS, V14, P907, DOI 10.1016/j.mechatronics.2004.04.005
   Kassies R, 2005, J MICROSC-OXFORD, V217, P109, DOI 10.1111/j.0022-2720.2005.01428.x
   Kellermayer MSZ, 2006, BIOPHYS J, V91, P2665, DOI 10.1529/biophysj.106.085456
   Kennedy E, 2011, J BIOPHOTONICS, V4, P588, DOI 10.1002/jbio.201100003
   Klar T. A., 2001, PHYS REV E, V64
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Lama G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052530
   Lejardi A, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811778
   Liu SY, 2010, SCANNING, V32, P61, DOI 10.1002/sca.20173
   Mathur AB, 2000, BIOPHYS J, V78, P1725, DOI 10.1016/S0006-3495(00)76724-5
   Melzak KA, 2011, SOFT MATTER, V7, P332, DOI 10.1039/c0sm00425a
   Moreno-Flores S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/44/445101
   Moreno-Flores S, 2010, MICROSC RES TECHNIQ, V73, P746, DOI 10.1002/jemt.20816
   MorenoFlores S, 2013, HYBRIDIZING SURFACE PROBE MICROSCOPIES: TOWARD A FULL DESCRIPTION OF THE MESO- AND NANOWORLDS, P1
   Morris V.J, 1999, ATOMIC FORCE MICROSC
   MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660
   Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100
   Nagao E, 1998, J MICROSC-OXFORD, V191, P8
   OBERLEITHNER H, 1995, KIDNEY INT, V48, P923, DOI 10.1038/ki.1995.373
   Oreopoulos J, 2010, BIOPHYS J, V98, P815, DOI 10.1016/j.bpj.2009.12.4327
   Oreopoulos J, 2009, BIOPHYS J, V96, P1970, DOI 10.1016/j.bpj.2008.11.041
   Paddock S. W., 1998, METHODS MOL BIOL
   Palankar R, 2013, J MATER CHEM B, V1, P1175, DOI 10.1039/c2tb00319h
   Patil SM, 2011, BIOCHEMISTRY-US, V50, P2808, DOI 10.1021/bi101908m
   Popa I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.228301
   Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003
   Radmacher M, 2002, METHOD CELL BIOL, V68, P67
   Raether H., 1988, SURFACE PLASMONS SMO
   Scheuring S, 2010, MOL MICROBIOL, V75, P1327, DOI 10.1111/j.1365-2958.2010.07064.x
   Serdyuk IN, 2007, METHODS IN MOLECULAR BIOPHYSICS: STRUCTURE, DYNAMICS, FUNCTION, P1
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Tabor RF, 2011, J PHYS CHEM LETT, V2, P961, DOI 10.1021/jz2003606
   Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1
   Trache A., 2010, JOVE-J VIS EXP, V44, P2072
   Verity JE, 2009, BIOPHYS J, V97, P1225, DOI 10.1016/j.bpj.2009.06.013
   Wong J, 1999, BIOMOL ENG, V16, P45, DOI 10.1016/S1050-3862(99)00035-2
   Wood BR, 2011, NANO LETT, V11, P1868, DOI 10.1021/nl103004n
NR 78
TC 8
Z9 8
U1 2
U2 101
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1860-6768
EI 1860-7314
J9 BIOTECHNOL J
JI Biotechnol. J.
PD JAN
PY 2014
VL 9
IS 1
SI SI
BP 51
EP 60
DI 10.1002/biot.201300087
PG 10
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA AJ3BM
UT WOS:000337540100006
PM 24265117
DA 2018-10-20
ER

PT J
AU Bugli, F
   Caprettini, V
   Cacaci, M
   Martini, C
   Sterbini, FP
   Torelli, R
   Della Longa, S
   Papi, M
   Palmieri, V
   Giardina, B
   Posteraro, B
   Sanguinetti, M
   Arcovito, A
AF Bugli, Francesca
   Caprettini, Valeria
   Cacaci, Margherita
   Martini, Cecilia
   Sterbini, Francesco Paroni
   Torelli, Riccardo
   Della Longa, Stefano
   Papi, Massimiliano
   Palmieri, Valentina
   Giardina, Bruno
   Posteraro, Brunella
   Sanguinetti, Maurizio
   Arcovito, Alessandro
TI Synthesis and characterization of different immunogenic viral
   nanoconstructs from rotavirus VP6 inner capsid protein
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE Virus-like particles; protein-based nanotubes; SUMO fusion tag; human
   rotavirus vaccine
ID VIRUS-LIKE PARTICLES; ATOMIC-FORCE MICROSCOPY; RECOMBINANT PROTEINS;
   DRUG-DELIVERY; FUSION; PURIFICATION; EXPRESSION; VACCINE; SOLUBILITY;
   POLYMERASE
AB In order to deliver low-cost viral capsomeres from a large amount of soluble viral VP6 protein from human rotavirus, we developed and optimized a biotechnological platform in Escherichia coli. Specifically, three different expression protocols were compared, differing in their genetic constructs, ie, a simple native histidine-tagged VP6 sequence, VP6 fused to thioredoxin, and VP6 obtained with the newly described small ubiquitin-like modifier ( SUMO) fusion system. Our results demonstrate that the histidine-tagged protein does not escape the accumulation in the inclusion bodies, and that SUMO is largely superior to the thioredoxin-fusion tag in enhancing the expression and solubility of VP6 protein. Moreover, the VP6 protein produced according to the SUMO fusion tag displays well-known assembly properties, as observed in both transmission electron microscopy and atomic force microscopy images, giving rise to either VP6 trimers, 60 nm spherical virus-like particles, or nanotubes a few microns long. This different quaternary organization of VP6 shows a higher level of immunogenicity for the elongated structures with respect to the spheres or the protein trimers. Therefore, the expression and purification strategy presented here-providing a large amount of the viral capsid protein in the native form with relatively simple, rapid, and economical procedures - opens a new route toward large-scale production of a more efficient antigenic compound to be used as a vaccination tool or as an adjuvant, and also represents a top-quality biomaterial to be further modified for biotechnological purposes.
C1 [Bugli, Francesca; Cacaci, Margherita; Martini, Cecilia; Sterbini, Francesco Paroni; Torelli, Riccardo; Posteraro, Brunella; Sanguinetti, Maurizio] Univ Cattolica Sacro Cuore, Ist Microbiol, I-00168 Rome, Italy.
   [Caprettini, Valeria] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy.
   [Della Longa, Stefano] Univ Aquila, Dipartimento Med Clin Sanita Pubbl Sci Vita & Amb, I-67100 Laquila, Italy.
   [Papi, Massimiliano; Palmieri, Valentina] Univ Cattolica Sacro Cuore, Ist Fis, I-00168 Rome, Italy.
   [Giardina, Bruno; Arcovito, Alessandro] Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, I-00168 Rome, Italy.
RP Arcovito, A (reprint author), Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, 1 Largo Francesco Vito, I-00168 Rome, Italy.
EM alessandro.arcovito@rm.unicatt.it
RI Palmieri, Valentina/H-7836-2012; Arcovito, Alessandro/I-5552-2012;
   Paroni Sterbini, Francesco/K-9290-2016
OI Palmieri, Valentina/0000-0002-6358-9647; Arcovito,
   Alessandro/0000-0002-8384-4844; Paroni Sterbini,
   Francesco/0000-0003-4708-1250; Caprettini, Valeria/0000-0002-2743-5536;
   Posteraro, Brunella/0000-0002-1663-7546; Cecilia,
   Martini/0000-0002-0490-896X; bugli, francesca/0000-0001-9038-3233;
   cacaci, margherita/0000-0002-5433-9400; Papi,
   Massimiliano/0000-0002-0029-1309; Torelli, Riccardo/0000-0001-7927-4343;
   della longa, stefano/0000-0002-8157-9530; Sanguinetti,
   Maurizio/0000-0002-9780-7059
FU Italian Ministry of University and Research (Linea D1 Universita
   Cattolica del Sacro Cuore)
FX Financial support by the Italian Ministry of University and Research
   (Linea D1 Universita Cattolica del Sacro Cuore) is gratefully
   acknowledged. We thank Professor Andrea Brancaccio from the Consiglio
   Nazionale delle Richerche for providing the pHis-Trx vector.
CR Blazevic V, 2011, VACCINE, V29, P8126, DOI 10.1016/j.vaccine.2011.08.026
   Brunelli R, 2007, FASEB J, V21, P3872, DOI 10.1096/fj.07-8189com
   Bugli F, 2008, TOXICON, V51, P547, DOI 10.1016/j.toxicon.2007.11.014
   Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016
   Chandran A, 2010, BIOL-TARGETS THER, V4, P213
   Clark KB, 2009, VIROLOGY, V387, P267, DOI 10.1016/j.virol.2009.02.023
   CLARKE BE, 1987, NATURE, V330, P381, DOI 10.1038/330381a0
   Crisci E, 2012, VET IMMUNOL IMMUNOP, V148, P211, DOI 10.1016/j.vetimm.2012.04.026
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   Ghosh MK, 2002, VIROLOGY, V302, P383, DOI 10.1006/viro.2002.1648
   Jenny RJ, 2003, PROTEIN EXPRES PURIF, V31, P1, DOI 10.1016/S1046-5928(03)00168-2
   Kanno T, 2002, ANAL BIOCHEM, V309, P196, DOI 10.1016/S0003-2697(02)00291-9
   Lepault J, 2001, EMBO J, V20, P1498, DOI 10.1093/emboj/20.7.1498
   Loughran ST, 2011, METHODS MOL BIOL, V681, P311, DOI 10.1007/978-1-60761-913-0_17
   Ma YJ, 2012, ADV DRUG DELIVER REV, V64, P811, DOI 10.1016/j.addr.2012.01.005
   Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52
   Mateu MG, 2012, VIRUS RES, V168, P1, DOI 10.1016/j.virusres.2012.06.008
   Mathieu M, 2001, EMBO J, V20, P1485, DOI 10.1093/emboj/20.7.1485
   Mena JA, 2006, J BIOTECHNOL, V122, P443, DOI 10.1016/j.jbiotec.2005.10.005
   Missori M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238001
   Molinari P, 2008, J VIROL METHODS, V147, P364, DOI 10.1016/j.jviromet.2007.09.002
   Mukhopadhya I, 2010, EPIDEMIOL INFECT, V138, P442, DOI 10.1017/S0950268809990732
   Olsson SE, 2007, VACCINE, V25, P4931, DOI 10.1016/j.vaccine.2007.03.049
   Papi M, 2010, EUR BIOPHYS J BIOPHY, V39, P1597, DOI 10.1007/s00249-010-0617-8
   Pattenden LK, 2005, TRENDS BIOTECHNOL, V23, P523, DOI 10.1016/j.tibtech.2005.07.011
   Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027
   Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211
   Sambrook J, 1989, MOL CLONING LAB MANU
   Shang WL, 2012, APPL MICROBIOL BIOT, V94, P39, DOI 10.1007/s00253-012-3958-7
   STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2
   Sun P, 2011, METHODS MOL BIOL, V705, P259, DOI 10.1007/978-1-61737-967-3_16
   USHIJIMA H, 1992, J MED VIROL, V38, P292, DOI 10.1002/jmv.1890380412
   Walls D, 2011, METHODS MOL BIOL, V681, P151, DOI 10.1007/978-1-60761-913-0_9
   Ward RL, 2010, J INFECT DIS, V202, pS101, DOI 10.1086/653556
   Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005
   Zhao QH, 2011, BIOCONJUGATE CHEM, V22, P346, DOI 10.1021/bc1002532
   Zuo X, 2005, PROTEIN EXPRES PURIF, V42, P100, DOI 10.1016/j.pep.2005.02.004
   Zuo Xun, 2005, Journal of Structural and Functional Genomics, V6, P103, DOI 10.1007/s10969-005-2664-4
NR 38
TC 15
Z9 16
U1 3
U2 13
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 2727
EP 2739
DI 10.2147/IJN.S60014
PG 13
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AJ5DA
UT WOS:000337700700001
PM 24936129
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wang, TX
   Shang, T
   Shen, LH
   Ren, L
AF Wang, Tian-xiao
   Shang, Ting
   Shen, Li-hua
   Ren, Lei
TI Uptake pathways and subsequent nucleus targeting of tat-conjugated
   gelatin-siloxane nanoparticles as nonviral gene vector
SO JOURNAL OF EXPERIMENTAL NANOSCIENCE
LA English
DT Article
DE cellular uptake; nucleus targeting; non-viral vector; tat peptide; gene
   delivery
ID FLUORESCENT SILICA NANOPARTICLES; MEDIATED CELLULAR DELIVERY;
   INTRACELLULAR DELIVERY; GOLD NANOPARTICLES; PEPTIDE; DNA; DRUGS; CELLS
AB Novel hybrid biomaterial of Tat peptide modified gelatin-siloxane nanoparticles (Tat-GS NPs), with positive surface potential was synthesised through a two-step sol-gel process. The particles were subsequently tested invitro with HeLa cells by fluorescent activitated cell sorter analysis, confocal laser scanning microscopy, and transmission electron microscopy to determine whether the functionalisation with Tat peptide allowed particles to transfer across the cell membrane and locate in the nucleus. Our current results indicated that the internalisation of Tat-GS NPs in HeLa cells is time- and concentration- dependent. Moreover, Tat-GS NPs could penetrate the nucleus membrane and enter into nucleus. The Tat-GS/pDNA nanocomplexes were formulated with higher encapsulation efficiency, and exhibited efficient transfection invitro. Tat-GS NPs are thus considered as novel non-viral vectors will be widely used in further study.
C1 [Wang, Tian-xiao; Shang, Ting; Shen, Li-hua; Ren, Lei] Xiamen Univ, Biomed Engn Res Ctr, Coll Mat, Dept Biomat, Xiamen 361005, Peoples R China.
   [Ren, Lei] Xiamen Univ, State Key Lab Phys Chem Solid Surfaces, Xiamen 361005, Peoples R China.
   [Ren, Lei] Xiamen Univ, China Australia Joint Lab Funct Nanomat, Xiamen 361005, Peoples R China.
RP Ren, L (reprint author), Xiamen Univ, Biomed Engn Res Ctr, Coll Mat, Dept Biomat, Xiamen 361005, Peoples R China.
EM renlei@xmu.edu.cn
RI ren, lei/G-3459-2010
OI ren, lei/0000-0003-2131-1601
FU National Natural Science Foundation of China [30970733, 30901175];
   National Basic Research Program of China (973 Program) [2010CB732402];
   Program for New Century Excellent Talents in Fujian Province University
FX This work was financially supported by the National Natural Science
   Foundation of China (30970733, 30901175), the National Basic Research
   Program of China (973 Program) (2010CB732402), and the Program for New
   Century Excellent Talents in Fujian Province University.
CR Arsianti M, 2010, BIOMACROMOLECULES, V11, P2521, DOI 10.1021/bm100748p
   Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102
   Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001
   Cang H, 2007, OPT LETT, V32, P2729, DOI 10.1364/OL.32.002729
   de la Fuente JM, 2005, BIOCONJUGATE CHEM, V16, P1176, DOI 10.1021/bc050033+
   de Lima MCP, 2001, ADV DRUG DELIVER REV, V47, P277
   Deshayes S, 2005, CELL MOL LIFE SCI, V62, P1839, DOI 10.1007/s00018-005-5109-0
   Faisal M, 2010, CHEM-EUR J, V16, P4266, DOI 10.1002/chem.200901823
   FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664
   Fuller JE, 2008, BIOMATERIALS, V29, P1526, DOI 10.1016/j.biomaterials.2007.11.025
   Gabrielson NP, 2006, BIOMACROMOLECULES, V7, P2427, DOI 10.1021/bm060300u
   Gait MJ, 2003, CELL MOL LIFE SCI, V60, P844, DOI 10.1007/s00018-003-3044-5
   Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016
   Hussain N, 2003, INT J PHARM, V254, P27, DOI 10.1016/S0378-5173(02)00672-5
   Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h
   Kakizawa Y, 2004, ADV MATER, V16, P699, DOI 10.1002/adma.200305782
   Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8
   Kneuer C, 2000, BIOCONJUGATE CHEM, V11, P926, DOI 10.1021/bc0000637
   Lechardeur D, 2005, ADV DRUG DELIVER REV, V57, P755, DOI 10.1016/j.addr.2004.12.008
   Nakata E, 2005, J AM CHEM SOC, V127, P13253, DOI 10.1021/ja052731a
   Nitin N, 2009, ANN BIOMED ENG, V37, P2018, DOI 10.1007/s10439-009-9768-0
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc01-06-0308
   Sanchez C, 2003, ADV MATER, V15, P1969, DOI 10.1002/adma.200300389
   Segura T, 2001, ANNU REV MATER RES, V31, P25, DOI 10.1146/annurev.matsci.31.1.25
   Torchilin VP, 2002, CELL MOL BIOL LETT, V7, P265
   Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175
   Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005
   Wang ZY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/44/445103
NR 29
TC 3
Z9 3
U1 1
U2 18
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1745-8080
EI 1745-8099
J9 J EXP NANOSCI
JI J. Exp. Nanosci.
PY 2014
VL 9
IS 7
BP 739
EP 748
DI 10.1080/17458080.2012.713126
PG 10
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AJ4BL
UT WOS:000337614600010
DA 2018-10-20
ER

PT J
AU Wang, KM
   Zhang, N
   Lu, J
   Yin, RX
   Nie, J
   Yui, Q
AF Wang, Kemin
   Zhang, Nan
   Lu, Jian
   Yin, Ruixue
   Nie, Jun
   Yui, Qiang
TI Preparation and Properties of Degradable Hydrogels Based on Diallyl
   Terminated Cyclic Acetal and PEG Monomer
SO JOURNAL OF POLYMER MATERIALS
LA English
DT Article
DE Synthetic biomaterial; Cyclic acetal; Degradable hydrogel;
   Photopolymerization
ID THIOL-ENE PHOTOPOLYMERIZATION; CELL ENCAPSULATION; CHEMISTRY; PROTEINS
AB Synthetic, hydrolytically degradable biomaterials have been widely developed for biomedical use. However, there are only a few examples whose polymer backbone does not form acidic products Upon degradation. In order to address this concern, we proposed to develop a novel hydro gel based on cyclic acetal units that produced diols and propanals upon hydrolytic degradation. The fabrication of hydro gels was achieved by thiol-ene photopolymerization of cyclic acetal and PEG diallyl monomers (EHDA and PEGDAL) in presence of multifunctional thiols. This degradable hydro gel based upon hydrophobic degradable segments of EHDA and hydrophilic segments of PEGDAL, produced diols and carbonyl end groups upon hydrolytic degradation and could be entirely devoid of acidic by-products. The chemical structure of the resulting hydro gel and thiol-ene photopolymerization kinetics were investigated by FT-IR. TGA analysis showed that the hydrogels exhibited a typical weight loss (97%) from around 320 degrees C to 500 degrees C. Degradation of this hydrogel was investigated in PBS medium so as to simulate physiological conditions. The remaining mass of the materials after 25 days incubation was 93%. In vitro cytotoxicity showed that the hydrogels had non-toxicity to cell L-929 and had good biocompatibility. The results indicate that this hydrogel has the potential to be used for long-term controlled drug delivery and implants.
C1 [Wang, Kemin; Zhang, Nan; Yui, Qiang] Changzhou Univ, Sch Mat Sci & Engn, Changzhou 213164, Peoples R China.
   [Lu, Jian] Beijing Univ Chem Technol, Changzhou Inst Adv Mat, Changzhou 213164, Peoples R China.
   [Yin, Ruixue; Nie, Jun] Beijing Univ Chem Technol, Key Lab Beijing City Preparat & Proc Novel Polyme, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China.
RP Wang, KM (reprint author), Changzhou Univ, Sch Mat Sci & Engn, Changzhou 213164, Peoples R China.
EM wangkm61@gmail.com
FU priority academic program development of jiangsu higher education
   institutions
FX The authors would like to thank a project funded by the priority
   academic program development of jiangsu higher education institutions
   for its financial support.
CR Betz MW, 2008, J BIOMED MATER RES A, V86A, P662, DOI 10.1002/jbm.a.31640
   Chen FM, 2007, J CONTROL RELEASE, V118, P65, DOI 10.1016/j.jconrel.2006.11.016
   DECKER C, 1989, MACROMOLECULES, V22, P4455, DOI 10.1021/ma00202a013
   Duncan R, 2006, ADV POLYM SCI, V192, P1, DOI 10.1007/12_037
   Falco E. E., 2007, J SURG RES, V149, P76
   Finne-Wistrand A, 2006, ANNU REV MATER RES, V36, P369, DOI 10.1146/annurev.matsci.36.032905.091005
   Gramlich WM, 2013, BIOMATERIALS, V34, P9803, DOI 10.1016/j.biomaterials.2013.08.089
   Gupta N, 2010, NAT CHEM, V2, P138, DOI [10.1038/NCHEM.478, 10.1038/nchem.478]
   Hua X, 2011, ACTA BIOMATER, V7, P1618, DOI [10.1016/j.actbio.2010.12.005, DOI 10.1016/J.ACTBIO.2010.12.005]
   Kaihara S, 2008, EUR J PHARM BIOPHARM, V68, P67, DOI 10.1016/j.ejpb.2007.05.019
   Kaihara S, 2007, MACROMOLECULES, V40, P7625, DOI 10.1021/ma071297p
   LAM KH, 1995, J BIOMED MATER RES, V29, P929, DOI 10.1002/jbm.820290804
   Li JJ, 2013, BIOMATERIALS, V34, P9071, DOI 10.1016/j.biomaterials.2013.08.031
   Lin CC, 2011, BIOMATERIALS, V32, P9685, DOI 10.1016/j.biomaterials.2011.08.083
   Lin PC, 2010, MACROMOL CHEM PHYS, V211, P136, DOI 10.1002/macp.200900539
   Lu H, 2005, DENT MATER, V21, P1129, DOI 10.1016/j.dental.2005.04.001
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Niu GG, 2010, POLYM ENG SCI, V50, P174, DOI 10.1002/pen.21465
   Roberts JJ, 2013, BIOMATERIALS, V34, P9969, DOI 10.1016/j.biomaterials.2013.09.020
   Rydholm A., 2004, AICHE ANN M C P AUST, P7
   Schlosser M, 2005, J BIOMED MATER RES A, V72A, P317, DOI 10.1002/jbm.a.30240
   Wang CQ, 2002, J APPL POLYM SCI, V86, P3120, DOI 10.1002/app.10950
   Wang KM, 2013, MAT SCI ENG C-MATER, V33, P1261, DOI 10.1016/j.msec.2012.12.024
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Zhou YS, 2008, BIOMACROMOLECULES, V9, P349, DOI 10.1021/bm7009015
NR 25
TC 0
Z9 0
U1 1
U2 12
PU M D PUBLICATIONS
PI NEW DELHI
PA PRINTS INDIA, 11, DARYA GANJ, NEW DELHI, 110 002, INDIA
SN 0973-8622
J9 J POLYM MATER
JI J. Polym. Mater.
PD JAN-MAR
PY 2014
VL 31
IS 1
BP 89
EP 99
PG 11
WC Polymer Science
SC Polymer Science
GA AJ4OG
UT WOS:000337655100008
DA 2018-10-20
ER

PT J
AU Moutzouri, AG
   Athanassiou, G
AF Moutzouri, Antonia G.
   Athanassiou, GeorgeM.
TI Insights into the Alteration of Osteoblast Mechanical Properties upon
   Adhesion on Chitosan
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; MEMBRANE TENSION; ELASTIC-MODULUS; IN-VITRO;
   CELLS; DYNAMICS; MICROPIPETTE; CHONDROCYTES; FIBROBLASTS; THALASSEMIA
AB Cell adhesion on substrates is accompanied by significant changes in shape and cytoskeleton organization, which affect subsequent cellular and tissue responses, determining the long-term success of an implant. Alterations in osteoblast stiffness upon adhesion on orthopaedic implants with different surface chemical composition and topography are, thus, of central interest in the field of bone implant research. This work aimed to study the mechanical response of osteoblasts upon adhesion on chitosan-coated glass surfaces and to investigate possible correlations with the level of adhesion, spreading, and cytoskeleton reorganization. Using the micropipette aspiration technique, the osteoblast elastic modulus was found higher on chitosan-coated than on uncoated control substrates, and it was found to increase in the course of spreading for both substrates. The cell-surface contact area was measured throughout several time points of adhesion to quantify cell spreading kinetics. Significant differences were found between chitosan and control surfaces regarding the response of cell spreading, while both groups displayed a sigmoidal kinetical behavior with an initially elevated spreading rate which stabilizes in the second hour of attachment. Actin filament structural changes were confirmed after observation with confocal microscope. Biomaterial surface modification can enhance osteoblast mechanical response and induce favorable structural organization for the implant integration.
C1 [Moutzouri, Antonia G.; Athanassiou, GeorgeM.] Univ Patras, Dept Aeronaut & Mech Engn, Lab Biomech & Biomed Engn, Patras 26504, Greece.
RP Athanassiou, G (reprint author), Univ Patras, Dept Aeronaut & Mech Engn, Lab Biomech & Biomed Engn, Patras 26504, Greece.
EM gathan@mech.upatras.gr
OI Athanassiou, George/0000-0003-3582-0204
CR Albuschies J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01658
   ATHANASIOU G, 1991, NOUV REV FR HEMATOL, V33, P15
   ATHANASSIOU G, 1994, NOUV REV FR HEMATOL, V36, P229
   Atilgan E, 2006, BIOPHYS J, V90, P65, DOI 10.1529/biophysj.105.071480
   Bausch AR, 1998, BIOPHYS J, V75, P2038, DOI 10.1016/S0006-3495(98)77646-5
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P423, DOI 10.1163/156856203766652048
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P1401, DOI 10.1163/156856203322599734
   Charras GT, 2002, BIOPHYS J, V82, P2970, DOI 10.1016/S0006-3495(02)75638-5
   Dao M, 2003, J MECH PHYS SOLIDS, V51, P2259, DOI 10.1016/j.jmps.2003.09.019
   Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019
   Domke J, 2000, COLLOID SURFACE B, V19, P367, DOI 10.1016/S0927-7765(00)00145-4
   EVANS EA, 1979, CRC CR REV BIOM ENG, V3, P181
   Fang N, 2005, MACROMOL BIOSCI, V5, P1022, DOI 10.1002/mabi.200500123
   Hansen JC, 2007, J BIOMECH, V40, P2865, DOI 10.1016/j.jbiomech.2007.03.018
   Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d
   Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X
   Jaasma MJ, 2007, J BIOMECH, V40, P1938, DOI 10.1016/j.jbiomech.2006.09.010
   Kaleridis V, 2010, CLIN HEMORHEOL MICRO, V45, P53, DOI 10.3233/CH-2010-1326
   Keren K, 2011, P NATL ACAD SCI USA, V108, P14379, DOI 10.1073/pnas.1111671108
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lieder R, 2012, J BIOMED MATER RES A, V100A, P3392, DOI 10.1002/jbm.a.34283
   Moutzouri AG, 2011, ANN BIOMED ENG, V39, P730, DOI 10.1007/s10439-010-0188-y
   Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957
   Pierres A., 2002, European Cells & Materials, V3, P31
   Pietuch A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130084
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Sen S., 2011, CELL MOL BIOENG, V4, P9
   Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7
   Shi P, 2009, CELL MOL BIOENG, V2, P464, DOI 10.1007/s12195-009-0097-z
   Shin D, 1999, J ORTHOPAED RES, V17, P880, DOI 10.1002/jor.1100170613
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Simon A, 2004, CELL MOL BIOL, V50, P255
   Simon A, 2003, CYTOM PART A, V54A, P36, DOI 10.1002/cyto.a.10052
   Stroka KM, 2011, CELL MOL BIOENG, V4, P9, DOI 10.1007/s12195-010-0142-y
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Takai E, 2005, ANN BIOMED ENG, V33, P963, DOI 10.1007/s10439-005-3555-3
   THERET DP, 1988, J BIOMECH ENG-T ASME, V110, P190, DOI 10.1115/1.3108430
   Thoumine O, 1999, EUR BIOPHYS J BIOPHY, V28, P222, DOI 10.1007/s002490050203
NR 39
TC 2
Z9 2
U1 0
U2 9
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 740726
DI 10.1155/2014/740726
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AJ2JM
UT WOS:000337481900001
PM 24987701
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Liu, LA
   Wang, LH
   Yin, LM
   Song, WH
   Yu, JH
   Liu, Y
AF Liu, Linan
   Wang, Lihua
   Yin, Liming
   Song, Wenhong
   Yu, Jinghua
   Liu, Ye
TI Effects of Different Solvents on the Surface Acidic Oxygen-containing
   Functional Groups on Xanthoceras sorbifolia Shell
SO BIORESOURCES
LA English
DT Article
DE Xanthoceras sorbifolia shell; Acidic functional group; Phenolic
   hydroxyl; Carboxyl; Solvent modification
ID ACTIVATED CARBON; AQUEOUS-SOLUTION; IONIC LIQUID; OIL REMOVAL;
   ADSORPTION; WASTE; CATALYST; STRAW; WATER; HEMICELLULOSES
AB This study reports the preparation of a novel biomaterial from a forestry residue - Xanthoceras sorbifolia shell (XSS) - by solvent modification. The effects of acid and base (hydrochloric acerbic, acetic acid, sodium hydroxide, ammonia water) and some organic solvents (ethanol, acetone, ethyl acetate, chloroform, petroleum ether, and n-hexane) on the surface acidic functional groups (SAFGs) on XSS were investigated. The amount of SAFGs was quantified using acid and alkali chemical titration methods, and the characteristics of virgin XSS were compared with treated ones by FT-IR spectroscopy. It was found that acid solutions can increase the concentration of SAFGs, while alkaline solutions reduce it. The XSS treated in 0.5 M HCl has the largest number of total acidic functional groups and phenolic hydroxyl groups. The shell extracted with 2 M acetic acid has the highest concentration of carboxyl. The SAFG contents were remarkably increased by treatments with ethanol and acetone, due to the outstanding enhancement of phenolic hydroxyl. These changes in the SAFGs of XSS brought about by treatments with various solutions could be a theoretical foundation for modifying this residue to create a new type of highly efficient absorbent material.
C1 [Liu, Linan; Wang, Lihua; Yin, Liming; Song, Wenhong; Yu, Jinghua; Liu, Ye] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China.
   [Wang, Lihua] Univ Chinese Acad Sci, Beijing 100039, Peoples R China.
RP Wang, LH (reprint author), Chinese Acad Sci, Inst Appl Ecol, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
EM lhwang@iae.ac.cn
FU National "Twelfth Five-Year" Plan for Science Technology [2012BAD32B08]
FX The authors acknowledge the financial support provided by the National
   "Twelfth Five-Year" Plan for Science & Technology Support
   (2012BAD32B08).
CR BOEHM HP, 1994, CARBON, V32, P759, DOI 10.1016/0008-6223(94)90031-0
   Cheng R., 2004, THESIS SHANDONG AGR
   Cong G. M., 1984, CHINA SYNTHETIC FIBE, V2, P49
   Fan Yanzhen, 2001, ENVIRON CHEM, V20, P444
   Foo KY, 2011, CHEM ENG J, V173, P385, DOI 10.1016/j.cej.2011.07.073
   Hayouni E, 2007, FOOD CHEM, V105, P1126, DOI 10.1016/j.foodchem.2007.02.010
   Iqbal M, 2009, J HAZARD MATER, V164, P161, DOI 10.1016/j.jhazmat.2008.07.141
   Kang S. G., 2012, COAL CHEM IND, V4, P20
   Li J, 2013, BIORESOURCE TECHNOL, V128, P673, DOI 10.1016/j.biortech.2012.11.009
   Li J, 2012, BIORESOURCE TECHNOL, V108, P112, DOI 10.1016/j.biortech.2011.12.129
   Liang Yong, 2006, China Tropical Medicine, V6, P135
   Liu C., 2005, WATER PURIF TECHNOL, V24, P50
   Liu SX, 2007, J HAZARD MATER, V141, P315, DOI 10.1016/j.jhazmat.2006.07.006
   [梅凡民 Mei Fanmin], 2010, [环境污染与防治, Environmental Pollution & Control], V32, P18
   Nomanbhay SM, 2005, ELECTRON J BIOTECHN, V8, P43
   Prado AGS, 1999, QUIM NOVA, V22, P894, DOI 10.1590/S0100-40421999000600018
   Ren JL, 2007, CARBOHYD POLYM, V70, P406, DOI 10.1016/j.carbpol.2007.04.022
   Shafeeyan MS, 2010, J ANAL APPL PYROL, V89, P143, DOI 10.1016/j.jaap.2010.07.006
   Shen W, 2009, CARBOHYD POLYM, V75, P110, DOI 10.1016/j.carbpol.2008.07.006
   Srinivasan A, 2010, BIORESOURCE TECHNOL, V101, P6594, DOI 10.1016/j.biortech.2010.03.079
   Su W, 2007, NEW CARBON MATER, V22, P135, DOI 10.1016/S1872-5805(07)60014-6
   Sun RC, 2000, CARBOHYD POLYM, V42, P111, DOI 10.1016/S0144-8617(99)00136-8
   Sun XF, 2004, BIORESOURCE TECHNOL, V95, P343, DOI 10.1016/j.biortech.2004.02.025
   Toles CA, 1999, CARBON, V37, P1207, DOI 10.1016/S0008-6223(98)00315-7
   Valdes H, 2002, LANGMUIR, V18, P2111, DOI 10.1021/la010920a
   Vazquez G, 2012, CHEM ENG J, V184, P147, DOI 10.1016/j.cej.2012.01.019
   Wang JT, 2012, IND CROP PROD, V40, P178, DOI 10.1016/j.indcrop.2012.03.002
   Wang Z., 2013, J CAPITAL NORMAL U, V34, P26
   Yang FQ, 1998, J CHROMATOGR A, V822, P316, DOI 10.1016/S0021-9673(98)00624-4
   Yao ZY, 2009, CLEAN-SOIL AIR WATER, V37, P642, DOI 10.1002/clen.200900093
   YATES SG, 1988, J AGR FOOD CHEM, V36, P337, DOI 10.1021/jf00080a023
   ZACHARA JM, 1986, ENVIRON SCI TECHNOL, V20, P620, DOI 10.1021/es00148a013
   Zhu B, 2008, J HAZARD MATER, V153, P300, DOI 10.1016/j.jhazmat.2007.08.050
NR 33
TC 3
Z9 3
U1 0
U2 7
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2014
VL 9
IS 2
BP 2248
EP 2258
PG 11
WC Materials Science, Paper & Wood
SC Materials Science
GA AI6DQ
UT WOS:000336960700034
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zhang, HY
   Pizzi, A
   Lu, XN
   Zhou, XH
AF Zhang, Haiyang
   Pizzi, Antonio
   Lu, Xiaoning
   Zhou, Xihe
TI Optimization of Tensile Shear Strength of Linear Mechanically Welded
   Outer-to-Inner Flattened Moso Bamboo (Phyllostachys pubescens)
SO BIORESOURCES
LA English
DT Article
DE Mechanical welding; Moso bamboo; Shear strength; Surface response
   methodology; Quadratic model
ID RESPONSE-SURFACE METHODOLOGY; WOOD
AB Mechanical welding technology has been widely employed in the making of bonding joints with wood. Moso bamboo, a lignocellulosic biomaterial, can also be bonded using mechanical welding technology. The surface response methodology was used to define welding parameters yielding optimal joint strength. In the range of this experiment, it was found that the vibration amplitude and the welding pressure both had a significant influence on the performance of the joint, while the welding time did not. The quadratic model was able to significantly fit the actual results and could be used to determine and optimize the bonding strength.
C1 [Zhang, Haiyang; Lu, Xiaoning; Zhou, Xihe] Nanjing Forestry Univ, Fac Wood Sci & Technol, Nanjing 210037, Jiangsu, Peoples R China.
   [Zhang, Haiyang; Pizzi, Antonio] Univ Lorraine, ENSTIB, LERMAB, F-880026 Epinal, France.
RP Zhang, HY (reprint author), Nanjing Forestry Univ, Fac Wood Sci & Technol, 159 Longpan Rd, Nanjing 210037, Jiangsu, Peoples R China.
EM zhanghaiyangnjfu@gmail.com
FU Forestry Industry Research Special Funds for Public Welfare Projects
   [201104042]; National High Technology Research and Development program
   of China [2012AA03A204]; Doctoral Fellowship Foundation of Nanjing
   Forestry University [2011YB013]
FX The authors acknowledge the financial support of the Forestry Industry
   Research Special Funds for Public Welfare Projects (201104042), the
   National High Technology Research and Development program of China
   (2012AA03A204), and the Doctoral Fellowship Foundation of Nanjing
   Forestry University (2011YB013).
CR Belleville B, 2011, J ADHES SCI TECHNOL, V25, P2745, DOI 10.1163/016942410X537323
   Duret X, 2013, BIORESOURCES, V8, P1258
   Ganne-Chedeville C, 2005, J ADHES SCI TECHNOL, V19, P1157, DOI 10.1163/156856105774429037
   Gfeller B, 2003, J ADHES SCI TECHNOL, V17, P1573, DOI 10.1163/156856103769207419
   Jiang Z. H., 2005, CHINA WOOD IND, V19, P23
   Leban JM, 2004, J ADHES SCI TECHNOL, V18, P673, DOI 10.1163/156856104839310
   Liu J, 2013, ACTA GEOL SINICA, V87, P1, DOI DOI 10.1155/2013/630537
   Martins S. A., 2013, EUROPEAN J WOOD WOOD, V71, P1
   Myers RH, 2004, J QUAL TECHNOL, V36, P53
   Omrani P, 2010, EUR J WOOD WOOD PROD, V68, P113, DOI 10.1007/s00107-009-0349-6
   Omrani P, 2009, EUR J WOOD WOOD PROD, V67, P479, DOI 10.1007/s00107-009-0334-0
   Pizzi A, 2004, J ADHES SCI TECHNOL, V18, P1263, DOI 10.1163/1568561041588192
   Stamm B, 2005, HOLZ ROH WERKST, V63, P388, DOI 10.1007/s00107-005-0002-y
   Teh CC, 2013, BIORESOURCES, V8, P5244
   Tondi G, 2007, J ADHES SCI TECHNOL, V21, P1633, DOI 10.1163/156856107782793258
   Wongprot T., 2012, BIORESOURCES, V8, P302
NR 16
TC 1
Z9 1
U1 0
U2 9
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2014
VL 9
IS 2
BP 2500
EP 2508
PG 9
WC Materials Science, Paper & Wood
SC Materials Science
GA AI6DQ
UT WOS:000336960700053
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Kapusetti, G
   Misra, N
   Singh, V
   Srivastava, S
   Roy, P
   Dana, K
   Maiti, P
AF Kapusetti, Govinda
   Misra, Nira
   Singh, Vakil
   Srivastava, Swati
   Roy, Partha
   Dana, Kausik
   Maiti, Pralay
TI Bone cement based nanohybrid as a super biomaterial for bone healing
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID LAYERED DOUBLE HYDROXIDE; MECHANICAL-PROPERTIES; FEMORAL COMPONENTS;
   NANOCOMPOSITES; MONTMORILLONITE; HYDROXYAPATITE; FILLERS; PLATES; CELLS;
   BEADS
AB A novel nanohybrid based on bone cement has been developed which is capable of healing fractured bone in 30 days, one-third of the time required for the natural healing process. Nanohybrids of bone cement based on poly( methyl methacrylate) (PMMA), currently used as a grouting material in joint replacement surgery, were prepared by simple mixing with organically modified layered silicates of varying chemical compositions. The temperature arising from exothermic polymerization in one of the nanohybrids is 12 degrees C lower than that in pure bone cement, thus circumventing the reported cell necrosis that occurs during implantation with pure bone cement. The thermal stability and mechanical superiority of this nanohybrid were verified in terms of its higher degradation temperature, better stiffness, superior toughness, and significantly higher fatigue resistance compared with pure bone cement; these properties make it appropriate for use as an implant material. The biocompatibility and bioactivity of the nanohybrid were confirmed using cell adhesion, cell viability, and fluorescence imaging studies. Osteoconductivity and bone bonding properties were monitored in vivo in rabbits through radiographic imaging and histopathological studies of growing bone and muscle near the surgery site. The observed dissimilarity of the properties of two different nanoclays used as fillers were visualized through interactions measured using spectroscopic techniques. Studies of the influence of different elements on bioactivity showed a higher efficiency for the nanoclay containing greater amounts of iron.
C1 [Kapusetti, Govinda; Misra, Nira] Banaras Hindu Univ, Indian Inst Technol, Sch Biomed Engn, Varanasi 221005, Uttar Pradesh, India.
   [Singh, Vakil] Banaras Hindu Univ, Indian Inst Technol, Dept Met Engn, Varanasi 221005, Uttar Pradesh, India.
   [Srivastava, Swati; Roy, Partha] Indian Inst Technol, Dept Biotechnol, Roorkee 247667, Uttar Pradesh, India.
   [Dana, Kausik] Cent Glass & Ceram Res Inst, Kolkata 700032, India.
   [Maiti, Pralay] Banaras Hindu Univ, Indian Inst Technol, Sch Mat Sci & Technol, Varanasi 221005, Uttar Pradesh, India.
RP Maiti, P (reprint author), Banaras Hindu Univ, Indian Inst Technol, Sch Mat Sci & Technol, Varanasi 221005, Uttar Pradesh, India.
EM pmaiti.mst@itbhu.ac.in
FU Council of Scientific and Industrial Research (CSIR), Government of
   India
FX Govinda Kapusetti gratefully acknowledges financial support from the
   Council of Scientific and Industrial Research (CSIR), Government of
   India in the form of a fellowship. The authors thank Dr S.K. Singh,
   Centre for Animal Surgery and Medicine and Dr A. Dwivedi, Department of
   Radiology, IMS, BHU for their help in this work. The authors acknowledge
   the help of Mr Sashank Mishra, laboratory attendant, Centre for Animal
   Surgery and Medicine, IMS, BHU for his help in the histopathology
   studies. The authors also acknowledge the support of Dr D.K. Avasthi and
   Mr P.K. Kulriya of IUAC, New Delhi for the XRD measurements and Dr S.
   Malik and Mr Chanchal Chakraborty of IACS, Kolkata for the TEM studies.
CR Amos R., 2008, J BIOMECH ENG, V41, P3017
   Ana L. D. V., 2011, J BIOMED MATER RES B, V99, P111
   BAYSTON R, 1982, J BONE JOINT SURG BR, V64, P460
   Benvenuti E., 2011, FRATTURAED INTEGRITA, V17, P23
   Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376
   Blanca V., 2005, BIOMATERIALS, V26, P4309
   Boumbimba RM, 2011, J ENG MATER-T ASME, V133, DOI 10.1115/1.4004052
   CASTALDINI A, 1985, BIOMATERIALS, V6, P55, DOI 10.1016/0142-9612(85)90039-0
   Choy JH, 2004, BIOMATERIALS, V25, P3059, DOI 10.1016/j.biomaterials.2003.09.083
   Costache MC, 2006, POLYM ADVAN TECHNOL, V17, P272, DOI 10.1002/pat.697
   Deka M, 2010, ELECTROCHIM ACTA, V55, P1836, DOI 10.1016/j.electacta.2009.10.076
   Dunne NJ, 2002, J MATER SCI-MATER M, V13, P17, DOI 10.1023/A:1013670132001
   Fang C, 2013, J MATER CHEM B, V1, P4043, DOI 10.1039/c3tb20608d
   FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489
   FUJISHIRO Y, 1995, J MATER SCI-MATER M, V6, P172, DOI 10.1007/BF00120295
   Hill Janet, 2008, International Journal of Nano and Biomaterials, V1, P237, DOI 10.1504/IJNBM.2008.016873
   Hill Janet, 2007, International Journal of Nano and Biomaterials, V1, P138, DOI 10.1504/IJNBM.2007.016558
   JASTY M, 1991, J BONE JOINT SURG BR, V73, P551
   JASTY M, 1990, J BONE JOINT SURG AM, V72A, P1220, DOI 10.2106/00004623-199072080-00015
   Kapusetti G, 2013, J MATER CHEM B, V1, P2275, DOI 10.1039/c3tb00004d
   Kapusetti G, 2012, J BIOMED MATER RES A, V100A, P3363, DOI 10.1002/jbm.a.34296
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kim HY, 1999, J BIOMED MATER RES, V48, P135, DOI 10.1002/(SICI)1097-4636(1999)48:2<135::AID-JBM7>3.0.CO;2-6
   KNOELL A, 1975, ANN BIOMED ENG, V3, P225, DOI 10.1007/BF02363073
   Kuehn KD, 2005, ORTHOP CLIN N AM, V36, P17, DOI 10.1016/j.ocl.2004.06.010
   KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0
   Kwon SY, 2007, MACROMOL SYMP, V249, P86, DOI 10.1002/masy.200750315
   Lin FH, 2006, BIOMATERIALS, V27, P3333, DOI 10.1016/j.biomaterials.2005.12.029
   Lin X., 1989, ANAL IDENTIFICATION
   Lopes P, 2009, ACTA BIOMATER, V5, P356, DOI 10.1016/j.actbio.2008.07.012
   MARRS B, 2007, THESIS U KENTUCKY US
   Matthias P., 2006, BIOMATERIALS, V27, P4955
   Miroslav H., 2007, EUR POLYM J, V43, P4891
   Misra N, 2011, J APPL POLYM SCI, V121, P1203, DOI 10.1002/app.33712
   Paluszkiewicza C, 2012, VIB SPECTROSC, V60, P185, DOI 10.1016/j.vibspec.2011.12.004
   POURDEYHIMI B, 1989, J BIOMED MATER RES, V23, P63, DOI 10.1002/jbm.820230106
   Puska MA, 2003, BIOMATERIALS, V24, P417, DOI 10.1016/S0142-9612(02)00354-X
   Rusu MC, 2008, J MATER SCI-MATER M, V19, P2609, DOI 10.1007/s10856-007-3357-2
   Saha D., 2005, ADV MATER, V17, P525
   SAHA S, 1983, J BIOMED MATER RES, V17, P1041, DOI 10.1002/jbm.820170613
   Sarkar M, 2011, T INDIAN CERAM SOC, V70, P23, DOI 10.1080/0371750X.2011.10600148
   Shafee EE, 1996, POLYM DEGRAD STABIL, V53, P57
   Shinzato S, 2000, J BIOMED MATER RES, V51, P258, DOI 10.1002/(SICI)1097-4636(200008)51:2<258::AID-JBM15>3.0.CO;2-S
   Si MY, 2006, MACROMOL MATER ENG, V291, P602, DOI 10.1002/mame.200500382
   Storer R. A., ANN BOOK ASTM STAND
   Tsukeoka T, 2006, BIOMATERIALS, V27, P3897, DOI 10.1016/j.biomaterials.2006.03.002
   Vallo CI, 2000, J BIOMED MATER RES, V53, P717, DOI 10.1002/1097-4636(2000)53:6<717::AID-JBM15>3.0.CO;2-H
   Vallo CI, 2004, J BIOMED MATER RES B, V70B, P407, DOI 10.1002/jbm.b.30054
   Wang CX, 2008, BIO-MED MATER ENG, V18, P367, DOI 10.3233/BME-2008-0553
   Wang JH, 2006, MACROMOL MATER ENG, V291, P661, DOI 10.1002/mame.200500389
   WANG JS, 1995, J APPL BIOMATER, V6, P105, DOI 10.1002/jab.770060204
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 52
TC 13
Z9 13
U1 3
U2 21
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 25
BP 3984
EP 3997
DI 10.1039/c4tb00501e
PG 14
WC Materials Science, Biomaterials
SC Materials Science
GA AI7WA
UT WOS:000337110700011
DA 2018-10-20
ER

PT J
AU Wang, WW
   Liu, JJ
   Li, C
   Zhang, J
   Liu, JF
   Dong, AJ
   Kong, DL
AF Wang, Weiwei
   Liu, Jinjian
   Li, Chen
   Zhang, Ju
   Liu, Jianfeng
   Dong, Anjie
   Kong, Deling
TI Real-time and non-invasive fluorescence tracking of in vivo degradation
   of the thermosensitive PEGlyated polyester hydrogel
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; COPOLYMER AQUEOUS-SOLUTIONS;
   POLY(D,L-LACTIDE-RAN-EPSILON-CAPROLACTONE)-POLY(ETHYLENE
   GLYCOL)-POLY(D,L-LACTIDE-RAN-EPSILON-CAPROLACTONE); HYDROLYTIC
   DEGRADATION; POLY(ETHYLENE GLYCOL); POLYMER DEGRADATION; TRIBLOCK
   COPOLYMERS; CONTROLLED-RELEASE; BLOCK-COPOLYMERS; SCAFFOLD
AB The real-time monitoring of materials degradation is crucial to determine the in vivo retention time and the design or screening of degradable biomaterials. However, in vivo performance cannot always be predicted through the traditional determination of in vitro erosion and current standard methods sacrifice samples or animals, preventing the sequential measurement of the same specimen. Herein, a non-invasive fluorescence imaging method was developed to sequentially follow in vivo loss of fluorescence signal to simultaneously characterize the hydrolytic and enzymatic degradation of PEGlyated polyester hydrogel. Rhodamine B was conjugated to thermosensitive amphiphilic triblock copolymer based on cyclic ether modified PCL and PEG (abbreviated as PECT) and no obvious influence on gelation time or gel strength was observed with the conjugation content under 0.121% (w/w). Both in vitro and in vivo degradation profiles followed linear fittings while in vivo and in vitro hydrogel degradation rates correlated in an exponential mathematical model, enabling the general prediction of in vivo erosion trends of new biomaterial formulations from in vitro data. This methodology possibly enabled rational design and rapid in vitro screening of degradable materials, and might be potentially extended to simultaneously determine the material erosion and speculate the drug release from a drug-incorporated scaffold, or the cell growth profile in tissue-engineering formulations.
C1 [Wang, Weiwei; Li, Chen; Zhang, Ju; Kong, Deling] Chinese Acad Med Sci, Inst Biomed Engn, Tianjin Key Lab Biomat Res, Tianjin 300192, Peoples R China.
   [Wang, Weiwei; Li, Chen; Zhang, Ju; Kong, Deling] Peking Union Med Coll, Tianjin 300192, Peoples R China.
   [Liu, Jinjian; Liu, Jianfeng] Chinese Acad Med Sci, Inst Radiat Med, Tianjin 300192, Peoples R China.
   [Liu, Jinjian; Liu, Jianfeng] Peking Union Med Coll, Tianjin 300192, Peoples R China.
   [Dong, Anjie] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
RP Wang, WW (reprint author), Chinese Acad Med Sci, Inst Biomed Engn, Tianjin Key Lab Biomat Res, Tianjin 300192, Peoples R China.
EM ajdong@tju.edu.cn; kongdeling@nankai.edu.cn
RI 刘, 鉴峰/I-8577-2015
OI 刘, 鉴峰/0000-0003-0541-5072
FU Tianjin Research Program of Application Foundation and Advanced
   Technology [13JCYBJC39300]; Chinese Postdoctoral Science Foundation
   [2013M540062]; National Natural Science Foundation of China [81301309,
   31271073, 51203189, 81220108015]
FX This study was. nancially supported by Tianjin Research Program of
   Application Foundation and Advanced Technology (no. 13JCYBJC39300),
   Chinese Postdoctoral Science Foundation (2013M540062) and National
   Natural Science Foundation of China (81301309, 31271073, 51203189, and
   81220108015).
CR Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   BAUMANN G, 1976, J CLIN INVEST, V57, P1109, DOI 10.1172/JCI108377
   Benny O, 2008, FASEB J, V22, P488, DOI 10.1096/fj.07-8801com
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Chao GT, 2008, J BIOMED MATER RES A, V85A, P36, DOI 10.1002/jbm.a.31362
   Cho HJ, 2006, BIOMATERIALS, V27, P544, DOI 10.1016/j.biomaterials.2005.06.026
   Cho HJ, 2004, BIOMATERIALS, V25, P3733, DOI 10.1016/j.biomaterials.2003.09.106
   Huynh CT, 2011, ACTA BIOMATER, V7, P3123, DOI 10.1016/j.actbio.2011.05.004
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Gong CY, 2009, ACTA BIOMATER, V5, P3358, DOI 10.1016/j.actbio.2009.05.025
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991
   HARTVEIT F, 1966, NATURE, V210, P1123, DOI 10.1038/2101123a0
   Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010
   Huynh DP, 2008, BIOMATERIALS, V29, P2527, DOI 10.1016/j.biomaterials.2008.02.016
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong B, 2012, ADV DRUG DELIVER REV, V64, P154, DOI 10.1016/j.addr.2012.09.012
   Joo MK, 2013, SOFT MATTER, V9, P8014, DOI 10.1039/c3sm51272j
   Jung YK, 2013, MACROMOLECULES, V46, P4215, DOI 10.1021/ma400268r
   Kang EY, 2012, BIOMACROMOLECULES, V13, P1750, DOI 10.1021/bm300085c
   KATZ AI, 1973, J CLIN INVEST, V52, P1113, DOI 10.1172/JCI107277
   Kim J., 2007, BIOMACROMOLECULES, V9, P149
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   KIM S, 2013, SCI REP, V0003
   KOST J, 1989, P NATL ACAD SCI USA, V86, P7663, DOI 10.1073/pnas.86.20.7663
   Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105
   Moon HJ, 2012, CHEM SOC REV, V41, P4860, DOI 10.1039/c2cs35078e
   Park JS, 2007, J CONTROL RELEASE, V124, P51, DOI 10.1016/j.jconrel.2007,08.030
   Park M. H., 2011, ACCOUNTS CHEM RES, V45, P424, DOI DOI 10.1021/AR200162J
   Park SH, 2008, MACROMOLECULES, V41, P6486, DOI 10.1021/ma800562s
   Potter LR, 2011, FEBS J, V278, P1808, DOI 10.1111/j.1742-4658.2011.08082.x
   Saldanha KJ, 2008, EUR CELLS MATER, V16, P17, DOI 10.22203/eCM.v016a03
   Shenoi RA, 2013, BIOMATERIALS, V34, P6068, DOI 10.1016/j.biomaterials.2013.04.043
   Shi XT, 2009, ACTA BIOMATER, V5, P1697, DOI 10.1016/j.actbio.2009.01.010
   Shim WS, 2006, BIOMATERIALS, V27, P5178, DOI 10.1016/j.biomaterials.2006.05.038
   Tzafriri AR, 2000, J CONTROL RELEASE, V63, P69, DOI 10.1016/S0168-3659(99)00174-1
   Wang WW, 2013, J MATER CHEM B, V1, P552, DOI 10.1039/c2tb00068g
   Wang WW, 2012, ACTA BIOMATER, V8, P3963, DOI 10.1016/j.actbio.2012.07.021
   Wang WW, 2012, SOFT MATTER, V8, P1575, DOI 10.1039/c1sm06693e
   Witt C, 2000, BIOMATERIALS, V21, P931, DOI 10.1016/S0142-9612(99)00262-8
   Woehl-Bruhn S., 2012, J CONTROL RELEASE, V162, P127
   Wu DQ, 2008, BIOMACROMOLECULES, V9, P1155, DOI 10.1021/bm7010328
   Yeon B, 2013, BIOMACROMOLECULES, V14, P3256, DOI 10.1021/bm400868j
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2014, ACTA BIOMATER, V10, P1251, DOI 10.1016/j.actbio.2013.12.007
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang CH, 2008, J CONTROL RELEASE, V131, P128, DOI 10.1016/j.jconrel.2008.07.026
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
   Zhang Z, 2010, BIOMATERIALS, V31, P7873, DOI 10.1016/j.biomaterials.2010.07.014
NR 50
TC 35
Z9 35
U1 3
U2 65
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 26
BP 4185
EP 4192
DI 10.1039/c4tb00275j
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA AI8DI
UT WOS:000337136000017
DA 2018-10-20
ER

PT J
AU He, B
   Yuan, X
   Jiang, DM
AF He, Bin
   Yuan, Xiao
   Jiang, Dianming
TI Molecular self-assembly guides the fabrication of peptide nanofiber
   scaffolds for nerve repair
SO RSC ADVANCES
LA English
DT Review
ID SPINAL-CORD-INJURY; NATIVE CHEMICAL LIGATION; NEURAL PROGENITOR CELLS;
   AMINO-ACID-SEQUENCE; REGENERATIVE MEDICINE; FUNCTIONAL RECOVERY;
   AMPHIPHILE NANOFIBERS; NEURITE OUTGROWTH; SYNTHETIC PEPTIDE; DESIGNED
   PEPTIDE
AB Peptide nanostructures formed through molecular self-assembly are increasingly important for material science and regenerative medicine. Peptide self-assembly allows the design and fabrication of supramolecular architectures at the nanoscale. In the b-sheet system, ionic self-complementary peptides and peptide amphiphiles (PAs) have been extensively developed to form cylindrical nanofibers and subsequent 3D biomaterial scaffolds, which have demonstrated the potential to repair nerves. In addition, modification with peptide epitopes (i.e. functional motifs) and incorporation of molecular signals are beneficial to the bioactivity of peptide nanofiber scaffolds, and these two methods contribute favorably to the improvement of cell function and tissue regeneration in neural tissue engineering. This review focuses on the design, fabrication and properties of these two peptide-based biomaterial scaffolds, as well as their application in nerve repair.
C1 [He, Bin; Jiang, Dianming] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped, Chongqing, Peoples R China.
   [Yuan, Xiao] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing, Peoples R China.
RP Jiang, DM (reprint author), Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped, Chongqing, Peoples R China.
EM jdm571026@vip.163.com
FU Natural Science Foundation Project of CQ CSTC [2009AB5080]; National
   Natural Science Foundation of China (NSFC) [81171685/H0604]; China
   National "973 Project"
FX D. M. Jiang was supported in part by China National "973 Project" and by
   the grant from the Natural Science Foundation Project of CQ CSTC
   (2009AB5080), and National Natural Science Foundation of China (NSFC,
   81171685/H0604). We apologize to all the scientists whose work we could
   not cite due to space restrictions.
CR An YH, 2006, BIOMED MATER, V1, pR38, DOI 10.1088/1748-6041/1/2/R02
   Angius D, 2012, BIOMATERIALS, V33, P8034, DOI 10.1016/j.biomaterials.2012.07.056
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Aulisa L, 2009, BIOMACROMOLECULES, V10, P2694, DOI 10.1021/bm900634x
   BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018
   Bromley EHC, 2008, ACS CHEM BIOL, V3, P38, DOI 10.1021/cb700249v
   Bull SR, 2005, NANO LETT, V5, P1, DOI 10.1021/nl0484898
   Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009
   Chan Carmen C M, 2008, Recent Pat CNS Drug Discov, V3, P189, DOI 10.2174/157488908786242434
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484
   Collier JH, 2003, BIOCONJUGATE CHEM, V14, P748, DOI 10.1021/bc034017t
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Cooper A, 2011, CARBOHYD POLYM, V85, P149, DOI 10.1016/j.carbpol.2011.02.008
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   Dienstknecht T, 2013, J HAND SURG-AM, V38A, P1119, DOI 10.1016/j.jhsa.2013.03.028
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009
   Duale H, 2009, J NEUROPATH EXP NEUR, V68, P168, DOI 10.1097/NEN.0b013e3181967df7
   Elias PZ, 2012, J NEUROSCI METH, V209, P199, DOI 10.1016/j.jneumeth.2012.06.003
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Erakat MS, 2013, J ORAL MAXIL SURG, V71, P833, DOI 10.1016/j.joms.2011.11.026
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Fitch MT, 1999, J NEUROSCI, V19, P8182
   Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296
   Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gelain F, 2011, ACS NANO, V5, P1845, DOI 10.1021/nn102663a
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001
   Haile Y, 2007, BIOMATERIALS, V28, P1163, DOI 10.1016/j.biomaterials.2006.10.030
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374
   Hou TY, 2012, TISSUE ENG PT A, V18, P974, DOI [10.1089/ten.tea.2011.0151, 10.1089/ten.TEA.2011.0151]
   Jain KK, 2006, NANOMEDICINE-UK, V1, P9, DOI 10.2217/17435889.1.1.9
   Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013
   JUCKER M, 1991, J NEUROSCI RES, V28, P507, DOI 10.1002/jnr.490280407
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   KHAN T, 1991, BRAIN RES, V541, P139, DOI 10.1016/0006-8993(91)91087-H
   Kiguchi N, 2012, CURR OPIN PHARMACOL, V12, P55, DOI 10.1016/j.coph.2011.10.007
   Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083
   Kim YT, 2009, BIOMATERIALS, V30, P2582, DOI 10.1016/j.biomaterials.2008.12.077
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Koutsopoulos S, 2012, J CONTROL RELEASE, V160, P451, DOI 10.1016/j.jconrel.2012.03.014
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Kubinova S, 2010, MINIM INVASIV THER, V19, P144, DOI 10.3109/13645706.2010.481398
   Kubinova S, 2010, NANOMEDICINE-UK, V5, P99, DOI [10.2217/nnm.09.93, 10.2217/NNM.09.93]
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Liang YX, 2011, NANOMED-NANOTECHNOL, V7, P351, DOI 10.1016/j.nano.2010.12.001
   Liu JP, 2011, NANOMEDICINE-UK, V6, P1621, DOI [10.2217/nnm.11.142, 10.2217/NNM.11.142]
   Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004
   Luo ZL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002364
   Luo ZL, 2008, MACROMOL BIOSCI, V8, P785, DOI 10.1002/mabi.200800003
   Luo ZL, 2013, BIOMATERIALS, V34, P4902, DOI 10.1016/j.biomaterials.2013.03.081
   Luo ZL, 2012, CHEM SOC REV, V41, P4736, DOI 10.1039/c2cs15360b
   Luo ZL, 2011, BIOMATERIALS, V32, P2013, DOI 10.1016/j.biomaterials.2010.11.049
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001
   MacPhee CE, 2004, CURR OPIN SOLID ST M, V8, P141, DOI 10.1016/j.cossms.2004.01.010
   McCreedy DA, 2012, NEUROSCI LETT, V519, P115, DOI 10.1016/j.neulet.2012.02.025
   McDonald JW, 2000, NAT MED, V6, P358, DOI 10.1038/74759
   McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307
   Moradi F, 2012, J NEUROSCI RES, V90, P2335, DOI 10.1002/jnr.23120
   Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Palmer LC, 2008, ACCOUNTS CHEM RES, V41, P1674, DOI 10.1021/ar8000926
   Paramonov SE, 2005, MACROMOLECULES, V38, P7555, DOI 10.1021/ma0514065
   Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Perale G, 2011, ACS CHEM NEUROSCI, V2, P336, DOI 10.1021/cn200030w
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Potter W, 2008, FRONT BIOSCI-LANDMRK, V13, P806, DOI 10.2741/2721
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001410
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004
   SECKEL BR, 1990, MUSCLE NERVE, V13, P785, DOI 10.1002/mus.880130904
   SEPHEL GC, 1989, BIOCHEM BIOPH RES CO, V162, P821, DOI 10.1016/0006-291X(89)92384-X
   Service RF, 2005, SCIENCE, V309, P95, DOI 10.1126/science.309.5731.95
   Siemionow M, 2010, MICROSURG, V30, P574, DOI 10.1002/micr.20799
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Smith GM, 2012, TRENDS NEUROSCI, V35, P156, DOI 10.1016/j.tins.2011.10.006
   Song YL, 2011, J BIOMAT SCI-POLYM E, V22, P475, DOI 10.1163/092050610X487756
   Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Sur S, 2012, BIOMATERIALS, V33, P545, DOI 10.1016/j.biomaterials.2011.09.093
   Tan A, 2012, J CONTROL RELEASE, V163, P342, DOI 10.1016/j.jconrel.2012.08.009
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Trumble TE, 2000, HAND CLIN, V16, P105
   Tysseling VM, 2010, J NEUROSCI RES, V88, P3161, DOI 10.1002/jnr.22472
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h
   Verreck G, 2005, BIOMATERIALS, V26, P1307, DOI 10.1016/j.biomaterials.2004.04.040
   Volpato FZ, 2013, BIOMATERIALS, V34, P4945, DOI 10.1016/j.biomaterials.2013.03.057
   Webber MJ, 2012, BIOMATERIALS, V33, P6823, DOI 10.1016/j.biomaterials.2012.06.003
   Wen XJ, 2006, BIOMATERIALS, V27, P3800, DOI 10.1016/j.biomaterials.2006.02.036
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Yamazaki CM, 2008, BIOPOLYMERS, V90, P816, DOI 10.1002/bip.21100
   Yang YL, 2009, NANO TODAY, V4, P193, DOI 10.1016/j.nantod.2009.02.009
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416
   Zarbin MA, 2013, CURR OPIN PHARMACOL, V13, P134, DOI 10.1016/j.coph.2012.10.003
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang ZX, 2010, BIOTECHNOL BIOPROC E, V15, P545, DOI 10.1007/s12257-009-3076-2
   Zhao F, 2009, CHEM SOC REV, V38, P883, DOI 10.1039/b806410p
   Zhao XJ, 2006, CHEM SOC REV, V35, P1105, DOI 10.1039/b511336a
   Zou ZW, 2010, J BIOMED MATER RES A, V95A, P1125, DOI 10.1002/jbm.a.32910
NR 136
TC 14
Z9 15
U1 1
U2 57
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 45
BP 23610
EP 23621
DI 10.1039/c4ra01826e
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA AI8FT
UT WOS:000337145900031
DA 2018-10-20
ER

PT J
AU Maciel, J
   Oliveira, MI
   Colton, E
   McNally, AK
   Oliveira, C
   Anderson, JM
   Barbosa, MA
AF Maciel, Joana
   Oliveira, Marta I.
   Colton, Erica
   McNally, Amy K.
   Oliveira, Carla
   Anderson, James M.
   Barbosa, Mario A.
TI Adsorbed Fibrinogen Enhances Production of Bone- and Angiogenic-Related
   Factors by Monocytes/Macrophages
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID GROWTH FACTOR-BB; ACUTE INFLAMMATORY RESPONSES; FOREIGN-BODY REACTION;
   INTERCELLULAR-ADHESION MOLECULE-1; MULTINUCLEATED GIANT-CELLS; HUMAN
   OSTEOBLASTIC CELLS; IN-VITRO; CYTOKINE PRODUCTION; FACTOR-BETA; MATRIX
   METALLOPROTEINASES
AB Macrophages are phagocytic cells with great importance in guiding multiple stages of inflammation and tissue repair. By producing a large number of biologically active molecules, they can affect the behavior of other cells and events, such as the foreign body response and angiogenesis. Since protein adsorption to biomaterials is crucial for the inflammatory process, we addressed the ability of the pro-inflammatory molecule fibrinogen (Fg) to modulate macrophage behavior toward tissue repair/regeneration. For this purpose, we used chitosan (Ch) as a substrate for Fg adsorption. Freshly isolated human monocytes were seeded on Ch substrates alone or previously adsorbed with Fg, and allowed to differentiate into macrophages for 10 days. Cell adhesion and morphology, formation of foreign body giant cells (FBGC), and secretion of a total of 80 cytokines and growth factors were evaluated. Both substrates showed similar numbers of adherent macrophages along differentiation as compared with RGD-coated surfaces, which were used as positive controls. Fg did not potentiate FBGC formation. In addition, actin cytoskeleton staining revealed the presence of punctuate F-actinwithmore elongated and interconnecting cells on Ch substrates. Antibody array screening and quantification of inflammation-and wound-healing-related factors indicated an overall reduction in Ch-based substrates versus RGD-coated surfaces. At late times, most inflammatory agents were down-regulated in the presence of Fg, in contrast to growth factor production, which was stimulated by Fg. Importantly, on Ch + Fg substrates, fully differentiated macrophages produced significant amounts of macrophage inflammatory protein-1delta (MIP-1 delta), platelet-derived growth factor-BB, bone morphogenetic protein (BMP)-5, and BMP-7 compared with Ch alone. In addition, other important factors involved in bone homeostasis and wound healing, such as growth hormone, transforming growth factor-beta 3, and insulin-like growth factor-binding proteins, as well as several angiogenic mediators, including endocrine gland-derived vascular endothelial factor, fibroblast growth factor-7, and placental growth factor, were significantly promoted by Fg. This work provides a new perspective on the inflammatory response in the context of bone repair/regenerationmediated by a pro-inflammatory protein (Fg) adsorbed onto a biomaterial (Ch) that does not otherwise exhibit osteogenic properties.
C1 [Maciel, Joana; Oliveira, Marta I.; Oliveira, Carla; Barbosa, Mario A.] Univ Porto, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Maciel, Joana] Univ Porto, Fac Engn, P-4150180 Oporto, Portugal.
   [Colton, Erica; McNally, Amy K.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Oliveira, Carla] Univ Porto, Inst Saude Publ, P-4100 Oporto, Portugal.
   [Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
   [Barbosa, Mario A.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal.
RP Maciel, J (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM mbarbosa@ineb.up.pt
RI Oliveira, Marta/M-9386-2013; Barbosa, Mario/F-5964-2011; Maciel,
   Joana/J-3956-2014
OI Oliveira, Marta/0000-0002-0578-9202; Barbosa, Mario/0000-0003-3568-7482;
   Maciel, Joana/0000-0003-3546-3817
FU FEDER funds through the Programa Operacional Factores de Competitividade
   - COMPETE; FEDER funds through the Programa Operacional Regional do
   Norte [ON.2 - O Novo Norte, NORTE-07-0124-FEDER-000005]; Portuguese
   funds through FCT - Fundacao para a Ciencia e a Tecnologia
   [PTDC/SAU-BEB/099954/2008]; FCT [SFRH/BD/37582/2007,
   SFRH/BPD/37090/2007]; NIH-NIBIB [EB000282]
FX The authors would like to thank Pieter Faber (Cleveland Clinic Genomics
   Core, Cleveland, Ohio, USA) for help with the microarray reading. This
   work was financed by FEDER funds through the Programa Operacional
   Factores de Competitividade - COMPETE and Programa Operacional Regional
   do Norte (ON.2 - O Novo Norte), in the framework of the project
   "NORTE-07-0124-FEDER-000005 - Project on Biomedical Engineering for
   Regenerative Therapies and Cancer", under Quadro de Referencia
   Estrategico Nacional (QREN), and by Portuguese funds through FCT -
   Fundacao para a Ciencia e a Tecnologia in the framework of the project
   PTDC/SAU-BEB/099954/2008. J.M. and M.I.O. are grateful to FCT for
   awarding them a doctoral (SFRH/BD/37582/2007) and a post-doctoral
   (SFRH/BPD/37090/2007) fellowships, respectively. Partial support for the
   study was also provided by a grant from the NIH-NIBIB, # EB000282.
CR Abe E, 2006, ANN NY ACAD SCI, V1068, P41, DOI 10.1196/annals.1346.007
   Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Almeida CR, 2012, J R SOC INTERFACE, V9, P261, DOI 10.1098/rsif.2011.0357
   Amaral IF, 2007, J BIOMAT SCI-POLYM E, V18, P469, DOI 10.1163/156856207780425068
   Amaral IF, 2006, J BIOMED MATER RES A, V76A, P335, DOI 10.1002/jbm.a.30522
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Antunes JC, 2011, BIOMACROMOLECULES, V12, P4183, DOI 10.1021/bm2008235
   Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499
   Boehm TK, 2010, CELL IMMUNOL, V263, P41, DOI 10.1016/j.cellimm.2010.02.014
   BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312
   Bostrom MPG, 1998, CLIN ORTHOP RELAT R, pS124
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Chang PC, 2010, GENE THER, V17, P95, DOI 10.1038/gt.2009.117
   Chellat F, 2005, BIOMATERIALS, V26, P961, DOI 10.1016/j.biomaterials.2004.04.006
   Chen CL, 2008, BIOMATERIALS, V29, P2173, DOI 10.1016/j.biomaterials.2008.01.023
   Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017
   Conover CA, 2008, AM J PHYSIOL-ENDOC M, V294, pE10, DOI 10.1152/ajpendo.00648.2007
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   Ding ZM, 1999, J IMMUNOL, V163, P5029
   Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691
   Fajardo M, 2009, CLIN ORTHOP RELAT R, V467, P3071, DOI 10.1007/s11999-009-0981-9
   Fernandes JC, 2008, J BONE MINER METAB, V26, P543, DOI 10.1007/s00774-008-0866-0
   Fulzele K, 2012, BONE, V50, P452, DOI 10.1016/j.bone.2011.06.018
   Gandhi A, 2005, BONE, V37, P482, DOI 10.1016/j.bone.2005.04.039
   Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7
   Hollinger JO, 2008, J BONE JOINT SURG AM, V90A, P48, DOI 10.2106/JBJS.G.01231
   Hollinger JO, 2008, J ORTHOP RES, V26, P83, DOI 10.1002/jor.20453
   Jensen T, 2007, THROMB HAEMOSTASIS, V97, P822, DOI 10.1160/TH07-01-0039
   Jiang T, 2008, CURR TOP MED CHEM, V8, P354
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kominsky SL, 2008, CANCER RES, V68, P1261, DOI 10.1158/0008-5472.CAN-07-6122
   LECOANETHENCHOZ S, 1995, IMMUNITY, V3, P119, DOI 10.1016/1074-7613(95)90164-7
   Lee YM, 2000, J PERIODONTOL, V71, P418, DOI 10.1902/jop.2000.71.3.418
   Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Moore DC, 2009, J BONE JOINT SURG AM, V91A, P1973, DOI 10.2106/JBJS.H.00540
   Mountziaris PM, 2008, TISSUE ENG PT B-REV, V14, P179, DOI 10.1089/ten.teb.2008.0038
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   NODA M, 1989, ENDOCRINOLOGY, V124, P2991, DOI 10.1210/endo-124-6-2991
   Oliveira MI, 2012, EUR CELLS MATER, V24, P136, DOI 10.22203/eCM.v024a10
   Park CJ, 2009, BIOMATERIALS, V30, P436, DOI 10.1016/j.biomaterials.2008.09.060
   Park YJ, 2000, BIOMATERIALS, V21, P153
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Sadhu C, 2007, J LEUKOCYTE BIOL, V81, P1395, DOI 10.1189/jlb.1106680
   Santos SG, 2013, ACTA BIOMATER, V9, P7209, DOI 10.1016/j.actbio.2013.04.008
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   SIEGEL S, 1988, NONPARAMETRIC STAT B
   Simion M, 2006, INT J PERIODONT REST, V26, P415
   SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111
   Solheim E, 2000, J BIOMED MATER RES, V49, P257, DOI 10.1002/(SICI)1097-4636(200002)49:2<257::AID-JBM15>3.0.CO;2-5
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Team R.C. R, 2012, LANG ENV STAT COMP
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Torres AL, 2013, ACTA BIOMATER, V9, P6553, DOI 10.1016/j.actbio.2013.01.015
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Ueno H, 2001, BIOMATERIALS, V22, P1667, DOI 10.1016/S0142-9612(00)00328-8
   Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   Wutzl A, 2010, J ORTHOP RES, V28, P1431, DOI 10.1002/jor.21144
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
NR 77
TC 14
Z9 14
U1 1
U2 18
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2014
VL 20
IS 1-2
BP 250
EP 263
DI 10.1089/ten.tea.2012.0439
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AI9TO
UT WOS:000337280600023
PM 23937279
OA Green Published
DA 2018-10-20
ER

PT S
AU Tank, KP
   Jogiya, BV
   Kanchan, DK
   Joshi, MJ
AF Tank, Kashmira P.
   Jogiya, Bhoomika V.
   Kanchan, D. K.
   Joshi, M. J.
BE Joshi, US
   Tripathi, D
   Rana, VA
   Jotania, RB
   Gajjar, PN
TI Dielectric properties of Pure and Strontium doped Nano-Hydroxyapatite
SO ADVANCES IN MATERIALS SCIENCE AND TECHNOLOGY (AMST)
SE Solid State Phenomena
LA English
DT Proceedings Paper
CT National Symposium on Advances in Materials Science and Technology
CY FEB 03-04, 2012
CL Gujarat Univ, Convent Ctr, Ahmedabad, INDIA
SP Univ Grants Commiss, Gujarat Council Sci & Technol, Dept Sci & Technol, Dept Atom Energy
HO Gujarat Univ, Convent Ctr
DE nano-hydroxyapatite; XRD; TEM; Dielectric study
ID SR-89 THERAPY; BONE; BIOCERAMICS; KINETICS
AB Hydroxyapatite (Ca-10(PO4)(6)(OH)(2)-HAp), is an excellent inorganic biomaterial and finds various applications. As it is similar to inorganic matrix of human bone and dental enamel, pure and doped HAps are widely studied. In the present study, pure nano-HAp and Strontium doped nano-HAp (Sr-HAp) with different concentrations were synthesized by surfactant mediated approach. The doping of strontium was confirmed by EDAX. The powder XRD study was carried out and it suggested nano-crystalline nature of the sample and the extra peaks observed other than HAp were due to the presence of brushite phase for higher concentration of Sr. TEM study revealed the needle type morphology for all the samples with size ranging from 23 nm to 78 nm. The dielectric study was carried out at room temperature within the frequency range from 10(2) Hz to 10(7) Hz and the variations of dielectric constant with frequency of applied field as well as with the concentration of strontium were studied. The results are discussed.
C1 [Tank, Kashmira P.; Jogiya, Bhoomika V.; Joshi, M. J.] Saurashtra Univ, Dept Phys, Rajkot 360005, Gujarat, India.
   [Kanchan, D. K.] M S Univ Baroda, Fac Sci, Dept Phys, Vadodara, Gujarat, India.
RP Tank, KP (reprint author), Saurashtra Univ, Dept Phys, Rajkot 360005, Gujarat, India.
EM kashmira_physics@yahoo.co.in; bhoomika.cpi@gmail.com;
   d_k_kanchan@yahoo.com; mshilp24@yahoo.co.in
FU UGC, New Delhi,; develop laboratory facilities under the project" Nano
   science and Nano technology and atmospheric Physics", at Physics
   Department, Saurashtra University
FX y The authors are thankful to the UGC, New Delhi,for financial
   assistance under DRS-SAP and the author (KPT) for the T_TOC-SRP under
   the Meritorious Student's Scheme. The authors are thankful to the Heads,
   Physics Departments (Saurashtra University and M. S. University) for
   their kind co-operation. The authors are thankful to Government of
   Gujarat for the financial assistance to develop laboratory facilities
   under the project" Nano science and Nano technology and atmospheric
   Physics", at Physics Department, Saurashtra University.
CR BECKER RO, 1972, B NEW YORK ACAD MED, V48, P627
   Bera J., 2004, P INT S ADV MAT PROC
   BLAKE GM, 1986, J NUCL MED, V27, P1030
   BLAKE GM, 1986, EUR J NUCL MED, V12, P447
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Jaffe WL, 1996, J BONE JOINT SURG AM, V78A, P1918, DOI 10.2106/00004623-199612000-00018
   LAKES RS, 1977, J APPL PHYS, V48, P808, DOI 10.1063/1.323674
   Li MO, 2008, J MATER SCI-MATER M, V19, P797, DOI 10.1007/s10856-007-3213-4
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   Tank KP, 2011, CRYST RES TECHNOL, V46, P1309, DOI 10.1002/crat.201100080
   Vasant SR, 2011, MOD PHYS LETT B, V25, P53, DOI 10.1142/S0217984911025419
NR 13
TC 1
Z9 1
U1 1
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1012-0394
J9 SOLID STATE PHENOMEN
PY 2014
VL 209
BP 151
EP +
DI 10.4028/www.scientific.net/SSP.209.151
PG 2
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA BA5TS
UT WOS:000337004800037
DA 2018-10-20
ER

PT J
AU Orczykowska, M
   Dziubinski, M
AF Orczykowska, Magdalena
   Dziubinski, Marek
TI COMPARISON OF VISCOELASTIC PROPERTIES OF CHESTNUT AND ACORN STARCH BY
   MEANS OF MECHANICAL MODELS WITH AN IN-BUILT SPRINGPOT
SO APPLIED RHEOLOGY
LA English
DT Article
DE fractional standard linear solid model; chestnut and acorn starch;
   viscoelastic behavior
ID CASTANEA-SATIVA; PHYSICOCHEMICAL PROPERTIES; RHEOLOGICAL BEHAVIOR;
   TEMPERATURE; QUALITY; GELS; MILL
AB The effect of concentration on viscoelastic properties of chestnut and acorn starch is discussed in the paper. The starch structure was assessed using a rheological fractional standard linear solid model FSLSM in contrary to very simple power-law model usually used in many published papers concerning determination of rheological properties of starch. Rheological parameters of this model were determined and their changes for different concentrations of the two tested types of starch were discussed. The values of the rheological parameter of FSLSM model give a useful of information concerning the elastic properties of materials such as total elasticity of networks, network oscillations, gel stiffness, structure of cross-linking and relaxation time of the materials. The proposed method for the interpretation of rheological measurements of the two types of starch allows for a comprehensive estimation of the analyzed biomaterial structure. The fractional rheological models can be very useful to control the biomaterial structure the needs of the final to meet envisaged product which is particularly significant from the point of view of materials engineering.
C1 [Orczykowska, Magdalena; Dziubinski, Marek] Lodz Univ Technol, Fac Proc & Environm Engn, PL-90924 Lodz, Poland.
RP Dziubinski, M (reprint author), Lodz Univ Technol, Fac Proc & Environm Engn, Ul Wolczanska 213, PL-90924 Lodz, Poland.
EM dziubin@wipos.p.lodz.pl
CR Alcoutlabi M, 1998, POLYMER, V39, P6269, DOI 10.1016/S0032-3861(98)00168-2
   Attanasio G, 2004, FOOD CHEM, V88, P583, DOI 10.1016/j.foodchem.2004.01.071
   Bahlouli MI, 2013, APPL RHEOL, V23, DOI 10.3933/ApplRheol-23-13435
   Borges O, 2008, FOOD CHEM, V106, P976, DOI 10.1016/j.foodchem.2007.07.011
   Burrell MM, 2003, J EXP BOT, V54, P451, DOI 10.1093/jxb/erg049
   Correia P, 2009, J FOOD ENG, V90, P325, DOI 10.1016/j.jfoodeng.2008.06.040
   Cruz BR, 2013, CARBOHYD POLYM, V94, P594, DOI 10.1016/j.carbpol.2012.12.060
   Demiate IM, 2001, BRAZ ARCH BIOL TECHN, V44, P69, DOI 10.1590/S1516-89132001000100010
   Dinzart F, 2009, ARCH MECH, V61, P459
   Dobraszczyk BJ, 2003, J CEREAL SCI, V38, P229, DOI 10.1016/S0733-5210(03)00059-6
   Huang JR, 2007, FOOD CHEM, V101, P1338, DOI 10.1016/j.foodchem.2006.03.039
   Ikeda S, 2001, FOOD HYDROCOLLOID, V15, P401, DOI 10.1016/S0268-005X(01)00052-2
   IZUKA A, 1992, MACROMOLECULES, V25, P2422, DOI 10.1021/ma00035a020
   Kim J. O., 1976, KOREAN J FOOD SCI TE, V8, P230
   Kim WW, 2009, INT J FOOD SCI TECH, V44, P503, DOI 10.1111/j.1365-2621.2008.01760.x
   Kobayashi M, 1985, J HOME EC KOR, V23, P33
   Kwon Joong-Ho, 2002, [Korean Journal of Food Science and Technology, 한국식품과학회지], V34, P1007
   Lee HA, 1998, THERMOCHIM ACTA, V322, P39
   Melito HS, 2012, APPL RHEOL, V22, P296, DOI [10.3933/ApplRheol-22-636, 10.3933/ApplRheol-22-63691]
   Moreira R, 2008, J FOOD ENG, V86, P584, DOI 10.1016/j.jfoodeng.2007.11.012
   Moreira R, 2012, J FOOD ENG, V112, P94, DOI 10.1016/j.jfoodeng.2012.03.021
   Orczykowska M, 2012, CHEM PROCESS ENG-INZ, V33, P141, DOI 10.2478/v10176-012-0013-2
   Pruska-Kedzior A, 2006, THESIS AGR U POZNAN, V373
   Ratnayake WS, 2002, STARCH-STARKE, V54, P217, DOI 10.1002/1521-379X(200206)54:6<217::AID-STAR217>3.0.CO;2-R
   Reyes-Melo ME, 2004, J OPTOELECTRON ADV M, V6, P1037
   Stevenson DG, 2006, STARCH-STARKE, V58, P553, DOI 10.1002/star.200600533
   Stevenson DG, 2006, STARCH-STARKE, V58, P323, DOI 10.1002/star.200600494
   Yang B, 2010, FOOD CHEM, V119, P995, DOI 10.1016/j.foodchem.2009.08.002
   Zhang M, 2011, STARCH-STARKE, V63, P260, DOI 10.1002/star.201000146
   Zhang PY, 2005, CARBOHYD POLYM, V59, P443, DOI 10.1016/j.carbpol.2004.10.014
NR 30
TC 4
Z9 4
U1 0
U2 3
PU KERSCHENSTEINER VERLAG GMBH
PI LAPPERSDORF
PA MORIKESTR 4, LAPPERSDORF, 93138, GERMANY
SN 1430-6395
J9 APPL RHEOL
JI Appl. Rheol.
PY 2014
VL 24
IS 2
AR 24766
DI 10.3933/ApplRheol-24-24766
PG 7
WC Mechanics
SC Mechanics
GA AI7YX
UT WOS:000337120000004
DA 2018-10-20
ER

PT J
AU Tam, H
   Vyavahare, N
AF Tam, Hobey
   Vyavahare, Narendra
TI Novel TRI (TM) Heart Valve Biomaterial Resists Calcification and Elicits
   Reduced Inflammatory Response
SO CARDIOLOGY
LA English
DT Meeting Abstract
C1 [Tam, Hobey; Vyavahare, Narendra] Clemson Univ, Clemson, SC USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0008-6312
EI 1421-9751
J9 CARDIOLOGY
JI Cardiology
PY 2014
VL 128
IS 2
BP 146
EP 146
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AI0GB
UT WOS:000336523100090
DA 2018-10-20
ER

PT J
AU Liang, LH
   Yan, W
AF Liang, Leo Hwa
   Yan, Wang
TI Advanced Biomaterial in Clinical Medicine
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Editorial Material
C1 [Liang, Leo Hwa] Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore.
   [Yan, Wang] Southern Med Univ, Inst Regenerat Med, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China.
RP Liang, LH (reprint author), Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore.
EM bielhl@nus.edu.sg; yanwang@smu.edu.cn
OI Leo, Hwa Liang/0000-0003-0592-6470
NR 0
TC 0
Z9 0
U1 1
U2 2
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PY 2014
VL 21
IS 22
BP 2467
EP 2468
DI 10.2174/0929867321666131212160131
PG 2
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA AI7TY
UT WOS:000337103800001
PM 24358970
DA 2018-10-20
ER

PT J
AU Bre, LP
   McCarthy, R
   Wang, W
AF Bre, L. P.
   McCarthy, R.
   Wang, W.
TI Prevention of Bioprosthetic Heart Valve Calcification: Strategies and
   Outcomes
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Article
DE Anticalcification; bioprosthesis; crosslinking; glutaraldehyde; heart
   valve replacement; mineralization
ID DERMAL SHEEP COLLAGEN; HANCOCK-II BIOPROSTHESIS; AORTIC-VALVE;
   CROSS-LINKING; IN-VITRO; PORCINE BIOPROSTHESIS; BOVINE PERICARDIUM;
   HEMODYNAMIC PERFORMANCE; MECHANICAL-PROPERTIES; PULSATILE BIOREACTOR
AB Despite the significant advances in cardiac surgery, heart valve replacement still faces a dilemma. While mechanical valves offer lifelong durability they also commit patients to anticoagulation treatment for the rest of their life. On the other hand, bioprosthetic valves have superior hemodynamic performance but durability of the bioprosthesis limits their use to the elderly, with early onset calcification being the primary cause of biomaterial breakdown. Considering that bioprosthetic valves are not reliant upon anticoagulation, there has been much focus on measures to overcome their issues with durability. Firstly, the calcification process has been studied and factors such as young patient age, use of glutaraldehyde fixative, the presence of phospholipids along with cell debris in the valve tissue and mechanical stress have been identified to influence tissue mineralization. Therefore different calcification reduction strategies are being sought: new fixatives have been developed and tested and post- treatments have been added to tissue processing. This review presents the pathophysiology of tissue valve calcification and focuses on the multiple approaches developed to prevent bioprosthetic heart valve calcification, as well as on their general outcomes and translation to clinical applications.
C1 [Bre, L. P.; McCarthy, R.; Wang, W.] Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway, Ireland.
RP Wang, W (reprint author), Natl Univ Ireland, Network Excellence Funct Biomat NFB, IDA Business Pk, Galway, Ireland.
EM wenxin.wang@ucd.ie
OI Wang, Wenxin/0000-0002-5053-0611
FU Irish Research Council (IRC) - Employment-based Postgraduate Programme;
   Boston Scientific
FX The authors thank Ms Crystal Anderson-Cunanan and Dr Michael Eppihimer
   for their valuable insight into the hurdles of bioprosthetic heart
   valves treatment. The authors would also like to acknowledge Mr. Maciej
   Doczyk for his contribution in graphical art of this manuscript. This
   research was supported by the Irish Research Council (IRC) -
   Employment-based Postgraduate Programme and by Boston Scientific.
CR Alferiev IS, 2005, J ORGANOMET CHEM, V690, P2543, DOI 10.1016/j.jorganchem.2004.10.011
   Alferiev IS, 2001, J POLYM SCI POL CHEM, V39, P105, DOI 10.1002/1099-0518(20010101)39:1<105::AID-POLA120>3.3.CO;2-#
   Aslam AK, 2007, INT J CARDIOL, V122, P99, DOI 10.1016/j.ijcard.2006.12.037
   Bailey M, 2001, AM J PATHOL, V159, P1981, DOI 10.1016/S0002-9440(10)63048-9
   Bailey MT, 2003, J BIOMED MATER RES A, V66A, P93, DOI 10.1002/jbm.a.10543
   Bakhtiary F, 2008, EUR J CARDIO-THORAC, V34, P960, DOI 10.1016/j.ejcts.2008.05.060
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P327, DOI 10.1115/1.1287158
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Borger MA, 2006, J HEART VALVE DIS, V15, P49
   Bourantas C.V., 2013, INT J CARDIOL, V168
   Breuer CK, 1996, BIOTECHNOL BIOENG, V50, P562, DOI 10.1002/(SICI)1097-0290(19960605)50:5<562::AID-BIT11>3.0.CO;2-L
   Brody S, 2007, J BIOMED MATER RES B, V83B, P16, DOI 10.1002/jbm.b.30763
   Butany J, 2003, CARDIOVASC PATHOL, V12, P119, DOI 10.1016/S1054-8807(03)00002-4
   Butany J., 2013, ISRN BIOMATER, P1, DOI DOI 10.5402/2013/728791
   Cannegieter SC, 1999, J INTERN MED, V245, P369, DOI 10.1046/j.1365-2796.1999.00460.x
   Chandy T, 1996, BIOMATERIALS, V17, P577, DOI 10.1016/0142-9612(96)88708-4
   Chang HW, 2011, INTERACT CARDIOV TH, V12, P903, DOI 10.1510/icvts.2010.259747
   CHEN WL, 1994, CIRCULATION, V90, P323, DOI 10.1161/01.CIR.90.1.323
   Colli A, 2007, INT J CARDIOL, V116, P144, DOI 10.1016/j.ijcard.2006.03.047
   Connolly JM, 2011, ANN THORAC SURG, V92, P858, DOI 10.1016/j.athoracsur.2011.04.104
   Connolly JM, 2005, AM J PATHOL, V166, P1, DOI 10.1016/S0002-9440(10)62227-4
   Connolly JM, 2004, J HEART VALVE DIS, V13, P487
   Cunanan CM, 2001, ANN THORAC SURG, V71, pS417, DOI 10.1016/S0003-4975(01)02493-6
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   David TE, 2003, J THORAC CARDIOV SUR, V126, P939, DOI 10.1016/S0022-5223(03)00731-1
   David TE, 2010, ANN THORAC SURG, V90, P775, DOI 10.1016/j.athoracsur.2010.05.034
   Dohmen PM, 2009, ANN THORAC CARDIOVAS, V15, P362
   Dumont K, 2002, ARTIF ORGANS, V26, P710, DOI 10.1046/j.1525-1594.2002.06931_3.x
   Fauci A. S., 2008, HARRISONS PRINCIPLES, V2
   Flameng W, 2014, J THORAC CARDIOV SUR, V147, P1219, DOI 10.1016/j.jtcvs.2013.03.025
   Flameng WJ, 2001, ANN THORAC SURG, V71, pS401, DOI 10.1016/S0003-4975(01)02527-9
   Flora L., 1988, U.S. Patent, Patent No. [4761, 406, 4761406]
   Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   Gott JP, 1997, ANN THORAC SURG, V64, P50, DOI 10.1016/S0003-4975(97)00118-5
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   Grabenwoger M, 1996, ANN THORAC SURG, V62, P772
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Hoerstrup SP, 2000, TISSUE ENG, V6, P75, DOI 10.1089/107632700320919
   Holmes DR, 2012, J AM COLL CARDIOL, V59, P1200, DOI 10.1016/j.jacc.2012.01.001
   HORSTKOTTE D, 1988, EUR HEART J, V9, P57, DOI 10.1093/eurheartj/9.suppl_E.57
   Imamura E, 1989, J Card Surg, V4, P50, DOI 10.1111/j.1540-8191.1989.tb00256.x
   Jamieson WRE, 2005, J THORAC CARDIOV SUR, V130, P994, DOI 10.1016/j.jtcvs.2005.03.040
   Jang W, 2012, KOREAN CIRC J, V42, P154, DOI 10.4070/kcj.2012.42.3.154
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Jockenhoevel S, 2002, ASAIO J, V48, P8, DOI 10.1097/00002480-200201000-00003
   JOHNSTON TP, 1993, J CONTROL RELEASE, V25, P227, DOI 10.1016/0168-3659(93)90081-F
   Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Kidane AG, 2009, J BIOMED MATER RES B, V88B, P290, DOI 10.1002/jbm.b.31151
   Knight Richard, 2004, V11, P72
   Lee C, 2011, EUR J CARDIO-THORAC, V39, P381, DOI 10.1016/j.ejcts.2010.07.015
   Lee JM, 1996, J MATER SCI-MATER M, V7, P531, DOI 10.1007/BF00122176
   LEE JM, 1994, J BIOMED MATER RES, V28, P981, DOI 10.1002/jbm.820280903
   LEVY RJ, 1995, J BIOMED MATER RES, V29, P217, DOI 10.1002/jbm.820290212
   LEVY RJ, 1983, AM J CARDIOL, V52, P629, DOI 10.1016/0002-9149(83)90040-1
   LEVY RJ, 1985, CIRCULATION, V71, P349, DOI 10.1161/01.CIR.71.2.349
   LEVY RJ, 1991, J BIOMED MATER RES, V25, P905, DOI 10.1002/jbm.820250802
   LEVY RJ, 1985, SCIENCE, V228, P190, DOI 10.1126/science.3919445
   Maitland A, 2011, J HEART VALVE DIS, V20, P327
   Manji RA, 2012, AM HEART J, V164, P177, DOI 10.1016/j.ahj.2012.05.011
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   McClure RS, 2010, ANN THORAC SURG, V89, P1410, DOI 10.1016/j.athoracsur.2010.01.046
   Moore MA, 2001, J BIOMED MATER RES, V56, P24, DOI 10.1002/1097-4636(200107)56:1<24::AID-JBM1064>3.0.CO;2-Q
   Myken PSU, 2009, J THORAC CARDIOV SUR, V137, P76, DOI 10.1016/j.jtcvs.2008.05.068
   Neuenschwander S, 2004, TRANSPL IMMUNOL, V12, P359, DOI 10.1016/S0966-3274(03)00116-3
   Niclauss L, 2013, INTERACT CARDIOV TH, V16, P501, DOI 10.1093/icvts/ivs514
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Nimni ME, 1997, J BIOMED MATER RES, V35, P531
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Ogle MF, 2003, ANN THORAC SURG, V75, P1267, DOI 10.1016/S0003-4975(02)04489-2
   Park KD, 1997, BIOMATERIALS, V18, P47, DOI 10.1016/S0142-9612(96)00096-8
   Pathak CP, 2004, J BIOMED MATER RES A, V69A, P140, DOI 10.1002/jbm.a.20129
   PEREIRA CA, 1990, J BIOMED MATER RES, V24, P345, DOI 10.1002/jbm.820240307
   Pibarot P, 2009, CIRCULATION, V119, P1034, DOI 10.1161/CIRCULATIONAHA.108.778886
   Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69
   Rapoport HS, 2007, BIOMATERIALS, V28, P690, DOI 10.1016/j.biomaterials.2006.09.029
   Research T.M., 2018, HEART VALVE DEVICES
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Riess FC, 2007, ANN THORAC SURG, V83, P1310, DOI 10.1016/j.athoracsur.2006.07.034
   Rothenburger M, 2001, THORAC CARDIOV SURG, V49, P204, DOI 10.1055/s-2001-16108
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015
   Schaefer BM, 2008, HEART, V94, P1634, DOI 10.1136/hrt.2007.1320902
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011
   Shinoka T, 1995, ANN THORAC SURG, V60, pS513, DOI 10.1016/0003-4975(95)00733-4
   Sinning Jan-Malte, 2012, Interv Cardiol Clin, V1, P37, DOI 10.1016/j.iccl.2011.09.002
   Solomons T.W.G., 1994, ORGANIC CHEM
   Stock UA, 2000, J THORAC CARDIOV SUR, V119, P732, DOI 10.1016/S0022-5223(00)70008-0
   Stock UA, 2006, BIOMATERIALS, V27, P1, DOI 10.1016/j.biomaterials.2005.05.100
   Sung H W, 1994, ASAIO J, V40, P192, DOI 10.1097/00002480-199404000-00013
   Sung H.W., 1993, ASAIO J, V39, pM537
   Sung HW, 1996, BIOMATERIALS, V17, P2357, DOI 10.1016/S0142-9612(96)00081-6
   TU R, 1994, J BIOMED MATER RES, V28, P677, DOI 10.1002/jbm.820280604
   TU R, 1993, J BIOMED MATER RES, V27, P3, DOI 10.1002/jbm.820270103
   TU R, 1993, INT J ARTIF ORGANS, V16, P537
   Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f
   Vyavahare N, 1997, CIRCULATION, V95, P479
   Vyavahare NR, 2000, J HEART VALVE DIS, V9, P561
   WEBB CL, 1988, ANN THORAC SURG, V46, P309, DOI 10.1016/S0003-4975(10)65932-2
   WEBB CL, 1989, EXP MOL PATHOL, V50, P291, DOI 10.1016/0014-4800(89)90039-7
   WEBB CL, 1991, AM J PATHOL, V138, P971
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
   Yetkin E, 2009, INT J CARDIOL, V135, P4, DOI 10.1016/j.ijcard.2009.03.108
   Zeeman R, 1999, J BIOMED MATER RES, V46, P424, DOI 10.1002/(SICI)1097-4636(19990905)46:3<424::AID-JBM16>3.0.CO;2-R
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
   Zhai WY, 2010, ACTA BIOMATER, V6, P389, DOI 10.1016/j.actbio.2009.07.035
   Zhai WY, 2009, J BIOMED MATER RES B, V90B, P913, DOI 10.1002/jbm.b.31363
   Zhai WY, 2006, BIOMATERIALS, V27, P3684, DOI 10.1016/j.biomaterials.2006.02.008
   Zilla P, 2005, ANN THORAC SURG, V79, P905, DOI 10.1016/j.athorascur.2003.12.026
   Zilla P, 2000, ANN THORAC SURG, V70, P2091, DOI 10.1016/S0003-4975(00)02011-7
   Zilla P, 2008, BIOMATERIALS, V29, P385, DOI 10.1016/j.biomaterials.2007.09.033
   Zund G, 1997, EUR J CARDIO-THORAC, V11, P493, DOI 10.1016/S1010-7940(96)01005-6
NR 118
TC 4
Z9 5
U1 4
U2 34
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PY 2014
VL 21
IS 22
BP 2553
EP 2564
DI 10.2174/0929867321666131212151216
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA AI7TY
UT WOS:000337103800008
PM 24358975
DA 2018-10-20
ER

PT J
AU Cicciu, M
   Bramanti, E
   Matacena, G
   Guglielmino, E
   Risitano, G
AF Cicciu, Marco
   Bramanti, Ennio
   Matacena, Giada
   Guglielmino, Eugenio
   Risitano, Giacomo
TI FEM evaluation of cemented-retained versus screw-retained dental implant
   single-tooth crown prosthesis
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE FEM analysis; bone tissue; load; dental implant
ID FINITE-ELEMENT-METHOD; STRESS-ANALYSIS; DESIGNS; SYSTEM; JOINT
AB Prosthetic rehabilitation of partial or total edentulous patients is today a challenge for clinicians and dental practitioners. The application of dental implants in order to recover areas of missing teeth is going to be a predictable technique, however some important points about the implant angulation, the stress distribution over the bone tissue and prosthetic components should be well investigated for having final long term clinical results. Two different system of the prosthesis fixation are commonly used. The screw retained crown and the cemented retained one. All of the two restoration techniques give to the clinicians several advantages and some disadvantages. Aim of this work is to evaluate all the mechanical features of each system, through engineering systems of investigations like FEM and Von Mises analyses. The FEM is today a useful tool for the prediction of stress effect upon material and biomaterial under load or strengths. Specifically three different area has been evaluated through this study: the dental crown with the bone interface; the passant screw connection area; the occlusal surface of the two different type of crown. The elastic features of the materials used in the study have been taken from recent literature data. Results revealed an adequate response for both type of prostheses, although cemented retained one showed better results over the occlusal area.
C1 [Cicciu, Marco] Univ Messina, Sch Dent, Dept Human Pathol, I-98100 Messina, Italy.
   [Bramanti, Ennio; Matacena, Giada] Univ Messina, Sch Dent, Dept Odontostomatol, I-98100 Messina, Italy.
   [Guglielmino, Eugenio; Risitano, Giacomo] Univ Messina, Dept Elect Engn Chem & Ind Engn, I-98100 Messina, Italy.
RP Cicciu, M (reprint author), Univ Messina, Sch Dent, Dept Human Pathol, Via Consolare Valeria, I-98100 Messina, Italy.
EM acromarco@yahoo.it; enniobramanti@hotmail.it
RI Risitano, Giacomo/G-3285-2014
OI Risitano, Giacomo/0000-0002-0506-8720; Cicciu,
   Marco/0000-0003-2311-9728; GUGLIELMINO, EGUGENIO/0000-0001-7793-7406
CR Al-Sukhun J, 2007, J BIOMED MATER RES A, V80A, P247, DOI 10.1002/jbm.a.30881
   Bergkvist G, 2008, CLIN IMPLANT DENT R, V10, P40, DOI 10.1111/j.1708-8208.2007.00059.x
   Boschian P., 2006, J ORAL REHABIL, V33, P690
   Bozkaya D, 2003, J BIOMECH, V36, P1649, DOI 10.1016/S0021-9290(03)00177-5
   Ciccio M, 2008, Minerva Stomatol, V57, P167
   Ciccio M, 2009, Minerva Stomatol, V58, P9
   Covani U, 2013, IMPLANT DENT, V22, P263, DOI 10.1097/ID.0b013e318292625f
   de Cos Juez FJ, 2008, APPL MATH COMPUT, V206, P952
   Kitagawa T, 2005, J BIOMED MATER RES B, V75B, P457, DOI 10.1002/jbm.b.30328
   Lan TH, 2008, KAOHSIUNG J MED SCI, V24, P138, DOI 10.1016/S1607-551X(08)70141-4
   Michailidis N, 2013, BIO-MED MATER ENG, V23, P317, DOI 10.3233/BME-130756
   Moon HJ, 1997, J MED ENG TECHNOL, V21, P233, DOI 10.3109/03091909709070014
   Pietrabissa R, 2000, J BIOMECH, V33, P1498
   Roychowdhury A, 2000, CRIT REV BIOMED ENG, V28, P411, DOI 10.1615/CritRevBiomedEng.v28.i34.110
   Roychowdhury A, 2000, CRIT REV BIOMED ENG, V28, P405, DOI 10.1615/CritRevBiomedEng.v28.i34.100
   Sano M, 2012, IMPLANT DENT, V21, P220, DOI 10.1097/ID.0b013e31825023f5
   Van Staden R. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P257, DOI 10.1080/10255840600837074
   van Staden RC, 2008, CLIN ORAL IMPLAN RES, V19, P303, DOI 10.1111/j.1600-0501.2007.01427.x
NR 18
TC 24
Z9 24
U1 0
U2 9
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2014
VL 7
IS 4
BP 817
EP 825
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AI3DV
UT WOS:000336740600003
PM 24955150
DA 2018-10-20
ER

PT J
AU Gelmi, A
   Ljunggren, MK
   Rafat, M
   Jager, EWH
AF Gelmi, A.
   Ljunggren, M. K.
   Rafat, M.
   Jager, E. W. H.
TI Influence of conductive polymer doping on the viability of cardiac
   progenitor cells
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; MESENCHYMAL STEM-CELLS; INFARCTED
   MYOCARDIUM; POLYPYRROLE FILMS; REGENERATION; BIOMATERIALS; STIMULATION;
   RELEASE; SURFACE; GROWTH
AB Cardiac tissue engineering via the use of stem cells is the future for repairing impaired heart function that results from a myocardial infarction. Developing an optimised platform to support the stem cells is vital to realising this, and through utilising new 'smart' materials such as conductive polymers we can provide a multi-pronged approach to supporting and stimulating the stem cells via engineered surface properties, electrical, and electromechanical stimulation. Here we present a fundamental study on the viability of cardiac progenitor cells on conductive polymer surfaces, focusing on the impact of surface properties such as roughness, surface energy, and surface chemistry with variation of the polymer dopant molecules. The conductive polymer materials were shown to provide a viable support for both endothelial and cardiac progenitor cells, while the surface energy and roughness were observed to influence viability for both progenitor cell types. Characterising the interaction between the cardiac progenitor cells and the conductive polymer surface is a critical step towards optimising these materials for cardiac tissue regeneration, and this study will advance the limited knowledge on biomaterial surface interactions with cardiac cells.
C1 [Gelmi, A.; Jager, E. W. H.] Linkoping Univ, Dept Phys Chem & Biol IFM, Biosensors & Bioelect Ctr, S-58183 Linkoping, Sweden.
   [Ljunggren, M. K.; Rafat, M.] Linkoping Univ, Dept Clin & Expt Med, Integrat Regenerat Med Ctr, S-58185 Linkoping, Sweden.
   [Rafat, M.] Linkoping Univ, Dept Biomed Engn, S-58185 Linkoping, Sweden.
RP Gelmi, A (reprint author), Linkoping Univ, Dept Phys Chem & Biol IFM, Biosensors & Bioelect Ctr, S-58183 Linkoping, Sweden.
EM amy.gelmi@liu.se
RI Jager, Edwin/F-1481-2013; Gelmi, Amy/D-4456-2012
OI Jager, Edwin/0000-0002-2071-7768; Gelmi, Amy/0000-0001-5184-4842
FU Linkoping University; IGEN (post-doc grant); COST-Action [MP1003]; Knut
   och Alice Wallenberg Commemorative Fund; European Research Agency -
   Marie Curie Actions-Career Integration Grant (CIG) [FP7-PEOPLE-2011-CIG]
FX We would like to acknowledge Prof. May Griffith and Link oping
   Integrative Regenerative Medicine Centre (IGEN), Linkoping University,
   for the supply of the progenitor cells and cell facilities. Prof.
   Anthony Turner is acknowledged for his support. Financial support was
   received from Linkoping University, IGEN (post-doc grant), COST-Action
   MP1003, Knut och Alice Wallenberg Commemorative Fund, and the European
   Research Agency for EU FP7-PEOPLE-2011-CIG-Marie Curie Actions-Career
   Integration Grant (CIG).
CR Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bendrea AD, 2011, J BIOMATER APPL, V26, P3, DOI 10.1177/0885328211402704
   Berry CC, 2007, IEEE T NANOBIOSCI, V6, P201, DOI 10.1109/TNB.2007.903457
   Bolin MH, 2009, SENSOR ACTUAT B-CHEM, V142, P451, DOI 10.1016/j.snb.2009.04.062
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui XY, 2003, SENSOR ACTUAT A-PHYS, V103, P384, DOI 10.1016/S0924-4247(02)00427-2
   Deb K. D., 2011, FRONT BIOSCI-LANDMRK, V17, P1747
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Fonner JM, 2008, BIOMED MATER, V3, P1
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   Gelmi A, 2013, SMALL, V9, P393, DOI 10.1002/smll.201201686
   Gelmi A, 2010, BIOMATERIALS, V31, P1974, DOI 10.1016/j.biomaterials.2009.11.040
   Ghafar-Zadeh E, 2011, LAB CHIP, V11, P3031, DOI 10.1039/c1lc20284g
   Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059
   Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047
   Guan JJ, 2011, BIOMATERIALS, V32, P5568, DOI 10.1016/j.biomaterials.2011.04.038
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Han DH, 2005, ELECTROCHIM ACTA, V50, P3085, DOI 10.1016/j.electacta.2004.10.085
   Jin L, 2012, J MATER CHEM, V22, P18321, DOI 10.1039/c2jm32165c
   Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Keiswetter K., 1996, BIOMED MATER, V32, P55
   Leor J, 2000, CIRCULATION, V102, P56
   Li D, 2011, REGEN MED, V6, P229, DOI 10.2217/RME.11.2
   Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007
   Lundin V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018624
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Nishizawa M, 2007, BIOMATERIALS, V28, P1480, DOI 10.1016/j.biomaterials.2006.11.034
   Pascale P, 2005, CHEST, V128, P2626, DOI 10.1378/chest.128.4.2626
   Rowlands AS, 2008, BIOMATERIALS, V29, P4510, DOI 10.1016/j.biomaterials.2008.07.052
   Salto C, 2008, LANGMUIR, V24, P14133, DOI 10.1021/la8028337
   Schmidt C, 2003, ACS SYM SER, V832, P154
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Serra Moreno J., 2008, BIOELECTROCHEMISTRY, V72, P3, DOI DOI 10.1016/J.BIOELECHEM.2007.11.002
   Serra Moreno J, 2009, J BIOMED MATER RES A, V88A, P832, DOI 10.1002/jbm.a.32230
   Shanmugasundaram S., 2010, TISSUE ENG PART A, V17, P831
   Silk T, 1998, SYNTHETIC MET, V93, P59, DOI 10.1016/S0379-6779(98)80131-8
   Svennersten K, 2011, LAB CHIP, V11, P3287, DOI 10.1039/c1lc20436j
   Svennersten K, 2009, BIOMATERIALS, V30, P6257, DOI 10.1016/j.biomaterials.2009.07.059
   Thompson BC, 2011, BIOMATERIALS, V32, P3822, DOI 10.1016/j.biomaterials.2011.01.053
   Thompson BC, 2010, J CONTROL RELEASE, V141, P161, DOI 10.1016/j.jconrel.2009.09.016
   Titushkin I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/743476
   TOURILLON G, 1983, J PHYS CHEM-US, V87, P2289, DOI 10.1021/j100236a010
   Wachem P. B. V., 1987, CELL, V8, P323
   Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027
   WARREN LF, 1987, J ELECTROCHEM SOC, V134, P101, DOI 10.1149/1.2100383
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Young PP, 2007, PROG CARDIOVASC DIS, V49, P421, DOI 10.1016/j.pcad.2007.02.004
   Zammaretti P, 2004, CURR OPIN BIOTECH, V15, P430, DOI 10.1016/j.copbio.2004.08.007
   ZINGER B, 1984, J AM CHEM SOC, V106, P6861, DOI 10.1021/ja00334a076
NR 56
TC 22
Z9 22
U1 3
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 24
BP 3860
EP 3867
DI 10.1039/c4tb00142g
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA AI4RV
UT WOS:000336853400015
OA Other Gold
DA 2018-10-20
ER

PT J
AU Moraes, C
   Kim, BC
   Zhu, XY
   Mills, KL
   Dixon, AR
   Thouless, MD
   Takayama, S
AF Moraes, Christopher
   Kim, Byoung Choul
   Zhu, Xiaoyue
   Mills, Kristen L.
   Dixon, Angela R.
   Thouless, M. D.
   Takayama, Shuichi
TI Defined topologically-complex protein matrices to manipulate cell shape
   via three-dimensional fiber-like patterns
SO LAB ON A CHIP
LA English
DT Article
ID PERINUCLEAR ACTIN CAP; NUCLEAR SHAPE; ELASTOMERIC NANOCHANNELS;
   STEM-CELLS; MECHANICS; CULTURE; TISSUE; 3RD-DIMENSION; ENVIRONMENTS;
   FRACTURE
AB Culturing cells in three-dimensional (3D) environments has been shown to significantly influence cell function, and may provide a more physiologically relevant environment within which to study the behavior of specific cell types. 3D tissues typically present a topologically complex fibrous adhesive environment, which is technically challenging to replicate in a controlled manner. Micropatterning technologies have provided significant insights into cell-biomaterial interactions, and can be used to create fiber-like adhesive structures, but are typically limited to flat culture systems; the methods are difficult to apply to topologically-complex surfaces. In this work, we utilize crack formation in multilayered microfabricated materials under applied strain to rapidly generate well-controlled and topologically complex 'fiber-like' adhesive protein patterns, capable of supporting cell culture and controlling cell shape on three-dimensional patterns. We first demonstrate that the features of the generated adhesive environments such as width, spacing and topology can be controlled, and that these factors influence cell morphology. The patterning technique is then applied to examine the influence of fiber structure on the nuclear morphology and actin cytoskeletal structure of cells cultured in a nanofibrous biomaterial matrix.
C1 [Moraes, Christopher; Kim, Byoung Choul; Zhu, Xiaoyue; Dixon, Angela R.; Takayama, Shuichi] Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Moraes, Christopher; Kim, Byoung Choul; Takayama, Shuichi] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.
   [Kim, Byoung Choul; Takayama, Shuichi] Univ Michigan, Coll Engn, Macromol Sci & Engn Ctr, Ann Arbor, MI 48109 USA.
   [Mills, Kristen L.; Thouless, M. D.] Univ Michigan, Coll Engn, Dept Mech Engn, Ann Arbor, MI 48109 USA.
   [Thouless, M. D.] Univ Michigan, Coll Engn, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Takayama, Shuichi] UNIST, WCU Project, Div Nano Bio & Chem Engn, Ulsan, South Korea.
RP Thouless, MD (reprint author), Univ Michigan, Coll Engn, Dept Mech Engn, 2350 Hayward St, Ann Arbor, MI 48109 USA.
EM thouless@umich.edu; takayama@umich.edu
OI Moraes, Christopher/0000-0002-8950-2212
FU Natural Sciences and Engineering Research Council of Canada; Banting
   postdoctoral fellowship programs; NIH [EB003793, HG004653];
   Biointerfaces Institute
FX We gratefully acknowledge support from the Natural Sciences and
   Engineering Research Council of Canada, and from the Banting
   postdoctoral fellowship programs to CM. Project support was provided by
   the NIH (EB003793 & HG004653) and the Biointerfaces Institute.
CR Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen HY, 2007, P NATL ACAD SCI USA, V104, P11173, DOI 10.1073/pnas.0702749104
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554
   Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989
   Dahl KN, 2011, J CELL SCI, V124, P675, DOI 10.1242/jcs.069096
   Desai RA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0717
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dixon AR, 2014, J BIOMED MATER RES A, V102, P1361, DOI 10.1002/jbm.a.34814
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fu Y, 2012, LAB CHIP, V12, P3774, DOI 10.1039/c2lc40477j
   Ginger DS, 2004, ANGEW CHEM INT EDIT, V43, P30, DOI 10.1002/anie.200300608
   Gomez EW, 2010, J CELL BIOCHEM, V110, P44, DOI 10.1002/jcb.22545
   Greiner AM, 2012, MACROMOL BIOSCI, V12, P1301, DOI 10.1002/mabi.201200132
   Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020
   Huang JX, 2014, J MATER SCI, V49, P255, DOI 10.1007/s10853-013-7700-3
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Huh D, 2007, NAT MATER, V6, P424, DOI 10.1038/nmat1907
   Khatau SB, 2010, NUCLEUS-AUSTIN, V1, P337, DOI 10.4161/nucl.1.4.12331
   Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim BC, 2014, BIOMATER SCI-UK, V2, P288, DOI 10.1039/c3bm60276a
   Kim BC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03027
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kim HN, 2011, LAB CHIP, V11, P717, DOI 10.1039/c0lc00277a
   Kim Jong Bin, 2004, Breast Cancer Research and Treatment, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b
   Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671
   Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009
   Lee J, 2013, BIOMATERIALS, V34, P8140, DOI 10.1016/j.biomaterials.2013.07.074
   Matsuoka T, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4816835
   Matsuoka T, 2012, NANO LETT, V12, P6480, DOI 10.1021/nl304063f
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Moraes C, 2013, BIOMATERIALS, V34, P9623, DOI 10.1016/j.biomaterials.2013.08.046
   Moraes C, 2013, INTEGR BIOL-UK, V5, P673, DOI 10.1039/c3ib20254b
   Moraes C, 2011, INTEGR BIOL-UK, V3, P959, DOI 10.1039/c1ib00056j
   Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068
   Nathan AS, 2011, ACTA BIOMATER, V7, P57, DOI 10.1016/j.actbio.2010.08.007
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Palchesko RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051499
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Pampaloni F, 2010, BIOTECHNOL GENET ENG, V26, P117
   Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023
   Petrzelka JE, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/7/075015
   Raghavan S, 2004, ADV MATER, V16, P1303, DOI 10.1002/adma.200400594
   Raghavan S, 2010, J CELL SCI, V123, P2877, DOI 10.1242/jcs.055079
   Ruder WC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00554
   Ruder WC, 2012, LAB CHIP, V12, P1775, DOI 10.1039/c2lc21117c
   Ruiz SA, 2007, SOFT MATTER, V3, P168, DOI 10.1039/b613349e
   Schwartz MA, 2013, SCIENCE, V339, P402, DOI 10.1126/science.1233814
   Shen C, 2013, BIOTECHNOL BIOENG, V110, P2173, DOI 10.1002/bit.24874
   Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242
   Sun YB, 2012, LANGMUIR, V28, P10789, DOI 10.1021/la300978x
   Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Tooley WW, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054013
   Uchida T, 2009, LANGMUIR, V25, P3102, DOI 10.1021/la801986k
   Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668
   Zhu XY, 2005, NAT MATER, V4, P403, DOI 10.1038/nmat1365
   Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229
   Zwerger M, 2011, ANNU REV BIOMED ENG, V13, P397, DOI 10.1146/annurev-bioeng-071910-124736
NR 64
TC 14
Z9 14
U1 4
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
EI 1473-0189
J9 LAB CHIP
JI Lab Chip
PY 2014
VL 14
IS 13
BP 2191
EP 2201
DI 10.1039/c4lc00122b
PG 11
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA AI7SE
UT WOS:000337096800007
PM 24632936
OA Green Accepted, Other Gold
DA 2018-10-20
ER

PT J
AU Taraballi, F
   Russo, L
   Battocchio, C
   Polzonetti, G
   Nicotra, F
   Cipolla, L
AF Taraballi, F.
   Russo, L.
   Battocchio, C.
   Polzonetti, G.
   Nicotra, F.
   Cipolla, L.
TI A model study for tethering of (bio)active molecules to biomaterial
   surfaces through arginine
SO ORGANIC & BIOMOLECULAR CHEMISTRY
LA English
DT Article
ID COLLAGEN; IMMOBILIZATION; STRATEGIES; CHEMISTRY; PEPTIDES; PROTEINS;
   AMINO
AB A new approach for tethering of bioactive molecules via arginine is proposed and validated on collagen 2D matrices. The method involves the introduction of a methyl ketone on arginine side-chains, followed by reaction with model alkoxyamino derivatives.
C1 [Taraballi, F.] Fdn IRCCS Policlin San Matteo, Pain Therapy Serv, I-27100 Pavia, Italy.
   [Russo, L.; Nicotra, F.; Cipolla, L.] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy.
   [Battocchio, C.; Polzonetti, G.] Univ Roma Tre, Dept Sci, INSTM CNISM & CISDiC, I-00146 Rome, Italy.
RP Cipolla, L (reprint author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Pzza Sci 2, I-20126 Milan, Italy.
EM laura.cipolla@unimib.it
RI battocchio, chiara/M-4686-2015; Russo, Laura/I-3237-2014
OI Russo, Laura/0000-0002-5914-766X; Taraballi,
   Francesca/0000-0002-4959-1169
FU Cariplo Foundation [2010-0378]; PRIN [2010L9SH3]
FX This work was funded by Cariplo Foundation under grant no. 2010-0378 and
   PRIN 2010L9SH3 K. Authors acknowledge Dr Alberto Visioli and Dr Elena
   Binda for fluorescence microscopy facility.
CR Abou Neel EA, 2013, ADV DRUG DELIVER REV, V65, P429, DOI 10.1016/j.addr.2012.08.010
   Aldini G, 2007, MED RES REV, V27, P817, DOI 10.1002/med.20073
   [Anonymous], 2012, NIST XRAY PHOT SPECT
   Baeza A, 2010, ACTA BIOMATER, V6, P743, DOI 10.1016/j.actbio.2009.09.004
   Battocchio C, 2006, NUCL INSTRUM METH B, V246, P136, DOI 10.1016/j.nimb.2005.12.035
   Beamson G., 1992, HIGH RESOLUTION XPS
   Bini D, 2014, ORG LETT, V16, P1298, DOI 10.1021/ol403476z
   Cheung S. T., 1976, BICH BIOPHYS RES COM, V90, P940
   Gratzer PF, 2004, BIOMATERIALS, V25, P2081, DOI 10.1016/j.biomaterials.2003.08.059
   Hackenberger CPR, 2008, ANGEW CHEM INT EDIT, V47, P10030, DOI 10.1002/anie.200801313
   Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P1
   Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349
   Leitner A, 2003, J MASS SPECTROM, V38, P891, DOI 10.1002/jms.477
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383
   Onofrejova L, 2008, J SEP SCI, V31, P499, DOI 10.1002/jssc.200700485
   Place N. S., 2009, NAT MATER, V8, P457
   Pradier C. M., 2011, BIOINTERFACE CHARACT, P101
   Russo L, 2014, CARBOHYD RES, V389, P12, DOI 10.1016/j.carres.2013.11.008
   Russo L, 2014, ACS CHEM NEUROSCI, V5, P261, DOI 10.1021/cn400222s
   Russo L, 2014, LANGMUIR, V30, P1336, DOI 10.1021/la404310p
   Shibamoto T, 2006, J PHARMACEUT BIOMED, V41, P12, DOI 10.1016/j.jpba.2006.01.047
   Slaney AM, 2011, ACS APPL MATER INTER, V3, P1601, DOI 10.1021/am200158y
   Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942
   Taraballi F, 2013, J COLLOID INTERF SCI, V394, P590, DOI 10.1016/j.jcis.2012.11.041
   Tirrell DA, 2004, NATURE, V430, P837, DOI 10.1038/430837a
   van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203
   Werz DB, 2012, METHODS MOL BIOL, V808, P13, DOI 10.1007/978-1-61779-373-8_2
   Wilchek M., 1990, METHOD ENZYMOL, V184, P167
NR 29
TC 7
Z9 7
U1 1
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-0520
EI 1477-0539
J9 ORG BIOMOL CHEM
JI Org. Biomol. Chem.
PY 2014
VL 12
IS 24
BP 4089
EP 4092
DI 10.1039/c4ob00160e
PG 4
WC Chemistry, Organic
SC Chemistry
GA AI4OJ
UT WOS:000336844400009
PM 24838600
DA 2018-10-20
ER

PT S
AU Leong, CH
   Muchtar, A
   Tan, CY
   Razali, M
AF Leong, C. H.
   Muchtar, A.
   Tan, C. Y.
   Razali, M.
BE Ismail, AE
   Nor, NHM
   Ali, MFM
   Ahmad, R
   Masood, I
   Tobi, ALM
   Ghafir, MFA
   Muhammad, M
   Wahab, MS
   Zain, BAM
TI A review: Effect of sintering method on the decomposition of
   hydroxyapatite and density of hydroxyapatite zirconia composites
SO 4TH MECHANICAL AND MANUFACTURING ENGINEERING, PTS 1 AND 2
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT 4th International Conference on Mechanical and Manufacturing Engineering
   (ICME 2013)
CY DEC 17-18, 2013
CL Bangi Putrajaya, MALAYSIA
SP Univ Tun Hussein Onn Malaysia, Fac Mech & Mfg Engn
DE hydroxyapatite; zirconia; biomedical applications; sintering method; HA
   decomposition
ID MECHANICAL-PROPERTIES; NANOCRYSTALLINE HYDROXYAPATITE; STABILIZED
   ZIRCONIA; POWDERS; CONSOLIDATION
AB Hydroxyapatite (HA) is a biomaterial with excellent biocompatibility. However, the brittleness and low fracture toughness of HA have limited its biomedical applications. As such, HA has been incorporated with zirconia (ZrO2) to enhance its mechanical strength. However, ZrO2 addition decreases the phase stability of HA. HA decomposition is not favored because it decreases the mechanical strength of HA/ZrO2. In this paper, the effect of sintering on HA decomposition is reviewed. Experimental results show that hot isostatic pressing of HA/ZrO2 is one of the most effective methods to suppress HA decomposition, yielding the highest relative density compared with other sintering methods.
C1 [Leong, C. H.; Muchtar, A.] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Mech & Mat Engn, Ukm Bangi 43600, Selangor, Malaysia.
   [Tan, C. Y.] Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur 50603, Malaysia.
   [Razali, M.] Univ Kebangsaan Malaysia, Fac Dent, Periodontol Dept, Kuala Lumpur 50300, Malaysia.
RP Leong, CH (reprint author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Mech & Mat Engn, Ukm Bangi 43600, Selangor, Malaysia.
EM cheehuan@hotmail.my; muchtar@eng.ukm.my; chouyong@um.edu.my;
   masfuah_razali@yahoo.com
RI Muchtar, Andanastuti/E-3806-2017
OI Muchtar, Andanastuti/0000-0002-1599-8964
FU Universiti Kebangsaan Malaysia [GUP-2012-060, FRGS/1/2013/SG06/UKM/01/1]
FX The authors acknowledge the sponsorship granted by the Universiti
   Kebangsaan Malaysia under the GUP-2012-060 and
   FRGS/1/2013/SG06/UKM/01/1.
CR Afzal MAF, 2012, MAT SCI ENG C-MATER, V32, P1164, DOI 10.1016/j.msec.2012.03.003
   Chiu CY, 2007, CERAM INT, V33, P715, DOI 10.1016/j.ceramint.2005.12.008
   Curran DJ, 2010, J MATER SCI-MATER M, V21, P1109, DOI 10.1007/s10856-009-3974-z
   Donald R, 2006, SCI ENG MAT
   Ergun C, 2011, CERAM INT, V37, P935, DOI 10.1016/j.ceramint.2010.11.001
   Evis Z, 2009, J EUR CERAM SOC, V29, P621, DOI 10.1016/j.jeurceramsoc.2008.07.020
   Gazza G.E., 1991, MRS ONLINE P LIB, P251
   Khalil KA, 2007, MAT SCI ENG A-STRUCT, V456, P368, DOI 10.1016/j.msea.2006.12.005
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Mazaheri M, 2009, J ALLOY COMPD, V471, P180, DOI 10.1016/j.jallcom.2008.03.066
   McNeese MD, 2000, MAT SCI ENG A-STRUCT, V280, P334, DOI 10.1016/S0921-5093(99)00550-X
   Miao XG, 2004, CERAM INT, V30, P1793, DOI 10.1016/j.ceramint.2003.12.117
   Nasiri-Tabrizi B, 2013, CERAM INT, V39, P5751, DOI 10.1016/j.ceramint.2012.12.093
   OBrien W J, 2009, DENT MAT THEIR SELEC
   Parente P, 2013, MAT SCI ENG C-MATER, V33, P864, DOI 10.1016/j.msec.2012.11.013
   Ramesh S, 2007, SCI TECHNOL ADV MAT, V8, P124, DOI 10.1016/j.stam.2006.11.002
   Ramesh S, 2007, CERAM INT, V33, P1363, DOI 10.1016/j.ceramint.2006.05.009
   Ramesh S, 2013, CERAM INT, V39, P111, DOI 10.1016/j.ceramint.2012.05.103
   Ramesh S, 2012, MATER DESIGN, V34, P148, DOI 10.1016/j.matdes.2011.08.011
   Rapacz-Kmita A, 2004, J MOL STRUCT, V704, P333, DOI 10.1016/j.molstruc.2004.02.047
   Silva VV, 2000, MATER CHARACT, V45, P51, DOI 10.1016/S1044-5803(00)00048-6
   Siswomihardjo W., 2012, INT J BIOMATER, P4
   Towler MR, 2001, J MATER SCI LETT, V20, P1719, DOI 10.1023/A:1012435124012
NR 23
TC 1
Z9 1
U1 1
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-933-9
J9 APPL MECH MATER
PY 2014
VL 465-466
BP 843
EP +
DI 10.4028/www.scientific.net/AMM.465-466.843
PG 3
WC Engineering, Manufacturing; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BA5FY
UT WOS:000336633600154
DA 2018-10-20
ER

PT S
AU Yuan, TK
   Muchtar, A
   Aboras, M
   Yahaya, N
   Ghazali, MJ
AF Yuan, Theng Kai
   Muchtar, Andanastuti
   Aboras, Mohamed
   Yahaya, Norziha
   Ghazali, M. J.
BE Ismail, AE
   Nor, NHM
   Ali, MFM
   Ahmad, R
   Masood, I
   Tobi, ALM
   Ghafir, MFA
   Muhammad, M
   Wahab, MS
   Zain, BAM
TI Properties and Survival Rate of All Ceramics Dental Crown: A Review
SO 4TH MECHANICAL AND MANUFACTURING ENGINEERING, PTS 1 AND 2
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT 4th International Conference on Mechanical and Manufacturing Engineering
   (ICME 2013)
CY DEC 17-18, 2013
CL Bangi Putrajaya, MALAYSIA
SP Univ Tun Hussein Onn Malaysia, Fac Mech & Mfg Engn
DE Dental crown; biomaterial; all ceramic restorations
ID CLINICAL-EVALUATION; ZIRCONIA; STRENGTH; STRESS
AB All-ceramic dental crown restoration is popular because it results in better aesthetic quality than metal alloy restoration. Ceramics also show superior biocompatibility and inertness to human biological systems. However, clinical experience indicates that all-ceramic crowns are not as durable as their porcelain-fused-to-metal counterparts, particularly on molar teeth. New ceramic biomaterials that combine durability with excellent aesthetic qualities have been developed. In this study, several promising bioceramics for dental crown applications are evaluated and compared. The evaluated parameters include strength of the material, survival rate in clinical performance, and aesthetic quality.
C1 [Yuan, Theng Kai; Muchtar, Andanastuti; Aboras, Mohamed; Ghazali, M. J.] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Mech & Mat Engn, Ukm Bangi 43600, Selangor, Malaysia.
   [Yahaya, Norziha] Univ Kebangsaan Malaysia, Fac Dent, Dept Prosthodont, Ukm Bangi 43600, Selangor, Malaysia.
RP Yuan, TK (reprint author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Mech & Mat Engn, Ukm Bangi 43600, Selangor, Malaysia.
EM terrance_trrnc@hotmail.com; muchtar@eng.ukm.my; milad22001@yahoo.co.uk;
   norzihayahaya@gmail.com; mariyam@eng.ukm.my
RI Muchtar, Andanastuti/E-3806-2017
OI Muchtar, Andanastuti/0000-0002-1599-8964
FU Universiti Kebangsaan Malaysia (UKM) under the Arus Perdana
   [FRGS/1/2013/SG06/UKM/01/1, GUP-2012-060]
FX The authors acknowledge the sponsorship granted by the Universiti
   Kebangsaan Malaysia (UKM) under the Arus Perdana Grant
   FRGS/1/2013/SG06/UKM/01/1 and GUP-2012-060.
CR Bona A.D., 2008, J AM DENT ASSOC, V139, p8S
   Fradeani M, 2005, QUINTESSENCE INT, V36, P105
   Gaddam A, 2013, T INDIAN CERAM SOC, V72, P56, DOI 10.1080/0371750X.2013.794027
   Galindo ML, 2011, J PROSTHET DENT, V106, P23, DOI 10.1016/S0022-3913(11)60089-9
   Gehrt M, 2013, CLIN ORAL INVEST, V17, P275, DOI 10.1007/s00784-012-0700-x
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Janyavula S, 2013, J PROSTHET DENT, V109, P22, DOI 10.1016/S0022-3913(13)60005-0
   Jiang L, 2011, J MATER SCI-MATER M, V22, P2429, DOI 10.1007/s10856-011-4438-9
   Kokubo Y, 2009, J ORAL REHABIL, V36, P786, DOI 10.1111/j.1365-2842.2009.01995.x
   Li Y, 2013, COMPUT BIOL MED, V43, P1214, DOI 10.1016/j.compbiomed.2013.06.007
   Lopez-Honorato E, 2012, CERAM INT, V38, P6777, DOI 10.1016/j.ceramint.2012.05.073
   Mouzon J, 2008, J MATER SCI, V43, P2849, DOI 10.1007/s10853-007-2261-y
   Naert I, 2005, J ORAL REHABIL, V32, P51, DOI 10.1111/j.1365-2842.2004.01374.x
   Ortorp A, 2012, J DENT, V40, P527, DOI 10.1016/j.jdent.2012.02.011
   Potiket N, 2004, J PROSTHET DENT, V92, P491, DOI 10.1016/j.prosdent.2004.09.001
   Reich S., 2012, CLIN ORAL INVEST, P1
   Rekow ED, 2006, DENT MATER, V22, P125, DOI 10.1016/j.dental.2005.04.010
   Succaria F, 2011, SAUDI DENT J, V23, P165, DOI 10.1016/j.sdentj.2011.10.001
   Walter MH, 2006, INT J PROSTHODONT, V19, P162
   Yang ZY, 2012, CERAM INT, V38, P4653, DOI 10.1016/j.ceramint.2012.02.047
NR 20
TC 0
Z9 0
U1 0
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-933-9
J9 APPL MECH MATER
PY 2014
VL 465-466
BP 857
EP +
DI 10.4028/www.scientific.net/AMM.465-466.857
PG 3
WC Engineering, Manufacturing; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BA5FY
UT WOS:000336633600157
DA 2018-10-20
ER

PT S
AU Malek, RA
   Hang, YC
AF Malek, Rohaya Abdul
   Hang, Yeoh Chieh
BE Abdullah, MMA
   Jamaludin, L
   Abdullah, A
   AbdRazak, R
   Hussin, K
TI Characterization of Different Additives of Sintered Cobalt F-75 Alloy in
   Biomaterial Applications
SO ADVANCED MATERIALS ENGINEERING AND TECHNOLOGY II
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT International Conference on Advanced Materials Engineering and
   Technology (ICAMET 2013)
CY NOV 28-29, 2013
CL Bandung, INDONESIA
SP Ctr Excellence Geopolymer & Green Technol, Univ Malaysia Perlis, Sch Mat Engn
DE Cobalt-Chormium-Molybdenum (Co-Cr-Mo); Hydroxyaapatite (HAP); Tricalcium
   phosphate (TCP) and powder metallurgy technique
ID BETA-TRICALCIUM PHOSPHATE
AB A Co-Cr-Mo (ASTM CoF-75) alloy is normally used because of their good in physical, mechanical, wear and as well as biocompatibility. In order to obtain similarity chemical structure of bone, addition of HAP or TCP into CoF-75 alloy is required. The samples were fabricated using powder metallurgy (P/M) technique under pressure of 350 MPa and sintered at 1200 degrees C under argon atmosphere. The results on the effect of different additives were studied in terms of shrinkage, bulk density, apparent porosity and microstructural analysis.
C1 [Malek, Rohaya Abdul] Univ Malaysia Perlis, Ctr Excelent Geopolymer & Green Technol CEGeoGTec, Kompleks Pusat Pengajian Jejawi 2, Jejawi 02600, Perlis, Malaysia.
   [Hang, Yeoh Chieh] Univ Malaysia Perlis, Sch Mat Engn, Kamaishi, Iwate 0260001, Japan.
RP Malek, RA (reprint author), Univ Malaysia Perlis, Ctr Excelent Geopolymer & Green Technol CEGeoGTec, Kompleks Pusat Pengajian Jejawi 2, Jejawi 02600, Perlis, Malaysia.
EM rohayamalek@unimap.edu.my; jane2209@hotmail.com
FU Short Term Grant of Universiti Malaysia Perlis [9001-00344]; CeGeoTECH
   Universiti Malaysia Perlis
FX This work was financially supported by the Short Term Grant of
   Universiti Malaysia Perlis (9001-00344) and in collaboration with
   CeGeoTECH Universiti Malaysia Perlis.
CR Bardos D.I., 1979, DEVICES ARTIF ORGANS, V7, P73
   Boretos JW, 1984, CONT BIOMATERIALS MA, P232
   Dabrowski JR, 2001, BIOMED TECH, V46, P106, DOI 10.1515/bmte.2001.46.4.106
   Gonzalez-Carasco J.L., 2009, METAL BONE REPAIR MA, P159
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Johnson J.L., 2004, ADV MATER PROCESS, V162, P84
   Kalita S.J, 2008, FUNTIONAL NANOSTRUCT, P202
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   Runkle C.J., 1984, INT POWD MET C, V16, P705
   Suryanarayana C, 2004, MECH ALLOYING MILLIN
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Tandom R., 1999, ASTM STP, P3
   YONEZAKI H, 1998, J MATER SCI-MATER M, V9, P381
NR 13
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2014
VL 594-595
BP 29
EP +
DI 10.4028/www.scientific.net/KEM.594-595.29
PG 2
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials;
   Materials Science, Characterization & Testing
SC Materials Science
GA BA4VG
UT WOS:000336337200007
DA 2018-10-20
ER

PT S
AU Lesci, IG
   Ciocca, L
   Dozza, B
   Lucarelli, E
   Squarzoni, S
   Donati, D
   Roveri, N
AF Lesci, I. G.
   Ciocca, L.
   Dozza, B.
   Lucarelli, E.
   Squarzoni, S.
   Donati, D.
   Roveri, N.
BE Antoniac, I
   Cotrut, CM
   Antoniac, A
TI Innovative Composite HA Scaffold Rapid Prototyping for Bone
   Reconstruction: an In-Vitro Pilot Study
SO BIOMMEDD V
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 5th international Conference on Biomaterials, Tissue Engineering and
   Medical Devices (BiomMedD 2012)
CY AUG 29-SEP 01, 2012
CL Constanta, ROMANIA
DE rapid prototyping; biomimetic Hydroxyapatite; biomaterial; bone scaffold
ID DRUG-DELIVERY; DEPOSITION; NANOCRYSTALS; COATINGS; TITANIUM; CELLS
AB The ability to control the architecture and strength of a bone tissue engineering scaffold is critical to achieve a harmony between the scaffold and the host tissue. The scaffold attempts to mimic the function of the natural extracellular matrix, providing a temporary template for the growth of target tissues. The study of nanocrystalline calcium phosphate physical-chemical characteristics and, thereafter, the possibility to imitate bone mineral for the development of new advanced biomaterials is constantly growing. Scaffolds should have suitable architecture and strength to serve their intended function. Rapid prototyping (RP) technique is applied to tissue engineering to satisfy this need and to create a scaffold directly from the scanned and digitized image of the defect site. Design and construction of complex structures with different shapes and sizes, at micro and macro scale, with fully interconnected pore structure and appropriate mechanical properties are possible by using RP techniques. In this study we present a new biocompatible hybrid scaffold obtained through two different experimental methods and formed by synthetic biomimetic Hydroxyapatite (HA) nanocrystals with high surface reactivity which synergistically interacts with Poly(e-caprolactone) (PCL) and polylactic acid (PLLA). The aim of this pilot study is to test the adhesion and the proliferation of human mesenchymal stem cells (MSC) on both the scaffolds. MSC growth and distribution was evaluated 24 h and 7 days after in-vitro seeding. The results allowed the conclusion that these scaffolds are biocompatible and allow the colonization and proliferation of MSC, therefore, due to their mechanical properties, they are adequate for bone tissue engineering.
C1 [Lesci, I. G.; Roveri, N.] Univ Bologna, Dep Chem, G Ciamician Via Selmi 2, I-40126 Bologna, Italy.
   [Ciocca, L.] Univ Bologna, Dept Biomed & Neuronnotor Sci, Bologna, Italy.
   [Dozza, B.; Lucarelli, E.; Donati, D.] Rizzoli Orthopaed Inst, Steoarticolar Regenerat Lab, Bologna, Italy.
   [Donati, D.] Locomotor Apparat, Dept Human Anat & Physiopathol, Bologna, Italy.
RP Lesci, IG (reprint author), Univ Bologna, Dep Chem, G Ciamician Via Selmi 2, I-40126 Bologna, Italy.
EM isidorogiorgio.lesci@unibo.it; leonardo.ciocca@unibo.it;
   barbara.dozza@ior.it; enrico.lucarelli@ior.it; stefano.squarzoni@ior.it;
   davide.donati@ior.it; norberto.roveri@unibo.it
RI Ciocca, Leonardo/K-4641-2015; Lucarelli, Enrico/G-3588-2015
OI Ciocca, Leonardo/0000-0002-2127-484X; Lucarelli,
   Enrico/0000-0002-6681-6374; DONATI, DAVIDE MARIA/0000-0002-9170-0576;
   Dozza, Barbara/0000-0002-7604-0039; Squarzoni,
   Stefano/0000-0001-6538-5923
CR Battistella E, 2012, J APPL BIOMATER FUNC, V10, P99, DOI 10.5301/JABFM.2012.9257
   BURNELL JM, 1980, CALCIFIED TISSUE INT, V31, P13, DOI 10.1007/BF02407162
   Ciocca L, 2009, COMPUT MED IMAG GRAP, V33, P58, DOI 10.1016/j.compmedimag.2008.10.005
   Ciocca L., 2012, J BIOMATER APPL
   Dozza B, 2012, TOXICOL IN VITRO, V26, P142, DOI 10.1016/j.tiv.2011.10.009
   DRIESSENS FCM, 1983, BIOCERAMICS CALCIUM, P1
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Hoque ME, 2005, J BIOMAT SCI-POLYM E, V16, P1595, DOI 10.1163/156856205774576709
   Iafisco M, 2012, ADV ENG MATER, V14, pB13, DOI 10.1002/adem.201180062
   Iafisco M, 2012, NANOSCALE, V4, P206, DOI 10.1039/c1nr11147g
   Iafisco M, 2009, J MATER CHEM, V19, P8385, DOI 10.1039/b914379c
   KAPLAN DL, 1994, BIOSYNTHETIC POLYSAC
   Manara S, 2008, INORG CHIM ACTA, V361, P1634, DOI 10.1016/j.ica.2007.03.044
   Mann S, 2001, BIOMINERALIZATION PR
   Matsunaga K, 2009, J PHYS CHEM B, V113, P3584, DOI 10.1021/jp808713m
   Palazzo B, 2007, ADV FUNCT MATER, V17, P2180, DOI 10.1002/adfm.200600361
   Pinar Y., 2008, MACROMOL S, V269, P92
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   Roveri Norberto, 2009, Recent Patents on Biomedical Engineering, V2, P197, DOI 10.2174/1874764710902030197
   Roveri N, 2008, EXPERT OPIN DRUG DEL, V5, P861, DOI 10.1517/17425247.5.8.861 
   SUTHERLAND IW, 1991, BIOMATERIALS, P307
   Tampieri A, 2009, J MATER CHEM, V19, P4973, DOI 10.1039/b900333a
   Vozzi G, 2002, TISSUE ENG, V8, P1089, DOI 10.1089/107632702320934182
   Walsh D, 2007, CHEM MATER, V19, P503, DOI 10.1021/cm0621951
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
NR 28
TC 0
Z9 0
U1 0
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2014
VL 583
BP 56
EP +
DI 10.4028/www.scientific.net/KEM.583.56
PG 3
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BA5DC
UT WOS:000336552600011
DA 2018-10-20
ER

PT S
AU Ghiban, B
   Bortun, CM
   Ghiban, A
   Ghiban, N
AF Ghiban, Brandusa
   Bortun, Cristina Maria
   Ghiban, Alexandru
   Ghiban, Nicolae
BE Antoniac, I
   Cotrut, CM
   Antoniac, A
TI Cobalt based Alloys for Dental Applications
SO BIOMMEDD V
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 5th international Conference on Biomaterials, Tissue Engineering and
   Medical Devices (BiomMedD 2012)
CY AUG 29-SEP 01, 2012
CL Constanta, ROMANIA
DE metallic biomaterial; cobalt alloys; dental applications; mechanical
   properties
AB The present paper put in evidence the mechanical behavior of some commercial dental cobalt alloys, after own classification. The experimental cobalt alloys were classified in according either with molybdenum content, or with Cr+Mo content. A hierarcy of the alloys was finally made. The fractographic surfaces were investigate both by stereomcroscopy and scanning electron microscopy, putting in evidence the main structural features.
C1 [Ghiban, Brandusa; Ghiban, Alexandru; Ghiban, Nicolae] Univ Politehn Bucuresti, 313 Splaiul Independentei, Bucharest 060042, Romania.
   [Bortun, Cristina Maria] Victor Babe Med & Pharm Univ, Victor, NY, Romania.
RP Ghiban, B (reprint author), Univ Politehn Bucuresti, 313 Splaiul Independentei, Bucharest 060042, Romania.
EM ghibanbrandusa@yahoo.com; cmbortun@gmail.com;
   alexandru.ghiban@gmail.com; nicolaeghiban@yahoo.com
FU M_ANUNET Project entitled: "Development of a new generation of cobalt
   alloys modified with titanium for dental applications"
FX The work has been funded by M_ANUNET Project entitled: "Development of a
   new generation of cobalt alloys modified with titanium for dental
   applications" with acronim DENTICO, 2012-2013.
CR Ardelean L, 2010, METAL INT, V15, P31
   Bortun CM, 2011, METAL INT, V16, P5
   Ghiban A., 2012, SOLID STATE PHENOM, V188, P93, DOI [10.4028/www.scientific.net/SSP.188.93, DOI 10.4028/WWW.SCIENTIFIC.NET/SSP.188.93]
   Ghiban A., 2012, 24 EUR C BIOM SEPT 4, P47
   GHIBAN A., 2011, THESIS
   Ghiban A., 2012, 9 WORLD BIOM C CHAND
NR 6
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2014
VL 583
BP 175
EP +
DI 10.4028/www.scientific.net/KEM.583.175
PG 2
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BA5DC
UT WOS:000336552600029
DA 2018-10-20
ER

PT S
AU Hu, SD
   Nie, BE
   Zhou, JL
AF Hu, Shidong
   Nie, Bin'en
   Zhou, Jianliang
BE Zhao, GM
   Chen, L
   Tang, Y
   Long, B
   Nie, Z
   He, L
   Chen, H
TI Advances in Biomaterial's Modification and Thrombosis Inhibition
SO EIGHTH CHINA NATIONAL CONFERENCE ON FUNCTIONAL MATERIALS AND
   APPLICATIONS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 8th China National Conference on Functional Materials and Applications
   (NCFMA 2013)
CY AUG 23-26, 2013
CL Harbin, PEOPLES R CHINA
SP China Instrument Control Soc, Instrument Funct Mat Branch, Natl Instrument Funct Mat Engn Technol Res Ctr, Chongqing Mat Res Inst & Chongqing Funct Mat Period Press, Chongqing Mat Res Inst
DE Thrombus; biomaterials; modification
ID ENDOTHELIAL PROGENITOR CELLS; GROWTH-FACTOR; HEART-VALVE; IN-VITRO;
   PLATELET-ADHESION; VASCULAR ENDOTHELIUM; EXTRACELLULAR-MATRIX; VEGF;
   PROLIFERATION; GRAFTS
AB With the development of modern medical technology, the clinical range of biomaterial applications have gradually expanded. However, bioactivity on the surface of biomaterials may be reduced and induce thrombus formation that will not only cause serious dysfunction of the biological materials, but can also affect the host. Modification of these biological materials can thus help to retain the biological activity on the surface of the material and inhibit thrombus formation, which underlines the importance of their clinical application. The current review will address the modification of biomaterials and inhibition of thrombosis on the surface of biomaterials.
C1 [Hu, Shidong; Nie, Bin'en; Zhou, Jianliang] Nan Chang Univ, Affiliated Hosp 2, Dept Cardiothorac Surg, Nanchang 330006, Jiangxi, Peoples R China.
RP Hu, SD (reprint author), Nan Chang Univ, Affiliated Hosp 2, Dept Cardiothorac Surg, Nanchang 330006, Jiangxi, Peoples R China.
EM zhoujianliang2010@163.com
CR Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Avci-Adali M, 2008, BIOMATERIALS, V29, P3936, DOI 10.1016/j.biomaterials.2008.07.002
   Bordenave L, 2005, CLIN HEMORHEOL MICRO, V33, P227
   Breuer CK, 2004, TISSUE ENG, V10, P1725, DOI 10.1089/ten.2004.10.1725
   BUNTING S, 1977, LANCET, V2, P1075
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   DENG Cheng, 2010, J CLIN CARDIOL CHINA, V26
   Dohmen Pascal M, 2003, Med Sci Monit, V9, pBR97
   Dohmen PM, 2002, ANN THORAC SURG, V74, P1438, DOI 10.1016/S0003-4975(02)03881-X
   DONG Nian-guo, 2010, J CLIN CARDIOL CHINA, V26
   Dong XC, 2009, J MATER SCI-MATER M, V20, P2327, DOI 10.1007/s10856-009-3791-4
   Hatakeyama H, 2006, BIOMATERIALS, V27, P5069, DOI 10.1016/j.biomaterials.2006.05.019
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013
   Hong H, 2008, ASAIO J, V54, P627, DOI 10.1097/MAT.0b013e31818965d3
   Jordan S. W., 2007, J VASC SURG, V45, P104
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Kasimir MT, 2005, THROMB HAEMOSTASIS, V94, P562, DOI 10.1160/TH05-01-0025
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Knetsch MLW, 2010, J BIOMED MATER RES A, V93A, P77, DOI 10.1002/jbm.a.32538
   Leach LK., 2006, BIOMATERIALS, V27, P3249
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   Lev EI, 2006, THROMB HAEMOSTASIS, V96, P498, DOI 10.1160/TH06-05-0250
   Li CW, 2009, J HUAZHONG U SCI-MED, V29, P592, DOI 10.1007/s11596-009-0512-7
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471
   Muller S, 2008, ADV FUNCT MATER, V18, P1767, DOI 10.1002/adfm.200701233
   Neufeld G, 1999, FASEB J, V13, P9
   Tran NQ, 2011, MACROMOL RES, V19, P300, DOI 10.1007/s13233-011-0309-y
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Poter A.M., 2011, BIOMACROMOLECULES, V12, P242
   RADOMSKI MW, 1987, LANCET, V2, P1057
   Rodenberg EJ, 2007, TISSUE ENG, V13, P2653, DOI 10.1089/ten.2007.0037
   Rothmans J.I., 2006, CAN J CARDIOL, V22, P929
   Schmidt D, 2005, EUR J CARDIO-THORAC, V27, P795, DOI 10.1016/j.ejcts.2005.01.064
   Schmidt D, 2004, ANN THORAC SURG, V78, P2094, DOI 10.1016/j.athoracsur.2004.06.052
   Schopka S, 2010, MATERIALS, V3, P638, DOI 10.3390/ma3010638
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shi JW, 2009, J HUAZHONG U SCI-MED, V29, P503, DOI 10.1007/s11596-009-0422-8
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Walpoth BH, 2007, J THORAC CARDIOV SUR, V133, P1163, DOI 10.1016/j.jtcvs.2007.01.029
   Wang H, 2009, J HUAZHONG U SCI-MED, V29, P80, DOI 10.1007/s11596-009-0117-1
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 46
TC 0
Z9 0
U1 4
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-969-8
J9 ADV MATER RES-SWITZ
PY 2014
VL 873
BP 635
EP 641
DI 10.4028/www.scientific.net/AMR.873.635
PG 7
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Materials Science, Composites
SC Materials Science
GA BA4VE
UT WOS:000336337000103
DA 2018-10-20
ER

PT S
AU Hutyrova, Z
   Zajac, J
   Fecova, V
AF Hutyrova, Zuzana
   Zajac, Jozef
   Fecova, Veronika
BE Kundrak, J
   Maros, Z
TI Machining of non-homogeneous composite material with natural fibers
   reinforcement and HDPE matrix
SO PRECISION MACHINING VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th International Congress of Precision Machining (ICPM 2013)
CY OCT 03-05, 2013
CL Miskolc, HUNGARY
SP Int Visegrad Fund, SANDVIK Cromant
DE turning; natural reinforcement; inhomogeneity
AB Depending on expanding population and its increasing purchasing power we are forced to use more and more renewable resources for a production of materials. When compared to other types of fibres, the natural fibres have a lot of advantages: they are affordable (only 1/10 of a glass fibre price), non- abrasive, recyclable, with relatively high strength and rigidity, low density (and low weight - in hollow profiles). When combined with plastic matrix the exceptional biomaterial, which is possible to describe as 'friendly environment', is created. It has high potential to succeed with a final customer. At present, a use of thermoplastic matrices (especially with WPC materials) is preferred. The final subject of this article is to point out considerable disadvantage from a perspective of machining - inhomogeneity of the material (in full profiles).
C1 [Hutyrova, Zuzana; Zajac, Jozef; Fecova, Veronika] Tech Univ Kosice Seat Presov, Fac Mfg Technol, Presov 08001, Slovakia.
RP Hutyrova, Z (reprint author), Tech Univ Kosice Seat Presov, Fac Mfg Technol, Sturova 31, Presov 08001, Slovakia.
EM zuzana.hutyrova@tuke.sk; jozef.zajac@tuke.sk; veronika.fecova@tuke.sk
CR [Anonymous], 36851999 STN EN ISO
   Coromant Sandvik, 2005, METALCUTTING TECHN G, V10
   Fecova V., 2012, IEEE 10 JUB INT S AP, P173
   Hatala M, 2012, APPL MECH MATER, V110-116, P3742, DOI 10.4028/www.scientific.net/AMM.110-116.3742
   Kumar V, 2011, REV CHEM ENG, V27, P253, DOI 10.1515/REVCE.2011.006
   Michalik P, 2012, FUTURE COMMUNICATION, V1, P421
   Mueller M., 2012, J APPL POLYM SCI, V125, P308
   Somsakova Z, 2012, MATER PLAST, V49, P55
   Stark N. M., 1984, POLYM DEGRADATION ST
NR 9
TC 1
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2014
VL 581
BP 95
EP 99
DI 10.4028/www.scientific.net/KEM.581.95
PG 5
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BA5IT
UT WOS:000336695600017
DA 2018-10-20
ER

PT S
AU Song, Y
   Wang, ZY
   Ji, AH
   Dai, ZD
AF Song, Yi
   Wang, Zhouyi
   Ji, Aihong
   Dai, Zhendong
BE Ren, L
   Wang, H
   Dai, Z
TI Mechanical performance tests of Bamboo Beetles Otidognathus Davidis
   Fairs' abdominal shells
SO ADVANCES IN BIONIC ENGINEERING
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT 4th International Conference of Bionic Engineering (ICBE 2013)
CY AUG 13-16, 2013
CL Nanjing, PEOPLES R CHINA
SP Int Soc Bionic Engn, Nanjing Univ Aeronaut & Astronaut, Jilin Univ, Natl Nat Sci Fdn China, Minist Sci & Technol China, Res Inst Petr Explorat & Dev
DE Bamboo Beetle Otidognathus davidis Fair; biomaterials; mechanical
   performances; tests
AB The biomaterials, with excellent properties such as high strength-weights ratio, will inspire inspirations about bionic composite materials to satisfy the scalding hypercriticisms for aerial materials. The investigations of biomaterial mechanical performances are of great advantages in bionic designs and bionic manufactures. The mechanical performances of Bamboo Beetles Otidognathus Davidis Fairs' abdominal shells were tested with a nano-indenter in this paper. The experiments results demonstrated that the harnesses and modulus are different at different test areas. The mechanical performances resemble much at the same latitude but decrease along longitude from the forehead to the rearward, indicating that the mechanical performances of the abdominal shells distribute topologically. What's more, the topological distributions of mechanical performances illustrate a kind of unlearned structure optimizations of insects which will provide edifications to designs of light and strong materials.
C1 [Song, Yi; Wang, Zhouyi; Ji, Aihong; Dai, Zhendong] Nanjing Univ Aeronaut & Astronaut, Inst Bioinspired Struct & Surface Engn, 29 Yudaojie St, Nanjing 210016, Jiangsu, Peoples R China.
   [Song, Yi] Nanjing Univ Aeronaut & Astronaut, Coll Aerosp Engn, Nanjing 210016, Jiangsu, Peoples R China.
   [Wang, Zhouyi; Ji, Aihong; Dai, Zhendong] Coll Mech & Elect Engn, NUAA, Nanjing, Peoples R China.
RP Ji, AH (reprint author), Nanjing Univ Aeronaut & Astronaut, Inst Bioinspired Struct & Surface Engn, 29 Yudaojie St, Nanjing 210016, Jiangsu, Peoples R China.
EM songyink@yeah.net; wzyxml@nuaa.edu.cn; meeahji@nuaa.edu.cn;
   zddai@nuaa.edu.cn
FU National Basic Research Program of China (973 Program) [2011CB302106];
   National Natural Science Foundation of China [50975140, 31070344]
FX This work was supported by the National Basic Research Program of China
   (973 Program) (Grant no. 2011CB302106), the National Natural Science
   Foundation of China ( Grant No. 50975140 and 31070344)
CR Breed R. S., 1909, BIOL BULL, V6, P289
   [陈斌 Chen Bin], 2003, [材料研究学报, Chinese Journal of Materials Research], V17, P630
   [陈锦祥 Chen Jinxiang], 2003, [复合材料学报, Acta Materiae Compositae Sinica], V20, P61
   Cheng Hong, 2002, Acta Entomologica Sinica, V45, P175
   Gorb SN, 2003, J MORPHOL, V257, P127, DOI 10.1002/jmor.10070
   Gulan P. J., 1994, INSECTS OUTLINE ENTO, P22
   Holleway B. A., 1997, NZ J ZOOLOGY, V24, P51
   Li Jianqiao, 1995, T CSAE, V11, P125
   Ren Luquan, 1995, CHINESE SCI BULL, V40, P1812
   Sun Jiu-rong, 2001, Acta Biophysica Sinica, V17, P785
   Wang Guolin, 1997, J AGR MACHINE, V28, P529
   Wang Liduo, 1996, J MAT ENG, V17, P325
   [杨志贤 YANG Zhixian], 2007, [复合材料学报, Acta Materiae Compositae Sinica], V24, P92
   Youdeowei A., 1977, LAB MANUAL ENTOMOLOG, P148
   Zhang G.P., 2000, FIBER COMPOSITES, V6, P25
   Zhang Yingchun, 2001, J NW U NATURAL SCI E, V31, P522
NR 16
TC 0
Z9 0
U1 2
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-932-2
J9 APPL MECH MATER
PY 2014
VL 461
BP 241
EP +
DI 10.4028/www.scientific.net/AMM.461.241
PG 2
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BA4RS
UT WOS:000336185100032
DA 2018-10-20
ER

PT S
AU Hua, ZK
   Fan, YW
AF Hua, Z. K.
   Fan, Y. W.
BE Ren, L
   Wang, H
   Dai, Z
TI A new Ortho-POD Biotribometer for Orthopaedic Biomaterials wear testing
SO ADVANCES IN BIONIC ENGINEERING
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT 4th International Conference of Bionic Engineering (ICBE 2013)
CY AUG 13-16, 2013
CL Nanjing, PEOPLES R CHINA
SP Int Soc Bionic Engn, Nanjing Univ Aeronaut & Astronaut, Jilin Univ, Natl Nat Sci Fdn China, Minist Sci & Technol China, Res Inst Petr Explorat & Dev
DE biotribology; wear; orthopaedic biomaterial; pin on disk; wear testing
ID HIP SIMULATOR; POLYETHYLENE; MOTION
AB Wear has been the primary failure mode affecting the long-term performance of orthopaedic implants. The tribological evaluation of orthopaedic biomaterials in vitro is regarded as an essential material characterization before implantation. In this paper, a new biotribometer of pin-on-disk type, the Ortho-POD, was designed and built for the biotribological tests of orthopaedic biomaterials. The primary goal of developing this Ortho-POD is to simulate and predict the wear properties of orthopaedic biomaterials in clinical application, especially in the form of hip, knee and spine prostheses. This 6-station Ortho-POD, including a pin guiding module, a motion module, a framework module and a loading module, provides multidirectional slide track shapes and variable load via a computer-controlled programmer. A frequency controller and heating system were assembled in the Ortho-POD so as to offer a wide range of testing conditions.
C1 [Hua, Z. K.; Fan, Y. W.] Shanghai Univ, Sch Mechatron Engn & Automat, Shanghai 200072, Peoples R China.
RP Hua, ZK (reprint author), Shanghai Univ, Sch Mechatron Engn & Automat, Shanghai 200072, Peoples R China.
EM zikai_hua@shu.edu.cn
CR Calonius O., 2003, ACTA POLYTECHNICA SC, V3, P43
   Hamilton MA, 2005, J TRIBOL-T ASME, V127, P280, DOI 10.1115/1.1843136
   Hua ZK, 2008, J BIONIC ENG, V5, P143, DOI 10.1016/S1672-6529(08)60085-2
   Hua Z. K., P STLE ASME INT JOIN, P37
   Jin ZM, 2006, CURR ORTHOPAED, V20, P32, DOI 10.1016/j.cuor.2005.09.005
   Kaddick C, 2001, P I MECH ENG H, V215, P429, DOI 10.1243/0954411011536019
   Korduba LA, 2011, WEAR, V271, P1220, DOI 10.1016/j.wear.2011.01.039
   Saikko V, 2005, P I MECH ENG H, V219, P437, DOI 10.1243/095441105X34419
   Saikko V, 2005, P I MECH ENG H, V219, P309, DOI 10.1243/095441105X34301
   Saikko V, 2003, J BIOMED MATER RES B, V65B, P186, DOI 10.1002/jbm.b.10556
   Saikko V, 2002, J AM CERAM SOC, V85, P2785
   Saikko V, 2001, WEAR, V249, P310, DOI 10.1016/S0043-1648(01)00567-1
   Saikko V, 1998, J BIOMED MATER RES, V41, P58, DOI 10.1002/(SICI)1097-4636(199807)41:1<58::AID-JBM7>3.3.CO;2-U
   Saildco V., 2005, P IMECHE C, V224, P97
   Wang A, 1997, WEAR, V203, P230, DOI 10.1016/S0043-1648(96)07362-0
NR 15
TC 0
Z9 0
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-932-2
J9 APPL MECH MATER
PY 2014
VL 461
BP 367
EP 372
DI 10.4028/www.scientific.net/AMM.461.367
PG 6
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BA4RS
UT WOS:000336185100049
DA 2018-10-20
ER

PT S
AU Liang, C
   Li, YQ
   Hu, BR
   Wu, WJ
AF Liang Chao
   Li Yunqiu
   Hu Biru
   Wu Wenjian
BE Ren, L
   Wang, H
   Dai, Z
TI Prokaryotic Expression and Functional Characterization of the 19 kDa
   Protein in Balanus albicostatus Cement
SO ADVANCES IN BIONIC ENGINEERING
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT 4th International Conference of Bionic Engineering (ICBE 2013)
CY AUG 13-16, 2013
CL Nanjing, PEOPLES R CHINA
SP Int Soc Bionic Engn, Nanjing Univ Aeronaut & Astronaut, Jilin Univ, Natl Nat Sci Fdn China, Minist Sci & Technol China, Res Inst Petr Explorat & Dev
DE underwater adhesives; barnacle cement; Bacp-19k; bacterial recombinant;
   molecular design
ID BARNACLE UNDERWATER ADHESIVE; MUSSEL
AB Barnacle is a unique sessile crustacean, which produces a multi-protein complex historically called barnacle cement to attach to diverse immersed materials permanently. The proteinaceous cement exhibits powerful adhesive property and special waterproof capability to cure at solid-liquid boundaries, which makes it ideal biomaterial for technical, medical and dental applications. It has been proved that a 19 kDa protein component, termed cp-19k in the cement plays a key role in surface coupling during underwater attachment. To verify whether the bacterial recombinant 19 kDa protein retains the adhesive ability, we cloned and sequenced the Bacp-19k gene in Balanus albicostatus. It encodes 173 amino acid residues, with seven biased ones, Thr, Lys, Gly, Ala, Val, Ser and Leu, comprising about 80% of the total. Two amino acid substitutions (F69L, I106L) were discovered in Bacp-19k due to the polymorphisms in barnacle cp-19ks, compared with the submitted one (GenBank: AB242295.1). Recombinant Bacp-19k was highly expressed in host strain Escherichia coli BL21 (DE3) and purified by affinity chromatography. Adsorption of recombinant Bacp-19k to glass substrata was examined by Coomassie brilliant blue staining. Future study will reveal the relationship between specific structures and functions for molecular design of novel biomimetic underwater adhesives.
C1 [Liang Chao; Li Yunqiu; Hu Biru; Wu Wenjian] Natl Univ Def Technol, Dept Biol & Chem, Coll Sci, Changsha 410073, Hunan, Peoples R China.
RP Liang, C (reprint author), Natl Univ Def Technol, Dept Biol & Chem, Coll Sci, Changsha 410073, Hunan, Peoples R China.
EM cru_tyciao@163.com; liyunqiu83@yahoo.com.cn; brhu@yeah.net;
   wjwu67@126.com
CR Callow Maureen E., 2002, Biologist (London), V49, P10
   Deming TJ, 2007, PROG POLYM SCI, V32, P858, DOI 10.1016/j.progpolymsci.2007.05.010
   Holm ER, 2012, INTEGR COMP BIOL, V52, P348, DOI 10.1093/icb/ics042
   Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004
   Kamino K, 2000, J BIOL CHEM, V275, P27360
   Kamino K, 2001, BIOCHEM J, V356, P503, DOI 10.1042/0264-6021:3560503
   Kamino K, 1996, BIOL BULL, V190, P403, DOI 10.2307/1543033
   Kamino K, 2008, MAR BIOTECHNOL, V10, P111, DOI 10.1007/s10126-007-9076-3
   Kamino K, 2006, BIOLOGICAL ADHESIVES, P145, DOI 10.1007/978-3-540-31049-5_8
   Kamino K, 2012, FEBS J, V279, P1750, DOI 10.1111/j.1742-4658.2012.08552.x
   Kamino K, 2010, J ADHESION, V86, P96, DOI 10.1080/00218460903418139
   Khandeparker L, 2007, INT J ADHES ADHES, V27, P165, DOI 10.1016/j.ijadhadh.2006.03.004
   Mori Y, 2007, FEBS J, V274, P6436, DOI 10.1111/j.1742-4658.2007.06161.x
   Nakano M, 2007, BIOMACROMOLECULES, V8, P1830, DOI 10.1021/bm0612236
   SAROYAN JR, 1970, BIOL BULL, V139, P333, DOI 10.2307/1540088
   Urushida Y, 2007, FEBS J, V274, P4336, DOI 10.1111/j.1742-4658.2007.05965.x
   WALKER G, 1972, J MAR BIOL ASSOC UK, V52, P429, DOI 10.1017/S0025315400018786
NR 17
TC 1
Z9 1
U1 0
U2 12
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-932-2
J9 APPL MECH MATER
PY 2014
VL 461
BP 445
EP 450
DI 10.4028/www.scientific.net/AMM.461.445
PG 6
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BA4RS
UT WOS:000336185100060
DA 2018-10-20
ER

PT J
AU Jarvinen, E
   Muhonen, V
   Haaparanta, AM
   Kellomaki, M
   Kiviranta, I
AF Jarvinen, Elina
   Muhonen, Virpi
   Haaparanta, Anne-Marie
   Kellomaki, Minna
   Kiviranta, Ilkka
TI Optical projection tomography can be used to investigate spatial
   distribution of chondrocytes in three-dimensional biomaterial scaffolds
   for cartilage tissue engineering
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Optical projection tomography; cell seeding; cartilage tissue
   engineering
AB Biomaterial scaffolds have been used in autologous chondrocyte implantation to facilitate the repair of large lesions and to advance the formation of articular cartilage [Exp. Biol. Med. (Maywood) 237(1) (2012), 10-17]. Biomaterial scaffolds are usually three-dimensional (3-D) porous structures consisting of biodegradable materials to support articular cartilage formation. Adequate porosity of the scaffold is necessary for uniform cell distribution and cell attachment, and the density of the cells in the scaffold should be appropriate for cartilage formation [Cartilage 3(2) (2012), 108-117]. There have been only a restricted number of studies on the spatial distribution of cells in scaffolds, and on the role of this to cartilage formation [J. Biotechnol. 129 (2007), 516-531; Biotechnol. Progr. 14 (1998), 193-202; Biotechnol. Bioeng. 84 (2003), 205-214]. This may be due to the limited availability of appropriate visualization methods. Acquiring 3-D images throughout the scaffold by histology or confocal methods are not applicable to all types of scaffolds, and moreover, they are time consuming, laborious and thus not very feasible for a large scale analysis. To make the visualization of the spatial distribution of the cells easier in biomaterial scaffolds we have applied optical projection tomography (OPT). OPT microscope produces high-resolution 3-D images of both fluorescent and non-fluorescent specimens [Science 296(5567) (2002), 541-545]. Here we demonstrate that the OPT method can be used for the evaluation and visualization of the cell seeding method, spatial distribution and density of cells in biomaterial scaffolds and thus establish the OPT as a valid tool for analysis of cell distribution in cartilage tissue engineering samples.
C1 [Jarvinen, Elina; Muhonen, Virpi; Kiviranta, Ilkka] Univ Helsinki, Dept Orthopaed & Traumatol, FIN-00290 Helsinki, Finland.
   [Haaparanta, Anne-Marie; Kellomaki, Minna] Tampere Univ Technol, Dept Biomed Engn, FIN-33101 Tampere, Finland.
   [Haaparanta, Anne-Marie; Kellomaki, Minna] BioMediTech, Tampere, Finland.
RP Jarvinen, E (reprint author), Univ Helsinki, Biomedicum Helsinki, Dept Orthopaed & Traumatol, Haartmaninkatu 8, FIN-00290 Helsinki, Finland.
EM elina.a.jarvinen@helsinki.fi
RI Kellomaki, Minna/G-6190-2010
OI Kellomaki, Minna/0000-0003-4321-1820
FU Finnish Funding Agency for Technology and Innovation [40091/09]
FX OPT imaging was performed at the Biomedicum Imaging Unit, Helsinki,
   Finland. We thank Jussi Kenkkila for technical support. Financial
   support from the Finnish Funding Agency for Technology and Innovation
   (Grant 40091/09) is acknowledged.
CR Bindzus C.B. Foldager, 2012, CARTILAGE, V3, P108
   Bueno EM, 2007, J BIOTECHNOL, V129, P516, DOI 10.1016/j.jbiotec.2007.01.005
   Danisovic L, 2012, EXP BIOL MED, V237, P10, DOI 10.1258/ebm.2011.011229
   Pulkkinen HJ, 2010, OSTEOARTHR CARTILAGE, V18, P1077, DOI 10.1016/j.joca.2010.05.004
   Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Wendt A., 2003, BIOTECHNOL BIOENG, V84, P205
NR 7
TC 0
Z9 0
U1 0
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2014
VL 24
IS 3
BP 1549
EP 1553
DI 10.3233/BME-140959
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AH8SM
UT WOS:000336408500002
PM 24840193
DA 2018-10-20
ER

PT J
AU Marycz, K
   Szarek, D
   Grzesiak, J
   Wrzeszcz, K
AF Marycz, Krzysztof
   Szarek, Dariusz
   Grzesiak, Jakub
   Wrzeszcz, Karol
TI Influence of modified alginate hydrogels on mesenchymal stem cells and
   olfactory bulb-derived glial cells cultures
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Hydrogel; fibrin; glial cells; mesenchymal stem cells
ID PERIPHERAL-NERVE REGENERATION; BONE-MARROW; AUTOLOGOUS KERATINOCYTES;
   FIBRIN SEALANT; STROMAL CELLS; GENE-THERAPY; DURAL REPAIR; MATRIX;
   DIFFERENTIATION; TISSUE
AB BACKGROUND: Great potential of cellular therapies has generated extensive research in the field of cells harvesting and culturing. Transplantation of cell cultures has been used in a variety of therapeutic programs but in many cases it appeared that biomaterial scaffold or sheath would enhance cells regenerative potential.
   OBJECTIVE: Hydrogels composed of different proportions sodium and calcium alginates, were undertaken to evaluate their influence on mesenchymal stem cells and olfactory bulb-derived glial cells cultures. Additionally, these biomaterials were also enriched with fibrin protein.
   METHODS: The structure of materials was visualized by means of scanning electron microscopy. After seeding with cells hydrogels were observed with inverted and fluorescence microscope. Cell's morphology, behavior and phenotype were analyzed in investigated materials by means of light, fluorescence and scanning electron microscopes. Also, viability assay was performed with Alamar Blue cytotoxic test.
   RESULTS: Our observations showed that basic alginate hydrogels had significant influence on both cell types. Materials maintained cells alive, which is desired attribute, however none of them kept cells in normal, flat form. Alginates with significant calcium component kept cells alive for longer period of culture.
   CONCLUSIONS: Addition of fibrin protein resulted in material's biocompatibility properties improvement, by creation of adhesion surface, which helps cells to keep proper morphology and behavior. Our findings suggest that addition of fibrin protein to alginate hydrogels improves them as cell carriers for regenerative medicine applications.
C1 [Marycz, Krzysztof; Grzesiak, Jakub; Wrzeszcz, Karol] Univ Environm & Life Sci, Electron Microscopy Lab, Wroclaw, Poland.
   [Szarek, Dariusz] Wroclaw Univ Hosp, Dept Neurosurg, Wroclaw, Poland.
RP Grzesiak, J (reprint author), Univ Environm & Life Sci, Electron Microscopy Lab, Kozuchowska 5b, Wroclaw, Poland.
EM grzesiak.kuba@gmail.com
RI Marycz, Krzysztof/A-2249-2017
FU NCN [1765/B/P01/2011/40]
FX This work was funded by NCN, grant number 1765/B/P01/2011/40.
CR Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Alovskaya A., 2007, TOPICS TISSUE ENG, V3
   Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005
   Black L, 2008, VET THER, V9
   Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chuah MI, 2011, EXP NEUROL, V229, P46, DOI 10.1016/j.expneurol.2010.08.012
   Devine SM, 2001, EXP HEMATOL, V29, P244, DOI 10.1016/S0301-472X(00)00635-4
   Dhoot NO, 2004, J BIOMED MATER RES A, V71A, P191, DOI 10.1002/jbm.a.30103
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Gelse K, 2003, ARTHRITIS RHEUM, V48, P430, DOI 10.1002/art.10759
   Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189
   Grant I, 2002, BRIT J PLAST SURG, V55, P219, DOI 10.1054/bjps.2002.3810
   Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158
   Hashimoto T, 2002, EXP BRAIN RES, V146, P356, DOI 10.1007/s00221-002-1173-y
   Higginson JR, 2011, EXP NEUROL, V229, P2, DOI 10.1016/j.expneurol.2010.08.020
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Hoogduijn MJ, 2010, INT IMMUNOPHARMACOL, V10, P1496, DOI 10.1016/j.intimp.2010.06.019
   Horch RE, 2001, TRANSPLANT P, V33, P642, DOI 10.1016/S0041-1345(00)02181-3
   Iannotti C, 2006, J NEUROTRAUM, V23, P853, DOI 10.1089/neu.2006.23.853
   Iyer SS, 2008, EXPERT OPIN BIOL TH, V8, P569, DOI [10.1517/14712590801997652, 10.1517/14712598.8.5.569 ]
   Jiao Y, 2011, EXP NEUROL, V229, P65, DOI 10.1016/j.expneurol.2010.10.008
   Kalbermatten DF, 2008, J PLAST RECONSTR AES, V61, P669, DOI 10.1016/j.bjps.2007.12.015
   Kalinski K, 2012, J ELECTRON MICROSC, V61, P47, DOI 10.1093/jmicro/dfr086
   Lee YS, 2002, J NEUROTRAUM, V19, P1203, DOI 10.1089/08977150260338001
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li JJ, 2010, J BIOMED MATER RES B, V95B, P308, DOI 10.1002/jbm.b.31715
   Matsuura S, 2006, UROLOGY, V68, P1366, DOI 10.1016/j.urology.2006.09.051
   Medrado GCB, 2006, BIOMED MATER, V1, P155, DOI 10.1088/1748-6041/1/3/010
   Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684
   Novikova LN, 2011, EXP NEUROL, V229, P132, DOI 10.1016/j.expneurol.2010.09.021
   O'Cearbhaill ED, 2010, ANN BIOMED ENG, V38, P649, DOI 10.1007/s10439-010-9912-x
   Ortinau S, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-70
   Pan LJ, 2009, J NEUROSCI RES, V87, P3207, DOI 10.1002/jnr.22142
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100
   Raisman Geoffrey, 2012, Handb Clin Neurol, V109, P541, DOI 10.1016/B978-0-444-52137-8.00033-4
   Ramon-Cueto A, 2011, EXP NEUROL, V229, P181, DOI 10.1016/j.expneurol.2010.10.001
   Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389
   Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev
   Sasaki M, 2011, EXP NEUROL, V229, P88, DOI 10.1016/j.expneurol.2011.01.010
   Seybold D, 2010, LANGENBECK ARCH SURG, V395, P719, DOI 10.1007/s00423-009-0588-3
   Shimada Y, 2006, J ORTHOP SCI, V11, P454, DOI 10.1007/s00776-006-1044-7
   Sorrell JM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt30
   Stamegna JC, 2011, EXP NEUROL, V229, P120, DOI 10.1016/j.expneurol.2010.07.002
   Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132
   Tosi P, 2000, LEUKEMIA, V14, P1310, DOI 10.1038/sj.leu.2401819
   Wan CD, 2008, HEPATOB PANCREAT DIS, V7, P29
   Yang CM, 2009, J TISSUE ENG REGEN M, V3, P601, DOI 10.1002/term.201
   Ziegler MD, 2011, EXP NEUROL, V229, P109, DOI 10.1016/j.expneurol.2011.01.007
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 51
TC 11
Z9 11
U1 3
U2 17
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2014
VL 24
IS 3
BP 1625
EP 1637
DI 10.3233/BME-140966
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AH8SM
UT WOS:000336408500009
PM 24840200
DA 2018-10-20
ER

PT S
AU Nicolae, G
   Brandusa, G
   Nicolae, S
   Alexandru, G
AF Nicolae, Ghiban
   Brandusa, Ghiban
   Nicolae, Serban
   Alexandru, Ghiban
BE Antoniac, I
   Cavalu, S
   Traistaru, T
TI Heat Treatments Influence on Corrosion Behaviour of some Metallic
   Biomaterials potentially used in Metal-Ceramic Prosthesis
SO BIOCERAMICS, VOL 25
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 25th Symposium and Annual Meeting of the
   International-Society-for-Ceramics-in-Medicine (ISCM)
CY NOV 07-10, 2013
CL Bucharest, ROMANIA
SP Int Soc Ceram Med
DE heat treatment; metallic biomaterial; corrosion resistance
AB The present paper put in evidence the influence of applying different heat treatments on some metallic materials such as cobalt and titanium alloys, usualy used for medical applications. The alloys were cobalt base alloy type CoCrMo (22%Cr, 6%Mo, rest Co), in nontreated state, quenching at 1100 degrees C /1h/aer, quenching at 1100 degrees C /lh/air+ sensiblizing at 550 degrees/4h/ air, 600 degrees/4h/air and/or 650 degrees C/4h/air and titanium base alloys - alloy TiMo0.3Ni0,7 (0.23%Mo, 0.72%Ni, Ti rest), alloy TiAl5Fe2V2Mol,5 (1.52%Mo, 5.15%Al, 2.56%Fe, 2.35%y, Ti rest), each of them in non treated state, annealing at 1050 degrees C/1h/air and annealing at 850 degrees C/1h/air. Corrosion tests were made at potentiostat-galvanostat AUTOLAB, in Ringer solution (for both alloys) and NaCl infusion solution (only for cobalt base alloy) by drawing the polarization curves. Our conclusion is that by applying correct and proper heat treatments to both at cobalt alloys and in titanium alloys there is an improving of the corrosion resistance.
C1 [Nicolae, Ghiban; Brandusa, Ghiban; Nicolae, Serban; Alexandru, Ghiban] Univ Politehn Bucuresti, Bucharest, Romania.
RP Nicolae, G (reprint author), Univ Politehn Bucuresti, Bucharest, Romania.
EM nicolaeghiban@yahoo.com; ghibanbrandusa@yahoo.com;
   serban.nicolae.sim@gmail.com; ghiban.alexandru@gmail.com
RI Serban, Nicolae/C-6636-2011
OI Serban, Nicolae/0000-0001-6373-1087
CR Brantley W.A., 2012, ADV MAT PROCESSES
   Ghiban A., 2012, SOLID STATE PHENOM, V188, P93
   Magheru A.M, 2012, SOLID STATE PHENOM, V188, P98
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Pignatello R., 2011, INTECH
NR 5
TC 0
Z9 0
U1 1
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2014
VL 587
BP 293
EP 296
DI 10.4028/www.scientific.net/KEM.587.293
PG 4
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Materials Science
GA BA4RR
UT WOS:000336185000048
DA 2018-10-20
ER

PT J
AU Ege, D
   Cameron, R
   Best, S
AF Ege, Duygu
   Cameron, Ruth
   Best, Serena
TI The degradation behavior of nanoscale HA/PLGA and alpha-TCP/PLGA
   composites
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE biodegradable; biomaterial; composites
ID MASSIVE POLY(ALPHA-HYDROXY ACIDS); STRUCTURE-PROPERTY RELATIONSHIPS;
   TISSUE ENGINEERING SCAFFOLDS; IN-VITRO DEGRADATION; BIODEGRADABLE
   POLYMERS; MECHANICAL-PROPERTIES; HYDROLYTIC DEGRADATION; ALIPHATIC
   POLYESTERS; AQUEOUS-MEDIA; HYDROXYAPATITE
AB The aim of this work was to prepare and analyze the degradation properties of pure PLGA, homogeneous a-tricalcium phosphate (alpha-TCP)/PLGA and hydroxyapatite (HA)/PLGA composites for potential bone replacement applications. alpha-TCP and HA powders were prepared in-house and 25 nominal wt% of calcium phosphate (CaP) powder was incorporated into commercially available PLGA pellets by twin screw extrusion. The degradation studies showed that pure PLGA had the fastest degradation rate followed by HA/PLGA and alpha-TCP/PLGA. Overall, it was found that alpha-TCP acted as a better buffering agent than HA, resulting in reduced acid group autocatalysis and hence a slower degradation rate.
C1 [Ege, Duygu; Cameron, Ruth; Best, Serena] Univ Cambridge, Cambridge Ctr Med Mat, Dept Mat Sci & Met, Cambridge, England.
RP Ege, D (reprint author), Univ Cambridge, Cambridge Ctr Med Mat, Dept Mat Sci & Met, New Museums Site, Cambridge, England.
EM duyguege258@gmail.com
RI Ege, Duygu/A-6423-2016
OI Ege, Duygu/0000-0002-9922-6995; Cameron, Ruth/0000-0003-1573-4923
FU Dorothy Hodgkin Scholarship
FX The authors thank Prof. Alexandre Bismarck for their support during the
   twin screw extrusion experiments. Duygu Ege is grateful to Simon Griggs
   of Cambridge University for his support during SEM. Duygu Ege would also
   like to acknowledge her funding body, Dorothy Hodgkin Scholarship, for
   their financial support.
CR Ara M, 2002, BIOMATERIALS, V23, P2479, DOI 10.1016/S0142-9612(01)00382-9
   Chouzouri G, 2007, J PLAST FILM SHEET, V23, P19, DOI 10.1177/8756087907076599
   Ehrenfried LM, 2008, J MATER SCI-MATER M, V19, P459, DOI 10.1007/s10856-006-0061-6
   Elliot J.C., 1994, STRUCTURE CHEM APATI
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   Huang YC, 2003, J BIOMED MATER RES A, V67A, P1384, DOI 10.1002/jbm.a.20036
   Jin HH, 2010, POLYM DEGRAD STABIL, V95, P1856, DOI 10.1016/j.polymdegradstab.2010.04.025
   Juang HY, 1996, BIOMATERIALS, V17, P2059, DOI 10.1016/0142-9612(96)88882-X
   Kitamura M, 2004, J MATER SCI-MATER M, V15, P1153, DOI 10.1023/B:JMSM.0000046399.40310.47
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   LI SM, 1990, J MATER SCI-MATER M, V1, P198, DOI 10.1007/BF00701077
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Lowry KJ, 1997, J BIOMED MATER RES, V36, P536
   Maquet V, 2003, J BIOMED MATER RES A, V66A, P335, DOI 10.1002/jbm.a.10587
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Neuendorf RE, 2008, ACTA BIOMATER, V4, P1288, DOI 10.1016/j.actbio.2008.04.006
   Petrtyl M, 1996, J BIOMECH, V29, P161, DOI 10.1016/0021-9290(94)00035-2
   Rauwendaal C, 2001, POLYM PROCESSING
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   Rosata D, 2000, INJECTION MOULDING H
   THERIN M, 1992, BIOMATERIALS, V13, P594, DOI 10.1016/0142-9612(92)90027-L
   Torres FG, 2007, COMPOS SCI TECHNOL, V67, P1139, DOI 10.1016/j.compscitech.2006.05.018
   VERT M, 1994, BIOMATERIALS, V15, P1209, DOI 10.1016/0142-9612(94)90271-2
   Wilberforce SIJ, 2011, J MECH BEHAV BIOMED, V4, P1081, DOI 10.1016/j.jmbbm.2011.03.017
   Wilberforce SIJ, 2011, POLYMER, V52, P2883, DOI 10.1016/j.polymer.2011.04.028
   Yang ZJ, 2009, ADV MATER, V21, P3900, DOI 10.1002/adma.200901093
   ZHU JH, 1991, J APPL POLYM SCI, V43, P2099, DOI 10.1002/app.1991.070431117
NR 28
TC 1
Z9 1
U1 2
U2 23
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2014
VL 3
IS 2
BP 85
EP 93
DI 10.1680/bbn.13.00027
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AH8ZU
UT WOS:000336428700003
DA 2018-10-20
ER

PT J
AU Roloff, F
   Strauss, S
   Vogt, PM
   Bicker, G
   Radtke, C
AF Roloff, Frank
   Strauss, Sarah
   Vogt, Peter M.
   Bicker, Gerd
   Radtke, Christine
TI Spider Silk as Guiding Biomaterial for Human Model Neurons
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID PERIPHERAL-NERVE REGENERATION; REPAIR; CELLS; CONDUITS; SPHERES; FIBERS;
   TUBE
AB Over the last years, a number of therapeutic strategies have emerged to promote axonal regeneration. An attractive strategy is the implantation of biodegradable and nonimmunogenic artificial scaffolds into injured peripheral nerves. In previous studies, transplantation of decellularized veins filled with spider silk for bridging critical size nerve defects resulted in axonal regeneration and remyelination by invading endogenous Schwann cells. Detailed interaction of elongating neurons and the spider silk as guidance material is unknown. To visualize direct cellular interactions between spider silk and neurons in vitro, we developed an in vitro crossed silk fiber array. Here, we describe in detail for the first time that human ( NT2) model neurons attach to silk scaffolds. Extending neurites can bridge gaps between single silk fibers and elongate afterwards on the neighboring fiber. Culturing human neurons on the silk arrays led to an increasing migration and adhesion of neuronal cell bodies to the spider silk fibers. Within three to four weeks, clustered somata and extending neurites formed ganglion-like cell structures. Microscopic imaging of human neurons on the crossed fiber arrays in vitro will allow for a more efficient development of methods to maximize cell adhesion and neurite growth on spider silk prior to transplantation studies.
C1 [Roloff, Frank; Bicker, Gerd] Univ Vet Med Hannover, Div Cell Biol, D-30173 Hannover, Germany.
   [Strauss, Sarah; Vogt, Peter M.; Radtke, Christine] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-30625 Hannover, Germany.
   [Bicker, Gerd] Ctr Syst Neurosci, Hannover, Germany.
RP Bicker, G (reprint author), Univ Vet Med Hannover, Div Cell Biol, Bischofsholer Damm15-102, D-30173 Hannover, Germany.
EM gerd.bicker@tiho-hannover.de; radtke.christine@mh-hannover.de
OI Radtke, Christine/0000-0001-6877-5038
FU German Research Foundation [1103, BI 262/16-2, Ra 1901/1-2]
FX The authors thank Torben Stemme for the image of the Nephila and Saime
   Tan for help with the neuron culture. This study was supported by a
   Grant from the German Research Foundation (Research Unit 1103) to Gerd
   Bicker (BI 262/16-2) and Christine Radtke (Ra 1901/1-2).
CR Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   Baranes D, 2007, TISSUE ENG, V13, P473, DOI 10.1089/ten.2006.0052
   Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   FIELDS RD, 1989, PROG NEUROBIOL, V33, P87, DOI 10.1016/0301-0082(89)90036-1
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Kuhbier JW, 2011, J BIOMED MATER RES B, V97B, P381, DOI 10.1002/jbm.b.31825
   Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Paquet-Durand F, 2003, DEV BRAIN RES, V142, P161, DOI 10.1016/S0165-3806(03)00065-8
   Paquet-Durand F, 2007, CURR MOL MED, V7, P541, DOI 10.2174/156652407781695747
   PLEASURE SJ, 1992, J NEUROSCI, V12, P1802
   Podrygajlo G, 2009, CELL TISSUE RES, V336, P439, DOI 10.1007/s00441-009-0783-0
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Tegenge MA, 2011, CELL MOL NEUROBIOL, V31, P635, DOI 10.1007/s10571-011-9659-4
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
NR 18
TC 6
Z9 7
U1 0
U2 20
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 906819
DI 10.1155/2014/906819
PG 7
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AI1BA
UT WOS:000336583400001
PM 24949480
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Carreon, H
   Barriuso, S
   Porro, JA
   Gonzalez-Carrasco, JL
   Ocana, JL
AF Carreon, H.
   Barriuso, S.
   Porro, J. A.
   Gonzalez-Carrasco, J. L.
   Ocana, J. L.
BE Heisterkamp, A
   Herman, PR
   Meunier, M
   Nolte, S
TI Thermoelectric assessment of laser peening induced effects on a metallic
   biomedical Ti6Al4V
SO FRONTIERS IN ULTRAFAST OPTICS: BIOMEDICAL, SCIENTIFIC, AND INDUSTRIAL
   APPLICATIONS XIV
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Frontiers in Ultrafast Optics - Biomedical, Scientific,
   and Industrial Applications XIV
CY FEB 02-05, 2014
CL San Francisco, CA
SP SPIE, Amplitude Syst, APE GmbH, TRUMPF Inc
DE Laser shock peening; Thermoelectric Measurements; Ti-6Al-4V; Biomaterial
ID MECHANICAL SURFACE TREATMENTS; POWER MEASUREMENTS; STAINLESS-STEEL;
   TI-6AL-4V; MICROSTRUCTURES; DEFORMATION; BEHAVIOR; STRESS; COLD
AB Laser peening has recently emerged as a useful technique to overcome detrimental effects associated to another well-known surface modification processes such as shot peening or grit blasting used in the biomedical field. It is worth to notice that besides the primary residual stress effect, thermally induced effects might also cause subtle surface and subsurface microstructural changes that might influence corrosion resistance. Moreover, since maximum loads use to occur at the surface, they could also play a critical role in the fatigue strength. In this work, plates of Ti-6Al-4V alloy of 7 mm in thickness were modified by laser peening without using a sacrificial outer layer. Irradiation by a Q-switched Nd-YAG laser (9.4 ns pulse length) working in fundamental harmonic at 2.8 J/pulse and with water as confining medium was used. Laser pulses with a 1.5 mm diameter at an equivalent overlapping density (EOD) of 5000 cm(-2) were applied. Attempts to analyze the global induced effects after laser peening were addressed by using the contacting and non-contacting thermoelectric power (TEP) techniques. It was demonstrated that the thermoelectric method is entirely insensitive to surface topography while it is uniquely sensitive to subtle variations in thermoelectric properties, which are associated with the different material effects induced by different surface modification treatments. These results indicate that the stress-dependence of the thermoelectric power in metals produces sufficient contrast to detect and quantitatively characterize regions under compressive residual stress based on their thermoelectric power contrast with respect to the surrounding intact material. However, further research is needed to better separate residual stress effects from secondary material effects, especially in the case of low-conductivity engineering materials like titanium alloys.
C1 [Carreon, H.] UMSNH IIM, Inst Invest Met, Edif U CU 58000-888, Morelia, Michoacan, Mexico.
   [Barriuso, S.; Gonzalez-Carrasco, J. L.] CENIM CSIC, E-28040 Madrid, Spain.
   [Porro, J. A.; Ocana, J. L.] CIBER BBN, Madrid, Spain.
RP Carreon, H (reprint author), UMSNH IIM, Inst Invest Met, Edif U CU 58000-888, Morelia, Michoacan, Mexico.
RI Porro Gonzalez, Juan Antonio/G-5696-2014; OCANA, JOSE LUIS/I-7475-2012
OI Porro Gonzalez, Juan Antonio/0000-0001-5260-527X; OCANA, JOSE
   LUIS/0000-0001-9263-8404; CARREON, HECTOR/0000-0002-4803-0650;
   Gonzalez-Carrasco, Jose Luis/0000-0003-2004-4505
FU CONACYT ( Mexico) [CB- 80883]; MINECO ( Spain) [MAT2009- 14695- C04, MAT
   2012- 37736- C05- 01, MAT 2012- 37782]; CSIC [JAE- I3P]
FX The authors acknowledge financial support to CONACYT ( Mexico) under
   project CB- 80883, MINECO ( Spain), under projects MAT2009- 14695- C04,
   MAT 2012- 37736- C05- 01 and MAT 2012- 37782 and CSIC for the
   scholarship JAE- I3P of S. B.
CR Altenberger I, 1999, MAT SCI ENG A-STRUCT, V264, P1, DOI 10.1016/S0921-5093(98)01121-6
   Altenberger I, 2012, INT J FATIGUE, V44, P292, DOI 10.1016/j.ijfatigue.2012.03.008
   Caballero FG, 2004, SCRIPTA MATER, V50, P1061, DOI 10.1016/j.scriptamat.2003.12.017
   Carreon H, 2007, NONDESTRUCT TEST EVA, V22, P299, DOI 10.1080/10589750701546960
   Carreon H, 2006, NDT&E INT, V39, P22, DOI 10.1016/j.ndteint.2005.05.002
   Carreon H, 2013, MAT SCI ENG C-MATER, V33, P1417, DOI 10.1016/j.msec.2012.12.045
   Carreon H, 2012, SURF COAT TECH, V206, P2941, DOI 10.1016/j.surfcoat.2011.12.026
   Carreon H, 2002, RES NONDESTRUCT EVAL, V14, P59, DOI 10.1007/s00164-002-0001-x
   Carreon H., 2000, 7 ASME NDE TOP C, V20, P209
   Carreon H, 2007, J ALLOY COMPD, V427, P183, DOI 10.1016/j.jallcom.2006.03.004
   Drechsler A, 1998, MAT SCI ENG A-STRUCT, V243, P217, DOI 10.1016/S0921-5093(97)00804-6
   Ferrer JP, 2007, ACTA MATER, V55, P2075, DOI 10.1016/j.actamat.2006.11.010
   Hanagarth H., 1993, RELAXATION SHOT PEEN, P337
   Kleber X, 2008, NDT&E INT, V41, P364, DOI 10.1016/j.ndteint.2008.01.003
   Lakshminayaran B., 2003, AIP, V22, P1523
   Martinez S.A., 2003, AIP, V22, P1531
   MORGNER W, 1994, NDT&E INT, V27, P263, DOI 10.1016/0963-8695(94)90131-7
   Ocana JL, 2007, P SOC PHOTO-OPT INS, V6346, pP3461, DOI 10.1117/12.738836
   Peyre P, 1997, P SOC PHOTO-OPT INS, V3097, P558
   Yu F, 2010, NDT&E INT, V43, P182, DOI 10.1016/j.ndteint.2009.11.001
   Zinn W, 1999, J MATER ENG PERFORM, V8, P145, DOI 10.1361/105994999770346972
NR 21
TC 0
Z9 0
U1 0
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9885-4
J9 PROC SPIE
PY 2014
VL 8972
AR UNSP 89721Q
DI 10.1117/12.2045335
PG 7
WC Engineering, Biomedical; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BA4NL
UT WOS:000336035000034
DA 2018-10-20
ER

PT J
AU Venkatesan, J
   Bhatnagar, I
   Kim, SK
AF Venkatesan, Jayachandran
   Bhatnagar, Ira
   Kim, Se-Kwon
TI Chitosan-Alginate Biocomposite Containing Fucoidan for Bone Tissue
   Engineering
SO MARINE DRUGS
LA English
DT Article
DE chitosan; alginate; fucoidan; bone tissue engineering; biomaterials
ID COMPOSITE SCAFFOLDS; BIOMEDICAL APPLICATIONS; CONTROLLED-RELEASE;
   COMPLEX; BEADS; CHITOSAN/ALGINATE; BIOMATERIALS; FABRICATION
AB Over the last few years, significant research has been conducted in the construction of artificial bone scaffolds. In the present study, different types of polymer scaffolds, such as chitosan-alginate (Chi-Alg) and chitosan-alginate with fucoidan (Chi-Alg-fucoidan), were developed by a freeze-drying method, and each was characterized as a bone graft substitute. The porosity, water uptake and retention ability of the prepared scaffolds showed similar efficacy. The pore size of the Chi-Alg and Chi-Alg-fucoidan scaffolds were measured from scanning electron microscopy and found to be 62-490 and 56-437 mu m, respectively. In vitro studies using the MG-63 cell line revealed profound cytocompatibility, increased cell proliferation and enhanced alkaline phosphatase secretion in the Chi-Alg-fucoidan scaffold compared to the Chi-Alg scaffold. Further, protein adsorption and mineralization were about two times greater in the Chi-Alg-fucoidan scaffold than the Chi-Alg scaffold. Hence, we suggest that Chi-Alg-fucoidan will be a promising biomaterial for bone tissue regeneration.
C1 [Venkatesan, Jayachandran; Kim, Se-Kwon] Pukyong Natl Univ, Dept Chem, Marine Bioproc Res Ctr, Pusan 608737, South Korea.
   [Bhatnagar, Ira] Ctr Cellular & Mol Biol, Nanotheranost Lab, Hyderabad 500007, Andhra Pradesh, India.
RP Kim, SK (reprint author), Pukyong Natl Univ, Dept Chem, Marine Bioproc Res Ctr, Pusan 608737, South Korea.
EM venkatjchem@pknu.ac.kr; ira@ccmb.res.in; sknkim@pknu.ac.kr
OI Kim, Se-Kwon/0000-0001-6507-9539
FU Marine Bioprocess Research Centre of the Marine Bio 21 Center - the
   Ministry of Land, Transport and Maritime, Korea
FX This work was supported by a grant from the Marine Bioprocess Research
   Centre of the Marine Bio 21 Center funded by the Ministry of Land,
   Transport and Maritime, Korea.
CR Anal AK, 2005, INT J PHARM, V290, P45, DOI 10.1016/j.ijpharm.2004.11.015
   Changotade SIT, 2008, J BIOMED MATER RES A, V87A, P666, DOI 10.1002/jbm.a.31819
   Cho YS, 2009, FOOD CHEM, V116, P990, DOI 10.1016/j.foodchem.2009.03.051
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Fisher J, 2003, TOPICS TISSUE ENG
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Gomez d'Ayala G., 2007, J BIOMEDICAL MAT R A, V81, P811
   Hamman JH, 2010, MAR DRUGS, V8, P1305, DOI 10.3390/md8041305
   Ho YC, 2009, INT J PHARMACEUT, V376, P69, DOI 10.1016/j.ijpharm.2009.04.048
   Hong HJ, 2008, BIOMATERIALS, V29, P4831, DOI 10.1016/j.biomaterials.2008.08.023
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Jin G, 2011, J MATER CHEM, V21, P17710, DOI 10.1039/c1jm12915e
   Kim S, 2010, LANGMUIR, V26, P7355, DOI 10.1021/la9043717
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   Lee JS, 2012, CARBOHYD POLYM, V90, P181, DOI 10.1016/j.carbpol.2012.05.012
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee M, 2009, BIOMATERIALS, V30, P6094, DOI 10.1016/j.biomaterials.2009.07.046
   Levene H.B., 2000, U.S. Patent, Patent No. [6103255, 6103255 A]
   Majima T, 2005, J ORTHOP SCI, V10, P302, DOI 10.1007/s00776-005-0891-y
   Mi FL, 2002, CARBOHYD POLYM, V48, P61, DOI 10.1016/S0144-8617(01)00212-0
   Murakami K, 2010, BIOMATERIALS, V31, P83, DOI 10.1016/j.biomaterials.2009.09.031
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Pallela R, 2012, J BIOMED MATER RES A, V100A, P486, DOI 10.1002/jbm.a.33292
   Park DJ, 2005, J CRANIO MAXILL SURG, V33, P50, DOI 10.1016/j.jcms.2004.05.011
   Park SJ, 2012, STEM CELLS DEV, V21, P2204, DOI 10.1089/scd.2011.0521
   Ribeiro AJ, 2005, EUR J PHARM SCI, V25, P31, DOI 10.1016/j.ejps.2005.01.016
   Rodriguez-Jasso RM, 2011, CARBOHYD POLYM, V86, P1137, DOI 10.1016/j.carbpol.2011.06.006
   Sezer AD, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0802039
   Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/bjm.a.31030
   Sowjanya JA, 2013, COLLOID SURFACE B, V109, P294, DOI 10.1016/j.colsurfb.2013.04.006
   Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Venkatesan J, 2012, INT J BIOL MACROMOL, V51, P1033, DOI 10.1016/j.ijbiomac.2012.08.020
   Venkatesan J, 2011, CARBOHYD POLYM, V83, P569, DOI 10.1016/j.carbpol.2010.08.019
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   Xu YM, 2007, INT J PHARM, V336, P329, DOI 10.1016/j.ijpharm.2006.12.019
   Zhang LN, 2000, J APPL POLYM SCI, V77, P610, DOI 10.1002/(SICI)1097-4628(20000718)77:3<610::AID-APP16>3.0.CO;2-B
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
NR 41
TC 53
Z9 55
U1 4
U2 37
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD JAN
PY 2014
VL 12
IS 1
BP 300
EP 316
DI 10.3390/md12010300
PG 17
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AH4HH
UT WOS:000336087500018
PM 24441614
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Martins, JRS
   Araujo, RO
   Donato, TAG
   Arana-Chavez, VE
   Buzalaf, MAR
   Grandini, CR
AF Martins, Jose R. S., Jr.
   Araujo, Raul O.
   Donato, Tatiani A. G.
   Arana-Chavez, Victor E.
   Buzalaf, Marilia A. R.
   Grandini, Carlos R.
TI Influence of Oxygen Content and Microstructure on the Mechanical
   Properties and Biocompatibility of Ti-15 wt%Mo Alloy Used for Biomedical
   Applications
SO MATERIALS
LA English
DT Article
DE Ti alloys; microstructure; Rietveld's method; modulus of elasticity;
   biocompatibility
ID TI-MO; TITANIUM-ALLOYS; BIOMATERIAL
AB The Ti-15Mo alloy has its mechanical properties strongly altered by heat treatments and by addition of interstitial elements, such as, oxygen, for example. In this sense, the objective of this paper is to analyze the effect of the introduction of oxygen in selected mechanical properties and the biocompatibility of Ti-15Mo alloy. The samples used in this study were prepared by arc-melting and characterized by density measurements, X-ray diffraction, scanning electron microscopy, microhardness, modulus of elasticity, and biocompatibility tests. Hardness measurements were shown to be sensitive to concentration of oxygen. The modulus results showed interstitial influence in value; this was verified under several conditions to which the samples were exposed. Cytotoxicity tests conducted in vitro showed that the various processing conditions did not alter the biocompatibility of the material.
C1 [Martins, Jose R. S., Jr.; Araujo, Raul O.; Grandini, Carlos R.] UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
   [Donato, Tatiani A. G.; Arana-Chavez, Victor E.] Univ Sao Paulo, Fac Odontol, Dept Biomat & Biol Oral, BR-05508900 Sao Paulo, Brazil.
   [Buzalaf, Marilia A. R.] Univ Sao Paulo, Fac Odontol Bauru, Dept Ciencias Biol, BR-17012901 Bauru, SP, Brazil.
RP Grandini, CR (reprint author), UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
EM jrsmjr@fc.unesp.br; raularaujo@fc.unesp.br; tatianidonato@gmail.com;
   vearana@usp.br; mbuzalaf@fob.usp.br; betog@fc.unesp.br
RI Buzalaf, Marilia/C-5228-2012; Grandini, Carlos Roberto/A-3790-2008;
   Martins Junior, Jose Roberto/E-2190-2014; Araujo, Raul/M-3471-2017
OI Grandini, Carlos Roberto/0000-0002-3336-309X; 
FU CNPq [307.471/2007-1]; FAPESP [2008/07.588-5, 2009/00.042-0]
FX The authors thank the Brazilian Agencies CNPq (Grant No.
   #307.471/2007-1) and FAPESP (Grant Nos. #2008/07.588-5and
   #2009/00.042-0) for their financial support.
CR [Anonymous], 2009, 109935 ISO
   [Anonymous], 2008, F206608 ASTM
   ATALA A, 2002, METHODS TISSUE ENG
   Chen YY, 2006, T NONFERR METAL SOC, V16, pS824, DOI 10.1016/S1003-6326(06)60308-7
   Correa DRN, 2014, MAT SCI ENG C-MATER, V34, P354, DOI 10.1016/j.msec.2013.09.032
   Donato TAG, 2009, MAT SCI ENG C-BIO S, V29, P1365, DOI 10.1016/j.msec.2008.10.021
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Grandini C.R., 2002, REV BRAS APL VACUO, V21, P13
   Guo H, 2006, SCRIPTA MATER, V54, P1409, DOI 10.1016/j.scriptamat.2005.11.053
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Lide D. R., 2004, CRC HDB CHEM PHYS RE, P7
   Lutjering G., 2007, TITANIUM
   Martins J. J. R. S., 2012, J APPL PHYS, V111
   MCLACHLAN DRC, 1995, ENVIRONMETRICS, V6, P233, DOI 10.1002/env.3170060303
   Nag S, 2005, MAT SCI ENG C-BIO S, V25, P357, DOI 10.1016/j.msec.2004.12.013
   Nanci A, 1996, MICROSC RES TECHNIQ, V33, P214
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Nowick A. S., 1972, ANELASTIC RELAXATION
   Oliveira NTC, 2008, CORROS SCI, V50, P938, DOI 10.1016/j.corsci.2007.09.009
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Pintao C.A.F., 2006, REV BRASILEIRA APLIC, V25, P189
   Puskar A., 2001, INTERNAL FRICTION MA
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Martins JRS, 2012, DEFECT DIFFUS FORUM, V326-328, P696, DOI 10.4028/www.scientific.net/DDF.326-328.696
   Martins JRS, 2011, MATER RES-IBERO-AM J, V14, P107, DOI 10.1590/S1516-14392011005000013
   Steinemann S., 1980, EVALUATION BIOMATERI
   Sugano M, 1998, MAT SCI ENG A-STRUCT, V243, P163, DOI 10.1016/S0921-5093(97)00795-8
   Sukedai E, 2003, MAT SCI ENG A-STRUCT, V350, P133, DOI 10.1016/S0921-5093(02)00714-1
NR 29
TC 5
Z9 5
U1 0
U2 19
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JAN
PY 2014
VL 7
IS 1
BP 232
EP 243
DI 10.3390/ma7010232
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA AH4HR
UT WOS:000336088500018
PM 28788453
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Elias-Zuniga, A
   Baylon, K
   Ferrer, I
   Sereno, L
   Garcia-Romeu, ML
   Bagudanch, I
   Grabalosa, J
   Perez-Recio, T
   Martinez-Romero, O
   Ortega-Lara, W
   Elizalde, LE
AF Elias-Zuniga, Alex
   Baylon, Karen
   Ferrer, Ines
   Sereno, Lidia
   Luisa Garcia-Romeu, Maria
   Bagudanch, Isabel
   Grabalosa, Jordi
   Perez-Recio, Tania
   Martinez-Romero, Oscar
   Ortega-Lara, Wendy
   Ernesto Elizalde, Luis
TI On the Rule of Mixtures for Predicting Stress-Softening and Residual
   Strain Effects in Biological Tissues and Biocompatible Materials
SO MATERIALS
LA English
DT Article
DE stress-softening effects; biomaterial residual strains; biological
   tissues; rule of mixtures; pseudo-elasticity theory
ID MECHANICAL-PROPERTIES; CONSTITUTIVE MODEL; RUBBER ELASTICITY; SOFT;
   ELASTOMERS; BEHAVIOR; DAMAGE
AB In this work, we use the rule of mixtures to develop an equivalent material model in which the total strain energy density is split into the isotropic part related to the matrix component and the anisotropic energy contribution related to the fiber effects. For the isotropic energy part, we select the amended non-Gaussian strain energy density model, while the energy fiber effects are added by considering the equivalent anisotropic volumetric fraction contribution, as well as the isotropized representation form of the eight-chain energy model that accounts for the material anisotropic effects. Furthermore, our proposed material model uses a phenomenological non-monotonous softening function that predicts stress softening effects and has an energy term, derived from the pseudo-elasticity theory, that accounts for residual strain deformations. The model's theoretical predictions are compared with experimental data collected from human vaginal tissues, mice skin, poly(glycolide-co-caprolactone) (PGC25 3-0) and polypropylene suture materials and tracheal and brain human tissues. In all cases examined here, our equivalent material model closely follows stress-softening and residual strain effects exhibited by experimental data.
C1 [Elias-Zuniga, Alex; Baylon, Karen; Perez-Recio, Tania; Martinez-Romero, Oscar; Ortega-Lara, Wendy] Tecnol Monterrey, Ctr Innovac Diseno & Tecnol, Monterrey 64849, NL, Mexico.
   [Ferrer, Ines; Sereno, Lidia; Luisa Garcia-Romeu, Maria; Bagudanch, Isabel; Grabalosa, Jordi] Univ Girona, Dept Mech Engn & Ind Construct, Girona 17071, Spain.
   [Ernesto Elizalde, Luis] Ctr Invest Quim Aplicada, Coahuila 25250, Mexico.
RP Elias-Zuniga, A (reprint author), Tecnol Monterrey, Ctr Innovac Diseno & Tecnol, Campus Monterrey,E Garza Sada 2501 Sur, Monterrey 64849, NL, Mexico.
EM aelias@itesm.mx; kl.baylon.phd.mty@itesm.mx; ines.iferrer@udg.edu;
   lidia.sereno@udg.edu; mluisa.gromeu@udg.edu; isabel.bagudanch@udg.edu;
   jordi.grabalosa@udg.edu; tany.nohemi@gmail.com; oscar.martinez@itesm.mx;
   wlortega@gmail.com; elizalde@ciqa.mx
RI Ortega, Wendy/B-4266-2014; ortega, wendy/B-4916-2015
OI Ortega, Wendy/0000-0002-8536-158X; ortega, wendy/0000-0002-8536-158X;
   Garcia-Romeu, Maria Luisa/0000-0001-5122-7908; FERRER REAL,
   INES/0000-0001-9535-1193; Bagudanch, Isabel/0000-0003-3431-326X;
   Elias-Zuniga, Alex/0000-0002-5661-2802
FU Tecnologico de Monterrey-Campus Monterrey, through the Research Chair in
   Nanomaterials for Medical Devices; Tecnologico de Monterrey-Campus
   Monterrey, through the Research Chair in Intelligent Machines; European
   Commission [FP7-PEOPLE-2009-IRSES-247476]; Consejo Nacional de Ciencia y
   Tecnologia (Conacyt), Mexico
FX This work was funded by Tecnologico de Monterrey-Campus Monterrey,
   through the Research Chair in Nanomaterials for Medical Devices and the
   Research Chair in Intelligent Machines. Additional support was provided
   from the European Commission project,
   IREBID(FP7-PEOPLE-2009-IRSES-247476) and from Consejo Nacional de
   Ciencia y Tecnologia (Conacyt), Mexico. This work is dedicated to
   Francisco J. Cantu Ortiz with esteem and appreciation.
CR ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6
   Beatty MF, 2000, J MECH PHYS SOLIDS, V48, P1931, DOI 10.1016/S0022-5096(99)00085-X
   Beatty MF, 2003, J ELASTICITY, V70, P65, DOI 10.1023/B:ELAS.0000005553.38563.91
   Cantournet S, 2007, J MECH PHYS SOLIDS, V55, P1321, DOI 10.1016/j.jmps.2006.07.010
   Cordova RK, 2013, MATERIALS, V6, P2873, DOI 10.3390/ma6072873
   De Tommasi D, 2010, BIOPHYS J, V98, P1941, DOI 10.1016/j.bpj.2010.01.021
   Dorfmann A, 2004, INT J SOLIDS STRUCT, V41, P1855, DOI 10.1016/j.ijsolstr.2003.11.014
   Ehret AE, 2009, INT J PLASTICITY, V25, P901, DOI 10.1016/j.ijplas.2008.06.001
   Elias-Zuniga A, 2002, INT J ENG SCI, V40, P2265, DOI 10.1016/S0020-7225(02)00140-4
   Elias-Zuniga A, 2010, INT J ENG SCI, V48, P1937, DOI 10.1016/j.ijengsci.2010.06.011
   Elias-Zuniga A, 2013, ADV MATER SCI ENG, DOI 10.1155/2013/249512
   Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004
   Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564
   Humphrey JD, 2003, P ROY SOC A-MATH PHY, V459, P3, DOI 10.1098/rspa.2002.1060
   Kima HS, 2001, J MATER PROCESS TECH, V112, P109
   Munoz MJ, 2008, J BIOMECH, V41, P93, DOI 10.1016/j.jbiomech.2007.07.013
   OGDEN RW, 1978, J MECH PHYS SOLIDS, V26, P37, DOI 10.1016/0022-5096(78)90012-1
   Pena E, 2011, J MECH BEHAV BIOMED, V4, P275, DOI 10.1016/j.jmbbm.2010.10.006
   Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671
   Sansour C, 2008, EUR J MECH A-SOLID, V27, P28, DOI [10.1016/j.euromechsol.2007.04.001, 10.1016/j.euromechso1.2007.04.001]
   SHAFFER TH, 1989, PEDIATR RES, V25, P143, DOI 10.1203/00006450-198902000-00013
   Teng ZZ, 2012, J BIOMECH, V45, P1717, DOI 10.1016/j.jbiomech.2012.04.002
   Toki S, 2002, MACROMOLECULES, V35, P6578, DOI 10.1021/ma0205921
NR 23
TC 8
Z9 8
U1 0
U2 9
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JAN
PY 2014
VL 7
IS 1
BP 441
EP 456
DI 10.3390/ma7010441
PG 16
WC Materials Science, Multidisciplinary
SC Materials Science
GA AH4HR
UT WOS:000336088500031
PM 28788466
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Vicente, FB
   Correa, DRN
   Donato, TAG
   Arana-Chavez, VE
   Buzalaf, MAR
   Grandini, CR
AF Vicente, Fabio B.
   Correa, Diego R. N.
   Donato, Tatiani A. G.
   Arana-Chavez, Victor E.
   Buzalaf, Marilia A. R.
   Grandini, Carlos R.
TI The Influence of Small Quantities of Oxygen in the Structure,
   Microstructure, Hardness, Elasticity Modulus and Cytocompatibility of
   Ti-Zr Alloys for Dental Applications
SO MATERIALS
LA English
DT Article
DE Ti alloys; interstitials; microstructure; mechanical properties;
   biocompatibility
ID MECHANICAL-PROPERTIES; BIOMEDICAL APPLICATIONS; TITANIUM-ALLOYS; YOUNGS
   MODULUS; HEAT-TREATMENT; GRINDABILITY; BIOMATERIAL; BIOCOMPATIBILITY;
   SPECTROSCOPY; NIOBIUM
AB The mechanical properties of Ti alloys are changed significantly with the addition of interstitial elements, such as oxygen. Because oxygen is a strong stabilizer of the a phase and has an effect on hardening in a solid solution, it has aroused great interest in the biomedical area. In this paper, Ti-Zr alloys were subjected to a doping process with small amounts of oxygen. The influence of interstitial oxygen in the structure, microstructure and some selected mechanical properties of interest for use as biomaterial and biocompatibility of the alloys were analyzed. The results showed that in the range of 0.02 wt% to 0.04 wt%, oxygen has no influence on the structure, microstructure or biocompatibility of the studied alloys, but causes hardening of the alloys, increasing the values of the microhardness and causing variation in the elasticity modulus values.
C1 [Vicente, Fabio B.; Correa, Diego R. N.; Grandini, Carlos R.] UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
   [Donato, Tatiani A. G.; Arana-Chavez, Victor E.] Univ Sao Paulo, Fac Odontol, Dept Biomat & Biol Oral, BR-05508900 Sao Paulo, Brazil.
   [Buzalaf, Marilia A. R.] Univ Sao Paulo, Fac Odontol, Dept Ciencias Biol, BR-17012901 Bauru, SP, Brazil.
RP Grandini, CR (reprint author), UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
EM fabiobv@fc.unesp.br; diegornc@fc.unesp.br; tatianidonato@gmail.com;
   vearana@usp.br; mbuzalaf@fob.usp.br; betog@fc.unesp.br
RI Rafael Nespeque Correa, Diego/J-3945-2014; Buzalaf, Marilia/C-5228-2012;
   Vicente, Fabio/M-9125-2014; Grandini, Carlos Roberto/A-3790-2008
OI Rafael Nespeque Correa, Diego/0000-0002-1803-6488; Vicente,
   Fabio/0000-0001-5702-0676; Grandini, Carlos Roberto/0000-0002-3336-309X
FU Brazilian Agency CNPq [307.471/2007-1]; Brazilian Agency FAPESP
   [2007/06.478-9, 2009/00.042-0]
FX The authors thank the Brazilian Agencies CNPq (Grant No.
   #307.471/2007-1) and FAPESP (Grant Nos. #2007/06.478-9 and
   #2009/00.042-0) for their financial support.
CR Almeida LH, 2009, MAT SCI ENG A-STRUCT, V521-22, P59, DOI 10.1016/j.msea.2008.09.123
   [Anonymous], 2009, 109935 ISO
   Besse M, 2011, ACTA MATER, V59, P5982, DOI 10.1016/j.actamat.2011.06.006
   Correa DRN, 2014, MAT SCI ENG C-MATER, V34, P354, DOI 10.1016/j.msec.2013.09.032
   da Silva LM, 2011, ARTIF ORGANS, V35, P516, DOI 10.1111/j.1525-1594.2011.01263.x
   de Almeida LH, 2005, MAT SCI ENG A-STRUCT, V412, P230, DOI 10.1016/j.msea.2005.08.218
   Donachie M. J., 2000, TITANIUM TECHNICAL G
   Donato TAG, 2009, MAT SCI ENG C-BIO S, V29, P1365, DOI 10.1016/j.msec.2008.10.021
   Florencio O, 2004, MAT SCI ENG A-STRUCT, V370, P131, DOI 10.1016/j.msea.2003.08.102
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   Grandini C.R., 2002, REV BRAS APL VACUO, V21, P13
   Ho WF, 2008, J MATER SCI-MATER M, V19, P3179, DOI 10.1007/s10856-008-3454-x
   Ho WF, 2012, MAT SCI ENG C-MATER, V32, P517, DOI 10.1016/j.msec.2011.12.003
   Ho WF, 2010, MATER CHEM PHYS, V121, P465, DOI 10.1016/j.matchemphys.2010.02.009
   Ho WF, 2009, MAT SCI ENG C-BIO S, V29, P36, DOI 10.1016/j.msec.2008.05.004
   Hsu HC, 2009, J ALLOY COMPD, V488, P279, DOI 10.1016/j.jallcom.2009.08.105
   Kim WG, 2009, THIN SOLID FILMS, V517, P5033, DOI 10.1016/j.tsf.2009.03.165
   Larson A.C., 2000, GSAS GEN STRUCTURE A, P223
   LEE YT, 1990, MAT SCI ENG A-STRUCT, V128, P77, DOI 10.1016/0921-5093(90)90097-M
   Leyens C., 2005, TITANIUM TITANIUM AL
   Li SJ, 2011, SCRIPTA MATER, V64, P1015, DOI 10.1016/j.scriptamat.2011.02.006
   Li Y, 2011, SCRIPTA MATER, V64, P584, DOI 10.1016/j.scriptamat.2010.11.048
   Lide D. R., 2004, CRC HDB CHEM PHYS RE, P7
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Martins Jr J.R.S., 2012, J APPL PHYS, V111
   Min XH, 2008, MAT SCI ENG A-STRUCT, V497, P74, DOI 10.1016/j.msea.2008.06.018
   Niemeyer TC, 2005, MAT SCI ENG A-STRUCT, V396, P285, DOI 10.1016/j.msea.2005.01.045
   Niinomi M., 2011, INT J BIOMATER, V2011
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Nogueira RA, 2008, J MATER SCI, V43, P5977, DOI 10.1007/s10853-008-2706-y
   Ouchi C, 1998, MAT SCI ENG A-STRUCT, V243, P186, DOI 10.1016/S0921-5093(97)00799-5
   Pintao C.A.F., 2006, REV BRASILEIRA APLIC, V25, P189
   Qazi JI, 2005, MAT SCI ENG C-BIO S, V25, P389, DOI 10.1016/j.msec.2005.01.022
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558
   Martins JRS, 2011, MATER RES-IBERO-AM J, V14, P107, DOI 10.1590/S1516-14392011005000013
   Tahara M, 2011, ACTA MATER, V59, P6208, DOI 10.1016/j.actamat.2011.06.015
   Zhao XL, 2011, MAT SCI ENG C-MATER, V31, P1436, DOI 10.1016/j.msec.2011.05.013
   Zhou YL, 2009, MAT SCI ENG C-BIO S, V29, P1061, DOI 10.1016/j.msec.2008.09.012
NR 40
TC 11
Z9 13
U1 1
U2 19
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JAN
PY 2014
VL 7
IS 1
BP 542
EP 553
DI 10.3390/ma7010542
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA AH4HR
UT WOS:000336088500038
PM 28788473
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Lv, FK
   Liu, BL
   Li, WJ
AF Lv, Fukou
   Liu, Baolin
   Li, Weijie
BE Yang, G
TI Devitrification and Recrystallization of Aqueous Glycerol and PEG-600
   Solutions with Nanoparticles
SO MATERIALS SCIENCE, MACHINERY AND ENERGY ENGINEERING
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Materials Science, Machinery and Energy
   Engineering (MSMEE 2013)
CY DEC 24-25, 2013
CL Hong Kong, PEOPLES R CHINA
DE Nanoparticles; Devitrification; Recrystallization; Morphology; Ice
   fraction
ID DIMETHYL-SULFOXIDE; ICE CRYSTALS; CRYSTALLIZATION; WATER;
   CRYOMICROSCOPY; NUCLEATION; GROWTH; 1,3-BUTANEDIOL; DSC; W/W
AB Nanoparticles in solution offer unique electrical, mechanical and thermal properties due to their physical presence and interaction with the state of dispersion. This work aimed to study the effects of hydroxyapatite (HA) nanoparticles on the behavior of devitrification and recrystallization of glycerol (60% w/w) and PEG-600 (50% w/w) solutions during warming. HA nanoparticles of different sizes (20nm, 40nm, 60nm) and contents (0.1%, 0.5% w/w) were incorporated into solutions, and were observed under a cryomicroscope. Experimental results showed that the morphologies of glycerol and PEG-600 solutions are dendritic and spheric respectively. The ice fraction of glycerol solution containing 0.1% HA with the size of 60nm decreased to 2/5 of that of solution without nanoparticles. The ice fractions of PEG-600 solutions with and without nanoparticles increased significantly between -64 degrees C and -54 degrees C, and the ice fraction of PEG-600 solution without nanoparticles increased by 92% within the temperature range. The findings have significant implications for biomaterial cryopreservation, food manufacturing, and cryosurgery.
C1 [Lv, Fukou; Liu, Baolin; Li, Weijie] Univ Shanghai Sci & Technol, Inst Biothermal & Technol, Shanghai 200093, Peoples R China.
RP Lv, FK (reprint author), Univ Shanghai Sci & Technol, Inst Biothermal & Technol, Shanghai 200093, Peoples R China.
EM fukoulv@163.com
CR BRONSHTEYN VL, 1995, CRYOBIOLOGY, V32, P1, DOI 10.1006/cryo.1995.1001
   Diller K R, 1970, Cryobiology, V7, P191
   Gage AA, 2002, CRYOLETTERS, V23, P69
   Gao D, 2000, ILAR J, V41, P187
   Gonda T, 2005, PROG CRYST GROWTH CH, V51, P70, DOI 10.1016/j.pcrysgrow.2005.10.005
   Hagiwara T, 2006, FOOD BIOPHYS, V1, P74, DOI 10.1007/s11483-006-9009-0
   Han X, 2008, MICROFLUID NANOFLUID, V4, P357, DOI 10.1007/s10404-007-0186-z
   Hey JM, 1997, J NON-CRYST SOLIDS, V211, P262, DOI 10.1016/S0022-3093(96)00637-0
   Hey JM, 1998, CRYOBIOLOGY, V37, P119, DOI 10.1006/cryo.1998.2108
   Hey JM, 1996, CRYOBIOLOGY, V33, P205, DOI 10.1006/cryo.1996.0021
   Kiani H, 2011, TRENDS FOOD SCI TECH, V22, P407, DOI 10.1016/j.tifs.2011.04.011
   Liu B., 2009, CRYOBIOLOGY, V59, P409
   Mazur P, 2011, CRYOBIOLOGY, V62, P1, DOI 10.1016/j.cryobiol.2010.10.159
   MEHL P, 1989, THERMOCHIM ACTA, V155, P187, DOI 10.1016/0040-6031(89)87145-X
   MEHL PM, 1990, CRYOBIOLOGY, V27, P378, DOI 10.1016/0011-2240(90)90016-W
   MEHL PM, 1992, THERMOCHIM ACTA, V203, P475, DOI 10.1016/0040-6031(92)85218-K
   MEHL PM, 1993, THERMOCHIM ACTA, V223, P157, DOI 10.1016/0040-6031(93)80130-3
   Muldrew K, 2001, CRYOBIOLOGY, V42, P182, DOI 10.1006/cryo.2001.2321
   Pegg DE, 2010, CRYOBIOLOGY, V60, pS36, DOI 10.1016/j.cryobiol.2010.02.003
   Petzold G, 2009, FOOD BIOPHYS, V4, P378, DOI 10.1007/s11483-009-9136-5
   Schmidt G, 2003, CURR OPIN COLLOID IN, V8, P103, DOI 10.1016/S1359-0294(03)00008-6
   SCHWARTZ GJ, 1982, CRYOBIOLOGY, V19, P529, DOI 10.1016/0011-2240(82)90182-1
   Seki S., 2012, PLOS ONE, V7
   Syamaladevi RM, 2012, FOOD BIOPHYS, V7, P57, DOI 10.1007/s11483-011-9243-y
   VIGIER G, 1987, J CRYST GROWTH, V84, P309, DOI 10.1016/0022-0248(87)90146-1
   Yu TH, 2005, CRYOBIOLOGY, V50, P174, DOI 10.1016/j.cryobiol.2005.01.001
NR 26
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-955-1
J9 ADV MATER RES-SWITZ
PY 2014
VL 853
BP 105
EP 110
DI 10.4028/www.scientific.net/AMR.853.105
PG 6
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BA4RY
UT WOS:000336188100019
DA 2018-10-20
ER

PT J
AU Sonmezoglu, S
AF Sonmezoglu, S.
TI Synthesis and characterisations of nanostructured TiO2-Te:CdO compound
   thin films
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Inorganic compounds; Thin films; Sol-gel growth; Surface properties;
   Crystal structure
ID FERRITE COMPOSITE NANOPARTICLES; CDTE SOLAR-CELLS; TITANIUM-DIOXIDE;
   PHOTOCATALYTIC ACTIVITY; ANTIMICROBIAL ACTIVITY; BIOMATERIAL SYSTEM;
   OPTICAL-PROPERTIES; TEXTILE FABRICS; CDO FILMS; DEPOSITION
AB TiO2-Te: CdO compound thin films were successfully synthesised and deposited on glass substrates by the sol-gel method. The compound oxide thin films were obtained from the mixture of the precursor solutions of Te doped CdO and TiO2. The microstructure and surface analysis of these compound thin films were investigated by using X-ray powder diffraction (XRD) and field emission scanning electron microscopy (FESEM). The XRD results show that TiO2, Te: CdO, and the compound TiO2-Te: CdO thin films exhibite the tetragonal structure of the anatase phase, monoclinic CdTeO3 structure, and rhombohedral structure, respectively. The values of the crystallite size were obtained from the both Scherrer equation and Williamson-Hall plot. FESEM analysis shows well crystallised nanostructures morphology with a diameter ranging from 25 to 30 nm. Ultraviolet visible (UV-vis) Spectrometry was applied to determine the basic optical parameters such as transparency, optical band gaps and refractive indices of the all thin films. The optical band gaps of the TiO2, Te: CdO and TiO2-Te: CdO compound thin films were obtained to be 3.65, 2.90 and 3.47 eV respectively.
C1 Karamanoglu Mehmetbey Univ, Dept Mat Sci & Engn, Fac Engn, Karaman, Turkey.
RP Sonmezoglu, S (reprint author), Karamanoglu Mehmetbey Univ, Dept Mat Sci & Engn, Fac Engn, Karaman, Turkey.
EM svssonmezoglu@kmu.edu.tr
RI SONMEZOGLU, Savas/K-9362-2016
OI SONMEZOGLU, Savas/0000-0002-6011-3504
FU Scientific Research Commision of Karamanoglu Mehmetbey University
   [23-M-11]
FX This study was partially funded by the Scientific Research Commision of
   Karamanoglu Mehmetbey University under project numbers 23-M-11.
CR Akin S, 2012, MATER TECHNOL, V27, P342, DOI 10.1179/1753555712Y.0000000017
   Chawengkijwanich C, 2008, INT J FOOD MICROBIOL, V123, P288, DOI 10.1016/j.ijfoodmicro.2007.12.017
   CULLITY BD, 1977, ELEMENTS XRAY DIFFRA, P81
   Dakhel AA, 2010, SOL ENERGY, V84, P1433, DOI 10.1016/j.solener.2010.05.003
   Daneshvar N, 2006, J ENVIRON SCI HEAL B, V41, P1273, DOI 10.1080/03601230600962302
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Duran N, 2007, J BIOMED NANOTECHNOL, V3, P203, DOI 10.1166/jbn.2007.022
   Ferekides CS, 2005, THIN SOLID FILMS, V480, P224, DOI 10.1016/j.tsf.2004.11.094
   Flores A. O., 2006, REV MEX FIS, V52, P15
   Fu G, 2005, J PHYS CHEM B, V109, P6416, DOI 10.1021/jp0454974
   GUGLIELMI M, 1992, J NON-CRYST SOLIDS, V147, P641, DOI 10.1016/S0022-3093(05)80691-X
   Guinebretiere R., 2010, XRAY DIFFRACTION POL, P560
   GURUMURUGAN K, 1994, SEMICOND SCI TECH, V9, P1827, DOI 10.1088/0268-1242/9/10/013
   Hou YQ, 2003, APPL SURF SCI, V218, P97, DOI 10.1016/S0169-4332(03)00569-5
   Jouhannaud J, 2008, J SOLID STATE CHEM, V181, P1439, DOI 10.1016/j.jssc.2008.02.040
   Kim H, 2008, THIN SOLID FILMS, V516, P5052, DOI 10.1016/j.tsf.2007.11.079
   King H. P., 1994, XRAY DIFFRACTION PRO, P966
   Lee HJ, 2003, J MATER SCI, V38, P2199, DOI 10.1023/A:1023736416361
   Li YX, 2001, SENSOR ACTUAT B-CHEM, V77, P27, DOI 10.1016/S0925-4005(01)00668-2
   Montenero A, 1997, APPL ORGANOMET CHEM, V11, P137, DOI 10.1002/(SICI)1099-0739(199702)11:2<137::AID-AOC560>3.0.CO;2-V
   Oliva FY, 2002, J PHOTOCH PHOTOBIO A, V146, P175, DOI 10.1016/S1010-6030(01)00614-1
   Poortmans J., 2006, THIN FILM SOLAR CELL, P637
   Radecka M, 2003, SOLID STATE IONICS, V157, P379, DOI 10.1016/S0167-2738(02)00236-9
   Rahim NA, 2010, RENEW ENERG, V35, P712, DOI 10.1016/j.renene.2009.08.021
   Ramirez M., 2011, APPL MICROBIOL BIOT, V5, P11
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Ray S, 2007, J PHYS D APPL PHYS, V40, P2445, DOI 10.1088/0022-3727/40/8/006
   Ryu J, 2008, APPL CATAL B-ENVIRON, V83, P1, DOI 10.1016/j.apcatb.2008.01.020
   Saha B, 2008, SOLID STATE COMMUN, V145, P33, DOI 10.1016/j.ssc.2007.10.001
   Serbetci Z, 2012, J SOL-GEL SCI TECHN, V61, P477, DOI 10.1007/s10971-011-2648-8
   Shukla S, 2005, POLYMER, V46, P12130, DOI 10.1016/j.polymer.2005.10.070
   Sonmezoglu S, 2012, MATER TECHNOL, V27, P251, DOI 10.1179/1753555712Y.0000000008
   Sonmezoglu S, 2012, CURR APPL PHYS, V12, P1372, DOI 10.1016/j.cap.2012.03.030
   Sonmezoglu S, 2012, APPL PHYS A-MATER, V107, P233, DOI 10.1007/s00339-011-6749-6
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Tai WP, 2002, SENSOR ACTUAT B-CHEM, V85, P154, DOI 10.1016/S0925-4005(02)00074-6
   TAUC J, 1970, MATER RES BULL, V5, P721, DOI 10.1016/0025-5408(70)90112-1
   Tavares CJ, 2007, MAT SCI ENG B-SOLID, V138, P139, DOI 10.1016/j.mseb.2005.11.043
   Termeli T. A., 2012, THESIS GAZIOSMANPASA
   TOUSKOVA J, 1995, SOL ENERG MAT SOL C, V37, P357, DOI 10.1016/0927-0248(95)00029-1
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Whang SJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2772665
   WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6
   Yang C, 2008, APPL SURF SCI, V254, P2685, DOI 10.1016/j.apsusc.2007.10.006
   Yao KS, 2008, J NANOSCI NANOTECHNO, V8, P2699, DOI 10.1166/jnn.2008.495
   Yao KS, 2007, SURF COAT TECH, V202, P1329, DOI 10.1016/j.surfcoat.2007.07.102
   Zhang MY, 2012, J MATER CHEM, V22, P10441, DOI [10.1039/c2jm31091k, 10.1039/c2m31091k]
NR 49
TC 6
Z9 6
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD JAN
PY 2014
VL 29
IS 1
BP 3
EP 7
DI 10.1179/175355513X13649076812440
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA AI0GV
UT WOS:000336525100002
DA 2018-10-20
ER

PT J
AU Cai, YB
   Zhang, JJ
   Sun, GY
   Wang, QQ
   Ye, HP
   Qiao, H
   Wei, QF
AF Cai, Y. B.
   Zhang, J. J.
   Sun, G. Y.
   Wang, Q. Q.
   Ye, H. P.
   Qiao, H.
   Wei, Q. F.
TI Fabrication, structural morphology and photocatalytic activity of porous
   TiO2 nanofibres through combination of sol-gel, electrospinning and
   doping-removal techniques
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Electrospinning; Porous nanofibres; Titania; Structural morphology;
   Photocatalytic activity
ID FERRITE COMPOSITE NANOPARTICLES; TITANIUM-DIOXIDE NANOFIBERS;
   BIOMATERIAL SYSTEM; MAGNETIC CORE; THIN-FILMS; ANTIMICROBIAL ACTIVITY;
   CERAMIC NANOFIBERS; OPTICAL-PROPERTIES; OXIDE NANOFIBERS; FIBERS
AB In this study, the TiO2/Al2O3 composite nanofibres were fabricated by electrospinning the composite spin dope containing both titanium(IV) n-butoxide and the precursor of Al2O3 (i.e. aluminium isopropoxide); thereafter, the Al2O3 component would then be removed via chemical etching with NaOH aqueous solution, resulting in the formation of nanoscale pores throughout the (final) TiO2 nanofibres. The morphology, crystalline structure, specific surface area and photocatalytic degradation properties on Reactive Orange KGN and Reactive Brilliant Blue KN-R of the porous TiO2 nanofibres were investigated by field emission SEM, X-ray diffractometry, high resolution transmission electron microscopy, Brunauer-Emmett-Teller (BET) surface area analyser and ultraviolet-visible spectrometer respectively. The results indicated that the fabricated porous TiO2 nanofibres possessed ribbon shaped morphology with homogeneous fibre diameters. The porous TiO2 nanofibres were polycrystalline and processed anatase phased TiO2 with a crystallinity of similar to 91%. The BET specific surface area of porous TiO2 nanofibres was similar to 106.5 m(2) g(-1), which was higher than that of solid TiO2 nanofibres (similar to 15.2 m(2) g(-1)). The porous TiO2 nanofibres could eliminate similar to 64% of the Reactive Orange KGN dye within 160 min and similar to 65% of Reactive Brilliant Blue KN-R dye within 200 min, which is attributed to its high photocatalytic degradation efficiency.
C1 [Cai, Y. B.; Zhang, J. J.; Sun, G. Y.; Wang, Q. Q.; Ye, H. P.; Qiao, H.; Wei, Q. F.] Jiangnan Univ, Key Lab Ecotext, Minist Educ, Wuxi 214122, Jiangsu, Peoples R China.
RP Cai, YB (reprint author), Jiangnan Univ, Key Lab Ecotext, Minist Educ, Wuxi 214122, Jiangsu, Peoples R China.
EM yibingcai@jiangnan.edu.cn; qfwei@jiangnan.edu.cn
OI Qiao, Hui/0000-0002-7222-9627; Wei, Qufu/0000-0003-2143-9939
FU National Natural Science Foundation of China [51006046, 21201083];
   Natural Science Foundation of Jiangsu Province [BK2010140]; National
   High-Tech R&D Program of China [2012AA030 313]; Program for New Century
   Excellent Talents in University; Undergraduate Innovation and Training
   Program of Jiangnan University [1203042]
FX This research was supported by National Natural Science Foundation of
   China (grant nos. 51006046 and 21201083), the Natural Science Foundation
   of Jiangsu Province (grant no. BK2010140), the National High-Tech R&D
   Program of China (grant no. 2012AA030 313), the Program for New Century
   Excellent Talents in University and the Undergraduate Innovation and
   Training Program of Jiangnan University (grant no. 1203042).
CR Akin S, 2012, MATER TECHNOL, V27, P342, DOI 10.1179/1753555712Y.0000000017
   Amna T, 2013, CERAM INT, V39, P3189, DOI 10.1016/j.ceramint.2012.10.003
   Amna T, 2013, FOOD BIOPROCESS TECH, V6, P988, DOI 10.1007/s11947-011-0741-1
   An GH, 2011, MATER LETT, V65, P2377, DOI 10.1016/j.matlet.2011.05.043
   Chandrasekar R, 2009, J MATER SCI, V44, P1198, DOI 10.1007/s10853-008-3201-1
   Cui QZ, 2008, J RARE EARTH, V26, P664, DOI 10.1016/S1002-0721(08)60158-1
   Ding B, 2004, FIBER POLYM, V5, P105, DOI 10.1007/BF02902922
   Ding YH, 2008, MATER LETT, V62, P3410, DOI 10.1016/j.matlet.2008.03.033
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Hamadanian M, 2011, FIBER POLYM, V12, P880, DOI 10.1007/s12221-011-0880-z
   Hassan MS, 2012, COLLOID SURFACE A, V415, P268, DOI 10.1016/j.colsurfa.2012.08.058
   Hwang SH, 2011, CHEM COMMUN, V47, P9164, DOI 10.1039/c1cc12872h
   Kanjwal MA, 2010, INT J APPL CERAM TEC, V7, pE54, DOI 10.1111/j.1744-7402.2009.02397.x
   Kanjwal MA, 2010, MACROMOL RES, V18, P233, DOI 10.1007/s13233-010-0303-9
   Li D, 2006, J AM CERAM SOC, V89, P1861, DOI 10.1111/j.1551-2916.2006.00989.x
   McCann JT, 2005, J MATER CHEM, V15, P735, DOI 10.1039/b415094e
   Mor GK, 2006, NANO LETT, V6, P215, DOI 10.1021/nl052099j
   Panda PK, 2007, J MATER SCI, V42, P2189, DOI 10.1007/s10853-007-1581-2
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Shah J, 2009, MAT SCI ENG A-STRUCT, V523, P199, DOI 10.1016/j.msea.2009.05.059
   Shah JS, 2011, ADV ENG MATER, V13, pB41, DOI 10.1002/adem.201080051
   Sigmund W, 2006, J AM CERAM SOC, V89, P395, DOI 10.1111/j.1551-2916.2005.00807.x
   Sonmezoglu S, 2012, MATER TECHNOL, V27, P251, DOI 10.1179/1753555712Y.0000000008
   Stengl V, 2011, ACS APPL MATER INTER, V3, P4014, DOI 10.1021/am2008757
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Thavasi V, 2008, ENERG ENVIRON SCI, V1, P205, DOI 10.1039/b809074m
   Torkian L, 2013, MATER TECHNOL, V28, P111, DOI 10.1179/1066785712Z.00000000095
   Nguyen TA, 2011, MATER LETT, V65, P2823, DOI 10.1016/j.matlet.2011.05.103
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Viswanathamurthi P, 2004, MATER LETT, V58, P3368, DOI 10.1016/j.matlet.2004.04.035
   Viswanathamurthi P, 2003, CHEM PHYS LETT, V374, P79, DOI 10.1016/S0009-2614(03)00702-4
   Xia X, 2012, EXPRESS POLYM LETT, V6, P169, DOI 10.3144/expresspolymlett.2012.18
   Yang Y, 2009, MATER LETT, V63, P331, DOI 10.1016/j.matlet.2008.10.037
   Yousef A, 2012, CERAM INT, V38, P4525, DOI 10.1016/j.ceramint.2012.02.029
   Yu DM, 2011, ENERG ENVIRON SCI, V4, P858, DOI 10.1039/c0ee00313a
   Zhan SH, 2007, CHEM COMMUN, P2043, DOI 10.1039/b618905a
   Zhan SH, 2006, J PHYS CHEM B, V110, P11199, DOI 10.1021/jp057372k
   Zhang W, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3193661
   Zhang XW, 2009, MATER LETT, V63, P1761, DOI 10.1016/j.matlet.2009.05.038
   Zhang YF, 2007, SCRIPTA MATER, V56, P409, DOI 10.1016/j.scriptamat.2006.10.032
   Zhao YY, 2010, FIBER POLYM, V11, P1119, DOI 10.1007/s12221-010-1119-0
NR 45
TC 4
Z9 4
U1 5
U2 41
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD JAN
PY 2014
VL 29
IS 1
BP 40
EP 46
DI 10.1179/1753555713Y.0000000098
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA AI0GV
UT WOS:000336525100009
DA 2018-10-20
ER

PT J
AU Tovar, N
   Jimbo, R
   Gangolli, R
   Witek, L
   Lorenzoni, F
   Marin, C
   Manne, L
   Perez-Troisi, L
   Baldassarri, M
   Coelho, PG
AF Tovar, Nick
   Jimbo, Ryo
   Gangolli, Riddhi
   Witek, Lukasz
   Lorenzoni, Fabio
   Marin, Charles
   Manne, Lakshmipradha
   Perez-Troisi, Lucia
   Baldassarri, Marta
   Coelho, Paulo G.
TI Modification of Xenogeneic Graft Materials for Improved Release of P-15
   Peptides in a Calvarium Defect Model
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Xenograft; bone regeneration; calvaria; P-15; osteoconductive
ID REPEATED INHALATION EXPOSURE; BONE REGENERATION; CALCIUM-SULFATE; SOCKET
   AUGMENTATION; EXTRACTION SOCKETS; AUTOGENOUS BONE; ALLOGRAFT;
   HYDROXYAPATITE; SUBSTITUTE; PHOSPHATE
AB Particulate bone augmentation is an established clinical alternative to regenerate bone. However, in regions of poor bone quality or previously infected sites, the clinical outcomes are more inconsistent. For that purpose, peptides have been added to particulate materials in an attempt to render them with antibacterial properties or to improve their osseoconductivity. For instance, competence-stimulating peptide (CSP) has been studied to decrease the division rate of Streptococcus mutans. Also, the addition of a specific short amino acid sequence peptide derived from type I collagen (P-15) to the bone substitutes has been introduced in an attempt to increase its osseoconductivity. The present study hypothesized that xenogeneic graft materials with and without CSP would present improved host-to-biomaterial response when used in combination with P-15. Particulate graft materials with and without P-15, OsteoGraf with CSP and OsteoGraf, were implanted in an 8-mm rabbit calvarial defect for 4 weeks, and thereafter, histological and histomorphometrical evaluation was performed. The results showed that both OsteoGraf and CSP groups with the addition of P-15 induced bone growth towards the center of the defect. Furthermore, the addition of CSP to Osteograf showed a tendency to increase its osteoconductivity when combined with P-15. The results of the current study suggested that P-15 had some impact on osteogenesis; however, the effect differed between different bone substitute materials. Further investigation is necessary to clarify its effectiveness when used in combination with bone substitutes.
C1 [Tovar, Nick; Gangolli, Riddhi; Manne, Lakshmipradha; Perez-Troisi, Lucia; Baldassarri, Marta; Coelho, Paulo G.] New York Univ Coll Dent, Dept Biomat & Biomimet, New York, NY 10010 USA.
   [Jimbo, Ryo] Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden.
   [Witek, Lukasz] Oklahoma State Univ, Sch Chem Engn, Stillwater, NY USA.
   [Lorenzoni, Fabio] Univ Sao Paulo Bauru Sch Dent, Dept Prosthodont, Bauru, Brazil.
   [Marin, Charles] UNIGRANRIO, Dept Dent, Duque De Caxias, Brazil.
RP Tovar, N (reprint author), New York Univ Coll Dent, Dept Biomat & Biomimet, New York, NY 10010 USA.
EM nicktovar@gmail.com
FU Dentsply International Inc. (York, PA, USA)
FX This study was funded by Dentsply International Inc. (York, PA, USA).
CR Aichelmann-Reidy ME, 2004, J PERIODONTOL, V75, P340, DOI 10.1902/jop.2004.75.3.340
   Al Ruhaimi KA, 2000, INT J ORAL MAX IMPL, V15, P859
   Anson D, 1998, Compend Contin Educ Dent, V19, ppassim
   Anson D, 1998, COMPEND CONTIN ED DE, V19, P286
   Anson D., 1998, COMPEND CONTIN ED DE, V19, P288
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P445, DOI 10.1111/j.1600-0501.2009.01876.x
   Baumgarten S, 2010, QUINTESSENCE INT, V41, P197
   Butz F, 2011, INT J ORAL MAX IMPL, V26, P1317
   Cho JS, 2014, J BIOMED MATER RES A, V102, P455, DOI 10.1002/jbm.a.34722
   den Boer FC, 2003, J ORTHOPAED RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Gapski R, 2006, INT J PERIODONT REST, V26, P59
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Hanks T, 2004, BIOMATERIALS, V25, P4831, DOI 10.1016/j.biomaterials.2003.12.007
   KRAJEWSKI A, 1981, BIOMATERIALS, V2, P105, DOI 10.1016/0142-9612(81)90007-7
   Kruse A, 2011, CLIN ORAL IMPLAN RES, V22, P506, DOI 10.1111/j.1600-0501.2010.02039.x
   Kubler N, 1995, J CRANIO MAXILL SURG, V23, P337, DOI 10.1016/S1010-5182(05)80128-3
   Kummoona RK, 2011, J CRANIOFAC SURG, V22, P2017, DOI 10.1097/SCS.0b013e318231978a
   LAURELL L, 1992, J PROSTHET DENT, V67, P645, DOI 10.1016/0022-3913(92)90163-5
   LeGeros R Z, 1991, Monogr Oral Sci, V15, P1
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Lemons JE, 1996, BONE, V19, pS121, DOI 10.1016/S8756-3282(96)00128-7
   Lundgren D, 1992, Clin Oral Implants Res, V3, P136, DOI 10.1034/j.1600-0501.1992.030306.x
   LUNDGREN D, 1992, J CRANIO MAXILL SURG, V20, P257, DOI 10.1016/S1010-5182(05)80438-X
   Lundgren D, 1992, Eur J Orthod, V14, P449
   LUNDGREN DL, 1992, RADIAT RES, V132, P325, DOI 10.2307/3578240
   LUNDGREN DL, 1992, RADIAT RES, V132, P312, DOI 10.2307/3578239
   Mazor Z, 2011, J ORAL IMPLANTOL, V37, P287, DOI 10.1563/AAID-JOI-D-10-00006.1
   Minichetti John C, 2004, J Oral Implantol, V30, P74, DOI 10.1563/0.693.1
   Notodihardjo FZ, 2012, J CRANIO MAXILL SURG, V40, P287, DOI 10.1016/j.jcms.2011.04.008
   Orsini M, 2008, J PERIODONTOL, V79, P1630, DOI [10.1902/jop.2008.070282, 10.1902/jop.2008.070282 ]
   Park JW, 2012, J BIOMED MATER RES A, V100A, P834, DOI 10.1002/jbm.a.34017
   Perry JA, 2009, MOL MICROBIOL, V72, P905, DOI 10.1111/j.1365-2958.2009.06693.x
   Qi FX, 2005, FEMS MICROBIOL LETT, V251, P321, DOI 10.1016/j.femsle.2005.08.018
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Sherman BP, 2010, EUR SPINE J, V19, P2156, DOI 10.1007/s00586-010-1546-z
   Skogh ACD, 2013, J CRANIOFAC SURG, V24, P339, DOI 10.1097/SCS.0b013e31827ff2b6
   Tieghi R, 2013, J CRANIOFAC SURG, V24, P505, DOI 10.1097/SCS.0b013e31827c86e2
   Tsao YP, 2006, J PERIODONTOL, V77, P416, DOI 10.1902/jop.2006.050109
   Vastardis Sotirios, 2006, Compend Contin Educ Dent, V27, P38
   Viscioni A, 2010, J Ir Dent Assoc, V56, P186
   Wang HL, 2008, INT J PERIODONT REST, V28, P231
   Wang HL, 2007, IMPLANT DENT, V16, P33, DOI 10.1097/ID.0b013e318031ece6
   Zins JE, 2010, J CRANIOFAC SURG, V21, P1755, DOI 10.1097/SCS.0b013e3181c34675
NR 44
TC 1
Z9 1
U1 2
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JAN
PY 2014
VL 25
IS 1
BP 70
EP 76
DI 10.1097/SCS.0b013e3182a2dfe7
PG 7
WC Surgery
SC Surgery
GA AH2CP
UT WOS:000335928600040
PM 24275773
DA 2018-10-20
ER

PT J
AU Liao, HT
   Chen, YY
   Lai, YT
   Hsieh, MF
   Jiang, CP
AF Liao, Han-Tsung
   Chen, Yo-Yu
   Lai, Yu-Ting
   Hsieh, Ming-Fa
   Jiang, Cho-Pei
TI The Osteogenesis of Bone Marrow Stem Cells on
   mPEG-PCL-mPEG/Hydroxyapatite Composite Scaffold via Solid Freeform
   Fabrication
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID IN-VITRO; OSTEOBLAST DIFFERENTIATION; BIOMATERIAL; DESIGN; GENES; REPAIR
AB The study described a novel bone tissue scaffold fabricated by computer-aided, air pressure-aided deposition system to control the macro-and microstructure precisely. The porcine bone marrow stem cells (PBMSCs) seeded on either mPEG-PCL-mPEG (PCL) or mPEG-PCL-mPEG/hydroxyapatite (PCL/HA) composite scaffold were cultured under osteogenic medium to test the ability of osteogenesis in vitro. The experimental outcomes indicated that both scaffolds possessed adequate pore size, porosity, and hydrophilicity for the attachment and proliferation of PBMSCs and the PBMSCs expressed upregulated genes of osteogensis and angiogenesis in similar manner on both scaffolds. The major differences between these two types of the scaffolds were the addition of HA leading to higher hardness of PCL/HA scaffold, cell proliferation, and VEGF gene expression in PCL/HA scaffold. However, the in vivo bone forming efficacy between PBMSCs seeded PCL and PCL/HA scaffold was different from the in vitro results. The outcome indicated that the PCL/HA scaffold which had bone-mimetic environment due to the addition of HA resulted in better bone regeneration and mechanical strength than those of PCL scaffold. Therefore, providing a bone-mimetic scaffold is another crucial factor for bone tissue engineering in addition to the biocompatibility, 3D architecture with high porosity, and interpored connection.
C1 [Liao, Han-Tsung; Lai, Yu-Ting] Chung Yuan Christian Univ, Chang Gung Mem Hosp, Coll Med, Craniofacial Res Ct,Dept Plast & Reconstruct Surg, Taoyuan 333, Taiwan.
   [Liao, Han-Tsung; Lai, Yu-Ting] Chung Yuan Christian Univ, Dept Chem & Mat Engn, Taoyuan 333, Taiwan.
   [Chen, Yo-Yu] Natl Formosa Univ, Inst Mech & Electromech Engn, Huwei 632, Yunlin County, Taiwan.
   [Hsieh, Ming-Fa] Chung Yuan Christian Univ, Dept Biomed Engn, Chungli 32023, Taiwan.
   [Jiang, Cho-Pei] Natl Formosa Univ, Dept Power Mech Engn, Huwei 632, Yunlin County, Taiwan.
RP Hsieh, MF (reprint author), Chung Yuan Christian Univ, Dept Biomed Engn, 200 Chung Pei Rd, Chungli 32023, Taiwan.
EM mfhsieh@cycu.edu.tw; cpjiang@nfu.edu.tw
RI Hsieh, Ming-Fa/C-3004-2011
OI Hsieh, Ming-Fa/0000-0001-5254-1341
FU National Science Council [NSC 100-2314-B-182A-041, NSC
   101-2632-M-033-001-MY2, NSC 102-2622-E-150-017-CC1]; Chang GungMemorial
   Hospital [CMRPG381331, CMRPG381332, CMRPG381333]
FX This study was supported by the National Science Council (Grant nos. NSC
   100-2314-B-182A-041, NSC 101-2632-M-033-001-MY2, and NSC
   102-2622-E-150-017-CC1) and Chang GungMemorial Hospital (CMRPG381331,
   CMRPG381332, and CMRPG381333).
CR Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Eosoly S, 2010, ACTA BIOMATER, V6, P2511, DOI 10.1016/j.actbio.2009.07.018
   Eshraghi S, 2010, ACTA BIOMATER, V6, P2467, DOI 10.1016/j.actbio.2010.02.002
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972
   He JW, 2010, TISSUE ENG PT A, V16, P127, DOI 10.1089/ten.TEA.2009.0255
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jiang CP, 2013, BIOMED MICRODEVICES, V15, P369, DOI 10.1007/s10544-013-9740-5
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200
   Lee EJ, 2010, ACTA BIOMATER, V6, P3557, DOI 10.1016/j.actbio.2010.03.022
   Lian J. B., 2003, Current Pharmaceutical Design, V9, P2677, DOI 10.2174/1381612033453659
   Liao H. T., 2013, J TISSUE ENG REGENER
   Liao HT, 2011, TISSUE ENG PART C-ME, V17, P1139, DOI 10.1089/ten.tec.2011.0140
   Liao HT, 2011, J TRAUMA, V70, P228, DOI 10.1097/TA.0b013e3181e12b56
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Park SA, 2011, BIOPROC BIOSYST ENG, V34, P505, DOI 10.1007/s00449-010-0499-2
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qi HL, 2003, P NATL ACAD SCI USA, V100, P3305, DOI 10.1073/pnas.0532693100
   Rai B, 2010, BIOMATERIALS, V31, P7960, DOI 10.1016/j.biomaterials.2010.07.001
   Ringe J, 2002, CELL TISSUE RES, V307, P321, DOI 10.1007/s00441-002-0525-z
   Roy TD, 2003, J BIOMED MATER RES A, V66A, P283, DOI 10.1002/jbm.a.10582
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Schreiber JJ, 2011, J BONE JOINT SURG AM, V93A, P1057, DOI 10.2106/JBJS.J.00160
   Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Sun H, 2008, TRANSPL P, V40, P2645, DOI 10.1016/j.transproceed.2008.07.096
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yeong WY, 2010, ACTA BIOMATER, V6, P2028, DOI 10.1016/j.actbio.2009.12.033
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
NR 33
TC 6
Z9 7
U1 1
U2 21
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 321549
DI 10.1155/2014/321549
PG 13
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AH0LO
UT WOS:000335811600001
PM 24868523
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Fedorova, P
   Srnec, R
   Pencik, J
   Schmid, P
   Amler, E
   Urbanova, L
   Necas, A
AF Fedorova, Petra
   Srnec, Robert
   Pencik, Jan
   Schmid, Pavel
   Amler, Evzen
   Urbanova, Lucie
   Necas, Alois
TI Mechanical testing of newly developed biomaterial designed for
   intra-articular reinforcement of partially ruptured cranial cruciate
   ligament: ex vivo pig model
SO ACTA VETERINARIA BRNO
LA English
DT Article
DE Knee stabilization; stifle surgery; polycaprolactone nanofibre;
   polyester; synthetic material; biodegradable screw
ID ORTHOPEDIC SUTURE MATERIAL; EXTRAARTICULAR STABILIZATION; DEFICIENT
   STIFLES; LEADER LINE; DISEASE; RECONSTRUCTION; DOGS
AB The study deals with mechanical testing of newly developed material polyethylene terephtalate coated with polycaprolactone nanofibers in combination with biodagradable Hexalon ACL/PCL screws as a new possibility of intra-articular reinforcement of partially ruptured cranial cruciate ligament. Four groups of ex vivo models of pig stifle joints were prepared and tested: a model with intact CCL (group 1), a model with partial CCL rupture (group 2), a model with CCL rupture stabilized with 7 mm Mersilene strip (group 3), and a model with CCL rupture stabilized with 5 mm PET/PCL biomaterial strip (group 4). The models were loaded in the standing angle of 1000 and the maximum load (N) and the shift (mm) were monitored. The mean maximum peak power and the shift were 1266.0 +/- 146.9 N and 13.7 +/- 2.5 mm for group 1, and 1164.7 +/- 228.2 N and 1 6.8 +/- 3.3 mm for group 2, respectively. In all cases after reaching the maximum load, a tibial fracture occurred but never a CCL rupture. In groups 3 and 4, the initial fixation failure occurred in the mean values of 375.7 +/- 81.5 and 360.4 +/- 52.0 N, respectively, and with a bigger shift of 52.3 +/- 11.9 mm and 39.4 +/- 14.6 mm, respectively, compared to group 1. A critical point of failure was the anchoring in the bone. It can be concluded that the PET/PCL substitute in the ex vivo model has mechanically comparable properties with the clinically used Mersilene (R), and based on its proven ability to carry stem cells it could be appropriate for partially ruptured CCL protection.
C1 [Fedorova, Petra; Urbanova, Lucie] Univ Vet & Pharmaceut Sci Brno, Fac Vet Med, Dept Surg & Orthopaed, Small Anim Clin, Brno 61242, Czech Republic.
   [Srnec, Robert; Necas, Alois] CEITEC Cent European Inst Technol, Brno, Czech Republic.
   [Pencik, Jan; Schmid, Pavel] Brno Univ Technol, Fac Civil Engn, Inst Bldg Testing, CS-61090 Brno, Czech Republic.
   [Amler, Evzen] Charles Univ Prague, Fac Med 2, Inst Biophys, Prague, Czech Republic.
   [Amler, Evzen] Acad Sci Czech Republic, Vvi, Inst Expt Med, Lab Tissue Engn, Prague, Czech Republic.
RP Fedorova, P (reprint author), Univ Vet & Pharmaceut Sci Brno, Fac Vet Med, Dept Surg & Orthopaed, Small Anim Clin, Palackeho Tr 1-3, Brno 61242, Czech Republic.
EM fedorovap@vfu.cz
RI Necas, Alois/E-5058-2012
FU Ministry of Education, Youth and Sport of the Czech Republic
   [39/2012/FVL]; European Regional Development Fund
   [CZ.1.05/1.1.00/02.0068]
FX This study was supported by Ministry of Education, Youth and Sport of
   the Czech Republic (Research project IGA VFU No. 39/2012/FVL) and by the
   project "CEITEC - Central European Institute of Technology"
   (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund.
CR Burgess R, 2010, VET SURG, V39, P208, DOI 10.1111/j.1532-950X.2009.00637.x
   Caporn TM, 1996, VET COMP ORTHOPAED, V9, P126
   Choate CJ, 2012, AM J VET RES, V73, P1519, DOI 10.2460/ajvr.73.10.1519
   Christopher SA, 2013, VET SURG, V42, P329, DOI 10.1111/j.1532-950X.2013.12001.x
   Cook JL, 2010, VET SURG, V39, P270, DOI 10.1111/j.1532-950X.2010.00653.x
   Ehrensberger M, 2013, CLIN BIOMECH, V28, P193, DOI 10.1016/j.clinbiomech.2012.12.007
   Griffon DJ, 2010, VET SURG, V39, P399, DOI 10.1111/j.1532-950X.2010.00654.x
   Hulse D, 2010, VET COMP ORTHOPAED T, V3, P163
   Jarvela T, 2007, KNEE SURG SPORT TR A, V15, P500, DOI 10.1007/s00167-006-0254-z
   Ledecky V, 2012, VET MED-CZECH, V57, P597, DOI 10.17221/6467-VETMED
   MILLER B. J., 1978, P ANN C 1978 MISS ST, P35
   Montavon PM, 2002, P 1 WORLD VET ORTH C
   Necas A, 2000, ACTA VET BRNO, V69, P305, DOI 10.2754/avb200069040305
   Panas E, 2009, 2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P286
   Rose ND, 2012, VET SURG, V41, P266, DOI 10.1111/j.1532-950X.2011.00887.x
NR 15
TC 2
Z9 2
U1 1
U2 18
PU VETERINARNI A FARMACEUTICKA UNIVERZITA BRNO
PI BRNO
PA PALACKEHO 1-3, BRNO CS-612 42, CZECH REPUBLIC
SN 0001-7213
EI 1801-7576
J9 ACTA VET BRNO
JI Acta Vet. BRNO
PY 2014
VL 83
IS 1
BP 55
EP 60
DI 10.2754/avb201483010055
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA AG1VQ
UT WOS:000335204700010
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zoccali, C
   Anelli, V
   Chichierchia, G
   Erba, F
   Biagini, R
AF Zoccali, C.
   Anelli, V.
   Chichierchia, G.
   Erba, F.
   Biagini, R.
TI THE USE OF ENGINEERED BIOMATERIAL BONE PLEXUR M (R) IN BENIGN EPIPHYSEAL
   TUMORS: OUR EXPERIENCE AT 20 MONTHS OF FOLLOW-UP
SO JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
LA English
DT Article
DE subchondral bone reconstruction; curettage; giant cell tumor; Plexur M;
   bone substitute; benign bone tumor
ID SUBCHONDRAL BONE; OSTEOARTHRITIS; KNEE
AB The objective is to reconstruct the subchondral bone after curettage of benign tumors located in the epiphysis, a relevant topic in oncological orthopedics. Several bones substituted are commercially available, yet none of these are suitably moldable to repair or be placed in the bone defect; although autologous bone for little defects and homologous for bigger defects are still considered the standard in reconstruction, we verify the ability to adapt and support articular cartilage through the application of Plexur M (R), a newly engineered biomaterial bone. In the present study, we enrolled the first ten consecutive cases referred to our department, where patients were affected by a benign epiphyseal tumor destroying the subchondral bone through to the articular cartilage. Every patient underwent curettage of the disease, apposition of a newly engineered biomaterial bone and filling with homologous morselized bone. The quality of reconstruction was evaluated by two surgeons and by a radiologist based on the achievement of surgical objectives and comparing pre and postoperative imaging. In seven out of eight cases of lesions located in the lower limbs the quality of reconstruction was considered good, restoring an adequate support to the articular cartilage. The quality of the remaining case was considered poor probably due to the extent of the spread of the disease, which destroyed the entire proximal tibial epiphysis. In the two cases where the disease was located in the upper limbs, the Plexur M (R) application restored support to the articular cartilage sufficiently well. However, in the case of a giant cell tumor of the distal radial epiphysis there was a slight reabsorption of the morselized homologous bone. Our series suggest that Plexur M (R) should be considered a valid option for orthopedic surgeons in restoring adequate mechanical support to the articular cartilage; nevertheless, considering its high cost, its use might be reserved to selected cases until further studies can verify the integration process, the effects on the survival of the articular cartilage and on the prevention of premature osteo arthritis.
C1 [Zoccali, C.; Anelli, V.; Chichierchia, G.; Erba, F.; Biagini, R.] Regina Elena Inst Canc Res, Rome, Italy.
RP Zoccali, C (reprint author), IFO Regina Elena Natl Canc Inst, Via Elio Chianesi 53, I-00144 Rome, Italy.
EM carminezoccali@libero.it
RI Zoccali, Carmine/K-6030-2016
OI Zoccali, Carmine/0000-0001-8847-6772; Biagini,
   Roberto/0000-0002-6819-2841
CR Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Buecker PJ, 2007, CLIN ORTHOP RELAT R, P170, DOI 10.1097/BLO.0b013e31804e8470
   Dinopoulos H, 2012, SURG-J R COLL SURG E, V10, P230, DOI 10.1016/j.surge.2012.04.001
   Errani C, 2010, CANCER TREAT REV, V36, P1, DOI 10.1016/j.ctrv.2009.09.002
   Fraquet N, 2009, ORTHOP TRAUMATOL-SUR, V95, P402, DOI 10.1016/j.otsr.2009.07.004
   Hayami T, 2004, ARTHRITIS RHEUM, V50, P1193, DOI 10.1002/art.20124
   Johansson B, 2001, DENTOMAXILLOFAC RAD, V30, P157, DOI 10.1038/sj.dmfr.4600601
   Kuzyk PRT, 2010, J ORTHOP RES, V28, P474, DOI 10.1002/jor.21005
   Pastoureau PC, 1999, OSTEOARTHR CARTILAGE, V7, P466, DOI 10.1053/joca.1999.0241
   St John Thomas A, 2003, Am J Orthop (Belle Mead NJ), V32, P18
   Xu HR, 2013, CHINESE MED J-PEKING, V126, P3053
   Yamada K, 2002, OSTEOARTHR CARTILAGE, V10, P360, DOI 10.1053/joca.2002.0525
NR 12
TC 0
Z9 0
U1 0
U2 0
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0393-974X
EI 1724-6083
J9 J BIOL REG HOMEOS AG
JI J. Biol. Regul. Homeost. Agents
PD JAN-MAR
PY 2014
VL 28
IS 1
BP 65
EP 71
PG 7
WC Endocrinology & Metabolism; Immunology; Medicine, Research &
   Experimental; Physiology
SC Endocrinology & Metabolism; Immunology; Research & Experimental
   Medicine; Physiology
GA AG0RN
UT WOS:000335123400007
PM 24750792
DA 2018-10-20
ER

PT J
AU Nie, RM
   Li, AY
   Deng, XY
AF Nie, Riming
   Li, Aiyuan
   Deng, Xianyu
TI Environmentally friendly biomaterials as an interfacial layer for highly
   efficient and air-stable inverted organic solar cells
SO JOURNAL OF MATERIALS CHEMISTRY A
LA English
DT Article
ID LIGHT-EMITTING-DIODES; WORK-FUNCTION; PHOTOVOLTAIC CELLS; POLYMER;
   ELECTRODE; CATHODE; INTERLAYERS; VOLTAGE
AB Appropriate interfacial modification plays an important role in the high performance of organic solar cells. We report that a transparent cathode of indium tin oxide (ITO) modified with an ultrathin layer of peptide, an environmentally friendly biomaterial, shows an obvious reduction in the work function. Investigation of the device exhibits that the power conversion efficiency (PCE) was significantly increased from 2.12% to 8.13% with the use of the peptide modification. The inverted device with the peptide-modified ITO as the cathode showed significantly longer time efficiency delay in air than conventional forward devices with an active metal as the cathode. Because peptides are biological materials that exist naturally in living things, the results provide an environmentally safe method to fabricate highly efficient and air-stable organic solar cells.
C1 [Nie, Riming; Li, Aiyuan; Deng, Xianyu] Harbin Inst Technol, Shenzhen Engn Lab Flexible Transparent Conduct Fi, Res Ctr Adv Funct Mat & Devices,Shenzhen Grad Sch, Shenzhen Key Lab Adv Mat,Sch Mat Sci & Engn, Shenzhen 518055, Peoples R China.
RP Deng, XY (reprint author), Harbin Inst Technol, Shenzhen Engn Lab Flexible Transparent Conduct Fi, Res Ctr Adv Funct Mat & Devices,Shenzhen Grad Sch, Shenzhen Key Lab Adv Mat,Sch Mat Sci & Engn, Shenzhen 518055, Peoples R China.
EM xydeng@hitsz.edu.cn
RI li, aiyuan/R-9498-2016
OI li, aiyuan/0000-0002-4641-8416; Deng, Xianyu/0000-0003-0653-6765
FU Natural Scientific Research Innovation Foundation at the Harbin
   Institute of Technology (HIT.NSRIF) [2009142]; Shenzhen Research
   Foundation Project [JC201005260119A, C201105160573A, JC201104220174A];
   NSFC [60706017]
FX We are grateful to Mr S.Z. Zheng, Prof. K.Y. Wong ( the Chinese
   University of Hong Kong) and Mr Nick K.C. Ho ( the Hong Kong University
   of Science and Technology) for the XPS and UPS measurements. We
   acknowledge financial support from the Natural Scientific Research
   Innovation Foundation at the Harbin Institute of Technology (HIT.NSRIF,
   2009142), the Shenzhen Research Foundation Project (JC201005260119A,
   C201105160573A, JC201104220174A) and NSFC (no. 60706017).
CR Aravinda S, 2004, ANGEW CHEM INT EDIT, V43, P6728, DOI 10.1002/anie.200461127
   Bai S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4719201
   Carl H. G., 1989, ACTA CRYSTALLOGR B, V45, P390
   Chen H.-Y., 2009, NAT PHOTONICS, V3, P650
   Chen S, 2012, ADV ENERGY MATER, V2, P1333, DOI 10.1002/aenm.201200184
   Cheng P, 2014, ENERG ENVIRON SCI, V7, P1351, DOI 10.1039/c3ee43041c
   Cui J, 2002, ADV MATER, V14, P565, DOI 10.1002/1521-4095(20020418)14:8<565::AID-ADMA565>3.0.CO;2-3
   Deng XY, 2004, APPL PHYS LETT, V84, P3522, DOI 10.1063/1.1739510
   Gao D, 2010, ADV MATER, V22, P5404, DOI 10.1002/adma.201002738
   Gnes S., 2007, CHEM REV, V107, P1324
   Guo TF, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1984101
   Hau SK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2945281
   He Z. C., 2012, NAT PHOTONICS, V6, P951
   Hsiao CC, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1942644
   Jeng JY, 2011, ADV ENERGY MATER, V1, P1192, DOI 10.1002/aenm.201100314
   Jiang L, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4773570
   Kang H, 2012, ADV MATER, V24, P3005, DOI 10.1002/adma.201200594
   Lacher S, 2011, J AM CHEM SOC, V133, P16997, DOI 10.1021/ja2067675
   Lee JH, 2012, PHYS STATUS SOLIDI A, V209, P1399, DOI 10.1002/pssa.201228199
   Li G, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2212270
   Lira-Cantu M, 2011, SOL ENERG MAT SOL C, V95, P1362, DOI 10.1016/j.solmat.2010.12.028
   Mihailetchi VD, 2003, J APPL PHYS, V94, P6849, DOI 10.1063/1.1620683
   Nuesch F, 1999, APPL PHYS LETT, V74, P880, DOI 10.1063/1.123397
   Osikowicz W, 2004, APPL PHYS LETT, V85, P1616, DOI 10.1063/1.1785873
   PARKER ID, 1994, J APPL PHYS, V75, P1656, DOI 10.1063/1.356350
   Ratcliff EL, 2011, J PHYS CHEM LETT, V2, P1337, DOI 10.1021/jz2002259
   Shim JW, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4745772
   Song M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802086
   Sun K, 2012, ACS APPL MATER INTER, V4, P2009, DOI 10.1021/am201844q
   Sun YM, 2011, ADV MATER, V23, P1679, DOI 10.1002/adma.201004301
   Thompson BC, 2008, ANGEW CHEM INT EDIT, V47, P58, DOI 10.1002/anie.200702506
   Tseng WH, 2011, SOL ENERG MAT SOL C, V95, P3424, DOI 10.1016/j.solmat.2011.07.036
   White S, 2006, APPL PHYS LETT, V89
   Xu Z, 2009, ADV FUNCT MATER, V19, P1227, DOI 10.1002/adfm.200801286
   YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789
   Zhou YH, 2012, SCIENCE, V336, P327, DOI 10.1126/science.1218829
   Zhou YH, 2009, SOL ENERG MAT SOL C, V93, P497, DOI 10.1016/j.solmat.2008.11.002
   Zilberberg K, 2013, ORG ELECTRON, V14, P951, DOI 10.1016/j.orgel.2013.01.018
NR 38
TC 14
Z9 14
U1 2
U2 44
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-7488
EI 2050-7496
J9 J MATER CHEM A
JI J. Mater. Chem. A
PY 2014
VL 2
IS 19
BP 6734
EP 6739
DI 10.1039/c4ta00152d
PG 6
WC Chemistry, Physical; Energy & Fuels; Materials Science,
   Multidisciplinary
SC Chemistry; Energy & Fuels; Materials Science
GA AF6PA
UT WOS:000334835800008
DA 2018-10-20
ER

PT J
AU Matesanz, MC
   Linares, J
   Lilue, I
   Sanchez-Salcedo, S
   Feito, MJ
   Arcos, D
   Vallet-Regi, M
   Portoles, MT
AF Concepcion Matesanz, Maria
   Linares, Javier
   Lilue, Isabel
   Sanchez-Salcedo, Sandra
   Jose Feito, Maria
   Arcos, Daniel
   Vallet-Regi, Maria
   Teresa Portoles, Maria
TI Nanocrystalline silicon substituted hydroxyapatite effects on osteoclast
   differentiation and resorptive activity
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; BONE-RESORPTION; IN-VITRO; MOLECULAR-MECHANISMS;
   OSTEOPOROSIS; MACROPHAGES; VIVO; BIOMATERIALS; BIOCERAMICS; INHIBITORS
AB In the present study, the effects of nanocrystalline hydroxyapatite (nano-HA) and nanocrystalline Si-substituted hydroxyapatite (nano-SiHA) on osteoclast differentiation and resorptive activity have been evaluated in vitro using osteoclast-like cells. The action of these materials on proinflammatory and reparative macrophage populations was also studied. Nano-SiHA disks delayed the osteoclast differentiation and decreased the resorptive activity of these cells on their surface, as compared to nano-HA samples, without affecting cell viability. Powdered nano-SiHA also induced an increase of the reparative macrophage population. These results along with the beneficial effects on osteoblasts previously observed with powdered nano-SiHA suggest the potential of this biomaterial for modulating the fundamental processes of bone formation and turnover, preventing bone resorption and enhancing bone formation at implantation sites in treatment of osteoporotic bone and in bone repair and regeneration.
C1 [Concepcion Matesanz, Maria; Linares, Javier; Lilue, Isabel; Jose Feito, Maria; Teresa Portoles, Maria] UCM, Fac Chem, Dept Biochem & Mol Biol 1, Madrid 28040, Spain.
   [Sanchez-Salcedo, Sandra; Arcos, Daniel; Vallet-Regi, Maria] UCM, Fac Chem, Inst Invest Sanitaria Hosp 12 Octubre I 12, Dept Inorgan & Bioinorgan Chem, Madrid 28040, Spain.
   [Linares, Javier; Sanchez-Salcedo, Sandra; Arcos, Daniel; Vallet-Regi, Maria] CIBER BBN, Networking Res Ctr Bioengn Biomat & Nanomed, Madrid, Spain.
RP Portoles, MT (reprint author), UCM, Fac Chem, Dept Biochem & Mol Biol 1, Madrid 28040, Spain.
EM portoles@quim.ucm.es
RI Vallet-Regi, Maria/M-3378-2014; Portoles, Maria Teresa/U-1678-2017;
   Arcos, Daniel/L-6167-2014; SANCHEZ-SALCEDO, SANDRA/N-4501-2014
OI Vallet-Regi, Maria/0000-0002-6104-4889; Portoles, Maria
   Teresa/0000-0002-9681-0184; Arcos, Daniel/0000-0002-5367-7272;
   SANCHEZ-SALCEDO, SANDRA/0000-0002-1889-2057
FU Comunidad de Madrid [S2009/MAT-1472]; Ministerio de Ciencia e Innovacion
   (MICINN) [MAT2012-35556, CSO2010-11384-E]
FX This study was supported by research grants from Comunidad de Madrid
   through the project S2009/MAT-1472 and the Ministerio de Ciencia e
   Innovacion (MICINN) through the projects MAT2012-35556 and
   CSO2010-11384-E (Agening Network of Excellence). M. C. Matesanz and J.
   Linares are greatly indebted to MICINN and CIBER-BBN respectively for
   predoctoral fellowships. The authors wish to also thank the staff of the
   Cytometry and Fluorescence Microscopy Centre of the Universidad
   Complutense de Madrid (Spain) and ICTS National Centre for Electron
   Microscopy (Spain).
CR Albrecht C., 2009, TOXICOL IN VITRO, V23
   Arcos D, 2014, ACTA BIOMATER, V10, P1793, DOI 10.1016/j.actbio.2014.01.004
   Arcos D, 2004, CHEM MATER, V16, P2300, DOI 10.1021/cm035337
   Atkins GJ, 2000, BONE, V26, P653, DOI 10.1016/S8756-3282(00)00280-5
   AUBIN JE, 1992, J BONE MINER RES, V7, P365
   Balamurugan A, 2008, DENT MATER, V24, P1374, DOI 10.1016/j.dental.2008.02.017
   Beck GR, 2012, NANOMED-NANOTECHNOL, V8, P793, DOI 10.1016/j.nano.2011.11.003
   BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207
   Blair HC, 2004, HISTOL HISTOPATHOL, V19, P189, DOI 10.14670/HH-19.189
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Botelho CM, 2006, J BIOMED MATER RES A, V79A, P723, DOI 10.1002/jbm.a.30806
   Botelho CM, 2006, J BIOMED MATER RES A, V78A, P709, DOI 10.1002/jbm.a.30726
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   CARLISLE EM, 1981, CALCIFIED TISSUE INT, V33, P27, DOI 10.1007/BF02409409
   Matesanz MC, 2014, J COLLOID INTERF SCI, V416, P59, DOI 10.1016/j.jcis.2013.10.045
   Matesanz MD, 2012, MACROMOL BIOSCI, V12, P446, DOI 10.1002/mabi.201100456
   Detsch R, 2010, ACTA BIOMATER, V6, P3223, DOI 10.1016/j.actbio.2010.03.003
   Dorozhkin SV, 2009, MATERIALS, V2, P1975, DOI 10.3390/ma2041975
   Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014
   Fini M, 2004, BIOMED PHARMACOTHER, V58, P487, DOI 10.1016/j.biopha.2004.08.016
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   He X, 2010, BIOCHEM BIOPH RES CO, V401, P356, DOI 10.1016/j.bbrc.2010.09.053
   Honda M, 2012, J MATER SCI-MATER M, V23, P2923, DOI 10.1007/s10856-012-4744-x
   Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200
   Hwang SY, 2011, BBA-MOL CELL RES, V1813, P979, DOI 10.1016/j.bbamcr.2010.11.002
   Jacome-Galarza CE, 2013, J BONE MINER RES, V28, P1203, DOI 10.1002/jbmr.1822
   Feito MJ, 2011, J MATER SCI-MATER M, V22, P405, DOI 10.1007/s10856-010-4193-3
   Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557
   Kitaura H, 2003, IMMUNOL LETT, V88, P193, DOI 10.1016/S0165-2478(03)00082-8
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Lehmann G, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/055001
   Luhmann T, 2012, J CONTROL RELEASE, V161, P198, DOI 10.1016/j.jconrel.2011.10.001
   Manolagas SC, 1998, AGING-CLIN EXP RES, V10, P182, DOI 10.1007/BF03339652
   da Silva HM, 2010, COLLOID SURFACE B, V80, P138, DOI 10.1016/j.colsurfb.2010.05.040
   Mladenovic Z, 2014, ACTA BIOMATER, V10, P406, DOI 10.1016/j.actbio.2013.08.039
   Moon SJ, 2013, CLIN EXP RHEUMATOL, V31, P31
   Nair SP, 1996, INFECT IMMUN, V64, P2371
   Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   Qin A, 2012, INT J BIOCHEM CELL B, V44, P1422, DOI 10.1016/j.biocel.2012.05.014
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Rozen N, 2000, BONE, V26, P469, DOI 10.1016/S8756-3282(00)00263-5
   Spence G, 2009, J BIOMED MATER RES A, V90A, P217, DOI 10.1002/jbm.a.32083
   Srinivasan S, 2010, ANN NY ACAD SCI, V1192, P245, DOI 10.1111/j.1749-6632.2009.05377.x
   Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345
   Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504
   Teitelbaum SL, 1997, J LEUKOCYTE BIOL, V61, P381
   Thian ES, 2010, ACTA BIOMATER, V6, P750, DOI 10.1016/j.actbio.2009.08.012
   Thian ES, 2006, BIOMATERIALS, V27, P2692, DOI 10.1016/j.biomaterials.2005.12.019
   Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019
   Vaananen HK, 2008, ARCH BIOCHEM BIOPHYS, V473, P132, DOI 10.1016/j.abb.2008.03.037
   Vaananen HK, 1998, MAT SCI ENG C-BIO S, V6, P205, DOI 10.1016/S0928-4931(98)00052-6
   Vallet-Regi M, 2005, J MATER CHEM, V15, P1509, DOI 10.1039/b414143a
   Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232
   Wiens M, 2010, BIOMATERIALS, V31, P7716, DOI 10.1016/j.biomaterials.2010.07.002
   Zou S, 2009, J BIOMED MATER RES B, V90B, P123, DOI 10.1002/jbm.b.31262
NR 60
TC 13
Z9 13
U1 5
U2 44
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 19
BP 2910
EP 2919
DI 10.1039/c3tb21697g
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AG2DC
UT WOS:000335225100012
DA 2018-10-20
ER

PT S
AU Pinheiro, ALB
   Soares, LGP
   Marques, AMC
   Aciole, JMS
   dos Santos, JN
   Silveira, L
AF Pinheiro, Antonio Luiz B.
   Soares, Luiz Guilherme P.
   Marques, Aparecida Maria C.
   Aciole, Jouber Mateus S.
   dos Santos, Jean Nunes
   Silveira, Landulfo, Jr.
BE Hamblin, MR
   Carroll, JD
   Arany, P
TI Raman and Histological Study of the Repair of Surgical Bone Defects
   Grafted with Biphasic Synthetic Micro-Granular HA plus beta - Calcium
   Triphosphate and Irradiated or not with lambda 780 nm Laser
SO MECHANISMS FOR LOW-LIGHT THERAPY IX
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Mechanisms for Low-Light Therapy IX
CY FEB 01-02, 2014
CL San Francisco, CA
SP SPIE
DE Biomaterial; Bone Repair; Hydroxyapatite; Laser Phototherapy
ID MINERAL TRIOXIDE AGGREGATE; MORPHOGENETIC PROTEINS; RODENT MODEL;
   IN-VIVO; REGENERATION; PHOTOBIOMODULATION; PHOTOTHERAPY; SPECTROSCOPY;
   THERAPY; LIGHT
AB The treatment of bone loss due to different etiologic factors is difficult and many techniques aim to improve repair, including a wide range of biomaterials and, recently, phototherapies. This work assessed, by Raman spectroscopy and histology, the mineralization of bone defects. Forty rats divided into 4 groups each subdivided into 2 subgroups according to the time of sacrifice were used. Bone defects were made on the femur of each animal with a trephine drill. On animals of group Clot the defect was filled only by blood clot, on group Laser the defect filled with the clot was further irradiated. On animals of groups Biomaterial and Laser + Biomaterial the defect was filled by biomaterial and the last one was further irradiated (lambda 780 nm, 70 mW, Phi similar to 0.4 cm(2), 20 J/cm(2)-session, 140 J/cm(2)-treatment). At both 15th and 30th days following sacrifice, samples were taken and analyzed by Raman spectroscopy and light microscopy. Raman peaks of inorganic and organic contents and a more advanced stage of repair were seen on group Laser + Biomaterial. It is concluded that the use of Laser phototherapy associated to biomaterial was effective to improve the repair of bone defects.
C1 [Pinheiro, Antonio Luiz B.; Soares, Luiz Guilherme P.; Marques, Aparecida Maria C.; Aciole, Jouber Mateus S.; dos Santos, Jean Nunes; Silveira, Landulfo, Jr.] Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br
RI Pinheiro, Antonio Luiz/A-1962-2008
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321
CR Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Gerbi MMEM, 2008, LASER MED SCI, V23, P313
   Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2013, LASER MED SCI, V28, P513, DOI 10.1007/s10103-012-1096-1
   Pinheiro ALB, 2012, LASER MED SCI, V27, P1013, DOI 10.1007/s10103-011-1033-8
   Pinheiro ALB, 2012, LASER MED SCI, V27, P903, DOI 10.1007/s10103-011-1010-2
   Pinheiro ALB, 2011, J BIOMED MATER RES A, V98A, P212, DOI 10.1002/jbm.a.33107
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Soares LGP, 2014, LASER MED SCI, V29, P1539, DOI 10.1007/s10103-013-1297-2
   Soares Luiz Guilherme P., 2013, Braz. Dent. J., V24, P218, DOI 10.1590/0103-6440201302186
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Yang C, 2014, J BIOMED MATER RES B, V102, P80, DOI 10.1002/jbm.b.32984
NR 20
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9845-8
J9 PROC SPIE
PY 2014
VL 8932
AR 89320L
DI 10.1117/12.2036867
PG 8
WC Biophysics; Optics; Radiology, Nuclear Medicine & Medical Imaging
SC Biophysics; Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BA3KX
UT WOS:000334338800015
DA 2018-10-20
ER

PT S
AU Soares, LGP
   Marques, AMC
   Aciole, JMS
   Trindade, R
   Santos, JN
   Pinheiro, ALB
AF Soares, Luiz G. P.
   Marques, Aparecida M. C.
   Aciole, Jouber M. S.
   Trindade, Renan
   Santos, Jean N.
   Pinheiro, Antonio L. B.
BE Hamblin, MR
   Carroll, JD
   Arany, P
TI Assessment Laser Phototherapy on bone defects grafted or not with
   Biphasic Synthetic Micro-Granular HA plus beta- Tricalcium Phosphate:
   Histological study in an animal model.
SO MECHANISMS FOR LOW-LIGHT THERAPY IX
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Mechanisms for Low-Light Therapy IX
CY FEB 01-02, 2014
CL San Francisco, CA
SP SPIE
DE Biomaterial; Bone Repair; Hydroxyapatite; Laser Phototherapy
ID MINERAL TRIOXIDE AGGREGATE; MORPHOGENETIC PROTEINS; RODENT MODEL;
   IN-VIVO; REGENERATION; PHOTOBIOMODULATION; THERAPY; LIGHT
AB Beside of biomaterials, Laser phototherapy has shown positive results as auxiliary therapy on bone repair. The aim of this study was to evaluate, through histological analysis, the influence of Laser phototherapy in the process of repair of bone defects grafted or not with Hydroxyapatite. Forty rats were divided into 4 groups each subdivided into 2 subgroups according to the time of sacrifice. Surgical bone defects were made on femur of each animal with a trephine drill. On animals of group Clot the defect was filled only by blood, on group Laser the defect filled with the clot and further irradiated. In group Biomaterial the defect was filled with HA + beta=TCP graft. In group Laser + Biomaterial, the defect was filled with biomaterial and further irradiated. The irradiation protocols were performed every 48 hours during for 15 days. Animal death occurred after 15 and 30 days. The specimens were routinely processed and evaluated by light microscopy. Qualitative analysis showed that group Laser + Biomaterial was in a more advanced stage of repair at the end of the experimental time. It was concluded that the Laser irradiation improved the repair of bone defects grafted or not.
C1 [Soares, Luiz G. P.; Marques, Aparecida M. C.; Aciole, Jouber M. S.; Trindade, Renan; Santos, Jean N.; Pinheiro, Antonio L. B.] Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
RP Soares, LGP (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br
RI Pinheiro, Antonio Luiz/A-1962-2008
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321
CR Carvalho F. B., 2011, P SOC PHOTO-OPT INS, V7887, P1
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Kalfas IH, 2001, NEUROSURG FOCUS, V10, P7
   Karu TI, 2004, PHOTOCHEM PHOTOBIOL, V80, P366, DOI 10.1562/2004-03-25-RA-123.1
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Pinheiro AL, 2010, PHOTOMED LASER SURG, V28, P89
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2013, LASER MED SCI, V28, P513, DOI 10.1007/s10103-012-1096-1
   Pinheiro ALB, 2011, J BIOMED MATER RES A, V98A, P212, DOI 10.1002/jbm.a.33107
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   PROLO DJ, 1990, CLIN NEUR, V36, P135
   Soares LGP, 2014, LASER MED SCI, V29, P1539, DOI 10.1007/s10103-013-1297-2
   Soares Luiz Guilherme P., 2013, Braz. Dent. J., V24, P218, DOI 10.1590/0103-6440201302186
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
NR 16
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9845-8
J9 PROC SPIE
PY 2014
VL 8932
AR 893211
DI 10.1117/12.2036872
PG 6
WC Biophysics; Optics; Radiology, Nuclear Medicine & Medical Imaging
SC Biophysics; Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BA3KX
UT WOS:000334338800021
DA 2018-10-20
ER

PT J
AU Guo, TL
   Kang, WY
   Xiao, DQ
   Duan, RQ
   Zhi, W
   Weng, J
AF Guo, Tailin
   Kang, Wenyuan
   Xiao, Dongqin
   Duan, Rongquan
   Zhi, Wei
   Weng, Jie
TI Molecular Docking Characterization of a Four-Domain Segment of Human
   Fibronectin Encompassing the RGD Loop with Hydroxyapatite
SO MOLECULES
LA English
DT Article
DE fibronectin; hydroxyapatite; molecular docking; RGD loop
ID BINDING SITE PREDICTION; PROTEIN ADSORPTION; INTEGRINS; IDENTIFICATION;
   SIMULATION; CRYSTALS; ADHESION
AB Fibronectin adsorption on biomaterial surfaces plays a key role in the biocompatibility of biomedical implants. In the current study, the adsorption behavior of the 7-10th type III modules of fibronectin (FN-III7-10) in the presence of hydroxyapatite (HAP) was systematically investigated by using molecular docking approach. It was revealed that the FN-III10 is the most important module among FN-III7-10 in promoting fibronectin binding to HAP by optimizing the interaction energy; the arginine residues were observed to directly interact with the hydroxyl group of HAP through electrostatic forces and hydrogen bonding. Moreover, it was found that the HAP-binding sites on FN-III10 are mainly located at the RGD loop region, which does not affect the interaction between the fibronectin protein and its cognate receptors on the cell surface.
C1 [Guo, Tailin; Kang, Wenyuan] Southwest Jiaotong Univ, Sch Life Sci & Engn, Chengdu 610031, Peoples R China.
   [Guo, Tailin; Xiao, Dongqin; Duan, Rongquan; Zhi, Wei; Weng, Jie] Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Minister Educ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
RP Weng, J (reprint author), Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Minister Educ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
EM jweng@swjtu.edu.cn
RI Weng, Jie/B-3005-2010
FU National Basic Research Program of China [2012CB933602]; National
   Natural Science Foundation of China [51172188]; Science and Technology
   Pillar Project of Sichuan [2010FZ0048]; Fundamental Research Funds for
   the Central Universities [2682013CX034, SWJTU11ZT25]; SRTP of SWJTU
   [201310613048]
FX This work was supported by the National Basic Research Program of China
   (No. 2012CB933602), the National Natural Science Foundation of China
   (No. 51172188), the Science and Technology Pillar Project of Sichuan
   (No. 2010FZ0048), the Fundamental Research Funds for the Central
   Universities (Nos. 2682013CX034 and SWJTU11ZT25), and the SRTP of SWJTU
   (No. 201310613048).
CR Amaral IF, 2005, J BIOMED MATER RES A, V75A, P387, DOI 10.1002/jbm.a.30436
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   BLOCK M S, 1989, International Journal of Oral and Maxillofacial Implants, V4, P219
   BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856
   BRUMFELD V, 1993, ARCH BIOCHEM BIOPHYS, V302, P134, DOI 10.1006/abbi.1993.1191
   Cairns ML, 2010, COLLOID SURFACE B, V78, P283, DOI 10.1016/j.colsurfb.2010.03.013
   Docheva D, 2010, BIOCHEM BIOPH RES CO, V402, P361, DOI 10.1016/j.bbrc.2010.10.034
   Dolatshahi-Pirouz A, 2009, LANGMUIR, V25, P2971, DOI 10.1021/la803142u
   Feki H.E., 1999, J ALLOY COMPD, V287, P114
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   GEORGE EL, 1993, DEVELOPMENT, V119, P1079
   Gibson JM, 2006, J AM CHEM SOC, V128, P5364, DOI 10.1021/ja056731m
   Hindie M, 2011, ACTA BIOMATER, V7, P387, DOI 10.1016/j.actbio.2010.08.001
   Holmberg K, 2003, NOVEL SURFACTANTS PR
   Huang BD, 2009, OMICS, V13, P325, DOI 10.1089/omi.2009.0045
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jiang XH, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-18
   Kandori K, 2007, LANGMUIR, V23, P2064, DOI 10.1021/la062562n
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Lu J., 2008, BIOCONJUGATE CHEM, V20, P87
   Menendez-Proupin E, 2011, J MECH BEHAV BIOMED, V4, P1011, DOI 10.1016/j.jmbbm.2011.03.001
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213
   Riener CK, 2003, ANAL CHIM ACTA, V497, P101, DOI 10.1016/j.aca.2003.08.041
   Romberger DJ, 1997, INT J BIOCHEM CELL B, V29, P939, DOI 10.1016/S1357-2725(96)00172-0
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   Sousa SF, 2006, PROTEINS, V65, P15, DOI 10.1002/prot.21082
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   VIGNOLES M, 1988, CALCIFIED TISSUE INT, V43, P33, DOI 10.1007/BF02555165
   VIGNOLES M, 1987, CALCIFIED TISSUE INT, V40, P64, DOI 10.1007/BF02555707
   Vitorino R, 2004, BIOCHEM BIOPH RES CO, V320, P342, DOI 10.1016/j.bbrc.2004.05.169
   Wallwork ML, 2001, LANGMUIR, V17, P2508, DOI 10.1021/la001281r
   Zhang ZM, 2011, BIOINFORMATICS, V27, P2083, DOI 10.1093/bioinformatics/btr331
NR 34
TC 3
Z9 3
U1 1
U2 13
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD JAN
PY 2014
VL 19
IS 1
BP 149
EP 158
DI 10.3390/molecules19010149
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA AF0QY
UT WOS:000334420300010
PM 24366091
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Duda, S
   Dreyer, L
   Behrens, P
   Wienecke, S
   Chakradeo, T
   Glasmacher, B
   Haastert-Talini, K
AF Duda, Sven
   Dreyer, Lutz
   Behrens, Peter
   Wienecke, Soenke
   Chakradeo, Tanmay
   Glasmacher, Birgit
   Haastert-Talini, Kirsten
TI Outer Electrospun Polycaprolactone Shell Induces Massive Foreign Body
   Reaction and Impairs Axonal Regeneration through 3D Multichannel
   Chitosan Nerve Guides
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID RAT SCIATIC-NERVE; POLY-EPSILON-CAPROLACTONE; LONG-TERM EVALUATION;
   IN-VIVO EVALUATION; FUNCTIONAL RECOVERY; PERIPHERAL-NERVES;
   SCHWANN-CELLS; CONDUITS; FIBERS; REPAIR
AB We report on the performance of composite nerve grafts with an inner 3D multichannel porous chitosan core and an outer electrospun polycaprolactone shell. The inner chitosan core provided multiple guidance channels for regrowing axons. To analyze the in vivo properties of the bare chitosan cores, we separately implanted them into an epineural sheath. The effects of both graft types on structural and functional regeneration across a 10 mm rat sciatic nerve gap were compared to autologous nerve transplantation (ANT). The mechanical biomaterial properties and the immunological impact of the grafts were assessed with histological techniques before and after transplantation in vivo. Furthermore during a 13-week examination period functional tests and electrophysiological recordings were performed and supplemented by nerve morphometry. The sheathing of the chitosan core with a polycaprolactone shell induced massive foreign body reaction and impairment of nerve regeneration. Although the isolated novel chitosan core did allow regeneration of axons in a similar size distribution as the ANT, the ANT was superior in terms of functional regeneration. We conclude that an outer polycaprolactone shell should not be used for the purpose of bioartificial nerve grafting, while 3D multichannel porous chitosan cores could be candidate scaffolds for structured nerve grafts.
C1 [Duda, Sven; Haastert-Talini, Kirsten] Hannover Med Sch, Inst Neuroanat, D-30625 Hannover, Germany.
   [Dreyer, Lutz; Behrens, Peter; Wienecke, Soenke; Chakradeo, Tanmay; Glasmacher, Birgit] Leibniz Univ Hannover, Inst Multiphase Proc, D-30167 Hannover, Germany.
   [Dreyer, Lutz] Leibniz Univ Hannover, Inst Biophys, D-30419 Hannover, Germany.
   [Haastert-Talini, Kirsten] Ctr Syst Neurosci ZSN Hannover, Hannover, Germany.
RP Haastert-Talini, K (reprint author), Hannover Med Sch, Inst Neuroanat, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM haastert-talini.kirsten@mh-hannover.de
RI Haastert-Talini, Kirsten/D-2348-2010
OI Haastert-Talini, Kirsten/0000-0003-2502-8969; Dreyer,
   Lutz/0000-0003-4380-890X
FU Internationale Stiftung Neurobionik, Germany
FX This work has been financially supported by a grant of the
   Internationale Stiftung Neurobionik, Germany (to K. Haastert-Talini).
   For excellent technical assistance the authors thank S. Fischer, N.
   Heidrich, K. Kuhlemann, J. Metzen, and H. Streich.
CR AITKEN JT, 1949, J ANAT, V83, P32
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ARBUTHNOTT ER, 1980, J PHYSIOL-LONDON, V308, P125, DOI 10.1113/jphysiol.1980.sp013465
   Bervar M, 2000, J NEUROSCI METH, V102, P109, DOI 10.1016/S0165-0270(00)00281-8
   Bozkurt A, 2008, J NEUROSCI METH, V170, P117, DOI 10.1016/j.jneumeth.2008.01.006
   Bozkurt A, 2011, NEUROL RES, V33, P1010, DOI 10.1179/1743132811Y.0000000029
   Bozkurt A, 2012, BIOMATERIALS, V33, P1363, DOI 10.1016/j.biomaterials.2011.10.069
   Chamberlain LJ, 1998, EXP NEUROL, V154, P315, DOI 10.1006/exnr.1998.6955
   Chamberlain LJ, 2000, J NEUROSCI RES, V60, P666, DOI 10.1002/(SICI)1097-4547(20000601)60:5<666::AID-JNR12>3.0.CO;2-0
   Cuddon PA, 2002, VET CLIN N AM-SMALL, V32, P31, DOI 10.1016/S0195-5616(03)00079-2
   Dahlin LB, 2008, SCAND J SURG, V97, P310, DOI 10.1177/145749690809700407
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5
   DenDunnen WFA, 1996, MICROSURG, V17, P348, DOI 10.1002/(SICI)1098-2752(1996)17:7<348::AID-MICR2>3.0.CO;2-C
   denDunnen WFA, 1997, J BIOMED MATER RES, V36, P337, DOI 10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.3.CO;2-8
   DEVOR M, 1979, J COMP NEUROL, V185, P211, DOI 10.1002/cne.901850113
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Dornseifer U, 2007, ZBL NEUROCHIR, V68, P101, DOI 10.1055/s-2007-984453
   Eser F, 2009, NEUROL INDIA, V57, P434, DOI 10.4103/0028-3886.55614
   Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M
   Geuna S, 2000, ANN ANAT, V182, P23, DOI 10.1016/S0940-9602(00)80117-X
   Geuna S, 2004, MICROSURG, V24, P72, DOI 10.1002/micr.10199
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Haastert K, 2010, NEUROSURGERY, V66, P567, DOI 10.1227/01.NEU.0000365768.78251.8C
   Haastert-Talini K, 2013, BIOMATERIALS, V34, P9886, DOI 10.1016/j.biomaterials.2013.08.074
   Haastert-Talini K, 2010, TISSUE ENG PT A, V16, P3085, DOI 10.1089/ten.TEA.2010.0180
   Hernandez-Cortes P, 2010, MICROSURG, V30, P414, DOI 10.1002/micr.20730
   Hsu SH, 2013, ACTA BIOMATER, V9, P6606, DOI 10.1016/j.actbio.2013.01.025
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Korte N, 2011, MUSCLE NERVE, V44, P63, DOI 10.1002/mus.22023
   Kuberka M, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 1, P485, DOI 10.1515/bmte.2002.47.s1a.485
   Kuberka M., 2004, BIOMED TECH, V49, P634
   Kuntzer T, 1997, MUSCLE NERVE, V20, P205
   Lee S, 2012, BRAIN BEHAV IMMUN, V26, P891, DOI 10.1016/j.bbi.2012.03.004
   Meek MF, 2009, MICROSURG, V29, P473, DOI 10.1002/micr.20642
   Meek MF, 1999, MICROSURG, V19, P247, DOI 10.1002/(SICI)1098-2752(1999)19:5<247::AID-MICR7>3.0.CO;2-E
   Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025
   Petersen A, 2006, HEAT MASS TRANSFER, V42, P929, DOI 10.1007/s00231-006-0153-3
   PODHAJSKY RJ, 1994, BRAIN RES, V662, P88, DOI 10.1016/0006-8993(94)90799-4
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Rasband WS, 1997, IMAGEJ
   Rupp A, 2007, J NEUROSCI METH, V166, P266, DOI 10.1016/j.jneumeth.2007.07.015
   Schmitte R, 2010, J NEUROSCI METH, V186, P202, DOI 10.1016/j.jneumeth.2009.11.023
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Schoof H, 2001, J BIOMED MATER RES, V58, P352, DOI 10.1002/jbm.1028
   Schoof H, 2000, J CRYST GROWTH, V209, P122, DOI 10.1016/S0022-0248(99)00519-9
   Siconolfi LB, 2001, J NEUROSCI, V21, P4348, DOI 10.1523/JNEUROSCI.21-12-04348.2001
   Szentivanyi AL, 2011, INT J ARTIF ORGANS, V34, P986, DOI 10.5301/ijao.5000062
   Vleggeert-Lankamp CLAM, 2007, J BIOMED MATER RES A, V80A, P965, DOI 10.1002/jbm.a.30941
   Vleggeert-Lankamp CLAM, 2007, J NEUROSURG, V107, P1168, DOI 10.3171/JNS-07/12/1168
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
   Zhang YG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029184
NR 53
TC 14
Z9 14
U1 1
U2 27
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 835269
DI 10.1155/2014/835269
PG 16
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AF6YX
UT WOS:000334861600001
PM 24818158
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Mravic, M
   Peault, B
   James, AW
AF Mravic, Marco
   Peault, Bruno
   James, Aaron W.
TI Current Trends in Bone Tissue Engineering
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; STROMAL CELLS; PERIVASCULAR CELLS; SONIC
   HEDGEHOG; HUMAN ORGANS; SINGLE-CELLS; IN-VIVO; REGENERATION;
   DIFFERENTIATION; SCAFFOLDS
AB The development of tissue engineering and regeneration constitutes a new platform for translational medical research. Effective therapies for bone engineering typically employ the coordinated manipulation of cells, biologically active signaling molecules, and biomimetic, biodegradable scaffolds. Bone tissue engineering has become increasingly dependent on the merging of innovations from each of these fields, as they continue to evolve independently. This foreword will highlight some of the most recent advances in bone tissue engineering and regeneration, emphasizing the interconnected fields of stem cell biology, cell signaling biology, and biomaterial research. These include, for example, novel methods for mesenchymal stem cell purification, new methods of Wnt signaling pathway manipulation, and cutting edge computer assisted nanoscale design of bone scaffold materials. In the following special issue, we sought to incorporate these diverse areas of emphasis in order to reflect current trends in the field.
C1 [James, Aaron W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, David Geffen Sch Med, Orthoped Hosp Res Ctr, Los Angeles, CA 90095 USA.
RP James, AW (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, 10833 Le Conte Ave,A3-251 CHS, Los Angeles, CA 90095 USA.
EM aaronwjames1@gmail.com
FU NIGMS NIH HHS [T34 GM008563]; Medical Research Council [G1000816]
CR Billstrom GH, 2013, INJURY, V44, pS28, DOI 10.1016/S0020-1383(13)70007-X
   Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008
   Center for Devices and Radiological Health, PUBL HLTH NOT MED DE
   Chalut KJ, 2012, BIOPHYS J, V103, P2060, DOI 10.1016/j.bpj.2012.10.015
   Chen CW, 2009, CYTOKINE GROWTH F R, V20, P429, DOI 10.1016/j.cytogfr.2009.10.014
   Cho DW, 2012, METHODS MOL BIOL, V868, P341, DOI 10.1007/978-1-61779-764-4_21
   Chung MT, 2013, TISSUE ENG PT A, V19, P989, DOI [10.1089/ten.tea.2012.0370, 10.1089/ten.TEA.2012.0370]
   Corselli M, 2013, CYTOM PART A, V83A, P714, DOI [10.1002/cyto.22313, 10.1002/cyto.a.22313]
   Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x
   Crisan M, 2009, ANN NY ACAD SCI, V1176, P118, DOI 10.1111/j.1749-6632.2009.04967.x
   De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537
   Ducheyne P, 2012, NAT MATER, V11, P652, DOI 10.1038/nmat3392
   Dudani JS, 2013, LAB CHIP, V13, P3728, DOI 10.1039/c3lc50649e
   Edwards PC, 2005, GENE THER, V12, P75, DOI 10.1038/sj.gt.3302386
   Galli C, 2013, CLIN ORAL IMPLAN RES, V24, P921, DOI 10.1111/j.1600-0501.2012.02488.x
   Garcia-Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034914
   Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109
   He XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060473
   Huh D, 2013, NAT PROTOC, V8, P2135, DOI 10.1038/nprot.2013.137
   Hur SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046550
   Ishimura D, 2008, TOHOKU J EXP MED, V216, P149, DOI 10.1620/tjem.216.149
   Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656
   James AW, 2012, STEM CELL TRANSL MED, V1, P673, DOI 10.5966/sctm.2012-0053
   James AW, 2012, STEM CELL TRANSL MED, V1, P510, DOI 10.5966/sctm.2012-0002
   James AW, 2012, STEM CELLS DEV, V21, P2170, DOI 10.1089/scd.2011.0461
   Janicki P, 2011, EUR CELLS MATER, V21, P488, DOI 10.22203/eCM.v021a37
   Jensen ED, 2010, J CELL BIOCHEM, V109, P672, DOI 10.1002/jcb.22462
   Jiang T, 2010, BIOMATERIALS, V31, P3564, DOI 10.1016/j.biomaterials.2010.01.050
   Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6
   Lee JW, 2011, BIOMATERIALS, V32, P744, DOI 10.1016/j.biomaterials.2010.09.035
   Lee JH, 2012, BIOMATERIALS, V33, P999, DOI 10.1016/j.biomaterials.2011.10.036
   Lee KB, 2012, J ORTHOP RES, V30, P1985, DOI 10.1002/jor.22160
   Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005
   Levi B, 2011, J BIOL CHEM, V286, P39497, DOI 10.1074/jbc.M111.256529
   Li WM, 2011, PLAST RECONSTR SURG, V127, P580, DOI 10.1097/PRS.0b013e3181fed5ae
   Li Y, 2013, BIOMATERIALS, V34, P5048, DOI 10.1016/j.biomaterials.2013.03.052
   Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234
   Lu Y, 2012, METHODS MOL BIOL, V868, P289, DOI 10.1007/978-1-61779-764-4_17
   Mariner PD, 2012, J TISSUE ENG REGEN M, V6, P314, DOI 10.1002/term.435
   Munshi N. C., 2012, P 54 ASH ANN M EXP A
   Murray I. R., CELLULAR MO IN PRESS
   Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173
   Pensak MJ, 2013, CURR PHARM DESIGN, V19, P3466, DOI 10.2174/1381612811319190012
   Pevsner-Fischer M, 2011, STEM CELL REV REP, V7, P560, DOI 10.1007/s12015-011-9229-7
   Phinney DG, 2012, J CELL BIOCHEM, V113, P2806, DOI 10.1002/jcb.24166
   Poldervaart MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072610
   Qing W., 2012, BIOMED RES INT, V2012
   Rivron NC, 2012, P NATL ACAD SCI USA, V109, P4413, DOI 10.1073/pnas.1117627109
   Rosen V, 2011, TISSUE ENG PART B-RE, V17, P475, DOI [10.1089/ten.teb.2011.0265, 10.1089/ten.TEB.2011.0265]
   Shen J, 2013, TISSUE ENG PT A, V19, P2390, DOI [10.1089/ten.TEA.2012.0519, 10.1089/ten.tea.2012.0519]
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Suga H, 2009, STEM CELLS DEV, V18, P1201, DOI 10.1089/scd.2009.0003
   Taipaleenmaki H, 2012, EUR J ENDOCRINOL, V166, P359, DOI 10.1530/EJE-11-0646
   Tamjid E, 2013, J BIOMED MATER RES A, V101, P2796, DOI 10.1002/jbm.a.34584
   Tierney EG, 2013, ORGANOGENESIS, V9, P22, DOI 10.4161/org.24329
   van Dinther M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062295
   van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6
   Watts C., 2011, SURG NEUROLOGY INT, V2
   Whitfield MJ, 2013, STEM CELL RES, V11, P1365, DOI 10.1016/j.scr.2013.09.004
   Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636
   Yum K., 2013, BIOTECHNOL J, V9, P16
   Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210
   Zhang XL, 2011, TISSUE ENG PT A, V17, P2497, DOI [10.1089/ten.TEA.2010.0705, 10.1089/ten.tea.2010.0705]
NR 65
TC 19
Z9 19
U1 0
U2 32
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 865270
DI 10.1155/2014/865270
PG 5
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AF6ZC
UT WOS:000334862100001
PM 24804256
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yamamoto, K
   Igawa, K
   Sugimoto, K
   Yoshizawa, Y
   Yanagiguchi, K
   Ikeda, T
   Yamada, S
   Hayashi, Y
AF Yamamoto, Kohei
   Igawa, Kazunari
   Sugimoto, Kouji
   Yoshizawa, Yuu
   Yanagiguchi, Kajiro
   Ikeda, Takeshi
   Yamada, Shizuka
   Hayashi, Yoshihiko
TI Biological Safety of Fish (Tilapia) Collagen
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID EXTRACELLULAR-MATRIX; SCAFFOLDS; DIFFERENTIATION; MORPHOGENESIS
AB Marine collagen derived from fish scales, skin, and bone has been widely investigated for application as a scaffold and carrier due to its bioactive properties, including excellent biocompatibility, low antigenicity, and high biodegradability and cell growth potential. Fish type I collagen is an effective material as a biodegradable scaffold or spacer replicating the natural extracellular matrix, which serves to spatially organize cells, providing them with environmental signals and directing site-specific cellular regulation. This study was conducted to confirm the safety of fish (tilapia) atelocollagen for use in clinical application. We performed in vitro and in vivo biological studies of medical materials to investigate the safety of fish collagen. The extract of fish collagen gel was examined to clarify its sterility. All present sterility tests concerning bacteria and viruses (including endotoxin) yielded negative results, and all evaluations of cell toxicity, sensitization, chromosomal aberrations, intracutaneous reactions, acute systemic toxicity, pyrogenic reactions, and hemolysis were negative according to the criteria of the ISO and the Ministry of Health, Labour and Welfare of Japan. The present study demonstrated that atelocollagen prepared from tilapia is a promising biomaterial for use as a scaffold in regenerative medicine.
C1 [Yamamoto, Kohei; Igawa, Kazunari; Sugimoto, Kouji; Yoshizawa, Yuu; Yanagiguchi, Kajiro; Ikeda, Takeshi; Yamada, Shizuka; Hayashi, Yoshihiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cariol, Nagasaki 8528588, Japan.
RP Hayashi, Y (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cariol, Nagasaki 8528588, Japan.
EM hayashi@nagasaki-u.ac.jp
FU Geriatrics Research and Development Expenditure; Ministry of Health,
   Labour and Welfare of Japan [23-10]
FX This work was supported in part by Geriatrics Research and Development
   Expenditure, Contract Grant Sponsor: Ministry of Health, Labour and
   Welfare of Japan and Contract Grant no. 23-10.
CR Alcaraz J, 2008, EMBO J, V27, P2829, DOI 10.1038/emboj.2008.206
   [Anonymous], 2012, GUID MED EQ
   Dillow A., 2002, BIOMIMETIC MAT DESIG
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Hayashi Y., 2011, MARINE COSMECEUTICAL, P133
   Hayashi Y, 2012, ADV FOOD NUTR RES, V65, P107, DOI 10.1016/B978-0-12-416003-3.00006-8
   HOTTA T, 1992, ACTA PATHOL JAPON, V42, P595
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   MAGNUSSON B, 1969, J INVEST DERMATOL, V52, P268, DOI 10.1038/jid.1969.42
   Mori H, 2013, DEVELOPMENT, V140, P343, DOI 10.1242/dev.084236
   Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315
   Pati F, 2012, J BIOMED MATER RES A, V100A, P1068, DOI 10.1002/jbm.a.33280
   Sofuni T., 1988, ATLAS CHROMOSOMAL AB, P16
   Wang JH, 2006, BIOMATERIALS, V27, P3441, DOI 10.1016/j.biomaterials.2006.02.002
   Winter AD, 2000, MOL CELL BIOL, V20, P4084, DOI 10.1128/MCB.20.11.4084-4093.2000
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 17
TC 8
Z9 8
U1 2
U2 22
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 630757
DI 10.1155/2014/630757
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AF6SU
UT WOS:000334845700001
PM 24809058
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Min, SK
   Kim, CR
   Kim, SH
   Shin, HS
AF Min, Seul Ki
   Kim, Cho Rong
   Kim, Sung Hoon
   Shin, Hwa Sung
TI Assessment of Morphology, Activity, and Infiltration of Astrocytes on
   Marine EPS-Imbedded Electrospun PCL Nanofiber
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY;
   CYTOKINE PRODUCTION; REACTIVE GLIOSIS; EXPRESSION; RAT; BRAIN;
   MICROGLIA; CNTF
AB Tissue engineering using a biomaterial including bioactive compounds has been researched as a way to restore injured neural systems. Extracellular polymeric substances (EPS) extracted from marine seaweeds have been known to produce positive effects on physiological activities in human tissues. In this study, an electrospun nanofiber containing brown seaweed EPS was proven to be a candidate biomaterial for neural tissue engineering. Glial fibrillary acidic protein (GFAP) as a specific marker protein increased in the astrocytes cultured on the polycaprolactone (PCL) nanofiber containing EPS (EPS-PCL nanofiber), compared with PCL nanofiber. The upregulation of GFAP indicates that the EPS-PCL nanofiber induced astrocyte activation, which supports physiological agents favorable to restore injured neural tissue. Astrocytes could infiltrate into the EPS-PCL nanofiber mat without toxicity, comparable to PCL nanofiber. These results imply that EPS-PCL nanofiber could be a useful biomaterial to regulate astrocyte activity at a molecular level and could be considered as a novel therapeutic material for neural tissue engineering.
C1 [Min, Seul Ki; Kim, Cho Rong; Kim, Sung Hoon; Shin, Hwa Sung] Inha Univ, Dept Biol Engn, Inchon 402751, South Korea.
RP Shin, HS (reprint author), Inha Univ, Dept Biol Engn, Inchon 402751, South Korea.
EM hsshin@inha.ac.kr
FU Marine Biotechnology Program - Ministry of Land, Transport and Maritime
   Affairs, Korea; INHA University
FX This research was supported by the Marine Biotechnology Program funded
   by the Ministry of Land, Transport and Maritime Affairs, Korea, and by
   the INHA University research grant.
CR Abe K, 2003, DEV BRAIN RES, V143, P99, DOI 10.1016/S0165(03)00096-8
   Alonso D, 2005, EXPERT OPIN THER PAT, V15, P1377, DOI 10.1517/13543776.15.10.1377
   Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006
   Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014
   East E, 2009, J TISSUE ENG REGEN M, V3, P634, DOI 10.1002/term.209
   Endo T, 2005, CURR DRUG TARGETS, V6, P427, DOI 10.2174/1389450054021909
   Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387
   FEDOROFF S, 2001, PROTOCOLS NEURAL CEL
   Fujiki K., 1993, SCI B FACULTY AGR KY, V47
   KAHN MA, 1995, BRAIN RES, V685, P55, DOI 10.1016/0006-8993(95)00411-I
   Kataoka K, 2001, J BIOMED MATER RES, V54, P373, DOI 10.1002/1097-4636(20010305)54:3<373::AID-JBM90>3.0.CO;2-Q
   Kim SH, 2012, COLLOID SURFACE B, V90, P113, DOI 10.1016/j.colsurfb.2011.10.004
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee MY, 1998, NEUROSCI LETT, V255, P79, DOI 10.1016/S0304-3940(98)00710-1
   Levison SW, 1996, EXP NEUROL, V141, P256, DOI 10.1006/exnr.1996.0160
   Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4
   LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355
   McDonnell P, 2010, ANIMAL, V4, P579, DOI 10.1017/S1751731109991376
   Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3
   Min SK, 2013, J BIOMED MATER RES A, V101, P3467, DOI 10.1002/jbm.a.34654
   Oyesiku NM, 1997, J NEUROBIOL, V32, P251, DOI 10.1002/(SICI)1097-4695(199703)32:3<251::AID-NEU1>3.3.CO;2-D
   Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8
   Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9
   RUDGE JS, 1990, J NEUROSCI, V10, P3594
   SCHAEFFER HE, 1982, INVEST OPHTH VIS SCI, V22, P220
   SCHWARTZ JP, 1994, BRAIN RES BULL, V35, P403, DOI 10.1016/0361-9230(94)90151-1
   Shah VB, 2008, J IMMUNOL, V180, P2777, DOI 10.4049/jimmunol.180.5.2777
   Shah VB, 2009, NEUROSCI LETT, V458, P111, DOI 10.1016/j.neulet.2009.04.039
   Sheng XH, 2011, NEUROSCI LETT, V503, P37, DOI 10.1016/j.neulet.2011.08.003
   Slezak M, 2003, TRENDS NEUROSCI, V26, P531, DOI 10.1016/j.tins.2003.08.005
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   STRAUSS S, 1994, NEUROSCI LETT, V168, P193, DOI 10.1016/0304-3940(94)90448-0
   TAKAMIYA Y, 1986, BRAIN RES, V383, P305, DOI 10.1016/0006-8993(86)90029-6
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
NR 36
TC 1
Z9 1
U1 0
U2 12
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-4110
EI 1687-4129
J9 J NANOMATER
JI J. Nanomater.
PY 2014
AR 302725
DI 10.1155/2014/302725
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AG0VL
UT WOS:000335133600001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Park, M
   Shin, M
   Kim, E
   Lee, S
   Park, KI
   Lee, H
   Jang, JH
AF Park, Minah
   Shin, Mikyung
   Kim, Eunmi
   Lee, Slgirim
   Park, Kook In
   Lee, Haeshin
   Jang, Jae-Hyung
TI The Promotion of Human Neural Stem Cells Adhesion Using Bioinspired
   Poly(norepinephrine) Nanoscale Coating
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID SURFACE MODIFICATION; CHEMISTRY; PROTEIN; FUNCTIONALIZATION;
   BIOMATERIALS; POLYDOPAMINE; INTERFACE; SCAFFOLD; CAPTURE; GROWTH
AB The establishment of versatile biomaterial interfaces that can facilitate cellular adhesion is crucial for elucidating the cellular processes that occur on biomaterial surfaces. Furthermore, biomaterial interfaces can provide physical or chemical cues that are capable of stimulating cellular behaviors by regulating intracellular signaling cascades. Herein, a method of creating a biomimetic functional biointerface was introduced to enhance human neural stem cell (hNSC) adhesion. The hNSC-compatible biointerface was prepared by the oxidative polymerization of the neurotransmitter norepinephrine, which generates a nanoscale organic thin layer, termed poly(norepinephrine) (pNE). Due to its adhesive property, pNE resulted in an adherent layer on various substrates, and pNE-coated biointerfaces provided a highly favorable microenvironment for hNSCs, with no observed cytotoxicity. Only a 2-hour incubation of hNSCs was required to firmly attach the stem cells, regardless of the type of substrate. Importantly, the adhesive properties of pNE interfaces led to micropatterns of cellular attachment, thereby demonstrating the ability of the interface to organize the stem cells. This highly facile surface-modification method using a biomimetic pNE thin layer can be applied to a number of suitable materials that were previously not compatible with hNSC technology.
C1 [Park, Minah; Kim, Eunmi; Lee, Slgirim; Jang, Jae-Hyung] Yonsei Univ, Dept Biomol & Chem Engn, Seoul 120749, South Korea.
   [Shin, Mikyung; Lee, Haeshin] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea.
   [Park, Kook In] Yonsei Univ, Coll Med, Dept Pediat, Seoul 120749, South Korea.
   [Lee, Haeshin] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Dept Chem, Taejon 305701, South Korea.
RP Lee, H (reprint author), Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea.
EM haeshin@kaist.ac.kr; j-jang@yonsei.ac.kr
RI Jang, Jae-Hyung/G-8030-2012; Lee, Haeshin/C-1720-2011; Shin,
   Mikyung/D-8483-2018
OI Lee, Haeshin/0000-0003-3961-9727; Shin, Mikyung/0000-0002-7990-5210
FU National Research Foundation of Korea (NRF) Grant through the Active
   Polymer Center for Pattern Integration - Ministry of Science, ICT &
   Future Planning (MSIP) [2007-0056091]; Basic Science Research Program -
   Ministry of Science, ICT & Future Planning (MSIP) [2012R1A1A1003397];
   Biomedical Technology Development Program - Ministry of Science, ICT &
   Future Planning (MSIP) [2012-0006085]
FX This work was supported by the National Research Foundation of Korea
   (NRF) Grant through the Active Polymer Center for Pattern Integration
   (no. 2007-0056091, Jae-Hyung Jang), Basic Science Research Program
   (2012R1A1A1003397, Jae-Hyung Jang), and Biomedical Technology
   Development Program (2012-0006085, Haeshin Lee) funded by the Ministry
   of Science, ICT & Future Planning (MSIP).
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Ham HO, 2011, ANGEW CHEM INT EDIT, V50, P732, DOI 10.1002/anie.201005001
   Heng LP, 2013, LANGMUIR, V29, P14947, DOI 10.1021/la403720s
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hong S, 2013, ANGEW CHEM INT EDIT, V52, P9187, DOI 10.1002/anie.201301646
   Kam L, 2002, BIOMATERIALS, V23, P511, DOI 10.1016/S0142-9612(01)00133-8
   Kang SM, 2013, B KOREAN CHEM SOC, V34, P960, DOI 10.5012/bkcs.2013.34.3.960
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   Kang SM, 2010, ANGEW CHEM INT EDIT, V49, P9401, DOI 10.1002/anie.201004693
   Kim E, 2012, ANGEW CHEM INT EDIT, V51, P5598, DOI 10.1002/anie.201201495
   Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015
   Ku SH, 2010, LANGMUIR, V26, P15104, DOI 10.1021/la102825p
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Liu XL, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2013.43
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Suh KY, 2004, BIOMATERIALS, V25, P557, DOI 10.1016/S0142-9612(03)00543-X
   Sung M.K., 2009, J AM CHEM SOC, V131, P13224
   Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087
   Wang ST, 2009, ANGEW CHEM INT EDIT, V48, P8970, DOI 10.1002/anie.200901668
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067
NR 30
TC 15
Z9 15
U1 2
U2 27
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-4110
EI 1687-4129
J9 J NANOMATER
JI J. Nanomater.
PY 2014
AR 793052
DI 10.1155/2014/793052
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AF5LV
UT WOS:000334755900001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Duarte, MAT
   Duek, EAD
   Motta, AC
AF Tomaz Duarte, Marcia Adriana
   de Rezende Duek, Eliana Aparecida p
   Motta, Adriana Cristina
TI In Vitro Degradation of Poly (L-co-D, L lactic acid) Containing PCL-T
SO POLIMEROS-CIENCIA E TECNOLOGIA
LA English
DT Article
DE Bioresorbable polymer; in vitro degradation; PLDLA/PCL-T
ID IMPLANTS; FILMS; VIVO; BONE
AB The application of polymer-based bioresorbable temporary devices in the medical field grows continuously, and professionals from several areas act to solve problems related to body functions lost due to diseases, accidents or natural wear. Here we study the influence from poly(caprolactonetriol) (PCL-T) on the degeneration process in the copolymer poly(L-co-DL-lactic acid) (PLDLA) membrane, by producing PLDLA/PCL-T blends with 90/10, 70/30 and 50/50 relative concentrations. The data for in vitro degradation showed that PCL-T decreases the rate of PLDLA. This was obtained with the following techniques: Differential Scanning Calorimetry (DSC), Thermogravimetric Analysis (TGA), Gel Permeation Chromatography (GPC) and Scanning Electron Microscopy (SEM). Therefore, it is possible to vary the membrane degradation rate by changing the blend composition, which is a tool to tailor a biomaterial.
C1 [Tomaz Duarte, Marcia Adriana] SOCIESC, Tupy IST, Master Engn Mech, Florianopolis, SC, Brazil.
   [de Rezende Duek, Eliana Aparecida p] Univ Estadual Campinas, UNICAMP, Fac Mech Engn, Dept Mat Engn, Campinas, SP, Brazil.
   [Motta, Adriana Cristina] PUC SP, Fac Med Sci, BR-18030095 Sorocaba, SP, Brazil.
RP Duek, EAD (reprint author), PUC SP, CCMB, Dept Ciencias Fisiol, Praca Dr Jose Ermirio Moraes 290,Jd Vergueiro, BR-18030095 Sorocaba, SP, Brazil.
EM eliduek@fem.unicamp.br
CR BALZER OS, 2009, THESIS FEDERAL U SAN
   BARAUNA G, 2007, THESIS STATE U CAMPI
   BRET D, 2011, J POLYM SCI POL PHYS, V49, P832
   Deng M, 2010, ADV FUNCT MATER, V20, P2794, DOI 10.1002/adfm.201000968
   DUARTE MAT, 2009, THESIS STATE U CAMPI
   Hou RX, 2010, APPL SURF SCI, V256, P5000, DOI 10.1016/j.apsusc.2010.03.042
   LAM KH, 1994, J MATER SCI-MATER M, V5, P181, DOI 10.1007/BF00121086
   Leiggener CS, 2006, BIOMATERIALS, V27, P202, DOI 10.1016/j.biomaterials.2005.05.068
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Luciano RM, 2003, J MATER SCI-MATER M, V14, P87, DOI 10.1023/A:1021509722296
   Maluf-Meiken LCV, 2006, J MATER SCI-MATER M, V17, P481, DOI 10.1007/s10856-006-8476-7
   Meier MM, 2004, POLYM ADVAN TECHNOL, V15, P593, DOI 10.1002/pat.517
   MOTTA AC, 2006, POLIMEROS, V11, P340
   Motta AC, 2007, POLIMEROS, V17, P123, DOI 10.1590/S0104-14282007000200011
   Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092
   Park KI, 2009, POLYM DEGRAD STABIL, V94, P834, DOI 10.1016/j.polymdegradstab.2009.01.030
   Pezzin APT, 2001, POLYMER, V42, P8303, DOI 10.1016/S0032-3861(01)00273-7
   TSUYI H, 2001, POLYM DEGRAD STABIL, V71, P415
   Walton M, 2007, J BIOMATER APPL, V21, P395, DOI 10.1177/0885328206065125
   Zou T, 2007, J BIOMED MATER RES B, V82B, P400, DOI 10.1002/jbm.b.30745
NR 20
TC 3
Z9 3
U1 0
U2 10
PU ASSOC BRASIL POLIMEROS
PI SAO CARLOS
PA RUA GEMINIANO COSTA NO 355, CP 490 13560-970, SAO CARLOS, SP 00000,
   BRAZIL
SN 0104-1428
J9 POLIMEROS
JI Polimeros
PY 2014
VL 24
IS 1
BP 1
EP 8
DI 10.4322/polimeros.2014.056
PG 8
WC Polymer Science
SC Polymer Science
GA AF0LD
UT WOS:000334404600001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Tan, S
   Zhang, BB
   Zhu, XM
   Ao, P
   Guo, HJ
   Yi, WH
   Zhou, GQ
AF Tan, Shuang
   Zhang, Binbin
   Zhu, Xiaomei
   Ao, Ping
   Guo, Huajie
   Yi, Weihong
   Zhou, Guang-Qian
TI Deregulation of Bone Forming Cells in Bone Diseases and Anabolic Effects
   of Strontium-Containing Agents and Biomaterials
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-I; PARATHYROID-HORMONE; OSTEOBLAST
   DIFFERENTIATION; POSTMENOPAUSAL WOMEN; PROTEASOMAL DEGRADATION;
   TRANSCRIPTIONAL CONTROL; INDUCED OSTEOPOROSIS; SIGNALING PATHWAYS;
   SENSING RECEPTOR
AB Age-related bone loss and osteoporosis are associated with bone remodeling changes that are featured with decreased trabecular and periosteal bone formation relative to bone resorption. Current anticatabolic therapies focusing on the inhibition of bone resorption may not be sufficient in the prevention or reversal of age-related bone deterioration and there is a big need in promoting osteoblastogenesis and bone formation. Enhanced understanding of the network formed by key signaling pathways and molecules regulating bone forming cells in health and diseases has therefore become highly significant. The successful development of agonist/ antagonist of the PTH and Wnt signaling pathways are profits of the understanding of these key pathways. As the core component of an approved antiosteoporosis agent, strontiumtakes its effect on osteoblasts at multilevel through multiple pathways, representing a good example in revealing and exploring anabolic mechanisms. The recognition of strontium effects on bone has led to its expected application in a variety of biomaterial scaffolds used in tissue engineering strategies aiming at bone repairing and regeneration. While summarizing the recent progress in these respects, this review also proposes the new approaches such as systems biology in order to reveal new insights in the pathology of osteoporosis as well as possible discovery of new therapies.
C1 [Tan, Shuang; Zhou, Guang-Qian] Sichuan Univ, Key State Lab Biotherapy, Chengdu 610065, Peoples R China.
   [Zhang, Binbin; Guo, Huajie; Zhou, Guang-Qian] Shenzhen Univ, Antiageing & Regenerat Med Ctr, Shenzhen 518060, Guangdong, Peoples R China.
   [Zhu, Xiaomei; Ao, Ping] Shanghai Jiao Tong Univ, Inst Syst Biomed, Shanghai 200240, Peoples R China.
   [Yi, Weihong] Nanshan Peoples Hosp, Dept Spinal Surg, Shenzhen 518000, Peoples R China.
RP Yi, WH (reprint author), Nanshan Peoples Hosp, Dept Spinal Surg, Shenzhen 518000, Peoples R China.
EM szyiwh@163.com; gqzhou@szu.edu.cn
FU Natural Science Foundation of China [NSFC81130034, 81171746]
FX The study was supported by Natural Science Foundation of China
   (NSFC81130034, 81171746). The content is solely the responsibility of
   the authors.
CR Ammann P, 2001, BONE, V28, pS220
   Arlot ME, 2008, J BONE MINER RES, V23, P215, DOI 10.1359/JBMR.071012
   Atkins GJ, 2009, OSTEOPOROSIS INT, V20, P653, DOI 10.1007/s00198-008-0728-6
   Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809
   Bain SD, 2009, OSTEOPOROSIS INT, V20, P1417, DOI 10.1007/s00198-008-0815-8
   Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074
   Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200
   Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018
   Brown EM, 2001, PHYSIOL REV, V81, P239
   Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7
   Caverzasio J, 2011, CELL PHYSIOL BIOCHEM, V27, P243, DOI 10.1159/000327950
   Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200
   Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954
   Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0
   Chenu C., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P132
   Chorev J M., 1996, PARATHYROID HORMONE
   Conigrave A. D., 2013, BEST PRACTICE RES CL
   Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835
   Coulombe J, 2001, J BONE MINER RES, V16, pS428
   Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016
   del Fattore A., 2011, FRONTIERS BIOSCIENCE, V4, P2302
   Delannoy P, 2002, METABOLISM, V51, P906, DOI 10.1053/meta.2002.33360
   DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   Dusso AS, 1998, AM J KIDNEY DIS, V32, pS13, DOI 10.1053/ajkd.1998.v32.pm9808140
   Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398
   Erben R. G., 2001, Journal of Musculoskeletal & Neuronal Interactions, V2, P59
   Esbrit P, 2013, BIOCHEM PHARMACOL, V85, P1417, DOI 10.1016/j.bcp.2013.03.002
   Faure H, 2009, CELL CALCIUM, V46, P323, DOI 10.1016/j.ceca.2009.09.004
   Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725
   Forsgren J, 2010, J MATER SCI-MATER M, V21, P1605, DOI 10.1007/s10856-010-4022-8
   Fromigue O, 2009, J CELL MOL MED, V13, P2189, DOI 10.1111/j.1582-4934.2009.00673.x
   Gilbert LC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1011, DOI 10.1152/ajpendo.00534.2004
   Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777
   Gulhan I, 2008, ARCH GYNECOL OBSTET, V278, P437, DOI 10.1007/s00404-008-0611-x
   Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200
   Hao J., 2013, CLIN ORAL IMPLANTS R
   Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660
   Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013
   Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716
   Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4367, DOI 10.1210/en.140.9.4367
   Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580
   Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564
   Iafisco M, 2014, MAT SCI ENG C-MATER, V35, P212, DOI 10.1016/j.msec.2013.11.009
   Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200
   Javed A, 2010, ORAL MAXIL SURG CLIN, V22, P283, DOI 10.1016/j.coms.2010.05.001
   Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X
   Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437
   Kassem M, 2011, AGING CELL, V10, P191, DOI 10.1111/j.1474-9726.2011.00669.x
   Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200
   Khosla S, 2005, ENDOCRIN METAB CLIN, V34, P1015, DOI 10.1016/j.ecl.2005.07.009
   Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JC133612
   Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200
   Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270
   Kok C, 2009, BEST PRACT RES CL RH, V23, P769, DOI 10.1016/j.berh.2009.09.006
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Krishnan V, 2003, MOL ENDOCRINOL, V17, P423, DOI 10.1210/me.2002.0225
   Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1
   Lin KL, 2013, BIOMATERIALS, V34, P10028, DOI 10.1016/j.biomaterials.2013.09.056
   Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602
   Ma B, 2013, EUR J PHARMACOL, V718, P524, DOI 10.1016/j.ejphar.2013.06.030
   Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104
   Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259
   Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010
   Marie P., 1995, J BONE MINER RES, V10, pS105
   Marie PJ, 2011, EUR J ENDOCRINOL, V165, P1, DOI 10.1530/EJE-11-0132
   Marie PJ, 2011, J CLIN ENDOCR METAB, V96, P600, DOI 10.1210/jc.2010-2113
   Marie PJ, 2005, CURR OPIN PHARMACOL, V5, P633, DOI 10.1016/j.coph.2005.05.005
   Marie PJ, 2005, J BONE MINER RES, V20, P1065, DOI 10.1359/jbmr.2005.20.6.1065
   Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816
   McLean Robert R, 2009, Curr Osteoporos Rep, V7, P134
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702
   Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239
   Pan HB, 2010, J R SOC INTERFACE, V7, P1025, DOI 10.1098/rsif.2009.0504
   Peng SL, 2014, J ORTHOP RES, V32, P477, DOI 10.1002/jor.22517
   Peng SL, 2011, BONE, V49, P1290, DOI 10.1016/j.bone.2011.08.031
   Peng SL, 2011, J BONE MINER RES, V26, P1272, DOI 10.1002/jbmr.325
   Peng SL, 2010, J ORTHOP RES, V28, P1208, DOI 10.1002/jor.21127
   Peng SL, 2009, CELL PHYSIOL BIOCHEM, V23, P165, DOI 10.1159/000204105
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Place ES, 2011, TISSUE ENG PT A, V17, P2713, DOI [10.1089/ten.TEA.2011.0059, 10.1089/ten.tea.2011.0059]
   Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200
   Poh PSP, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045005
   Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087
   Recker RR, 2011, CLIN ORTHOP RELAT R, V469, P2207, DOI 10.1007/s11999-011-1909-8
   Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774
   Ren J., 2013, J BIOMEDICAL MAT R A
   Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763
   Riggs BL, 2005, J BONE MINER RES, V20, P177, DOI 10.1359/JBMR.041114
   Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200
   RUBIN CT, 1987, J ORTHOPAED RES, V5, P300, DOI 10.1002/jor.1100050217
   Rybchyn MS, 2011, J BIOL CHEM, V286, P23771, DOI 10.1074/jbc.M111.251116
   Sabareeswaran A, 2013, BIOMATERIALS, V34, P9278, DOI 10.1016/j.biomaterials.2013.08.070
   Saidak Z, 2012, AGING CELL, V11, P467, DOI 10.1111/j.1474-9726.2012.00804.x
   Sardella C, 2010, J ENDOCRINOL INVEST, V33, P20, DOI 10.1007/BF03346555
   Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8
   Sekine K, 2013, IEEE ENG MED BIO, P858, DOI 10.1109/EMBC.2013.6609636
   Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197
   Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X
   Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743
   Sprague SM, 2004, SEMIN NEPHROL, V24, P82, DOI 10.1053/j.semnephrol.2003.08.012
   Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137
   Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504
   Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919
   Verborgt O, 2002, J BONE MINER RES, V17, P907, DOI 10.1359/jbmr.2002.17.5.907
   Wahl EC, 2010, J BONE MINER RES, V25, P114, DOI 10.1359/jbmr.090708
   Weitzmann M. N., 2013, SCIENTIFICA, V2013, DOI DOI 10.1155/2013/125705
   Winslow MM, 2006, IMMUNITY, V24, P141, DOI 10.1016/j.immuni.2005.12.013
   Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006
   Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053
   Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453
   Xing LP, 2005, BIOCHEM BIOPH RES CO, V328, P709, DOI 10.1016/j.bbrc.2004.11.072
   Xu Z, 2007, BONE, V41, P68, DOI 10.1016/j.bone.2007.03.009
   Yamaguchi M, 2011, INT J MOL MED, V27, P3, DOI 10.3892/ijmm.2010.562
   Yang G.-l., 2012, INT J ORAL MAXILLOFA, V27
   Zhang J., 2014, ACTA BIOMATERIALIA
   Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009
NR 118
TC 11
Z9 11
U1 1
U2 21
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 814057
DI 10.1155/2014/814057
PG 12
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AE7XP
UT WOS:000334213300001
PM 24800251
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU He, Y
   Wang, X
   Chen, L
   Ding, JD
AF He, Yao
   Wang, Xuan
   Chen, Liang
   Ding, Jiandong
TI Preparation of hydroxyapatite micropatterns for the study of
   cell-biomaterial interactions
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; SURFACE-TOPOGRAPHY;
   HUMAN OSTEOBLASTS; GROWTH-FACTOR; COATINGS; ADHESION; BIOCERAMICS;
   SCAFFOLDS; CULTURE
AB A regular hydroxyapatite (HAp) micropattern was prepared combining post-lift-off photolithography, surface grafting of negatively charged chemicals, and simulated body fluid incubation. The chemical micropatterning of the bioceramics on glass was thus successfully generated. The resulting regular HAp microarray was confirmed by scanning electron microscopy, transmission electron microscopy, energy dispersive X-ray spectroscopy, X-ray diffraction, Raman spectroscopy, and Fourier transform infrared spectroscopy. A chemical micropattern of cell-adhesive bioceramic microislands on a non-fouling background was obtained after the glass background was passivated by poly(ethylene glycol). Culture of mammal cells (MC3T3) on the micropattern illustrated that the cell localization on the HAp microislands was well achieved. The present work affords a methodology of micropatterning of bioceramics for the study of interactions between cells and bioceramics.
C1 [He, Yao; Wang, Xuan; Chen, Liang; Ding, Jiandong] Fudan Univ, Dept Macromol Sci, State Key Lab Mol Engn Polymers, Adv Mat Lab, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, Dept Macromol Sci, State Key Lab Mol Engn Polymers, Adv Mat Lab, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
FU NSF of China [21034002, 91127028, 51273046]; Chinese Ministry of Science
   and Technology (973 program) [2011CB606203]; Science and Technology
   Developing Foundation of Shanghai [13XD1401000]
FX The authors are grateful for the financial support from the NSF of China
   (grants no. 21034002, no. 91127028, and no. 51273046), the Chinese
   Ministry of Science and Technology (973 program no. 2011CB606203), and
   the Science and Technology Developing Foundation of Shanghai (grant no.
   13XD1401000).
CR Bucaro MA, 2012, ACS NANO, V6, P6222, DOI 10.1021/nn301654e
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen XY, 2012, ADV ENG MATER, V14, pB216, DOI 10.1002/adem.201180073
   Choi SY, 2012, J MATER CHEM, V22, P25288, DOI 10.1039/c2jm33354f
   Costa DO, 2013, BIOMATERIALS, V34, P7215, DOI 10.1016/j.biomaterials.2013.06.014
   Costa DO, 2012, LANGMUIR, V28, P3871, DOI 10.1021/la203224a
   Matesanz MD, 2012, MACROMOL BIOSCI, V12, P446, DOI 10.1002/mabi.201100456
   Efremov AN, 2013, BIOMATERIALS, V34, P1757, DOI 10.1016/j.biomaterials.2012.11.034
   Harris GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081113
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Holthaus MG, 2012, ACTA BIOMATER, V8, P394, DOI 10.1016/j.actbio.2011.07.031
   Hong ZD, 2010, J BIOMED MATER RES A, V93A, P878, DOI 10.1002/jbm.a.32556
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Jin L, 2014, J MATER CHEM B, V2, P129, DOI 10.1039/c3tb21219j
   Kim HM, 2004, J ROY SOC INTERFACE, V1, P17, DOI 10.1098/rsif.2004.0003
   Kobayashi T, 2012, CRYSTENGCOMM, V14, P1143, DOI 10.1039/c1ce06114c
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lee JS, 2010, ADV MATER, V22, P5494, DOI 10.1002/adma.201002970
   Li JG, 2013, APPL SURF SCI, V273, P24, DOI 10.1016/j.apsusc.2013.01.058
   Li MM, 2013, ACS APPL MATER INTER, V5, P5921, DOI 10.1021/am401937m
   Lin KL, 2013, ACS APPL MATER INTER, V5, P8008, DOI 10.1021/am402089w
   Liu GM, 2012, ANAL METHODS-UK, V4, P609, DOI 10.1039/c2ay05838c
   Liu WY, 2011, LANGMUIR, V27, P9088, DOI 10.1021/la2018105
   Liu XC, 2012, INT J NANOMED, V7, P1239, DOI 10.2147/IJN.S28098
   Lopez-Bosque MJ, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/25/255305
   Okada S, 2011, ACTA BIOMATER, V7, P1290, DOI 10.1016/j.actbio.2010.10.010
   Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023
   Panda RN, 2003, J PHYS CHEM SOLIDS, V64, P193, DOI 10.1016/S0022-3697(02)00257-3
   Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Reardon PJT, 2013, J MATER CHEM B, V1, P6170, DOI 10.1039/c3tb21073a
   Suarez-Gonzalez D, 2012, BIOMATERIALS, V33, P713, DOI 10.1016/j.biomaterials.2011.09.095
   Sugawara A, 2013, J MATER CHEM B, V1, P1081, DOI 10.1039/c2tb00061j
   Tan GX, 2013, APPL SURF SCI, V279, P293, DOI 10.1016/j.apsusc.2013.04.088
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Tas AC, 2004, J MATER RES, V19, P2742, DOI 10.1557/JMR.2004.0349
   Wang DX, 2013, INT J NANOMED, V8, P1855, DOI 10.2147/IJN.S43706
   Wang GC, 2013, J MATER CHEM B, V1, P2455, DOI 10.1039/c3tb20164c
   Wang XL, 2013, J BIOMED MATER RES A, V101, P3388, DOI 10.1002/jbm.a.34645
   Wang XL, 2013, SOFT MATTER, V9, P4160, DOI 10.1039/c3sm27818b
   Wang X, 2013, BIOMATERIALS, V34, P2865, DOI 10.1016/j.biomaterials.2013.01.021
   Weiger MC, 2010, BIOMATERIALS, V31, P2955, DOI 10.1016/j.biomaterials.2010.01.012
   Yan C, 2011, BIOMATERIALS, V32, P3931, DOI 10.1016/j.biomaterials.2011.01.078
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Yao X, 2013, BIOMATERIALS, V34, P9001, DOI 10.1016/j.biomaterials.2013.08.013
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Zhang PB, 2011, BIOMACROMOLECULES, V12, P2667, DOI 10.1021/bm2004725
   Zhao YC, 2012, CHINESE J CHEM, V30, P491, DOI 10.1002/cjoc.201100252
   Zheng WF, 2013, ADV HEALTHC MATER, V2, P95, DOI 10.1002/adhm.201200104
NR 49
TC 14
Z9 14
U1 12
U2 113
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 16
BP 2220
EP 2227
DI 10.1039/c4tb00146j
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA AE6RG
UT WOS:000334120800003
DA 2018-10-20
ER

PT J
AU Mollet, BB
   Comellas-Aragones, M
   Spiering, AJH
   Sontjens, SHM
   Meijer, EW
   Dankers, PYW
AF Mollet, Bjorne B.
   Comellas-Aragones, Marta
   Spiering, A. J. H.
   Sontjens, Serge H. M.
   Meijer, E. W.
   Dankers, Patricia Y. W.
TI A modular approach to easily processable supramolecular bilayered
   scaffolds with tailorable properties
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID HUMAN TUBULAR CELLS; BIOARTIFICIAL KIDNEY; EXTRACELLULAR-MATRIX; TISSUE;
   BIOMATERIALS; MEMBRANES; POLYMERS; COATINGS; MESHES
AB Engineering of anisotropic tissues demands extracellular matrix (ECM) mimicking scaffolds with an asymmetric distribution of functionalities. We here describe a convenient, modular approach based on supramolecular building blocks to form electrospun bilayered scaffolds with tailorable properties. Polymers and peptides functionalized with hydrogen-bonding ureido-pyrimidinone (UPy) moieties can easily be mixed-and-matched to explore new material combinations with optimal properties. These combinatorial supramolecular biomaterials, processed by electrospinning, enable the formation of modular fibrous scaffolds. We demonstrate how UPy-functionalized polymers based on polycaprolactone and poly(ethylene glycol) enable us to unite both cell-adhesive and non-cell adhesive characters into a single electrospun bilayered scaffold. We furthermore show that the non-cell adhesive layer can be bioactivated and made adhesive for kidney epithelial cells by the incorporation of 4 mol% of UPy-modified Arg-Gly-Asp (RGD) peptide in the electrospinning solution. These findings show that the UPy-based supramolecular biomaterial system offers a versatile toolbox to form modular multilayered scaffolds for tissue engineering and regenerative medicine applications such as the formation of membranes for a living bioartificial kidney.
C1 [Mollet, Bjorne B.; Comellas-Aragones, Marta; Meijer, E. W.; Dankers, Patricia Y. W.] Eindhoven Univ Technol, Biol Chem Lab, NL-5600 MB Eindhoven, Netherlands.
   [Mollet, Bjorne B.; Comellas-Aragones, Marta; Spiering, A. J. H.; Meijer, E. W.; Dankers, Patricia Y. W.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands.
   [Spiering, A. J. H.; Meijer, E. W.] Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands.
   [Sontjens, Serge H. M.] SyMO Chem BV, NL-5612 AZ Eindhoven, Netherlands.
RP Dankers, PYW (reprint author), Eindhoven Univ Technol, Biol Chem Lab, POB 513, NL-5600 MB Eindhoven, Netherlands.
EM p.y.w.dankers@tue.nl
RI Sontjens, Serge/A-9259-2009
OI Sontjens, Serge/0000-0001-5939-6925
FU Ministry of Education, Culture and Science [024.001.035]; Netherlands
   Organisation for Scientific Research (NWO); European Research Council
   [308045, 246829]; Marie Curie Actions
   [VLPsiRNA-FP7-PEOPLE-2009-IOF-254069]; Dutch Ministry of Economic
   Affairs; Dutch Kidney Foundation
FX The authors thank Eduard Ebberink and Bas Meusen for initial
   experiments, and Simone Hendrikse, Michel van Houtem and Henk Janssen
   for synthesis help. We thank Geert van Almen and Ewelina
   Burakowska-Meise for useful discussions. The research leading to these
   results has received funding from the Ministry of Education, Culture and
   Science (Gravity program 024.001.035), the Netherlands Organisation for
   Scientific Research (NWO), the European Research Council (FP7/2007-2013)
   ERC Grant Agreement 308045 and 246829, and from Marie Curie Actions
   (VLPsiRNA-FP7-PEOPLE-2009-IOF-254069 M.C.-A.). This research forms part
   of the Project P3.01 BioKid of the research program of the BioMedical
   Materials institute, co-funded by the Dutch Ministry of Economic
   Affairs. The financial contribution of the Dutch Kidney Foundation is
   gratefully acknowledged.
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   AEBISCHER P, 1987, LIFE SUPPORT SYST, V5, P159
   Ahmed F, 2013, BIOMACROMOLECULES, V14, P3850, DOI 10.1021/bm400938n
   Beijer FH, 1998, J AM CHEM SOC, V120, P6761, DOI 10.1021/ja974112a
   Collier JH, 2010, CHEM SOC REV, V39, P3413, DOI 10.1039/b914337h
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Dankers P. Y. W., 2006, THESIS EINDHOVEN U T
   Dankers PYW, 2007, B CHEM SOC JPN, V80, P2047, DOI 10.1246/bcsj.80.2047
   Dankers PYW, 2007, EUR J ORG CHEM, P3622, DOI 10.1002/ejoc.200700191
   Dankers PYW, 2011, BIOMATERIALS, V32, P723, DOI 10.1016/j.biomaterials.2010.09.020
   Dankers PYW, 2010, MACROMOL BIOSCI, V10, P1345, DOI 10.1002/mabi.201000146
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   de Boer J., 2013, MATERIOMICS HIGH THR
   Halfter W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067660
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hook AL, 2010, BIOMATERIALS, V31, P187, DOI 10.1016/j.biomaterials.2009.09.037
   Humes HD, 2000, SEMIN NEPHROL, V20, P71
   Kautz H, 2006, MACROMOLECULES, V39, P4265, DOI 10.1021/ma060706z
   Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063
   Kieltyka RE, 2012, CHEM COMMUN, V48, P1452, DOI 10.1039/c1cc14728e
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Korossis S, 2006, TISSUE ENG, V12, P635, DOI 10.1089/ten.2006.12.635
   Kouwer PHJ, 2013, NATURE, V493, P651, DOI 10.1038/nature11839
   Lehn JM, 2007, CHEM SOC REV, V36, P151, DOI 10.1039/b616752g
   Lensen M. C., 2011, BIOMATERIALS PHYS CH
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   MacNeil S, 2008, MATER TODAY, V11, P26, DOI 10.1016/S1369-7021(08)70087-7
   Mangera A, 2012, NEUROUROL URODYNAM, V31, P13, DOI 10.1002/nau.21156
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   Mol A, 2009, EXPERT REV MED DEVIC, V6, P259, DOI [10.1586/erd.09.12, 10.1586/ERD.09.12]
   Ni M, 2011, BIOMATERIALS, V32, P1465, DOI 10.1016/j.biomaterials.2010.10.061
   Nooeaid P, 2014, ADV ENG MATER, V16, P319, DOI 10.1002/adem.201300072
   Polini A, 2010, SOFT MATTER, V6, P1668, DOI 10.1039/b921932c
   RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6
   Saito A, 2011, HEMODIAL INT, V15, P183, DOI 10.1111/j.1542-4758.2011.00530.x
   Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601
   Soletti L, 2010, ACTA BIOMATER, V6, P110, DOI 10.1016/j.actbio.2009.06.026
   Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208
   Ueda H, 2006, J BIOMED MATER RES A, V77A, P19, DOI 10.1002/jbm.a.30606
   Vedula SRK, 2014, NAT MATER, V13, P87, DOI [10.1038/NMAT3814, 10.1038/nmat3814]
   VINEY C, 1993, MAT SCI ENG R, V10, P187, DOI 10.1016/0920-2307(93)90006-Z
   Wang XF, 2013, MATER TODAY, V16, P229, DOI 10.1016/j.mattod.2013.06.005
   Wisse E, 2011, J POLYM SCI POL CHEM, V49, P1764, DOI 10.1002/pola.24598
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zhang HS, 2009, BIOMATERIALS, V30, P2899, DOI 10.1016/j.biomaterials.2009.01.046
NR 46
TC 19
Z9 19
U1 0
U2 41
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 17
BP 2483
EP 2493
DI 10.1039/c3tb21516d
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AE6RK
UT WOS:000334121500015
OA Bronze
DA 2018-10-20
ER

PT J
AU Johnson, JC
   Wanasekara, ND
   Korley, LTJ
AF Johnson, J. Casey
   Wanasekara, Nandula D.
   Korley, LaShanda T. J.
TI Influence of secondary structure and hydrogenbonding arrangement on the
   mechanical properties of peptidic-polyurea hybrids
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID TAPPING-MODE AFM; BETA-SHEET; SEGMENTED POLYURETHANES; MULTIBLOCK
   COPOLYMERS; BIOLOGICAL-MATERIALS; TRIBLOCK COPOLYMERS; FORCE MICROSCOPY;
   AMYLOID FIBRIL; HARD SEGMENTS; ALPHA-HELIX
AB Bio-inspired materials design is an important strategy used in the fabrication of tunable and mechanically enhanced polymeric systems. An important aspect of bio-inspiration is to understand how components, such as hierarchy and self-assembly, affect the properties of the designed materials. In this investigation, we explore the use of polypeptide secondary structure and hydrogen bonding arrangement, in order to determine their effects on the thermal and mechanical properties of fully synthetic peptidic polyureas. Specifically, we incorporate either short beta-sheet forming peptide blocks of poly(beta-benzyl-I-aspartate)(5) or poly(epsilon-carbobenzyloxy-L-lysine)(5) or longer peptide blocks of poly(beta-benzyl-L-aspartate)(20) or poly(epsilon-carbobenzyloxy-L-lysine)(20) as alpha-helix forming domains into non-chain extended polyureas based on 1,6-hexamethylene diisocyanate and poly(dimethysiloxane). Secondary structure was found to be influenced by the weight fraction of peptide, e. g. increasing peptide weight fractions increased sheet or helical ordering. Additionally, the polyurea microstructure was comprised of nanofibrils with a secondary structure dependent fiber width, attributed to the peptidic motif alignment within the nanothreads. Analysis of the thermomechanical and tensile response revealed multiple trends, such as increased toughness attributed to beta-sheet ordering and increased modulus with increased peptide weight fraction. It is anticipated that this observed interplay between peptide organization and mechanics will be applicable to engineering and biomaterial development due to the simplicity of the synthetic protocol and the promising mechanical tunability guided by the peptide segment.
C1 [Johnson, J. Casey; Wanasekara, Nandula D.; Korley, LaShanda T. J.] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA.
RP Korley, LTJ (reprint author), Case Western Reserve Univ, Dept Macromol Sci & Engn, 2100 Adelbert Rd, Cleveland, OH 44106 USA.
EM lashanda.korley@case.edu
OI Korley, LaShanda/0000-0002-8266-5000
FU National Science Foundation [CAREER DMR-0953236]; ACS PRF Starter G
   [47999-G7]; Defense University Research Instrumentation Program (DURIP)
   grant [W911NF1110343]
FX This work was financially supported by the National Science Foundation
   (CAREER DMR-0953236), ACS PRF Starter G 47999-G7 and Defense University
   Research Instrumentation Program (DURIP) grant W911NF1110343. The
   authors greatly appreciate Daniel (Dan) Scheiman, NASA Glenn, Cleveland,
   Ohio, for his assistance with ATR-FTIR.
CR Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104
   Aneja A, 2003, POLYMER, V44, P7221, DOI 10.1016/j.polymer.2003.07.007
   Brulc B, 2011, MACROMOL CHEM PHYS, V212, P550, DOI 10.1002/macp.201000710
   Buehler MJ, 2008, NANO RES, V1, P63, DOI 10.1007/s12274-008-8006-7
   Buehler MJ, 2008, PROG MATER SCI, V53, P1101, DOI 10.1016/j.pmatsci.2008.06.002
   CHOU KC, 1982, J MOL BIOL, V162, P89, DOI 10.1016/0022-2836(82)90163-2
   DALY WH, 1988, TETRAHEDRON LETT, V29, P5859, DOI 10.1016/S0040-4039(00)82209-1
   Das S, 2007, POLYMER, V48, P290, DOI 10.1016/j.polymer.2006.10.029
   Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110
   Fu SY, 1996, COMPOS SCI TECHNOL, V56, P1179, DOI 10.1016/S0266-3538(96)00072-3
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   Groschel AH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1707
   Hoffmann T, 2013, PHYS CHEM CHEM PHYS, V15, P15767, DOI 10.1039/c3cp52142g
   Ibarboure E, 2006, J POLYM SCI POL CHEM, V44, P4668, DOI 10.1002/pola.21559
   James PJ, 2001, LANGMUIR, V17, P349, DOI 10.1021/la000332h
   Johnson JC, 2012, SOFT MATTER, V8, P11431, DOI 10.1039/c2sm26185e
   Johnson JC, 2012, BIOMACROMOLECULES, V13, P1279, DOI 10.1021/bm201800v
   KATAKAI R, 1985, J ORG CHEM, V50, P715, DOI 10.1021/jo00205a039
   Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670
   Kim HJ, 2000, BIOMATERIALS, V21, P131, DOI 10.1016/S0142-9612(99)00140-4
   Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057
   Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Liu KS, 2011, NANO TODAY, V6, P155, DOI 10.1016/j.nantod.2011.02.002
   McLean RS, 1997, MACROMOLECULES, V30, P8314, DOI 10.1021/ma970350e
   Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854
   Naik SS, 2009, MACROMOLECULES, V42, P7114, DOI 10.1021/ma9011126
   Perticaroli S., 2013, SOFT MATTER, P9548
   Qin Z, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.198304
   Rathore O, 2001, J AM CHEM SOC, V123, P5231, DOI 10.1021/ja004030d
   Rathore O, 2001, MACROMOLECULES, V34, P1477, DOI 10.1021/ma001553x
   Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/nmat3115, 10.1038/NMAT3115]
   Sheth JP, 2005, POLYMER, V46, P7317, DOI 10.1016/j.polymer.2005.04.041
   SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001
   Tai K, 2007, NAT MATER, V6, P454, DOI 10.1038/nmat1911
   Tanaka S, 2004, MACROMOLECULES, V37, P1370, DOI 10.1021/ma035472n
   Termonia Y, 2004, BIOMACROMOLECULES, V5, P2404, DOI 10.1021/bm049662x
   Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539
   Versteegen RM, 2006, MACROMOLECULES, V39, P772, DOI 10.1021/ma051874e
   Wildman KAH, 2002, BIOPOLYMERS, V64, P246, DOI 10.1002/bip.10180
   Winningham MJ, 1997, MACROMOLECULES, V30, P862, DOI 10.1021/ma960804s
   Woolfson DN, 2010, BIOPOLYMERS, V94, P118, DOI 10.1002/bip.21345
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
NR 44
TC 13
Z9 13
U1 2
U2 45
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 17
BP 2554
EP 2561
DI 10.1039/c3tb21476a
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA AE6RK
UT WOS:000334121500022
DA 2018-10-20
ER

PT S
AU Tzeranis, DS
   So, PTC
   Yannas, IV
AF Tzeranis, Dimitrios S.
   So, Peter T. C.
   Yannas, Ioannis V.
BE Achilefu, S
   Raghavachari, R
TI Quantifying the Surface Chemistry of 3D Matrices in situ
SO REPORTERS, MARKERS, DYES, NANOPARTICLES, AND MOLECULAR PROBES FOR
   BIOMEDICAL APPLICATIONS VI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Reporters, Markers, Dyes, Nanoparticles, and Molecular
   Probes for Biomedical Applications VI
CY FEB 02-05, 2014
CL San Francisco, CA
SP SPIE
DE Biomaterials; Surface chemistry; Adhesion Ligands; Extracellular matrix;
   Spectral Microscopy
ID INTEGRIN ALPHA-2-BETA-1; BINDING-SITE; COLLAGEN; DOMAIN; BIOMATERIALS;
   RECOGNITION; SCAFFOLDS; LAMININ
AB Despite the major role of the matrix (the insoluble environment around cells) in physiology and pathology, there are very few and limited methods that can quantify the surface chemistry of a 3D matrix such as a biomaterial or tissue ECM. This study describes a novel optical-based methodology that can quantify the surface chemistry (density of adhesion ligands for particular cell adhesion receptors) of a matrix in situ. The methodology utilizes fluorescent analogs (markers) of the receptor of interest and a series of binding assays, where the amount of bound markers on the matrix is quantified via spectral multi-photon imaging. The study provides preliminary results for the quantification of the ligands for the two major collagen-binding integrins (alpha(1)beta(1), alpha(2)beta(1)) in porous collagen scaffolds that have been shown to be able to induce maximum regeneration in transected peripheral nerves. The developed methodology opens the way for quantitative descriptions of the insoluble microenvironment of cells in physiology and pathology, and for integrating the matrix in quantitative models of cell signaling.
C1 [Tzeranis, Dimitrios S.; So, Peter T. C.; Yannas, Ioannis V.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
RP Tzeranis, DS (reprint author), MIT, Dept Mech Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
OI Tzeranis, Dimitrios/0000-0001-8730-301X
CR Adams S, 2002, FORBES, V169, P124
   Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Barber TA, 2005, BIOMATERIALS, V26, P6897, DOI 10.1016/j.biomaterials.2005.04.043
   Buehler C, 2005, J FLUORESC, V15, P41, DOI 10.1007/s10895-005-0212-z
   Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   Harbers GM, 2005, LANGMUIR, V21, P8374, DOI 10.1021/la050396y
   KAMATA T, 1994, J BIOL CHEM, V269, P26006
   Naba A., 2012, MOL CELL PROTEOMICS, V11
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026
   Soller EC, 2012, BIOMATERIALS, V33, P4783, DOI 10.1016/j.biomaterials.2012.03.068
   TUCKWELL D, 1995, J CELL SCI, V108, P1629
   Tulla M, 2008, EXP CELL RES, V314, P1734, DOI 10.1016/j.yexcr.2008.01.025
   Vakonakis I, 2007, CURR OPIN CELL BIOL, V19, P578
   Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200
   Yannas I., 2001, TISSUE ORGAN REGENER
NR 19
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9869-4
J9 PROC SPIE
PY 2014
VL 8956
DI 10.1117/12.2038664
PG 6
WC Nanoscience & Nanotechnology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Science & Technology - Other Topics; Optics; Radiology, Nuclear Medicine
   & Medical Imaging
GA BA3BW
UT WOS:000334099100010
OA Green Published
DA 2018-10-20
ER

PT J
AU Fu, RH
   Wang, YC
   Liu, SP
   Shih, TR
   Lin, HL
   Chen, YM
   Sung, JH
   Lu, CH
   Wei, JR
   Wang, ZW
   Huang, SJ
   Tsai, CH
   Shyu, WC
   Lin, SZ
AF Fu, Ru-Huei
   Wang, Yu-Chi
   Liu, Shih-Ping
   Shih, Ton-Ru
   Lin, Hsin-Lien
   Chen, Yue-Mi
   Sung, Jiun-Huei
   Lu, Chia-Hui
   Wei, Jing-Rong
   Wang, Zih-Wan
   Huang, Shyh-Jer
   Tsai, Chang-Hai
   Shyu, Woei-Cherng
   Lin, Shinn-Zong
TI Decellularization and Recellularization Technologies in Tissue
   Engineering
SO CELL TRANSPLANTATION
LA English
DT Review
DE Biomaterial; Decellularization; Extracellular matrix (ECM); Organ
   bioengineering and regeneration; Recellularization
ID EXTRACELLULAR-MATRIX SCAFFOLDS; ANTERIOR CRUCIATE LIGAMENT;
   URINARY-BLADDER MATRIX; PATELLAR TENDON-BONE; STEM-CELLS; REGENERATIVE
   MEDICINE; MECHANICAL-PROPERTIES; BIOARTIFICIAL LUNG; COLLAGEN MATRICES;
   CARDIAC TISSUE
AB Decellularization is the process by which cells are discharged from tissues/organs, but all of the essential cues for cell preservation and homeostasis are retained in a three-dimensional structure of the organ and its extracellular matrix components. During tissue decellularization, maintenance of the native ultrastructure and composition of the extracellular matrix (ECM) is extremely acceptable. For recellularization, the scaffold/matrix is seeded with cells, the final goal being to form a practical organ. In this review, we focus on the biological properties of the ECM that remains when a variety of decellularization methods are used, comparing recellularization technologies, including bioreactor expansion for perfusion-based bioartificial organs, and we discuss cell sources. In the future, decellularization-recellularization procedures may solve the problem of organ assembly on demand.
C1 [Fu, Ru-Huei; Shih, Ton-Ru; Lin, Hsin-Lien; Chen, Yue-Mi; Sung, Jiun-Huei; Lu, Chia-Hui; Wei, Jing-Rong; Wang, Zih-Wan; Shyu, Woei-Cherng; Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung 40402, Taiwan.
   [Fu, Ru-Huei; Liu, Shih-Ping; Shyu, Woei-Cherng; Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung 40447, Taiwan.
   [Wang, Yu-Chi] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan.
   [Liu, Shih-Ping] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan.
   [Huang, Shyh-Jer] China Med Univ Hosp, Chinese Med Res & Dev Ctr, Taichung 40447, Taiwan.
   [Tsai, Chang-Hai] China Med Univ, Dept Pediat, Taichung 40402, Taiwan.
   [Tsai, Chang-Hai] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan.
   [Lin, Shinn-Zong] China Med Univ, Beigang Hosp, Dept Neurosurg, Yunlin, Taiwan.
   [Lin, Shinn-Zong] China Med Univ, Tainan Municipal An Nan Hosp, Dept Neurosurg, Tainan 40402, Taiwan.
RP Lin, SZ (reprint author), China Med Univ Hosp, Ctr Neuropsychiat, 2 Yude Rd, Taichung 40447, Taiwan.
EM rhfu@mail.cmu.edu.tw; shinnzong@yahoo.com.tw
FU National Science Council (Taiwan) [NSC 100-2314-B-039-036-MY2]; Taiwan
   Department of Health Clinical Trial and Research Center of Excellence
   [DOH102-TD-B-111-004]; China Medical University [DMR103-054]
FX This work was supported by the National Science Council (Taiwan) (NSC
   100-2314-B-039-036-MY2), the Taiwan Department of Health Clinical Trial
   and Research Center of Excellence (DOH102-TD-B-111-004), and China
   Medical University (DMR103-054). The authors declare no conflicts of
   interest.
CR Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989
   Allen RA, 2010, TISSUE ENG PT A, V16, P3363, DOI [10.1089/ten.tea.2010.0005, 10.1089/ten.TEA.2010.0005]
   AUNINS JG, 1989, BIOTECHNOL BIOENG, V34, P1127, DOI 10.1002/bit.260340902
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Baiguera S, 2010, TRANSPLANTATION, V89, P485, DOI 10.1097/TP.0b013e3181cd4ad3
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Boer U, 2011, BIOMATERIALS, V32, P9730, DOI 10.1016/j.biomaterials.2011.09.015
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Bonvillain RW, 2012, TISSUE ENG PT A, V18, P2437, DOI [10.1089/ten.tea.2011.0594, 10.1089/ten.TEA.2011.0594]
   Booth C, 2012, WORLD J GASTROENTERO, V18, P6926, DOI 10.3748/wjg.v18.i47.6926
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Cartmell JS, 2000, J BIOMED MATER RES, V49, P134, DOI 10.1002/(SICI)1097-4636(200001)49:1<134::AID-JBM17>3.3.CO;2-4
   Oliveira AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066538
   Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589
   COLE MB, 1984, J MICROSC-OXFORD, V133, P129, DOI 10.1111/j.1365-2818.1984.tb00478.x
   Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136
   De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1097/01.ju.0000027662.69103.72
   Decaris ML, 2012, TISSUE ENG PT A, V18, P2148, DOI [10.1089/ten.TEA.2011.0677, 10.1089/ten.tea.2011.0677]
   Deeken CR, 2011, J BIOMED MATER RES B, V96B, P199, DOI 10.1002/jbm.b.31753
   Evan G, 2010, DEV CELL, V19, P185, DOI 10.1016/j.devcel.2010.07.023
   Falke G, 2003, TISSUE ENG, V9, P871, DOI 10.1089/107632703322495529
   Fissell WH, 2001, ANN NY ACAD SCI, V944, P284
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   GAILIT J, 1988, J BIOL CHEM, V263, P12927
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goh SK, 2013, BIOMATERIALS, V34, P6760, DOI 10.1016/j.biomaterials.2013.05.066
   Gorschewsky O, 2005, BIO-MED MATER ENG, V15, P403
   Gorschewsky O, 2005, AM J SPORT MED, V33, P1202, DOI 10.1177/0363546504271510
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   Ho TC, 1997, INVEST OPHTH VIS SCI, V38, P1110
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315
   HUMES HD, 1992, EXP CELL RES, V201, P8, DOI 10.1016/0014-4827(92)90342-6
   Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002
   Issa RI, 2011, TISSUE ENG PT A, V17, P1479, DOI [10.1089/ten.tea.2010.0484, 10.1089/ten.TEA.2010.0484]
   Jamur MC, 2010, METHODS MOL BIOL, V588, P55, DOI 10.1007/978-1-59745-324-0_8
   Kang YQ, 2012, BIOMATERIALS, V33, P6998, DOI 10.1016/j.biomaterials.2012.06.061
   Kim K, 2011, ACTA BIOMATER, V7, P1249, DOI 10.1016/j.actbio.2010.11.007
   KLEBE RJ, 1974, NATURE, V250, P248, DOI 10.1038/250248a0
   Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lawrence B. J., 2008, BIOTECHNOL BIOENG, V102, P935
   Liu Y, 2009, BIOMATERIALS, V30, P3865, DOI 10.1016/j.biomaterials.2009.04.008
   Lu HX, 2012, J BIOMED MATER RES A, V100A, P2507, DOI 10.1002/jbm.a.34150
   Lumpkins SB, 2008, ACTA BIOMATER, V4, P808, DOI 10.1016/j.actbio.2008.01.016
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Maidhof R, 2012, J TISSUE ENG REGEN M, V6, pe12, DOI 10.1002/term.525
   Melchels FPW, 2011, BIOMATERIALS, V32, P2878, DOI 10.1016/j.biomaterials.2011.01.023
   Mishra DK, 2012, ANN THORAC SURG, V93, P1075, DOI 10.1016/j.athoracsur.2012.01.011
   Montoya CV, 2009, TISSUE ENG PART C-ME, V15, P191, DOI 10.1089/ten.tec.2008.0372
   Moran Emma C, 2012, Biomed Sci Instrum, V48, P303
   Murry CE, 2011, NEW ENGL J MED, V364, P177, DOI 10.1056/NEJMcibr1013069
   Nagata H, 2007, GASTROENTEROLOGY, V132, P321, DOI 10.1053/j.gastro.2006.10.013
   Nahmias Y, 2007, ADV BIOCHEM ENG BIOT, V103, P309, DOI 10.1007/10_029
   Nakamura T, 2011, GEN THORAC CARDIOVAS, V59, P91, DOI 10.1007/s11748-010-0677-9
   Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI 10.1089/ten.TEA.2009.0602
   Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Patel N, 2008, PROTEOMICS, V8, P1055, DOI 10.1002/pmic.200700856
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Prasertsung I, 2008, J BIOMED MATER RES B, V85B, P210, DOI 10.1002/jbm.b.30938
   Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Roh JD, 2007, TISSUE ENG, V13, P2743, DOI 10.1089/ten.2007.0171
   Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145
   Sadr N, 2012, BIOMATERIALS, V33, P5085, DOI 10.1016/j.biomaterials.2012.03.082
   Sano MB, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-83
   Schechner JS, 2003, FASEB J, V17, P2250, DOI 10.1096/fj.03-0257com
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011
   Shirakigawa N, 2012, J BIOSCI BIOENG, V114, P546, DOI 10.1016/j.jbiosc.2012.05.022
   Shupe T, 2010, ORGANOGENESIS, V6, P134, DOI 10.4161/org.6.2.11546
   Simionescu DT, 2003, J HEART VALVE DIS, V12, P226
   Song JJ, 2012, AM J TRANSPLANT, V12, P283, DOI 10.1111/j.1600-6143.2011.03808.x
   Song JJ, 2011, ANN THORAC SURG, V92, P998, DOI 10.1016/j.athoracsur.2011.05.018
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698
   Soto-Gutierrez A, 2010, CELL TRANSPLANT, V19, P655, DOI 10.3727/096368910X508753
   Stapleton TW, 2008, TISSUE ENG PT A, V14, P505, DOI 10.1089/tea.2007.0233
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tandon N, 2008, IEEE ENG MED BIO, P3594, DOI 10.1109/IEMBS.2008.4649983
   Toni R, 2011, ANN ANAT, V193, P381, DOI 10.1016/j.aanat.2011.06.004
   Traverse JH, 2011, JAMA-J AM MED ASSOC, V306, P2110, DOI 10.1001/jama.2011.1670
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Villalona GA, 2010, TISSUE ENG PART B-RE, V16, P341, DOI 10.1089/ten.TEB.2009.0527
   Volkmer E, 2008, TISSUE ENG PT A, V14, P1331, DOI 10.1089/ten.tea.2007.0231
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143
   Weinand C, 2009, J BIOMED MATER RES B, V91B, P80, DOI 10.1002/jbm.b.31376
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
   Xia Y, 2011, J MATER SCI-MATER M, V22, P389, DOI 10.1007/s10856-010-4211-5
   Yang B, 2010, TISSUE ENG PART C-ME, V16, P1201, DOI [10.1089/ten.tec.2009.0311, 10.1089/ten.TEC.2009.0311]
   Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099
NR 100
TC 32
Z9 32
U1 0
U2 52
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2014
VL 23
IS 4-5
BP 621
EP 630
DI 10.3727/096368914X678382
PG 10
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA AE3OD
UT WOS:000333884900021
PM 24816454
OA Bronze
DA 2018-10-20
ER

PT J
AU Halpern, JM
   Gormley, CA
   Keech, MA
   von Recum, HA
AF Halpern, Jeffrey M.
   Gormley, Catherine A.
   Keech, Melissa A.
   von Recum, Horst A.
TI Thermomechanical properties, antibiotic release, and bioactivity of a
   sterilized cyclodextrin drug delivery system
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID ETHYLENE-OXIDE STERILIZATION; MECHANICAL-PROPERTIES; IRRADIATION
   STERILIZATION; RADIATION STERILIZATION; THERMAL-TREATMENT; HYDROGELS;
   POLY(L-LACTIDE); MICROSPHERES; POLYLACTIDES; BIOMATERIAL
AB Various local drug delivery devices and coatings are being developed as slow, sustained release mechanism for drugs, yet the polymers are typically not evaluated after commercial sterilization techniques. We examine the effect that commercial sterilization techniques have on the physical, mechanical, and drug delivery properties of polyurethane polymers. Specifically we tested cyclodextrin-hexamethyl diisocyanate crosslinked polymers before and after autoclave, ethylene oxide, and gamma radiation sterilization processes. We found that there is no significant change in the properties of polymers sterilized by ethylene oxide and gamma radiation compared to non-sterilized polymers. Polymers sterilized by autoclave showed increased tensile strength (p < 0.0001) compared to non-sterilized polymers. In the release of drugs, which were loaded after the autoclave sterilization process, we observed a prolonged release (p < 0.05) and a prolonged therapeutic effect (p < 0.05) but less drug loading (p < 0.0001) compared to non-sterilized polymers. The change in the release profile and tensile strength in polymers sterilized by autoclave was interpreted as being caused by additional crosslinking from residual, unreacted, or partially-reacted crosslinker contained within the polymer. Autoclaving therefore represents additional thermo-processing to modify rate and dose from polyurethanes and other materials.
C1 [Halpern, Jeffrey M.; Gormley, Catherine A.; Keech, Melissa A.; von Recum, Horst A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44118 USA.
RP von Recum, HA (reprint author), Case Western Reserve Univ, Dept Biomed Engn, 10900 Euclid Ave, Cleveland, OH 44118 USA.
EM hav1@case.edu
OI Halpern, Jeffrey/0000-0003-0814-1986
FU National Institutes of Health under Ruth L. Kirschstein National
   Research Service Award from the NIH NIAMS [T32 AR007505]; NSF CAREER
   Award [CBET1235738]; Innovation Incentive Program
FX This investigation was supported by the National Institutes of Health
   under Ruth L. Kirschstein National Research Service Award T32 AR007505
   from the NIH NIAMS, the Innovation Incentive Program administered by the
   Advanced Platform Technology Center within Veteran Affairs Hospitals,
   and von Recum's REU supplement of his NSF CAREER Award (CBET1235738).
CR Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Calis S, 2002, FARMACO, V57, P55, DOI 10.1016/S0014-827X(01)01171-5
   Chmielewski AG, 2005, NUCL INSTRUM METH B, V236, P44, DOI 10.1016/j.nimb.2005.03.2247
   DARMADY EM, 1961, J CLIN PATHOL, V14, P38, DOI 10.1136/jcp.14.1.38
   FORD JH, 1953, ANAL CHEM, V25, P1195, DOI 10.1021/ac60080a014
   Fouad H, 2013, INT J ELECTROCHEM SC, V8, P2293
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gibas I, 2010, CHEM CHEM TECHOL, V4, P297
   Gogolewski S, 1997, BIOMATERIALS, V18, P251, DOI 10.1016/S0142-9612(96)00132-9
   Gogolewski S, 1996, BIOMATERIALS, V17, P523, DOI 10.1016/0142-9612(96)82727-X
   Goldman M, 1996, POLYMER, V37, P2909, DOI 10.1016/0032-3861(96)89386-4
   Grabow N, 2005, J BIOMECH ENG-T ASME, V127, P25, DOI 10.1115/1.1835349
   Harth KC, 2010, J SURG RES, V163, P337, DOI 10.1016/j.jss.2010.03.065
   HIRATA N, 1995, RADIAT PHYS CHEM, V46, P377, DOI 10.1016/0969-806X(94)00134-6
   Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010
   ISHIGAKI I, 1992, RADIAT PHYS CHEM, V39, P527
   Juan A. S., 2012, MAT SCI ENG A-STRUCT, V31, P1
   Koo G.-H., 2013, J APPL POLYM SCI, P4515
   Lerouge S., 2001, PLASMAS POLYM, V6, P175, DOI DOI 10.1023/A:1013196629791
   Mendes GCC, 2007, AM J INFECT CONTROL, V35, P574, DOI 10.1016/j.ajic.2006.10.014
   Merritt SR, 2013, EXP EYE RES, V116, P9, DOI 10.1016/j.exer.2013.07.005
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P81, DOI 10.1007/s10561-006-9019-7
   Odelius K, 2008, BIOMATERIALS, V29, P129, DOI 10.1016/j.biomaterials.2007.08.046
   Phillip E, 2013, J BIOMED MATER RES B, V101B, P532, DOI 10.1002/jbm.b.32853
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Razem D, 2008, RADIAT PHYS CHEM, V77, P288, DOI 10.1016/j.radphyschem.2007.06.006
   Reich MS, 2013, CELL TISSUE BANK, V14, P381, DOI 10.1007/s10561-012-9335-z
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   Thatiparti TR, 2011, MACROMOL BIOSCI, V11, P1544, DOI 10.1002/mabi.201100159
   Thatiparti TR, 2010, BIOMATERIALS, V31, P2335, DOI 10.1016/j.biomaterials.2009.11.087
   Thatiparti TR, 2010, MACROMOL BIOSCI, V10, P82, DOI 10.1002/mabi.200900204
   VOLLAND C, 1994, J CONTROL RELEASE, V31, P293, DOI 10.1016/0168-3659(94)90012-4
   Zahraoui C, 1999, BONE, V25, p63S, DOI 10.1016/S8756-3282(99)00136-2
NR 34
TC 20
Z9 20
U1 0
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 18
BP 2764
EP 2772
DI 10.1039/c4tb00083h
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA AE6RQ
UT WOS:000334122300014
PM 24949201
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Johnson, TD
   DeQuach, JA
   Gaetani, R
   Ungerleider, J
   Elhag, D
   Nigam, V
   Behfar, A
   Christman, KL
AF Johnson, Todd D.
   DeQuach, Jessica A.
   Gaetani, Roberto
   Ungerleider, Jessica
   Elhag, Dean
   Nigam, Vishal
   Behfar, Atta
   Christman, Karen L.
TI Human versus porcine tissue sourcing for an injectable myocardial matrix
   hydrogel
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID SOURCE ANIMAL AGE; EXTRACELLULAR-MATRIX; IN-VITRO; PROGENITOR CELLS;
   CARDIAC-FUNCTION; SCAFFOLD; DIFFERENTIATION; INFARCTION;
   DECELLULARIZATION; CARDIOMYOCYTES
AB Heart failure (HF) after myocardial infarction (MI) is a leading cause of death in the western world with a critical need for new therapies. A previously developed injectable hydrogel derived from porcine myocardial matrix (PMM) has had successful results in both small and large animal MI models. In this study, we sought to evaluate the impact of tissue source on this biomaterial, specifically comparing porcine and human myocardium sources. We first developed an analogous hydrogel derived from human myocardial matrix (HMM). The biochemical and physical properties of the PMM and HMM hydrogels were then characterized, including residual dsDNA, protein content, sulfated glycosaminoglycan (sGAG) content, complex viscosity, storage and loss moduli, and nano-scale topography. Biochemical activity was investigated with in vitro studies for the proliferation of vascular cells and differentiation of human cardiomyocyte progenitor cells (hCMPCs). Next, in vivo gelation and material spread were confirmed for both PMM and HMM after intramyocardial injection. After extensive comparison, the matrices were found to be similar, yet did show some differences. Because of the rarity of collecting healthy human hearts, the increased difficulty in processing the human tissue, shifts in extracellular matrix (ECM) composition due to aging, and significant patient-to-patient variability, these studies suggest that the HMM is not a viable option as a scalable product for the clinic; however, the HMM has potential as a tool for in vitro cell culture.
C1 [Johnson, Todd D.; DeQuach, Jessica A.; Gaetani, Roberto; Ungerleider, Jessica; Elhag, Dean; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.
   [Gaetani, Roberto] Univ Med Ctr Utrecht, HLCU, Dept Cardiol, Utrecht, Netherlands.
   [Nigam, Vishal] Rady Childrens Hosp, Div Cardiol, Dept Pediat, San Diego, CA USA.
   [Nigam, Vishal] Univ Calif San Diego, La Jolla, CA 92037 USA.
   [Behfar, Atta] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA.
RP Johnson, TD (reprint author), Univ Calif San Diego, Dept Bioengn, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.
EM christman@eng.ucsd.edu
FU NIH Heart, Lung, Blood Institute [5R01HL113468]; Leducq Foundation
   Transatlantic Career Development Award (RG); NSF; NHLBI; Powell
   Foundation
FX The authors would like to thank Dr Ghassemian and Matt Joens for their
   technical expertise in mass spectrometry and scanning electron
   microscopy, respectively. The authors would also like to thank
   Lifesharing for their assistance in obtaining the human cardiac tissue.
   Funding for this study was provided by the NIH Heart, Lung, Blood
   Institute 5R01HL113468 (KLC) and the Leducq Foundation Transatlantic
   Career Development Award (RG). TDJ received funding during this project
   from the NSF as a graduate student fellow, the NHLBI as a training grant
   recipient, and as a Powell Fellow from the Powell Foundation. KLC is
   co-founder, board member, and holds equity interest in Ventrix, Inc.
CR Anna Biernacka N. G. F., 2011, AGING DIS, V2, P158
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082
   Burgess ML, 2001, MECH AGEING DEV, V122, P1739, DOI 10.1016/S0047-6374(01)00296-2
   Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   de Souza RR, 2002, BIOGERONTOLOGY, V3, P325, DOI 10.1023/A:1021312027486
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Johnson T. D., 2012, EXPERT OPIN DRUG DEL, P1
   Johnson TD, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494015
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Leeuwenburgh C, 1997, ARCH BIOCHEM BIOPHYS, V346, P74, DOI 10.1006/abbi.1997.0297
   Oberwallner B., 2013, J BIOMED MAT RES
   Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   SANANTONIO JD, 1993, ARTERIOSCLER THROMB, V13, P748, DOI 10.1161/01.ATV.13.5.748
   Seif-Naraghi S. B., 2013, SCI TRANSL MED, V5, P173
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Sellaro TL, 2007, TISSUE ENG, V13, P2301, DOI 10.1089/ten.2006.0437
   Sicari BM, 2012, BIOMATERIALS, V33, P5524, DOI 10.1016/j.biomaterials.2012.04.017
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2011, MACROMOL BIOSCI, V11, P731, DOI 10.1002/mabi.201000423
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229
   Tottey S, 2011, BIOMATERIALS, V32, P128, DOI 10.1016/j.biomaterials.2010.09.006
   Uriel S, 2009, TISSUE ENG PART C-ME, V15, P309, DOI 10.1089/ten.tec.2008.0309
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
NR 37
TC 11
Z9 11
U1 0
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 5
BP 735
EP 744
DI 10.1039/c3bm60283d
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AD9IW
UT WOS:000333579600015
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hansen, TD
   Koepsel, JT
   Le, NN
   Nguyen, EH
   Zorn, S
   Parlato, M
   Loveland, SG
   Schwartz, MP
   Murphy, WL
AF Hansen, Tyler D.
   Koepsel, Justin T.
   Ngoc Nhi Le
   Nguyen, Eric H.
   Zorn, Stefan
   Parlato, Matthew
   Loveland, Samuel G.
   Schwartz, Michael P.
   Murphy, William L.
TI Biomaterial arrays with defined adhesion ligand densities and matrix
   stiffness identify distinct phenotypes for tumorigenic and
   non-tumorigenic human mesenchymal cell types
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID HT1080 FIBROSARCOMA CELLS; SELF-ASSEMBLED MONOLAYERS; AGGRESSIVE
   TUMOR-GROWTH; RHO-KINASE; FOCAL ADHESIONS; MIGRATION SPEED; STEM-CELLS;
   RAS GENE; FIBROBLASTS; INVASION
AB Here, we aimed to investigate migration of a model tumor cell line (HT-1080 fibrosarcoma cells, HT-1080s) using synthetic biomaterials to systematically vary peptide ligand density and substrate stiffness. A range of substrate elastic moduli were investigated by using poly(ethylene glycol) (PEG) hydrogel arrays (0.34-17 kPa) and self-assembled monolayer (SAM) arrays (similar to 0.1-1 GPa), while cell adhesion was tuned by varying the presentation of Arg-Gly-Asp (RGD)-containing peptides. HT-1080 motility was insensitive to cell adhesion ligand density on RGD-SAMs, as they migrated with similar speed and directionality for a wide range of RGD densities (0.2-5% mol fraction RGD). Similarly, HT-1080 migration speed was weakly dependent on adhesion on 0.34 kPa PEG surfaces. On 13 kPa surfaces, a sharp initial increase in cell speed was observed at low RGD concentration, with no further changes observed as RGD concentration was increased further. An increase in cell speed similar to two-fold for the 13 kPa relative to the 0.34 kPa PEG surface suggested an important role for substrate stiffness in mediating motility, which was confirmed for HT-1080s migrating on variable modulus PEG hydrogels with constant RGD concentration. Notably, despite similar to two-fold changes in cell speed over a wide range of moduli, HT-1080s adopted rounded morphologies on all surfaces investigated, which contrasted with well spread primary human mesenchymal stem cells (hMSCs). Taken together, our results demonstrate that HT-1080s are morphologically distinct from primary mesenchymal cells (hMSCs) and migrate with minimal dependence on cell adhesion for surfaces within a wide range of moduli, whereas motility is strongly influenced by matrix mechanical properties.
C1 [Hansen, Tyler D.; Koepsel, Justin T.; Nguyen, Eric H.; Zorn, Stefan; Parlato, Matthew; Loveland, Samuel G.; Schwartz, Michael P.; Murphy, William L.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Ngoc Nhi Le; Murphy, William L.] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.
   [Murphy, William L.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI USA.
RP Hansen, TD (reprint author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
EM mpschwartz@wisc.edu; wlmurphy@wisc.edu
RI Schwartz, Mike/O-7963-2016; Schwartz, Michael/B-3417-2008; Murphy,
   William/I-4096-2014
OI Schwartz, Mike/0000-0003-3785-6606; Schwartz,
   Michael/0000-0003-3785-6606; 
FU National Institutes of Health (NIH) [R01 HL093282-01A1, R21 EB016381-01,
   1UH2 TR000506-01]; National Science Foundation for a Graduate Research
   Fellowship [DGE-0718123]; University of Wisconsin Graduate Engineering
   Research Scholars, and the Gates Millennium Scholars Program
FX Funding was provided by the National Institutes of Health (NIH R01
   HL093282-01A1, NIH R21 EB016381-01, NIH 1UH2 TR000506-01) and a donation
   in the memory of Gerald E. Whitbeck (generously provided by his family
   and Follett Corp). NNL thanks the National Science Foundation for a
   Graduate Research Fellowship (Grant DGE-0718123), the University of
   Wisconsin Graduate Engineering Research Scholars, and the Gates
   Millennium Scholars Program.
CR Asthana A, 2013, DRUG DISCOV TODAY, V18, P533, DOI 10.1016/j.drudis.2012.12.005
   Baba AI, 2007, COMP ONCOLOGY
   Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051
   Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881
   BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5
   BROWN AF, 1982, J CELL SCI, V58, P455
   BROWN R, 1984, EMBO J, V3, P1321, DOI 10.1002/j.1460-2075.1984.tb01970.x
   BUBENIK J, 1979, INT J CANCER, V23, P392, DOI 10.1002/ijc.2910230318
   Coman DR, 1944, CANCER RES, V4, P625
   COTTLERFOX M, 1980, INT J CANCER, V26, P689, DOI 10.1002/ijc.2910260523
   Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077
   DAVIDPFEUTY T, 1980, P NATL ACAD SCI-BIOL, V77, P6687, DOI 10.1073/pnas.77.11.6687
   DelRio F. W., 2009, APPL PHYS LETT, V94
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dubiel EA, 2011, CHEM REV, V111, P2900, DOI 10.1021/cr9002598
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062
   Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075
   Gupta S, 2001, MOL CELL BIOL, V21, P5846, DOI 10.1128/MCB.21.17.5846-5856.2001
   Gupta S, 2000, MOL CELL BIOL, V20, P9294, DOI 10.1128/MCB.20.24.9294-9306.2000
   Hakanson M, 2011, INTEGR BIOL-UK, V3, P31, DOI 10.1039/c0ib00074d
   HALL A, 1983, NATURE, V303, P396, DOI 10.1038/303396a0
   Hoffmann JC, 2013, INTEGR BIOL-UK, V5, P817, DOI 10.1039/c3ib20280a
   Hudalla GA, 2011, SOFT MATTER, V7, P9561, DOI 10.1039/c1sm05596h
   Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001
   Huttenlocher A., 2011, COLD SPRING HARBOR P, P3
   Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669
   Koepsel JT, 2012, INTEGR BIOL-UK, V4, P1508, DOI 10.1039/c2ib20029e
   Koepsel JT, 2012, J MATER CHEM, V22, P19474, DOI 10.1039/c2jm32242k
   Koepsel JT, 2012, CHEMBIOCHEM, V13, P1717, DOI 10.1002/cbic.201200226
   Koepsel JT, 2012, INTEGR BIOL-UK, V4, P914, DOI 10.1039/c2ib20055d
   Koepsel JT, 2009, LANGMUIR, V25, P12825, DOI 10.1021/la901938e
   Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Levental I., 2007, SOFT MATTER, P3
   LEWIS L, 1982, J CELL SCI, V53, P21
   Loessner D, 2013, INTEGR BIOL-UK, V5, P597, DOI 10.1039/c3ib20252f
   Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064
   Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013
   Miyake K., 2006, APPL PHYS LETT, P89
   Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e
   Mrksich M, 2009, ACTA BIOMATER, V5, P832, DOI 10.1016/j.actbio.2009.01.016
   Nelson CM, 2005, SEMIN CANCER BIOL, V15, P342, DOI 10.1016/j.semcancer.2005.05.001
   Niggli V, 2006, BIOCHEM BIOPH RES CO, V343, P602, DOI 10.1016/j.bbrc.2006.03.022
   Niggli V, 2009, BIOCHEM BIOPH RES CO, V386, P688, DOI 10.1016/j.bbrc.2009.06.098
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PLANTEFABER LC, 1989, CELL, V56, P281, DOI 10.1016/0092-8674(89)90902-1
   Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009
   RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z
   RAZ A, 1982, CANCER RES, V42, P5183
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   SABATANI E, 1987, J ELECTROANAL CHEM, V219, P365, DOI 10.1016/0022-0728(87)85054-4
   Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195
   Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019
   Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020
   SCHLIWA M, 1984, J CELL BIOL, V99, P1045, DOI 10.1083/jcb.99.3.1045
   Schwartz MP, 2010, INTEGR BIOL-UK, V2, P32, DOI 10.1039/b912438a
   Schwartz MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081689
   Shabbir SH, 2010, ANGEW CHEM INT EDIT, V49, P7706, DOI 10.1002/anie.201002699
   Stroka KM, 2009, CELL MOTIL CYTOSKEL, V66, P328, DOI 10.1002/cm.20363
   Sung KE, 2011, INTEGR BIOL-UK, V3, P439, DOI 10.1039/c0ib00063a
   Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223
   VOLK T, 1984, CANCER RES, V44, P811
   Witze ES, 2013, DEV CELL, V26, P645, DOI 10.1016/j.devcel.2013.08.019
   Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006
   Zaman MH, 2013, NAT REV CANCER, V13, P596, DOI 10.1038/nrc3564
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
NR 75
TC 20
Z9 20
U1 0
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 5
BP 745
EP 756
DI 10.1039/c3bm60278h
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA AD9IW
UT WOS:000333579600016
PM 25386339
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Cai, L
   Dinh, CB
   Heilshorn, SC
AF Cai, Lei
   Dinh, Cong B.
   Heilshorn, Sarah C.
TI One-pot synthesis of elastin-like polypeptide hydrogels with grafted
   VEGF-mimetic peptides
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; CELL BEHAVIOR; CROSS-LINKING; IN-VIVO; PEG
   HYDROGELS; ANGIOGENESIS; RGD; DELIVERY; BIOMATERIALS; DEGRADATION
AB Immobilization of growth factors to polymeric matrices has been a common strategy in the design of tissue engineering scaffolds to promote tissue regeneration, which requires complex cell signaling events with the surrounding matrix. However, the use of large protein growth factors in polymeric scaffolds is often plagued by immunogenicity, short in vivo half-lives, and reduced bioactivity. To address these concerns, we developed a single-step, cell-compatible strategy to tether small, growth-factor-mimetic peptides into a protein-engineered hydrogel with tunable biomaterial properties. Specifically, we covalently immobilized the QK peptide, an angiogenic peptide mimicking the receptor-binding region of vascular endothelial growth factor (VEGF), within tunable elastin-like polypeptide (ELP) hydrogels that include a cell-adhesive RGD sequence. Using a cell-compatible, amine-reactive crosslinker, we conducted a one-pot synthesis to simultaneously encapsulate cells while precisely controlling the QK grafting density (10 nM-100 mu M) in the ELP hydrogels without altering other material properties. Fluorescence analysis of fluor-labeled QK peptides demonstrated that the conjugation efficiency to ELP hydrogels was >75% and that covalent immobilization effectively eliminates all QK diffusion. Compared with pristine ELP hydrogels, human umbilical vein endothelial cell (HUVEC) proliferation was significantly enhanced on ELP hydrogels immobilized with 10 nM or 1 mu M QK. Moreover, upon encapsulation within tethered QK-ELP hydrogels, HUVEC spheroids maintained near 100% viability and demonstrated significantly more three-dimensional outgrowth compared to those supplemented with soluble QK peptide at the same concentration. These results encourage the further development of protein-engineered scaffolds decorated with growth-factor-mimetic peptides to provide long-term biological signals using this versatile, single-step synthesis.
C1 [Cai, Lei; Dinh, Cong B.; Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
   [Heilshorn, Sarah C.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.
RP Cai, L (reprint author), Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
EM heilshorn@stanford.edu
FU NSF [DMR-0846363]; NIH [R01-DK085720, DP2-OD006477]; Stanford Vice
   Provost for Undergraduate Education Research Experience for
   Undergraduates (VPUE-REU) Program
FX Cong Dinh acknowledges support from the Stanford Vice Provost for
   Undergraduate Education Research Experience for Undergraduates
   (VPUE-REU) Program. This study was supported by grants from NSF
   (DMR-0846363) and NIH (R01-DK085720, DP2-OD006477). The authors thank
   Karen Dubbin for FRAP method optimization and Kyle Lampe for advice on
   spheroid generation.
CR Amiram M, 2013, J CONTROL RELEASE, V172, P144, DOI 10.1016/j.jconrel.2013.07.021
   Annex BH, 2013, NAT REV CARDIOL, V10, P387, DOI 10.1038/nrcardio.2013.70
   Barker TH, 2011, BIOMATERIALS, V32, P4211, DOI 10.1016/j.biomaterials.2011.02.027
   Boyd L, 2006, EUR SPINE J, V15, P414
   Brey DM, 2008, J BIOMED MATER RES A, V85A, P731, DOI 10.1002/jbm.a.31494
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Cai L., 2014, ACTA BIOMATER, DOI [10.1016/j.actbio.2013.1012.1028, DOI 10.1016/J.ACTBI0.2013.1012.1028]
   Cai L, 2012, BIOMACROMOLECULES, V13, P1663, DOI 10.1021/bm300381d
   Calderon L, 2010, EUR CELLS MATER, V20, P134
   Chan TR, 2011, ADV FUNCT MATER, V21, P4252, DOI 10.1002/adfm.201101163
   Chung C, 2013, BIOMATER SCI-UK, V1, P1082, DOI 10.1039/c3bm60139k
   Chung C, 2012, BIOMACROMOLECULES, V13, P3912, DOI 10.1021/bm3015279
   Chung C, 2012, SOFT MATTER, V8, P10141, DOI 10.1039/c2sm26082d
   D'Andrea LD, 2005, P NATL ACAD SCI USA, V102, P14215, DOI 10.1073/pnas.0505047102
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   DiMarco RL, 2012, ADV MATER, V24, P3923, DOI 10.1002/adma.201200051
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   Eppler SM, 2002, CLIN PHARMACOL THER, V72, P20, DOI 10.1067/mcp.2002.126179
   Finetti F, 2012, BIOCHEM PHARMACOL, V84, P303, DOI 10.1016/j.bcp.2012.04.011
   Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Jonsson P, 2008, BIOPHYS J, V95, P5334, DOI 10.1529/biophysj.108.134874
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Koepsel JT, 2012, INTEGR BIOL-UK, V4, P914, DOI 10.1039/c2ib20055d
   Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033
   Lampe KJ, 2012, NEUROSCI LETT, V519, P138, DOI 10.1016/j.neulet.2012.01.042
   Lee JS, 2010, ADV MATER, V22, P5494, DOI 10.1002/adma.201002970
   Leslie-Barbick JE, 2011, BIOMATERIALS, V32, P5782, DOI 10.1016/j.biomaterials.2011.04.060
   Levy-Mishali M, 2009, TISSUE ENG PT A, V15, P935, DOI 10.1089/ten.tea.2008.0111
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Moktan S, 2012, MOL CANCER THER, V11, P1547, DOI 10.1158/1535-7163.MCT-11-0998
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574
   Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   Santulli G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-41
   Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Shu JY, 2013, ANNU REV PHYS CHEM, V64, P631, DOI 10.1146/annurev-physchem-040412-110108
   Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Vulic K., 2011, J AM CHEM SOC, V134, P882
   Wang XT, 2012, TISSUE ENG PART B-RE, V18, P396, DOI 10.1089/ten.teb.2012.0011
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 49
TC 34
Z9 34
U1 3
U2 66
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 5
BP 757
EP 765
DI 10.1039/c3bm60293a
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA AD9IW
UT WOS:000333579600017
PM 24729868
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Draman, SFS
   Daik, R
   Latif, FA
   El-Sheikh, SM
AF Draman, Sarifah Fauziah Syed
   Daik, Rusli
   Latif, Famiza Abdul
   El-Sheikh, Said M.
TI Characterization and Thermal Decomposition Kinetics of Kapok (Ceiba
   pentandra L.)-Based Cellulose
SO BIORESOURCES
LA English
DT Article
DE Biodegradable; Biomaterial; Renewable; Kapok cellulose
ID PENTANDRA L. GAERTN.; THERMOGRAVIMETRIC ANALYSIS; ACTIVATION-ENERGY;
   FIBERS; DEGRADATION; EXTRACTION; SISAL; BIOCOMPOSITES; NANOCRYSTALS;
   COMPOSITES
AB Interest in using kapok (Ceiba pentandra L.)-based cellulose in composite preparation is growing due to its advantages, including cost-effectiveness, light weight, non-toxicity, and biodegradability. In this study, chloroform, sodium chlorite, and sodium hydroxide were used for wax removal, delignification, and hemicellulose removal, respectively. It was observed that the air entrapment inside kapok fiber disappeared after it was treated with alkali. The structure became completely flattened and similar to a flat ribbon-like shape when examined using a vapour pressure scanning electron microscope (VPSEM). Fourier transform infrared (FTIR) spectroscopy was used to characterize the untreated and treated kapok fibers. The peak at 898 cm(-1), which is attributed to the glucose ring stretching in cellulose, was observed for the obtained cellulose samples. Peaks corresponding to lignin (1505 and 1597 cm(-1)) and hemicellulose (1737 and 1248 cm(-1)) disappeared. The results of differential scanning colorimetry (DSC) indicated that the degradation of cellulose appeared as an exothermic peak at about 300 to 350 degrees C. The activation energy for thermal decomposition of kapok cellulose and its hemicelluloses was 185 kJ/mol and 110 kJ/mol, respectively. The activation energy for thermal decomposition can be used as an alternative approach to determine the purity of cellulose.
C1 [Draman, Sarifah Fauziah Syed] Univ Teknol MARA Terengganu, Fac Sci Appl, Dungun 23000, Terengganu, Malaysia.
   [Daik, Rusli] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Chem Sci & Food Technol, Bangi 43600, Selangor, Malaysia.
   [Latif, Famiza Abdul] Univ Teknol MARA Malaysia, Fac Sci Appl, Shah Alam 40450, Selangor, Malaysia.
   [El-Sheikh, Said M.] Cent Met Res & Dev Inst, Nanostruct Mat & Nanotechnol Div, Cairo 11421, Egypt.
RP Daik, R (reprint author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Chem Sci & Food Technol, Bangi 43600, Selangor, Malaysia.
EM rusli@ukm.my
RI El-Sheikh, Said/S-5877-2016
OI El-Sheikh, Said/0000-0002-2570-8326
FU Universiti Teknologi MARA; Ministry of Higher Education Malaysia;
   Universiti Kebangsaan Malaysia
FX The authors would like to acknowledge the Universiti Teknologi MARA and
   Ministry of Higher Education Malaysia for a scholarship. We would also
   like to express our gratitude to Universiti Kebangsaan Malaysia for
   providing the laboratory facilities, and for technical and financial
   support given throughout the research work.
CR Abdullah MA, 2010, J HAZARD MATER, V177, P683, DOI 10.1016/j.jhazmat.2009.12.085
   Alvarez VA, 2004, POLYM DEGRAD STABIL, V84, P13, DOI 10.1016/j.polvmdegradstab.2003.09.003
   Bindu S. P., 2011, IND ENG CHEM RES, V50, P871
   Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5
   BONO A, 2009, ADV NATURAL APPL SCI, V3, P5
   Cabrales L, 2010, J THERM ANAL CALORIM, V102, P485, DOI 10.1007/s10973-010-0911-9
   Carrier M, 2011, BIOMASS BIOENERG, V35, P298, DOI 10.1016/j.biombioe.2010.08.067
   de la Motte H, 2011, CARBOHYD POLYM, V85, P738, DOI 10.1016/j.carbpol.2011.03.038
   Frone AN, 2011, UNIV POLITEH BUCHAR, V73, P133
   Ge DT, 2010, ELECTROCHEM COMMUN, V12, P1367, DOI 10.1016/j.elecom.2010.07.022
   Gronli MG, 2002, IND ENG CHEM RES, V41, P4201, DOI 10.1021/ie0201157
   Guimaraes JL, 2009, IND CROP PROD, V30, P407, DOI 10.1016/j.indcrop.2009.07.013
   Hori K, 2000, J WOOD SCI, V46, P401, DOI 10.1007/BF00776404
   Huijbrechts AAML, 2007, J POLYM SCI POL CHEM, V45, P2734, DOI 10.1002/pola.22029
   Johar N, 2012, IND CROP PROD, V37, P93, DOI 10.1016/j.indcrop.2011.12.016
   John MJ, 2008, CARBOHYD POLYM, V71, P343, DOI 10.1016/j.carbpol.2007.05.040
   Kim WI, 2000, J IND ENG CHEM, V6, P348
   Mahadeva S. K., 2010, SENS ACTUATOR A, V165, P194
   Moran JI, 2008, CELLULOSE, V15, P149, DOI 10.1007/s10570-007-9145-9
   Muraleedharan K, 2011, J THERM ANAL CALORIM, V103, P943, DOI 10.1007/s10973-010-1162-5
   Mwaikambo LY, 2002, J APPL POLYM SCI, V84, P2222, DOI 10.1002/app.10460
   Nazir MS, 2013, BIORESOURCES, V8, P2161
   Nilsson T, 2008, INT BIODETER BIODEGR, V61, P11, DOI 10.1016/j.ibiod.2007.06.009
   Panwar NL, 2011, RENEW SUST ENERG REV, V15, P1513, DOI 10.1016/j.rser.2010.11.037
   Pirani S., 2012, CARBOHYD POLYM, V93, P357
   Rahmah AU, 2011, DESALINATION, V266, P51, DOI 10.1016/j.desal.2010.08.001
   Reddy N, 2009, BIORESOURCE TECHNOL, V100, P3563, DOI 10.1016/j.biortech.2009.02.047
   Rengasamy RS, 2011, J HAZARD MATER, V186, P526, DOI 10.1016/j.jhazmat.2010.11.031
   Rosa MF, 2010, CARBOHYD POLYM, V81, P83, DOI 10.1016/j.carbpol.2010.01.059
   Rosli NA, 2013, BIORESOURCES, V8, P1893
   Sanchez-Jimenez PE, 2011, CELLULOSE, V18, P1487, DOI 10.1007/s10570-011-9602-3
   SOARES S, 1995, POLYM DEGRAD STABIL, V49, P275, DOI 10.1016/0141-3910(95)87009-1
   Sun JX, 2004, POLYM DEGRAD STABIL, V84, P331, DOI 10.1016/S0141-3910(04)00045-X
   Trindade WG, 2005, BIOMACROMOLECULES, V6, P2485, DOI 10.1021/bm058006+
   Varhegyi G, 2011, ENERG FUEL, V25, P24, DOI 10.1021/ef101079r
   Walia YK, 2009, INT J THEOR APPL SCI, V1, P15
   Yao F, 2008, POLYM DEGRAD STABIL, V93, P90, DOI 10.1016/j.polymdegradstab.2007.10.012
NR 37
TC 18
Z9 18
U1 2
U2 16
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2014
VL 9
IS 1
BP 8
EP 23
PG 16
WC Materials Science, Paper & Wood
SC Materials Science
GA AB7UO
UT WOS:000331996500003
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Wasik, AM
   Grabarek, J
   Pantovic, A
   Cieslar-Pobuda, A
   Asgari, HR
   Bundgaard-Nielsen, C
   Rafat, M
   Dixon, IMC
   Ghavami, S
   Los, MJ
AF Wasik, Agata M.
   Grabarek, Jerzy
   Pantovic, Aleksandar
   Cieslar-Pobuda, Artur
   Asgari, Hamid R.
   Bundgaard-Nielsen, Caspar
   Rafat, Mehrdad
   Dixon, Ian M. C.
   Ghavami, Saeid
   Los, Marek J.
BE Jeon, KW
TI Reprogramming and Carcinogenesis-Parallels and Distinctions
SO INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 308
SE International Review of Cell and Molecular Biology
LA English
DT Review; Book Chapter
ID PLURIPOTENT STEM-CELLS; TUMOR-INITIATING CELLS; BREAST-CANCER;
   SELF-RENEWAL; DNA-DAMAGE; MOUSE FIBROBLASTS; IPS CELLS; C-MYC;
   EXPRESSION SIGNATURE; REGULATES AUTOPHAGY
AB Rapid progress made in various areas of regenerative medicine in recent years occurred both at the cellular level, with the Nobel prize-winning discovery of reprogramming (generation of induced pluripotent stem (iPS) cells) and also at the biomaterial level. The use of four transcription factors, Oct3/4, Sox2, c-Myc, and Klf4 (called commonly "Yamanaka factors") for the conversion of differentiated cells, back to the pluripotent/embryonic stage, has opened virtually endless and ethically acceptable source of stem cells for medical use. Various types of stem cells are becoming increasingly popular as starting components for the development of replacement tissues, or artificial organs. Interestingly, many of the transcription factors, key to the maintenance of stemness phenotype in various cells, are also overexpressed in cancer (stem) cells, and some of them may find the use as prognostic factors. In this review, we describe various methods of iPS creation, followed by overview of factors known to interfere with the efficiency of reprogramming. Next, we discuss similarities between cancer stem cells and various stem cell types. Final paragraphs are dedicated to interaction of biomaterials with tissues, various adverse reactions generated as a result of such interactions, and measures available, that allow for mitigation of such negative effects.
C1 [Wasik, Agata M.] Karolinska Inst, Div Pathol, Dept Lab Med, Karolinska Univ Hosp, Stockholm, Sweden.
   [Grabarek, Jerzy; Los, Marek J.] Pomeranian Med Univ, Dept Pathol, Szczecin, Poland.
   [Pantovic, Aleksandar] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Belgrade, Serbia.
   [Pantovic, Aleksandar] Mil Med Acad, Neurol Clin, Belgrade 11002, Serbia.
   [Cieslar-Pobuda, Artur; Bundgaard-Nielsen, Caspar; Rafat, Mehrdad; Los, Marek J.] Linkoping Univ, Dept Clin & Expt Med IKE, Div Cell Biol, Linkoping, Sweden.
   [Cieslar-Pobuda, Artur; Bundgaard-Nielsen, Caspar; Rafat, Mehrdad; Los, Marek J.] Linkoping Univ, Integrat Regenerat Med Ctr IGEN, Linkoping, Sweden.
   [Cieslar-Pobuda, Artur] Silesian Tech Univ, Inst Automat Control, Biosyst Grp, Gliwice, Poland.
   [Asgari, Hamid R.] Univ Tehran Med Sci, Tehran, Iran.
   [Bundgaard-Nielsen, Caspar] Aalborg Univ, Lab Stem Cell Res, Aalborg, Denmark.
   [Dixon, Ian M. C.; Ghavami, Saeid] Univ Manitoba, Dept Physiol, St Boniface Res Ctr, Winnipeg, MB, Canada.
   [Dixon, Ian M. C.; Ghavami, Saeid] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB, Canada.
   [Rafat, Mehrdad] Linkoping Univ, Dept Biomed Engn IMT, Linkoping, Sweden.
   [Los, Marek J.] BioApplicat Enterprises, Winnipeg, MB, Canada.
RP Los, MJ (reprint author), Pomeranian Med Univ, Dept Pathol, Szczecin, Poland.
EM marek.los@liu.se
RI Grabarek, Jerzy/A-9631-2015; Ghavami, Saeid/Q-8918-2016
OI Dixon, Ian/0000-0002-3763-5961; Los, Marek/0000-0001-9518-1411
CR Abounit Kadija, 2012, World J Biol Chem, V3, P1, DOI 10.4331/wjbc.v3.i1.1
   Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307
   Auernheimer J, 2005, CHEMBIOCHEM, V6, P2034, DOI 10.1002/cbic.200500031
   Bae D, 2012, STEM CELLS DEV, V21, P1344, DOI 10.1089/scd.2011.0225
   Banito A, 2010, EMBO REP, V11, P353, DOI 10.1038/embor.2010.47
   Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609
   Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236
   Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465
   Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405
   Beier D, 2008, BRAIN PATHOL, V18, P370, DOI 10.1111/j.1750-3639.2008.00130.x
   Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127
   Binyamin Gary, 2006, Semin Pediatr Surg, V15, P276, DOI 10.1053/j.sempedsurg.2006.07.007
   Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741
   Booth HAF, 2004, GENOMICS, V84, P229, DOI 10.1016/j.ygeno.2004.02.014
   BRAND KG, 1994, J BIOMATER APPL, V8, P325
   Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657
   Cao DF, 2011, MODERN PATHOL, V24, P288, DOI 10.1038/modpathol.2010.195
   CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701
   Chappell J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-63
   Chen SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036784
   Chen TT, 2011, AGING CELL, V10, P908, DOI 10.1111/j.1474-9726.2011.00722.x
   Chen YJ, 2008, CANCER BIOL THER, V7, P777, DOI 10.4161/cbt.7.5.5768
   Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404
   Chylicki K, 2000, CELL GROWTH DIFFER, V11, P561
   Cobaleda C, 2010, METHODS MOL BIOL, V636, P233, DOI 10.1007/978-1-60761-691-7_15
   de Cremoux P, 1999, J NATL CANCER I, V91, P641, DOI 10.1093/jnci/91.7.641
   Denishefsky I., 1967, CANCER RES, V27, P833
   Dickinson LE, 2011, MACROMOL BIOSCI, V11, P36, DOI 10.1002/mabi.201000245
   Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471
   Eberhard D, 2010, CELL TISSUE RES, V342, P31, DOI 10.1007/s00441-010-1028-y
   Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821
   Eshghi S., 2008, STEM BOOK INTERNET, P1
   Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001
   Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x
   FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168
   FEINSTEIN E, 1992, ONCOGENE, V7, P1853
   Feng C, 2012, CELL CYCLE, V11, P2486, DOI 10.4161/cc.20893
   Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321
   Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925
   Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348
   Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364
   Ghavami S, 2012, BBA-MOL CELL RES, V1823, P2274, DOI 10.1016/j.bbamcr.2012.09.008
   Ghavami S, 2012, AM J PHYSIOL-LUNG C, V302, pL420, DOI 10.1152/ajplung.00312.2011
   Ghavami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016523
   Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129
   Ghule PN, 2011, J CELL PHYSIOL, V226, P1149, DOI 10.1002/jcp.22440
   Girouard SD, 2012, LAB INVEST, V92, P362, DOI 10.1038/labinvest.2011.188
   Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006
   Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805
   Guo XP, 2013, CLIN EXP MED, V13, P99, DOI 10.1007/s10238-012-0187-4
   Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x
   Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427
   Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200
   Hanley J, 2010, BRIT J HAEMATOL, V151, P16, DOI 10.1111/j.1365-2141.2010.08296.x
   Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592
   Harper LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-166
   Hauff K, 2005, ARCH IMMUNOL THER EX, V53, P308
   Hellebrekers DMEI, 2007, BBA-REV CANCER, V1775, P76, DOI 10.1016/j.bbcan.2006.07.003
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014
   Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370
   Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235
   Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI [10.1002/jcb.21912, 10.1002/jcb21912]
   Hu XW, 2012, CELL CYCLE, V11, P2691, DOI 10.4161/cc.21021
   Huang PZ, 2011, CLIN BIOCHEM, V44, P582, DOI 10.1016/j.clinbiochem.2011.02.012
   Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001
   Jangamreddy JR, 2013, BBA-MOL CELL RES, V1833, P2057, DOI 10.1016/j.bbamcr.2013.04.011
   Jangamreddy JR, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6159
   Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29
   Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/nmeth.1426, 10.1038/NMETH.1426]
   Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822
   Jia XP, 2011, J MOL CELL BIOL, V3, P230, DOI 10.1093/jmcb/mjr002
   Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526
   Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864
   Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191
   Karimi-Busheri F, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2583
   Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311
   Kharas MG, 2007, BLOOD, V109, P747, DOI 10.1182/blood-2006-03-011106
   Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005
   Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436
   Kochhar R, 2005, BREAST J, V11, P367, DOI 10.1111/j.1075-122X.2005.00031.x
   Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105
   Lafontan M, 2008, INT J OBESITY, V32, pS39, DOI 10.1038/ijo.2008.237
   Lee Y, 2013, J CELL BIOCHEM, V114, P79, DOI 10.1002/jcb.24303
   Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019
   Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42
   Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290
   Li WL, 2009, STEM CELLS, V27, P2992, DOI 10.1002/stem.240
   Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589
   Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015
   Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287
   Matsuoka J, 2012, J SURG RES, V174, P130, DOI 10.1016/j.jss.2010.11.903
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   Menendez JA, 2011, CELL CYCLE, V10, P3658, DOI 10.4161/cc.10.21.18128
   Menendez S, 2010, CELL CYCLE, V9, P3887, DOI 10.4161/cc.9.19.13301
   Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056
   Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102
   Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554
   Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108
   Moawad AR, 2011, CELL REPROGRAM, V13, P289, DOI 10.1089/cell.2010.0089
   Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410
   Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145
   Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832
   Nagata T, 2012, BREAST CANC
   Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374
   Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107
   Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708
   Neumann J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-518
   Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016
   Oliver L, 2012, STEM CELLS DEV, V21, P2779, DOI 10.1089/scd.2012.0124
   Parry MC, 2010, BIOMATERIALS, V31, P4477, DOI 10.1016/j.biomaterials.2010.02.038
   Patel M, 2010, STEM CELL REV REP, V6, P367, DOI 10.1007/s12015-010-9123-8
   Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Plews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014397
   Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404
   Raisanen L, 2000, J BIOMED MATER RES, V49, P79
   Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009
   Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167
   Ribatti D, 2012, CANCER LETT, V321, P13, DOI 10.1016/j.canlet.2012.02.024
   Rius M, 2012, ONCOGENE, V31, P4257, DOI 10.1038/onc.2011.601
   Rotter D, 2012, PHARMACOL RES, V66, P494, DOI 10.1016/j.phrs.2012.10.001
   Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314
   Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sabisz M, 2009, CELL CYCLE, V8, P3208, DOI 10.4161/cc.8.19.9758
   Saigusa S, 2009, ANN SURG ONCOL, V16, P3488, DOI 10.1245/s10434-009-0617-z
   Salemi S, 2012, CELL RES, V22, P432, DOI 10.1038/cr.2011.200
   Sato H, 2006, BIOCHEM BIOPH RES CO, V342, P107, DOI 10.1016/j.bbrc.2006.01.116
   Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033
   Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745
   Singh J, 1998, ONCOL REP, V5, P1307
   Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004
   Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075
   Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001
   Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910
   Stolzenburg S, 2012, NUCLEIC ACIDS RES, V40, P6725, DOI 10.1093/nar/gks360
   Suhr Steven T, 2010, PLoS One, V5, pe14095, DOI 10.1371/journal.pone.0014095
   Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469
   Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x
   Tsaousi A, 2010, MUTAT RES-GEN TOX EN, V697, P1, DOI 10.1016/j.mrgentox.2010.01.012
   Uchino K, 2012, EXP CELL RES, V318, P1799, DOI 10.1016/j.yexcr.2012.04.011
   Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8
   van den Berg A, 2008, BBA-GENE REGUL MECH, V1779, P668, DOI 10.1016/j.bbagrm.2008.07.005
   van Tuyn J, 2007, FASEB J, V21, P3369, DOI 10.1096/fj.07-8211com
   Vazquez P, 2012, AUTOPHAGY, V8, P187, DOI 10.4161/auto.8.2.18535
   Vessoni AT, 2012, STEM CELLS DEV, V21, P513, DOI 10.1089/scd.2011.0526
   Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797
   Vincent FC, 2011, HEPAT MON, V11, P331
   Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040
   Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392
   Wang X, 2012, CANCER INVEST, V30, P79, DOI 10.3109/07357907.2011.630049
   Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012
   Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6
   Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001
   West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210
   Wiechec E, 2013, CELL ONCOL, V36, P113, DOI 10.1007/s13402-012-0117-1
   Wiechec E, 2011, EXPERT REV MOL DIAGN, V11, P445, DOI [10.1586/erm.11.21, 10.1586/ERM.11.21]
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
   Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863
   Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034
   Yang SB, 2012, ONCOL REP, V28, P186, DOI 10.3892/or.2012.1765
   Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001
   Yoshimori Tamotsu, 2004, Tanpakushitsu Kakusan Koso, V49, P1029
   Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482
   Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137
   Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x
   Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353
   Zhang N, 2012, INT J ONCOL, V40, P2038, DOI 10.3892/ijo.2012.1395
   Zhang Q, 2012, STEM CELLS DEV, V21, P1321, DOI 10.1089/scd.2011.0684
   Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200
   Zhao MZ, 2012, J PROTEOMICS, V75, P3560, DOI 10.1016/j.jprot.2012.03.033
   Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443
   Zhou L, 2007, LARYNGOSCOPE, V117, P455, DOI 10.1097/01.mlg.0000251586.15299.35
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
NR 185
TC 27
Z9 27
U1 1
U2 18
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1937-6448
BN 978-0-12-800097-7
J9 INT REV CEL MOL BIO
JI Int. Rev. Cell Mol. Biol.
PY 2014
VL 308
BP 167
EP 203
DI 10.1016/B978-0-12-800097-7.00005-1
PG 37
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA BA2GS
UT WOS:000333378100005
PM 24411172
DA 2018-10-20
ER

PT J
AU Hryniewicz, T
   Rokosz, K
AF Hryniewicz, Tadeusz
   Rokosz, Krzysztof
TI Corrosion resistance of magnetoelectropolished AISI 316L SS biomaterial
SO ANTI-CORROSION METHODS AND MATERIALS
LA English
DT Article
DE Corrosion; Surface preparation; Medical; Materials; Pitting
ID STAINLESS-STEEL SURFACE; TITANIUM BIOMATERIAL; MAGNETIC-FIELD; XPS; SIMS
AB Purpose - Corrosion resistance measurements were performed on AISI 316L stainless steel biomaterial samples after three types of treatments: abrasive finishing (MP), standard electropolishing (EP), and magnetoelectropolishing (MEP). The corrosion studies were carried out in Ringer's solution at a room temperature. Potentiodynamic plots obtained were the basis for the analysis of measurement accuracy and uncertainty with the statistical tests results done in Statistica 64/10 software. The results of corrosion studies indicate a significant difference in the breaking potential (Epit) values, dependent on surface treatment. The highest mean values have been obtained on samples after MEP (Epit = 961 mV), much lower after a standard electropolishing EP (Epit = 525 mV), and the lowest - after the abrasive treatment MP (Epit = 222 mV), all of them measured against a saturated calomel electrode SCE potential. The corrosion results obtained are well correlated with the nanoindentation measurement results (Young's modulus and nanohardness). The paper aims to discuss these issues.
   Design/methodology/approach - The AISI 316L austenitic stainless steel samples served for the study. There were 11 (MP) and 14 (EP) samples used for each of the treatment, and 31 samples used for magnetoelectropolishing MEP. All polarization measurements were made after one hour immersion in the Ringer's solution. Statistical tests were used to treat the results obtained.
   Findings - After magnetoelectropolishing MEP130, the pitting corrosion resistance is much better than that after abrasive polishing MP and/or a standard electropolishing EP130. It was proved on a big statistical sample that the pitting corrosion potential Epit after MEP130 is over 1.8 times higher than that after EP130 and over 4.3 times higher than that after MP The results obtained are in good agreement with the nanoindentation measurement results.
   Originality/value - This is an original study of the corrosion resistance of AISI 316L SS in Ringer's solution. The breaking potential Eb obtained is comparable with that of NiTi alloys, not reported anywhere before. The results have been well confirmed statistically (on 31 samples after MEP).
C1 [Hryniewicz, Tadeusz; Rokosz, Krzysztof] Koszalin Univ Technol, Surface Electrochem Div, Koszalin, Poland.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Surface Electrochem Div, Koszalin, Poland.
EM Tadeusz.Hryniewicz@tu.koszalin.pl
CR [Anonymous], 2009, G6186 ASTM, P8
   ARENDALSKI J, 2006, UNCERTAINTY MEASUREM
   ASM International, 1990, METALS HDB, V1
   de Assis KS, 2012, CORROS SCI, V59, P71, DOI 10.1016/j.corsci.2012.02.014
   Finsgar M, 2013, CORROS SCI, V68, P51, DOI 10.1016/j.corsci.2012.10.032
   Hryniewicz T, 2008, CORROS SCI, V50, P2676, DOI 10.1016/j.corsci.2008.06.048
   Hryniewicz T, 2008, CORROSION, V64, P660, DOI 10.5006/1.3279927
   Hryniewicz T, 2008, MATER LETT, V62, P3073, DOI 10.1016/j.matlet.2008.01.130
   Hryniewicz T, 2007, T I MET FINISH, V85, P325, DOI 10.1179/174591907X246537
   Hryniewicz T, 2012, APPL SURF SCI, V263, P357, DOI 10.1016/j.apsusc.2012.09.060
   Hryniewicz Tadeusz, 2011, Pomiary Automatyka Kontrola, V57, P609
   HRYNIEWICZ T, 1994, SURF COAT TECH, V64, P75, DOI 10.1016/S0257-8972(09)90006-8
   Hryniewicz T, 2010, MATER CHEM PHYS, V123, P47, DOI 10.1016/j.matchemphys.2010.03.060
   Hryniewicz T, 2010, SURF COAT TECH, V204, P2583, DOI 10.1016/j.surfcoat.2010.02.005
   Hryniewicz Tadeusz, 2009, Pomiary Automatyka Kontrola, V55, P247
   Hryniewicz T, 2009, SURF COAT TECH, V203, P1508, DOI 10.1016/j.surfcoat.2008.11.028
   HRYNIEWICZ T, 2014, BIOMATERIALS SCI ENG, P227
   HRYNIEWICZ T, 2012, WORLD J ENG
   HRYNIEWICZ T, 2010, THEORETICAL BASICS P, P112
   Hryniewicz T., 2009, MAT RES SOC S P E, V1244E, P21, DOI DOI 10.1557/PROC-1244-3
   Hryniewicz T, 2013, APPL SURF SCI, V265, P931, DOI 10.1016/j.apsusc.2012.11.104
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Hryniewicz T, 2012, SURF COAT TECH, V206, P4027, DOI 10.1016/j.surfcoat.2012.03.083
   Hryniewicz T, 2011, SURF COAT TECH, V205, P4228, DOI 10.1016/j.surfcoat.2011.03.024
   Hryniewicz T, 2010, MATER CHEM PHYS, V122, P169, DOI 10.1016/j.matchemphys.2010.02.055
   Hryniewicz T, 2009, MATERIALS, V2, P129, DOI 10.3390/ma2010129
   Kerber SJ, 2000, ADV MATER PROCESS, V158, P33
   Kusnerova M, 2013, MEAS SCI REV, V13, P1, DOI 10.2478/msr-2013-0007
   Lee JB, 2010, MATER CHEM PHYS, V122, P194, DOI 10.1016/j.matchemphys.2010.02.033
   LISOWSKI M, 2011, UNCERTAINTY MEASUREM, pCH7
   Mudali UK, 2002, CORROS SCI, V44, P2183, DOI 10.1016/S0010-938X(02)00035-5
   PAREDES EC, 2007, CORROS SCI, V58, P52
   Peguet L, 2007, CORROS SCI, V49, P1933, DOI 10.1016/j.corsci.2006.08.021
   Praisarnti C, 2010, J ENDODONT, V36, P1354, DOI 10.1016/j.joen.2010.02.025
   Rokicki R, 2008, T I MET FINISH, V86, P280, DOI 10.1179/174591908X345040
   Rokicki R, 2012, T I MET FINISH, V90, P188, DOI 10.1179/0020296712Z.00000000031
   Rokicki R., 2008, MED DEVICE DIAGN IND, V30, P102
   Rokicki R., 2009, US Patent, Patent No. 7632390
   Rokicki R, 2012, J MATER SCI-MATER M, V23, P2127, DOI 10.1007/s10856-012-4696-1
   Rokosz Krzysztof, 2012, Pomiary Automatyka Kontrola, V58, P460
   Rokosz K., 2011, OCHRONA PRZED KOROZJ, V54, P487
   ROKOSZ K, 2012, ELECTROCHEMICAL POLI, P211
   ROKOSZ K, 2010, CORROSION J SCI ENG, V66
   Rokosz K, 2012, STEEL RES INT, V83, P910, DOI 10.1002/srin.201200046
   Shih CC, 2004, CORROS SCI, V46, P427, DOI 10.1016/S0010-938X(03)00148-3
   STATSOFT INC, 2011, STATISTICA DAT AN SO
   SUEPTITZ R, 2013, MATER CORROS, V63, P9999
NR 47
TC 18
Z9 18
U1 2
U2 25
PU EMERALD GROUP PUBLISHING LIMITED
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0003-5599
EI 1758-4221
J9 ANTI-CORROS METHOD M
JI Anti-Corros. Methods Mater.
PY 2014
VL 61
IS 2
BP 57
EP 64
DI 10.1108/ACMM-03-2013-1249
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA AC2TM
UT WOS:000332356900001
DA 2018-10-20
ER

PT J
AU Kamba, AS
   Zakaria, ZA
AF Kamba, Abdullahi Shafiu
   Zakaria, Zuki Abu Bakar
TI Osteoblasts Growth Behaviour on Bio-Based Calcium Carbonate Aragonite
   Nanocrystal
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID NATURAL CORAL; IN-VIVO; CELLS; SUBSTITUTION; BIOMATERIAL; IMPLANTS;
   TISSUE; BONE
AB Calcium carbonate (CaCO3) nanocrystals derived from cockle shells emerge to present a good concert in bone tissue engineering because of their potential to mimic the composition, structure, and properties of native bone. The aim of this study was to evaluate the biological response of CaCO3 nanocrystals on hFOB 1.19 and MC3T3 E-1 osteoblast cells in vitro. Cell viability and proliferation were assessed by MTT and BrdU assays, and LDH was measured to determine the effect of CaCO3 nanocrystals on cell membrane integrity. Cellular morphology was examined by SEM and fluorescence microscopy. The results showed that CaCO3 nanocrystals had no toxic effects to some extent. Cell proliferation, alkaline phosphatase activity, and protein synthesis were enhanced by the nanocrystals when compared to the control. Cellular interactions were improved, as indicated by SEM and fluorescent microscopy. The production of VEGF and TGF-1 was also affected by the CaCO3 nanocrystals. Therefore, bio-based CaCO3 nanocrystals were shown to stimulate osteoblast differentiation and improve the osteointegration process.
C1 [Kamba, Abdullahi Shafiu; Zakaria, Zuki Abu Bakar] Univ Putra Malaysia, Inst Biosci, Lab Mol Biomed, Serdang 43400, Selangor, Malaysia.
   [Zakaria, Zuki Abu Bakar] Univ Putra Malaysia, Fac Vet Med, Serdang 43400, Selangor, Malaysia.
RP Zakaria, ZA (reprint author), Univ Putra Malaysia, Inst Biosci, Lab Mol Biomed, Serdang 43400, Selangor, Malaysia.
EM mdzukiabubakar@gmail.com
CR Awang-Hazmi AJ, 2007, J ANIM VET ADV, V6, P591
   Chen J.-C., 2013, J NANOMATER, V2013
   Choi SJ, 2009, J INORG BIOCHEM, V103, P463, DOI 10.1016/j.jinorgbio.2008.12.017
   Deckers GH, 2000, J STEROID BIOCHEM, V74, P83, DOI 10.1016/S0960-0760(00)00093-5
   Gopal S. N., 2013, REV NANOMEDICINE, V8, P639
   Hernandez-Ortiz M., 2012, BIOMEDICAL ENG ONLIN, V11
   IRIGARAY JL, 1995, J MATER SCI-MATER M, V6, P230, DOI 10.1007/BF00146861
   Kamba AS, 2013, J NANOMATER, DOI 10.1155/2013/398357
   Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2
   MullerMai C, 1996, J MATER SCI-MATER M, V7, P479, DOI 10.1007/BF00705429
   Nhiem T, 2011, ACTA BIOMATER, V7, P1298, DOI 10.1016/j.actbio.2010.10.004
   Peattie RA, 2004, BIOMATERIALS, V25, P2789, DOI 10.1016/j.biomaterials.2003.09.054
   Rausch-fan XH, 2008, DENT MATER, V24, P102, DOI 10.1016/j.dental.2007.03.001
   Sahari F., 2011, P 3 INT C APPL CREAT
   Samir H., 2013, MAT SCI ENG C, V33, P537
   Sanders JE, 2003, TISSUE ENG, V9, P1271, DOI 10.1089/10763270360728189
   Schlaeppi JM, 1997, ENDOCR RES, V23, P213, DOI 10.3109/07435809709031855
   Tanase CE, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025002
NR 18
TC 4
Z9 4
U1 0
U2 16
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 215097
DI 10.1155/2014/215097
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AC9QV
UT WOS:000332870200001
PM 24734228
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Su, W
   Hagstrom, JA
   Jia, YH
   Lu, YP
   Kong, FX
AF Su Wen
   Hagstrom, Johannes A.
   Jia Yuhong
   Lu Yaping
   Kong Fanxiang
TI Effects of rice straw on the cell viability, photosynthesis, and growth
   of Microcystis aeruginosa
SO CHINESE JOURNAL OF OCEANOLOGY AND LIMNOLOGY
LA English
DT Article
DE esterase activity; membrane potential; Phyto-PAM; rice straw;
   Microcystis; flow cytometry
ID FRESH-WATER ALGAE; FLOW-CYTOMETRY; BARLEY STRAW; MARINE-PHYTOPLANKTON;
   METABOLIC-ACTIVITY; SATIVA HULLS; INHIBITION; TOXICITY; CYANOBACTERIA;
   INFECTION
AB Rice straw is supposed to be an environment-friendly biomaterial for inhibiting the growth of harmful blooms of the cyanobacterium Microcystis aeruginosa. However, its potential mechanism is not well known. To explore this mechanism, the growth, cell viability (esterase activity, membrane potential, and membrane integrity), photosynthesis, and cell size of M. aeruginosa were determined using flow cytometry and Phyto-PAM after exposure to rice straw extracts (RSE). The results show that doses from 2.0 to 10.0 g/L of RSE efficiently inhibited the alga for 15 days, while the physiologic and morphologic responses of the cyanobacteria were time-dependent. RSE interfered with the cell membrane potential, cell size, and in vivo chlorophyll-a fluorescence on the first day. After 7 days of exposure, RSE was transported into the cytosol, which disrupted enzyme activity and photosynthesis. The cyanobacteria then started to repair its physiology (enzyme activity, photosynthesis) and remained viable, suggesting that rice straw act as an algistatic agent.
C1 [Su Wen; Jia Yuhong; Lu Yaping; Kong Fanxiang] Chinese Acad Sci, State Key Lab Lake & Environm Sci, Nanjing Inst Geog & Limnol, Nanjing 210008, Jiangsu, Peoples R China.
   [Su Wen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Hagstrom, Johannes A.] Linnaeus Univ, EEMiS, Sch Nat Sci, S-39182 Kalmar, Sweden.
RP Kong, FX (reprint author), Chinese Acad Sci, State Key Lab Lake & Environm Sci, Nanjing Inst Geog & Limnol, Nanjing 210008, Jiangsu, Peoples R China.
EM fxkong@niglas.ac.cn
FU National Basic Research Program of China (973 Program) [2008CB418002];
   National Major Science and Technology Program for Water Pollution
   Control and Treatment [2012ZX07103-002]; CAS/SAFEA International
   Partnership Program for Creative Research Teams of Chinese Academy of
   Sciences [KZZD-EW-TZ-08-01]; National Natural Science Foundation of
   China [20807043]
FX Supported by the National Basic Research Program of China (973 Program)
   (No. 2008CB418002), the National Major Science and Technology Program
   for Water Pollution Control and Treatment (No. 2012ZX07103-002), the
   CAS/SAFEA International Partnership Program for Creative Research Teams
   of Chinese Academy of Sciences (No. KZZD-EW-TZ-08-01), and the National
   Natural Science Foundation of China (No. 20807043)
CR Amor K. B., 2002, Applied and Environmental Microbiology, V68, P5209
   Anderson D. M., 2000, ESTIMATED ANN EC IMP
   Bailey S, 2004, RES MICROBIOL, V155, P720, DOI 10.1016/j.resmic.2004.06.002
   Brookes JD, 2000, MAR FRESHWATER RES, V51, P817, DOI 10.1071/MF00048
   Choe S, 2002, J IND ENG CHEM, V8, P297
   Chung IM, 2007, PHYTOCHEM ANALYSIS, V18, P133, DOI 10.1002/pca.961
   Daniel ET, 2002, J APPL PHYCOL, V14, P275
   Emily K P, 2008, LIMNOL OCEANOGR, V53, P531
   Feng Jing, 2008, Huanjing Kexue, V29, P3376
   Ferrier MD, 2005, BIORESOURCE TECHNOL, V96, P1788, DOI [10.1016/j.biortech.2005.01.021, 10.1016/j.biotech.2005.01.021]
   GIBSON M T, 1990, Journal of Applied Phycology, V2, P241, DOI 10.1007/BF02179781
   Hagstrom JA, 2010, J AM WATER RESOUR AS, V46, P187, DOI 10.1111/j.1752-1688.2009.00402.x
   Jochem FJ, 1999, MAR BIOL, V135, P721, DOI 10.1007/s002270050673
   Johnson I, 1998, HISTOCHEM J, V30, P123, DOI 10.1023/A:1003287101868
   Juttner F, 2000, ARCH HYDROBIOL, V147, P505
   Lawrence JE, 2006, APPL ENVIRON MICROB, V72, P7829, DOI 10.1128/AEM.01207-06
   Legrand C, 2003, PHYCOLOGIA, V42, P406, DOI 10.2216/i0031-8884-42-4-406.1
   Li FM, 2005, APPL ENVIRON MICROB, V71, P6545, DOI 10.1128/AEM.71.11.6545-6553.2005
   [刘洁生 LIU JieSheng], 2007, [生态学报, Acta Ecologica Sinica], V27, P4498
   Millenium Ecosystem Aseessment, 2005, EC HUM WELL BEING SY, P1
   Monfort P, 1996, J MICROBIOL METH, V25, P79, DOI 10.1016/0167-7012(95)00089-5
   Muller S, 2000, J MICROBIOL METH, V40, P67, DOI 10.1016/S0167-7012(99)00130-X
   Murray D, 2010, ENVIRON TECHNOL, V31, P455, DOI 10.1080/09593331003663294
   NEWMAN JR, 1993, J AQUAT PLANT MANAGE, V31, P203
   Novo DJ, 2000, ANTIMICROB AGENTS CH, V44, P827, DOI 10.1128/AAC.44.4.827-834.2000
   Pan G, 2006, ENVIRON POLLUT, V141, P206, DOI 10.1016/j.envpol.2005.08.047
   Park MH, 2006, LETT APPL MICROBIOL, V43, P307, DOI 10.1111/j.1472-765X.2006.01951.x
   Park MH, 2009, B ENVIRON CONTAM TOX, V83, P97, DOI 10.1007/s00128-009-9732-6
   Park MH, 2009, AQUAT BOT, V90, P309, DOI 10.1016/j.aquabot.2008.11.007
   Penyige A, 2002, BIOCHEM BIOPH RES CO, V290, P1169, DOI 10.1006/bbrc.2001.6317
   Prado R, 2009, ENVIRON INT, V35, P240, DOI 10.1016/j.envint.2008.06.012
   RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1
   Schenk M, 2011, LWT-FOOD SCI TECHNOL, V44, P191, DOI 10.1016/j.lwt.2010.05.012
   Shapiro HM, 2000, METHODS, V21, P271, DOI 10.1006/meth.2000.1007
   Street M., 1978, GAME CONSERV ANN REV, V10, P56
   Suggett D J, 2010, CHLOROPHYLL FLUORESC, P427
   THOMPSON PA, 1991, J PHYCOL, V27, P351, DOI 10.1111/j.0022-3646.1991.00351.x
   Tiffany L, 2004, CURR OPIN PLANT BIOL, V7, P472
   Ueckert J, 1995, INT J FOOD MICROBIOL, V28, P317, DOI 10.1016/0168-1605(95)00066-6
   Veldhuis MJW, 2000, SCI MAR, V64, P121, DOI 10.3989/scimar.2000.64n2121
   Vives-Rego J, 2000, FEMS MICROBIOL REV, V24, P429, DOI 10.1111/j.1574-6976.2000.tb00549.x
   Xiao X, 2010, CHEMOSPHERE, V81, P1118, DOI 10.1016/j.chemosphere.2010.09.001
   Yu JQ, 1997, J CHEM ECOL, V23, P817, DOI 10.1023/B:JOEC.0000006413.98507.55
   Yu Y, 2007, ECOTOX ENVIRON SAFE, V66, P49, DOI 10.1016/j.ecoenv.2005.10.014
   Zhang M, 2007, INT REV HYDROBIOL, V92, P281, DOI 10.1002/iroh.200610927
   Zhang M, 2007, WORLD J MICROB BIOT, V23, P663, DOI 10.1007/s11274-006-9280-8
NR 46
TC 6
Z9 9
U1 1
U2 34
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING, 100717, PEOPLES R CHINA
SN 0254-4059
EI 1993-5005
J9 CHIN J OCEANOL LIMN
JI Chin. J. Oceanol. Limnol.
PD JAN
PY 2014
VL 32
IS 1
BP 120
EP 129
DI 10.1007/s00343-014-3063-0
PG 10
WC Limnology; Oceanography
SC Marine & Freshwater Biology; Oceanography
GA AB7XD
UT WOS:000332003500014
DA 2018-10-20
ER

PT J
AU Cazon, JP
   Viera, M
   Sala, S
   Donati, E
AF Plaza Cazon, J.
   Viera, M.
   Sala, S.
   Donati, E.
TI Biochemical characterization of Macrocystis pyrifera and Undaria
   pinnatifida (Phaeophyceae) in relation to their potentiality as
   biosorbents
SO PHYCOLOGIA
LA English
DT Article
DE Biochemical characterization; Biosorption; Macrocystis pyrifera; Undaria
   pinnatifida; Zinc
ID HEAVY-METAL IONS; BROWN-ALGAE; AQUEOUS-SOLUTION; BIOSORPTION;
   EXTRACTION; BIOMASS; EQUILIBRIUM; GREEN; RED; CADMIUM(II)
AB Undaria pinnatifida and Macrocystis pyrifera from Patagonia were characterized in terms of the alginate, protein, total carbohydrate and organic matter content, cation exchange capacity and acid-base properties to assess the suitability of both species as potential biosorbents of metals. Environmental scanning electron microscopy equipped with an energy dispersive X-ray microanalysis system, Fourier transform infrared spectroscopy (FT-IR) and Brunauer, Emmett and Teller surface area analysis were also applied for characterization. The results showed that U. pinnatifida had a higher percentage of organic matter, alginate and protein and a larger specific surface area than M. pyrifera, although the latter exhibited a higher ionic exchange capacity. The groups with a weak acid behaviour represented 84% and 97% of the total acid groups in M. pyrifera and U. pinnatifida, respectively. FT-IR analysis confirmed the presence of different chemical groups such as sulphonate in both biomaterial M. pyrifera and U. pinnatifida. Besides, Zn(II) adsorption capacity was different among different parts of the thallus of each species. The difference founded in the physicochemical properties of both algae could affect their biosorption capacities.
C1 [Plaza Cazon, J.; Viera, M.; Donati, E.] UNLP, Fac Ciencias Exactas, Ctr Invest & Desarrollo Fermentac Ind, RA-1900 La Plata, Buenos Aires, Argentina.
   [Sala, S.] Fac Ciencias Nat & Museo, Div Cient Ficol, RA-1900 La Plata, Buenos Aires, Argentina.
RP Viera, M (reprint author), Ctr Invest Tecnol Pinturas, La Plata, Buenos Aires, Argentina.
EM marisa.rviera@gmail.com
RI Donati, Edgardo/I-8241-2017
OI Donati, Edgardo/0000-0002-3534-2938
CR Ahmady-Asbchin S, 2008, BIORESOURCE TECHNOL, V99, P6150, DOI 10.1016/j.biortech.2007.12.040
   Andrade LR, 2004, J STRUCT BIOL, V145, P216, DOI 10.1016/j.jsb.2003.11.011
   ANDRIAMANANTOANINA A., 2010, CARBOHYD POLYM, V82, P555
   [Anonymous], 2005, J APPL PHYCOLOGY, V17, P447
   ARVIZUHIGUERA DL, 1995, CIENC MAR, V21, P25, DOI 10.7773/cm.v21i1.983
   Boraso A., 2012, ATLAS SENSIBILIDAD A
   Bulgariu D, 2012, BIORESOURCE TECHNOL, V103, P489, DOI 10.1016/j.biortech.2011.10.016
   Cazon JPH, 2012, ENG LIFE SCI, V12, P95, DOI 10.1002/elsc.201100098
   Chapman VJ, 1980, SEAWEEDS THEIR USES
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   de Aragao BJG, 2008, J BRAZIL CHEM SOC, V19, P1582, DOI 10.1590/S0103-50532008000800019
   Dellatorre F.G., 2012, ALGA EXOTICA UNDARIA
   EYRAS M. C., COMPOST SCI UTILIZAT, V6, P74
   Ghasemi M, 2011, J HAZARD MATER, V189, P141, DOI 10.1016/j.jhazmat.2011.02.011
   Graham L. E., 2000, ALGAE
   Hawari AH, 2006, BIORESOURCE TECHNOL, V97, P692, DOI 10.1016/j.biortech.2005.03.033
   Hernandez-Carmona G, 1999, J APPL PHYCOL, V11, P493, DOI 10.1023/A:1008114709681
   Ibrahim WM, 2011, J HAZARD MATER, V192, P1827, DOI 10.1016/j.jhazmat.2011.07.019
   Larsen B, 2003, CARBOHYD RES, V338, P2325, DOI 10.1016/S0008-6215(03)00378-1
   Luna AS, 2010, BIORESOURCE TECHNOL, V101, P5104, DOI 10.1016/j.biortech.2010.01.138
   Montazer-Rahmati MM, 2011, J HAZARD MATER, V185, P401, DOI 10.1016/j.jhazmat.2010.09.047
   Murphy V, 2008, CHEMOSPHERE, V70, P1128, DOI 10.1016/j.chemosphere.2007.08.015
   Norton L, 2004, ADV ENVIRON RES, V8, P629, DOI 10.1016/S1093-0191(03)00035-2
   Oliveira RC, 2011, PROCESS BIOCHEM, V46, P736, DOI 10.1016/j.procbio.2010.11.021
   ORHAN Y., ENG LIFE SCI, V6, P399
   Pan JH, 2006, COLLOID SURFACE B, V52, P89, DOI 10.1016/j.colsurfb.2006.05.016
   Panikkar R, 1996, CARBOHYD RES, V293, P119, DOI 10.1016/0008-6215(96)00193-0
   Pavasant P, 2006, BIORESOURCE TECHNOL, V97, P2321, DOI 10.1016/j.biortech.2005.10.032
   Romera E, 2006, CRIT REV BIOTECHNOL, V26, P223, DOI 10.1080/07388550600972153
   SAGREDO M.C., 2007, CIENCIA AHORA, V20, P46
   SANTOS AFONSO M., 2010, COLLOID SURFACE B, V81, P620
   Stengel DB, 2011, BIOTECHNOL ADV, V29, P483, DOI 10.1016/j.biotechadv.2011.05.016
   Svecova L, 2006, SEP PURIF TECHNOL, V52, P142, DOI 10.1016/j.seppur.2006.03.024
   Vauchel P, 2009, BIORESOURCE TECHNOL, V100, P1291, DOI 10.1016/j.biortech.2008.03.005
   VILAR V. J. P., 2012, CHEM ENG J, V200-202, P140
   Volesky B., 2003, SORPTION BIOSORPTION
   Volesky Bohumil, 1990, BIOSORPTION HEAVY ME
NR 37
TC 4
Z9 4
U1 0
U2 16
PU INT PHYCOLOGICAL SOC
PI LAWRENCE
PA NEW BUSINESS OFFICE, PO BOX 1897, LAWRENCE, KS 66044-8897 USA
SN 0031-8884
J9 PHYCOLOGIA
JI Phycologia
PD JAN
PY 2014
VL 53
IS 1
BP 100
EP 108
DI 10.2216/12-106.1
PG 9
WC Plant Sciences; Marine & Freshwater Biology
SC Plant Sciences; Marine & Freshwater Biology
GA AD2WY
UT WOS:000333098400011
DA 2018-10-20
ER

PT J
AU Horak, M
   Handl, M
   Podskubka, A
   Kana, R
   Adler, J
   Povysil, C
AF Horak, M.
   Handl, M.
   Podskubka, A.
   Kana, R.
   Adler, J.
   Povysil, C.
TI Comparison of the Cellular Composition of Two Different
   Chondrocyte-Seeded Biomaterials and the Results of Their Transplantation
   in Humans
SO FOLIA BIOLOGICA
LA English
DT Article
ID BOVINE ARTICULAR CHONDROCYTES; CARTILAGE DEFECTS; SUB-POPULATIONS;
   MATRIX; SCAFFOLDS; KNEE; IMPLANTATION; EXPRESSION; CELLS
AB Our study compares the histological and immunohistochemical cellular composition of two different chondrocyte-seeded biomaterials and the results of their transplantation. Our study cohort included 21 patients, comprising 19 men and two women with a mean age of 32 years, who were affected by single chondral lesions of the femoral condyles. These patients were enrolled in our study and treated with arthroscopic implantation of the tissue Hyalograft C and/or Brno culture. Brno culture bioengineered with a fibrin-based scaffold contains round cells showing features of differentiated chondrocytes expressing S-100 protein and a-smooth muscle actin. In contrast, in the case of Hyalograft C, the scaffold was made up of a fibrillar network composed of biomaterial fibres of the esters of hyaluronic acid and cells resembling fibroblasts and myofibroblasts and expressing only a-smooth muscle actin. The average size of the defects was 2.5 cm(2). Patients were evaluated using the standardized guidelines of the International Knee Documentation Committee. During the comparison of bioptic samples obtained from both patient cohorts, we did not observe any important differences in the histological makeup of the newly formed cartilage. This was predominantly composed of hyaline cartilage with small areas of fibrocartilage. The histological analysis of these two groups of homogeneous patients shows that this bioengineered approach, under proper indications, may offer favourable and stable clinical results over time, in spite of the different matrix and cellular composition of the two transplants used.
C1 [Horak, M.] Homolka Hosp, Dept Radiol, Prague 15000 5, Czech Republic.
   [Handl, M.] Univ Hosp Motol, Dept Orthoped, Prague, Czech Republic.
   [Podskubka, A.] Teaching Hosp Na Bulovce, Dept Orthoped, Prague, Czech Republic.
   [Kana, R.] Gen Univ Hosp, Dept Otorhinolaryngol, Prague, Czech Republic.
   [Adler, J.] Univ Hosp Bohunice, Tissue Bank, Brno, Czech Republic.
   [Povysil, C.] Charles Univ Prague, Inst Pathol, Fac Med 1, Prague, Czech Republic.
   [Povysil, C.] Gen Univ Hosp, Prague, Czech Republic.
RP Horak, M (reprint author), Homolka Hosp, Dept Radiol, Roentgenova 2, Prague 15000 5, Czech Republic.
EM martin.horak@homolka.cz
RI Povysil, Ctibor/H-7976-2017; Podskubka, Ales/J-3993-2017
OI Povysil, Ctibor/0000-0002-8457-0953; Podskubka, Ales/0000-0003-2154-0471
FU  [PRVOUK- P27/LF1/1]
FX This work was supported by grant PRVOUK- P27/LF1/1.
CR AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P223, DOI 10.3109/03008208809016809
   AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P205, DOI 10.3109/03008208809016808
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brun P, 1999, J BIOMED MATER RES, V46, P337, DOI 10.1002/(SICI)1097-4636(19990905)46:3<337::AID-JBM5>3.3.CO;2-H
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021
   Coates EE, 2010, ANN BIOMED ENG, V38, P3371, DOI 10.1007/s10439-010-0096-1
   Filardo G, 2011, AM J SPORT MED, V39, P2153, DOI 10.1177/0363546511415658
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   Girotto D, 2003, BIOMATERIALS, V24, P3265, DOI 10.1016/S0142-9612(03)00160-1
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   Hollander A. P., 2006, TISSUE ENG, V12, P1778
   HOLLANDER AP, 2003, TISSUE ENG CART BONE, V249, P218
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Lee CR, 2003, J ORTHOPAED RES, V21, P272, DOI 10.1016/S0736-0266(02)00153-5
   Magnussen RA, 2008, CLIN ORTHOP RELAT R, V466, P952, DOI 10.1007/s11999-007-0097-z
   Mainil-Varlet P., 2002, EUR CELL MAT S1, V4, P44
   Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038
   Podskubka A, 2006, Acta Chir Orthop Traumatol Cech, V73, P251
   Povysil C, 1997, HUM PATHOL, V28, P316, DOI 10.1016/S0046-8177(97)90130-1
   Povysil C., 2008, PATHOL RES PRACT, V204, P885
   Tognana E, 2007, CELLS TISSUES ORGANS, V186, P97, DOI 10.1159/000102539
   Wang Q, 2000, WOUND REPAIR REGEN, V8, P145, DOI 10.1046/j.1524-475x.2000.00145.x
NR 23
TC 2
Z9 2
U1 0
U2 7
PU CHARLES UNIV PRAGUE, FIRST FACULTY MEDICINE
PI PRAGUE 6
PA FLEMINGOVO NAM. 2, PRAGUE 6 166 37, CZECH REPUBLIC
SN 0015-5500
J9 FOLIA BIOL-PRAGUE
JI Folia Biol.-Prague
PY 2014
VL 60
IS 1
BP 1
EP 9
PG 9
WC Biochemistry & Molecular Biology; Biology; Oncology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Oncology; Cell Biology
GA AB9VI
UT WOS:000332143400001
PM 24594051
DA 2018-10-20
ER

EF